# RGD-PIPELINE: ftp-file-extracts # MODULE: annotations-version-1.1.9 (Oct 10, 2019) # GENERATED-ON: 2024/11/16 # PURPOSE: annotations about active Rat objects extracted from RGD database # ONTOLOGY: MP: Mammalian Phenotype # CONTACT: rgd.data@mcw.edu # FORMAT: tab delimited text # NOTES: multiple values in a single column are separated by '|' # #COLUMN INFORMATION: # #1 RGD_ID unique RGD_ID of the annotated object #2 OBJECT_SYMBOL official symbol of the annotated object #3 OBJECT_NAME official name of the annotated object #4 OBJECT_TYPE annotated object data type: one of ['gene','qtl','strain'] #5 TERM_ACC_ID ontology term accession id #6 TERM_NAME ontology term name #7 QUALIFIER optional qualifier #8 EVIDENCE evidence #9 WITH with info #10 ASPECT aspect #11 REFERENCES db references (Reference RGDID|PUBMED ID) #12 CREATED_DATE created date #13 ASSIGNED_BY assigned by #14 MESH_OMIM_ID MESH:xxx or OMIM:xxx id corresponding to RDO:xxx id found in TERM_ACC_ID column (RGD/CTD Disease Ontology annotations only) #15 CURATION_NOTES curation notes provided by RGD curators #16 ORIGINAL_REFERENCE original reference RGD_ID OBJECT_SYMBOL OBJECT_NAME OBJECT_TYPE TERM_ACC_ID TERM_NAME QUALIFIER EVIDENCE WITH ASPECT REFERENCES CREATED_DATE ASSIGNED_BY MESH_OMIM_ID CURATION_NOTES ORIGINAL_REFERENCE 10000 ACI/N A X C 9935, Irish strain MP:0004348 long femur IAGP N RGD:6480192|PMID:21334473 20200414 RGD compared to female F344/NHsd 10000 ACI/N A X C 9935, Irish strain MP:0010123 increased bone mineral content IAGP N RGD:6480192|PMID:21334473 20200414 RGD compared to F344/NHsd female 10002743 DA.E3-(D20Rat42-D20Rat49)/Rhd strain MP:0002936 joint swelling severity IAGP XCO:0000265,XCO:0000281 N RGD:737659|PMID:8972741 20200814 RGD compared to LEW.1AV1/Kini 10002743 DA.E3-(D20Rat42-D20Rat49)/Rhd strain MP:0002936 joint swelling susceptibility IAGP XCO:0000265 N RGD:737659|PMID:8972741 20200814 RGD 10002745 DA.E3-(D20Rat47-AA858870)/Rhd strain MP:0001973 increased thermal nociceptive threshold IAGP N RGD:10002747|PMID:20471989 20201005 RGD 10002745 DA.E3-(D20Rat47-AA858870)/Rhd strain MP:0020955 increased mechanical nociceptive threshold IAGP N RGD:10002747|PMID:20471989 20150423 RGD 10002755 Sbf1m1Ipcv SET binding factor 1; mutation 1, Institute of Physiology, Czechoslovac Academy of Sciences gene MP:0001925 male infertility IAGP N RGD:38549340|PMID:27335132 20201210 RGD 10002755 Sbf1m1Ipcv SET binding factor 1; mutation 1, Institute of Physiology, Czechoslovac Academy of Sciences gene MP:0004852 decreased testis weight IAGP N RGD:38549340|PMID:27335132 20201210 RGD 10002755 Sbf1m1Ipcv SET binding factor 1; mutation 1, Institute of Physiology, Czechoslovac Academy of Sciences gene MP:0005159 azoospermia IAGP N RGD:38549340|PMID:27335132 20201210 RGD 10002755 Sbf1m1Ipcv SET binding factor 1; mutation 1, Institute of Physiology, Czechoslovac Academy of Sciences gene MP:0008279 arrest of spermiogenesis IAGP N RGD:38549340|PMID:27335132 20201210 RGD 10002782 SHR-Sbf1m1Ipcv strain MP:0001925 male infertility IAGP N RGD:38549340|PMID:27335132 20200827 RGD compared to wild type 10002782 SHR-Sbf1m1Ipcv strain MP:0004852 decreased testis weight IAGP N RGD:38549340|PMID:27335132 20200827 RGD compared to wild type 10002782 SHR-Sbf1m1Ipcv strain MP:0005159 azoospermia IAGP N RGD:38549340|PMID:27335132 20200827 RGD compared to wild type 10002782 SHR-Sbf1m1Ipcv strain MP:0008279 arrest of spermiogenesis IAGP N RGD:38549340|PMID:27335132 20200827 RGD compared to wild type control 10003 BBDR/Rhw strain MP:0001846 increased inflammatory response induced IAGP XCO:0000281 N RGD:61067|PMID:11001927 19990101 RGD compared to BN 10003 BBDR/Rhw strain MP:0004804 decreased susceptibility to autoimmune diabetes IAGP N RGD:2306526|PMID:19351909 20200303 RGD compared to BBDR.BBDP-(D4Rhw11-D4Rhw10)/Rhw 10004 BC/CpbU strain MP:0002666 increased circulating aldosterone level induced IAGP XCO:0000246,XCO:0000025 N RGD:629577|PMID:12482837 19990101 RGD compared to treated LEW/OlaHsd 10004 BC/CpbU strain MP:0005179 decreased circulating cholesterol level induced IAGP XCO:0000246,XCO:0000025 N RGD:629577|PMID:12482837 19990101 RGD compared to control BC/CpbU males 10008 BN/SsNHsd strain MP:0000635 pituitary gland hyperplasia induced IAGP XCO:0000295 N RGD:1300042|PMID:15166088 20200313 RGD 10008 BN/SsNHsd strain MP:0002891 increased insulin sensitivity IAGP N RGD:6893578|PMID:22947656 20200413 RGD 10008 BN/SsNHsd strain MP:0003026 decreased vasoconstriction IAGP N RGD:2316923|PMID:20026763 20201208 RGD compared to SHR/NHsd and congenics 10008 BN/SsNHsd strain MP:0003109 short femur IAGP N RGD:6480192|PMID:21334473 20200414 RGD compared to female ACI/N 10008 BN/SsNHsd strain MP:0008331 increased lactotroph cell number induced IAGP XCO:0000295 N RGD:1300042|PMID:15166088 20200313 RGD 10008 BN/SsNHsd strain MP:0008938 decreased pituitary gland weight IAGP N RGD:1642526|PMID:17876666 20200327 RGD compared to ACI/SegHsd 10008 BN/SsNHsd strain MP:0008938 decreased pituitary gland weight induced IAGP XCO:0000092 N RGD:1642526|PMID:17876666 20200327 RGD compared to treated ACI/SegHsd 10008 BN/SsNHsd strain MP:0008939 increased pituitary gland weight induced IAGP XCO:0000092 N RGD:1642526|PMID:17876666 20200327 RGD compared to BN/SsNHsd 10008 BN/SsNHsd strain MP:0009289 decreased epididymal fat pad weight IAGP N RGD:38548922|PMID:29193816 20200825 RGD compared to BUF/NHsd, ACI, F344/NHsd, WKY/NHsd HS founder strains 10008 BN/SsNHsd strain MP:0009305 decreased retroperitoneal fat pad weight IAGP N RGD:38548922|PMID:29193816 20200825 RGD compared to BUF/NHsd, ACI, F344/NHsd, WKY/NHsd HS founder strains 10008 BN/SsNHsd strain MP:0010124 decreased bone mineral content IAGP N RGD:6480192|PMID:21334473 20200414 RGD compared to female NAft:HS 10008 BN/SsNHsd strain MP:0020330 increased capillary density induced IAGP XCO:0000295 N RGD:1300042|PMID:15166088 20200313 RGD in pituitary gland 10008 BN/SsNHsd strain MP:0030794 broad femur neck IAGP N RGD:6480192|PMID:21334473 20200414 RGD compared to females of BN/SsNHsd, F344/NHsd, WKY/NHsd 10011 COP/OlaHsd strain MP:0002834 decreased heart weight IAGP N RGD:731241|PMID:11015562 19990101 RGD compared to DA/OlaHsd 10011 COP/OlaHsd strain MP:0002843 decreased systemic arterial blood pressure IAGP N RGD:731241|PMID:11015562 20200629 RGD compared to DA/OlaHsd 10011 COP/OlaHsd strain MP:0003061 decreased aerobic running capacity induced IAGP XCO:0000296 N RGD:731241|PMID:11015562 19990101 RGD compared to DA/OlaHsd 10011 COP/OlaHsd strain MP:0008770 decreased survivor rate induced IAGP XCO:0000668 N RGD:2302114|PMID:17998886 20090522 RGD compared to BN/HsdMcwiCrl 10011 COP/OlaHsd strain MP:0009828 increased tumor latency induced IAGP XCO:0000092 N RGD:1358956|PMID:11713205 20200310 RGD compared to ACI/SegHsd 10015 FHH/Eur strain MP:0002833 increased heart weight IAGP N RGD:724742|PMID:8329672 20201012 RGD compared to WAG/OlaHsd 10015 FHH/Eur strain MP:0002962 increased urine protein level IAGP N RGD:724742|PMID:8329672 20120112 RGD compared to WAG/OlaHsd 10015 FHH/Eur strain MP:0005527 increased renal glomerular filtration rate IAGP N RGD:724742|PMID:8329672 19990101 RGD compared to WAG/OlaHsd 10015 FHH/Eur strain MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:724742|PMID:8329672 19990101 RGD compared to FHL/Eur 10016 GH/Omr Genetically Hypertensive strain MP:0001260 increased body weight IAGP N RGD:2301936|PMID:18925692 20191125 RGD 10016 GH/Omr Genetically Hypertensive strain MP:0003211 abnormal aorta elastic fiber morphology severity IAGP N RGD:619605|PMID:11526202 20191125 RGD 10016 GH/Omr Genetically Hypertensive strain MP:0004184 abnormal baroreceptor physiology IAGP N RGD:2301936|PMID:18925692 20191125 RGD 10016 GH/Omr Genetically Hypertensive strain MP:0004875 increased mean systemic arterial blood pressure IAGP N RGD:2301936|PMID:18925692 20081114 RGD 10016 GH/Omr Genetically Hypertensive strain MP:0006143 increased systemic arterial diastolic blood pressure IAGP N RGD:2301936|PMID:18925692 20191125 RGD 10016 GH/Omr Genetically Hypertensive strain MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:2301936|PMID:18925692 20191125 RGD 10017 GK/KyoSwe Goto Kakizaki strain MP:0001260 increased body weight IAGP N RGD:61082|PMID:8528247 20200303 RGD compared to F344/DuCrl 10017 GK/KyoSwe Goto Kakizaki strain MP:0001559 hyperglycemia IAGP N RGD:61082|PMID:8528247 20191126 RGD compared to F344/DuCrl 10017 GK/KyoSwe Goto Kakizaki strain MP:0005293 impaired glucose tolerance IAGP N RGD:61082|PMID:8528247 20200303 RGD compared to F344/DuCrl 10017 GK/KyoSwe Goto Kakizaki strain MP:0020087 increased susceptibility to non-insulin-dependent diabetes IAGP N RGD:61082|PMID:8528247 20200303 RGD compared to F344/DuCrl 10018 IS/Kyo ishibashi rat strain MP:0002966 decreased circulating alkaline phosphatase level IAGP N RGD:1302444|PMID:6951716 19990101 RGD compared to BN, SHR and other inbreds 10021 LH/Mav strain MP:0000182 increased circulating LDL cholesterol level IAGP N RGD:1580389|PMID:8301098 20191203 RGD compared to LN/Mav 10021 LH/Mav strain MP:0001260 increased body weight IAGP N RGD:13513906|PMID:16882881 20200214 RGD compared to LL/Mav 10021 LH/Mav strain MP:0001260 increased body weight IAGP N RGD:1580389|PMID:8301098 19990101 RGD compared to LN/Mav 10021 LH/Mav strain MP:0001260 increased body weight IAGP N RGD:2313340|PMID:19462495 20200207 RGD compared to BN/NHsdMcwi 10021 LH/Mav strain MP:0001548 hyperlipidemia IAGP N RGD:1580389|PMID:8301098 19990101 RGD compared to LN/Mav 10021 LH/Mav strain MP:0001552 increased circulating triglyceride level IAGP N RGD:1580389|PMID:8301098 19990101 RGD compared to LN/Mav 10021 LH/Mav strain MP:0001552 increased circulating triglyceride level IAGP N RGD:2313340|PMID:19462495 20200207 RGD compared to BN/NHsdMcwi 10021 LH/Mav strain MP:0001556 increased circulating HDL cholesterol level IAGP N RGD:1580389|PMID:8301098 20191203 RGD compared to LN/Mav 10021 LH/Mav strain MP:0001559 hyperglycemia induced IAGP XCO:0000103 N RGD:13441562|PMID:18443571 20191126 RGD associated with diabetes mellitus 10021 LH/Mav strain MP:0002079 increased circulating insulin level IAGP N RGD:1580389|PMID:8301098 19990101 RGD compared to LN/Mav 10021 LH/Mav strain MP:0002962 increased urine protein level IAGP N RGD:13441562|PMID:18443571 20200220 RGD compared to LL/Mav 10021 LH/Mav strain MP:0002962 increased urine protein level IAGP N RGD:2313340|PMID:19462495 20200207 RGD compared to BN/NHsdMcwi 10021 LH/Mav strain MP:0002962 increased urine protein level induced IAGP XCO:0000241 N RGD:13441562|PMID:18443571 20200220 RGD associated with diabetes mellitus 10021 LH/Mav strain MP:0003058 increased insulin secretion IAGP N RGD:2313340|PMID:19462495 20200207 RGD compared to BN/NHsdMcwi 10021 LH/Mav strain MP:0003915 increased heart left ventricle weight IAGP N RGD:13513906|PMID:16882881 20200214 RGD compared to LL/Mav 10021 LH/Mav strain MP:0003915 increased heart left ventricle weight IAGP N RGD:2290181|PMID:18285521 20200611 RGD compared to BN/NHsdMcwi 10021 LH/Mav strain MP:0003915 increased heart left ventricle weight IAGP N RGD:2313340|PMID:19462495 20200207 RGD compared to BN/NHsdMcwi 10021 LH/Mav strain MP:0003917 increased kidney weight treatment IAGP XCO:0000588 N RGD:13441562|PMID:18443571 20191126 RGD associated with diabetes mellitus 10021 LH/Mav strain MP:0003980 increased circulating phospholipid level IAGP N RGD:1580389|PMID:8301098 19990101 RGD compared to LN/Mav 10021 LH/Mav strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:2290181|PMID:18285521 20200611 RGD 10021 LH/Mav strain MP:0004875 increased mean systemic arterial blood pressure IAGP N RGD:1580389|PMID:8301098 20191203 RGD compared to LN/Mav 10021 LH/Mav strain MP:0004875 increased mean systemic arterial blood pressure induced IAGP XCO:0000164 N RGD:2313340|PMID:19462495 20200207 RGD compared to BN/NHsdMcwi 10021 LH/Mav strain MP:0005145 increased circulating VLDL cholesterol level IAGP N RGD:1580389|PMID:8301098 20191203 RGD compared to LN/Mav 10021 LH/Mav strain MP:0005178 increased circulating cholesterol level IAGP N RGD:13441562|PMID:18443571 20191126 RGD compared to LL/Mav 10021 LH/Mav strain MP:0005178 increased circulating cholesterol level induced IAGP XCO:0000241 N RGD:13441562|PMID:18443571 20200220 RGD associated with diabetes mellitus 10021 LH/Mav strain MP:0005293 impaired glucose tolerance induced IAGP XCO:0000241 N RGD:13441562|PMID:18443571 20200220 RGD associated with diabetes mellitus 10021 LH/Mav strain MP:0005553 increased circulating creatinine level induced IAGP XCO:0000241 N RGD:13441562|PMID:18443571 20200220 RGD associated with diabetes mellitus 10021 LH/Mav strain MP:0005583 decreased renin activity IAGP N RGD:2313340|PMID:19462495 20200207 RGD compared to BN/NHsdMcwi 10021 LH/Mav strain MP:0006143 increased systemic arterial diastolic blood pressure IAGP N RGD:1580389|PMID:8301098 19990101 RGD compared to LN/Mav 10021 LH/Mav strain MP:0006143 increased systemic arterial diastolic blood pressure IAGP N RGD:61057|PMID:7981757 20191203 RGD compared to LN/Mav 10021 LH/Mav strain MP:0006143 increased systemic arterial diastolic blood pressure IAGP N RGD:61058|PMID:9329963 20191202 RGD compared to LN/Mav 10021 LH/Mav strain MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:13441562|PMID:18443571 20191126 RGD compared to LL/Mav 10021 LH/Mav strain MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:13513906|PMID:16882881 20200214 RGD compared to LL/Mav 10021 LH/Mav strain MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:1580389|PMID:8301098 19990101 RGD compared to LN/Mav 10021 LH/Mav strain MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:2316962|PMID:16928787 20191202 RGD compared to LN/Mav 10021 LH/Mav strain MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:61058|PMID:9329963 20191202 RGD compared to LN/Mav 10021 LH/Mav strain MP:0006144 increased systemic arterial systolic blood pressure induced IAGP XCO:0000241 N RGD:13441562|PMID:18443571 20200220 RGD associated with diabetes mellitus 10021 LH/Mav strain MP:0006316 increased urine sodium level induced IAGP XCO:0000164 N RGD:2313340|PMID:19462495 20200207 RGD compared to BN/NHsdMcwi 10024 M520/N strain MP:0001262 decreased body weight IAGP N RGD:6893578|PMID:22947656 20131021 RGD 10024 M520/N strain MP:0005331 insulin resistance IAGP N RGD:6893578|PMID:22947656 20131021 RGD 10024 M520/N strain MP:0009289 decreased epididymal fat pad weight IAGP N RGD:38548922|PMID:29193816 20200825 RGD compared to BUF/NHsd, ACI, F344/NHsd, WKY/NHsd HS founder strains 10024 M520/N strain MP:0009305 decreased retroperitoneal fat pad weight IAGP N RGD:38548922|PMID:29193816 20200825 RGD compared to BUF/NHsd, ACI, F344/NHsd, WKY/NHsd HS founder strains 10025 MHS/Gib Milan Hypertensive Strain strain MP:0000208 decreased hematocrit IAGP N RGD:126925235|PMID:3611769 20210707 RGD compared to MNS/Gib 10025 MHS/Gib Milan Hypertensive Strain strain MP:0002591 decreased mean corpuscular volume IAGP N RGD:126925235|PMID:3611769 20210707 RGD compared to MNS/Gib 10025 MHS/Gib Milan Hypertensive Strain strain MP:0002591 decreased mean corpuscular volume IAGP N RGD:126925957|PMID:1390856 20210714 RGD compared to MNS/Gib 10025 MHS/Gib Milan Hypertensive Strain strain MP:0002874 decreased hemoglobin content IAGP N RGD:126925235|PMID:3611769 20210707 RGD compared to MNS/Gib 10025 MHS/Gib Milan Hypertensive Strain strain MP:0006143 increased systemic arterial diastolic blood pressure IAGP N RGD:69692|PMID:11082136 19990101 RGD compared to MNS/Gib 10025 MHS/Gib Milan Hypertensive Strain strain MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:69692|PMID:11082136 19990101 RGD compared to MNS/Gib 10025 MHS/Gib Milan Hypertensive Strain strain MP:0010109 abnormal renal sodium reabsorption induces IAGP XCO:0000154 N RGD:126925991|PMID:3759227 20210713 RGD compared to MNS/Gib 10025 MHS/Gib Milan Hypertensive Strain strain MP:0012364 decreased erythrocyte sodium level IAGP N RGD:126925235|PMID:3611769 20210707 RGD compared to MNS/Gib 10025 MHS/Gib Milan Hypertensive Strain strain MP:0012364 decreased erythrocyte sodium level IAGP N RGD:126925957|PMID:1390856 20210714 RGD compared to MNS/Gib 10025 MHS/Gib Milan Hypertensive Strain strain MP:0012377 decreased erythrocyte potassium ion content IAGP N RGD:126925957|PMID:1390856 20210714 RGD compared to MNS/Gib 10028 MNS/Gib Milan Normotensive Strain strain MP:0003917 increased kidney weight IAGP N RGD:127284836|PMID:2838080 20210822 RGD 10028 MNS/Gib Milan Normotensive Strain strain MP:0010111 abnormal renal calcium reabsorption IAGP N RGD:127284836|PMID:2838080 20210822 RGD 10040 SR/Jr Salt Resistant strain MP:0001263 weight loss induced IAGP XCO:0000022 N RGD:61040|PMID:9685318 19990101 RGD 8%NaCl diet 10041 SS/Jr Salt Sensitive strain MP:0000274 enlarged heart IAGP N RGD:619631|PMID:10051321 19990101 RGD 10041 SS/Jr Salt Sensitive strain MP:0001260 increased body weight IAGP N RGD:619631|PMID:10051321 19990101 RGD 10041 SS/Jr Salt Sensitive strain MP:0001260 increased body weight IAGP N RGD:634617|PMID:12707388 19990101 RGD compared to SHR/NHsd 10041 SS/Jr Salt Sensitive strain MP:0002625 heart left ventricle hypertrophy induced IAGP XCO:0000022 N RGD:2301185|PMID:18806617 20100611 RGD 10041 SS/Jr Salt Sensitive strain MP:0002625 heart left ventricle hypertrophy induced IAGP XCO:0000022 N RGD:7421631|PMID:19461651 20201215 RGD compared to C2S.M21 10041 SS/Jr Salt Sensitive strain MP:0002626 increased heart rate induced IAGP XCO:0000022 N RGD:2301185|PMID:18806617 20191205 RGD compared to LEW 10041 SS/Jr Salt Sensitive strain MP:0002962 increased urine protein level IAGP N RGD:634617|PMID:12707388 20120112 RGD compared to SHR/NHsd 10041 SS/Jr Salt Sensitive strain MP:0004084 abnormal cardiac muscle relaxation induced IAGP XCO:0000022 N RGD:2301185|PMID:18806617 20191205 RGD 10041 SS/Jr Salt Sensitive strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:2301185|PMID:18806617 20191205 RGD 10041 SS/Jr Salt Sensitive strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:619649|PMID:11875185 20200109 RGD compared to SS.LEW-(D5Rat130-D5Mco10)/Jr; MMO:0000031 10041 SS/Jr Salt Sensitive strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:69710|PMID:9383281 19990101 RGD 10041 SS/Jr Salt Sensitive strain MP:0004217 salt-sensitive hypertension susceptibility IAGP N RGD:8657072|PMID:21602714 20210108 RGD compared to congenics with Lewis alleles 10041 SS/Jr Salt Sensitive strain MP:0005599 increased cardiac muscle contractility induced IAGP XCO:0000022 N RGD:2301185|PMID:18806617 20191205 RGD compared to LEW 10041 SS/Jr Salt Sensitive strain MP:0006144 increased systemic arterial systolic blood pressure induced IAGP XCO:0000022 N RGD:61516|PMID:11015598 19990101 RGD compared to SHR/NHsd strain 10043120 BBDP.ACI-(D2Mit8-D2Rat69)/Sunn strain MP:0001823 thymus hypoplasia IAGP N RGD:10043114|PMID:24920533 20200302 RGD compared to BBDP/WorSunn 10043120 BBDP.ACI-(D2Mit8-D2Rat69)/Sunn strain MP:0002492 decreased IgE level IAGP N RGD:10043114|PMID:24920533 20200302 RGD compared to BBDP/WorSunn 10043120 BBDP.ACI-(D2Mit8-D2Rat69)/Sunn strain MP:0005425 increased macrophage cell number IAGP N RGD:10043114|PMID:24920533 20200302 RGD compared to ACI.BBDP-(RT1u)(Gimap5)/Sunn, spleen 10043122 BBDP.ACI-(D2Mit8-D2Arb16)(D2Rat354-D2Rat69)/Sunn strain MP:0000708 thymus hyperplasia IAGP N RGD:10043114|PMID:24920533 20200302 RGD compared to ACI.BBDP-(RT1u)(Gimap5)/Sunn 10043122 BBDP.ACI-(D2Mit8-D2Arb16)(D2Rat354-D2Rat69)/Sunn strain MP:0002492 decreased IgE level IAGP N RGD:10043114|PMID:24920533 20200302 RGD compared to BBDP/WorSunn 10043122 BBDP.ACI-(D2Mit8-D2Arb16)(D2Rat354-D2Rat69)/Sunn strain MP:0005425 increased macrophage cell number IAGP N RGD:10043114|PMID:24920533 20200302 RGD compared to ACI.BBDP-(RT1u)(Gimap5)/Sunn, spleen 10043122 BBDP.ACI-(D2Mit8-D2Arb16)(D2Rat354-D2Rat69)/Sunn strain MP:0010168 increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number IAGP N RGD:10043114|PMID:24920533 20200302 RGD compared to BBDP/WorSunn 10043124 BBDP.ACI-(D2Mit8-D2Arb16)/Sunn strain MP:0000708 thymus hyperplasia IAGP N RGD:10043114|PMID:24920533 20200302 RGD compared to ACI.BBDP-(RT1u)(Gimap5)/Sunn 10043124 BBDP.ACI-(D2Mit8-D2Arb16)/Sunn strain MP:0002492 decreased IgE level IAGP N RGD:10043114|PMID:24920533 20200302 RGD compared to BBDP/WorSunn 10043124 BBDP.ACI-(D2Mit8-D2Arb16)/Sunn strain MP:0003884 decreased macrophage cell number IAGP N RGD:10043114|PMID:24920533 20200302 RGD compared to BBDP/WorSunn, spleen 10043124 BBDP.ACI-(D2Mit8-D2Arb16)/Sunn strain MP:0004804 decreased susceptibility to autoimmune diabetes IAGP N RGD:10043114|PMID:24920533 20200302 RGD compared to BBDP/WorSunn 10043127 BBDP.ACI-(D2Mit8-D2Rat354)/Sunn strain MP:0000708 thymus hyperplasia IAGP N RGD:10043114|PMID:24920533 20200302 RGD compared to ACI.BBDP-(RT1u)(Gimap5)/Sunn 10043127 BBDP.ACI-(D2Mit8-D2Rat354)/Sunn strain MP:0002492 decreased IgE level IAGP N RGD:10043114|PMID:24920533 20200302 RGD compared to BBDP/WorSunn 10043127 BBDP.ACI-(D2Mit8-D2Rat354)/Sunn strain MP:0003884 decreased macrophage cell number IAGP N RGD:10043114|PMID:24920533 20200302 RGD compared to BBDP/WorSunn, spleen 10043127 BBDP.ACI-(D2Mit8-D2Rat354)/Sunn strain MP:0004804 decreased susceptibility to autoimmune diabetes IAGP N RGD:10043114|PMID:24920533 20200302 RGD compared to BBDP/WorSunn 10043127 BBDP.ACI-(D2Mit8-D2Rat354)/Sunn strain MP:0010169 decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number IAGP N RGD:10043114|PMID:24920533 20200302 RGD compared to BBDP/WorSunn 10043129 BBDP.ACI-(D2Arb16-D2Rat63)/Sunn strain MP:0001823 thymus hypoplasia IAGP N RGD:10043114|PMID:24920533 20200302 RGD compared to BBDP/WorSunn 10043129 BBDP.ACI-(D2Arb16-D2Rat63)/Sunn strain MP:0002492 decreased IgE level IAGP N RGD:10043114|PMID:24920533 20200302 RGD compared to BBDP/WorSunn 10043129 BBDP.ACI-(D2Arb16-D2Rat63)/Sunn strain MP:0004804 decreased susceptibility to autoimmune diabetes IAGP N RGD:10043114|PMID:24920533 20200302 RGD compared to BBDP/WorSunn 10043129 BBDP.ACI-(D2Arb16-D2Rat63)/Sunn strain MP:0005425 increased macrophage cell number IAGP N RGD:10043114|PMID:24920533 20200302 RGD compared to ACI.BBDP-(RT1u)(Gimap5)/Sunn, spleen 10043129 BBDP.ACI-(D2Arb16-D2Rat63)/Sunn strain MP:0010169 decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number IAGP N RGD:10043114|PMID:24920533 20200302 RGD compared to BBDP/WorSunn 10043132 BBDP.ACI-(D2Rat50-D2Rat63)/Sunn strain MP:0000708 thymus hyperplasia IAGP N RGD:10043114|PMID:24920533 20200302 RGD compared to ACI.BBDP-(RT1u)(Gimap5)/Sunn 10043132 BBDP.ACI-(D2Rat50-D2Rat63)/Sunn strain MP:0002492 decreased IgE level IAGP N RGD:10043114|PMID:24920533 20200302 RGD compared to BBDP/WorSunn 10043132 BBDP.ACI-(D2Rat50-D2Rat63)/Sunn strain MP:0005425 increased macrophage cell number IAGP N RGD:10043114|PMID:24920533 20200302 RGD compared to ACI.BBDP-(RT1u)(Gimap5)/Sunn, spleen 10043136 Iddm54 Insulin dependent diabetes mellitus QTL 54 qtl MP:0001759 increased urine glucose level susceptibility IAGP N RGD:10043114|PMID:24920533 20150617 RGD 10043136 Iddm54 Insulin dependent diabetes mellitus QTL 54 qtl MP:0005559 increased circulating glucose level susceptibility IAGP N RGD:10043114|PMID:24920533 20161102 RGD 10043139 Iddm55 Insulin dependent diabetes mellitus QTL 55 qtl MP:0001759 increased urine glucose level susceptibility IAGP N RGD:10043114|PMID:24920533 20150617 RGD 10043139 Iddm55 Insulin dependent diabetes mellitus QTL 55 qtl MP:0005559 increased circulating glucose level susceptibility IAGP N RGD:10043114|PMID:24920533 20161102 RGD 10045545 CDS/Sasz Cohen diabetic-sensitive rat strain MP:0001559 hyperglycemia IAGP XCO:0000014 N RGD:1342468|PMID:11679430 20200205 RGD compared to CDr/Sasz; sexual dimorphism 10045545 CDS/Sasz Cohen diabetic-sensitive rat strain MP:0002079 increased circulating insulin level IAGP XCO:0000014 N RGD:1342468|PMID:11679430 20200205 RGD compared to CDr/Sasz; sexual dimorphism 10045545 CDS/Sasz Cohen diabetic-sensitive rat strain MP:0003564 abnormal insulin secretion IAGP XCO:0000014 N RGD:1342468|PMID:11679430 20200205 RGD compared to CDr/Sasz; sexual dimorphism 10045545 CDS/Sasz Cohen diabetic-sensitive rat strain MP:0005293 impaired glucose tolerance IAGP XCO:0000014 N RGD:1342468|PMID:11679430 20200205 RGD compared to CDr/Sasz; sexual dimorphism 10045592 Dmdem1Kykn dystrophin; CRISPR/Cas9 system induced mutant 1, Keitaro Yamanouchi gene MP:0000749 muscle degeneration IMP N RGD:11040981|PMID:25005781 20170501 RGD 10045592 Dmdem1Kykn dystrophin; CRISPR/Cas9 system induced mutant 1, Keitaro Yamanouchi gene MP:0001262 decreased body weight IMP N RGD:11040981|PMID:25005781 20170502 RGD 10045592 Dmdem1Kykn dystrophin; CRISPR/Cas9 system induced mutant 1, Keitaro Yamanouchi gene MP:0002833 increased heart weight IMP N RGD:11040981|PMID:25005781 20170502 RGD 10045592 Dmdem1Kykn dystrophin; CRISPR/Cas9 system induced mutant 1, Keitaro Yamanouchi gene MP:0009402 decreased skeletal muscle fiber diameter IMP N RGD:11040981|PMID:25005781 20170502 RGD 10045592 Dmdem1Kykn dystrophin; CRISPR/Cas9 system induced mutant 1, Keitaro Yamanouchi gene MP:0009404 centrally nucleated skeletal muscle fibers IMP N RGD:11040981|PMID:25005781 20170501 RGD 10045592 Dmdem1Kykn dystrophin; CRISPR/Cas9 system induced mutant 1, Keitaro Yamanouchi gene MP:0009427 increased tibialis anterior weight IMP N RGD:11040981|PMID:25005781 20170502 RGD 10045592 Dmdem1Kykn dystrophin; CRISPR/Cas9 system induced mutant 1, Keitaro Yamanouchi gene MP:0020280 increased creatine kinase level IMP N RGD:11040981|PMID:25005781 20170502 RGD 10045593 W-Dmdem1Kykn strain MP:0000749 muscle degeneration IMP N RGD:11040981|PMID:25005781 20170501 RGD 10045593 W-Dmdem1Kykn strain MP:0001262 decreased body weight IMP N RGD:11040981|PMID:25005781 20170502 RGD 10045593 W-Dmdem1Kykn strain MP:0002833 increased heart weight IMP N RGD:11040981|PMID:25005781 20170502 RGD 10045593 W-Dmdem1Kykn strain MP:0009402 decreased skeletal muscle fiber diameter IMP N RGD:11040981|PMID:25005781 20170502 RGD 10045593 W-Dmdem1Kykn strain MP:0009404 centrally nucleated skeletal muscle fibers IMP N RGD:11040981|PMID:25005781 20170501 RGD 10045593 W-Dmdem1Kykn strain MP:0009427 increased tibialis anterior weight IMP N RGD:11040981|PMID:25005781 20170502 RGD 10045593 W-Dmdem1Kykn strain MP:0020280 increased creatine kinase level IMP N RGD:11040981|PMID:25005781 20170502 RGD 10045594 Nfe2l2em1Kyo nuclear factor, erythroid 2-like 2; zinc finger nuclease induced mutant 1, Kyoto University gene MP:0000601 small liver IMP N RGD:12910550|PMID:27071940 20170620 RGD 10045594 Nfe2l2em1Kyo nuclear factor, erythroid 2-like 2; zinc finger nuclease induced mutant 1, Kyoto University gene MP:0009766 increased susceptibility to xenobiotic induced morbidity/mortality IMP CHEBI:2504 N RGD:12910550|PMID:27071940 20201210 RGD 10045594 Nfe2l2em1Kyo nuclear factor, erythroid 2-like 2; zinc finger nuclease induced mutant 1, Kyoto University gene MP:0010096 abnormal incisor color IMP N RGD:12910550|PMID:27071940 20170620 RGD 10045597 F344-Nfe2l2em1Kyo strain MP:0000601 small liver IMP N RGD:12910550|PMID:27071940 20170620 RGD 10045597 F344-Nfe2l2em1Kyo strain MP:0009766 increased susceptibility to xenobiotic induced morbidity/mortality IMP CHEBI:2504 N RGD:12910550|PMID:27071940 20190226 RGD 10045597 F344-Nfe2l2em1Kyo strain MP:0010096 abnormal incisor color IMP N RGD:12910550|PMID:27071940 20170620 RGD 10045598 Nfe2l2em2Kyo nuclear factor, erythroid 2-like 2; zinc finger nuclease induced mutant 2, Kyoto University gene MP:0000601 small liver IMP N RGD:12910550|PMID:27071940 20170620 RGD 10045598 Nfe2l2em2Kyo nuclear factor, erythroid 2-like 2; zinc finger nuclease induced mutant 2, Kyoto University gene MP:0010096 abnormal incisor color IMP N RGD:12910550|PMID:27071940 20170620 RGD 10045600 F344-Nfe2l2em2Kyo strain MP:0000601 small liver IMP N RGD:12910550|PMID:27071940 20170620 RGD 10045600 F344-Nfe2l2em2Kyo strain MP:0010096 abnormal incisor color IMP N RGD:12910550|PMID:27071940 20170620 RGD 10047391 LE/OrlBarth Long-Evans/Cryptorchid strain MP:0002082 postnatal lethality IAGP N RGD:12911229|PMID:26502805 20180504 RGD 10047391 LE/OrlBarth Long-Evans/Cryptorchid strain MP:0002683 delayed fertility IAGP N RGD:12911229|PMID:26502805 20180504 RGD 10053700 Scort23 Serum corticosterone level QTL 23 qtl MP:0005345 abnormal circulating corticosterone level IDA N RGD:10053640|PMID:21029000 20150811 RGD 10053715 Scort24 Serum corticosterone level QTL 24 qtl MP:0005345 abnormal circulating corticosterone level IDA N RGD:10053640|PMID:21029000 20150811 RGD 10053718 Scort25 Serum corticosterone level QTL 25 qtl MP:0005345 abnormal circulating corticosterone level IDA N RGD:10053640|PMID:21029000 20150811 RGD 10053720 Scort26 Serum corticosterone level QTL 26 qtl MP:0005345 abnormal circulating corticosterone level IDA N RGD:10053640|PMID:21029000 20150811 RGD 10053722 Scort27 Serum corticosterone level QTL 27 qtl MP:0005345 abnormal circulating corticosterone level IDA N RGD:10053640|PMID:21029000 20150811 RGD 10054088 Scort28 Serum corticosterone level QTL 28 qtl MP:0005345 abnormal circulating corticosterone level IDA N RGD:10053640|PMID:21029000 20150811 RGD 10054123 Srcrt6 Stress Responsive Cort QTL 6 qtl MP:0005345 abnormal circulating corticosterone level IDA N RGD:10053640|PMID:21029000 20150811 RGD 10054125 Srcrt7 Stress Responsive Cort QTL 7 qtl MP:0005345 abnormal circulating corticosterone level IDA N RGD:10053640|PMID:21029000 20150811 RGD 10054130 Srcrt8 Stress Responsive Cort QTL 8 qtl MP:0005345 abnormal circulating corticosterone level IDA N RGD:10053640|PMID:21029000 20150811 RGD 10054132 Srcrt9 Stress Responsive Cort QTL 9 qtl MP:0005345 abnormal circulating corticosterone level IDA N RGD:10053640|PMID:21029000 20150811 RGD 10054135 Gmadr2 Adrenal mass QTL 2 qtl MP:0012689 abnormal adrenal gland weight IDA N RGD:10053640|PMID:21029000 20150811 RGD 10054138 Gmadr3 Adrenal mass QTL 3 qtl MP:0012689 abnormal adrenal gland weight IDA N RGD:10053640|PMID:21029000 20150811 RGD 10054141 Gmadr4 Adrenal mass QTL 4 qtl MP:0012689 abnormal adrenal gland weight IDA N RGD:10053640|PMID:21029000 20150811 RGD 10054395 Glaem2Mcwi galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin gene MP:0000414 alopecia IMP N RGD:401976416|PMID:29979634 20240321 RGD 10054395 Glaem2Mcwi galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin gene MP:0000647 abnormal sebaceous gland morphology IMP N RGD:401976416|PMID:29979634 20240321 RGD 10054395 Glaem2Mcwi galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin gene MP:0000937 abnormal motor neuron morphology IMP N RGD:401976419|PMID:34541380 20240229 RGD compared to wild type 10054395 Glaem2Mcwi galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin gene MP:0000965 abnormal sensory neuron morphology IMP N RGD:150429980|PMID:29563343 20211021 RGD compared to wild type 10054395 Glaem2Mcwi galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin gene MP:0000965 abnormal sensory neuron morphology IMP N RGD:401976419|PMID:34541380 20240229 RGD compared to wild type 10054395 Glaem2Mcwi galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin gene MP:0001260 increased body weight IMP N RGD:401976416|PMID:29979634 20240321 RGD compared to Wild type females 10054395 Glaem2Mcwi galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin gene MP:0001262 decreased body weight IMP N RGD:401976416|PMID:29979634 20240321 RGD compared to Wild type males 10054395 Glaem2Mcwi galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin gene MP:0001314 cornea opacity severity IMP N RGD:401976417|PMID:31253878 20240815 RGD compared to wild type 10054395 Glaem2Mcwi galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin gene MP:0001402 decreased locomotor activity sexual_dimorphism IMP N RGD:401976421|PMID:36660199 20240229 RGD compared to wild type female 10054395 Glaem2Mcwi galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin gene MP:0001442 decreased grooming behavior sexual_dimorphism IMP N RGD:401976421|PMID:36660199 20240229 RGD compared to wild type female 10054395 Glaem2Mcwi galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin gene MP:0001759 increased urine glucose level onset IMP N RGD:401976416|PMID:29979634 20240321 RGD compared to Wild type males 10054395 Glaem2Mcwi galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin gene MP:0002413 abnormal megakaryocyte progenitor cell morphology IMP N RGD:401976418|PMID:34320241 20240229 RGD compared to wild type 10054395 Glaem2Mcwi galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin gene MP:0002424 abnormal reticulocyte morphology IMP N RGD:401976418|PMID:34320241 20240229 RGD compared to wild type 10054395 Glaem2Mcwi galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin gene MP:0002591 decreased mean corpuscular volume IMP N RGD:401976418|PMID:34320241 20240229 RGD compared to wild type 10054395 Glaem2Mcwi galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin gene MP:0002738 hyperresponsive to tactile stimuli IMP N RGD:150429980|PMID:29563343 20211021 RGD compared to wild type 10054395 Glaem2Mcwi galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin gene MP:0002840 abnormal lens fiber morphology severity IMP N RGD:401976417|PMID:31253878 20240815 RGD compared to wild type 10054395 Glaem2Mcwi galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin gene MP:0002968 increased circulating alkaline phosphatase level onset IMP N RGD:401976416|PMID:29979634 20240321 RGD compared to Wild type 10054395 Glaem2Mcwi galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin gene MP:0003131 increased erythrocyte cell number IMP N RGD:401976418|PMID:34320241 20240229 RGD compared to wild type 10054395 Glaem2Mcwi galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin gene MP:0003177 allodynia IMP N RGD:150429980|PMID:29563343 20211021 RGD compared to wild type 10054395 Glaem2Mcwi galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin gene MP:0004720 abnormal platelet morphology IMP N RGD:401976418|PMID:34320241 20240229 RGD compared to wild type 10054395 Glaem2Mcwi galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin gene MP:0004756 abnormal proximal convoluted tubule morphology IMP N RGD:401976416|PMID:29979634 20240321 RGD 10054395 Glaem2Mcwi galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin gene MP:0005058 abnormal lysosome morphology IMP N RGD:401976418|PMID:34320241 20240229 RGD compared to wild type 10054395 Glaem2Mcwi galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin gene MP:0005058 abnormal lysosome morphology IMP N RGD:401976419|PMID:34541380 20240229 RGD compared to wild type 10054395 Glaem2Mcwi galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin gene MP:0005059 lysosomal protein accumulation IMP N RGD:401976418|PMID:34320241 20240229 RGD compared to wild type 10054395 Glaem2Mcwi galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin gene MP:0005059 lysosomal protein accumulation IMP N RGD:401976419|PMID:34541380 20240229 RGD compared to wild type 10054395 Glaem2Mcwi galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin gene MP:0005140 decreased cardiac muscle contractility onset IMP N RGD:401976416|PMID:29979634 20240321 RGD compared to Wild type 10054395 Glaem2Mcwi galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin gene MP:0005179 decreased circulating cholesterol level IMP N RGD:401976416|PMID:29979634 20240321 RGD compared to Wild type female 10054395 Glaem2Mcwi galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin gene MP:0005343 increased circulating aspartate transaminase level onset IMP N RGD:401976416|PMID:29979634 20240321 RGD compared to Wild type 10054395 Glaem2Mcwi galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin gene MP:0005419 decreased circulating serum albumin level IMP N RGD:401976416|PMID:29979634 20240321 RGD compared to Wild type 10054395 Glaem2Mcwi galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin gene MP:0005425 increased macrophage cell number IMP N RGD:401976418|PMID:34320241 20240229 RGD compared to wild type 10054395 Glaem2Mcwi galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin gene MP:0005441 increased urine calcium level onset IMP N RGD:401976416|PMID:29979634 20240321 RGD compared to Wild type 10054395 Glaem2Mcwi galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin gene MP:0005505 thrombocytosis IMP N RGD:401976418|PMID:34320241 20240229 RGD compared to wild type 10054395 Glaem2Mcwi galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin gene MP:0005527 increased renal glomerular filtration rate onset IMP N RGD:401976416|PMID:29979634 20240321 RGD compared to Wild type 10054395 Glaem2Mcwi galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin gene MP:0005560 decreased circulating glucose level IMP N RGD:401976416|PMID:29979634 20240321 RGD compared to Wild type males 10054395 Glaem2Mcwi galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin gene MP:0005562 decreased mean corpuscular hemoglobin IMP N RGD:401976418|PMID:34320241 20240229 RGD compared to wild type 10054395 Glaem2Mcwi galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin gene MP:0005565 increased blood urea nitrogen level onset IMP N RGD:401976416|PMID:29979634 20240321 RGD compared to Wild type 10054395 Glaem2Mcwi galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin gene MP:0005567 decreased circulating total protein level IMP N RGD:401976416|PMID:29979634 20240321 RGD compared to Wild type 10054395 Glaem2Mcwi galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin gene MP:0005603 neuron hypertrophy IMP N RGD:401976419|PMID:34541380 20240229 RGD compared to wild type 10054395 Glaem2Mcwi galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin gene MP:0005627 increased circulating potassium level IMP N RGD:401976416|PMID:29979634 20240321 RGD compared to Wild type 10054395 Glaem2Mcwi galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin gene MP:0008250 abnormal myeloid leukocyte morphology IMP N RGD:401976418|PMID:34320241 20240229 RGD compared to wild type 10054395 Glaem2Mcwi galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin gene MP:0008553 increased circulating tumor necrosis factor level IMP N RGD:401976418|PMID:34320241 20240229 RGD compared to wild type 10054395 Glaem2Mcwi galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin gene MP:0008570 lipidosis IMP N RGD:401976419|PMID:34541380 20240229 RGD compared to wild type 10054395 Glaem2Mcwi galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin gene MP:0008614 increased circulating interleukin-17 level IMP N RGD:401976418|PMID:34320241 20240229 RGD compared to wild type 10054395 Glaem2Mcwi galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin gene MP:0009906 increased tongue size IMP N RGD:401976416|PMID:29979634 20240321 RGD compared to Wild type 10054395 Glaem2Mcwi galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin gene MP:0010097 abnormal retina blood vessel morphology IMP N RGD:401976417|PMID:31253878 20240815 RGD 10054395 Glaem2Mcwi galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin gene MP:0010179 rough coat IMP N RGD:401976416|PMID:29979634 20240321 RGD compared to Wild type 10054395 Glaem2Mcwi galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin gene MP:0010210 abnormal circulating cytokine level IMP N RGD:401976418|PMID:34320241 20240229 RGD compared to wild type 10054395 Glaem2Mcwi galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin gene MP:0010620 thick mitral valve onset IMP N RGD:401976416|PMID:29979634 20240321 RGD compared to Wild type 10054395 Glaem2Mcwi galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin gene MP:0010769 abnormal survival IMP N RGD:401976416|PMID:29979634 20240321 RGD compared to Wild type males 10054395 Glaem2Mcwi galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin gene MP:0011363 renal glomerulus atrophy onset IMP N RGD:401976416|PMID:29979634 20240321 RGD 10054395 Glaem2Mcwi galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin gene MP:0011431 increased urine flow rate IMP N RGD:401976416|PMID:29979634 20240321 RGD compared to Wild type males 10054395 Glaem2Mcwi galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin gene MP:0011913 abnormal reticulocyte cell number IMP N RGD:401976418|PMID:34320241 20240229 RGD compared to wild type 10054395 Glaem2Mcwi galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin gene MP:0012230 abnormal sphingolipid level IMP N RGD:401976417|PMID:31253878 20240815 RGD in eyes;compared to wild type 10054395 Glaem2Mcwi galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin gene MP:0013661 abnormal myeloid cell number IMP N RGD:401976418|PMID:34320241 20240229 RGD compared to wild type 10054395 Glaem2Mcwi galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin gene MP:0014062 nervous system inclusion bodies IMP N RGD:150429980|PMID:29563343 20211021 RGD compared to wild type 10054395 Glaem2Mcwi galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin gene MP:0020194 abnormal glycosphingolipid level IMP N RGD:150429980|PMID:29563343 20211021 RGD compared to wild type 10054395 Glaem2Mcwi galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin gene MP:0020194 abnormal glycosphingolipid level IMP N RGD:401976418|PMID:34320241 20240229 RGD compared to wild type 10054395 Glaem2Mcwi galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin gene MP:0020194 abnormal glycosphingolipid level IMP N RGD:401976419|PMID:34541380 20240229 RGD compared to wild type 10054395 Glaem2Mcwi galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin gene MP:0020300 long tongue IMP N RGD:401976416|PMID:29979634 20240321 RGD compared to Wild type 10054395 Glaem2Mcwi galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin gene MP:0020954 decreased mechanical nociceptive threshold IMP N RGD:150429980|PMID:29563343 20211021 RGD compared to wild type 10054395 Glaem2Mcwi galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin gene MP:0021158 decreased heart left ventricle wall thickness onset IMP N RGD:401976416|PMID:29979634 20240321 RGD compared to Wild type 10054395 Glaem2Mcwi galactosidase, alpha; CRISPR/Cas9 system induced mutant 2, Medical College of Wisconsin gene MP:0021198 abnormal sleep duration sexual_dimorphism IMP N RGD:401976421|PMID:36660199 20240229 RGD compared to wild type female 10054398 DA-Glaem2Mcwi strain MP:0000414 alopecia IMP N RGD:401976416|PMID:29979634 20240318 RGD 10054398 DA-Glaem2Mcwi strain MP:0000647 abnormal sebaceous gland morphology IMP N RGD:401976416|PMID:29979634 20240318 RGD 10054398 DA-Glaem2Mcwi strain MP:0000937 abnormal motor neuron morphology IMP N RGD:401976419|PMID:34541380 20240227 RGD compared to wild type 10054398 DA-Glaem2Mcwi strain MP:0000965 abnormal sensory neuron morphology IMP N RGD:150429980|PMID:29563343 20211020 RGD compared to wild type 10054398 DA-Glaem2Mcwi strain MP:0000965 abnormal sensory neuron morphology IMP N RGD:401976419|PMID:34541380 20240227 RGD compared to wild type 10054398 DA-Glaem2Mcwi strain MP:0001260 increased body weight IMP N RGD:401976416|PMID:29979634 20240318 RGD compared to Wild type females 10054398 DA-Glaem2Mcwi strain MP:0001262 decreased body weight IMP N RGD:401976416|PMID:29979634 20240318 RGD compared to Wild type males 10054398 DA-Glaem2Mcwi strain MP:0001314 cornea opacity severity IMP N RGD:401976417|PMID:31253878 20240812 RGD compared to wild type 10054398 DA-Glaem2Mcwi strain MP:0001402 decreased locomotor activity sexual_dimorphism IMP N RGD:401976421|PMID:36660199 20240226 RGD compared to wild type female 10054398 DA-Glaem2Mcwi strain MP:0001442 decreased grooming behavior sexual_dimorphism IMP N RGD:401976421|PMID:36660199 20240226 RGD compared to wild type female 10054398 DA-Glaem2Mcwi strain MP:0001759 increased urine glucose level onset IMP N RGD:401976416|PMID:29979634 20240319 RGD compared to Wild type males 10054398 DA-Glaem2Mcwi strain MP:0002413 abnormal megakaryocyte progenitor cell morphology IMP N RGD:401976418|PMID:34320241 20240227 RGD compared to wild type 10054398 DA-Glaem2Mcwi strain MP:0002424 abnormal reticulocyte morphology IMP N RGD:401976418|PMID:34320241 20240227 RGD compared to wild type 10054398 DA-Glaem2Mcwi strain MP:0002591 decreased mean corpuscular volume IMP N RGD:401976418|PMID:34320241 20240227 RGD compared to wild type 10054398 DA-Glaem2Mcwi strain MP:0002738 hyperresponsive to tactile stimuli IMP N RGD:150429980|PMID:29563343 20211020 RGD compared to wild type 10054398 DA-Glaem2Mcwi strain MP:0002840 abnormal lens fiber morphology severity IMP N RGD:401976417|PMID:31253878 20240812 RGD compared to wild type 10054398 DA-Glaem2Mcwi strain MP:0002968 increased circulating alkaline phosphatase level onset IMP N RGD:401976416|PMID:29979634 20240318 RGD compared to Wild type 10054398 DA-Glaem2Mcwi strain MP:0003131 increased erythrocyte cell number IMP N RGD:401976418|PMID:34320241 20240227 RGD compared to wild type 10054398 DA-Glaem2Mcwi strain MP:0003177 allodynia IMP N RGD:150429980|PMID:29563343 20211020 RGD compared to wild type 10054398 DA-Glaem2Mcwi strain MP:0004720 abnormal platelet morphology IMP N RGD:401976418|PMID:34320241 20240227 RGD compared to wild type 10054398 DA-Glaem2Mcwi strain MP:0004756 abnormal proximal convoluted tubule morphology IMP N RGD:401976416|PMID:29979634 20240318 RGD 10054398 DA-Glaem2Mcwi strain MP:0005058 abnormal lysosome morphology IMP N RGD:401976418|PMID:34320241 20240227 RGD compared to wild type 10054398 DA-Glaem2Mcwi strain MP:0005058 abnormal lysosome morphology IMP N RGD:401976419|PMID:34541380 20240227 RGD compared to wild type 10054398 DA-Glaem2Mcwi strain MP:0005059 lysosomal protein accumulation IMP N RGD:401976418|PMID:34320241 20240227 RGD compared to wild type 10054398 DA-Glaem2Mcwi strain MP:0005059 lysosomal protein accumulation IMP N RGD:401976419|PMID:34541380 20240227 RGD compared to wild type 10054398 DA-Glaem2Mcwi strain MP:0005140 decreased cardiac muscle contractility onset IMP N RGD:401976416|PMID:29979634 20240319 RGD compared to Wild type 10054398 DA-Glaem2Mcwi strain MP:0005179 decreased circulating cholesterol level IMP N RGD:401976416|PMID:29979634 20240319 RGD compared to Wild type female 10054398 DA-Glaem2Mcwi strain MP:0005343 increased circulating aspartate transaminase level onset IMP N RGD:401976416|PMID:29979634 20240318 RGD compared to Wild type 10054398 DA-Glaem2Mcwi strain MP:0005419 decreased circulating serum albumin level IMP N RGD:401976416|PMID:29979634 20240318 RGD compared to Wild type 10054398 DA-Glaem2Mcwi strain MP:0005425 increased macrophage cell number IMP N RGD:401976418|PMID:34320241 20240227 RGD compared to wild type 10054398 DA-Glaem2Mcwi strain MP:0005441 increased urine calcium level onset IMP N RGD:401976416|PMID:29979634 20240318 RGD compared to Wild type 10054398 DA-Glaem2Mcwi strain MP:0005505 thrombocytosis IMP N RGD:401976418|PMID:34320241 20240227 RGD compared to wild type 10054398 DA-Glaem2Mcwi strain MP:0005527 increased renal glomerular filtration rate onset IMP N RGD:401976416|PMID:29979634 20240318 RGD compared to Wild type 10054398 DA-Glaem2Mcwi strain MP:0005560 decreased circulating glucose level IMP N RGD:401976416|PMID:29979634 20240318 RGD compared to Wild type males 10054398 DA-Glaem2Mcwi strain MP:0005562 decreased mean corpuscular hemoglobin IMP N RGD:401976418|PMID:34320241 20240227 RGD compared to wild type 10054398 DA-Glaem2Mcwi strain MP:0005565 increased blood urea nitrogen level onset IMP N RGD:401976416|PMID:29979634 20240318 RGD compared to Wild type 10054398 DA-Glaem2Mcwi strain MP:0005567 decreased circulating total protein level IMP N RGD:401976416|PMID:29979634 20240318 RGD compared to Wild type 10054398 DA-Glaem2Mcwi strain MP:0005603 neuron hypertrophy IMP N RGD:401976419|PMID:34541380 20240227 RGD compared to wild type 10054398 DA-Glaem2Mcwi strain MP:0005627 increased circulating potassium level IMP N RGD:401976416|PMID:29979634 20240318 RGD compared to Wild type 10054398 DA-Glaem2Mcwi strain MP:0008250 abnormal myeloid leukocyte morphology IMP N RGD:401976418|PMID:34320241 20240227 RGD compared to wild type 10054398 DA-Glaem2Mcwi strain MP:0008553 increased circulating tumor necrosis factor level IMP N RGD:401976418|PMID:34320241 20240227 RGD compared to wild type 10054398 DA-Glaem2Mcwi strain MP:0008570 lipidosis IMP N RGD:401976419|PMID:34541380 20240227 RGD compared to wild type 10054398 DA-Glaem2Mcwi strain MP:0008614 increased circulating interleukin-17 level IMP N RGD:401976418|PMID:34320241 20240227 RGD compared to wild type 10054398 DA-Glaem2Mcwi strain MP:0009906 increased tongue size IMP N RGD:401976416|PMID:29979634 20240318 RGD compared to Wild type 10054398 DA-Glaem2Mcwi strain MP:0010097 abnormal retina blood vessel morphology IMP N RGD:401976417|PMID:31253878 20240813 RGD 10054398 DA-Glaem2Mcwi strain MP:0010179 rough coat IMP N RGD:401976416|PMID:29979634 20240318 RGD compared to Wild type 10054398 DA-Glaem2Mcwi strain MP:0010210 abnormal circulating cytokine level IMP N RGD:401976418|PMID:34320241 20240227 RGD compared to wild type 10054398 DA-Glaem2Mcwi strain MP:0010620 thick mitral valve onset IMP N RGD:401976416|PMID:29979634 20240319 RGD compared to Wild type 10054398 DA-Glaem2Mcwi strain MP:0010769 abnormal survival IMP N RGD:401976416|PMID:29979634 20240318 RGD compared to Wild type males 10054398 DA-Glaem2Mcwi strain MP:0011363 renal glomerulus atrophy onset IMP N RGD:401976416|PMID:29979634 20240318 RGD 10054398 DA-Glaem2Mcwi strain MP:0011431 increased urine flow rate IMP N RGD:401976416|PMID:29979634 20240318 RGD compared to Wild type males 10054398 DA-Glaem2Mcwi strain MP:0011913 abnormal reticulocyte cell number IMP N RGD:401976418|PMID:34320241 20240227 RGD compared to wild type 10054398 DA-Glaem2Mcwi strain MP:0012230 abnormal sphingolipid level IMP N RGD:401976417|PMID:31253878 20240813 RGD in eyes;compared to wild type 10054398 DA-Glaem2Mcwi strain MP:0013661 abnormal myeloid cell number IMP N RGD:401976418|PMID:34320241 20240227 RGD compared to wild type 10054398 DA-Glaem2Mcwi strain MP:0014062 nervous system inclusion bodies IMP N RGD:150429980|PMID:29563343 20211020 RGD compared to wild type 10054398 DA-Glaem2Mcwi strain MP:0020194 abnormal glycosphingolipid level IMP N RGD:150429980|PMID:29563343 20211020 RGD compared to wild type 10054398 DA-Glaem2Mcwi strain MP:0020194 abnormal glycosphingolipid level IMP N RGD:401976418|PMID:34320241 20240227 RGD compared to wild type 10054398 DA-Glaem2Mcwi strain MP:0020194 abnormal glycosphingolipid level IMP N RGD:401976419|PMID:34541380 20240227 RGD compared to wild type 10054398 DA-Glaem2Mcwi strain MP:0020300 long tongue IMP N RGD:401976416|PMID:29979634 20240318 RGD compared to Wild type 10054398 DA-Glaem2Mcwi strain MP:0020954 decreased mechanical nociceptive threshold IMP N RGD:150429980|PMID:29563343 20211020 RGD compared to wild type 10054398 DA-Glaem2Mcwi strain MP:0021158 decreased heart left ventricle wall thickness onset IMP N RGD:401976416|PMID:29979634 20240319 RGD compared to Wild type 10054398 DA-Glaem2Mcwi strain MP:0021198 abnormal sleep duration sexual_dimorphism IMP N RGD:401976421|PMID:36660199 20240226 RGD compared to wild type female 10058949 Gmadr5 Adrenal mass QTL 5 qtl MP:0012689 abnormal adrenal gland weight IDA N RGD:10053640|PMID:21029000 20150811 RGD 10058952 Gmadr6 Adrenal mass QTL 6 qtl MP:0012689 abnormal adrenal gland weight IDA N RGD:10053640|PMID:21029000 20150811 RGD 10058954 Gmadr7 Adrenal mass QTL 7 qtl MP:0012689 abnormal adrenal gland weight IDA N RGD:10053640|PMID:21029000 20150811 RGD 10059570 WI;WDB-Kiss1tm1Nips strain MP:0002773 decreased circulating luteinizing hormone level IMP N RGD:10059342|PMID:25582792 20170815 RGD 10059570 WI;WDB-Kiss1tm1Nips strain MP:0003379 absent sexual maturation IMP N RGD:10059342|PMID:25582792 20170815 RGD 10059587 Bw173 Body weight QTL 173 qtl MP:0001260 increased body weight IDA N RGD:10053637|PMID:23302051 20150923 RGD 10059590 Kidm44 Kidney mass QTL 44 qtl MP:0003918 decreased kidney weight IDA N RGD:10053637|PMID:23302051 20150923 RGD 10059592 Kidm45 Kidney mass QTL 45 qtl MP:0003918 decreased kidney weight IDA N RGD:10053637|PMID:23302051 20150923 RGD 10059594 Kidm46 Kidney mass QTL 46 qtl MP:0003918 decreased kidney weight IDA N RGD:10053637|PMID:23302051 20150923 RGD 10059597 Bp377 Blood pressure QTL 377 qtl MP:0003820 increased left ventricle systolic pressure IDA N RGD:10053637|PMID:23302051 20150923 RGD 10059600 Bp378 Blood pressure QTL 378 qtl MP:0003820 increased left ventricle systolic pressure IDA N RGD:10053637|PMID:23302051 20150923 RGD 10059603 Bw174 Body weight QTL 174 qtl MP:0001260 increased body weight IDA N RGD:10053637|PMID:23302051 20150923 RGD 10059605 Kidm47 Kidney mass QTL 47 qtl MP:0003918 decreased kidney weight IDA N RGD:10053637|PMID:23302051 20150923 RGD 10401208 F344-Tg(Prp-APP,Prp-PS1)19/Rrrc strain MP:0001363 increased anxiety-related response IAGP N RGD:40924641|PMID:29107184 20210115 RGD compared to wild type F344/NHsd 10401208 F344-Tg(Prp-APP,Prp-PS1)19/Rrrc strain MP:0002229 neurodegeneration IAGP N RGD:10401209|PMID:23575824 20210115 RGD compared to wild type littermate; 10401208 F344-Tg(Prp-APP,Prp-PS1)19/Rrrc strain MP:0003354 astrocytosis IAGP N RGD:10401209|PMID:23575824 20210115 RGD compared to wild type littermate; 10401208 F344-Tg(Prp-APP,Prp-PS1)19/Rrrc strain MP:0004254 cerebral amyloid angiopathy IAGP N RGD:10401209|PMID:23575824 20210115 RGD compared to wild type littermate; 10401208 F344-Tg(Prp-APP,Prp-PS1)19/Rrrc strain MP:0008414 abnormal spatial reference memory IAGP N RGD:10401209|PMID:23575824 20210115 RGD compared to wild type littermate; 10401208 F344-Tg(Prp-APP,Prp-PS1)19/Rrrc strain MP:0008428 abnormal spatial working memory IAGP N RGD:10401209|PMID:23575824 20210115 RGD compared to wild type littermate; 10401208 F344-Tg(Prp-APP,Prp-PS1)19/Rrrc strain MP:0008918 microgliosis IAGP N RGD:10401209|PMID:23575824 20210115 RGD compared to wild type littermate; 10401796 Kidm48 Kidney mass QTL 48 qtl MP:0003918 decreased kidney weight IDA N RGD:10045846|PMID:25707311 20151007 RGD 10401800 Kidm49 Kidney mass QTL 49 qtl MP:0003918 decreased kidney weight IDA N RGD:10045846|PMID:25707311 20151007 RGD 10401803 Kidm50 Kidney mass QTL 50 qtl MP:0003918 decreased kidney weight IDA N RGD:10045846|PMID:25707311 20151007 RGD 10401805 Kidm51 Kidney mass QTL 51 qtl MP:0003918 decreased kidney weight IDA N RGD:10045846|PMID:25707311 20151007 RGD 10401807 Kidm52 Kidney mass QTL 52 qtl MP:0003918 decreased kidney weight IDA N RGD:10045846|PMID:25707311 20151007 RGD 10401810 Kidm53 Kidney mass QTL 53 qtl MP:0003918 decreased kidney weight IDA N RGD:10045846|PMID:25707311 20151007 RGD 10401812 Kidm54 Kidney mass QTL 54 qtl MP:0003918 decreased kidney weight IDA N RGD:10045846|PMID:25707311 20151007 RGD 10401839 WKY.F344-(D17Rat47-D17Rat51)/Tja strain MP:0004013 decreased pulmonary artery pressure induced IAGP XCO:0000010 N RGD:10401832|PMID:26258299 20200130 RGD compared to WKY/Cruk 10401842 Slc39a12em77Tja solute carrier family 39 (zinc transporter), member 12; zinc finger nuclease induced mutant 77, Timothy J. Aitman gene MP:0004013 decreased pulmonary artery pressure IMP N RGD:10401832|PMID:26258299 20200130 RGD 10402051 Gdil2 Gastrointestinal dilation QTL 2 qtl MP:0002926 aganglionic megacolon severity IDA N RGD:10402048|PMID:25790447 20151014 RGD 10402839 LEW.SS-(D10Mgh6-D10Mgh1)/Ayd strain MP:0004875 increased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:10402053|PMID:25963546 20160114 RGD compared to LEW/Crl 10402852 LEW.SS-(D7Rat27-D7Mgh1)(D17Rat15-D17Rat51)(D10Mgh6-D10Mgh1)/Ayd strain MP:0004875 increased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:10402053|PMID:25963546 20160114 RGD compared to LEW/Crl 10402855 Bp379 Blood pressure QTL 379 qtl MP:0002842 increased systemic arterial blood pressure IDA N RGD:10402053|PMID:25963546 20151130 RGD 10402857 Bp380 Blood pressure QTL 380 qtl MP:0002842 increased systemic arterial blood pressure IDA N RGD:10402053|PMID:25963546 20151130 RGD 10402859 Bp381 Blood pressure QTL 381 qtl MP:0002842 increased systemic arterial blood pressure IDA N RGD:10402053|PMID:25963546 20151130 RGD 10413846 Abcc6em2Qlju ATP-binding cassette, subfamily C (CFTR/MRP), member 6; zinc finger nuclease induced mutant 2, Qiaoli Li gene MP:0001566 increased circulating phosphate level IAGP N RGD:13792593|PMID:28111129 20180920 RGD 10413852 SD-Abcc6em2Qlju-/- strain MP:0001566 increased circulating phosphate level IAGP N RGD:13792593|PMID:28111129 20180920 RGD 10450493 Bp382 Blood pressure QTL 382 qtl MP:0002842 increased systemic arterial blood pressure IDA N RGD:10402053|PMID:25963546 20160114 RGD 10450495 Bp383 Blood pressure QTL 383 qtl MP:0002842 increased systemic arterial blood pressure IDA N RGD:10402053|PMID:25963546 20160114 RGD 10450498 Bp384 Blood pressure QTL 384 qtl MP:0002842 increased systemic arterial blood pressure IDA N RGD:10402053|PMID:25963546 20160114 RGD 10450500 Bp385 Blood pressure QTL 385 qtl MP:0002842 increased systemic arterial blood pressure IDA N RGD:10402053|PMID:25963546 20160114 RGD 10450503 Bp386 Blood pressure QTL 386 qtl MP:0002842 increased systemic arterial blood pressure IDA N RGD:10402053|PMID:25963546 20160114 RGD 10450794 Scl69 Serum cholesterol level QTL 69 qtl MP:0000182 increased circulating LDL cholesterol level IDA N RGD:10402111|PMID:25296178 20160122 RGD 10450804 Scl70 Serum cholesterol level QTL 70 qtl MP:0000182 increased circulating LDL cholesterol level IDA N RGD:10402111|PMID:25296178 20160122 RGD 10450806 Scl71 Serum cholesterol level QTL 71 qtl MP:0000182 increased circulating LDL cholesterol level IDA N RGD:10402111|PMID:25296178 20160122 RGD 10450808 Scl72 Serum cholesterol level QTL 72 qtl MP:0000182 increased circulating LDL cholesterol level IDA N RGD:10402111|PMID:25296178 20160122 RGD 10450811 Scl73 Serum cholesterol level QTL 73 qtl MP:0000182 increased circulating LDL cholesterol level IDA N RGD:10402111|PMID:25296178 20160122 RGD 10450813 Scl74 Serum cholesterol level QTL 74 qtl MP:0000182 increased circulating LDL cholesterol level IDA N RGD:10402111|PMID:25296178 20160122 RGD 10450816 Scl75 Serum cholesterol level QTL 75 qtl MP:0000182 increased circulating LDL cholesterol level IDA N RGD:10402111|PMID:25296178 20160122 RGD 10450818 Scl76 Serum cholesterol level QTL 76 qtl MP:0005145 increased circulating VLDL cholesterol level IDA N RGD:10402111|PMID:25296178 20160122 RGD 10450821 Scl77 Serum cholesterol level QTL 77 qtl MP:0005145 increased circulating VLDL cholesterol level IDA N RGD:10402111|PMID:25296178 20160122 RGD 10450825 Scl78 Serum cholesterol level QTL 78 qtl MP:0005145 increased circulating VLDL cholesterol level IDA N RGD:10402111|PMID:25296178 20160122 RGD 10450828 Scl79 Serum cholesterol level QTL 79 qtl MP:0001556 increased circulating HDL cholesterol level IDA N RGD:10402111|PMID:25296178 20160122 RGD 10450831 Scl80 Serum cholesterol level QTL 80 qtl MP:0000182 increased circulating LDL cholesterol level IDA N RGD:10402111|PMID:25296178 20160122 RGD 10450852 Stl33 Serum triglyceride level QTL 33 qtl MP:0001552 increased circulating triglyceride level IDA N RGD:10402111|PMID:25296178 20160122 RGD 10450854 Stl34 Serum triglyceride level QTL 34 qtl MP:0001552 increased circulating triglyceride level IDA N RGD:10402111|PMID:25296178 20160122 RGD 10450856 Livw4 Liver weight QTL 4 qtl MP:0002981 increased liver weight IDA N RGD:10402111|PMID:25296178 20160122 RGD 10450862 Kidm55 Kidney mass QTL 55 qtl MP:0003917 increased kidney weight IDA N RGD:10402111|PMID:25296178 20160122 RGD 10450865 Bw175 Body weight QTL 175 qtl MP:0000008 increased white adipose tissue amount IDA N RGD:10402111|PMID:25296178 20160122 RGD 10755350 F344.ZUC-(Leprfa),OLETF-(D14Rat23-D14Rat12)/Tj strain MP:0001260 increased body weight IAGP N RGD:10755343|PMID:26296322 20160906 RGD as compared to F344/NSlc; 10755350 F344.ZUC-(Leprfa),OLETF-(D14Rat23-D14Rat12)/Tj strain MP:0005293 impaired glucose tolerance IAGP N RGD:10755343|PMID:26296322 20160906 RGD 10755350 F344.ZUC-(Leprfa),OLETF-(D14Rat23-D14Rat12)/Tj strain MP:0005331 insulin resistance IAGP N RGD:10755343|PMID:26296322 20160906 RGD as compared to F344/NSlc; 10755350 F344.ZUC-(Leprfa),OLETF-(D14Rat23-D14Rat12)/Tj strain MP:0011939 increased food intake IAGP N RGD:10755343|PMID:26296322 20160906 RGD as compared to F344/NSlc; 10755352 LH/MavRrrcAek Lyon Hypertensive strain MP:0001260 increased body weight IAGP N RGD:10755325|PMID:25573024 20160126 RGD as compared to LN/MavRrrcAek 10755352 LH/MavRrrcAek Lyon Hypertensive strain MP:0001552 increased circulating triglyceride level IAGP N RGD:10755325|PMID:25573024 20160126 RGD as compared to LN/MavRrrcAek at 18 wk old 10755352 LH/MavRrrcAek Lyon Hypertensive strain MP:0002626 increased heart rate IAGP N RGD:10755325|PMID:25573024 20200113 RGD as compared to LN/MavRrrcAek 10755352 LH/MavRrrcAek Lyon Hypertensive strain MP:0002865 increased growth rate IAGP N RGD:10755325|PMID:25573024 20200113 RGD as compared to LN/MavRrrcAek 10755352 LH/MavRrrcAek Lyon Hypertensive strain MP:0004875 increased mean systemic arterial blood pressure IAGP N RGD:10755325|PMID:25573024 20200113 RGD as compared to LN/MavRrrcAek 10755352 LH/MavRrrcAek Lyon Hypertensive strain MP:0005178 increased circulating cholesterol level IAGP N RGD:10755325|PMID:25573024 20191202 RGD as compared to LN/MavRrrcAek at 16 wk old 10755352 LH/MavRrrcAek Lyon Hypertensive strain MP:0005560 decreased circulating glucose level IAGP N RGD:10755325|PMID:25573024 20200113 RGD as compared to LN/MavRrrcAek at 12 wk old 10755352 LH/MavRrrcAek Lyon Hypertensive strain MP:0005669 increased circulating leptin level IAGP N RGD:10755325|PMID:25573024 20200113 RGD as compared to LN/MavRrrcAek 10755352 LH/MavRrrcAek Lyon Hypertensive strain MP:0006143 increased systemic arterial diastolic blood pressure IAGP N RGD:10755325|PMID:25573024 20200113 RGD as compared to LN/MavRrrcAek 10755352 LH/MavRrrcAek Lyon Hypertensive strain MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:10755325|PMID:25573024 20200113 RGD as compared to LN/MavRrrcAek 10755352 LH/MavRrrcAek Lyon Hypertensive strain MP:0014145 increased white adipose tissue mass IAGP N RGD:10755325|PMID:25573024 20200113 RGD as compared to LN/MavRrrcAek 10755424 Ednrbsl endothelin receptor type B, spotting lethal gene MP:0000692 small spleen IAGP N RGD:7207471|PMID:22975636 20171206 RGD 10755424 Ednrbsl endothelin receptor type B, spotting lethal gene MP:0002075 abnormal coat/hair pigmentation IAGP N RGD:628515|PMID:8570650 20171204 RGD 10755424 Ednrbsl endothelin receptor type B, spotting lethal gene MP:0002926 aganglionic megacolon IAGP N RGD:6480215|PMID:22132166 20210218 RGD 10755424 Ednrbsl endothelin receptor type B, spotting lethal gene MP:0002926 aganglionic megacolon IAGP N RGD:6480217|PMID:21915282 20171206 RGD 10755424 Ednrbsl endothelin receptor type B, spotting lethal gene MP:0004364 thin stria vascularis IAGP N RGD:6480217|PMID:21915282 20171206 RGD 10755424 Ednrbsl endothelin receptor type B, spotting lethal gene MP:0004750 syndromic hearing loss IAGP N RGD:6480217|PMID:21915282 20210218 RGD 10755424 Ednrbsl endothelin receptor type B, spotting lethal gene MP:0004956 decreased thymus weight IAGP N RGD:7207471|PMID:22975636 20171206 RGD 10755424 Ednrbsl endothelin receptor type B, spotting lethal gene MP:0005408 hypopigmentation IAGP N RGD:6480217|PMID:21915282 20210218 RGD 10755424 Ednrbsl endothelin receptor type B, spotting lethal gene MP:0008470 abnormal spleen B cell follicle morphology IAGP N RGD:7207471|PMID:22975636 20171206 RGD 10755424 Ednrbsl endothelin receptor type B, spotting lethal gene MP:0008477 decreased spleen red pulp amount IAGP N RGD:7207471|PMID:22975636 20171207 RGD 10755424 Ednrbsl endothelin receptor type B, spotting lethal gene MP:0008770 decreased survivor rate IAGP N RGD:6480217|PMID:21915282 20210218 RGD 10755424 Ednrbsl endothelin receptor type B, spotting lethal gene MP:0009323 abnormal spleen development IAGP N RGD:7207471|PMID:22975636 20171206 RGD 10755430 Coatc6 Coat color QTL 6 qtl MP:0002075 abnormal coat/hair pigmentation IDA N RGD:10755346|PMID:26796131 20160128 RGD 10755434 Coatc7 Coat color QTL 7 qtl MP:0002075 abnormal coat/hair pigmentation IDA N RGD:10755346|PMID:26796131 20160128 RGD 10755436 Coatc8 Coat color QTL 8 qtl MP:0002075 abnormal coat/hair pigmentation IDA N RGD:10755346|PMID:26796131 20160128 RGD 10755438 Coatc9 Coat color QTL 9 qtl MP:0002075 abnormal coat/hair pigmentation IDA N RGD:10755346|PMID:26796131 20160128 RGD 10755440 Coatc10 Coat color QTL 10 qtl MP:0002075 abnormal coat/hair pigmentation IDA N RGD:10755346|PMID:26796131 20160128 RGD 10755451 Coatc11 Coat color QTL 11 qtl MP:0002075 abnormal coat/hair pigmentation IDA N RGD:10755346|PMID:26796131 20160128 RGD 10755453 Coatc12 Coat color QTL 12 qtl MP:0002075 abnormal coat/hair pigmentation IDA N RGD:10755346|PMID:26796131 20160128 RGD 10755455 Coatc13 Coat color QTL 13 qtl MP:0002075 abnormal coat/hair pigmentation IDA N RGD:10755346|PMID:26796131 20160128 RGD 10755457 Coatc14 Coat color QTL 14 qtl MP:0002075 abnormal coat/hair pigmentation IDA N RGD:10755346|PMID:26796131 20160128 RGD 10755459 Coatc15 Coat color QTL 15 qtl MP:0002075 abnormal coat/hair pigmentation IDA N RGD:10755346|PMID:26796131 20160128 RGD 10755461 Coatc16 Coat color QTL 16 qtl MP:0002075 abnormal coat/hair pigmentation IDA N RGD:10755346|PMID:26796131 20160128 RGD 10755495 Bp387 Blood pressure QTL 387 qtl MP:0006144 increased systemic arterial systolic blood pressure IDA N RGD:10755344|PMID:22912817 20160202 RGD 10755497 Bp388 Blood pressure QTL 388 qtl MP:0006144 increased systemic arterial systolic blood pressure IDA N RGD:10755344|PMID:22912817 20160202 RGD 10755499 Bp389 Blood pressure QTL 389 qtl MP:0006143 increased systemic arterial diastolic blood pressure IDA N RGD:10755344|PMID:22912817 20160202 RGD 10755501 Bp390 Blood pressure QTL 390 qtl MP:0006143 increased systemic arterial diastolic blood pressure IDA N RGD:10755344|PMID:22912817 20160202 RGD 10755503 Bp391 Blood pressure QTL 391 qtl MP:0006144 increased systemic arterial systolic blood pressure IDA N RGD:10755344|PMID:22912817 20160202 RGD 11040521 SHR-Ndufc2em2Mcwi-/+ SHR-Ndufc2em2Mcwi-/Ndufc2em2Mcwi+ strain MP:0002962 increased urine protein level induced IMP XCO:0000022, XCO:0000032, XCO:0000030 N RGD:11040458|PMID:26888427 20160816 RGD compared to SHR/Bbb 11040521 SHR-Ndufc2em2Mcwi-/+ SHR-Ndufc2em2Mcwi-/Ndufc2em2Mcwi+ strain MP:0003076 increased susceptibility to ischemic brain injury induced IMP XCO:0000022,XCO:0000032,XCO:0000030 N RGD:11040458|PMID:26888427 20200116 RGD compared to SHR/Bbb 11040521 SHR-Ndufc2em2Mcwi-/+ SHR-Ndufc2em2Mcwi-/Ndufc2em2Mcwi+ strain MP:0006059 decreased susceptibility to ischemic brain injury induced IMP XCO:0000022,XCO:0000032,XCO:0000030 N RGD:11040458|PMID:26888427 20200116 RGD compared to SHRSP/Bbb 11040962 F344-Bscl2m1Kyo strain MP:0001262 decreased body weight IMP N RGD:11085488|PMID:25934999 20190109 RGD 11040962 F344-Bscl2m1Kyo strain MP:0001552 increased circulating triglyceride level IMP N RGD:11085488|PMID:25934999 20190109 RGD 11040962 F344-Bscl2m1Kyo strain MP:0001783 decreased white adipose tissue amount IMP N RGD:11085488|PMID:25934999 20190109 RGD 11040962 F344-Bscl2m1Kyo strain MP:0002079 increased circulating insulin level IMP N RGD:11085488|PMID:25934999 20190109 RGD 11040962 F344-Bscl2m1Kyo strain MP:0002175 decreased brain weight IMP N RGD:11085488|PMID:25934999 20190109 RGD 11040962 F344-Bscl2m1Kyo strain MP:0002981 increased liver weight IMP N RGD:11085488|PMID:25934999 20190109 RGD 11040962 F344-Bscl2m1Kyo strain MP:0003960 increased lean body mass IMP N RGD:11085488|PMID:25934999 20190109 RGD 11040962 F344-Bscl2m1Kyo strain MP:0004852 decreased testis weight IMP N RGD:11085488|PMID:25934999 20190109 RGD 11040962 F344-Bscl2m1Kyo strain MP:0005178 increased circulating cholesterol level IMP N RGD:11085488|PMID:25934999 20190109 RGD 11040962 F344-Bscl2m1Kyo strain MP:0005289 increased oxygen consumption IMP N RGD:11085488|PMID:25934999 20190109 RGD 11040962 F344-Bscl2m1Kyo strain MP:0005668 decreased circulating leptin level IMP N RGD:11085488|PMID:25934999 20190109 RGD 11040962 F344-Bscl2m1Kyo strain MP:0008428 abnormal spatial working memory IMP N RGD:11085488|PMID:25934999 20190109 RGD 11040962 F344-Bscl2m1Kyo strain MP:0009355 increased liver triglyceride level IMP N RGD:11085488|PMID:25934999 20190109 RGD 11073608 Mir29b1em1Mcwi microRNA 29b-1; TALEN induced mutant 1, Medical College of Wisconsin gene MP:0005591 decreased vasodilation IMP N RGD:13702880|PMID:29374012 20200508 RGD 11073612 SS-Chr 13BN-Mir29bem1Mcwi strain MP:0005591 decreased vasodilation IMP N RGD:13702880|PMID:29374012 20200508 RGD 11081149 SD-Esr2em1Soar strain MP:0001134 absent corpus luteum IMP N RGD:38548924|PMID:28520870 20200825 RGD 11081149 SD-Esr2em1Soar strain MP:0001134 absent corpus luteum IMP N RGD:38548925|PMID:29580824 20200825 RGD 11081149 SD-Esr2em1Soar strain MP:0001926 female infertility IMP N RGD:38548925|PMID:29580824 20200825 RGD 11081149 SD-Esr2em1Soar strain MP:0002773 decreased circulating luteinizing hormone level IMP N RGD:38548924|PMID:28520870 20200825 RGD 11081149 SD-Esr2em1Soar strain MP:0002790 decreased circulating follicle stimulating hormone level IMP N RGD:38548924|PMID:28520870 20200825 RGD 11081149 SD-Esr2em1Soar strain MP:0004805 absent oocytes induced IMP XCO:0000228 N RGD:38548924|PMID:28520870 20200825 RGD compared to wild type 11081149 SD-Esr2em1Soar strain MP:0004856 decreased ovary weight IMP N RGD:38548924|PMID:28520870 20200825 RGD 11081149 SD-Esr2em1Soar strain MP:0004856 decreased ovary weight induced IMP XCO:0000228 N RGD:38548925|PMID:29580824 20200825 RGD compared to wild type 11081149 SD-Esr2em1Soar strain MP:0004905 decreased uterus weight IMP N RGD:38548924|PMID:28520870 20200825 RGD 11081149 SD-Esr2em1Soar strain MP:0005158 ovary hypoplasia induced IMP XCO:0000228 N RGD:38548924|PMID:28520870 20200825 RGD compared to wild type 11081149 SD-Esr2em1Soar strain MP:0005181 decreased circulating estradiol level IMP N RGD:38548924|PMID:28520870 20200825 RGD 11081149 SD-Esr2em1Soar strain MP:0005185 decreased circulating progesterone level induced IMP XCO:0000228 N RGD:38548925|PMID:29580824 20200825 RGD compared to wild type 11081149 SD-Esr2em1Soar strain MP:0008869 anovulation IMP N RGD:38548925|PMID:29580824 20200825 RGD 11081149 SD-Esr2em1Soar strain MP:0008869 anovulation induced IMP XCO:0000228 N RGD:38548924|PMID:28520870 20200825 RGD compared to wild type 11081149 SD-Esr2em1Soar strain MP:0008869 anovulation induced IMP XCO:0000228 N RGD:38548925|PMID:29580824 20200825 RGD compared to wild type 11081149 SD-Esr2em1Soar strain MP:0009013 abnormal proestrus IMP N RGD:38548924|PMID:28520870 20200825 RGD 11081149 SD-Esr2em1Soar strain MP:0009819 abnormal circulating androgen level induced IMP XCO:0000228 N RGD:38548925|PMID:29580824 20200825 RGD compared to wild type 11081177 F344tl toothless (tl) strain MP:0000062 increased bone mineral density IAGP N RGD:628338|PMID:12379742 20180430 RGD 11081177 F344tl toothless (tl) strain MP:0000065 abnormal bone marrow cavity morphology IAGP N RGD:628338|PMID:12379742 20180430 RGD 11087551 SD-Il15em1Soar strain MP:0004953 decreased spleen weight IMP N RGD:12910490|PMID:28395334 20170616 RGD 11087551 SD-Il15em1Soar strain MP:0008045 decreased NK cell number IMP N RGD:12910490|PMID:28395334 20170616 RGD 11087551 SD-Il15em1Soar strain MP:0008957 abnormal placenta junctional zone morphology IMP N RGD:12910490|PMID:28395334 20170616 RGD 11087551 SD-Il15em1Soar strain MP:0012726 abnormal uterine spiral artery morphology IMP N RGD:12910490|PMID:28395334 20170616 RGD 11087553 SD-Mmp12em1Soar strain MP:0009431 decreased fetal weight IMP N RGD:12910498|PMID:27807143 20170616 RGD 11353947 Bp392 Blood pressure QTL 392 qtl MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:11353859|PMID:27113531 20170424 RGD 11353949 Bp393 Blood pressure QTL 393 qtl MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:11353859|PMID:27113531 20170424 RGD 11353951 Bp394 Blood pressure QTL 394 qtl MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:11353859|PMID:27113531 20170424 RGD 11353957 Bmd92 Bone mineral density QTL 92 qtl MP:0000558 abnormal tibia morphology IAGP N RGD:11353859|PMID:27113531 20170424 RGD 11354901 SS.SHR-(D9Mco110-D9Mco124)/Bj strain MP:0004876 decreased mean systemic arterial blood pressure IAGP N RGD:11353859|PMID:27113531 20160729 RGD as compared to SS/Jr; 11354901 SS.SHR-(D9Mco110-D9Mco124)/Bj strain MP:0005333 decreased heart rate IAGP N RGD:11353859|PMID:27113531 20160729 RGD as compared to SS/Jr; 11354901 SS.SHR-(D9Mco110-D9Mco124)/Bj strain MP:0006263 decreased systemic arterial diastolic blood pressure IAGP N RGD:11353859|PMID:27113531 20160729 RGD as compared to SS/Jr; 11354901 SS.SHR-(D9Mco110-D9Mco124)/Bj strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:11353859|PMID:27113531 20160729 RGD as compared to SS/Jr; 11354901 SS.SHR-(D9Mco110-D9Mco124)/Bj strain MP:0006266 decreased pulse pressure IAGP N RGD:11353859|PMID:27113531 20160729 RGD as compared to SS/Jr; 11354901 SS.SHR-(D9Mco110-D9Mco124)/Bj strain MP:0011532 decreased urine major urinary protein level IAGP N RGD:11353859|PMID:27113531 20160729 RGD as compared to SS/Jr; 11354903 SS.SHR-(D9Mco110-D9Mco121)/Bj strain MP:0004876 decreased mean systemic arterial blood pressure IAGP N RGD:11353859|PMID:27113531 20160729 RGD as compared to SS/Jr; 11354903 SS.SHR-(D9Mco110-D9Mco121)/Bj strain MP:0006263 decreased systemic arterial diastolic blood pressure IAGP N RGD:11353859|PMID:27113531 20160729 RGD as compared to SS/Jr; 11354903 SS.SHR-(D9Mco110-D9Mco121)/Bj strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:11353859|PMID:27113531 20160729 RGD as compared to SS/Jr; 11354903 SS.SHR-(D9Mco110-D9Mco121)/Bj strain MP:0011532 decreased urine major urinary protein level IAGP N RGD:11353859|PMID:27113531 20160729 RGD as compared to SS/Jr; 11354924 SS.SHR-(D9Mco113-D9Mco124)/Bj strain MP:0004876 decreased mean systemic arterial blood pressure IAGP N RGD:11353859|PMID:27113531 20160729 RGD as compared to SS/Jr; 11354924 SS.SHR-(D9Mco113-D9Mco124)/Bj strain MP:0006263 decreased systemic arterial diastolic blood pressure IAGP N RGD:11353859|PMID:27113531 20160729 RGD as compared to SS/Jr; 11354924 SS.SHR-(D9Mco113-D9Mco124)/Bj strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:11353859|PMID:27113531 20160729 RGD as compared to SS/Jr; 11354924 SS.SHR-(D9Mco113-D9Mco124)/Bj strain MP:0009346 decreased trabecular bone thickness IAGP N RGD:11353859|PMID:27113531 20160729 RGD 11354924 SS.SHR-(D9Mco113-D9Mco124)/Bj strain MP:0010873 decreased trabecular bone mass IAGP N RGD:11353859|PMID:27113531 20160729 RGD 11354924 SS.SHR-(D9Mco113-D9Mco124)/Bj strain MP:0010876 decreased bone volume IAGP N RGD:11353859|PMID:27113531 20160729 RGD 11354924 SS.SHR-(D9Mco113-D9Mco124)/Bj strain MP:0010933 decreased trabecular bone connectivity density IAGP N RGD:11353859|PMID:27113531 20160729 RGD 11354924 SS.SHR-(D9Mco113-D9Mco124)/Bj strain MP:0010962 decreased compact bone mass IAGP N RGD:11353859|PMID:27113531 20160729 RGD 11354924 SS.SHR-(D9Mco113-D9Mco124)/Bj strain MP:0010968 decreased compact bone area IAGP N RGD:11353859|PMID:27113531 20160729 RGD 11354924 SS.SHR-(D9Mco113-D9Mco124)/Bj strain MP:0011532 decreased urine major urinary protein level IAGP N RGD:11353859|PMID:27113531 20160729 RGD as compared to SS/Jr; 11354926 SS.SHR-(D9Mco110-D9Got111)/Bj strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:11353859|PMID:27113531 20160729 RGD as compared to SS/Jr; 11354926 SS.SHR-(D9Mco110-D9Got111)/Bj strain MP:0011532 decreased urine major urinary protein level IAGP N RGD:11353859|PMID:27113531 20160729 RGD as compared to SS/Jr; 11528588 SHR.LEW-(D4Rat76-D4Mgh11)/Anra strain MP:0001399 hyperactivity IAGP N RGD:11528586|PMID:24386249 20160817 RGD as compared to SHR/NIcoCrlf 11528588 SHR.LEW-(D4Rat76-D4Mgh11)/Anra strain MP:0004000 impaired passive avoidance behavior IAGP N RGD:11528586|PMID:24386249 20160817 RGD as compared to SHR/NIcoCrlf 11528588 SHR.LEW-(D4Rat76-D4Mgh11)/Anra strain MP:0012294 enhanced active avoidance behavior IAGP N RGD:11528586|PMID:24386249 20160817 RGD as compared to SHR/NIcoCrlf 11528620 Bss113 Bone structure and strength QTL 113 qtl MP:0000559 abnormal femur morphology IAGP N RGD:11528619|PMID:26297441 20170424 RGD 11528624 Bss114 Bone structure and strength QTL 114 qtl MP:0001542 abnormal bone strength IAGP N RGD:11528619|PMID:26297441 20170424 RGD 11528628 Bss116 Bone structure and strength QTL 116 qtl MP:0000559 abnormal femur morphology IAGP N RGD:11528619|PMID:26297441 20170424 RGD 11528631 Bss117 Bone structure and strength QTL 117 qtl MP:0001542 abnormal bone strength IAGP N RGD:11528619|PMID:26297441 20170424 RGD 11528636 Bss120 Bone structure and strength QTL 120 qtl MP:0000559 abnormal femur morphology IAGP N RGD:11528619|PMID:26297441 20170424 RGD 11528640 Bss121 Bone structure and strength QTL 121 qtl MP:0000559 abnormal femur morphology IAGP N RGD:11528619|PMID:26297441 20170424 RGD 11528644 Bss115 Bone structure and strength QTL 115 qtl MP:0000559 abnormal femur morphology IAGP N RGD:11528619|PMID:26297441 20170424 RGD 11528648 Bss118 Bone structure and strength QTL 118 qtl MP:0001542 abnormal bone strength IAGP N RGD:11528619|PMID:26297441 20170424 RGD 11530002 Bss119 Bone structure and strength QTL 119 qtl MP:0003049 abnormal lumbar vertebrae morphology IAGP N RGD:11528619|PMID:26297441 20170424 RGD 11530004 Niddm71 Non-insulin dependent diabetes mellitus QTL 71 qtl MP:0005559 increased circulating glucose level IAGP N RGD:11528530|PMID:27463508 20170424 RGD 11530006 Niddm72 Non-insulin dependent diabetes mellitus QTL 72 qtl MP:0005559 increased circulating glucose level IAGP N RGD:11528530|PMID:27463508 20170424 RGD 11530022 Npyem6Sage neuropeptide Y; zinc finger nuclease induced mutant 6, Sigma Advanced Genetic Engineering Labs gene MP:0001262 decreased body weight IAGP N RGD:11530013|PMID:27461754 20201210 RGD as compared to NP/Iusm; 11530022 Npyem6Sage neuropeptide Y; zinc finger nuclease induced mutant 6, Sigma Advanced Genetic Engineering Labs gene MP:0001987 alcohol preference IAGP N RGD:11530013|PMID:27461754 20201210 RGD as compared to NP/Iusm; 11530022 Npyem6Sage neuropeptide Y; zinc finger nuclease induced mutant 6, Sigma Advanced Genetic Engineering Labs gene MP:0003545 increased alcohol consumption IAGP N RGD:11530013|PMID:27461754 20201210 RGD as compared to NP/Iusm; 11531091 SD-F8em1Sage-/-/Novo strain MP:0000218 increased leukocyte cell number IMP N RGD:11530071|PMID:24931420 20160825 RGD as compared to wild type Sprague Dawley 11531091 SD-F8em1Sage-/-/Novo strain MP:0001914 hemorrhage IMP N RGD:11530071|PMID:24931420 20160825 RGD 11531091 SD-F8em1Sage-/-/Novo strain MP:0002933 joint inflammation treatment IMP N RGD:150520059|PMID:27060449 20211026 RGD 11531091 SD-F8em1Sage-/-/Novo strain MP:0002998 abnormal bone remodeling treatment IMP N RGD:150520059|PMID:27060449 20211026 RGD 11531091 SD-F8em1Sage-/-/Novo strain MP:0005245 hemarthrosis treatment IMP N RGD:150520059|PMID:27060449 20211026 RGD 11531091 SD-F8em1Sage-/-/Novo strain MP:0005245 hemarthrosis treatment IMP N RGD:150520060|PMID:31899798 20211026 RGD 11531091 SD-F8em1Sage-/-/Novo strain MP:0005419 decreased circulating serum albumin level IMP N RGD:11530071|PMID:24931420 20160825 RGD as compared to wild type Sprague Dawley 11531091 SD-F8em1Sage-/-/Novo strain MP:0005505 thrombocytosis IMP N RGD:11530071|PMID:24931420 20160825 RGD as compared to wild type Sprague Dawley 11531091 SD-F8em1Sage-/-/Novo strain MP:0005567 decreased circulating total protein level IMP N RGD:11530071|PMID:24931420 20160825 RGD as compared to wild type Sprague Dawley 11531091 SD-F8em1Sage-/-/Novo strain MP:0005606 increased bleeding time treatment IMP N RGD:150520060|PMID:31899798 20211026 RGD 11531091 SD-F8em1Sage-/-/Novo strain MP:0009676 abnormal hemostasis treatment IMP N RGD:150520060|PMID:31899798 20211026 RGD 11531091 SD-F8em1Sage-/-/Novo strain MP:0012359 increased partial thromboplastin time IMP N RGD:11530071|PMID:24931420 20160825 RGD as compared to wild type Sprague Dawley 11531096 F8em1Sage coagulation factor VIII, procoagulant component; zinc finger nuclease induced mutant1, Sage gene MP:0000218 increased leukocyte cell number IMP N RGD:11530071|PMID:24931420 20190711 RGD 11531096 F8em1Sage coagulation factor VIII, procoagulant component; zinc finger nuclease induced mutant1, Sage gene MP:0001914 hemorrhage IMP N RGD:11530071|PMID:24931420 20190711 RGD 11531096 F8em1Sage coagulation factor VIII, procoagulant component; zinc finger nuclease induced mutant1, Sage gene MP:0002933 joint inflammation treatment IMP N RGD:150520059|PMID:27060449 20211028 RGD 11531096 F8em1Sage coagulation factor VIII, procoagulant component; zinc finger nuclease induced mutant1, Sage gene MP:0002998 abnormal bone remodeling treatment IMP N RGD:150520059|PMID:27060449 20211028 RGD 11531096 F8em1Sage coagulation factor VIII, procoagulant component; zinc finger nuclease induced mutant1, Sage gene MP:0005245 hemarthrosis treatment IMP N RGD:150520059|PMID:27060449 20211028 RGD 11531096 F8em1Sage coagulation factor VIII, procoagulant component; zinc finger nuclease induced mutant1, Sage gene MP:0005245 hemarthrosis treatment IMP N RGD:150520060|PMID:31899798 20211028 RGD 11531096 F8em1Sage coagulation factor VIII, procoagulant component; zinc finger nuclease induced mutant1, Sage gene MP:0005419 decreased circulating serum albumin level IMP N RGD:11530071|PMID:24931420 20190711 RGD 11531096 F8em1Sage coagulation factor VIII, procoagulant component; zinc finger nuclease induced mutant1, Sage gene MP:0005505 thrombocytosis IMP N RGD:11530071|PMID:24931420 20190711 RGD 11531096 F8em1Sage coagulation factor VIII, procoagulant component; zinc finger nuclease induced mutant1, Sage gene MP:0005567 decreased circulating total protein level IMP N RGD:11530071|PMID:24931420 20190711 RGD 11531096 F8em1Sage coagulation factor VIII, procoagulant component; zinc finger nuclease induced mutant1, Sage gene MP:0005606 increased bleeding time treatment IMP N RGD:150520060|PMID:31899798 20211028 RGD 11531096 F8em1Sage coagulation factor VIII, procoagulant component; zinc finger nuclease induced mutant1, Sage gene MP:0009676 abnormal hemostasis treatment IMP N RGD:150520060|PMID:31899798 20211028 RGD 11531096 F8em1Sage coagulation factor VIII, procoagulant component; zinc finger nuclease induced mutant1, Sage gene MP:0012359 increased partial thromboplastin time IMP N RGD:11530071|PMID:24931420 20190711 RGD 11531104 iNP-Npyem6Sage+/-/Iusm strain MP:0001262 decreased body weight IAGP N RGD:11530013|PMID:27461754 20160826 RGD as compared to NP/Iusm; 11531104 iNP-Npyem6Sage+/-/Iusm strain MP:0001987 alcohol preference IAGP N RGD:11530013|PMID:27461754 20160826 RGD as compared to NP/Iusm; 11531104 iNP-Npyem6Sage+/-/Iusm strain MP:0003545 increased alcohol consumption IAGP N RGD:11530013|PMID:27461754 20160826 RGD as compared to NP/Iusm; 11531106 iNP-Npyem6Sage-/-/Iusm strain MP:0001262 decreased body weight IAGP N RGD:11530013|PMID:27461754 20160826 RGD as compared to NP/Iusm; 11532742 Atp7bhts ATPase copper transporting beta; hepatitis gene MP:0000186 decreased circulating HDL cholesterol level IAGP N RGD:2292672|PMID:17303181 20170628 RGD 11532742 Atp7bhts ATPase copper transporting beta; hepatitis gene MP:0000611 jaundice IAGP N RGD:1302456|PMID:11509115 20201214 RGD 11532742 Atp7bhts ATPase copper transporting beta; hepatitis gene MP:0001262 decreased body weight IAGP N RGD:2292672|PMID:17303181 20170628 RGD 11532742 Atp7bhts ATPase copper transporting beta; hepatitis gene MP:0002703 abnormal renal tubule morphology IAGP N RGD:1302456|PMID:11509115 20210218 RGD 11532742 Atp7bhts ATPase copper transporting beta; hepatitis gene MP:0002941 increased circulating alanine transaminase level IAGP N RGD:2292672|PMID:17303181 20170628 RGD 11532742 Atp7bhts ATPase copper transporting beta; hepatitis gene MP:0003066 increased liver copper level IAGP N RGD:2292672|PMID:17303181 20170628 RGD 11532742 Atp7bhts ATPase copper transporting beta; hepatitis gene MP:0003402 decreased liver weight IAGP N RGD:2292672|PMID:17303181 20170628 RGD 11532742 Atp7bhts ATPase copper transporting beta; hepatitis gene MP:0005344 increased circulating bilirubin level IAGP N RGD:2292672|PMID:17303181 20170628 RGD 11532742 Atp7bhts ATPase copper transporting beta; hepatitis gene MP:0006349 decreased circulating copper level IAGP N RGD:2292672|PMID:17303181 20170628 RGD 11532742 Atp7bhts ATPase copper transporting beta; hepatitis gene MP:0008743 decreased liver iron level IAGP N RGD:1302456|PMID:11509115 20210218 RGD compared to LEC/Tj; 11532742 Atp7bhts ATPase copper transporting beta; hepatitis gene MP:0009355 increased liver triglyceride level IAGP N RGD:2292672|PMID:17303181 20170628 RGD 11532742 Atp7bhts ATPase copper transporting beta; hepatitis gene MP:0010027 increased liver cholesterol level IAGP N RGD:2292672|PMID:17303181 20170628 RGD 11532742 Atp7bhts ATPase copper transporting beta; hepatitis gene MP:0031022 hepatic megalocytosis IAGP N RGD:1302456|PMID:11509115 20201214 RGD 11532753 F344.ZUC-(Leprfa),OLETF-(D5Rat166-D5Rat90)/Tj strain MP:0001260 increased body weight IAGP N RGD:11532750|PMID:27523322 20160906 RGD as compared to F344/NSlc; 11532753 F344.ZUC-(Leprfa),OLETF-(D5Rat166-D5Rat90)/Tj strain MP:0003059 decreased insulin secretion IAGP N RGD:11532750|PMID:27523322 20160906 RGD as compared to F344/NSlc; 11532753 F344.ZUC-(Leprfa),OLETF-(D5Rat166-D5Rat90)/Tj strain MP:0005293 impaired glucose tolerance IAGP N RGD:11532750|PMID:27523322 20160906 RGD 11532753 F344.ZUC-(Leprfa),OLETF-(D5Rat166-D5Rat90)/Tj strain MP:0005331 insulin resistance IAGP N RGD:11532750|PMID:27523322 20160906 RGD 11534996 Anks6PKD ankyrin repeat and sterile alpha motif domain containing 6, polycystic kidney disease gene MP:0000208 decreased hematocrit IAGP N RGD:1300446|PMID:7933831 20210211 RGD compared to PKD 11534996 Anks6PKD ankyrin repeat and sterile alpha motif domain containing 6, polycystic kidney disease gene MP:0002083 premature death IAGP N RGD:1300446|PMID:7933831 20210211 RGD 11534996 Anks6PKD ankyrin repeat and sterile alpha motif domain containing 6, polycystic kidney disease gene MP:0003068 enlarged kidney IAGP N RGD:1300446|PMID:7933831 20210211 RGD 11534996 Anks6PKD ankyrin repeat and sterile alpha motif domain containing 6, polycystic kidney disease gene MP:0003917 increased kidney weight IAGP N RGD:1300446|PMID:7933831 20210211 RGD compared to PKD 11534996 Anks6PKD ankyrin repeat and sterile alpha motif domain containing 6, polycystic kidney disease gene MP:0005553 increased circulating creatinine level IAGP N RGD:1300446|PMID:7933831 20210211 RGD compared to PKD 11534996 Anks6PKD ankyrin repeat and sterile alpha motif domain containing 6, polycystic kidney disease gene MP:0005565 increased blood urea nitrogen level IAGP N RGD:1300446|PMID:7933831 20210211 RGD compared to PKD 11553854 Shc1em1Mcwi SHC adaptor protein 1; ZFN induced mutant 1, Medical College of Wisconsin gene MP:0003025 increased vasoconstriction IMP N RGD:12792230|PMID:27270176 20200131 RGD 11553862 SS-Shc1em1Mcwi strain MP:0003025 increased vasoconstriction induced IMP XCO:0000613, XCO:0000022 N RGD:12792230|PMID:27270176 20200131 RGD compared to SS/JrHsdMcwi, SS-Shc1em5Mcwi 11553872 Fmr1em2Mcwi FMRP translational regulator 1; CRISPR/Cas9 induced mutant 2, Medical College of Wisconsin gene MP:0001399 hyperactivity IMP N RGD:401976422|PMID:38378836 20240307 RGD 11553872 Fmr1em2Mcwi FMRP translational regulator 1; CRISPR/Cas9 induced mutant 2, Medical College of Wisconsin gene MP:0001486 abnormal startle reflex no_association IAGP N RGD:35668860|PMID:32144356 20240321 RGD compared to wild type controls 11553872 Fmr1em2Mcwi FMRP translational regulator 1; CRISPR/Cas9 induced mutant 2, Medical College of Wisconsin gene MP:0001486 abnormal startle reflex sexual_dimorphism IAGP N RGD:35668860|PMID:32144356 20240321 RGD in wild type controls 11553872 Fmr1em2Mcwi FMRP translational regulator 1; CRISPR/Cas9 induced mutant 2, Medical College of Wisconsin gene MP:0003088 abnormal prepulse inhibition no_association IAGP N RGD:35668860|PMID:32144356 20240321 RGD compared to wild type controls 11553872 Fmr1em2Mcwi FMRP translational regulator 1; CRISPR/Cas9 induced mutant 2, Medical College of Wisconsin gene MP:0003088 abnormal prepulse inhibition sexual_dimorphism IAGP N RGD:35668860|PMID:32144356 20240321 RGD in wild type controls 11553872 Fmr1em2Mcwi FMRP translational regulator 1; CRISPR/Cas9 induced mutant 2, Medical College of Wisconsin gene MP:0008840 abnormal spike wave discharge IMP N RGD:401976423|PMID:38107412 20240321 RGD compared to wild type controls 11553872 Fmr1em2Mcwi FMRP translational regulator 1; CRISPR/Cas9 induced mutant 2, Medical College of Wisconsin gene MP:0012307 impaired spatial learning IMP N RGD:401976422|PMID:38378836 20240307 RGD 11553872 Fmr1em2Mcwi FMRP translational regulator 1; CRISPR/Cas9 induced mutant 2, Medical College of Wisconsin gene MP:0014255 increased paired-pulse inhibition IMP N RGD:401976422|PMID:38378836 20240307 RGD 11553872 Fmr1em2Mcwi FMRP translational regulator 1; CRISPR/Cas9 induced mutant 2, Medical College of Wisconsin gene MP:0014255 increased paired-pulse inhibition IMP N RGD:401976423|PMID:38107412 20240321 RGD compared to wild type controls 11553872 Fmr1em2Mcwi FMRP translational regulator 1; CRISPR/Cas9 induced mutant 2, Medical College of Wisconsin gene MP:0014365 impaired short-term object recognition memory IMP N RGD:401976422|PMID:38378836 20240321 RGD compared to wild type controls 11553873 LE-Fmr1em2Mcwi strain MP:0001399 hyperactivity IMP N RGD:401976422|PMID:38378836 20240301 RGD compared to wild type controls 11553873 LE-Fmr1em2Mcwi strain MP:0001486 abnormal startle reflex no_association IAGP N RGD:35668860|PMID:32144356 20240319 RGD compared to wild type controls 11553873 LE-Fmr1em2Mcwi strain MP:0001486 abnormal startle reflex sexual_dimorphism IAGP N RGD:35668860|PMID:32144356 20240319 RGD in wild type controls 11553873 LE-Fmr1em2Mcwi strain MP:0003088 abnormal prepulse inhibition no_association IAGP N RGD:35668860|PMID:32144356 20240319 RGD compared to wild type controls 11553873 LE-Fmr1em2Mcwi strain MP:0003088 abnormal prepulse inhibition sexual_dimorphism IAGP N RGD:35668860|PMID:32144356 20240319 RGD in wild type controls 11553873 LE-Fmr1em2Mcwi strain MP:0008840 abnormal spike wave discharge IMP N RGD:401976423|PMID:38107412 20240319 RGD compared to wild type controls 11553873 LE-Fmr1em2Mcwi strain MP:0012307 impaired spatial learning IMP N RGD:401976422|PMID:38378836 20240301 RGD compared to wild type controls 11553873 LE-Fmr1em2Mcwi strain MP:0014255 increased paired-pulse inhibition IMP N RGD:401976422|PMID:38378836 20240301 RGD compared to wild type controls 11553873 LE-Fmr1em2Mcwi strain MP:0014255 increased paired-pulse inhibition IMP N RGD:401976423|PMID:38107412 20240319 RGD compared to wild type controls 11553873 LE-Fmr1em2Mcwi strain MP:0014365 impaired short-term object recognition memory IMP N RGD:401976422|PMID:38378836 20240301 RGD compared to wild type controls 11553911 Trpc6em1Mcwi transient receptor potential cation channel, subfamily C, member 6; CRISPR/Cas9 induced mutant 1, Medical College of Wisconsin gene MP:0001262 decreased body weight induces IMP XCO:0000245,XCO:0000241 N RGD:149735534|PMID:29923767 20210729 RGD compared to wild type and SS-Trpc6em1Mcwi vehicle-treated control 11553911 Trpc6em1Mcwi transient receptor potential cation channel, subfamily C, member 6; CRISPR/Cas9 induced mutant 1, Medical College of Wisconsin gene MP:0002959 increased urine microalbumin level induces IMP XCO:0000245,XCO:0000241 N RGD:149735534|PMID:29923767 20210729 RGD compared to vehicle-treated control 11553911 Trpc6em1Mcwi transient receptor potential cation channel, subfamily C, member 6; CRISPR/Cas9 induced mutant 1, Medical College of Wisconsin gene MP:0005264 glomerulosclerosis induces IMP XCO:0000245,XCO:0000241 N RGD:149735534|PMID:29923767 20210729 RGD compared to wild type vehicle-treated control 11553911 Trpc6em1Mcwi transient receptor potential cation channel, subfamily C, member 6; CRISPR/Cas9 induced mutant 1, Medical College of Wisconsin gene MP:0005558 decreased creatinine clearance induces IMP XCO:0000245,XCO:0000241 N RGD:149735534|PMID:29923767 20210729 RGD compared to STZ-treated wild type 11553911 Trpc6em1Mcwi transient receptor potential cation channel, subfamily C, member 6; CRISPR/Cas9 induced mutant 1, Medical College of Wisconsin gene MP:0005559 increased circulating glucose level induces IMP XCO:0000245,XCO:0000241 N RGD:149735534|PMID:29923767 20210729 RGD compared to vehicle-treated wild type and control 11553911 Trpc6em1Mcwi transient receptor potential cation channel, subfamily C, member 6; CRISPR/Cas9 induced mutant 1, Medical College of Wisconsin gene MP:0011431 increased urine flow rate induces IMP XCO:0000245,XCO:0000241 N RGD:149735534|PMID:29923767 20210729 RGD compared to vehicle-treated wild type and control 11553912 SS-Trpc6em1Mcwi strain MP:0001262 decreased body weight induces IMP XCO:0000245,XCO:0000241 N RGD:149735534|PMID:29923767 20210726 RGD compared to wild type and SS-Trpc6em1Mcwi vehicle-treated control 11553912 SS-Trpc6em1Mcwi strain MP:0002959 increased urine microalbumin level induces IMP XCO:0000245,XCO:0000241 N RGD:149735534|PMID:29923767 20210726 RGD compared to vehicle-treated control 11553912 SS-Trpc6em1Mcwi strain MP:0005264 glomerulosclerosis induces IMP XCO:0000245,XCO:0000241 N RGD:149735534|PMID:29923767 20210726 RGD compared to wild type vehicle-treated control 11553912 SS-Trpc6em1Mcwi strain MP:0005558 decreased creatinine clearance induces IMP XCO:0000245,XCO:0000241 N RGD:149735534|PMID:29923767 20210726 RGD compared to STZ-treated wild type 11553912 SS-Trpc6em1Mcwi strain MP:0005559 increased circulating glucose level induces IMP XCO:0000245,XCO:0000241 N RGD:149735534|PMID:29923767 20210726 RGD compared to vehicle-treated wild type and control 11553912 SS-Trpc6em1Mcwi strain MP:0011431 increased urine flow rate induces IMP XCO:0000245,XCO:0000241 N RGD:149735534|PMID:29923767 20210726 RGD compared to vehicle-treated wild type and control 11553913 Shc1em4Mcwi SHC adaptor protein 1; ZFN induced mutant 4, Medical College of Wisconsin gene MP:0003025 increased vasoconstriction IMP N RGD:12792230|PMID:27270176 20200131 RGD 11553913 Shc1em4Mcwi SHC adaptor protein 1; ZFN induced mutant 4, Medical College of Wisconsin gene MP:0005264 glomerulosclerosis ameliorates IMP N RGD:12792230|PMID:27270176 20210409 RGD 11553913 Shc1em4Mcwi SHC adaptor protein 1; ZFN induced mutant 4, Medical College of Wisconsin gene MP:0005540 decreased urine albumin level IMP N RGD:12792230|PMID:27270176 20200131 RGD 11553914 SS-Shc1em4Mcwi strain MP:0003025 increased vasoconstriction induced IMP XCO:0000022,XCO:0000612 N RGD:12792230|PMID:27270176 20210405 RGD compared to SS-Shc1em5Mcwi 11553914 SS-Shc1em4Mcwi strain MP:0003025 increased vasoconstriction induced IMP XCO:0000613, XCO:0000022 N RGD:12792230|PMID:27270176 20200131 RGD compared to SS/JrHsdMcwi, SS-Shc1em5Mcwi 11553914 SS-Shc1em4Mcwi strain MP:0005264 glomerulosclerosis ameliorates IMP N RGD:12792230|PMID:27270176 20210409 RGD compared to SS/JrHsdMcwi 11553914 SS-Shc1em4Mcwi strain MP:0005540 decreased urine albumin level IMP N RGD:12792230|PMID:27270176 20200131 RGD compared to SS/JrHsdMcwi 11553915 Shc1em5Mcwi SHC adaptor protein 1; ZFN induced mutant 5, Medical College of Wisconsin gene MP:0011296 decreased tubuloglomerular feedback response IMP N RGD:12792230|PMID:27270176 20200131 RGD 11553916 SS-Shc1em5Mcwi strain MP:0011296 decreased tubuloglomerular feedback response IMP N RGD:12792230|PMID:27270176 20200131 RGD compared to SS-Chr 2BN/Mcwi,SS-Shc1em1Mcwi, SS-Shc1em4Mcwi 11554327 BDIX.BDIV-D10Mit3-D10Mgh16/Zte strain MP:0004502 decreased incidence of tumors by chemical induction IAGP N RGD:11554205|PMID:26530423 20161026 RGD 11554329 BDIX.BDIV-D10Got1-D10Rat45/Zte strain MP:0004502 decreased incidence of tumors by chemical induction IAGP N RGD:11554205|PMID:26530423 20161026 RGD 11556286 Cm81 Cardiac mass QTL 81 qtl MP:0002834 decreased heart weight susceptibility IAGP N RGD:61054|PMID:9045857 20161102 RGD 11564348 Aspaem34Kyo aspartoacylase;TALEN induced mutant 34,Kyo gene MP:0008025 brain vacuoles IMP N RGD:13464274|PMID:27026062 20180103 RGD 11564348 Aspaem34Kyo aspartoacylase;TALEN induced mutant 34,Kyo gene MP:0013438 dysmyelination IMP N RGD:13464274|PMID:27026062 20180103 RGD 11564349 F344-Aspaem34Kyo strain MP:0008025 brain vacuoles IMP N RGD:13464274|PMID:27026062 20180103 RGD 11564349 F344-Aspaem34Kyo strain MP:0013438 dysmyelination IMP N RGD:13464274|PMID:27026062 20180103 RGD 11564350 SCR/Sscr Shumiya Cataract Rat strain MP:0003983 decreased cholesterol level IAGP N RGD:1626611|PMID:16440058 20210521 RGD lens 11564350 SCR/Sscr Shumiya Cataract Rat strain MP:0005178 increased circulating cholesterol level IAGP N RGD:1626611|PMID:16440058 20210521 RGD 11564350 SCR/Sscr Shumiya Cataract Rat strain MP:0010161 decreased brain cholesterol level IAGP N RGD:1626611|PMID:16440058 20210521 RGD 11565090 Ccdc85cem1Kyo coiled-coil domain containing 85C; TALEN induced mutant1,Kyo gene MP:0001915 intracranial hemorrhage IMP N RGD:150520163|PMID:31341137 20211104 RGD 11565090 Ccdc85cem1Kyo coiled-coil domain containing 85C; TALEN induced mutant1,Kyo gene MP:0002083 premature death IMP N RGD:150520163|PMID:31341137 20211104 RGD 11565091 F344-Ccdc85cem1Kyo strain MP:0001915 intracranial hemorrhage IMP N RGD:150520163|PMID:31341137 20211028 RGD 11565091 F344-Ccdc85cem1Kyo strain MP:0002083 premature death IMP N RGD:150520163|PMID:31341137 20211028 RGD 11565180 Kidm56 Kidney mass QTL 56 qtl MP:0002707 abnormal kidney weight IAGP N RGD:1599557|PMID:17143582 20170425 RGD 11565181 Bw176 Body weight QTL 176 qtl MP:0001259 abnormal body weight IAGP N RGD:1599557|PMID:17143582 20170426 RGD 11565451 Bw177 Body weight QTL 177 qtl MP:0001259 abnormal body weight IAGP N RGD:1599557|PMID:17143582 20170426 RGD 11565452 Kidm57 Kidney mass QTL 57 qtl MP:0002707 abnormal kidney weight IAGP N RGD:1599557|PMID:17143582 20170425 RGD 11565453 Kidm58 Kidney mass QTL 58 qtl MP:0002707 abnormal kidney weight IAGP N RGD:1599557|PMID:17143582 20170425 RGD 11565454 Kidm59 Kidney mass QTL 59 qtl MP:0002707 abnormal kidney weight IAGP N RGD:1599557|PMID:17143582 20170425 RGD 11565825 Ttnem1Sage Titin; zinc finger nuclease induced mutant 1,Sigma Advanced Genetic Engineering Labs gene MP:0002972 abnormal cardiac muscle contractility IAGP N RGD:11565821|PMID:27869827 20170711 RGD 11565825 Ttnem1Sage Titin; zinc finger nuclease induced mutant 1,Sigma Advanced Genetic Engineering Labs gene MP:0020419 decreased cardiac muscle relaxation IAGP N RGD:11565821|PMID:27869827 20170711 RGD 11565826 F344-Ttnem1Sage strain MP:0002972 abnormal cardiac muscle contractility IAGP N RGD:11565821|PMID:27869827 20161129 RGD 11565826 F344-Ttnem1Sage strain MP:0020419 decreased cardiac muscle relaxation IAGP N RGD:11565821|PMID:27869827 20161129 RGD 11565827 Ttnem2Sage Titin; zinc finger nuclease induced mutant 2,Sigma Advanced Genetic Engineering Labs gene MP:0000280 thin ventricular wall IAGP N RGD:11565821|PMID:27869827 20170711 RGD 11565827 Ttnem2Sage Titin; zinc finger nuclease induced mutant 2,Sigma Advanced Genetic Engineering Labs gene MP:0002972 abnormal cardiac muscle contractility IAGP N RGD:11565821|PMID:27869827 20170711 RGD 11565827 Ttnem2Sage Titin; zinc finger nuclease induced mutant 2,Sigma Advanced Genetic Engineering Labs gene MP:0003824 decreased left ventricle developed pressure IAGP N RGD:11565821|PMID:27869827 20170711 RGD 11565827 Ttnem2Sage Titin; zinc finger nuclease induced mutant 2,Sigma Advanced Genetic Engineering Labs gene MP:0011952 decreased cardiac stroke volume IAGP N RGD:11565821|PMID:27869827 20170711 RGD 11565827 Ttnem2Sage Titin; zinc finger nuclease induced mutant 2,Sigma Advanced Genetic Engineering Labs gene MP:0020419 decreased cardiac muscle relaxation IAGP N RGD:11565821|PMID:27869827 20170711 RGD 11565829 F344-Ttnem2Sage strain MP:0000280 thin ventricular wall IAGP N RGD:11565821|PMID:27869827 20161128 RGD 11565829 F344-Ttnem2Sage strain MP:0002972 abnormal cardiac muscle contractility IAGP N RGD:11565821|PMID:27869827 20161129 RGD 11565829 F344-Ttnem2Sage strain MP:0003824 decreased left ventricle developed pressure IAGP N RGD:11565821|PMID:27869827 20161129 RGD 11565829 F344-Ttnem2Sage strain MP:0011952 decreased cardiac stroke volume IAGP N RGD:11565821|PMID:27869827 20161128 RGD 11565829 F344-Ttnem2Sage strain MP:0020419 decreased cardiac muscle relaxation IAGP N RGD:11565821|PMID:27869827 20161129 RGD 11567272 SD-Mecp2em1Sage strain MP:0000120 malocclusion IMP N RGD:11568037|PMID:27313794 20210318 RGD 11567272 SD-Mecp2em1Sage strain MP:0000120 malocclusion sexual_dimorphism IMP N RGD:40924662|PMID:27329765 20210323 RGD compared to female heterozygote mutant 11567272 SD-Mecp2em1Sage strain MP:0001255 decreased body height IMP N RGD:11568037|PMID:27313794 20210318 RGD 11567272 SD-Mecp2em1Sage strain MP:0001260 increased body weight sexual_dimorphism IMP N RGD:40924662|PMID:27329765 20210323 RGD compared to SD wild-type female 11567272 SD-Mecp2em1Sage strain MP:0001262 decreased body weight IMP N RGD:11568037|PMID:27313794 20210318 RGD 11567272 SD-Mecp2em1Sage strain MP:0001402 decreased locomotor activity IMP N RGD:11568037|PMID:27313794 20210318 RGD 11567272 SD-Mecp2em1Sage strain MP:0001402 decreased locomotor activity IMP N RGD:40924662|PMID:27329765 20210323 RGD compared to SD wild-type 11567272 SD-Mecp2em1Sage strain MP:0001407 short stride length IMP N RGD:40924662|PMID:27329765 20210323 RGD compared to SD wild-type 11567272 SD-Mecp2em1Sage strain MP:0001513 limb grasping penetrance IMP N RGD:40924662|PMID:27329765 20210323 RGD compared to SD wild-type 11567272 SD-Mecp2em1Sage strain MP:0001516 abnormal motor coordination/balance IMP N RGD:40924662|PMID:27329765 20210323 RGD compared to SD wild-type 11567272 SD-Mecp2em1Sage strain MP:0002083 premature death sexual_dimorphism IMP N RGD:40924662|PMID:27329765 20210323 RGD compared to male SD wild-type 11567272 SD-Mecp2em1Sage strain MP:0002175 decreased brain weight IMP N RGD:40924662|PMID:27329765 20210323 RGD compared to SD wild-type 11567272 SD-Mecp2em1Sage strain MP:0002669 abnormal scrotum morphology IMP N RGD:40924662|PMID:27329765 20210323 RGD compared to SD wild-type male 11567272 SD-Mecp2em1Sage strain MP:0005402 abnormal action potential IMP N RGD:11568037|PMID:27313794 20210318 RGD 11567272 SD-Mecp2em1Sage strain MP:0005572 abnormal pulmonary respiratory rate IMP N RGD:11568037|PMID:27313794 20210318 RGD 11567272 SD-Mecp2em1Sage strain MP:0005573 increased pulmonary respiratory rate sexual_dimorphism IMP N RGD:40924662|PMID:27329765 20210323 RGD compared to SD wild-type female 11567272 SD-Mecp2em1Sage strain MP:0005574 decreased pulmonary respiratory rate sexual_dimorphism IMP N RGD:40924662|PMID:27329765 20210323 RGD compared to SD wild-type male 11567272 SD-Mecp2em1Sage strain MP:0009004 progressive hair loss IMP N RGD:40924662|PMID:27329765 20210323 RGD compared to SD wild-type 11567272 SD-Mecp2em1Sage strain MP:0009105 penis prolapse IMP N RGD:11568037|PMID:27313794 20210318 RGD 11567272 SD-Mecp2em1Sage strain MP:0010053 decreased grip strength IMP N RGD:11568037|PMID:27313794 20210318 RGD 11567272 SD-Mecp2em1Sage strain MP:0010179 rough coat sexual_dimorphism IMP N RGD:40924662|PMID:27329765 20210323 RGD compared to SD wild-type male 11567272 SD-Mecp2em1Sage strain MP:0010946 hyperpnea IMP N RGD:11568037|PMID:27313794 20210318 RGD 11567272 SD-Mecp2em1Sage strain MP:0020395 abnormal response to social novelty IMP N RGD:11568037|PMID:27313794 20210318 RGD 11568035 Mecp2em1Sage methyl CpG binding protein 2; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0000120 malocclusion IMP N RGD:11568037|PMID:27313794 20210325 RGD 11568035 Mecp2em1Sage methyl CpG binding protein 2; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0000120 malocclusion sexual_dimorphism IMP N RGD:40924662|PMID:27329765 20210325 RGD compared to female heterozygote mutant 11568035 Mecp2em1Sage methyl CpG binding protein 2; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0001255 decreased body height IMP N RGD:11568037|PMID:27313794 20210325 RGD 11568035 Mecp2em1Sage methyl CpG binding protein 2; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0001260 increased body weight sexual_dimorphism IMP N RGD:40924662|PMID:27329765 20210325 RGD compared to SD wild-type female 11568035 Mecp2em1Sage methyl CpG binding protein 2; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0001262 decreased body weight IMP N RGD:11568037|PMID:27313794 20210325 RGD 11568035 Mecp2em1Sage methyl CpG binding protein 2; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0001402 decreased locomotor activity IMP N RGD:11568037|PMID:27313794 20210325 RGD 11568035 Mecp2em1Sage methyl CpG binding protein 2; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0001402 decreased locomotor activity IMP N RGD:40924662|PMID:27329765 20210325 RGD compared to SD wild-type 11568035 Mecp2em1Sage methyl CpG binding protein 2; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0001407 short stride length IMP N RGD:40924662|PMID:27329765 20210325 RGD compared to SD wild-type 11568035 Mecp2em1Sage methyl CpG binding protein 2; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0001513 limb grasping IMP N RGD:40924662|PMID:27329765 20210325 RGD compared to SD wild-type 11568035 Mecp2em1Sage methyl CpG binding protein 2; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0001516 abnormal motor coordination/balance IMP N RGD:40924662|PMID:27329765 20210325 RGD compared to SD wild-type 11568035 Mecp2em1Sage methyl CpG binding protein 2; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0002083 premature death sexual_dimorphism IMP N RGD:40924662|PMID:27329765 20210325 RGD compared to male SD wild-type 11568035 Mecp2em1Sage methyl CpG binding protein 2; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0002175 decreased brain weight IMP N RGD:40924662|PMID:27329765 20210325 RGD compared to SD wild-type 11568035 Mecp2em1Sage methyl CpG binding protein 2; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0002669 abnormal scrotum morphology IMP N RGD:40924662|PMID:27329765 20210325 RGD compared to SD wild-type male 11568035 Mecp2em1Sage methyl CpG binding protein 2; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0005402 abnormal action potential IMP N RGD:11568037|PMID:27313794 20210325 RGD 11568035 Mecp2em1Sage methyl CpG binding protein 2; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0005572 abnormal pulmonary respiratory rate IMP N RGD:11568037|PMID:27313794 20210325 RGD 11568035 Mecp2em1Sage methyl CpG binding protein 2; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0005573 increased pulmonary respiratory rate sexual_dimorphism IMP N RGD:40924662|PMID:27329765 20210325 RGD compared to SD wild-type female 11568035 Mecp2em1Sage methyl CpG binding protein 2; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0005574 decreased pulmonary respiratory rate sexual_dimorphism IMP N RGD:40924662|PMID:27329765 20210325 RGD compared to SD wild-type male 11568035 Mecp2em1Sage methyl CpG binding protein 2; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0009004 progressive hair loss IMP N RGD:40924662|PMID:27329765 20210325 RGD compared to SD wild-type 11568035 Mecp2em1Sage methyl CpG binding protein 2; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0009105 penis prolapse IMP N RGD:11568037|PMID:27313794 20210325 RGD 11568035 Mecp2em1Sage methyl CpG binding protein 2; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0010053 decreased grip strength IMP N RGD:11568037|PMID:27313794 20210325 RGD 11568035 Mecp2em1Sage methyl CpG binding protein 2; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0010179 rough coat sexual_dimorphism IMP N RGD:40924662|PMID:27329765 20210325 RGD compared to SD wild-type male 11568035 Mecp2em1Sage methyl CpG binding protein 2; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0010946 hyperpnea IMP N RGD:11568037|PMID:27313794 20210325 RGD 11568035 Mecp2em1Sage methyl CpG binding protein 2; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0020395 abnormal response to social novelty IMP N RGD:11568037|PMID:27313794 20210325 RGD 11568040 SD-Fmr1em1Sage strain MP:0001148 enlarged testis IMP N RGD:38548928|PMID:30877790 20200922 RGD DNA:deletion:intron 7, exon 8: 11568040 SD-Fmr1em1Sage strain MP:0001148 enlarged testis IMP N RGD:9831152|PMID:24773431 20170921 RGD 11568040 SD-Fmr1em1Sage strain MP:0001262 decreased body weight IMP N RGD:405100966|PMID:35328827 20240329 RGD compared to wild type 11568040 SD-Fmr1em1Sage strain MP:0001399 hyperactivity IMP N RGD:401976427|PMID:36581671 20240320 RGD compared to wild type controls 11568040 SD-Fmr1em1Sage strain MP:0002803 abnormal operant conditioning behavior IMP N RGD:38548928|PMID:30877790 20200922 RGD compared to SD control, DNA:deletion:intron 7, exon 8: 11568040 SD-Fmr1em1Sage strain MP:0002882 abnormal neuron morphology IMP N RGD:11080370|PMID:26166728 20240319 RGD compared to wild type controls 11568040 SD-Fmr1em1Sage strain MP:0003412 abnormal afterhyperpolarization IMP N RGD:401976434|PMID:36536454 20240321 RGD 11568040 SD-Fmr1em1Sage strain MP:0005179 decreased circulating cholesterol level IMP N RGD:405100966|PMID:35328827 20240329 RGD compared to wild type 11568040 SD-Fmr1em1Sage strain MP:0009141 increased prepulse inhibition IMP N RGD:9831152|PMID:24773431 20170921 RGD 11568040 SD-Fmr1em1Sage strain MP:0010026 decreased liver cholesterol level IMP N RGD:405100966|PMID:35328827 20240329 RGD compared to wild type 11568040 SD-Fmr1em1Sage strain MP:0010748 abnormal visual evoked potential IMP N RGD:38548926|PMID:27465362 20200922 RGD compared to SD control, DNA:deletion:intron 7, exon 8: 11568040 SD-Fmr1em1Sage strain MP:0011620 abnormal habituation to a new environment IMP N RGD:401976434|PMID:36536454 20240321 RGD 11568040 SD-Fmr1em1Sage strain MP:0011940 decreased food intake IMP N RGD:405100966|PMID:35328827 20240329 RGD compared to wild type 11568040 SD-Fmr1em1Sage strain MP:0012006 abnormal hippocampus physiology IMP N RGD:401976434|PMID:36536454 20240321 RGD 11568040 SD-Fmr1em1Sage strain MP:0012307 impaired spatial learning IMP N RGD:401976434|PMID:36536454 20240321 RGD 11568040 SD-Fmr1em1Sage strain MP:0012343 increased gnawing activity IMP N RGD:9831152|PMID:24773431 20170921 RGD 11568040 SD-Fmr1em1Sage strain MP:0020437 abnormal social play behavior IMP N RGD:9831152|PMID:24773431 20170921 RGD 11568040 SD-Fmr1em1Sage strain MP:0020870 decreased thigmotaxis onset IMP N RGD:401976427|PMID:36581671 20240320 RGD in juveniles, compared to wild type controls 11568040 SD-Fmr1em1Sage strain MP:0021119 abnormal auditory behavior IMP N RGD:405100968|PMID:34751141 20240329 RGD compared to wild type 11568040 SD-Fmr1em1Sage strain MP:0031391 increased locomotor activity IMP N RGD:401976434|PMID:36536454 20240321 RGD 11568041 Fmr1em1Sage FMRP translational regulator 1; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0001148 enlarged testis IMP N RGD:38548928|PMID:30877790 20200922 RGD DNA:deletion:intron 7, exon 8: 11568041 Fmr1em1Sage FMRP translational regulator 1; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0001148 enlarged testis IMP N RGD:9831152|PMID:24773431 20170921 RGD 11568041 Fmr1em1Sage FMRP translational regulator 1; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0001262 decreased body weight IMP N RGD:405100966|PMID:35328827 20240404 RGD compared to wild type 11568041 Fmr1em1Sage FMRP translational regulator 1; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0001399 hyperactivity IMP N RGD:401976427|PMID:36581671 20240321 RGD compared to wild type controls 11568041 Fmr1em1Sage FMRP translational regulator 1; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0002803 abnormal operant conditioning behavior IMP N RGD:38548928|PMID:30877790 20200922 RGD DNA:deletion:intron 7, exon 8: 11568041 Fmr1em1Sage FMRP translational regulator 1; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0002882 abnormal neuron morphology IMP N RGD:11080370|PMID:26166728 20240321 RGD compared to wild type controls 11568041 Fmr1em1Sage FMRP translational regulator 1; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0003412 abnormal afterhyperpolarization IMP N RGD:401976434|PMID:36536454 20240328 RGD 11568041 Fmr1em1Sage FMRP translational regulator 1; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0005179 decreased circulating cholesterol level IMP N RGD:405100966|PMID:35328827 20240404 RGD compared to wild type 11568041 Fmr1em1Sage FMRP translational regulator 1; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0009141 increased prepulse inhibition IMP N RGD:9831152|PMID:24773431 20170921 RGD 11568041 Fmr1em1Sage FMRP translational regulator 1; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0010026 decreased liver cholesterol level IMP N RGD:405100966|PMID:35328827 20240404 RGD compared to wild type 11568041 Fmr1em1Sage FMRP translational regulator 1; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0010748 abnormal visual evoked potential IMP N RGD:38548926|PMID:27465362 20200922 RGD DNA:deletion:intron 7, exon 8: 11568041 Fmr1em1Sage FMRP translational regulator 1; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0011620 abnormal habituation to a new environment IMP N RGD:401976434|PMID:36536454 20240328 RGD 11568041 Fmr1em1Sage FMRP translational regulator 1; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0011940 decreased food intake IMP N RGD:405100966|PMID:35328827 20240404 RGD compared to wild type 11568041 Fmr1em1Sage FMRP translational regulator 1; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0012006 abnormal hippocampus physiology IMP N RGD:401976434|PMID:36536454 20240328 RGD 11568041 Fmr1em1Sage FMRP translational regulator 1; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0012307 impaired spatial learning IMP N RGD:401976434|PMID:36536454 20240328 RGD 11568041 Fmr1em1Sage FMRP translational regulator 1; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0012343 increased gnawing activity IMP N RGD:9831152|PMID:24773431 20170921 RGD 11568041 Fmr1em1Sage FMRP translational regulator 1; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0020437 abnormal social play behavior IMP N RGD:9831152|PMID:24773431 20170921 RGD 11568041 Fmr1em1Sage FMRP translational regulator 1; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0020870 decreased thigmotaxis onset IMP N RGD:401976427|PMID:36581671 20240321 RGD in juveniles, compared to wild type controls 11568041 Fmr1em1Sage FMRP translational regulator 1; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0021119 abnormal auditory behavior IMP N RGD:405100968|PMID:34751141 20240404 RGD compared to wild type 11568041 Fmr1em1Sage FMRP translational regulator 1; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0031391 increased locomotor activity IMP N RGD:401976434|PMID:36536454 20240328 RGD 11568058 SD-Nrxn1em1Sage strain MP:0001262 decreased body weight IMP N RGD:12914797|PMID:25420124 20210521 RGD compared to wild type littermate 11568058 SD-Nrxn1em1Sage strain MP:0001399 hyperactivity IMP N RGD:12914797|PMID:25420124 20210521 RGD 11568058 SD-Nrxn1em1Sage strain MP:0001488 increased startle reflex IMP N RGD:12914797|PMID:25420124 20210521 RGD compared to wild type littermate 11568058 SD-Nrxn1em1Sage strain MP:0011620 abnormal habituation to a new environment IMP N RGD:12914797|PMID:25420124 20210521 RGD 11568058 SD-Nrxn1em1Sage strain MP:0012296 impaired discrimination learning sexual_dimorphism IMP N RGD:12914797|PMID:25420124 20210521 RGD compared to wild type male 11568059 Nrxn1em1 neurexin 1; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0001262 decreased body weight IMP N RGD:12914797|PMID:25420124 20210527 RGD compared to wild type littermate 11568059 Nrxn1em1 neurexin 1; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0001399 hyperactivity IMP N RGD:12914797|PMID:25420124 20210527 RGD 11568059 Nrxn1em1 neurexin 1; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0001488 increased startle reflex IMP N RGD:12914797|PMID:25420124 20210527 RGD compared to wild type littermate 11568059 Nrxn1em1 neurexin 1; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0011620 abnormal habituation to a new environment IMP N RGD:12914797|PMID:25420124 20210527 RGD 11568059 Nrxn1em1 neurexin 1; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0012296 impaired discrimination learning sexual_dimorphism IMP N RGD:12914797|PMID:25420124 20210527 RGD compared to wild type male 11568646 SD-Cntnap2em1Sage strain MP:0001262 decreased body weight IMP N RGD:126790476|PMID:30126973 20210422 RGD in males 11568646 SD-Cntnap2em1Sage strain MP:0001399 hyperactivity IMP N RGD:126790476|PMID:30126973 20210422 RGD 11568646 SD-Cntnap2em1Sage strain MP:0001399 hyperactivity IMP N RGD:12880397|PMID:28364455 20170505 RGD 11568646 SD-Cntnap2em1Sage strain MP:0001488 increased startle reflex IMP N RGD:126790476|PMID:30126973 20210422 RGD 11568646 SD-Cntnap2em1Sage strain MP:0001501 abnormal sleep pattern IMP N RGD:12880397|PMID:28364455 20170505 RGD 11568646 SD-Cntnap2em1Sage strain MP:0003088 abnormal prepulse inhibition IMP N RGD:126790476|PMID:30126973 20210422 RGD worsens with age 11568646 SD-Cntnap2em1Sage strain MP:0004738 abnormal auditory brainstem response IMP N RGD:126790476|PMID:30126973 20210422 RGD peak amplitudes and transmission latency 11568646 SD-Cntnap2em1Sage strain MP:0009358 environmentally induced seizures IMP N RGD:12880397|PMID:28364455 20170505 RGD 11568646 SD-Cntnap2em1Sage strain MP:0011617 abnormal habituation IMP N RGD:126790476|PMID:30126973 20210422 RGD in young animals 11568647 Cntnap2em1Sage contactin associated protein-like 2; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0001262 decreased body weight IMP N RGD:126790476|PMID:30126973 20210429 RGD in males 11568647 Cntnap2em1Sage contactin associated protein-like 2; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0001399 hyperactivity IMP N RGD:126790476|PMID:30126973 20210429 RGD 11568647 Cntnap2em1Sage contactin associated protein-like 2; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0001399 hyperactivity IMP N RGD:12880397|PMID:28364455 20170505 RGD 11568647 Cntnap2em1Sage contactin associated protein-like 2; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0001488 increased startle reflex IMP N RGD:126790476|PMID:30126973 20210429 RGD 11568647 Cntnap2em1Sage contactin associated protein-like 2; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0001501 abnormal sleep pattern IMP N RGD:12880397|PMID:28364455 20170505 RGD 11568647 Cntnap2em1Sage contactin associated protein-like 2; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0003088 abnormal prepulse inhibition IMP N RGD:126790476|PMID:30126973 20210429 RGD worsens with age 11568647 Cntnap2em1Sage contactin associated protein-like 2; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0004738 abnormal auditory brainstem response IMP N RGD:126790476|PMID:30126973 20210429 RGD peak amplitudes and transmission latency 11568647 Cntnap2em1Sage contactin associated protein-like 2; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0009358 environmentally induced seizures IMP N RGD:12880397|PMID:28364455 20170505 RGD 11568647 Cntnap2em1Sage contactin associated protein-like 2; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0011617 abnormal habituation IMP N RGD:126790476|PMID:30126973 20210429 RGD in young animals 11568700 SD-Nlgn3em1Sage strain MP:0001262 decreased body weight IMP N RGD:126790492|PMID:28958035 20210423 RGD 11568700 SD-Nlgn3em1Sage strain MP:0001262 decreased body weight IMP N RGD:9831152|PMID:24773431 20170921 RGD 11568700 SD-Nlgn3em1Sage strain MP:0001360 abnormal social investigation IMP N RGD:126790492|PMID:28958035 20210423 RGD 11568700 SD-Nlgn3em1Sage strain MP:0001363 increased anxiety-related response IMP N RGD:126790492|PMID:28958035 20210423 RGD 11568700 SD-Nlgn3em1Sage strain MP:0001364 decreased anxiety-related response IMP N RGD:9831152|PMID:24773431 20170921 RGD 11568700 SD-Nlgn3em1Sage strain MP:0001399 hyperactivity IMP N RGD:126790492|PMID:28958035 20210423 RGD 11568700 SD-Nlgn3em1Sage strain MP:0001441 increased grooming behavior IMP N RGD:9831152|PMID:24773431 20170921 RGD 11568700 SD-Nlgn3em1Sage strain MP:0002574 increased vertical activity IMP N RGD:9831152|PMID:24773431 20170921 RGD 11568700 SD-Nlgn3em1Sage strain MP:0004994 abnormal brain wave pattern IMP N RGD:126790492|PMID:28958035 20210423 RGD 11568700 SD-Nlgn3em1Sage strain MP:0009142 decreased prepulse inhibition IMP N RGD:126790492|PMID:28958035 20210423 RGD 11568700 SD-Nlgn3em1Sage strain MP:0009142 decreased prepulse inhibition IMP N RGD:9831152|PMID:24773431 20170921 RGD 11568700 SD-Nlgn3em1Sage strain MP:0012288 abnormal paradoxical sleep pattern IMP N RGD:126790492|PMID:28958035 20210423 RGD during light cycle 11568700 SD-Nlgn3em1Sage strain MP:0012289 abnormal non-rapid eye movement sleep pattern IMP N RGD:126790492|PMID:28958035 20210423 RGD during light cycle 11568700 SD-Nlgn3em1Sage strain MP:0012343 increased gnawing activity IMP N RGD:126790492|PMID:28958035 20210423 RGD 11568700 SD-Nlgn3em1Sage strain MP:0012343 increased gnawing activity IMP N RGD:9831152|PMID:24773431 20170921 RGD 11568700 SD-Nlgn3em1Sage strain MP:0020437 abnormal social play behavior IMP N RGD:126790492|PMID:28958035 20210423 RGD 11568700 SD-Nlgn3em1Sage strain MP:0020437 abnormal social play behavior IMP N RGD:9831152|PMID:24773431 20170921 RGD 11568701 Nlgn3em1Sage neuroligin 3; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0001262 decreased body weight IMP N RGD:126790492|PMID:28958035 20210429 RGD 11568701 Nlgn3em1Sage neuroligin 3; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0001262 decreased body weight IMP N RGD:9831152|PMID:24773431 20170921 RGD 11568701 Nlgn3em1Sage neuroligin 3; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0001360 abnormal social investigation IMP N RGD:126790492|PMID:28958035 20210429 RGD 11568701 Nlgn3em1Sage neuroligin 3; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0001363 increased anxiety-related response IMP N RGD:126790492|PMID:28958035 20210429 RGD 11568701 Nlgn3em1Sage neuroligin 3; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0001364 decreased anxiety-related response IMP N RGD:9831152|PMID:24773431 20170921 RGD 11568701 Nlgn3em1Sage neuroligin 3; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0001399 hyperactivity IMP N RGD:126790492|PMID:28958035 20210429 RGD 11568701 Nlgn3em1Sage neuroligin 3; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0001441 increased grooming behavior IMP N RGD:9831152|PMID:24773431 20170921 RGD 11568701 Nlgn3em1Sage neuroligin 3; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0002574 increased vertical activity IMP N RGD:9831152|PMID:24773431 20170921 RGD 11568701 Nlgn3em1Sage neuroligin 3; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0004994 abnormal brain wave pattern IMP N RGD:126790492|PMID:28958035 20210429 RGD 11568701 Nlgn3em1Sage neuroligin 3; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0009142 decreased prepulse inhibition IMP N RGD:126790492|PMID:28958035 20210429 RGD 11568701 Nlgn3em1Sage neuroligin 3; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0009142 decreased prepulse inhibition IMP N RGD:9831152|PMID:24773431 20170921 RGD 11568701 Nlgn3em1Sage neuroligin 3; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0012288 abnormal paradoxical sleep pattern IMP N RGD:126790492|PMID:28958035 20210429 RGD during light cycle 11568701 Nlgn3em1Sage neuroligin 3; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0012289 abnormal non-rapid eye movement sleep pattern IMP N RGD:126790492|PMID:28958035 20210429 RGD during light cycle 11568701 Nlgn3em1Sage neuroligin 3; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0012343 increased gnawing activity IMP N RGD:126790492|PMID:28958035 20210429 RGD 11568701 Nlgn3em1Sage neuroligin 3; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0012343 increased gnawing activity IMP N RGD:9831152|PMID:24773431 20170921 RGD 11568701 Nlgn3em1Sage neuroligin 3; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0020437 abnormal social play behavior IMP N RGD:126790492|PMID:28958035 20210429 RGD 11568701 Nlgn3em1Sage neuroligin 3; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0020437 abnormal social play behavior IMP N RGD:9831152|PMID:24773431 20170921 RGD 11568703 SD-Cacna1cem1Sage strain MP:0001441 increased grooming behavior IMP N RGD:42724472|PMID:30902660 20210310 RGD compared to wild-type female 11568703 SD-Cacna1cem1Sage strain MP:0001529 abnormal vocalization IMP N RGD:42724471|PMID:29739816 20210310 RGD compared to wide-type male 11568703 SD-Cacna1cem1Sage strain MP:0001529 abnormal vocalization IMP N RGD:42724472|PMID:30902660 20210310 RGD compared to wild-type female 11568703 SD-Cacna1cem1Sage strain MP:0002757 decreased vertical activity IMP N RGD:42724472|PMID:30902660 20210310 RGD compared to wild-type female 11568703 SD-Cacna1cem1Sage strain MP:0012307 impaired spatial learning sexual_dimorphism IMP N RGD:42724470|PMID:29800644 20210310 RGD compared to female wild-type 11568703 SD-Cacna1cem1Sage strain MP:0014115 cognitive inflexibility sexual_dimorphism IMP N RGD:42724470|PMID:29800644 20210310 RGD compared to male wild-type 11568703 SD-Cacna1cem1Sage strain MP:0020437 abnormal social play behavior IMP N RGD:42724471|PMID:29739816 20210310 RGD compared to wide-type male 11568704 Cacna1cem1Sage calcium voltage-gated channel subunit alpha1 C; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0001441 increased grooming behavior IMP N RGD:42724472|PMID:30902660 20210311 RGD compared to wild-type female 11568704 Cacna1cem1Sage calcium voltage-gated channel subunit alpha1 C; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0001529 abnormal vocalization IMP N RGD:42724471|PMID:29739816 20210311 RGD compared to wide-type male 11568704 Cacna1cem1Sage calcium voltage-gated channel subunit alpha1 C; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0001529 abnormal vocalization IMP N RGD:42724472|PMID:30902660 20210311 RGD compared to wild-type female 11568704 Cacna1cem1Sage calcium voltage-gated channel subunit alpha1 C; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0002757 decreased vertical activity IMP N RGD:42724472|PMID:30902660 20210311 RGD compared to wild-type female 11568704 Cacna1cem1Sage calcium voltage-gated channel subunit alpha1 C; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0012307 impaired spatial learning sexual_dimorphism IMP N RGD:42724470|PMID:29800644 20210311 RGD compared to female wild-type 11568704 Cacna1cem1Sage calcium voltage-gated channel subunit alpha1 C; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0014115 cognitive inflexibility sexual_dimorphism IMP N RGD:42724470|PMID:29800644 20210311 RGD compared to male wild-type 11568704 Cacna1cem1Sage calcium voltage-gated channel subunit alpha1 C; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0020437 abnormal social play behavior IMP N RGD:42724471|PMID:29739816 20210311 RGD compared to wide-type male 11570416 Krt71Rex keratin 71; autosomal dominant Rex gene MP:0003810 abnormal hair cuticle IAGP N RGD:11570415|PMID:20179389 20211028 RGD DNA:deletion:cds:intron 1, p.Val149_Gln154 del 11570416 Krt71Rex keratin 71; autosomal dominant Rex gene MP:0009004 progressive hair loss IAGP N RGD:11570415|PMID:20179389 20211028 RGD DNA:deletion:cds:intron 1, p.Val149_Gln154 del 11570416 Krt71Rex keratin 71; autosomal dominant Rex gene MP:0009351 thin hair shaft IAGP N RGD:11570415|PMID:20179389 20211028 RGD DNA:deletion:cds:intron 1, p.Val149_Gln154 del 11570416 Krt71Rex keratin 71; autosomal dominant Rex gene MP:0010699 dilated hair follicle IAGP N RGD:11570415|PMID:20179389 20211028 RGD DNA:deletion:cds:intron 1, p.Val149_Gln154 del 11570565 Leprcp leptin receptor;corpulent gene MP:0005669 increased circulating leptin level IAGP N RGD:11570540|PMID:9032111 20210211 RGD compared to lean littermates 11570565 Leprcp leptin receptor;corpulent gene MP:0006087 increased body mass index IAGP N RGD:11570540|PMID:9032111 20210211 RGD compared to lean littermates 11667077 SD-Esr2em2Soar strain MP:0001134 absent corpus luteum IMP N RGD:38548924|PMID:28520870 20200825 RGD 11667077 SD-Esr2em2Soar strain MP:0001134 absent corpus luteum IMP N RGD:38548925|PMID:29580824 20200825 RGD 11667077 SD-Esr2em2Soar strain MP:0001926 female infertility IMP N RGD:38548925|PMID:29580824 20200825 RGD 11667077 SD-Esr2em2Soar strain MP:0002773 decreased circulating luteinizing hormone level IMP N RGD:38548924|PMID:28520870 20200825 RGD 11667077 SD-Esr2em2Soar strain MP:0002790 decreased circulating follicle stimulating hormone level IMP N RGD:38548924|PMID:28520870 20200825 RGD 11667077 SD-Esr2em2Soar strain MP:0004805 absent oocytes induced IMP XCO:0000228 N RGD:38548924|PMID:28520870 20200825 RGD compared to wild-type 11667077 SD-Esr2em2Soar strain MP:0004856 decreased ovary weight IMP N RGD:38548924|PMID:28520870 20200825 RGD 11667077 SD-Esr2em2Soar strain MP:0004856 decreased ovary weight induced IMP XCO:0000228 N RGD:38548925|PMID:29580824 20200825 RGD compared to wild-type 11667077 SD-Esr2em2Soar strain MP:0004905 decreased uterus weight IMP N RGD:38548924|PMID:28520870 20200825 RGD 11667077 SD-Esr2em2Soar strain MP:0005158 ovary hypoplasia induced IMP XCO:0000228 N RGD:38548924|PMID:28520870 20200825 RGD compared to wild-type 11667077 SD-Esr2em2Soar strain MP:0005181 decreased circulating estradiol level IMP N RGD:38548924|PMID:28520870 20200825 RGD 11667077 SD-Esr2em2Soar strain MP:0005185 decreased circulating progesterone level induced IMP XCO:0000228 N RGD:38548925|PMID:29580824 20200825 RGD compared to wild-type 11667077 SD-Esr2em2Soar strain MP:0008869 anovulation IMP N RGD:38548925|PMID:29580824 20200825 RGD 11667077 SD-Esr2em2Soar strain MP:0008869 anovulation induced IMP XCO:0000228 N RGD:38548924|PMID:28520870 20200825 RGD compared to wild-type 11667077 SD-Esr2em2Soar strain MP:0008869 anovulation induced IMP XCO:0000228 N RGD:38548925|PMID:29580824 20200825 RGD compared to wild-type 11667077 SD-Esr2em2Soar strain MP:0009013 abnormal proestrus IMP N RGD:38548924|PMID:28520870 20200825 RGD 11667081 BDIV-Myo5a/StcRrrc strain MP:0000921 demyelination IAGP N RGD:42721980|PMID:29217155 20210226 RGD in axons in striatum; compared to control BD-IV 11667081 BDIV-Myo5a/StcRrrc strain MP:0002066 abnormal motor capabilities/coordination/movement IAGP N RGD:41412185|PMID:27771352 20210301 RGD compared to control BD-IV 11667081 BDIV-Myo5a/StcRrrc strain MP:0002229 neurodegeneration IAGP N RGD:41412185|PMID:27771352 20210301 RGD compared to control BD-IV 11667081 BDIV-Myo5a/StcRrrc strain MP:0003224 neuron degeneration IAGP N RGD:42722007|PMID:22639889 20210301 RGD compared to control BD-IV 11667081 BDIV-Myo5a/StcRrrc strain MP:0003354 astrocytosis IAGP N RGD:42722007|PMID:22639889 20210302 RGD compared to control BD-IV 11667081 BDIV-Myo5a/StcRrrc strain MP:0004102 abnormal dorsal striatum morphology IAGP N RGD:42721980|PMID:29217155 20210226 RGD compared to control BD-IV 11667081 BDIV-Myo5a/StcRrrc strain MP:0004250 tau protein deposits IAGP N RGD:42721980|PMID:29217155 20210226 RGD in brain stem, mesencephalon, olfactory bulb, frontal cortex; compared to control BD-IV 11667081 BDIV-Myo5a/StcRrrc strain MP:0004495 decreased synaptic glutamate release induced IAGP XCO:0000521 N RGD:41412185|PMID:27771352 20210301 RGD compared to control BD-IV 11667081 BDIV-Myo5a/StcRrrc strain MP:0005237 abnormal olfactory tract morphology IAGP N RGD:42721980|PMID:29217155 20210226 RGD 11667081 BDIV-Myo5a/StcRrrc strain MP:0005366 variegated coat color IAGP N RGD:41412185|PMID:27771352 20210301 RGD compared to control BD-IV 11667081 BDIV-Myo5a/StcRrrc strain MP:0005366 variegated coat color IAGP N RGD:42721980|PMID:29217155 20210226 RGD compared to control BD-IV 11667081 BDIV-Myo5a/StcRrrc strain MP:0008462 abnormal medium spiny neuron morphology IAGP N RGD:42722007|PMID:22639889 20210302 RGD compared to control BD-IV 11667081 BDIV-Myo5a/StcRrrc strain MP:0008493 alpha-synuclein inclusion body IAGP N RGD:41412185|PMID:27771352 20210301 RGD in striatum, frontal cortex, mesencephalon; compared to control BD-IV 11667081 BDIV-Myo5a/StcRrrc strain MP:0008493 alpha-synuclein inclusion body IAGP N RGD:42721980|PMID:29217155 20210226 RGD in brain stem, mesencephalon, olfactory bulb, frontal cortex, hippocampus; compared to control BD-IV 11667081 BDIV-Myo5a/StcRrrc strain MP:0008493 alpha-synuclein inclusion body IAGP N RGD:42722007|PMID:22639889 20210302 RGD compared to control BDIV 11667081 BDIV-Myo5a/StcRrrc strain MP:0008572 abnormal Purkinje cell dendrite morphology IAGP N RGD:42721980|PMID:29217155 20210226 RGD compared to control BD-IV 11667081 BDIV-Myo5a/StcRrrc strain MP:0008657 increased interleukin-1 beta secretion IAGP N RGD:42722007|PMID:22639889 20210302 RGD compared to control BD-IV 11667081 BDIV-Myo5a/StcRrrc strain MP:0008918 microgliosis IAGP N RGD:42722007|PMID:22639889 20210302 RGD compared to control BD-IV 11667081 BDIV-Myo5a/StcRrrc strain MP:0009941 abnormal olfactory bulb interneuron morphology IAGP N RGD:42722007|PMID:22639889 20210302 RGD compared to control BD-IV 11667081 BDIV-Myo5a/StcRrrc strain MP:0010149 abnormal synaptic dopamine release induced IAGP XCO:0000520 N RGD:41412185|PMID:27771352 20210301 RGD compared to control BD-IV 11667081 BDIV-Myo5a/StcRrrc strain MP:0010956 abnormal mitochondrial ATP synthesis coupled electron transport IAGP N RGD:42721980|PMID:29217155 20210226 RGD compared to control BD-IV 11667081 BDIV-Myo5a/StcRrrc strain MP:0011270 decreased excitatory postsynaptic current amplitude induced IAGP XCO:0000521 N RGD:41412185|PMID:27771352 20210301 RGD compared to control BD-IV 11667081 BDIV-Myo5a/StcRrrc strain MP:0011448 decreased dopaminergic neuron number IAGP N RGD:41412185|PMID:27771352 20210301 RGD in substantia nigra pars compacta; compared to control BD-IV 11667081 BDIV-Myo5a/StcRrrc strain MP:0013219 abnormal substantia nigra pars compacta morphology IAGP N RGD:42721980|PMID:29217155 20210226 RGD compared to control BD-IV 11667081 BDIV-Myo5a/StcRrrc strain MP:0013219 abnormal substantia nigra pars compacta morphology IAGP N RGD:42722007|PMID:22639889 20210302 RGD compared to control BD-IV 11667081 BDIV-Myo5a/StcRrrc strain MP:0030939 abnormal autophagosome formation IAGP N RGD:42721980|PMID:29217155 20210226 RGD compared to control BD-IV 11667088 SD-Esr1em1Soar strain MP:0000628 abnormal mammary gland development IMP N RGD:8552987|PMID:24506075 20170623 RGD 11667088 SD-Esr1em1Soar strain MP:0001119 abnormal female reproductive system morphology IMP N RGD:8552987|PMID:24506075 20170623 RGD 11667088 SD-Esr1em1Soar strain MP:0001145 abnormal male reproductive system morphology IMP N RGD:8552987|PMID:24506075 20170623 RGD 11667088 SD-Esr1em1Soar strain MP:0001147 small testis IMP N RGD:8552987|PMID:24506075 20170623 RGD 11667088 SD-Esr1em1Soar strain MP:0001750 increased circulating follicle stimulating hormone level IMP N RGD:8552987|PMID:24506075 20170623 RGD 11667088 SD-Esr1em1Soar strain MP:0001751 increased circulating luteinizing hormone level IMP N RGD:8552987|PMID:24506075 20170623 RGD 11667088 SD-Esr1em1Soar strain MP:0003956 abnormal body size IMP N RGD:8552987|PMID:24506075 20170623 RGD 11667088 SD-Esr1em1Soar strain MP:0004852 decreased testis weight IMP N RGD:8552987|PMID:24506075 20170623 RGD 124713544 W-Cyp27b1em1Thka strain MP:0000163 abnormal cartilage morphology IMP N RGD:32716373|PMID:32231239 20210323 RGD 124713544 W-Cyp27b1em1Thka strain MP:0000195 decreased circulating calcium level treatment IMP XCO:0000545 N RGD:32716373|PMID:32231239 20210323 RGD compared to Jcl:Wi and untreated 124713544 W-Cyp27b1em1Thka strain MP:0000559 abnormal femur morphology treatment IMP XCO:0000545 N RGD:32716373|PMID:32231239 20210323 RGD compared to Jcl:Wi and untreated 124713544 W-Cyp27b1em1Thka strain MP:0001255 decreased body height IMP N RGD:32716373|PMID:32231239 20210323 RGD 124713544 W-Cyp27b1em1Thka strain MP:0001260 increased body weight treatment IMP XCO:0000545 N RGD:32716373|PMID:32231239 20210323 RGD compared to untreated 124713544 W-Cyp27b1em1Thka strain MP:0002904 increased circulating parathyroid hormone level treatment IMP XCO:0000545 N RGD:32716373|PMID:32231239 20210323 RGD compared to Jcl:Wi and treated 124713544 W-Cyp27b1em1Thka strain MP:0009445 osteomalacia treatment IMP XCO:0000545 N RGD:32716373|PMID:32231239 20210323 RGD compared to Jcl:Wi and treated 124713544 W-Cyp27b1em1Thka strain MP:0010769 abnormal survival penetrance IMP XCO:0000014 N RGD:32716373|PMID:32231239 20210323 RGD compared to CE-2 diet containing 1.15% calcium fed Cyp27b1-KO rats 124713544 W-Cyp27b1em1Thka strain MP:0020011 increased bone mineral density of femur treatment IMP XCO:0000545 N RGD:32716373|PMID:32231239 20210323 RGD compared to Jcl:Wi and untreated 124713545 Cyp27b1em1Thka cytochrome P450, family 27, subfamily b, polypeptide 1; CRISPR/Cas9 induced mutant 1, Thka gene MP:0000163 abnormal cartilage morphology IMP N RGD:32716373|PMID:32231239 20210325 RGD 124713545 Cyp27b1em1Thka cytochrome P450, family 27, subfamily b, polypeptide 1; CRISPR/Cas9 induced mutant 1, Thka gene MP:0000195 decreased circulating calcium level treatment IMP XCO:0000545 N RGD:32716373|PMID:32231239 20210325 RGD compared to Jcl:Wi and untreated 124713545 Cyp27b1em1Thka cytochrome P450, family 27, subfamily b, polypeptide 1; CRISPR/Cas9 induced mutant 1, Thka gene MP:0000559 abnormal femur morphology treatment IMP XCO:0000545 N RGD:32716373|PMID:32231239 20210325 RGD compared to Jcl:Wi and untreated 124713545 Cyp27b1em1Thka cytochrome P450, family 27, subfamily b, polypeptide 1; CRISPR/Cas9 induced mutant 1, Thka gene MP:0001255 decreased body height IMP N RGD:32716373|PMID:32231239 20210325 RGD 124713545 Cyp27b1em1Thka cytochrome P450, family 27, subfamily b, polypeptide 1; CRISPR/Cas9 induced mutant 1, Thka gene MP:0001260 increased body weight treatment IMP XCO:0000545 N RGD:32716373|PMID:32231239 20210325 RGD compared to untreated 124713545 Cyp27b1em1Thka cytochrome P450, family 27, subfamily b, polypeptide 1; CRISPR/Cas9 induced mutant 1, Thka gene MP:0002904 increased circulating parathyroid hormone level treatment IMP XCO:0000545 N RGD:32716373|PMID:32231239 20210325 RGD compared to Jcl:Wi and treated 124713545 Cyp27b1em1Thka cytochrome P450, family 27, subfamily b, polypeptide 1; CRISPR/Cas9 induced mutant 1, Thka gene MP:0009445 osteomalacia treatment IMP XCO:0000545 N RGD:32716373|PMID:32231239 20210325 RGD compared to Jcl:Wi and treated 124713545 Cyp27b1em1Thka cytochrome P450, family 27, subfamily b, polypeptide 1; CRISPR/Cas9 induced mutant 1, Thka gene MP:0010769 abnormal survival IMP N RGD:32716373|PMID:32231239 20210325 RGD compared to CE-2 diet containing 1.15% calcium fed Cyp27b1-KO rats 124713545 Cyp27b1em1Thka cytochrome P450, family 27, subfamily b, polypeptide 1; CRISPR/Cas9 induced mutant 1, Thka gene MP:0020011 increased bone mineral density of femur treatment IMP XCO:0000545 N RGD:32716373|PMID:32231239 20210325 RGD compared to Jcl:Wi and untreated 124713546 W-Vdrem1Thka strain MP:0000130 abnormal trabecular bone morphology IMP N RGD:32716373|PMID:32231239 20210323 RGD 124713546 W-Vdrem1Thka strain MP:0000163 abnormal cartilage morphology IMP N RGD:32716373|PMID:32231239 20210323 RGD 124713546 W-Vdrem1Thka strain MP:0000195 decreased circulating calcium level treatment IMP XCO:0000545 N RGD:32716373|PMID:32231239 20210323 RGD compared to Jcl:Wi and untreated 124713546 W-Vdrem1Thka strain MP:0000559 abnormal femur morphology IMP N RGD:32716373|PMID:32231239 20210323 RGD 124713546 W-Vdrem1Thka strain MP:0002904 increased circulating parathyroid hormone level treatment IMP XCO:0000545 N RGD:32716373|PMID:32231239 20210323 RGD compared to Jcl:Wi and treated 124713546 W-Vdrem1Thka strain MP:0009445 osteomalacia IMP N RGD:32716373|PMID:32231239 20210323 RGD 124713547 Vdrem1Thka vitamin D receptor; CRISPR/Cas9 induced mutant 1, Thka gene MP:0000130 abnormal trabecular bone morphology IMP N RGD:32716373|PMID:32231239 20210325 RGD 124713547 Vdrem1Thka vitamin D receptor; CRISPR/Cas9 induced mutant 1, Thka gene MP:0000163 abnormal cartilage morphology IMP N RGD:32716373|PMID:32231239 20210325 RGD 124713547 Vdrem1Thka vitamin D receptor; CRISPR/Cas9 induced mutant 1, Thka gene MP:0000195 decreased circulating calcium level treatment IMP XCO:0000545 N RGD:32716373|PMID:32231239 20210325 RGD compared to Jcl:Wi and untreated 124713547 Vdrem1Thka vitamin D receptor; CRISPR/Cas9 induced mutant 1, Thka gene MP:0000559 abnormal femur morphology IMP N RGD:32716373|PMID:32231239 20210325 RGD 124713547 Vdrem1Thka vitamin D receptor; CRISPR/Cas9 induced mutant 1, Thka gene MP:0002904 increased circulating parathyroid hormone level treatment IMP XCO:0000545 N RGD:32716373|PMID:32231239 20210325 RGD compared to Jcl:Wi and treated 124713547 Vdrem1Thka vitamin D receptor; CRISPR/Cas9 induced mutant 1, Thka gene MP:0009445 osteomalacia IMP N RGD:32716373|PMID:32231239 20210325 RGD 124713548 W-Vdrem2Thka strain MP:0000130 abnormal trabecular bone morphology IMP N RGD:32716373|PMID:32231239 20210323 RGD 124713548 W-Vdrem2Thka strain MP:0000163 abnormal cartilage morphology IMP N RGD:32716373|PMID:32231239 20210323 RGD 124713548 W-Vdrem2Thka strain MP:0000414 alopecia IMP N RGD:32716373|PMID:32231239 20210323 RGD 124713548 W-Vdrem2Thka strain MP:0002708 nephrolithiasis IMP N RGD:32716373|PMID:32231239 20210323 RGD 124713548 W-Vdrem2Thka strain MP:0002904 increased circulating parathyroid hormone level IMP XCO:0000545 N RGD:32716373|PMID:32231239 20210323 RGD 124713548 W-Vdrem2Thka strain MP:0009931 abnormal skin appearance IMP N RGD:32716373|PMID:32231239 20210323 RGD 124713550 Vdrem2Thka vitamin D receptor; CRISPR/Cas9 induced mutant 2, Thka gene MP:0000130 abnormal trabecular bone morphology IMP N RGD:32716373|PMID:32231239 20210325 RGD 124713550 Vdrem2Thka vitamin D receptor; CRISPR/Cas9 induced mutant 2, Thka gene MP:0000163 abnormal cartilage morphology IMP N RGD:32716373|PMID:32231239 20210325 RGD 124713550 Vdrem2Thka vitamin D receptor; CRISPR/Cas9 induced mutant 2, Thka gene MP:0000414 alopecia IMP N RGD:32716373|PMID:32231239 20210325 RGD 124713550 Vdrem2Thka vitamin D receptor; CRISPR/Cas9 induced mutant 2, Thka gene MP:0002708 nephrolithiasis IMP N RGD:32716373|PMID:32231239 20210325 RGD 124713550 Vdrem2Thka vitamin D receptor; CRISPR/Cas9 induced mutant 2, Thka gene MP:0002904 increased circulating parathyroid hormone level IMP XCO:0000545 N RGD:32716373|PMID:32231239 20210325 RGD 124713550 Vdrem2Thka vitamin D receptor; CRISPR/Cas9 induced mutant 2, Thka gene MP:0009931 abnormal skin appearance IMP N RGD:32716373|PMID:32231239 20210325 RGD 124715480 Fmr1em1Mzhe FMRP translational regulator 1; CRISPR/Cas9 induced mutant1, Mzhe gene MP:0001148 enlarged testis IMP N RGD:38501107|PMID:28894415 20210329 RGD 124715480 Fmr1em1Mzhe FMRP translational regulator 1; CRISPR/Cas9 induced mutant1, Mzhe gene MP:0001468 abnormal temporal memory IMP N RGD:38501107|PMID:28894415 20210329 RGD 124715480 Fmr1em1Mzhe FMRP translational regulator 1; CRISPR/Cas9 induced mutant1, Mzhe gene MP:0012307 impaired spatial learning IMP N RGD:38501107|PMID:28894415 20210329 RGD 124715480 Fmr1em1Mzhe FMRP translational regulator 1; CRISPR/Cas9 induced mutant1, Mzhe gene MP:0020395 abnormal response to social novelty IMP N RGD:38501107|PMID:28894415 20210329 RGD 124715481 Pon1em1Lizh paraoxonase 1; CRISPR/Cas9 induced mutant 1, Lizh gene MP:0000322 increased granulocyte number IMP N RGD:45073131|PMID:30262871 20210722 RGD in peripheral blood, compared to SD 124715481 Pon1em1Lizh paraoxonase 1; CRISPR/Cas9 induced mutant 1, Lizh gene MP:0000706 small thymus IMP N RGD:45073131|PMID:30262871 20210722 RGD compared to SD 124715481 Pon1em1Lizh paraoxonase 1; CRISPR/Cas9 induced mutant 1, Lizh gene MP:0000715 decreased thymocyte number IMP N RGD:45073131|PMID:30262871 20210722 RGD compared to SD 124715481 Pon1em1Lizh paraoxonase 1; CRISPR/Cas9 induced mutant 1, Lizh gene MP:0001825 arrested T cell differentiation IMP N RGD:45073131|PMID:30262871 20210722 RGD compared to SD 124715481 Pon1em1Lizh paraoxonase 1; CRISPR/Cas9 induced mutant 1, Lizh gene MP:0003674 oxidative stress IMP N RGD:45073131|PMID:30262871 20210722 RGD compared to SD 124715481 Pon1em1Lizh paraoxonase 1; CRISPR/Cas9 induced mutant 1, Lizh gene MP:0005017 decreased B cell number IMP N RGD:45073131|PMID:30262871 20210722 RGD in spleen, compared to SD 124715481 Pon1em1Lizh paraoxonase 1; CRISPR/Cas9 induced mutant 1, Lizh gene MP:0005018 decreased T cell number IMP N RGD:45073131|PMID:30262871 20210722 RGD compared to SD 124715481 Pon1em1Lizh paraoxonase 1; CRISPR/Cas9 induced mutant 1, Lizh gene MP:0005425 increased macrophage cell number IMP N RGD:45073131|PMID:30262871 20210722 RGD in bone marrow and peripheral blood, compared to SD 124715481 Pon1em1Lizh paraoxonase 1; CRISPR/Cas9 induced mutant 1, Lizh gene MP:0006413 increased T cell apoptosis IMP N RGD:45073131|PMID:30262871 20210722 RGD compared to SD 125097486 SD-Nr3c1em1Kuan strain MP:0001745 increased circulating corticosterone level sexual_dimorphism IMP XCO:0000159 N RGD:407571699|PMID:31329100 20241104 RGD compared to female wild type littermate 125097486 SD-Nr3c1em1Kuan strain MP:0003063 increased coping response sexual_dimorphism IMP XCO:0001269 N RGD:407571699|PMID:31329100 20241104 RGD compared to male wild type littermate 125097486 SD-Nr3c1em1Kuan strain MP:0009455 enhanced cued conditioning behavior sexual_dimorphism IMP N RGD:407571699|PMID:31329100 20241104 RGD associated with abnormal freezing behavior (MP:0020420); compared to female wild type littermate 125097486 SD-Nr3c1em1Kuan strain MP:0012318 slow extinction of fear memory sexual_dimorphism IMP N RGD:407571699|PMID:31329100 20241104 RGD associated with abnormal freezing behavior (MP:0020420); compared to female wild type littermate 125097486 SD-Nr3c1em1Kuan strain MP:0020421 increased freezing behavior sexual_dimorphism IMP N RGD:407571699|PMID:31329100 20241104 RGD compared to female wild type littermate 125097487 Nr3c1em1Kuan nuclear receptor subfamily 3, group C, member 1; CRISPR/Cas9 induced mutant1, Kuan gene MP:0001745 increased circulating corticosterone level sexual_dimorphism IMP XCO:0000159 N RGD:407571699|PMID:31329100 20241107 RGD compared to female wild type littermate 125097487 Nr3c1em1Kuan nuclear receptor subfamily 3, group C, member 1; CRISPR/Cas9 induced mutant1, Kuan gene MP:0003063 increased coping response sexual_dimorphism IMP XCO:0001269 N RGD:407571699|PMID:31329100 20241107 RGD compared to male wild type littermate 125097487 Nr3c1em1Kuan nuclear receptor subfamily 3, group C, member 1; CRISPR/Cas9 induced mutant1, Kuan gene MP:0009455 enhanced cued conditioning behavior sexual_dimorphism IMP N RGD:407571699|PMID:31329100 20241107 RGD associated with abnormal freezing behavior (MP:0020420); compared to female wild type littermate 125097487 Nr3c1em1Kuan nuclear receptor subfamily 3, group C, member 1; CRISPR/Cas9 induced mutant1, Kuan gene MP:0012318 slow extinction of fear memory sexual_dimorphism IMP N RGD:407571699|PMID:31329100 20241107 RGD associated with abnormal freezing behavior (MP:0020420); compared to female wild type littermate 125097487 Nr3c1em1Kuan nuclear receptor subfamily 3, group C, member 1; CRISPR/Cas9 induced mutant1, Kuan gene MP:0020421 increased freezing behavior sexual_dimorphism IMP N RGD:407571699|PMID:31329100 20241107 RGD compared to female wild type littermate 126777684 WI-Mkxem1Asah strain MP:0001406 abnormal gait IMP N RGD:40924660|PMID:27370800 20210409 RGD compared to Wistar 126777684 WI-Mkxem1Asah strain MP:0003098 decreased tendon stiffness IMP N RGD:40924660|PMID:27370800 20210409 RGD compared to Wistar 126777684 WI-Mkxem1Asah strain MP:0005503 abnormal tendon morphology IMP N RGD:40924660|PMID:27370800 20210409 RGD compared to Wistar 126777684 WI-Mkxem1Asah strain MP:0011643 abnormal tendon collagen fibril morphology IMP N RGD:40924660|PMID:27370800 20210409 RGD compared to Wistar 126777684 WI-Mkxem1Asah strain MP:0013179 wavy tail IMP N RGD:40924660|PMID:27370800 20210409 RGD compared to Wistar 126777684 WI-Mkxem1Asah strain MP:0020039 increased bone ossification IMP N RGD:40924660|PMID:27370800 20210409 RGD compared to Wistar 126777685 Mkxem1Asah mohawk homeobox; CRISPR/Cas9 system induced mutant 1, Asah gene MP:0001406 abnormal gait IMP N RGD:40924660|PMID:27370800 20210415 RGD compared to Wistar 126777685 Mkxem1Asah mohawk homeobox; CRISPR/Cas9 system induced mutant 1, Asah gene MP:0003098 decreased tendon stiffness IMP N RGD:40924660|PMID:27370800 20210415 RGD compared to Wistar 126777685 Mkxem1Asah mohawk homeobox; CRISPR/Cas9 system induced mutant 1, Asah gene MP:0005503 abnormal tendon morphology IMP N RGD:40924660|PMID:27370800 20210415 RGD compared to Wistar 126777685 Mkxem1Asah mohawk homeobox; CRISPR/Cas9 system induced mutant 1, Asah gene MP:0011643 abnormal tendon collagen fibril morphology IMP N RGD:40924660|PMID:27370800 20210415 RGD compared to Wistar 126777685 Mkxem1Asah mohawk homeobox; CRISPR/Cas9 system induced mutant 1, Asah gene MP:0013179 wavy tail IMP N RGD:40924660|PMID:27370800 20210415 RGD compared to Wistar 126777685 Mkxem1Asah mohawk homeobox; CRISPR/Cas9 system induced mutant 1, Asah gene MP:0020039 increased bone ossification IMP N RGD:40924660|PMID:27370800 20210415 RGD compared to Wistar 126777687 WKY-Dnd1ter/Ztm strain MP:0001156 abnormal spermatogenesis IAGP N RGD:40924659|PMID:22655094 20210412 RGD compared to WKY 126777687 WKY-Dnd1ter/Ztm strain MP:0001924 infertility IAGP N RGD:40924659|PMID:22655094 20210412 RGD compared to WKY 126777687 WKY-Dnd1ter/Ztm strain MP:0002016 ovary cyst IAGP N RGD:40924659|PMID:22655094 20210412 RGD compared to WKY 126777687 WKY-Dnd1ter/Ztm strain MP:0004806 absent germ cells IAGP N RGD:40924659|PMID:22655094 20210412 RGD compared to WKY 126777687 WKY-Dnd1ter/Ztm strain MP:0004852 decreased testis weight IAGP N RGD:40924659|PMID:22655094 20210412 RGD compared to WKY and heterozygous 126777687 WKY-Dnd1ter/Ztm strain MP:0004856 decreased ovary weight IAGP N RGD:40924659|PMID:22655094 20210412 RGD compared to WKY 126777687 WKY-Dnd1ter/Ztm strain MP:0013600 testis degeneration IAGP N RGD:40924659|PMID:22655094 20210412 RGD compared to WKY 126779578 LOU/MWsl strain MP:0001262 decreased body weight induced IAGP XCO:0000779 N RGD:125093741|PMID:6585590 20210330 RGD rat IgM immunocytoma cells from LOU/C 126779578 LOU/MWsl strain MP:0002871 albuminuria induced IAGP XCO:0000539 N RGD:45073132|PMID:3456068 20210312 RGD worse in males; doxorubicin XCO:0000539 126779578 LOU/MWsl strain MP:0002962 increased urine protein level induced IAGP XCO:0000779 N RGD:125093741|PMID:6585590 20210330 RGD rat IgM immunocytoma cells from LOU/C 126779578 LOU/MWsl strain MP:0005419 decreased circulating serum albumin level induced IAGP XCO:0000539 N RGD:45073132|PMID:3456068 20210312 RGD worse in males; doxorubicin XCO:0000539 126779578 LOU/MWsl strain MP:0005419 decreased circulating serum albumin level induced IAGP XCO:0000779 N RGD:125093741|PMID:6585590 20210330 RGD rat IgM immunocytoma cells from LOU/C 126779591 SD-Csf1rtm(EGFP)-/-/Tset strain MP:0000195 decreased circulating calcium level IMP N RGD:41404725|PMID:30249809 20210413 RGD 126779591 SD-Csf1rtm(EGFP)-/-/Tset strain MP:0000198 decreased circulating phosphate level IMP N RGD:41404725|PMID:30249809 20210413 RGD 126779591 SD-Csf1rtm(EGFP)-/-/Tset strain MP:0000223 decreased monocyte cell number IMP N RGD:41404725|PMID:30249809 20210413 RGD 126779591 SD-Csf1rtm(EGFP)-/-/Tset strain MP:0000322 increased granulocyte number IMP N RGD:41404725|PMID:30249809 20210413 RGD 126779591 SD-Csf1rtm(EGFP)-/-/Tset strain MP:0001262 decreased body weight IMP N RGD:41404725|PMID:30249809 20210413 RGD 126779591 SD-Csf1rtm(EGFP)-/-/Tset strain MP:0001783 decreased white adipose tissue amount IMP N RGD:41404725|PMID:30249809 20210413 RGD 126779591 SD-Csf1rtm(EGFP)-/-/Tset strain MP:0002680 decreased corpora lutea number IMP N RGD:41404725|PMID:30249809 20210413 RGD 126779591 SD-Csf1rtm(EGFP)-/-/Tset strain MP:0002942 decreased circulating alanine transaminase level IMP N RGD:41404725|PMID:30249809 20210413 RGD 126779591 SD-Csf1rtm(EGFP)-/-/Tset strain MP:0003884 decreased macrophage cell number IMP N RGD:41404725|PMID:30249809 20210413 RGD 126779591 SD-Csf1rtm(EGFP)-/-/Tset strain MP:0004985 decreased osteoclast cell number IMP N RGD:41404725|PMID:30249809 20210413 RGD 126779591 SD-Csf1rtm(EGFP)-/-/Tset strain MP:0008119 decreased Langerhans cell number IMP N RGD:41404725|PMID:30249809 20210413 RGD 126779591 SD-Csf1rtm(EGFP)-/-/Tset strain MP:0011982 decreased microglial cell number IMP N RGD:41404725|PMID:30249809 20210413 RGD 126779591 SD-Csf1rtm(EGFP)-/-/Tset strain MP:0030088 microdontia IMP N RGD:41404725|PMID:30249809 20210413 RGD 126779592 DA-Csf1rtm(EGFP)-/-/Hume strain MP:0000913 abnormal brain development IMP N RGD:126781687|PMID:33450391 20210414 RGD 126779592 DA-Csf1rtm(EGFP)-/-/Hume strain MP:0001732 postnatal growth retardation IMP N RGD:126781687|PMID:33450391 20210414 RGD 126779592 DA-Csf1rtm(EGFP)-/-/Hume strain MP:0002083 premature death IMP N RGD:126781687|PMID:33450391 20210414 RGD 126779592 DA-Csf1rtm(EGFP)-/-/Hume strain MP:0008222 decreased hippocampal commissure size IMP N RGD:126781687|PMID:33450391 20210414 RGD 126779592 DA-Csf1rtm(EGFP)-/-/Hume strain MP:0008226 decreased anterior commissure size IMP N RGD:126781687|PMID:33450391 20210414 RGD 126779592 DA-Csf1rtm(EGFP)-/-/Hume strain MP:0011380 enlarged brain ventricles IMP N RGD:126781687|PMID:33450391 20210414 RGD 126779592 DA-Csf1rtm(EGFP)-/-/Hume strain MP:0011982 decreased microglial cell number IMP N RGD:126781687|PMID:33450391 20210414 RGD 126779592 DA-Csf1rtm(EGFP)-/-/Hume strain MP:0012460 decreased dentate gyrus size IMP N RGD:126781687|PMID:33450391 20210414 RGD 126779592 DA-Csf1rtm(EGFP)-/-/Hume strain MP:0020545 decreased hippocampal fornix size IMP N RGD:126781687|PMID:33450391 20210414 RGD 126779592 DA-Csf1rtm(EGFP)-/-/Hume strain MP:0020573 abnormal corpus callosum size IMP N RGD:126781687|PMID:33450391 20210414 RGD 126779592 DA-Csf1rtm(EGFP)-/-/Hume strain MP:0030610 absent teeth IMP N RGD:126781687|PMID:33450391 20210414 RGD 126781692 Csf1rtm(EGFP)Tset colony stimulating factor 1 receptor; target mutant, Tset gene MP:0000195 decreased circulating calcium level IMP N RGD:41404725|PMID:30249809 20210416 RGD 126781692 Csf1rtm(EGFP)Tset colony stimulating factor 1 receptor; target mutant, Tset gene MP:0000198 decreased circulating phosphate level IMP N RGD:41404725|PMID:30249809 20210416 RGD 126781692 Csf1rtm(EGFP)Tset colony stimulating factor 1 receptor; target mutant, Tset gene MP:0000223 decreased monocyte cell number IMP N RGD:41404725|PMID:30249809 20210416 RGD 126781692 Csf1rtm(EGFP)Tset colony stimulating factor 1 receptor; target mutant, Tset gene MP:0000322 increased granulocyte number IMP N RGD:41404725|PMID:30249809 20210416 RGD 126781692 Csf1rtm(EGFP)Tset colony stimulating factor 1 receptor; target mutant, Tset gene MP:0000913 abnormal brain development IMP N RGD:126781687|PMID:33450391 20210416 RGD 126781692 Csf1rtm(EGFP)Tset colony stimulating factor 1 receptor; target mutant, Tset gene MP:0001262 decreased body weight IMP N RGD:41404725|PMID:30249809 20210416 RGD 126781692 Csf1rtm(EGFP)Tset colony stimulating factor 1 receptor; target mutant, Tset gene MP:0001732 postnatal growth retardation IMP N RGD:126781687|PMID:33450391 20210416 RGD 126781692 Csf1rtm(EGFP)Tset colony stimulating factor 1 receptor; target mutant, Tset gene MP:0001783 decreased white adipose tissue amount IMP N RGD:41404725|PMID:30249809 20210416 RGD 126781692 Csf1rtm(EGFP)Tset colony stimulating factor 1 receptor; target mutant, Tset gene MP:0002083 premature death IMP N RGD:126781687|PMID:33450391 20210416 RGD 126781692 Csf1rtm(EGFP)Tset colony stimulating factor 1 receptor; target mutant, Tset gene MP:0002680 decreased corpora lutea number IMP N RGD:41404725|PMID:30249809 20210416 RGD 126781692 Csf1rtm(EGFP)Tset colony stimulating factor 1 receptor; target mutant, Tset gene MP:0002942 decreased circulating alanine transaminase level IMP N RGD:41404725|PMID:30249809 20210416 RGD 126781692 Csf1rtm(EGFP)Tset colony stimulating factor 1 receptor; target mutant, Tset gene MP:0003884 decreased macrophage cell number IMP N RGD:41404725|PMID:30249809 20210416 RGD 126781692 Csf1rtm(EGFP)Tset colony stimulating factor 1 receptor; target mutant, Tset gene MP:0004985 decreased osteoclast cell number IMP N RGD:41404725|PMID:30249809 20210416 RGD 126781692 Csf1rtm(EGFP)Tset colony stimulating factor 1 receptor; target mutant, Tset gene MP:0008119 decreased Langerhans cell number IMP N RGD:41404725|PMID:30249809 20210416 RGD 126781692 Csf1rtm(EGFP)Tset colony stimulating factor 1 receptor; target mutant, Tset gene MP:0008222 decreased hippocampal commissure size IMP N RGD:126781687|PMID:33450391 20210416 RGD 126781692 Csf1rtm(EGFP)Tset colony stimulating factor 1 receptor; target mutant, Tset gene MP:0008226 decreased anterior commissure size IMP N RGD:126781687|PMID:33450391 20210416 RGD 126781692 Csf1rtm(EGFP)Tset colony stimulating factor 1 receptor; target mutant, Tset gene MP:0011380 enlarged brain ventricles IMP N RGD:126781687|PMID:33450391 20210416 RGD 126781692 Csf1rtm(EGFP)Tset colony stimulating factor 1 receptor; target mutant, Tset gene MP:0011982 decreased microglial cell number IMP N RGD:126781687|PMID:33450391 20210416 RGD 126781692 Csf1rtm(EGFP)Tset colony stimulating factor 1 receptor; target mutant, Tset gene MP:0011982 decreased microglial cell number IMP N RGD:41404725|PMID:30249809 20210416 RGD 126781692 Csf1rtm(EGFP)Tset colony stimulating factor 1 receptor; target mutant, Tset gene MP:0012460 decreased dentate gyrus size IMP N RGD:126781687|PMID:33450391 20210416 RGD 126781692 Csf1rtm(EGFP)Tset colony stimulating factor 1 receptor; target mutant, Tset gene MP:0020545 decreased hippocampal fornix size IMP N RGD:126781687|PMID:33450391 20210416 RGD 126781692 Csf1rtm(EGFP)Tset colony stimulating factor 1 receptor; target mutant, Tset gene MP:0020573 abnormal corpus callosum size IMP N RGD:126781687|PMID:33450391 20210416 RGD 126781692 Csf1rtm(EGFP)Tset colony stimulating factor 1 receptor; target mutant, Tset gene MP:0030088 microdontia IMP N RGD:41404725|PMID:30249809 20210416 RGD 126781692 Csf1rtm(EGFP)Tset colony stimulating factor 1 receptor; target mutant, Tset gene MP:0030610 absent teeth IMP N RGD:126781687|PMID:33450391 20210416 RGD 126790464 SD-Ube3aem1Jue strain MP:0001405 impaired coordination IMP N RGD:126790466|PMID:32066685 20210422 RGD 126790464 SD-Ube3aem1Jue strain MP:0001417 decreased exploration in new environment IMP N RGD:126790466|PMID:32066685 20210422 RGD 126790464 SD-Ube3aem1Jue strain MP:0002757 decreased vertical activity IMP N RGD:126790466|PMID:32066685 20210422 RGD 126790464 SD-Ube3aem1Jue strain MP:0002804 abnormal motor learning IMP N RGD:126790466|PMID:32066685 20210422 RGD 126790464 SD-Ube3aem1Jue strain MP:0005356 positive geotaxis IMP N RGD:126790466|PMID:32066685 20210422 RGD 126790464 SD-Ube3aem1Jue strain MP:0012315 impaired learning IMP N RGD:126790466|PMID:32066685 20210422 RGD 126790464 SD-Ube3aem1Jue strain MP:0012317 impaired conditioning behavior IMP N RGD:126790466|PMID:32066685 20210422 RGD 126790464 SD-Ube3aem1Jue strain MP:0020351 decreased vocalization IMP N RGD:126790466|PMID:32066685 20210422 RGD 126790465 Ube3aem1Jue ubiquitin protein ligase E3A; CRISPR/Cas9 induced mutant1, Jue gene MP:0001405 impaired coordination IMP N RGD:126790466|PMID:32066685 20210429 RGD 126790465 Ube3aem1Jue ubiquitin protein ligase E3A; CRISPR/Cas9 induced mutant1, Jue gene MP:0001417 decreased exploration in new environment IMP N RGD:126790466|PMID:32066685 20210429 RGD 126790465 Ube3aem1Jue ubiquitin protein ligase E3A; CRISPR/Cas9 induced mutant1, Jue gene MP:0002757 decreased vertical activity IMP N RGD:126790466|PMID:32066685 20210429 RGD 126790465 Ube3aem1Jue ubiquitin protein ligase E3A; CRISPR/Cas9 induced mutant1, Jue gene MP:0002804 abnormal motor learning IMP N RGD:126790466|PMID:32066685 20210429 RGD 126790465 Ube3aem1Jue ubiquitin protein ligase E3A; CRISPR/Cas9 induced mutant1, Jue gene MP:0005356 positive geotaxis IMP N RGD:126790466|PMID:32066685 20210429 RGD 126790465 Ube3aem1Jue ubiquitin protein ligase E3A; CRISPR/Cas9 induced mutant1, Jue gene MP:0012315 impaired learning IMP N RGD:126790466|PMID:32066685 20210429 RGD 126790465 Ube3aem1Jue ubiquitin protein ligase E3A; CRISPR/Cas9 induced mutant1, Jue gene MP:0012317 impaired conditioning behavior IMP N RGD:126790466|PMID:32066685 20210429 RGD 126790465 Ube3aem1Jue ubiquitin protein ligase E3A; CRISPR/Cas9 induced mutant1, Jue gene MP:0020351 decreased vocalization IMP N RGD:126790466|PMID:32066685 20210429 RGD 126790496 SD-Shank2em13Sage strain MP:0001360 abnormal social investigation IMP N RGD:126790534|PMID:29970986 20210426 RGD 126790496 SD-Shank2em13Sage strain MP:0001399 hyperactivity IMP N RGD:126790534|PMID:29970986 20210426 RGD 126790496 SD-Shank2em13Sage strain MP:0002574 increased vertical activity IMP N RGD:126790534|PMID:29970986 20210426 RGD 126790496 SD-Shank2em13Sage strain MP:0002803 abnormal operant conditioning behavior IMP N RGD:126790534|PMID:29970986 20210426 RGD 126790496 SD-Shank2em13Sage strain MP:0003234 enhanced NMDA-mediated synaptic currents IMP N RGD:126790534|PMID:29970986 20210426 RGD 126790496 SD-Shank2em13Sage strain MP:0004738 abnormal auditory brainstem response IMP N RGD:126790534|PMID:29970986 20210426 RGD 126790496 SD-Shank2em13Sage strain MP:0012315 impaired learning IMP N RGD:126790534|PMID:29970986 20210426 RGD 126790496 SD-Shank2em13Sage strain MP:0012316 enhanced conditioning behavior IMP N RGD:126790534|PMID:29970986 20210426 RGD 126790496 SD-Shank2em13Sage strain MP:0020338 abnormal hippocampal pyramidal neuron dendrite morphology IMP N RGD:126790534|PMID:29970986 20210426 RGD 126790496 SD-Shank2em13Sage strain MP:0020396 abnormal social recognition IMP N RGD:126790534|PMID:29970986 20210426 RGD 126790496 SD-Shank2em13Sage strain MP:0020437 abnormal social play behavior IMP N RGD:126790534|PMID:29970986 20210426 RGD 126790496 SD-Shank2em13Sage strain MP:0020870 decreased thigmotaxis IMP N RGD:126790534|PMID:29970986 20210426 RGD 126790499 Shank2em13Sage SH3 and multiple ankyrin repeat domains 2; ZFN induced mutant13, Sage gene MP:0001360 abnormal social investigation IMP N RGD:126790534|PMID:29970986 20210429 RGD 126790499 Shank2em13Sage SH3 and multiple ankyrin repeat domains 2; ZFN induced mutant13, Sage gene MP:0001399 hyperactivity IMP N RGD:126790534|PMID:29970986 20210429 RGD 126790499 Shank2em13Sage SH3 and multiple ankyrin repeat domains 2; ZFN induced mutant13, Sage gene MP:0002574 increased vertical activity IMP N RGD:126790534|PMID:29970986 20210429 RGD 126790499 Shank2em13Sage SH3 and multiple ankyrin repeat domains 2; ZFN induced mutant13, Sage gene MP:0002803 abnormal operant conditioning behavior IMP N RGD:126790534|PMID:29970986 20210429 RGD 126790499 Shank2em13Sage SH3 and multiple ankyrin repeat domains 2; ZFN induced mutant13, Sage gene MP:0003234 enhanced NMDA-mediated synaptic currents IMP N RGD:126790534|PMID:29970986 20210429 RGD 126790499 Shank2em13Sage SH3 and multiple ankyrin repeat domains 2; ZFN induced mutant13, Sage gene MP:0004738 abnormal auditory brainstem response IMP N RGD:126790534|PMID:29970986 20210429 RGD 126790499 Shank2em13Sage SH3 and multiple ankyrin repeat domains 2; ZFN induced mutant13, Sage gene MP:0012315 impaired learning IMP N RGD:126790534|PMID:29970986 20210429 RGD 126790499 Shank2em13Sage SH3 and multiple ankyrin repeat domains 2; ZFN induced mutant13, Sage gene MP:0012316 enhanced conditioning behavior IMP N RGD:126790534|PMID:29970986 20210429 RGD 126790499 Shank2em13Sage SH3 and multiple ankyrin repeat domains 2; ZFN induced mutant13, Sage gene MP:0020338 abnormal hippocampal pyramidal neuron dendrite morphology IMP N RGD:126790534|PMID:29970986 20210429 RGD 126790499 Shank2em13Sage SH3 and multiple ankyrin repeat domains 2; ZFN induced mutant13, Sage gene MP:0020396 abnormal social recognition IMP N RGD:126790534|PMID:29970986 20210429 RGD 126790499 Shank2em13Sage SH3 and multiple ankyrin repeat domains 2; ZFN induced mutant13, Sage gene MP:0020437 abnormal social play behavior IMP N RGD:126790534|PMID:29970986 20210429 RGD 126790499 Shank2em13Sage SH3 and multiple ankyrin repeat domains 2; ZFN induced mutant13, Sage gene MP:0020870 decreased thigmotaxis IMP N RGD:126790534|PMID:29970986 20210429 RGD 126790510 Ahrem2Sage aryl hydrocarbon receptor; ZFN induced mutant2, Sage gene MP:0000519 hydronephrosis IMP N RGD:13204753|PMID:23859880 20210715 RGD compared to Hsd:SD 126790510 Ahrem2Sage aryl hydrocarbon receptor; ZFN induced mutant2, Sage gene MP:0000536 hydroureter IMP N RGD:13204753|PMID:23859880 20210715 RGD compared to Hsd:SD 126790510 Ahrem2Sage aryl hydrocarbon receptor; ZFN induced mutant2, Sage gene MP:0002590 increased mean corpuscular volume IMP N RGD:13204753|PMID:23859880 20210715 RGD compared to Hsd:SD 126790510 Ahrem2Sage aryl hydrocarbon receptor; ZFN induced mutant2, Sage gene MP:0002606 increased basophil cell number IMP N RGD:13204753|PMID:23859880 20210715 RGD compared to Hsd:SD 126790510 Ahrem2Sage aryl hydrocarbon receptor; ZFN induced mutant2, Sage gene MP:0003179 thrombocytopenia IMP N RGD:13204753|PMID:23859880 20210715 RGD compared to Hsd:SD 126790510 Ahrem2Sage aryl hydrocarbon receptor; ZFN induced mutant2, Sage gene MP:0003630 abnormal urothelium morphology IMP N RGD:13204753|PMID:23859880 20210708 RGD compared to Hsd:SD 126790510 Ahrem2Sage aryl hydrocarbon receptor; ZFN induced mutant2, Sage gene MP:0003917 increased kidney weight sexual_dimorphism IMP N RGD:13204753|PMID:23859880 20210715 RGD females compared to Hsd:SD females 126790510 Ahrem2Sage aryl hydrocarbon receptor; ZFN induced mutant2, Sage gene MP:0004789 increased bile salt level sexual_dimorphism IMP N RGD:13204753|PMID:23859880 20210715 RGD females compared to Hsd:SD females 126790510 Ahrem2Sage aryl hydrocarbon receptor; ZFN induced mutant2, Sage gene MP:0004852 decreased testis weight IMP N RGD:13204753|PMID:23859880 20210708 RGD compared to Hsd:SD 126790510 Ahrem2Sage aryl hydrocarbon receptor; ZFN induced mutant2, Sage gene MP:0004856 decreased ovary weight IMP N RGD:13204753|PMID:23859880 20210708 RGD compared to Hsd:SD 126790510 Ahrem2Sage aryl hydrocarbon receptor; ZFN induced mutant2, Sage gene MP:0004860 dilated kidney collecting duct IMP N RGD:13204753|PMID:23859880 20210715 RGD compared to Hsd:SD 126790510 Ahrem2Sage aryl hydrocarbon receptor; ZFN induced mutant2, Sage gene MP:0004953 decreased spleen weight sexual_dimorphism IMP N RGD:13204753|PMID:23859880 20210708 RGD females compared to Hsd:SD females 126790510 Ahrem2Sage aryl hydrocarbon receptor; ZFN induced mutant2, Sage gene MP:0005016 decreased lymphocyte cell number IMP N RGD:13204753|PMID:23859880 20210708 RGD compared to Hsd:SD 126790510 Ahrem2Sage aryl hydrocarbon receptor; ZFN induced mutant2, Sage gene MP:0005343 increased circulating aspartate transaminase level sexual_dimorphism IMP N RGD:13204753|PMID:23859880 20210715 RGD females compared to Hsd:SD females 126790510 Ahrem2Sage aryl hydrocarbon receptor; ZFN induced mutant2, Sage gene MP:0005561 increased mean corpuscular hemoglobin IMP N RGD:13204753|PMID:23859880 20210715 RGD compared to Hsd:SD 126790510 Ahrem2Sage aryl hydrocarbon receptor; ZFN induced mutant2, Sage gene MP:0011347 abnormal kidney medullary ray morphology IMP N RGD:13204753|PMID:23859880 20210708 RGD compared to Hsd:SD 126790510 Ahrem2Sage aryl hydrocarbon receptor; ZFN induced mutant2, Sage gene MP:0011431 increased urine flow rate sexual_dimorphism IMP N RGD:13204753|PMID:23859880 20210715 RGD males compared to Hsd:SD 126790510 Ahrem2Sage aryl hydrocarbon receptor; ZFN induced mutant2, Sage gene MP:0013880 absent ductus venosus IMP N RGD:13204753|PMID:23859880 20210708 RGD 126790510 Ahrem2Sage aryl hydrocarbon receptor; ZFN induced mutant2, Sage gene MP:0020969 impaired conditioned taste aversion behavior sexual dimorphism IMP N RGD:407419883|PMID:30769105 20240912 RGD 126790547 SD-Rin1em1-/-Hcz strain MP:0002063 abnormal learning/memory/conditioning IMP N RGD:126790555|PMID:32174475 20210426 RGD 126790547 SD-Rin1em1-/-Hcz strain MP:0020422 decreased freezing behavior IMP N RGD:126790555|PMID:32174475 20210426 RGD 126790548 Rin1em1Hcz Ras and Rab interactor 1; TALEN induced mutant 1, Hcz gene MP:0002063 abnormal learning/memory/conditioning IMP N RGD:126790555|PMID:32174475 20210429 RGD 126790548 Rin1em1Hcz Ras and Rab interactor 1; TALEN induced mutant 1, Hcz gene MP:0020422 decreased freezing behavior IMP N RGD:126790555|PMID:32174475 20210429 RGD 126848737 WI- Msh6m1Hubr strain MP:0002020 increased tumor incidence IMP N RGD:2292505|PMID:18417481 20210428 RGD 126848737 WI- Msh6m1Hubr strain MP:0002083 premature death IMP N RGD:2292505|PMID:18417481 20210428 RGD 126848738 Msh6m1Hubr mutS homolog 6; ENU induced mutant 1, Hubr gene MP:0002020 increased tumor incidence IMP N RGD:2292505|PMID:18417481 20210429 RGD 126848738 Msh6m1Hubr mutS homolog 6; ENU induced mutant 1, Hubr gene MP:0002083 premature death IMP N RGD:2292505|PMID:18417481 20210429 RGD 126848739 Lpar1m1Hubr lysophosphatidic acid receptor 1; ENU induced mutant 1, Hubr gene MP:0001265 decreased body size IMP N RGD:13825198|PMID:20531371 20210429 RGD 126848739 Lpar1m1Hubr lysophosphatidic acid receptor 1; ENU induced mutant 1, Hubr gene MP:0003935 abnormal craniofacial development IMP N RGD:13825198|PMID:20531371 20210429 RGD 126848793 SS-Gper1em1Bj-/- strain MP:0001257 increased body length IMP N RGD:39939000|PMID:30354811 20220204 RGD compared to wild type SS rat 126848793 SS-Gper1em1Bj-/- strain MP:0001260 increased body weight IMP N RGD:39939000|PMID:30354811 20220204 RGD compared to wild type SS rat 126848793 SS-Gper1em1Bj-/- strain MP:0004876 decreased mean systemic arterial blood pressure IMP N RGD:39939000|PMID:30354811 20220204 RGD compared to wild type SS rat 126848793 SS-Gper1em1Bj-/- strain MP:0005590 increased vasodilation IMP N RGD:39939000|PMID:30354811 20220204 RGD compared to wild type SS rat 126848793 SS-Gper1em1Bj-/- strain MP:0006263 decreased systemic arterial diastolic blood pressure IMP N RGD:39939000|PMID:30354811 20220204 RGD compared to wild type SS rat 126848793 SS-Gper1em1Bj-/- strain MP:0006264 decreased systemic arterial systolic blood pressure IMP N RGD:39939000|PMID:30354811 20220204 RGD compared to wild type SS rat 126848793 SS-Gper1em1Bj-/- strain MP:0006266 decreased pulse pressure IMP N RGD:39939000|PMID:30354811 20220204 RGD compared to wild type SS rat 126848793 SS-Gper1em1Bj-/- strain MP:0010358 abnormal free fatty acids level IMP N RGD:39939000|PMID:30354811 20220204 RGD compared to wild type SS rat 126848794 SHR-Zbtb16em1Ipcv+/- strain MP:0001262 decreased body weight IMP N RGD:150340623|PMID:28396530 20220128 RGD compared to wild type SHR/OlaIpcv; 126848794 SHR-Zbtb16em1Ipcv+/- strain MP:0002644 decreased circulating triglyceride level IMP N RGD:150340623|PMID:28396530 20220128 RGD compared to wild type SHR/OlaIpcv; 126848794 SHR-Zbtb16em1Ipcv+/- strain MP:0002891 increased insulin sensitivity IMP N RGD:150340623|PMID:28396530 20220128 RGD compared to wild type SHR/OlaIpcv; 126848794 SHR-Zbtb16em1Ipcv+/- strain MP:0004565 decreased myocardial fiber size IMP N RGD:150340623|PMID:28396530 20220128 RGD compared to wild type SHR/OlaIpcv; 126848794 SHR-Zbtb16em1Ipcv+/- strain MP:0005179 decreased circulating cholesterol level IMP N RGD:150340623|PMID:28396530 20220128 RGD compared to wild type SHR/OlaIpcv; 126848794 SHR-Zbtb16em1Ipcv+/- strain MP:0005292 improved glucose tolerance IMP N RGD:150340623|PMID:28396530 20220128 RGD compared to wild type SHR/OlaIpcv; 126848794 SHR-Zbtb16em1Ipcv+/- strain MP:0005608 cardiac interstitial fibrosis ameliorates IMP N RGD:150340623|PMID:28396530 20220128 RGD 126848794 SHR-Zbtb16em1Ipcv+/- strain MP:0009289 decreased epididymal fat pad weight IMP N RGD:150340623|PMID:28396530 20220128 RGD compared to wild type SHR/OlaIpcv; 126848794 SHR-Zbtb16em1Ipcv+/- strain MP:0009356 decreased liver triglyceride level IMP N RGD:150340623|PMID:28396530 20220128 RGD compared to wild type SHR/OlaIpcv; 126848794 SHR-Zbtb16em1Ipcv+/- strain MP:0010026 decreased liver cholesterol level IMP N RGD:150340623|PMID:28396530 20220128 RGD compared to wild type SHR/OlaIpcv; 126848804 F344-Trpc4Tn(sb)1Bni strain MP:0020906 abnormal acquisiton of operant behavior for a cocaine reinforcer IMP N RGD:126848803|PMID:26988269 20210504 RGD 126848804 F344-Trpc4Tn(sb)1Bni strain MP:0020906 abnormal acquisiton of operant behavior for a cocaine reinforcer IMP N RGD:126848805|PMID:24555056 20210504 RGD 126848808 Trpc4Tn(sb)Tngen transient receptor potential cation channel, subfamily C, member 4; sleeping beauty induced mutant, Tngen gene MP:0020906 abnormal acquisiton of operant behavior for a cocaine reinforcer IMP N RGD:126848803|PMID:26988269 20210506 RGD 126848808 Trpc4Tn(sb)Tngen transient receptor potential cation channel, subfamily C, member 4; sleeping beauty induced mutant, Tngen gene MP:0020906 abnormal acquisiton of operant behavior for a cocaine reinforcer IMP N RGD:126848805|PMID:24555056 20210506 RGD 126908010 SD-Kcnk3em1Ang-/- strain MP:0002626 increased heart rate IMP N RGD:151347452|PMID:31347976 20220127 RGD 126908010 SD-Kcnk3em1Ang-/- strain MP:0003034 increased pulmonary vascular resistance IMP N RGD:151347452|PMID:31347976 20220127 RGD 126908010 SD-Kcnk3em1Ang-/- strain MP:0005591 decreased vasodilation IMP N RGD:151347452|PMID:31347976 20220127 RGD 126908010 SD-Kcnk3em1Ang-/- strain MP:0010758 increased right ventricle systolic pressure onset IMP N RGD:151347452|PMID:31347976 20220127 RGD 126908010 SD-Kcnk3em1Ang-/- strain MP:0011641 abnormal pulmonary collagen fibril morphology IMP N RGD:151347452|PMID:31347976 20220127 RGD 126908015 Kcnk3em1Ang potassium two pore domain channel subfamily K member 3; CRISPR/Cas9 induced mutant1, Ang gene MP:0002626 increased heart rate IMP N RGD:151347452|PMID:31347976 20220203 RGD 126908015 Kcnk3em1Ang potassium two pore domain channel subfamily K member 3; CRISPR/Cas9 induced mutant1, Ang gene MP:0003034 increased pulmonary vascular resistance IMP N RGD:151347452|PMID:31347976 20220203 RGD 126908015 Kcnk3em1Ang potassium two pore domain channel subfamily K member 3; CRISPR/Cas9 induced mutant1, Ang gene MP:0005591 decreased vasodilation IMP N RGD:151347452|PMID:31347976 20220203 RGD 126908015 Kcnk3em1Ang potassium two pore domain channel subfamily K member 3; CRISPR/Cas9 induced mutant1, Ang gene MP:0010758 increased right ventricle systolic pressure onset IMP N RGD:151347452|PMID:31347976 20220203 RGD 126908015 Kcnk3em1Ang potassium two pore domain channel subfamily K member 3; CRISPR/Cas9 induced mutant1, Ang gene MP:0011641 abnormal pulmonary collagen fibril morphology IMP N RGD:151347452|PMID:31347976 20220203 RGD 126925134 SD-Il36rntm1(Myh6-cre)Mhzh strain MP:0003822 decreased left ventricle systolic pressure IMP N RGD:126925167|PMID:32048631 20210513 RGD 126925134 SD-Il36rntm1(Myh6-cre)Mhzh strain MP:0005598 decreased heart ventricle muscle contractility IMP N RGD:126925167|PMID:32048631 20210513 RGD 126925134 SD-Il36rntm1(Myh6-cre)Mhzh strain MP:0011971 increased circulating lactate dehydrogenase level IMP N RGD:126925167|PMID:32048631 20210513 RGD 126925134 SD-Il36rntm1(Myh6-cre)Mhzh strain MP:0031077 increased circulating troponin level IMP N RGD:126925167|PMID:32048631 20210513 RGD 126925134 SD-Il36rntm1(Myh6-cre)Mhzh strain MP:0031108 increased circulating myoglobin level IMP N RGD:126925167|PMID:32048631 20210513 RGD 126925135 SD-Il1rl2tm1(Myh6-cre)Mhzh strain MP:0003223 decreased cardiomyocyte apoptosis IMP N RGD:126925167|PMID:32048631 20210513 RGD compared to Wild Type in cardiopulmonary bypass model 126925135 SD-Il1rl2tm1(Myh6-cre)Mhzh strain MP:0003674 oxidative stress IMP N RGD:126925167|PMID:32048631 20210513 RGD compared to Wild Type in cardiopulmonary bypass model 126925135 SD-Il1rl2tm1(Myh6-cre)Mhzh strain MP:0003820 increased left ventricle systolic pressure IMP N RGD:126925167|PMID:32048631 20210513 RGD compared to Wild Type in cardiopulmonary bypass model 126925135 SD-Il1rl2tm1(Myh6-cre)Mhzh strain MP:0003884 decreased macrophage cell number IMP N RGD:126925167|PMID:32048631 20210513 RGD compared to Wild Type in cardiopulmonary bypass model 126925135 SD-Il1rl2tm1(Myh6-cre)Mhzh strain MP:0003957 abnormal nitric oxide homeostasis IMP N RGD:126925167|PMID:32048631 20210513 RGD compared to Wild Type in cardiopulmonary bypass model 126925135 SD-Il1rl2tm1(Myh6-cre)Mhzh strain MP:0005599 increased cardiac muscle contractility IMP N RGD:126925167|PMID:32048631 20210513 RGD compared to Wild Type in cardiopulmonary bypass model 126925135 SD-Il1rl2tm1(Myh6-cre)Mhzh strain MP:0008554 decreased circulating tumor necrosis factor level IMP N RGD:126925167|PMID:32048631 20210513 RGD compared to Wild Type in cardiopulmonary bypass model 126925135 SD-Il1rl2tm1(Myh6-cre)Mhzh strain MP:0008658 decreased interleukin-1 beta secretion IMP N RGD:126925167|PMID:32048631 20210513 RGD compared to Wild Type in cardiopulmonary bypass model 126925135 SD-Il1rl2tm1(Myh6-cre)Mhzh strain MP:0010209 abnormal circulating chemokine level IMP N RGD:126925167|PMID:32048631 20210513 RGD compared to Wild Type in cardiopulmonary bypass model 126925135 SD-Il1rl2tm1(Myh6-cre)Mhzh strain MP:0011972 decreased circulating lactate dehydrogenase level IMP N RGD:126925167|PMID:32048631 20210513 RGD compared to Wild Type in cardiopulmonary bypass model 126925135 SD-Il1rl2tm1(Myh6-cre)Mhzh strain MP:0031076 decreased circulating troponin level IMP N RGD:126925167|PMID:32048631 20210513 RGD compared to Wild Type in cardiopulmonary bypass model 126925135 SD-Il1rl2tm1(Myh6-cre)Mhzh strain MP:0031107 abnormal circulating myoglobin level IMP N RGD:126925167|PMID:32048631 20210513 RGD compared to Wild Type in cardiopulmonary bypass model 126925136 SD-Mstnem1Cqin strain MP:0001260 increased body weight sexual_dimorphism IMP N RGD:13831345|PMID:27289021 20220121 RGD compared to wild type male 126925138 SD-Ubdem1 strain MP:0003037 increased myocardial infarct size IMP N RGD:126925221|PMID:29438664 20210518 RGD associated with induced myocardial infarction 126925138 SD-Ubdem1 strain MP:0003222 increased cardiomyocyte apoptosis IMP N RGD:126925221|PMID:29438664 20210518 RGD associated with induced myocardial infarction 126925138 SD-Ubdem1 strain MP:0005140 decreased cardiac muscle contractility IMP N RGD:126925221|PMID:29438664 20210518 RGD associated with induced myocardial infarction 126925138 SD-Ubdem1 strain MP:0005608 cardiac interstitial fibrosis IMP N RGD:126925221|PMID:29438664 20210518 RGD associated with induced myocardial infarction 126925139 SD-Dnmt1tm1(Myh6-cre)Cqin strain MP:0008877 abnormal DNA methylation IMP N RGD:126925233|PMID:32051532 20210518 RGD 126925159 Il1rl2tm1(Myh6-cre)Mhzh interleukin 1 receptor-like 2; tm1 (Myh6-cre), Mhzh gene MP:0003223 decreased cardiomyocyte apoptosis IMP N RGD:126925167|PMID:32048631 20210520 RGD compared to Wild Type in cardiopulmonary bypass model 126925159 Il1rl2tm1(Myh6-cre)Mhzh interleukin 1 receptor-like 2; tm1 (Myh6-cre), Mhzh gene MP:0003674 oxidative stress IMP N RGD:126925167|PMID:32048631 20210520 RGD compared to Wild Type in cardiopulmonary bypass model 126925159 Il1rl2tm1(Myh6-cre)Mhzh interleukin 1 receptor-like 2; tm1 (Myh6-cre), Mhzh gene MP:0003820 increased left ventricle systolic pressure IMP N RGD:126925167|PMID:32048631 20210520 RGD compared to Wild Type in cardiopulmonary bypass model 126925159 Il1rl2tm1(Myh6-cre)Mhzh interleukin 1 receptor-like 2; tm1 (Myh6-cre), Mhzh gene MP:0003884 decreased macrophage cell number IMP N RGD:126925167|PMID:32048631 20210520 RGD compared to Wild Type in cardiopulmonary bypass model 126925159 Il1rl2tm1(Myh6-cre)Mhzh interleukin 1 receptor-like 2; tm1 (Myh6-cre), Mhzh gene MP:0003957 abnormal nitric oxide homeostasis IMP N RGD:126925167|PMID:32048631 20210520 RGD compared to Wild Type in cardiopulmonary bypass model 126925159 Il1rl2tm1(Myh6-cre)Mhzh interleukin 1 receptor-like 2; tm1 (Myh6-cre), Mhzh gene MP:0005599 increased cardiac muscle contractility IMP N RGD:126925167|PMID:32048631 20210520 RGD compared to Wild Type in cardiopulmonary bypass model 126925159 Il1rl2tm1(Myh6-cre)Mhzh interleukin 1 receptor-like 2; tm1 (Myh6-cre), Mhzh gene MP:0008554 decreased circulating tumor necrosis factor level IMP N RGD:126925167|PMID:32048631 20210520 RGD compared to Wild Type in cardiopulmonary bypass model 126925159 Il1rl2tm1(Myh6-cre)Mhzh interleukin 1 receptor-like 2; tm1 (Myh6-cre), Mhzh gene MP:0008658 decreased interleukin-1 beta secretion IMP N RGD:126925167|PMID:32048631 20210520 RGD compared to Wild Type in cardiopulmonary bypass model 126925159 Il1rl2tm1(Myh6-cre)Mhzh interleukin 1 receptor-like 2; tm1 (Myh6-cre), Mhzh gene MP:0010209 abnormal circulating chemokine level IMP N RGD:126925167|PMID:32048631 20210520 RGD compared to Wild Type in cardiopulmonary bypass model 126925159 Il1rl2tm1(Myh6-cre)Mhzh interleukin 1 receptor-like 2; tm1 (Myh6-cre), Mhzh gene MP:0011972 decreased circulating lactate dehydrogenase level IMP N RGD:126925167|PMID:32048631 20210520 RGD compared to Wild Type in cardiopulmonary bypass model 126925159 Il1rl2tm1(Myh6-cre)Mhzh interleukin 1 receptor-like 2; tm1 (Myh6-cre), Mhzh gene MP:0031076 decreased circulating troponin level IMP N RGD:126925167|PMID:32048631 20210520 RGD compared to Wild Type in cardiopulmonary bypass model 126925159 Il1rl2tm1(Myh6-cre)Mhzh interleukin 1 receptor-like 2; tm1 (Myh6-cre), Mhzh gene MP:0031107 abnormal circulating myoglobin level IMP N RGD:126925167|PMID:32048631 20210520 RGD compared to Wild Type in cardiopulmonary bypass model 126925161 Il36rntm1(Myh6-cre)Mhzh interleukin 36 receptor antagonist; tm1, Mhzh gene MP:0003822 decreased left ventricle systolic pressure IMP N RGD:126925167|PMID:32048631 20210520 RGD 126925161 Il36rntm1(Myh6-cre)Mhzh interleukin 36 receptor antagonist; tm1, Mhzh gene MP:0005598 decreased heart ventricle muscle contractility IMP N RGD:126925167|PMID:32048631 20210520 RGD 126925161 Il36rntm1(Myh6-cre)Mhzh interleukin 36 receptor antagonist; tm1, Mhzh gene MP:0011971 increased circulating lactate dehydrogenase level IMP N RGD:126925167|PMID:32048631 20210520 RGD 126925161 Il36rntm1(Myh6-cre)Mhzh interleukin 36 receptor antagonist; tm1, Mhzh gene MP:0031077 increased circulating troponin level IMP N RGD:126925167|PMID:32048631 20210520 RGD 126925161 Il36rntm1(Myh6-cre)Mhzh interleukin 36 receptor antagonist; tm1, Mhzh gene MP:0031108 increased circulating myoglobin level IMP N RGD:126925167|PMID:32048631 20210520 RGD 126925165 Dnmt1tm1(Myh6-cre)Cqin DNA methyltransferase 1; tm1(Myh6-cre), Cqin gene MP:0008877 abnormal DNA methylation IMP N RGD:126925233|PMID:32051532 20210520 RGD 126925166 Ubdem1 ubiquitin D; CRISPR/Cas9 induced mutant1 gene MP:0003037 increased myocardial infarct size IMP N RGD:126925221|PMID:29438664 20210520 RGD associated with induced myocardial infarction 126925166 Ubdem1 ubiquitin D; CRISPR/Cas9 induced mutant1 gene MP:0003222 increased cardiomyocyte apoptosis IMP N RGD:126925221|PMID:29438664 20210520 RGD associated with induced myocardial infarction 126925166 Ubdem1 ubiquitin D; CRISPR/Cas9 induced mutant1 gene MP:0005140 decreased cardiac muscle contractility IMP N RGD:126925221|PMID:29438664 20210520 RGD associated with induced myocardial infarction 126925166 Ubdem1 ubiquitin D; CRISPR/Cas9 induced mutant1 gene MP:0005608 cardiac interstitial fibrosis IMP N RGD:126925221|PMID:29438664 20210520 RGD associated with induced myocardial infarction 126925212 WI- Drd1m1Hubr strain MP:0001262 decreased body weight IMP N RGD:13825241|PMID:27483345 20210517 RGD compared to wild type 126925212 WI- Drd1m1Hubr strain MP:0001360 abnormal social investigation IMP N RGD:13825241|PMID:27483345 20210517 RGD compared to wild type 126925212 WI- Drd1m1Hubr strain MP:0001529 abnormal vocalization IMP N RGD:13825241|PMID:27483345 20210517 RGD compared to wild type 126925212 WI- Drd1m1Hubr strain MP:0002757 decreased vertical activity IMP N RGD:13825241|PMID:27483345 20210517 RGD compared to wild type 126925212 WI- Drd1m1Hubr strain MP:0020395 abnormal response to social novelty IMP N RGD:13825241|PMID:27483345 20210517 RGD compared to wild type 126925213 Drd1m1Hubr dopamine receptor D1; ENU induced mutant 1, Hubr gene MP:0001262 decreased body weight IMP N RGD:13825241|PMID:27483345 20210520 RGD compared to wild type 126925213 Drd1m1Hubr dopamine receptor D1; ENU induced mutant 1, Hubr gene MP:0001360 abnormal social investigation IMP N RGD:13825241|PMID:27483345 20210520 RGD compared to wild type 126925213 Drd1m1Hubr dopamine receptor D1; ENU induced mutant 1, Hubr gene MP:0001529 abnormal vocalization IMP N RGD:13825241|PMID:27483345 20210520 RGD compared to wild type 126925213 Drd1m1Hubr dopamine receptor D1; ENU induced mutant 1, Hubr gene MP:0002757 decreased vertical activity IMP N RGD:13825241|PMID:27483345 20210520 RGD compared to wild type 126925213 Drd1m1Hubr dopamine receptor D1; ENU induced mutant 1, Hubr gene MP:0020395 abnormal response to social novelty IMP N RGD:13825241|PMID:27483345 20210520 RGD compared to wild type 126925756 SD-Cryba1Nuc1Dbsa strain MP:0001306 small lens IMP N RGD:126925760|PMID:15721615 20210519 RGD 126925756 SD-Cryba1Nuc1Dbsa strain MP:0002182 abnormal astrocyte morphology IMP N RGD:2303652|PMID:17931883 20210519 RGD 126925756 SD-Cryba1Nuc1Dbsa strain MP:0002792 abnormal retina vasculature morphology IMP N RGD:2303652|PMID:17931883 20210519 RGD 126925756 SD-Cryba1Nuc1Dbsa strain MP:0003734 abnormal retina inner plexiform layer morphology IMP N RGD:126925760|PMID:15721615 20210519 RGD 126925756 SD-Cryba1Nuc1Dbsa strain MP:0005241 abnormal retina ganglion layer morphology IMP N RGD:126925760|PMID:15721615 20210519 RGD 126925756 SD-Cryba1Nuc1Dbsa strain MP:0008260 abnormal autophagy IMP N RGD:126925759|PMID:21266465 20210519 RGD 126925756 SD-Cryba1Nuc1Dbsa strain MP:0008842 lipofuscinosis IMP N RGD:126925759|PMID:21266465 20210519 RGD 126925756 SD-Cryba1Nuc1Dbsa strain MP:0011996 abnormal retina inner nuclear layer thickness IMP N RGD:126925760|PMID:15721615 20210519 RGD 126925756 SD-Cryba1Nuc1Dbsa strain MP:0011997 abnormal retina outer nuclear layer thickness IMP N RGD:126925760|PMID:15721615 20210519 RGD 126925756 SD-Cryba1Nuc1Dbsa strain MP:0030006 decreased retina apoptosis IMP N RGD:126925760|PMID:15721615 20210519 RGD 126925758 Cryba1Nuc1Dbsa crystallin, beta A1;Nuc1 mutant, Dbsa gene MP:0001306 small lens IMP N RGD:126925760|PMID:15721615 20210520 RGD 126925758 Cryba1Nuc1Dbsa crystallin, beta A1;Nuc1 mutant, Dbsa gene MP:0002182 abnormal astrocyte morphology IMP N RGD:2303652|PMID:17931883 20210520 RGD 126925758 Cryba1Nuc1Dbsa crystallin, beta A1;Nuc1 mutant, Dbsa gene MP:0002792 abnormal retina vasculature morphology IMP N RGD:2303652|PMID:17931883 20210520 RGD 126925758 Cryba1Nuc1Dbsa crystallin, beta A1;Nuc1 mutant, Dbsa gene MP:0003734 abnormal retina inner plexiform layer morphology IMP N RGD:126925760|PMID:15721615 20210520 RGD 126925758 Cryba1Nuc1Dbsa crystallin, beta A1;Nuc1 mutant, Dbsa gene MP:0005241 abnormal retina ganglion layer morphology IMP N RGD:126925760|PMID:15721615 20210520 RGD 126925758 Cryba1Nuc1Dbsa crystallin, beta A1;Nuc1 mutant, Dbsa gene MP:0008260 abnormal autophagy IMP N RGD:126925759|PMID:21266465 20210520 RGD 126925758 Cryba1Nuc1Dbsa crystallin, beta A1;Nuc1 mutant, Dbsa gene MP:0008842 lipofuscinosis IMP N RGD:126925759|PMID:21266465 20210520 RGD 126925758 Cryba1Nuc1Dbsa crystallin, beta A1;Nuc1 mutant, Dbsa gene MP:0011996 abnormal retina inner nuclear layer thickness IMP N RGD:126925760|PMID:15721615 20210520 RGD 126925758 Cryba1Nuc1Dbsa crystallin, beta A1;Nuc1 mutant, Dbsa gene MP:0011997 abnormal retina outer nuclear layer thickness IMP N RGD:126925760|PMID:15721615 20210520 RGD 126925758 Cryba1Nuc1Dbsa crystallin, beta A1;Nuc1 mutant, Dbsa gene MP:0030006 decreased retina apoptosis IMP N RGD:126925760|PMID:15721615 20210520 RGD 126925949 SD-Myh7bem1Blar+/- strain MP:0002625 heart left ventricle hypertrophy IMP N RGD:126925946|PMID:32207065 20210816 RGD 126925949 SD-Myh7bem1Blar+/- strain MP:0003141 cardiac fibrosis IMP N RGD:126925946|PMID:32207065 20210816 RGD 126925949 SD-Myh7bem1Blar+/- strain MP:0004090 abnormal sarcomere morphology IMP N RGD:126925946|PMID:32207065 20210816 RGD 126925949 SD-Myh7bem1Blar+/- strain MP:0004564 increased myocardial fiber size IMP N RGD:126925946|PMID:32207065 20210816 RGD 126925949 SD-Myh7bem1Blar+/- strain MP:0010724 thick interventricular septum IMP N RGD:126925946|PMID:32207065 20210816 RGD 126925949 SD-Myh7bem1Blar+/- strain MP:0020346 abnormal myocardial fiber calcium currents IMP N RGD:126925946|PMID:32207065 20210816 RGD 126925949 SD-Myh7bem1Blar+/- strain MP:0021140 increased cardiac muscle calcium level IMP N RGD:126925946|PMID:32207065 20210816 RGD 126925949 SD-Myh7bem1Blar+/- strain MP:0021161 increased heart left ventricle posterior wall thickness IMP N RGD:126925946|PMID:32207065 20220711 RGD 126925952 SD-Myh7bem1Blar-/- strain MP:0001262 decreased body weight IMP N RGD:126925946|PMID:32207065 20210816 RGD 126925952 SD-Myh7bem1Blar-/- strain MP:0002625 heart left ventricle hypertrophy IMP N RGD:126925946|PMID:32207065 20210816 RGD 126925952 SD-Myh7bem1Blar-/- strain MP:0003141 cardiac fibrosis IMP N RGD:126925946|PMID:32207065 20210816 RGD 126925952 SD-Myh7bem1Blar-/- strain MP:0004090 abnormal sarcomere morphology IMP N RGD:126925946|PMID:32207065 20210816 RGD 126925952 SD-Myh7bem1Blar-/- strain MP:0004564 increased myocardial fiber size IMP N RGD:126925946|PMID:32207065 20210816 RGD 126925952 SD-Myh7bem1Blar-/- strain MP:0010724 thick interventricular septum IMP N RGD:126925946|PMID:32207065 20210816 RGD 126925952 SD-Myh7bem1Blar-/- strain MP:0020346 abnormal myocardial fiber calcium currents IMP N RGD:126925946|PMID:32207065 20210816 RGD 126925952 SD-Myh7bem1Blar-/- strain MP:0021140 increased cardiac muscle calcium level IMP N RGD:126925946|PMID:32207065 20210816 RGD 126925952 SD-Myh7bem1Blar-/- strain MP:0021161 increased heart left ventricle posterior wall thickness IMP N RGD:126925946|PMID:32207065 20220711 RGD 126925953 Myh7bem1Blar myosin heavy chain 7B; CRISPR/Cas9 induced mutant 1, Blar gene MP:0001262 decreased body weight IMP N RGD:126925946|PMID:32207065 20210819 RGD 126925953 Myh7bem1Blar myosin heavy chain 7B; CRISPR/Cas9 induced mutant 1, Blar gene MP:0002625 heart left ventricle hypertrophy IMP N RGD:126925946|PMID:32207065 20210819 RGD 126925953 Myh7bem1Blar myosin heavy chain 7B; CRISPR/Cas9 induced mutant 1, Blar gene MP:0003141 cardiac fibrosis IMP N RGD:126925946|PMID:32207065 20210819 RGD 126925953 Myh7bem1Blar myosin heavy chain 7B; CRISPR/Cas9 induced mutant 1, Blar gene MP:0004090 abnormal sarcomere morphology IMP N RGD:126925946|PMID:32207065 20210819 RGD 126925953 Myh7bem1Blar myosin heavy chain 7B; CRISPR/Cas9 induced mutant 1, Blar gene MP:0004564 increased myocardial fiber size IMP N RGD:126925946|PMID:32207065 20210819 RGD 126925953 Myh7bem1Blar myosin heavy chain 7B; CRISPR/Cas9 induced mutant 1, Blar gene MP:0010724 thick interventricular septum IMP N RGD:126925946|PMID:32207065 20210819 RGD 126925953 Myh7bem1Blar myosin heavy chain 7B; CRISPR/Cas9 induced mutant 1, Blar gene MP:0020346 abnormal myocardial fiber calcium currents IMP N RGD:126925946|PMID:32207065 20210819 RGD 126925953 Myh7bem1Blar myosin heavy chain 7B; CRISPR/Cas9 induced mutant 1, Blar gene MP:0021140 increased cardiac muscle calcium level IMP N RGD:126925946|PMID:32207065 20210819 RGD 126925953 Myh7bem1Blar myosin heavy chain 7B; CRISPR/Cas9 induced mutant 1, Blar gene MP:0021161 increased heart left ventricle posterior wall thickness IMP N RGD:126925946|PMID:32207065 20220714 RGD 126925978 SD-Ercc6em1Cgen strain MP:0000852 small cerebellum IMP N RGD:126925983|PMID:31644904 20210525 RGD 126925978 SD-Ercc6em1Cgen strain MP:0003354 astrocytosis IMP N RGD:126925983|PMID:31644904 20210525 RGD 126925978 SD-Ercc6em1Cgen strain MP:0004097 abnormal cerebellar cortex morphology IMP N RGD:126925983|PMID:31644904 20210525 RGD 126925978 SD-Ercc6em1Cgen strain MP:0008410 increased cellular sensitivity to ultraviolet irradiation IMP N RGD:126925983|PMID:31644904 20210525 RGD 126925978 SD-Ercc6em1Cgen strain MP:0009796 abnormal base-excision repair IMP N RGD:126925983|PMID:31644904 20210525 RGD 126925978 SD-Ercc6em1Cgen strain MP:0011639 decreased mitochondrial DNA content IMP N RGD:126925983|PMID:31644904 20210525 RGD 126925980 Ercc6em1Cgen ERCC excision repair 6, chromatin remodeling factor; CRISPR/Cas9 induced mutant 1, Cgen gene MP:0000852 small cerebellum IMP N RGD:126925983|PMID:31644904 20210527 RGD 126925980 Ercc6em1Cgen ERCC excision repair 6, chromatin remodeling factor; CRISPR/Cas9 induced mutant 1, Cgen gene MP:0003354 astrocytosis IMP N RGD:126925983|PMID:31644904 20210527 RGD 126925980 Ercc6em1Cgen ERCC excision repair 6, chromatin remodeling factor; CRISPR/Cas9 induced mutant 1, Cgen gene MP:0004097 abnormal cerebellar cortex morphology IMP N RGD:126925983|PMID:31644904 20210527 RGD 126925980 Ercc6em1Cgen ERCC excision repair 6, chromatin remodeling factor; CRISPR/Cas9 induced mutant 1, Cgen gene MP:0008410 increased cellular sensitivity to ultraviolet irradiation IMP N RGD:126925983|PMID:31644904 20210527 RGD 126925980 Ercc6em1Cgen ERCC excision repair 6, chromatin remodeling factor; CRISPR/Cas9 induced mutant 1, Cgen gene MP:0009796 abnormal base-excision repair IMP N RGD:126925983|PMID:31644904 20210527 RGD 126925980 Ercc6em1Cgen ERCC excision repair 6, chromatin remodeling factor; CRISPR/Cas9 induced mutant 1, Cgen gene MP:0011639 decreased mitochondrial DNA content IMP N RGD:126925983|PMID:31644904 20210527 RGD 126925992 SD-Cftrem1Ang strain MP:0001262 decreased body weight IMP N RGD:126928119|PMID:31942562 20210526 RGD 126925992 SD-Cftrem1Ang strain MP:0001732 postnatal growth retardation IMP N RGD:126928119|PMID:31942562 20210526 RGD 126925992 SD-Cftrem1Ang strain MP:0001732 postnatal growth retardation treatment IMP N RGD:126928119|PMID:31942562 20210526 RGD DietGel 31M and 6% osmotic laxative (PEG3350) and DietGel Boost added to drinking water 126925992 SD-Cftrem1Ang strain MP:0008770 decreased survivor rate IMP N RGD:126928119|PMID:31942562 20210526 RGD 126925992 SD-Cftrem1Ang strain MP:0008770 decreased survivor rate treatment IMP N RGD:126928119|PMID:31942562 20210526 RGD DietGel 31M and 6% osmotic laxative (PEG3350) and DietGel Boost added to drinking water 126925992 SD-Cftrem1Ang strain MP:0012020 abnormal olfactory epithelium physiology IMP N RGD:126928119|PMID:31942562 20210526 RGD 126925992 SD-Cftrem1Ang strain MP:0014028 decreased respiratory epithelial chloride transmembrane transport IMP N RGD:126928119|PMID:31942562 20210526 RGD 126925992 SD-Cftrem1Ang strain MP:0014183 increased respiratory epithelial sodium ion transmembrane transport IMP N RGD:126928119|PMID:31942562 20210526 RGD 126925992 SD-Cftrem1Ang strain MP:0030544 abnormal enamel development IMP N RGD:126928119|PMID:31942562 20210526 RGD 126925993 Cftrem1Ang cystic fibrosis transmembrane conductance regulator; CRISPR/Cas9 induced mutant 1, Ang gene MP:0001262 decreased body weight IMP N RGD:126928119|PMID:31942562 20210527 RGD 126925993 Cftrem1Ang cystic fibrosis transmembrane conductance regulator; CRISPR/Cas9 induced mutant 1, Ang gene MP:0001732 postnatal growth retardation IMP N RGD:126928119|PMID:31942562 20210527 RGD 126925993 Cftrem1Ang cystic fibrosis transmembrane conductance regulator; CRISPR/Cas9 induced mutant 1, Ang gene MP:0001732 postnatal growth retardation treatment IMP N RGD:126928119|PMID:31942562 20210527 RGD DietGel 31M and 6% osmotic laxative (PEG3350) and DietGel Boost added to drinking water 126925993 Cftrem1Ang cystic fibrosis transmembrane conductance regulator; CRISPR/Cas9 induced mutant 1, Ang gene MP:0008770 decreased survivor rate IMP N RGD:126928119|PMID:31942562 20210527 RGD 126925993 Cftrem1Ang cystic fibrosis transmembrane conductance regulator; CRISPR/Cas9 induced mutant 1, Ang gene MP:0008770 decreased survivor rate treatment IMP N RGD:126928119|PMID:31942562 20210527 RGD DietGel 31M and 6% osmotic laxative (PEG3350) and DietGel Boost added to drinking water 126925993 Cftrem1Ang cystic fibrosis transmembrane conductance regulator; CRISPR/Cas9 induced mutant 1, Ang gene MP:0012020 abnormal olfactory epithelium physiology IMP N RGD:126928119|PMID:31942562 20210527 RGD 126925993 Cftrem1Ang cystic fibrosis transmembrane conductance regulator; CRISPR/Cas9 induced mutant 1, Ang gene MP:0014028 decreased respiratory epithelial chloride transmembrane transport IMP N RGD:126928119|PMID:31942562 20210527 RGD 126925993 Cftrem1Ang cystic fibrosis transmembrane conductance regulator; CRISPR/Cas9 induced mutant 1, Ang gene MP:0014183 increased respiratory epithelial sodium ion transmembrane transport IMP N RGD:126928119|PMID:31942562 20210527 RGD 126925993 Cftrem1Ang cystic fibrosis transmembrane conductance regulator; CRISPR/Cas9 induced mutant 1, Ang gene MP:0030544 abnormal enamel development IMP N RGD:126928119|PMID:31942562 20210527 RGD 126925994 SD-Cftrem2Ang strain MP:0001262 decreased body weight IMP N RGD:126928119|PMID:31942562 20210526 RGD 126925994 SD-Cftrem2Ang strain MP:0001732 postnatal growth retardation IMP N RGD:126928119|PMID:31942562 20210526 RGD 126925994 SD-Cftrem2Ang strain MP:0001732 postnatal growth retardation treatment IMP N RGD:126928119|PMID:31942562 20210526 RGD DietGel 31M and 6% osmotic laxative (PEG3350) and DietGel Boost added to drinking water 126925994 SD-Cftrem2Ang strain MP:0003557 absent vas deferens IMP N RGD:126928119|PMID:31942562 20210526 RGD 126925994 SD-Cftrem2Ang strain MP:0008770 decreased survivor rate IMP N RGD:126928119|PMID:31942562 20210526 RGD 126925994 SD-Cftrem2Ang strain MP:0008770 decreased survivor rate treatment IMP N RGD:126928119|PMID:31942562 20210526 RGD DietGel 31M and 6% osmotic laxative (PEG3350) and DietGel Boost added to drinking water 126925994 SD-Cftrem2Ang strain MP:0012020 abnormal olfactory epithelium physiology IMP N RGD:126928119|PMID:31942562 20210526 RGD 126925994 SD-Cftrem2Ang strain MP:0014028 decreased respiratory epithelial chloride transmembrane transport IMP N RGD:126928119|PMID:31942562 20210526 RGD 126925994 SD-Cftrem2Ang strain MP:0014183 increased respiratory epithelial sodium ion transmembrane transport IMP N RGD:126928119|PMID:31942562 20210526 RGD 126925994 SD-Cftrem2Ang strain MP:0030544 abnormal enamel development IMP N RGD:126928119|PMID:31942562 20210526 RGD 126925995 Cftrem2Ang cystic fibrosis transmembrane conductance regulator; CRISPR/Cas9 induced mutant 2, Ang gene MP:0001262 decreased body weight IMP N RGD:126928119|PMID:31942562 20210527 RGD 126925995 Cftrem2Ang cystic fibrosis transmembrane conductance regulator; CRISPR/Cas9 induced mutant 2, Ang gene MP:0001732 postnatal growth retardation IMP N RGD:126928119|PMID:31942562 20210527 RGD 126925995 Cftrem2Ang cystic fibrosis transmembrane conductance regulator; CRISPR/Cas9 induced mutant 2, Ang gene MP:0001732 postnatal growth retardation treatment IMP N RGD:126928119|PMID:31942562 20210527 RGD DietGel 31M and 6% osmotic laxative (PEG3350) and DietGel Boost added to drinking water 126925995 Cftrem2Ang cystic fibrosis transmembrane conductance regulator; CRISPR/Cas9 induced mutant 2, Ang gene MP:0003557 absent vas deferens IMP N RGD:126928119|PMID:31942562 20210527 RGD 126925995 Cftrem2Ang cystic fibrosis transmembrane conductance regulator; CRISPR/Cas9 induced mutant 2, Ang gene MP:0008770 decreased survivor rate IMP N RGD:126928119|PMID:31942562 20210527 RGD 126925995 Cftrem2Ang cystic fibrosis transmembrane conductance regulator; CRISPR/Cas9 induced mutant 2, Ang gene MP:0008770 decreased survivor rate treatment IMP N RGD:126928119|PMID:31942562 20210527 RGD DietGel 31M and 6% osmotic laxative (PEG3350) and DietGel Boost added to drinking water 126925995 Cftrem2Ang cystic fibrosis transmembrane conductance regulator; CRISPR/Cas9 induced mutant 2, Ang gene MP:0012020 abnormal olfactory epithelium physiology IMP N RGD:126928119|PMID:31942562 20210527 RGD 126925995 Cftrem2Ang cystic fibrosis transmembrane conductance regulator; CRISPR/Cas9 induced mutant 2, Ang gene MP:0014028 decreased respiratory epithelial chloride transmembrane transport IMP N RGD:126928119|PMID:31942562 20210527 RGD 126925995 Cftrem2Ang cystic fibrosis transmembrane conductance regulator; CRISPR/Cas9 induced mutant 2, Ang gene MP:0014183 increased respiratory epithelial sodium ion transmembrane transport IMP N RGD:126928119|PMID:31942562 20210527 RGD 126925995 Cftrem2Ang cystic fibrosis transmembrane conductance regulator; CRISPR/Cas9 induced mutant 2, Ang gene MP:0030544 abnormal enamel development IMP N RGD:126928119|PMID:31942562 20210527 RGD 126928146 ACI.Cg.-Cdkn1bem1Musc strain MP:0001260 increased body weight IMP N RGD:126908018|PMID:30893315 20210607 RGD 126928146 ACI.Cg.-Cdkn1bem1Musc strain MP:0001304 cataract IMP N RGD:126908018|PMID:30893315 20210607 RGD 126928146 ACI.Cg.-Cdkn1bem1Musc strain MP:0001921 reduced fertility IMP N RGD:126908018|PMID:30893315 20210607 RGD 126928146 ACI.Cg.-Cdkn1bem1Musc strain MP:0002176 increased brain weight IMP N RGD:126908018|PMID:30893315 20210607 RGD 126928146 ACI.Cg.-Cdkn1bem1Musc strain MP:0002981 increased liver weight IMP N RGD:126908018|PMID:30893315 20210607 RGD 126928146 ACI.Cg.-Cdkn1bem1Musc strain MP:0004952 increased spleen weight IMP N RGD:126908018|PMID:30893315 20210607 RGD 126928146 ACI.Cg.-Cdkn1bem1Musc strain MP:0004955 increased thymus weight IMP N RGD:126908018|PMID:30893315 20210607 RGD 126928146 ACI.Cg.-Cdkn1bem1Musc strain MP:0005124 increased circulating prolactin level IMP N RGD:126908018|PMID:30893315 20210607 RGD at 4-6 weeks 126928146 ACI.Cg.-Cdkn1bem1Musc strain MP:0005182 increased circulating estradiol level IMP N RGD:126908018|PMID:30893315 20210607 RGD at 9 weeks 126928146 ACI.Cg.-Cdkn1bem1Musc strain MP:0005630 increased lung weight IMP N RGD:126908018|PMID:30893315 20210607 RGD 126928146 ACI.Cg.-Cdkn1bem1Musc strain MP:0008939 increased pituitary gland weight IMP N RGD:126908018|PMID:30893315 20210607 RGD 126928146 ACI.Cg.-Cdkn1bem1Musc strain MP:0009296 increased mammary fat pad weight IMP N RGD:126908018|PMID:30893315 20210607 RGD 126928146 ACI.Cg.-Cdkn1bem1Musc strain MP:0010173 increased mammary gland epithelial cell proliferation IMP N RGD:126908018|PMID:30893315 20210607 RGD 126928146 ACI.Cg.-Cdkn1bem1Musc strain MP:0013781 abnormal mammary gland luminal epithelium morphology IMP N RGD:126908018|PMID:30893315 20210607 RGD 126928147 Cdkn1bem1Musc cyclin-dependent kinase inhibitor 1B; CRISPR/Cas9 induced mutant 1, Musc gene MP:0001260 increased body weight IMP N RGD:126908018|PMID:30893315 20210610 RGD 126928147 Cdkn1bem1Musc cyclin-dependent kinase inhibitor 1B; CRISPR/Cas9 induced mutant 1, Musc gene MP:0001304 cataract IMP N RGD:126908018|PMID:30893315 20210610 RGD 126928147 Cdkn1bem1Musc cyclin-dependent kinase inhibitor 1B; CRISPR/Cas9 induced mutant 1, Musc gene MP:0001921 reduced fertility IMP N RGD:126908018|PMID:30893315 20210610 RGD 126928147 Cdkn1bem1Musc cyclin-dependent kinase inhibitor 1B; CRISPR/Cas9 induced mutant 1, Musc gene MP:0002176 increased brain weight IMP N RGD:126908018|PMID:30893315 20210610 RGD 126928147 Cdkn1bem1Musc cyclin-dependent kinase inhibitor 1B; CRISPR/Cas9 induced mutant 1, Musc gene MP:0002981 increased liver weight IMP N RGD:126908018|PMID:30893315 20210610 RGD 126928147 Cdkn1bem1Musc cyclin-dependent kinase inhibitor 1B; CRISPR/Cas9 induced mutant 1, Musc gene MP:0004952 increased spleen weight IMP N RGD:126908018|PMID:30893315 20210610 RGD 126928147 Cdkn1bem1Musc cyclin-dependent kinase inhibitor 1B; CRISPR/Cas9 induced mutant 1, Musc gene MP:0004955 increased thymus weight IMP N RGD:126908018|PMID:30893315 20210610 RGD 126928147 Cdkn1bem1Musc cyclin-dependent kinase inhibitor 1B; CRISPR/Cas9 induced mutant 1, Musc gene MP:0005124 increased circulating prolactin level IMP N RGD:126908018|PMID:30893315 20210610 RGD at 4-6 weeks 126928147 Cdkn1bem1Musc cyclin-dependent kinase inhibitor 1B; CRISPR/Cas9 induced mutant 1, Musc gene MP:0005182 increased circulating estradiol level IMP N RGD:126908018|PMID:30893315 20210610 RGD at 9 weeks 126928147 Cdkn1bem1Musc cyclin-dependent kinase inhibitor 1B; CRISPR/Cas9 induced mutant 1, Musc gene MP:0005630 increased lung weight IMP N RGD:126908018|PMID:30893315 20210610 RGD 126928147 Cdkn1bem1Musc cyclin-dependent kinase inhibitor 1B; CRISPR/Cas9 induced mutant 1, Musc gene MP:0008939 increased pituitary gland weight IMP N RGD:126908018|PMID:30893315 20210610 RGD 126928147 Cdkn1bem1Musc cyclin-dependent kinase inhibitor 1B; CRISPR/Cas9 induced mutant 1, Musc gene MP:0009296 increased mammary fat pad weight IMP N RGD:126908018|PMID:30893315 20210610 RGD 126928147 Cdkn1bem1Musc cyclin-dependent kinase inhibitor 1B; CRISPR/Cas9 induced mutant 1, Musc gene MP:0010173 increased mammary gland epithelial cell proliferation IMP N RGD:126908018|PMID:30893315 20210610 RGD 126928147 Cdkn1bem1Musc cyclin-dependent kinase inhibitor 1B; CRISPR/Cas9 induced mutant 1, Musc gene MP:0013781 abnormal mammary gland luminal epithelium morphology IMP N RGD:126908018|PMID:30893315 20210610 RGD 126928150 ACI.Cg.-Cdkn1bem4Musc strain MP:0001260 increased body weight IMP N RGD:126908018|PMID:30893315 20210607 RGD 126928150 ACI.Cg.-Cdkn1bem4Musc strain MP:0001304 cataract IMP N RGD:126908018|PMID:30893315 20210607 RGD 126928150 ACI.Cg.-Cdkn1bem4Musc strain MP:0001921 reduced fertility IMP N RGD:126908018|PMID:30893315 20210607 RGD 126928150 ACI.Cg.-Cdkn1bem4Musc strain MP:0002176 increased brain weight IMP N RGD:126908018|PMID:30893315 20210607 RGD 126928150 ACI.Cg.-Cdkn1bem4Musc strain MP:0002981 increased liver weight IMP N RGD:126908018|PMID:30893315 20210607 RGD 126928150 ACI.Cg.-Cdkn1bem4Musc strain MP:0004952 increased spleen weight IMP N RGD:126908018|PMID:30893315 20210607 RGD 126928150 ACI.Cg.-Cdkn1bem4Musc strain MP:0004955 increased thymus weight IMP N RGD:126908018|PMID:30893315 20210607 RGD 126928150 ACI.Cg.-Cdkn1bem4Musc strain MP:0005124 increased circulating prolactin level IMP N RGD:126908018|PMID:30893315 20210607 RGD at 4-6 weeks 126928150 ACI.Cg.-Cdkn1bem4Musc strain MP:0005182 increased circulating estradiol level IMP N RGD:126908018|PMID:30893315 20210607 RGD at 9 weeks 126928150 ACI.Cg.-Cdkn1bem4Musc strain MP:0005630 increased lung weight IMP N RGD:126908018|PMID:30893315 20210607 RGD 126928150 ACI.Cg.-Cdkn1bem4Musc strain MP:0008939 increased pituitary gland weight IMP N RGD:126908018|PMID:30893315 20210607 RGD 126928150 ACI.Cg.-Cdkn1bem4Musc strain MP:0009296 increased mammary fat pad weight IMP N RGD:126908018|PMID:30893315 20210607 RGD 126928150 ACI.Cg.-Cdkn1bem4Musc strain MP:0010173 increased mammary gland epithelial cell proliferation IMP N RGD:126908018|PMID:30893315 20210607 RGD 126928150 ACI.Cg.-Cdkn1bem4Musc strain MP:0013781 abnormal mammary gland luminal epithelium morphology IMP N RGD:126908018|PMID:30893315 20210607 RGD 126928151 Cdkn1bem4Musc cyclin-dependent kinase inhibitor 1B; CRISPR/Cas9 induced mutant 4, Musc gene MP:0001260 increased body weight IMP N RGD:126908018|PMID:30893315 20210610 RGD 126928151 Cdkn1bem4Musc cyclin-dependent kinase inhibitor 1B; CRISPR/Cas9 induced mutant 4, Musc gene MP:0001304 cataract IMP N RGD:126908018|PMID:30893315 20210610 RGD 126928151 Cdkn1bem4Musc cyclin-dependent kinase inhibitor 1B; CRISPR/Cas9 induced mutant 4, Musc gene MP:0001921 reduced fertility IMP N RGD:126908018|PMID:30893315 20210610 RGD 126928151 Cdkn1bem4Musc cyclin-dependent kinase inhibitor 1B; CRISPR/Cas9 induced mutant 4, Musc gene MP:0002176 increased brain weight IMP N RGD:126908018|PMID:30893315 20210610 RGD 126928151 Cdkn1bem4Musc cyclin-dependent kinase inhibitor 1B; CRISPR/Cas9 induced mutant 4, Musc gene MP:0002981 increased liver weight IMP N RGD:126908018|PMID:30893315 20210610 RGD 126928151 Cdkn1bem4Musc cyclin-dependent kinase inhibitor 1B; CRISPR/Cas9 induced mutant 4, Musc gene MP:0004952 increased spleen weight IMP N RGD:126908018|PMID:30893315 20210610 RGD 126928151 Cdkn1bem4Musc cyclin-dependent kinase inhibitor 1B; CRISPR/Cas9 induced mutant 4, Musc gene MP:0004955 increased thymus weight IMP N RGD:126908018|PMID:30893315 20210610 RGD 126928151 Cdkn1bem4Musc cyclin-dependent kinase inhibitor 1B; CRISPR/Cas9 induced mutant 4, Musc gene MP:0005124 increased circulating prolactin level IMP N RGD:126908018|PMID:30893315 20210610 RGD at 4-6 weeks 126928151 Cdkn1bem4Musc cyclin-dependent kinase inhibitor 1B; CRISPR/Cas9 induced mutant 4, Musc gene MP:0005182 increased circulating estradiol level IMP N RGD:126908018|PMID:30893315 20210610 RGD at 9 weeks 126928151 Cdkn1bem4Musc cyclin-dependent kinase inhibitor 1B; CRISPR/Cas9 induced mutant 4, Musc gene MP:0005630 increased lung weight IMP N RGD:126908018|PMID:30893315 20210610 RGD 126928151 Cdkn1bem4Musc cyclin-dependent kinase inhibitor 1B; CRISPR/Cas9 induced mutant 4, Musc gene MP:0008939 increased pituitary gland weight IMP N RGD:126908018|PMID:30893315 20210610 RGD 126928151 Cdkn1bem4Musc cyclin-dependent kinase inhibitor 1B; CRISPR/Cas9 induced mutant 4, Musc gene MP:0009296 increased mammary fat pad weight IMP N RGD:126908018|PMID:30893315 20210610 RGD 126928151 Cdkn1bem4Musc cyclin-dependent kinase inhibitor 1B; CRISPR/Cas9 induced mutant 4, Musc gene MP:0010173 increased mammary gland epithelial cell proliferation IMP N RGD:126908018|PMID:30893315 20210610 RGD 126928151 Cdkn1bem4Musc cyclin-dependent kinase inhibitor 1B; CRISPR/Cas9 induced mutant 4, Musc gene MP:0013781 abnormal mammary gland luminal epithelium morphology IMP N RGD:126908018|PMID:30893315 20210610 RGD 127284837 GK/Wnsm strain MP:0001262 decreased body weight IAGP N RGD:127284556|PMID:14963671 20210609 RGD compared to Crl:WI(RS:0001011) 127284837 GK/Wnsm strain MP:0002834 decreased heart weight IAGP N RGD:127284556|PMID:14963671 20210609 RGD compared to Crl:WI(RS:0001011) 127284837 GK/Wnsm strain MP:0005559 increased circulating glucose level IAGP N RGD:127284556|PMID:14963671 20210609 RGD compared to Crl:WI(RS:0001011) 127284837 GK/Wnsm strain MP:0006353 increased glycosylated hemoglobin level IAGP N RGD:127284556|PMID:14963671 20210609 RGD compared to Crl:WI(RS:0001011) 127284870 F344-Nppcem3Kyo strain MP:0001258 decreased body length IMP N RGD:127284867|PMID:29566041 20220117 RGD compared to wild type 127284870 F344-Nppcem3Kyo strain MP:0001262 decreased body weight IMP N RGD:127284867|PMID:29566041 20220117 RGD compared to wild type 127284870 F344-Nppcem3Kyo strain MP:0002764 short tibia IMP N RGD:127284867|PMID:29566041 20220117 RGD compared to wild type 127284870 F344-Nppcem3Kyo strain MP:0002834 decreased heart weight IMP N RGD:127284867|PMID:29566041 20220117 RGD compared to wild type 127284870 F344-Nppcem3Kyo strain MP:0003109 short femur IMP N RGD:127284867|PMID:29566041 20220117 RGD compared to wild type 127284870 F344-Nppcem3Kyo strain MP:0003409 decreased width of hypertrophic chondrocyte zone IMP N RGD:127284867|PMID:29566041 20220117 RGD compared to wild type 127284870 F344-Nppcem3Kyo strain MP:0003918 decreased kidney weight IMP N RGD:127284867|PMID:29566041 20220117 RGD compared to wild type 127284870 F344-Nppcem3Kyo strain MP:0004355 short radius IMP N RGD:127284867|PMID:29566041 20220117 RGD compared to wild type 127284870 F344-Nppcem3Kyo strain MP:0004657 small sacral vertebrae IMP N RGD:127284867|PMID:29566041 20220117 RGD compared to wild type 127284870 F344-Nppcem3Kyo strain MP:0011862 decreased cranium length IMP N RGD:127284867|PMID:29566041 20220117 RGD compared to wild type 127284871 Nppcem3Kyo natriuretic peptide C; ZFN induced mutant 3, Kyo gene MP:0001258 decreased body length IMP N RGD:127284867|PMID:29566041 20220120 RGD compared to wild type 127284871 Nppcem3Kyo natriuretic peptide C; ZFN induced mutant 3, Kyo gene MP:0001262 decreased body weight IMP N RGD:127284867|PMID:29566041 20220120 RGD compared to wild type 127284871 Nppcem3Kyo natriuretic peptide C; ZFN induced mutant 3, Kyo gene MP:0002764 short tibia IMP N RGD:127284867|PMID:29566041 20220120 RGD compared to wild type 127284871 Nppcem3Kyo natriuretic peptide C; ZFN induced mutant 3, Kyo gene MP:0002834 decreased heart weight IMP N RGD:127284867|PMID:29566041 20220120 RGD compared to wild type 127284871 Nppcem3Kyo natriuretic peptide C; ZFN induced mutant 3, Kyo gene MP:0003109 short femur IMP N RGD:127284867|PMID:29566041 20220120 RGD compared to wild type 127284871 Nppcem3Kyo natriuretic peptide C; ZFN induced mutant 3, Kyo gene MP:0003409 decreased width of hypertrophic chondrocyte zone IMP N RGD:127284867|PMID:29566041 20220120 RGD compared to wild type 127284871 Nppcem3Kyo natriuretic peptide C; ZFN induced mutant 3, Kyo gene MP:0003918 decreased kidney weight IMP N RGD:127284867|PMID:29566041 20220120 RGD compared to wild type 127284871 Nppcem3Kyo natriuretic peptide C; ZFN induced mutant 3, Kyo gene MP:0004355 short radius IMP N RGD:127284867|PMID:29566041 20220120 RGD compared to wild type 127284871 Nppcem3Kyo natriuretic peptide C; ZFN induced mutant 3, Kyo gene MP:0004657 small sacral vertebrae IMP N RGD:127284867|PMID:29566041 20220120 RGD compared to wild type 127284871 Nppcem3Kyo natriuretic peptide C; ZFN induced mutant 3, Kyo gene MP:0011862 decreased cranium length IMP N RGD:127284867|PMID:29566041 20220120 RGD compared to wild type 127284872 F344-Nppcem4Kyo strain MP:0001258 decreased body length IMP N RGD:127284867|PMID:29566041 20220117 RGD compared to wild type 127284872 F344-Nppcem4Kyo strain MP:0001262 decreased body weight IMP N RGD:127284867|PMID:29566041 20220117 RGD compared to wild type 127284872 F344-Nppcem4Kyo strain MP:0002764 short tibia IMP N RGD:127284867|PMID:29566041 20220117 RGD compared to wild type 127284872 F344-Nppcem4Kyo strain MP:0003109 short femur IMP N RGD:127284867|PMID:29566041 20220117 RGD compared to wild type 127284872 F344-Nppcem4Kyo strain MP:0003409 decreased width of hypertrophic chondrocyte zone IMP N RGD:127284867|PMID:29566041 20220117 RGD compared to wild type 127284872 F344-Nppcem4Kyo strain MP:0004355 short radius IMP N RGD:127284867|PMID:29566041 20220117 RGD compared to wild type 127284872 F344-Nppcem4Kyo strain MP:0004657 small sacral vertebrae IMP N RGD:127284867|PMID:29566041 20220117 RGD compared to wild type 127284872 F344-Nppcem4Kyo strain MP:0011862 decreased cranium length IMP N RGD:127284867|PMID:29566041 20220117 RGD compared to wild type 127284873 Nppcem4Kyo natriuretic peptide C; ZFN induced mutant 4, Kyo gene MP:0001258 decreased body length IMP N RGD:127284867|PMID:29566041 20220120 RGD compared to wild type 127284873 Nppcem4Kyo natriuretic peptide C; ZFN induced mutant 4, Kyo gene MP:0001262 decreased body weight IMP N RGD:127284867|PMID:29566041 20220120 RGD compared to wild type 127284873 Nppcem4Kyo natriuretic peptide C; ZFN induced mutant 4, Kyo gene MP:0002764 short tibia IMP N RGD:127284867|PMID:29566041 20220120 RGD compared to wild type 127284873 Nppcem4Kyo natriuretic peptide C; ZFN induced mutant 4, Kyo gene MP:0003109 short femur IMP N RGD:127284867|PMID:29566041 20220120 RGD compared to wild type 127284873 Nppcem4Kyo natriuretic peptide C; ZFN induced mutant 4, Kyo gene MP:0003409 decreased width of hypertrophic chondrocyte zone IMP N RGD:127284867|PMID:29566041 20220120 RGD compared to wild type 127284873 Nppcem4Kyo natriuretic peptide C; ZFN induced mutant 4, Kyo gene MP:0004355 short radius IMP N RGD:127284867|PMID:29566041 20220120 RGD compared to wild type 127284873 Nppcem4Kyo natriuretic peptide C; ZFN induced mutant 4, Kyo gene MP:0004657 small sacral vertebrae IMP N RGD:127284867|PMID:29566041 20220120 RGD compared to wild type 127284873 Nppcem4Kyo natriuretic peptide C; ZFN induced mutant 4, Kyo gene MP:0011862 decreased cranium length IMP N RGD:127284867|PMID:29566041 20220120 RGD compared to wild type 127284883 SD-Aqp4em1Hrt strain MP:0020371 abnormal glymphatic system physiology IMP N RGD:127284879|PMID:33574749 20220117 RGD 127284884 Aqp4em1Hrt aquaporin 4; TALEN induced mutant 1, Hrt gene MP:0020371 abnormal glymphatic system physiology IMP N RGD:127284879|PMID:33574749 20220120 RGD 127285404 SHR-Cfbem1Tja strain MP:0001780 decreased brown adipose tissue amount IMP N RGD:127285403|PMID:28739975 20220114 RGD compared to wild type SHR 127285404 SHR-Cfbem1Tja strain MP:0002667 decreased circulating aldosterone level IMP N RGD:127285403|PMID:28739975 20220114 RGD compared to wild type SHR 127285404 SHR-Cfbem1Tja strain MP:0002891 increased insulin sensitivity IMP N RGD:127285403|PMID:28739975 20220114 RGD compared to wild type SHR 127285404 SHR-Cfbem1Tja strain MP:0005179 decreased circulating cholesterol level IMP N RGD:127285403|PMID:28739975 20220114 RGD compared to wild type SHR 127285404 SHR-Cfbem1Tja strain MP:0005318 decreased triglyceride level IMP N RGD:127285403|PMID:28739975 20220114 RGD compared to wild type SHR 127285404 SHR-Cfbem1Tja strain MP:0006264 decreased systemic arterial systolic blood pressure IMP N RGD:127285403|PMID:28739975 20220114 RGD compared to wild type SHR 127285404 SHR-Cfbem1Tja strain MP:0008578 decreased circulating interferon-gamma level IMP N RGD:127285403|PMID:28739975 20220114 RGD compared to wild type SHR 127285404 SHR-Cfbem1Tja strain MP:0008594 decreased circulating interleukin-10 level IMP N RGD:127285403|PMID:28739975 20220114 RGD compared to wild type SHR 127285404 SHR-Cfbem1Tja strain MP:0009289 decreased epididymal fat pad weight IMP N RGD:127285403|PMID:28739975 20220114 RGD compared to wild type SHR 127285404 SHR-Cfbem1Tja strain MP:0009299 decreased mesenteric fat pad weight IMP N RGD:127285403|PMID:28739975 20220114 RGD compared to wild type SHR 127285404 SHR-Cfbem1Tja strain MP:0009305 decreased retroperitoneal fat pad weight IMP N RGD:127285403|PMID:28739975 20220114 RGD compared to wild type SHR 127285404 SHR-Cfbem1Tja strain MP:0010934 increased subcutaneous adipose tissue amount IMP N RGD:127285403|PMID:28739975 20220114 RGD compared to wild type SHR 127285404 SHR-Cfbem1Tja strain MP:0013278 decreased fasting circulating glucose level IMP N RGD:127285403|PMID:28739975 20220114 RGD compared to wild type SHR 127285405 Cfbem1Tja complement factor B, ZFN induced mutant 1, Tja gene MP:0001780 decreased brown adipose tissue amount IMP N RGD:127285403|PMID:28739975 20220120 RGD compared to wild type SHR 127285405 Cfbem1Tja complement factor B, ZFN induced mutant 1, Tja gene MP:0002667 decreased circulating aldosterone level IMP N RGD:127285403|PMID:28739975 20220120 RGD compared to wild type SHR 127285405 Cfbem1Tja complement factor B, ZFN induced mutant 1, Tja gene MP:0002891 increased insulin sensitivity IMP N RGD:127285403|PMID:28739975 20220120 RGD compared to wild type SHR 127285405 Cfbem1Tja complement factor B, ZFN induced mutant 1, Tja gene MP:0005179 decreased circulating cholesterol level IMP N RGD:127285403|PMID:28739975 20220120 RGD compared to wild type SHR 127285405 Cfbem1Tja complement factor B, ZFN induced mutant 1, Tja gene MP:0005318 decreased triglyceride level IMP N RGD:127285403|PMID:28739975 20220120 RGD compared to wild type SHR 127285405 Cfbem1Tja complement factor B, ZFN induced mutant 1, Tja gene MP:0006264 decreased systemic arterial systolic blood pressure IMP N RGD:127285403|PMID:28739975 20220120 RGD compared to wild type SHR 127285405 Cfbem1Tja complement factor B, ZFN induced mutant 1, Tja gene MP:0008578 decreased circulating interferon-gamma level IMP N RGD:127285403|PMID:28739975 20220120 RGD compared to wild type SHR 127285405 Cfbem1Tja complement factor B, ZFN induced mutant 1, Tja gene MP:0008594 decreased circulating interleukin-10 level IMP N RGD:127285403|PMID:28739975 20220120 RGD compared to wild type SHR 127285405 Cfbem1Tja complement factor B, ZFN induced mutant 1, Tja gene MP:0009289 decreased epididymal fat pad weight IMP N RGD:127285403|PMID:28739975 20220120 RGD compared to wild type SHR 127285405 Cfbem1Tja complement factor B, ZFN induced mutant 1, Tja gene MP:0009299 decreased mesenteric fat pad weight IMP N RGD:127285403|PMID:28739975 20220120 RGD compared to wild type SHR 127285405 Cfbem1Tja complement factor B, ZFN induced mutant 1, Tja gene MP:0009305 decreased retroperitoneal fat pad weight IMP N RGD:127285403|PMID:28739975 20220120 RGD compared to wild type SHR 127285405 Cfbem1Tja complement factor B, ZFN induced mutant 1, Tja gene MP:0010934 increased subcutaneous adipose tissue amount IMP N RGD:127285403|PMID:28739975 20220120 RGD compared to wild type SHR 127285405 Cfbem1Tja complement factor B, ZFN induced mutant 1, Tja gene MP:0013278 decreased fasting circulating glucose level IMP N RGD:127285403|PMID:28739975 20220120 RGD compared to wild type SHR 127285409 SD-Abcc8em1Cgen strain MP:0001262 decreased body weight IMP N RGD:150573710|PMID:30616503 20220111 RGD compared to wild type 127285409 SD-Abcc8em1Cgen strain MP:0002891 increased insulin sensitivity induces IMP XCO:0000245 N RGD:150573710|PMID:30616503 20220111 RGD 127285409 SD-Abcc8em1Cgen strain MP:0003059 decreased insulin secretion IMP N RGD:150573710|PMID:30616503 20220111 RGD compared to wild type 127285409 SD-Abcc8em1Cgen strain MP:0005293 impaired glucose tolerance IAGP N RGD:150573710|PMID:30616503 20220111 RGD compared to wild type 127285409 SD-Abcc8em1Cgen strain MP:0008489 slow postnatal weight gain IMP N RGD:150573710|PMID:30616503 20220111 RGD compared to wild type male 127285409 SD-Abcc8em1Cgen strain MP:0010400 increased liver glycogen level IMP N RGD:150573710|PMID:30616503 20220111 RGD compared to wild type 127285409 SD-Abcc8em1Cgen strain MP:0010401 increased skeletal muscle glycogen level IMP N RGD:150573710|PMID:30616503 20220111 RGD compared to wild type 127285409 SD-Abcc8em1Cgen strain MP:0013278 decreased fasting circulating glucose level IAGP N RGD:150573710|PMID:30616503 20220111 RGD compared to wild type 127285598 Abcc8em1Cgen ATP binding cassette subfamily C member 8; TALEN induced mutant 1, Cgen gene MP:0001262 decreased body weight IMP N RGD:150573710|PMID:30616503 20220113 RGD compared to wild type 127285598 Abcc8em1Cgen ATP binding cassette subfamily C member 8; TALEN induced mutant 1, Cgen gene MP:0002891 increased insulin sensitivity induces IMP XCO:0000245 N RGD:150573710|PMID:30616503 20220113 RGD 127285598 Abcc8em1Cgen ATP binding cassette subfamily C member 8; TALEN induced mutant 1, Cgen gene MP:0003059 decreased insulin secretion IMP N RGD:150573710|PMID:30616503 20220113 RGD compared to wild type 127285598 Abcc8em1Cgen ATP binding cassette subfamily C member 8; TALEN induced mutant 1, Cgen gene MP:0005293 impaired glucose tolerance IAGP N RGD:150573710|PMID:30616503 20220113 RGD compared to wild type 127285598 Abcc8em1Cgen ATP binding cassette subfamily C member 8; TALEN induced mutant 1, Cgen gene MP:0008489 slow postnatal weight gain IMP N RGD:150573710|PMID:30616503 20220113 RGD compared to wild type male 127285598 Abcc8em1Cgen ATP binding cassette subfamily C member 8; TALEN induced mutant 1, Cgen gene MP:0010400 increased liver glycogen level IMP N RGD:150573710|PMID:30616503 20220113 RGD compared to wild type 127285598 Abcc8em1Cgen ATP binding cassette subfamily C member 8; TALEN induced mutant 1, Cgen gene MP:0010401 increased skeletal muscle glycogen level IMP N RGD:150573710|PMID:30616503 20220113 RGD compared to wild type 127285598 Abcc8em1Cgen ATP binding cassette subfamily C member 8; TALEN induced mutant 1, Cgen gene MP:0013278 decreased fasting circulating glucose level IAGP N RGD:150573710|PMID:30616503 20220113 RGD compared to wild type 127285617 Ppargm1Kyo peroxisome proliferator-activated receptor gamma; ENU induced mutant 1, Kyo gene MP:0002981 increased liver weight induces IAGP XCO:0000025 N RGD:127285618|PMID:27381370 20220113 RGD 127285617 Ppargm1Kyo peroxisome proliferator-activated receptor gamma; ENU induced mutant 1, Kyo gene MP:0005293 impaired glucose tolerance IAGP N RGD:127285618|PMID:27381370 20220113 RGD compared to wild type rats 127285617 Ppargm1Kyo peroxisome proliferator-activated receptor gamma; ENU induced mutant 1, Kyo gene MP:0005331 insulin resistance induces IAGP XCO:0000025 N RGD:127285618|PMID:27381370 20220113 RGD compared to wild type rats 127285617 Ppargm1Kyo peroxisome proliferator-activated receptor gamma; ENU induced mutant 1, Kyo gene MP:0006094 increased fat cell size IAGP N RGD:127285618|PMID:27381370 20220113 RGD 127285617 Ppargm1Kyo peroxisome proliferator-activated receptor gamma; ENU induced mutant 1, Kyo gene MP:0008907 decreased total fat pad weight induces IAGP XCO:0000069 N RGD:127285618|PMID:27381370 20220113 RGD compared to wild type rats 127285617 Ppargm1Kyo peroxisome proliferator-activated receptor gamma; ENU induced mutant 1, Kyo gene MP:0009289 decreased epididymal fat pad weight IAGP N RGD:127285618|PMID:27381370 20220113 RGD 127285617 Ppargm1Kyo peroxisome proliferator-activated receptor gamma; ENU induced mutant 1, Kyo gene MP:0009355 increased liver triglyceride level IAGP N RGD:127285618|PMID:27381370 20220113 RGD 127285617 Ppargm1Kyo peroxisome proliferator-activated receptor gamma; ENU induced mutant 1, Kyo gene MP:0010238 increased skeletal muscle weight induces IAGP XCO:0000025 N RGD:127285618|PMID:27381370 20220113 RGD 127285617 Ppargm1Kyo peroxisome proliferator-activated receptor gamma; ENU induced mutant 1, Kyo gene MP:0011168 abnormal fat cell differentiation IAGP N RGD:127285618|PMID:27381370 20220113 RGD 127285661 SD-Adgrl3em1Huyc strain MP:0001399 hyperactivity IMP N RGD:127285660|PMID:31176715 20210625 RGD compared to wild type 127285661 SD-Adgrl3em1Huyc strain MP:0001488 increased startle reflex IMP N RGD:127285660|PMID:31176715 20210625 RGD compared to wild type 127285661 SD-Adgrl3em1Huyc strain MP:0008489 slow postnatal weight gain sexual_dimorphism IMP N RGD:127285660|PMID:31176715 20210625 RGD compared to wild type male 127285661 SD-Adgrl3em1Huyc strain MP:0030585 enhanced behavioral response to amphetamine sexual_dimorphism IMP N RGD:127285660|PMID:31176715 20210625 RGD compared to wild type female 127285662 Adgrl3em1Huyc adhesion G protein-coupled receptor L3; CRISPR/Cas9 induced mutant1, Huyc gene MP:0001399 hyperactivity IMP N RGD:127285660|PMID:31176715 20210701 RGD compared to wild type 127285662 Adgrl3em1Huyc adhesion G protein-coupled receptor L3; CRISPR/Cas9 induced mutant1, Huyc gene MP:0001488 increased startle reflex IMP N RGD:127285660|PMID:31176715 20210701 RGD compared to wild type 127285662 Adgrl3em1Huyc adhesion G protein-coupled receptor L3; CRISPR/Cas9 induced mutant1, Huyc gene MP:0008489 slow postnatal weight gain sexual_dimorphism IMP N RGD:127285660|PMID:31176715 20210701 RGD compared to wild type male 127285662 Adgrl3em1Huyc adhesion G protein-coupled receptor L3; CRISPR/Cas9 induced mutant1, Huyc gene MP:0030585 enhanced behavioral response to amphetamine sexual_dimorphism IMP N RGD:127285660|PMID:31176715 20210701 RGD compared to wild type female 127345123 F344-Angptl8em1Kyo-/- strain MP:0001262 decreased body weight IMP N RGD:38549347|PMID:30042156 20210709 RGD compared to wild type rats 127345123 F344-Angptl8em1Kyo-/- strain MP:0002644 decreased circulating triglyceride level IMP N RGD:38549347|PMID:30042156 20210709 RGD compared to wild type rats 127345123 F344-Angptl8em1Kyo-/- strain MP:0003976 decreased circulating VLDL triglyceride level IMP N RGD:38549347|PMID:30042156 20210709 RGD compared to wild type rats 127345123 F344-Angptl8em1Kyo-/- strain MP:0005659 decreased susceptibility to diet-induced obesity IMP N RGD:38549347|PMID:30042156 20210709 RGD compared to wild type rats 127345123 F344-Angptl8em1Kyo-/- strain MP:0009269 decreased fat cell size IMP N RGD:38549347|PMID:30042156 20210709 RGD compared to wild type rats 127345123 F344-Angptl8em1Kyo-/- strain MP:0009289 decreased epididymal fat pad weight IMP N RGD:38549347|PMID:30042156 20210709 RGD compared to wild type rats 127345124 F344-Angptl8em1Kyo+/- strain MP:0001262 decreased body weight IMP N RGD:38549347|PMID:30042156 20210709 RGD compared to wild type rats 127345124 F344-Angptl8em1Kyo+/- strain MP:0002644 decreased circulating triglyceride level induces IMP XCO:0000013 N RGD:38549347|PMID:30042156 20210709 RGD compared to wild type rats 127345127 Angptl8em1Kyo angiopoietin-like 8; CRISPR/Cas9 induced mutant 1, Kyo gene MP:0001262 decreased body weight IMP N RGD:38549347|PMID:30042156 20210715 RGD compared to wild type rats 127345127 Angptl8em1Kyo angiopoietin-like 8; CRISPR/Cas9 induced mutant 1, Kyo gene MP:0002644 decreased circulating triglyceride level IMP N RGD:38549347|PMID:30042156 20210715 RGD compared to wild type rats 127345127 Angptl8em1Kyo angiopoietin-like 8; CRISPR/Cas9 induced mutant 1, Kyo gene MP:0002644 decreased circulating triglyceride level induces IMP XCO:0000013 N RGD:38549347|PMID:30042156 20210715 RGD compared to wild type rats 127345127 Angptl8em1Kyo angiopoietin-like 8; CRISPR/Cas9 induced mutant 1, Kyo gene MP:0003976 decreased circulating VLDL triglyceride level IMP N RGD:38549347|PMID:30042156 20210715 RGD compared to wild type rats 127345127 Angptl8em1Kyo angiopoietin-like 8; CRISPR/Cas9 induced mutant 1, Kyo gene MP:0005659 decreased susceptibility to diet-induced obesity IMP N RGD:38549347|PMID:30042156 20210715 RGD compared to wild type rats 127345127 Angptl8em1Kyo angiopoietin-like 8; CRISPR/Cas9 induced mutant 1, Kyo gene MP:0009269 decreased fat cell size IMP N RGD:38549347|PMID:30042156 20210715 RGD compared to wild type rats 127345127 Angptl8em1Kyo angiopoietin-like 8; CRISPR/Cas9 induced mutant 1, Kyo gene MP:0009289 decreased epididymal fat pad weight IMP N RGD:38549347|PMID:30042156 20210715 RGD compared to wild type rats 12738218 SD-GEPR-9 strain MP:0009358 environmentally induced seizures IAGP XCO:0000048 N RGD:13450925|PMID:21458955 20200622 RGD 12738372 BDIX.BDIV-D6Mit1-D6Mgh2/Zte strain MP:0004502 decreased incidence of tumors by chemical induction IAGP N RGD:11556249|PMID:21427360 20211222 RGD compared to BDIX inbred strain 12738372 BDIX.BDIV-D6Mit1-D6Mgh2/Zte strain MP:0009767 decreased susceptibility to xenobiotic induced morbidity/mortality IAGP N RGD:11556249|PMID:21427360 20211222 RGD compared to BDIX inbred strain 12743611 SS-Renem1Mcwi+/- SS-Renem1Mcwi+/Renem1Mcwi- strain MP:0002135 abnormal kidney morphology exacerbates IMP N RGD:7771614|PMID:21242461 20220128 RGD compared to wild type 12743611 SS-Renem1Mcwi+/- SS-Renem1Mcwi+/Renem1Mcwi- strain MP:0004876 decreased mean systemic arterial blood pressure sexual_dimorphism IMP N RGD:7771614|PMID:21242461 20220128 RGD compared to wild type male 12743611 SS-Renem1Mcwi+/- SS-Renem1Mcwi+/Renem1Mcwi- strain MP:0006263 decreased systemic arterial diastolic blood pressure sexual_dimorphism IMP N RGD:7771614|PMID:21242461 20220128 RGD compared to wild type male 12743611 SS-Renem1Mcwi+/- SS-Renem1Mcwi+/Renem1Mcwi- strain MP:0006264 decreased systemic arterial systolic blood pressure sexual_dimorphism IMP N RGD:7771614|PMID:21242461 20220128 RGD compared to wild type male 12790679 PCK-P2rx7em8Mcwi strain MP:0004876 decreased mean systemic arterial blood pressure IMP N RGD:14995937|PMID:31630543 20191105 RGD 12790679 PCK-P2rx7em8Mcwi strain MP:0005556 abnormal renal filtration rate IMP N RGD:14995937|PMID:31630543 20191105 RGD 12790721 SS.BN-(D13Rat151-D13Rat197)-Serpinc1em2Mcwi strain MP:0004041 increased susceptibility to kidney reperfusion injury IMP N RGD:11354006|PMID:26108065 20170310 RGD 12790722 Serpinc1em2Mcwi serpin family C member 1; ZFN induced mutant 2, Medical College of Wisconsin gene MP:0004041 increased susceptibility to kidney reperfusion injury IMP N RGD:11354006|PMID:26108065 20180119 RGD 12790970 Pax6Sey2 paired box gene 6, small eye mutation 2 gene MP:0001070 abnormal abducens nerve morphology IAGP N RGD:731242|PMID:9247338 20201210 RGD 12790970 Pax6Sey2 paired box gene 6, small eye mutation 2 gene MP:0001076 abnormal hypoglossal nerve morphology IAGP N RGD:731242|PMID:9247338 20201210 RGD 12790970 Pax6Sey2 paired box gene 6, small eye mutation 2 gene MP:0002557 abnormal social/conspecific interaction behavior IAGP N RGD:8552339|PMID:21203536 20210415 RGD compared to SD 12790970 Pax6Sey2 paired box gene 6, small eye mutation 2 gene MP:0002757 decreased vertical activity IAGP N RGD:8552339|PMID:21203536 20201210 RGD 12790970 Pax6Sey2 paired box gene 6, small eye mutation 2 gene MP:0003460 decreased fear-related response IAGP N RGD:8552339|PMID:21203536 20210415 RGD compared to SD 12790970 Pax6Sey2 paired box gene 6, small eye mutation 2 gene MP:0006369 supernumerary incisors IAGP N RGD:12790971|PMID:16795023 20201210 RGD 12790970 Pax6Sey2 paired box gene 6, small eye mutation 2 gene MP:0010070 decreased serotonin level IAGP N RGD:8552339|PMID:21203536 20201210 RGD 12790970 Pax6Sey2 paired box gene 6, small eye mutation 2 gene MP:0011275 abnormal behavioral response to light IAGP N RGD:8552339|PMID:21203536 20210415 RGD compared to SD 12790970 Pax6Sey2 paired box gene 6, small eye mutation 2 gene MP:0020351 decreased vocalization IAGP N RGD:8552339|PMID:21203536 20210415 RGD compared to SD 12791992 Gja8m1Cub gap junction protein, alpha 8; mutant 1 Cub gene MP:0000183 decreased circulating LDL cholesterol level IAGP N RGD:150429989|PMID:27871290 20231005 RGD 12791992 Gja8m1Cub gap junction protein, alpha 8; mutant 1 Cub gene MP:0000186 decreased circulating HDL cholesterol level IAGP N RGD:150429989|PMID:27871290 20231005 RGD 12791992 Gja8m1Cub gap junction protein, alpha 8; mutant 1 Cub gene MP:0001297 microphthalmia IAGP N RGD:2293186|PMID:18470322 20231005 RGD 12791992 Gja8m1Cub gap junction protein, alpha 8; mutant 1 Cub gene MP:0001304 cataract IAGP N RGD:2293186|PMID:18470322 20231005 RGD 12791992 Gja8m1Cub gap junction protein, alpha 8; mutant 1 Cub gene MP:0001552 increased circulating triglyceride level IAGP N RGD:150429989|PMID:27871290 20231005 RGD 12791992 Gja8m1Cub gap junction protein, alpha 8; mutant 1 Cub gene MP:0002079 increased circulating insulin level IAGP N RGD:150429989|PMID:27871290 20231005 RGD 12791992 Gja8m1Cub gap junction protein, alpha 8; mutant 1 Cub gene MP:0002727 decreased circulating insulin level IAGP N RGD:150429989|PMID:27871290 20231005 RGD 12791992 Gja8m1Cub gap junction protein, alpha 8; mutant 1 Cub gene MP:0005545 abnormal lens development IAGP N RGD:2293186|PMID:18470322 20170412 RGD 12791992 Gja8m1Cub gap junction protein, alpha 8; mutant 1 Cub gene MP:0008553 increased circulating tumor necrosis factor level IAGP N RGD:150429989|PMID:27871290 20231005 RGD 12791992 Gja8m1Cub gap junction protein, alpha 8; mutant 1 Cub gene MP:0008614 increased circulating interleukin-17 level IAGP N RGD:150429989|PMID:27871290 20231005 RGD 12791992 Gja8m1Cub gap junction protein, alpha 8; mutant 1 Cub gene MP:0008663 increased interleukin-12 secretion IAGP N RGD:150429989|PMID:27871290 20231005 RGD 12791992 Gja8m1Cub gap junction protein, alpha 8; mutant 1 Cub gene MP:0008684 increased interleukin-18 secretion IAGP N RGD:150429989|PMID:27871290 20231005 RGD 12791992 Gja8m1Cub gap junction protein, alpha 8; mutant 1 Cub gene MP:0008705 increased interleukin-6 secretion IAGP N RGD:150429989|PMID:27871290 20231005 RGD 12791992 Gja8m1Cub gap junction protein, alpha 8; mutant 1 Cub gene MP:0009288 increased epididymal fat pad weight IAGP N RGD:150429989|PMID:27871290 20231005 RGD 12791992 Gja8m1Cub gap junction protein, alpha 8; mutant 1 Cub gene MP:0009289 decreased epididymal fat pad weight IAGP N RGD:150429989|PMID:27871290 20231005 RGD 12791992 Gja8m1Cub gap junction protein, alpha 8; mutant 1 Cub gene MP:0009699 hyperchylomicronemia IAGP N RGD:150429989|PMID:27871290 20231005 RGD 12791992 Gja8m1Cub gap junction protein, alpha 8; mutant 1 Cub gene MP:0011603 decreased glutathione peroxidase activity IAGP N RGD:150429989|PMID:27871290 20231005 RGD 12791992 Gja8m1Cub gap junction protein, alpha 8; mutant 1 Cub gene MP:0012604 decreased glutathione level IAGP N RGD:150429989|PMID:27871290 20231005 RGD 12791992 Gja8m1Cub gap junction protein, alpha 8; mutant 1 Cub gene MP:0012629 decreased glutathione reductase level IAGP N RGD:150429989|PMID:27871290 20231005 RGD 12791992 Gja8m1Cub gap junction protein, alpha 8; mutant 1 Cub gene MP:0012655 increased catalase level IAGP N RGD:150429989|PMID:27871290 20231005 RGD 12791992 Gja8m1Cub gap junction protein, alpha 8; mutant 1 Cub gene MP:0012659 decreased superoxide dismutase level IAGP N RGD:150429989|PMID:27871290 20231005 RGD 12791992 Gja8m1Cub gap junction protein, alpha 8; mutant 1 Cub gene MP:0013278 decreased fasting circulating glucose level induces IAGP XCO:0000275,XCO:0000444 N RGD:150429989|PMID:27871290 20231005 RGD 12791992 Gja8m1Cub gap junction protein, alpha 8; mutant 1 Cub gene MP:0031251 increased circulating CCL3 level IAGP N RGD:150429989|PMID:27871290 20231005 RGD 12792211 SS.BN-(D13Hmgc1048-D13Hmgc664)/Mcwi strain MP:0005333 decreased heart rate induced IAGP XCO:0000022 N RGD:11553579|PMID:26534937 20191125 RGD compared to SS/JrHsdMcwi 12792211 SS.BN-(D13Hmgc1048-D13Hmgc664)/Mcwi strain MP:0005540 decreased urine albumin level induced IAGP XCO:0000022 N RGD:11553579|PMID:26534937 20191125 RGD compared to SS/JrHsdMcwi 12792211 SS.BN-(D13Hmgc1048-D13Hmgc664)/Mcwi strain MP:0012046 decreased susceptibility to hypertension induced IAGP XCO:0000022 N RGD:11553579|PMID:26534937 20191125 RGD compared to SS/JrHsdMcwi 12792212 SS.BN-(D13Hmgc1048-D13Hmgc1045)/Mcwi strain MP:0005540 decreased urine albumin level induced IAGP XCO:0000022 N RGD:11553579|PMID:26534937 20191125 RGD compared to SS/JrHsdMcwi 12792212 SS.BN-(D13Hmgc1048-D13Hmgc1045)/Mcwi strain MP:0012046 decreased susceptibility to hypertension induced IAGP XCO:0000022 N RGD:11553579|PMID:26534937 20191125 RGD compared to SS/JrHsdMcwi 12792213 SS.BN-(D13Hmgc1048-D13Hmgc1050)/Mcwi strain MP:0005333 decreased heart rate induced IAGP XCO:0000022 N RGD:11553579|PMID:26534937 20191125 RGD compared to SS/JrHsdMcwi 12792213 SS.BN-(D13Hmgc1048-D13Hmgc1050)/Mcwi strain MP:0005540 decreased urine albumin level induced IAGP XCO:0000022 N RGD:11553579|PMID:26534937 20191125 RGD compared to SS/JrHsdMcwi 12792213 SS.BN-(D13Hmgc1048-D13Hmgc1050)/Mcwi strain MP:0012046 decreased susceptibility to hypertension induced IAGP XCO:0000022 N RGD:11553579|PMID:26534937 20191125 RGD compared to SS/JrHsdMcwi 12792214 SS.BN-(D13Hmgc1041-D13Hmgc664)/Mcwi strain MP:0002871 albuminuria induced IAGP XCO:0000022 N RGD:11553579|PMID:26534937 20191125 RGD 12792214 SS.BN-(D13Hmgc1041-D13Hmgc664)/Mcwi strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:11553579|PMID:26534937 20191125 RGD 12792216 SS.BN-(D13Hmgc885-D13Hmgc664)/Mcwi strain MP:0005333 decreased heart rate induced IAGP XCO:0000022 N RGD:11553579|PMID:26534937 20191125 RGD compared to SS/JrHsdMcwi 12792216 SS.BN-(D13Hmgc885-D13Hmgc664)/Mcwi strain MP:0012046 decreased susceptibility to hypertension induced IAGP XCO:0000022 N RGD:11553579|PMID:26534937 20191125 RGD compared to SS/JrHsdMcwi 12792217 SS.BN-(D13Hmgc1041-D13Hmgc885)/Mcwi strain MP:0002871 albuminuria induced IAGP XCO:0000022 N RGD:11553579|PMID:26534937 20191125 RGD 12792217 SS.BN-(D13Hmgc1041-D13Hmgc885)/Mcwi strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:11553579|PMID:26534937 20191125 RGD 12792226 SS.BN-(D13Got45-D13Hmgc664)/Mcwi strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:12792227|PMID:24714719 20170316 RGD compared to SS/JrHsdMcwi 12792226 SS.BN-(D13Got45-D13Hmgc664)/Mcwi strain MP:0005540 decreased urine albumin level induced IAGP XCO:0000022 N RGD:12792227|PMID:24714719 20170316 RGD compared to SS/JrHsdMcwi 12792283 Scn1am1Kyo sodium voltage-gated channel alpha subunit 1; ENU induced mutant1, Kyo gene MP:0012349 increased susceptibility to induction of seizure by inducing agent IMP N RGD:12792282|PMID:20410126 20170411 RGD 12792284 Scn1am2Kyo sodium voltage-gated channel alpha subunit 1; ENU induced mutant2, Kyo gene MP:0012349 increased susceptibility to induction of seizure by inducing agent IMP N RGD:12792282|PMID:20410126 20170411 RGD 12792941 Abcc2TR- ATP binding cassette subfamily C member 2;transport deficient mutant , gene MP:0005344 increased circulating bilirubin level IAGP N RGD:14985241|PMID:19525466 20191015 RGD 12792942 Dpp4DPPIV dipeptidylpeptidase 4; DPPIV mutant gene MP:0001263 weight loss IAGP N RGD:41408336|PMID:19327106 20210211 RGD compared to DA/Ztm 12792942 Dpp4DPPIV dipeptidylpeptidase 4; DPPIV mutant gene MP:0001364 decreased anxiety-related response IAGP N RGD:41408336|PMID:19327106 20210211 RGD compared to DA/Ztm 12792942 Dpp4DPPIV dipeptidylpeptidase 4; DPPIV mutant gene MP:0001415 increased exploration in new environment IAGP N RGD:41408336|PMID:19327106 20210211 RGD compared to DA/Ztm 12792942 Dpp4DPPIV dipeptidylpeptidase 4; DPPIV mutant gene MP:0001566 increased circulating phosphate level IAGP N RGD:41408336|PMID:19327106 20210211 RGD compared to DA/Ztm 12792942 Dpp4DPPIV dipeptidylpeptidase 4; DPPIV mutant gene MP:0002644 decreased circulating triglyceride level IAGP N RGD:41408336|PMID:19327106 20210211 RGD compared to DA/Ztm 12792942 Dpp4DPPIV dipeptidylpeptidase 4; DPPIV mutant gene MP:0002664 decreased circulating adrenocorticotropin level IAGP N RGD:41408336|PMID:19327106 20210211 RGD compared to DA/Ztm 12792942 Dpp4DPPIV dipeptidylpeptidase 4; DPPIV mutant gene MP:0002665 decreased circulating corticosterone level IAGP N RGD:41408336|PMID:19327106 20210211 RGD compared to DA/Ztm 12792942 Dpp4DPPIV dipeptidylpeptidase 4; DPPIV mutant gene MP:0002712 increased circulating glucagon level IAGP N RGD:41408336|PMID:19327106 20210211 RGD compared to DA/Ztm 12792942 Dpp4DPPIV dipeptidylpeptidase 4; DPPIV mutant gene MP:0002942 decreased circulating alanine transaminase level IAGP N RGD:41408336|PMID:19327106 20210211 RGD compared to DA/Ztm 12792942 Dpp4DPPIV dipeptidylpeptidase 4; DPPIV mutant gene MP:0002966 decreased circulating alkaline phosphatase level IAGP N RGD:41408336|PMID:19327106 20210211 RGD compared to DA/Ztm 12792942 Dpp4DPPIV dipeptidylpeptidase 4; DPPIV mutant gene MP:0004977 increased B-1 B cell number IAGP N RGD:41408336|PMID:19327106 20210211 RGD compared to DA/Ztm 12792942 Dpp4DPPIV dipeptidylpeptidase 4; DPPIV mutant gene MP:0005012 decreased eosinophil cell number IAGP N RGD:41408336|PMID:19327106 20210211 RGD compared to DA/Ztm 12792942 Dpp4DPPIV dipeptidylpeptidase 4; DPPIV mutant gene MP:0005016 decreased lymphocyte cell number IAGP N RGD:41408336|PMID:19327106 20210211 RGD compared to DA/Ztm 12792942 Dpp4DPPIV dipeptidylpeptidase 4; DPPIV mutant gene MP:0005070 impaired natural killer cell mediated cytotoxicity IAGP N RGD:41408336|PMID:19327106 20210211 RGD compared to DA/Ztm 12792942 Dpp4DPPIV dipeptidylpeptidase 4; DPPIV mutant gene MP:0005292 improved glucose tolerance IAGP N RGD:41408336|PMID:19327106 20210211 RGD compared to DA/Ztm 12792942 Dpp4DPPIV dipeptidylpeptidase 4; DPPIV mutant gene MP:0005565 increased blood urea nitrogen level IAGP N RGD:41408336|PMID:19327106 20210211 RGD compared to DA/Ztm 12792942 Dpp4DPPIV dipeptidylpeptidase 4; DPPIV mutant gene MP:0005632 decreased circulating aspartate transaminase level IAGP N RGD:41408336|PMID:19327106 20210211 RGD compared to DA/Ztm 12792942 Dpp4DPPIV dipeptidylpeptidase 4; DPPIV mutant gene MP:0005659 decreased susceptibility to diet-induced obesity IAGP N RGD:41408336|PMID:19327106 20210211 RGD compared to DA/Ztm 12792942 Dpp4DPPIV dipeptidylpeptidase 4; DPPIV mutant gene MP:0008044 increased NK cell number IAGP N RGD:41408336|PMID:19327106 20210211 RGD compared to DA/Ztm 12792942 Dpp4DPPIV dipeptidylpeptidase 4; DPPIV mutant gene MP:0008597 decreased circulating interleukin-6 level IAGP N RGD:41408336|PMID:19327106 20210211 RGD compared to DA/Ztm 12792942 Dpp4DPPIV dipeptidylpeptidase 4; DPPIV mutant gene MP:0008706 decreased interleukin-6 secretion IAGP N RGD:41408336|PMID:19327106 20210211 RGD compared to DA/Ztm 12792942 Dpp4DPPIV dipeptidylpeptidase 4; DPPIV mutant gene MP:0010167 decreased response to stress-induced hyperthermia IAGP N RGD:41408336|PMID:19327106 20210211 RGD compared to DA/Ztm 12792942 Dpp4DPPIV dipeptidylpeptidase 4; DPPIV mutant gene MP:0010182 decreased susceptibility to weight gain IAGP N RGD:41408336|PMID:19327106 20210211 RGD compared to DA/Ztm 12792944 SS.BN-(D13Got42-D13Got45)/Mcwi strain MP:0002871 albuminuria induced IAGP XCO:0000022 N RGD:12792227|PMID:24714719 20191125 RGD 12792944 SS.BN-(D13Got42-D13Got45)/Mcwi strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:12792227|PMID:24714719 20170316 RGD 12792945 SS.BN-(D13Got42-D13Rat130)/Mcwi strain MP:0002871 albuminuria induced IAGP XCO:0000022 N RGD:12792227|PMID:24714719 20170316 RGD 12792945 SS.BN-(D13Got42-D13Rat130)/Mcwi strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:12792227|PMID:24714719 20170316 RGD 12792946 SS.BN-(D13Got42-D13Hmgc354)/Mcwi strain MP:0002871 albuminuria induced IAGP XCO:0000022 N RGD:12792227|PMID:24714719 20170316 RGD 12792946 SS.BN-(D13Got42-D13Hmgc354)/Mcwi strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:12792227|PMID:24714719 20170316 RGD 12792947 SS.BN-(D13Got42-D13Hmgc497)/Mcwi strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:12792227|PMID:24714719 20170316 RGD compared to SS/JrHsdMcwi 12792947 SS.BN-(D13Got42-D13Hmgc497)/Mcwi strain MP:0005540 decreased urine albumin level induced IAGP XCO:0000022 N RGD:12792227|PMID:24714719 20170316 RGD compared to SS/JrHsdMcwi 12792948 SS.BN-(D13Got42-D13Hmgc885)/Mcwi strain MP:0002871 albuminuria induced IAGP XCO:0000022 N RGD:12792227|PMID:24714719 20170316 RGD 12792948 SS.BN-(D13Got42-D13Hmgc885)/Mcwi strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:12792227|PMID:24714719 20170316 RGD compared to SS/JrHsdMcwi 12792949 SS.BN-(D13Got42-D13Hmgc664)/Mcwi strain MP:0002871 albuminuria induced IAGP XCO:0000022 N RGD:12792227|PMID:24714719 20170316 RGD 12792949 SS.BN-(D13Got42-D13Hmgc664)/Mcwi strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:12792227|PMID:24714719 20170316 RGD compared to SS/JrHsdMcwi 12792950 SS.BN-(D13Mit5-D13Rat32)/Mcwi strain MP:0002871 albuminuria induced IAGP XCO:0000022 N RGD:12792227|PMID:24714719 20170316 RGD 12792950 SS.BN-(D13Mit5-D13Rat32)/Mcwi strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:12792227|PMID:24714719 20170316 RGD 12792951 SS.BN-(D13Hmgc5885-D13Rat32)/Mcwi strain MP:0002871 albuminuria induced IAGP XCO:0000022 N RGD:12792227|PMID:24714719 20170316 RGD 12792951 SS.BN-(D13Hmgc5885-D13Rat32)/Mcwi strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:12792227|PMID:24714719 20170316 RGD 12792952 SS.BN-(D13Hmgc354-D13Rat32)/Mcwi strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:12792227|PMID:24714719 20170316 RGD compared to SS/JrHsdMcwi 12792952 SS.BN-(D13Hmgc354-D13Rat32)/Mcwi strain MP:0005540 decreased urine albumin level induced IAGP XCO:0000022 N RGD:12792227|PMID:24714719 20170316 RGD compared to SS/JrHsdMcwi 12792953 SS.BN-(D13Rat130-D13Rat32)/Mcwi strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:12792227|PMID:24714719 20170316 RGD compared to SS/JrHsdMcwi 12792953 SS.BN-(D13Rat130-D13Rat32)/Mcwi strain MP:0005540 decreased urine albumin level induced IAGP XCO:0000022 N RGD:12792227|PMID:24714719 20170316 RGD compared to SS/JrHsdMcwi 12792954 SS.BN-(D13Got45-D13Rat32)/Mcwi strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:12792227|PMID:24714719 20170316 RGD compared to SS/JrHsdMcwi 12792954 SS.BN-(D13Got45-D13Rat32)/Mcwi strain MP:0005540 decreased urine albumin level induced IAGP XCO:0000022 N RGD:12792227|PMID:24714719 20170316 RGD compared to SS/JrHsdMcwi 12792962 Sv2am1Kyo synaptic vesicle glycoprotein 2a; ENU induced mutant 1, Kyo, gene MP:0002906 increased susceptibility to pharmacologically induced seizures IMP N RGD:12792961|PMID:27265781 20170410 RGD 12792962 Sv2am1Kyo synaptic vesicle glycoprotein 2a; ENU induced mutant 1, Kyo, gene MP:0020424 increased kindling response IMP N RGD:12792961|PMID:27265781 20170410 RGD 12792963 Lepm1Kyo leptin; ENU induced mutant1, Kyo gene MP:0001552 increased circulating triglyceride level IMP N RGD:8549777|PMID:23800849 20170410 RGD 12792963 Lepm1Kyo leptin; ENU induced mutant1, Kyo gene MP:0005178 increased circulating cholesterol level IMP N RGD:8549777|PMID:23800849 20170410 RGD 12792963 Lepm1Kyo leptin; ENU induced mutant1, Kyo gene MP:0009355 increased liver triglyceride level IMP N RGD:8549777|PMID:23800849 20170410 RGD 12792970 Lgi1m1Kyo leucine-rich, glioma inactivated 1; ENU induced mutant1, Kyo gene MP:0001496 audiogenic seizures IMP N RGD:14995940|PMID:30813600 20200130 RGD 12792970 Lgi1m1Kyo leucine-rich, glioma inactivated 1; ENU induced mutant1, Kyo gene MP:0002083 premature death IMP N RGD:12792971|PMID:22589250 20170410 RGD DNA:missense mutation:cds:p.L385R (c.1154T>G) 12792970 Lgi1m1Kyo leucine-rich, glioma inactivated 1; ENU induced mutant1, Kyo gene MP:0012349 increased susceptibility to induction of seizure by inducing agent IMP N RGD:12792971|PMID:22589250 20170410 RGD DNA:missense mutation:cds:p.L385R (c.1154T>G) 12792972 Tyrem1Kyo tyrosinase; TALEN induced mutant1, Kyo gene MP:0005171 absent coat pigmentation IMP N RGD:12792973|PMID:23409244 20170410 RGD 12798529 SS.BN-(D13Hmgc37-D13Got22)/Mcwi strain MP:0002963 decreased urine protein level induced IAGP XCO:0000022 N RGD:12798539|PMID:21257920 20170324 RGD compared to SS/JrHsdMcwi 12798529 SS.BN-(D13Hmgc37-D13Got22)/Mcwi strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:12798539|PMID:21257920 20170324 RGD compared to SS/JrHsdMcwi 12798530 SS.BN-(D13Rat115-D13Got22)/Mcwi strain MP:0002963 decreased urine protein level induced IAGP XCO:0000022 N RGD:12798539|PMID:21257920 20170324 RGD compared to SS/JrHsdMcwi 12798530 SS.BN-(D13Rat115-D13Got22)/Mcwi strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:12798539|PMID:21257920 20170324 RGD compared to SS/JrHsdMcwi 12798531 SS.BN-(D13Hmgc86-D13Got22)/Mcwi strain MP:0002963 decreased urine protein level induced IAGP XCO:0000022 N RGD:12798539|PMID:21257920 20170324 RGD compared to SS/JrHsdMcwi 12798531 SS.BN-(D13Hmgc86-D13Got22)/Mcwi strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:12798539|PMID:21257920 20170324 RGD compared to SS/JrHsdMcwi 12798532 SS.BN-(D13Hmgc40-D13Got22)/Mcwi strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:12798539|PMID:21257920 20170324 RGD 12798533 SS.BN-(D13Hmgc85-D13Got22)/Mcwi strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:12798539|PMID:21257920 20170324 RGD 12798534 SS.BN-(D13Rat77-D13Got22)/Mcwi strain MP:0002962 increased urine protein level induced IAGP XCO:0000022 N RGD:12798539|PMID:21257920 20191213 RGD compared to SS/JrHsdMcwi 12798534 SS.BN-(D13Rat77-D13Got22)/Mcwi strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:12798539|PMID:21257920 20170324 RGD 12798535 SS.BN-(D13Rat111-D13Rat115)/Mcwi strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:12798539|PMID:21257920 20170324 RGD 12798536 SS.BN-(D13Rat111-D13Hmgc86)/Mcwi strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:12798539|PMID:21257920 20170324 RGD 12798537 SS.BN-(D13Rat111-D13Rat20)/Mcwi strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:12798539|PMID:21257920 20170324 RGD 12798538 SS.BN-(D13Rat111-D13Hmgc85)/Mcwi strain MP:0002963 decreased urine protein level induced IAGP XCO:0000022 N RGD:12798539|PMID:21257920 20170324 RGD compared to SS/JrHsdMcwi 12798538 SS.BN-(D13Rat111-D13Hmgc85)/Mcwi strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:12798539|PMID:21257920 20170324 RGD compared to SS/JrHsdMcwi 12802344 Kcnq1dfk potassium voltage-gated channel subfamily Q member 1;deafness Kyoto gene MP:0001262 decreased body weight IAGP N RGD:1581602|PMID:16368876 20170411 RGD 12802344 Kcnq1dfk potassium voltage-gated channel subfamily Q member 1;deafness Kyoto gene MP:0001525 impaired balance IAGP N RGD:1581602|PMID:16368876 20170411 RGD 12802344 Kcnq1dfk potassium voltage-gated channel subfamily Q member 1;deafness Kyoto gene MP:0001544 abnormal cardiovascular system physiology IAGP N RGD:1581602|PMID:16368876 20170411 RGD 12802344 Kcnq1dfk potassium voltage-gated channel subfamily Q member 1;deafness Kyoto gene MP:0003233 prolonged QT interval IAGP N RGD:1581602|PMID:16368876 20200124 RGD 12802344 Kcnq1dfk potassium voltage-gated channel subfamily Q member 1;deafness Kyoto gene MP:0005211 increased stomach mucosa thickness IAGP N RGD:1581602|PMID:16368876 20170411 RGD 12802344 Kcnq1dfk potassium voltage-gated channel subfamily Q member 1;deafness Kyoto gene MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:1581602|PMID:16368876 20200124 RGD 12802344 Kcnq1dfk potassium voltage-gated channel subfamily Q member 1;deafness Kyoto gene MP:0008006 increased stomach pH IAGP N RGD:1581602|PMID:16368876 20200124 RGD 12802344 Kcnq1dfk potassium voltage-gated channel subfamily Q member 1;deafness Kyoto gene MP:0011967 increased or absent threshold for auditory brainstem response IAGP N RGD:1581602|PMID:16368876 20200124 RGD 12802346 Plp1md proteolipid protein 1; Myelin-deficient gene MP:0000745 tremors IAGP N RGD:1358781|PMID:2479544 20170412 RGD 12802346 Plp1md proteolipid protein 1; Myelin-deficient gene MP:0002083 premature death IAGP N RGD:1358781|PMID:2479544 20170412 RGD 12802353 Unc5chob unc-5 netrin receptor C; hobble mutant gene MP:0000865 absent cerebellum vermis IAGP N RGD:1302461|PMID:14993736 20170406 RGD 12802355 Unc5ccvd unc-5 netrin receptor C; cerebellar vermis defect gene MP:0000865 absent cerebellum vermis IAGP N RGD:1302461|PMID:14993736 20170406 RGD 12802362 SS.BN-(D13Rat25-RN34_13048990782)/Mcwi strain MP:0002871 albuminuria IAGP N RGD:12802369|PMID:23460292 20170407 RGD 12802362 SS.BN-(D13Rat25-RN34_13048990782)/Mcwi strain MP:0002871 albuminuria sexual_dimorphism IAGP XCO:0000795 N RGD:12802368|PMID:23817491 20170406 RGD more severe in male 12802362 SS.BN-(D13Rat25-RN34_13048990782)/Mcwi strain MP:0004217 salt-sensitive hypertension IAGP N RGD:12802369|PMID:23460292 20170407 RGD 12802362 SS.BN-(D13Rat25-RN34_13048990782)/Mcwi strain MP:0004217 salt-sensitive hypertension sexual_dimorphism IAGP XCO:0000795 N RGD:12802368|PMID:23817491 20170406 RGD more severe in male on 8% NaCl diet 12802362 SS.BN-(D13Rat25-RN34_13048990782)/Mcwi strain MP:0004876 decreased mean systemic arterial blood pressure sexual_dimorphism IAGP XCO:0000795 N RGD:12802368|PMID:23817491 20191122 RGD in female, compared to SS/JrHsdMcwi; 12802362 SS.BN-(D13Rat25-RN34_13048990782)/Mcwi strain MP:0005540 decreased urine albumin level sexual_dimorphism IAGP XCO:0000795 N RGD:12802368|PMID:23817491 20191122 RGD in female, compared to SS/JrHsdMcwi; 12802363 SS.BN-(D13Rat25-rs106935835)/Mcwi strain MP:0002871 albuminuria induced IAGP XCO:0000022 N RGD:12802368|PMID:23817491 20170406 RGD 12802363 SS.BN-(D13Rat25-rs106935835)/Mcwi strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:12802368|PMID:23817491 20170406 RGD 12802364 SS.BN-(D13Rat25-rs198199323)/Mcwi strain MP:0002871 albuminuria sexual_dimorphism IAGP XCO:0000795 N RGD:12802368|PMID:23817491 20170406 RGD more severe in male 12802364 SS.BN-(D13Rat25-rs198199323)/Mcwi strain MP:0004217 salt-sensitive hypertension sexual_dimorphism IAGP XCO:0000795 N RGD:12802368|PMID:23817491 20170406 RGD more severe in male on 8% NaCl diet 12802364 SS.BN-(D13Rat25-rs198199323)/Mcwi strain MP:0004876 decreased mean systemic arterial blood pressure sexual_dimorphism IAGP XCO:0000795 N RGD:12802368|PMID:23817491 20191122 RGD in female, compared to SS/JrHsdMcwi; 12802364 SS.BN-(D13Rat25-rs198199323)/Mcwi strain MP:0005540 decreased urine albumin level sexual_dimorphism IAGP XCO:0000795 N RGD:12802368|PMID:23817491 20191122 RGD in female, compared to SS/JrHsdMcwi; 12802366 SS.BN-(D13Hmgc64-4582)/Mcwi strain MP:0002871 albuminuria IAGP N RGD:12802369|PMID:23460292 20170407 RGD 12802366 SS.BN-(D13Hmgc64-4582)/Mcwi strain MP:0004217 salt-sensitive hypertension IAGP N RGD:12802369|PMID:23460292 20170407 RGD 12802366 SS.BN-(D13Hmgc64-4582)/Mcwi strain MP:0005602 decreased angiogenesis IAGP N RGD:12832723|PMID:21521778 20191122 RGD 12802367 SS.BN-(2340-RN34_13048990782)/Mcwi strain MP:0002871 albuminuria IAGP N RGD:12802369|PMID:23460292 20170407 RGD 12802367 SS.BN-(2340-RN34_13048990782)/Mcwi strain MP:0004217 salt-sensitive hypertension IAGP N RGD:12802369|PMID:23460292 20170407 RGD 12859278 Slc:ZUC-Leprfa-/- Zucker fatty rats strain MP:0001260 increased body weight IAGP N RGD:12859276|PMID:23671847 20200320 RGD compared to fa/+ heterozygotes 12859278 Slc:ZUC-Leprfa-/- Zucker fatty rats strain MP:0001260 increased body weight IAGP N RGD:2300017|PMID:14756693 20200113 RGD compared to SHRSP/Izm 12859278 Slc:ZUC-Leprfa-/- Zucker fatty rats strain MP:0001552 increased circulating triglyceride level IAGP N RGD:2300017|PMID:14756693 20200113 RGD compared to SHRSP/Izm 12859278 Slc:ZUC-Leprfa-/- Zucker fatty rats strain MP:0001552 increased circulating triglyceride level IAGP XCO:0000025, XCO:0000246,XCO:0000164 N RGD:21076282|PMID:20606728 20200313 RGD compared to standard diet rats 12859278 Slc:ZUC-Leprfa-/- Zucker fatty rats strain MP:0001554 increased circulating free fatty acids level IAGP XCO:0000025, XCO:0000246,XCO:0000164 N RGD:21076282|PMID:20606728 20200313 RGD compared to standard diet rats 12859278 Slc:ZUC-Leprfa-/- Zucker fatty rats strain MP:0001860 liver inflammation IAGP XCO:0000025, XCO:0000246,XCO:0000164 N RGD:21076282|PMID:20606728 20200313 RGD compared to standard diet rats 12859278 Slc:ZUC-Leprfa-/- Zucker fatty rats strain MP:0002079 increased circulating insulin level IAGP N RGD:12859276|PMID:23671847 20170414 RGD compared to fa/+ heterozygotes 12859278 Slc:ZUC-Leprfa-/- Zucker fatty rats strain MP:0002079 increased circulating insulin level IAGP N RGD:2300017|PMID:14756693 20200113 RGD compared to SHRSP/Izm 12859278 Slc:ZUC-Leprfa-/- Zucker fatty rats strain MP:0002941 increased circulating alanine transaminase level IAGP XCO:0000025, XCO:0000246,XCO:0000164 N RGD:21076282|PMID:20606728 20200313 RGD compared to standard diet rats 12859278 Slc:ZUC-Leprfa-/- Zucker fatty rats strain MP:0002981 increased liver weight IAGP N RGD:2300017|PMID:14756693 20200113 RGD compared to SHRSP/Izm 12859278 Slc:ZUC-Leprfa-/- Zucker fatty rats strain MP:0002981 increased liver weight IAGP XCO:0000025, XCO:0000246,XCO:0000164 N RGD:21076282|PMID:20606728 20200313 RGD compared to standard diet rats 12859278 Slc:ZUC-Leprfa-/- Zucker fatty rats strain MP:0003674 oxidative stress IAGP XCO:0000025, XCO:0000246,XCO:0000164 N RGD:21076282|PMID:20606728 20200313 RGD compared to standard diet rats 12859278 Slc:ZUC-Leprfa-/- Zucker fatty rats strain MP:0005178 increased circulating cholesterol level IAGP N RGD:2300017|PMID:14756693 20200113 RGD compared to SHRSP/Izm 12859278 Slc:ZUC-Leprfa-/- Zucker fatty rats strain MP:0005178 increased circulating cholesterol level IAGP XCO:0000025, XCO:0000246,XCO:0000164 N RGD:21076282|PMID:20606728 20200313 RGD compared to standard diet rats 12859278 Slc:ZUC-Leprfa-/- Zucker fatty rats strain MP:0005293 impaired glucose tolerance IAGP N RGD:12859275|PMID:25961052 20170414 RGD 12859278 Slc:ZUC-Leprfa-/- Zucker fatty rats strain MP:0005331 insulin resistance IAGP N RGD:12859275|PMID:25961052 20201006 RGD 12859278 Slc:ZUC-Leprfa-/- Zucker fatty rats strain MP:0005559 increased circulating glucose level IAGP N RGD:2300017|PMID:14756693 20200113 RGD compared to SHRSP/Izm 12859278 Slc:ZUC-Leprfa-/- Zucker fatty rats strain MP:0005559 increased circulating glucose level IAGP XCO:0000025, XCO:0000246,XCO:0000164 N RGD:21076282|PMID:20606728 20200313 RGD compared to standard diet rats 12859278 Slc:ZUC-Leprfa-/- Zucker fatty rats strain MP:0005669 increased circulating leptin level IAGP N RGD:2300017|PMID:14756693 20200113 RGD compared to SHRSP/Izm 12859278 Slc:ZUC-Leprfa-/- Zucker fatty rats strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:2300017|PMID:14756693 20200113 RGD compared to SHRSP/Izm 12859278 Slc:ZUC-Leprfa-/- Zucker fatty rats strain MP:0009288 increased epididymal fat pad weight IAGP N RGD:2300017|PMID:14756693 20200113 RGD compared to SHRSP/Izm 12859278 Slc:ZUC-Leprfa-/- Zucker fatty rats strain MP:0009298 increased mesenteric fat pad weight IAGP N RGD:2300017|PMID:14756693 20200113 RGD compared to SHRSP/Izm 12859278 Slc:ZUC-Leprfa-/- Zucker fatty rats strain MP:0009355 increased liver triglyceride level IAGP XCO:0000025, XCO:0000246,XCO:0000164 N RGD:21076282|PMID:20606728 20200313 RGD compared to standard diet rats 12859278 Slc:ZUC-Leprfa-/- Zucker fatty rats strain MP:0011594 decreased catalase activity IAGP XCO:0000025, XCO:0000246,XCO:0000164 N RGD:21076282|PMID:20606728 20200313 RGD compared to standard diet rats 12859278 Slc:ZUC-Leprfa-/- Zucker fatty rats strain MP:0011603 decreased glutathione peroxidase activity IAGP XCO:0000025, XCO:0000246,XCO:0000164 N RGD:21076282|PMID:20606728 20200313 RGD compared to standard diet rats 12859278 Slc:ZUC-Leprfa-/- Zucker fatty rats strain MP:0012659 decreased superoxide dismutase level IAGP XCO:0000025, XCO:0000246,XCO:0000164 N RGD:21076282|PMID:20606728 20200313 RGD compared to standard diet rats 12859279 Ho:ZFDM-Leprfa Zucker Fatty Diabetes Mellitus rats strain MP:0001258 decreased body length IAGP N RGD:12859276|PMID:23671847 20200320 RGD compared to fa/+ heterozygotes 12859279 Ho:ZFDM-Leprfa Zucker Fatty Diabetes Mellitus rats strain MP:0001260 increased body weight IAGP N RGD:12859276|PMID:23671847 20200320 RGD compared to fa/+ heterozygotes 12859279 Ho:ZFDM-Leprfa Zucker Fatty Diabetes Mellitus rats strain MP:0001552 increased circulating triglyceride level IAGP N RGD:12859276|PMID:23671847 20200320 RGD compared to fa/+ heterozygotes 12859279 Ho:ZFDM-Leprfa Zucker Fatty Diabetes Mellitus rats strain MP:0001554 increased circulating free fatty acids level IAGP N RGD:12859276|PMID:23671847 20170414 RGD compared to fa/+ heterozygotes 12859279 Ho:ZFDM-Leprfa Zucker Fatty Diabetes Mellitus rats strain MP:0001556 increased circulating HDL cholesterol level IAGP N RGD:12859276|PMID:23671847 20200320 RGD compared to fa/+ heterozygotes 12859279 Ho:ZFDM-Leprfa Zucker Fatty Diabetes Mellitus rats strain MP:0001559 hyperglycemia IAGP N RGD:12859276|PMID:23671847 20170414 RGD compared to fa/+ heterozygotes 12859279 Ho:ZFDM-Leprfa Zucker Fatty Diabetes Mellitus rats strain MP:0002079 increased circulating insulin level IAGP N RGD:12859276|PMID:23671847 20170414 RGD compared to fa/+ heterozygotes 12859279 Ho:ZFDM-Leprfa Zucker Fatty Diabetes Mellitus rats strain MP:0003334 pancreas fibrosis IAGP N RGD:12859276|PMID:23671847 20200320 RGD compared to fa/+ heterozygotes 12859279 Ho:ZFDM-Leprfa Zucker Fatty Diabetes Mellitus rats strain MP:0003980 increased circulating phospholipid level IAGP N RGD:12859276|PMID:23671847 20200320 RGD compared to fa/+ heterozygotes 12859279 Ho:ZFDM-Leprfa Zucker Fatty Diabetes Mellitus rats strain MP:0005178 increased circulating cholesterol level IAGP N RGD:12859276|PMID:23671847 20200320 RGD compared to fa/+ heterozygotes 12859279 Ho:ZFDM-Leprfa Zucker Fatty Diabetes Mellitus rats strain MP:0005293 impaired glucose tolerance IAGP N RGD:12859275|PMID:25961052 20170414 RGD 12859279 Ho:ZFDM-Leprfa Zucker Fatty Diabetes Mellitus rats strain MP:0005331 insulin resistance IAGP N RGD:12859275|PMID:25961052 20201006 RGD 12859279 Ho:ZFDM-Leprfa Zucker Fatty Diabetes Mellitus rats strain MP:0005559 increased circulating glucose level IAGP N RGD:12859276|PMID:23671847 20200320 RGD compared to fa/+ heterozygotes 12859279 Ho:ZFDM-Leprfa Zucker Fatty Diabetes Mellitus rats strain MP:0005669 increased circulating leptin level IAGP N RGD:12859276|PMID:23671847 20200320 RGD compared to fa/+ heterozygotes 12859279 Ho:ZFDM-Leprfa Zucker Fatty Diabetes Mellitus rats strain MP:0006087 increased body mass index IAGP N RGD:12859276|PMID:23671847 20200320 RGD compared to fa/+ heterozygotes 12859279 Ho:ZFDM-Leprfa Zucker Fatty Diabetes Mellitus rats strain MP:0009254 disorganized pancreatic islets IAGP N RGD:12859276|PMID:23671847 20200320 RGD compared to fa/+ heterozygotes 12859279 Ho:ZFDM-Leprfa Zucker Fatty Diabetes Mellitus rats strain MP:0020087 increased susceptibility to non-insulin-dependent diabetes IAGP N RGD:12859276|PMID:23671847 20200320 RGD compared to fa/+ heterozygotes 12859287 ZDF-Leprfa/Drt Zucker Diabetic Fatty Rat strain MP:0001260 increased body weight IAGP N RGD:1354693|PMID:15319354 20200306 RGD compared to Zucker Lean, Zucker Lean pair-fed, diazoxide treated Zucker Lean 12859287 ZDF-Leprfa/Drt Zucker Diabetic Fatty Rat strain MP:0001260 increased body weight induced IAGP XCO:0000669|XCO:0000670 N RGD:1354693|PMID:15319354 20200306 RGD 12859287 ZDF-Leprfa/Drt Zucker Diabetic Fatty Rat strain MP:0001262 decreased body weight induced IAGP XCO:0000669|XCO:0000670 N RGD:1354693|PMID:15319354 20200306 RGD 12859287 ZDF-Leprfa/Drt Zucker Diabetic Fatty Rat strain MP:0001552 increased circulating triglyceride level IAGP N RGD:1354693|PMID:15319354 20200306 RGD compared to Zucker Lean 12859287 ZDF-Leprfa/Drt Zucker Diabetic Fatty Rat strain MP:0001552 increased circulating triglyceride level induced IAGP XCO:0000669 N RGD:1354693|PMID:15319354 20200306 RGD compared to Zucker Lean, Zucker Lean pair-fed, diazoxide treated Zucker Lean 12859287 ZDF-Leprfa/Drt Zucker Diabetic Fatty Rat strain MP:0001554 increased circulating free fatty acids level IAGP N RGD:1354693|PMID:15319354 20200306 RGD compared to Zucker Lean, Zucker Lean pair-fed, diazoxide treated Zucker Lean 12859287 ZDF-Leprfa/Drt Zucker Diabetic Fatty Rat strain MP:0001554 increased circulating free fatty acids level induced IAGP XCO:0000669|XCO:0000670 N RGD:1354693|PMID:15319354 20200306 RGD 12859287 ZDF-Leprfa/Drt Zucker Diabetic Fatty Rat strain MP:0002079 increased circulating insulin level IAGP N RGD:1354693|PMID:15319354 20200306 RGD compared to Zucker Lean, Zucker Lean pair-fed, diazoxide treated Zucker Lean 12859287 ZDF-Leprfa/Drt Zucker Diabetic Fatty Rat strain MP:0002079 increased circulating insulin level induced IAGP XCO:0000669|XCO:0000670 N RGD:1354693|PMID:15319354 20200306 RGD 12859287 ZDF-Leprfa/Drt Zucker Diabetic Fatty Rat strain MP:0002644 decreased circulating triglyceride level induced IAGP XCO:0000669 N RGD:1354693|PMID:15319354 20200306 RGD compared to ZDF-Leprfa/Drt, ZDF-Leprfa/Drt pair-fed 12859287 ZDF-Leprfa/Drt Zucker Diabetic Fatty Rat strain MP:0002702 decreased circulating free fatty acids level induced IAGP XCO:0000669 N RGD:1354693|PMID:15319354 20200306 RGD compared to ZDF-Leprfa/Drt, ZDF-Leprfa/Drt pair-fed 12859287 ZDF-Leprfa/Drt Zucker Diabetic Fatty Rat strain MP:0002727 decreased circulating insulin level IAGP XCO:0000670 N RGD:1354693|PMID:15319354 20200306 RGD compared to ZDF-Leprfa/Drt 12859287 ZDF-Leprfa/Drt Zucker Diabetic Fatty Rat strain MP:0002891 increased insulin sensitivity induced IAGP XCO:0000669 N RGD:1354693|PMID:15319354 20200306 RGD compared to ZDF-Leprfa/Drt 12859287 ZDF-Leprfa/Drt Zucker Diabetic Fatty Rat strain MP:0005455 increased susceptibility to weight gain IAGP N RGD:1354693|PMID:15319354 20200306 RGD compared to Zucker Lean, Zucker Lean pair-fed, diazoxide treated Zucker Lean 12859287 ZDF-Leprfa/Drt Zucker Diabetic Fatty Rat strain MP:0005455 increased susceptibility to weight gain induced IAGP XCO:0000669|XCO:0000670 N RGD:1354693|PMID:15319354 20200306 RGD 12859287 ZDF-Leprfa/Drt Zucker Diabetic Fatty Rat strain MP:0005668 decreased circulating leptin level induced IAGP XCO:0000669 N RGD:1354693|PMID:15319354 20200306 RGD compared to ZDF-Leprfa/Drt, ZDF-Leprfa/Drt pair-fed 12859287 ZDF-Leprfa/Drt Zucker Diabetic Fatty Rat strain MP:0005669 increased circulating leptin level IAGP N RGD:1354693|PMID:15319354 20200306 RGD compared to Zucker Lean, Zucker Lean pair-fed, diazoxide treated Zucker Lean 12859287 ZDF-Leprfa/Drt Zucker Diabetic Fatty Rat strain MP:0005669 increased circulating leptin level induced IAGP XCO:0000669 N RGD:1354693|PMID:15319354 20200306 RGD compared to Zucker Lean, Zucker Lean pair-fed, diazoxide treated Zucker Lean 12859287 ZDF-Leprfa/Drt Zucker Diabetic Fatty Rat strain MP:0006352 decreased glycosylated hemoglobin level induced IAGP XCO:0000669 N RGD:1354693|PMID:15319354 20200306 RGD compared to ZDF-Leprfa/Drt, ZDF-Leprfa/Drt pair-fed 12859287 ZDF-Leprfa/Drt Zucker Diabetic Fatty Rat strain MP:0010182 decreased susceptibility to weight gain induced IAGP XCO:0000669|XCO:0000670 N RGD:1354693|PMID:15319354 20200306 RGD 12859287 ZDF-Leprfa/Drt Zucker Diabetic Fatty Rat strain MP:0011939 increased food intake IAGP N RGD:1354693|PMID:15319354 20200306 RGD compared to Zucker Lean, Zucker Lean pair-fed, diazoxide treated Zucker Lean 12859287 ZDF-Leprfa/Drt Zucker Diabetic Fatty Rat strain MP:0011939 increased food intake induced IAGP XCO:0000669|XCO:0000670 N RGD:1354693|PMID:15319354 20200306 RGD 12859287 ZDF-Leprfa/Drt Zucker Diabetic Fatty Rat strain MP:0011940 decreased food intake induced IAGP XCO:0000669|XCO:0000670 N RGD:1354693|PMID:15319354 20200306 RGD 12859287 ZDF-Leprfa/Drt Zucker Diabetic Fatty Rat strain MP:0013278 decreased fasting circulating glucose level induced IAGP XCO:0000669|XCO:0000670 N RGD:1354693|PMID:15319354 20200306 RGD 12859287 ZDF-Leprfa/Drt Zucker Diabetic Fatty Rat strain MP:0013279 increased fasting circulating glucose level IAGP N RGD:1354693|PMID:15319354 20200306 RGD compared to Zucker Lean, Zucker Lean pair-fed, diazoxide treated Zucker Lean 12859287 ZDF-Leprfa/Drt Zucker Diabetic Fatty Rat strain MP:0013279 increased fasting circulating glucose level IAGP XCO:0000670 N RGD:1354693|PMID:15319354 20200306 RGD compared to Zucker Lean, Zucker Lean pair-fed, diazoxide treated Zucker Lean 12859287 ZDF-Leprfa/Drt Zucker Diabetic Fatty Rat strain MP:0020088 decreased susceptibility to non-insulin-dependent diabetes induced IAGP XCO:0000669 N RGD:1354693|PMID:15319354 20200306 RGD 12859287 ZDF-Leprfa/Drt Zucker Diabetic Fatty Rat strain MP:0030969 increased circulating adiponectin level induced IAGP XCO:0000669 N RGD:1354693|PMID:15319354 20200306 RGD compared to ZDF-Leprfa/Drt, ZDF-Leprfa/Drt pair-fed 12879386 W-Ghsrem1Ottc strain MP:0000005 increased brown adipose tissue amount IMP N RGD:13825258|PMID:29453460 20181204 RGD 12879386 W-Ghsrem1Ottc strain MP:0001262 decreased body weight IMP N RGD:13825258|PMID:29453460 20181204 RGD 12879386 W-Ghsrem1Ottc strain MP:0011940 decreased food intake IMP N RGD:13825258|PMID:29453460 20181204 RGD 12879386 W-Ghsrem1Ottc strain MP:0012042 low alcohol preference IMP N RGD:13825259|PMID:30456835 20181204 RGD 12879394 F344-Atmm1Kyo Atm missense rats strain MP:0000755 hindlimb paralysis IMP N RGD:12879393|PMID:27895165 20170418 RGD 12879394 F344-Atmm1Kyo Atm missense rats strain MP:0000755 hindlimb paralysis IMP N RGD:12879399|PMID:28007901 20170418 RGD 12879394 F344-Atmm1Kyo Atm missense rats strain MP:0001130 abnormal ovarian folliculogenesis IMP N RGD:12879393|PMID:27895165 20170418 RGD 12879394 F344-Atmm1Kyo Atm missense rats strain MP:0002216 abnormal seminiferous tubule morphology IMP N RGD:12879393|PMID:27895165 20170418 RGD 12879394 F344-Atmm1Kyo Atm missense rats strain MP:0005018 decreased T cell number IMP N RGD:12879393|PMID:27895165 20170418 RGD 12879394 F344-Atmm1Kyo Atm missense rats strain MP:0005091 increased double-positive T cell number IMP N RGD:12879393|PMID:27895165 20170418 RGD 12879394 F344-Atmm1Kyo Atm missense rats strain MP:0010769 abnormal survival IMP N RGD:12879393|PMID:27895165 20170418 RGD 12879395 Atmm1Kyo ATM serine/threonine kinase; ENU induced mutant 1, Kyo gene MP:0000755 hindlimb paralysis IMP N RGD:12879393|PMID:27895165 20170418 RGD 12879395 Atmm1Kyo ATM serine/threonine kinase; ENU induced mutant 1, Kyo gene MP:0000755 hindlimb paralysis IMP N RGD:12879399|PMID:28007901 20230119 RGD 12879395 Atmm1Kyo ATM serine/threonine kinase; ENU induced mutant 1, Kyo gene MP:0001130 abnormal ovarian folliculogenesis IMP N RGD:12879393|PMID:27895165 20170418 RGD 12879395 Atmm1Kyo ATM serine/threonine kinase; ENU induced mutant 1, Kyo gene MP:0002216 abnormal seminiferous tubule morphology IMP N RGD:12879393|PMID:27895165 20170418 RGD 12879395 Atmm1Kyo ATM serine/threonine kinase; ENU induced mutant 1, Kyo gene MP:0005018 decreased T cell number IMP N RGD:12879393|PMID:27895165 20170418 RGD 12879395 Atmm1Kyo ATM serine/threonine kinase; ENU induced mutant 1, Kyo gene MP:0005091 increased double-positive T cell number IMP N RGD:12879393|PMID:27895165 20170418 RGD 12879395 Atmm1Kyo ATM serine/threonine kinase; ENU induced mutant 1, Kyo gene MP:0010769 abnormal survival IMP N RGD:12879393|PMID:27895165 20170418 RGD 12879400 F344-Atmem1Kyo ZFN-Atm rats strain MP:0000755 hindlimb paralysis IMP N RGD:12879399|PMID:28007901 20170418 RGD 12879400 F344-Atmem1Kyo ZFN-Atm rats strain MP:0000939 decreased motor neuron number IMP N RGD:12879399|PMID:28007901 20170418 RGD 12879400 F344-Atmem1Kyo ZFN-Atm rats strain MP:0001130 abnormal ovarian folliculogenesis IMP N RGD:12879399|PMID:28007901 20170418 RGD 12879400 F344-Atmem1Kyo ZFN-Atm rats strain MP:0002216 abnormal seminiferous tubule morphology IMP N RGD:12879399|PMID:28007901 20170418 RGD 12879400 F344-Atmem1Kyo ZFN-Atm rats strain MP:0003674 oxidative stress IMP N RGD:12879399|PMID:28007901 20170418 RGD 12879400 F344-Atmem1Kyo ZFN-Atm rats strain MP:0008918 microgliosis IMP N RGD:12879399|PMID:28007901 20170418 RGD 12879400 F344-Atmem1Kyo ZFN-Atm rats strain MP:0010762 abnormal microglial cell activation IMP N RGD:12879399|PMID:28007901 20170418 RGD 12879400 F344-Atmem1Kyo ZFN-Atm rats strain MP:0011982 decreased microglial cell number IMP N RGD:12879399|PMID:28007901 20170418 RGD 12879401 Atmem1Kyo ATM serine/threonine kinase; ZFN induced mutant 1, Kyo gene MP:0000136 abnormal microglial cell morphology IMP N RGD:12879399|PMID:28007901 20170418 RGD 12879401 Atmem1Kyo ATM serine/threonine kinase; ZFN induced mutant 1, Kyo gene MP:0000755 hindlimb paralysis IMP N RGD:12879399|PMID:28007901 20170418 RGD 12879401 Atmem1Kyo ATM serine/threonine kinase; ZFN induced mutant 1, Kyo gene MP:0000939 decreased motor neuron number IMP N RGD:12879399|PMID:28007901 20170418 RGD 12879401 Atmem1Kyo ATM serine/threonine kinase; ZFN induced mutant 1, Kyo gene MP:0001130 abnormal ovarian folliculogenesis IMP N RGD:12879399|PMID:28007901 20170418 RGD 12879401 Atmem1Kyo ATM serine/threonine kinase; ZFN induced mutant 1, Kyo gene MP:0002216 abnormal seminiferous tubule morphology IMP N RGD:12879399|PMID:28007901 20170418 RGD 12879401 Atmem1Kyo ATM serine/threonine kinase; ZFN induced mutant 1, Kyo gene MP:0003674 oxidative stress IMP N RGD:12879399|PMID:28007901 20170418 RGD 12879401 Atmem1Kyo ATM serine/threonine kinase; ZFN induced mutant 1, Kyo gene MP:0008918 microgliosis IMP N RGD:12879399|PMID:28007901 20230119 RGD 12879401 Atmem1Kyo ATM serine/threonine kinase; ZFN induced mutant 1, Kyo gene MP:0010762 abnormal microglial cell activation IMP N RGD:12879399|PMID:28007901 20230119 RGD 12879401 Atmem1Kyo ATM serine/threonine kinase; ZFN induced mutant 1, Kyo gene MP:0011982 decreased microglial cell number IMP N RGD:12879399|PMID:28007901 20230119 RGD 12879401 Atmem1Kyo ATM serine/threonine kinase; ZFN induced mutant 1, Kyo gene MP:0020448 increased microglial cell activation IMP N RGD:12879399|PMID:28007901 20170418 RGD 12879506 Pur33 Proteinuria QTL 33 qtl MP:0002962 increased urine protein level IAGP N RGD:11353859|PMID:27113531 20170424 RGD 12879830 Bw178 Body weight QTL 178 qtl MP:0001259 abnormal body weight IAGP N RGD:1599557|PMID:17143582 20170427 RGD 12879831 Cm82 Cardiac mass QTL 82 qtl MP:0004857 abnormal heart weight IAGP N RGD:1599557|PMID:17143582 20170427 RGD 12879832 Cm83 Cardiac mass QTL 83 qtl MP:0020204 abnormal heart left ventricle weight IAGP N RGD:1599557|PMID:17143582 20170427 RGD 12879833 Cm84 Cardiac mass QTL 84 qtl MP:0020205 abnormal heart right ventricle weight IAGP N RGD:1599557|PMID:17143582 20170426 RGD 12879834 Am1 Aortic mass QTL 1 qtl MP:0002846 abnormal aortic mass IAGP N RGD:1599557|PMID:17143582 20170426 RGD 12879837 Am2 Aortic mass QTL 2 qtl MP:0002846 abnormal aortic mass IAGP N RGD:1599557|PMID:17143582 20170426 RGD 12879838 Cm86 Cardiac mass QTL 86 qtl MP:0020204 abnormal heart left ventricle weight IAGP N RGD:1599557|PMID:17143582 20170427 RGD 12879839 Cm85 Cardiac mass QTL 85 qtl MP:0004857 abnormal heart weight IAGP N RGD:1599557|PMID:17143582 20170427 RGD 12879840 Bw179 Body weight QTL 179 qtl MP:0001259 abnormal body weight IAGP N RGD:1599557|PMID:17143582 20170427 RGD 12879841 Cm87 Cardiac mass QTL 87 qtl MP:0004857 abnormal heart weight IAGP N RGD:1599557|PMID:17143582 20170427 RGD 12879842 Cm88 Cardiac mass QTL 88 qtl MP:0020204 abnormal heart left ventricle weight IAGP N RGD:1599557|PMID:17143582 20170427 RGD 12879843 Am3 Aortic mass QTL 3 qtl MP:0002846 abnormal aortic mass IAGP N RGD:1599557|PMID:17143582 20170426 RGD 12879845 Cm89 Cardiac mass QTL 89 qtl MP:0020204 abnormal heart left ventricle weight IAGP N RGD:1599557|PMID:17143582 20170427 RGD 12879846 Cm90 Cardiac mass QTL 90 qtl MP:0020205 abnormal heart right ventricle weight IAGP N RGD:1599557|PMID:17143582 20170427 RGD 12879847 Am4 Aortic mass QTL 4 qtl MP:0002846 abnormal aortic mass IAGP N RGD:1599557|PMID:17143582 20170426 RGD 12879848 Bw181 Body weght QTL 181 qtl MP:0001259 abnormal body weight IAGP N RGD:1599557|PMID:17143582 20170615 RGD 12879849 Bw180 Body weight QTL 180 qtl MP:0001259 abnormal body weight IAGP N RGD:1599557|PMID:17143582 20170615 RGD 12879850 Cm91 Cardiac mass QTL 91 qtl MP:0004857 abnormal heart weight IAGP N RGD:1599557|PMID:17143582 20170428 RGD 12879851 Cm92 Cardiac mass QTL 92 qtl MP:0020204 abnormal heart left ventricle weight IAGP N RGD:1599557|PMID:17143582 20170428 RGD 12879852 Cm93 Cardiac mass QTL 93 qtl MP:0020205 abnormal heart right ventricle weight IAGP N RGD:1599557|PMID:17143582 20170428 RGD 12879853 Am5 Aortic mass QTL 5 qtl MP:0002845 abnormal aortic weight IAGP N RGD:1599557|PMID:17143582 20170428 RGD 12879854 Kidm63 Kidney mass QTL 63 qtl MP:0002707 abnormal kidney weight IAGP N RGD:1599557|PMID:17143582 20170510 RGD 12879860 Tgrdw thyroglobulin; rdw mutant gene MP:0001262 decreased body weight IAGP N RGD:13605608|PMID:10760744 20201210 RGD 12879860 Tgrdw thyroglobulin; rdw mutant gene MP:0001262 decreased body weight IAGP N RGD:730133|PMID:11089535 20210930 RGD compared to wild type and heterozygotes 12879860 Tgrdw thyroglobulin; rdw mutant gene MP:0003351 decreased circulating levels of thyroid hormone IAGP N RGD:13605608|PMID:10760744 20201210 RGD 12879860 Tgrdw thyroglobulin; rdw mutant gene MP:0005135 increased thyroid-stimulating hormone level IAGP N RGD:13605608|PMID:10760744 20201210 RGD 12879860 Tgrdw thyroglobulin; rdw mutant gene MP:0008321 small adenohypophysis IAGP N RGD:12880373|PMID:3366187 20170503 RGD 12879860 Tgrdw thyroglobulin; rdw mutant gene MP:0008321 small adenohypophysis IAGP N RGD:730133|PMID:11089535 20170503 RGD 12879860 Tgrdw thyroglobulin; rdw mutant gene MP:0009378 abnormal endoplasmic reticulum morphology IAGP N RGD:730133|PMID:11089535 20210930 RGD compared to wild type and heterozygotes 12879860 Tgrdw thyroglobulin; rdw mutant gene MP:0020168 decreased thyroid gland weight IAGP N RGD:13605608|PMID:10760744 20201210 RGD 12879860 Tgrdw thyroglobulin; rdw mutant gene MP:0020354 increased endoplasmic reticulum stress IAGP N RGD:730133|PMID:11089535 20210930 RGD compared to wild type and heterozygotes 12879863 Bp402 Blood pressure QTL 402 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:1599557|PMID:17143582 20170428 RGD 12879866 Cm94 Cardiac mass QTL 94 qtl MP:0020204 abnormal heart left ventricle weight IAGP N RGD:1599557|PMID:17143582 20081029 RGD 12879868 Am6 Aortic mass QTL 6 qtl MP:0002845 abnormal aortic weight IAGP N RGD:1599557|PMID:17143582 20081029 RGD 12879871 Am7 Aortic mass QTL 7 qtl MP:0002845 abnormal aortic weight IAGP N RGD:1599557|PMID:17143582 20170428 RGD 12879872 Cm97 Cardiac mass QTL 97 qtl MP:0020204 abnormal heart left ventricle weight IAGP N RGD:1599557|PMID:17143582 20170428 RGD 12879873 Cm96 Cardiac mass QTL 96 qtl MP:0004857 abnormal heart weight IAGP N RGD:1599557|PMID:17143582 20170428 RGD 12879874 Cm98 Cardiac mass QTL 98 qtl MP:0020205 abnormal heart right ventricle weight IAGP N RGD:1599557|PMID:17143582 20170428 RGD 12879875 Kidm64 Kidney mass QTL 64 qtl MP:0002707 abnormal kidney weight IAGP N RGD:1599557|PMID:17143582 20170510 RGD 12879878 Bw183 Body weight QTL 183 qtl MP:0001259 abnormal body weight IAGP N RGD:1599557|PMID:17143582 20081029 RGD 12879879 Cm99 Cardiac mass QTL 99 qtl MP:0004857 abnormal heart weight IAGP N RGD:1599557|PMID:17143582 20081029 RGD 12879880 Cm100 Cardiac mass QTL 100 qtl MP:0020204 abnormal heart left ventricle weight IAGP N RGD:1599557|PMID:17143582 20081029 RGD 12879881 Cm101 Cardiac mass QTL 101 qtl MP:0020205 abnormal heart right ventricle weight IAGP N RGD:1599557|PMID:17143582 20170428 RGD 12879882 Am8 Aortic mass QTL 8 qtl MP:0002845 abnormal aortic weight IAGP N RGD:1599557|PMID:17143582 20081029 RGD 12879883 Kidm65 Kidney mass QTL 65 qtl MP:0002707 abnormal kidney weight IAGP N RGD:1599557|PMID:17143582 20081029 RGD 12880021 SD-Apoeem1Sage strain MP:0000272 abnormal aorta morphology IMP N RGD:150520219|PMID:29166645 20211108 RGD 12880021 SD-Apoeem1Sage strain MP:0002842 increased systemic arterial blood pressure IMP N RGD:150520219|PMID:29166645 20211108 RGD 12880022 Apoeem1Sage apolipoprotein E; endonuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0000272 abnormal aorta morphology IMP N RGD:150520219|PMID:29166645 20211111 RGD 12880022 Apoeem1Sage apolipoprotein E; endonuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0002842 increased systemic arterial blood pressure IMP N RGD:150520219|PMID:29166645 20211111 RGD 12880023 Bw184 Body weight QTL 184 qtl MP:0001259 abnormal body weight IAGP N RGD:1599557|PMID:17143582 20170509 RGD 12880025 Cm102 Cardiac mass QTL 102 qtl MP:0004857 abnormal heart weight IAGP N RGD:1599557|PMID:17143582 20081029 RGD 12880028 Cm103 Cardiac mass QTL 103 qtl MP:0020204 abnormal heart left ventricle weight IAGP N RGD:1599557|PMID:17143582 20080418 RGD 12880032 Dmdem1Ang dystrophin; TALEN-induced mutant1, Ang gene MP:0000747 muscle weakness IMP N RGD:12880034|PMID:25310701 20170502 RGD 12880032 Dmdem1Ang dystrophin; TALEN-induced mutant1, Ang gene MP:0001258 decreased body length IMP N RGD:12880034|PMID:25310701 20170502 RGD 12880032 Dmdem1Ang dystrophin; TALEN-induced mutant1, Ang gene MP:0001262 decreased body weight IMP N RGD:12880034|PMID:25310701 20170502 RGD 12880032 Dmdem1Ang dystrophin; TALEN-induced mutant1, Ang gene MP:0001402 decreased locomotor activity IMP N RGD:12880034|PMID:25310701 20170502 RGD 12880032 Dmdem1Ang dystrophin; TALEN-induced mutant1, Ang gene MP:0002834 decreased heart weight IMP N RGD:12880034|PMID:25310701 20170502 RGD 12880032 Dmdem1Ang dystrophin; TALEN-induced mutant1, Ang gene MP:0006086 decreased body mass index IMP N RGD:12880034|PMID:25310701 20170502 RGD 12880032 Dmdem1Ang dystrophin; TALEN-induced mutant1, Ang gene MP:0009402 decreased skeletal muscle fiber diameter IMP N RGD:12880034|PMID:25310701 20170502 RGD 12880032 Dmdem1Ang dystrophin; TALEN-induced mutant1, Ang gene MP:0009428 decreased tibialis anterior weight IMP N RGD:12880034|PMID:25310701 20170502 RGD 12880032 Dmdem1Ang dystrophin; TALEN-induced mutant1, Ang gene MP:0010090 increased circulating creatine kinase level IMP N RGD:12880034|PMID:25310701 20170502 RGD 12880032 Dmdem1Ang dystrophin; TALEN-induced mutant1, Ang gene MP:0011925 abnormal heart echocardiography feature IMP N RGD:12880034|PMID:25310701 20170502 RGD 12880037 SD-Dmdem1Ang strain MP:0000747 muscle weakness IMP N RGD:12880034|PMID:25310701 20170502 RGD 12880037 SD-Dmdem1Ang strain MP:0001258 decreased body length IMP N RGD:12880034|PMID:25310701 20170502 RGD 12880037 SD-Dmdem1Ang strain MP:0001262 decreased body weight IMP N RGD:12880034|PMID:25310701 20170502 RGD 12880037 SD-Dmdem1Ang strain MP:0001402 decreased locomotor activity IMP N RGD:12880034|PMID:25310701 20170502 RGD 12880037 SD-Dmdem1Ang strain MP:0002834 decreased heart weight IMP N RGD:12880034|PMID:25310701 20170502 RGD 12880037 SD-Dmdem1Ang strain MP:0006086 decreased body mass index IMP N RGD:12880034|PMID:25310701 20170502 RGD 12880037 SD-Dmdem1Ang strain MP:0009402 decreased skeletal muscle fiber diameter IMP N RGD:12880034|PMID:25310701 20170502 RGD 12880037 SD-Dmdem1Ang strain MP:0009428 decreased tibialis anterior weight IMP N RGD:12880034|PMID:25310701 20170502 RGD 12880037 SD-Dmdem1Ang strain MP:0010090 increased circulating creatine kinase level IMP N RGD:12880034|PMID:25310701 20170502 RGD 12880037 SD-Dmdem1Ang strain MP:0011925 abnormal heart echocardiography feature IMP N RGD:12880034|PMID:25310701 20170502 RGD 12880044 Am9 Aortic mass QTL 9 qtl MP:0002845 abnormal aortic weight IAGP N RGD:1599557|PMID:17143582 20081029 RGD 12880050 Am10 Aortic mass QTL 10 qtl MP:0002845 abnormal aortic weight IAGP N RGD:1599557|PMID:17143582 20081029 RGD 12880053 Cm104 Cardiac mass QTL 104 qtl MP:0020205 abnormal heart right ventricle weight IAGP N RGD:1599557|PMID:17143582 20081029 RGD 12880055 Am11 Aortic mass QTL 11 qtl MP:0002845 abnormal aortic weight IAGP N RGD:1599557|PMID:17143582 20081029 RGD 12880368 Bw187 Body weight QTL 187 qtl MP:0001259 abnormal body weight IAGP N RGD:1599557|PMID:17143582 20081029 RGD 12880370 Cm105 Cardiac mass QTL 105 qtl MP:0004857 abnormal heart weight IAGP N RGD:1599557|PMID:17143582 20081029 RGD 12880371 Cm106 Cardiac mass QTL 106 qtl MP:0020204 abnormal heart left ventricle weight IAGP N RGD:1599557|PMID:17143582 20170503 RGD 12880372 Am12 Aortic mass QTL 12 qtl MP:0002845 abnormal aortic weight IAGP N RGD:1599557|PMID:17143582 20170503 RGD 12880375 Kidm66 Kidney mass QTL 66 qtl MP:0002707 abnormal kidney weight IAGP N RGD:1599557|PMID:17143582 20081029 RGD 12880380 Gh1sdr gene MP:0005136 decreased growth hormone level IAGP N RGD:1578506|PMID:2152867 20170504 RGD 12880380 Gh1sdr gene MP:0005138 decreased prolactin level IAGP N RGD:1578506|PMID:2152867 20170504 RGD 12880382 Cacna1agry calcium voltage-gated channel subunit alpha1 A; groggy mutant gene MP:0003218 decreased spike-wave discharge type I IAGP N RGD:1598976|PMID:17196942 20170504 RGD 12880383 Kcna1Adms potassium voltage-gated channel subfamily A member 1;autosomal dominant myokymia and seizures gene MP:0000947 convulsive seizures IAGP N RGD:10047237|PMID:22206926 20170504 RGD 12880383 Kcna1Adms potassium voltage-gated channel subfamily A member 1;autosomal dominant myokymia and seizures gene MP:0009358 environmentally induced seizures IAGP N RGD:10047237|PMID:22206926 20170504 RGD 12880384 Cm107 Cardiac mass QTL 107 qtl MP:0004857 abnormal heart weight IAGP N RGD:1599557|PMID:17143582 20170509 RGD 12880385 Cm108 Cardiac mass QTL 108 qtl MP:0020204 abnormal heart left ventricle weight IAGP N RGD:1599557|PMID:17143582 20170509 RGD 12880395 Cm109 Cardiac mass QTL 109 qtl MP:0020205 abnormal heart right ventricle weight IAGP N RGD:1599557|PMID:17143582 20170509 RGD 12880396 Am13 Aortic mass QTL 13 qtl MP:0002845 abnormal aortic weight IAGP N RGD:1599557|PMID:17143582 20170509 RGD 12880398 Kidm67 Kidney mass QTL 67 qtl MP:0002707 abnormal kidney weight IAGP N RGD:1599557|PMID:17143582 20170509 RGD 12880435 Ghsrem1Ottc growth hormone secretagogue receptor;CRISPR induced mutant 1, Ottc gene MP:0000005 increased brown adipose tissue amount IMP N RGD:13825258|PMID:29453460 20181204 RGD 12880435 Ghsrem1Ottc growth hormone secretagogue receptor;CRISPR induced mutant 1, Ottc gene MP:0001262 decreased body weight IMP N RGD:13825258|PMID:29453460 20181204 RGD 12880435 Ghsrem1Ottc growth hormone secretagogue receptor;CRISPR induced mutant 1, Ottc gene MP:0011940 decreased food intake IMP N RGD:13825258|PMID:29453460 20181204 RGD 12880435 Ghsrem1Ottc growth hormone secretagogue receptor;CRISPR induced mutant 1, Ottc gene MP:0012042 low alcohol preference IMP N RGD:13825259|PMID:30456835 20181204 RGD 12902614 SS.LEW-(D10M11Mit119-D10Rat27)/Ayd strain MP:0002843 decreased systemic arterial blood pressure IAGP N RGD:704345|PMID:12939233 20201022 RGD compared to Dahl SS 12902615 Bw185 Body weight QTL 185 qtl MP:0001259 abnormal body weight IAGP N RGD:1599557|PMID:17143582 20170509 RGD 12902621 SD-Bdnfem1Sage+/- strain MP:0001260 increased body weight IMP N RGD:38501054|PMID:23583595 20200819 RGD compared to WT 12902621 SD-Bdnfem1Sage+/- strain MP:0009712 impaired conditioned place preference behavior IMP N RGD:38501054|PMID:23583595 20210216 RGD compared to WT 12902621 SD-Bdnfem1Sage+/- strain MP:0012342 high preference for an addictive substance ameliorates IMP N RGD:38501054|PMID:23583595 20200819 RGD WT compared to heterozygous rats 12902622 Bdnfem1Sage brain-derived neurotrophic factor; ZFN induced mutant 1, Sage gene MP:0001260 increased body weight IMP N RGD:38501054|PMID:23583595 20201210 RGD compared to WT 12902622 Bdnfem1Sage brain-derived neurotrophic factor; ZFN induced mutant 1, Sage gene MP:0001260 increased body weight severity IMP N RGD:38501054|PMID:23583595 20200820 RGD 12902622 Bdnfem1Sage brain-derived neurotrophic factor; ZFN induced mutant 1, Sage gene MP:0001988 cocaine preference severity IMP N RGD:38501054|PMID:23583595 20200820 RGD 12902622 Bdnfem1Sage brain-derived neurotrophic factor; ZFN induced mutant 1, Sage gene MP:0002555 addiction severity IMP N RGD:38501054|PMID:23583595 20200820 RGD 12902622 Bdnfem1Sage brain-derived neurotrophic factor; ZFN induced mutant 1, Sage gene MP:0009712 impaired conditioned place preference behavior IMP N RGD:38501054|PMID:23583595 20210218 RGD compared to WT 12902622 Bdnfem1Sage brain-derived neurotrophic factor; ZFN induced mutant 1, Sage gene MP:0012342 high preference for an addictive substance ameliorates IMP N RGD:38501054|PMID:23583595 20210225 RGD WT compared to heterozygous rats 12902625 SD-Nr1i2em1Sage strain MP:0001260 increased body weight IMP N RGD:13432137|PMID:28716828 20170920 RGD 12902625 SD-Nr1i2em1Sage strain MP:0005319 abnormal enzyme/coenzyme level induced IMP XCO:0000372 N RGD:127285625|PMID:27856527 20210630 RGD Por 12902625 SD-Nr1i2em1Sage strain MP:0020169 increased thyroid gland weight induced IMP XCO:0000845 N RGD:38549342|PMID:29548889 20210629 RGD 12902626 Nr1i2em1Sage nuclear receptor subfamily 1, group I, member 2; ZFN induced mutant1, Sage gene MP:0001260 increased body weight IMP N RGD:13432137|PMID:28716828 20201210 RGD 12902626 Nr1i2em1Sage nuclear receptor subfamily 1, group I, member 2; ZFN induced mutant1, Sage gene MP:0005319 abnormal enzyme/coenzyme level IMP N RGD:127285625|PMID:27856527 20210701 RGD Por 12902626 Nr1i2em1Sage nuclear receptor subfamily 1, group I, member 2; ZFN induced mutant1, Sage gene MP:0020169 increased thyroid gland weight IMP N RGD:38549342|PMID:29548889 20210701 RGD 12903245 Cm110 Cardiac mass QTL 110 qtl MP:0004857 abnormal heart weight IAGP N RGD:1599557|PMID:17143582 20170510 RGD 12903246 Cm111 Cardiac mass QTL 111 qtl MP:0020204 abnormal heart left ventricle weight IAGP N RGD:1599557|PMID:17143582 20170510 RGD 12903247 Cm112 Cardiac mass QTL 112 qtl MP:0020205 abnormal heart right ventricle weight IAGP N RGD:1599557|PMID:17143582 20170510 RGD 12903248 Am14 Aortic mass QTL 14 qtl MP:0002845 abnormal aortic weight IAGP N RGD:1599557|PMID:17143582 20170510 RGD 12903249 Kidm68 Kidney mass QTL 68 qtl MP:0002707 abnormal kidney weight IAGP N RGD:1599557|PMID:17143582 20170510 RGD 12903252 Cm113 Cardiac mass QTL 113 qtl MP:0020204 abnormal heart left ventricle weight IAGP N RGD:1599557|PMID:17143582 20170510 RGD 12903266 Cm114 Cardiac mass QTL 114 qtl MP:0020205 abnormal heart right ventricle weight IAGP N RGD:1599557|PMID:17143582 20170510 RGD 12903267 SD-Nr1i3em1Sage strain MP:0001262 decreased body weight IMP N RGD:13432137|PMID:28716828 20170920 RGD male rats 12903268 Nr1i3em1Sage nuclear receptor subfamily 1, group I, member 3; ZFN induced mutant 1,SAGE gene MP:0001262 decreased body weight IMP N RGD:13432137|PMID:28716828 20201210 RGD male rats 12903269 Am15 Aortic mass QTL 15 qtl MP:0002845 abnormal aortic weight IAGP N RGD:1599557|PMID:17143582 20170510 RGD 12903270 SD-Nr1i2em1Sage Nr1i3em1Sage strain MP:0001262 decreased body weight IMP N RGD:13432137|PMID:28716828 20170920 RGD male rats 12903278 Am16 Aortic mass QTL 16 qtl MP:0002845 abnormal aortic weight IAGP N RGD:1599557|PMID:17143582 20170510 RGD 12903279 Cm115 Cardiac mass QTL 115 qtl MP:0004857 abnormal heart weight IAGP N RGD:1599557|PMID:17143582 20170510 RGD 12903281 Cm116 Cardiac mass QTL 116 qtl MP:0020204 abnormal heart left ventricle weight IAGP N RGD:1599557|PMID:17143582 20170510 RGD 12903952 Cm117 Cardiac mass QTL 117 qtl MP:0020205 abnormal heart right ventricle weight IAGP N RGD:1599557|PMID:17143582 20170511 RGD 12903954 Bw186 Body weight QTL 186 qtl MP:0001259 abnormal body weight IAGP N RGD:1599557|PMID:17143582 20170511 RGD 12903955 Kidm69 Kidney mass QTL 69 qtl MP:0002707 abnormal kidney weight IAGP N RGD:1599557|PMID:17143582 20170511 RGD 12903978 Cm118 Cardiac mass QTL 118 qtl MP:0004857 abnormal heart weight IAGP N RGD:1599557|PMID:17143582 20170512 RGD 12903979 Cm119 Cardiac mass QTL 119 qtl MP:0020204 abnormal heart left ventricle weight IAGP N RGD:1599557|PMID:17143582 20170512 RGD 12903980 Cm120 Cardiac mass QTL 120 qtl MP:0020205 abnormal heart right ventricle weight IAGP N RGD:1599557|PMID:17143582 20170512 RGD 12903981 Am17 Aortic mass QTL 17 qtl MP:0002845 abnormal aortic weight IAGP N RGD:1599557|PMID:17143582 20170512 RGD 12903982 Kidm70 Kidney mass QTL 70 qtl MP:0002707 abnormal kidney weight IAGP N RGD:1599557|PMID:17143582 20170512 RGD 12904057 SD-Abcb1aem1Sage -/- SD-Abcb1aem1-/Abcb1aem1- strain MP:0008875 abnormal xenobiotic pharmacokinetics IMP N RGD:14392811|PMID:22711747 20210916 RGD compared to wildtype controls, CHEBI:45863|CHEBI:6532|CHEBI:51619 12904057 SD-Abcb1aem1Sage -/- SD-Abcb1aem1-/Abcb1aem1- strain MP:0008875 abnormal xenobiotic pharmacokinetics IMP N RGD:150429695|PMID:24398459 20210916 RGD compared to wildtype control, CHEBI:6532|CHEBI:4551|CHEBI:40050|CHEBI:28593|CHEBI:8364|CHEBI:45783|CHEBI:9948|CHEBI:3723 12904058 Abcb1aem1Sage ATP binding cassette subfamily B member 1A; ZFN induced mutant 1, Sage gene MP:0008875 abnormal xenobiotic pharmacokinetics IMP N RGD:14392811|PMID:22711747 20210923 RGD compared to wildtype controls, CHEBI:45863|CHEBI:6532|CHEBI:51619 12904058 Abcb1aem1Sage ATP binding cassette subfamily B member 1A; ZFN induced mutant 1, Sage gene MP:0008875 abnormal xenobiotic pharmacokinetics IMP N RGD:150429695|PMID:24398459 20210923 RGD compared to wildtype control, CHEBI:6532|CHEBI:4551|CHEBI:40050|CHEBI:28593|CHEBI:8364|CHEBI:45783|CHEBI:9948|CHEBI:3723 12904063 SD-Abcg2em1Sage strain MP:0008875 abnormal xenobiotic pharmacokinetics IMP N RGD:14392811|PMID:22711747 20210916 RGD compared to wildtype controls, CHEBI:9334|CHEBI:51619 12904064 Abcg2em1Sage ATP-binding cassette, subfamily G (WHITE), member 2; ZFN induced mutatn 1, Sage gene MP:0008875 abnormal xenobiotic pharmacokinetics IMP N RGD:14392811|PMID:22711747 20210923 RGD compared to wildtype controls, CHEBI:9334|CHEBI:51619 12904067 Cm122 Cardiac mass QTL 122 qtl MP:0004857 abnormal heart weight IAGP N RGD:1599557|PMID:17143582 20170516 RGD 12904069 Cm123 Cardiac mass QTL 123 qtl MP:0020204 abnormal heart left ventricle weight IAGP N RGD:1599557|PMID:17143582 20170516 RGD 12904070 Cm124 Cardiac mass QTL 124 qtl MP:0020205 abnormal heart right ventricle weight IAGP N RGD:1599557|PMID:17143582 20170516 RGD 12904071 Am18 Aortic mass QTL 18 qtl MP:0002845 abnormal aortic weight IAGP N RGD:1599557|PMID:17143582 20170516 RGD 12904073 Kidm71 Kidney mass QTL 71 qtl MP:0002707 abnormal kidney weight IAGP N RGD:1599557|PMID:17143582 20170516 RGD 12904668 Bw188 Body weight QTL 188 qtl MP:0001259 abnormal body weight IAGP N RGD:1599557|PMID:17143582 20170517 RGD 12904669 Cm125 Cardiac mass QTL 125 qtl MP:0004857 abnormal heart weight IAGP N RGD:1599557|PMID:17143582 20170517 RGD 12904670 Cm126 Cardiac mass QTL 126 qtl MP:0020204 abnormal heart left ventricle weight IAGP N RGD:1599557|PMID:17143582 20170517 RGD 12904673 Cm127 Cardiac mass QTL 127 qtl MP:0020205 abnormal heart right ventricle weight IAGP N RGD:1599557|PMID:17143582 20170517 RGD 12904675 Am19 Aortic mass QTL 19 qtl MP:0002845 abnormal aortic weight IAGP N RGD:1599557|PMID:17143582 20170517 RGD 12904677 Kidm72 Kidney mass QTL 72 qtl MP:0002707 abnormal kidney weight IAGP N RGD:1599557|PMID:17143582 20170517 RGD 12904679 WKY-Cyp2j4em1Sage/Tja strain MP:0000008 increased white adipose tissue amount induces IMP XCO:0000914 N RGD:150520032|PMID:29656108 20211101 RGD compared to wild type and standard diet 12904679 WKY-Cyp2j4em1Sage/Tja strain MP:0001260 increased body weight induces IMP XCO:0000914 N RGD:150520032|PMID:29656108 20211101 RGD compared to standard diet 12904679 WKY-Cyp2j4em1Sage/Tja strain MP:0001260 increased body weight onset IMP N RGD:150520032|PMID:29656108 20211101 RGD compared to wild type 12904679 WKY-Cyp2j4em1Sage/Tja strain MP:0002079 increased circulating insulin level IMP N RGD:150520032|PMID:29656108 20211101 RGD compared to wild type 12904679 WKY-Cyp2j4em1Sage/Tja strain MP:0005559 increased circulating glucose level induces IMP XCO:0000914 N RGD:150520032|PMID:29656108 20211101 RGD compared to wild type 12904679 WKY-Cyp2j4em1Sage/Tja strain MP:0006094 increased fat cell size induces IMP XCO:0000914 N RGD:150520032|PMID:29656108 20211101 RGD compared to standard diet and wild type 12904679 WKY-Cyp2j4em1Sage/Tja strain MP:0008752 abnormal tumor necrosis factor level induces IMP XCO:0000914 N RGD:150520032|PMID:29656108 20211102 RGD compared to standard diet 12904679 WKY-Cyp2j4em1Sage/Tja strain MP:0009355 increased liver triglyceride level induces IMP XCO:0000914 N RGD:150520032|PMID:29656108 20211101 RGD compared to wild type 12904679 WKY-Cyp2j4em1Sage/Tja strain MP:0013258 abnormal extracellular matrix morphology induces IMP XCO:0000914 N RGD:150520032|PMID:29656108 20211102 RGD compared to standard diet 12904679 WKY-Cyp2j4em1Sage/Tja strain MP:0020253 increased collagen level induces IMP XCO:0000914 N RGD:150520032|PMID:29656108 20211102 RGD compared to wild type 12904680 Bw189 Body weight QTL 189 qtl MP:0001259 abnormal body weight IAGP N RGD:1599557|PMID:17143582 20170517 RGD 12904681 Cyp2j4em1Sage cytochrome P450, family 2, subfamily j, polypeptide 4, ZFN induced mutant 1, Sage gene MP:0000008 increased white adipose tissue amount induces IMP XCO:0000914 N RGD:150520032|PMID:29656108 20211104 RGD compared to wild type and standard diet 12904681 Cyp2j4em1Sage cytochrome P450, family 2, subfamily j, polypeptide 4, ZFN induced mutant 1, Sage gene MP:0001260 increased body weight induces IMP XCO:0000914 N RGD:150520032|PMID:29656108 20211104 RGD compared to standard diet 12904681 Cyp2j4em1Sage cytochrome P450, family 2, subfamily j, polypeptide 4, ZFN induced mutant 1, Sage gene MP:0001260 increased body weight onset IMP N RGD:150520032|PMID:29656108 20211104 RGD compared to wild type 12904681 Cyp2j4em1Sage cytochrome P450, family 2, subfamily j, polypeptide 4, ZFN induced mutant 1, Sage gene MP:0002079 increased circulating insulin level IMP N RGD:150520032|PMID:29656108 20211104 RGD compared to wild type 12904681 Cyp2j4em1Sage cytochrome P450, family 2, subfamily j, polypeptide 4, ZFN induced mutant 1, Sage gene MP:0005559 increased circulating glucose level induces IMP XCO:0000914 N RGD:150520032|PMID:29656108 20211104 RGD compared to wild type 12904681 Cyp2j4em1Sage cytochrome P450, family 2, subfamily j, polypeptide 4, ZFN induced mutant 1, Sage gene MP:0006094 increased fat cell size induces IMP XCO:0000914 N RGD:150520032|PMID:29656108 20211104 RGD compared to standard diet and wild type 12904681 Cyp2j4em1Sage cytochrome P450, family 2, subfamily j, polypeptide 4, ZFN induced mutant 1, Sage gene MP:0008752 abnormal tumor necrosis factor level induces IMP XCO:0000914 N RGD:150520032|PMID:29656108 20211104 RGD compared to standard diet 12904681 Cyp2j4em1Sage cytochrome P450, family 2, subfamily j, polypeptide 4, ZFN induced mutant 1, Sage gene MP:0009355 increased liver triglyceride level induces IMP XCO:0000914 N RGD:150520032|PMID:29656108 20211104 RGD compared to wild type 12904681 Cyp2j4em1Sage cytochrome P450, family 2, subfamily j, polypeptide 4, ZFN induced mutant 1, Sage gene MP:0013258 abnormal extracellular matrix morphology induces IMP XCO:0000914 N RGD:150520032|PMID:29656108 20211104 RGD compared to standard diet 12904681 Cyp2j4em1Sage cytochrome P450, family 2, subfamily j, polypeptide 4, ZFN induced mutant 1, Sage gene MP:0020253 increased collagen level induces IMP XCO:0000914 N RGD:150520032|PMID:29656108 20211104 RGD compared to wild type 12904685 SD-Abcc2em1Sage strain MP:0008875 abnormal xenobiotic pharmacokinetics IMP N RGD:14392811|PMID:22711747 20210916 RGD compared to wildtype controls, CHEBI:9334|CHEBI:45863|CHEBI:51619 12904687 Abcc2em1Sage ATP binding cassette subfamily C member 2; ZFN induced mutant 1, Sage gene MP:0008875 abnormal xenobiotic pharmacokinetics IMP N RGD:14392811|PMID:22711747 20210923 RGD compared to wildtype controls, CHEBI:9334|CHEBI:45863|CHEBI:51619 12904689 Cm128 Cardiac mass QTL 128 qtl MP:0004857 abnormal heart weight IAGP N RGD:1599557|PMID:17143582 20081029 RGD 12904690 Cm129 Cardiac mass QTL 129 qtl MP:0020204 abnormal heart left ventricle weight IAGP N RGD:1599557|PMID:17143582 20081029 RGD 12904691 Cm130 Cardiac mass QTL 130 qtl MP:0020205 abnormal heart right ventricle weight IAGP N RGD:1599557|PMID:17143582 20170517 RGD 12904693 Am20 Aortic mass QTL 20 qtl MP:0002845 abnormal aortic weight IAGP N RGD:1599557|PMID:17143582 20170517 RGD 12904695 Kidm73 Kidney mass QTL 73 qtl MP:0002707 abnormal kidney weight IAGP N RGD:1599557|PMID:17143582 20170517 RGD 12904714 Cm131 Cardiac mass QTL 131 qtl MP:0020204 abnormal heart left ventricle weight IAGP N RGD:1599557|PMID:17143582 20170518 RGD 12904715 Cm132 Cardiac mass QTL 132 qtl MP:0020205 abnormal heart right ventricle weight IAGP N RGD:1599557|PMID:17143582 20170518 RGD 12904716 Am21 Aortic mass QTL 21 qtl MP:0002845 abnormal aortic weight IAGP N RGD:1599557|PMID:17143582 20170518 RGD 12904736 Cm121 Cardiac mass QTL 121 qtl MP:0004857 abnormal heart weight IAGP N RGD:1599557|PMID:17143582 20170519 RGD 12904897 SD-Tp53em1Sage strain MP:0001153 small seminiferous tubules IMP N RGD:14995504|PMID:28834365 20210928 RGD compared to SD 12904897 SD-Tp53em1Sage strain MP:0001154 seminiferous tubule degeneration IMP N RGD:14995504|PMID:28834365 20210928 RGD compared to SD 12904897 SD-Tp53em1Sage strain MP:0001262 decreased body weight IMP N RGD:14995504|PMID:28834365 20210928 RGD compared to SD 12904897 SD-Tp53em1Sage strain MP:0002020 increased tumor incidence IMP N RGD:11075077|PMID:22917926 20170920 RGD 12904897 SD-Tp53em1Sage strain MP:0004227 increased cellular sensitivity to ionizing radiation IMP N RGD:14995504|PMID:28834365 20210928 RGD compared to SD 12904897 SD-Tp53em1Sage strain MP:0004852 decreased testis weight IMP N RGD:14995504|PMID:28834365 20210928 RGD compared to SD 12904897 SD-Tp53em1Sage strain MP:0004930 small epididymis IMP N RGD:14995504|PMID:28834365 20210928 RGD compared to SD 12904897 SD-Tp53em1Sage strain MP:0020851 abnormal vacuole morphology IMP N RGD:14995504|PMID:28834365 20210928 RGD seminiferous tubule; compared to SD 12904898 Tp53em1Sage tumor protein p53; ZFN induced mutant 1, Sage gene MP:0001153 small seminiferous tubules IMP N RGD:14995504|PMID:28834365 20210930 RGD compared to SD 12904898 Tp53em1Sage tumor protein p53; ZFN induced mutant 1, Sage gene MP:0001154 seminiferous tubule degeneration IMP N RGD:14995504|PMID:28834365 20210930 RGD compared to SD 12904898 Tp53em1Sage tumor protein p53; ZFN induced mutant 1, Sage gene MP:0001262 decreased body weight IMP N RGD:14995504|PMID:28834365 20210930 RGD compared to SD 12904898 Tp53em1Sage tumor protein p53; ZFN induced mutant 1, Sage gene MP:0002020 increased tumor incidence IMP N RGD:11075077|PMID:22917926 20170920 RGD 12904898 Tp53em1Sage tumor protein p53; ZFN induced mutant 1, Sage gene MP:0004227 increased cellular sensitivity to ionizing radiation IMP N RGD:14995504|PMID:28834365 20210930 RGD compared to SD 12904898 Tp53em1Sage tumor protein p53; ZFN induced mutant 1, Sage gene MP:0004852 decreased testis weight IMP N RGD:14995504|PMID:28834365 20210930 RGD compared to SD 12904898 Tp53em1Sage tumor protein p53; ZFN induced mutant 1, Sage gene MP:0004930 small epididymis IMP N RGD:14995504|PMID:28834365 20210930 RGD compared to SD 12904898 Tp53em1Sage tumor protein p53; ZFN induced mutant 1, Sage gene MP:0020851 abnormal vacuole morphology IMP N RGD:14995504|PMID:28834365 20210930 RGD seminiferous tubule; compared to SD 12904907 SD-Prkdcem1Sage strain MP:0001262 decreased body weight IMP N RGD:39938998|PMID:30485360 20211111 RGD 12904907 SD-Prkdcem1Sage strain MP:0004953 decreased spleen weight IMP N RGD:39938998|PMID:30485360 20211111 RGD 12904907 SD-Prkdcem1Sage strain MP:0009763 increased susceptibility to induced morbidity/mortality IMP N RGD:39938998|PMID:30485360 20211111 RGD 12904907 SD-Prkdcem1Sage strain MP:0012555 decreased cell death IMP N RGD:39938998|PMID:30485360 20211111 RGD 12904908 SD-Ldlrem1Sage strain MP:0001260 increased body weight IMP N RGD:12910100|PMID:28469073 20170608 RGD 12904908 SD-Ldlrem1Sage strain MP:0001554 increased circulating free fatty acids level IMP N RGD:12910100|PMID:28469073 20170608 RGD 12904908 SD-Ldlrem1Sage strain MP:0005293 impaired glucose tolerance IMP N RGD:12910100|PMID:28469073 20170608 RGD 12904908 SD-Ldlrem1Sage strain MP:0005669 increased circulating leptin level IMP N RGD:12910100|PMID:28469073 20170608 RGD 12904908 SD-Ldlrem1Sage strain MP:0009355 increased liver triglyceride level IMP N RGD:12910100|PMID:28469073 20170608 RGD 12904908 SD-Ldlrem1Sage strain MP:0010027 increased liver cholesterol level IMP N RGD:12910100|PMID:28469073 20170608 RGD 12904909 Ldlrem1Sage low density lipoprotein receptor; ZFN induced mutant 1, Sage gene MP:0001260 increased body weight IMP N RGD:12910100|PMID:28469073 20170608 RGD 12904909 Ldlrem1Sage low density lipoprotein receptor; ZFN induced mutant 1, Sage gene MP:0001554 increased circulating free fatty acids level IMP N RGD:12910100|PMID:28469073 20170608 RGD 12904909 Ldlrem1Sage low density lipoprotein receptor; ZFN induced mutant 1, Sage gene MP:0005293 impaired glucose tolerance IMP N RGD:12910100|PMID:28469073 20170608 RGD 12904909 Ldlrem1Sage low density lipoprotein receptor; ZFN induced mutant 1, Sage gene MP:0005669 increased circulating leptin level IMP N RGD:12910100|PMID:28469073 20170608 RGD 12904909 Ldlrem1Sage low density lipoprotein receptor; ZFN induced mutant 1, Sage gene MP:0009355 increased liver triglyceride level IMP N RGD:12910100|PMID:28469073 20170608 RGD 12904909 Ldlrem1Sage low density lipoprotein receptor; ZFN induced mutant 1, Sage gene MP:0010027 increased liver cholesterol level IMP N RGD:12910100|PMID:28469073 20170608 RGD 12904912 SD-Lepem1Sage-/- strain MP:0000182 increased circulating LDL cholesterol level IMP N RGD:12904911|PMID:22948215 20170526 RGD 12904912 SD-Lepem1Sage-/- strain MP:0001556 increased circulating HDL cholesterol level IMP N RGD:12904911|PMID:22948215 20170526 RGD 12904912 SD-Lepem1Sage-/- strain MP:0005018 decreased T cell number IMP N RGD:12904911|PMID:22948215 20170526 RGD 12904912 SD-Lepem1Sage-/- strain MP:0005559 increased circulating glucose level IMP N RGD:12904911|PMID:22948215 20170526 RGD 12904912 SD-Lepem1Sage-/- strain MP:0008750 abnormal interferon level IMP N RGD:12904911|PMID:22948215 20170526 RGD 12904927 Lepem1Sage leptin; zinc finger nuclease induced mutant1, Sage gene MP:0000182 increased circulating LDL cholesterol level IMP N RGD:12904911|PMID:22948215 20170526 RGD 12904927 Lepem1Sage leptin; zinc finger nuclease induced mutant1, Sage gene MP:0001260 increased body weight IMP N RGD:12904911|PMID:22948215 20201210 RGD 12904927 Lepem1Sage leptin; zinc finger nuclease induced mutant1, Sage gene MP:0001556 increased circulating HDL cholesterol level IMP N RGD:12904911|PMID:22948215 20170526 RGD 12904927 Lepem1Sage leptin; zinc finger nuclease induced mutant1, Sage gene MP:0005018 decreased T cell number IMP N RGD:12904911|PMID:22948215 20170526 RGD 12904927 Lepem1Sage leptin; zinc finger nuclease induced mutant1, Sage gene MP:0005559 increased circulating glucose level IMP N RGD:12904911|PMID:22948215 20170526 RGD 12904927 Lepem1Sage leptin; zinc finger nuclease induced mutant1, Sage gene MP:0008750 abnormal interferon level IMP N RGD:12904911|PMID:22948215 20170526 RGD 12907568 WI-Abcb1aem2Sage strain MP:0001666 abnormal intestinal absorption IMP N RGD:8657330|PMID:22049154 20170607 RGD 12907568 WI-Abcb1aem2Sage strain MP:0005167 abnormal blood-brain barrier function IMP N RGD:8657330|PMID:22049154 20170607 RGD 12907569 Abcb1aem2Sage ATP binding cassette subfamily B member 1A; ZFN induced mutant 2, Sage gene MP:0001666 abnormal intestinal absorption IMP N RGD:8657330|PMID:22049154 20170607 RGD 12907569 Abcb1aem2Sage ATP binding cassette subfamily B member 1A; ZFN induced mutant 2, Sage gene MP:0005167 abnormal blood-brain barrier function IMP N RGD:8657330|PMID:22049154 20170607 RGD 12910101 SD-Ldlrem1 strain MP:0010359 increased liver free fatty acids level IMP N RGD:12910104|PMID:27378433 20170608 RGD 12910102 Ldlrem1 low density lipoprotein receptor; ZFN induced mutant 1 gene MP:0010359 increased liver free fatty acids level IMP N RGD:12910104|PMID:27378433 20170608 RGD 12910127 SD-Tg(Th-Ghsros) strain MP:0001258 decreased body length IMP N RGD:625699|PMID:12045256 20170613 RGD 12910127 SD-Tg(Th-Ghsros) strain MP:0001262 decreased body weight IMP N RGD:625699|PMID:12045256 20170613 RGD 12910127 SD-Tg(Th-Ghsros) strain MP:0009289 decreased epididymal fat pad weight IMP N RGD:625699|PMID:12045256 20170613 RGD 12910127 SD-Tg(Th-Ghsros) strain MP:0009299 decreased mesenteric fat pad weight IMP N RGD:625699|PMID:12045256 20170613 RGD 12910127 SD-Tg(Th-Ghsros) strain MP:0009305 decreased retroperitoneal fat pad weight IMP N RGD:625699|PMID:12045256 20170613 RGD 12910127 SD-Tg(Th-Ghsros) strain MP:0011940 decreased food intake IMP N RGD:625699|PMID:12045256 20170613 RGD 12910491 Il15em1Soar interleukin 15; ZFN induced mutant 1, Soar gene MP:0004953 decreased spleen weight IMP N RGD:12910490|PMID:28395334 20170616 RGD 12910491 Il15em1Soar interleukin 15; ZFN induced mutant 1, Soar gene MP:0008045 decreased NK cell number IMP N RGD:12910490|PMID:28395334 20170616 RGD 12910491 Il15em1Soar interleukin 15; ZFN induced mutant 1, Soar gene MP:0008957 abnormal placenta junctional zone morphology IMP N RGD:12910490|PMID:28395334 20170616 RGD 12910491 Il15em1Soar interleukin 15; ZFN induced mutant 1, Soar gene MP:0012726 abnormal uterine spiral artery morphology IMP N RGD:12910490|PMID:28395334 20170616 RGD 12910493 LEW.1WR1-Ifnar1em1 strain MP:0004031 insulitis IMP N RGD:12910492|PMID:27999109 20170616 RGD 12910493 LEW.1WR1-Ifnar1em1 strain MP:0004804 decreased susceptibility to autoimmune diabetes induced IMP XCO:0000235 N RGD:12910492|PMID:27999109 20200127 RGD compared to LEW.1WR1/WorBrm 12910493 LEW.1WR1-Ifnar1em1 strain MP:0009791 increased susceptibility to viral infection induced morbidity/mortality induced IMP XCO:0000237 N RGD:12910492|PMID:27999109 20200127 RGD encephalomyocarditis virus induced; compared to LEW.1WR1/WorBrm 12910494 LEW.1WR1-Ifnar1em2 strain MP:0004031 insulitis IMP N RGD:12910492|PMID:27999109 20170616 RGD 12910494 LEW.1WR1-Ifnar1em2 strain MP:0004804 decreased susceptibility to autoimmune diabetes induced IMP XCO:0000235 N RGD:12910492|PMID:27999109 20200127 RGD compared to LEW.1WR1/WorBrm 12910494 LEW.1WR1-Ifnar1em2 strain MP:0009791 increased susceptibility to viral infection induced morbidity/mortality induced IMP XCO:0000237 N RGD:12910492|PMID:27999109 20200127 RGD encephalomyocarditis virus induced 12910495 Ifnar1em1 interferon alpha and beta receptor subunit 1; CRISPR/Cas9 induced mutant 1 gene MP:0004031 insulitis IMP N RGD:12910492|PMID:27999109 20170616 RGD 12910495 Ifnar1em1 interferon alpha and beta receptor subunit 1; CRISPR/Cas9 induced mutant 1 gene MP:0004804 decreased susceptibility to autoimmune diabetes IMP N RGD:12910492|PMID:27999109 20200127 RGD 12910495 Ifnar1em1 interferon alpha and beta receptor subunit 1; CRISPR/Cas9 induced mutant 1 gene MP:0009791 increased susceptibility to viral infection induced morbidity/mortality IMP N RGD:12910492|PMID:27999109 20200127 RGD 12910496 Ifnar1em2 interferon alpha and beta receptor subunit 1; CRISPR/Cas9 induced mutant 2 gene MP:0004031 insulitis IMP N RGD:12910492|PMID:27999109 20170616 RGD 12910496 Ifnar1em2 interferon alpha and beta receptor subunit 1; CRISPR/Cas9 induced mutant 2 gene MP:0004804 decreased susceptibility to autoimmune diabetes IMP N RGD:12910492|PMID:27999109 20200127 RGD 12910496 Ifnar1em2 interferon alpha and beta receptor subunit 1; CRISPR/Cas9 induced mutant 2 gene MP:0009791 increased susceptibility to viral infection induced morbidity/mortality IMP N RGD:12910492|PMID:27999109 20200127 RGD 12910500 Mmp12em1Soar matrix metallopeptidase 12; TALEN induced mutant 1,Soar gene MP:0009431 decreased fetal weight IMP N RGD:12910498|PMID:27807143 20170616 RGD 12910505 SD-Mmp12em2Soar strain MP:0001935 decreased litter size IMP N RGD:12910498|PMID:27807143 20170616 RGD 12910505 SD-Mmp12em2Soar strain MP:0009431 decreased fetal weight IMP N RGD:12910498|PMID:27807143 20170616 RGD 12910506 Mmp12em2Soar matrix metallopeptidase 12; TALEN induced mutant 2,Soar gene MP:0001935 decreased litter size IMP N RGD:12910498|PMID:27807143 20170616 RGD 12910506 Mmp12em2Soar matrix metallopeptidase 12; TALEN induced mutant 2,Soar gene MP:0009431 decreased fetal weight IMP N RGD:12910498|PMID:27807143 20170616 RGD 12910519 SD-Leprem3 strain MP:0001552 increased circulating triglyceride level IMP N RGD:12910507|PMID:27225180 20170619 RGD 12910519 SD-Leprem3 strain MP:0002941 increased circulating alanine transaminase level IMP N RGD:12910507|PMID:27225180 20170619 RGD 12910519 SD-Leprem3 strain MP:0005178 increased circulating cholesterol level IMP N RGD:12910507|PMID:27225180 20170619 RGD 12910519 SD-Leprem3 strain MP:0005293 impaired glucose tolerance IMP N RGD:12910507|PMID:27225180 20170619 RGD 12910519 SD-Leprem3 strain MP:0005343 increased circulating aspartate transaminase level IMP N RGD:12910507|PMID:27225180 20170619 RGD 12910519 SD-Leprem3 strain MP:0006094 increased fat cell size IMP N RGD:12910507|PMID:27225180 20170619 RGD 12910546 Leprem3 leptin receptor; TALEN induced mutant 3 gene MP:0001552 increased circulating triglyceride level IMP N RGD:12910507|PMID:27225180 20170619 RGD 12910546 Leprem3 leptin receptor; TALEN induced mutant 3 gene MP:0002941 increased circulating alanine transaminase level IMP N RGD:12910507|PMID:27225180 20170619 RGD 12910546 Leprem3 leptin receptor; TALEN induced mutant 3 gene MP:0005178 increased circulating cholesterol level IMP N RGD:12910507|PMID:27225180 20170619 RGD 12910546 Leprem3 leptin receptor; TALEN induced mutant 3 gene MP:0005293 impaired glucose tolerance IMP N RGD:12910507|PMID:27225180 20170619 RGD 12910546 Leprem3 leptin receptor; TALEN induced mutant 3 gene MP:0005343 increased circulating aspartate transaminase level IMP N RGD:12910507|PMID:27225180 20170619 RGD 12910546 Leprem3 leptin receptor; TALEN induced mutant 3 gene MP:0006094 increased fat cell size IMP N RGD:12910507|PMID:27225180 20170619 RGD 12910736 Esr1em1Soar estrogen receptor 1; ZFN induced mutant 1, Soar gene MP:0000628 abnormal mammary gland development IMP N RGD:8552987|PMID:24506075 20170623 RGD 12910736 Esr1em1Soar estrogen receptor 1; ZFN induced mutant 1, Soar gene MP:0001119 abnormal female reproductive system morphology IMP N RGD:8552987|PMID:24506075 20170623 RGD 12910736 Esr1em1Soar estrogen receptor 1; ZFN induced mutant 1, Soar gene MP:0001145 abnormal male reproductive system morphology IMP N RGD:8552987|PMID:24506075 20170623 RGD 12910736 Esr1em1Soar estrogen receptor 1; ZFN induced mutant 1, Soar gene MP:0001147 small testis IMP N RGD:8552987|PMID:24506075 20170623 RGD 12910736 Esr1em1Soar estrogen receptor 1; ZFN induced mutant 1, Soar gene MP:0001750 increased circulating follicle stimulating hormone level IMP N RGD:8552987|PMID:24506075 20170623 RGD 12910736 Esr1em1Soar estrogen receptor 1; ZFN induced mutant 1, Soar gene MP:0001751 increased circulating luteinizing hormone level IMP N RGD:8552987|PMID:24506075 20170623 RGD 12910736 Esr1em1Soar estrogen receptor 1; ZFN induced mutant 1, Soar gene MP:0003956 abnormal body size IMP N RGD:8552987|PMID:24506075 20170623 RGD 12910736 Esr1em1Soar estrogen receptor 1; ZFN induced mutant 1, Soar gene MP:0004852 decreased testis weight IMP N RGD:8552987|PMID:24506075 20170623 RGD 12910762 BN-KitWs strain MP:0000371 diluted coat color IMP N RGD:5133424|PMID:1912576 20170623 RGD 12910762 BN-KitWs strain MP:0000373 belly spot IMP N RGD:5133424|PMID:1912576 20170623 RGD 12910762 BN-KitWs strain MP:0001473 reduced long-term potentiation IMP N RGD:2292520|PMID:11112797 20170623 RGD 12910762 BN-KitWs strain MP:0002811 macrocytic anemia IMP N RGD:5133424|PMID:1912576 20170623 RGD 12910762 BN-KitWs strain MP:0002875 decreased erythrocyte cell number IMP N RGD:5133424|PMID:1912576 20170623 RGD 12910762 BN-KitWs strain MP:0009536 abnormal interstitial cell of Cajal morphology IMP N RGD:12910822|PMID:17322067 20170626 RGD 12910762 BN-KitWs strain MP:0011696 absent mast cells IMP N RGD:5133424|PMID:1912576 20170623 RGD 12910762 BN-KitWs strain MP:0012307 impaired spatial learning IMP N RGD:2292520|PMID:11112797 20170623 RGD 12910763 KitWs KIT proto-oncogene receptor tyrosine kinase; mutant 1 gene MP:0000371 diluted coat color IMP N RGD:5133424|PMID:1912576 20170623 RGD 12910763 KitWs KIT proto-oncogene receptor tyrosine kinase; mutant 1 gene MP:0000373 belly spot IMP N RGD:5133424|PMID:1912576 20170623 RGD 12910763 KitWs KIT proto-oncogene receptor tyrosine kinase; mutant 1 gene MP:0001473 reduced long-term potentiation IMP N RGD:2292520|PMID:11112797 20170623 RGD 12910763 KitWs KIT proto-oncogene receptor tyrosine kinase; mutant 1 gene MP:0002811 macrocytic anemia IMP N RGD:5133424|PMID:1912576 20170623 RGD 12910763 KitWs KIT proto-oncogene receptor tyrosine kinase; mutant 1 gene MP:0002875 decreased erythrocyte cell number IMP N RGD:5133424|PMID:1912576 20170623 RGD 12910763 KitWs KIT proto-oncogene receptor tyrosine kinase; mutant 1 gene MP:0009536 abnormal interstitial cell of Cajal morphology IMP N RGD:12910822|PMID:17322067 20170626 RGD 12910763 KitWs KIT proto-oncogene receptor tyrosine kinase; mutant 1 gene MP:0011696 absent mast cells IMP N RGD:5133424|PMID:1912576 20170623 RGD 12910763 KitWs KIT proto-oncogene receptor tyrosine kinase; mutant 1 gene MP:0012307 impaired spatial learning IMP N RGD:2292520|PMID:11112797 20170623 RGD 12910834 Zbtb16Lx zinc finger and BTB domain containing 16, Lx mutant gene MP:0009743 preaxial polydactyly IAGP N RGD:2312786|PMID:19191224 20170626 RGD 12910940 SD-Cdkn1bwe strain MP:0002050 increased pheochromocytoma incidence IAGP N RGD:619590|PMID:12036912 20180503 RGD 12910940 SD-Cdkn1bwe strain MP:0003498 thyroid gland hyperplasia IAGP N RGD:619590|PMID:12036912 20180503 RGD 12910941 Cdkn1bwe cyclin-dependent kinase inhibitor 1B; white eye mutation gene MP:0002050 increased pheochromocytoma incidence IAGP N RGD:619590|PMID:12036912 20201210 RGD 12910941 Cdkn1bwe cyclin-dependent kinase inhibitor 1B; white eye mutation gene MP:0003498 thyroid gland hyperplasia IAGP N RGD:619590|PMID:12036912 20201210 RGD 12910954 Csf1tl colony stimulating factor 1; tooth less mutant gene MP:0000062 increased bone mineral density IAGP N RGD:628338|PMID:12379742 20180430 RGD 12910954 Csf1tl colony stimulating factor 1; tooth less mutant gene MP:0000065 abnormal bone marrow cavity morphology IAGP N RGD:628338|PMID:12379742 20180430 RGD 12910954 Csf1tl colony stimulating factor 1; tooth less mutant gene MP:0001265 decreased body size IAGP N RGD:70875|PMID:12074592 20180430 RGD 12910954 Csf1tl colony stimulating factor 1; tooth less mutant gene MP:0003723 abnormal long bone morphology IAGP N RGD:628338|PMID:12379742 20170629 RGD 12910954 Csf1tl colony stimulating factor 1; tooth less mutant gene MP:0030610 absent teeth IAGP N RGD:628338|PMID:12379742 20170629 RGD 1298065 Scl16 Serum cholesterol level QTL 16 qtl MP:0005178 increased circulating cholesterol level QTM N RGD:737694|PMID:14739155 19990101 RGD 1298066 Bp159 Blood pressure QTL 159 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:61040|PMID:9685318 19990101 RGD 1298066 Bp159 Blood pressure QTL 159 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:61047|PMID:9271663 19990101 RGD 1298066 Bp159 Blood pressure QTL 159 qtl MP:0002843 decreased systemic arterial blood pressure QTM N RGD:61047|PMID:9271663 19990101 RGD 1298067 Scl15 Serum cholesterol level QTL 15 qtl MP:0005178 increased circulating cholesterol level QTM N RGD:737694|PMID:14739155 19990101 RGD 1298068 Bp167 Blood pressure QTL 167 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:61042|PMID:7963489 19990101 RGD 1298069 Bp168 Blood pressure QTL 168 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:61040|PMID:9685318 19990101 RGD 1298070 Scl18 Serum cholesterol level QTL 18 qtl MP:0000182 increased circulating LDL cholesterol level QTM N RGD:737694|PMID:14739155 19990101 RGD 1298071 Edpm12 Estrogen-dependent pituitary mass QTL 12 qtl MP:0000635 pituitary gland hyperplasia QTM N RGD:629550|PMID:11003699 19990101 RGD 1298072 Cia26 Collagen induced arthritis QTL 26 qtl MP:0002936 joint swelling QTM N RGD:1285224|PMID:15334486 19990101 RGD 1298073 Cm13 Cardiac mass QTL 13 qtl MP:0002833 increased heart weight QTM N RGD:69705|PMID:9922389 19990101 RGD 1298073 Cm13 Cardiac mass QTL 13 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:69705|PMID:9922389 19990101 RGD 1298074 Bp164 Blood pressure QTL 164 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:728179|PMID:11980293 19990101 RGD 1298075 Scl17 Serum cholesterol level QTL 17 qtl MP:0005178 increased circulating cholesterol level QTM N RGD:737694|PMID:14739155 19990101 RGD 1298076 Bp166 Blood pressure QTL 166 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:728179|PMID:11980293 19990101 RGD 1298077 Bp157 Blood pressure QTL 157 qtl MP:0002843 decreased systemic arterial blood pressure IAGP N RGD:619649|PMID:11875185 19990101 RGD 1298078 Stresp5 Stress response QTL 5 qtl MP:0001745 increased circulating corticosterone level QTM N RGD:737981|PMID:15013833 19990101 RGD 1298079 Activ2 Activity QTL 2 qtl MP:0001415 increased exploration in new environment IDA N RGD:631228|PMID:12660808 19990101 RGD 1298080 Bp163 Blood pressure QTL 163 qtl MP:0002833 increased heart weight IAGP N RGD:68910|PMID:10642295 19990101 RGD 1298080 Bp163 Blood pressure QTL 163 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:68910|PMID:10642295 19990101 RGD 1298081 Cia25 Collagen induced arthritis QTL 25 qtl MP:0002936 joint swelling QTM N RGD:1285224|PMID:15334486 19990101 RGD 1298082 Stresp4 Stress response QTL 4 qtl MP:0001745 increased circulating corticosterone level QTM N RGD:737981|PMID:15013833 19990101 RGD 1298083 Bp158 Blood pressure QTL 158 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:61038|PMID:8040284 19990101 RGD 1298084 Thym4 Thymus enlargement QTL 4 qtl MP:0000709 enlarged thymus QTM N RGD:70859|PMID:10792781 19990101 RGD 1298085 Bp165 Blood pressure QTL 165 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:728179|PMID:11980293 19990101 RGD 1298086 Bp156 Blood pressure QTL 156 qtl MP:0002843 decreased systemic arterial blood pressure IAGP N RGD:619649|PMID:11875185 19990101 RGD 1298087 Iddm18 Insulin dependent diabetes mellitus QTL 18 qtl MP:0001260 increased body weight IAGP N RGD:619685|PMID:11327715 19990101 RGD 1298087 Iddm18 Insulin dependent diabetes mellitus QTL 18 qtl MP:0001552 increased circulating triglyceride level IAGP N RGD:619685|PMID:11327715 19990101 RGD 1298087 Iddm18 Insulin dependent diabetes mellitus QTL 18 qtl MP:0005178 increased circulating cholesterol level IAGP N RGD:619685|PMID:11327715 19990101 RGD 1298088 Edpm11 Estrogen-dependent pituitary mass QTL 11 qtl MP:0000635 pituitary gland hyperplasia QTM N RGD:629550|PMID:11003699 19990101 RGD 1298088 Edpm11 Estrogen-dependent pituitary mass QTL 11 qtl MP:0003044 impaired basement membrane formation QTM N RGD:629550|PMID:11003699 19990101 RGD 1298089 Scl14 Serum cholesterol level QTL 14 qtl MP:0005178 increased circulating cholesterol level QTM N RGD:737694|PMID:14739155 19990101 RGD 1298090 Bp155 Blood pressure QTL 155 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:731210|PMID:14678232 20100217 RGD 1298093 LEW/NHsd strain MP:0009752 enhanced behavioral response to nicotine IAGP N RGD:401959299|PMID:21745336 20240118 RGD compared to Fischer344 rats 1298524 Oia8 Oil induced arthritis QTL 8 qtl MP:0002933 joint inflammation IAGP N RGD:629560|PMID:12571866 19990101 RGD 1298525 Cm1 Cardiac mass QTL 1 qtl MP:0002833 increased heart weight QTM N RGD:69710|PMID:9383281 19990101 RGD 1298526 Arunc3 Aerobic running capacity QTL 3 qtl MP:0003060 increased aerobic running capacity QTM N RGD:619535|PMID:12079278 19990101 RGD 1298526 Arunc3 Aerobic running capacity QTL 3 qtl MP:0003061 decreased aerobic running capacity IAGP N RGD:619535|PMID:12079278 19990101 RGD 1298527 Arunc2 Aerobic running capacity QTL 2 qtl MP:0003060 increased aerobic running capacity QTM N RGD:619535|PMID:12079278 19990101 RGD 1298527 Arunc2 Aerobic running capacity QTL 2 qtl MP:0003061 decreased aerobic running capacity IAGP N RGD:619535|PMID:12079278 19990101 RGD 1298528 Bp169 Blood pressure QTL 169 qtl MP:0006264 decreased systemic arterial systolic blood pressure QTM N RGD:69711|PMID:11247666 19990101 RGD 1298529 Arunc1 Aerobic running capacity QTL 1 qtl MP:0003060 increased aerobic running capacity QTM N RGD:619535|PMID:12079278 19990101 RGD 1298529 Arunc1 Aerobic running capacity QTL 1 qtl MP:0003061 decreased aerobic running capacity IAGP N RGD:619535|PMID:12079278 19990101 RGD 1299868 SS.SR-(D7Uia1-D7Mco7)/Jr strain MP:0002834 decreased heart weight IAGP N RGD:629613|PMID:12682779 20201021 RGD compared to SS/Jr 1299868 SS.SR-(D7Uia1-D7Mco7)/Jr strain MP:0006264 decreased systemic arterial systolic blood pressure IMP N RGD:69711|PMID:11247666 20201030 RGD as compared to SS/Jr on 2% Nacl diet 1299868 SS.SR-(D7Uia1-D7Mco7)/Jr strain MP:0006264 decreased systemic arterial systolic blood pressure MODEL: induced IAGP N RGD:629613|PMID:12682779 20090507 RGD as compared to SS/Jr on 2% Nacl diet 1299869 SS.SR-(Cyp11b1)/Jr strain MP:0002843 decreased systemic arterial blood pressure IAGP N RGD:69710|PMID:9383281 20191127 RGD compared to SS/Jr 1299869 SS.SR-(Cyp11b1)/Jr strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:69710|PMID:9383281 20191127 RGD 1299870 SS.LEW-(D5Uia8-D5Rat108)/Jr strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:619649|PMID:11875185 19990101 RGD compared to SS/Jr 1299871 DA.F344-(D20Arb2-D20Arb8)/Arb strain MP:0002933 joint inflammation induced IAGP XCO:0000281,XCO:0000263,XCO:0000265 N RGD:629569|PMID:12209529 20070214 RGD compared to DA/Bkl 1299871 DA.F344-(D20Arb2-D20Arb8)/Arb strain MP:0002936 joint swelling induced IAGP XCO:0000281,XCO:0000263,XCO:0000265 N RGD:629569|PMID:12209529 20070214 RGD compared to DA/Bkl 1299872 DA.F344-(D8Arb15-D8Arb22)/Arb strain MP:0003561 rheumatoid arthritis induced IAGP XCO:0000281|XCO:0000263 N RGD:629569|PMID:12209529 20200720 RGD 1299872 DA.F344-(D8Arb15-D8Arb22)/Arb strain MP:0003561 rheumatoid arthritis penetrance IAGP XCO:0000265 N RGD:629569|PMID:12209529 20200720 RGD 1299872 DA.F344-(D8Arb15-D8Arb22)/Arb strain MP:0008719 impaired neutrophil recruitment induced IAGP XCO:0000273 N RGD:1599708|PMID:17277140 20070214 RGD compared to DA/BklArbNsi 1299873 SS.LEW-(D5Mco34-D5Rat108)/Jr strain MP:0002843 decreased systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:619649|PMID:11875185 19990101 RGD compared to SS/Jr 1299873 SS.LEW-(D5Mco34-D5Rat108)/Jr strain MP:0004876 decreased mean systemic arterial blood pressure IAGP N RGD:1643012|PMID:17938377 20191127 RGD compared to SS/Jr 1299875 DA.F344-(D7Rat22-D7Mit2)/Nsi strain MP:0003561 rheumatoid arthritis induced IAGP XCO:0000281|XCO:0000263|XCO:0000265 N RGD:629569|PMID:12209529 20200720 RGD 1299875 DA.F344-(D7Rat22-D7Mit2)/Nsi strain MP:0008561 decreased tumor necrosis factor secretion induced IAGP XCO:0000273 N RGD:1599708|PMID:17277140 20070214 RGD compared to DA/BklArbNsi 1299875 DA.F344-(D7Rat22-D7Mit2)/Nsi strain MP:0008719 impaired neutrophil recruitment induced IAGP XCO:0000273 N RGD:1599708|PMID:17277140 20070214 RGD compared to DA/BklArbNsi 1299876 SS.LEW-(D5Rat54-D5Rat108)/Jr strain MP:0002842 increased systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:619649|PMID:11875185 19990101 RGD compared to LEW/Jr 1299876 SS.LEW-(D5Rat54-D5Rat108)/Jr strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:619649|PMID:11875185 19990101 RGD 1299877 DA.F344-(D10Rat204-D10Arb22)/Arb strain MP:0003561 rheumatoid arthritis induced IAGP XCO:0000281|XCO:0000263 N RGD:629569|PMID:12209529 20200720 RGD 1299877 DA.F344-(D10Rat204-D10Arb22)/Arb strain MP:0003561 rheumatoid arthritis penetrance IAGP XCO:0000265 N RGD:629569|PMID:12209529 20200720 RGD 1299878 DA.F344-(D4Arb30-D4Arb4)/Arb strain MP:0003079 decreased susceptibility to induced joint inflammation induced IAGP XCO:0000281| XCO:0000263 N RGD:7243954|PMID:22076633 20130604 RGD 1299878 DA.F344-(D4Arb30-D4Arb4)/Arb strain MP:0003561 rheumatoid arthritis induced IAGP XCO:0000281|XCO:0000263 N RGD:629569|PMID:12209529 20200720 RGD 1299878 DA.F344-(D4Arb30-D4Arb4)/Arb strain MP:0003561 rheumatoid arthritis penetrance IAGP XCO:0000265 N RGD:629569|PMID:12209529 20200720 RGD 1299879 SS.SR-(D7Mco7-D7Wox19)/Jr strain MP:0006264 decreased systemic arterial systolic blood pressure IMP N RGD:69711|PMID:11247666 20201030 RGD as compared to SS/Jr on 2% Nacl diet 1299880 F344.DA-(D20Arb2-D20Arb8)/Arb strain MP:0002933 joint inflammation induced IAGP XCO:0000281,XCO:0000263,XCO:0000265 N RGD:629569|PMID:12209529 20070214 RGD 1299880 F344.DA-(D20Arb2-D20Arb8)/Arb strain MP:0002936 joint swelling induced IAGP XCO:0000281,XCO:0000263,XCO:0000265 N RGD:629569|PMID:12209529 20070214 RGD compared to DA/Bkl 1299881 SS.LEW-(D5Wox3-D5Rat108)/Jr strain MP:0002843 decreased systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:619649|PMID:11875185 19990101 RGD compared to SS/Jr 1300075 Glom7 Glomerulus QTL 7 qtl MP:0005325 abnormal renal glomerulus morphology IAGP N RGD:730279|PMID:14638907 20111108 RGD 1300076 Glom8 Glomerulus QTL 8 qtl MP:0005325 abnormal renal glomerulus morphology IAGP N RGD:730279|PMID:14638907 20111108 RGD 1300107 Rf18 Renal function QTL 18 qtl MP:0001762 polyuria IAGP N RGD:727992|PMID:14532335 19990101 RGD 1300107 Rf18 Renal function QTL 18 qtl MP:0009643 abnormal urine homeostasis QTM N RGD:727992|PMID:14532335 19990101 RGD 1300108 Rf8 Renal function QTL 8 qtl MP:0005524 abnormal renal plasma flow rate QTM N RGD:727992|PMID:14532335 19990101 RGD 1300108 Rf8 Renal function QTL 8 qtl MP:0005526 decreased renal plasma flow rate IAGP N RGD:727992|PMID:14532335 19990101 RGD 1300108 Rf8 Renal function QTL 8 qtl MP:0005531 increased renal vascular resistance IAGP N RGD:727992|PMID:14532335 19990101 RGD 1300109 Rf13 Renal function QTL 13 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:727992|PMID:14532335 19990101 RGD 1300109 Rf13 Renal function QTL 13 qtl MP:0005524 abnormal renal plasma flow rate QTM N RGD:727992|PMID:14532335 19990101 RGD 1300110 Stl7 Serum triglyceride level QTL 7 qtl MP:0001552 increased circulating triglyceride level QTM N RGD:727992|PMID:14532335 19990101 RGD 1300110 Stl7 Serum triglyceride level QTL 7 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:727992|PMID:14532335 19990101 RGD 1300110 Stl7 Serum triglyceride level QTL 7 qtl MP:0005328 abnormal circulating creatinine level QTM N RGD:727992|PMID:14532335 19990101 RGD 1300111 Rf12 Renal function QTL 12 qtl MP:0001859 kidney inflammation QTM N RGD:727992|PMID:14532335 19990101 RGD 1300111 Rf12 Renal function QTL 12 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:727992|PMID:14532335 19990101 RGD 1300111 Rf12 Renal function QTL 12 qtl MP:0005325 abnormal renal glomerulus morphology QTM N RGD:727992|PMID:14532335 19990101 RGD 1300111 Rf12 Renal function QTL 12 qtl MP:0005524 abnormal renal plasma flow rate QTM N RGD:727992|PMID:14532335 19990101 RGD 1300112 Bp183 Blood pressure QTL 183 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:727992|PMID:14532335 19990101 RGD 1300113 Bp176 Blood pressure QTL 176 qtl MP:0002706 abnormal kidney size QTM N RGD:727992|PMID:14532335 19990101 RGD 1300113 Bp176 Blood pressure QTL 176 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:727992|PMID:14532335 19990101 RGD 1300114 Srn2 Serum renin concentration QTL 2 qtl MP:0005581 abnormal renin activity QTM N RGD:727992|PMID:14532335 19990101 RGD 1300115 Hrtrt7 Heart rate QTL 7 qtl MP:0001629 abnormal heart rate QTM N RGD:727992|PMID:14532335 19990101 RGD 1300115 Hrtrt7 Heart rate QTL 7 qtl MP:0002626 increased heart rate IAGP N RGD:727992|PMID:14532335 19990101 RGD 1300116 Hrtrt5 Heart rate QTL 5 qtl MP:0001629 abnormal heart rate QTM N RGD:727992|PMID:14532335 19990101 RGD 1300116 Hrtrt5 Heart rate QTL 5 qtl MP:0002626 increased heart rate IAGP N RGD:727992|PMID:14532335 19990101 RGD 1300117 Hrtrt8 Heart rate QTL 8 qtl MP:0001552 increased circulating triglyceride level QTM N RGD:727992|PMID:14532335 19990101 RGD 1300117 Hrtrt8 Heart rate QTL 8 qtl MP:0001629 abnormal heart rate QTM N RGD:727992|PMID:14532335 19990101 RGD 1300117 Hrtrt8 Heart rate QTL 8 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:727992|PMID:14532335 19990101 RGD 1300118 Bp190 Blood pressure QTL 190 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:727992|PMID:14532335 19990101 RGD 1300119 Bp180 Blood pressure QTL 180 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:727992|PMID:14532335 19990101 RGD 1300120 Kidm7 Kidney mass QTL 7 qtl MP:0002707 abnormal kidney weight QTM N RGD:727992|PMID:14532335 19990101 RGD 1300120 Kidm7 Kidney mass QTL 7 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:727992|PMID:14532335 19990101 RGD 1300120 Kidm7 Kidney mass QTL 7 qtl MP:0005524 abnormal renal plasma flow rate QTM N RGD:727992|PMID:14532335 19990101 RGD 1300121 Hrtrt1 Heart rate QTL 1 qtl MP:0001629 abnormal heart rate QTM N RGD:727992|PMID:14532335 19990101 RGD 1300121 Hrtrt1 Heart rate QTL 1 qtl MP:0002626 increased heart rate IAGP N RGD:727992|PMID:14532335 19990101 RGD 1300122 Wbc1 White blood cell count QTL 1 qtl MP:0000217 abnormal leukocyte cell number QTM N RGD:727992|PMID:14532335 19990101 RGD 1300122 Wbc1 White blood cell count QTL 1 qtl MP:0000218 increased leukocyte cell number IAGP N RGD:727992|PMID:14532335 19990101 RGD 1300123 Bp194 Blood pressure QTL 194 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:727992|PMID:14532335 19990101 RGD 1300124 Cm4 Cardiac mass QTL 4 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:727992|PMID:14532335 19990101 RGD 1300124 Cm4 Cardiac mass QTL 4 qtl MP:0005406 abnormal heart size QTM N RGD:727992|PMID:14532335 19990101 RGD 1300124 Cm4 Cardiac mass QTL 4 qtl MP:0005524 abnormal renal plasma flow rate QTM N RGD:727992|PMID:14532335 19990101 RGD 1300125 Rf26 Renal function QTL 26 qtl MP:0005618 decreased urine potassium level QTM N RGD:727992|PMID:14532335 19990101 RGD 1300126 Bp175 Blood pressure QTL 175 qtl MP:0001859 kidney inflammation QTM N RGD:727992|PMID:14532335 19990101 RGD 1300126 Bp175 Blood pressure QTL 175 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:727992|PMID:14532335 19990101 RGD 1300127 Srn1 Serum renin concentration QTL 1 qtl MP:0005581 abnormal renin activity QTM N RGD:727992|PMID:14532335 19990101 RGD 1300128 Rf16 Renal function QTL 16 qtl MP:0005524 abnormal renal plasma flow rate QTM N RGD:727992|PMID:14532335 19990101 RGD 1300128 Rf16 Renal function QTL 16 qtl MP:0005526 decreased renal plasma flow rate IAGP N RGD:727992|PMID:14532335 19990101 RGD 1300129 Rf25 Renal function QTL 25 qtl MP:0005328 abnormal circulating creatinine level QTM N RGD:727992|PMID:14532335 19990101 RGD 1300129 Rf25 Renal function QTL 25 qtl MP:0005556 abnormal renal filtration rate QTM N RGD:727992|PMID:14532335 19990101 RGD 1300129 Rf25 Renal function QTL 25 qtl MP:0005558 decreased creatinine clearance IAGP N RGD:727992|PMID:14532335 19990101 RGD 1300130 Rf20 Renal function QTL 20 qtl MP:0001859 kidney inflammation QTM N RGD:727992|PMID:14532335 19990101 RGD 1300130 Rf20 Renal function QTL 20 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:727992|PMID:14532335 19990101 RGD 1300130 Rf20 Renal function QTL 20 qtl MP:0005325 abnormal renal glomerulus morphology QTM N RGD:727992|PMID:14532335 19990101 RGD 1300131 Bp193 Blood pressure QTL 193 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:727992|PMID:14532335 19990101 RGD 1300132 Bp182 Blood pressure QTL 182 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:727992|PMID:14532335 19990101 RGD 1300133 Rf24 Renal function QTL 24 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:727992|PMID:14532335 19990101 RGD 1300133 Rf24 Renal function QTL 24 qtl MP:0005328 abnormal circulating creatinine level QTM N RGD:727992|PMID:14532335 19990101 RGD 1300133 Rf24 Renal function QTL 24 qtl MP:0005556 abnormal renal filtration rate QTM N RGD:727992|PMID:14532335 19990101 RGD 1300134 Bp185 Blood pressure QTL 185 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:727992|PMID:14532335 19990101 RGD 1300135 Rf19 Renal function QTL 19 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:727992|PMID:14532335 19990101 RGD 1300135 Rf19 Renal function QTL 19 qtl MP:0002963 decreased urine protein level QTM N RGD:727992|PMID:14532335 19990101 RGD 1300135 Rf19 Renal function QTL 19 qtl MP:0005328 abnormal circulating creatinine level QTM N RGD:727992|PMID:14532335 19990101 RGD 1300135 Rf19 Renal function QTL 19 qtl MP:0005556 abnormal renal filtration rate QTM N RGD:727992|PMID:14532335 19990101 RGD 1300136 Rf22 Renal function QTL 22 qtl MP:0005524 abnormal renal plasma flow rate QTM N RGD:727992|PMID:14532335 19990101 RGD 1300136 Rf22 Renal function QTL 22 qtl MP:0005531 increased renal vascular resistance IAGP N RGD:727992|PMID:14532335 19990101 RGD 1300137 Bp186 Blood pressure QTL 186 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:727992|PMID:14532335 19990101 RGD 1300138 Hrtrt9 Heart rate QTL 9 qtl MP:0001629 abnormal heart rate QTM N RGD:727992|PMID:14532335 19990101 RGD 1300138 Hrtrt9 Heart rate QTL 9 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:727992|PMID:14532335 19990101 RGD 1300138 Hrtrt9 Heart rate QTL 9 qtl MP:0009643 abnormal urine homeostasis QTM N RGD:727992|PMID:14532335 19990101 RGD 1300139 Hrtrt6 Heart rate QTL 6 qtl MP:0001629 abnormal heart rate QTM N RGD:727992|PMID:14532335 19990101 RGD 1300139 Hrtrt6 Heart rate QTL 6 qtl MP:0002626 increased heart rate IAGP N RGD:727992|PMID:14532335 19990101 RGD 1300140 Srn3 Serum renin concentration QTL 3 qtl MP:0005581 abnormal renin activity QTM N RGD:727992|PMID:14532335 19990101 RGD 1300141 Bp178 Blood pressure QTL 178 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:727992|PMID:14532335 19990101 RGD 1300142 Bp191 Blood pressure QTL 191 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:727992|PMID:14532335 19990101 RGD 1300143 Rf14 Renal function QTL 14 qtl MP:0005524 abnormal renal plasma flow rate QTM N RGD:727992|PMID:14532335 19990101 RGD 1300143 Rf14 Renal function QTL 14 qtl MP:0005558 decreased creatinine clearance IAGP N RGD:727992|PMID:14532335 19990101 RGD 1300144 Rf23 Renal function QTL 23 qtl MP:0005524 abnormal renal plasma flow rate QTM N RGD:727992|PMID:14532335 19990101 RGD 1300144 Rf23 Renal function QTL 23 qtl MP:0005531 increased renal vascular resistance IAGP N RGD:727992|PMID:14532335 19990101 RGD 1300145 Rf7 Renal function QTL 7 qtl MP:0005556 abnormal renal filtration rate QTM N RGD:727992|PMID:14532335 19990101 RGD 1300145 Rf7 Renal function QTL 7 qtl MP:0005558 decreased creatinine clearance IAGP N RGD:727992|PMID:14532335 19990101 RGD 1300146 Rf17 Renal function QTL 17 qtl MP:0005524 abnormal renal plasma flow rate QTM N RGD:727992|PMID:14532335 19990101 RGD 1300146 Rf17 Renal function QTL 17 qtl MP:0005526 decreased renal plasma flow rate IAGP N RGD:727992|PMID:14532335 19990101 RGD 1300147 Bp187 Blood pressure QTL 187 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:727992|PMID:14532335 19990101 RGD 1300148 Bp192 Blood pressure QTL 192 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:727992|PMID:14532335 19990101 RGD 1300149 Cm6 Cardiac mass QTL 6 qtl MP:0000217 abnormal leukocyte cell number QTM N RGD:727992|PMID:14532335 19990101 RGD 1300149 Cm6 Cardiac mass QTL 6 qtl MP:0002596 abnormal hematocrit QTM N RGD:727992|PMID:14532335 19990101 RGD 1300149 Cm6 Cardiac mass QTL 6 qtl MP:0005294 abnormal heart ventricle morphology QTM N RGD:727992|PMID:14532335 19990101 RGD 1300149 Cm6 Cardiac mass QTL 6 qtl MP:0005406 abnormal heart size QTM N RGD:727992|PMID:14532335 19990101 RGD 1300150 Cm3 Cardiac mass QTL 3 qtl MP:0005406 abnormal heart size QTM N RGD:727992|PMID:14532335 19990101 RGD 1300151 Bp181 Blood pressure QTL 181 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:727992|PMID:14532335 19990101 RGD 1300152 Bp195 Blood pressure QTL 195 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:727992|PMID:14532335 19990101 RGD 1300153 Bp171 Blood pressure QTL 171 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:727992|PMID:14532335 19990101 RGD 1300154 Bp189 Blood pressure QTL 189 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:727992|PMID:14532335 19990101 RGD 1300155 Bp174 Blood pressure QTL 174 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:727992|PMID:14532335 19990101 RGD 1300155 Bp174 Blood pressure QTL 174 qtl MP:0009643 abnormal urine homeostasis QTM N RGD:727992|PMID:14532335 19990101 RGD 1300156 Bp179 Blood pressure QTL 179 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:727992|PMID:14532335 19990101 RGD 1300157 Rf21 Renal function QTL 21 qtl MP:0005526 decreased renal plasma flow rate QTM N RGD:727992|PMID:14532335 19990101 RGD 1300158 Bp173 Blood pressure QTL 173 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:727992|PMID:14532335 19990101 RGD 1300159 Kidm4 Kidney mass QTL 4 qtl MP:0002706 abnormal kidney size QTM N RGD:727992|PMID:14532335 19990101 RGD 1300159 Kidm4 Kidney mass QTL 4 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:727992|PMID:14532335 19990101 RGD 1300159 Kidm4 Kidney mass QTL 4 qtl MP:0005524 abnormal renal plasma flow rate QTM N RGD:727992|PMID:14532335 19990101 RGD 1300160 Hrtrt3 Heart rate QTL 3 qtl MP:0001629 abnormal heart rate QTM N RGD:727992|PMID:14532335 19990101 RGD 1300160 Hrtrt3 Heart rate QTL 3 qtl MP:0002626 increased heart rate IAGP N RGD:727992|PMID:14532335 19990101 RGD 1300160 Hrtrt3 Heart rate QTL 3 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:727992|PMID:14532335 19990101 RGD 1300161 Rf10 Renal function QTL 10 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:727992|PMID:14532335 19990101 RGD 1300161 Rf10 Renal function QTL 10 qtl MP:0005524 abnormal renal plasma flow rate QTM N RGD:727992|PMID:14532335 19990101 RGD 1300162 Bp188 Blood pressure QTL 188 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:727992|PMID:14532335 19990101 RGD 1300163 Cardf1 Cardiac cell morphology QTL 1 qtl MP:0000272 abnormal aorta morphology QTM N RGD:727992|PMID:14532335 19990101 RGD 1300164 Rf15 Renal function QTL 15 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:727992|PMID:14532335 19990101 RGD 1300164 Rf15 Renal function QTL 15 qtl MP:0005524 abnormal renal plasma flow rate QTM N RGD:727992|PMID:14532335 19990101 RGD 1300165 Rf9 Renal function QTL 9 qtl MP:0001859 kidney inflammation QTM N RGD:727992|PMID:14532335 19990101 RGD 1300165 Rf9 Renal function QTL 9 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:727992|PMID:14532335 19990101 RGD 1300165 Rf9 Renal function QTL 9 qtl MP:0005325 abnormal renal glomerulus morphology QTM N RGD:727992|PMID:14532335 19990101 RGD 1300166 Kidm6 Kidney mass QTL 6 qtl MP:0002707 abnormal kidney weight QTM N RGD:727992|PMID:14532335 19990101 RGD 1300167 Hrtrt2 Heart rate QTL 2 qtl MP:0001629 abnormal heart rate QTM N RGD:727992|PMID:14532335 19990101 RGD 1300167 Hrtrt2 Heart rate QTL 2 qtl MP:0002626 increased heart rate IAGP N RGD:727992|PMID:14532335 19990101 RGD 1300168 Bp170 Blood pressure QTL 170 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:727992|PMID:14532335 19990101 RGD 1300169 Bp177 Blood pressure QTL 177 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:727992|PMID:14532335 19990101 RGD 1300170 Rf6 Renal function QTL 6 qtl MP:0005524 abnormal renal plasma flow rate QTM N RGD:727992|PMID:14532335 19990101 RGD 1300170 Rf6 Renal function QTL 6 qtl MP:0005526 decreased renal plasma flow rate IAGP N RGD:727992|PMID:14532335 19990101 RGD 1300171 Bp184 Blood pressure QTL 184 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:727992|PMID:14532335 19990101 RGD 1300172 Bp172 Blood pressure QTL 172 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:727992|PMID:14532335 19990101 RGD 1300173 Rf11 Renal function QTL 11 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:727992|PMID:14532335 19990101 RGD 1300173 Rf11 Renal function QTL 11 qtl MP:0005524 abnormal renal plasma flow rate QTM N RGD:727992|PMID:14532335 19990101 RGD 1300174 Bw15 Body weight QTL 15 qtl MP:0001259 abnormal body weight QTM N RGD:727992|PMID:14532335 19990101 RGD 1300175 Cm5 Cardiac mass QTL 5 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:727992|PMID:14532335 19990101 RGD 1300175 Cm5 Cardiac mass QTL 5 qtl MP:0005406 abnormal heart size QTM N RGD:727992|PMID:14532335 19990101 RGD 1300175 Cm5 Cardiac mass QTL 5 qtl MP:0005524 abnormal renal plasma flow rate QTM N RGD:727992|PMID:14532335 19990101 RGD 1300176 Hrtrt10 Heart rate QTL 10 qtl MP:0001629 abnormal heart rate QTM N RGD:727992|PMID:14532335 19990101 RGD 1300176 Hrtrt10 Heart rate QTL 10 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:727992|PMID:14532335 19990101 RGD 1300177 Cm2 Cardiac mass QTL 2 qtl MP:0001629 abnormal heart rate QTM N RGD:727992|PMID:14532335 19990101 RGD 1300177 Cm2 Cardiac mass QTL 2 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:727992|PMID:14532335 19990101 RGD 1300177 Cm2 Cardiac mass QTL 2 qtl MP:0005406 abnormal heart size QTM N RGD:727992|PMID:14532335 19990101 RGD 1300178 Hrtrt4 Heart rate QTL 4 qtl MP:0001629 abnormal heart rate QTM N RGD:727992|PMID:14532335 19990101 RGD 1300178 Hrtrt4 Heart rate QTL 4 qtl MP:0002626 increased heart rate IAGP N RGD:727992|PMID:14532335 19990101 RGD 1300179 Kidm5 Kidney mass QTL 5 qtl MP:0002707 abnormal kidney weight QTM N RGD:727992|PMID:14532335 19990101 RGD 1300180 Bw14 Body weight QTL 14 qtl MP:0001259 abnormal body weight QTM N RGD:727992|PMID:14532335 19990101 RGD 1300180 Bw14 Body weight QTL 14 qtl MP:0001260 increased body weight IAGP N RGD:727992|PMID:14532335 19990101 RGD 1300433 LAA/FDSC Hatano Low Avoidance strain MP:0003967 abnormal follicle stimulating hormone level IAGP N RGD:1300227|PMID:12374463 19990101 RGD compared to LAA/FDSC 1300433 LAA/FDSC Hatano Low Avoidance strain MP:0004855 increased ovary weight IAGP N RGD:1300227|PMID:12374463 20201106 RGD compared to HAA/FDSC 1300433 LAA/FDSC Hatano Low Avoidance strain MP:0004905 decreased uterus weight IAGP N RGD:1300227|PMID:12374463 20201106 RGD compared to HAA/FDSC 1300433 LAA/FDSC Hatano Low Avoidance strain MP:0008939 increased pituitary gland weight IAGP N RGD:1300227|PMID:12374463 20201106 RGD compared to HAA/FDSC 1300433 LAA/FDSC Hatano Low Avoidance strain MP:0013308 decreased adrenal gland weight IAGP N RGD:1300227|PMID:12374463 20201106 RGD compared to HAA/FDSC 1302372 SDDIO/Rrrc strain MP:0000812 abnormal dentate gyrus morphology IAGP N RGD:21408576|PMID:27173431 20200320 RGD compared to SDDR/Rrrc strain 1302372 SDDIO/Rrrc strain MP:0001260 increased body weight IAGP N RGD:1302371|PMID:9277561 20200320 RGD compared to SDDR/Rrrc strain 1302372 SDDIO/Rrrc strain MP:0001260 increased body weight IAGP N RGD:21408576|PMID:27173431 20200320 RGD compared to SDDR/Rrrc strain 1302372 SDDIO/Rrrc strain MP:0002079 increased circulating insulin level IAGP N RGD:1302371|PMID:9277561 20200320 RGD compared to SDDR/Rrrc strain 1302372 SDDIO/Rrrc strain MP:0002981 increased liver weight IAGP N RGD:1302371|PMID:9277561 20200320 RGD compared to SDDR/Rrrc strain 1302372 SDDIO/Rrrc strain MP:0003674 oxidative stress IAGP N RGD:21408576|PMID:27173431 20200320 RGD compared to SDDR/Rrrc strain 1302372 SDDIO/Rrrc strain MP:0004981 decreased neuronal precursor cell number IAGP N RGD:21408576|PMID:27173431 20200320 RGD compared to SDDR/Rrrc strain 1302372 SDDIO/Rrrc strain MP:0005448 abnormal energy homeostasis IAGP N RGD:21408576|PMID:27173431 20200320 RGD compared to SDDR/Rrrc strain 1302372 SDDIO/Rrrc strain MP:0005559 increased circulating glucose level IAGP XCO:0000069 N RGD:1302371|PMID:9277561 20200320 RGD compared to SDDR/Rrrc strain 1302372 SDDIO/Rrrc strain MP:0005658 increased susceptibility to diet-induced obesity IAGP N RGD:1302371|PMID:9277561 19990101 RGD compared to SDDR/Rrrc strain 1302372 SDDIO/Rrrc strain MP:0005669 increased circulating leptin level IAGP N RGD:21408576|PMID:27173431 20200320 RGD compared to SDDR/Rrrc strain 1302372 SDDIO/Rrrc strain MP:0008414 abnormal spatial reference memory IAGP N RGD:21408576|PMID:27173431 20200320 RGD compared to SDDR/Rrrc strain 1302372 SDDIO/Rrrc strain MP:0009304 increased retroperitoneal fat pad weight IAGP N RGD:1302371|PMID:9277561 20200320 RGD compared to SDDR/Rrrc strain 1302372 SDDIO/Rrrc strain MP:0010951 abnormal lipid oxidation IAGP N RGD:21408576|PMID:27173431 20200320 RGD compared to SDDR/Rrrc strain 1302372 SDDIO/Rrrc strain MP:0011939 increased food intake IAGP N RGD:21408576|PMID:27173431 20200320 RGD compared to SDDR/Rrrc strain 1302372 SDDIO/Rrrc strain MP:0014142 increased body fat mass IAGP N RGD:1302371|PMID:9277561 20200320 RGD compared to SDDR/Rrrc strain 1302372 SDDIO/Rrrc strain MP:0030772 increased urine noradrenaline level sexual_dimorphism IAGP N RGD:1302371|PMID:9277561 20200320 RGD compared to SDDR/Rrrc strain, males only 1302373 SDDR/Rrrc strain MP:0001262 decreased body weight IAGP N RGD:1302371|PMID:9277561 19990101 RGD compared to SDDIO/Rrrc strain 1302373 SDDR/Rrrc strain MP:0005659 decreased susceptibility to diet-induced obesity IAGP N RGD:1302371|PMID:9277561 19990101 RGD compared to SDDIO/Rrrc strain 1302377 SPRD-Anks6PKD/Rrrc strain MP:0000208 decreased hematocrit IAGP N RGD:1300446|PMID:7933831 20200416 RGD compared to PKD 1302377 SPRD-Anks6PKD/Rrrc strain MP:0002083 premature death IAGP N RGD:1300446|PMID:7933831 20180816 RGD 1302377 SPRD-Anks6PKD/Rrrc strain MP:0003068 enlarged kidney IAGP N RGD:1300446|PMID:7933831 19990101 RGD 1302377 SPRD-Anks6PKD/Rrrc strain MP:0003917 increased kidney weight IAGP N RGD:1300446|PMID:7933831 20200416 RGD compared to PKD 1302377 SPRD-Anks6PKD/Rrrc strain MP:0005553 increased circulating creatinine level IAGP N RGD:1300446|PMID:7933831 20200416 RGD compared to PKD 1302377 SPRD-Anks6PKD/Rrrc strain MP:0005565 increased blood urea nitrogen level IAGP N RGD:1300446|PMID:7933831 20200416 RGD compared to PKD 1302404 Cia27 Collagen induced arthritis QTL 27 qtl MP:0002933 joint inflammation IAGP N RGD:61063|PMID:9870869 19990101 RGD 1302404 Cia27 Collagen induced arthritis QTL 27 qtl MP:0002936 joint swelling IAGP N RGD:61063|PMID:9870869 19990101 RGD 1302597 LEXF7C/Stm strain MP:0002024 increased T cell derived lymphoma incidence induced IAGP XCO:0000437 N RGD:619600|PMID:10360666 19990101 RGD 1302604 LEXF4/Stm strain MP:0002024 increased T cell derived lymphoma incidence penetrance IAGP XCO:0000437 N RGD:619600|PMID:10360666 19990101 RGD 1302604 LEXF4/Stm strain MP:0002026 increased leukemia incidence penetrance IAGP XCO:0000437 N RGD:619600|PMID:10360666 19990101 RGD 1302605 LEXF2A/Stm strain MP:0002024 increased T cell derived lymphoma incidence penetrance IAGP XCO:0000437 N RGD:619600|PMID:10360666 19990101 RGD 1302605 LEXF2A/Stm strain MP:0002026 increased leukemia incidence penetrance IAGP XCO:0000437 N RGD:619600|PMID:10360666 19990101 RGD 1302610 KMI/Tky miniature rat ishikawa strain MP:0000165 abnormal long bone hypertrophic chondrocyte zone IAGP N RGD:150429792|PMID:15466490 20210929 RGD compared to wild type 1302610 KMI/Tky miniature rat ishikawa strain MP:0000592 short tail IAGP N RGD:150429793|PMID:19149413 20210929 RGD compared to wild type, and heterozygous litter mates 1302610 KMI/Tky miniature rat ishikawa strain MP:0001258 decreased body length IAGP N RGD:150429793|PMID:19149413 20210929 RGD compared to wild type, and heterozygous litter mates 1302610 KMI/Tky miniature rat ishikawa strain MP:0001262 decreased body weight IAGP N RGD:150429793|PMID:19149413 20210929 RGD compared to wild type, and heterozygous litter mates 1302610 KMI/Tky miniature rat ishikawa strain MP:0001732 postnatal growth retardation IAGP N RGD:150429792|PMID:15466490 20210929 RGD compared to wild type 1302610 KMI/Tky miniature rat ishikawa strain MP:0001732 postnatal growth retardation IAGP N RGD:150429793|PMID:19149413 20210929 RGD compared to wild type, and heterozygous litter mates 1302610 KMI/Tky miniature rat ishikawa strain MP:0002999 abnormal bone healing IAGP N RGD:150429792|PMID:15466490 20210929 RGD compared to wild type 1302610 KMI/Tky miniature rat ishikawa strain MP:0006398 increased long bone epiphyseal plate size IAGP N RGD:150429792|PMID:15466490 20210929 RGD compared to wild type 1302610 KMI/Tky miniature rat ishikawa strain MP:0008272 abnormal endochondral bone ossification IAGP N RGD:150429793|PMID:19149413 20210929 RGD compared to wild type, and heterozygous litter mates 1302610 KMI/Tky miniature rat ishikawa strain MP:0009305 decreased retroperitoneal fat pad weight IAGP N RGD:150429793|PMID:19149413 20210929 RGD compared to wild type, and heterozygous litter mates 1302610 KMI/Tky miniature rat ishikawa strain MP:0030315 small neurocranium IAGP N RGD:150429793|PMID:19149413 20210929 RGD compared to wild type, and heterozygous litter mates 1302612 LEXF10C/Stm strain MP:0002024 increased T cell derived lymphoma incidence induced IAGP XCO:0000437 N RGD:619600|PMID:10360666 19990101 RGD 1302616 LEXF10B/Stm strain MP:0002024 increased T cell derived lymphoma incidence penetrance IAGP XCO:0000437 N RGD:619600|PMID:10360666 19990101 RGD 1302618 LEXF9/Stm strain MP:0002026 increased leukemia incidence induced IAGP XCO:0000437 N RGD:619600|PMID:10360666 20200710 RGD 1302621 LEXF10A/Stm strain MP:0002024 increased T cell derived lymphoma incidence induced IAGP XCO:0000437 N RGD:619600|PMID:10360666 19990101 RGD 1302623 TM/Kyo tester moriyama rat strain MP:0004725 decreased platelet serotonin level IAGP N RGD:1302447|PMID:9250486 20111109 RGD 1302623 TM/Kyo tester moriyama rat strain MP:0005606 increased bleeding time IAGP N RGD:1302447|PMID:9250486 19990101 RGD 1302627 F344/NSlc strain MP:0005027 increased susceptibility to parasitic infection IAGP N RGD:1578305|PMID:16465509 19990101 RGD 1302627 F344/NSlc strain MP:0008911 induced hyperactivity IAGP XCO:0000048 N RGD:14995940|PMID:30813600 20200130 RGD compared to F344-Lgi1m1Kyo 1302630 F344.OLETF-(D10Wox7-D10Wox6)/Tj strain MP:0001262 decreased body weight induced IAGP XCO:0000275 N RGD:625760|PMID:12420133 20201201 RGD 1302631 BN/SsNSlc strain MP:0005012 decreased eosinophil cell number IAGP N RGD:5134976|PMID:20660993 20200708 RGD in bone marrow; compared to MES/Slc 1302636 WKY.SHRSP-(D1Wox29-D1Arb21)/Izm strain MP:0000231 hypertension susceptibility IAGP XCO:0000307 N RGD:1302892|PMID:15480093 20200109 RGD compared to WKY/Izm 1302636 WKY.SHRSP-(D1Wox29-D1Arb21)/Izm strain MP:0002067 abnormal sensory capabilities/reflexes/nociception susceptibility IAGP XCO:0000307 N RGD:1302892|PMID:15480093 20070306 RGD compared to WKY/Izm 1302636 WKY.SHRSP-(D1Wox29-D1Arb21)/Izm strain MP:0002626 increased heart rate IAGP XCO:0000337 N RGD:1578503|PMID:16239369 20070306 RGD compared to control strain WKY/Izm 1302636 WKY.SHRSP-(D1Wox29-D1Arb21)/Izm strain MP:0002833 increased heart weight susceptibility IAGP N RGD:1302892|PMID:15480093 20200109 RGD compared to WKY/Izm 1302636 WKY.SHRSP-(D1Wox29-D1Arb21)/Izm strain MP:0002842 increased systemic arterial blood pressure susceptibility IAGP N RGD:1302892|PMID:15480093 19990101 RGD compared to WKY/Izm 1302636 WKY.SHRSP-(D1Wox29-D1Arb21)/Izm strain MP:0003917 increased kidney weight susceptibility IAGP N RGD:1302892|PMID:15480093 20200109 RGD compared to WKY/Izm 1302636 WKY.SHRSP-(D1Wox29-D1Arb21)/Izm strain MP:0004050 abnormal renal sympathetic nerve activity induced IAGP XCO:0000337 N RGD:1578503|PMID:16239369 20191209 RGD compared to hypertensive strain SHRSP/Izm 1302636 WKY.SHRSP-(D1Wox29-D1Arb21)/Izm strain MP:0004051 increased renal sympathetic nerve activity IAGP N RGD:1578503|PMID:16239369 20070306 RGD compared to control strain WKY/Izm 1302636 WKY.SHRSP-(D1Wox29-D1Arb21)/Izm strain MP:0004183 abnormal sympathetic nervous system physiology IAGP N RGD:2302408|PMID:19047583 20081217 RGD 1302636 WKY.SHRSP-(D1Wox29-D1Arb21)/Izm strain MP:0004484 abnormal response of heart to induced stress susceptibility IAGP XCO:0000158 N RGD:4889147|PMID:21063213 20191216 RGD compared to WKY/Izm in response to restraint stress 1302636 WKY.SHRSP-(D1Wox29-D1Arb21)/Izm strain MP:0004484 abnormal response of heart to induced stress susceptibility IAGP XCO:0000307,XCO:0000310 N RGD:1302892|PMID:15480093 20200109 RGD compared to WKY/Izm 1302636 WKY.SHRSP-(D1Wox29-D1Arb21)/Izm strain MP:0004875 increased mean systemic arterial blood pressure induced IAGP XCO:0000100 N RGD:2296063|PMID:16445571 20200107 RGD compared to WKY/Izm 1302636 WKY.SHRSP-(D1Wox29-D1Arb21)/Izm strain MP:0005525 increased renal plasma flow rate induced IAGP XCO:0000373 N RGD:2296063|PMID:16445571 20200203 RGD compared to sham surgery. 1302636 WKY.SHRSP-(D1Wox29-D1Arb21)/Izm strain MP:0005530 decreased renal vascular resistance induced IAGP XCO:0000373 N RGD:2296063|PMID:16445571 20200107 RGD compared to WKY.SHRSP-(D1Wox29-D1Arb21)/Izm with sham surgery 1302636 WKY.SHRSP-(D1Wox29-D1Arb21)/Izm strain MP:0005665 increased circulating noradrenaline level susceptibility IAGP N RGD:1302892|PMID:15480093 19990101 RGD compared to WKY/Izm 1302636 WKY.SHRSP-(D1Wox29-D1Arb21)/Izm strain MP:0006143 increased systemic arterial diastolic blood pressure susceptibility IAGP N RGD:1302892|PMID:15480093 20200109 RGD compared to WKY/Izm 1302636 WKY.SHRSP-(D1Wox29-D1Arb21)/Izm strain MP:0006144 increased systemic arterial systolic blood pressure susceptibility IAGP N RGD:1302892|PMID:15480093 20200109 RGD compared to WKY/Izm 1302636 WKY.SHRSP-(D1Wox29-D1Arb21)/Izm strain MP:0006144 increased systemic arterial systolic blood pressure susceptibility IAGP N RGD:4889147|PMID:21063213 20191216 RGD baseline compared to WKY/Izm 1302636 WKY.SHRSP-(D1Wox29-D1Arb21)/Izm strain MP:0006316 increased urine sodium level induced IAGP XCO:0000373 N RGD:2296063|PMID:16445571 20200203 RGD compared to sham surgery. 1302636 WKY.SHRSP-(D1Wox29-D1Arb21)/Izm strain MP:0012046 decreased susceptibility to hypertension susceptibility IAGP N RGD:1578503|PMID:16239369 20191209 RGD compared to hypertensive strain SHRSP/Izm 1302636 WKY.SHRSP-(D1Wox29-D1Arb21)/Izm strain MP:0012574 decreased noradrenaline level induced IAGP XCO:0000373 N RGD:2296063|PMID:16445571 20200203 RGD compared to sham surgery 1302636 WKY.SHRSP-(D1Wox29-D1Arb21)/Izm strain MP:0030768 increased urine dopamine level susceptibility IAGP N RGD:1302892|PMID:15480093 20200109 RGD compared to WKY/Izm 1302636 WKY.SHRSP-(D1Wox29-D1Arb21)/Izm strain MP:0030770 increased urine adrenaline level susceptibility IAGP N RGD:1302892|PMID:15480093 20200109 RGD compared to WKY/Izm 1302636 WKY.SHRSP-(D1Wox29-D1Arb21)/Izm strain MP:0030772 increased urine noradrenaline level susceptibility IAGP N RGD:1302892|PMID:15480093 20200109 RGD compared to WKY/Izm 1302636 WKY.SHRSP-(D1Wox29-D1Arb21)/Izm strain MP:0030772 increased urine noradrenaline level susceptibility IAGP XCO:0000307 N RGD:4889147|PMID:21063213 20191216 RGD compared to WKY/Izm in response to cold stress 1302638 LEXF11/Stm strain MP:0002024 increased T cell derived lymphoma incidence induced IAGP XCO:0000437 N RGD:619600|PMID:10360666 19990101 RGD 1302641 LEXF1A/Stm strain MP:0002024 increased T cell derived lymphoma incidence induced IAGP XCO:0000437 N RGD:619600|PMID:10360666 19990101 RGD 1302645 DMY/Kyo demyelination rat strain MP:0006036 abnormal mitochondrial physiology IMP N RGD:12793070|PMID:21253565 20170320 RGD DNA:missense mutation:intron (Mrs2) 1302646 LEXF2C/Stm strain MP:0002024 increased T cell derived lymphoma incidence induced IAGP XCO:0000437 N RGD:619600|PMID:10360666 20200710 RGD 1302648 LEC/Hok Long Evans Cinnamon strain MP:0000611 jaundice IAGP N RGD:1302497|PMID:3429843 19990101 RGD 1302648 LEC/Hok Long Evans Cinnamon strain MP:0000611 jaundice IAGP XCO:0000212 N RGD:25823141|PMID:30733544 20200708 RGD compared to LEA/Hok 1302648 LEC/Hok Long Evans Cinnamon strain MP:0001263 weight loss IAGP XCO:0000212 N RGD:25823141|PMID:30733544 20200708 RGD compared to LEA/Hok 1302648 LEC/Hok Long Evans Cinnamon strain MP:0002083 premature death IAGP XCO:0000212 N RGD:25823141|PMID:30733544 20200708 RGD compared to LEA/Hok 1302648 LEC/Hok Long Evans Cinnamon strain MP:0002628 hepatic steatosis IAGP N RGD:25823147|PMID:2022751 20200501 RGD 1302648 LEC/Hok Long Evans Cinnamon strain MP:0002941 increased circulating alanine transaminase level IAGP XCO:0000212 N RGD:25823141|PMID:30733544 20200708 RGD compared to LEA/Hok 1302648 LEC/Hok Long Evans Cinnamon strain MP:0003066 increased liver copper level IAGP N RGD:15036817|PMID:8291609 20191120 RGD 1302648 LEC/Hok Long Evans Cinnamon strain MP:0003066 increased liver copper level IAGP N RGD:25823154|PMID:1561010 20200501 RGD compared to LEA/Hok 1302648 LEC/Hok Long Evans Cinnamon strain MP:0003066 increased liver copper level IAGP XCO:0000212 N RGD:25823141|PMID:30733544 20200708 RGD compared to LEA/Hok 1302648 LEC/Hok Long Evans Cinnamon strain MP:0003674 oxidative stress IAGP XCO:0000212 N RGD:25823141|PMID:30733544 20200708 RGD compared to LEA/Hok 1302648 LEC/Hok Long Evans Cinnamon strain MP:0005343 increased circulating aspartate transaminase level IAGP XCO:0000212 N RGD:25823141|PMID:30733544 20200708 RGD compared to LEA/Hok 1302648 LEC/Hok Long Evans Cinnamon strain MP:0005344 increased circulating bilirubin level IAGP XCO:0000212 N RGD:25823141|PMID:30733544 20200708 RGD compared to LEA/Hok 1302648 LEC/Hok Long Evans Cinnamon strain MP:0006349 decreased circulating copper level IAGP N RGD:25823147|PMID:2022751 20200501 RGD compared to LEA/Hok 1302648 LEC/Hok Long Evans Cinnamon strain MP:0012612 decreased ceruloplasmin level IAGP XCO:0000212 N RGD:25823141|PMID:30733544 20200708 RGD compared to LEA/Hok 1302648 LEC/Hok Long Evans Cinnamon strain MP:0012661 decreased circulating ceruloplasmin level IAGP N RGD:25823154|PMID:1561010 20200501 RGD compared to LEA/Hok 1302649 LEXF7B/Stm strain MP:0002024 increased T cell derived lymphoma incidence penetrance IAGP XCO:0000437 N RGD:619600|PMID:10360666 19990101 RGD 1302649 LEXF7B/Stm strain MP:0002026 increased leukemia incidence penetrance IAGP XCO:0000437 N RGD:619600|PMID:10360666 19990101 RGD 1302652 LEXF7A/Stm strain MP:0002024 increased T cell derived lymphoma incidence induced IAGP XCO:0000437 N RGD:619600|PMID:10360666 19990101 RGD 1302653 LEXF8A/Stm strain MP:0002026 increased leukemia incidence penetrance IAGP XCO:0000437 N RGD:619600|PMID:10360666 20200710 RGD 1302654 F344.OLETF-(D7Mgh16-D7Mgh20)/Tj strain MP:0001262 decreased body weight IAGP N RGD:1643009|PMID:17710484 20071117 RGD compared to F344/Slc 1302654 F344.OLETF-(D7Mgh16-D7Mgh20)/Tj strain MP:0005293 impaired glucose tolerance induced IAGP XCO:0000103 N RGD:1643009|PMID:17710484 20071117 RGD compared to F344/Slc 1302654 F344.OLETF-(D7Mgh16-D7Mgh20)/Tj strain MP:0005668 decreased circulating leptin level IAGP N RGD:1643009|PMID:17710484 20201103 RGD compared to F344/Slc 1302654 F344.OLETF-(D7Mgh16-D7Mgh20)/Tj strain MP:0009289 decreased epididymal fat pad weight IAGP N RGD:1643009|PMID:17710484 20201103 RGD compared to F344/Slc 1302654 F344.OLETF-(D7Mgh16-D7Mgh20)/Tj strain MP:0009299 decreased mesenteric fat pad weight induced IAGP N RGD:1643009|PMID:17710484 20201103 RGD compared to F344/Slc 1302654 F344.OLETF-(D7Mgh16-D7Mgh20)/Tj strain MP:0009305 decreased retroperitoneal fat pad weight induced IAGP N RGD:1643009|PMID:17710484 20201103 RGD compared to F344/Slc 1302654 F344.OLETF-(D7Mgh16-D7Mgh20)/Tj strain MP:0011940 decreased food intake IAGP N RGD:1643009|PMID:17710484 20201119 RGD compared to F344/Slc 1302654 F344.OLETF-(D7Mgh16-D7Mgh20)/Tj strain MP:0013279 increased fasting circulating glucose level induced IAGP XCO:0000275 N RGD:625760|PMID:12420133 20201201 RGD compared to F344/Slc 1302657 DOP/Nem dilute-opisthotonus (dop) strain MP:0001393 ataxia IAGP N RGD:1600835|PMID:17185506 20210914 RGD compared to wild-type 1302657 DOP/Nem dilute-opisthotonus (dop) strain MP:0002880 opisthotonus IAGP N RGD:1600835|PMID:17185506 20210914 RGD compared to wild-type 1302657 DOP/Nem dilute-opisthotonus (dop) strain MP:0003996 clonic seizures IAGP N RGD:1600835|PMID:17185506 20210914 RGD compared to wild-type 1302657 DOP/Nem dilute-opisthotonus (dop) strain MP:0009378 abnormal endoplasmic reticulum morphology IAGP N RGD:1600835|PMID:17185506 20210914 RGD compared to wild-type 1302660 RCS/Kyo royal college of surgeons rat strain MP:0005201 abnormal retina pigment epithelium morphology treatment IAGP XCO:0000529 N RGD:69668|PMID:11592982 20200313 RGD 1302660 RCS/Kyo royal college of surgeons rat strain MP:0008450 retina photoreceptor degeneration treatment IAGP XCO:0000529 N RGD:69668|PMID:11592982 20200313 RGD 1302660 RCS/Kyo royal college of surgeons rat strain MP:0008515 thin retina outer nuclear layer IAGP N RGD:69668|PMID:11592982 20190802 RGD 1302661 F344.OLETF-(D14Rat23-D14Rat12)/Tj strain MP:0001260 increased body weight IAGP N RGD:1643009|PMID:17710484 20071117 RGD compared to F344/Slc 1302661 F344.OLETF-(D14Rat23-D14Rat12)/Tj strain MP:0001262 decreased body weight IAGP N RGD:10755343|PMID:26296322 20160906 RGD as compared to F344/NSlc; 1302661 F344.OLETF-(D14Rat23-D14Rat12)/Tj strain MP:0002079 increased circulating insulin level induced IAGP XCO:0000103 N RGD:1643009|PMID:17710484 20071117 RGD compared to F344/Slc 1302661 F344.OLETF-(D14Rat23-D14Rat12)/Tj strain MP:0009298 increased mesenteric fat pad weight IAGP N RGD:1643009|PMID:17710484 20201103 RGD compared to F344/Slc 1302661 F344.OLETF-(D14Rat23-D14Rat12)/Tj strain MP:0009304 increased retroperitoneal fat pad weight IAGP N RGD:1643009|PMID:17710484 20201103 RGD compared to F344/Slc 1302663 F344.OLETF-(D11Rat4-D11Rat1)/Tj strain MP:0001262 decreased body weight induced IAGP XCO:0000275 N RGD:625760|PMID:12420133 20201201 RGD compared to F344/Slc 1302663 F344.OLETF-(D11Rat4-D11Rat1)/Tj strain MP:0013279 increased fasting circulating glucose level induced IAGP XCO:0000275 N RGD:625760|PMID:12420133 20201201 RGD compared to F344/Slc 1302666 LEXF1C/Stm strain MP:0002024 increased T cell derived lymphoma incidence induced IAGP XCO:0000437 N RGD:619600|PMID:10360666 19990101 RGD 1302667 F344.OLETF-(D5Mgh5-D5Mgh23)/Tj strain MP:0001262 decreased body weight induced IAGP XCO:0000275 N RGD:625760|PMID:12420133 20201201 RGD compared to F344/Slc 1302674 VF/Kyo vacuole formation rat strain MP:0000745 tremors IAGP N RGD:1302449|PMID:12012723 19990101 RGD 1302674 VF/Kyo vacuole formation rat strain MP:0008025 brain vacuoles IAGP N RGD:40818080|PMID:24863653 20201110 RGD 1302674 VF/Kyo vacuole formation rat strain MP:0013438 dysmyelination IAGP N RGD:40818080|PMID:24863653 20201110 RGD 1302675 WKY.SHRSP-(D1Smu13-D1Smu11)/Izm strain MP:0030772 increased urine noradrenaline level susceptibility IAGP XCO:0000307 N RGD:4889147|PMID:21063213 20191216 RGD compared to WKY/Izm in response to cold stress 1302678 NAR/Slc non albumin rat strain MP:0005419 decreased circulating serum albumin level susceptibility IAGP N RGD:126781840|PMID:451621 20210421 RGD 1302686 F344/Stm strain MP:0002024 increased T cell derived lymphoma incidence induced IAGP XCO:0000437 N RGD:619600|PMID:10360666 20200712 RGD 1302689 WKY.SHRSP-(Ntrk3-D1Smu13)/Izm strain MP:0030772 increased urine noradrenaline level susceptibility IAGP XCO:0000307 N RGD:4889147|PMID:21063213 20191216 RGD compared to WKY/Izm in response to cold stress 1302695 SER/Kyo spontaneously epileptic rat strain MP:0000745 tremors susceptibility IAGP N RGD:1302445|PMID:3559168 20200923 RGD compared to heterozygous rats 1302695 SER/Kyo spontaneously epileptic rat strain MP:0000947 convulsive seizures IAGP N RGD:1600256|PMID:17326796 20200923 RGD compared to Wistar rats 1302695 SER/Kyo spontaneously epileptic rat strain MP:0002064 seizures susceptibility IAGP N RGD:1302445|PMID:3559168 20200923 RGD compared to heterozygous rats 1302695 SER/Kyo spontaneously epileptic rat strain MP:0002826 tonic seizures IAGP N RGD:1600256|PMID:17326796 20070306 RGD compared to Wistar rats 1302695 SER/Kyo spontaneously epileptic rat strain MP:0002826 tonic seizures treatment IAGP N RGD:39128157|PMID:16146430 20200923 RGD 1302695 SER/Kyo spontaneously epileptic rat strain MP:0003216 absence seizures IAGP N RGD:1600256|PMID:17326796 20200923 RGD compared to Wistar rats 1302695 SER/Kyo spontaneously epileptic rat strain MP:0003216 absence seizures treatment IAGP N RGD:39128157|PMID:16146430 20200923 RGD 1302695 SER/Kyo spontaneously epileptic rat strain MP:0003471 abnormal summary potential threshold IAGP N RGD:1600256|PMID:17326796 20200923 RGD compared to Wistar rats 1302695 SER/Kyo spontaneously epileptic rat strain MP:0004231 abnormal calcium ion homeostasis IAGP N RGD:1600256|PMID:17326796 20070306 RGD compared to Wistar rats 1302695 SER/Kyo spontaneously epileptic rat strain MP:0011269 increased excitatory postsynaptic current amplitude IAGP N RGD:1600256|PMID:17326796 20200923 RGD compared to Wistar rats 1302695 SER/Kyo spontaneously epileptic rat strain MP:0011274 short excitatory postsynaptic current decay time IAGP N RGD:1600256|PMID:17326796 20200923 RGD compared to Wistar rats 1302698 SDR/Slc Spontaneous dwarf rat strain MP:0005136 decreased growth hormone level IAGP N RGD:1578505|PMID:2752987 20170504 RGD 1302698 SDR/Slc Spontaneous dwarf rat strain MP:0005138 decreased prolactin level IAGP N RGD:1578505|PMID:2752987 20170504 RGD 1302699 LEXF8D/Stm strain MP:0002024 increased T cell derived lymphoma incidence penetrance IAGP XCO:0000437 N RGD:619600|PMID:10360666 20200710 RGD 1302699 LEXF8D/Stm strain MP:0002026 increased leukemia incidence penetrance IAGP XCO:0000437 N RGD:619600|PMID:10360666 20200710 RGD 1302700 HOB/Snk hobble rat strain MP:0000865 absent cerebellum vermis IAGP N RGD:1302461|PMID:14993736 20170412 RGD 1302702 TRM/Kyo tremor rat strain MP:0000410 waved hair IAGP N RGD:13602102|PMID:4018151 20180605 RGD 1302702 TRM/Kyo tremor rat strain MP:0000745 tremors susceptibility IAGP N RGD:11060746|PMID:25970616 20200910 RGD compared to TRMR/Kyo and WTC/Kyo 1302702 TRM/Kyo tremor rat strain MP:0001116 small gonad IAGP N RGD:13602102|PMID:4018151 20180605 RGD 1302702 TRM/Kyo tremor rat strain MP:0001274 curly vibrissae IAGP N RGD:13602102|PMID:4018151 20180605 RGD 1302702 TRM/Kyo tremor rat strain MP:0001930 abnormal meiosis treatment IDA N RGD:38549346|PMID:23903057 20200831 RGD compared to untreated 1302702 TRM/Kyo tremor rat strain MP:0003216 absence seizures IAGP N RGD:13602101|PMID:3104669 20090209 RGD 1302702 TRM/Kyo tremor rat strain MP:0004852 decreased testis weight treatment IDA N RGD:38549346|PMID:23903057 20200831 RGD compared to untreated 1302702 TRM/Kyo tremor rat strain MP:0008025 brain vacuoles IAGP N RGD:13602102|PMID:4018151 20090209 RGD 1302702 TRM/Kyo tremor rat strain MP:0008279 arrest of spermiogenesis IDA N RGD:38549346|PMID:23903057 20200831 RGD compared to untreated 1302702 TRM/Kyo tremor rat strain MP:0013236 ovary degeneration treatment IDA N RGD:38549346|PMID:23903057 20200831 RGD compared to untreated 1302702 TRM/Kyo tremor rat strain MP:0031396 abnormal aspartoacylase level IAGP N RGD:628404|PMID:10820213 20220531 RGD compared to WTC 1302707 LEXF3/Stm strain MP:0002024 increased T cell derived lymphoma incidence penetrance IAGP XCO:0000437 N RGD:619600|PMID:10360666 19990101 RGD 1302707 LEXF3/Stm strain MP:0002026 increased leukemia incidence penetrance IAGP XCO:0000437 N RGD:619600|PMID:10360666 19990101 RGD 1302710 LEXF2B/Stm strain MP:0002024 increased T cell derived lymphoma incidence penetrance IAGP XCO:0000437 N RGD:619600|PMID:10360666 19990101 RGD 1302711 ExHC/Seac strain MP:0005178 increased circulating cholesterol level induced IAGP XCO:0000246, XCO:0000025 N RGD:2300117|PMID:18753676 20100217 RGD 1302713 F344.OLETF-(D8Rat58-D8Mgh17)/Tj strain MP:0005559 increased circulating glucose level IAGP N RGD:2300331|PMID:18421176 20080912 RGD heterozygous genotype at the Niddm21 locus 1302713 F344.OLETF-(D8Rat58-D8Mgh17)/Tj strain MP:0013279 increased fasting circulating glucose level induced IAGP XCO:0000275 N RGD:625760|PMID:12420133 20201201 RGD compared to F344/Slc 1302721 LEC/Tj strain MP:0000611 jaundice IAGP N RGD:1302456|PMID:11509115 20191119 RGD 1302721 LEC/Tj strain MP:0008076 abnormal CD4-positive T cell differentiation IAGP N RGD:15036800|PMID:17434290 20090211 RGD 1302721 LEC/Tj strain MP:0031022 hepatic megalocytosis IAGP N RGD:1302456|PMID:11509115 20191119 RGD 1302723 LEXF5/Stm strain MP:0002026 increased leukemia incidence penetrance IAGP XCO:0000437 N RGD:619600|PMID:10360666 20200710 RGD 1302727 SHRSR/Ta strain MP:0002833 increased heart weight IAGP N RGD:12904885|PMID:2941600 20191216 RGD compared to WKY 1302728 MES/Slc Matsumoto Eosinophilia Shinshu strain MP:0002978 absent otoliths IAGP N RGD:11040542|PMID:19406829 20170828 RGD DNA:deletion:splice junction: 1302728 MES/Slc Matsumoto Eosinophilia Shinshu strain MP:0005011 increased eosinophil cell number IAGP N RGD:5134988|PMID:21512270 20110711 RGD compared to BN/SsN 1302728 MES/Slc Matsumoto Eosinophilia Shinshu strain MP:0020447 decreased NAD(P)H oxidase activity IAGP N RGD:11040542|PMID:19406829 20170828 RGD 1302786 Kidm8 Kidney mass QTL 8 qtl MP:0003068 enlarged kidney QTM N RGD:629573|PMID:9097967 19990101 RGD 1302786 Kidm8 Kidney mass QTL 8 qtl MP:0005565 increased blood urea nitrogen level QTM N RGD:629573|PMID:9097967 19990101 RGD 1302787 Stl25 Serum triglyceride level QTL 25 qtl MP:0001552 increased circulating triglyceride level QTM N RGD:1299960|PMID:14709677 19990101 RGD 1302787 Stl25 Serum triglyceride level QTL 25 qtl MP:0005178 increased circulating cholesterol level QTM N RGD:1299960|PMID:14709677 19990101 RGD 1302788 Scl19 Serum cholesterol QTL 19 qtl MP:0005178 increased circulating cholesterol level QTM N RGD:1299960|PMID:14709677 19990101 RGD 1302789 Stl26 Serum triglyceride level QTL 26 qtl MP:0001552 increased circulating triglyceride level QTM N RGD:1299960|PMID:14709677 19990101 RGD 1302790 Scl20 Serum cholesterol level QTL 20 qtl MP:0005179 decreased circulating cholesterol level QTM N RGD:1299960|PMID:14709677 19990101 RGD 1302791 Stl29 Serum triglyceride level QTL 29 qtl MP:0001552 increased circulating triglyceride level IDA N RGD:1299960|PMID:14709677 20121002 RGD 1302791 Stl29 Serum triglyceride level QTL 29 qtl MP:0001552 increased circulating triglyceride level QTM N RGD:1299960|PMID:14709677 19990101 RGD 1302792 Scl21 Serum cholesterol level QTL 21 qtl MP:0005179 decreased circulating cholesterol level QTM N RGD:1299960|PMID:14709677 19990101 RGD 1302793 Bw16 Body weight QTL 16 qtl MP:0001260 increased body weight IAGP N RGD:1299960|PMID:14709677 19990101 RGD 1302794 Stl27 Serum triglyceride level QTL 27 qtl MP:0001552 increased circulating triglyceride level QTM N RGD:1299960|PMID:14709677 19990101 RGD 1302795 HTG Prague hypertriglyceridemic strain MP:0001260 increased body weight sexual_dimorphism IAGP N RGD:1299960|PMID:14709677 20200408 RGD compared to HTG females, LEW females 1302795 HTG Prague hypertriglyceridemic strain MP:0001262 decreased body weight IAGP N RGD:1342424|PMID:1513201 20200420 RGD compared to Wistar 1302795 HTG Prague hypertriglyceridemic strain MP:0001552 increased circulating triglyceride level IAGP N RGD:1299960|PMID:14709677 20200408 RGD compared to LEW 1302795 HTG Prague hypertriglyceridemic strain MP:0001552 increased circulating triglyceride level IAGP N RGD:1342424|PMID:1513201 20200420 RGD compared to Wistar 1302795 HTG Prague hypertriglyceridemic strain MP:0001554 increased circulating free fatty acids level IAGP N RGD:1342424|PMID:1513201 20200420 RGD compared to Wistar 1302795 HTG Prague hypertriglyceridemic strain MP:0002833 increased heart weight IAGP N RGD:1303386|PMID:14640890 19990101 RGD compared to LEW/Cub 1302795 HTG Prague hypertriglyceridemic strain MP:0003918 decreased kidney weight IAGP N RGD:1303386|PMID:14640890 19990101 RGD compared to LEW/Cub 1302795 HTG Prague hypertriglyceridemic strain MP:0004875 increased mean systemic arterial blood pressure IAGP N RGD:1342424|PMID:1513201 20200420 RGD compared to Wistar 1302795 HTG Prague hypertriglyceridemic strain MP:0005179 decreased circulating cholesterol level IAGP N RGD:1299960|PMID:14709677 19990101 RGD compared to LEW females 1302795 HTG Prague hypertriglyceridemic strain MP:0005292 improved glucose tolerance IAGP N RGD:1342424|PMID:1513201 20200420 RGD compared to Wistar 1302795 HTG Prague hypertriglyceridemic strain MP:0005331 insulin resistance IAGP N RGD:1342424|PMID:1513201 20200420 RGD compared to Wistar 1302795 HTG Prague hypertriglyceridemic strain MP:0005662 increased circulating adrenaline level IAGP N RGD:1342424|PMID:1513201 20200420 RGD compared to Wistar 1302795 HTG Prague hypertriglyceridemic strain MP:0005665 increased circulating noradrenaline level IAGP N RGD:1342424|PMID:1513201 20200420 RGD compared to Wistar 1302795 HTG Prague hypertriglyceridemic strain MP:0006143 increased systemic arterial diastolic blood pressure IAGP N RGD:1303386|PMID:14640890 19990101 RGD compared to LEW/Cub 1302795 HTG Prague hypertriglyceridemic strain MP:0006143 increased systemic arterial diastolic blood pressure IAGP N RGD:1342424|PMID:1513201 20200420 RGD compared to Wistar 1302795 HTG Prague hypertriglyceridemic strain MP:0006143 increased systemic arterial diastolic blood pressure sexual_dimorphism IAGP N RGD:1299960|PMID:14709677 19990101 RGD compared to HTG females, LEW males 1302795 HTG Prague hypertriglyceridemic strain MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:1299960|PMID:14709677 19990101 RGD compared to LEW 1302795 HTG Prague hypertriglyceridemic strain MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:1303386|PMID:14640890 19990101 RGD compared to LEWCub 1302795 HTG Prague hypertriglyceridemic strain MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:1342424|PMID:1513201 20200420 RGD compared to Wistar 1302795 HTG Prague hypertriglyceridemic strain MP:0006353 increased glycosylated hemoglobin level IAGP N RGD:1342424|PMID:1513201 20200421 RGD compared to Wistar 1302921 F344-Tg(NPHS2-HBEGF)Wig strain MP:0002962 increased urine protein level induced IMP XCO:0000736 N RGD:1556472|PMID:16107576 20200908 RGD 1302921 F344-Tg(NPHS2-HBEGF)Wig strain MP:0011753 decreased podocyte number induced IMP XCO:0000736 N RGD:1556472|PMID:16107576 20200908 RGD 1303024 Krt83 keratin 83 gene MP:0002073 abnormal hair growth IAGP N RGD:2316553|PMID:18420582 20100216 RGD DNA:deletion 1303393 LEC/Ncu strain MP:0003992 increased mortality induced by ionizing radiation IAGP N RGD:69702|PMID:11003700 19990101 RGD compared to BN/Sea 1304562 Tbc1d1 TBC1 domain family member 1 gene MP:0002327 abnormal respiratory function induces IMP XCO:0000392 N RGD:150521563|PMID:28808062 20211125 RGD 1304562 Tbc1d1 TBC1 domain family member 1 gene MP:0002727 decreased circulating insulin level induces IMP XCO:0000275,XCO:0000102,XCO:0000025 N RGD:150521607|PMID:28177704 20211125 RGD compared to Wild type 1304562 Tbc1d1 TBC1 domain family member 1 gene MP:0003059 decreased insulin secretion induces IMP XCO:0000669,XCO:0000275,XCO:0000312 N RGD:150521607|PMID:28177704 20211125 RGD compared to Wild type 1304562 Tbc1d1 TBC1 domain family member 1 gene MP:0003646 increased muscle fatigability induces IMP XCO:0000005 N RGD:150521563|PMID:28808062 20211125 RGD 1304562 Tbc1d1 TBC1 domain family member 1 gene MP:0005289 increased oxygen consumption induces IMP XCO:0000392 N RGD:150521563|PMID:28808062 20211125 RGD 1304562 Tbc1d1 TBC1 domain family member 1 gene MP:0005559 increased circulating glucose level induces IMP XCO:0000275 N RGD:150521563|PMID:28808062 20211125 RGD compared to Wild type 1304562 Tbc1d1 TBC1 domain family member 1 gene MP:0006042 increased apoptosis IMP N RGD:150521607|PMID:28177704 20211125 RGD 1304562 Tbc1d1 TBC1 domain family member 1 gene MP:0009114 decreased pancreatic beta cell mass induces IMP XCO:0000025 N RGD:150521607|PMID:28177704 20211125 RGD compared to Wild type 1304562 Tbc1d1 TBC1 domain family member 1 gene MP:0010061 increased creatine level induces IMP XCO:0000521 N RGD:150521563|PMID:28808062 20211125 RGD 1304562 Tbc1d1 TBC1 domain family member 1 gene MP:0010147 abnormal endocrine pancreas physiology induces IMP XCO:0000025 N RGD:150521607|PMID:28177704 20211125 RGD compared to Wild type 1304562 Tbc1d1 TBC1 domain family member 1 gene MP:0010401 increased skeletal muscle glycogen level induces IMP XCO:0000521 N RGD:150521563|PMID:28808062 20211125 RGD 1304562 Tbc1d1 TBC1 domain family member 1 gene MP:0013243 abnormal carbohydrate metabolism induces IMP XCO:0000181 N RGD:150521563|PMID:28808062 20211125 RGD 1304562 Tbc1d1 TBC1 domain family member 1 gene MP:0013278 decreased fasting circulating glucose level induces IMP XCO:0000245,XCO:0000025 N RGD:150521607|PMID:28177704 20211125 RGD compared to Wild type and heterozygous 1304562 Tbc1d1 TBC1 domain family member 1 gene MP:0013279 increased fasting circulating glucose level induces IMP XCO:0000275,XCO:0000025 N RGD:150521607|PMID:28177704 20211125 RGD compared to Wild type 1304562 Tbc1d1 TBC1 domain family member 1 gene MP:0014171 increased fatty acid oxidation induces IMP XCO:0000181 N RGD:150521563|PMID:28808062 20211125 RGD 1304562 Tbc1d1 TBC1 domain family member 1 gene MP:0030022 decreased muscle cell glucose uptake induces IMP XCO:0000521 N RGD:150521563|PMID:28808062 20211125 RGD compared to Wild type 1304773 Cop1 COP1, E3 ubiquitin ligase gene MP:0004217 salt-sensitive hypertension IMP N RGD:12792227|PMID:24714719 20170316 RGD 1304773 Cop1 COP1, E3 ubiquitin ligase gene MP:0011022 abnormal circadian regulation of systemic arterial blood pressure IMP N RGD:12792227|PMID:24714719 20170316 RGD 1304916 Optc opticin gene MP:0002871 albuminuria IAGP N RGD:12802368|PMID:23817491 20170406 RGD 1304916 Optc opticin gene MP:0004217 salt-sensitive hypertension IAGP N RGD:12802368|PMID:23817491 20170406 RGD 1305304 Etnk2 ethanolamine kinase 2 gene MP:0002871 albuminuria IAGP N RGD:12802369|PMID:23460292 20170407 RGD 1305304 Etnk2 ethanolamine kinase 2 gene MP:0004217 salt-sensitive hypertension IAGP N RGD:12802369|PMID:23460292 20170407 RGD 1305369 Nkx3-1 NK3 homeobox 1 gene MP:0001167 prostate gland epithelial hyperplasia IMP N RGD:150573817|PMID:33368416 20220224 RGD compared to wild type 1305369 Nkx3-1 NK3 homeobox 1 gene MP:0001922 reduced male fertility IMP N RGD:150573817|PMID:33368416 20220224 RGD compared to wild type 1305369 Nkx3-1 NK3 homeobox 1 gene MP:0001935 decreased litter size IMP N RGD:150573817|PMID:33368416 20220224 RGD compared to wild type 1305369 Nkx3-1 NK3 homeobox 1 gene MP:0004962 decreased prostate gland weight IMP N RGD:150573817|PMID:33368416 20220224 RGD compared to wild type 1305369 Nkx3-1 NK3 homeobox 1 gene MP:0030982 abnormal copulatory plug deposition IMP N RGD:150573817|PMID:33368416 20220224 RGD compared to wild type 1305379 Clcn6 chloride voltage-gated channel 6 gene MP:0001262 decreased body weight IMP N RGD:8662415|PMID:24006081 20190717 RGD as compared to the wild-type 1305379 Clcn6 chloride voltage-gated channel 6 gene MP:0002834 decreased heart weight IMP N RGD:8662415|PMID:24006081 20190717 RGD as compared to the wild-type 1305379 Clcn6 chloride voltage-gated channel 6 gene MP:0002963 decreased urine protein level IMP N RGD:8662415|PMID:24006081 20190717 RGD as compared to the wild-type 1305379 Clcn6 chloride voltage-gated channel 6 gene MP:0004876 decreased mean systemic arterial blood pressure IMP N RGD:8662415|PMID:24006081 20190717 RGD as compared to the wild-type 1305379 Clcn6 chloride voltage-gated channel 6 gene MP:0006263 decreased systemic arterial diastolic blood pressure IMP N RGD:8662415|PMID:24006081 20190717 RGD as compared to the wild-type 1305379 Clcn6 chloride voltage-gated channel 6 gene MP:0006317 decreased urine sodium level IMP N RGD:8662415|PMID:24006081 20190717 RGD as compared to the wild-type 1305379 Clcn6 chloride voltage-gated channel 6 gene MP:0011471 decreased urine creatinine level IMP N RGD:8662415|PMID:24006081 20190717 RGD as compared to the wild-type 1305399 Ifnar1 interferon alpha and beta receptor subunit 1 gene MP:0004031 insulitis IMP N RGD:12910492|PMID:27999109 20170616 RGD 1305399 Ifnar1 interferon alpha and beta receptor subunit 1 gene MP:0004804 decreased susceptibility to autoimmune diabetes IMP N RGD:12910492|PMID:27999109 20200127 RGD 1305399 Ifnar1 interferon alpha and beta receptor subunit 1 gene MP:0009791 increased susceptibility to viral infection induced morbidity/mortality IMP N RGD:12910492|PMID:27999109 20200127 RGD 1305399 Ifnar1 interferon alpha and beta receptor subunit 1 gene MP:0020162 decreased susceptibility to virus induced diabetes IMP N RGD:12910492|PMID:27999109 20200127 RGD 1305534 Dop1a DOP1 leucine zipper like protein A gene MP:0008025 brain vacuoles IAGP N RGD:40818080|PMID:24863653 20201110 RGD 1305534 Dop1a DOP1 leucine zipper like protein A gene MP:0013438 dysmyelination IAGP N RGD:40818080|PMID:24863653 20201110 RGD 1305588 Rag2 recombination activating 2 gene MP:0000692 small spleen IMP N RGD:38508903|PMID:30206106 20200821 RGD 1305588 Rag2 recombination activating 2 gene MP:0002021 increased incidence of induced tumors induced IMP N RGD:38508903|PMID:30206106 20200821 RGD XCO:0000709 1305588 Rag2 recombination activating 2 gene MP:0004956 decreased thymus weight IMP N RGD:38508903|PMID:30206106 20200821 RGD 1305588 Rag2 recombination activating 2 gene MP:0005092 decreased double-positive T cell number IMP N RGD:38508903|PMID:30206106 20200821 RGD 1305588 Rag2 recombination activating 2 gene MP:0008044 increased NK cell number IMP N RGD:38508903|PMID:30206106 20200821 RGD 1305588 Rag2 recombination activating 2 gene MP:0008212 absent mature B cells IMP N RGD:38508903|PMID:30206106 20200821 RGD 1305646 Chit1 chitinase 1 gene MP:0002871 albuminuria IAGP N RGD:12802369|PMID:23460292 20170407 RGD 1305646 Chit1 chitinase 1 gene MP:0004217 salt-sensitive hypertension IAGP N RGD:12802369|PMID:23460292 20170407 RGD 1305652 Mkx mohawk homeobox gene MP:0001406 abnormal gait IMP N RGD:40924660|PMID:27370800 20210415 RGD compared to Wistar 1305652 Mkx mohawk homeobox gene MP:0003098 decreased tendon stiffness IMP N RGD:40924660|PMID:27370800 20210415 RGD compared to Wistar 1305652 Mkx mohawk homeobox gene MP:0005503 abnormal tendon morphology IMP N RGD:40924660|PMID:27370800 20210415 RGD compared to Wistar 1305652 Mkx mohawk homeobox gene MP:0011643 abnormal tendon collagen fibril morphology IMP N RGD:40924660|PMID:27370800 20210415 RGD compared to Wistar 1305652 Mkx mohawk homeobox gene MP:0013179 wavy tail IMP N RGD:40924660|PMID:27370800 20210415 RGD compared to Wistar 1305652 Mkx mohawk homeobox gene MP:0020039 increased bone ossification IMP N RGD:40924660|PMID:27370800 20210415 RGD compared to Wistar 1305769 Pink1 PTEN induced kinase 1 gene MP:0001260 increased body weight IMP N RGD:13210569|PMID:24969022 20170912 RGD 1305769 Pink1 PTEN induced kinase 1 gene MP:0001402 decreased locomotor activity IMP N RGD:13210569|PMID:24969022 20170912 RGD 1305769 Pink1 PTEN induced kinase 1 gene MP:0001406 abnormal gait IMP N RGD:13210569|PMID:24969022 20170912 RGD 1305769 Pink1 PTEN induced kinase 1 gene MP:0001516 abnormal motor coordination/balance IMP N RGD:13210569|PMID:24969022 20170912 RGD 1305769 Pink1 PTEN induced kinase 1 gene MP:0001906 increased dopamine level IMP N RGD:13210569|PMID:24969022 20170912 RGD 1305769 Pink1 PTEN induced kinase 1 gene MP:0002757 decreased vertical activity IMP N RGD:13210569|PMID:24969022 20170912 RGD 1305769 Pink1 PTEN induced kinase 1 gene MP:0003244 loss of dopaminergic neurons IMP N RGD:13210569|PMID:24969022 20170912 RGD 1305769 Pink1 PTEN induced kinase 1 gene MP:0004142 abnormal muscle tone IMP N RGD:13210569|PMID:24969022 20170912 RGD 1305769 Pink1 PTEN induced kinase 1 gene MP:0005289 increased oxygen consumption onset IMP N RGD:11560775|PMID:25421206 20210218 RGD compared to LEH 1305769 Pink1 PTEN induced kinase 1 gene MP:0010053 decreased grip strength IMP N RGD:13210569|PMID:24969022 20170912 RGD 1305769 Pink1 PTEN induced kinase 1 gene MP:0010069 increased serotonin level IMP N RGD:13210569|PMID:24969022 20170912 RGD 1305769 Pink1 PTEN induced kinase 1 gene MP:0020078 decreased brain tyrosine 3-monooxygenase activity IMP N RGD:13210569|PMID:24969022 20170912 RGD 1305769 Pink1 PTEN induced kinase 1 gene MP:0020543 decreased substantia nigra size IMP N RGD:11560775|PMID:25421206 20210218 RGD compared to LEH 1305769 Pink1 PTEN induced kinase 1 gene MP:0020726 decreased substantia nigra cell number IMP N RGD:11560775|PMID:25421206 20210218 RGD compared to LEH 1306212 Tmem163 transmembrane protein 163 gene MP:0004217 salt-sensitive hypertension IAGP N RGD:12798539|PMID:21257920 20170324 RGD 1306277 Ccdc39 coiled-coil domain 39 molecular ruler complex subunit gene MP:0000219 increased neutrophil cell number IMP N RGD:150521527|PMID:31771992 20211109 RGD 1306277 Ccdc39 coiled-coil domain 39 molecular ruler complex subunit gene MP:0000825 dilated lateral ventricle IMP N RGD:150521527|PMID:31771992 20211109 RGD 1306277 Ccdc39 coiled-coil domain 39 molecular ruler complex subunit gene MP:0001732 postnatal growth retardation IMP N RGD:150521527|PMID:31771992 20211109 RGD 1306277 Ccdc39 coiled-coil domain 39 molecular ruler complex subunit gene MP:0001891 hydrocephaly IMP N RGD:150521527|PMID:31771992 20211109 RGD 1306277 Ccdc39 coiled-coil domain 39 molecular ruler complex subunit gene MP:0001915 intracranial hemorrhage IMP N RGD:150521527|PMID:31771992 20211109 RGD 1306277 Ccdc39 coiled-coil domain 39 molecular ruler complex subunit gene MP:0002083 premature death IMP N RGD:150521527|PMID:31771992 20211109 RGD 1306277 Ccdc39 coiled-coil domain 39 molecular ruler complex subunit gene MP:0005425 increased macrophage cell number IMP N RGD:150521527|PMID:31771992 20211109 RGD 1306277 Ccdc39 coiled-coil domain 39 molecular ruler complex subunit gene MP:0006042 increased apoptosis IMP N RGD:150521527|PMID:31771992 20211109 RGD 1306277 Ccdc39 coiled-coil domain 39 molecular ruler complex subunit gene MP:0013438 dysmyelination IMP N RGD:150521527|PMID:31771992 20211109 RGD 1306277 Ccdc39 coiled-coil domain 39 molecular ruler complex subunit gene MP:0013907 abnormal cerebrospinal fluid flow IMP N RGD:150521527|PMID:31771992 20211109 RGD 1306277 Ccdc39 coiled-coil domain 39 molecular ruler complex subunit gene MP:0020371 abnormal glymphatic system physiology IMP N RGD:150521527|PMID:31771992 20211109 RGD 1306277 Ccdc39 coiled-coil domain 39 molecular ruler complex subunit gene MP:0031109 subarachnoid hemorrhage IMP N RGD:150521527|PMID:31771992 20211109 RGD 1306361 Ube3a ubiquitin protein ligase E3A gene MP:0001405 impaired coordination IMP N RGD:126790466|PMID:32066685 20210422 RGD 1306361 Ube3a ubiquitin protein ligase E3A gene MP:0001417 decreased exploration in new environment IMP N RGD:126790466|PMID:32066685 20210422 RGD 1306361 Ube3a ubiquitin protein ligase E3A gene MP:0002757 decreased vertical activity IMP N RGD:126790466|PMID:32066685 20210422 RGD 1306361 Ube3a ubiquitin protein ligase E3A gene MP:0002804 abnormal motor learning IMP N RGD:126790466|PMID:32066685 20210422 RGD 1306361 Ube3a ubiquitin protein ligase E3A gene MP:0005356 positive geotaxis IMP N RGD:126790466|PMID:32066685 20210422 RGD 1306361 Ube3a ubiquitin protein ligase E3A gene MP:0012315 impaired learning IMP N RGD:126790466|PMID:32066685 20210422 RGD 1306361 Ube3a ubiquitin protein ligase E3A gene MP:0012317 impaired conditioning behavior IMP N RGD:126790466|PMID:32066685 20210422 RGD 1306361 Ube3a ubiquitin protein ligase E3A gene MP:0020351 decreased vocalization IMP N RGD:126790466|PMID:32066685 20210422 RGD 1306897 Nek8 NIMA-related kinase 8 gene MP:0020382 increased kidney epithelial cell primary cilium length IAGP N RGD:40924667|PMID:22899815 20210304 RGD compared to control Lewis 1307076 Cntnap2 contactin associated protein 2 gene MP:0001262 decreased body weight IMP N RGD:126790476|PMID:30126973 20210422 RGD in males 1307076 Cntnap2 contactin associated protein 2 gene MP:0001399 hyperactivity IMP N RGD:126790476|PMID:30126973 20210422 RGD 1307076 Cntnap2 contactin associated protein 2 gene MP:0001399 hyperactivity IMP N RGD:12880397|PMID:28364455 20201210 RGD 1307076 Cntnap2 contactin associated protein 2 gene MP:0001488 increased startle reflex IMP N RGD:126790476|PMID:30126973 20210422 RGD 1307076 Cntnap2 contactin associated protein 2 gene MP:0001501 abnormal sleep pattern IMP N RGD:12880397|PMID:28364455 20201210 RGD 1307076 Cntnap2 contactin associated protein 2 gene MP:0003088 abnormal prepulse inhibition IMP N RGD:126790476|PMID:30126973 20210422 RGD worsens with age 1307076 Cntnap2 contactin associated protein 2 gene MP:0004738 abnormal auditory brainstem response IMP N RGD:126790476|PMID:30126973 20210422 RGD peak amplitudes and transmission latency 1307076 Cntnap2 contactin associated protein 2 gene MP:0009358 environmentally induced seizures IMP N RGD:12880397|PMID:28364455 20201210 RGD 1307076 Cntnap2 contactin associated protein 2 gene MP:0011617 abnormal habituation IMP N RGD:126790476|PMID:30126973 20210422 RGD in young animals 1307090 Sbf1 SET binding factor 1 gene MP:0001925 male infertility IAGP N RGD:38549340|PMID:27335132 20200827 RGD DNA:substitution:intron 37:G>A (rat) 1307090 Sbf1 SET binding factor 1 gene MP:0004852 decreased testis weight IAGP N RGD:38549340|PMID:27335132 20200827 RGD DNA:substitution:intron 37:G>A (rat) 1307090 Sbf1 SET binding factor 1 gene MP:0005159 azoospermia IAGP N RGD:38549340|PMID:27335132 20200827 RGD DNA:substitution:intron 37:G>A (rat) 1307090 Sbf1 SET binding factor 1 gene MP:0008279 arrest of spermiogenesis IAGP N RGD:38549340|PMID:27335132 20200827 RGD DNA:substitution:intron 37:G>A (rat) 1307204 Epha2 Eph receptor A2 gene MP:0003711 pathological neovascularization IDA N RGD:1580975|PMID:16359662 20061031 RGD 1307272 Zeb2 zinc finger E-box binding homeobox 2 gene MP:0002183 gliosis IMP N RGD:155882542|PMID:34852714 20230130 RGD 1307272 Zeb2 zinc finger E-box binding homeobox 2 gene MP:0003354 astrocytosis IMP N RGD:155882542|PMID:34852714 20230130 RGD 1307404 Serpinc1 serpin family C member 1 gene MP:0004041 increased susceptibility to kidney reperfusion injury IMP N RGD:11354006|PMID:26108065 20180119 RGD 1307427 Rbm20 RNA binding motif protein 20 gene MP:0003061 decreased aerobic running capacity IMP N RGD:126925234|PMID:24367651 20210518 RGD 1307488 Cntrob centrobin, centriole duplication and spindle assembly protein gene MP:0000565 oligodactyly IAGP N RGD:150521555|PMID:19710508 20211111 RGD DNA:insertion:intron 10 (rat) 1307511 Ndufc2 NADH:ubiquinone oxidoreductase subunit C2 gene MP:0001728 failure of embryo implantation IMP N RGD:11040458|PMID:26888427 20160816 RGD DNA:deletion:exon1:no homozygous knockout embryos found at implantation stage 1307511 Ndufc2 NADH:ubiquinone oxidoreductase subunit C2 gene MP:0002962 increased urine protein level IMP N RGD:11040458|PMID:26888427 20160816 RGD DNA:deletion:exon1:heterozygous 107 bp deletion 1307646 Lpin1 lipin 1 gene MP:0000351 increased cell proliferation IMP N RGD:38599010|PMID:21715287 20200909 RGD 1307646 Lpin1 lipin 1 gene MP:0001263 weight loss IMP N RGD:38599010|PMID:21715287 20200909 RGD 1307646 Lpin1 lipin 1 gene MP:0002651 abnormal sciatic nerve morphology IMP N RGD:38599010|PMID:21715287 20200909 RGD 1307646 Lpin1 lipin 1 gene MP:0011174 lipodystrophy IMP N RGD:38599010|PMID:21715287 20200909 RGD 1307646 Lpin1 lipin 1 gene MP:0013438 dysmyelination IMP N RGD:38599010|PMID:21715287 20200909 RGD 1307992 Ptpn22 protein tyrosine phosphatase, non-receptor type 22 gene MP:0001559 hyperglycemia IAGP N RGD:9835029|PMID:25505293 20160906 RGD 1307992 Ptpn22 protein tyrosine phosphatase, non-receptor type 22 gene MP:0001759 increased urine glucose level IAGP N RGD:9835029|PMID:25505293 20160906 RGD 1307994 Myh7b myosin heavy chain 7B gene MP:0001262 decreased body weight IMP N RGD:126925946|PMID:32207065 20210816 RGD 1307994 Myh7b myosin heavy chain 7B gene MP:0002625 heart left ventricle hypertrophy IMP N RGD:126925946|PMID:32207065 20210816 RGD 1307994 Myh7b myosin heavy chain 7B gene MP:0003141 cardiac fibrosis IMP N RGD:126925946|PMID:32207065 20210816 RGD 1307994 Myh7b myosin heavy chain 7B gene MP:0004090 abnormal sarcomere morphology IMP N RGD:126925946|PMID:32207065 20210816 RGD 1307994 Myh7b myosin heavy chain 7B gene MP:0004564 increased myocardial fiber size IMP N RGD:126925946|PMID:32207065 20210816 RGD 1307994 Myh7b myosin heavy chain 7B gene MP:0010724 thick interventricular septum IMP N RGD:126925946|PMID:32207065 20210816 RGD 1307994 Myh7b myosin heavy chain 7B gene MP:0020346 abnormal myocardial fiber calcium currents IMP N RGD:126925946|PMID:32207065 20210816 RGD 1307994 Myh7b myosin heavy chain 7B gene MP:0021140 increased cardiac muscle calcium level IMP N RGD:126925946|PMID:32207065 20210816 RGD 1307994 Myh7b myosin heavy chain 7B gene MP:0021161 increased heart left ventricle posterior wall thickness IMP N RGD:126925946|PMID:32207065 20220711 RGD 1308135 Bscl2 BSCL2 lipid droplet biogenesis associated, seipin gene MP:0001262 decreased body weight IMP N RGD:11085488|PMID:25934999 20190109 RGD 1308135 Bscl2 BSCL2 lipid droplet biogenesis associated, seipin gene MP:0001552 increased circulating triglyceride level IMP N RGD:11085488|PMID:25934999 20190109 RGD 1308135 Bscl2 BSCL2 lipid droplet biogenesis associated, seipin gene MP:0001783 decreased white adipose tissue amount IMP N RGD:11085488|PMID:25934999 20190109 RGD 1308135 Bscl2 BSCL2 lipid droplet biogenesis associated, seipin gene MP:0002079 increased circulating insulin level IMP N RGD:11085488|PMID:25934999 20190109 RGD 1308135 Bscl2 BSCL2 lipid droplet biogenesis associated, seipin gene MP:0002175 decreased brain weight IMP N RGD:11085488|PMID:25934999 20190109 RGD 1308135 Bscl2 BSCL2 lipid droplet biogenesis associated, seipin gene MP:0002981 increased liver weight IMP N RGD:11085488|PMID:25934999 20190109 RGD 1308135 Bscl2 BSCL2 lipid droplet biogenesis associated, seipin gene MP:0003960 increased lean body mass IMP N RGD:11085488|PMID:25934999 20190109 RGD 1308135 Bscl2 BSCL2 lipid droplet biogenesis associated, seipin gene MP:0004852 decreased testis weight IMP N RGD:11085488|PMID:25934999 20190109 RGD 1308135 Bscl2 BSCL2 lipid droplet biogenesis associated, seipin gene MP:0005178 increased circulating cholesterol level IMP N RGD:11085488|PMID:25934999 20190109 RGD 1308135 Bscl2 BSCL2 lipid droplet biogenesis associated, seipin gene MP:0005289 increased oxygen consumption IMP N RGD:11085488|PMID:25934999 20190109 RGD 1308135 Bscl2 BSCL2 lipid droplet biogenesis associated, seipin gene MP:0005668 decreased circulating leptin level IMP N RGD:11085488|PMID:25934999 20190109 RGD 1308135 Bscl2 BSCL2 lipid droplet biogenesis associated, seipin gene MP:0008428 abnormal spatial working memory IMP N RGD:11085488|PMID:25934999 20190109 RGD 1308135 Bscl2 BSCL2 lipid droplet biogenesis associated, seipin gene MP:0009355 increased liver triglyceride level IMP N RGD:11085488|PMID:25934999 20190109 RGD 1308466 Ctns cystinosin, lysosomal cystine transporter gene MP:0001262 decreased body weight IMP N RGD:155630629|PMID:35695380 20230221 RGD 1308466 Ctns cystinosin, lysosomal cystine transporter gene MP:0001426 polydipsia IMP N RGD:155630629|PMID:35695380 20230221 RGD 1308466 Ctns cystinosin, lysosomal cystine transporter gene MP:0001759 increased urine glucose level IMP N RGD:155630629|PMID:35695380 20230221 RGD 1308466 Ctns cystinosin, lysosomal cystine transporter gene MP:0001762 polyuria IMP N RGD:155630629|PMID:35695380 20230221 RGD 1308466 Ctns cystinosin, lysosomal cystine transporter gene MP:0002871 albuminuria IMP N RGD:155630629|PMID:35695380 20230221 RGD 1308466 Ctns cystinosin, lysosomal cystine transporter gene MP:0002900 abnormal urine phosphate level IMP N RGD:155630629|PMID:35695380 20230221 RGD 1308466 Ctns cystinosin, lysosomal cystine transporter gene MP:0002962 increased urine protein level IMP N RGD:155630629|PMID:35695380 20230221 RGD 1308466 Ctns cystinosin, lysosomal cystine transporter gene MP:0003504 thyroid gland inflammation IMP N RGD:155630629|PMID:35695380 20230221 RGD 1308466 Ctns cystinosin, lysosomal cystine transporter gene MP:0003917 increased kidney weight IMP N RGD:155630629|PMID:35695380 20230221 RGD 1308466 Ctns cystinosin, lysosomal cystine transporter gene MP:0004756 abnormal proximal convoluted tubule morphology IMP N RGD:155630629|PMID:35695380 20230221 RGD 1308466 Ctns cystinosin, lysosomal cystine transporter gene MP:0005060 accumulation of giant lysosomes in kidney/renal tubule cells IMP N RGD:155630629|PMID:35695380 20230221 RGD 1308466 Ctns cystinosin, lysosomal cystine transporter gene MP:0005325 abnormal renal glomerulus morphology IMP N RGD:155630629|PMID:35695380 20230221 RGD 1308466 Ctns cystinosin, lysosomal cystine transporter gene MP:0005441 increased urine calcium level IMP N RGD:155630629|PMID:35695380 20230221 RGD 1308466 Ctns cystinosin, lysosomal cystine transporter gene MP:0005471 decreased thyroxine level IMP N RGD:155630629|PMID:35695380 20230221 RGD 1308466 Ctns cystinosin, lysosomal cystine transporter gene MP:0005544 cornea deposits IMP N RGD:155630629|PMID:35695380 20230221 RGD 1308466 Ctns cystinosin, lysosomal cystine transporter gene MP:0005553 increased circulating creatinine level IMP N RGD:155630629|PMID:35695380 20230221 RGD 1308466 Ctns cystinosin, lysosomal cystine transporter gene MP:0005558 decreased creatinine clearance IMP N RGD:155630629|PMID:35695380 20230221 RGD 1308466 Ctns cystinosin, lysosomal cystine transporter gene MP:0005565 increased blood urea nitrogen level IMP N RGD:155630629|PMID:35695380 20230221 RGD 1308466 Ctns cystinosin, lysosomal cystine transporter gene MP:0010110 abnormal renal phosphate reabsorption IMP N RGD:155630629|PMID:35695380 20230221 RGD 1308466 Ctns cystinosin, lysosomal cystine transporter gene MP:0010932 increased trabecular bone connectivity density IMP N RGD:155630629|PMID:35695380 20230221 RGD 1308466 Ctns cystinosin, lysosomal cystine transporter gene MP:0011346 renal tubule atrophy IMP N RGD:155630629|PMID:35695380 20230221 RGD 1308466 Ctns cystinosin, lysosomal cystine transporter gene MP:0011368 increased kidney apoptosis IMP N RGD:155630629|PMID:35695380 20230221 RGD 1308466 Ctns cystinosin, lysosomal cystine transporter gene MP:0011467 decreased urine urea nitrogen level IMP N RGD:155630629|PMID:35695380 20230221 RGD 1308466 Ctns cystinosin, lysosomal cystine transporter gene MP:0011471 decreased urine creatinine level IMP N RGD:155630629|PMID:35695380 20230221 RGD 1308466 Ctns cystinosin, lysosomal cystine transporter gene MP:0011555 increased urine microglobulin level IMP N RGD:155630629|PMID:35695380 20230221 RGD 1308518 Ngly1 N-glycanase 1 gene MP:0000161 scoliosis sexual_dimorphism IMP N RGD:39457703|PMID:32259258 20210805 RGD compared to wild type 1308518 Ngly1 N-glycanase 1 gene MP:0000832 abnormal thalamus morphology IMP N RGD:39457703|PMID:32259258 20201013 RGD 1308518 Ngly1 N-glycanase 1 gene MP:0001265 decreased body size IMP N RGD:39457703|PMID:32259258 20201013 RGD 1308518 Ngly1 N-glycanase 1 gene MP:0001402 decreased locomotor activity IMP N RGD:39457703|PMID:32259258 20201013 RGD 1308518 Ngly1 N-glycanase 1 gene MP:0001407 short stride length IMP N RGD:39457703|PMID:32259258 20201013 RGD 1308518 Ngly1 N-glycanase 1 gene MP:0001489 decreased startle reflex IMP N RGD:39457703|PMID:32259258 20201013 RGD 1308518 Ngly1 N-glycanase 1 gene MP:0001513 limb grasping IMP N RGD:39457703|PMID:32259258 20201013 RGD 1308518 Ngly1 N-glycanase 1 gene MP:0001522 impaired swimming IMP N RGD:39457703|PMID:32259258 20201013 RGD 1308518 Ngly1 N-glycanase 1 gene MP:0001525 impaired balance IMP N RGD:39457703|PMID:32259258 20201013 RGD 1308518 Ngly1 N-glycanase 1 gene MP:0001924 infertility IMP N RGD:39457703|PMID:32259258 20201013 RGD 1308518 Ngly1 N-glycanase 1 gene MP:0002175 decreased brain weight IMP N RGD:39457703|PMID:32259258 20201013 RGD 1308518 Ngly1 N-glycanase 1 gene MP:0002651 abnormal sciatic nerve morphology IMP N RGD:39457703|PMID:32259258 20201013 RGD 1308518 Ngly1 N-glycanase 1 gene MP:0003225 axonal dystrophy IMP N RGD:39457703|PMID:32259258 20201013 RGD 1308518 Ngly1 N-glycanase 1 gene MP:0005498 hyporesponsive to tactile stimuli IMP N RGD:39457703|PMID:32259258 20201013 RGD 1308518 Ngly1 N-glycanase 1 gene MP:0009422 decreased gastrocnemius weight IMP N RGD:39457703|PMID:32259258 20201013 RGD 1308518 Ngly1 N-glycanase 1 gene MP:0009428 decreased tibialis anterior weight IMP N RGD:39457703|PMID:32259258 20201013 RGD 1308518 Ngly1 N-glycanase 1 gene MP:0010053 decreased grip strength IMP N RGD:39457703|PMID:32259258 20201013 RGD 1308518 Ngly1 N-glycanase 1 gene MP:0011110 preweaning lethality, incomplete penetrance IMP N RGD:39457703|PMID:32259258 20201013 RGD 1308518 Ngly1 N-glycanase 1 gene MP:0012307 impaired spatial learning IMP N RGD:39457703|PMID:32259258 20201013 RGD 1308518 Ngly1 N-glycanase 1 gene MP:0013178 tail necrosis IMP N RGD:39457703|PMID:32259258 20201013 RGD 1308873 Ano3 anoctamin 3 gene MP:0002738 hyperresponsive to tactile stimuli IMP N RGD:9681745|PMID:23872594 20141208 RGD 1308873 Ano3 anoctamin 3 gene MP:0003998 decreased thermal nociceptive threshold IMP N RGD:9681745|PMID:23872594 20141208 RGD 1308982 Prkdc protein kinase, DNA-activated, catalytic subunit gene MP:0000694 spleen hypoplasia IMP N RGD:8696027|PMID:22981234 20170608 RGD 1308982 Prkdc protein kinase, DNA-activated, catalytic subunit gene MP:0001262 decreased body weight IMP N RGD:39938998|PMID:30485360 20211111 RGD 1308982 Prkdc protein kinase, DNA-activated, catalytic subunit gene MP:0001262 decreased body weight IMP N RGD:8696027|PMID:22981234 20170608 RGD 1308982 Prkdc protein kinase, DNA-activated, catalytic subunit gene MP:0001823 thymus hypoplasia IMP N RGD:8696027|PMID:22981234 20170608 RGD 1308982 Prkdc protein kinase, DNA-activated, catalytic subunit gene MP:0002460 decreased immunoglobulin level IMP N RGD:8696027|PMID:22981234 20170608 RGD 1308982 Prkdc protein kinase, DNA-activated, catalytic subunit gene MP:0004953 decreased spleen weight IMP N RGD:39938998|PMID:30485360 20211111 RGD 1308982 Prkdc protein kinase, DNA-activated, catalytic subunit gene MP:0009763 increased susceptibility to induced morbidity/mortality IMP N RGD:39938998|PMID:30485360 20211111 RGD 1308982 Prkdc protein kinase, DNA-activated, catalytic subunit gene MP:0012555 decreased cell death IMP N RGD:39938998|PMID:30485360 20211111 RGD 1309305 Slc39a12 solute carrier family 39 member 12 gene MP:0004013 decreased pulmonary artery pressure IMP N RGD:10401832|PMID:26258299 20200130 RGD 1309329 Lrp5 LDL receptor related protein 5 gene MP:0000559 abnormal femur morphology IMP N RGD:40902996|PMID:32833527 20210206 RGD 1309329 Lrp5 LDL receptor related protein 5 gene MP:0009346 decreased trabecular bone thickness IMP N RGD:40902996|PMID:32833527 20210206 RGD 1309329 Lrp5 LDL receptor related protein 5 gene MP:0010097 abnormal retina blood vessel morphology IMP N RGD:40902996|PMID:32833527 20210206 RGD 1309329 Lrp5 LDL receptor related protein 5 gene MP:0010098 abnormal retina blood vessel pattern IMP N RGD:40902996|PMID:32833527 20210206 RGD 1309329 Lrp5 LDL receptor related protein 5 gene MP:0010869 decreased bone trabecula number IMP N RGD:40902996|PMID:32833527 20210206 RGD 1309329 Lrp5 LDL receptor related protein 5 gene MP:0010873 decreased trabecular bone mass IMP N RGD:40902996|PMID:32833527 20210211 RGD 1309329 Lrp5 LDL receptor related protein 5 gene MP:0013630 increased bone trabecular spacing IMP N RGD:40902996|PMID:32833527 20210206 RGD 1309329 Lrp5 LDL receptor related protein 5 gene MP:0013630 increased bone trabecular spacing sexual_dimorphism IMP N RGD:40902996|PMID:32833527 20210211 RGD 1309424 Ncf2 neutrophil cytosolic factor 2 gene MP:0004217 salt-sensitive hypertension ameliorates IMP N RGD:9587793|PMID:22326221 20230928 RGD compared to wild-type littermates 1309424 Ncf2 neutrophil cytosolic factor 2 gene MP:0012046 decreased susceptibility to hypertension IMP N RGD:9587793|PMID:22326221 20171101 RGD 1309424 Ncf2 neutrophil cytosolic factor 2 gene MP:0012046 decreased susceptibility to hypertension induces IMP XCO:0000795 N RGD:9587793|PMID:22326221 20230928 RGD compared to wild-type littermates 1309424 Ncf2 neutrophil cytosolic factor 2 gene MP:0020447 decreased NAD(P)H oxidase activity IMP N RGD:9587793|PMID:22326221 20171101 RGD 1309424 Ncf2 neutrophil cytosolic factor 2 gene MP:0020447 decreased NAD(P)H oxidase activity induces IMP XCO:0000795 N RGD:9587793|PMID:22326221 20230928 RGD compared to wild-type littermates 1309674 Sox13 SRY-box transcription factor 13 gene MP:0002871 albuminuria IAGP N RGD:12802369|PMID:23460292 20170407 RGD 1309674 Sox13 SRY-box transcription factor 13 gene MP:0004217 salt-sensitive hypertension IAGP N RGD:12802369|PMID:23460292 20170407 RGD 1309874 Rarres2 retinoic acid receptor responder 2 gene MP:0002965 increased circulating serum albumin level sexual_dimorphism IAGP N RGD:38596340|PMID:29906243 20201210 RGD compared to male knockout 1309874 Rarres2 retinoic acid receptor responder 2 gene MP:0002965 increased circulating serum albumin level sexual_dimorphism IMP N RGD:38596340|PMID:29906243 20200904 RGD 1309874 Rarres2 retinoic acid receptor responder 2 gene MP:0003025 increased vasoconstriction IMP N RGD:38596340|PMID:29906243 20201210 RGD compared to wild-type 1309874 Rarres2 retinoic acid receptor responder 2 gene MP:0003025 increased vasoconstriction sexual_dimorphism IAGP XCO:0000734 N RGD:38596340|PMID:29906243 20201210 RGD compared to female knockout 1309874 Rarres2 retinoic acid receptor responder 2 gene MP:0003025 increased vasoconstriction sexual_dimorphism IMP XCO:0000734 N RGD:38596340|PMID:29906243 20200904 RGD 1309874 Rarres2 retinoic acid receptor responder 2 gene MP:0004875 increased mean systemic arterial blood pressure sexual_dimorphism IMP N RGD:38596340|PMID:29906243 20200904 RGD 1309874 Rarres2 retinoic acid receptor responder 2 gene MP:0004875 increased mean systemic arterial blood pressure sexual_dimorphism IMP XCO:0000192,XCO:0000022 N RGD:38596340|PMID:29906243 20201210 RGD compared to male wild-type 1309874 Rarres2 retinoic acid receptor responder 2 gene MP:0004876 decreased mean systemic arterial blood pressure sexual_dimorphism IMP N RGD:38596340|PMID:29906243 20200904 RGD 1309874 Rarres2 retinoic acid receptor responder 2 gene MP:0004876 decreased mean systemic arterial blood pressure sexual_dimorphism IMP XCO:0000192,XCO:0000022 N RGD:38596340|PMID:29906243 20201210 RGD compared to female wild-type 1309874 Rarres2 retinoic acid receptor responder 2 gene MP:0005333 decreased heart rate sexual_dimorphism IMP N RGD:38596340|PMID:29906243 20200904 RGD 1309874 Rarres2 retinoic acid receptor responder 2 gene MP:0005333 decreased heart rate sexual_dimorphism IMP XCO:0000192,XCO:0000022 N RGD:38596340|PMID:29906243 20201210 RGD compared to male wild-type 1309874 Rarres2 retinoic acid receptor responder 2 gene MP:0005632 decreased circulating aspartate transaminase level sexual_dimorphism IMP N RGD:38596340|PMID:29906243 20200904 RGD 1309874 Rarres2 retinoic acid receptor responder 2 gene MP:0005632 decreased circulating aspartate transaminase level sexual_dimorphism IMP N RGD:38596340|PMID:29906243 20201210 RGD compared to male wild-type 1309874 Rarres2 retinoic acid receptor responder 2 gene MP:0006143 increased systemic arterial diastolic blood pressure sexual_dimorphism IMP N RGD:38596340|PMID:29906243 20200904 RGD 1309874 Rarres2 retinoic acid receptor responder 2 gene MP:0006144 increased systemic arterial systolic blood pressure sexual_dimorphism IMP N RGD:38596340|PMID:29906243 20200904 RGD 1309874 Rarres2 retinoic acid receptor responder 2 gene MP:0006144 increased systemic arterial systolic blood pressure sexual_dimorphism IMP XCO:0000192,XCO:0000022 N RGD:38596340|PMID:29906243 20201210 RGD compared to male wild-type 1309874 Rarres2 retinoic acid receptor responder 2 gene MP:0006263 decreased systemic arterial diastolic blood pressure sexual_dimorphism IMP N RGD:38596340|PMID:29906243 20200904 RGD 1309874 Rarres2 retinoic acid receptor responder 2 gene MP:0006263 decreased systemic arterial diastolic blood pressure sexual_dimorphism IMP XCO:0000192,XCO:0000022 N RGD:38596340|PMID:29906243 20201210 RGD compared to female wild-type 1309874 Rarres2 retinoic acid receptor responder 2 gene MP:0006264 decreased systemic arterial systolic blood pressure sexual_dimorphism IMP N RGD:38596340|PMID:29906243 20200904 RGD 1309874 Rarres2 retinoic acid receptor responder 2 gene MP:0006264 decreased systemic arterial systolic blood pressure sexual_dimorphism IMP XCO:0000192,XCO:0000022 N RGD:38596340|PMID:29906243 20201210 RGD compared to female wild-type 1309874 Rarres2 retinoic acid receptor responder 2 gene MP:0006265 increased pulse pressure sexual_dimorphism IMP N RGD:38596340|PMID:29906243 20200904 RGD 1309874 Rarres2 retinoic acid receptor responder 2 gene MP:0006265 increased pulse pressure sexual_dimorphism IMP XCO:0000192,XCO:0000022 N RGD:38596340|PMID:29906243 20201210 RGD compared to male wild-type 1309912 Fcgr1a Fc gamma receptor 1A gene MP:0001973 increased thermal nociceptive threshold IMP N RGD:127338469|PMID:32510872 20210707 RGD 1309912 Fcgr1a Fc gamma receptor 1A gene MP:0020955 increased mechanical nociceptive threshold IMP N RGD:127338469|PMID:32510872 20210707 RGD 1309918 Rnaset2 ribonuclease T2 gene MP:0001417 decreased exploration in new environment IMP N RGD:13781889|PMID:29752287 20180810 RGD 1309918 Rnaset2 ribonuclease T2 gene MP:0001847 brain inflammation IMP N RGD:13781889|PMID:29752287 20180810 RGD 1309927 Wwox WW domain-containing oxidoreductase gene MP:0001153 small seminiferous tubules IAGP N RGD:150429974|PMID:18676360 20211021 RGD compared to wild type and heterozygotes 1309927 Wwox WW domain-containing oxidoreductase gene MP:0001262 decreased body weight IAGP N RGD:150429974|PMID:18676360 20211021 RGD compared to wild type and heterozygotes 1309927 Wwox WW domain-containing oxidoreductase gene MP:0001262 decreased body weight IAGP N RGD:150429979|PMID:19500159 20211008 RGD DNA:deletion:cds:exon 9, 13bp nucleotides 1190-1202 1309927 Wwox WW domain-containing oxidoreductase gene MP:0001496 audiogenic seizures IAGP N RGD:150429979|PMID:19500159 20211008 RGD DNA:deletion:cds:exon 9, 13bp nucleotides 1190-1202 1309927 Wwox WW domain-containing oxidoreductase gene MP:0002083 premature death IAGP N RGD:150429974|PMID:18676360 20211021 RGD compared to wild type and heterozygotes 1309927 Wwox WW domain-containing oxidoreductase gene MP:0002083 premature death IAGP N RGD:150429978|PMID:17803050 20211021 RGD compared to wild type and heterozygotes 1309927 Wwox WW domain-containing oxidoreductase gene MP:0002083 premature death IAGP N RGD:150429979|PMID:19500159 20211008 RGD DNA:deletion:cds:exon 9, 13bp nucleotides 1190-1202 1309927 Wwox WW domain-containing oxidoreductase gene MP:0002176 increased brain weight IAGP N RGD:150429978|PMID:17803050 20211021 RGD compared to wild type and heterozygotes 1309927 Wwox WW domain-containing oxidoreductase gene MP:0002773 decreased circulating luteinizing hormone level IAGP N RGD:150429974|PMID:18676360 20211021 RGD compared to wild type and heterozygotes 1309927 Wwox WW domain-containing oxidoreductase gene MP:0002780 decreased circulating testosterone level IAGP N RGD:150429974|PMID:18676360 20211021 RGD compared to wild type and heterozygotes 1309927 Wwox WW domain-containing oxidoreductase gene MP:0002786 abnormal Leydig cell morphology IAGP N RGD:150429974|PMID:18676360 20211021 RGD compared to wild type and heterozygotes 1309927 Wwox WW domain-containing oxidoreductase gene MP:0002786 abnormal Leydig cell morphology IAGP N RGD:150429978|PMID:17803050 20211021 RGD compared to wild type and heterozygotes 1309927 Wwox WW domain-containing oxidoreductase gene MP:0002786 abnormal Leydig cell morphology IAGP N RGD:150429979|PMID:19500159 20211008 RGD DNA:deletion:cds:exon 9, 13bp nucleotides 1190-1202 1309927 Wwox WW domain-containing oxidoreductase gene MP:0002790 decreased circulating follicle stimulating hormone level IAGP N RGD:150429974|PMID:18676360 20211021 RGD compared to wild type and heterozygotes 1309927 Wwox WW domain-containing oxidoreductase gene MP:0004852 decreased testis weight IAGP N RGD:150429974|PMID:18676360 20211021 RGD compared to wild type and heterozygotes 1309927 Wwox WW domain-containing oxidoreductase gene MP:0004852 decreased testis weight IAGP N RGD:150429978|PMID:17803050 20211021 RGD compared to wild type and heterozygotes 1309927 Wwox WW domain-containing oxidoreductase gene MP:0004910 decreased seminal vesicle weight IAGP N RGD:150429974|PMID:18676360 20211021 RGD compared to wild type and heterozygotes 1309927 Wwox WW domain-containing oxidoreductase gene MP:0004929 decreased epididymis weight IAGP N RGD:150429974|PMID:18676360 20211021 RGD compared to wild type and heterozygotes 1309927 Wwox WW domain-containing oxidoreductase gene MP:0004962 decreased prostate gland weight IAGP N RGD:150429974|PMID:18676360 20211021 RGD compared to wild type and heterozygotes 1309927 Wwox WW domain-containing oxidoreductase gene MP:0005250 decreased Sertoli cell number IAGP N RGD:150429974|PMID:18676360 20211021 RGD compared to wild type and heterozygotes 1309927 Wwox WW domain-containing oxidoreductase gene MP:0008025 brain vacuoles IAGP N RGD:150429978|PMID:17803050 20211021 RGD compared to wild type and heterozygotes 1309927 Wwox WW domain-containing oxidoreductase gene MP:0008025 brain vacuoles IAGP N RGD:150429979|PMID:19500159 20211008 RGD DNA:deletion:cds:exon 9, 13bp nucleotides 1190-1202 1309927 Wwox WW domain-containing oxidoreductase gene MP:0008325 abnormal gonadotroph morphology IAGP N RGD:150429974|PMID:18676360 20211021 RGD compared to wild type and heterozygotes 1309927 Wwox WW domain-containing oxidoreductase gene MP:0008938 decreased pituitary gland weight IAGP N RGD:150429974|PMID:18676360 20211021 RGD compared to wild type and heterozygotes 1309927 Wwox WW domain-containing oxidoreductase gene MP:0014052 increased male germ cell apoptosis IAGP N RGD:150429974|PMID:18676360 20211021 RGD compared to wild type and heterozygotes 1309947 Crb1 crumbs cell polarity complex component 1 gene MP:0005103 abnormal retina pigmentation IAGP N RGD:13451131|PMID:25878282 20171115 RGD 1309947 Crb1 crumbs cell polarity complex component 1 gene MP:0005547 abnormal Muller cell morphology IAGP N RGD:13451131|PMID:25878282 20171115 RGD 1309947 Crb1 crumbs cell polarity complex component 1 gene MP:0008516 disorganized retina outer nuclear layer IAGP N RGD:13451131|PMID:25878282 20171115 RGD 1309952 Mthfr methylenetetrahydrofolate reductase gene MP:0002833 increased heart weight IMP N RGD:8662415|PMID:24006081 20190717 RGD as compared to the wild-type 1309952 Mthfr methylenetetrahydrofolate reductase gene MP:0002962 increased urine protein level IMP N RGD:8662415|PMID:24006081 20190717 RGD as compared to the wild-type 1310046 Adamts16 ADAM metallopeptidase with thrombospondin type 1 motif, 16 gene MP:0000280 thin ventricular wall IMP N RGD:9685162|PMID:23185005 20171010 RGD As compared to SS parents 1310046 Adamts16 ADAM metallopeptidase with thrombospondin type 1 motif, 16 gene MP:0001147 small testis IMP N RGD:13434925|PMID:24983376 20171010 RGD 1310046 Adamts16 ADAM metallopeptidase with thrombospondin type 1 motif, 16 gene MP:0001661 extended life span IMP N RGD:9685162|PMID:23185005 20171010 RGD As compared to SS parents 1310046 Adamts16 ADAM metallopeptidase with thrombospondin type 1 motif, 16 gene MP:0002843 decreased systemic arterial blood pressure IAGP N RGD:2312639|PMID:19423552 20100408 RGD DNA:polymorphism 1310046 Adamts16 ADAM metallopeptidase with thrombospondin type 1 motif, 16 gene MP:0002962 increased urine protein level IMP N RGD:9685162|PMID:23185005 20171010 RGD As compared to SS parents 1310046 Adamts16 ADAM metallopeptidase with thrombospondin type 1 motif, 16 gene MP:0006263 decreased systemic arterial diastolic blood pressure IMP N RGD:9685162|PMID:23185005 20171010 RGD As compared to SS parents 1310046 Adamts16 ADAM metallopeptidase with thrombospondin type 1 motif, 16 gene MP:0006264 decreased systemic arterial systolic blood pressure IMP N RGD:9685162|PMID:23185005 20171010 RGD As compared to SS parents 1310046 Adamts16 ADAM metallopeptidase with thrombospondin type 1 motif, 16 gene MP:0020253 increased collagen level IMP N RGD:38548917|PMID:32037220 20200821 RGD 1310332 Cyfip1 cytoplasmic FMR1 interacting protein 1 gene MP:0008026 abnormal brain white matter morphology IMP N RGD:14981598|PMID:31371763 20191009 RGD 1310332 Cyfip1 cytoplasmic FMR1 interacting protein 1 gene MP:0009808 decreased oligodendrocyte number IMP N RGD:14981598|PMID:31371763 20191009 RGD 1310332 Cyfip1 cytoplasmic FMR1 interacting protein 1 gene MP:0011731 decreased myelin sheath thickness IMP N RGD:14981598|PMID:31371763 20191009 RGD 1310537 Ipo9 importin 9 gene MP:0002871 albuminuria IAGP N RGD:12802369|PMID:23460292 20170407 RGD 1310537 Ipo9 importin 9 gene MP:0004217 salt-sensitive hypertension IAGP N RGD:12802369|PMID:23460292 20170407 RGD 1310788 Hvcn1 hydrogen voltage-gated channel 1 gene MP:0002843 decreased systemic arterial blood pressure IMP N RGD:14985214|PMID:24935944 20191009 RGD 1310788 Hvcn1 hydrogen voltage-gated channel 1 gene MP:0004876 decreased mean systemic arterial blood pressure IMP N RGD:14985214|PMID:24935944 20191009 RGD 1310788 Hvcn1 hydrogen voltage-gated channel 1 gene MP:0011854 cerebral edema IMP N RGD:14985213|PMID:31250553 20191105 RGD 1311039 Pde6b phosphodiesterase 6B gene MP:0001326 retina degeneration IMP N RGD:40924664|PMID:31009522 20210304 RGD compared to wild-type 1311039 Pde6b phosphodiesterase 6B gene MP:0008450 retina photoreceptor degeneration IMP N RGD:40924664|PMID:31009522 20210304 RGD compared to wild-type 1311039 Pde6b phosphodiesterase 6B gene MP:0008515 thin retina outer nuclear layer IMP N RGD:40924664|PMID:31009522 20210304 RGD compared to wild-type 1311039 Pde6b phosphodiesterase 6B gene MP:0008518 retina outer nuclear layer degeneration IMP N RGD:40924664|PMID:31009522 20210304 RGD compared to wild-type 1311039 Pde6b phosphodiesterase 6B gene MP:0010098 abnormal retina blood vessel pattern IMP N RGD:40924664|PMID:31009522 20210304 RGD compared to wild-type 1311039 Pde6b phosphodiesterase 6B gene MP:0030005 increased retina apoptosis IMP N RGD:40924664|PMID:31009522 20210304 RGD compared to wild-type 1311139 Aire autoimmune regulator gene MP:0000414 alopecia IMP N RGD:38599145|PMID:29959280 20200910 RGD 1311139 Aire autoimmune regulator gene MP:0000703 abnormal thymus morphology IMP N RGD:38599145|PMID:29959280 20200910 RGD 1311139 Aire autoimmune regulator gene MP:0003725 increased autoantibody level IMP N RGD:38599145|PMID:29959280 20200910 RGD 1311139 Aire autoimmune regulator gene MP:0005554 decreased circulating creatinine level IMP N RGD:38599145|PMID:29959280 20200910 RGD 1311139 Aire autoimmune regulator gene MP:0008043 abnormal NK cell number IMP N RGD:38599145|PMID:29959280 20200910 RGD 1311139 Aire autoimmune regulator gene MP:0010016 variable depigmentation IMP N RGD:38599145|PMID:29959280 20200910 RGD 1311139 Aire autoimmune regulator gene MP:0011627 decreased skin pigmentation IMP N RGD:38599145|PMID:29959280 20200910 RGD 1311139 Aire autoimmune regulator gene MP:0012400 nail dystrophy IMP N RGD:38599145|PMID:29959280 20200910 RGD 1311139 Aire autoimmune regulator gene MP:0020242 increased autopod size IMP N RGD:38599145|PMID:29959280 20200910 RGD 1311212 Il36rn interleukin 36 receptor antagonist gene MP:0003822 decreased left ventricle systolic pressure IMP N RGD:126925167|PMID:32048631 20210513 RGD 1311212 Il36rn interleukin 36 receptor antagonist gene MP:0005598 decreased heart ventricle muscle contractility IMP N RGD:126925167|PMID:32048631 20210513 RGD 1311212 Il36rn interleukin 36 receptor antagonist gene MP:0011971 increased circulating lactate dehydrogenase level IMP N RGD:126925167|PMID:32048631 20210513 RGD 1311212 Il36rn interleukin 36 receptor antagonist gene MP:0031077 increased circulating troponin level IMP N RGD:126925167|PMID:32048631 20210513 RGD 1311212 Il36rn interleukin 36 receptor antagonist gene MP:0031108 increased circulating myoglobin level IMP N RGD:126925167|PMID:32048631 20210513 RGD 1311509 Ercc6 ERCC excision repair 6, chromatin remodeling factor gene MP:0000852 small cerebellum IMP N RGD:126925983|PMID:31644904 20210525 RGD 1311509 Ercc6 ERCC excision repair 6, chromatin remodeling factor gene MP:0003354 astrocytosis IMP N RGD:126925983|PMID:31644904 20210525 RGD 1311509 Ercc6 ERCC excision repair 6, chromatin remodeling factor gene MP:0004097 abnormal cerebellar cortex morphology IMP N RGD:126925983|PMID:31644904 20210525 RGD 1311509 Ercc6 ERCC excision repair 6, chromatin remodeling factor gene MP:0008410 increased cellular sensitivity to ultraviolet irradiation IMP N RGD:126925983|PMID:31644904 20210525 RGD 1311509 Ercc6 ERCC excision repair 6, chromatin remodeling factor gene MP:0009796 abnormal base-excision repair IMP N RGD:126925983|PMID:31644904 20210525 RGD 1311509 Ercc6 ERCC excision repair 6, chromatin remodeling factor gene MP:0011639 decreased mitochondrial DNA content IMP N RGD:126925983|PMID:31644904 20210525 RGD 1311535 Depdc5 DEP domain containing 5, GATOR1 subcomplex subunit gene MP:0000823 abnormal lateral ventricle morphology IMP N RGD:11573213|PMID:26873552 20200921 RGD 1311535 Depdc5 DEP domain containing 5, GATOR1 subcomplex subunit gene MP:0001698 decreased embryo size treatment IMP N RGD:11573213|PMID:26873552 20200921 RGD 1311535 Depdc5 DEP domain containing 5, GATOR1 subcomplex subunit gene MP:0002882 abnormal neuron morphology IMP N RGD:11573213|PMID:26873552 20200921 RGD 1311535 Depdc5 DEP domain containing 5, GATOR1 subcomplex subunit gene MP:0003412 abnormal afterhyperpolarization IMP N RGD:11573213|PMID:26873552 20200921 RGD 1311535 Depdc5 DEP domain containing 5, GATOR1 subcomplex subunit gene MP:0003477 abnormal nerve fiber response IMP N RGD:11573213|PMID:26873552 20200921 RGD 1311535 Depdc5 DEP domain containing 5, GATOR1 subcomplex subunit gene MP:0008547 abnormal neocortex morphology IMP N RGD:11573213|PMID:26873552 20200921 RGD 1311535 Depdc5 DEP domain containing 5, GATOR1 subcomplex subunit gene MP:0008762 embryonic lethality IMP N RGD:11573213|PMID:26873552 20200921 RGD 1311590 Alms1 ALMS1, centrosome and basal body associated protein gene MP:0001260 increased body weight IMP N RGD:151361229|PMID:30385718 20220303 RGD compared to wild type 1311590 Alms1 ALMS1, centrosome and basal body associated protein gene MP:0004217 salt-sensitive hypertension exacerbates IMP N RGD:151361229|PMID:30385718 20220303 RGD compared to wild type 1311590 Alms1 ALMS1, centrosome and basal body associated protein gene MP:0004875 increased mean systemic arterial blood pressure exacerbates IMP N RGD:151361229|PMID:30385718 20220303 RGD compared to wild type 1311590 Alms1 ALMS1, centrosome and basal body associated protein gene MP:0006144 increased systemic arterial systolic blood pressure exacerbates IMP N RGD:151361229|PMID:30385718 20220303 RGD compared to wild type 1311590 Alms1 ALMS1, centrosome and basal body associated protein gene MP:0006316 increased urine sodium level induces IMP XCO:0000925 N RGD:151361229|PMID:30385718 20220303 RGD 1311590 Alms1 ALMS1, centrosome and basal body associated protein gene MP:0011431 increased urine flow rate induces IMP XCO:0000925 N RGD:151361229|PMID:30385718 20220303 RGD 13204704 W-Myo7atnd/Hubr Wistar tornado rat strain MP:0001394 circling IAGP N RGD:1581470|PMID:15965244 20170713 RGD DNA:nonsense mutation:cds 13204704 W-Myo7atnd/Hubr Wistar tornado rat strain MP:0001399 hyperactivity IAGP N RGD:1581470|PMID:15965244 20170713 RGD DNA:nonsense mutation:cds 13204704 W-Myo7atnd/Hubr Wistar tornado rat strain MP:0004521 abnormal cochlear hair cell stereociliary bundle morphology IAGP N RGD:1581470|PMID:15965244 20170713 RGD DNA:nonsense mutation:cds 13204704 W-Myo7atnd/Hubr Wistar tornado rat strain MP:0004738 abnormal auditory brainstem response IAGP N RGD:1581470|PMID:15965244 20170713 RGD DNA:nonsense mutation:cds 13204704 W-Myo7atnd/Hubr Wistar tornado rat strain MP:0004742 abnormal vestibular system physiology IAGP N RGD:1581470|PMID:15965244 20170713 RGD DNA:nonsense mutation:cds 13204705 Myo7atnd/Hubr myosin VIIA; ENU induced tornado mutant, Hubr gene MP:0001394 circling IAGP N RGD:1581470|PMID:15965244 20170713 RGD DNA:nonsense mutation:cds 13204705 Myo7atnd/Hubr myosin VIIA; ENU induced tornado mutant, Hubr gene MP:0001399 hyperactivity IAGP N RGD:1581470|PMID:15965244 20170713 RGD DNA:nonsense mutation:cds 13204705 Myo7atnd/Hubr myosin VIIA; ENU induced tornado mutant, Hubr gene MP:0004521 abnormal cochlear hair cell stereociliary bundle morphology IAGP N RGD:1581470|PMID:15965244 20170713 RGD DNA:nonsense mutation:cds 13204705 Myo7atnd/Hubr myosin VIIA; ENU induced tornado mutant, Hubr gene MP:0004738 abnormal auditory brainstem response IAGP N RGD:1581470|PMID:15965244 20170713 RGD DNA:nonsense mutation:cds 13204705 Myo7atnd/Hubr myosin VIIA; ENU induced tornado mutant, Hubr gene MP:0004742 abnormal vestibular system physiology IAGP N RGD:1581470|PMID:15965244 20170713 RGD DNA:nonsense mutation:cds 13204831 CitfhJjlo citron rho-interacting serine/threonine kinase; flat head mutant, Jjlo gene MP:0003708 binucleate IAGP N RGD:13204832|PMID:11932363 20170721 RGD 13204831 CitfhJjlo citron rho-interacting serine/threonine kinase; flat head mutant, Jjlo gene MP:0012138 decreased forebrain size IAGP N RGD:13204832|PMID:11932363 20170721 RGD 13204831 CitfhJjlo citron rho-interacting serine/threonine kinase; flat head mutant, Jjlo gene MP:0012174 flat head IAGP N RGD:13204836|PMID:10219263 20180501 RGD 13208518 SD-Nfe2l2em1Mcwi-/- SD-Nfe2l2em1Mcwi-/Nfe2l2em1Mcwi- strain MP:0005591 decreased vasodilation IMP XCO:0000143, XCO:0000191, XCO:0000795 N RGD:11344212|PMID:26637559 20170913 RGD compared to SD 13209000 Cybam1Sdi cytochrome b-245 alpha chain;mutant 1,Sdi gene MP:0002978 absent otoliths IAGP N RGD:11040542|PMID:19406829 20170828 RGD DNA:deletion:splice junction: 13209000 Cybam1Sdi cytochrome b-245 alpha chain;mutant 1,Sdi gene MP:0020447 decreased NAD(P)H oxidase activity IAGP N RGD:11040542|PMID:19406829 20170828 RGD DNA:deletion:splice junction: 1331720 Rf43 Renal function QTL 43 qtl MP:0005531 increased renal vascular resistance IAGP N RGD:70849|PMID:11721057 19990101 RGD 1331721 Bp210 Blood pressure QTL 210 qtl MP:0002626 increased heart rate IAGP N RGD:70849|PMID:11721057 19990101 RGD 1331721 Bp210 Blood pressure QTL 210 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:70849|PMID:11721057 19990101 RGD 1331722 Thshl1 Thyroid stimulating hormone level QTL 1 qtl MP:0005122 increased circulating thyroid-stimulating hormone level IAGP N RGD:1302891|PMID:15514085 19990101 RGD 1331723 Bw25 Body weight QTL 25 qtl MP:0001260 increased body weight IAGP N RGD:70849|PMID:11721057 19990101 RGD 1331724 Bp223 Blood pressure QTL 223 qtl MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:70849|PMID:11721057 19990101 RGD 1331725 Bp212 Blood pressure QTL 212 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:70849|PMID:11721057 19990101 RGD 1331726 Bp208 Blood pressure QTL 208 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:70849|PMID:11721057 19990101 RGD 1331726 Bp208 Blood pressure QTL 208 qtl MP:0005526 decreased renal plasma flow rate IAGP N RGD:70849|PMID:11721057 19990101 RGD 1331727 Bp237 Blood pressure QTL 237 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:70849|PMID:11721057 19990101 RGD 1331728 Bp214 Blood pressure QTL 214 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:70849|PMID:11721057 19990101 RGD 1331729 Rf42 Renal function QTL 42 qtl MP:0005526 decreased renal plasma flow rate IAGP N RGD:70849|PMID:11721057 19990101 RGD 1331729 Rf42 Renal function QTL 42 qtl MP:0005531 increased renal vascular resistance IAGP N RGD:70849|PMID:11721057 19990101 RGD 1331730 Scl27 Serum cholesterol level QTL 27 qtl MP:0001556 increased circulating HDL cholesterol level IAGP N RGD:70849|PMID:11721057 19990101 RGD 1331731 Bp216 Blood pressure QTL 216 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:70849|PMID:11721057 19990101 RGD 1331732 Srn4 Serum renin concentration QTL 4 qtl MP:0003352 increased circulating renin level IAGP N RGD:70849|PMID:11721057 19990101 RGD 1331733 Bp233 Blood pressure QTL 233 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:70849|PMID:11721057 19990101 RGD 1331734 Bp204 Blood pressure QTL 204 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:70849|PMID:11721057 19990101 RGD 1331735 Rf44 Renal function QTL 44 qtl MP:0002962 increased urine protein level IAGP N RGD:70849|PMID:11721057 19990101 RGD 1331736 Bp227 Blood pressure QTL 227 qtl MP:0006143 increased systemic arterial diastolic blood pressure IAGP N RGD:70849|PMID:11721057 19990101 RGD 1331737 Uae29 Urinary albumin excretion QTL 29 qtl MP:0002962 increased urine protein level IAGP N RGD:1300043|PMID:15161966 19990101 RGD 1331738 Bp209 Blood pressure QTL 209 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:70849|PMID:11721057 19990101 RGD 1331739 Hrtrt14 Heart rate QTL 14 qtl MP:0002626 increased heart rate IAGP N RGD:70849|PMID:11721057 19990101 RGD 1331739 Hrtrt14 Heart rate QTL 14 qtl MP:0003928 increased heart rate variability IAGP N RGD:70849|PMID:11721057 19990101 RGD 1331740 Bw26 Body weight QTL 26 qtl MP:0001260 increased body weight IAGP N RGD:70849|PMID:11721057 19990101 RGD 1331740 Bw26 Body weight QTL 26 qtl MP:0002625 heart left ventricle hypertrophy IAGP N RGD:70849|PMID:11721057 19990101 RGD 1331740 Bw26 Body weight QTL 26 qtl MP:0006143 increased systemic arterial diastolic blood pressure IAGP N RGD:70849|PMID:11721057 19990101 RGD 1331741 Bp232 Blood pressure QTL 232 qtl MP:0006143 increased systemic arterial diastolic blood pressure IAGP N RGD:70849|PMID:11721057 19990101 RGD 1331742 Bp228 Blood pressure QTL 228 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:70849|PMID:11721057 19990101 RGD 1331743 Uae28 Urinary albumin excretion QTL 28 qtl MP:0002871 albuminuria IAGP N RGD:1300043|PMID:15161966 19990101 RGD 1331743 Uae28 Urinary albumin excretion QTL 28 qtl MP:0002962 increased urine protein level IDA N RGD:1300043|PMID:15161966 20120112 RGD 1331744 Bp217 Blood pressure QTL 217 qtl MP:0002962 increased urine protein level IDA N RGD:70849|PMID:11721057 20120112 RGD 1331744 Bp217 Blood pressure QTL 217 qtl MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:70849|PMID:11721057 19990101 RGD 1331745 Bp203 Blood pressure QTL 203 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:70849|PMID:11721057 19990101 RGD 1331745 Bp203 Blood pressure QTL 203 qtl MP:0006143 increased systemic arterial diastolic blood pressure IAGP N RGD:70849|PMID:11721057 19990101 RGD 1331746 Kidm9 Kidney mass QTL 9 qtl MP:0003068 enlarged kidney IAGP N RGD:70849|PMID:11721057 19990101 RGD 1331747 Hrtrt16 Heart rate QTL 16 qtl MP:0002626 increased heart rate IAGP N RGD:70849|PMID:11721057 19990101 RGD 1331748 Bp215 Blood pressure QTL 215 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:70849|PMID:11721057 19990101 RGD 1331749 Hrtrt11 Heart rate QTL 11 qtl MP:0002626 increased heart rate IAGP N RGD:70849|PMID:11721057 19990101 RGD 1331750 Bp220 Blood pressure QTL 220 qtl MP:0006143 increased systemic arterial diastolic blood pressure IAGP N RGD:70849|PMID:11721057 19990101 RGD 1331751 Bp199 Blood pressure QTL 199 qtl MP:0006143 increased systemic arterial diastolic blood pressure IAGP N RGD:70849|PMID:11721057 19990101 RGD 1331752 Bw27 Body weight QTL 27 qtl MP:0001260 increased body weight IAGP N RGD:70849|PMID:11721057 19990101 RGD 1331753 Bp231 Blood pressure QTL 231 qtl MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:70849|PMID:11721057 19990101 RGD 1331754 Bp230 Blood pressure QTL 230 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:70849|PMID:11721057 19990101 RGD 1331755 Bp219 Blood pressure QTL 219 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:70849|PMID:11721057 19990101 RGD 1331756 Rf34 Renal function QTL 34 qtl MP:0005526 decreased renal plasma flow rate IAGP N RGD:70849|PMID:11721057 19990101 RGD 1331757 Cdexp1 CD45RC expression in CD8 T cells QTL 1 qtl MP:0005010 abnormal CD8-positive, alpha beta T cell morphology IAGP N RGD:1302824|PMID:15322174 19990101 RGD 1331758 Bp207 Blood pressure QTL 207 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:70849|PMID:11721057 19990101 RGD 1331759 Hrtrt13 Heart rate QTL 13 qtl MP:0002626 increased heart rate IAGP N RGD:70849|PMID:11721057 19990101 RGD 1331759 Hrtrt13 Heart rate QTL 13 qtl MP:0003928 increased heart rate variability IAGP N RGD:70849|PMID:11721057 19990101 RGD 1331760 Bp206 Blood pressure QTL 206 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:70849|PMID:11721057 19990101 RGD 1331761 Bp218 Blood pressure QTL 218 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:70849|PMID:11721057 19990101 RGD 1331762 Rf40 Renal function QTL 40 qtl MP:0005531 increased renal vascular resistance IAGP N RGD:70849|PMID:11721057 19990101 RGD 1331763 Wbc2 White blood cell count QTL 2 qtl MP:0000218 increased leukocyte cell number IAGP N RGD:70849|PMID:11721057 19990101 RGD 1331764 Bp205 Blood pressure QTL 205 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:70849|PMID:11721057 19990101 RGD 1331765 Hrtrt15 Heart rate QTL 15 qtl MP:0002626 increased heart rate IAGP N RGD:70849|PMID:11721057 19990101 RGD 1331765 Hrtrt15 Heart rate QTL 15 qtl MP:0003928 increased heart rate variability IAGP N RGD:70849|PMID:11721057 19990101 RGD 1331766 Bp236 Blood pressure QTL 236 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:70849|PMID:11721057 19990101 RGD 1331767 Hrtrt12 Heart rate QTL 12 qtl MP:0002626 increased heart rate IAGP N RGD:70849|PMID:11721057 19990101 RGD 1331768 Kidm10 Kidney mass QTL 10 qtl MP:0003068 enlarged kidney IAGP N RGD:70849|PMID:11721057 19990101 RGD 1331769 Rf39 Renal function QTL 39 qtl MP:0001762 polyuria IAGP N RGD:70849|PMID:11721057 19990101 RGD 1331770 Bp234 Blood pressure QTL 234 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:70849|PMID:11721057 19990101 RGD 1331771 Rf35 Renal function QTL 35 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:70849|PMID:11721057 19990101 RGD 1331772 Cdexp2 CD45RC expression in CD8 T cells QTL 2 qtl MP:0005010 abnormal CD8-positive, alpha beta T cell morphology IAGP N RGD:1302824|PMID:15322174 19990101 RGD 1331773 Scl26 Serum cholesterol level QTL 26 qtl MP:0005178 increased circulating cholesterol level IAGP N RGD:70849|PMID:11721057 19990101 RGD 1331774 Bp226 Blood pressure QTL 226 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:70849|PMID:11721057 19990101 RGD 1331775 Bp235 Blood pressure QTL 235 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:70849|PMID:11721057 19990101 RGD 1331776 Bp225 Blood pressure QTL 225 qtl MP:0006143 increased systemic arterial diastolic blood pressure IAGP N RGD:70849|PMID:11721057 19990101 RGD 1331777 Bw24 Body weight QTL 24 qtl MP:0001260 increased body weight IAGP N RGD:70849|PMID:11721057 19990101 RGD 1331778 Rf28 Renal function QTL 28 qtl MP:0005619 increased urine potassium level IAGP N RGD:70849|PMID:11721057 19990101 RGD 1331779 Rf38 Renal function QTL 38 qtl MP:0003606 kidney failure IAGP N RGD:70849|PMID:11721057 19990101 RGD 1331779 Rf38 Renal function QTL 38 qtl MP:0005529 abnormal renal vascular resistance IAGP N RGD:70849|PMID:11721057 19990101 RGD 1331780 Bp238 Blood pressure QTL 238 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:70849|PMID:11721057 19990101 RGD 1331781 Scl28 Serum cholesterol level QTL 28 qtl MP:0005178 increased circulating cholesterol level IAGP N RGD:70849|PMID:11721057 19990101 RGD 1331782 Rf36 Renal function QTL 36 qtl MP:0005524 abnormal renal plasma flow rate IAGP N RGD:70849|PMID:11721057 19990101 RGD 1331783 Bp221 Blood pressure QTL 221 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:70849|PMID:11721057 19990101 RGD 1331783 Bp221 Blood pressure QTL 221 qtl MP:0006143 increased systemic arterial diastolic blood pressure IAGP N RGD:70849|PMID:11721057 19990101 RGD 1331784 Bp222 Blood pressure QTL 222 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:70849|PMID:11721057 19990101 RGD 1331786 Kidm11 Kidney mass QTL 11 qtl MP:0003068 enlarged kidney IAGP N RGD:70849|PMID:11721057 19990101 RGD 1331786 Kidm11 Kidney mass QTL 11 qtl MP:0003917 increased kidney weight IAGP N RGD:70849|PMID:11721057 19990101 RGD 1331787 Rf41 Renal function QTL 41 qtl MP:0005524 abnormal renal plasma flow rate IAGP N RGD:70849|PMID:11721057 19990101 RGD 1331788 Rf45 Renal function QTL 45 qtl MP:0005524 abnormal renal plasma flow rate IAGP N RGD:70849|PMID:11721057 19990101 RGD 1331789 Rf37 Renal function QTL 37 qtl MP:0001761 abnormal urination pattern IAGP N RGD:70849|PMID:11721057 19990101 RGD 1331789 Rf37 Renal function QTL 37 qtl MP:0005529 abnormal renal vascular resistance IAGP N RGD:70849|PMID:11721057 19990101 RGD 1331790 Bp201 Blood pressure QTL 201 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:70849|PMID:11721057 19990101 RGD 1331791 Cm31 Cardiac mass QTL 31 qtl MP:0002833 increased heart weight IAGP N RGD:70849|PMID:11721057 19990101 RGD 1331791 Cm31 Cardiac mass QTL 31 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:70849|PMID:11721057 19990101 RGD 1331792 Rf29 Renal function QTL 29 qtl MP:0005619 increased urine potassium level IAGP N RGD:70849|PMID:11721057 19990101 RGD 1331793 Bp200 Blood pressure QTL 200 qtl MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:70849|PMID:11721057 19990101 RGD 1331794 Bp202 Blood pressure QTL 202 qtl MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:70849|PMID:11721057 19990101 RGD 1331795 Rf30 Renal function QTL 30 qtl MP:0002987 abnormal urine osmolality IAGP N RGD:70849|PMID:11721057 19990101 RGD 1331795 Rf30 Renal function QTL 30 qtl MP:0009643 abnormal urine homeostasis IDA N RGD:70849|PMID:11721057 20120112 RGD 1331796 Thshl2 Thyroid stimulating hormone level QTL 2 qtl MP:0005122 increased circulating thyroid-stimulating hormone level IAGP N RGD:1302891|PMID:15514085 19990101 RGD 1331797 Bp213 Blood pressure QTL 213 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:70849|PMID:11721057 19990101 RGD 1331798 Bp224 Blood pressure QTL 224 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:70849|PMID:11721057 19990101 RGD 1331799 Bp211 Blood pressure QTL 211 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:70849|PMID:11721057 19990101 RGD 1331800 Scl25 Serum cholesterol level QTL 25 qtl MP:0005178 increased circulating cholesterol level IAGP N RGD:70849|PMID:11721057 19990101 RGD 1331801 Rf33 Renal function QTL 33 qtl MP:0003606 kidney failure IAGP N RGD:70849|PMID:11721057 19990101 RGD 1331801 Rf33 Renal function QTL 33 qtl MP:0005529 abnormal renal vascular resistance IAGP N RGD:70849|PMID:11721057 19990101 RGD 1331802 Srn5 Serum renin concentration QTL 5 qtl MP:0003349 abnormal circulating renin level IAGP N RGD:70849|PMID:11721057 19990101 RGD 1331803 Rf32 Renal function QTL 32 qtl MP:0003606 kidney failure IAGP N RGD:70849|PMID:11721057 19990101 RGD 1331803 Rf32 Renal function QTL 32 qtl MP:0005529 abnormal renal vascular resistance IAGP N RGD:70849|PMID:11721057 19990101 RGD 1331804 Cm30 Cardiac mass QTL 30 qtl MP:0001260 increased body weight IAGP N RGD:70849|PMID:11721057 19990101 RGD 1331804 Cm30 Cardiac mass QTL 30 qtl MP:0002833 increased heart weight IAGP N RGD:70849|PMID:11721057 19990101 RGD 1331805 Cm29 Cardiac mass QTL 29 qtl MP:0002833 increased heart weight IAGP N RGD:70849|PMID:11721057 19990101 RGD 1331806 Bp229 Blood pressure QTL 229 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:70849|PMID:11721057 19990101 RGD 1331807 Rf31 Renal function QTL 31 qtl MP:0002987 abnormal urine osmolality IAGP N RGD:70849|PMID:11721057 19990101 RGD 1331807 Rf31 Renal function QTL 31 qtl MP:0009643 abnormal urine homeostasis IDA N RGD:70849|PMID:11721057 20120112 RGD 1331815 LEW/Mol LEW/Mol strain MP:0003917 increased kidney weight sexual_dimorphism IAGP XCO:0000022 N RGD:25314241|PMID:10872564 20210709 RGD compared to female 1331816 DA.ACI-(D10Rat2-D10Rat29)/Kini strain MP:0004800 decreased susceptibility to experimental autoimmune encephalomyelitis induced IAGP XCO:0000195 N RGD:1302437|PMID:15240732 20200430 RGD compared to DA/Ztmkini 1331816 DA.ACI-(D10Rat2-D10Rat29)/Kini strain MP:0004800 decreased susceptibility to experimental autoimmune encephalomyelitis induced IAGP XCO:0000195 N RGD:1302800|PMID:11486278 20200430 RGD compared to DA/ZtmKini 1331824 DA.ACI-(D10Rat219-D10Rat29) strain MP:0009763 increased susceptibility to induced morbidity/mortality induced IAGP XCO:0000195 N RGD:1302437|PMID:15240732 20200430 RGD compared to DA/Ztmkini 1331828 DA.ACI-(D10Rat12-D10Rat144) strain MP:0004800 decreased susceptibility to experimental autoimmune encephalomyelitis induced IAGP XCO:0000195 N RGD:1302437|PMID:15240732 20200430 RGD compared to DA/Ztmkini 1331830 F344.BN-(D5Rat1-D5Mit5)/Dlw strain MP:0008331 increased lactotroph cell number induced IAGP XCO:0000295 N RGD:1300042|PMID:15166088 20200313 RGD 1331830 F344.BN-(D5Rat1-D5Mit5)/Dlw strain MP:0008939 increased pituitary gland weight induced IAGP XCO:0000295 N RGD:1300042|PMID:15166088 20200313 RGD 1331833 DA.ACI-(D10Rat15-D10Rat29) strain MP:0004800 decreased susceptibility to experimental autoimmune encephalomyelitis induced IAGP XCO:0000195 N RGD:1302437|PMID:15240732 20200430 RGD compared to DA/Ztmkini 1331833 DA.ACI-(D10Rat15-D10Rat29) strain MP:0009763 increased susceptibility to induced morbidity/mortality induced IAGP XCO:0000195 N RGD:1302437|PMID:15240732 20200430 RGD compared to DA/Ztmkini 1331837 Bw23 Body weight QTL 23 qtl MP:0001260 increased body weight IAGP N RGD:1300044|PMID:15164172 19990101 RGD 1331838 Niddm61 Non-insulin dependent diabetes mellitus QTL 61 qtl MP:0002079 increased circulating insulin level IAGP N RGD:1300044|PMID:15164172 19990101 RGD 1331838 Niddm61 Non-insulin dependent diabetes mellitus QTL 61 qtl MP:0003058 increased insulin secretion IAGP N RGD:1300044|PMID:15164172 19990101 RGD 1331839 Eae18b Experimental allergic encephalomyelitis QTL 18b qtl MP:0000753 paralysis QTM N RGD:1302437|PMID:15240732 19990101 RGD 1332593 Or9r3b olfactory receptor family 9 subfamily R member 3B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332594 Or2f1 olfactory receptor family 2 subfamily F member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332597 Or8g37c olfactory receptor family 8 subfamily G member 37C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332598 Or10a5 olfactory receptor family 10 subfamily A member 5 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332599 Or52n2b olfactory receptor family 52 subfamily N member 2B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332600 Or4c117b olfactory receptor family 4 subfamily C member 117B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332601 Or4d2 olfactory receptor family 4 subfamily D member 2 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332602 Or4f61b olfactory receptor family 4 subfamily F member 61B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332603 Or2t48e olfactory receptor family 2 subfamily T member 48E gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332604 Or10ag52b olfactory receptor family 10 subfamily AG member 52B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332606 Or13c7d olfactory receptor family 13 subfamily C member 7D gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332608 Or5h27b olfactory receptor family 5 subfamily H member 27B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332610 Or4l1 olfactory receptor family 4 subfamily L member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332612 Or13c3 olfactory receptor family 13 subfamily C member 3 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332615 Or2t48d olfactory receptor family 2 subfamily T member 48D gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332619 Or8k31 olfactory receptor family 8 subfamily K member 31 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332620 Or10c1 olfactory receptor family 10 subfamily C member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332621 Or4d10 olfactory receptor family 4 subfamily D member 10 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332623 Or12d2b olfactory receptor family 12 subfamily D member 2B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332626 Or4k45 olfactory receptor family 4 subfamily K member 45 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332628 Or14j3e olfactory receptor family 14 subfamily J member 3E gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332629 Or1j12 olfactory receptor family 1 subfamily J member 12 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332630 Or51l4 olfactory receptor family 51 subfamily L member 4 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332631 Or6d12b olfactory receptor family 6 subfamily D member 12B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332632 Or6c216 olfactory receptor family 6 subfamily C member 216 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332633 Or11g27 olfactory receptor family 11 subfamily G member 27 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332634 Or2n1e olfactory receptor family 2 subfamily N member 1E gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332635 Or4a71 olfactory receptor family 4 subfamily A member 71 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332636 Or5m10 olfactory receptor family 5 subfamily M member 10 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332637 Or5aq6 olfactory receptor family 5 subfamily AQ member 6 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332638 Or52n2e olfactory receptor family 52 subfamily N member 2E gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332639 Or8g51 olfactory receptor family 8 subfamily G member 51 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332640 Or4p20b olfactory receptor family 4 subfamily P member 20B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332641 Or51g2 olfactory receptor family 51 subfamily G member 2 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332642 Or11g26b olfactory receptor family 11 subfamily G member 26B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332643 Or6c66b olfactory receptor family 6 subfamily C member 66B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332644 Or13a27b olfactory receptor family 13 subfamily A member 27B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332645 Or5p56 olfactory receptor family 5 subfamily P member 56 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332647 Or5m9 olfactory receptor family 5 subfamily M member 9 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332648 Or10j27 olfactory receptor family 10 subfamily J member 27 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332650 Or5be3 olfactory receptor family 5 subfamily BE member 3 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332651 Or1o11b olfactory receptor family 1 subfamily O member 11B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332652 Or2n1n olfactory receptor family 2 subfamily N member 1N gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332654 Or5b105 olfactory receptor family 5 subfamily B member 105 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332655 Or4c58 olfactory receptor family 4 subfamily C member 58 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332657 Or10ag59 olfactory receptor family 10 subfamily AG member 59 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332659 Or52ae8b olfactory receptor family 52 subfamily AE member 8B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332662 Or8c13 olfactory receptor family 8 subfamily C member 13 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332664 Or14c43 olfactory receptor family 14 subfamily C member 43 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332666 Or8b44b olfactory receptor family 8 subfamily B member 44B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332669 Or11n2 olfactory receptor family 11 subfamily N member 2 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332670 Or2t47 olfactory receptor family 2 subfamily T member 47 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332671 Or1f19 olfactory receptor family 1 subfamily F member 19 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332672 Or6k4 olfactory receptor family 6 subfamily K member 14B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332673 Olr1102 olfactory receptor 1102 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332674 Or8k3 olfactory receptor family 8 subfamily K member 3 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332675 Or5p76b olfactory receptor family 5 subfamily P member 76B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332681 Or8b12c olfactory receptor family 8 subfamily B member 12C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332682 Or1j1 olfactory receptor family 1 subfamily J member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332683 Or6k14b olfactory receptor family 6 subfamily K member 14B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332684 Or13e8 olfactory receptor family 13 subfamily E member 8 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332685 Or1a1 olfactory receptor family 1 subfamily A member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332686 Or5w8b olfactory receptor family 5 subfamily W member 8B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332687 Or56a3b olfactory receptor family 56 subfamily A member 3B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332688 Or2t29 olfactory receptor family 2 subfamily T member 29 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332689 Or8b43 olfactory receptor family 8 subfamily B member 43 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332690 Or2ak4c olfactory receptor family 2 subfamily AK member 4C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332691 Or1o11 olfactory receptor family 1 subfamily O member 11 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332692 Or4p20 olfactory receptor family 4 subfamily P member 20 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332693 Or8g2 olfactory receptor family 8 subfamily G member 2 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332695 Or8h10c olfactory receptor family 8 subfamily H member 10C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332696 Or4a77b olfactory receptor family 4 subfamily A member 77B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332697 Or2n1k olfactory receptor family 2 subfamily N member 1K gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332698 Or8d6 olfactory receptor family 8 subfamily D member 6 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332701 Or2n1g olfactory receptor family 2 subfamily N member 1G gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332702 Or6c7 olfactory receptor family 6 subfamily C member 7 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332704 Or5ak25 olfactory receptor family 5 subfamily AK member 25 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332706 Olr1433 olfactory receptor 1433 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332707 Or4c104 olfactory receptor family 4 subfamily C member 104 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332708 Or2ak6c olfactory receptor family 2 subfamily AK member 6C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332714 Or8c15b olfactory receptor family 8 subfamily C member 15B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332715 Or7g41 olfactory receptor family 7 subfamily G member 41 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332716 Or2a25 olfactory receptor family 2 subfamily A member 25 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332717 Or6c207 olfactory receptor family 6 subfamily C member 207 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332718 Olr220 olfactory receptor 220 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332720 Olr716 olfactory receptor 716 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332721 Or52j3b olfactory receptor family 52 subfamily J member 3B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332722 Or2y16 olfactory receptor family 2 subfamily Y member 16 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332723 Or4c112b olfactory receptor family 4 subfamily C member 112B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332725 Or2h2c olfactory receptor family 2 subfamily H member 2C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332726 Or8g20b olfactory receptor family 8 subfamily G member 20B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332727 Or8b55 olfactory receptor family 8 subfamily B member 55 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332728 Or8c18 olfactory receptor family 8 subfamily C member 18 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332732 Or6c33 olfactory receptor family 6 subfamily C member 33 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332733 Or14j3d olfactory receptor family 14 subfamily J member 3D gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332734 Or4f6 olfactory receptor family 4 subfamily F member 6 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332735 Or8a1 olfactory receptor family 8 subfamily A member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332737 Or9a4 olfactory receptor family 9 subfamily A member 4 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332740 Or7a44 olfactory receptor family 7 subfamily A member 44 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332741 Or2ag17 olfactory receptor family 2 subfamily AG member 17 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332742 Or7d11c olfactory receptor family 7 subfamily D member 11C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332743 Or5p60b olfactory receptor family 5 subfamily P member 60B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332744 Or8g23 olfactory receptor family 8 subfamily G member 23 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332745 Or5m11 olfactory receptor family 5 subfamily M member 11 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332746 Or6b2 olfactory receptor family 6 subfamily B member 2 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332747 Or13c7c olfactory receptor family 13 subfamily C member 7C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332749 Or4k77 olfactory receptor family 4 subfamily K member 77 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332754 Or13a26c olfactory receptor family 13 subfamily A member 26C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332756 Or1e22 olfactory receptor family 1 subfamily E member 22 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332757 Or1e31 olfactory receptor family 1 subfamily E member 30 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332758 Or12k7b olfactory receptor family 12 subfamily K member 7B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332759 Or2p2 olfactory receptor family 2 subfamily P member 2 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332760 Or52e5 olfactory receptor family 52 subfamily E member 5 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332761 Or6z7 olfactory receptor family 6 subfamily Z member 7 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332763 Or14j5b olfactory receptor family 14 subfamily J member 5B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332764 Or13f5l1 olfactory receptor family 13 subfamily F member 5 like 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332765 Or10d5jl olfactory receptor family 10 subfamily D member 5J like gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332767 Or51i2 olfactory receptor family 51 subfamily I member 2 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332768 Or14a257 olfactory receptor family 14 subfamily A member 257 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332769 Or5p76 olfactory receptor family 5 subfamily P member 76 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332770 Or5al7 olfactory receptor family 5 subfamily AL member 7 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332771 Or6z1 olfactory receptor family 6 subfamily Z member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332772 Or4f61d olfactory receptor family 4 subfamily F member 61D gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332773 Or51f2 olfactory receptor family 51 subfamily F member 2 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332774 Or2ak6b olfactory receptor family 2 subfamily AK member 6B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332775 Or6c74 olfactory receptor family 6 subfamily C member 74 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332776 Or52l1 olfactory receptor family 52 subfamily L member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332777 Or10ag59b olfactory receptor family 10 subfamily AG member 59B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332780 Or52e4 olfactory receptor family 52 subfamily E member 4 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332781 Or5p6 olfactory receptor family 5 subfamily P member 6 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332782 Or2b4 olfactory receptor family 2 subfamily B member 4 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332783 Or4x6 olfactory receptor family 4 subfamily X member 6 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332786 Or1f33 olfactory receptor family 1 subfamily F member 33 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332788 Or8g20e olfactory receptor family 8 subfamily G member 20E gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332789 Or56a5 olfactory receptor family 56 subfamily A member 5 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332791 Or10d1b olfactory receptor family 10 subfamily D member 1B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332792 Or2y1e olfactory receptor family 2 subfamily Y member 1E gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332793 Or1f21c olfactory receptor family 1 subfamily F member 21C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332794 Or1x2d olfactory receptor family 1 subfamily X member 2D gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332795 Or8k27 olfactory receptor family 8 subfamily K member 27 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332799 Or4c124b olfactory receptor family 4 subfamily C member 124B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332801 Or4x5 olfactory receptor family 4 subfamily X member 5 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332804 Or1p1e olfactory receptor family 1 subfamily P member 1E gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332806 Or2y11 olfactory receptor family 2 subfamily Y member 11 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332807 Or4k49 olfactory receptor family 4 subfamily K member 49 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332808 Or10j7 olfactory receptor family 10 subfamily J member 7 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332809 Or9e1 olfactory receptor family 9 subfamily E member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332810 Or6c69 olfactory receptor family 6 subfamily C member 69 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332811 Or4c117 olfactory receptor family 4 subfamily C member 117 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332812 Or5b116 olfactory receptor family 5 subfamily B member 116 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332813 Or5p69b olfactory receptor family 5 subfamily P member 69B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332815 Or52r1c olfactory receptor family 52 subfamily R member 1C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332816 Olr1563 olfactory receptor 1563 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332818 Or6d13 olfactory receptor family 6 subfamily D member 13 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332819 Or5ap2b olfactory receptor family 5 subfamily AP member 2B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332820 Or9g20 olfactory receptor family 9 subfamily G member 20 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332822 Or4a15b olfactory receptor family 4 subfamily A member 15B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332823 Or8b12d olfactory receptor family 8 subfamily B member 12D gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332824 Or6c35f olfactory receptor family 6 subfamily C member 35F gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332825 Or1l4b olfactory receptor family 1 subfamily L member 4B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332827 Or10d4 olfactory receptor family 10 subfamily D member 4 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332829 Or8k23 olfactory receptor family 8 subfamily K member 23 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332833 Or51e1 olfactory receptor family 51 subfamily E member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332834 Or4c11 olfactory receptor family 4 subfamily C member 11 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332835 Or2ak4 olfactory receptor family 2 subfamily AK member 4 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332836 Or8b101c olfactory receptor family 8 subfamily B member 101C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332841 Or52e7 olfactory receptor family 52 subfamily E member 7 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332842 Or4c108b olfactory receptor family 4 subfamily C member 108B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332843 Or1x2 olfactory receptor family 1 subfamily X member 2 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332844 Or1e28 olfactory receptor family 1 subfamily E member 28 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332845 Or13p9 olfactory receptor family 13 subfamily P member 9 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332846 Or2ag2 olfactory receptor family 2 subfamily AG member 2 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332847 Or5h17 olfactory receptor family 5 subfamily H member 17 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332848 Or7g16 olfactory receptor family 7 subfamily G member 16 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332849 Or4a66b olfactory receptor family 4 subfamily A member 66B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332850 Or4k52 olfactory receptor family 4 subfamily K member 52 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332851 Or1e20b olfactory receptor family 1 subfamily E member 20B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332860 Or4k51 olfactory receptor family 4 subfamily K member 51 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332862 Or1f20 olfactory receptor family 1 subfamily F member 20 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332863 Or4d5 olfactory receptor family 4 subfamily D member 5 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332867 Olr1092 olfactory receptor 1092 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332868 Or4f59 olfactory receptor family 4 subfamily F member 59 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332869 Or10am5 olfactory receptor family 10 subfamily AM member 5 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332870 Or10d4b olfactory receptor family 10 subfamily D member 4B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332871 Or52n4e olfactory receptor family 52 subfamily N member 4E gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332872 Or2a51 olfactory receptor family 2 subfamily A member 51 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332873 Or7e174 olfactory receptor family 7 subfamily E member 174 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332874 Or8b1d olfactory receptor family 8 subfamily B member 1D gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332875 Or6d12c olfactory receptor family 6 subfamily D member 12C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332876 Or2h2 olfactory receptor family 2 subfamily H member 2 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332880 Or6c215 olfactory receptor family 6 subfamily C member 215 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332881 Or8g2c olfactory receptor family 8 subfamily G member 2C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332882 Or2ag1 olfactory receptor family 2 subfamily AG member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332883 Or6c202f olfactory receptor family 6 subfamily C member 202F gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332884 Or8g34 olfactory receptor family 8 subfamily G member 34 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332887 Olr193 olfactory receptor 193 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332888 Olr943 olfactory receptor 943 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332889 Or51f1f olfactory receptor family 51 subfamily F member 1F gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332890 Or6c3d olfactory receptor family 6 subfamily C member 3D gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332891 Or6c203l1 olfactory receptor family 6 subfamily C member 203 like 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332892 Or5d37 olfactory receptor family 5 subfamily D member 37 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332893 Or10ak7 olfactory receptor family 10 subfamily AK member 7 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332894 Or51ah3 olfactory receptor family 51 subfamily AH member 3 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332901 Olr385 olfactory receptor 385 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332902 Or13n4b olfactory receptor family 13 subfamily N member 4B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332903 Or52n2 olfactory receptor family 52 subfamily N member 2 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332905 Or14n1 olfactory receptor family 14 subfamily N member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332907 Or5ak4 olfactory receptor family 5 subfamily AK member 4 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332908 Or6c33b olfactory receptor family 6 subfamily C member 33B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332909 Or10p1 olfactory receptor family 10 subfamily P member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332910 OR6c8 olfactory receptor family 6 subfamily C member 8 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332911 Or8k30b olfactory receptor family 8 subfamily K member 30B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332916 Or1j13b olfactory receptor family 1 subfamily J member 13B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332919 Or4f52 olfactory receptor family 4 subfamily F member 52 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332920 Or2k2 olfactory receptor family 2 subfamily K member 2 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332921 Or10ak7f olfactory receptor family 10 subfamily AK member 7F gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332922 Or5aq1b olfactory receptor family 5 subfamily AQ member 1B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332924 Or5ac23b olfactory receptor family 5 subfamily AC member 23B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332925 Or1f19e olfactory receptor family 1 subfamily F member 19E gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332926 Or8u10 olfactory receptor family 8 subfamily U member 10 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332928 Or5p72 olfactory receptor family 5 subfamily P member 72 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332929 Or14a260 olfactory receptor family 14 subfamily A member 260 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332930 Olr1520 olfactory receptor 1520 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332931 Or51k1 olfactory receptor family 51 subfamily K member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332933 Or13c3g olfactory receptor family 13 subfamily C member 3G gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332937 Or5w20 olfactory receptor family 5 subfamily W member 20 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332939 Or52h7 olfactory receptor family 52 subfamily H member 7 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332940 Or5g27 olfactory receptor family 5 subfamily G member 27 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332941 Or4p18b olfactory receptor family 4 subfamily P member 18B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332942 Or5w13 olfactory receptor family 5 subfamily W member 13 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332943 Or2ak5f olfactory receptor family 2 subfamily AK member 5F gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332944 Or1l4 olfactory receptor family 1 subfamily L member 4 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332945 Or2ak5d olfactory receptor family 2 subfamily AK member 5D gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332947 Or4c3e olfactory receptor family 4 subfamily C member 3E gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332948 Or5af1 olfactory receptor family 5 subfamily AF member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332950 Or5p78 olfactory receptor family 5 subfamily P member 78 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332951 Or5d14 olfactory receptor family 5 subfamily D member 14 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332952 Or4c31e olfactory receptor family 4 subfamily C member 31E gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332953 Or51f5 olfactory receptor family 51 subfamily F member 5 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332954 Or52u1 olfactory receptor family 52 subfamily U member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332955 Or1j15 olfactory receptor family 1 subfamily J member 15 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332956 Or4c31c olfactory receptor family 4 subfamily C member 31C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332957 Or13a27c olfactory receptor family 13 subfamily A member 27C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332958 Or52b2 olfactory receptor family 52 subfamily B member 2 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332964 Or4g7 olfactory receptor family 4 subfamily G member 7 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332965 Or5k3 olfactory receptor family 5 subfamily K member 3 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332966 Or5h17b olfactory receptor family 5 subfamily H member 17B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332967 Or8u3 olfactory receptor family 8 subfamily U member 3 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332969 Or1f30 olfactory receptor family 1 subfamily F member 30 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332970 Or6c6h olfactory receptor family 6 subfamily C member 6H gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332971 Or52e19 olfactory receptor family 52 subfamily E member 19 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332974 Or8b57 olfactory receptor family 8 subfamily B member 57 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332976 Or6c212 olfactory receptor family 6 subfamily C member 212 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332977 Olr703 olfactory receptor 703 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332978 Olr995 olfactory receptor 995 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332979 Or5d40 olfactory receptor family 5 subfamily D member 40 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332980 Or51b4b olfactory receptor family 51 subfamily B member 4B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332981 Olr1471 olfactory receptor 1471 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332982 Or2at1 olfactory receptor family 2 subfamily AT member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332984 Or52ac1 olfactory receptor family 52 subfamily AC member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332985 Or56b2k olfactory receptor family 56 subfamily B member 2K gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332986 Or6p1 olfactory receptor family 6 subfamily P member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332988 Or8b51 olfactory receptor family 8 subfamily B member 51 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332991 Or5m3 olfactory receptor family 5 subfamily M member 3 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332992 Or7e173d olfactory receptor family 7 subfamily E member 173D gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332993 Or4p8 olfactory receptor family 4 subfamily P member 8 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332994 Or6k14 olfactory receptor family 6 subfamily K member 14 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332995 Or5h17c olfactory receptor family 5 subfamily H member 17C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332997 Or4a77c olfactory receptor family 4 subfamily A member 77C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1332998 Or7g35 olfactory receptor family 7 subfamily G member 35 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333000 Or11a4 olfactory receptor family 11 subfamily A member 4 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333004 Or8g18e olfactory receptor family 8 subfamily G member 18E gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333008 Or52a5b olfactory receptor family 52 subfamily A member 5B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333009 Or8c10b olfactory receptor family 8 subfamily C member 10B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333011 Or2a20 olfactory receptor family 2 subfamily A member 20 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333012 Or1e16 olfactory receptor family 1 subfamily E member 16 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333013 Olr1428 olfactory receptor 1428 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333014 Or6c1 olfactory receptor family 6 subfamily C member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333015 Or5a3 olfactory receptor family 5 subfamily A member 3 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333016 Or10g1 olfactory receptor family 10 subfamily G member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333017 Or1e21b olfactory receptor family 1 subfamily E member 21B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333018 Or8s8 olfactory receptor family 8 subfamily S member 8 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333019 Or12e13b olfactory receptor family 12 subfamily E member 13B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333020 Or7g26b olfactory receptor family 7 subfamily G member 26B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333021 Or1m1 olfactory receptor family 1 subfamily M member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333022 Or6c68 olfactory receptor family 6 subfamily C member 68 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333023 Or11i1 olfactory receptor family 11 subfamily I member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333024 Or2v2 olfactory receptor family 2 subfamily V member 2 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333026 Or6b6 olfactory receptor family 6 subfamily B member 6 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333028 Or52k2 olfactory receptor family 52 subfamily K member 2 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333030 Or9i16 olfactory receptor family 9 subfamily I member 16 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333031 Or7g12 olfactory receptor family 7 subfamily G member 12 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333032 Or13a18c olfactory receptor family 13 subfamily A member 18C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333035 Or7g34 olfactory receptor family 7 subfamily G member 34 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333036 Or2av10 olfactory receptor family 2 subfamily AV member 10 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333038 Or10ag52 olfactory receptor family 10 subfamily AG member 52 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333039 Or10g9 olfactory receptor family 10 subfamily G member 9 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333041 Or8b51b olfactory receptor family 8 subfamily B member 51B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333042 Or4c114 olfactory receptor family 4 subfamily C member 114 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333044 Or7a38b olfactory receptor family 7 subfamily A member 38B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333045 Or10q12 olfactory receptor family 10 subfamily Q member 12 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333046 Or8h7b olfactory receptor family 8 subfamily H member 7B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333047 Or6d13c olfactory receptor family 6 subfamily D member 13C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333048 Or6d12 olfactory receptor family 6 subfamily D member 12 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333049 Or8w1b olfactory receptor family 8 subfamily W member 1B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333050 Or10q1 olfactory receptor family 10 subfamily Q member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333051 Or2ak4e olfactory receptor family 2 subfamily AK member 4E gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333052 Or4c31 olfactory receptor family 4 subfamily C member 31 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333053 Or4p22d olfactory receptor family 4 subfamily P member 22D gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333055 Or9k2 olfactory receptor family 9 subfamily K member 2 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333057 Or14c39b olfactory receptor family 14 subfamily C member 39B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333058 Or1r1 olfactory receptor family 1 subfamily R member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333059 Or8b1 olfactory receptor family 8 subfamily B member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333060 Or12d2c olfactory receptor family 12 subfamily D member 2C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333061 Or2t47e olfactory receptor family 2 subfamily T member 47E gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333063 Or4p18 olfactory receptor family 4 subfamily P member 18 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333064 Olr1523 olfactory receptor 1523 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333066 Or8k39 olfactory receptor family 8 subfamily K member 39 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333067 Or4f14e olfactory receptor family 4 subfamily F member 14E gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333068 Olr1564 olfactory receptor 1564 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333069 Or5w14 olfactory receptor family 5 subfamily W member 14 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333070 Or9s14 olfactory receptor family 9 subfamily S member 14 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333072 Olr1049 olfactory receptor 1049 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333073 Or5h18 olfactory receptor family 5 subfamily H member 18 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333074 Or10d4c olfactory receptor family 10 subfamily D member 4C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333075 Or2d36b olfactory receptor family 2 subfamily D member 36B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333076 Olr1093 olfactory receptor 1093 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333078 Or7h7 olfactory receptor family 7 subfamily H member 7 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333079 Or11m3 olfactory receptor family 11 subfamily M member 3 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333080 Olr1143 olfactory receptor 1143 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333081 Or5ac22 olfactory receptor family 5 subfamily AC member 22 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333082 Or1j4 olfactory receptor family 1 subfamily J member 4 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333084 Or1j15b olfactory receptor family 1 subfamily J member 15B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333085 Or9e1b olfactory receptor family 9 subfamily E member 1B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333086 Or5ap2 olfactory receptor family 5 subfamily AP member 2 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333088 Or1e26b olfactory receptor family 1 subfamily E member 26B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333089 Or4a80 olfactory receptor family 4 subfamily A member 80 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333092 Or5w16 olfactory receptor family 5 subfamily W member 16 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333093 Or6z5 olfactory receptor family 6 subfamily Z member 5 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333097 Or1j22 olfactory receptor family 1 subfamily J member 22 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333098 Or2a14 olfactory receptor family 2 subfamily A member 14 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333100 Or2y1h olfactory receptor family 2 subfamily Y member 1H gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333102 Or5m5 olfactory receptor family 5 subfamily M member 5 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333103 Or1n2 olfactory receptor family 1 subfamily N member 2 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333104 Or6c203c olfactory receptor family 6 subfamily C member 203C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333105 Or4a73 olfactory receptor family 4 subfamily A member 73 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333109 Or2ad1 olfactory receptor family 2 subfamily AD member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333111 Or7d12 olfactory receptor family 7 subfamily D member 12 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333113 Or10ak7e olfactory receptor family 10 subfamily AK member 7E gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333115 Or6c3b olfactory receptor family 6 subfamily C member 3B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333116 Or10k2 olfactory receptor family 10 subfamily K member 2 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333119 Or4a77 olfactory receptor family 4 subfamily A member 77 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333121 Or8b37 olfactory receptor family 8 subfamily B member 37 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333123 Or10al6 olfactory receptor family 10 subfamily AL member 6 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333124 Or13a18 olfactory receptor family 13 subfamily A member 18 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333125 Or5b24 olfactory receptor family 5 subfamily B member 24 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333126 Or4d10c olfactory receptor family 4 subfamily D member 10C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333127 Or14j1 olfactory receptor family 14 subfamily J member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333128 Or5g24 olfactory receptor family 5 subfamily G member 24 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333129 Or8k20 olfactory receptor family 8 subfamily K member 20 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333133 Or13c3e olfactory receptor family 13 subfamily C member 3E gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333134 Or10d5b olfactory receptor family 10 subfamily D member 5B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333136 Or4f53b olfactory receptor family 4 subfamily F member 53B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333138 Or12d14c olfactory receptor family 12 subfamily D member 14C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333139 Or5c1 olfactory receptor family 5 subfamily C member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333140 Or4a47 olfactory receptor family 4 subfamily A member 47 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333141 Or52a5 olfactory receptor family 52 subfamily A member 5 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333142 Or8b4 olfactory receptor family 8 subfamily B member 4 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333144 Or5ak24 olfactory receptor family 5 subfamily AK member 24 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333145 Or10d1g olfactory receptor family 10 subfamily D member 1G gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333146 Or3a1f olfactory receptor family 3 subfamily A member 1F gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333149 Or1f28 olfactory receptor family 1 subfamily F member 28 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333150 Or4z4 olfactory receptor family 4 subfamily Z member 4 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333151 Or11g2 olfactory receptor family 11 subfamily G member 2 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333156 Or10a49 olfactory receptor family 10 subfamily A member 49 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333157 Or52e15c olfactory receptor family 52 subfamily E member 15C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333158 Or52s1 olfactory receptor family 52 subfamily S member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333161 Or51s1 olfactory receptor family 51 subfamily S member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333164 Or8b101 olfactory receptor family 8 subfamily B member 101 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333165 Or5w12 olfactory receptor family 5 subfamily W member 12 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333167 Or52n4c olfactory receptor family 52 subfamily N member 4C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333171 Or6d15b olfactory receptor family 6 subfamily D member 15B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333172 Or4a2 olfactory receptor family 4 subfamily A member 2 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333174 Or5p1 olfactory receptor family 5 subfamily P member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333175 Or8g4 olfactory receptor family 8 subfamily G member 4 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333176 Or52s1b olfactory receptor family 52 subfamily S member 1B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333177 Or2j3 olfactory receptor family 2 subfamily J member 3 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333178 Or1e35b olfactory receptor family 1 subfamily E member 35B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333181 Or9i2 olfactory receptor family 9 subfamily I member 2 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333182 Olr1088 olfactory receptor 1088 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333183 Or8s10 olfactory receptor family 8 subfamily S member 10 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333184 Or10x1 olfactory receptor family 10 subfamily X member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333185 Or12j2 olfactory receptor family 12 subfamily J member 2 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333186 Or14j5e olfactory receptor family 14 subfamily J member 5E gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333188 Or2r3 olfactory receptor family 2 subfamily R member 3 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333189 Or4a78 olfactory receptor family 4 subfamily A member 78 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333191 Or2g1 olfactory receptor family 2 subfamily G member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333192 Or10al5b olfactory receptor family 10 subfamily AL member 5B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333194 Or6c211 olfactory receptor family 6 subfamily C member 211 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333195 Or8g36b olfactory receptor family 8 subfamily G member 36B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333196 Or6c3 olfactory receptor family 6 subfamily C member 3 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333198 Or6c214 olfactory receptor family 6 subfamily C member 214 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333199 Or12j3 olfactory receptor family 12 subfamily J member 3 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333201 Or52n4 olfactory receptor family 52 subfamily N member 4 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333203 Or6e1 olfactory receptor family 6 subfamily E member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333205 Or13a25 olfactory receptor family 13 subfamily A member 25 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333207 Or52e3 olfactory receptor family 52 subfamily E member 3 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333209 Or1j20 olfactory receptor family 1 subfamily J member 20 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333211 Or13p5 olfactory receptor family 13 subfamily P member 5 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333212 Or1f26 olfactory receptor family 1 subfamily F member 26 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333213 Or8b50 olfactory receptor family 8 subfamily B member 50 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333214 Or8c16c olfactory receptor family 8 subfamily C member 16C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333217 Or8g50b olfactory receptor family 8 subfamily G member 50B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333218 Or51f23c olfactory receptor family 51 subfamily F member 23C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333219 Or5bb12 olfactory receptor family 5 subfamily BB member 12 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333221 Or6ae1 olfactory receptor family 6 subfamily A member E1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333222 Or5t7 olfactory receptor family 5 subfamily T member 7 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333223 Or52s6 olfactory receptor family 52 subfamily S member 6 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333224 Or12e7 olfactory receptor family 12 subfamily E member 7 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333225 Or8w1 olfactory receptor family 8 subfamily W member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333226 Or7c19 olfactory receptor family 7 subfamily C member 19 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333227 Or56b6 olfactory receptor family 56 subfamily B member 6 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333228 Or51f4 olfactory receptor family 51 subfamily F member 4 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333229 Or52b1 olfactory receptor family 52 subfamily B member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333231 Or5h24b olfactory receptor family 5 subfamily H member 24B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333235 Or12e8 olfactory receptor family 12 subfamily E member 8 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333237 Or5w15 olfactory receptor family 5 subfamily W member 15 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333238 Or5an10 olfactory receptor family 5 subfamily AN member 10 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333239 Or5h26b olfactory receptor family 5 subfamily H member 26B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333240 Or51a25 olfactory receptor family 51 subfamily A member 25 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333241 Or10al4b olfactory receptor family 10 subfamily AL member 4B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333242 Or11g24 olfactory receptor family 11 subfamily G member 24 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333243 Or6c69d olfactory receptor family 6 subfamily C member 69D gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333245 Or2av9 olfactory receptor family 2 subfamily AV member 9 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333246 Or8h10 olfactory receptor family 8 subfamily H member 10 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333247 Or8g26 olfactory receptor family 8 subfamily G member 26 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333249 Or10n1 olfactory receptor family 10 subfamily N member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333250 Or5b116b olfactory receptor family 5 subfamily B member 116B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333251 Or1f21b olfactory receptor family 1 subfamily F member 21B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333253 Or1e1e olfactory receptor family 1 subfamily E member 1E gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333254 Or4c127 olfactory receptor family 4 subfamily C member 127 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333255 Or5p66b olfactory receptor family 5 subfamily P member 66B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333258 Or2m12 olfactory receptor family 2 subfamily M member 12 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333259 Or8k40 olfactory receptor family 8 subfamily K member 40 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333260 Or6c70 olfactory receptor family 6 subfamily C member 70 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333263 Or52e18 olfactory receptor family 52 subfamily E member 18 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333264 Or10ag2 olfactory receptor family 10 subfamily AG member 2 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333265 Or8b1b olfactory receptor family 8 subfamily B member 1B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333266 Or8g52b olfactory receptor family 8 subfamily G member 52B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333268 Or10ak14b olfactory receptor family 10 subfamily AK member 14B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333269 Or11j4 olfactory receptor family 11 subfamily J member 4 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333270 Or8c16 olfactory receptor family 8 subfamily C member 16 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333276 Or10v1 olfactory receptor family 10 subfamily V member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333281 Or6aa1b olfactory receptor family 6 subfamily A member A1B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333285 Or5j1 olfactory receptor family 5 subfamily J member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333287 Or6al1 olfactory receptor family 6 subfamily A member L1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333288 Or9i14 olfactory receptor family 9 subfamily I member 14 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333289 Or10w1 olfactory receptor family 10 subfamily W member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333290 Or7r1 olfactory receptor family 7 subfamily R member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333293 Or52k1 olfactory receptor family 52 subfamily K member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333294 Or9s23b olfactory receptor family 9 subfamily S member 23B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333297 Olr1585 olfactory receptor 1585 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333299 Or10s1 olfactory receptor family 10 subfamily S member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333300 Or2v2c olfactory receptor family 2 subfamily V member 2C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333302 Or13a19b olfactory receptor family 13 subfamily A member 19B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333303 Or9i13 olfactory receptor family 9 subfamily I member 13 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333305 Or4p22e olfactory receptor family 4 subfamily P member 22E gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333306 Or7a36 olfactory receptor family 7 subfamily A member 36 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333309 Or5ac23 olfactory receptor family 5 subfamily AC member 23 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333310 Or5l13 olfactory receptor family 5 subfamily L member 13 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333311 Or2h1 olfactory receptor family 2 subfamily H member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333316 Or52z12 olfactory receptor family 52 subfamily Z member 12 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333318 Or11h4c olfactory receptor family 11 subfamily H member 4C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333319 Or8s2 olfactory receptor family 8 subfamily S member 2 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333320 Or52d3 olfactory receptor family 52 subfamily D member 3 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333321 Or13c3c olfactory receptor family 13 subfamily C member 3C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333323 Or5b96 olfactory receptor family 5 subfamily B member 96 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333325 Olr36 olfactory receptor 36 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333326 Or4f58 olfactory receptor family 4 subfamily F member 58 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333328 Or5an6 olfactory receptor family 5 subfamily AN member 6 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333329 Or8g20 olfactory receptor family 8 subfamily G member 20 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333331 Or10ak7b olfactory receptor family 5 subfamily AK member 7B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333332 Or1af1 olfactory receptor family 1 subfamily AF member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333333 Or1b1 olfactory receptor family 1 subfamily B member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333334 Or7g25 olfactory receptor family 7 subfamily G member 25 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333335 Or4f7c olfactory receptor family 4 subfamily F member 7C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333336 Or5p50 olfactory receptor family 5 subfamily P member 50 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333343 Or5g25 olfactory receptor family 5 subfamily G member 25 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333345 Or9s23 olfactory receptor family 9 subfamily S member 23 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333346 Or5aq1d olfactory receptor family 5 subfamily AQ member 1D gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333347 Or5h25b olfactory receptor family 5 subfamily H member 25B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333349 Or8h9 olfactory receptor family 8 subfamily H member 9 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333350 Or4c1 olfactory receptor family 4 subfamily C member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333353 Or13a26 olfactory receptor family 13 subfamily A member 26 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333354 Or4c103b olfactory receptor family 4 subfamily C member 103B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333356 Or55b4 olfactory receptor family 55 subfamily B member 4 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333358 Or6b13 olfactory receptor family 6 subfamily B member 13 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333360 Or8g52 olfactory receptor family 8 subfamily G member 52 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333361 Or6c75 olfactory receptor family 6 subfamily C member 75 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333362 Or2l13 olfactory receptor family 2 subfamily L member 13 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333363 Olr1057 olfactory receptor 1057 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333365 Or8k1 olfactory receptor family 8 subfamily K member 16 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333366 Or5b106 olfactory receptor family 5 subfamily B member 106 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333367 Or6b1 olfactory receptor family 6 subfamily B member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333368 Or6s1 olfactory receptor family 6 subfamily S member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333369 Or5ac25 olfactory receptor family 5 subfamily AC member 25 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333370 Or4c102 olfactory receptor family 4 subfamily C member 102 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333371 Or51b6 olfactory receptor family 51 subfamily B member 6 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333372 Or13a23 olfactory receptor family 13 subfamily A member 23 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333374 Or13c7 olfactory receptor family 13 subfamily C member 7 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333377 Or51a25b olfactory receptor family 51 subfamily A member 25B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333379 Or51a42 olfactory receptor family 51 subfamily A member 42 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333381 Or10ac1 olfactory receptor family 10 subfamily AC member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333383 Or5au1 olfactory receptor family 5 subfamily AU member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333384 Or13c3f olfactory receptor family 13 subfamily C member 3F gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333385 Or7g26 olfactory receptor family 7 subfamily G member 26 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333387 Or14a257c olfactory receptor family 14 subfamily A member 257C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333390 Or52e5b olfactory receptor family 52 subfamily E member 5B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333391 Or10g9b olfactory receptor family 10 subfamily G member 9B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333392 Or8b46b olfactory receptor family 8 subfamily B member 46B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333393 Or4m1 olfactory receptor family 4 subfamily M member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333394 Or51b17 olfactory receptor family 51 subfamily B member 17 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333395 Or2h1b olfactory receptor family 2 subfamily H member 1B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333397 Olr1214 olfactory receptor 1214 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333398 Or13c25 olfactory receptor family 13 subfamily C member 25 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333399 Or7g23c olfactory receptor family 7 subfamily G member 23C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333400 Or5m8 olfactory receptor family 5 subfamily M member 8 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333402 Or2y1g olfactory receptor family 2 subfamily Y member 1G gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333403 Or8b53b olfactory receptor family 8 subfamily B member 53B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333406 Or8b101b olfactory receptor family 8 subfamily B member 101B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333407 Olr387 olfactory receptor 387 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333409 Or14j15 olfactory receptor family 14 subfamily J member 15 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333410 Or8h7 olfactory receptor family 8 subfamily H member 7 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333411 Or12k5 olfactory receptor family 12 subfamily K member 5 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333415 Or4c103 olfactory receptor family 4 subfamily C member 103 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333416 Or51v14 olfactory receptor family 51 subfamily V member 14 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333417 Or4c99 olfactory receptor family 4 subfamily C member 99 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333418 Or1j10 olfactory receptor family 1 subfamily J member 10 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333419 Or2y15 olfactory receptor family 2 subfamily Y member 15 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333420 Or5d41 olfactory receptor family 5 subfamily D member 41 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333421 Or5p5b olfactory receptor family 5 subfamily P member 5B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333422 Or2t48 olfactory receptor family 2 subfamily T member 48 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333423 Or5b107 olfactory receptor family 5 subfamily B member 107 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333424 Or52s19 olfactory receptor family 52 subfamily S member 19 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333425 Or9s18 olfactory receptor family 9 subfamily S member 18 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333427 Or10g1b olfactory receptor family 10 subfamily G member 1B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333428 Olr35 olfactory receptor 35 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333430 Or4c122 olfactory receptor family 4 subfamily C member 122 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333431 Or8g36c olfactory receptor family 8 subfamily G member 36C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333434 Or7a35 olfactory receptor family 7 subfamily A member 35 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333435 Or52ae7 olfactory receptor family 52 subfamily AE member 7 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333436 Or8b46c olfactory receptor family 8 subfamily B member 46C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333437 Or5t9b olfactory receptor family 5 subfamily T member 9B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333439 Or4s2 olfactory receptor family 4 subfamily S member 2 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333440 Or2y1 olfactory receptor family 2 subfamily Y member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333441 Or5p66 olfactory receptor family 5 subfamily P member 66 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333442 Or1j8b olfactory receptor family 1 subfamily J member 8B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333443 Or2d4 olfactory receptor family 2 subfamily D member 4 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333444 Or52h2 olfactory receptor family 52 subfamily H member 2 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333445 Olr5 olfactory receptor 5 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333448 Or10j3b olfactory receptor family 10 subfamily J member 3B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333449 Or5h27 olfactory receptor family 5 subfamily H member 27 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333452 Or56b2b olfactory receptor family 56 subfamily B member 2B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333453 Olr1610 olfactory receptor 1610 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333455 Or8j3 olfactory receptor family 8 subfamily J member 3 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333456 Or4p4 olfactory receptor family 4 subfamily P member 4 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333461 Or4x13 olfactory receptor family 4 subfamily X member 13 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333462 Or6c202 olfactory receptor family 6 subfamily C member 202 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333463 Olr1537 olfactory receptor 1537 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333465 Olr1675 olfactory receptor 1675 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333466 Or7g33c olfactory receptor family 7 subfamily G member 33C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333467 Or1j13 olfactory receptor family 1 subfamily J member 13 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333468 Olr951 olfactory receptor 951 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333472 Or8k16b olfactory receptor family 8 subfamily K member 16B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333473 Or5d47 olfactory receptor family 5 subfamily D member 47 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333475 Or5b102 olfactory receptor family 5 subfamily B member 102 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333476 Or8b46 olfactory receptor family 8 subfamily B member 46 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333477 Or5b123b olfactory receptor family 5 subfamily B member 123B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333478 Or8g36 olfactory receptor family 8 subfamily G member 36 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333480 Or4a15 olfactory receptor family 4 subfamily A member 15 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333481 Or51k7 olfactory receptor family 51 subfamily K member 7 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333482 Or1p1 olfactory receptor family 1 subfamily P member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333483 Or5b123 olfactory receptor family 5 subfamily B member 123 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333485 Or9s14b olfactory receptor family 9 subfamily S member 14B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333486 Or51l14 olfactory receptor family 51 subfamily L member 14 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333489 Or9s15 olfactory receptor family 9 subfamily S member 15 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333491 Or4f47 olfactory receptor family 4 subfamily F member 47 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333492 Or8b52 olfactory receptor family 8 subfamily B member 52 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333493 Or4x11 olfactory receptor family 4 subfamily X member 11 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333494 Or8s5 olfactory receptor family 8 subfamily S member 5 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333496 Or1l8 olfactory receptor family 1 subfamily L member 8 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333498 Or5ak22 olfactory receptor family 5 subfamily AK member 22 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333499 Or4f14 olfactory receptor family 4 subfamily F member 14 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333500 Or2d2 olfactory receptor family 2 subfamily D member 2 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333502 Or2n1 olfactory receptor family 2 subfamily N member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333503 Or4e5 olfactory receptor family 4 subfamily E member 14 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333504 Or13m2 olfactory receptor family 13 subfamily M member 2 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333506 Or14j5c olfactory receptor family 14 subfamily J member 5C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333510 Or4p19 olfactory receptor family 4 subfamily P member 19 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333511 Or6c213f olfactory receptor family 6 subfamily C member 213F gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333512 Or8c20 olfactory receptor family 8 subfamily C member 20 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333513 Or13a27d olfactory receptor family 13 subfamily A member 27D gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333514 Or51r1 olfactory receptor family 51 subfamily R member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333516 Or10u3 olfactory receptor family 10 subfamily U member 3 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333517 Or1e27 olfactory receptor family 1 subfamily E member 27 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333520 Or8b3c olfactory receptor family 8 subfamily B member 3C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333521 Or4k42b olfactory receptor family 4 subfamily K member 42B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333522 Or6b9 olfactory receptor family 6 subfamily B member 9 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333525 Or8b59 olfactory receptor family 8 subfamily B member 59 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333526 Or4k48 olfactory receptor family 4 subfamily K member 48 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333528 Or5k16 olfactory receptor family 5 subfamily K member 16 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333529 Or4k1 olfactory receptor family 4 subfamily K member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333531 Or52p2 olfactory receptor family 52 subfamily P member 2 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333532 Or51l1 olfactory receptor family 51 subfamily L member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333536 Or1j13c olfactory receptor family 1 subfamily J member 13C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333537 Or5m13b olfactory receptor family 5 subfamily M member 13B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333538 Or5w19 olfactory receptor family 5 subfamily W member 19 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333539 Or7g18 olfactory receptor family 7 subfamily G member 18 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333543 Olr1090 olfactory receptor 1090 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333545 Or4k37 olfactory receptor family 4 subfamily K member 37 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333546 Or52ae9 olfactory receptor family 52 subfamily AE member 9 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333547 Or52m1 olfactory receptor family 52 subfamily M member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333548 Or10p22 olfactory receptor family 10 subfamily P member 22 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333549 Or6c69b olfactory receptor family 6 subfamily C member 69B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333550 Or5g28 olfactory receptor family 5 subfamily G member 28 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333551 Or13c9 olfactory receptor family 13 subfamily C member 9 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333552 Or9g19 olfactory receptor family 9 subfamily G member 19 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333556 Or5m10b olfactory receptor family 5 subfamily M member 10B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333557 Olr920 olfactory receptor 920 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333560 Or52z13 olfactory receptor family 52 subfamily Z member 13 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333561 Or8g26c olfactory receptor family 8 subfamily G member 26C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333562 Or4c123 olfactory receptor family 4 subfamily C member 123 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333563 Or6c208b olfactory receptor family 6 subfamily C member 208B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333565 Or10h1d olfactory receptor family 10 subfamily H member 1D gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333568 Or1o2 olfactory receptor family 1 subfamily O member 2 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333569 Olr908 olfactory receptor 908 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333571 Or2y1c olfactory receptor family 2 subfamily Y member 1C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333574 Or11h4 olfactory receptor family 11 subfamily H member 4 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333575 Or5a21 olfactory receptor family 5 subfamily A member 21 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333576 Or52ab4 olfactory receptor family 52 subfamily AB member 4 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333577 Or13a27 olfactory receptor family 13 subfamily A member 27 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333578 Or4n4 olfactory receptor family 4 subfamily N member 4 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333581 Or1f29 olfactory receptor family 1 subfamily F member 29 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333582 Or6c206 olfactory receptor family 6 subfamily C member 206 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333584 Or13g1 olfactory receptor family 13 subfamily G member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333585 Or1e33 olfactory receptor family 1 subfamily E member 33 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333588 Or4f14f olfactory receptor family 4 subfamily F member 14F gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333590 Or1e16d olfactory receptor family 1 subfamily E member 16D gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333592 Or7g20 olfactory receptor family 7 subfamily G member 20 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333594 Or4a77e olfactory receptor family 4 subfamily A member 77E gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333595 Or9q2 olfactory receptor family 9 subfamily Q member 2 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333596 Or1ad5 olfactory receptor family 1 subfamily AD member 5 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333597 Or6n2 olfactory receptor family 6 subfamily N member 2 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333598 Or5g27b olfactory receptor family 5 subfamily G member 27B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333601 Or4d6 olfactory receptor family 4 subfamily D member 6 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333603 Or4a69 olfactory receptor family 4 subfamily A member 69 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333604 Or4k35 olfactory receptor family 4 subfamily K member 35 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333605 Or5p81 olfactory receptor family 5 subfamily P member 81 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333606 Or5w8 olfactory receptor family 5 subfamily W member 8 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333608 Or1aa2 olfactory receptor family 1 subfamily AA member 2 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333610 Or7e173 olfactory receptor family 7 subfamily E member 173 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333612 Or1e27b olfactory receptor family 1 subfamily E member 27B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333615 Or9s27 olfactory receptor family 9 subfamily S member 27 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333617 Or7e169 olfactory receptor family 7 subfamily E member 169 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333618 Or2n1j olfactory receptor family 2 subfamily N member 1J gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333619 Or5ac24 olfactory receptor family 5 subfamily AC member 24 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333620 Or7a38e olfactory receptor family 7 subfamily A member 38E gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333621 Or2d36 olfactory receptor family 2 subfamily D member 36 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333622 Or2aj4 olfactory receptor family 1 subfamily O member 4 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333623 Or5ar1 olfactory receptor family 5 subfamily AR member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333624 Or5g29 olfactory receptor family 5 subfamily G member 29 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333625 Or5b99 olfactory receptor family 5 subfamily B member 99 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333626 Or5k17 olfactory receptor family 5 subfamily K member 17 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333628 Or6d15 olfactory receptor family 6 subfamily D member 15 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333629 Olr1720 olfactory receptor 1720 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333630 Or1f19f olfactory receptor family 1 subfamily F member 19F gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333631 Or10h1 olfactory receptor family 10 subfamily H member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333633 Or5h25d olfactory receptor family 5 subfamily H member 25D gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333635 Or6c219 olfactory receptor family 6 subfamily C member 219 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333636 Or2ag18 olfactory receptor family 2 subfamily AG member 18 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333637 Or8b54c olfactory receptor family 8 subfamily B member 54C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333639 Or5p60c olfactory receptor family 5 subfamily P member 60C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333640 Or2t48b olfactory receptor family 2 subfamily T member 48B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333641 Or4f6b olfactory receptor family 4 subfamily F member 6B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333643 Or4c109b olfactory receptor family 4 subfamily C member 109B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333644 Or1e23 olfactory receptor family 1 subfamily E member 23 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333645 Or5l14b olfactory receptor family 5 subfamily L member 14B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333647 Or14a258 olfactory receptor family 14 subfamily A member 258 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333650 Or4c107 olfactory receptor family 4 subfamily C member 107 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333653 Or5t9 olfactory receptor family 5 subfamily T member 9 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333654 Or4f4a olfactory receptor family 4 subfamily F member 4A gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333655 Or8h10b olfactory receptor family 8 subfamily H member 10B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333656 Or1q1 olfactory receptor family 1 subfamily Q member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333657 Or7a37 olfactory receptor family 7 subfamily A member 37 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333658 Or7a41 olfactory receptor family 7 subfamily A member 41 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333659 Or7g89 olfactory receptor family 7 subfamily G member 89 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333660 Or4c121 olfactory receptor family 4 subfamily C member 121 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333662 Or52r1 olfactory receptor family 52 subfamily R member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333663 Or8k32 olfactory receptor family 8 subfamily K member 32 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333664 Or2ag19 olfactory receptor family 2 subfamily AG member 19 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333665 Or7g31 olfactory receptor family 7 subfamily G member 31 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333667 Or14j10b olfactory receptor family 14 subfamily J member 10B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333668 Or10d3 olfactory receptor family 10 subfamily D member 3 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333669 Or2ag13 olfactory receptor family 2 subfamily AG member 13 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333670 Or6c63 olfactory receptor family 6 subfamily C member 63 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333671 Or5i1 olfactory receptor family 5 subfamily I member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333672 Or10j3 olfactory receptor family 10 subfamily J member 3 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333673 Or10d5 olfactory receptor family 10 subfamily D member 5 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333675 Or10x1b olfactory receptor family 10 subfamily X member 1B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333677 Or2f1b olfactory receptor family 2 subfamily F member 1B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333681 Or2w2 olfactory receptor family 2 subfamily W member 2 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333682 Or9m1b olfactory receptor family 9 subfamily M member 1B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333684 Olr1571 olfactory receptor 1571 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333686 Or10ag57 olfactory receptor family 10 subfamily AG member 57 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333687 Or5d41b olfactory receptor family 5 subfamily D member 41B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333691 Or2ag2b olfactory receptor family 2 subfamily AG member 2B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333692 Or9g10 olfactory receptor family 9 subfamily G member 10 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333693 Or4c15b olfactory receptor family 4 subfamily C member 15B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333696 Or2n1l olfactory receptor family 2 subfamily N member 1L gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333697 Or52e51 olfactory receptor family 52 subfamily E member 51 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333698 Or8b42 olfactory receptor family 8 subfamily B member 42 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333700 Or6z3 olfactory receptor family 6 subfamily Z member 3 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333701 Or8g37b olfactory receptor family 8 subfamily G member 37B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333702 Or10j5 olfactory receptor family 10 subfamily J member 5 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333703 Or12e9 olfactory receptor family 12 subfamily E member 9 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333707 Or51ac3 olfactory receptor family 51 subfamily AC member 3 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333710 Olr936 olfactory receptor 936 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333711 Or1o1 olfactory receptor family 1 subfamily O member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333712 Or2l13c olfactory receptor family 2 subfamily L member 13C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333714 Or2g25 olfactory receptor family 2 subfamily G member 25 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333715 Or52h1 olfactory receptor family 52 subfamily H member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333720 Or51a41 olfactory receptor family 51 subfamily A member 41 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333722 Or8b56 olfactory receptor family 8 subfamily B member 56 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333724 Or13j1 olfactory receptor family 13 subfamily J member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333726 Or9r3 olfactory receptor family 9 subfamily R member 3 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333728 Or5p69 olfactory receptor family 5 subfamily P member 69 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333730 Or12j5 olfactory receptor family 12 subfamily J member 5 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333732 Or2y12 olfactory receptor family 2 subfamily Y member 12 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333734 Or8c19 olfactory receptor family 8 subfamily C member 19 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333735 Or5k15 olfactory receptor family 5 subfamily K member 15 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333736 Or2t47d olfactory receptor family 2 subfamily T member 47D gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333738 Or1o2e olfactory receptor family 1 subfamily O member 2E gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333739 Or8b54b olfactory receptor family 8 subfamily B member 54 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333740 Or8d4 olfactory receptor family 8 subfamily D member 4 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333741 Or8g24 olfactory receptor family 8 subfamily G member 24 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333742 Or12k8 olfactory receptor family 12 subfamily K member 8 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333743 Olr1451 olfactory receptor 1451 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333744 Or4g16 olfactory receptor family 4 subfamily G member 16 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333745 Or7g22 olfactory receptor family 7 subfamily G member 22 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333746 Or4p22 olfactory receptor family 4 subfamily P member 22 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333747 Or4a70 olfactory receptor family 4 subfamily A member 70 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333748 Or4x11c olfactory receptor family 4 subfamily X member 11C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333749 Or13p4 olfactory receptor family 13 subfamily P member 4 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333751 Or2aj4b olfactory receptor family 2 subfamily AJ member 4B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333752 Or10a3 olfactory receptor family 10 subfamily A member 3 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333754 Or4b1 olfactory receptor family 4 subfamily B member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333756 Or4c116 olfactory receptor family 4 subfamily C member 116 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333757 Or56b2 olfactory receptor family 56 subfamily B member 2 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333758 Or5w18 olfactory receptor family 5 subfamily W member 18 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333760 Or5b100 olfactory receptor family 5 subfamily B member 100 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333761 Or7h7b olfactory receptor family 7 subfamily H member 7B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333763 Or14c39 olfactory receptor family 14 subfamily C member 39 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333764 Or8b44 olfactory receptor family 8 subfamily B member 44 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333767 Or6al2 olfactory receptor family 6 subfamily A member L2 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333768 Or8c10 olfactory receptor family 8 subfamily C member 10 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333770 Or52e15b olfactory receptor family 52 subfamily E member 15B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333771 Or52h9 olfactory receptor family 52 subfamily H member 9 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333773 Or4c108 olfactory receptor family 4 subfamily C member 108 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333774 Or5al1 olfactory receptor family 5 subfamily AL member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333775 Or5h24 olfactory receptor family 5 subfamily H member 24 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333777 Or2b11 olfactory receptor family 2 subfamily B member 11 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333779 Or7g29 olfactory receptor family 7 subfamily G member 29 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333781 Olr1633 olfactory receptor 1633 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333782 Or5w13b olfactory receptor family 5 subfamily W member 13B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333783 Or4d2b olfactory receptor family 4 subfamily D member 2B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333784 Or6k2 olfactory receptor family 6 subfamily K member 2 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333788 Or8b47 olfactory receptor family 8 subfamily B member 47 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333789 Or5aq1 olfactory receptor family 5 subfamily AQ member 1B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333791 Or51ag1 olfactory receptor family 51 subfamily AG member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333793 Or6c35 olfactory receptor family 6 subfamily C member 35 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333794 Or52s20 olfactory receptor family 52 subfamily S member 20 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333795 Or4k44 olfactory receptor family 4 subfamily K member 44 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333796 Or5a1 olfactory receptor family 5 subfamily A member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333797 Or9g4b olfactory receptor family 9 subfamily G member 4B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333798 Or4c3 olfactory receptor family 4 subfamily C member 3 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333800 Or7g25c olfactory receptor family 7 subfamily G member 25C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333801 Or7a38d olfactory receptor family 7 subfamily A member 38D gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333803 Or8g28 olfactory receptor family 8 subfamily G member 28 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333804 Or5k8 olfactory receptor family 5 subfamily K member 8 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333806 Or51a7b olfactory receptor family 51 subfamily A member 7B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333808 Olr673 olfactory receptor 673 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333809 Or14c40 olfactory receptor family 14 subfamily C member 40 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333811 Or2r3b olfactory receptor family 2 subfamily R member 3B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333812 Or1j12b olfactory receptor family 1 subfamily J member 12B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333813 Or14j5 olfactory receptor family 14 subfamily J member 5 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333814 Or6d13b olfactory receptor family 6 subfamily D member 13B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333815 Or5m13 olfactory receptor family 5 subfamily M member 13 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333816 Or51b4 olfactory receptor family 51 subfamily B member 4 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333817 Or4c110 olfactory receptor family 4 subfamily C member 110 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333818 Or52n1b olfactory receptor family 52 subfamily N member 1B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333819 Or8c17 olfactory receptor family 8 subfamily C member 17 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333821 Or4f56 olfactory receptor family 4 subfamily F member 56 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333823 Or5t18 olfactory receptor family 5 subfamily T member 18 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333825 Or12e1 olfactory receptor family 12 subfamily E member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333826 Or7e169c olfactory receptor family 7 subfamily E member 169C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333828 Or13a19c olfactory receptor family 13 subfamily A member 19C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333829 Or4k48b olfactory receptor family 4 subfamily K member 48B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333833 Or4c10b olfactory receptor family 4 subfamily C member 10B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333835 Or52x1 olfactory receptor family 52 subfamily X member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333836 Or5aq7 olfactory receptor family 5 subfamily AQ member 7 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333837 Or6c203 olfactory receptor family 6 subfamily C member 203 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333840 Or8g17d olfactory receptor family 8 subfamily G member 17D gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333841 Or52n4d olfactory receptor family 52 subfamily N member 4D gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333843 Or13p3 olfactory receptor family 13 subfamily P member 3 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333844 Or6c35d olfactory receptor family 6 subfamily C member 35D gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333845 Or1d2 olfactory receptor family 1 subfamily D member 2 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333846 Or1x2b olfactory receptor family 1 subfamily X member 2B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333847 Or6c202d olfactory receptor family 6 subfamily C member 202D gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333848 Or9s13 olfactory receptor family 9 subfamily S member 13 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333849 Or4k6 olfactory receptor family 4 subfamily K member 6 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333851 Olr1177 olfactory receptor 1177 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333852 Olr1454 olfactory receptor 1454 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333853 Or5ac16 olfactory receptor family 5 subfamily AC member 16 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333854 Or1e25 olfactory receptor family 1 subfamily E member 25 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333856 Or1ad8 olfactory receptor family 1 subfamily AD member 8 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333858 Or2y1i olfactory receptor family 2 subfamily Y member 1I gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333859 Or8u9 olfactory receptor family 8 subfamily U member 9 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333860 Or10d1 olfactory receptor family 10 subfamily D member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333861 Or51q1 olfactory receptor family 51 subfamily Q member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333864 Or8b43b olfactory receptor family 8 subfamily B member 43B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333865 Or52ab2b olfactory receptor family 52 subfamily AB member 2B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333866 Or2ag20 olfactory receptor family 2 subfamily AG member 20 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333867 Or4f15 olfactory receptor family 4 subfamily F member 15 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333870 Olr1198 olfactory receptor 1198 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333873 Or7g21 olfactory receptor family 7 subfamily G member 21 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333874 Or52ae10 olfactory receptor family 52 subfamily AE member 10 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333875 Or7a38 olfactory receptor family 7 subfamily A member 38 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333878 Or5af1b olfactory receptor family 5 subfamily AF member 1B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333879 Or7g23 olfactory receptor family 7 subfamily G member 23 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333881 Or52n1 olfactory receptor family 52 subfamily N member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333882 Or1j19 olfactory receptor family 1 subfamily J member 19 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333884 Or8s16 olfactory receptor family 8 subfamily S member 16 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333885 Or2ag16b olfactory receptor family 2 subfamily AG member 16B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333886 Or1f32 olfactory receptor family 1 subfamily F member 32 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333888 Or1s2 olfactory receptor family 1 subfamily S member 2 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333892 Or3a1 olfactory receptor family 3 subfamily A member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333893 Or10u3b olfactory receptor family 10 subfamily U member 3B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333894 Or8g30 olfactory receptor family 8 subfamily G member 30 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333897 Or7g23e olfactory receptor family 7 subfamily G member 23E gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333898 Or2ak5e olfactory receptor family 2 subfamily AK member 5E gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333900 Or1j14 olfactory receptor family 1 subfamily J member 14 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333901 Or5p78c olfactory receptor family 5 subfamily P member 78C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333902 Or13a1 olfactory receptor family 13 subfamily A member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333903 Or10g3c olfactory receptor family 10 subfamily G member 3C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333904 Or4k50 olfactory receptor family 4 subfamily K member 50 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333906 Or10z1 olfactory receptor family 10 subfamily Z member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333908 Or8b45 olfactory receptor family 8 subfamily B member 45 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333909 Or10a4 olfactory receptor family 10 subfamily A member 4 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333910 Or5g9 olfactory receptor family 5 subfamily G member 9 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333911 Or2ak5 olfactory receptor family 2 subfamily AK member 5 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333912 Or5b104b olfactory receptor family 5 subfamily B member 104B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333913 Or4c112 olfactory receptor family 4 subfamily C member 112 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333914 Or1j21 olfactory receptor family 1 subfamily J member 21 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333916 Or8j3b olfactory receptor family 8 subfamily J member 3B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333918 Or8g50 olfactory receptor family 8 subfamily G member 50 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333920 Or8b9 olfactory receptor family 8 subfamily B member 9 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333922 Or5b124 olfactory receptor family 5 subfamily B member 124 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333923 Or12j4 olfactory receptor family 12 subfamily J member 4 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333926 Or1f31 olfactory receptor family 1 subfamily F member 31 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333927 Olr1400 olfactory receptor 1400 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333928 Or2ah1 olfactory receptor family 2 subfamily AH member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333929 Or5k14 olfactory receptor family 5 subfamily K member 14 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333930 Or9i1b olfactory receptor family 9 subfamily I member 1B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333931 Or13p10 olfactory receptor family 13 subfamily P member 10 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333932 Or5as1 olfactory receptor family 5 subfamily AS member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333933 Olr1731 olfactory receptor 1731 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333934 Or52j3 olfactory receptor family 52 subfamily J member 3 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333935 Or10ag54b olfactory receptor family 10 subfamily AG member 54B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333936 Or8b49 olfactory receptor family 8 subfamily B member 49 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333938 Or2ak6e olfactory receptor family 2 subfamily AK member 6E gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333940 Or1o2b olfactory receptor family 1 subfamily O member 2B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333941 Or9k7 olfactory receptor family 9 subfamily K member 7 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333942 Or2n1i olfactory receptor family 2 subfamily N member 1I gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333944 Or12e14 olfactory receptor family 12 subfamily E member 14 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333946 Or11g1 olfactory receptor family 11 subfamily G member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333947 Or2t35 olfactory receptor family 2 subfamily T member 35 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333948 Or5aq7b olfactory receptor family 5 subfamily AQ member 7B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333950 Or2f2 olfactory receptor family 2 subfamily F member 2 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333951 Or4f60 olfactory receptor family 4 subfamily F member 60 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333952 Olr1481 olfactory receptor 1481 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333953 Or51a10 olfactory receptor family 51 subfamily A member 10 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333955 Or52e8b olfactory receptor family 52 subfamily E member 8B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333956 Or52ab2 olfactory receptor family 52 subfamily AB member 2 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333957 Or6k6 olfactory receptor family 6 subfamily K member 6 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333958 Or5p52 olfactory receptor family 5 subfamily P member 52 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333960 Or1f21 olfactory receptor family 1 subfamily F member 21 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333961 Or52ad1 olfactory receptor family 52 subfamily AD member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333962 Or4c12 olfactory receptor family 4 subfamily C member 12 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333964 Or4k2 olfactory receptor family 4 subfamily K member 2 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333969 Or2aa1 olfactory receptor family 2 subfamily AA member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333970 Or6c6f olfactory receptor family 6 subfamily C member 6F gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333972 Or52d1 olfactory receptor family 52 subfamily D member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333973 Or7e171d olfactory receptor family 7 subfamily E member 171D gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333974 Or52n3 olfactory receptor family 52 subfamily N member 3 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333975 Or2q1 olfactory receptor family 2 subfamily Q member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333977 Or5p79 olfactory receptor family 5 subfamily P member 79 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333978 Or4c129 olfactory receptor family 4 subfamily C member 129 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333980 Or4k36 olfactory receptor family 4 subfamily K member 36 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333981 Or7g23b olfactory receptor family 7 subfamily G member 23B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333983 Or52d13 olfactory receptor family 52 subfamily D member 13 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333985 Or4c15 olfactory receptor family 4 subfamily C member 15 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333987 Or5an9 olfactory receptor family 5 subfamily AN member 9 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333988 Or5t5 olfactory receptor family 5 subfamily T member 5 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333989 Or1e1 olfactory receptor family 1 subfamily E member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333990 Or2t44b olfactory receptor family 2 subfamily T member 44B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333993 Or4c52 olfactory receptor family 4 subfamily C member 52 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333994 Or2n1h olfactory receptor family 2 subfamily N member 1H gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333996 Or2w6 olfactory receptor family 2 subfamily W member 6 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333997 Or51af1 olfactory receptor family 51 subfamily AF member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333998 Or6aa1 olfactory receptor family 6 subfamily A member A1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1333999 Or4c125 olfactory receptor family 4 subfamily C member 125 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334000 Or1o2c olfactory receptor family 1 subfamily O member 2C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334001 Or12d2 olfactory receptor family 12 subfamily D member 2 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334002 Or10a2 olfactory receptor family 10 subfamily A member 2 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334003 Or8b46d olfactory receptor family 8 subfamily B member 46D gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334007 Or10ak14 olfactory receptor family 10 subfamily AK member 14 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334008 Or5p4 olfactory receptor family 5 subfamily P member 4 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334009 Or52m2 olfactory receptor family 52 subfamily M member 2 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334011 Or4f7 olfactory receptor family 4 subfamily F member 7 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334013 Olr1500 olfactory receptor 1500 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334014 Or7c70 olfactory receptor family 7 subfamily C member 70 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334015 Or52e2 olfactory receptor family 52 subfamily E member 2 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334017 Or6c1h olfactory receptor family 6 subfamily C member 1H gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334018 Or2ag19b olfactory receptor family 2 subfamily AG member 19B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334019 Or1o11c olfactory receptor family 1 subfamily O member 11C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334023 Olr623 olfactory receptor 623 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334025 Or8k33 olfactory receptor family 8 subfamily K member 33 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334026 Or8b35 olfactory receptor family 8 subfamily B member 35 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334027 Or12e10 olfactory receptor family 12 subfamily E member 10 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334028 Or2d3 olfactory receptor family 2 subfamily D member 3 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334030 Olr1191 olfactory receptor 1191 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334032 Olr765 olfactory receptor 765 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334033 Or8b56g olfactory receptor family 8 subfamily B member 56G gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334034 Or6d14 olfactory receptor family 6 subfamily D member 14 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334037 Or51ab3 olfactory receptor family 51 subfamily AB member 3 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334039 Or8b3 olfactory receptor family 8 subfamily B member 3 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334040 Or14j3 olfactory receptor family 14 subfamily J member 3 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334041 Or2w1 olfactory receptor family 2 subfamily W member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334043 Or2d3c olfactory receptor family 2 subfamily D member 3C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334046 Or4c29 olfactory receptor family 4 subfamily C member 29 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334047 Or4k46 olfactory receptor family 4 subfamily K member 46 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334048 Or56b6b olfactory receptor family 56 subfamily B member 6B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334050 Or8i2 olfactory receptor family 8 subfamily I member 2 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334051 Or12j2b olfactory receptor family 12 subfamily J member 2B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334053 Or2t45 olfactory receptor family 2 subfamily T member 45 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334054 Or14a257b olfactory receptor family 14 subfamily A member 257B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334055 Olr1096 olfactory receptor 1096 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334056 Or6c2b olfactory receptor family 6 subfamily C member 2B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334058 Or14p1 olfactory receptor family 14 subfamily P member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334059 Or4n5 olfactory receptor family 4 subfamily N member 5 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334060 Or52e15 olfactory receptor family 52 subfamily E member 15 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334062 Or5v1b olfactory receptor family 5 subfamily V member 1B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334063 Or5b12b olfactory receptor family 5 subfamily B member 12B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334067 Or7e166 olfactory receptor family 7 subfamily E member 166 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334069 Or4c120 olfactory receptor family 4 subfamily C member 120 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334070 Or5an1 olfactory receptor family 5 subfamily AN member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334071 Or4b1c olfactory receptor family 4 subfamily B member 1C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334072 Or10v9b olfactory receptor family 10 subfamily V member 9B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334073 Or4e2 olfactory receptor family 4 subfamily E member 5 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334075 Or4k15c olfactory receptor family 4 subfamily K member 15C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334076 Or13c7b olfactory receptor family 13 subfamily C member 7B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334077 Or2t45b olfactory receptor family 2 subfamily T member 45B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334078 Or1x2c olfactory receptor family 1 subfamily O member 2C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334079 Or5an1b olfactory receptor family 5 subfamily AN member 1B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334081 Or52b4 olfactory receptor family 52 subfamily B member 4 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334083 Or1e21 olfactory receptor family 1 subfamily E member 21 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334086 Or1f34 olfactory receptor family 1 subfamily F member 34 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334087 Or10aa1 olfactory receptor family 10 subfamily AA member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334088 Or2ab1 olfactory receptor family 2 subfamily AB member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334089 Or52n20 olfactory receptor family 52 subfamily N member 20 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334091 Or5b21 olfactory receptor family 5 subfamily B member 21 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334093 Or52p1 olfactory receptor family 52 subfamily P member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334096 Or2ak6 olfactory receptor family 2 subfamily AK member 6 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334098 Or6c6i olfactory receptor family 6 subfamily C member 6I gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334099 Or13a26b olfactory receptor family 13 subfamily A member 26B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334102 Or2t6 olfactory receptor family 2 subfamily T member 6 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334104 Or8c11 olfactory receptor family 8 subfamily C member 11 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334106 Olr1052 olfactory receptor 1052 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334108 Or9q1 olfactory receptor family 9 subfamily Q member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334110 Olr947 olfactory receptor 947 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334112 Or5t5b olfactory receptor family 5 subfamily T member 5B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334113 Or1f27 olfactory receptor family 1 subfamily F member 27 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334115 Or8h11 olfactory receptor family 8 subfamily H member 11 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334116 Or4a66 olfactory receptor family 4 subfamily A member 66 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334120 Or8b1c olfactory receptor family 8 subfamily B member 1C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334121 Or10ag58 olfactory receptor family 10 subfamily AG member 58 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334122 Or14j6 olfactory receptor family 14 subfamily J member 6 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334123 Or5h25 olfactory receptor family 5 subfamily H member 25 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334127 Or51i1 olfactory receptor family 51 subfamily I member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334128 Or7g32 olfactory receptor family 7 subfamily G member 32 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334132 Or10al27 olfactory receptor family 10 subfamily AL member 27 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334138 Or13d1 olfactory receptor family 13 subfamily D member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334139 Or2y14 olfactory receptor family 2 subfamily Y member 14 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334141 Or6b3 olfactory receptor family 6 subfamily B member 3 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334144 Or4a68 olfactory receptor family 4 subfamily A member 68 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334147 Or8b101d olfactory receptor family 8 subfamily B member 101D gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334148 Or7e171b olfactory receptor family 7 subfamily E member 171B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334149 Or7e171 olfactory receptor family 7 subfamily E member 171 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334151 Or4c115 olfactory receptor family 4 subfamily C member 115 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334152 Or2y1d olfactory receptor family 2 subfamily Y member 1D gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334153 Or56b6c olfactory receptor family 56 subfamily B member 6C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334154 Or5b95 olfactory receptor family 5 subfamily B member 95 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334155 Or5af1c olfactory receptor family 5 subfamily AF member 1C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334157 Or1j16b olfactory receptor family 1 subfamily J member 16B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334159 Or2a57 olfactory receptor family 2 subfamily A member 57 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334160 Or2d2b olfactory receptor family 2 subfamily D member 2B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334162 Or4f7b olfactory receptor family 4 subfamily F member 7B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334163 Or7d11 olfactory receptor family 7 subfamily D member 11 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334164 Or11l3 olfactory receptor family 11 subfamily L member 3 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334165 Or5p53 olfactory receptor family 5 subfamily P member 53 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334167 Or2ak5b olfactory receptor family 2 subfamily AK member 5B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334168 Or5p68 olfactory receptor family 5 subfamily P member 68 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334171 Or10a3c olfactory receptor family 10 subfamily A member 3C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334173 Or13n4 olfactory receptor family 13 subfamily N member 4 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334176 Or4c105 olfactory receptor family 4 subfamily C member 105 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334178 Or9r3c olfactory receptor family 9 subfamily R member 3C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334180 Or10ab4 olfactory receptor family 10 subfamily AB member 4 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334181 Or1e32 olfactory receptor family 1 subfamily E member 32 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334182 Or11h4d olfactory receptor family 11 subfamily H member 4D gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334183 Or8c9 olfactory receptor family 8 subfamily C member 9 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334187 Or8k24 olfactory receptor family 8 subfamily K member 24 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334188 Or8b8 olfactory receptor family 8 subfamily B member 8 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334189 Or8g35b olfactory receptor family 8 subfamily G member 35B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334190 Or1e18 olfactory receptor family 1 subfamily E member 18 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334192 Or5d20 olfactory receptor family 5 subfamily D member 20 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334193 Or7g33 olfactory receptor family 7 subfamily G member 33 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334194 Or2r11 olfactory receptor family 2 subfamily R member 11 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334195 Or3a4 olfactory receptor family 3 subfamily A member 4 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334196 Or7g24 olfactory receptor family 7 subfamily G member 24 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334197 Or4e1 olfactory receptor family 4 subfamily E member 2 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334198 Or6c76b olfactory receptor family 6 subfamily C member 76B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334200 Or8g18c olfactory receptor family 8 subfamily G member 18C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334201 Olr952 olfactory receptor 952 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334203 Or13l2 olfactory receptor family 13 subfamily L member 2 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334204 Or55b10 olfactory receptor family 55 subfamily B member 10 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334206 Or5ac21 olfactory receptor family 5 subfamily AC member 21 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334209 Or2a7 olfactory receptor family 2 subfamily A member 7 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334210 Or4c35 olfactory receptor family 4 subfamily C member 35 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334212 Or51v8 olfactory receptor family 51 subfamily V member 8 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334213 Olr990 olfactory receptor 990 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334214 Or6b2b olfactory receptor family 6 subfamily B member 2B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334216 Or13a18b olfactory receptor family 13 subfamily A member 18B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334217 Or1j16 olfactory receptor family 1 subfamily J member 16 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334218 Or4c109 olfactory receptor family 4 subfamily C member 109 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334219 Or5p5 olfactory receptor family 5 subfamily P member 5 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334220 Or6c201 olfactory receptor family 6 subfamily C member 201 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334222 Or2h15 olfactory receptor family 2 subfamily H member 15 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334224 Or6y1 olfactory receptor family 6 subfamily Y member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334226 Or5ac19 olfactory receptor family 5 subfamily AC member 19 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334227 Or8k22 olfactory receptor family 8 subfamily K member 22 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334228 Or1e1c olfactory receptor family 1 subfamily E member 1C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334232 Or12d13 olfactory receptor family 12 subfamily D member 13 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334235 Or6c208 olfactory receptor family 6 subfamily C member 208 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334237 Or3a1e olfactory receptor family 3 subfamily A member 1E gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334238 Or52z14 olfactory receptor family 52 subfamily Z member 14 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334242 Or8a1b olfactory receptor family 8 subfamily A member 1B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334246 Or1i2 olfactory receptor family 1 subfamily I member 2 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334248 Or4k5 olfactory receptor family 4 subfamily K member 5 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334249 Or4f60b olfactory receptor family 4 subfamily F member 60B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334251 Or13a27e olfactory receptor family 13 subfamily A member 27E gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334252 Or4c111 olfactory receptor family 4 subfamily C member 111 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334253 Olr1505 olfactory receptor 1505 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334254 Or6c2 olfactory receptor family 6 subfamily C member 2 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334255 Or5p60d olfactory receptor family 5 subfamily P member 60D gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334258 Or1ad1 olfactory receptor family 1 subfamily AD member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334259 Or11h23b olfactory receptor family 11 subfamily H member 23B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334260 Or51k2 olfactory receptor family 51 subfamily K member 2 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334262 Or52ae7b olfactory receptor family 52 subfamily AE member 7B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334263 Or10g3 olfactory receptor family 10 subfamily G member 3 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334264 Or13c7e olfactory receptor family 13 subfamily C member 7E gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334265 Or1f20b olfactory receptor family 1 subfamily F member 20B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334266 Or7d10 olfactory receptor family 7 subfamily D member 10 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334267 Or14a257d olfactory receptor family 14 subfamily A member 257D gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334269 Or5al5b olfactory receptor family 5 subfamily AL member 5B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334273 Olr440 olfactory receptor 440 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334276 Or8u8 olfactory receptor family 8 subfamily U member 8 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334277 Or51q1e olfactory receptor family 51 subfamily Q member 1E gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334278 Or8k25 olfactory receptor family 8 subfamily K member 25 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334279 Or7a39 olfactory receptor family 7 subfamily A member 39 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334280 Or4c31b olfactory receptor family 4 subfamily C member 31B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334281 Olr726 olfactory receptor 726 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334282 Or5t16 olfactory receptor family 5 subfamily T member 16 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334283 Or52l1b olfactory receptor family 52 subfamily L member 1B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334285 Or5w22 olfactory receptor family 5 subfamily W member 22 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334286 Or4a77d olfactory receptor family 4 subfamily A member 77D gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334287 Or4b1d olfactory receptor family 4 subfamily B member 1D gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334290 Or1f20d olfactory receptor family 1 subfamily F member 20D gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334291 Or7e176 olfactory receptor family 7 subfamily E member 176 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334292 Or51g1 olfactory receptor family 51 subfamily G member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334294 Or4f14d olfactory receptor family 4 subfamily F member 14D gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334296 Or12d14b olfactory receptor family 12 subfamily D member 14B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334297 Or7d9 olfactory receptor family 7 subfamily D member 9 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334301 Or5p73 olfactory receptor family 5 subfamily P member 73 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334302 Or51aa2 olfactory receptor family 51 subfamily AA member 2 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334305 Or1n1b olfactory receptor family 1 subfamily N member 1B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334306 Or8b12 olfactory receptor family 8 subfamily B member 12 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334309 Or10ag54 olfactory receptor family 10 subfamily AG member 54 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334310 Or8g21 olfactory receptor family 8 subfamily G member 21 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334311 Olr551 olfactory receptor 551 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334313 Or9g4 olfactory receptor family 9 subfamily G member 4 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334315 Or10d5j olfactory receptor family 10 subfamily D member 5J gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334316 Or52ae8 olfactory receptor family 52 subfamily AE member 8 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334317 Or6c214b olfactory receptor family 6 subfamily C member 214B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334318 Or10ak13 olfactory receptor family 10 subfamily AK member 13 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334321 Or1ad6 olfactory receptor family 1 subfamily AD member 6 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334322 Or6c202e olfactory receptor family 6 subfamily C member 202E gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334323 Or4b13b olfactory receptor family 4 subfamily B member 13B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334326 Or2t44 olfactory receptor family 2 subfamily T member 44 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334327 Or52z1 olfactory receptor family 52 subfamily Z member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334332 Or8b53 olfactory receptor family 8 subfamily B member 53 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334333 Olr520 olfactory receptor 520 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334334 Or4g17 olfactory receptor family 4 subfamily G member 17 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334335 Or7g34b olfactory receptor family 7 subfamily G member 34B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334338 Or6k8 olfactory receptor family 6 subfamily K member 8 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334339 Olr655 olfactory receptor 655 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334340 Or5h26 olfactory receptor family 5 subfamily H member 26 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334341 Or4a72 olfactory receptor family 4 subfamily A member 72 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334346 Or4d11 olfactory receptor family 4 subfamily D member 11 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334348 Or2ag16 olfactory receptor family 2 subfamily AG member 16 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334349 Or11h6 olfactory receptor family 11 subfamily H member 6 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334352 Or8g35 olfactory receptor family 8 subfamily G member 35 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334353 Or2v1 olfactory receptor family 2 subfamily V member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334354 Or51q1d olfactory receptor family 51 subfamily Q member 1D gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334356 Or5w17 olfactory receptor family 5 subfamily W member 17 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334358 Olr906 olfactory receptor 906 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334360 Or5w1 olfactory receptor family 5 subfamily W member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334361 Or2t1 olfactory receptor family 2 subfamily T member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334362 Or5p6b olfactory receptor family 5 subfamily P member 6B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334364 Or52e8 olfactory receptor family 52 subfamily E member 8 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334368 Or1f20e olfactory receptor family 1 subfamily F member 20E gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334370 Or5p59 olfactory receptor family 5 subfamily P member 59 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334372 Or5w11 olfactory receptor family 5 subfamily W member 11 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334373 Or5ae1 olfactory receptor family 5 subfamily AE member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334374 Or5b12 olfactory receptor family 5 subfamily B member 12 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334376 Or2c1 olfactory receptor family 2 subfamily C member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334377 Or4a81 olfactory receptor family 4 subfamily A member 81 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334379 Or4f53 olfactory receptor family 4 subfamily F member 53 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334380 Or2l5 olfactory receptor family 2 subfamily L member 5 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334384 Or5bh3 olfactory receptor family 5 subfamily BH member 3 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334385 Or6x1 olfactory receptor family 6 subfamily X member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334386 Or10n7 olfactory receptor family 10 subfamily N member 7 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334387 Or10a48 olfactory receptor family 10 subfamily A member 48B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334388 Or14j3b olfactory receptor family 14 subfamily J member 3B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334389 Or12k7 olfactory receptor family 12 subfamily K member 7 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334390 Or51v8b olfactory receptor family 51 subfamily V member 8B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334391 Or8g34b olfactory receptor family 8 subfamily G member 34B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334393 Or52n2f olfactory receptor family 52 subfamily N member 2F gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334395 Or6c213c olfactory receptor family 6 subfamily C member 213C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334396 Or10w3 olfactory receptor family 10 subfamily W member 3 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334397 Or51a7 olfactory receptor family 51 subfamily A member 7 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334399 Or6f1 olfactory receptor family 6 subfamily F member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334400 Or7g30 olfactory receptor family 7 subfamily G member 30 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334403 Or5o1 olfactory receptor family 5 subfamily O member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334404 Or10al4c olfactory receptor family 10 subfamily AL member 4C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334405 Or8h6 olfactory receptor family 8 subfamily H member 6 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334406 Or5b104 olfactory receptor family 5 subfamily B member 104 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334407 Or10aa3 olfactory receptor family 10 subfamily AA member 3 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334408 Or4f57 olfactory receptor family 4 subfamily F member 57 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334409 Or9k2b olfactory receptor family 9 subfamily K member 2B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334410 Olr1024 olfactory receptor 1024 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334411 Or56b1 olfactory receptor family 56 subfamily B member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334412 Or4c105b olfactory receptor family 4 subfamily C member 105B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334413 Or6c38 olfactory receptor family 6 subfamily C member 38 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334415 Or2a5 olfactory receptor family 2 subfamily A member 5 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334416 Or5b3 olfactory receptor family 5 subfamily B member 3 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334418 Or6c6b olfactory receptor family 6 subfamily C member 6B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334421 Or51a39 olfactory receptor family 51 subfamily A member 39 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334422 Olr621 olfactory receptor 621 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334424 Or52a20 olfactory receptor family 52 subfamily A member 20 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334425 Or51b6b olfactory receptor family 51 subfamily B member 6B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334426 Or9g3 olfactory receptor family 9 subfamily G member 3 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334428 Or5ac15 olfactory receptor family 5 subfamily AC member 15 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334429 Or4p7 olfactory receptor family 4 subfamily P member 7 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334430 Or6c69e olfactory receptor family 6 subfamily C member 69E gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334431 Or4k15 olfactory receptor family 4 subfamily K member 15 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334432 Or51f1g olfactory receptor family 51 subfamily F member 1G gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334433 Or6c88 olfactory receptor family 6 subfamily C member 88 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334434 Or4a66c olfactory receptor family 4 subfamily A member 66C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334435 Or6n1 olfactory receptor family 6 subfamily N member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334436 Or1a1b olfactory receptor family 1 subfamily A member 1B gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 1334437 Or1ak2 olfactory receptor family 1 subfamily AK member 2 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 13432064 Ugt1a1j UDP glucuronosyltransferase family 1 member A1, jaundice mutant gene MP:0002591 decreased mean corpuscular volume IAGP N RGD:1354701|PMID:20323028 20201210 RGD compared to Gunn rats 13432064 Ugt1a1j UDP glucuronosyltransferase family 1 member A1, jaundice mutant gene MP:0002640 reticulocytosis IAGP N RGD:1354701|PMID:20323028 20201210 RGD compared to Gunn rats 13432064 Ugt1a1j UDP glucuronosyltransferase family 1 member A1, jaundice mutant gene MP:0002988 decreased urine osmolality treatment IAGP XCO:0000683, XCO:0000283 N RGD:1354700|PMID:1127102 20201210 RGD 13432064 Ugt1a1j UDP glucuronosyltransferase family 1 member A1, jaundice mutant gene MP:0005344 increased circulating bilirubin level IAGP N RGD:13432067|PMID:16337205 20170918 RGD 13432064 Ugt1a1j UDP glucuronosyltransferase family 1 member A1, jaundice mutant gene MP:0005344 increased circulating bilirubin level IAGP N RGD:1354701|PMID:20323028 20201210 RGD compared to Gunn rats 13432064 Ugt1a1j UDP glucuronosyltransferase family 1 member A1, jaundice mutant gene MP:0005344 increased circulating bilirubin level IAGP N RGD:1354702|PMID:15753292 20201210 RGD 13432064 Ugt1a1j UDP glucuronosyltransferase family 1 member A1, jaundice mutant gene MP:0005344 increased circulating bilirubin level treatment IAGP XCO:0000683, XCO:0000283 N RGD:1354700|PMID:1127102 20201210 RGD 13432064 Ugt1a1j UDP glucuronosyltransferase family 1 member A1, jaundice mutant gene MP:0008489 slow postnatal weight gain IAGP N RGD:1354701|PMID:20323028 20201210 RGD compared to Gunn rats 13432064 Ugt1a1j UDP glucuronosyltransferase family 1 member A1, jaundice mutant gene MP:0010108 abnormal renal water reabsorption treatment IAGP XCO:0000683, XCO:0000283 N RGD:1354700|PMID:1127102 20201210 RGD 13432064 Ugt1a1j UDP glucuronosyltransferase family 1 member A1, jaundice mutant gene MP:0013305 isosthenuria treatment IAGP XCO:0000683, XCO:0000283 N RGD:1354700|PMID:1127102 20201210 RGD 13432148 SS.ZUC-Leprfa-/-/Slc strain MP:0001260 increased body weight IAGP N RGD:13432147|PMID:23154293 20170921 RGD 13432148 SS.ZUC-Leprfa-/-/Slc strain MP:0001433 polyphagia IAGP N RGD:13432147|PMID:23154293 20170921 RGD 13432148 SS.ZUC-Leprfa-/-/Slc strain MP:0002628 hepatic steatosis IAGP N RGD:13432147|PMID:23154293 20170921 RGD 13432148 SS.ZUC-Leprfa-/-/Slc strain MP:0002941 increased circulating alanine transaminase level IAGP N RGD:13432147|PMID:23154293 20170921 RGD 13432148 SS.ZUC-Leprfa-/-/Slc strain MP:0005178 increased circulating cholesterol level IAGP N RGD:13432147|PMID:23154293 20170921 RGD 13432148 SS.ZUC-Leprfa-/-/Slc strain MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:13432147|PMID:23154293 20170921 RGD 13432148 SS.ZUC-Leprfa-/-/Slc strain MP:0008770 decreased survivor rate IAGP N RGD:13432147|PMID:23154293 20170921 RGD 13432153 Leprfa leptin receptor; fa mutant gene MP:0001260 increased body weight IAGP N RGD:13432147|PMID:23154293 20170921 RGD 13432153 Leprfa leptin receptor; fa mutant gene MP:0001260 increased body weight sexual_dimorphism IAGP N RGD:7365117|PMID:20159938 20201210 RGD compared to BN 13432153 Leprfa leptin receptor; fa mutant gene MP:0001260 increased body weight treatment IAGP XCO:0000015 N RGD:628581|PMID:11500530 20201210 RGD compared to ad lib fed rats 13432153 Leprfa leptin receptor; fa mutant gene MP:0001261 obese IAGP N RGD:628581|PMID:11500530 20201210 RGD compared to heterozygous controls +/fa 13432153 Leprfa leptin receptor; fa mutant gene MP:0001261 obese IAGP N RGD:628910|PMID:9843879 20201210 RGD compared to age-matched lean heterozygous +/fa rats 13432153 Leprfa leptin receptor; fa mutant gene MP:0001261 obese treatment IAGP XCO:0000015 N RGD:628581|PMID:11500530 20201210 RGD compared to ad lib fed rats 13432153 Leprfa leptin receptor; fa mutant gene MP:0001433 polyphagia IAGP N RGD:13432147|PMID:23154293 20170921 RGD 13432153 Leprfa leptin receptor; fa mutant gene MP:0001548 hyperlipidemia IAGP N RGD:628581|PMID:11500530 20201210 RGD compared to heterozygous controls +/fa 13432153 Leprfa leptin receptor; fa mutant gene MP:0001552 increased circulating triglyceride level treatment IAGP XCO:0000015 N RGD:628581|PMID:11500530 20201210 RGD compared to ad lib fed rats 13432153 Leprfa leptin receptor; fa mutant gene MP:0002628 hepatic steatosis IAGP N RGD:13432147|PMID:23154293 20170921 RGD 13432153 Leprfa leptin receptor; fa mutant gene MP:0002871 albuminuria sexual_dimorphism IAGP N RGD:7365117|PMID:20159938 20201210 RGD compared to BN 13432153 Leprfa leptin receptor; fa mutant gene MP:0002871 albuminuria treatment IAGP XCO:0000015 N RGD:628581|PMID:11500530 20201210 RGD compared to ad lib fed rats 13432153 Leprfa leptin receptor; fa mutant gene MP:0002941 increased circulating alanine transaminase level IAGP N RGD:13432147|PMID:23154293 20170921 RGD 13432153 Leprfa leptin receptor; fa mutant gene MP:0005178 increased circulating cholesterol level IAGP N RGD:13432147|PMID:23154293 20170921 RGD 13432153 Leprfa leptin receptor; fa mutant gene MP:0005669 increased circulating leptin level IAGP N RGD:11570540|PMID:9032111 20210211 RGD compared to lean littermates 13432153 Leprfa leptin receptor; fa mutant gene MP:0006087 increased body mass index IAGP N RGD:11570540|PMID:9032111 20210211 RGD compared to lean littermates 13432153 Leprfa leptin receptor; fa mutant gene MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:13432147|PMID:23154293 20170921 RGD 13432153 Leprfa leptin receptor; fa mutant gene MP:0008770 decreased survivor rate IAGP N RGD:13432147|PMID:23154293 20170921 RGD 13432153 Leprfa leptin receptor; fa mutant gene MP:0009130 increased white fat cell number IAGP N RGD:628910|PMID:9843879 20201210 RGD compared to age-matched lean heterozygous +/fa rats 13432153 Leprfa leptin receptor; fa mutant gene MP:0009285 increased gonadal fat pad weight sexual_dimorphism IAGP N RGD:7365117|PMID:20159938 20201210 RGD compared to BN 13432153 Leprfa leptin receptor; fa mutant gene MP:0009288 increased epididymal fat pad weight IAGP N RGD:628910|PMID:9843879 20201210 RGD compared to age-matched lean heterozygous +/fa rats 13432153 Leprfa leptin receptor; fa mutant gene MP:0009292 increased inguinal fat pad weight IAGP N RGD:628910|PMID:9843879 20201210 RGD compared to age-matched lean heterozygous +/fa rats 13432153 Leprfa leptin receptor; fa mutant gene MP:0009304 increased retroperitoneal fat pad weight IAGP N RGD:628910|PMID:9843879 20201210 RGD compared to age-matched lean heterozygous +/fa rats 13432153 Leprfa leptin receptor; fa mutant gene MP:0009304 increased retroperitoneal fat pad weight sexual_dimorphism IAGP N RGD:7365117|PMID:20159938 20201210 RGD compared to BN 13432153 Leprfa leptin receptor; fa mutant gene MP:0011377 renal glomerulus fibrosis treatment IAGP XCO:0000015 N RGD:628581|PMID:11500530 20201210 RGD compared to ad lib fed rats; increased desmin, fibronectin and collagenase 13432153 Leprfa leptin receptor; fa mutant gene MP:0011939 increased food intake IAGP N RGD:628910|PMID:9843879 20201210 RGD compared to age-matched lean heterozygous +/fa rats 13432199 SHRSP.WKY-(D3Wox20-D3Rat114)/Gcrc strain MP:0012046 decreased susceptibility to hypertension IAGP N RGD:13432198|PMID:27755386 20170926 RGD as compared to SHRSP/Gcrc 13432200 SHRSP.WKY-(D3Mgh16-D3Rat80)/Gcrc strain MP:0002834 decreased heart weight IAGP N RGD:13432198|PMID:27755386 20170926 RGD as compared to SHRSP/Gcrc 13432200 SHRSP.WKY-(D3Mgh16-D3Rat80)/Gcrc strain MP:0003916 decreased heart left ventricle weight IAGP N RGD:13432198|PMID:27755386 20170926 RGD as compared to SHRSP/Gcrc 13432200 SHRSP.WKY-(D3Mgh16-D3Rat80)/Gcrc strain MP:0006263 decreased systemic arterial diastolic blood pressure IAGP N RGD:13432198|PMID:27755386 20170926 RGD as compared to SHRSP/Gcrc 13432200 SHRSP.WKY-(D3Mgh16-D3Rat80)/Gcrc strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:13432198|PMID:27755386 20170926 RGD as compared to SHRSP/Gcrc 13432201 SHRSP.WKY-(D3Mgh16-D3Wox3)/Gcrc strain MP:0002834 decreased heart weight IAGP N RGD:13432198|PMID:27755386 20170926 RGD as compared to SHRSP/Gcrc 13432201 SHRSP.WKY-(D3Mgh16-D3Wox3)/Gcrc strain MP:0003916 decreased heart left ventricle weight IAGP N RGD:13432198|PMID:27755386 20170926 RGD as compared to SHRSP/Gcrc 13432201 SHRSP.WKY-(D3Mgh16-D3Wox3)/Gcrc strain MP:0006263 decreased systemic arterial diastolic blood pressure IAGP N RGD:13432198|PMID:27755386 20170926 RGD as compared to SHRSP/Gcrc 13432201 SHRSP.WKY-(D3Mgh16-D3Wox3)/Gcrc strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:13432198|PMID:27755386 20170926 RGD as compared to SHRSP/Gcrc 13432201 SHRSP.WKY-(D3Mgh16-D3Wox3)/Gcrc strain MP:0006266 decreased pulse pressure IAGP N RGD:13432198|PMID:27755386 20170926 RGD as compared to SHRSP/Gcrc 13432202 SHRSP.WKY-(D3Mgh16-rs65433898)/Gcrc strain MP:0002834 decreased heart weight IAGP N RGD:13432198|PMID:27755386 20170926 RGD as compared to SHRSP/Gcrc 13432202 SHRSP.WKY-(D3Mgh16-rs65433898)/Gcrc strain MP:0003916 decreased heart left ventricle weight IAGP N RGD:13432198|PMID:27755386 20170926 RGD as compared to SHRSP/Gcrc 13432202 SHRSP.WKY-(D3Mgh16-rs65433898)/Gcrc strain MP:0006263 decreased systemic arterial diastolic blood pressure IAGP N RGD:13432198|PMID:27755386 20170926 RGD as compared to SHRSP/Gcrc 13432202 SHRSP.WKY-(D3Mgh16-rs65433898)/Gcrc strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:13432198|PMID:27755386 20170926 RGD as compared to SHRSP/Gcrc 13432202 SHRSP.WKY-(D3Mgh16-rs65433898)/Gcrc strain MP:0006266 decreased pulse pressure IAGP N RGD:13432198|PMID:27755386 20170926 RGD as compared to SHRSP/Gcrc 13432203 SHRSP.WKY-(D3Mgh16-rs197649383)/Gcrc strain MP:0002962 increased urine protein level IAGP N RGD:13432198|PMID:27755386 20170926 RGD as compared to WKY/Gcrc 13432203 SHRSP.WKY-(D3Mgh16-rs197649383)/Gcrc strain MP:0012046 decreased susceptibility to hypertension IAGP N RGD:13432198|PMID:27755386 20170926 RGD as compared to SHRSP/Gcrc 13437612 SS-Adamts16em1Bj strain MP:0000280 thin ventricular wall IMP N RGD:9685162|PMID:23185005 20171010 RGD As compared to SS parents 13437612 SS-Adamts16em1Bj strain MP:0001147 small testis IMP N RGD:13434925|PMID:24983376 20171010 RGD 13437612 SS-Adamts16em1Bj strain MP:0001661 extended life span IMP N RGD:9685162|PMID:23185005 20171010 RGD As compared to SS parents 13437612 SS-Adamts16em1Bj strain MP:0002962 increased urine protein level IMP N RGD:9685162|PMID:23185005 20171010 RGD As compared to SS parents 13437612 SS-Adamts16em1Bj strain MP:0006263 decreased systemic arterial diastolic blood pressure IMP N RGD:9685162|PMID:23185005 20171010 RGD As compared to SS parents 13437612 SS-Adamts16em1Bj strain MP:0006264 decreased systemic arterial systolic blood pressure IMP N RGD:9685162|PMID:23185005 20171010 RGD As compared to SS parents 13437612 SS-Adamts16em1Bj strain MP:0020253 increased collagen level IMP N RGD:38548917|PMID:32037220 20200821 RGD 13437613 Adamts16em1Bj ADAM metallopeptidase with thrombospondin type 1 motif, 16; ZFN mutant1,Bj gene MP:0000280 thin ventricular wall IMP N RGD:9685162|PMID:23185005 20171010 RGD As compared to SS parents 13437613 Adamts16em1Bj ADAM metallopeptidase with thrombospondin type 1 motif, 16; ZFN mutant1,Bj gene MP:0001147 small testis IMP N RGD:13434925|PMID:24983376 20171010 RGD 13437613 Adamts16em1Bj ADAM metallopeptidase with thrombospondin type 1 motif, 16; ZFN mutant1,Bj gene MP:0001661 extended life span IMP N RGD:9685162|PMID:23185005 20171010 RGD As compared to SS parents 13437613 Adamts16em1Bj ADAM metallopeptidase with thrombospondin type 1 motif, 16; ZFN mutant1,Bj gene MP:0002962 increased urine protein level IMP N RGD:9685162|PMID:23185005 20171010 RGD As compared to SS parents 13437613 Adamts16em1Bj ADAM metallopeptidase with thrombospondin type 1 motif, 16; ZFN mutant1,Bj gene MP:0006263 decreased systemic arterial diastolic blood pressure IMP N RGD:9685162|PMID:23185005 20171010 RGD As compared to SS parents 13437613 Adamts16em1Bj ADAM metallopeptidase with thrombospondin type 1 motif, 16; ZFN mutant1,Bj gene MP:0006264 decreased systemic arterial systolic blood pressure IMP N RGD:9685162|PMID:23185005 20171010 RGD As compared to SS parents 13437613 Adamts16em1Bj ADAM metallopeptidase with thrombospondin type 1 motif, 16; ZFN mutant1,Bj gene MP:0020253 increased collagen level IMP N RGD:38548917|PMID:32037220 20200821 RGD 13450922 SD-GEPR-3 strain MP:0001496 audiogenic seizures induced IAGP XCO:0000048 N RGD:13450923|PMID:29105300 20171108 RGD 13450922 SD-GEPR-3 strain MP:0012348 decreased susceptibility to induction of seizure by inducing agent treatment IAGP XCO:0000638 N RGD:13450923|PMID:29105300 20200615 RGD associated with audiogenic seizure 13451132 BN-Crb1m1 strain MP:0005103 abnormal retina pigmentation IAGP N RGD:13451131|PMID:25878282 20171115 RGD 13451132 BN-Crb1m1 strain MP:0005547 abnormal Muller cell morphology IAGP N RGD:13451131|PMID:25878282 20171115 RGD 13451132 BN-Crb1m1 strain MP:0008516 disorganized retina outer nuclear layer IAGP N RGD:13451131|PMID:25878282 20171115 RGD 13451133 Crb1m1 crumbs 1, cell polarity complex component, mutant 1 gene MP:0005103 abnormal retina pigmentation IAGP N RGD:13451131|PMID:25878282 20171115 RGD 13451133 Crb1m1 crumbs 1, cell polarity complex component, mutant 1 gene MP:0005547 abnormal Muller cell morphology IAGP N RGD:13451131|PMID:25878282 20171115 RGD 13451133 Crb1m1 crumbs 1, cell polarity complex component, mutant 1 gene MP:0008516 disorganized retina outer nuclear layer IAGP N RGD:13451131|PMID:25878282 20171115 RGD 13451538 FHH-Chr 1BN-Dusp5em1Mcwi strain MP:0003026 decreased vasoconstriction induced IMP XCO:0000466 N RGD:13446412|PMID:25397684 20201221 RGD compared to FHH.1BN 13451539 Dusp5em1Mcwi dual specificity phosphatase 5; ZFN induced mutant1, Mcwi gene MP:0003026 decreased vasoconstriction IMP N RGD:13446412|PMID:25397684 20210114 RGD compared to FHH.1BN 13452382 SD-Tg(Htt*) strain MP:0001262 decreased body weight IMP N RGD:13452381|PMID:12620967 20190726 RGD 13452382 SD-Tg(Htt*) strain MP:0001524 impaired limb coordination IMP N RGD:13452381|PMID:12620967 20171117 RGD 13452382 SD-Tg(Htt*) strain MP:0002229 neurodegeneration IMP N RGD:13452380|PMID:25162006 20171117 RGD 13452382 SD-Tg(Htt*) strain MP:0004191 neuronal intranuclear inclusions IMP N RGD:13452381|PMID:12620967 20190726 RGD 13452382 SD-Tg(Htt*) strain MP:0005643 decreased dopamine level IMP N RGD:13452381|PMID:12620967 20171117 RGD 13452382 SD-Tg(Htt*) strain MP:0008535 enlarged lateral ventricles IMP N RGD:13452381|PMID:12620967 20190726 RGD 13452382 SD-Tg(Htt*) strain MP:0014115 cognitive inflexibility IMP N RGD:13452381|PMID:12620967 20171117 RGD 13464329 FPL/Iet Fused pulmonary lobes, FPL strain MP:0000564 syndactyly IAGP N RGD:13464328|PMID:21756877 20180103 RGD 13464329 FPL/Iet Fused pulmonary lobes, FPL strain MP:0009263 abnormal eyelid fusion IAGP N RGD:13464328|PMID:21756877 20180103 RGD 13464329 FPL/Iet Fused pulmonary lobes, FPL strain MP:0010977 fused right lung lobes IAGP N RGD:13464328|PMID:21756877 20180103 RGD 13464330 Frem2fpl Fras1 related extracellular matrix protein 2;fpl mutant gene MP:0000564 syndactyly IAGP N RGD:13464328|PMID:21756877 20180103 RGD 13464330 Frem2fpl Fras1 related extracellular matrix protein 2;fpl mutant gene MP:0009263 abnormal eyelid fusion IAGP N RGD:13464328|PMID:21756877 20180103 RGD 13464330 Frem2fpl Fras1 related extracellular matrix protein 2;fpl mutant gene MP:0010977 fused right lung lobes IAGP N RGD:13464328|PMID:21756877 20180103 RGD 13503336 W;Cg-Acrtm1Osb Acr KO, Acr {tm1 Osb} strain MP:0001935 decreased litter size IMP N RGD:13464336|PMID:28859281 20180112 RGD 13503336 W;Cg-Acrtm1Osb Acr KO, Acr {tm1 Osb} strain MP:0004542 impaired acrosome reaction IMP N RGD:13464336|PMID:28859281 20180112 RGD 13506737 GK strain MP:0001559 hyperglycemia IAGP N RGD:631853|PMID:12783625 20191126 RGD 13506737 GK strain MP:0005333 decreased heart rate IAGP N RGD:13513908|PMID:25903955 20191126 RGD 13506737 GK strain MP:0006143 increased systemic arterial diastolic blood pressure IAGP N RGD:13513908|PMID:25903955 20191126 RGD 13506737 GK strain MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:13513908|PMID:25903955 20191126 RGD 13506737 GK strain MP:0010087 increased circulating fructosamine level IAGP N RGD:13513908|PMID:25903955 20191126 RGD 13506738 GK/Par strain MP:0001262 decreased body weight IAGP N RGD:13506736|PMID:2010050 20180209 RGD compared to Wistar rats 13506738 GK/Par strain MP:0001559 hyperglycemia IAGP N RGD:13506736|PMID:2010050 20180209 RGD compared to Wistar rats 13506738 GK/Par strain MP:0002079 increased circulating insulin level susceptibility IAGP N RGD:13506736|PMID:2010050 20200318 RGD compared to Wistar rats 13506738 GK/Par strain MP:0002833 increased heart weight IAGP N RGD:126775141|PMID:30621358 20210604 RGD compared to Crl:WI rats 13506738 GK/Par strain MP:0003564 abnormal insulin secretion IAGP N RGD:13506736|PMID:2010050 20180209 RGD 13506738 GK/Par strain MP:0005293 impaired glucose tolerance susceptibility IAGP N RGD:13506736|PMID:2010050 20200318 RGD compared to Wistar rats 13506738 GK/Par strain MP:0005559 increased circulating glucose level IAGP N RGD:126775141|PMID:30621358 20210604 RGD compared to Crl:WI rats 13506738 GK/Par strain MP:0005559 increased circulating glucose level susceptibility IAGP N RGD:13506736|PMID:2010050 20200318 RGD compared to Wistar rats 13506738 GK/Par strain MP:0020087 increased susceptibility to non-insulin-dependent diabetes susceptibility IAGP N RGD:13506736|PMID:2010050 20200318 RGD compared to Wistar rats 13506739 GK/Jcl strain MP:0001552 increased circulating triglyceride level IAGP N RGD:13506789|PMID:26447526 20191126 RGD 13506739 GK/Jcl strain MP:0001552 increased circulating triglyceride level IAGP N RGD:13592596|PMID:19966469 20191126 RGD 13506739 GK/Jcl strain MP:0002079 increased circulating insulin level IAGP N RGD:13592596|PMID:19966469 20191126 RGD 13506739 GK/Jcl strain MP:0005178 increased circulating cholesterol level IAGP N RGD:13506789|PMID:26447526 20191126 RGD 13506739 GK/Jcl strain MP:0005178 increased circulating cholesterol level IAGP N RGD:13592596|PMID:19966469 20191126 RGD 13506739 GK/Jcl strain MP:0009355 increased liver triglyceride level IAGP N RGD:13592596|PMID:19966469 20191126 RGD 13506739 GK/Jcl strain MP:0010027 increased liver cholesterol level IAGP N RGD:13592596|PMID:19966469 20191126 RGD 13524863 LEC/Crlj Long Evans Cinnamon strain MP:0003066 increased liver copper level treatment IAGP N RGD:1554300|PMID:15511628 20200501 RGD 13524863 LEC/Crlj Long Evans Cinnamon strain MP:0004780 abnormal surfactant secretion IAGP N RGD:13524861|PMID:28438206 20180501 RGD 13524863 LEC/Crlj Long Evans Cinnamon strain MP:0005606 increased bleeding time IAGP N RGD:2324690|PMID:19897744 20180501 RGD 13524863 LEC/Crlj Long Evans Cinnamon strain MP:0006349 decreased circulating copper level treatment IAGP N RGD:1554300|PMID:15511628 20200501 RGD 13524863 LEC/Crlj Long Evans Cinnamon strain MP:0010815 enlarged alveolar lamellar bodies IAGP N RGD:13524861|PMID:28438206 20180501 RGD 13524863 LEC/Crlj Long Evans Cinnamon strain MP:0010856 dilated respiratory conducting tube IAGP N RGD:2324690|PMID:19897744 20180501 RGD 13524863 LEC/Crlj Long Evans Cinnamon strain MP:0012612 decreased ceruloplasmin level treatment IAGP N RGD:1554300|PMID:15511628 20200429 RGD 13524998 UPL strain MP:0001306 small lens IAGP N RGD:727242|PMID:8282038 20180502 RGD 13524998 UPL strain MP:0003237 abnormal lens epithelium morphology IAGP N RGD:727242|PMID:8282038 20180502 RGD 1354580 Scort1 Serum corticosterone level QTL 1 qtl MP:0005345 abnormal circulating corticosterone level QTM N RGD:1302893|PMID:15452030 19990101 RGD 1354581 Bp247 Blood pressure QTL 247 qtl MP:0000230 abnormal systemic arterial blood pressure QTM N RGD:1302893|PMID:15452030 19990101 RGD 1354581 Bp247 Blood pressure QTL 247 qtl MP:0006265 increased pulse pressure IAGP N RGD:1302893|PMID:15452030 19990101 RGD 1354582 Stl11 Serum triglyceride level QTL 11 qtl MP:0001552 increased circulating triglyceride level IAGP N RGD:737686|PMID:14724732 19990101 RGD 1354583 Despr3 Despair related QTL3 qtl MP:0002573 behavioral despair IAGP N RGD:1302894|PMID:15457344 19990101 RGD 1354584 Despr6 Despair related QTL 6 qtl MP:0002573 behavioral despair IAGP N RGD:1302894|PMID:15457344 19990101 RGD 1354585 Eae18a Experimental allergic encephalomyelitis QTL 18a qtl MP:0000753 paralysis QTM N RGD:1302437|PMID:15240732 19990101 RGD 1354586 Despr1 Despair related QTL 1 qtl MP:0002573 behavioral despair IAGP N RGD:1302894|PMID:15457344 19990101 RGD 1354587 Kidm21 Kidney mass QTL 21 qtl MP:0002707 abnormal kidney weight QTM N RGD:1302893|PMID:15452030 19990101 RGD 1354588 Bvd4 Brain ventricular dilatation QTL 4 qtl MP:0000822 abnormal brain ventricle morphology QTM N RGD:1302890|PMID:15473982 19990101 RGD 1354588 Bvd4 Brain ventricular dilatation QTL 4 qtl MP:0001891 hydrocephaly QTM N RGD:1302890|PMID:15473982 19990101 RGD 1354589 Bw31 Body weight QTL 31 qtl MP:0001259 abnormal body weight QTM N RGD:1302893|PMID:15452030 19990101 RGD 1354590 Despr11 Despair related QTL 11 qtl MP:0002573 behavioral despair IAGP N RGD:1302894|PMID:15457344 19990101 RGD 1354591 Cm36 Cardiac mass QTL 36 qtl MP:0002625 heart left ventricle hypertrophy IAGP N RGD:1302893|PMID:15452030 19990101 RGD 1354591 Cm36 Cardiac mass QTL 36 qtl MP:0005406 abnormal heart size QTM N RGD:1302893|PMID:15452030 19990101 RGD 1354592 Rf50 Renal function QTL 50 qtl MP:0001762 polyuria QTM N RGD:1302893|PMID:15452030 19990101 RGD 1354593 Stl12 Serum triglyceride level QTL 12 qtl MP:0001552 increased circulating triglyceride level IAGP N RGD:737686|PMID:14724732 19990101 RGD 1354594 Despr10 Despair related QTL 10 qtl MP:0002573 behavioral despair IAGP N RGD:1302894|PMID:15457344 19990101 RGD 1354595 Despr4 Despair related QTL 4 qtl MP:0002573 behavioral despair IAGP N RGD:1302894|PMID:15457344 19990101 RGD 1354596 Bw32 Body weight QTL 32 qtl MP:0001259 abnormal body weight QTM N RGD:1302893|PMID:15452030 19990101 RGD 1354597 Kidm13 Kidney mass QTL 13 qtl MP:0002707 abnormal kidney weight QTM N RGD:1302893|PMID:15452030 19990101 RGD 1354598 Srn6 Serum renin concentration QTL 6 qtl MP:0003349 abnormal circulating renin level QTM N RGD:1302893|PMID:15452030 19990101 RGD 1354598 Srn6 Serum renin concentration QTL 6 qtl MP:0003353 decreased circulating renin level IAGP N RGD:1302893|PMID:15452030 19990101 RGD 1354599 Bw29 Body weight QTL 29 qtl MP:0001263 weight loss IDA N RGD:1302889|PMID:15252022 20100217 RGD 1354600 Salc2 Saline consumption QTL 2 qtl MP:0001422 abnormal drinking behavior QTM N RGD:1302889|PMID:15252022 19990101 RGD 1354601 Slep1 Serum leptin concentration QTL 1 qtl MP:0005669 increased circulating leptin level IAGP N RGD:737686|PMID:14724732 19990101 RGD 1354602 Bw35 Body weight QTL 35 qtl MP:0001259 abnormal body weight QTM N RGD:1302893|PMID:15452030 19990101 RGD 1354603 Bp243 Blood pressure QTL 243 qtl MP:0000230 abnormal systemic arterial blood pressure QTM N RGD:1302893|PMID:15452030 19990101 RGD 1354603 Bp243 Blood pressure QTL 243 qtl MP:0006143 increased systemic arterial diastolic blood pressure IAGP N RGD:1302893|PMID:15452030 19990101 RGD 1354604 Bw36 Body weight QTL 36 qtl MP:0001259 abnormal body weight QTM N RGD:1302893|PMID:15452030 19990101 RGD 1354605 Rf48 Renal function QTL 48 qtl MP:0005328 abnormal circulating creatinine level QTM N RGD:1302893|PMID:15452030 19990101 RGD 1354606 Bp246 Blood pressure QTL 246 qtl MP:0000230 abnormal systemic arterial blood pressure QTM N RGD:1302893|PMID:15452030 19990101 RGD 1354606 Bp246 Blood pressure QTL 246 qtl MP:0006265 increased pulse pressure IAGP N RGD:1302893|PMID:15452030 19990101 RGD 1354607 Gmadr1 Adrenal mass QTL 1 qtl MP:0002768 small adrenal glands IAGP N RGD:1302889|PMID:15252022 19990101 RGD 1354608 Cm33 Cardiac mass QTL 33 qtl MP:0002625 heart left ventricle hypertrophy IAGP N RGD:1302893|PMID:15452030 19990101 RGD 1354608 Cm33 Cardiac mass QTL 33 qtl MP:0005406 abnormal heart size QTM N RGD:1302893|PMID:15452030 19990101 RGD 1354609 Niddm62 Non-insulin dependent diabetes mellitus QTL 62 qtl MP:0002079 increased circulating insulin level IAGP N RGD:1302801|PMID:15266047 19990101 RGD 1354609 Niddm62 Non-insulin dependent diabetes mellitus QTL 62 qtl MP:0003058 increased insulin secretion IAGP N RGD:1302801|PMID:15266047 19990101 RGD 1354609 Niddm62 Non-insulin dependent diabetes mellitus QTL 62 qtl MP:0005293 impaired glucose tolerance IAGP N RGD:1302801|PMID:15266047 19990101 RGD 1354610 Bw34 Body weight QTL 34 qtl MP:0001259 abnormal body weight QTM N RGD:1302893|PMID:15452030 19990101 RGD 1354611 Despr2 Despair related QTL 2 qtl MP:0002573 behavioral despair IAGP N RGD:1302894|PMID:15457344 19990101 RGD 1354612 Foco1 Food consumption QTL 1 qtl MP:0005449 abnormal food intake QTM N RGD:1302889|PMID:15252022 19990101 RGD 1354613 Kidm14 Kidney mass QTL 14 qtl MP:0002707 abnormal kidney weight QTM N RGD:1302893|PMID:15452030 19990101 RGD 1354614 Hpcl1 Hepatic cholesterol level QTL 1 qtl MP:0003191 abnormal cellular cholesterol metabolism IAGP N RGD:629576|PMID:9600105 19990101 RGD 1354614 Hpcl1 Hepatic cholesterol level QTL 1 qtl MP:0003982 increased cholesterol level IAGP N RGD:629576|PMID:9600105 19990101 RGD 1354615 Cm32 Cardiac mass QTL 32 qtl MP:0002625 heart left ventricle hypertrophy IAGP N RGD:1302893|PMID:15452030 19990101 RGD 1354615 Cm32 Cardiac mass QTL 32 qtl MP:0005406 abnormal heart size QTM N RGD:1302893|PMID:15452030 19990101 RGD 1354616 Despr12 Despair related QTL 12 qtl MP:0002573 behavioral despair IAGP N RGD:1302894|PMID:15457344 19990101 RGD 1354617 Bp240 Blood pressure QTL 240 qtl MP:0000230 abnormal systemic arterial blood pressure QTM N RGD:1302893|PMID:15452030 19990101 RGD 1354617 Bp240 Blood pressure QTL 240 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:1302893|PMID:15452030 19990101 RGD 1354618 Kidm15 Kidney mass QTL 15 qtl MP:0002707 abnormal kidney weight QTM N RGD:1302893|PMID:15452030 19990101 RGD 1354619 Bp242 Blood pressure QTL 242 qtl MP:0000230 abnormal systemic arterial blood pressure QTM N RGD:1302893|PMID:15452030 19990101 RGD 1354619 Bp242 Blood pressure QTL 242 qtl MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:1302893|PMID:15452030 19990101 RGD 1354620 Kidm19 Kidney mass QTL 19 qtl MP:0002707 abnormal kidney weight QTM N RGD:1302893|PMID:15452030 19990101 RGD 1354621 Rf47 Renal function QTL 47 qtl MP:0003349 abnormal circulating renin level QTM N RGD:1302893|PMID:15452030 19990101 RGD 1354622 Kidm16 Kidney mass QTL 16 qtl MP:0002707 abnormal kidney weight QTM N RGD:1302893|PMID:15452030 19990101 RGD 1354623 Rf46 Renal function QTL 46 qtl MP:0005328 abnormal circulating creatinine level QTM N RGD:1302893|PMID:15452030 19990101 RGD 1354624 Cm35 Cardiac mass QTL35 qtl MP:0002625 heart left ventricle hypertrophy IAGP N RGD:1302893|PMID:15452030 19990101 RGD 1354624 Cm35 Cardiac mass QTL35 qtl MP:0005406 abnormal heart size QTM N RGD:1302893|PMID:15452030 19990101 RGD 1354625 Despr7 Despair related QTL 7 qtl MP:0002573 behavioral despair IAGP N RGD:1302894|PMID:15457344 19990101 RGD 1354626 Bvd1 Brain ventricular dilatation QTL 1 qtl MP:0000822 abnormal brain ventricle morphology QTM N RGD:1302890|PMID:15473982 19990101 RGD 1354626 Bvd1 Brain ventricular dilatation QTL 1 qtl MP:0001891 hydrocephaly QTM N RGD:1302890|PMID:15473982 19990101 RGD 1354627 Despr14 Despair related QTL 14 qtl MP:0002573 behavioral despair IAGP N RGD:1302894|PMID:15457344 19990101 RGD 1354628 Stl13 Serum triglyceride level QTL 13 qtl MP:0000187 abnormal triglyceride level QTM N RGD:1302893|PMID:15452030 19990101 RGD 1354628 Stl13 Serum triglyceride level QTL 13 qtl MP:0001552 increased circulating triglyceride level IAGP N RGD:1302893|PMID:15452030 19990101 RGD 1354628 Stl13 Serum triglyceride level QTL 13 qtl MP:0005145 increased circulating VLDL cholesterol level IAGP N RGD:1302893|PMID:15452030 19990101 RGD 1354629 Scl31 Serum cholesterol level QTL 31 qtl MP:0000180 abnormal circulating cholesterol level QTM N RGD:1302893|PMID:15452030 19990101 RGD 1354629 Scl31 Serum cholesterol level QTL 31 qtl MP:0005178 increased circulating cholesterol level IAGP N RGD:1302893|PMID:15452030 19990101 RGD 1354630 Cm34 Cardiac mass QTL 34 qtl MP:0002625 heart left ventricle hypertrophy IAGP N RGD:1302893|PMID:15452030 19990101 RGD 1354630 Cm34 Cardiac mass QTL 34 qtl MP:0005406 abnormal heart size QTM N RGD:1302893|PMID:15452030 19990101 RGD 1354631 Swd2 Spike wave discharge measurement QTL 2 qtl MP:0003219 increased spike-wave discharge type II QTM N RGD:1302436|PMID:15270755 19990101 RGD 1354632 Scl29 Serum cholesterol level QTL 29 qtl MP:0005178 increased circulating cholesterol level IAGP N RGD:737686|PMID:14724732 19990101 RGD 1354633 Bw28 Body weight QTL 28 qtl MP:0001263 weight loss IDA N RGD:1302889|PMID:15252022 20100217 RGD 1354634 Kidm12 Kidney mass QTL 12 qtl MP:0002707 abnormal kidney weight QTM N RGD:1302893|PMID:15452030 19990101 RGD 1354635 Bp245 Blood pressure QTL 245 qtl MP:0000230 abnormal systemic arterial blood pressure QTM N RGD:1302893|PMID:15452030 19990101 RGD 1354635 Bp245 Blood pressure QTL 245 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:1302893|PMID:15452030 19990101 RGD 1354636 Lmblg1 Limb length QTL 1 qtl MP:0000558 abnormal tibia morphology QTM N RGD:1302893|PMID:15452030 19990101 RGD 1354637 Scl30 Serum cholesterol level QTL 30 qtl MP:0000180 abnormal circulating cholesterol level QTM N RGD:1302893|PMID:15452030 19990101 RGD 1354637 Scl30 Serum cholesterol level QTL 30 qtl MP:0005178 increased circulating cholesterol level IAGP N RGD:1302893|PMID:15452030 19990101 RGD 1354638 Insul1 Insulin level QTL 1 qtl MP:0001560 abnormal circulating insulin level QTM N RGD:1302893|PMID:15452030 19990101 RGD 1354639 Spl5 Serum phospholipid level QTL 5 qtl MP:0000181 abnormal circulating LDL cholesterol level QTM N RGD:1302893|PMID:15452030 19990101 RGD 1354640 Scl32 Serum cholesterol level QTL 32 qtl MP:0000184 abnormal circulating HDL cholesterol level QTM N RGD:1302893|PMID:15452030 19990101 RGD 1354640 Scl32 Serum cholesterol level QTL 32 qtl MP:0001556 increased circulating HDL cholesterol level IAGP N RGD:1302893|PMID:15452030 19990101 RGD 1354641 Bvd2 Brain ventricular dilatation QTL 2 qtl MP:0000822 abnormal brain ventricle morphology QTM N RGD:1302890|PMID:15473982 19990101 RGD 1354641 Bvd2 Brain ventricular dilatation QTL 2 qtl MP:0001891 hydrocephaly QTM N RGD:1302890|PMID:15473982 19990101 RGD 1354642 Despr15 Despair related QTL 15 qtl MP:0002573 behavioral despair IAGP N RGD:1302894|PMID:15457344 19990101 RGD 1354643 Foco2 Food consumption QTL 2 qtl MP:0005449 abnormal food intake QTM N RGD:1302889|PMID:15252022 19990101 RGD 1354644 Spl4 Serum phospholipid level QTL 4 qtl MP:0006084 abnormal circulating phospholipid level QTM N RGD:1302893|PMID:15452030 19990101 RGD 1354645 Swd1 Spike wave discharge measurement QTL 1 qtl MP:0003217 increased spike-wave discharge type I QTM N RGD:1302436|PMID:15270755 19990101 RGD 1354646 Kidm18 Kidney mass QTL 18 qtl MP:0002707 abnormal kidney weight QTM N RGD:1302893|PMID:15452030 19990101 RGD 1354647 Despr8 Despair related QTL 8 qtl MP:0002573 behavioral despair IAGP N RGD:1302894|PMID:15457344 19990101 RGD 1354648 Bp239 Blood pressure QTL 239 qtl MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:629612|PMID:9260980 19990101 RGD 1354649 Kidm17 Kidney mass QTL 17 qtl MP:0002707 abnormal kidney weight QTM N RGD:1302893|PMID:15452030 19990101 RGD 1354650 Despr5 Despair related QTL 5 qtl MP:0002573 behavioral despair IAGP N RGD:1302894|PMID:15457344 19990101 RGD 1354651 Lmblg2 Limb length QTL 2 qtl MP:0000558 abnormal tibia morphology QTM N RGD:1302893|PMID:15452030 19990101 RGD 1354652 Kidm20 Kidney mass QTL 20 qtl MP:0002707 abnormal kidney weight QTM N RGD:1302893|PMID:15452030 19990101 RGD 1354653 Despr9 Despair related QTL 9 qtl MP:0002573 behavioral despair IAGP N RGD:1302894|PMID:15457344 19990101 RGD 1354654 Spl7 Serum phospholipid level QTL 7 qtl MP:0006084 abnormal circulating phospholipid level QTM N RGD:1302893|PMID:15452030 19990101 RGD 1354655 Bp241 Blood pressure QTL 241 qtl MP:0000230 abnormal systemic arterial blood pressure QTM N RGD:1302893|PMID:15452030 19990101 RGD 1354655 Bp241 Blood pressure QTL 241 qtl MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:1302893|PMID:15452030 19990101 RGD 1354656 Bvd3 Brain ventricular dilatation QTL 3 qtl MP:0000822 abnormal brain ventricle morphology QTM N RGD:1302890|PMID:15473982 19990101 RGD 1354656 Bvd3 Brain ventricular dilatation QTL 3 qtl MP:0001891 hydrocephaly QTM N RGD:1302890|PMID:15473982 19990101 RGD 1354657 Despr13 Despair related QTL 13 qtl MP:0002573 behavioral despair IAGP N RGD:1302894|PMID:15457344 19990101 RGD 1354658 Spl8 Serum phospholipid level QTL 8 qtl MP:0005144 abnormal circulating VLDL cholesterol level QTM N RGD:1302893|PMID:15452030 19990101 RGD 1354659 Scl68 Serum cholesterol level QTL 68 qtl MP:0005144 abnormal circulating VLDL cholesterol level QTM N RGD:1302893|PMID:15452030 19990101 RGD 1354660 Salc1 Saline consumption QTL 1 qtl MP:0001422 abnormal drinking behavior QTM N RGD:1302889|PMID:15252022 19990101 RGD 1354661 Bw33 Body weight QTL 33 qtl MP:0001259 abnormal body weight QTM N RGD:1302893|PMID:15452030 19990101 RGD 1354662 Rf49 Renal function QTL 49 qtl MP:0005328 abnormal circulating creatinine level QTM N RGD:1302893|PMID:15452030 19990101 RGD 1354663 Bvd5 Brain ventricular dilatation QTL 5 qtl MP:0000822 abnormal brain ventricle morphology QTM N RGD:1302890|PMID:15473982 19990101 RGD 1354663 Bvd5 Brain ventricular dilatation QTL 5 qtl MP:0001891 hydrocephaly QTM N RGD:1302890|PMID:15473982 19990101 RGD 1354664 Slep2 Serum leptin concentration QTL 2 qtl MP:0005669 increased circulating leptin level IAGP N RGD:737686|PMID:14724732 19990101 RGD 1354665 Stl10 Serum triglyceride level QTL 10 qtl MP:0001552 increased circulating triglyceride level IAGP N RGD:737686|PMID:14724732 19990101 RGD 1354666 Bp244 Blood pressure QTL 244 qtl MP:0000230 abnormal systemic arterial blood pressure QTM N RGD:1302893|PMID:15452030 19990101 RGD 1354666 Bp244 Blood pressure QTL 244 qtl MP:0006143 increased systemic arterial diastolic blood pressure IAGP N RGD:1302893|PMID:15452030 19990101 RGD 1357172 WF.BBDR-(D4Arb29-D4Rat44)/Wor strain MP:0004803 increased susceptibility to autoimmune diabetes induced IAGP XCO:0000231,XCO:0000235 N RGD:1304485|PMID:12401717 20111108 RGD 1357176 WF.BBDR-(D4Arb29-D4Rat96)/Wor strain MP:0004804 decreased susceptibility to autoimmune diabetes induced IAGP XCO:0000231,XCO:0000235 N RGD:1304485|PMID:12401717 19990101 RGD 1357178 CD Cohen diabetic rat strain MP:0000230 abnormal systemic arterial blood pressure IAGP XCO:0000658,XCO:0000212,XCO:0000211 N RGD:1354518|PMID:8467325 20200129 RGD 1357178 CD Cohen diabetic rat strain MP:0000231 hypertension IAGP XCO:0000212,XCO:0000211,XCO:0000658 N RGD:1354518|PMID:8467325 19990101 RGD 1357178 CD Cohen diabetic rat strain MP:0000231 hypertension susceptibility IAGP XCO:0000094|XCO:0000201 N RGD:1354519|PMID:6365715 20200129 RGD 1357178 CD Cohen diabetic rat strain MP:0001559 hyperglycemia IAGP XCO:0000212,XCO:0000211 N RGD:1354520 19990101 RGD 1357178 CD Cohen diabetic rat strain MP:0001559 hyperglycemia IAGP XCO:0000212,XCO:0000211 N RGD:18937003|PMID:2134214 20200129 RGD compared to normal diet CD 1357178 CD Cohen diabetic rat strain MP:0002962 increased urine protein level IAGP XCO:0000212,XCO:0000211 N RGD:18937003|PMID:2134214 20200129 RGD compared to normal diet CD 1357178 CD Cohen diabetic rat strain MP:0005264 glomerulosclerosis IAGP XCO:0000212,XCO:0000211 N RGD:1354520 19990101 RGD 1357178 CD Cohen diabetic rat strain MP:0005264 glomerulosclerosis IAGP XCO:0000212,XCO:0000211 N RGD:18937003|PMID:2134214 20200129 RGD compared to normal diet CD 1357178 CD Cohen diabetic rat strain MP:0005264 glomerulosclerosis IAGP XCO:0000658,XCO:0000212,XCO:0000211 N RGD:1354518|PMID:8467325 20200129 RGD 1357178 CD Cohen diabetic rat strain MP:0005293 impaired glucose tolerance IAGP XCO:0000212,XCO:0000211 N RGD:1354520 20200129 RGD 1357178 CD Cohen diabetic rat strain MP:0005328 abnormal circulating creatinine level IAGP XCO:0000658,XCO:0000212,XCO:0000211 N RGD:1354518|PMID:8467325 20200129 RGD 1357178 CD Cohen diabetic rat strain MP:0009644 uremia IAGP XCO:0000658,XCO:0000212,XCO:0000211 N RGD:1354518|PMID:8467325 20200129 RGD 1357178 CD Cohen diabetic rat strain MP:0011855 abnormal glomerular filtration barrier morphology IAGP XCO:0000212,XCO:0000211 N RGD:18937003|PMID:2134214 20200129 RGD compared to normal diet CD 1357178 CD Cohen diabetic rat strain MP:0011856 abnormal glomerular filtration barrier function IAGP XCO:0000212,XCO:0000211 N RGD:18937003|PMID:2134214 20200129 RGD compared to normal diet CD 1357179 SS.WKY-(D2N35-Mme),MNS-(D10Mit11-D10M11Mit119)/Mco strain MP:0002834 decreased heart weight IAGP XCO:0000022 N RGD:619640|PMID:9541488 20201123 RGD compared to SS/Jr 1357179 SS.WKY-(D2N35-Mme),MNS-(D10Mit11-D10M11Mit119)/Mco strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP XCO:0000022 N RGD:619640|PMID:9541488 20201123 RGD compared to SS/Jr 1357180 SS.LEW-(D8Chm14-D8Rat16)/Ayd strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:7421500|PMID:23814039 20131211 RGD compared to parental SS/Jr 1357183 SS.MNS-(D10Mco10-Aldoc)/Jr strain MP:0002843 decreased systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:619626|PMID:9096100 20070607 RGD compared to SS/Jr 1357185 RHA.Gunn-Ugt1a1j/N strain MP:0004773 abnormal bile composition IAGP N RGD:13432068|PMID:12143043 20200421 RGD 1357185 RHA.Gunn-Ugt1a1j/N strain MP:0005344 increased circulating bilirubin level IAGP N RGD:13432068|PMID:12143043 20170918 RGD 1357186 Gunn-Ugt1a1j/BluHsd Gunn rat strain MP:0002591 decreased mean corpuscular volume IAGP N RGD:1354701|PMID:20323028 20200416 RGD compared to Gunn rats 1357186 Gunn-Ugt1a1j/BluHsd Gunn rat strain MP:0002640 reticulocytosis IAGP N RGD:1354701|PMID:20323028 20200414 RGD compared to Gunn rats 1357186 Gunn-Ugt1a1j/BluHsd Gunn rat strain MP:0002988 decreased urine osmolality treatment IAGP XCO:0000683, XCO:0000283 N RGD:1354700|PMID:1127102 20200427 RGD 1357186 Gunn-Ugt1a1j/BluHsd Gunn rat strain MP:0005344 increased circulating bilirubin level IAGP N RGD:13432067|PMID:16337205 20170918 RGD 1357186 Gunn-Ugt1a1j/BluHsd Gunn rat strain MP:0005344 increased circulating bilirubin level IAGP N RGD:1354701|PMID:20323028 20180502 RGD compared to Gunn rats 1357186 Gunn-Ugt1a1j/BluHsd Gunn rat strain MP:0005344 increased circulating bilirubin level IAGP N RGD:1354702|PMID:15753292 20190802 RGD 1357186 Gunn-Ugt1a1j/BluHsd Gunn rat strain MP:0005344 increased circulating bilirubin level treatment IAGP XCO:0000683, XCO:0000283 N RGD:1354700|PMID:1127102 20200427 RGD 1357186 Gunn-Ugt1a1j/BluHsd Gunn rat strain MP:0008489 slow postnatal weight gain IAGP N RGD:1354701|PMID:20323028 20200414 RGD compared to Gunn rats 1357186 Gunn-Ugt1a1j/BluHsd Gunn rat strain MP:0010108 abnormal renal water reabsorption treatment IAGP XCO:0000683, XCO:0000283 N RGD:1354700|PMID:1127102 20200427 RGD 1357186 Gunn-Ugt1a1j/BluHsd Gunn rat strain MP:0013305 isosthenuria treatment IAGP XCO:0000683, XCO:0000283 N RGD:1354700|PMID:1127102 20200427 RGD 1357187 WF.BBDR-(D4Rat16-D4Got39)/Wor strain MP:0004804 decreased susceptibility to autoimmune diabetes induced IAGP XCO:0000231,XCO:0000235 N RGD:1304485|PMID:12401717 19990101 RGD 1357189 SS.LEW-(D8Rat56-D8Rat51)/Ayd strain MP:0004875 increased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:7421500|PMID:23814039 20131211 RGD compared to parental SS/Jr 1357191 CDS/Ygl Cohen diabetic-sensitive rat strain MP:0003674 oxidative stress IAGP N RGD:13825197|PMID:30361421 20220111 RGD compared to CDR/Ygl 1357191 CDS/Ygl Cohen diabetic-sensitive rat strain MP:0003917 increased kidney weight IAGP XCO:0000014 N RGD:8552897|PMID:24192394 20200205 RGD compared to SBN/Ygl 1357191 CDS/Ygl Cohen diabetic-sensitive rat strain MP:0005293 impaired glucose tolerance IAGP XCO:0000014 N RGD:8552897|PMID:24192394 20200131 RGD compared to SBN/Ygl 1357191 CDS/Ygl Cohen diabetic-sensitive rat strain MP:0005558 decreased creatinine clearance IAGP XCO:0000014 N RGD:8552897|PMID:24192394 20200205 RGD 1357191 CDS/Ygl Cohen diabetic-sensitive rat strain MP:0005565 increased blood urea nitrogen level IAGP XCO:0000014 N RGD:8552897|PMID:24192394 20200205 RGD 1357192 WF.BBDR-(D4Got39-D4Rat44)/Wor strain MP:0004803 increased susceptibility to autoimmune diabetes induced IAGP XCO:0000231,XCO:0000235 N RGD:1304485|PMID:12401717 20200225 RGD 1357193 WF.BBDR-(D4Got51-D4Rat44)/Wor strain MP:0004804 decreased susceptibility to autoimmune diabetes induced IAGP XCO:0000231,XCO:0000235 N RGD:1304485|PMID:12401717 20200225 RGD 1357194 WF.BBDR-(D4Rat96-D4Rat44)/Wor strain MP:0004803 increased susceptibility to autoimmune diabetes induced IAGP XCO:0000231,XCO:0000235 N RGD:1304485|PMID:12401717 20111108 RGD 1357194 WF.BBDR-(D4Rat96-D4Rat44)/Wor strain MP:0004803 increased susceptibility to autoimmune diabetes induced IAGP XCO:0000231,XCO:0000235 N RGD:1600776|PMID:17376830 20200225 RGD 1357196 WF.BBDR-(D4Arb29-D4Rat265)/Wor strain MP:0004803 increased susceptibility to autoimmune diabetes induced IAGP XCO:0000231,XCO:0000235 N RGD:1304485|PMID:12401717 20111108 RGD 1357336 Gluco6 Glucose level QTL 6 qtl MP:0005291 abnormal glucose tolerance IAGP N RGD:619533|PMID:12016513 19990101 RGD 1357336 Gluco6 Glucose level QTL 6 qtl MP:0005293 impaired glucose tolerance IAGP N RGD:619533|PMID:12016513 19990101 RGD 1357337 Gluco3 Glucose level QTL 3 qtl MP:0004185 abnormal adipocyte glucose uptake IAGP N RGD:61078|PMID:9171835 19990101 RGD 1357338 Stl17 Serum triglyceride level QTL 17 qtl MP:0001552 increased circulating triglyceride level IAGP N RGD:1357168|PMID:11374884 19990101 RGD 1357339 Stl14 Serum triglyceride level QTL 14 qtl MP:0001552 increased circulating triglyceride level IAGP N RGD:1357168|PMID:11374884 19990101 RGD 1357340 Bp250 Blood pressure QTL 250 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:619625|PMID:9607182 19990101 RGD 1357341 Gluco5 Glucose level QTL 5 qtl MP:0001553 abnormal circulating free fatty acids level IAGP N RGD:61078|PMID:9171835 19990101 RGD 1357342 Bw40 Body weight QTL 40 qtl MP:0001260 increased body weight IAGP N RGD:69707|PMID:9530522 19990101 RGD 1357343 Gluco4 Glucose level QTL 4 qtl MP:0004185 abnormal adipocyte glucose uptake IAGP N RGD:61078|PMID:9171835 19990101 RGD 1357344 Bp249 Blood pressure QTL 249 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:619626|PMID:9096100 19990101 RGD 1357346 BB.SHR-(D4Mit6-Spr)/K strain MP:0001552 increased circulating triglyceride level IAGP N RGD:619667|PMID:9633608 20191220 RGD compared to strain BB/OK 1357346 BB.SHR-(D4Mit6-Spr)/K strain MP:0005178 increased circulating cholesterol level IAGP N RGD:619667|PMID:9633608 19990101 RGD compared to strain BB/OK 1357396 Bw44 Body weight QTL 44 qtl MP:0001260 increased body weight IAGP N RGD:1357168|PMID:11374884 19990101 RGD 1357397 Bw41 Body weight QTL 41 qtl MP:0001260 increased body weight IAGP N RGD:1357168|PMID:11374884 19990101 RGD 1357398 Slep3 Serum leptin concentration QTL 3 qtl MP:0005669 increased circulating leptin level IAGP N RGD:1357168|PMID:11374884 19990101 RGD 1357399 Bw45 Body weight QTL 45 qtl MP:0001260 increased body weight IAGP N RGD:1357168|PMID:11374884 19990101 RGD 1357400 Bw62 Body weight QTL62 qtl MP:0010024 increased total body fat amount IDA N RGD:1357168|PMID:11374884 20111107 RGD 1357401 Bw43 Body weight QTL 43 qtl MP:0001260 increased body weight IAGP N RGD:1357168|PMID:11374884 19990101 RGD 1357402 Bw46 Body weight QTL 46 qtl MP:0001260 increased body weight IAGP N RGD:1357168|PMID:11374884 19990101 RGD 1357403 Slep4 Serum leptin concentration QTL 4 qtl MP:0005669 increased circulating leptin level IAGP N RGD:1357168|PMID:11374884 19990101 RGD 1357404 Bw42 Body weight QTL 42 qtl MP:0001260 increased body weight IAGP N RGD:1357168|PMID:11374884 19990101 RGD 1357417 SD-Tg(Npy)400Mcwi strain MP:0000280 thin ventricular wall induced IAGP XCO:0000285 N RGD:1357410|PMID:15699473 19990101 RGD compared to wild-type littermate 1357417 SD-Tg(Npy)400Mcwi strain MP:0002834 decreased heart weight induced IAGP XCO:0000285 N RGD:1357410|PMID:15699473 19990101 RGD compared to wild-type littermate 1357954 F344/NHfr strain MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:1342467|PMID:15471977 19990101 RGD compared to BN/RijHfr 1357959 FHH.BN-(D1Hmgc14-D1Hmgc15)/Mcwi strain MP:0002871 albuminuria IAGP N RGD:1357409|PMID:15758045 19990101 RGD compared to BN 1357959 FHH.BN-(D1Hmgc14-D1Hmgc15)/Mcwi strain MP:0002962 increased urine protein level IAGP N RGD:1357409|PMID:15758045 20120112 RGD compared to BN 1357959 FHH.BN-(D1Hmgc14-D1Hmgc15)/Mcwi strain MP:0011856 abnormal glomerular filtration barrier function IAGP N RGD:1357409|PMID:15758045 20201030 RGD compared to BN 1357974 BB.SHR-(D4Got41-Gimap5)/K strain MP:0000186 decreased circulating HDL cholesterol level IAGP N RGD:1334440|PMID:15173549 20200320 RGD compared to BB.SHR-(D4Got41-Tacr1)/K 1357974 BB.SHR-(D4Got41-Gimap5)/K strain MP:0002644 decreased circulating triglyceride level IAGP N RGD:1334440|PMID:15173549 20200320 RGD compared to BB.SHR-(D4Got41-Tacr1)/K 1357974 BB.SHR-(D4Got41-Gimap5)/K strain MP:0005179 decreased circulating cholesterol level IAGP N RGD:1334440|PMID:15173549 20200320 RGD compared to BB.SHR-(D4Got41-Tacr1)/K 1357974 BB.SHR-(D4Got41-Gimap5)/K strain MP:0005293 impaired glucose tolerance IAGP N RGD:1334440|PMID:15173549 20200320 RGD compared to BB.SHR-(D4Got41-Tacr1)/K, with age 1357974 BB.SHR-(D4Got41-Gimap5)/K strain MP:0005668 decreased circulating leptin level IAGP N RGD:1334440|PMID:15173549 20200320 RGD compared to BB.SHR-(D4Got41-Tacr1)/K 1357976 BB.SHR-(D4Got41-D4Rat171)/K strain MP:0000186 decreased circulating HDL cholesterol level IAGP N RGD:1334440|PMID:15173549 20200320 RGD compared to BB.SHR-(D4Got41-Tacr1)/K 1357976 BB.SHR-(D4Got41-D4Rat171)/K strain MP:0002644 decreased circulating triglyceride level IAGP N RGD:1334440|PMID:15173549 20200320 RGD compared to BB.SHR-(D4Got41-Tacr1)/K 1357976 BB.SHR-(D4Got41-D4Rat171)/K strain MP:0002727 decreased circulating insulin level IAGP N RGD:1334440|PMID:15173549 20200320 RGD compared to BB.SHR-(D4Got41-Tacr1)/K and BB.SHR-(D4Got41-Gimap5)/K 1357976 BB.SHR-(D4Got41-D4Rat171)/K strain MP:0005179 decreased circulating cholesterol level IAGP N RGD:1334440|PMID:15173549 20200320 RGD compared to BB.SHR-(D4Got41-Tacr1)/K 1357976 BB.SHR-(D4Got41-D4Rat171)/K strain MP:0005293 impaired glucose tolerance IAGP N RGD:1334440|PMID:15173549 20200320 RGD compared to BB.SHR-(D4Got41-Tacr1)/K, with age 1357976 BB.SHR-(D4Got41-D4Rat171)/K strain MP:0005668 decreased circulating leptin level IAGP N RGD:1334440|PMID:15173549 20200320 RGD compared to BB.SHR-(D4Got41-Tacr1)/K 1357980 BB.SHR-(D4Got41-Tacr1)/K strain MP:0009292 increased inguinal fat pad weight IAGP N RGD:1334440|PMID:15173549 20200320 RGD compared to BB.SHR-(D4Got41-D4Rat171)/K and BB.SHR-(D4Got41-Gimap5)/K 1357981 SS.LEW-(D3Mco21-D3Rat17)/Ayd strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:724791|PMID:14517349 20191202 RGD 1357982 SS.LEW-(D3Rat52-D3Chm63)/Ayd strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:724791|PMID:14517349 19990101 RGD compared to SS/Jr 1357982 SS.LEW-(D3Rat52-D3Chm63)/Ayd strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:7421500|PMID:23814039 20131211 RGD compared to parental SS/Jr 1357982 SS.LEW-(D3Rat52-D3Chm63)/Ayd strain MP:0006263 decreased systemic arterial diastolic blood pressure induced IAGP XCO:0000022 N RGD:724791|PMID:14517349 20191202 RGD compared to SS/Jr 1357982 SS.LEW-(D3Rat52-D3Chm63)/Ayd strain MP:0006264 decreased systemic arterial systolic blood pressure induced IAGP XCO:0000022 N RGD:724791|PMID:14517349 20191202 RGD compared to SS/Jr 1357988 SS.LEW-(D3Rat52-D3Rat17)/Ayd strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:724791|PMID:14517349 19990101 RGD compared to SS/Jr 1357988 SS.LEW-(D3Rat52-D3Rat17)/Ayd strain MP:0006263 decreased systemic arterial diastolic blood pressure induced IAGP XCO:0000022 N RGD:724791|PMID:14517349 19990101 RGD 1357988 SS.LEW-(D3Rat52-D3Rat17)/Ayd strain MP:0006264 decreased systemic arterial systolic blood pressure induced IAGP XCO:0000022 N RGD:724791|PMID:14517349 20191202 RGD compared to SS/Jr 1357990 Ael1 Aortic elastin QTL 1 qtl MP:0003907 decreased aorta elastin content IAGP N RGD:1334448|PMID:15668357 19990101 RGD 1357991 Ael2 Aortic elastin QTL 2 qtl MP:0003907 decreased aorta elastin content IAGP N RGD:1334448|PMID:15668357 19990101 RGD 1358112 WKY/NCrl strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:27095952|PMID:17551266 20200728 RGD compared to SHRSP/A3N 1358112 WKY/NCrl strain MP:0011506 glomerular crescent susceptibility IAGP XCO:0000255 N RGD:2293335|PMID:16482158 20080528 RGD 1358112 WKY/NCrl strain MP:0012613 increased ceruloplasmin level induces IAGP XCO:0000769 N RGD:150521658|PMID:28450461 20211116 RGD compared to LEW 1358114 SS-Chr 5BN/Mcwi strain MP:0004502 decreased incidence of tumors by chemical induction induced IAGP XCO:0000090 N RGD:4143380|PMID:20737482 20101025 RGD compared to SS/JrHsdMcwi 1358114 SS-Chr 5BN/Mcwi strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:2300225|PMID:18653478 20080910 RGD compared to SS/JrHsdMcwi 1358114 SS-Chr 5BN/Mcwi strain MP:0005540 decreased urine albumin level induced IAGP XCO:0000022 N RGD:2300225|PMID:18653478 20080910 RGD compared to SS/JrHsdMcwi 1358114 SS-Chr 5BN/Mcwi strain MP:0010269 decreased mammary gland tumor incidence induced IAGP XCO:0000090 N RGD:4143380|PMID:20737482 20191211 RGD compared to SS/JrHsdMcwi 1358152 SS-Chr 14BN/Mcwi strain MP:0004876 decreased mean systemic arterial blood pressure sexual_dimorphism IAGP XCO:0000022 N RGD:2300225|PMID:18653478 20200122 RGD compared to male SS-Chr 14BN/Mcwi 1358152 SS-Chr 14BN/Mcwi strain MP:0005540 decreased urine albumin level sexual_dimorphism IAGP XCO:0000022 N RGD:2300225|PMID:18653478 20200122 RGD compared to female SS/JrHsdMcwi�� 1358152 SS-Chr 14BN/Mcwi strain MP:0010308 decreased tumor latency induced IAGP XCO:0000090 N RGD:4143380|PMID:20737482 20101025 RGD compared to SS/JrHsdMcwi 1358153 COP/CrCrl strain MP:0004955 increased thymus weight IAGP N RGD:2292503|PMID:18420736 20200710 RGD compared to ACI/SegHsd 1358153 COP/CrCrl strain MP:0004956 decreased thymus weight induced IAGP XCO:0000092 N RGD:2292503|PMID:18420736 20200710 RGD compared to ACI/SegHsd 1358153 COP/CrCrl strain MP:0005121 decreased circulating prolactin level induced IAGP XCO:0000092 N RGD:2292503|PMID:18420736 20200710 RGD compared to ACI/SegHsd 1358153 COP/CrCrl strain MP:0005124 increased circulating prolactin level induced IAGP XCO:0000092 N RGD:1358963|PMID:10688907 20200327 RGD compared to COP/CrCrl 1358153 COP/CrCrl strain MP:0008938 decreased pituitary gland weight induced IAGP XCO:0000092 N RGD:2292503|PMID:18420736 20200710 RGD compared to ACI/SegHsd 1358153 COP/CrCrl strain MP:0008939 increased pituitary gland weight induced IAGP XCO:0000092 N RGD:1358963|PMID:10688907 20200327 RGD compared to COP/CrCrl 1358153 COP/CrCrl strain MP:0008939 increased pituitary gland weight induced IAGP XCO:0000295 N RGD:1358974|PMID:10342874 20200313 RGD 1358154 SS-Chr 3BN/Mcwi strain MP:0004502 decreased incidence of tumors by chemical induction induced IAGP XCO:0000090 N RGD:4143380|PMID:20737482 20101025 RGD compared to SS/JrHsdMcwi 1358154 SS-Chr 3BN/Mcwi strain MP:0005540 decreased urine albumin level sexual_dimorphism IAGP XCO:0000022 N RGD:2300225|PMID:18653478 20200122 RGD compared to male SS-Chr 3BN/Mcwi�� 1358154 SS-Chr 3BN/Mcwi strain MP:0009828 increased tumor latency induced IAGP XCO:0000090 N RGD:4143380|PMID:20737482 20101025 RGD compared to SS/JrHsdMcwi 1358154 SS-Chr 3BN/Mcwi strain MP:0010269 decreased mammary gland tumor incidence induced IAGP XCO:0000090 N RGD:4143380|PMID:20737482 20101025 RGD compared to SS/JrHsdMcwi 1358156 SS.MNS-(D2Rat183-D2Chm113)/Ayd strain MP:0002843 decreased systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:7421631|PMID:19461651 20131206 RGD compared to parental SS/Jr 1358160 SS.BN-(D8Rat163-D8Rat81)/Mcwi strain MP:0004876 decreased mean systemic arterial blood pressure sexual_dimorphism IAGP XCO:0000022 N RGD:2300225|PMID:18653478 20200122 RGD compared to male SS/JrHsdMCWi 1358160 SS.BN-(D8Rat163-D8Rat81)/Mcwi strain MP:0005540 decreased urine albumin level induced IAGP XCO:0000022 N RGD:2300225|PMID:18653478 20200122 RGD compared to male and female SS/JrHsdMcwi�� 1358162 SS-Chr 12BN/Mcwi strain MP:0001883 increased mammary adenocarcinoma incidence induced IAGP XCO:0000090 N RGD:2301186|PMID:18786441 20081119 RGD compared to BN/NHsdMcwi 1358162 SS-Chr 12BN/Mcwi strain MP:0002871 albuminuria sexual_dimorphism IAGP XCO:0000022 N RGD:2300225|PMID:18653478 20191212 RGD in male 1358171 SS-Chr 17BN/Mcwi strain MP:0005540 decreased urine albumin level sexual_dimorphism IAGP XCO:0000022 N RGD:2300225|PMID:18653478 20191212 RGD in female 1358174 SS-Chr 19BN/Mcwi strain MP:0001883 increased mammary adenocarcinoma incidence induced IAGP XCO:0000090 N RGD:4143380|PMID:20737482 20101025 RGD compared to SS/JrHsdMcwi 1358174 SS-Chr 19BN/Mcwi strain MP:0005540 decreased urine albumin level sexual_dimorphism IAGP XCO:0000022 N RGD:2300225|PMID:18653478 20200122 RGD compared to female SS/JrHsdMCWi 1358174 SS-Chr 19BN/Mcwi strain MP:0010308 decreased tumor latency induced IAGP XCO:0000090 N RGD:4143380|PMID:20737482 20101025 RGD compared to SS/JrHsdMcwi 1358177 SS.MNS-(D2Chm25-D2Mit14)/Ayd strain MP:0002843 decreased systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:7421631|PMID:19461651 20131206 RGD compared to parental SS/Jr 1358178 SS-Chr 10BN/Mcwi strain MP:0001883 increased mammary adenocarcinoma incidence induced IAGP XCO:0000090 N RGD:2301186|PMID:18786441 20081119 RGD compared to BN/NHsdMcwi 1358178 SS-Chr 10BN/Mcwi strain MP:0004876 decreased mean systemic arterial blood pressure sexual_dimorphism IAGP XCO:0000022 N RGD:2300225|PMID:18653478 20200122 RGD compared to female SS/JrHsdMCWi 1358178 SS-Chr 10BN/Mcwi strain MP:0005540 decreased urine albumin level induced IAGP XCO:0000022 N RGD:2300225|PMID:18653478 20200122 RGD compared to male SS-Chr10BN/MCWi, female SS/JrHsdMcwi�� 1358178 SS-Chr 10BN/Mcwi strain MP:0010308 decreased tumor latency induced IAGP XCO:0000090 N RGD:2301186|PMID:18786441 20191211 RGD compared to SS/JrHsdMcwi 1358185 Ept6 Estrogen-induced pituitary tumorigenesis QTL 6 qtl MP:0000635 pituitary gland hyperplasia IAGP N RGD:1334449|PMID:15687265 19990101 RGD 1358186 Ept2 Estrogen-induced pituitary tumorigenesis QTL 2 qtl MP:0000635 pituitary gland hyperplasia IAGP N RGD:1334449|PMID:15687265 19990101 RGD 1358187 Emca1 Estrogen-induced mammary cancer QTL 1 qtl MP:0001883 increased mammary adenocarcinoma incidence IAGP N RGD:1358124|PMID:15611180 19990101 RGD 1358188 Ept9 Estrogen-induced pituitary tumorigenesis QTL 9 qtl MP:0000635 pituitary gland hyperplasia IAGP N RGD:1334449|PMID:15687265 19990101 RGD 1358189 Cstrr1 Cold stress response QTL 1 qtl MP:0002067 abnormal sensory capabilities/reflexes/nociception IAGP N RGD:1302892|PMID:15480093 19990101 RGD 1358189 Cstrr1 Cold stress response QTL 1 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:1302892|PMID:15480093 19990101 RGD 1358189 Cstrr1 Cold stress response QTL 1 qtl MP:0005665 increased circulating noradrenaline level IAGP N RGD:1302892|PMID:15480093 19990101 RGD 1358190 Ept1 Estrogen-induced pituitary tumorigenesis QTL 1 qtl MP:0000635 pituitary gland hyperplasia IAGP N RGD:1334449|PMID:15687265 19990101 RGD 1358191 Ept10 Estrogen-induced pituitary tumorigenesis QTL 10 qtl MP:0000635 pituitary gland hyperplasia IAGP N RGD:1334449|PMID:15687265 19990101 RGD 1358192 Ept13 Estrogen-induced pituitary tumorigenesis QTL 13 qtl MP:0000635 pituitary gland hyperplasia IAGP N RGD:1334449|PMID:15687265 19990101 RGD 1358193 Emca2 Estrogen-induced mammary cancer QTL 2 qtl MP:0001883 increased mammary adenocarcinoma incidence IAGP N RGD:1358124|PMID:15611180 19990101 RGD 1358200 Insglur2 Insulin/glucose ratio QTL 2 qtl MP:0005331 insulin resistance IAGP N RGD:619533|PMID:12016513 19990101 RGD 1358201 Gluco12 Glucose level QTL12 qtl MP:0001669 abnormal intestinal glucose absorption IAGP N RGD:1357415|PMID:15752738 19990101 RGD 1358201 Gluco12 Glucose level QTL12 qtl MP:0002078 abnormal glucose homeostasis IAGP N RGD:1357415|PMID:15752738 19990101 RGD 1358202 Gluco11 Glucose level QTL 11 qtl MP:0001669 abnormal intestinal glucose absorption IAGP N RGD:1357415|PMID:15752738 19990101 RGD 1358202 Gluco11 Glucose level QTL 11 qtl MP:0002078 abnormal glucose homeostasis IAGP N RGD:1357415|PMID:15752738 19990101 RGD 1358203 Stl19 Serum triglyceride level QTL 19 qtl MP:0001552 increased circulating triglyceride level IAGP N RGD:1357415|PMID:15752738 19990101 RGD 1358203 Stl19 Serum triglyceride level QTL 19 qtl MP:0005317 increased triglyceride level IAGP N RGD:1357415|PMID:15752738 19990101 RGD 1358204 Insglur1 Insulin/glucose ratio QTL 1 qtl MP:0005331 insulin resistance IAGP N RGD:619533|PMID:12016513 19990101 RGD 1358258 RCS/LavRrrc royal college of surgeons rat strain MP:0001326 retina degeneration IAGP N RGD:632096|PMID:1164921 20200421 RGD 1358258 RCS/LavRrrc royal college of surgeons rat strain MP:0005103 abnormal retina pigmentation IAGP N RGD:632096|PMID:1164921 20200421 RGD 1358258 RCS/LavRrrc royal college of surgeons rat strain MP:0008450 retina photoreceptor degeneration IAGP N RGD:632096|PMID:1164921 20200421 RGD 1358258 RCS/LavRrrc royal college of surgeons rat strain MP:0008456 abnormal retina rod cell outer segment morphology IAGP N RGD:632096|PMID:1164921 20200429 RGD 1358258 RCS/LavRrrc royal college of surgeons rat strain MP:0008515 thin retina outer nuclear layer IAGP N RGD:632096|PMID:1164921 20200421 RGD 1358258 RCS/LavRrrc royal college of surgeons rat strain MP:0008518 retina outer nuclear layer degeneration IAGP N RGD:632096|PMID:1164921 20200429 RGD 1358277 RCS-rdy+/LavRrrc strain MP:0001326 retina degeneration MODEL: control IAGP N RGD:1358250|PMID:7216680 19990101 RGD 1358277 RCS-rdy+/LavRrrc strain MP:0005103 abnormal retina pigmentation IAGP N RGD:1358250|PMID:7216680 19990101 RGD 1358278 RCS-rdy+p+/LavRrrc strain MP:0001326 retina degeneration MODEL: control IAGP N RGD:1358250|PMID:7216680 19990101 RGD 1358278 RCS-rdy+p+/LavRrrc strain MP:0005103 abnormal retina pigmentation MODEL: control IAGP N RGD:1358250|PMID:7216680 19990101 RGD 1358292 Cm37 Cardiac mass QTL 37 qtl MP:0002833 increased heart weight IAGP N RGD:1334448|PMID:15668357 19990101 RGD 1358293 Bw38 Body weight QTL 38 qtl MP:0001260 increased body weight IAGP N RGD:1334448|PMID:15668357 19990101 RGD 1358293 Bw38 Body weight QTL 38 qtl MP:0001262 decreased body weight IAGP N RGD:1334448|PMID:15668357 19990101 RGD 1358294 Bw37 Body weight QTL 37 qtl MP:0001260 increased body weight IAGP N RGD:1334448|PMID:15668357 19990101 RGD 1358294 Bw37 Body weight QTL 37 qtl MP:0001262 decreased body weight IAGP N RGD:1334448|PMID:15668357 19990101 RGD 1358295 Aocep1 Aortic cell protein QTL 1 qtl MP:0003903 increased cell mass IAGP N RGD:1334448|PMID:15668357 19990101 RGD 1358296 Ael3 Aortic elastin QTL 3 qtl MP:0003907 decreased aorta elastin content IAGP N RGD:1334448|PMID:15668357 19990101 RGD 1358302 SD-Tg(Rho*S334X)3Lav strain MP:0006068 abnormal retina horizontal cell morphology IMP N RGD:13208816|PMID:20127257 20201201 RGD mouse transgene in rat model 1358302 SD-Tg(Rho*S334X)3Lav strain MP:0011996 abnormal retina inner nuclear layer thickness IMP N RGD:13208816|PMID:20127257 20201201 RGD mouse transgene in rat model 1358302 SD-Tg(Rho*S334X)3Lav strain MP:0031186 abnormal retina horizontal cell density IMP N RGD:13208816|PMID:20127257 20201201 RGD mouse transgene in rat model 1358302 SD-Tg(Rho*S334X)3Lav strain MP:0031189 abnormal retina rod bipolar cell density IMP N RGD:13208816|PMID:20127257 20201201 RGD mouse transgene in rat model 1358352 Srcrt3 Stress Responsive Cort QTL 3 qtl MP:0003963 abnormal corticosterone level IDA N RGD:1598980|PMID:16895972 20080311 RGD 1358353 Srcrtb2 Stress Responsive Cort Basal QTL 2 qtl MP:0003963 abnormal corticosterone level IDA N RGD:1598980|PMID:16895972 20080311 RGD 1358354 Srcrt5 Stress Responsive Cort QTL 5 qtl MP:0001745 increased circulating corticosterone level IDA N RGD:1598980|PMID:16895972 20080311 RGD 1358355 Srcrt4 Stress Responsive Cort QTL 4 qtl MP:0002665 decreased circulating corticosterone level IDA N RGD:1598980|PMID:16895972 20080311 RGD 1358356 Srcrt1 Stress Responsive Cort QTL1 qtl MP:0001745 increased circulating corticosterone level IDA N RGD:1598980|PMID:16895972 20080311 RGD 1358357 Srcrtb1 Stress Responsive Cort Basal QTL 1 qtl MP:0003963 abnormal corticosterone level IDA N RGD:1598980|PMID:16895972 20080311 RGD 1358358 Sradr6 Stress Responsive Adrenal Weight QTL 6 qtl MP:0000639 abnormal adrenal gland morphology IDA N RGD:1598980|PMID:16895972 20080311 RGD 1358359 Sradr1 Stress Responsive Adrenal Weight QTL 1 qtl MP:0000639 abnormal adrenal gland morphology IDA N RGD:1598980|PMID:16895972 20080311 RGD 1358360 Sradr2 Stress Responsive Adrenal Weight QTL 2 qtl MP:0000639 abnormal adrenal gland morphology IDA N RGD:1598980|PMID:16895972 20080311 RGD 1358361 Sradr5 Stress Responsive Adrenal Weight QTL 5 qtl MP:0000639 abnormal adrenal gland morphology IDA N RGD:1598980|PMID:16895972 20080311 RGD 1358362 Srcrt2 Stress Responsive Cort QTL 2 qtl MP:0002665 decreased circulating corticosterone level IDA N RGD:1598980|PMID:16895972 20080311 RGD 1358363 Sradr3 Stress Responsive Adrenal Weight QTL 3 qtl MP:0000639 abnormal adrenal gland morphology IDA N RGD:1598980|PMID:16895972 20080311 RGD 1358364 Sradr4 Stress Responsive Adrenal Weight QTL 4 qtl MP:0000639 abnormal adrenal gland morphology IDA N RGD:1598980|PMID:16895972 20080311 RGD 1358885 Bp251 Blood pressure QTL 251 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:1303389|PMID:12545249 19990101 RGD 1358886 Bp260 Blood pressure QTL 260 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:1303386|PMID:14640890 19990101 RGD 1358887 Bw50 Body weight QTL 50 qtl MP:0001260 increased body weight QTM N RGD:1303386|PMID:14640890 19990101 RGD 1358888 Bp264 Blood pressure QTL 264 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:1303386|PMID:14640890 19990101 RGD 1358889 Bp261 Blood pressure QTL 261 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:1303386|PMID:14640890 19990101 RGD 1358890 Bp259 Blood pressure QTL 259 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:1303386|PMID:14640890 19990101 RGD 1358891 Bp265 Blood pressure QTL 265 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:1303386|PMID:14640890 19990101 RGD 1358892 Kidm26 Kidney mass QTL 26 qtl MP:0003917 increased kidney weight IAGP N RGD:1303386|PMID:14640890 19990101 RGD 1358892 Kidm26 Kidney mass QTL 26 qtl MP:0003918 decreased kidney weight IAGP N RGD:1303386|PMID:14640890 19990101 RGD 1358894 Kidm24 Kidney mass QTL 24 qtl MP:0003917 increased kidney weight IAGP N RGD:1303386|PMID:14640890 19990101 RGD 1358894 Kidm24 Kidney mass QTL 24 qtl MP:0003918 decreased kidney weight IAGP N RGD:1303386|PMID:14640890 19990101 RGD 1358895 Bp254 Blood pressure QTL 254 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:1303389|PMID:12545249 19990101 RGD 1358896 Bp262 Blood pressure QTL 262 qtl MP:0002843 decreased systemic arterial blood pressure IAGP N RGD:1303386|PMID:14640890 19990101 RGD 1358897 Stresp6 Stress response QTL 6 qtl MP:0005665 increased circulating noradrenaline level IAGP N RGD:1332590|PMID:15547139 19990101 RGD 1358898 Bp255 Blood pressure QTL 255 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:1303389|PMID:12545249 19990101 RGD 1358899 Kidm23 Kidney mass QTL 23 qtl MP:0003917 increased kidney weight IAGP N RGD:1303386|PMID:14640890 19990101 RGD 1358899 Kidm23 Kidney mass QTL 23 qtl MP:0003918 decreased kidney weight IAGP N RGD:1303386|PMID:14640890 19990101 RGD 1358900 Bw48 Body weight QTL 48 qtl MP:0001260 increased body weight QTM N RGD:1303386|PMID:14640890 19990101 RGD 1358901 Cm38 Cardiac mass QTL 38 qtl MP:0002833 increased heart weight IAGP N RGD:1303386|PMID:14640890 19990101 RGD 1358902 Bw47 Body weight QTL 47 qtl MP:0001260 increased body weight IAGP N RGD:1303386|PMID:14640890 19990101 RGD 1358903 Bp252 Blood pressure QTL 252 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:1303389|PMID:12545249 19990101 RGD 1358904 Cm39 Cardiac mass QTL 39 qtl MP:0002833 increased heart weight IAGP N RGD:1303386|PMID:14640890 19990101 RGD 1358905 Hrtrt17 Heart rate QTL 17 qtl MP:0002626 increased heart rate IAGP N RGD:1358133|PMID:9286932 19990101 RGD 1358906 Bp253 Blood pressure QTL 253 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:1303389|PMID:12545249 19990101 RGD 1358907 Cm40 Cardiac mass QTL 40 qtl MP:0002833 increased heart weight IAGP N RGD:1303386|PMID:14640890 19990101 RGD 1358908 Bw49 Body weight QTL 49 qtl MP:0001260 increased body weight QTM N RGD:1303386|PMID:14640890 19990101 RGD 1358909 Kidm25 Kidney mass QTL 25 qtl MP:0003917 increased kidney weight IAGP N RGD:1303386|PMID:14640890 19990101 RGD 1358910 Kidm27 Kidney mass QTL 27 qtl MP:0003917 increased kidney weight IAGP N RGD:1303386|PMID:14640890 19990101 RGD 1358910 Kidm27 Kidney mass QTL 27 qtl MP:0003918 decreased kidney weight IAGP N RGD:1303386|PMID:14640890 19990101 RGD 1358911 Kidm28 Kidney mass QTL 28 qtl MP:0003917 increased kidney weight IAGP N RGD:1303386|PMID:14640890 19990101 RGD 1358911 Kidm28 Kidney mass QTL 28 qtl MP:0003918 decreased kidney weight IAGP N RGD:1303386|PMID:14640890 19990101 RGD 1358912 Bw51 Body weight QTL 51 qtl MP:0001260 increased body weight QTM N RGD:1303386|PMID:14640890 19990101 RGD 1358913 Cm41 Cardiac mass QTL 41 qtl MP:0002833 increased heart weight IAGP N RGD:1303386|PMID:14640890 19990101 RGD 1358914 Bp266 Blood pressure QTL 266 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:1303386|PMID:14640890 19990101 RGD 1358915 Stresp7 Stress response QTL 7 qtl MP:0005665 increased circulating noradrenaline level IAGP N RGD:1332590|PMID:15547139 19990101 RGD 1358916 Kidm22 Kidney mass QTL 22 qtl MP:0003917 increased kidney weight IAGP N RGD:1303386|PMID:14640890 19990101 RGD 1358917 Cm42 Cardiac mass QTL 42 qtl MP:0002833 increased heart weight IAGP N RGD:1303386|PMID:14640890 19990101 RGD 1358918 W-Plp1md/Nya W-Plp1md strain MP:0000745 tremors IAGP N RGD:1358781|PMID:2479544 20170412 RGD 1358918 W-Plp1md/Nya W-Plp1md strain MP:0000745 tremors IAGP N RGD:1358782|PMID:434110 19990101 RGD 1358918 W-Plp1md/Nya W-Plp1md strain MP:0000921 demyelination IAGP N RGD:1358782|PMID:434110 19990101 RGD 1358918 W-Plp1md/Nya W-Plp1md strain MP:0002064 seizures IAGP N RGD:1358782|PMID:434110 19990101 RGD 1358918 W-Plp1md/Nya W-Plp1md strain MP:0002083 premature death IAGP N RGD:1358781|PMID:2479544 20170412 RGD 1358918 W-Plp1md/Nya W-Plp1md strain MP:0002229 neurodegeneration IAGP N RGD:1358782|PMID:434110 19990101 RGD 1358923 LE-Mbpmd strain MP:0000745 tremors IAGP N RGD:1358775|PMID:8569154 19990101 RGD 1358923 LE-Mbpmd strain MP:0001393 ataxia IAGP N RGD:1358775|PMID:8569154 19990101 RGD 1358923 LE-Mbpmd strain MP:0013438 dysmyelination IAGP N RGD:1358775|PMID:8569154 19990101 RGD 1358989 WKY.SHR-(D2Rat174-D2Rat28)(D2Rat161-D2Rat185) strain MP:0006144 increased systemic arterial systolic blood pressure IMP N RGD:629618|PMID:12209022 19990101 RGD compared to WKY/NCrl 1358992 SHR.WKY-(D2Rat40-D2Rat50) strain MP:0006264 decreased systemic arterial systolic blood pressure IMP N RGD:629618|PMID:12209022 20201117 RGD compared to SHR/NCrlPrin on a 8% NaCl diet 1358994 SHR.WKY-(D2Rat161-D2Rat241) strain MP:0002843 decreased systemic arterial blood pressure IMP N RGD:629618|PMID:12209022 19990101 RGD compared to SHR/NCrlPrin 1358995 F344.OLETF-(D1Rat166-D1Rat90)/Tj strain MP:0001260 increased body weight IAGP N RGD:1358859|PMID:15883013 20191106 RGD F344/DuCrlCrlj 1358995 F344.OLETF-(D1Rat166-D1Rat90)/Tj strain MP:0009286 increased abdominal fat pad weight IAGP N RGD:1358859|PMID:15883013 20191106 RGD F344/DuCrlCrlj 1358995 F344.OLETF-(D1Rat166-D1Rat90)/Tj strain MP:0009288 increased epididymal fat pad weight IAGP N RGD:1358859|PMID:15883013 20191106 RGD F344/DuCrlCrlj 1358995 F344.OLETF-(D1Rat166-D1Rat90)/Tj strain MP:0009298 increased mesenteric fat pad weight IAGP N RGD:1358859|PMID:15883013 20191106 RGD F344/DuCrlCrlj 1358995 F344.OLETF-(D1Rat166-D1Rat90)/Tj strain MP:0009304 increased retroperitoneal fat pad weight IAGP N RGD:1358859|PMID:15883013 20191106 RGD F344/DuCrlCrlj 1358996 SHR.WKY-(D2Rat10-D2Mgh13) strain MP:0002843 decreased systemic arterial blood pressure IMP N RGD:629618|PMID:12209022 19990101 RGD compared to SHR/NCrlPrin 1358998 BUF/NHsd strain MP:0001260 increased body weight IAGP N RGD:38548922|PMID:29193816 20200825 RGD compared to ACI, BN/SsnHsd, M520/N HS founder strains 1358998 BUF/NHsd strain MP:0001260 increased body weight IAGP N RGD:6480192|PMID:21334473 20200414 RGD compared to female ACI/N 1358998 BUF/NHsd strain MP:0001260 increased body weight IAGP N RGD:6893578|PMID:22947656 20131021 RGD 1358998 BUF/NHsd strain MP:0004348 long femur IAGP N RGD:6480192|PMID:21334473 20200414 RGD compared to females of BN/SsNHsd, F344/NHsd 1358998 BUF/NHsd strain MP:0005331 insulin resistance IAGP N RGD:6893578|PMID:22947656 20200413 RGD 1358998 BUF/NHsd strain MP:0006087 increased body mass index IAGP N RGD:38548922|PMID:29193816 20200825 RGD compared to ACI, BN/SsnHsd, F344/NHsd, M520/N, WKY/NHsd inbred HS founder strains 1358998 BUF/NHsd strain MP:0009288 increased epididymal fat pad weight IAGP N RGD:38548922|PMID:29193816 20200825 RGD compared to ACI, BN/SsnHsd, F344/NHsd, M520/N, WKY/NHsd inbred HS founder strains 1358998 BUF/NHsd strain MP:0009304 increased retroperitoneal fat pad weight IAGP N RGD:38548922|PMID:29193816 20200825 RGD compared to ACI, BN/SsnHsd, M520/N, WKY/NHsd inbred HS founder strains 1358998 BUF/NHsd strain MP:0010123 increased bone mineral content IAGP N RGD:6480192|PMID:21334473 20200414 RGD female 1358998 BUF/NHsd strain MP:0013617 increased areal bone mineral density IAGP N RGD:6480192|PMID:21334473 20200414 RGD female 1358999 WKY.SHR-(D2Rat174-D2Rat28) strain MP:0006144 increased systemic arterial systolic blood pressure IMP N RGD:629618|PMID:12209022 19990101 RGD compared to WKY/NCrl 1359000 DA.F344-(D10Arb27-D10Rat6)/Nsi strain MP:0002933 joint inflammation IAGP N RGD:1359065|PMID:15944295 20070214 RGD 1359000 DA.F344-(D10Arb27-D10Rat6)/Nsi strain MP:0002936 joint swelling IAGP N RGD:1359065|PMID:15944295 20070214 RGD 1359001 WKY.SHR-(D2Rat42-D2Rat139) strain MP:0006144 increased systemic arterial systolic blood pressure IMP N RGD:629618|PMID:12209022 19990101 RGD compared to WKY/NCrl 1359004 DA.F344-(D10Mit9-D10Rat11)/Nsi strain MP:0002933 joint inflammation IAGP N RGD:1359065|PMID:15944295 20070214 RGD 1359004 DA.F344-(D10Mit9-D10Rat11)/Nsi strain MP:0002936 joint swelling IAGP N RGD:1359065|PMID:15944295 20070214 RGD 1359005 SHR.WKY-(D2Rat15-D2Rat50) strain MP:0002843 decreased systemic arterial blood pressure IMP N RGD:629618|PMID:12209022 19990101 RGD compared to SHR/NCrlPrin 1359007 WKY.SHR-(D2Rat174-D2Rat62) strain MP:0006144 increased systemic arterial systolic blood pressure IMP N RGD:629618|PMID:12209022 19990101 RGD compared to WKY/NCrl 1359009 WKY.SHR-(D2Rat174-D2Rat185) strain MP:0006144 increased systemic arterial systolic blood pressure IMP N RGD:629618|PMID:12209022 19990101 RGD compared to WKY/NCrl 1359017 Hrtrt21 Heart rate QTL 21 qtl MP:0002626 increased heart rate IAGP N RGD:625381|PMID:11882571 19990101 RGD 1359018 Hrtrt20 Heart rate QTL 20 qtl MP:0002626 increased heart rate IAGP N RGD:625381|PMID:11882571 19990101 RGD 1359019 Hrtrt19 Heart rate QTL 19 qtl MP:0005333 decreased heart rate IAGP N RGD:625381|PMID:11882571 19990101 RGD 1359020 Ppulsi2 Prepulse inhibition QTL 2 qtl MP:0003088 abnormal prepulse inhibition QTM N RGD:629579|PMID:12426667 19990101 RGD 1359021 Bp271 Blood pressure QTL 271 qtl MP:0002843 decreased systemic arterial blood pressure IAGP N RGD:625381|PMID:11882571 19990101 RGD 1359022 Ppulsi1 Prepulse inhibition QTL 1 qtl MP:0003088 abnormal prepulse inhibition QTM N RGD:629579|PMID:12426667 19990101 RGD 1359023 Bp272 Blood pressure QTL 272 qtl MP:0002843 decreased systemic arterial blood pressure IAGP N RGD:625381|PMID:11882571 19990101 RGD 1359030 Bp277 Blood pressure QTL 277 qtl MP:0002843 decreased systemic arterial blood pressure QTM N RGD:629618|PMID:12209022 19990101 RGD 1359031 Bp275 Blood pressure QTL 275 qtl MP:0006144 increased systemic arterial systolic blood pressure QTM N RGD:629618|PMID:12209022 19990101 RGD 1359032 Hrtrt18 Heart rate QTL 18 qtl MP:0001629 abnormal heart rate QTM N RGD:629618|PMID:12209022 19990101 RGD 1359032 Hrtrt18 Heart rate QTL 18 qtl MP:0005333 decreased heart rate IAGP N RGD:629618|PMID:12209022 19990101 RGD 1359033 Bp273 Blood pressure QTL 273 qtl MP:0001968 abnormal touch/ nociception IAGP N RGD:1358955|PMID:12388796 19990101 RGD 1359033 Bp273 Blood pressure QTL 273 qtl MP:0002843 decreased systemic arterial blood pressure IAGP N RGD:1358955|PMID:12388796 19990101 RGD 1359034 Bp274 Blood pressure QTL 274 qtl MP:0006144 increased systemic arterial systolic blood pressure QTM N RGD:629618|PMID:12209022 19990101 RGD 1359035 Bp276 Blood pressure QTL 276 qtl MP:0002843 decreased systemic arterial blood pressure QTM N RGD:629618|PMID:12209022 19990101 RGD 1359346 Agtrap angiotensin II receptor-associated protein gene MP:0002962 increased urine protein level IMP N RGD:8662415|PMID:24006081 20190717 RGD as compared to the wild-type 13627261 Avpdi arginine vasopressin; diabetes insipidus mutant gene MP:0001762 polyuria IAGP N RGD:2314654|PMID:10919858 20201210 RGD 13628730 SD-Il2rgem1Ang strain MP:0000333 decreased bone marrow cell number IMP N RGD:13628403|PMID:29688994 20180620 RGD 13628730 SD-Il2rgem1Ang strain MP:0000694 spleen hypoplasia IMP N RGD:13628403|PMID:29688994 20180620 RGD 13628730 SD-Il2rgem1Ang strain MP:0000715 decreased thymocyte number IMP N RGD:13628403|PMID:29688994 20180620 RGD 13628730 SD-Il2rgem1Ang strain MP:0005018 decreased T cell number IMP N RGD:13628403|PMID:29688994 20180620 RGD 13628730 SD-Il2rgem1Ang strain MP:0008045 decreased NK cell number IMP N RGD:13628403|PMID:29688994 20180620 RGD 13628730 SD-Il2rgem1Ang strain MP:0008075 decreased CD4-positive, alpha-beta T cell number IMP N RGD:13628403|PMID:29688994 20180620 RGD 13628730 SD-Il2rgem1Ang strain MP:0008079 decreased CD8-positive, alpha-beta T cell number IMP N RGD:13628403|PMID:29688994 20180620 RGD 13628730 SD-Il2rgem1Ang strain MP:0008101 lymph node hypoplasia IMP N RGD:13628403|PMID:29688994 20180620 RGD 13628730 SD-Il2rgem1Ang strain MP:0008211 decreased mature B cell number IMP N RGD:13628403|PMID:29688994 20180620 RGD 13628731 Il2rgem1Ang interleukin 2 receptor subunit gamma;TALEN induced mutant1, Ang gene MP:0000333 decreased bone marrow cell number IMP N RGD:13628403|PMID:29688994 20180620 RGD 13628731 Il2rgem1Ang interleukin 2 receptor subunit gamma;TALEN induced mutant1, Ang gene MP:0000694 spleen hypoplasia IMP N RGD:13628403|PMID:29688994 20180620 RGD 13628731 Il2rgem1Ang interleukin 2 receptor subunit gamma;TALEN induced mutant1, Ang gene MP:0000715 decreased thymocyte number IMP N RGD:13628403|PMID:29688994 20180620 RGD 13628731 Il2rgem1Ang interleukin 2 receptor subunit gamma;TALEN induced mutant1, Ang gene MP:0005018 decreased T cell number IMP N RGD:13628403|PMID:29688994 20180620 RGD 13628731 Il2rgem1Ang interleukin 2 receptor subunit gamma;TALEN induced mutant1, Ang gene MP:0008045 decreased NK cell number IMP N RGD:13628403|PMID:29688994 20180620 RGD 13628731 Il2rgem1Ang interleukin 2 receptor subunit gamma;TALEN induced mutant1, Ang gene MP:0008075 decreased CD4-positive, alpha-beta T cell number IMP N RGD:13628403|PMID:29688994 20180620 RGD 13628731 Il2rgem1Ang interleukin 2 receptor subunit gamma;TALEN induced mutant1, Ang gene MP:0008079 decreased CD8-positive, alpha-beta T cell number IMP N RGD:13628403|PMID:29688994 20180620 RGD 13628731 Il2rgem1Ang interleukin 2 receptor subunit gamma;TALEN induced mutant1, Ang gene MP:0008101 lymph node hypoplasia IMP N RGD:13628403|PMID:29688994 20180620 RGD 13628731 Il2rgem1Ang interleukin 2 receptor subunit gamma;TALEN induced mutant1, Ang gene MP:0008211 decreased mature B cell number IMP N RGD:13628403|PMID:29688994 20180620 RGD 13702080 SD-Ahrem1Soar strain MP:0008028 pregnancy-related premature death induces IMP XCO:0000600 N RGD:407420268|PMID:34747641 20240726 RGD 13702080 SD-Ahrem1Soar strain MP:0008874 decreased physiological sensitivity to xenobiotic IMP N RGD:405878088|PMID:34256052 20240716 RGD 13702080 SD-Ahrem1Soar strain MP:0009767 decreased susceptibility to xenobiotic induced morbidity/mortality induces IMP XCO:0000600 N RGD:407420268|PMID:34747641 20240726 RGD 13702080 SD-Ahrem1Soar strain MP:0014515 decreased circulating anti-Mullerian hormone level IMP N RGD:405878088|PMID:34256052 20240716 RGD 13702081 Ahrem1Soar aryl hydrocarbon receptor; CRISPR/Cas9 induced mutant1, Soar gene MP:0008028 pregnancy-related premature death induces IMP XCO:0000600 N RGD:407420268|PMID:34747641 20240801 RGD 13702081 Ahrem1Soar aryl hydrocarbon receptor; CRISPR/Cas9 induced mutant1, Soar gene MP:0008874 decreased physiological sensitivity to xenobiotic IMP N RGD:405878088|PMID:34256052 20240718 RGD 13702081 Ahrem1Soar aryl hydrocarbon receptor; CRISPR/Cas9 induced mutant1, Soar gene MP:0009767 decreased susceptibility to xenobiotic induced morbidity/mortality induces IMP XCO:0000600 N RGD:407420268|PMID:34747641 20240801 RGD 13702081 Ahrem1Soar aryl hydrocarbon receptor; CRISPR/Cas9 induced mutant1, Soar gene MP:0014515 decreased circulating anti-Mullerian hormone level IMP N RGD:405878088|PMID:34256052 20240822 RGD 13703119 SD-Lamp2em1 strain MP:0001392 abnormal locomotor behavior IMP N RGD:13703117|PMID:29720683 20180803 RGD in hemizygote mutant male (LAMP2y/-) 13703119 SD-Lamp2em1 strain MP:0002063 abnormal learning/memory/conditioning IMP N RGD:13703117|PMID:29720683 20180803 RGD in hemizygote mutant male (LAMP2y/-) 13703119 SD-Lamp2em1 strain MP:0002083 premature death IMP N RGD:13703118|PMID:28124283 20180803 RGD in hemizygote mutant male (LAMP2y/-) 13703119 SD-Lamp2em1 strain MP:0002833 increased heart weight IMP N RGD:13703117|PMID:29720683 20180803 RGD in hemizygote mutant male (LAMP2y/-) 13703119 SD-Lamp2em1 strain MP:0002953 thick ventricular wall IMP N RGD:13703117|PMID:29720683 20180803 RGD in hemizygote mutant male (LAMP2y/-) 13703119 SD-Lamp2em1 strain MP:0002968 increased circulating alkaline phosphatase level IMP N RGD:13703118|PMID:28124283 20180803 RGD in hemizygote mutant male (LAMP2y/-) 13703119 SD-Lamp2em1 strain MP:0005178 increased circulating cholesterol level IMP N RGD:13703118|PMID:28124283 20180803 RGD in hemizygote mutant male (LAMP2y/-) 13703119 SD-Lamp2em1 strain MP:0005343 increased circulating aspartate transaminase level IMP N RGD:13703118|PMID:28124283 20180803 RGD in hemizygote mutant male (LAMP2y/-) 13703119 SD-Lamp2em1 strain MP:0005415 intrahepatic cholestasis IMP N RGD:13703118|PMID:28124283 20180803 RGD in hemizygote mutant male (LAMP2y/-) 13703119 SD-Lamp2em1 strain MP:0005559 increased circulating glucose level IMP N RGD:13703118|PMID:28124283 20180803 RGD in hemizygote mutant male (LAMP2y/-) 13703119 SD-Lamp2em1 strain MP:0008489 slow postnatal weight gain IMP N RGD:13703118|PMID:28124283 20180803 RGD in hemizygote mutant male (LAMP2y/-) 13703119 SD-Lamp2em1 strain MP:0010724 thick interventricular septum IMP N RGD:13703117|PMID:29720683 20180803 RGD in hemizygote mutant male (LAMP2y/-) 13703119 SD-Lamp2em1 strain MP:0012144 decreased b-wave amplitude IMP N RGD:13703117|PMID:29720683 20180803 RGD in hemizygote mutant male (LAMP2y/-) 13703119 SD-Lamp2em1 strain MP:0014046 abnormal mitophagy IMP N RGD:13703118|PMID:28124283 20180803 RGD in hemizygote mutant male (LAMP2y/-) 13703119 SD-Lamp2em1 strain MP:0020280 increased creatine kinase level IMP N RGD:13703117|PMID:29720683 20180803 RGD in hemizygote mutant male (LAMP2y/-) 13703121 Lamp2em1 lysosomal-associated membrane protein 2; TALEN induced mutant1 gene MP:0001392 abnormal locomotor behavior IMP N RGD:13703117|PMID:29720683 20180803 RGD in hemizygote mutant male (LAMP2y/-) 13703121 Lamp2em1 lysosomal-associated membrane protein 2; TALEN induced mutant1 gene MP:0002063 abnormal learning/memory/conditioning IMP N RGD:13703117|PMID:29720683 20180803 RGD in hemizygote mutant male (LAMP2y/-) 13703121 Lamp2em1 lysosomal-associated membrane protein 2; TALEN induced mutant1 gene MP:0002083 premature death IMP N RGD:13703118|PMID:28124283 20180803 RGD 13703121 Lamp2em1 lysosomal-associated membrane protein 2; TALEN induced mutant1 gene MP:0002833 increased heart weight IMP N RGD:13703117|PMID:29720683 20180803 RGD in hemizygote mutant male (LAMP2y/-) 13703121 Lamp2em1 lysosomal-associated membrane protein 2; TALEN induced mutant1 gene MP:0002953 thick ventricular wall IMP N RGD:13703117|PMID:29720683 20180803 RGD in hemizygote mutant male (LAMP2y/-) 13703121 Lamp2em1 lysosomal-associated membrane protein 2; TALEN induced mutant1 gene MP:0002968 increased circulating alkaline phosphatase level IMP N RGD:13703118|PMID:28124283 20180803 RGD in hemizygote mutant male (LAMP2y/-) 13703121 Lamp2em1 lysosomal-associated membrane protein 2; TALEN induced mutant1 gene MP:0005178 increased circulating cholesterol level IMP N RGD:13703118|PMID:28124283 20180803 RGD 13703121 Lamp2em1 lysosomal-associated membrane protein 2; TALEN induced mutant1 gene MP:0005343 increased circulating aspartate transaminase level IMP N RGD:13703118|PMID:28124283 20180803 RGD 13703121 Lamp2em1 lysosomal-associated membrane protein 2; TALEN induced mutant1 gene MP:0005415 intrahepatic cholestasis IMP N RGD:13703118|PMID:28124283 20180803 RGD 13703121 Lamp2em1 lysosomal-associated membrane protein 2; TALEN induced mutant1 gene MP:0005559 increased circulating glucose level IMP N RGD:13703118|PMID:28124283 20180803 RGD 13703121 Lamp2em1 lysosomal-associated membrane protein 2; TALEN induced mutant1 gene MP:0008489 slow postnatal weight gain IMP N RGD:13703118|PMID:28124283 20180803 RGD 13703121 Lamp2em1 lysosomal-associated membrane protein 2; TALEN induced mutant1 gene MP:0010724 thick interventricular septum IMP N RGD:13703117|PMID:29720683 20180803 RGD in hemizygote mutant male (LAMP2y/-) 13703121 Lamp2em1 lysosomal-associated membrane protein 2; TALEN induced mutant1 gene MP:0012144 decreased b-wave amplitude IMP N RGD:13703117|PMID:29720683 20180803 RGD in hemizygote mutant male (LAMP2y/-) 13703121 Lamp2em1 lysosomal-associated membrane protein 2; TALEN induced mutant1 gene MP:0014046 abnormal mitophagy IMP N RGD:13703118|PMID:28124283 20180803 RGD in hemizygote mutant male (LAMP2y/-) 13703121 Lamp2em1 lysosomal-associated membrane protein 2; TALEN induced mutant1 gene MP:0020280 increased creatine kinase level IMP N RGD:13703117|PMID:29720683 20180803 RGD in hemizygote mutant male (LAMP2y/-) 13781890 SD-Rnaset2em1Sage strain MP:0001417 decreased exploration in new environment IMP N RGD:13781889|PMID:29752287 20180810 RGD 13781890 SD-Rnaset2em1Sage strain MP:0001847 brain inflammation IMP N RGD:13781889|PMID:29752287 20180810 RGD 13781891 Rnaset2em1Sage ribonuclease T2; CRISPR/Cas9 induced mutant 1, Sage gene MP:0001417 decreased exploration in new environment IMP N RGD:13781889|PMID:29752287 20180810 RGD 13781891 Rnaset2em1Sage ribonuclease T2; CRISPR/Cas9 induced mutant 1, Sage gene MP:0001847 brain inflammation IMP N RGD:13781889|PMID:29752287 20180810 RGD 13782146 SD-Bace1em1Sage-/- SD-Bace1em1Sage-/Bace1em1Sage- strain MP:0001402 decreased locomotor activity IMP N RGD:13782149|PMID:28281673 20180823 RGD 13782146 SD-Bace1em1Sage-/- SD-Bace1em1Sage-/Bace1em1Sage- strain MP:0001489 decreased startle reflex IMP N RGD:13782149|PMID:28281673 20180823 RGD 13782146 SD-Bace1em1Sage-/- SD-Bace1em1Sage-/Bace1em1Sage- strain MP:0001516 abnormal motor coordination/balance IMP N RGD:13782149|PMID:28281673 20180823 RGD 13782146 SD-Bace1em1Sage-/- SD-Bace1em1Sage-/Bace1em1Sage- strain MP:0001973 increased thermal nociceptive threshold IMP N RGD:13782149|PMID:28281673 20180823 RGD 13782146 SD-Bace1em1Sage-/- SD-Bace1em1Sage-/Bace1em1Sage- strain MP:0002083 premature death IMP N RGD:13782149|PMID:28281673 20180823 RGD 13782146 SD-Bace1em1Sage-/- SD-Bace1em1Sage-/Bace1em1Sage- strain MP:0009141 increased prepulse inhibition IMP N RGD:13782149|PMID:28281673 20180823 RGD 13782146 SD-Bace1em1Sage-/- SD-Bace1em1Sage-/Bace1em1Sage- strain MP:0011731 decreased myelin sheath thickness IMP N RGD:13782149|PMID:28281673 20180823 RGD 13782148 Bace1em1Sage gene MP:0001402 decreased locomotor activity IMP N RGD:13782149|PMID:28281673 20180823 RGD 13782148 Bace1em1Sage gene MP:0001489 decreased startle reflex IMP N RGD:13782149|PMID:28281673 20180823 RGD 13782148 Bace1em1Sage gene MP:0001516 abnormal motor coordination/balance IMP N RGD:13782149|PMID:28281673 20180823 RGD 13782148 Bace1em1Sage gene MP:0001973 increased thermal nociceptive threshold IMP N RGD:13782149|PMID:28281673 20180823 RGD 13782148 Bace1em1Sage gene MP:0002083 premature death IMP N RGD:13782149|PMID:28281673 20180823 RGD 13782148 Bace1em1Sage gene MP:0009141 increased prepulse inhibition IMP N RGD:13782149|PMID:28281673 20180823 RGD 13782148 Bace1em1Sage gene MP:0011731 decreased myelin sheath thickness IMP N RGD:13782149|PMID:28281673 20180823 RGD 13782351 SS-Kcnj1em1Kasu+/- strain MP:0004217 salt-sensitive hypertension IMP N RGD:13782272|PMID:23753405 20180906 RGD 13782351 SS-Kcnj1em1Kasu+/- strain MP:0012046 decreased susceptibility to hypertension IMP N RGD:13782272|PMID:23753405 20180906 RGD 13782352 Kcnj1em1Kasu potassium voltage-gated channel subfamily J member 1; ZFN induced mutant 1,Kasu gene MP:0001262 decreased body weight IMP N RGD:13782272|PMID:23753405 20180906 RGD 13782352 Kcnj1em1Kasu potassium voltage-gated channel subfamily J member 1; ZFN induced mutant 1,Kasu gene MP:0002608 increased hematocrit IMP N RGD:13782272|PMID:23753405 20180906 RGD 13782352 Kcnj1em1Kasu potassium voltage-gated channel subfamily J member 1; ZFN induced mutant 1,Kasu gene MP:0003017 decreased circulating bicarbonate level IMP N RGD:13782272|PMID:23753405 20180906 RGD 13782352 Kcnj1em1Kasu potassium voltage-gated channel subfamily J member 1; ZFN induced mutant 1,Kasu gene MP:0003019 increased circulating chloride level IMP N RGD:13782272|PMID:23753405 20180906 RGD 13782352 Kcnj1em1Kasu potassium voltage-gated channel subfamily J member 1; ZFN induced mutant 1,Kasu gene MP:0004217 salt-sensitive hypertension IMP N RGD:13782272|PMID:23753405 20180906 RGD 13782352 Kcnj1em1Kasu potassium voltage-gated channel subfamily J member 1; ZFN induced mutant 1,Kasu gene MP:0005565 increased blood urea nitrogen level IMP N RGD:13782272|PMID:23753405 20180906 RGD 13782352 Kcnj1em1Kasu potassium voltage-gated channel subfamily J member 1; ZFN induced mutant 1,Kasu gene MP:0005627 increased circulating potassium level IMP N RGD:13782272|PMID:23753405 20180906 RGD 13782352 Kcnj1em1Kasu potassium voltage-gated channel subfamily J member 1; ZFN induced mutant 1,Kasu gene MP:0005633 increased circulating sodium level IMP N RGD:13782272|PMID:23753405 20180906 RGD 13782352 Kcnj1em1Kasu potassium voltage-gated channel subfamily J member 1; ZFN induced mutant 1,Kasu gene MP:0012046 decreased susceptibility to hypertension IMP N RGD:13782272|PMID:23753405 20180906 RGD 13782353 SS-Kcnj1em1Kasu-/- strain MP:0001262 decreased body weight IMP N RGD:13782272|PMID:23753405 20180906 RGD 13782353 SS-Kcnj1em1Kasu-/- strain MP:0002608 increased hematocrit IMP N RGD:13782272|PMID:23753405 20180906 RGD 13782353 SS-Kcnj1em1Kasu-/- strain MP:0003017 decreased circulating bicarbonate level IMP N RGD:13782272|PMID:23753405 20180906 RGD 13782353 SS-Kcnj1em1Kasu-/- strain MP:0003019 increased circulating chloride level IMP N RGD:13782272|PMID:23753405 20180906 RGD 13782353 SS-Kcnj1em1Kasu-/- strain MP:0005565 increased blood urea nitrogen level IMP N RGD:13782272|PMID:23753405 20180906 RGD 13782353 SS-Kcnj1em1Kasu-/- strain MP:0005627 increased circulating potassium level IMP N RGD:13782272|PMID:23753405 20180906 RGD 13782353 SS-Kcnj1em1Kasu-/- strain MP:0005633 increased circulating sodium level IMP N RGD:13782272|PMID:23753405 20180906 RGD 13782371 SD-Cacna1f csnb congenital stationary night blindness rat strain MP:0002734 abnormal mechanical nociception IAGP N RGD:13792551|PMID:22800190 20180912 RGD DNA:mutation:cds: c.2941C>T 13782371 SD-Cacna1f csnb congenital stationary night blindness rat strain MP:0002841 impaired skeletal muscle contractility IAGP N RGD:13782369|PMID:25748727 20180910 RGD DNA:mutation:cds: c.2941C>T (rat) 13782371 SD-Cacna1f csnb congenital stationary night blindness rat strain MP:0004022 abnormal cone electrophysiology IAGP N RGD:13782370|PMID:18246026 20180910 RGD DNA:mutation:cds: c.2941C>T (rat) 13782371 SD-Cacna1f csnb congenital stationary night blindness rat strain MP:0006068 abnormal retina horizontal cell morphology IAGP N RGD:13782386|PMID:22634626 20180910 RGD DNA:mutation:cds: c.2941C>T (rat) 13782371 SD-Cacna1f csnb congenital stationary night blindness rat strain MP:0008519 thin retina outer plexiform layer IAGP N RGD:13782386|PMID:22634626 20180910 RGD DNA:mutation:cds: c.2941C>T (rat) 13782371 SD-Cacna1f csnb congenital stationary night blindness rat strain MP:0010053 decreased grip strength IAGP N RGD:13782369|PMID:25748727 20180910 RGD DNA:mutation:cds: c.2941C>T (rat) 13782371 SD-Cacna1f csnb congenital stationary night blindness rat strain MP:0012031 abnormal b-wave amplitude IAGP N RGD:13782370|PMID:18246026 20180910 RGD DNA:mutation:cds: c.2941C>T (rat) 13782371 SD-Cacna1f csnb congenital stationary night blindness rat strain MP:0012143 decreased a-wave amplitude IAGP N RGD:13782370|PMID:18246026 20180910 RGD DNA:mutation:cds: c.2941C>T (rat) 13782371 SD-Cacna1f csnb congenital stationary night blindness rat strain MP:0020439 absent b-wave IAGP N RGD:13782191|PMID:23425697 20180910 RGD DNA:mutation:cds: c.2941C>T (rat) 13782372 Cacna1f csnb calcium voltage-gated channel subunit alpha1 F; congenital stationary night blindness mutant gene MP:0002734 abnormal mechanical nociception IAGP N RGD:13792551|PMID:22800190 20180912 RGD DNA:mutation:cds: c.2941C>T 13782372 Cacna1f csnb calcium voltage-gated channel subunit alpha1 F; congenital stationary night blindness mutant gene MP:0002841 impaired skeletal muscle contractility IAGP N RGD:13782369|PMID:25748727 20180910 RGD DNA:mutation:cds: c.2941C>T (rat) 13782372 Cacna1f csnb calcium voltage-gated channel subunit alpha1 F; congenital stationary night blindness mutant gene MP:0004022 abnormal cone electrophysiology IAGP N RGD:13782370|PMID:18246026 20180910 RGD DNA:mutation:cds: c.2941C>T (rat) 13782372 Cacna1f csnb calcium voltage-gated channel subunit alpha1 F; congenital stationary night blindness mutant gene MP:0006068 abnormal retina horizontal cell morphology IAGP N RGD:13782386|PMID:22634626 20180910 RGD DNA:mutation:cds: c.2941C>T (rat) 13782372 Cacna1f csnb calcium voltage-gated channel subunit alpha1 F; congenital stationary night blindness mutant gene MP:0008519 thin retina outer plexiform layer IAGP N RGD:13782386|PMID:22634626 20180910 RGD DNA:mutation:cds: c.2941C>T (rat) 13782372 Cacna1f csnb calcium voltage-gated channel subunit alpha1 F; congenital stationary night blindness mutant gene MP:0010053 decreased grip strength IAGP N RGD:13782369|PMID:25748727 20180910 RGD DNA:mutation:cds: c.2941C>T (rat) 13782372 Cacna1f csnb calcium voltage-gated channel subunit alpha1 F; congenital stationary night blindness mutant gene MP:0012031 abnormal b-wave amplitude IAGP N RGD:13782370|PMID:18246026 20180910 RGD DNA:mutation:cds: c.2941C>T (rat) 13782372 Cacna1f csnb calcium voltage-gated channel subunit alpha1 F; congenital stationary night blindness mutant gene MP:0012143 decreased a-wave amplitude IAGP N RGD:13782370|PMID:18246026 20180910 RGD DNA:mutation:cds: c.2941C>T (rat) 13782372 Cacna1f csnb calcium voltage-gated channel subunit alpha1 F; congenital stationary night blindness mutant gene MP:0020439 absent b-wave IAGP N RGD:13782191|PMID:23425697 20180910 RGD DNA:mutation:cds: c.2941C>T (rat) 13792571 Oprl1m1Hubr opioid related nociceptin receptor 1; ENU induced mutant1, Hubr gene MP:0001363 increased anxiety-related response IMP N RGD:126925219|PMID:21184763 20210520 RGD 13792571 Oprl1m1Hubr opioid related nociceptin receptor 1; ENU induced mutant1, Hubr gene MP:0003063 increased coping response IMP N RGD:126925219|PMID:21184763 20210520 RGD 13792571 Oprl1m1Hubr opioid related nociceptin receptor 1; ENU induced mutant1, Hubr gene MP:0003858 enhanced coordination IMP N RGD:126925219|PMID:21184763 20210520 RGD 13792571 Oprl1m1Hubr opioid related nociceptin receptor 1; ENU induced mutant1, Hubr gene MP:0008532 decreased chemical nociceptive threshold induces IMP XCO:0000834 N RGD:126925219|PMID:21184763 20210520 RGD 13792571 Oprl1m1Hubr opioid related nociceptin receptor 1; ENU induced mutant1, Hubr gene MP:0009046 muscle twitch IMP N RGD:126925219|PMID:21184763 20210520 RGD 13792571 Oprl1m1Hubr opioid related nociceptin receptor 1; ENU induced mutant1, Hubr gene MP:0009713 enhanced conditioned place preference behavior IMP N RGD:14348962|PMID:21095077 20190204 RGD 13792571 Oprl1m1Hubr opioid related nociceptin receptor 1; ENU induced mutant1, Hubr gene MP:0020954 decreased mechanical nociceptive threshold IMP N RGD:14349028|PMID:25704616 20190206 RGD 13792572 WI-Oprl1m1Hubr-/- NOPr knockout rat strain MP:0001363 increased anxiety-related response IMP N RGD:126925219|PMID:21184763 20210517 RGD 13792572 WI-Oprl1m1Hubr-/- NOPr knockout rat strain MP:0003063 increased coping response IMP N RGD:126925219|PMID:21184763 20210517 RGD 13792572 WI-Oprl1m1Hubr-/- NOPr knockout rat strain MP:0003858 enhanced coordination IMP N RGD:126925219|PMID:21184763 20210517 RGD 13792572 WI-Oprl1m1Hubr-/- NOPr knockout rat strain MP:0008532 decreased chemical nociceptive threshold induces IMP XCO:0000834 N RGD:126925219|PMID:21184763 20210517 RGD 13792572 WI-Oprl1m1Hubr-/- NOPr knockout rat strain MP:0009046 muscle twitch IMP N RGD:126925219|PMID:21184763 20210517 RGD 13792572 WI-Oprl1m1Hubr-/- NOPr knockout rat strain MP:0009713 enhanced conditioned place preference behavior IMP N RGD:14348962|PMID:21095077 20190204 RGD morphine: morphine hydrochloride trihydrate (CHEBI:55348) 13792572 WI-Oprl1m1Hubr-/- NOPr knockout rat strain MP:0020954 decreased mechanical nociceptive threshold induced IMP XCO:0000610 N RGD:14349028|PMID:25704616 20190206 RGD 13792573 SD-Lepem1Sage+/- strain MP:0001260 increased body weight IMP N RGD:12904911|PMID:22948215 20180913 RGD 13792606 SD-Cd59em1Ask-/- SD-Cd59em1-/Cd59em1- strain MP:0002640 reticulocytosis IMP N RGD:13792592|PMID:28212662 20180924 RGD 13792606 SD-Cd59em1Ask-/- SD-Cd59em1-/Cd59em1- strain MP:0002875 decreased erythrocyte cell number IMP N RGD:13792592|PMID:28212662 20180924 RGD 13792606 SD-Cd59em1Ask-/- SD-Cd59em1-/Cd59em1- strain MP:0005615 increased susceptibility to type III hypersensitivity reaction IMP N RGD:13792592|PMID:28212662 20180924 RGD 13792606 SD-Cd59em1Ask-/- SD-Cd59em1-/Cd59em1- strain MP:0010067 increased red blood cell distribution width IMP N RGD:13792592|PMID:28212662 20180924 RGD 13792701 SD-Trpv1em1Sage-/- strain MP:0002626 increased heart rate induces IDA N RGD:13792700|PMID:27335281 20211116 RGD compared to 0 min 13792701 SD-Trpv1em1Sage-/- strain MP:0004875 increased mean systemic arterial blood pressure induces IDA N RGD:13792700|PMID:27335281 20211116 RGD compared to 0 min 13792701 SD-Trpv1em1Sage-/- strain MP:0004876 decreased mean systemic arterial blood pressure induces IDA N RGD:13792700|PMID:27335281 20211116 RGD compared to 0 min 13792701 SD-Trpv1em1Sage-/- strain MP:0004876 decreased mean systemic arterial blood pressure induces IDA N RGD:13792700|PMID:27335281 20211116 RGD compared to untreated 13792701 SD-Trpv1em1Sage-/- strain MP:0005610 increased circulating antidiuretic hormone level induces IDA N RGD:13792700|PMID:27335281 20211116 RGD compared to 0 min 13792701 SD-Trpv1em1Sage-/- strain MP:0005633 increased circulating sodium level induces IDA N RGD:13792700|PMID:27335281 20211116 RGD compared to 0 min 13792701 SD-Trpv1em1Sage-/- strain MP:0008997 increased blood osmolality induces IDA N RGD:13792700|PMID:27335281 20211116 RGD compared to 0 min 13792720 Cd59em1Ask CD59 molecule; CRISPR/Cas9 induced mutant1, Ask gene MP:0002640 reticulocytosis IMP N RGD:13792592|PMID:28212662 20180924 RGD 13792720 Cd59em1Ask CD59 molecule; CRISPR/Cas9 induced mutant1, Ask gene MP:0002875 decreased erythrocyte cell number IMP N RGD:13792592|PMID:28212662 20180924 RGD 13792720 Cd59em1Ask CD59 molecule; CRISPR/Cas9 induced mutant1, Ask gene MP:0005615 increased susceptibility to type III hypersensitivity reaction IMP N RGD:13792592|PMID:28212662 20180924 RGD 13792720 Cd59em1Ask CD59 molecule; CRISPR/Cas9 induced mutant1, Ask gene MP:0010067 increased red blood cell distribution width IMP N RGD:13792592|PMID:28212662 20180924 RGD 13792794 SD-Fhem1+/- strain MP:0000208 decreased hematocrit IMP N RGD:13792708|PMID:27556703 20181008 RGD 13792794 SD-Fhem1+/- strain MP:0000221 decreased leukocyte cell number IMP N RGD:13792708|PMID:27556703 20181008 RGD 13792794 SD-Fhem1+/- strain MP:0000223 decreased monocyte cell number IMP N RGD:13792708|PMID:27556703 20181008 RGD 13792794 SD-Fhem1+/- strain MP:0001260 increased body weight IMP N RGD:13792708|PMID:27556703 20181008 RGD male only; 13792794 SD-Fhem1+/- strain MP:0001935 decreased litter size IMP N RGD:13792708|PMID:27556703 20181008 RGD 13792794 SD-Fhem1+/- strain MP:0002135 abnormal kidney morphology IMP N RGD:13792708|PMID:27556703 20181008 RGD 13792794 SD-Fhem1+/- strain MP:0002619 abnormal lymphocyte morphology IMP N RGD:13792708|PMID:27556703 20181008 RGD 13792794 SD-Fhem1+/- strain MP:0005012 decreased eosinophil cell number IMP N RGD:13792708|PMID:27556703 20181008 RGD 13792794 SD-Fhem1+/- strain MP:0005016 decreased lymphocyte cell number IMP N RGD:13792708|PMID:27556703 20181008 RGD 13792794 SD-Fhem1+/- strain MP:0005553 increased circulating creatinine level IMP N RGD:13792708|PMID:27556703 20181008 RGD 13792794 SD-Fhem1+/- strain MP:0005565 increased blood urea nitrogen level IMP N RGD:13792708|PMID:27556703 20181008 RGD 13792794 SD-Fhem1+/- strain MP:0008822 decreased blood uric acid level IMP N RGD:13792708|PMID:27556703 20181008 RGD 13792797 Fhem1 fumarate hydratase; TALEN induced mutant 1 gene MP:0000208 decreased hematocrit IMP N RGD:13792708|PMID:27556703 20181008 RGD 13792797 Fhem1 fumarate hydratase; TALEN induced mutant 1 gene MP:0000221 decreased leukocyte cell number IMP N RGD:13792708|PMID:27556703 20181008 RGD 13792797 Fhem1 fumarate hydratase; TALEN induced mutant 1 gene MP:0000223 decreased monocyte cell number IMP N RGD:13792708|PMID:27556703 20181008 RGD 13792797 Fhem1 fumarate hydratase; TALEN induced mutant 1 gene MP:0001260 increased body weight IMP N RGD:13792708|PMID:27556703 20181008 RGD male only; 13792797 Fhem1 fumarate hydratase; TALEN induced mutant 1 gene MP:0001935 decreased litter size IMP N RGD:13792708|PMID:27556703 20181008 RGD 13792797 Fhem1 fumarate hydratase; TALEN induced mutant 1 gene MP:0002135 abnormal kidney morphology IMP N RGD:13792708|PMID:27556703 20181008 RGD 13792797 Fhem1 fumarate hydratase; TALEN induced mutant 1 gene MP:0002619 abnormal lymphocyte morphology IMP N RGD:13792708|PMID:27556703 20181008 RGD 13792797 Fhem1 fumarate hydratase; TALEN induced mutant 1 gene MP:0005012 decreased eosinophil cell number IMP N RGD:13792708|PMID:27556703 20181008 RGD 13792797 Fhem1 fumarate hydratase; TALEN induced mutant 1 gene MP:0005016 decreased lymphocyte cell number IMP N RGD:13792708|PMID:27556703 20181008 RGD 13792797 Fhem1 fumarate hydratase; TALEN induced mutant 1 gene MP:0005553 increased circulating creatinine level IMP N RGD:13792708|PMID:27556703 20181008 RGD 13792797 Fhem1 fumarate hydratase; TALEN induced mutant 1 gene MP:0005565 increased blood urea nitrogen level IMP N RGD:13792708|PMID:27556703 20181008 RGD 13792797 Fhem1 fumarate hydratase; TALEN induced mutant 1 gene MP:0008762 embryonic lethality IMP N RGD:13792708|PMID:27556703 20181008 RGD 13792797 Fhem1 fumarate hydratase; TALEN induced mutant 1 gene MP:0008822 decreased blood uric acid level IMP N RGD:13792708|PMID:27556703 20181008 RGD 13800556 F344-Hsd11b2em1Jmul-/- F344-Hsd11b2em1Jmul-/Hsd11b2em1Jmul- strain MP:0000642 enlarged adrenal glands IMP N RGD:13800514|PMID:26077568 20220131 RGD compared to wild type 13800556 F344-Hsd11b2em1Jmul-/- F344-Hsd11b2em1Jmul-/Hsd11b2em1Jmul- strain MP:0001262 decreased body weight IMP N RGD:13800514|PMID:26077568 20220131 RGD compared to wild type 13800556 F344-Hsd11b2em1Jmul-/- F344-Hsd11b2em1Jmul-/Hsd11b2em1Jmul- strain MP:0002833 increased heart weight IMP N RGD:13800514|PMID:26077568 20220131 RGD compared to wild type 13800556 F344-Hsd11b2em1Jmul-/- F344-Hsd11b2em1Jmul-/Hsd11b2em1Jmul- strain MP:0002891 increased insulin sensitivity IMP N RGD:13800514|PMID:26077568 20220131 RGD compared to wild type 13800556 F344-Hsd11b2em1Jmul-/- F344-Hsd11b2em1Jmul-/Hsd11b2em1Jmul- strain MP:0003353 decreased circulating renin level IMP N RGD:13800514|PMID:26077568 20220131 RGD compared to wild type 13800556 F344-Hsd11b2em1Jmul-/- F344-Hsd11b2em1Jmul-/Hsd11b2em1Jmul- strain MP:0003402 decreased liver weight IMP N RGD:13800514|PMID:26077568 20220131 RGD compared to wild type 13800556 F344-Hsd11b2em1Jmul-/- F344-Hsd11b2em1Jmul-/Hsd11b2em1Jmul- strain MP:0003917 increased kidney weight IMP N RGD:13800514|PMID:26077568 20220131 RGD compared to wild type 13800556 F344-Hsd11b2em1Jmul-/- F344-Hsd11b2em1Jmul-/Hsd11b2em1Jmul- strain MP:0004217 salt-sensitive hypertension IMP N RGD:13800514|PMID:26077568 20220131 RGD 13800556 F344-Hsd11b2em1Jmul-/- F344-Hsd11b2em1Jmul-/Hsd11b2em1Jmul- strain MP:0004757 abnormal distal convoluted tubule morphology IMP N RGD:13800514|PMID:26077568 20220131 RGD 13800556 F344-Hsd11b2em1Jmul-/- F344-Hsd11b2em1Jmul-/Hsd11b2em1Jmul- strain MP:0008289 abnormal adrenal medulla morphology IMP N RGD:13800514|PMID:26077568 20220131 RGD 13800556 F344-Hsd11b2em1Jmul-/- F344-Hsd11b2em1Jmul-/Hsd11b2em1Jmul- strain MP:0008293 abnormal adrenal gland zona glomerulosa morphology IMP N RGD:13800514|PMID:26077568 20220131 RGD 13800556 F344-Hsd11b2em1Jmul-/- F344-Hsd11b2em1Jmul-/Hsd11b2em1Jmul- strain MP:0008295 abnormal adrenal gland zona reticularis morphology IMP N RGD:13800514|PMID:26077568 20220131 RGD 13800556 F344-Hsd11b2em1Jmul-/- F344-Hsd11b2em1Jmul-/Hsd11b2em1Jmul- strain MP:0009269 decreased fat cell size IMP N RGD:13800514|PMID:26077568 20220131 RGD compared to wild type 13800556 F344-Hsd11b2em1Jmul-/- F344-Hsd11b2em1Jmul-/Hsd11b2em1Jmul- strain MP:0009299 decreased mesenteric fat pad weight IMP N RGD:13800514|PMID:26077568 20220131 RGD compared to wild type 13800560 Hsd11b2em1Jmul hydroxysteroid 11-beta dehydrogenase 2; ZFN induced mutant1, Jmul gene MP:0000642 enlarged adrenal glands IMP N RGD:13800514|PMID:26077568 20220203 RGD compared to wild type 13800560 Hsd11b2em1Jmul hydroxysteroid 11-beta dehydrogenase 2; ZFN induced mutant1, Jmul gene MP:0001262 decreased body weight IMP N RGD:13800514|PMID:26077568 20220203 RGD compared to wild type 13800560 Hsd11b2em1Jmul hydroxysteroid 11-beta dehydrogenase 2; ZFN induced mutant1, Jmul gene MP:0002833 increased heart weight IMP N RGD:13800514|PMID:26077568 20220203 RGD compared to wild type 13800560 Hsd11b2em1Jmul hydroxysteroid 11-beta dehydrogenase 2; ZFN induced mutant1, Jmul gene MP:0002891 increased insulin sensitivity IMP N RGD:13800514|PMID:26077568 20220203 RGD compared to wild type 13800560 Hsd11b2em1Jmul hydroxysteroid 11-beta dehydrogenase 2; ZFN induced mutant1, Jmul gene MP:0003353 decreased circulating renin level IMP N RGD:13800514|PMID:26077568 20220203 RGD compared to wild type 13800560 Hsd11b2em1Jmul hydroxysteroid 11-beta dehydrogenase 2; ZFN induced mutant1, Jmul gene MP:0003402 decreased liver weight IMP N RGD:13800514|PMID:26077568 20220203 RGD compared to wild type 13800560 Hsd11b2em1Jmul hydroxysteroid 11-beta dehydrogenase 2; ZFN induced mutant1, Jmul gene MP:0003917 increased kidney weight IMP N RGD:13800514|PMID:26077568 20220203 RGD compared to wild type 13800560 Hsd11b2em1Jmul hydroxysteroid 11-beta dehydrogenase 2; ZFN induced mutant1, Jmul gene MP:0004217 salt-sensitive hypertension IMP N RGD:13800514|PMID:26077568 20220203 RGD 13800560 Hsd11b2em1Jmul hydroxysteroid 11-beta dehydrogenase 2; ZFN induced mutant1, Jmul gene MP:0004757 abnormal distal convoluted tubule morphology IMP N RGD:13800514|PMID:26077568 20220203 RGD 13800560 Hsd11b2em1Jmul hydroxysteroid 11-beta dehydrogenase 2; ZFN induced mutant1, Jmul gene MP:0008289 abnormal adrenal medulla morphology IMP N RGD:13800514|PMID:26077568 20220203 RGD 13800560 Hsd11b2em1Jmul hydroxysteroid 11-beta dehydrogenase 2; ZFN induced mutant1, Jmul gene MP:0008293 abnormal adrenal gland zona glomerulosa morphology IMP N RGD:13800514|PMID:26077568 20220203 RGD 13800560 Hsd11b2em1Jmul hydroxysteroid 11-beta dehydrogenase 2; ZFN induced mutant1, Jmul gene MP:0008295 abnormal adrenal gland zona reticularis morphology IMP N RGD:13800514|PMID:26077568 20220203 RGD 13800560 Hsd11b2em1Jmul hydroxysteroid 11-beta dehydrogenase 2; ZFN induced mutant1, Jmul gene MP:0009269 decreased fat cell size IMP N RGD:13800514|PMID:26077568 20220203 RGD compared to wild type 13800560 Hsd11b2em1Jmul hydroxysteroid 11-beta dehydrogenase 2; ZFN induced mutant1, Jmul gene MP:0009299 decreased mesenteric fat pad weight IMP N RGD:13800514|PMID:26077568 20220203 RGD compared to wild type 13800746 SS-F8em1Mcwi strain MP:0005245 hemarthrosis treatment IMP N RGD:150520060|PMID:31899798 20211026 RGD 13800746 SS-F8em1Mcwi strain MP:0005606 increased bleeding time treatment IMP N RGD:150520060|PMID:31899798 20211026 RGD 13800746 SS-F8em1Mcwi strain MP:0009676 abnormal hemostasis treatment IMP N RGD:150520060|PMID:31899798 20211026 RGD 13800747 F8em1Mcwi coagulation factor VIII, procoagulant component; CRISPR/Cas9 induced mutant1, Mcwi gene MP:0005245 hemarthrosis treatment IMP N RGD:150520060|PMID:31899798 20211028 RGD 13800747 F8em1Mcwi coagulation factor VIII, procoagulant component; CRISPR/Cas9 induced mutant1, Mcwi gene MP:0005606 increased bleeding time treatment IMP N RGD:150520060|PMID:31899798 20211028 RGD 13800747 F8em1Mcwi coagulation factor VIII, procoagulant component; CRISPR/Cas9 induced mutant1, Mcwi gene MP:0009676 abnormal hemostasis treatment IMP N RGD:150520060|PMID:31899798 20211028 RGD 13825199 WI-Mc4rm1Hubr strain MP:0000008 increased white adipose tissue amount IMP N RGD:6478803|PMID:21527895 20181129 RGD 13825199 WI-Mc4rm1Hubr strain MP:0001257 increased body length IMP N RGD:6478803|PMID:21527895 20181129 RGD 13825199 WI-Mc4rm1Hubr strain MP:0001260 increased body weight IMP N RGD:13825242|PMID:24400148 20210609 RGD 13825199 WI-Mc4rm1Hubr strain MP:0001260 increased body weight IMP N RGD:6478803|PMID:21527895 20181129 RGD 13825199 WI-Mc4rm1Hubr strain MP:0001261 obese IMP N RGD:13825198|PMID:20531371 20201012 RGD 13825199 WI-Mc4rm1Hubr strain MP:0001402 decreased locomotor activity IMP N RGD:6478803|PMID:21527895 20181129 RGD 13825199 WI-Mc4rm1Hubr strain MP:0001433 polyphagia IMP N RGD:13825242|PMID:24400148 20210609 RGD 13825199 WI-Mc4rm1Hubr strain MP:0001433 polyphagia IMP N RGD:6478803|PMID:21527895 20181129 RGD 13825199 WI-Mc4rm1Hubr strain MP:0001552 increased circulating triglyceride level IMP N RGD:13825242|PMID:24400148 20181130 RGD 13825199 WI-Mc4rm1Hubr strain MP:0001554 increased circulating free fatty acids level IMP N RGD:13825242|PMID:24400148 20181130 RGD 13825199 WI-Mc4rm1Hubr strain MP:0001762 polyuria IMP N RGD:13825242|PMID:24400148 20210609 RGD 13825199 WI-Mc4rm1Hubr strain MP:0002079 increased circulating insulin level IMP N RGD:13825242|PMID:24400148 20181130 RGD 13825199 WI-Mc4rm1Hubr strain MP:0002833 increased heart weight IMP N RGD:13825242|PMID:24400148 20181130 RGD 13825199 WI-Mc4rm1Hubr strain MP:0003025 increased vasoconstriction IMP XCO:0000312 N RGD:13825242|PMID:24400148 20210623 RGD 13825199 WI-Mc4rm1Hubr strain MP:0003026 decreased vasoconstriction IMP XCO:0000145 N RGD:13825242|PMID:24400148 20210623 RGD 13825199 WI-Mc4rm1Hubr strain MP:0003867 increased defecation amount IMP N RGD:6478803|PMID:21527895 20181129 RGD 13825199 WI-Mc4rm1Hubr strain MP:0003917 increased kidney weight IMP N RGD:13825242|PMID:24400148 20181130 RGD 13825199 WI-Mc4rm1Hubr strain MP:0004876 decreased mean systemic arterial blood pressure IMP XCO:0000843 N RGD:13825242|PMID:24400148 20210623 RGD 13825199 WI-Mc4rm1Hubr strain MP:0004878 increased systemic vascular resistance IMP N RGD:13825242|PMID:24400148 20210609 RGD 13825199 WI-Mc4rm1Hubr strain MP:0005178 increased circulating cholesterol level IMP N RGD:13825242|PMID:24400148 20181130 RGD 13825199 WI-Mc4rm1Hubr strain MP:0005333 decreased heart rate IMP N RGD:13825242|PMID:24400148 20210609 RGD compared with Wistar/Crl 13825199 WI-Mc4rm1Hubr strain MP:0005333 decreased heart rate IMP XCO:0000630 N RGD:13825242|PMID:24400148 20210609 RGD compared with WI-MC4r^m1Hubr 13825199 WI-Mc4rm1Hubr strain MP:0005669 increased circulating leptin level IMP N RGD:13825242|PMID:24400148 20210609 RGD 13825199 WI-Mc4rm1Hubr strain MP:0005669 increased circulating leptin level IMP N RGD:6478803|PMID:21527895 20181129 RGD 13825199 WI-Mc4rm1Hubr strain MP:0006094 increased fat cell size IMP N RGD:6478803|PMID:21527895 20181129 RGD 13825199 WI-Mc4rm1Hubr strain MP:0006353 increased glycosylated hemoglobin level IMP N RGD:13825242|PMID:24400148 20181130 RGD 13825199 WI-Mc4rm1Hubr strain MP:0010934 increased subcutaneous adipose tissue amount IMP N RGD:6478803|PMID:21527895 20181129 RGD 13825199 WI-Mc4rm1Hubr strain MP:0011941 increased fluid intake IMP N RGD:13825242|PMID:24400148 20210609 RGD 13825199 WI-Mc4rm1Hubr strain MP:0011941 increased fluid intake IMP N RGD:6478803|PMID:21527895 20181129 RGD 13825200 Mc4rm1Hubr melanocortin 4 receptor; ENU induced mutation 1, Hubr gene MP:0000008 increased white adipose tissue amount IMP N RGD:6478803|PMID:21527895 20181129 RGD 13825200 Mc4rm1Hubr melanocortin 4 receptor; ENU induced mutation 1, Hubr gene MP:0001257 increased body length IMP N RGD:6478803|PMID:21527895 20181129 RGD 13825200 Mc4rm1Hubr melanocortin 4 receptor; ENU induced mutation 1, Hubr gene MP:0001260 increased body weight IMP N RGD:13825242|PMID:24400148 20210609 RGD 13825200 Mc4rm1Hubr melanocortin 4 receptor; ENU induced mutation 1, Hubr gene MP:0001260 increased body weight IMP N RGD:6478803|PMID:21527895 20181129 RGD 13825200 Mc4rm1Hubr melanocortin 4 receptor; ENU induced mutation 1, Hubr gene MP:0001261 obese IMP N RGD:13825198|PMID:20531371 20201210 RGD 13825200 Mc4rm1Hubr melanocortin 4 receptor; ENU induced mutation 1, Hubr gene MP:0001402 decreased locomotor activity IMP N RGD:6478803|PMID:21527895 20181129 RGD 13825200 Mc4rm1Hubr melanocortin 4 receptor; ENU induced mutation 1, Hubr gene MP:0001433 polyphagia IMP N RGD:13825242|PMID:24400148 20210609 RGD 13825200 Mc4rm1Hubr melanocortin 4 receptor; ENU induced mutation 1, Hubr gene MP:0001433 polyphagia IMP N RGD:6478803|PMID:21527895 20181129 RGD 13825200 Mc4rm1Hubr melanocortin 4 receptor; ENU induced mutation 1, Hubr gene MP:0001552 increased circulating triglyceride level IMP N RGD:13825242|PMID:24400148 20181130 RGD 13825200 Mc4rm1Hubr melanocortin 4 receptor; ENU induced mutation 1, Hubr gene MP:0001554 increased circulating free fatty acids level IMP N RGD:13825242|PMID:24400148 20181130 RGD 13825200 Mc4rm1Hubr melanocortin 4 receptor; ENU induced mutation 1, Hubr gene MP:0001762 polyuria IMP N RGD:13825242|PMID:24400148 20210609 RGD 13825200 Mc4rm1Hubr melanocortin 4 receptor; ENU induced mutation 1, Hubr gene MP:0002079 increased circulating insulin level IMP N RGD:13825242|PMID:24400148 20181130 RGD 13825200 Mc4rm1Hubr melanocortin 4 receptor; ENU induced mutation 1, Hubr gene MP:0002833 increased heart weight IMP N RGD:13825242|PMID:24400148 20181130 RGD 13825200 Mc4rm1Hubr melanocortin 4 receptor; ENU induced mutation 1, Hubr gene MP:0003025 increased vasoconstriction IMP XCO:0000312 N RGD:13825242|PMID:24400148 20210624 RGD 13825200 Mc4rm1Hubr melanocortin 4 receptor; ENU induced mutation 1, Hubr gene MP:0003026 decreased vasoconstriction IMP XCO:0000145 N RGD:13825242|PMID:24400148 20210624 RGD 13825200 Mc4rm1Hubr melanocortin 4 receptor; ENU induced mutation 1, Hubr gene MP:0003867 increased defecation amount IMP N RGD:6478803|PMID:21527895 20181129 RGD 13825200 Mc4rm1Hubr melanocortin 4 receptor; ENU induced mutation 1, Hubr gene MP:0003917 increased kidney weight IMP N RGD:13825242|PMID:24400148 20181130 RGD 13825200 Mc4rm1Hubr melanocortin 4 receptor; ENU induced mutation 1, Hubr gene MP:0004876 decreased mean systemic arterial blood pressure IMP XCO:0000843 N RGD:13825242|PMID:24400148 20210624 RGD 13825200 Mc4rm1Hubr melanocortin 4 receptor; ENU induced mutation 1, Hubr gene MP:0004878 increased systemic vascular resistance IMP N RGD:13825242|PMID:24400148 20210609 RGD 13825200 Mc4rm1Hubr melanocortin 4 receptor; ENU induced mutation 1, Hubr gene MP:0005178 increased circulating cholesterol level IMP N RGD:13825242|PMID:24400148 20181130 RGD 13825200 Mc4rm1Hubr melanocortin 4 receptor; ENU induced mutation 1, Hubr gene MP:0005333 decreased heart rate IMP N RGD:13825242|PMID:24400148 20210609 RGD 13825200 Mc4rm1Hubr melanocortin 4 receptor; ENU induced mutation 1, Hubr gene MP:0005333 decreased heart rate IMP XCO:0000630 N RGD:13825242|PMID:24400148 20210610 RGD compared with WI-MC4r^m1Hubr 13825200 Mc4rm1Hubr melanocortin 4 receptor; ENU induced mutation 1, Hubr gene MP:0005669 increased circulating leptin level IMP N RGD:13825242|PMID:24400148 20210609 RGD 13825200 Mc4rm1Hubr melanocortin 4 receptor; ENU induced mutation 1, Hubr gene MP:0005669 increased circulating leptin level IMP N RGD:6478803|PMID:21527895 20181129 RGD 13825200 Mc4rm1Hubr melanocortin 4 receptor; ENU induced mutation 1, Hubr gene MP:0006094 increased fat cell size IMP N RGD:6478803|PMID:21527895 20181129 RGD 13825200 Mc4rm1Hubr melanocortin 4 receptor; ENU induced mutation 1, Hubr gene MP:0006353 increased glycosylated hemoglobin level IMP N RGD:13825242|PMID:24400148 20181130 RGD 13825200 Mc4rm1Hubr melanocortin 4 receptor; ENU induced mutation 1, Hubr gene MP:0010934 increased subcutaneous adipose tissue amount IMP N RGD:6478803|PMID:21527895 20181129 RGD 13825200 Mc4rm1Hubr melanocortin 4 receptor; ENU induced mutation 1, Hubr gene MP:0011941 increased fluid intake IMP N RGD:13825242|PMID:24400148 20210609 RGD 13825200 Mc4rm1Hubr melanocortin 4 receptor; ENU induced mutation 1, Hubr gene MP:0011941 increased fluid intake IMP N RGD:6478803|PMID:21527895 20181129 RGD 13838727 Bscl2m1Kyo BSCL2, seipin lipid droplet biogenesis associated; ENU induced mutant1, Kyo gene MP:0001262 decreased body weight IMP N RGD:11085488|PMID:25934999 20190109 RGD 13838727 Bscl2m1Kyo BSCL2, seipin lipid droplet biogenesis associated; ENU induced mutant1, Kyo gene MP:0001552 increased circulating triglyceride level IMP N RGD:11085488|PMID:25934999 20190109 RGD 13838727 Bscl2m1Kyo BSCL2, seipin lipid droplet biogenesis associated; ENU induced mutant1, Kyo gene MP:0001783 decreased white adipose tissue amount IMP N RGD:11085488|PMID:25934999 20190109 RGD 13838727 Bscl2m1Kyo BSCL2, seipin lipid droplet biogenesis associated; ENU induced mutant1, Kyo gene MP:0002079 increased circulating insulin level IMP N RGD:11085488|PMID:25934999 20190109 RGD 13838727 Bscl2m1Kyo BSCL2, seipin lipid droplet biogenesis associated; ENU induced mutant1, Kyo gene MP:0002175 decreased brain weight IMP N RGD:11085488|PMID:25934999 20190109 RGD 13838727 Bscl2m1Kyo BSCL2, seipin lipid droplet biogenesis associated; ENU induced mutant1, Kyo gene MP:0002981 increased liver weight IMP N RGD:11085488|PMID:25934999 20190109 RGD 13838727 Bscl2m1Kyo BSCL2, seipin lipid droplet biogenesis associated; ENU induced mutant1, Kyo gene MP:0003960 increased lean body mass IMP N RGD:11085488|PMID:25934999 20190109 RGD 13838727 Bscl2m1Kyo BSCL2, seipin lipid droplet biogenesis associated; ENU induced mutant1, Kyo gene MP:0004852 decreased testis weight IMP N RGD:11085488|PMID:25934999 20190109 RGD 13838727 Bscl2m1Kyo BSCL2, seipin lipid droplet biogenesis associated; ENU induced mutant1, Kyo gene MP:0005178 increased circulating cholesterol level IMP N RGD:11085488|PMID:25934999 20190109 RGD 13838727 Bscl2m1Kyo BSCL2, seipin lipid droplet biogenesis associated; ENU induced mutant1, Kyo gene MP:0005289 increased oxygen consumption IMP N RGD:11085488|PMID:25934999 20190109 RGD 13838727 Bscl2m1Kyo BSCL2, seipin lipid droplet biogenesis associated; ENU induced mutant1, Kyo gene MP:0005668 decreased circulating leptin level IMP N RGD:11085488|PMID:25934999 20190109 RGD 13838727 Bscl2m1Kyo BSCL2, seipin lipid droplet biogenesis associated; ENU induced mutant1, Kyo gene MP:0008428 abnormal spatial working memory IMP N RGD:11085488|PMID:25934999 20190109 RGD 13838727 Bscl2m1Kyo BSCL2, seipin lipid droplet biogenesis associated; ENU induced mutant1, Kyo gene MP:0009355 increased liver triglyceride level IMP N RGD:11085488|PMID:25934999 20190109 RGD 13838845 SD-Ahrem2Sage strain MP:0000519 hydronephrosis IMP N RGD:13204753|PMID:23859880 20210707 RGD compared to Hsd:SD 13838845 SD-Ahrem2Sage strain MP:0000536 hydroureter IMP N RGD:13204753|PMID:23859880 20210707 RGD compared to Hsd:SD 13838845 SD-Ahrem2Sage strain MP:0002590 increased mean corpuscular volume IMP N RGD:13204753|PMID:23859880 20210707 RGD compared to Hsd:SD 13838845 SD-Ahrem2Sage strain MP:0002606 increased basophil cell number IMP N RGD:13204753|PMID:23859880 20210707 RGD compared to Hsd:SD 13838845 SD-Ahrem2Sage strain MP:0003179 thrombocytopenia IMP N RGD:13204753|PMID:23859880 20210707 RGD compared to Hsd:SD 13838845 SD-Ahrem2Sage strain MP:0003630 abnormal urothelium morphology IMP N RGD:13204753|PMID:23859880 20210707 RGD compared to Hsd:SD 13838845 SD-Ahrem2Sage strain MP:0003917 increased kidney weight sexual_dimorphism IMP N RGD:13204753|PMID:23859880 20210707 RGD females compared to Hsd:SD females 13838845 SD-Ahrem2Sage strain MP:0004789 increased bile salt level sexual_dimorphism IMP N RGD:13204753|PMID:23859880 20210707 RGD females compared to Hsd:SD females 13838845 SD-Ahrem2Sage strain MP:0004852 decreased testis weight IMP N RGD:13204753|PMID:23859880 20210707 RGD compared to Hsd:SD 13838845 SD-Ahrem2Sage strain MP:0004856 decreased ovary weight IMP N RGD:13204753|PMID:23859880 20210707 RGD compared to Hsd:SD 13838845 SD-Ahrem2Sage strain MP:0004860 dilated kidney collecting duct IMP N RGD:13204753|PMID:23859880 20210707 RGD compared to Hsd:SD 13838845 SD-Ahrem2Sage strain MP:0004953 decreased spleen weight sexual_dimorphism IMP N RGD:13204753|PMID:23859880 20210707 RGD females compared to Hsd:SD females 13838845 SD-Ahrem2Sage strain MP:0005016 decreased lymphocyte cell number IMP N RGD:13204753|PMID:23859880 20210707 RGD compared to Hsd:SD 13838845 SD-Ahrem2Sage strain MP:0005343 increased circulating aspartate transaminase level sexual_dimorphism IMP N RGD:13204753|PMID:23859880 20210707 RGD females compared to Hsd:SD females 13838845 SD-Ahrem2Sage strain MP:0005561 increased mean corpuscular hemoglobin IMP N RGD:13204753|PMID:23859880 20210707 RGD compared to Hsd:SD 13838845 SD-Ahrem2Sage strain MP:0011347 abnormal kidney medullary ray morphology IMP N RGD:13204753|PMID:23859880 20210707 RGD compared to Hsd:SD 13838845 SD-Ahrem2Sage strain MP:0011431 increased urine flow rate sexual_dimorphism IMP N RGD:13204753|PMID:23859880 20210707 RGD males compared to Hsd:SD 13838845 SD-Ahrem2Sage strain MP:0013880 absent ductus venosus IMP N RGD:13204753|PMID:23859880 20210707 RGD 13838845 SD-Ahrem2Sage strain MP:0020969 impaired conditioned taste aversion behavior sexual dimorphism IMP N RGD:407419883|PMID:30769105 20240724 RGD 14390067 WI-Slc6a4m1Hubr-/- strain MP:0001363 increased anxiety-related response IMP N RGD:4889509|PMID:18295409 20210521 RGD compared to wild type littermate 14390067 WI-Slc6a4m1Hubr-/- strain MP:0008911 induced hyperactivity induces IMP XCO:0001017 N RGD:4889490|PMID:18581099 20231215 RGD compared to wild type littermate 14390067 WI-Slc6a4m1Hubr-/- strain MP:0009710 anhedonia IMP N RGD:4889509|PMID:18295409 20210521 RGD compared to wild type littermate 14390067 WI-Slc6a4m1Hubr-/- strain MP:0009713 enhanced conditioned place preference behavior IMP N RGD:4889490|PMID:18581099 20231215 RGD compared to wild type littermate 14390067 WI-Slc6a4m1Hubr-/- strain MP:0009754 enhanced behavioral response to cocaine IMP N RGD:4889490|PMID:18581099 20231215 RGD compared to wild type littermate 14390067 WI-Slc6a4m1Hubr-/- strain MP:0010166 increased response to stress-induced hyperthermia IMP N RGD:4889490|PMID:18581099 20231215 RGD 14390067 WI-Slc6a4m1Hubr-/- strain MP:0020523 decreased susceptibility to induced hypothermia IMP N RGD:4889490|PMID:18581099 20231215 RGD compared to wild type littermate 14390067 WI-Slc6a4m1Hubr-/- strain MP:0020905 abnormal cocaine self-administration IMP N RGD:401938631|PMID:30144237 20240102 RGD 14390067 WI-Slc6a4m1Hubr-/- strain MP:0020906 abnormal acquisiton of operant behavior for a cocaine reinforcer IMP N RGD:4889490|PMID:18581099 20231215 RGD compared to wild type littermate 14390068 Slc6a4m1Hubr solute carrier family 6 member 4; ZFN induced mutant1, Hubr gene MP:0001363 increased anxiety-related response IMP N RGD:4889509|PMID:18295409 20210527 RGD compared to wild type littermate 14390068 Slc6a4m1Hubr solute carrier family 6 member 4; ZFN induced mutant1, Hubr gene MP:0008911 induced hyperactivity induces IMP XCO:0001017 N RGD:4889490|PMID:18581099 20231221 RGD compared to wild type littermate 14390068 Slc6a4m1Hubr solute carrier family 6 member 4; ZFN induced mutant1, Hubr gene MP:0009710 anhedonia IMP N RGD:4889509|PMID:18295409 20210527 RGD compared to wild type littermate 14390068 Slc6a4m1Hubr solute carrier family 6 member 4; ZFN induced mutant1, Hubr gene MP:0009713 enhanced conditioned place preference behavior IMP N RGD:4889490|PMID:18581099 20231221 RGD compared to wild type littermate 14390068 Slc6a4m1Hubr solute carrier family 6 member 4; ZFN induced mutant1, Hubr gene MP:0009754 enhanced behavioral response to cocaine IMP N RGD:4889490|PMID:18581099 20231221 RGD compared to wild type littermate 14390068 Slc6a4m1Hubr solute carrier family 6 member 4; ZFN induced mutant1, Hubr gene MP:0010166 increased response to stress-induced hyperthermia IMP N RGD:4889490|PMID:18581099 20231221 RGD 14390068 Slc6a4m1Hubr solute carrier family 6 member 4; ZFN induced mutant1, Hubr gene MP:0020523 decreased susceptibility to induced hypothermia IMP N RGD:4889490|PMID:18581099 20231221 RGD compared to wild type littermate 14390068 Slc6a4m1Hubr solute carrier family 6 member 4; ZFN induced mutant1, Hubr gene MP:0020905 abnormal cocaine self-administration IMP N RGD:401938631|PMID:30144237 20240104 RGD 14390068 Slc6a4m1Hubr solute carrier family 6 member 4; ZFN induced mutant1, Hubr gene MP:0020906 abnormal acquisiton of operant behavior for a cocaine reinforcer IMP N RGD:4889490|PMID:18581099 20231221 RGD compared to wild type littermate 14392814 Cftrem1Sage cystic fibrosis transmembrane conductance regulator; ZFN induced mutant 1 Sage gene MP:0000219 increased neutrophil cell number IMP N RGD:11566051|PMID:24608905 20220120 RGD 14392814 Cftrem1Sage cystic fibrosis transmembrane conductance regulator; ZFN induced mutant 1 Sage gene MP:0001262 decreased body weight IMP N RGD:151347176|PMID:29190650 20220120 RGD 14392814 Cftrem1Sage cystic fibrosis transmembrane conductance regulator; ZFN induced mutant 1 Sage gene MP:0002238 abnormal nasal mucosa morphology IMP N RGD:11566051|PMID:24608905 20220120 RGD 14392814 Cftrem1Sage cystic fibrosis transmembrane conductance regulator; ZFN induced mutant 1 Sage gene MP:0003109 short femur IMP N RGD:151347176|PMID:29190650 20220120 RGD 14392814 Cftrem1Sage cystic fibrosis transmembrane conductance regulator; ZFN induced mutant 1 Sage gene MP:0003120 abnormal tracheal cartilage morphology IMP N RGD:11566051|PMID:24608905 20220120 RGD 14392814 Cftrem1Sage cystic fibrosis transmembrane conductance regulator; ZFN induced mutant 1 Sage gene MP:0004148 increased compact bone thickness IMP N RGD:151347176|PMID:29190650 20220120 RGD 14392814 Cftrem1Sage cystic fibrosis transmembrane conductance regulator; ZFN induced mutant 1 Sage gene MP:0004701 decreased circulating insulin-like growth factor I level IMP N RGD:151347176|PMID:29190650 20220120 RGD 14392814 Cftrem1Sage cystic fibrosis transmembrane conductance regulator; ZFN induced mutant 1 Sage gene MP:0005018 decreased T cell number IMP N RGD:11566051|PMID:24608905 20220120 RGD 14392814 Cftrem1Sage cystic fibrosis transmembrane conductance regulator; ZFN induced mutant 1 Sage gene MP:0005416 abnormal circulating protein level IMP N RGD:11566051|PMID:24608905 20220120 RGD 14392814 Cftrem1Sage cystic fibrosis transmembrane conductance regulator; ZFN induced mutant 1 Sage gene MP:0005419 decreased circulating serum albumin level IMP N RGD:11566051|PMID:24608905 20220120 RGD 14392814 Cftrem1Sage cystic fibrosis transmembrane conductance regulator; ZFN induced mutant 1 Sage gene MP:0005565 increased blood urea nitrogen level IMP N RGD:11566051|PMID:24608905 20220120 RGD 14392814 Cftrem1Sage cystic fibrosis transmembrane conductance regulator; ZFN induced mutant 1 Sage gene MP:0006395 abnormal epiphyseal plate morphology IMP N RGD:151347176|PMID:29190650 20220120 RGD 14392814 Cftrem1Sage cystic fibrosis transmembrane conductance regulator; ZFN induced mutant 1 Sage gene MP:0008108 abnormal small intestinal villus morphology IMP N RGD:11566051|PMID:24608905 20220120 RGD 14392814 Cftrem1Sage cystic fibrosis transmembrane conductance regulator; ZFN induced mutant 1 Sage gene MP:0010879 decreased trabecular bone volume IMP N RGD:151347176|PMID:29190650 20220120 RGD 14392814 Cftrem1Sage cystic fibrosis transmembrane conductance regulator; ZFN induced mutant 1 Sage gene MP:0010965 decreased compact bone volume IMP N RGD:151347176|PMID:29190650 20220120 RGD 14392814 Cftrem1Sage cystic fibrosis transmembrane conductance regulator; ZFN induced mutant 1 Sage gene MP:0012007 abnormal chloride level IMP N RGD:11566051|PMID:24608905 20220120 RGD 14392814 Cftrem1Sage cystic fibrosis transmembrane conductance regulator; ZFN induced mutant 1 Sage gene MP:0013129 abnormal tooth color IMP N RGD:11566051|PMID:24608905 20220120 RGD 14392814 Cftrem1Sage cystic fibrosis transmembrane conductance regulator; ZFN induced mutant 1 Sage gene MP:0013494 abnormal trachea gland morphology IMP N RGD:11566051|PMID:24608905 20220120 RGD 14392815 SD-Cftrem1Sage-/- strain MP:0000219 increased neutrophil cell number IMP N RGD:11566051|PMID:24608905 20220118 RGD 14392815 SD-Cftrem1Sage-/- strain MP:0001262 decreased body weight IMP N RGD:151347176|PMID:29190650 20220118 RGD 14392815 SD-Cftrem1Sage-/- strain MP:0002238 abnormal nasal mucosa morphology IMP N RGD:11566051|PMID:24608905 20220118 RGD 14392815 SD-Cftrem1Sage-/- strain MP:0003109 short femur IMP N RGD:151347176|PMID:29190650 20220118 RGD 14392815 SD-Cftrem1Sage-/- strain MP:0003120 abnormal tracheal cartilage morphology IMP N RGD:11566051|PMID:24608905 20220118 RGD 14392815 SD-Cftrem1Sage-/- strain MP:0004148 increased compact bone thickness IMP N RGD:151347176|PMID:29190650 20220118 RGD 14392815 SD-Cftrem1Sage-/- strain MP:0004701 decreased circulating insulin-like growth factor I level IMP N RGD:151347176|PMID:29190650 20220118 RGD 14392815 SD-Cftrem1Sage-/- strain MP:0005018 decreased T cell number IMP N RGD:11566051|PMID:24608905 20220118 RGD 14392815 SD-Cftrem1Sage-/- strain MP:0005416 abnormal circulating protein level IMP N RGD:11566051|PMID:24608905 20220118 RGD 14392815 SD-Cftrem1Sage-/- strain MP:0005419 decreased circulating serum albumin level IMP N RGD:11566051|PMID:24608905 20220118 RGD 14392815 SD-Cftrem1Sage-/- strain MP:0005565 increased blood urea nitrogen level IMP N RGD:11566051|PMID:24608905 20220118 RGD 14392815 SD-Cftrem1Sage-/- strain MP:0006395 abnormal epiphyseal plate morphology IMP N RGD:151347176|PMID:29190650 20220118 RGD 14392815 SD-Cftrem1Sage-/- strain MP:0008108 abnormal small intestinal villus morphology IMP N RGD:11566051|PMID:24608905 20220118 RGD 14392815 SD-Cftrem1Sage-/- strain MP:0010879 decreased trabecular bone volume IMP N RGD:151347176|PMID:29190650 20220118 RGD 14392815 SD-Cftrem1Sage-/- strain MP:0010965 decreased compact bone volume IMP N RGD:151347176|PMID:29190650 20220118 RGD 14392815 SD-Cftrem1Sage-/- strain MP:0012007 abnormal chloride level IMP N RGD:11566051|PMID:24608905 20220118 RGD 14392815 SD-Cftrem1Sage-/- strain MP:0013129 abnormal tooth color IMP N RGD:11566051|PMID:24608905 20220118 RGD 14392815 SD-Cftrem1Sage-/- strain MP:0013494 abnormal trachea gland morphology IMP N RGD:11566051|PMID:24608905 20220118 RGD 14398460 SS-Cd40em1Uthal-/- strain MP:0002963 decreased urine protein level IMP N RGD:14398462|PMID:27692815 20190418 RGD as compared to SS/JrHsd 14398460 SS-Cd40em1Uthal-/- strain MP:0005554 decreased circulating creatinine level IMP N RGD:14398462|PMID:27692815 20190418 RGD as compared to SS/JrHsd 14398460 SS-Cd40em1Uthal-/- strain MP:0005557 increased creatinine clearance IMP N RGD:14398462|PMID:27692815 20190418 RGD as compared to SS/JrHsd 14398460 SS-Cd40em1Uthal-/- strain MP:0020254 decreased collagen level IMP N RGD:14398462|PMID:27692815 20190418 RGD as compared to SS/JrHsd 14398461 Cd40em1Uthal CD40 molecule; ZFN induced mutant 1, Uthal gene MP:0002963 decreased urine protein level IMP N RGD:14398462|PMID:27692815 20190418 RGD 14398461 Cd40em1Uthal CD40 molecule; ZFN induced mutant 1, Uthal gene MP:0005554 decreased circulating creatinine level IMP N RGD:14398462|PMID:27692815 20190418 RGD 14398461 Cd40em1Uthal CD40 molecule; ZFN induced mutant 1, Uthal gene MP:0005557 increased creatinine clearance IMP N RGD:14398462|PMID:27692815 20190418 RGD 14398461 Cd40em1Uthal CD40 molecule; ZFN induced mutant 1, Uthal gene MP:0020254 decreased collagen level IMP N RGD:14398462|PMID:27692815 20190418 RGD 14398765 EdaraddswhKyo EDAR-associated death domain;swh Kyo mutant gene MP:0000379 decreased hair follicle number IAGP N RGD:2304219|PMID:15829729 20201217 RGD compared to heterozygous animals 14398765 EdaraddswhKyo EDAR-associated death domain;swh Kyo mutant gene MP:0000380 small hair follicles IAGP N RGD:2304219|PMID:15829729 20201214 RGD compared to heterozygous animals 14398765 EdaraddswhKyo EDAR-associated death domain;swh Kyo mutant gene MP:0000400 abnormal awl hair morphology IAGP N RGD:14398762|PMID:22013926 20190430 RGD DNA:missense mutation:exon:p.Pro153Ser(rat) 14398765 EdaraddswhKyo EDAR-associated death domain;swh Kyo mutant gene MP:0000410 waved hair IAGP N RGD:2304219|PMID:15829729 20201214 RGD compared to heterozygous animals 14398765 EdaraddswhKyo EDAR-associated death domain;swh Kyo mutant gene MP:0000416 sparse hair IAGP N RGD:2304219|PMID:15829729 20201214 RGD compared to heterozygous animals 14398765 EdaraddswhKyo EDAR-associated death domain;swh Kyo mutant gene MP:0000762 abnormal tongue morphology IAGP N RGD:14398762|PMID:22013926 20190430 RGD DNA:missense mutation:exon:p.Pro153Ser(rat) 14398765 EdaraddswhKyo EDAR-associated death domain;swh Kyo mutant gene MP:0001262 decreased body weight IAGP N RGD:2304219|PMID:15829729 20201214 RGD compared to heterozygous animals 14398765 EdaraddswhKyo EDAR-associated death domain;swh Kyo mutant gene MP:0002074 abnormal hair texture IAGP N RGD:2304219|PMID:15829729 20201214 RGD compared to heterozygous animals 14398765 EdaraddswhKyo EDAR-associated death domain;swh Kyo mutant gene MP:0002716 small male preputial gland IAGP N RGD:14398762|PMID:22013926 20190430 RGD DNA:missense mutation:exon:p.Pro153Ser(rat) 14398765 EdaraddswhKyo EDAR-associated death domain;swh Kyo mutant gene MP:0003344 mammary gland hypoplasia IAGP N RGD:2304219|PMID:15829729 20201214 RGD in females, compared to heterozygous animals 14398765 EdaraddswhKyo EDAR-associated death domain;swh Kyo mutant gene MP:0006236 absent Meibomian glands IAGP N RGD:14398762|PMID:22013926 20190430 RGD DNA:missense mutation:exon:p.Pro153Ser(rat) 14398765 EdaraddswhKyo EDAR-associated death domain;swh Kyo mutant gene MP:0006367 absent sweat gland IAGP N RGD:14398762|PMID:22013926 20190430 RGD DNA:missense mutation:exon:p.Pro153Ser(rat) 14398765 EdaraddswhKyo EDAR-associated death domain;swh Kyo mutant gene MP:0009506 abnormal mammary gland alveolus morphology IAGP N RGD:14398762|PMID:22013926 20190430 RGD DNA:missense mutation:exon:p.Pro153Ser(rat) 14398765 EdaraddswhKyo EDAR-associated death domain;swh Kyo mutant gene MP:0014033 abnormal submucosal gland morphology IAGP N RGD:14398763|PMID:31028034 20190430 RGD 14398765 EdaraddswhKyo EDAR-associated death domain;swh Kyo mutant gene MP:0030457 abnormal molar cusp morphology IAGP N RGD:14398762|PMID:22013926 20190430 RGD DNA:missense mutation:exon:p.Pro153Ser(rat) 14398825 SD-Fahem15Dlli-/- strain MP:0001262 decreased body weight IMP N RGD:14398823|PMID:27510266 20191120 RGD after NTBC withdrawal in the drinking water 14398825 SD-Fahem15Dlli-/- strain MP:0011085 postnatal lethality, complete penetrance IMP N RGD:14398823|PMID:27510266 20190502 RGD 14398825 SD-Fahem15Dlli-/- strain MP:0013139 moribund IMP N RGD:14398823|PMID:27510266 20191120 RGD 14398825 SD-Fahem15Dlli-/- strain MP:0013723 increased circulating tyrosine level IMP N RGD:14398823|PMID:27510266 20191120 RGD after NTBC withdrawal in the drinking water 14398826 Fahem15Dlli-/- fumarylacetoacetate hydrolase; CRISPR/Cas9 induced mutant 15, Dlli gene MP:0001262 decreased body weight IMP N RGD:14398823|PMID:27510266 20191120 RGD after NTBC withdrawal in the drinking water 14398826 Fahem15Dlli-/- fumarylacetoacetate hydrolase; CRISPR/Cas9 induced mutant 15, Dlli gene MP:0011085 postnatal lethality, complete penetrance IMP N RGD:14398823|PMID:27510266 20190502 RGD 14398826 Fahem15Dlli-/- fumarylacetoacetate hydrolase; CRISPR/Cas9 induced mutant 15, Dlli gene MP:0013139 moribund IMP N RGD:14398823|PMID:27510266 20191120 RGD 14398826 Fahem15Dlli-/- fumarylacetoacetate hydrolase; CRISPR/Cas9 induced mutant 15, Dlli gene MP:0013723 increased circulating tyrosine level IMP N RGD:14398823|PMID:27510266 20191120 RGD after NTBC withdrawal in the drinking water 14402419 LE-Chrna5em18Pas strain MP:0009756 impaired behavioral response to nicotine IMP N RGD:14694852|PMID:30293722 20211207 RGD 14402419 LE-Chrna5em18Pas strain MP:0020908 abnormal reinstatement of an extinguished operant behavior for a cocaine reinforcer IMP N RGD:150530292|PMID:32841724 20211207 RGD 14402420 Chrna5em18Pas cholinergic receptor, nicotinic, alpha 5 (neuronal); ZFN induced mutant 18,Pas gene MP:0009756 impaired behavioral response to nicotine IMP N RGD:14694852|PMID:30293722 20211209 RGD 14402420 Chrna5em18Pas cholinergic receptor, nicotinic, alpha 5 (neuronal); ZFN induced mutant 18,Pas gene MP:0020908 abnormal reinstatement of an extinguished operant behavior for a cocaine reinforcer IMP N RGD:150530292|PMID:32841724 20211209 RGD 14402421 LE-Chrna5em20(D398N)Pas strain MP:0003545 increased alcohol consumption IMP N RGD:150530288|PMID:31288250 20211207 RGD compared to wild type 14402421 LE-Chrna5em20(D398N)Pas strain MP:0012342 high preference for an addictive substance IMP N RGD:150530288|PMID:31288250 20211207 RGD compared to wild type 14402421 LE-Chrna5em20(D398N)Pas strain MP:0020906 abnormal acquisiton of operant behavior for a cocaine reinforcer IMP N RGD:150530292|PMID:32841724 20211207 RGD 14402422 Chrna5em20(D398N)Pas cholinergic receptor, nicotinic, alpha 5 (neuronal); ZFN induced mutant 20,Pas gene MP:0003545 increased alcohol consumption IMP N RGD:150530288|PMID:31288250 20211209 RGD compared to wild type 14402422 Chrna5em20(D398N)Pas cholinergic receptor, nicotinic, alpha 5 (neuronal); ZFN induced mutant 20,Pas gene MP:0012342 high preference for an addictive substance IMP N RGD:150530288|PMID:31288250 20211209 RGD compared to wild type 14402422 Chrna5em20(D398N)Pas cholinergic receptor, nicotinic, alpha 5 (neuronal); ZFN induced mutant 20,Pas gene MP:0020906 abnormal acquisiton of operant behavior for a cocaine reinforcer IMP N RGD:150530292|PMID:32841724 20211209 RGD 14695004 BBDR.F344-(D4Mgh24-D4Rhw6),BBDP-(D4Rhw6-D4Rhw10)/Rhw strain MP:0005580 periinsulitis susceptibility IAGP N RGD:2306526|PMID:19351909 20200303 RGD 14696715 SD-Htr7em1Msu strain MP:0002644 decreased circulating triglyceride level IMP N RGD:14696717|PMID:31125290 20190718 RGD in male 14696715 SD-Htr7em1Msu strain MP:0002966 decreased circulating alkaline phosphatase level IMP N RGD:14696717|PMID:31125290 20190718 RGD in male 14696715 SD-Htr7em1Msu strain MP:0003025 increased vasoconstriction IMP N RGD:14696718|PMID:31125292 20190719 RGD venous contraction induced by 5 HT 14696715 SD-Htr7em1Msu strain MP:0005179 decreased circulating cholesterol level IMP N RGD:14696717|PMID:31125290 20190718 RGD in male 14696716 Htr7em1Msu 5-hydroxytryptamine receptor 7; CRISPR/Cas9 induced mutant 1, Msu gene MP:0002644 decreased circulating triglyceride level IMP N RGD:14696717|PMID:31125290 20190718 RGD in male 14696716 Htr7em1Msu 5-hydroxytryptamine receptor 7; CRISPR/Cas9 induced mutant 1, Msu gene MP:0002966 decreased circulating alkaline phosphatase level IMP N RGD:14696717|PMID:31125290 20190718 RGD in male 14696716 Htr7em1Msu 5-hydroxytryptamine receptor 7; CRISPR/Cas9 induced mutant 1, Msu gene MP:0003025 increased vasoconstriction IMP N RGD:14696718|PMID:31125292 20190719 RGD 14696716 Htr7em1Msu 5-hydroxytryptamine receptor 7; CRISPR/Cas9 induced mutant 1, Msu gene MP:0005179 decreased circulating cholesterol level IMP N RGD:14696717|PMID:31125290 20190718 RGD in male 149735330 Kcnn2Trdk potassium calcium-activated channel subfamily N member 2; Trdk mutant gene MP:0000745 tremors IMP N RGD:38508907|PMID:28917524 20210722 RGD DNA:missense mutation:cds:c. 866T>A (p. I289N)(rat) 149735334 SD-Wfs1em1Ptsn strain MP:0001059 optic nerve atrophy onset IMP N RGD:149735331|PMID:28860598 20210723 RGD 149735334 SD-Wfs1em1Ptsn strain MP:0001263 weight loss onset IMP N RGD:149735331|PMID:28860598 20210723 RGD 149735334 SD-Wfs1em1Ptsn strain MP:0001559 hyperglycemia onset IMP N RGD:149735331|PMID:28860598 20210723 RGD 149735334 SD-Wfs1em1Ptsn strain MP:0001759 increased urine glucose level onset IMP N RGD:149735331|PMID:28860598 20210723 RGD 149735334 SD-Wfs1em1Ptsn strain MP:0003059 decreased insulin secretion induces IMP XCO:0000135 N RGD:150519890|PMID:29976929 20211013 RGD 149735334 SD-Wfs1em1Ptsn strain MP:0005277 abnormal brainstem morphology onset IMP N RGD:149735331|PMID:28860598 20210723 RGD 149735334 SD-Wfs1em1Ptsn strain MP:0005293 impaired glucose tolerance onset IMP N RGD:149735331|PMID:28860598 20210723 RGD 149735334 SD-Wfs1em1Ptsn strain MP:0005559 increased circulating glucose level onset IMP N RGD:149735331|PMID:28860598 20210723 RGD 149735334 SD-Wfs1em1Ptsn strain MP:0009114 decreased pancreatic beta cell mass onset IMP N RGD:149735331|PMID:28860598 20210723 RGD 149735334 SD-Wfs1em1Ptsn strain MP:0009168 decreased pancreatic islet number onset IMP N RGD:149735331|PMID:28860598 20210723 RGD 149735334 SD-Wfs1em1Ptsn strain MP:0009172 small pancreatic islets onset IMP N RGD:149735331|PMID:28860598 20210723 RGD 149735334 SD-Wfs1em1Ptsn strain MP:0009392 retina gliosis onset IMP N RGD:149735331|PMID:28860598 20210723 RGD 149735334 SD-Wfs1em1Ptsn strain MP:0010050 hypermyelination onset IMP N RGD:149735331|PMID:28860598 20210723 RGD 149735334 SD-Wfs1em1Ptsn strain MP:0020354 increased endoplasmic reticulum stress onset IMP N RGD:149735331|PMID:28860598 20210723 RGD 149735334 SD-Wfs1em1Ptsn strain MP:0020354 increased endoplasmic reticulum stress treatment IMP XCO:0000135 N RGD:150519890|PMID:29976929 20211013 RGD 149735335 Wfs1em1Ptsn wolframin ER transmembrane glycoprotein; ZFN induced mutant 1 gene MP:0001059 optic nerve atrophy onset IMP N RGD:149735331|PMID:28860598 20210729 RGD 149735335 Wfs1em1Ptsn wolframin ER transmembrane glycoprotein; ZFN induced mutant 1 gene MP:0001263 weight loss onset IMP N RGD:149735331|PMID:28860598 20210729 RGD 149735335 Wfs1em1Ptsn wolframin ER transmembrane glycoprotein; ZFN induced mutant 1 gene MP:0001559 hyperglycemia onset IMP N RGD:149735331|PMID:28860598 20210729 RGD 149735335 Wfs1em1Ptsn wolframin ER transmembrane glycoprotein; ZFN induced mutant 1 gene MP:0001759 increased urine glucose level onset IMP N RGD:149735331|PMID:28860598 20210729 RGD 149735335 Wfs1em1Ptsn wolframin ER transmembrane glycoprotein; ZFN induced mutant 1 gene MP:0003059 decreased insulin secretion induces IMP XCO:0000135 N RGD:150519890|PMID:29976929 20211014 RGD 149735335 Wfs1em1Ptsn wolframin ER transmembrane glycoprotein; ZFN induced mutant 1 gene MP:0005277 abnormal brainstem morphology onset IMP N RGD:149735331|PMID:28860598 20210729 RGD 149735335 Wfs1em1Ptsn wolframin ER transmembrane glycoprotein; ZFN induced mutant 1 gene MP:0005293 impaired glucose tolerance onset IMP N RGD:149735331|PMID:28860598 20210729 RGD 149735335 Wfs1em1Ptsn wolframin ER transmembrane glycoprotein; ZFN induced mutant 1 gene MP:0005559 increased circulating glucose level onset IMP N RGD:149735331|PMID:28860598 20210729 RGD 149735335 Wfs1em1Ptsn wolframin ER transmembrane glycoprotein; ZFN induced mutant 1 gene MP:0009114 decreased pancreatic beta cell mass onset IMP N RGD:149735331|PMID:28860598 20210729 RGD 149735335 Wfs1em1Ptsn wolframin ER transmembrane glycoprotein; ZFN induced mutant 1 gene MP:0009168 decreased pancreatic islet number onset IMP N RGD:149735331|PMID:28860598 20210729 RGD 149735335 Wfs1em1Ptsn wolframin ER transmembrane glycoprotein; ZFN induced mutant 1 gene MP:0009172 small pancreatic islets onset IMP N RGD:149735331|PMID:28860598 20210729 RGD 149735335 Wfs1em1Ptsn wolframin ER transmembrane glycoprotein; ZFN induced mutant 1 gene MP:0009392 retina gliosis onset IMP N RGD:149735331|PMID:28860598 20210729 RGD 149735335 Wfs1em1Ptsn wolframin ER transmembrane glycoprotein; ZFN induced mutant 1 gene MP:0010050 hypermyelination onset IMP N RGD:149735331|PMID:28860598 20210729 RGD 149735335 Wfs1em1Ptsn wolframin ER transmembrane glycoprotein; ZFN induced mutant 1 gene MP:0020354 increased endoplasmic reticulum stress onset IMP N RGD:149735331|PMID:28860598 20210729 RGD 149735335 Wfs1em1Ptsn wolframin ER transmembrane glycoprotein; ZFN induced mutant 1 gene MP:0020354 increased endoplasmic reticulum stress treatment IMP XCO:0000135 N RGD:150519890|PMID:29976929 20211014 RGD 149735336 SD-Wfs1em2Ptsn strain MP:0005293 impaired glucose tolerance onset IMP N RGD:149735331|PMID:28860598 20210723 RGD 149735337 Wfs1em2Ptsn wolframin ER transmembrane glycoprotein; ZFN induced mutant 2 gene MP:0005293 impaired glucose tolerance onset IMP N RGD:149735331|PMID:28860598 20210729 RGD 149735338 SD-Wfs1em3Ptsn strain MP:0005293 impaired glucose tolerance onset IMP N RGD:149735331|PMID:28860598 20210723 RGD 149735339 Wfs1em3Ptsn wolframin ER transmembrane glycoprotein; ZFN induced mutant 3 gene MP:0005293 impaired glucose tolerance onset IMP N RGD:149735331|PMID:28860598 20210729 RGD 149735560 LE-Gad1em15Yyan strain MP:0001402 decreased locomotor activity IMP N RGD:158012686|PMID:33293518 20240531 RGD 149735560 LE-Gad1em15Yyan strain MP:0002083 premature death IMP N RGD:158012686|PMID:33293518 20240531 RGD 149735560 LE-Gad1em15Yyan strain MP:0002573 behavioral despair IMP N RGD:158012686|PMID:33293518 20240531 RGD 149735560 LE-Gad1em15Yyan strain MP:0002757 decreased vertical activity IMP N RGD:158012686|PMID:33293518 20240531 RGD 149735560 LE-Gad1em15Yyan strain MP:0003461 abnormal response to novel object IMP N RGD:158012686|PMID:33293518 20240531 RGD 149735560 LE-Gad1em15Yyan strain MP:0003867 increased defecation amount IMP N RGD:158012686|PMID:33293518 20240531 RGD 149735560 LE-Gad1em15Yyan strain MP:0008840 abnormal spike wave discharge onset IMP N RGD:405855846|PMID:37830095 20240611 RGD 149735560 LE-Gad1em15Yyan strain MP:0009674 decreased birth weight IMP N RGD:158012686|PMID:33293518 20240531 RGD 149735560 LE-Gad1em15Yyan strain MP:0012307 impaired spatial learning IMP N RGD:158012686|PMID:33293518 20240531 RGD 149735560 LE-Gad1em15Yyan strain MP:0021111 decreased social investigation IMP N RGD:158012686|PMID:33293518 20240531 RGD 149735560 LE-Gad1em15Yyan strain MP:0030733 decreased gamma-aminobutyric acid level IMP N RGD:158012686|PMID:33293518 20240531 RGD 149735561 Gad1em15Yyan glutamate decarboxylase 1; CRISPR/Cas9 induced mutant 15, Yyan gene MP:0001402 decreased locomotor activity IMP N RGD:158012686|PMID:33293518 20240606 RGD 149735561 Gad1em15Yyan glutamate decarboxylase 1; CRISPR/Cas9 induced mutant 15, Yyan gene MP:0002083 premature death IMP N RGD:158012686|PMID:33293518 20240606 RGD 149735561 Gad1em15Yyan glutamate decarboxylase 1; CRISPR/Cas9 induced mutant 15, Yyan gene MP:0002573 behavioral despair IMP N RGD:158012686|PMID:33293518 20240606 RGD 149735561 Gad1em15Yyan glutamate decarboxylase 1; CRISPR/Cas9 induced mutant 15, Yyan gene MP:0002757 decreased vertical activity IMP N RGD:158012686|PMID:33293518 20240606 RGD 149735561 Gad1em15Yyan glutamate decarboxylase 1; CRISPR/Cas9 induced mutant 15, Yyan gene MP:0003461 abnormal response to novel object IMP N RGD:158012686|PMID:33293518 20240606 RGD 149735561 Gad1em15Yyan glutamate decarboxylase 1; CRISPR/Cas9 induced mutant 15, Yyan gene MP:0003867 increased defecation amount IMP N RGD:158012686|PMID:33293518 20240606 RGD 149735561 Gad1em15Yyan glutamate decarboxylase 1; CRISPR/Cas9 induced mutant 15, Yyan gene MP:0008840 abnormal spike wave discharge onset IMP N RGD:405855846|PMID:37830095 20240613 RGD 149735561 Gad1em15Yyan glutamate decarboxylase 1; CRISPR/Cas9 induced mutant 15, Yyan gene MP:0009674 decreased birth weight IMP N RGD:158012686|PMID:33293518 20240606 RGD 149735561 Gad1em15Yyan glutamate decarboxylase 1; CRISPR/Cas9 induced mutant 15, Yyan gene MP:0012307 impaired spatial learning IMP N RGD:158012686|PMID:33293518 20240606 RGD 149735561 Gad1em15Yyan glutamate decarboxylase 1; CRISPR/Cas9 induced mutant 15, Yyan gene MP:0021111 decreased social investigation IMP N RGD:158012686|PMID:33293518 20240606 RGD 149735561 Gad1em15Yyan glutamate decarboxylase 1; CRISPR/Cas9 induced mutant 15, Yyan gene MP:0030733 decreased gamma-aminobutyric acid level IMP N RGD:158012686|PMID:33293518 20240606 RGD 149735565 Ngly1em1Ta N-glycanase 1; CRISPR/Cas9 induced mutant 1, Ta gene MP:0000161 scoliosis sexual_dimorphism IMP N RGD:39457703|PMID:32259258 20210729 RGD compared to wild type 149735565 Ngly1em1Ta N-glycanase 1; CRISPR/Cas9 induced mutant 1, Ta gene MP:0000832 abnormal thalamus morphology IMP N RGD:39457703|PMID:32259258 20210729 RGD 149735565 Ngly1em1Ta N-glycanase 1; CRISPR/Cas9 induced mutant 1, Ta gene MP:0001265 decreased body size IMP N RGD:39457703|PMID:32259258 20210729 RGD 149735565 Ngly1em1Ta N-glycanase 1; CRISPR/Cas9 induced mutant 1, Ta gene MP:0001402 decreased locomotor activity IMP N RGD:39457703|PMID:32259258 20210729 RGD 149735565 Ngly1em1Ta N-glycanase 1; CRISPR/Cas9 induced mutant 1, Ta gene MP:0001407 short stride length IMP N RGD:39457703|PMID:32259258 20210729 RGD 149735565 Ngly1em1Ta N-glycanase 1; CRISPR/Cas9 induced mutant 1, Ta gene MP:0001489 decreased startle reflex IMP N RGD:39457703|PMID:32259258 20210729 RGD compared to wild type 149735565 Ngly1em1Ta N-glycanase 1; CRISPR/Cas9 induced mutant 1, Ta gene MP:0001513 limb grasping IMP N RGD:39457703|PMID:32259258 20210729 RGD 149735565 Ngly1em1Ta N-glycanase 1; CRISPR/Cas9 induced mutant 1, Ta gene MP:0001522 impaired swimming IMP N RGD:39457703|PMID:32259258 20210729 RGD 149735565 Ngly1em1Ta N-glycanase 1; CRISPR/Cas9 induced mutant 1, Ta gene MP:0001525 impaired balance IMP N RGD:39457703|PMID:32259258 20210729 RGD 149735565 Ngly1em1Ta N-glycanase 1; CRISPR/Cas9 induced mutant 1, Ta gene MP:0001924 infertility IMP N RGD:39457703|PMID:32259258 20210729 RGD 149735565 Ngly1em1Ta N-glycanase 1; CRISPR/Cas9 induced mutant 1, Ta gene MP:0002175 decreased brain weight IMP N RGD:39457703|PMID:32259258 20210729 RGD 149735565 Ngly1em1Ta N-glycanase 1; CRISPR/Cas9 induced mutant 1, Ta gene MP:0002651 abnormal sciatic nerve morphology IMP N RGD:39457703|PMID:32259258 20210729 RGD 149735565 Ngly1em1Ta N-glycanase 1; CRISPR/Cas9 induced mutant 1, Ta gene MP:0003225 axonal dystrophy IMP N RGD:39457703|PMID:32259258 20210729 RGD 149735565 Ngly1em1Ta N-glycanase 1; CRISPR/Cas9 induced mutant 1, Ta gene MP:0005498 hyporesponsive to tactile stimuli IMP N RGD:39457703|PMID:32259258 20210729 RGD 149735565 Ngly1em1Ta N-glycanase 1; CRISPR/Cas9 induced mutant 1, Ta gene MP:0009422 decreased gastrocnemius weight IMP N RGD:39457703|PMID:32259258 20210729 RGD 149735565 Ngly1em1Ta N-glycanase 1; CRISPR/Cas9 induced mutant 1, Ta gene MP:0009428 decreased tibialis anterior weight IMP N RGD:39457703|PMID:32259258 20210729 RGD 149735565 Ngly1em1Ta N-glycanase 1; CRISPR/Cas9 induced mutant 1, Ta gene MP:0010053 decreased grip strength IMP N RGD:39457703|PMID:32259258 20210729 RGD 149735565 Ngly1em1Ta N-glycanase 1; CRISPR/Cas9 induced mutant 1, Ta gene MP:0011110 preweaning lethality, incomplete penetrance IMP N RGD:39457703|PMID:32259258 20210729 RGD 149735565 Ngly1em1Ta N-glycanase 1; CRISPR/Cas9 induced mutant 1, Ta gene MP:0012307 impaired spatial learning IMP N RGD:39457703|PMID:32259258 20210729 RGD 149735565 Ngly1em1Ta N-glycanase 1; CRISPR/Cas9 induced mutant 1, Ta gene MP:0013178 tail necrosis IMP N RGD:39457703|PMID:32259258 20210729 RGD 14985210 LE-Cyfip1em1Sage+/- strain MP:0008026 abnormal brain white matter morphology IMP N RGD:14981598|PMID:31371763 20191009 RGD 14985210 LE-Cyfip1em1Sage+/- strain MP:0009808 decreased oligodendrocyte number IMP N RGD:14981598|PMID:31371763 20191009 RGD 14985210 LE-Cyfip1em1Sage+/- strain MP:0011731 decreased myelin sheath thickness IMP N RGD:14981598|PMID:31371763 20191009 RGD 14985211 Cyfip1em1Sage cytoplasmic FMR1 interacting protein 1; CRISPR/Cas9 induced mutant 1, Sage gene MP:0008026 abnormal brain white matter morphology IMP N RGD:14981598|PMID:31371763 20191009 RGD 14985211 Cyfip1em1Sage cytoplasmic FMR1 interacting protein 1; CRISPR/Cas9 induced mutant 1, Sage gene MP:0009808 decreased oligodendrocyte number IMP N RGD:14981598|PMID:31371763 20191009 RGD 14985211 Cyfip1em1Sage cytoplasmic FMR1 interacting protein 1; CRISPR/Cas9 induced mutant 1, Sage gene MP:0011731 decreased myelin sheath thickness IMP N RGD:14981598|PMID:31371763 20191009 RGD 14995941 Wpk Wistar polycystic kidney rat strain MP:0000781 decreased corpus callosum size IAGP N RGD:15014788|PMID:15052665 20191115 RGD 14995941 Wpk Wistar polycystic kidney rat strain MP:0001262 decreased body weight IAGP N RGD:15014788|PMID:15052665 20191115 RGD 14995941 Wpk Wistar polycystic kidney rat strain MP:0003917 increased kidney weight IAGP N RGD:15014788|PMID:15052665 20191115 RGD 14995941 Wpk Wistar polycystic kidney rat strain MP:0004952 increased spleen weight IAGP N RGD:15014788|PMID:15052665 20191115 RGD 14995941 Wpk Wistar polycystic kidney rat strain MP:0004955 increased thymus weight IAGP N RGD:15014788|PMID:15052665 20191115 RGD 14995941 Wpk Wistar polycystic kidney rat strain MP:0005565 increased blood urea nitrogen level IAGP N RGD:15014788|PMID:15052665 20191115 RGD 14995941 Wpk Wistar polycystic kidney rat strain MP:0008055 increased urine osmolality IAGP N RGD:15014788|PMID:15052665 20191115 RGD 14995943 Tmem67wpk transmembrane protein 67; wpk mutant gene MP:0000781 decreased corpus callosum size IAGP N RGD:15014788|PMID:15052665 20201210 RGD 14995943 Tmem67wpk transmembrane protein 67; wpk mutant gene MP:0000825 dilated lateral ventricle IAGP N RGD:14995942|PMID:30705305 20200130 RGD 14995943 Tmem67wpk transmembrane protein 67; wpk mutant gene MP:0001255 decreased body height IAGP N RGD:14995942|PMID:30705305 20201210 RGD 14995943 Tmem67wpk transmembrane protein 67; wpk mutant gene MP:0001262 decreased body weight IAGP N RGD:14995942|PMID:30705305 20200130 RGD 14995943 Tmem67wpk transmembrane protein 67; wpk mutant gene MP:0001262 decreased body weight IAGP N RGD:15014788|PMID:15052665 20201210 RGD 14995943 Tmem67wpk transmembrane protein 67; wpk mutant gene MP:0002176 increased brain weight IAGP N RGD:14995942|PMID:30705305 20200130 RGD 14995943 Tmem67wpk transmembrane protein 67; wpk mutant gene MP:0003070 increased vascular permeability IAGP N RGD:14995942|PMID:30705305 20200131 RGD 14995943 Tmem67wpk transmembrane protein 67; wpk mutant gene MP:0003917 increased kidney weight IAGP N RGD:14995942|PMID:30705305 20200130 RGD 14995943 Tmem67wpk transmembrane protein 67; wpk mutant gene MP:0003917 increased kidney weight IAGP N RGD:15014788|PMID:15052665 20201210 RGD 14995943 Tmem67wpk transmembrane protein 67; wpk mutant gene MP:0004875 increased mean systemic arterial blood pressure IAGP N RGD:1300514|PMID:11095650 20201210 RGD 14995943 Tmem67wpk transmembrane protein 67; wpk mutant gene MP:0004952 increased spleen weight IAGP N RGD:15014788|PMID:15052665 20201210 RGD 14995943 Tmem67wpk transmembrane protein 67; wpk mutant gene MP:0004955 increased thymus weight IAGP N RGD:15014788|PMID:15052665 20201210 RGD 14995943 Tmem67wpk transmembrane protein 67; wpk mutant gene MP:0005099 abnormal ciliary body morphology IAGP N RGD:14995942|PMID:30705305 20201210 RGD 14995943 Tmem67wpk transmembrane protein 67; wpk mutant gene MP:0005553 increased circulating creatinine level IAGP N RGD:1300514|PMID:11095650 20201210 RGD 14995943 Tmem67wpk transmembrane protein 67; wpk mutant gene MP:0005565 increased blood urea nitrogen level IAGP N RGD:1300514|PMID:11095650 20201210 RGD 14995943 Tmem67wpk transmembrane protein 67; wpk mutant gene MP:0005565 increased blood urea nitrogen level IAGP N RGD:15014788|PMID:15052665 20201210 RGD 14995943 Tmem67wpk transmembrane protein 67; wpk mutant gene MP:0006088 abnormal blood-cerebrospinal fluid barrier function IAGP N RGD:14995942|PMID:30705305 20200130 RGD 14995943 Tmem67wpk transmembrane protein 67; wpk mutant gene MP:0008055 increased urine osmolality IAGP N RGD:1300514|PMID:11095650 20201210 RGD 14995943 Tmem67wpk transmembrane protein 67; wpk mutant gene MP:0008055 increased urine osmolality IAGP N RGD:15014788|PMID:15052665 20201210 RGD 14995943 Tmem67wpk transmembrane protein 67; wpk mutant gene MP:0008535 enlarged lateral ventricles IAGP N RGD:14995942|PMID:30705305 20201210 RGD 14995943 Tmem67wpk transmembrane protein 67; wpk mutant gene MP:0011495 abnormal head shape IAGP N RGD:14995942|PMID:30705305 20200130 RGD 14995943 Tmem67wpk transmembrane protein 67; wpk mutant gene MP:0011496 abnormal head size IAGP N RGD:14995942|PMID:30705305 20200130 RGD 14995943 Tmem67wpk transmembrane protein 67; wpk mutant gene MP:0013907 abnormal cerebrospinal fluid flow IAGP N RGD:14995942|PMID:30705305 20200131 RGD 14995943 Tmem67wpk transmembrane protein 67; wpk mutant gene MP:0030965 increased brain ependyma motile cilium length IAGP N RGD:14995942|PMID:30705305 20200130 RGD 15004087 Ighm immunoglobulin heavy constant epsilon gene MP:0001805 decreased IgG level IMP N RGD:150523760|PMID:21038471 20211118 RGD 15004087 Ighm immunoglobulin heavy constant epsilon gene MP:0001806 decreased IgM level IMP N RGD:150523760|PMID:21038471 20211118 RGD 15004087 Ighm immunoglobulin heavy constant epsilon gene MP:0001807 decreased IgA level IMP N RGD:150523760|PMID:21038471 20211118 RGD 15004087 Ighm immunoglobulin heavy constant epsilon gene MP:0002492 decreased IgE level IMP N RGD:150523760|PMID:21038471 20211118 RGD 15004087 Ighm immunoglobulin heavy constant epsilon gene MP:0004751 increased length of allograft survival IMP N RGD:150523760|PMID:21038471 20211118 RGD 15004087 Ighm immunoglobulin heavy constant epsilon gene MP:0005017 decreased B cell number IMP N RGD:150523760|PMID:21038471 20211118 RGD 15017093 Wpk +/- Wpk heterozygous rat strain MP:0000825 dilated lateral ventricle IAGP N RGD:14995942|PMID:30705305 20200130 RGD compared to Wpk 15017093 Wpk +/- Wpk heterozygous rat strain MP:0008535 enlarged lateral ventricles IAGP N RGD:14995942|PMID:30705305 20191121 RGD 15017094 Wpk -/- Wpk homozygous rat strain MP:0000825 dilated lateral ventricle IAGP N RGD:14995942|PMID:30705305 20191121 RGD 15017094 Wpk -/- Wpk homozygous rat strain MP:0001255 decreased body height IAGP N RGD:14995942|PMID:30705305 20191121 RGD 15017094 Wpk -/- Wpk homozygous rat strain MP:0001262 decreased body weight IAGP N RGD:14995942|PMID:30705305 20200130 RGD compared to Wpk and Wpk +/- 15017094 Wpk -/- Wpk homozygous rat strain MP:0002176 increased brain weight IAGP N RGD:14995942|PMID:30705305 20200130 RGD compared to Wpk and Wpk +/- 15017094 Wpk -/- Wpk homozygous rat strain MP:0003070 increased vascular permeability IAGP N RGD:14995942|PMID:30705305 20200131 RGD compared to Wild-type and Wpk +/- 15017094 Wpk -/- Wpk homozygous rat strain MP:0003917 increased kidney weight IAGP N RGD:14995942|PMID:30705305 20191121 RGD 15017094 Wpk -/- Wpk homozygous rat strain MP:0004875 increased mean systemic arterial blood pressure IAGP N RGD:1300514|PMID:11095650 20191118 RGD 15017094 Wpk -/- Wpk homozygous rat strain MP:0005099 abnormal ciliary body morphology IAGP N RGD:14995942|PMID:30705305 20191121 RGD 15017094 Wpk -/- Wpk homozygous rat strain MP:0005553 increased circulating creatinine level IAGP N RGD:1300514|PMID:11095650 20191118 RGD 15017094 Wpk -/- Wpk homozygous rat strain MP:0005565 increased blood urea nitrogen level IAGP N RGD:1300514|PMID:11095650 20191118 RGD 15017094 Wpk -/- Wpk homozygous rat strain MP:0006088 abnormal blood-cerebrospinal fluid barrier function IAGP N RGD:14995942|PMID:30705305 20200130 RGD compared to Wpk and Wpk +/- 15017094 Wpk -/- Wpk homozygous rat strain MP:0008055 increased urine osmolality IAGP N RGD:1300514|PMID:11095650 20191118 RGD 15017094 Wpk -/- Wpk homozygous rat strain MP:0011495 abnormal head shape IAGP N RGD:14995942|PMID:30705305 20200130 RGD compared to Wpk 15017094 Wpk -/- Wpk homozygous rat strain MP:0011496 abnormal head size IAGP N RGD:14995942|PMID:30705305 20191121 RGD 15017094 Wpk -/- Wpk homozygous rat strain MP:0013907 abnormal cerebrospinal fluid flow IAGP N RGD:14995942|PMID:30705305 20200130 RGD compared to Wpk 15017094 Wpk -/- Wpk homozygous rat strain MP:0030965 increased brain ependyma motile cilium length IAGP N RGD:14995942|PMID:30705305 20200130 RGD compared to Wpk and Wpk +/- 150340617 SHRSP.SHR-(rs197197017 -rs198445122)/Utx strain MP:0001805 decreased IgG level IAGP N RGD:150429819|PMID:32075490 20211002 RGD compared to SHR/Utx, SHRSP/BbbUtx renal anti-dsDNA antibodies at 18 weeks old 150340617 SHRSP.SHR-(rs197197017 -rs198445122)/Utx strain MP:0002494 increased IgM level IAGP N RGD:150429819|PMID:32075490 20211002 RGD compared to SHR/Utx renal anti-dsDNA antibodies 150340617 SHRSP.SHR-(rs197197017 -rs198445122)/Utx strain MP:0002871 albuminuria IAGP N RGD:150429819|PMID:32075490 20211002 RGD compared to SHR/Utx 150340617 SHRSP.SHR-(rs197197017 -rs198445122)/Utx strain MP:0005014 increased B cell number IAGP N RGD:150429819|PMID:32075490 20211002 RGD compared to SHR/Utx kidney 150340617 SHRSP.SHR-(rs197197017 -rs198445122)/Utx strain MP:0005015 increased T cell number IAGP N RGD:150429819|PMID:32075490 20211002 RGD compared to SHR/Utx kidney 150340617 SHRSP.SHR-(rs197197017 -rs198445122)/Utx strain MP:0006413 increased T cell apoptosis IAGP N RGD:150429819|PMID:32075490 20211002 RGD compared to SHR/Utx CD4+ T cells 150340617 SHRSP.SHR-(rs197197017 -rs198445122)/Utx strain MP:0008074 increased CD4-positive, alpha-beta T cell number IAGP N RGD:150429819|PMID:32075490 20211002 RGD compared to SHR/Utx kidney 150340617 SHRSP.SHR-(rs197197017 -rs198445122)/Utx strain MP:0008078 increased CD8-positive, alpha-beta T cell number IAGP N RGD:150429819|PMID:32075490 20211002 RGD compared to SHR/Utx kidney 150340617 SHRSP.SHR-(rs197197017 -rs198445122)/Utx strain MP:0008688 decreased interleukin-2 secretion IAGP XCO:0000891,XCO:0000889 N RGD:149735373|PMID:32300198 20210910 RGD compared to SHR/Utx T cells 150340617 SHRSP.SHR-(rs197197017 -rs198445122)/Utx strain MP:0020879 abnormal calcium level IAGP XCO:0000178,XCO:0000185 N RGD:149735373|PMID:32300198 20210910 RGD compared to SHR/Utx PBMC 150340617 SHRSP.SHR-(rs197197017 -rs198445122)/Utx strain MP:0020992 increased urine HAVCR1 level IAGP N RGD:150429819|PMID:32075490 20211002 RGD compared to SHR/Utx 150340622 Dnd1ter DND microRNA-mediated repression inhibitor 1, ter mutant gene MP:0001156 abnormal spermatogenesis IAGP N RGD:40924659|PMID:22655094 20210826 RGD compared to WKY 150340622 Dnd1ter DND microRNA-mediated repression inhibitor 1, ter mutant gene MP:0001924 infertility IAGP N RGD:40924659|PMID:22655094 20210826 RGD compared to WKY 150340622 Dnd1ter DND microRNA-mediated repression inhibitor 1, ter mutant gene MP:0002016 ovary cyst IAGP N RGD:40924659|PMID:22655094 20210826 RGD compared to WKY 150340622 Dnd1ter DND microRNA-mediated repression inhibitor 1, ter mutant gene MP:0004806 absent germ cells IAGP N RGD:40924659|PMID:22655094 20210826 RGD compared to WKY 150340622 Dnd1ter DND microRNA-mediated repression inhibitor 1, ter mutant gene MP:0004852 decreased testis weight IAGP N RGD:40924659|PMID:22655094 20210826 RGD compared to WKY and heterozygous 150340622 Dnd1ter DND microRNA-mediated repression inhibitor 1, ter mutant gene MP:0004856 decreased ovary weight IAGP N RGD:40924659|PMID:22655094 20210826 RGD compared to WKY 150340622 Dnd1ter DND microRNA-mediated repression inhibitor 1, ter mutant gene MP:0013600 testis degeneration IAGP N RGD:40924659|PMID:22655094 20210826 RGD compared to WKY 150340624 Zbtb16em1Ipcv zinc finger and BTB domain containing 16; TALEN induced mutant 1, Ipcv gene MP:0001262 decreased body weight IMP N RGD:150340623|PMID:28396530 20220203 RGD compared to wild type SHR/OlaIpcv; 150340624 Zbtb16em1Ipcv zinc finger and BTB domain containing 16; TALEN induced mutant 1, Ipcv gene MP:0002644 decreased circulating triglyceride level IMP N RGD:150340623|PMID:28396530 20220203 RGD compared to wild type SHR/OlaIpcv; 150340624 Zbtb16em1Ipcv zinc finger and BTB domain containing 16; TALEN induced mutant 1, Ipcv gene MP:0002891 increased insulin sensitivity IMP N RGD:150340623|PMID:28396530 20220203 RGD compared to wild type SHR/OlaIpcv; 150340624 Zbtb16em1Ipcv zinc finger and BTB domain containing 16; TALEN induced mutant 1, Ipcv gene MP:0004565 decreased myocardial fiber size IMP N RGD:150340623|PMID:28396530 20220203 RGD compared to wild type SHR/OlaIpcv; 150340624 Zbtb16em1Ipcv zinc finger and BTB domain containing 16; TALEN induced mutant 1, Ipcv gene MP:0005179 decreased circulating cholesterol level IMP N RGD:150340623|PMID:28396530 20220203 RGD compared to wild type SHR/OlaIpcv; 150340624 Zbtb16em1Ipcv zinc finger and BTB domain containing 16; TALEN induced mutant 1, Ipcv gene MP:0005292 improved glucose tolerance IMP N RGD:150340623|PMID:28396530 20220203 RGD compared to wild type SHR/OlaIpcv; 150340624 Zbtb16em1Ipcv zinc finger and BTB domain containing 16; TALEN induced mutant 1, Ipcv gene MP:0005608 cardiac interstitial fibrosis ameliorates IMP N RGD:150340623|PMID:28396530 20220203 RGD 150340624 Zbtb16em1Ipcv zinc finger and BTB domain containing 16; TALEN induced mutant 1, Ipcv gene MP:0009289 decreased epididymal fat pad weight IMP N RGD:150340623|PMID:28396530 20220203 RGD compared to wild type SHR/OlaIpcv; 150340624 Zbtb16em1Ipcv zinc finger and BTB domain containing 16; TALEN induced mutant 1, Ipcv gene MP:0009356 decreased liver triglyceride level IMP N RGD:150340623|PMID:28396530 20220203 RGD compared to wild type SHR/OlaIpcv; 150340624 Zbtb16em1Ipcv zinc finger and BTB domain containing 16; TALEN induced mutant 1, Ipcv gene MP:0010026 decreased liver cholesterol level IMP N RGD:150340623|PMID:28396530 20220203 RGD compared to wild type SHR/OlaIpcv; 150404267 LEW-Myo15aci2/Ztm strain MP:0002090 abnormal vision induces IAGP XCO:0000181 N RGD:150429616|PMID:21479269 20210909 RGD compared to LEW/Ztm 150404267 LEW-Myo15aci2/Ztm strain MP:0008450 retina photoreceptor degeneration induces IAGP XCO:0000181 N RGD:150429616|PMID:21479269 20210909 RGD compared to LEW/Ztm 150404267 LEW-Myo15aci2/Ztm strain MP:0008518 retina outer nuclear layer degeneration induces IAGP XCO:0000181 N RGD:150429616|PMID:21479269 20210909 RGD compared to LEW/Ztm 150404267 LEW-Myo15aci2/Ztm strain MP:0012038 abnormal a-wave implicit time induces IAGP XCO:0000181 N RGD:150429616|PMID:21479269 20210909 RGD compared to LEW/Ztm 150404267 LEW-Myo15aci2/Ztm strain MP:0012039 abnormal b-wave implicit time induces IAGP XCO:0000181 N RGD:150429616|PMID:21479269 20210909 RGD compared to LEW/Ztm 150404269 Myo15aci2 myosin XVA; ci2 mutant gene MP:0002090 abnormal vision induces IAGP XCO:0000181 N RGD:150429616|PMID:21479269 20210916 RGD compared to LEW/Ztm 150404269 Myo15aci2 myosin XVA; ci2 mutant gene MP:0008450 retina photoreceptor degeneration induces IAGP XCO:0000181 N RGD:150429616|PMID:21479269 20210916 RGD compared to LEW/Ztm 150404269 Myo15aci2 myosin XVA; ci2 mutant gene MP:0008518 retina outer nuclear layer degeneration induces IAGP XCO:0000181 N RGD:150429616|PMID:21479269 20210916 RGD compared to LEW/Ztm 150404269 Myo15aci2 myosin XVA; ci2 mutant gene MP:0012038 abnormal a-wave implicit time induces IAGP XCO:0000181 N RGD:150429616|PMID:21479269 20210916 RGD compared to LEW/Ztm 150404269 Myo15aci2 myosin XVA; ci2 mutant gene MP:0012039 abnormal b-wave implicit time induces IAGP XCO:0000181 N RGD:150429616|PMID:21479269 20210916 RGD compared to LEW/Ztm 150429606 MWF.SHR-(D6Rat1-D6Rat81)/Rkb strain MP:0004505 decreased renal glomerulus number IAGP N RGD:15023481|PMID:30900988 20210908 RGD compared to MWF.SHR-(D6Rat1-D6Mgh4) 150429614 FHH-Tg(CAG-Add3)McwiRoman strain MP:0003025 increased vasoconstriction induces IMP XCO:0000168 N RGD:150340736|PMID:32029431 20210910 RGD compared to FHH 150429615 SD-Add3em1Mcwi/ Roman strain MP:0003026 decreased vasoconstriction induces IMP XCO:0000168 N RGD:150340736|PMID:32029431 20210916 RGD compared to wild-type 150429615 SD-Add3em1Mcwi/ Roman strain MP:0011296 decreased tubuloglomerular feedback response induces IMP XCO:0000168 N RGD:150340736|PMID:32029431 20210916 RGD compared to wild-type 150429617 Add3em1Mcwi adducin 3; ZFN induced mutant1, Mcwi gene MP:0003026 decreased vasoconstriction induces IMP XCO:0000168 N RGD:150340736|PMID:32029431 20210923 RGD compared to wild-type 150429617 Add3em1Mcwi adducin 3; ZFN induced mutant1, Mcwi gene MP:0011296 decreased tubuloglomerular feedback response induces IMP XCO:0000168 N RGD:150340736|PMID:32029431 20210923 RGD compared to wild-type 150429618 FHH-Chr 1BN-Add3em2Mcwi /Roman strain MP:0003026 decreased vasoconstriction induces IMP XCO:0000168 N RGD:150340736|PMID:32029431 20210910 RGD compared to WT 150429618 FHH-Chr 1BN-Add3em2Mcwi /Roman strain MP:0011296 decreased tubuloglomerular feedback response induces IMP XCO:0000168 N RGD:150340736|PMID:32029431 20210910 RGD compared to WT 150429619 Add3em2Mcwi adducin 3; ZFN induced mutant2, Mcwi gene MP:0003026 decreased vasoconstriction induces IMP XCO:0000168 N RGD:150340736|PMID:32029431 20210916 RGD compared to WT 150429619 Add3em2Mcwi adducin 3; ZFN induced mutant2, Mcwi gene MP:0011296 decreased tubuloglomerular feedback response induces IMP XCO:0000168 N RGD:150340736|PMID:32029431 20210916 RGD compared to WT 150429632 Hcn1em1Kyo hyperpolarization-activated cyclic nucleotide-gated potassium channel 1; TALEN induced mutant 1, Kyo gene MP:0001961 abnormal reflex IMP N RGD:26923909|PMID:30408474 20211104 RGD 150429632 Hcn1em1Kyo hyperpolarization-activated cyclic nucleotide-gated potassium channel 1; TALEN induced mutant 1, Kyo gene MP:0003217 increased spike-wave discharge type I onset IMP N RGD:26923909|PMID:30408474 20211104 RGD 150429632 Hcn1em1Kyo hyperpolarization-activated cyclic nucleotide-gated potassium channel 1; TALEN induced mutant 1, Kyo gene MP:0003218 decreased spike-wave discharge type I treatment IMP XCO:0000913 N RGD:26923909|PMID:30408474 20211104 RGD compared to untreated 150429632 Hcn1em1Kyo hyperpolarization-activated cyclic nucleotide-gated potassium channel 1; TALEN induced mutant 1, Kyo gene MP:0003481 decreased nerve fiber response intensity induces IMP XCO:0000055 N RGD:26923909|PMID:30408474 20211104 RGD 150429632 Hcn1em1Kyo hyperpolarization-activated cyclic nucleotide-gated potassium channel 1; TALEN induced mutant 1, Kyo gene MP:0003996 clonic seizures induces IMP XCO:0000887 N RGD:26923909|PMID:30408474 20211104 RGD 150429632 Hcn1em1Kyo hyperpolarization-activated cyclic nucleotide-gated potassium channel 1; TALEN induced mutant 1, Kyo gene MP:0008035 behavioral arrest IMP N RGD:26923909|PMID:30408474 20211104 RGD 150429634 F344 -Aspaem34Kyo Hcn1em1Kyo strain MP:0000745 tremors treatment IAGP N RGD:150429620|PMID:32507787 20220225 RGD 150429707 SD-Cyp2c11em1Nju strain MP:0001935 decreased litter size IMP N RGD:150429710|PMID:29444903 20210920 RGD compared to wild type 150429707 SD-Cyp2c11em1Nju strain MP:0002683 delayed fertility IMP N RGD:150429710|PMID:29444903 20210920 RGD compared to wild type 150429707 SD-Cyp2c11em1Nju strain MP:0008875 abnormal xenobiotic pharmacokinetics IMP XCO:0000252 N RGD:150429710|PMID:29444903 20210920 RGD compared to wild type 150429707 SD-Cyp2c11em1Nju strain MP:0008875 abnormal xenobiotic pharmacokinetics sexual_dimorphism IAGP XCO:0000252 N RGD:150429710|PMID:29444903 20210920 RGD compared between male and female 150429708 Cyp2c11em1Nju cytochrome P450, subfamily 2, polypeptide 11; CRISPR/Cas9 induced mutant 1, Nju gene MP:0001935 decreased litter size IMP N RGD:150429710|PMID:29444903 20210923 RGD compared to wild type 150429708 Cyp2c11em1Nju cytochrome P450, subfamily 2, polypeptide 11; CRISPR/Cas9 induced mutant 1, Nju gene MP:0002683 delayed fertility IMP N RGD:150429710|PMID:29444903 20210923 RGD compared to wild type 150429708 Cyp2c11em1Nju cytochrome P450, subfamily 2, polypeptide 11; CRISPR/Cas9 induced mutant 1, Nju gene MP:0008875 abnormal xenobiotic pharmacokinetics IMP XCO:0000252 N RGD:150429710|PMID:29444903 20210923 RGD compared to wild type 150429708 Cyp2c11em1Nju cytochrome P450, subfamily 2, polypeptide 11; CRISPR/Cas9 induced mutant 1, Nju gene MP:0008875 abnormal xenobiotic pharmacokinetics sexual_dimorphism IAGP XCO:0000252 N RGD:150429710|PMID:29444903 20210923 RGD compared between male and female 150429760 SHRSP.SHR-(rs198233821-rs198932221)/Utx strain MP:0009764 decreased susceptibility to induced morbidity/mortality IAGP XCO:0000795 N RGD:150429755|PMID:31608789 20210927 RGD compared to SHRSP/BbbUtx 150429814 SD-Gnalem1Hpng+/- strain MP:0001392 abnormal locomotor behavior IMP N RGD:150429833|PMID:31678405 20211004 RGD compared to wildtype controls 150429814 SD-Gnalem1Hpng+/- strain MP:0001475 reduced long-term depression IMP N RGD:150429833|PMID:31678405 20211004 RGD compared to wildtype controls 150429814 SD-Gnalem1Hpng+/- strain MP:0002804 abnormal motor learning IMP N RGD:150429833|PMID:31678405 20211004 RGD compared to wildtype controls 150429814 SD-Gnalem1Hpng+/- strain MP:0002917 decreased synaptic depression IMP N RGD:150429833|PMID:31678405 20211004 RGD compared to wildtype controls 150429816 Gnalem1Hpng G protein subunit alpha L; CRISPR/Cas9 induced mutant 1, Hpng gene MP:0001392 abnormal locomotor behavior IMP N RGD:150429833|PMID:31678405 20211007 RGD compared to wildtype controls 150429816 Gnalem1Hpng G protein subunit alpha L; CRISPR/Cas9 induced mutant 1, Hpng gene MP:0001475 reduced long-term depression IMP N RGD:150429833|PMID:31678405 20211007 RGD compared to wildtype controls 150429816 Gnalem1Hpng G protein subunit alpha L; CRISPR/Cas9 induced mutant 1, Hpng gene MP:0001732 postnatal growth retardation IMP N RGD:150429833|PMID:31678405 20211007 RGD compared to wildtype controls and heterozygotes 150429816 Gnalem1Hpng G protein subunit alpha L; CRISPR/Cas9 induced mutant 1, Hpng gene MP:0002082 postnatal lethality IMP N RGD:150429833|PMID:31678405 20211007 RGD compared to wildtype controls and heterozygotes 150429816 Gnalem1Hpng G protein subunit alpha L; CRISPR/Cas9 induced mutant 1, Hpng gene MP:0002804 abnormal motor learning IMP N RGD:150429833|PMID:31678405 20211007 RGD compared to wildtype controls 150429816 Gnalem1Hpng G protein subunit alpha L; CRISPR/Cas9 induced mutant 1, Hpng gene MP:0002917 decreased synaptic depression IMP N RGD:150429833|PMID:31678405 20211007 RGD compared to wildtype controls 150429817 SD-Gnalem1Hpng-/- strain MP:0001732 postnatal growth retardation IMP N RGD:150429833|PMID:31678405 20211004 RGD compared to wildtype controls and heterozygotes 150429817 SD-Gnalem1Hpng-/- strain MP:0002082 postnatal lethality IMP N RGD:150429833|PMID:31678405 20211004 RGD compared to wildtype controls and heterozygotes 150429825 SD-Scn9a*tm1Amgn/Crl strain MP:0001970 abnormal pain threshold induces IMP XCO:0000834 N RGD:150429745|PMID:31550995 20211004 RGD 150429825 SD-Scn9a*tm1Amgn/Crl strain MP:0001973 increased thermal nociceptive threshold induces IMP XCO:0000308 N RGD:150429745|PMID:31550995 20211004 RGD 150429825 SD-Scn9a*tm1Amgn/Crl strain MP:0002578 impaired ability to fire action potentials induces IMP XCO:0000240 N RGD:150429745|PMID:31550995 20211004 RGD 150429825 SD-Scn9a*tm1Amgn/Crl strain MP:0003412 abnormal afterhyperpolarization induces IMP XCO:0000240 N RGD:150429745|PMID:31550995 20211004 RGD 150429825 SD-Scn9a*tm1Amgn/Crl strain MP:0008531 increased chemical nociceptive threshold induces IMP XCO:0000834 N RGD:150429745|PMID:31550995 20211004 RGD 150429825 SD-Scn9a*tm1Amgn/Crl strain MP:0020523 decreased susceptibility to induced hypothermia induces IMP XCO:0000306,XCO:0000165 N RGD:150429745|PMID:31550995 20211004 RGD 150429827 Scn9a*tm1Amgn sodium voltage-gated channel alpha subunit 9;ZFN induced target mutant1, Amgn gene MP:0001970 abnormal pain threshold induces IMP XCO:0000834 N RGD:150429745|PMID:31550995 20211007 RGD 150429827 Scn9a*tm1Amgn sodium voltage-gated channel alpha subunit 9;ZFN induced target mutant1, Amgn gene MP:0001973 increased thermal nociceptive threshold induces IMP XCO:0000308 N RGD:150429745|PMID:31550995 20211007 RGD 150429827 Scn9a*tm1Amgn sodium voltage-gated channel alpha subunit 9;ZFN induced target mutant1, Amgn gene MP:0002578 impaired ability to fire action potentials induces IMP XCO:0000240 N RGD:150429745|PMID:31550995 20211007 RGD 150429827 Scn9a*tm1Amgn sodium voltage-gated channel alpha subunit 9;ZFN induced target mutant1, Amgn gene MP:0003412 abnormal afterhyperpolarization induces IMP XCO:0000240 N RGD:150429745|PMID:31550995 20211007 RGD 150429827 Scn9a*tm1Amgn sodium voltage-gated channel alpha subunit 9;ZFN induced target mutant1, Amgn gene MP:0008531 increased chemical nociceptive threshold induces IMP XCO:0000834 N RGD:150429745|PMID:31550995 20211007 RGD 150429827 Scn9a*tm1Amgn sodium voltage-gated channel alpha subunit 9;ZFN induced target mutant1, Amgn gene MP:0020523 decreased susceptibility to induced hypothermia induces IMP XCO:0000306,XCO:0000165 N RGD:150429745|PMID:31550995 20211007 RGD 150429828 SD-Tspoem1Vpl strain MP:0001739 abnormal adrenal gland secretion induces IMP XCO:0000143,XCO:0000228 N RGD:150429771|PMID:29074640 20211005 RGD 150429828 SD-Tspoem1Vpl strain MP:0002665 decreased circulating corticosterone level induces IMP XCO:0000143,XCO:0000228 N RGD:150429771|PMID:29074640 20211005 RGD 150429828 SD-Tspoem1Vpl strain MP:0002780 decreased circulating testosterone level IMP N RGD:150429771|PMID:29074640 20211005 RGD 150429830 SD-Tspoem2Vpl strain MP:0001739 abnormal adrenal gland secretion induces IMP XCO:0000143,XCO:0000228 N RGD:150429771|PMID:29074640 20211005 RGD 150429830 SD-Tspoem2Vpl strain MP:0002665 decreased circulating corticosterone level induces IMP XCO:0000143,XCO:0000228 N RGD:150429771|PMID:29074640 20211005 RGD 150429830 SD-Tspoem2Vpl strain MP:0002780 decreased circulating testosterone level IMP N RGD:150429771|PMID:29074640 20211005 RGD 150429831 Tspoem1Vpl translocator protein; ZFN induced mutant1, Vpl gene MP:0001739 abnormal adrenal gland secretion induces IMP XCO:0000143,XCO:0000228 N RGD:150429771|PMID:29074640 20211007 RGD 150429831 Tspoem1Vpl translocator protein; ZFN induced mutant1, Vpl gene MP:0002665 decreased circulating corticosterone level induces IMP XCO:0000143,XCO:0000228 N RGD:150429771|PMID:29074640 20211007 RGD 150429831 Tspoem1Vpl translocator protein; ZFN induced mutant1, Vpl gene MP:0002780 decreased circulating testosterone level IMP N RGD:150429771|PMID:29074640 20211007 RGD 150429832 Tspoem2Vpl translocator protein; ZFN induced mutant2, Vpl gene MP:0001739 abnormal adrenal gland secretion induces IMP XCO:0000143,XCO:0000228 N RGD:150429771|PMID:29074640 20211007 RGD 150429832 Tspoem2Vpl translocator protein; ZFN induced mutant2, Vpl gene MP:0002665 decreased circulating corticosterone level induces IMP XCO:0000143,XCO:0000228 N RGD:150429771|PMID:29074640 20211007 RGD 150429832 Tspoem2Vpl translocator protein; ZFN induced mutant2, Vpl gene MP:0002780 decreased circulating testosterone level IMP N RGD:150429771|PMID:29074640 20211007 RGD 150429960 WIC-Wwoxlde/Fta strain MP:0001153 small seminiferous tubules IAGP N RGD:150429974|PMID:18676360 20211008 RGD compared to wild type and heterozygotes 150429960 WIC-Wwoxlde/Fta strain MP:0001262 decreased body weight IAGP N RGD:150429974|PMID:18676360 20211008 RGD compared to wild type and heterozygotes 150429960 WIC-Wwoxlde/Fta strain MP:0001262 decreased body weight IAGP N RGD:150429979|PMID:19500159 20211008 RGD compared to wild type and heterozygotes 150429960 WIC-Wwoxlde/Fta strain MP:0001496 audiogenic seizures IAGP N RGD:150429979|PMID:19500159 20211008 RGD compared to wild type and heterozygotes 150429960 WIC-Wwoxlde/Fta strain MP:0002083 premature death IAGP N RGD:150429974|PMID:18676360 20211008 RGD compared to wild type and heterozygotes 150429960 WIC-Wwoxlde/Fta strain MP:0002083 premature death IAGP N RGD:150429978|PMID:17803050 20211008 RGD compared to wild type and heterozygotes 150429960 WIC-Wwoxlde/Fta strain MP:0002083 premature death IAGP N RGD:150429979|PMID:19500159 20211008 RGD compared to wild type and heterozygotes 150429960 WIC-Wwoxlde/Fta strain MP:0002176 increased brain weight IAGP N RGD:150429978|PMID:17803050 20211008 RGD compared to wild type and heterozygotes 150429960 WIC-Wwoxlde/Fta strain MP:0002773 decreased circulating luteinizing hormone level IAGP N RGD:150429974|PMID:18676360 20211008 RGD compared to wild type and heterozygotes 150429960 WIC-Wwoxlde/Fta strain MP:0002780 decreased circulating testosterone level IAGP N RGD:150429974|PMID:18676360 20211008 RGD compared to wild type and heterozygotes 150429960 WIC-Wwoxlde/Fta strain MP:0002786 abnormal Leydig cell morphology IAGP N RGD:150429974|PMID:18676360 20211008 RGD compared to wild type and heterozygotes 150429960 WIC-Wwoxlde/Fta strain MP:0002786 abnormal Leydig cell morphology IAGP N RGD:150429978|PMID:17803050 20211008 RGD compared to wild type and heterozygotes 150429960 WIC-Wwoxlde/Fta strain MP:0002786 abnormal Leydig cell morphology IAGP N RGD:150429979|PMID:19500159 20211008 RGD compared to wild type and heterozygotes 150429960 WIC-Wwoxlde/Fta strain MP:0002790 decreased circulating follicle stimulating hormone level IAGP N RGD:150429974|PMID:18676360 20211008 RGD compared to wild type and heterozygotes 150429960 WIC-Wwoxlde/Fta strain MP:0004852 decreased testis weight IAGP N RGD:150429974|PMID:18676360 20211008 RGD compared to wild type and heterozygotes 150429960 WIC-Wwoxlde/Fta strain MP:0004852 decreased testis weight IAGP N RGD:150429978|PMID:17803050 20211008 RGD compared to wild type and heterozygotes 150429960 WIC-Wwoxlde/Fta strain MP:0004910 decreased seminal vesicle weight IAGP N RGD:150429974|PMID:18676360 20211008 RGD compared to wild type and heterozygotes 150429960 WIC-Wwoxlde/Fta strain MP:0004929 decreased epididymis weight IAGP N RGD:150429974|PMID:18676360 20211008 RGD compared to wild type and heterozygotes 150429960 WIC-Wwoxlde/Fta strain MP:0004962 decreased prostate gland weight IAGP N RGD:150429974|PMID:18676360 20211008 RGD compared to wild type and heterozygotes 150429960 WIC-Wwoxlde/Fta strain MP:0005250 decreased Sertoli cell number IAGP N RGD:150429974|PMID:18676360 20211008 RGD compared to wild type and heterozygotes 150429960 WIC-Wwoxlde/Fta strain MP:0008025 brain vacuoles IAGP N RGD:150429978|PMID:17803050 20211008 RGD compared to wild type and heterozygotes 150429960 WIC-Wwoxlde/Fta strain MP:0008025 brain vacuoles IAGP N RGD:150429979|PMID:19500159 20211008 RGD compared to wild type and heterozygotes 150429960 WIC-Wwoxlde/Fta strain MP:0008325 abnormal gonadotroph morphology IAGP N RGD:150429974|PMID:18676360 20211008 RGD compared to wild type and heterozygotes 150429960 WIC-Wwoxlde/Fta strain MP:0008938 decreased pituitary gland weight IAGP N RGD:150429974|PMID:18676360 20211008 RGD compared to wild type and heterozygotes 150429960 WIC-Wwoxlde/Fta strain MP:0014052 increased male germ cell apoptosis IAGP N RGD:150429974|PMID:18676360 20211008 RGD compared to wild type and heterozygotes 150429961 Wwoxlde WW domain-containing oxidoreductase; lde mutant gene MP:0001153 small seminiferous tubules IAGP N RGD:150429974|PMID:18676360 20211014 RGD compared to wild type and heterozygotes 150429961 Wwoxlde WW domain-containing oxidoreductase; lde mutant gene MP:0001262 decreased body weight IAGP N RGD:150429974|PMID:18676360 20211014 RGD compared to wild type and heterozygotes 150429961 Wwoxlde WW domain-containing oxidoreductase; lde mutant gene MP:0001262 decreased body weight IAGP N RGD:150429979|PMID:19500159 20211014 RGD compared to wild type and heterozygotes 150429961 Wwoxlde WW domain-containing oxidoreductase; lde mutant gene MP:0001496 audiogenic seizures IAGP N RGD:150429979|PMID:19500159 20211014 RGD compared to wild type and heterozygotes 150429961 Wwoxlde WW domain-containing oxidoreductase; lde mutant gene MP:0002083 premature death IAGP N RGD:150429974|PMID:18676360 20211014 RGD compared to wild type and heterozygotes 150429961 Wwoxlde WW domain-containing oxidoreductase; lde mutant gene MP:0002083 premature death IAGP N RGD:150429978|PMID:17803050 20211014 RGD compared to wild type and heterozygotes 150429961 Wwoxlde WW domain-containing oxidoreductase; lde mutant gene MP:0002083 premature death IAGP N RGD:150429979|PMID:19500159 20211014 RGD compared to wild type and heterozygotes 150429961 Wwoxlde WW domain-containing oxidoreductase; lde mutant gene MP:0002176 increased brain weight IAGP N RGD:150429978|PMID:17803050 20211014 RGD compared to wild type and heterozygotes 150429961 Wwoxlde WW domain-containing oxidoreductase; lde mutant gene MP:0002773 decreased circulating luteinizing hormone level IAGP N RGD:150429974|PMID:18676360 20211014 RGD compared to wild type and heterozygotes 150429961 Wwoxlde WW domain-containing oxidoreductase; lde mutant gene MP:0002780 decreased circulating testosterone level IAGP N RGD:150429974|PMID:18676360 20211014 RGD compared to wild type and heterozygotes 150429961 Wwoxlde WW domain-containing oxidoreductase; lde mutant gene MP:0002786 abnormal Leydig cell morphology IAGP N RGD:150429974|PMID:18676360 20211014 RGD compared to wild type and heterozygotes 150429961 Wwoxlde WW domain-containing oxidoreductase; lde mutant gene MP:0002786 abnormal Leydig cell morphology IAGP N RGD:150429978|PMID:17803050 20211014 RGD compared to wild type and heterozygotes 150429961 Wwoxlde WW domain-containing oxidoreductase; lde mutant gene MP:0002786 abnormal Leydig cell morphology IAGP N RGD:150429979|PMID:19500159 20211014 RGD compared to wild type and heterozygotes 150429961 Wwoxlde WW domain-containing oxidoreductase; lde mutant gene MP:0002790 decreased circulating follicle stimulating hormone level IAGP N RGD:150429974|PMID:18676360 20211014 RGD compared to wild type and heterozygotes 150429961 Wwoxlde WW domain-containing oxidoreductase; lde mutant gene MP:0004852 decreased testis weight IAGP N RGD:150429974|PMID:18676360 20211014 RGD compared to wild type and heterozygotes 150429961 Wwoxlde WW domain-containing oxidoreductase; lde mutant gene MP:0004852 decreased testis weight IAGP N RGD:150429978|PMID:17803050 20211014 RGD compared to wild type and heterozygotes 150429961 Wwoxlde WW domain-containing oxidoreductase; lde mutant gene MP:0004910 decreased seminal vesicle weight IAGP N RGD:150429974|PMID:18676360 20211014 RGD compared to wild type and heterozygotes 150429961 Wwoxlde WW domain-containing oxidoreductase; lde mutant gene MP:0004929 decreased epididymis weight IAGP N RGD:150429974|PMID:18676360 20211014 RGD compared to wild type and heterozygotes 150429961 Wwoxlde WW domain-containing oxidoreductase; lde mutant gene MP:0004962 decreased prostate gland weight IAGP N RGD:150429974|PMID:18676360 20211014 RGD compared to wild type and heterozygotes 150429961 Wwoxlde WW domain-containing oxidoreductase; lde mutant gene MP:0005250 decreased Sertoli cell number IAGP N RGD:150429974|PMID:18676360 20211014 RGD compared to wild type and heterozygotes 150429961 Wwoxlde WW domain-containing oxidoreductase; lde mutant gene MP:0008025 brain vacuoles IAGP N RGD:150429978|PMID:17803050 20211014 RGD compared to wild type and heterozygotes 150429961 Wwoxlde WW domain-containing oxidoreductase; lde mutant gene MP:0008025 brain vacuoles IAGP N RGD:150429979|PMID:19500159 20211014 RGD compared to wild type and heterozygotes 150429961 Wwoxlde WW domain-containing oxidoreductase; lde mutant gene MP:0008325 abnormal gonadotroph morphology IAGP N RGD:150429974|PMID:18676360 20211014 RGD compared to wild type and heterozygotes 150429961 Wwoxlde WW domain-containing oxidoreductase; lde mutant gene MP:0008938 decreased pituitary gland weight IAGP N RGD:150429974|PMID:18676360 20211014 RGD compared to wild type and heterozygotes 150429961 Wwoxlde WW domain-containing oxidoreductase; lde mutant gene MP:0014052 increased male germ cell apoptosis IAGP N RGD:150429974|PMID:18676360 20211014 RGD compared to wild type and heterozygotes 150429963 WI-Pmchm1Hubr strain MP:0001783 decreased white adipose tissue amount IMP N RGD:150429945|PMID:19934402 20211014 RGD 150429963 WI-Pmchm1Hubr strain MP:0003402 decreased liver weight IMP N RGD:150429945|PMID:19934402 20211014 RGD 150429963 WI-Pmchm1Hubr strain MP:0003961 decreased lean body mass IMP N RGD:150429945|PMID:19934402 20211014 RGD 150429963 WI-Pmchm1Hubr strain MP:0004890 decreased energy expenditure IMP N RGD:150429945|PMID:19934402 20211014 RGD 150429963 WI-Pmchm1Hubr strain MP:0004956 decreased thymus weight induces IMP XCO:0000030 N RGD:150429945|PMID:19934402 20211014 RGD 150429963 WI-Pmchm1Hubr strain MP:0005668 decreased circulating leptin level IMP N RGD:150429944|PMID:23555928 20211011 RGD compared to wild-type 150429963 WI-Pmchm1Hubr strain MP:0005668 decreased circulating leptin level IMP N RGD:150429945|PMID:19934402 20211014 RGD 150429963 WI-Pmchm1Hubr strain MP:0009133 decreased white fat cell size IMP N RGD:150429944|PMID:23555928 20220511 RGD 150429963 WI-Pmchm1Hubr strain MP:0011940 decreased food intake IMP N RGD:150429945|PMID:19934402 20211014 RGD 150429963 WI-Pmchm1Hubr strain MP:0012311 decreased defecation amount IMP N RGD:150429945|PMID:19934402 20211014 RGD 150429963 WI-Pmchm1Hubr strain MP:0014143 decreased body fat mass IMP N RGD:150429944|PMID:23555928 20211011 RGD compared to wild-type 150429963 WI-Pmchm1Hubr strain MP:0014143 decreased body fat mass IMP N RGD:150429945|PMID:19934402 20211014 RGD 150429963 WI-Pmchm1Hubr strain MP:0014146 decreased white adipose tissue mass IMP N RGD:150429944|PMID:23555928 20211011 RGD compared to wild-type 150429963 WI-Pmchm1Hubr strain MP:0014169 decreased brown adipose tissue mass IMP N RGD:150429944|PMID:23555928 20211011 RGD compared to wild-type 150429963 WI-Pmchm1Hubr strain MP:0021022 decreased adipose tissue noradrenaline turnover IMP N RGD:150429944|PMID:23555928 20220511 RGD 150429964 Pmchm1Hubr pro-melanin-concentrating hormone; ENU induced mutant1, Hubr gene MP:0001783 decreased white adipose tissue amount IMP N RGD:150429945|PMID:19934402 20211021 RGD 150429964 Pmchm1Hubr pro-melanin-concentrating hormone; ENU induced mutant1, Hubr gene MP:0003402 decreased liver weight IMP N RGD:150429945|PMID:19934402 20211021 RGD 150429964 Pmchm1Hubr pro-melanin-concentrating hormone; ENU induced mutant1, Hubr gene MP:0003961 decreased lean body mass IMP N RGD:150429945|PMID:19934402 20211021 RGD 150429964 Pmchm1Hubr pro-melanin-concentrating hormone; ENU induced mutant1, Hubr gene MP:0004890 decreased energy expenditure IMP N RGD:150429945|PMID:19934402 20211021 RGD 150429964 Pmchm1Hubr pro-melanin-concentrating hormone; ENU induced mutant1, Hubr gene MP:0004956 decreased thymus weight induces IMP XCO:0000030 N RGD:150429945|PMID:19934402 20211021 RGD 150429964 Pmchm1Hubr pro-melanin-concentrating hormone; ENU induced mutant1, Hubr gene MP:0005668 decreased circulating leptin level IMP N RGD:150429944|PMID:23555928 20211014 RGD compared to wild-type 150429964 Pmchm1Hubr pro-melanin-concentrating hormone; ENU induced mutant1, Hubr gene MP:0005668 decreased circulating leptin level IMP N RGD:150429945|PMID:19934402 20211021 RGD 150429964 Pmchm1Hubr pro-melanin-concentrating hormone; ENU induced mutant1, Hubr gene MP:0009133 decreased white fat cell size IMP N RGD:150429944|PMID:23555928 20220512 RGD 150429964 Pmchm1Hubr pro-melanin-concentrating hormone; ENU induced mutant1, Hubr gene MP:0011940 decreased food intake IMP N RGD:150429945|PMID:19934402 20211021 RGD 150429964 Pmchm1Hubr pro-melanin-concentrating hormone; ENU induced mutant1, Hubr gene MP:0012311 decreased defecation amount IMP N RGD:150429945|PMID:19934402 20211021 RGD 150429964 Pmchm1Hubr pro-melanin-concentrating hormone; ENU induced mutant1, Hubr gene MP:0014143 decreased body fat mass IMP N RGD:150429944|PMID:23555928 20211014 RGD compared to wild-type 150429964 Pmchm1Hubr pro-melanin-concentrating hormone; ENU induced mutant1, Hubr gene MP:0014143 decreased body fat mass IMP N RGD:150429945|PMID:19934402 20211021 RGD 150429964 Pmchm1Hubr pro-melanin-concentrating hormone; ENU induced mutant1, Hubr gene MP:0014146 decreased white adipose tissue mass IMP N RGD:150429944|PMID:23555928 20211014 RGD compared to wild-type 150429964 Pmchm1Hubr pro-melanin-concentrating hormone; ENU induced mutant1, Hubr gene MP:0014169 decreased brown adipose tissue mass IMP N RGD:150429944|PMID:23555928 20211014 RGD compared to wild-type 150429964 Pmchm1Hubr pro-melanin-concentrating hormone; ENU induced mutant1, Hubr gene MP:0021022 decreased adipose tissue noradrenaline turnover IMP N RGD:150429944|PMID:23555928 20220512 RGD 150429965 SD-Apoa4em1Bcgen strain MP:0002628 hepatic steatosis induces IMP XCO:0000102 N RGD:150429948|PMID:31303888 20211012 RGD compared to wild type 150429965 SD-Apoa4em1Bcgen strain MP:0005560 decreased circulating glucose level induces IMP XCO:0000275,XCO:0000102 N RGD:150429948|PMID:31303888 20211012 RGD compared to wild type 150429966 Apoa4em1Bcgen apolipoprotein A4; TALEN induced mutant 1, Bcgn gene MP:0002628 hepatic steatosis induces IMP XCO:0000102 N RGD:150429948|PMID:31303888 20211014 RGD compared to wild type 150429966 Apoa4em1Bcgen apolipoprotein A4; TALEN induced mutant 1, Bcgn gene MP:0005560 decreased circulating glucose level induces IMP XCO:0000275,XCO:0000102 N RGD:150429948|PMID:31303888 20211014 RGD compared to wild type 150429988 SHR-Tg(EEF1A1-Wars2)Ipcv strain MP:0001262 decreased body weight IMP N RGD:150429949|PMID:29261326 20211013 RGD 150429988 SHR-Tg(EEF1A1-Wars2)Ipcv strain MP:0009289 decreased epididymal fat pad weight IMP N RGD:150429949|PMID:29261326 20211013 RGD 150519901 F344-Prkar1bem2Tua strain MP:0001473 reduced long-term potentiation IMP N RGD:150519900|PMID:33479380 20211018 RGD 150519901 F344-Prkar1bem2Tua strain MP:0001973 increased thermal nociceptive threshold IMP N RGD:150519900|PMID:33479380 20211018 RGD 150519901 F344-Prkar1bem2Tua strain MP:0002574 increased vertical activity IMP N RGD:150519900|PMID:33479380 20211018 RGD 150519901 F344-Prkar1bem2Tua strain MP:0002912 abnormal excitatory postsynaptic potential IMP N RGD:150519900|PMID:33479380 20211018 RGD 150519901 F344-Prkar1bem2Tua strain MP:0020422 decreased freezing behavior IMP N RGD:150519900|PMID:33479380 20211018 RGD 150519903 Prkar1bem2Tua protein kinase cAMP-dependent type I regulatory subunit beta; CRISPR/Cas9 induced mutant 2, Tua gene MP:0001473 reduced long-term potentiation IMP N RGD:150519900|PMID:33479380 20211021 RGD 150519903 Prkar1bem2Tua protein kinase cAMP-dependent type I regulatory subunit beta; CRISPR/Cas9 induced mutant 2, Tua gene MP:0001973 increased thermal nociceptive threshold IMP N RGD:150519900|PMID:33479380 20211021 RGD 150519903 Prkar1bem2Tua protein kinase cAMP-dependent type I regulatory subunit beta; CRISPR/Cas9 induced mutant 2, Tua gene MP:0002574 increased vertical activity IMP N RGD:150519900|PMID:33479380 20211021 RGD 150519903 Prkar1bem2Tua protein kinase cAMP-dependent type I regulatory subunit beta; CRISPR/Cas9 induced mutant 2, Tua gene MP:0002912 abnormal excitatory postsynaptic potential IMP N RGD:150519900|PMID:33479380 20211021 RGD 150519903 Prkar1bem2Tua protein kinase cAMP-dependent type I regulatory subunit beta; CRISPR/Cas9 induced mutant 2, Tua gene MP:0020422 decreased freezing behavior IMP N RGD:150519900|PMID:33479380 20211021 RGD 150520049 WBN-Ht/Kob strain MP:0000324 increased mast cell number IAGP N RGD:150520053|PMID:16858425 20211025 RGD compared to wild type 150520049 WBN-Ht/Kob strain MP:0001242 hyperkeratosis IAGP N RGD:150520054|PMID:10889953 20211025 RGD compared to wild type 150520049 WBN-Ht/Kob strain MP:0002083 premature death IAGP N RGD:150520054|PMID:10889953 20211025 RGD compared to wild type 150520189 SD-Apoeem1Ejt strain MP:0000272 abnormal aorta morphology IMP N RGD:150520219|PMID:29166645 20211108 RGD 150520189 SD-Apoeem1Ejt strain MP:0002842 increased systemic arterial blood pressure IMP N RGD:150520219|PMID:29166645 20211108 RGD 150520190 Apoeem1Ejt apolipoprotein E; TALEN induced mutant 1, Ejt gene MP:0000272 abnormal aorta morphology IMP N RGD:150520219|PMID:29166645 20211111 RGD 150520190 Apoeem1Ejt apolipoprotein E; TALEN induced mutant 1, Ejt gene MP:0002842 increased systemic arterial blood pressure IMP N RGD:150520219|PMID:29166645 20211111 RGD 150520204 SHR/OlaIpcv-mtLEW/Ipcv strain MP:0001554 increased circulating free fatty acids level IAGP N RGD:150429987|PMID:22414913 20211108 RGD 150520204 SHR/OlaIpcv-mtLEW/Ipcv strain MP:0001554 increased circulating free fatty acids level induces IAGP XCO:0000244,XCO:0000275,XCO:0000102 N RGD:150429987|PMID:22414913 20211108 RGD 150520204 SHR/OlaIpcv-mtLEW/Ipcv strain MP:0002078 abnormal glucose homeostasis induces IAGP XCO:0000245,XCO:0000244 N RGD:150429987|PMID:22414913 20211108 RGD 150520205 SHR-Gja8m1+/-Cub strain MP:0000183 decreased circulating LDL cholesterol level IAGP N RGD:150429989|PMID:27871290 20211109 RGD 150520205 SHR-Gja8m1+/-Cub strain MP:0000186 decreased circulating HDL cholesterol level IAGP N RGD:150429989|PMID:27871290 20211109 RGD 150520205 SHR-Gja8m1+/-Cub strain MP:0001552 increased circulating triglyceride level IAGP N RGD:150429989|PMID:27871290 20211109 RGD 150520205 SHR-Gja8m1+/-Cub strain MP:0002079 increased circulating insulin level IAGP N RGD:150429989|PMID:27871290 20211109 RGD 150520205 SHR-Gja8m1+/-Cub strain MP:0008553 increased circulating tumor necrosis factor level IAGP N RGD:150429989|PMID:27871290 20211108 RGD 150520205 SHR-Gja8m1+/-Cub strain MP:0008614 increased circulating interleukin-17 level IAGP N RGD:150429989|PMID:27871290 20211108 RGD 150520205 SHR-Gja8m1+/-Cub strain MP:0008663 increased interleukin-12 secretion IAGP N RGD:150429989|PMID:27871290 20211108 RGD 150520205 SHR-Gja8m1+/-Cub strain MP:0008684 increased interleukin-18 secretion IAGP N RGD:150429989|PMID:27871290 20211108 RGD 150520205 SHR-Gja8m1+/-Cub strain MP:0008705 increased interleukin-6 secretion IAGP N RGD:150429989|PMID:27871290 20211108 RGD 150520205 SHR-Gja8m1+/-Cub strain MP:0009288 increased epididymal fat pad weight IAGP N RGD:150429989|PMID:27871290 20211109 RGD 150520205 SHR-Gja8m1+/-Cub strain MP:0009699 hyperchylomicronemia IAGP N RGD:150429989|PMID:27871290 20211109 RGD 150520205 SHR-Gja8m1+/-Cub strain MP:0011603 decreased glutathione peroxidase activity IAGP N RGD:150429989|PMID:27871290 20211108 RGD 150520205 SHR-Gja8m1+/-Cub strain MP:0012604 decreased glutathione level IAGP N RGD:150429989|PMID:27871290 20211108 RGD 150520205 SHR-Gja8m1+/-Cub strain MP:0012629 decreased glutathione reductase level IAGP N RGD:150429989|PMID:27871290 20211108 RGD 150520205 SHR-Gja8m1+/-Cub strain MP:0012655 increased catalase level IAGP N RGD:150429989|PMID:27871290 20211108 RGD 150520205 SHR-Gja8m1+/-Cub strain MP:0012659 decreased superoxide dismutase level IAGP N RGD:150429989|PMID:27871290 20211108 RGD 150520205 SHR-Gja8m1+/-Cub strain MP:0013278 decreased fasting circulating glucose level induces IAGP XCO:0000275,XCO:0000444 N RGD:150429989|PMID:27871290 20211109 RGD 150520205 SHR-Gja8m1+/-Cub strain MP:0031251 increased circulating CCL3 level IAGP N RGD:150429989|PMID:27871290 20211108 RGD 150520220 SD-Ccdc39em1Jgn strain MP:0000219 increased neutrophil cell number IMP N RGD:150521527|PMID:31771992 20211109 RGD 150520220 SD-Ccdc39em1Jgn strain MP:0000825 dilated lateral ventricle IMP N RGD:150521527|PMID:31771992 20211109 RGD 150520220 SD-Ccdc39em1Jgn strain MP:0001732 postnatal growth retardation IMP N RGD:150521527|PMID:31771992 20211109 RGD 150520220 SD-Ccdc39em1Jgn strain MP:0001891 hydrocephaly IMP N RGD:150521527|PMID:31771992 20211109 RGD 150520220 SD-Ccdc39em1Jgn strain MP:0001915 intracranial hemorrhage IMP N RGD:150521527|PMID:31771992 20211109 RGD 150520220 SD-Ccdc39em1Jgn strain MP:0002083 premature death IMP N RGD:150521527|PMID:31771992 20211109 RGD 150520220 SD-Ccdc39em1Jgn strain MP:0005425 increased macrophage cell number IMP N RGD:150521527|PMID:31771992 20211109 RGD 150520220 SD-Ccdc39em1Jgn strain MP:0006042 increased apoptosis IMP N RGD:150521527|PMID:31771992 20211109 RGD 150520220 SD-Ccdc39em1Jgn strain MP:0013438 dysmyelination IMP N RGD:150521527|PMID:31771992 20211109 RGD 150520220 SD-Ccdc39em1Jgn strain MP:0013907 abnormal cerebrospinal fluid flow IMP N RGD:150521527|PMID:31771992 20211109 RGD 150520220 SD-Ccdc39em1Jgn strain MP:0020371 abnormal glymphatic system physiology IMP N RGD:150521527|PMID:31771992 20211109 RGD 150520220 SD-Ccdc39em1Jgn strain MP:0031109 subarachnoid hemorrhage IMP N RGD:150521527|PMID:31771992 20211109 RGD 150520221 SD-Slco1b2em1Myliu strain MP:0008875 abnormal xenobiotic pharmacokinetics IMP N RGD:150521535|PMID:32528832 20211109 RGD 150521524 Slco1b2em1Myliu solute carrier organic anion transporter family member 1B2; CRISPR/Case9 induced mutant 1, Myliu gene MP:0008875 abnormal xenobiotic pharmacokinetics IMP N RGD:150521535|PMID:32528832 20211111 RGD 150521525 Ccdc39em1Jgn coiled-coil domain containing 39; CRISPR/Cas9 induced mutant 1, Jgn gene MP:0000219 increased neutrophil cell number IMP N RGD:150521527|PMID:31771992 20211111 RGD 150521525 Ccdc39em1Jgn coiled-coil domain containing 39; CRISPR/Cas9 induced mutant 1, Jgn gene MP:0000825 dilated lateral ventricle IMP N RGD:150521527|PMID:31771992 20211111 RGD 150521525 Ccdc39em1Jgn coiled-coil domain containing 39; CRISPR/Cas9 induced mutant 1, Jgn gene MP:0001732 postnatal growth retardation IMP N RGD:150521527|PMID:31771992 20211111 RGD 150521525 Ccdc39em1Jgn coiled-coil domain containing 39; CRISPR/Cas9 induced mutant 1, Jgn gene MP:0001891 hydrocephaly IMP N RGD:150521527|PMID:31771992 20211111 RGD 150521525 Ccdc39em1Jgn coiled-coil domain containing 39; CRISPR/Cas9 induced mutant 1, Jgn gene MP:0001915 intracranial hemorrhage IMP N RGD:150521527|PMID:31771992 20211111 RGD 150521525 Ccdc39em1Jgn coiled-coil domain containing 39; CRISPR/Cas9 induced mutant 1, Jgn gene MP:0002083 premature death IMP N RGD:150521527|PMID:31771992 20211111 RGD 150521525 Ccdc39em1Jgn coiled-coil domain containing 39; CRISPR/Cas9 induced mutant 1, Jgn gene MP:0005425 increased macrophage cell number IMP N RGD:150521527|PMID:31771992 20211111 RGD 150521525 Ccdc39em1Jgn coiled-coil domain containing 39; CRISPR/Cas9 induced mutant 1, Jgn gene MP:0006042 increased apoptosis IMP N RGD:150521527|PMID:31771992 20211111 RGD 150521525 Ccdc39em1Jgn coiled-coil domain containing 39; CRISPR/Cas9 induced mutant 1, Jgn gene MP:0013438 dysmyelination IMP N RGD:150521527|PMID:31771992 20211111 RGD 150521525 Ccdc39em1Jgn coiled-coil domain containing 39; CRISPR/Cas9 induced mutant 1, Jgn gene MP:0013907 abnormal cerebrospinal fluid flow IMP N RGD:150521527|PMID:31771992 20211111 RGD 150521525 Ccdc39em1Jgn coiled-coil domain containing 39; CRISPR/Cas9 induced mutant 1, Jgn gene MP:0020371 abnormal glymphatic system physiology IMP N RGD:150521527|PMID:31771992 20211111 RGD 150521525 Ccdc39em1Jgn coiled-coil domain containing 39; CRISPR/Cas9 induced mutant 1, Jgn gene MP:0031109 subarachnoid hemorrhage IMP N RGD:150521527|PMID:31771992 20211111 RGD 150521538 SD-Uoxem1Cya strain MP:0005565 increased blood urea nitrogen level IMP N RGD:150521544|PMID:32368418 20211109 RGD 150521538 SD-Uoxem1Cya strain MP:0008821 increased blood uric acid level IMP N RGD:150521544|PMID:32368418 20211109 RGD 150521538 SD-Uoxem1Cya strain MP:0011405 tubulointerstitial nephritis IMP N RGD:150521544|PMID:32368418 20211109 RGD 150521540 Uoxem1Cya urate oxidase; CRISPR/Cas9 induced mutant1, Cya gene MP:0005565 increased blood urea nitrogen level IMP N RGD:150521544|PMID:32368418 20211111 RGD 150521540 Uoxem1Cya urate oxidase; CRISPR/Cas9 induced mutant1, Cya gene MP:0008821 increased blood uric acid level IMP N RGD:150521544|PMID:32368418 20211111 RGD 150521540 Uoxem1Cya urate oxidase; CRISPR/Cas9 induced mutant1, Cya gene MP:0011405 tubulointerstitial nephritis IMP N RGD:150521544|PMID:32368418 20211111 RGD 150521554 Cntrobhd centrobin, centriole duplication and spindle assembly protein; hypodacty mutant gene MP:0000565 oligodactyly IAGP N RGD:150521555|PMID:19710508 20211110 RGD DNA:insertion:intron 10 (rat) 150521556 SD-Trpm4em1Sage strain MP:0001900 impaired synaptic plasticity induces IMP XCO:0000521 N RGD:150521558|PMID:29971514 20211110 RGD 150521556 SD-Trpm4em1Sage strain MP:0008428 abnormal spatial working memory IMP N RGD:150521558|PMID:29971514 20211110 RGD 150521556 SD-Trpm4em1Sage strain MP:0008432 abnormal long-term spatial reference memory IMP N RGD:150521558|PMID:29971514 20211110 RGD 150521556 SD-Trpm4em1Sage strain MP:0012006 abnormal hippocampus physiology induces IMP XCO:0000521 N RGD:150521526|PMID:30553915 20211110 RGD 150521556 SD-Trpm4em1Sage strain MP:0012006 abnormal hippocampus physiology induces IMP XCO:0000521 N RGD:150521558|PMID:29971514 20211110 RGD 150521559 LEW.SD-CD8am1Trg strain MP:0004800 decreased susceptibility to experimental autoimmune encephalomyelitis induces IMP XCO:0000266,XCO:0000195 N RGD:38508908|PMID:23664330 20211111 RGD compared to Wildtype 150521599 SD-Tshrem1Mlit strain MP:0001924 infertility IMP N RGD:150521601|PMID:29507327 20211111 RGD 150521599 SD-Tshrem1Mlit strain MP:0003499 thyroid gland hypoplasia IMP N RGD:150521601|PMID:29507327 20211111 RGD 150521599 SD-Tshrem1Mlit strain MP:0005122 increased circulating thyroid-stimulating hormone level IMP N RGD:150521601|PMID:29507327 20211111 RGD 150521599 SD-Tshrem1Mlit strain MP:0005478 decreased circulating thyroxine level IMP N RGD:150521601|PMID:29507327 20211111 RGD 150521599 SD-Tshrem1Mlit strain MP:0005479 decreased circulating triiodothyronine level IMP N RGD:150521601|PMID:29507327 20211111 RGD 150521600 Tshrem1Mlit thyroid stimulating hormone receptor; CRISPR/Cas9 induced mutant 1, Mlit gene MP:0001924 infertility IMP N RGD:150521601|PMID:29507327 20211118 RGD 150521600 Tshrem1Mlit thyroid stimulating hormone receptor; CRISPR/Cas9 induced mutant 1, Mlit gene MP:0003499 thyroid gland hypoplasia IMP N RGD:150521601|PMID:29507327 20211118 RGD 150521600 Tshrem1Mlit thyroid stimulating hormone receptor; CRISPR/Cas9 induced mutant 1, Mlit gene MP:0005122 increased circulating thyroid-stimulating hormone level IMP N RGD:150521601|PMID:29507327 20211118 RGD 150521600 Tshrem1Mlit thyroid stimulating hormone receptor; CRISPR/Cas9 induced mutant 1, Mlit gene MP:0005478 decreased circulating thyroxine level IMP N RGD:150521601|PMID:29507327 20211118 RGD 150521600 Tshrem1Mlit thyroid stimulating hormone receptor; CRISPR/Cas9 induced mutant 1, Mlit gene MP:0005479 decreased circulating triiodothyronine level IMP N RGD:150521601|PMID:29507327 20211118 RGD 150521602 OFA(SD)-Dsg4hr/Crl strain MP:0000414 alopecia IMP N RGD:150521560|PMID:15606503 20211111 RGD 150521603 Dsg4hr desmoglein 4; hairless mutant gene MP:0000414 alopecia IMP N RGD:150521560|PMID:15606503 20211118 RGD 150521708 SD-Tbc1d1Tn(sb)1Fkh strain MP:0002327 abnormal respiratory function induces IMP XCO:0000392 N RGD:150521563|PMID:28808062 20211124 RGD 150521708 SD-Tbc1d1Tn(sb)1Fkh strain MP:0002727 decreased circulating insulin level induces IMP XCO:0000275,XCO:0000102,XCO:0000025 N RGD:150521607|PMID:28177704 20211123 RGD compared to Wild type 150521708 SD-Tbc1d1Tn(sb)1Fkh strain MP:0003059 decreased insulin secretion induces IMP XCO:0000669,XCO:0000275,XCO:0000312 N RGD:150521607|PMID:28177704 20211123 RGD compared to Wild type 150521708 SD-Tbc1d1Tn(sb)1Fkh strain MP:0003646 increased muscle fatigability induces IMP XCO:0000005 N RGD:150521563|PMID:28808062 20211124 RGD 150521708 SD-Tbc1d1Tn(sb)1Fkh strain MP:0005289 increased oxygen consumption induces IMP XCO:0000392 N RGD:150521563|PMID:28808062 20211124 RGD 150521708 SD-Tbc1d1Tn(sb)1Fkh strain MP:0005559 increased circulating glucose level induces IMP XCO:0000275 N RGD:150521563|PMID:28808062 20211124 RGD compared to Wild type 150521708 SD-Tbc1d1Tn(sb)1Fkh strain MP:0006042 increased apoptosis IMP N RGD:150521607|PMID:28177704 20211123 RGD 150521708 SD-Tbc1d1Tn(sb)1Fkh strain MP:0009114 decreased pancreatic beta cell mass induces IMP XCO:0000025 N RGD:150521607|PMID:28177704 20211123 RGD compared to Wild type 150521708 SD-Tbc1d1Tn(sb)1Fkh strain MP:0010061 increased creatine level induces IMP XCO:0000521 N RGD:150521563|PMID:28808062 20211124 RGD 150521708 SD-Tbc1d1Tn(sb)1Fkh strain MP:0010147 abnormal endocrine pancreas physiology induces IMP XCO:0000025 N RGD:150521607|PMID:28177704 20211123 RGD compared to Wild type 150521708 SD-Tbc1d1Tn(sb)1Fkh strain MP:0010401 increased skeletal muscle glycogen level induces IMP XCO:0000521 N RGD:150521563|PMID:28808062 20211124 RGD 150521708 SD-Tbc1d1Tn(sb)1Fkh strain MP:0013243 abnormal carbohydrate metabolism induces IMP XCO:0000181 N RGD:150521563|PMID:28808062 20211124 RGD 150521708 SD-Tbc1d1Tn(sb)1Fkh strain MP:0013278 decreased fasting circulating glucose level induces IMP XCO:0000245,XCO:0000025 N RGD:150521607|PMID:28177704 20211123 RGD compared to Wild type and heterozygous 150521708 SD-Tbc1d1Tn(sb)1Fkh strain MP:0013279 increased fasting circulating glucose level induces IMP XCO:0000275,XCO:0000025 N RGD:150521607|PMID:28177704 20211123 RGD compared to Wild type 150521708 SD-Tbc1d1Tn(sb)1Fkh strain MP:0014171 increased fatty acid oxidation induces IMP XCO:0000181 N RGD:150521563|PMID:28808062 20211124 RGD 150521708 SD-Tbc1d1Tn(sb)1Fkh strain MP:0030022 decreased muscle cell glucose uptake induces IMP XCO:0000521 N RGD:150521563|PMID:28808062 20211124 RGD compared to Wild type 150521709 Tbc1d1Tn(sb)1Fkh TBC1 domain family member 1; Sleeping Beauty induced mutant 1, Fkh gene MP:0002327 abnormal respiratory function induces IMP XCO:0000392 N RGD:150521563|PMID:28808062 20211125 RGD 150521709 Tbc1d1Tn(sb)1Fkh TBC1 domain family member 1; Sleeping Beauty induced mutant 1, Fkh gene MP:0002727 decreased circulating insulin level induces IMP XCO:0000275,XCO:0000102,XCO:0000025 N RGD:150521607|PMID:28177704 20211125 RGD compared to Wild type 150521709 Tbc1d1Tn(sb)1Fkh TBC1 domain family member 1; Sleeping Beauty induced mutant 1, Fkh gene MP:0003059 decreased insulin secretion induces IMP XCO:0000669,XCO:0000275,XCO:0000312 N RGD:150521607|PMID:28177704 20211125 RGD compared to Wild type 150521709 Tbc1d1Tn(sb)1Fkh TBC1 domain family member 1; Sleeping Beauty induced mutant 1, Fkh gene MP:0003646 increased muscle fatigability induces IMP XCO:0000005 N RGD:150521563|PMID:28808062 20211125 RGD 150521709 Tbc1d1Tn(sb)1Fkh TBC1 domain family member 1; Sleeping Beauty induced mutant 1, Fkh gene MP:0005289 increased oxygen consumption induces IMP XCO:0000392 N RGD:150521563|PMID:28808062 20211125 RGD 150521709 Tbc1d1Tn(sb)1Fkh TBC1 domain family member 1; Sleeping Beauty induced mutant 1, Fkh gene MP:0005559 increased circulating glucose level induces IMP XCO:0000275 N RGD:150521563|PMID:28808062 20211125 RGD compared to Wild type 150521709 Tbc1d1Tn(sb)1Fkh TBC1 domain family member 1; Sleeping Beauty induced mutant 1, Fkh gene MP:0006042 increased apoptosis IMP N RGD:150521607|PMID:28177704 20211125 RGD 150521709 Tbc1d1Tn(sb)1Fkh TBC1 domain family member 1; Sleeping Beauty induced mutant 1, Fkh gene MP:0009114 decreased pancreatic beta cell mass induces IMP XCO:0000025 N RGD:150521607|PMID:28177704 20211125 RGD compared to Wild type 150521709 Tbc1d1Tn(sb)1Fkh TBC1 domain family member 1; Sleeping Beauty induced mutant 1, Fkh gene MP:0010061 increased creatine level induces IMP XCO:0000521 N RGD:150521563|PMID:28808062 20211125 RGD 150521709 Tbc1d1Tn(sb)1Fkh TBC1 domain family member 1; Sleeping Beauty induced mutant 1, Fkh gene MP:0010147 abnormal endocrine pancreas physiology induces IMP XCO:0000025 N RGD:150521607|PMID:28177704 20211125 RGD compared to Wild type 150521709 Tbc1d1Tn(sb)1Fkh TBC1 domain family member 1; Sleeping Beauty induced mutant 1, Fkh gene MP:0010401 increased skeletal muscle glycogen level induces IMP XCO:0000521 N RGD:150521563|PMID:28808062 20211125 RGD 150521709 Tbc1d1Tn(sb)1Fkh TBC1 domain family member 1; Sleeping Beauty induced mutant 1, Fkh gene MP:0013243 abnormal carbohydrate metabolism induces IMP XCO:0000181 N RGD:150521563|PMID:28808062 20211125 RGD 150521709 Tbc1d1Tn(sb)1Fkh TBC1 domain family member 1; Sleeping Beauty induced mutant 1, Fkh gene MP:0013278 decreased fasting circulating glucose level induces IMP XCO:0000245,XCO:0000025 N RGD:150521607|PMID:28177704 20211125 RGD compared to Wild type and heterozygous 150521709 Tbc1d1Tn(sb)1Fkh TBC1 domain family member 1; Sleeping Beauty induced mutant 1, Fkh gene MP:0013279 increased fasting circulating glucose level induces IMP XCO:0000275,XCO:0000025 N RGD:150521607|PMID:28177704 20211125 RGD compared to Wild type 150521709 Tbc1d1Tn(sb)1Fkh TBC1 domain family member 1; Sleeping Beauty induced mutant 1, Fkh gene MP:0014171 increased fatty acid oxidation induces IMP XCO:0000181 N RGD:150521563|PMID:28808062 20211125 RGD 150521709 Tbc1d1Tn(sb)1Fkh TBC1 domain family member 1; Sleeping Beauty induced mutant 1, Fkh gene MP:0030022 decreased muscle cell glucose uptake induces IMP XCO:0000521 N RGD:150521563|PMID:28808062 20211125 RGD compared to Wild type 150523755 SD-Ighmem1Ang strain MP:0001805 decreased IgG level IMP N RGD:150523760|PMID:21038471 20211118 RGD 150523755 SD-Ighmem1Ang strain MP:0001806 decreased IgM level IMP N RGD:150523760|PMID:21038471 20211118 RGD 150523755 SD-Ighmem1Ang strain MP:0001807 decreased IgA level IMP N RGD:150523760|PMID:21038471 20211118 RGD 150523755 SD-Ighmem1Ang strain MP:0002492 decreased IgE level IMP N RGD:150523760|PMID:21038471 20211118 RGD 150523755 SD-Ighmem1Ang strain MP:0004751 increased length of allograft survival IMP N RGD:150523760|PMID:21038471 20211118 RGD 150523755 SD-Ighmem1Ang strain MP:0005017 decreased B cell number IMP N RGD:150523760|PMID:21038471 20211118 RGD 150523756 Ighmem1Ang immunoglobulin heavy constant mu; ZFN induced mutant1, Ang gene MP:0001805 decreased IgG level IMP N RGD:150523760|PMID:21038471 20211125 RGD 150523756 Ighmem1Ang immunoglobulin heavy constant mu; ZFN induced mutant1, Ang gene MP:0001806 decreased IgM level IMP N RGD:150523760|PMID:21038471 20211125 RGD 150523756 Ighmem1Ang immunoglobulin heavy constant mu; ZFN induced mutant1, Ang gene MP:0001807 decreased IgA level IMP N RGD:150523760|PMID:21038471 20211125 RGD 150523756 Ighmem1Ang immunoglobulin heavy constant mu; ZFN induced mutant1, Ang gene MP:0002492 decreased IgE level IMP N RGD:150523760|PMID:21038471 20211125 RGD 150523756 Ighmem1Ang immunoglobulin heavy constant mu; ZFN induced mutant1, Ang gene MP:0004751 increased length of allograft survival IMP N RGD:150523760|PMID:21038471 20211125 RGD 150523756 Ighmem1Ang immunoglobulin heavy constant mu; ZFN induced mutant1, Ang gene MP:0005017 decreased B cell number IMP N RGD:150523760|PMID:21038471 20211125 RGD 150523757 SD-Ighmem2Ang strain MP:0001805 decreased IgG level IMP N RGD:150523760|PMID:21038471 20211118 RGD 150523757 SD-Ighmem2Ang strain MP:0001806 decreased IgM level IMP N RGD:150523760|PMID:21038471 20211118 RGD 150523757 SD-Ighmem2Ang strain MP:0001807 decreased IgA level IMP N RGD:150523760|PMID:21038471 20211118 RGD 150523757 SD-Ighmem2Ang strain MP:0002492 decreased IgE level IMP N RGD:150523760|PMID:21038471 20211118 RGD 150523757 SD-Ighmem2Ang strain MP:0004751 increased length of allograft survival IMP N RGD:150523760|PMID:21038471 20211118 RGD 150523757 SD-Ighmem2Ang strain MP:0005017 decreased B cell number IMP N RGD:150523760|PMID:21038471 20211118 RGD 150523758 Ighmem2Ang immunoglobulin heavy constant mu; ZFN induced mutant2, Ang gene MP:0001805 decreased IgG level IMP N RGD:150523760|PMID:21038471 20211125 RGD 150523758 Ighmem2Ang immunoglobulin heavy constant mu; ZFN induced mutant2, Ang gene MP:0001806 decreased IgM level IMP N RGD:150523760|PMID:21038471 20211125 RGD 150523758 Ighmem2Ang immunoglobulin heavy constant mu; ZFN induced mutant2, Ang gene MP:0001807 decreased IgA level IMP N RGD:150523760|PMID:21038471 20211125 RGD 150523758 Ighmem2Ang immunoglobulin heavy constant mu; ZFN induced mutant2, Ang gene MP:0002492 decreased IgE level IMP N RGD:150523760|PMID:21038471 20211125 RGD 150523758 Ighmem2Ang immunoglobulin heavy constant mu; ZFN induced mutant2, Ang gene MP:0004751 increased length of allograft survival IMP N RGD:150523760|PMID:21038471 20211125 RGD 150523758 Ighmem2Ang immunoglobulin heavy constant mu; ZFN induced mutant2, Ang gene MP:0005017 decreased B cell number IMP N RGD:150523760|PMID:21038471 20211125 RGD 150573816 SD-Nkx3-1em1Pjhak+/- strain MP:0001167 prostate gland epithelial hyperplasia IMP N RGD:150573817|PMID:33368416 20220217 RGD compared to wild type 150573818 SD-Nkx3-1em1Pjhak-/- strain MP:0001167 prostate gland epithelial hyperplasia IMP N RGD:150573817|PMID:33368416 20220217 RGD compared to wild type 150573818 SD-Nkx3-1em1Pjhak-/- strain MP:0001922 reduced male fertility IMP N RGD:150573817|PMID:33368416 20220217 RGD compared to wild type 150573818 SD-Nkx3-1em1Pjhak-/- strain MP:0001935 decreased litter size IMP N RGD:150573817|PMID:33368416 20220217 RGD compared to wild type 150573818 SD-Nkx3-1em1Pjhak-/- strain MP:0004962 decreased prostate gland weight IMP N RGD:150573817|PMID:33368416 20220217 RGD compared to wild type 150573818 SD-Nkx3-1em1Pjhak-/- strain MP:0030982 abnormal copulatory plug deposition IMP N RGD:150573817|PMID:33368416 20220217 RGD compared to wild type 150573819 Nkx3-1em1Pjhak NK3 homeobox 1; TALEN induced mutant 1, Pjhak gene MP:0001167 prostate gland epithelial hyperplasia IMP N RGD:150573817|PMID:33368416 20220224 RGD compared to wild type 150573819 Nkx3-1em1Pjhak NK3 homeobox 1; TALEN induced mutant 1, Pjhak gene MP:0001922 reduced male fertility IMP N RGD:150573817|PMID:33368416 20220224 RGD compared to wild type 150573819 Nkx3-1em1Pjhak NK3 homeobox 1; TALEN induced mutant 1, Pjhak gene MP:0001935 decreased litter size IMP N RGD:150573817|PMID:33368416 20220224 RGD compared to wild type 150573819 Nkx3-1em1Pjhak NK3 homeobox 1; TALEN induced mutant 1, Pjhak gene MP:0004962 decreased prostate gland weight IMP N RGD:150573817|PMID:33368416 20220224 RGD compared to wild type 150573819 Nkx3-1em1Pjhak NK3 homeobox 1; TALEN induced mutant 1, Pjhak gene MP:0030982 abnormal copulatory plug deposition IMP N RGD:150573817|PMID:33368416 20220224 RGD compared to wild type 151232284 Prkdcem1Sage protein kinase, DNA-activated, catalytic subunit; ZFN induced mutant 1, Sage gene MP:0001262 decreased body weight IMP N RGD:39938998|PMID:30485360 20220120 RGD 151232284 Prkdcem1Sage protein kinase, DNA-activated, catalytic subunit; ZFN induced mutant 1, Sage gene MP:0004953 decreased spleen weight IMP N RGD:39938998|PMID:30485360 20220120 RGD 151232284 Prkdcem1Sage protein kinase, DNA-activated, catalytic subunit; ZFN induced mutant 1, Sage gene MP:0009763 increased susceptibility to induced morbidity/mortality IMP N RGD:39938998|PMID:30485360 20220120 RGD 151232284 Prkdcem1Sage protein kinase, DNA-activated, catalytic subunit; ZFN induced mutant 1, Sage gene MP:0012555 decreased cell death IMP N RGD:39938998|PMID:30485360 20220120 RGD 151347430 Mstnem1Cqin myostatin; ZFN induced mutant 1, Cqin gene MP:0001260 increased body weight sexual_dimorphism IMP N RGD:13831345|PMID:27289021 20220127 RGD compared to wild type male 151347605 SD-Ddah1em1Ywxu strain MP:0003674 oxidative stress exacerbates IMP XCO:0000642 N RGD:151347602|PMID:31402164 20220128 RGD 151347605 SD-Ddah1em1Ywxu strain MP:0003913 increased heart right ventricle weight exacerbates IMP XCO:0000642 N RGD:151347602|PMID:31402164 20220128 RGD 151347605 SD-Ddah1em1Ywxu strain MP:0006050 pulmonary fibrosis induces IMP XCO:0000642 N RGD:151347602|PMID:31402164 20220128 RGD compared to wild type 151347605 SD-Ddah1em1Ywxu strain MP:0010758 increased right ventricle systolic pressure induces IMP XCO:0000642 N RGD:151347602|PMID:31402164 20220128 RGD compared to wild type 151347605 SD-Ddah1em1Ywxu strain MP:0010996 increased aorta wall thickness exacerbates IMP XCO:0000642 N RGD:151347602|PMID:31402164 20220128 RGD 151347605 SD-Ddah1em1Ywxu strain MP:0010996 increased aorta wall thickness induces IMP N RGD:151347602|PMID:31402164 20220128 RGD compared to wild type 151347606 Ddah1em1Ywxu dimethylarginine dimethylaminohydrolase 1; CRISPR/Cas9 induced mutant 1, Ywxu gene MP:0003674 oxidative stress exacerbates IMP XCO:0000642 N RGD:151347602|PMID:31402164 20220203 RGD 151347606 Ddah1em1Ywxu dimethylarginine dimethylaminohydrolase 1; CRISPR/Cas9 induced mutant 1, Ywxu gene MP:0003913 increased heart right ventricle weight exacerbates IMP XCO:0000642 N RGD:151347602|PMID:31402164 20220203 RGD 151347606 Ddah1em1Ywxu dimethylarginine dimethylaminohydrolase 1; CRISPR/Cas9 induced mutant 1, Ywxu gene MP:0006050 pulmonary fibrosis induces IMP XCO:0000642 N RGD:151347602|PMID:31402164 20220203 RGD compared to wild type 151347606 Ddah1em1Ywxu dimethylarginine dimethylaminohydrolase 1; CRISPR/Cas9 induced mutant 1, Ywxu gene MP:0010758 increased right ventricle systolic pressure induces IMP XCO:0000642 N RGD:151347602|PMID:31402164 20220203 RGD compared to wild type 151347606 Ddah1em1Ywxu dimethylarginine dimethylaminohydrolase 1; CRISPR/Cas9 induced mutant 1, Ywxu gene MP:0010996 increased aorta wall thickness exacerbates IMP XCO:0000642 N RGD:151347602|PMID:31402164 20220203 RGD 151347606 Ddah1em1Ywxu dimethylarginine dimethylaminohydrolase 1; CRISPR/Cas9 induced mutant 1, Ywxu gene MP:0010996 increased aorta wall thickness induces IMP N RGD:151347602|PMID:31402164 20220203 RGD compared to wild type 151347865 Gper1em1Bj G protein-coupled estrogen receptor 1; CRISPR/Cas 9 induced mutant 1, Bj gene MP:0001257 increased body length IMP N RGD:39939000|PMID:30354811 20220210 RGD compared to wild type SS rat 151347865 Gper1em1Bj G protein-coupled estrogen receptor 1; CRISPR/Cas 9 induced mutant 1, Bj gene MP:0001260 increased body weight IMP N RGD:39939000|PMID:30354811 20220210 RGD compared to wild type SS rat 151347865 Gper1em1Bj G protein-coupled estrogen receptor 1; CRISPR/Cas 9 induced mutant 1, Bj gene MP:0004876 decreased mean systemic arterial blood pressure IMP N RGD:39939000|PMID:30354811 20220210 RGD compared to wild type SS rat 151347865 Gper1em1Bj G protein-coupled estrogen receptor 1; CRISPR/Cas 9 induced mutant 1, Bj gene MP:0005590 increased vasodilation IMP N RGD:39939000|PMID:30354811 20220210 RGD compared to wild type SS rat 151347865 Gper1em1Bj G protein-coupled estrogen receptor 1; CRISPR/Cas 9 induced mutant 1, Bj gene MP:0006263 decreased systemic arterial diastolic blood pressure IMP N RGD:39939000|PMID:30354811 20220210 RGD compared to wild type SS rat 151347865 Gper1em1Bj G protein-coupled estrogen receptor 1; CRISPR/Cas 9 induced mutant 1, Bj gene MP:0006264 decreased systemic arterial systolic blood pressure IMP N RGD:39939000|PMID:30354811 20220210 RGD compared to wild type SS rat 151347865 Gper1em1Bj G protein-coupled estrogen receptor 1; CRISPR/Cas 9 induced mutant 1, Bj gene MP:0006266 decreased pulse pressure IMP N RGD:39939000|PMID:30354811 20220210 RGD compared to wild type SS rat 151347865 Gper1em1Bj G protein-coupled estrogen receptor 1; CRISPR/Cas 9 induced mutant 1, Bj gene MP:0010358 abnormal free fatty acids level IMP N RGD:39939000|PMID:30354811 20220210 RGD compared to wild type SS rat 151356741 SD-Tg(Alb-TAg)Mlcr strain MP:0003331 increased hepatocellular carcinoma incidence IMP N RGD:151356742|PMID:8053496 20220211 RGD 151356741 SD-Tg(Alb-TAg)Mlcr strain MP:0003430 increased pancreatic islet cell adenoma incidence IMP N RGD:151356742|PMID:8053496 20220211 RGD 151664748 SD-Slc9a6 em1Moro strain MP:0000435 shortened head IMP N RGD:151664747|PMID:34928329 20231218 RGD 151664748 SD-Slc9a6 em1Moro strain MP:0000852 small cerebellum IMP N RGD:151664747|PMID:34928329 20231218 RGD 151664748 SD-Slc9a6 em1Moro strain MP:0000880 decreased Purkinje cell number IMP N RGD:151664747|PMID:34928329 20231218 RGD 151664748 SD-Slc9a6 em1Moro strain MP:0001402 decreased locomotor activity IMP N RGD:151664747|PMID:34928329 20231218 RGD 151664748 SD-Slc9a6 em1Moro strain MP:0001405 impaired coordination IMP N RGD:151664747|PMID:34928329 20231218 RGD 151664748 SD-Slc9a6 em1Moro strain MP:0002757 decreased vertical activity IMP N RGD:151664747|PMID:34928329 20231218 RGD 151664748 SD-Slc9a6 em1Moro strain MP:0003172 abnormal lysosome physiology IMP N RGD:151664747|PMID:34928329 20231218 RGD 151664748 SD-Slc9a6 em1Moro strain MP:0003240 loss of hippocampal neurons IMP N RGD:151664747|PMID:34928329 20231218 RGD 151664748 SD-Slc9a6 em1Moro strain MP:0003241 loss of cortex neurons IMP N RGD:151664747|PMID:34928329 20231218 RGD 151664748 SD-Slc9a6 em1Moro strain MP:0003354 astrocytosis IMP N RGD:151664747|PMID:34928329 20231218 RGD 151664748 SD-Slc9a6 em1Moro strain MP:0005405 axon degeneration IMP N RGD:151664747|PMID:34928329 20231218 RGD 151664748 SD-Slc9a6 em1Moro strain MP:0008535 enlarged lateral ventricles IMP N RGD:151664747|PMID:34928329 20231218 RGD 151664748 SD-Slc9a6 em1Moro strain MP:0008918 microgliosis IMP N RGD:151664747|PMID:34928329 20231218 RGD 151664748 SD-Slc9a6 em1Moro strain MP:0020602 decreased cerebral cortex average cell area IMP N RGD:151664747|PMID:34928329 20231218 RGD 151664748 SD-Slc9a6 em1Moro strain MP:0030940 impaired autophagy IMP N RGD:151664747|PMID:34928329 20231218 RGD 151664748 SD-Slc9a6 em1Moro strain MP:0031561 increased ganglioside level IMP N RGD:151664747|PMID:34928329 20231218 RGD 151664749 Slc9a6 em1Moro solute carrier family 9 member A6;CRISPR/Cas9 induced mutant1, Moro gene MP:0000435 shortened head IMP N RGD:151664747|PMID:34928329 20231221 RGD 151664749 Slc9a6 em1Moro solute carrier family 9 member A6;CRISPR/Cas9 induced mutant1, Moro gene MP:0000852 small cerebellum IMP N RGD:151664747|PMID:34928329 20231221 RGD 151664749 Slc9a6 em1Moro solute carrier family 9 member A6;CRISPR/Cas9 induced mutant1, Moro gene MP:0000880 decreased Purkinje cell number IMP N RGD:151664747|PMID:34928329 20231221 RGD 151664749 Slc9a6 em1Moro solute carrier family 9 member A6;CRISPR/Cas9 induced mutant1, Moro gene MP:0001402 decreased locomotor activity IMP N RGD:151664747|PMID:34928329 20231221 RGD 151664749 Slc9a6 em1Moro solute carrier family 9 member A6;CRISPR/Cas9 induced mutant1, Moro gene MP:0001405 impaired coordination IMP N RGD:151664747|PMID:34928329 20231221 RGD 151664749 Slc9a6 em1Moro solute carrier family 9 member A6;CRISPR/Cas9 induced mutant1, Moro gene MP:0002757 decreased vertical activity IMP N RGD:151664747|PMID:34928329 20231221 RGD 151664749 Slc9a6 em1Moro solute carrier family 9 member A6;CRISPR/Cas9 induced mutant1, Moro gene MP:0003172 abnormal lysosome physiology IMP N RGD:151664747|PMID:34928329 20231221 RGD 151664749 Slc9a6 em1Moro solute carrier family 9 member A6;CRISPR/Cas9 induced mutant1, Moro gene MP:0003240 loss of hippocampal neurons IMP N RGD:151664747|PMID:34928329 20231221 RGD 151664749 Slc9a6 em1Moro solute carrier family 9 member A6;CRISPR/Cas9 induced mutant1, Moro gene MP:0003241 loss of cortex neurons IMP N RGD:151664747|PMID:34928329 20231221 RGD 151664749 Slc9a6 em1Moro solute carrier family 9 member A6;CRISPR/Cas9 induced mutant1, Moro gene MP:0003354 astrocytosis IMP N RGD:151664747|PMID:34928329 20231221 RGD 151664749 Slc9a6 em1Moro solute carrier family 9 member A6;CRISPR/Cas9 induced mutant1, Moro gene MP:0005405 axon degeneration IMP N RGD:151664747|PMID:34928329 20231221 RGD 151664749 Slc9a6 em1Moro solute carrier family 9 member A6;CRISPR/Cas9 induced mutant1, Moro gene MP:0008535 enlarged lateral ventricles IMP N RGD:151664747|PMID:34928329 20231221 RGD 151664749 Slc9a6 em1Moro solute carrier family 9 member A6;CRISPR/Cas9 induced mutant1, Moro gene MP:0008918 microgliosis IMP N RGD:151664747|PMID:34928329 20231221 RGD 151664749 Slc9a6 em1Moro solute carrier family 9 member A6;CRISPR/Cas9 induced mutant1, Moro gene MP:0020602 decreased cerebral cortex average cell area IMP N RGD:151664747|PMID:34928329 20231221 RGD 151664749 Slc9a6 em1Moro solute carrier family 9 member A6;CRISPR/Cas9 induced mutant1, Moro gene MP:0030940 impaired autophagy IMP N RGD:151664747|PMID:34928329 20231221 RGD 151664749 Slc9a6 em1Moro solute carrier family 9 member A6;CRISPR/Cas9 induced mutant1, Moro gene MP:0031561 increased ganglioside level IMP N RGD:151664747|PMID:34928329 20240321 RGD 152600899 Mir146bem1Mcwi microRNA 146b; CRISPR/Cas9 induced mutant 1, Mcwi gene MP:0003985 renal fibrosis sexual_dimorphism IMP XCO:0000017 N RGD:127285407|PMID:31668631 20220526 RGD 1547869 ACI/Eur August x Copenhagen Irish strain MP:0003059 decreased insulin secretion IAGP N RGD:6893578|PMID:22947656 20131021 RGD 1547869 ACI/Eur August x Copenhagen Irish strain MP:0005293 impaired glucose tolerance IAGP XCO:0000103 N RGD:6893578|PMID:22947656 20131021 RGD 1547869 ACI/Eur August x Copenhagen Irish strain MP:0005293 impaired glucose tolerance induced IAGP XCO:0000103 N RGD:2316693|PMID:20068026 20200825 RGD compared to BN/SsN, BUF/N, F344/N 1547869 ACI/Eur August x Copenhagen Irish strain MP:0013279 increased fasting circulating glucose level IAGP N RGD:6893578|PMID:22947656 20131021 RGD 1549794 SS.LEW-(D2Rat199-D2Mco17)/Ayd strain MP:0004875 increased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:7421500|PMID:23814039 20131211 RGD compared to parental SS/Jr 1549799 BB.SHR-(D6Rat184-D6Rat3)/K strain MP:0001260 increased body weight IAGP N RGD:619685|PMID:11327715 20200206 RGD compared to BB/OK, sexual dimorphism 1549799 BB.SHR-(D6Rat184-D6Rat3)/K strain MP:0001552 increased circulating triglyceride level IAGP N RGD:619685|PMID:11327715 20200206 RGD compared to BB/OK, sexual dimorphism 1549799 BB.SHR-(D6Rat184-D6Rat3)/K strain MP:0001830 decreased activated T cell number IAGP N RGD:619685|PMID:11327715 20200206 RGD compared to BB/OK 1549799 BB.SHR-(D6Rat184-D6Rat3)/K strain MP:0004804 decreased susceptibility to autoimmune diabetes IAGP N RGD:619685|PMID:11327715 20200206 RGD compared to BB/OK 1549799 BB.SHR-(D6Rat184-D6Rat3)/K strain MP:0005178 increased circulating cholesterol level IAGP N RGD:619685|PMID:11327715 20200206 RGD compared to BB/OK 1549799 BB.SHR-(D6Rat184-D6Rat3)/K strain MP:0008090 increased T-helper 2 cell number IAGP N RGD:619685|PMID:11327715 20200206 RGD compared to BB/OK 1549811 ACI/NJcl strain MP:0010301 increased stomach tumor incidence IAGP N RGD:69698|PMID:10706129 20201029 RGD compared to BUF 1549813 F344.ACI-Lmx1aqc/Kyo strain MP:0000592 short tail IAGP N RGD:1549451|PMID:15804398 20080423 RGD 1549813 F344.ACI-Lmx1aqc/Kyo strain MP:0000755 hindlimb paralysis IAGP N RGD:1549451|PMID:15804398 20201112 RGD 1549813 F344.ACI-Lmx1aqc/Kyo strain MP:0000780 abnormal corpus callosum morphology IAGP N RGD:1549451|PMID:15804398 20080423 RGD 1549813 F344.ACI-Lmx1aqc/Kyo strain MP:0000820 abnormal choroid plexus morphology IAGP N RGD:1549451|PMID:15804398 20080423 RGD 1549813 F344.ACI-Lmx1aqc/Kyo strain MP:0000851 cerebellum hypoplasia IAGP N RGD:1549451|PMID:15804398 20080423 RGD 1549813 F344.ACI-Lmx1aqc/Kyo strain MP:0001523 impaired righting response IAGP N RGD:1549451|PMID:15804398 20201112 RGD 1549813 F344.ACI-Lmx1aqc/Kyo strain MP:0002730 head shaking IAGP N RGD:1549451|PMID:15804398 20201112 RGD 1549813 F344.ACI-Lmx1aqc/Kyo strain MP:0008283 small hippocampus IAGP N RGD:1549451|PMID:15804398 20201112 RGD 1549827 Scl46 Serum cholesterol level QTL 46 qtl MP:0005178 increased circulating cholesterol level IAGP N RGD:1547851|PMID:16061941 19990101 RGD 1549828 Bp258 Blood pressure QTL 258 qtl MP:0000230 abnormal systemic arterial blood pressure IAGP N RGD:1357413|PMID:15738349 19990101 RGD 1549829 Scl48 Serum cholesterol level QTL 48 qtl MP:0005178 increased circulating cholesterol level IAGP N RGD:1547851|PMID:16061941 19990101 RGD 1549830 Bss1 Bone structure and strength QTL 1 qtl MP:0001542 abnormal bone strength QTM N RGD:1549683|PMID:16059631 19990101 RGD 1549831 Bss6 Bone structure and strength QTL 6 qtl MP:0001542 abnormal bone strength QTM N RGD:1549683|PMID:16059631 19990101 RGD 1549832 Bss3 Bone structure and strength QTL 3 qtl MP:0003795 abnormal bone structure QTM N RGD:1549683|PMID:16059631 19990101 RGD 1549833 Bp257 Blood pressure QTL 257 qtl MP:0000230 abnormal systemic arterial blood pressure IAGP N RGD:1357413|PMID:15738349 19990101 RGD 1549834 Scl45 Serum cholesterol level QTL 45 qtl MP:0005178 increased circulating cholesterol level IAGP N RGD:1547851|PMID:16061941 19990101 RGD 1549835 Tcas7 Tongue tumor susceptibility QTL 7 qtl MP:0010272 increased tongue tumor incidence IDA N RGD:1358147|PMID:15876484 20111115 RGD 1549836 Bss2 Bone structure and strength QTL 2 qtl MP:0001542 abnormal bone strength QTM N RGD:1549683|PMID:16059631 19990101 RGD 1549836 Bss2 Bone structure and strength QTL 2 qtl MP:0003795 abnormal bone structure QTM N RGD:1549683|PMID:16059631 19990101 RGD 1549837 Hcar15 Hepatocarcinoma resistance QTL 15 qtl MP:0006043 decreased apoptosis IAGP N RGD:1358145|PMID:15771619 19990101 RGD 1549837 Hcar15 Hepatocarcinoma resistance QTL 15 qtl MP:0010265 decreased hepatoma incidence IDA N RGD:1358145|PMID:15771619 20111107 RGD 1549837 Hcar15 Hepatocarcinoma resistance QTL 15 qtl MP:0010266 decreased liver tumor incidence IDA N RGD:1358145|PMID:15771619 20111107 RGD 1549838 Bss4 Bone structure and strength QTL 4 qtl MP:0001542 abnormal bone strength QTM N RGD:1549683|PMID:16059631 19990101 RGD 1549838 Bss4 Bone structure and strength QTL 4 qtl MP:0003795 abnormal bone structure QTM N RGD:1549683|PMID:16059631 19990101 RGD 1549839 Bw52 Body weight QTL 52 qtl MP:0001260 increased body weight IAGP N RGD:1358143|PMID:15833945 19990101 RGD 1549840 Bss5 Bone structure and strength QTL 5 qtl MP:0003795 abnormal bone structure QTM N RGD:1549683|PMID:16059631 19990101 RGD 1549841 Bp256 Blood pressure QTL 256 qtl MP:0000230 abnormal systemic arterial blood pressure IAGP N RGD:1357413|PMID:15738349 19990101 RGD 1549842 Bp248 Blood pressure QTL 248 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:1300037|PMID:15080379 19990101 RGD 1549843 Bw53 Body weight QTL 53 qtl MP:0001260 increased body weight IAGP N RGD:1358143|PMID:15833945 19990101 RGD 1549844 Bss7 Bone structure and strength QTL 7 qtl MP:0003795 abnormal bone structure QTM N RGD:1549683|PMID:16059631 19990101 RGD 1549845 Scl44 Serum cholesterol level QTL 44 qtl MP:0005178 increased circulating cholesterol level IAGP N RGD:1547851|PMID:16061941 19990101 RGD 1549846 Scl47 Serum cholesterol level QTL 47 qtl MP:0005178 increased circulating cholesterol level IAGP N RGD:1547851|PMID:16061941 19990101 RGD 1549847 Bss8 Bone structure and strength QTL 8 qtl MP:0001542 abnormal bone strength QTM N RGD:1549683|PMID:16059631 19990101 RGD 1549848 Bvd6 Brain ventricular dilatation QTL 6 qtl MP:0001891 hydrocephaly IAGP N RGD:68693|PMID:11178739 20100217 RGD 1549897 Stresp12 Stress response QTL 12 qtl MP:0001363 increased anxiety-related response IAGP N RGD:1358767|PMID:15685431 19990101 RGD 1549897 Stresp12 Stress response QTL 12 qtl MP:0003062 abnormal coping response IAGP N RGD:1358767|PMID:15685431 19990101 RGD 1549897 Stresp12 Stress response QTL 12 qtl MP:0003064 decreased coping response IAGP N RGD:1358767|PMID:15685431 19990101 RGD 1549898 Neuinf3 Neuroinflammation QTL 3 qtl MP:0005042 abnormal level of surface class II molecules IAGP N RGD:1358788|PMID:14586010 19990101 RGD 1549899 Stresp8 Stress response QTL 8 qtl MP:0001363 increased anxiety-related response IAGP N RGD:1358767|PMID:15685431 19990101 RGD 1549899 Stresp8 Stress response QTL 8 qtl MP:0003062 abnormal coping response IAGP N RGD:1358767|PMID:15685431 19990101 RGD 1549899 Stresp8 Stress response QTL 8 qtl MP:0003064 decreased coping response IAGP N RGD:1358767|PMID:15685431 19990101 RGD 1549900 Iddm20 Insulin dependent diabetes mellitus QTL 20 qtl MP:0001559 hyperglycemia IAGP N RGD:1358924|PMID:15793267 19990101 RGD 1549900 Iddm20 Insulin dependent diabetes mellitus QTL 20 qtl MP:0001844 autoimmune response IAGP N RGD:1358924|PMID:15793267 19990101 RGD 1549901 Neudeg2 Neurodegradation QTL 2 qtl MP:0000939 decreased motor neuron number IAGP N RGD:1358788|PMID:14586010 19990101 RGD 1549901 Neudeg2 Neurodegradation QTL 2 qtl MP:0005090 increased double-negative T cell number IAGP N RGD:1358788|PMID:14586010 19990101 RGD 1549902 Bp269 Blood pressure QTL 269 qtl MP:0006143 increased systemic arterial diastolic blood pressure IAGP N RGD:1358144|PMID:15809361 19990101 RGD 1549903 Bp267 Blood pressure QTL 267 qtl MP:0006143 increased systemic arterial diastolic blood pressure IAGP N RGD:1358144|PMID:15809361 19990101 RGD 1549903 Bp267 Blood pressure QTL 267 qtl MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:1358144|PMID:15809361 19990101 RGD 1549904 Neuinf1 Neuroinflammation QTL 1 qtl MP:0005090 increased double-negative T cell number IAGP N RGD:1358788|PMID:14586010 19990101 RGD 1549905 Stresp10 Stress response QTL 10 qtl MP:0001363 increased anxiety-related response IAGP N RGD:1358767|PMID:15685431 19990101 RGD 1549905 Stresp10 Stress response QTL 10 qtl MP:0003062 abnormal coping response IAGP N RGD:1358767|PMID:15685431 19990101 RGD 1549905 Stresp10 Stress response QTL 10 qtl MP:0003064 decreased coping response IAGP N RGD:1358767|PMID:15685431 19990101 RGD 1549907 Neuinf2 Neuroinflammation QTL 2 qtl MP:0005042 abnormal level of surface class II molecules IAGP N RGD:1358788|PMID:14586010 19990101 RGD 1549908 Neudeg1 Neurodegradation QTL 1 qtl MP:0000938 motor neuron degeneration IAGP N RGD:1358788|PMID:14586010 19990101 RGD 1549908 Neudeg1 Neurodegradation QTL 1 qtl MP:0000939 decreased motor neuron number IAGP N RGD:1358788|PMID:14586010 19990101 RGD 1549909 Stresp11 Stress response QTL 11 qtl MP:0001363 increased anxiety-related response IAGP N RGD:1358767|PMID:15685431 19990101 RGD 1549909 Stresp11 Stress response QTL 11 qtl MP:0003062 abnormal coping response IAGP N RGD:1358767|PMID:15685431 19990101 RGD 1549909 Stresp11 Stress response QTL 11 qtl MP:0003064 decreased coping response IAGP N RGD:1358767|PMID:15685431 19990101 RGD 1549910 Bw54 Body weight QTL 54 qtl MP:0001260 increased body weight IAGP N RGD:1358859|PMID:15883013 19990101 RGD 1549910 Bw54 Body weight QTL 54 qtl MP:0005334 abnormal fat pad morphology IAGP N RGD:1358859|PMID:15883013 19990101 RGD 1549911 Stresp9 Stress response QTL 9 qtl MP:0001363 increased anxiety-related response IAGP N RGD:1358767|PMID:15685431 19990101 RGD 1549911 Stresp9 Stress response QTL 9 qtl MP:0003062 abnormal coping response IAGP N RGD:1358767|PMID:15685431 19990101 RGD 1549911 Stresp9 Stress response QTL 9 qtl MP:0003064 decreased coping response IAGP N RGD:1358767|PMID:15685431 19990101 RGD 1549912 Bp268 Blood pressure QTL 268 qtl MP:0006143 increased systemic arterial diastolic blood pressure IAGP N RGD:1358144|PMID:15809361 19990101 RGD 1549912 Bp268 Blood pressure QTL 268 qtl MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:1358144|PMID:15809361 19990101 RGD 1549913 Stresp13 Stress response QTL 13 qtl MP:0001363 increased anxiety-related response IAGP N RGD:1358767|PMID:15685431 19990101 RGD 1549913 Stresp13 Stress response QTL 13 qtl MP:0003062 abnormal coping response IAGP N RGD:1358767|PMID:15685431 19990101 RGD 1549913 Stresp13 Stress response QTL 13 qtl MP:0003064 decreased coping response IAGP N RGD:1358767|PMID:15685431 19990101 RGD 1554302 HOB-Unc5chob/Snk hobble rat strain MP:0000865 absent cerebellum vermis IAGP N RGD:1302461|PMID:14993736 20170406 RGD 1554317 Bmd4 Bone mineral density QTL 4 qtl MP:0000062 increased bone mineral density IAGP N RGD:1553896|PMID:16180139 19990101 RGD 1554318 Bmd5 Bone mineral density QTL 5 qtl MP:0000062 increased bone mineral density IAGP N RGD:1553896|PMID:16180139 19990101 RGD 1554319 Bmd2 Bone mineral density QTL 2 qtl MP:0000062 increased bone mineral density IAGP N RGD:1553896|PMID:16180139 19990101 RGD 1554320 Bmd1 Bone mineral density QTL 1 qtl MP:0000062 increased bone mineral density IAGP N RGD:1553896|PMID:16180139 19990101 RGD 1554321 Bmd3 Bone mineral density QTL 3 qtl MP:0000062 increased bone mineral density IAGP N RGD:1553896|PMID:16180139 19990101 RGD 1554322 ApcPirc APC, WNT signaling pathway regulator; polyposis in the rat colon gene MP:0001263 weight loss sexual_dimorphism IMP N RGD:1601201|PMID:17360473 20201210 RGD compared to females 1554322 ApcPirc APC, WNT signaling pathway regulator; polyposis in the rat colon gene MP:0001577 anemia sexual_dimorphism IMP N RGD:1601201|PMID:17360473 20201210 RGD compared to females 1554322 ApcPirc APC, WNT signaling pathway regulator; polyposis in the rat colon gene MP:0001661 extended life span sexual_dimorphism IMP N RGD:1601201|PMID:17360473 20201210 RGD compared to males 1554322 ApcPirc APC, WNT signaling pathway regulator; polyposis in the rat colon gene MP:0002044 increased colon adenoma incidence IMP N RGD:1601201|PMID:17360473 20201210 RGD compared to treated females, mock treated males 1554322 ApcPirc APC, WNT signaling pathway regulator; polyposis in the rat colon gene MP:0002957 increased intestinal adenocarcinoma incidence sexual_dimorphism IMP XCO:0000345 N RGD:1601201|PMID:17360473 20201210 RGD compared to treated females 1554322 ApcPirc APC, WNT signaling pathway regulator; polyposis in the rat colon gene MP:0003269 colon polyps IMP N RGD:1601201|PMID:17360473 20201210 RGD 1554322 ApcPirc APC, WNT signaling pathway regulator; polyposis in the rat colon gene MP:0003293 rectal hemorrhage sexual_dimorphism IMP N RGD:1601201|PMID:17360473 20201210 RGD compared to females 155598601 SD-Bmal1em1Mcwi strain MP:0001262 decreased body weight IMP N RGD:155598602|PMID:32306766 20221025 RGD compared to wild type 155598601 SD-Bmal1em1Mcwi strain MP:0002626 increased heart rate sexual_dimorphism IMP N RGD:155598602|PMID:32306766 20221025 RGD in female 155598601 SD-Bmal1em1Mcwi strain MP:0004876 decreased mean systemic arterial blood pressure IMP N RGD:155598602|PMID:32306766 20221025 RGD compared to wild type 155598601 SD-Bmal1em1Mcwi strain MP:0006263 decreased systemic arterial diastolic blood pressure IMP N RGD:155598602|PMID:32306766 20221025 RGD compared to wild type 155598601 SD-Bmal1em1Mcwi strain MP:0006264 decreased systemic arterial systolic blood pressure IMP N RGD:155598602|PMID:32306766 20221025 RGD compared to wild type 155598601 SD-Bmal1em1Mcwi strain MP:0006274 abnormal urine sodium level sex_dimorphism IMP N RGD:155598602|PMID:32306766 20221025 RGD in male 155598601 SD-Bmal1em1Mcwi strain MP:0011940 decreased food intake IMP N RGD:155598602|PMID:32306766 20221025 RGD compared to wild type 155598603 Bmal1em1Mcwi basic helix-loop-helix ARNT like 1;CRISPR/Cas9 induced mutant 1,Mcwi gene MP:0001262 decreased body weight IMP N RGD:155598602|PMID:32306766 20221027 RGD compared to wild type 155598603 Bmal1em1Mcwi basic helix-loop-helix ARNT like 1;CRISPR/Cas9 induced mutant 1,Mcwi gene MP:0002626 increased heart rate sexual_dimorphism IMP N RGD:155598602|PMID:32306766 20221027 RGD in female 155598603 Bmal1em1Mcwi basic helix-loop-helix ARNT like 1;CRISPR/Cas9 induced mutant 1,Mcwi gene MP:0004876 decreased mean systemic arterial blood pressure IMP N RGD:155598602|PMID:32306766 20221027 RGD compared to wild type 155598603 Bmal1em1Mcwi basic helix-loop-helix ARNT like 1;CRISPR/Cas9 induced mutant 1,Mcwi gene MP:0006263 decreased systemic arterial diastolic blood pressure IMP N RGD:155598602|PMID:32306766 20221027 RGD compared to wild type 155598603 Bmal1em1Mcwi basic helix-loop-helix ARNT like 1;CRISPR/Cas9 induced mutant 1,Mcwi gene MP:0006264 decreased systemic arterial systolic blood pressure IMP N RGD:155598602|PMID:32306766 20221027 RGD compared to wild type 155598603 Bmal1em1Mcwi basic helix-loop-helix ARNT like 1;CRISPR/Cas9 induced mutant 1,Mcwi gene MP:0006274 abnormal urine sodium level sex_dimorphism IMP N RGD:155598602|PMID:32306766 20221027 RGD in male 155598603 Bmal1em1Mcwi basic helix-loop-helix ARNT like 1;CRISPR/Cas9 induced mutant 1,Mcwi gene MP:0011940 decreased food intake IMP N RGD:155598602|PMID:32306766 20221027 RGD compared to wild type 155631259 Taiep strain MP:0000745 tremors IAGP N RGD:155631258|PMID:2724922 20221028 RGD 155631259 Taiep strain MP:0001921 reduced fertility IAGP N RGD:155631258|PMID:2724922 20221028 RGD 155641235 WMI/Eer WKY most immobile strain MP:0001402 decreased locomotor activity IAGP N RGD:4891104|PMID:14593430 20110107 RGD compared to WLI/Eer 155641235 WMI/Eer WKY most immobile strain MP:0001522 impaired swimming IAGP N RGD:4891104|PMID:14593430 20110105 RGD compared to WLI/Eer 155641235 WMI/Eer WKY most immobile strain MP:0001522 impaired swimming IAGP XCO:0000561 N RGD:4891104|PMID:14593430 20110105 RGD compared to treated 155641235 WMI/Eer WKY most immobile strain MP:0002665 decreased circulating corticosterone level IAGP N RGD:4891104|PMID:14593430 20110105 RGD compared to WLI/Eer 155641237 WLI/Eer WKY least immobile strain MP:0001522 impaired swimming IAGP XCO:0000561 N RGD:4891104|PMID:14593430 20110107 RGD compared to treated 1558640 Prcs2 Prostate cancer susceptibility QTL 2 qtl MP:0000659 prostate gland hyperplasia IAGP N RGD:1358944|PMID:15805257 19990101 RGD 1558640 Prcs2 Prostate cancer susceptibility QTL 2 qtl MP:0001158 abnormal prostate gland morphology IAGP N RGD:1358944|PMID:15805257 19990101 RGD 1558640 Prcs2 Prostate cancer susceptibility QTL 2 qtl MP:0003607 abnormal prostate gland physiology IAGP N RGD:1358944|PMID:15805257 19990101 RGD 1558640 Prcs2 Prostate cancer susceptibility QTL 2 qtl MP:0010357 increased prostate gland tumor incidence IDA N RGD:1358944|PMID:15805257 20111109 RGD 1558641 Cm47 Cardiac mass QTL 47 qtl MP:0001625 cardiac hypertrophy IAGP N RGD:1554311|PMID:16097372 19990101 RGD 1558641 Cm47 Cardiac mass QTL 47 qtl MP:0002833 increased heart weight IAGP N RGD:1554311|PMID:16097372 19990101 RGD 1558642 Prcr2 Prostate cancer resistance QTL 2 qtl MP:0001158 abnormal prostate gland morphology IAGP N RGD:1358944|PMID:15805257 19990101 RGD 1558642 Prcr2 Prostate cancer resistance QTL 2 qtl MP:0003607 abnormal prostate gland physiology IAGP N RGD:1358944|PMID:15805257 19990101 RGD 1558642 Prcr2 Prostate cancer resistance QTL 2 qtl MP:0005147 prostate gland hypoplasia IAGP N RGD:1358944|PMID:15805257 19990101 RGD 1558642 Prcr2 Prostate cancer resistance QTL 2 qtl MP:0010357 increased prostate gland tumor incidence IDA N RGD:1358944|PMID:15805257 20111109 RGD 1558643 Cm44 Cardiac mass QTL 44 qtl MP:0001625 cardiac hypertrophy IAGP N RGD:1554311|PMID:16097372 19990101 RGD 1558643 Cm44 Cardiac mass QTL 44 qtl MP:0002833 increased heart weight IAGP N RGD:1554311|PMID:16097372 19990101 RGD 1558644 Cm45 Cardiac mass QTL 45 qtl MP:0001625 cardiac hypertrophy IAGP N RGD:1554311|PMID:16097372 19990101 RGD 1558644 Cm45 Cardiac mass QTL 45 qtl MP:0002833 increased heart weight IAGP N RGD:1554311|PMID:16097372 19990101 RGD 1558645 Bw55 Body weight QTL 55 qtl MP:0001259 abnormal body weight IAGP N RGD:1554311|PMID:16097372 19990101 RGD 1558645 Bw55 Body weight QTL 55 qtl MP:0001260 increased body weight IAGP N RGD:1554311|PMID:16097372 19990101 RGD 1558646 Swd5 Spike wave discharge measurement QTL 5 qtl MP:0003216 absence seizures IAGP N RGD:1553898|PMID:15030491 19990101 RGD 1558647 Cm46 Cardiac mass QTL 46 qtl MP:0001625 cardiac hypertrophy IAGP N RGD:1554311|PMID:16097372 19990101 RGD 1558647 Cm46 Cardiac mass QTL 46 qtl MP:0002833 increased heart weight IAGP N RGD:1554311|PMID:16097372 19990101 RGD 1558648 Smcn1 Smooth muscle cell number QTL 1 qtl MP:0005489 vascular smooth muscle hyperplasia IAGP N RGD:1357419|PMID:15741507 19990101 RGD 1558649 Bw58 Body weight QTL 58 qtl MP:0001259 abnormal body weight IAGP N RGD:1554311|PMID:16097372 19990101 RGD 1558649 Bw58 Body weight QTL 58 qtl MP:0001260 increased body weight IAGP N RGD:1554311|PMID:16097372 19990101 RGD 1558650 Cm48 Cardiac mass QTL 48 qtl MP:0001625 cardiac hypertrophy IAGP N RGD:1554311|PMID:16097372 19990101 RGD 1558650 Cm48 Cardiac mass QTL 48 qtl MP:0002833 increased heart weight IAGP N RGD:1554311|PMID:16097372 19990101 RGD 1558651 Swd3 Spike wave discharge measurement QTL 3 qtl MP:0003216 absence seizures IAGP N RGD:1553898|PMID:15030491 19990101 RGD 1558652 Bw57 Body weight QTL 57 qtl MP:0001259 abnormal body weight IAGP N RGD:1554311|PMID:16097372 19990101 RGD 1558652 Bw57 Body weight QTL 57 qtl MP:0001260 increased body weight IAGP N RGD:1554311|PMID:16097372 19990101 RGD 1558653 Prcr1 Prostate cancer resistance QTL 1 qtl MP:0001158 abnormal prostate gland morphology IAGP N RGD:1358944|PMID:15805257 19990101 RGD 1558653 Prcr1 Prostate cancer resistance QTL 1 qtl MP:0003607 abnormal prostate gland physiology IAGP N RGD:1358944|PMID:15805257 19990101 RGD 1558653 Prcr1 Prostate cancer resistance QTL 1 qtl MP:0005147 prostate gland hypoplasia IAGP N RGD:1358944|PMID:15805257 19990101 RGD 1558653 Prcr1 Prostate cancer resistance QTL 1 qtl MP:0010357 increased prostate gland tumor incidence IDA N RGD:1358944|PMID:15805257 20111109 RGD 1558654 Bw56 Body weight QTL 56 qtl MP:0001259 abnormal body weight IAGP N RGD:1554311|PMID:16097372 19990101 RGD 1558654 Bw56 Body weight QTL 56 qtl MP:0001260 increased body weight IAGP N RGD:1554311|PMID:16097372 19990101 RGD 1558655 Swd4 Spike wave discharge measurement QTL 4 qtl MP:0003216 absence seizures IAGP N RGD:1553898|PMID:15030491 19990101 RGD 1558656 Prcs1 Prostate cancer susceptibility QTL 1 qtl MP:0000659 prostate gland hyperplasia IAGP N RGD:1358944|PMID:15805257 19990101 RGD 1558656 Prcs1 Prostate cancer susceptibility QTL 1 qtl MP:0001158 abnormal prostate gland morphology IAGP N RGD:1358944|PMID:15805257 19990101 RGD 1558656 Prcs1 Prostate cancer susceptibility QTL 1 qtl MP:0003607 abnormal prostate gland physiology IAGP N RGD:1358944|PMID:15805257 19990101 RGD 1558656 Prcs1 Prostate cancer susceptibility QTL 1 qtl MP:0010357 increased prostate gland tumor incidence IDA N RGD:1358944|PMID:15805257 20111109 RGD 1558657 Cm43 Cardiac mass QTL 43 qtl MP:0001625 cardiac hypertrophy IAGP N RGD:1554311|PMID:16097372 19990101 RGD 1558657 Cm43 Cardiac mass QTL 43 qtl MP:0002833 increased heart weight IAGP N RGD:1554311|PMID:16097372 19990101 RGD 1558658 Bw59 Body weight QTL 59 qtl MP:0001259 abnormal body weight IAGP N RGD:1554311|PMID:16097372 19990101 RGD 1558658 Bw59 Body weight QTL 59 qtl MP:0001260 increased body weight IAGP N RGD:1554311|PMID:16097372 19990101 RGD 1558659 Tescar1 Testicular tumor resistance QTL 1 qtl MP:0006262 increased testis tumor incidence IAGP N RGD:1358944|PMID:15805257 19990101 RGD 1558660 SHRSP/Tkyo strain MP:0001262 decreased body weight susceptibility IAGP N RGD:1554311|PMID:16097372 19990101 RGD compared to WKY/Tkyo 1558660 SHRSP/Tkyo strain MP:0002833 increased heart weight susceptibility IAGP N RGD:1554311|PMID:16097372 19990101 RGD compared to WKY/Tkyo 1558660 SHRSP/Tkyo strain MP:0002834 decreased heart weight treatment IAGP XCO:0000438 N RGD:18337260|PMID:19015604 20200117 RGD 1558660 SHRSP/Tkyo strain MP:0006144 increased systemic arterial systolic blood pressure susceptibility IAGP N RGD:1554311|PMID:16097372 19990101 RGD compared to WKY/Tkyo 1558660 SHRSP/Tkyo strain MP:0006264 decreased systemic arterial systolic blood pressure treatment IAGP XCO:0000438|XCO:0000551 N RGD:18337260|PMID:19015604 20200117 RGD 1558662 SHR/Tkyo strain MP:0001262 decreased body weight IAGP N RGD:1554311|PMID:16097372 19990101 RGD compared to WKY/Tkyo 1558662 SHR/Tkyo strain MP:0002833 increased heart weight susceptibility IAGP N RGD:1554311|PMID:16097372 19990101 RGD compared to WKY/Tkyo 1558662 SHR/Tkyo strain MP:0006144 increased systemic arterial systolic blood pressure susceptibility IAGP N RGD:1554311|PMID:16097372 19990101 RGD compared to WKY/Tkyo 1559030 LEC-Tg(ATP7B)Tohm strain MP:0001661 extended life span IMP N RGD:1554300|PMID:15511628 20200429 RGD compared to non-transgenic littermate 1559030 LEC-Tg(ATP7B)Tohm strain MP:0002942 decreased circulating alanine transaminase level IMP N RGD:1554300|PMID:15511628 20200429 RGD compared to non-transgenic littermate 1559030 LEC-Tg(ATP7B)Tohm strain MP:0005632 decreased circulating aspartate transaminase level IMP N RGD:1554300|PMID:15511628 20200429 RGD compared to non-transgenic littermate 1559030 LEC-Tg(ATP7B)Tohm strain MP:0005635 decreased circulating bilirubin level IMP N RGD:1554300|PMID:15511628 20200429 RGD compared to non-transgenic littermate 1559030 LEC-Tg(ATP7B)Tohm strain MP:0010265 decreased hepatoma incidence IMP N RGD:1554300|PMID:15511628 20200429 RGD compared to non-transgenic littermate 1559030 LEC-Tg(ATP7B)Tohm strain MP:0012613 increased ceruloplasmin level IMP N RGD:1554300|PMID:15511628 20200429 RGD compared to LEC/Crlj 1559035 SS.LEW-(D17Chm14-D17Rat181)/Ayd strain MP:0002842 increased systemic arterial blood pressure IAGP N RGD:1601352|PMID:17420333 20071117 RGD compared to LEW/Crlc 1559035 SS.LEW-(D17Chm14-D17Rat181)/Ayd strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:1601352|PMID:17420333 20071117 RGD 1559035 SS.LEW-(D17Chm14-D17Rat181)/Ayd strain MP:0004876 decreased mean systemic arterial blood pressure IAGP N RGD:1601352|PMID:17420333 20071117 RGD as compared to SS/Jr 1559035 SS.LEW-(D17Chm14-D17Rat181)/Ayd strain MP:0005333 decreased heart rate IAGP N RGD:1601352|PMID:17420333 20071117 RGD compared to SS/Jr 1559036 LEW/Jms strain MP:0001891 hydrocephaly IAGP N RGD:1559416|PMID:12541080 19990101 RGD 1559036 LEW/Jms strain MP:0012676 dilated brain ventricle IAGP N RGD:1559416|PMID:12541080 20190827 RGD 1559039 ODS/Shi Osteogenic disorder Shionogi strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:1556471|PMID:11693268 20200420 RGD compared to SHR.ODS-Gulo^od/Shi strain 1559039 ODS/Shi Osteogenic disorder Shionogi strain MP:0031257 decreased circulating vitamin C level induced IDA N RGD:1556471|PMID:11693268 20200420 RGD compared to ODS/shi fed on deficient diet supplemented with ascorbic acid (300 mg/kg) 1559043 MV/Opu myelin vacuolation rat strain MP:0000745 tremors IAGP N RGD:1299186|PMID:12379762 20090216 RGD 1559043 MV/Opu myelin vacuolation rat strain MP:0005404 abnormal axon morphology IAGP N RGD:1299186|PMID:12379762 20201215 RGD 1559043 MV/Opu myelin vacuolation rat strain MP:0008025 brain vacuoles IAGP N RGD:1299186|PMID:12379762 20201215 RGD 1559043 MV/Opu myelin vacuolation rat strain MP:0011731 decreased myelin sheath thickness IAGP N RGD:1299186|PMID:12379762 20201215 RGD 1559043 MV/Opu myelin vacuolation rat strain MP:0020456 decreased myelin sheath amount IAGP N RGD:1299186|PMID:12379762 20201215 RGD 1559044 SS.SR-(D3Mco19-D3Mco5)/Jr strain MP:0002834 decreased heart weight induced IAGP XCO:0000022 N RGD:1581650|PMID:17028336 20061213 RGD compared to SS/Jr 1559044 SS.SR-(D3Mco19-D3Mco5)/Jr strain MP:0002834 decreased heart weight induced IAGP XCO:0000022 N RGD:69705|PMID:9922389 19990101 RGD compared to SS/Jr 1559044 SS.SR-(D3Mco19-D3Mco5)/Jr strain MP:0002843 decreased systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:69705|PMID:9922389 19990101 RGD compared to SS/Jr 1559044 SS.SR-(D3Mco19-D3Mco5)/Jr strain MP:0006264 decreased systemic arterial systolic blood pressure induced IAGP XCO:0000022 N RGD:1581650|PMID:17028336 20061213 RGD compared to SS/Jr 1559045 LEW/Crlc strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:8657131|PMID:23442991 20210113 RGD compared to SS/JrHsd 1559047 SHRSP/Ezo strain MP:0003990 decreased neurotransmitter release IAGP N RGD:1556766|PMID:8610323 20200127 RGD compared to WKY 1559047 SHRSP/Ezo strain MP:0004000 impaired passive avoidance behavior IAGP XCO:0000055 N RGD:1556766|PMID:8610323 20190729 RGD compared to WKY 1559047 SHRSP/Ezo strain MP:0004836 abnormal synaptic acetylcholine release IAGP XCO:0000587 N RGD:1556766|PMID:8610323 20200127 RGD compared to WKY 1559047 SHRSP/Ezo strain MP:0030753 decreased choline level IAGP N RGD:1556766|PMID:8610323 20190729 RGD compared to WKY 1559048 SHR.ODS-Gulood/Shi strain MP:0001262 decreased body weight IAGP N RGD:1556471|PMID:11693268 20200420 RGD compared to ODS/Shi strain 1559048 SHR.ODS-Gulood/Shi strain MP:0002833 increased heart weight IAGP N RGD:1556471|PMID:11693268 20200128 RGD compared to ODS/Jcl strain 1559048 SHR.ODS-Gulood/Shi strain MP:0002833 increased heart weight induced IDA N RGD:1556471|PMID:11693268 20200420 RGD compared to SHR.ODS-Gulo^od/Shi fed on deficient diet supplemented with ascorbic acid (300 mg/kg) 1559048 SHR.ODS-Gulood/Shi strain MP:0002981 increased liver weight IAGP N RGD:1556471|PMID:11693268 20200420 RGD compared to ODS/Jcl strain 1559048 SHR.ODS-Gulood/Shi strain MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:1556471|PMID:11693268 20200420 RGD compared to ODS/Shi strain 1559048 SHR.ODS-Gulood/Shi strain MP:0006264 decreased systemic arterial systolic blood pressure induced IDA N RGD:1556471|PMID:11693268 20200128 RGD compared to SHR.ODS-Gulo^od/Shi fed on deficient diet supplemented with ascorbic acid (300 mg/kg) 1559048 SHR.ODS-Gulood/Shi strain MP:0011585 decreased alkaline phosphatase activity induced IDA N RGD:1556471|PMID:11693268 20200128 RGD compared to SHR.ODS-Gulo^od/Shi fed on deficient diet supplemented with ascorbic acid (300 mg/kg) 1559048 SHR.ODS-Gulood/Shi strain MP:0031195 decreased testicular artery wall-to-lumen ratio induced IDA N RGD:1556471|PMID:11693268 20200420 RGD compared to SHR.ODS-Gulo^od/Shi fed on deficient diet supplemented with ascorbic acid (300 mg/kg) 1559048 SHR.ODS-Gulood/Shi strain MP:0031257 decreased circulating vitamin C level IAGP N RGD:1556471|PMID:11693268 20200420 RGD compared to ODS/Shi strain 1559048 SHR.ODS-Gulood/Shi strain MP:0031260 decreased liver vitamin C level induced IDA N RGD:1556471|PMID:11693268 20200420 RGD compared to SHR.ODS-Gulo^od/Shi fed on deficient diet supplemented with ascorbic acid (300 mg/kg) 1559055 Bp278 Blood pressure QTL 278 qtl MP:0000230 abnormal systemic arterial blood pressure IAGP N RGD:1547847|PMID:15632271 19990101 RGD 1559282 Emca5 Estrogen-induced mammary cancer QTL 5 qtl MP:0001883 increased mammary adenocarcinoma incidence susceptibility IDA N RGD:1642522|PMID:16885383 20070928 RGD estrogen induced 1559283 Emca4 Estrogen-induced mammary cancer QTL 4 qtl MP:0001883 increased mammary adenocarcinoma incidence susceptibility IDA N RGD:1642522|PMID:16885383 20070928 RGD estrogen induced 1560339 Lgr6 leucine-rich repeat-containing G protein-coupled receptor 6 gene MP:0002871 albuminuria IAGP N RGD:12802369|PMID:23460292 20170407 RGD 1560339 Lgr6 leucine-rich repeat-containing G protein-coupled receptor 6 gene MP:0004217 salt-sensitive hypertension IAGP N RGD:12802369|PMID:23460292 20170407 RGD 1560849 Themis thymocyte selection associated gene MP:0002581 abnormal ileum morphology IAGP N RGD:38599149|PMID:22275874 20200914 RGD DNA:frameshift mutation: 1560849 Themis thymocyte selection associated gene MP:0003271 abnormal duodenum morphology IAGP N RGD:38599149|PMID:22275874 20200914 RGD DNA:frameshift mutation: 1560849 Themis thymocyte selection associated gene MP:0004002 abnormal jejunum morphology IAGP N RGD:38599149|PMID:22275874 20200914 RGD DNA:frameshift mutation: 1560849 Themis thymocyte selection associated gene MP:0005348 increased T cell proliferation IAGP N RGD:38599149|PMID:22275874 20200914 RGD DNA:frameshift mutation: 1560849 Themis thymocyte selection associated gene MP:0008567 decreased interferon-gamma secretion IAGP N RGD:38599149|PMID:22275874 20200914 RGD DNA:frameshift mutation: 1560849 Themis thymocyte selection associated gene MP:0008660 increased interleukin-10 secretion IAGP N RGD:38599149|PMID:22275874 20200914 RGD DNA:frameshift mutation: 1560849 Themis thymocyte selection associated gene MP:0008681 increased interleukin-17 secretion IAGP N RGD:38599149|PMID:22275874 20200914 RGD DNA:frameshift mutation: 1560849 Themis thymocyte selection associated gene MP:0008699 increased interleukin-4 secretion IAGP N RGD:38599149|PMID:22275874 20200914 RGD DNA:frameshift mutation: 1560849 Themis thymocyte selection associated gene MP:0013956 decreased colon length IAGP N RGD:38599149|PMID:22275874 20200914 RGD DNA:frameshift mutation: 1560849 Themis thymocyte selection associated gene MP:0013958 decreased small intestine length IAGP N RGD:38599149|PMID:22275874 20200914 RGD DNA:frameshift mutation: 1561168 Lrrk2 leucine-rich repeat kinase 2 gene MP:0000203 abnormal circulating aspartate transaminase level IMP N RGD:13462048|PMID:23799078 20201210 RGD 1561168 Lrrk2 leucine-rich repeat kinase 2 gene MP:0000208 decreased hematocrit IMP N RGD:13462048|PMID:23799078 20171206 RGD 1561168 Lrrk2 leucine-rich repeat kinase 2 gene MP:0001260 increased body weight IMP N RGD:12880447|PMID:24244710 20170508 RGD 1561168 Lrrk2 leucine-rich repeat kinase 2 gene MP:0001747 hypersecretion of adrenocorticotropin IMP N RGD:13462048|PMID:23799078 20171206 RGD 1561168 Lrrk2 leucine-rich repeat kinase 2 gene MP:0001751 increased circulating luteinizing hormone level IMP N RGD:13462048|PMID:23799078 20171206 RGD 1561168 Lrrk2 leucine-rich repeat kinase 2 gene MP:0002176 increased brain weight IMP N RGD:12880447|PMID:24244710 20170508 RGD 1561168 Lrrk2 leucine-rich repeat kinase 2 gene MP:0002644 decreased circulating triglyceride level IMP N RGD:13462048|PMID:23799078 20171206 RGD 1561168 Lrrk2 leucine-rich repeat kinase 2 gene MP:0002781 increased circulating testosterone level IMP N RGD:13462048|PMID:23799078 20171206 RGD 1561168 Lrrk2 leucine-rich repeat kinase 2 gene MP:0002874 decreased hemoglobin content IMP N RGD:13462048|PMID:23799078 20171206 RGD 1561168 Lrrk2 leucine-rich repeat kinase 2 gene MP:0002875 decreased erythrocyte cell number IMP N RGD:12880447|PMID:24244710 20170508 RGD 1561168 Lrrk2 leucine-rich repeat kinase 2 gene MP:0002875 decreased erythrocyte cell number IMP N RGD:13462048|PMID:23799078 20171206 RGD 1561168 Lrrk2 leucine-rich repeat kinase 2 gene MP:0002942 decreased circulating alanine transaminase level IMP N RGD:13462048|PMID:23799078 20171206 RGD 1561168 Lrrk2 leucine-rich repeat kinase 2 gene MP:0002965 increased circulating serum albumin level IMP N RGD:13462048|PMID:23799078 20171206 RGD 1561168 Lrrk2 leucine-rich repeat kinase 2 gene MP:0003020 decreased circulating chloride level IMP N RGD:13462048|PMID:23799078 20171206 RGD 1561168 Lrrk2 leucine-rich repeat kinase 2 gene MP:0003058 increased insulin secretion IMP N RGD:13462048|PMID:23799078 20171206 RGD 1561168 Lrrk2 leucine-rich repeat kinase 2 gene MP:0005012 decreased eosinophil cell number IMP N RGD:13462048|PMID:23799078 20171206 RGD 1561168 Lrrk2 leucine-rich repeat kinase 2 gene MP:0005016 decreased lymphocyte cell number IMP N RGD:13462048|PMID:23799078 20171206 RGD 1561168 Lrrk2 leucine-rich repeat kinase 2 gene MP:0005121 decreased circulating prolactin level IMP N RGD:13462048|PMID:23799078 20171206 RGD 1561168 Lrrk2 leucine-rich repeat kinase 2 gene MP:0005178 increased circulating cholesterol level IMP N RGD:12880447|PMID:24244710 20170508 RGD 1561168 Lrrk2 leucine-rich repeat kinase 2 gene MP:0005178 increased circulating cholesterol level IMP N RGD:13462048|PMID:23799078 20171206 RGD 1561168 Lrrk2 leucine-rich repeat kinase 2 gene MP:0005238 increased brain size IMP N RGD:12880447|PMID:24244710 20170508 RGD 1561168 Lrrk2 leucine-rich repeat kinase 2 gene MP:0005455 increased susceptibility to weight gain IMP N RGD:13462048|PMID:23799078 20171206 RGD 1561168 Lrrk2 leucine-rich repeat kinase 2 gene MP:0005553 increased circulating creatinine level IMP N RGD:12880447|PMID:24244710 20170508 RGD 1561168 Lrrk2 leucine-rich repeat kinase 2 gene MP:0005628 decreased circulating potassium level IMP N RGD:13462048|PMID:23799078 20171206 RGD 1561168 Lrrk2 leucine-rich repeat kinase 2 gene MP:0005632 decreased circulating aspartate transaminase level IMP N RGD:13462048|PMID:23799078 20171206 RGD 1561168 Lrrk2 leucine-rich repeat kinase 2 gene MP:0005635 decreased circulating bilirubin level IMP N RGD:13462048|PMID:23799078 20171206 RGD 1561168 Lrrk2 leucine-rich repeat kinase 2 gene MP:0010815 enlarged alveolar lamellar bodies IMP N RGD:13462051|PMID:24465451 20171207 RGD 1561168 Lrrk2 leucine-rich repeat kinase 2 gene MP:0010891 increased alveolar lamellar body number IMP N RGD:12880447|PMID:24244710 20170508 RGD 1561168 Lrrk2 leucine-rich repeat kinase 2 gene MP:0010993 decreased surfactant secretion IMP N RGD:13462051|PMID:24465451 20171207 RGD 1561201 Foxo4 forkhead box O4 gene MP:0004920 increased placenta weight IMP N RGD:158013768|PMID:36607602 20240912 RGD 1561201 Foxo4 forkhead box O4 gene MP:0008957 abnormal placenta junctional zone morphology IMP N RGD:158013768|PMID:36607602 20240912 RGD 1561201 Foxo4 forkhead box O4 gene MP:0011520 increased placental labyrinth size IMP N RGD:158013768|PMID:36607602 20240912 RGD 1561609 Tbc1d4 TBC1 domain family, member 4 gene MP:0005293 impaired glucose tolerance IMP N RGD:38596323|PMID:32053588 20200903 RGD 1561609 Tbc1d4 TBC1 domain family, member 4 gene MP:0005293 impaired glucose tolerance IMP N RGD:38596332|PMID:31034517 20200903 RGD 1561609 Tbc1d4 TBC1 domain family, member 4 gene MP:0005331 insulin resistance IMP N RGD:38596323|PMID:32053588 20200903 RGD 1561609 Tbc1d4 TBC1 domain family, member 4 gene MP:0005331 insulin resistance IMP N RGD:38596332|PMID:31034517 20200903 RGD 1561873 Myo15a myosin XVA gene MP:0002090 abnormal vision induces IAGP N RGD:150429616|PMID:21479269 20210909 RGD DNA:missense mutation:cds:exon 56 T>C, p.Leu3157Pro (rat) 1561873 Myo15a myosin XVA gene MP:0002090 abnormal vision induces IAGP XCO:0000181 N RGD:150429616|PMID:21479269 20210916 RGD compared to LEW/Ztm 1561873 Myo15a myosin XVA gene MP:0008450 retina photoreceptor degeneration induces IAGP N RGD:150429616|PMID:21479269 20210909 RGD DNA:missense mutation:cds:exon 56 T>C, p.Leu3157Pro (rat) 1561873 Myo15a myosin XVA gene MP:0008450 retina photoreceptor degeneration induces IAGP XCO:0000181 N RGD:150429616|PMID:21479269 20210916 RGD compared to LEW/Ztm 1561873 Myo15a myosin XVA gene MP:0008518 retina outer nuclear layer degeneration induces IAGP N RGD:150429616|PMID:21479269 20210909 RGD DNA:missense mutation:cds:exon 56 T>C, p.Leu3157Pro (rat) 1561873 Myo15a myosin XVA gene MP:0008518 retina outer nuclear layer degeneration induces IAGP XCO:0000181 N RGD:150429616|PMID:21479269 20210916 RGD compared to LEW/Ztm 1561873 Myo15a myosin XVA gene MP:0012038 abnormal a-wave implicit time induces IAGP N RGD:150429616|PMID:21479269 20210909 RGD DNA:missense mutation:cds:exon 56 T>C, p.Leu3157Pro (rat) 1561873 Myo15a myosin XVA gene MP:0012038 abnormal a-wave implicit time induces IAGP XCO:0000181 N RGD:150429616|PMID:21479269 20210916 RGD compared to LEW/Ztm 1561873 Myo15a myosin XVA gene MP:0012039 abnormal b-wave implicit time induces IAGP N RGD:150429616|PMID:21479269 20210909 RGD DNA:missense mutation:cds:exon 56 T>C, p.Leu3157Pro (rat) 1561873 Myo15a myosin XVA gene MP:0012039 abnormal b-wave implicit time induces IAGP XCO:0000181 N RGD:150429616|PMID:21479269 20210916 RGD compared to LEW/Ztm 1562468 Aph1b aph-1 homolog B, gamma secretase subunit gene MP:0012344 decreased gnawing activity IAGP N RGD:13703127|PMID:15721236 20180803 RGD DNA:duplications 1562710 Nmb neuromedin B gene MP:0001402 decreased locomotor activity IDA N RGD:1642338|PMID:7823417 20070912 RGD 1562710 Nmb neuromedin B gene MP:0001412 excessive scratching IDA N RGD:1642338|PMID:7823417 20070912 RGD increased frequency of episodes, not necessarily time spent 1562710 Nmb neuromedin B gene MP:0001441 increased grooming behavior IDA N RGD:1642338|PMID:7823417 20070912 RGD increased frequency of episodes, not necessarily time spent 1563582 Slc9a6 solute carrier family 9 member A6 gene MP:0000435 shortened head IMP N RGD:151664747|PMID:34928329 20231221 RGD 1563582 Slc9a6 solute carrier family 9 member A6 gene MP:0000852 small cerebellum IMP N RGD:151664747|PMID:34928329 20231221 RGD 1563582 Slc9a6 solute carrier family 9 member A6 gene MP:0000880 decreased Purkinje cell number IMP N RGD:151664747|PMID:34928329 20231221 RGD 1563582 Slc9a6 solute carrier family 9 member A6 gene MP:0001402 decreased locomotor activity IMP N RGD:151664747|PMID:34928329 20231221 RGD 1563582 Slc9a6 solute carrier family 9 member A6 gene MP:0001405 impaired coordination IMP N RGD:151664747|PMID:34928329 20231221 RGD 1563582 Slc9a6 solute carrier family 9 member A6 gene MP:0002757 decreased vertical activity IMP N RGD:151664747|PMID:34928329 20231221 RGD 1563582 Slc9a6 solute carrier family 9 member A6 gene MP:0003172 abnormal lysosome physiology IMP N RGD:151664747|PMID:34928329 20231221 RGD 1563582 Slc9a6 solute carrier family 9 member A6 gene MP:0003240 loss of hippocampal neurons IMP N RGD:151664747|PMID:34928329 20231221 RGD 1563582 Slc9a6 solute carrier family 9 member A6 gene MP:0003241 loss of cortex neurons IMP N RGD:151664747|PMID:34928329 20231221 RGD 1563582 Slc9a6 solute carrier family 9 member A6 gene MP:0003354 astrocytosis IMP N RGD:151664747|PMID:34928329 20231221 RGD 1563582 Slc9a6 solute carrier family 9 member A6 gene MP:0005405 axon degeneration IMP N RGD:151664747|PMID:34928329 20231221 RGD 1563582 Slc9a6 solute carrier family 9 member A6 gene MP:0008535 enlarged lateral ventricles IMP N RGD:151664747|PMID:34928329 20231221 RGD 1563582 Slc9a6 solute carrier family 9 member A6 gene MP:0008918 microgliosis IMP N RGD:151664747|PMID:34928329 20231221 RGD 1563582 Slc9a6 solute carrier family 9 member A6 gene MP:0020602 decreased cerebral cortex average cell area IMP N RGD:151664747|PMID:34928329 20231221 RGD 1563582 Slc9a6 solute carrier family 9 member A6 gene MP:0030940 impaired autophagy IMP N RGD:151664747|PMID:34928329 20231221 RGD 1563582 Slc9a6 solute carrier family 9 member A6 gene MP:0031561 increased ganglioside level IMP N RGD:151664747|PMID:34928329 20240321 RGD 1563709 tuba1c-ps1 tubulin, alpha 1C, pseudogene 1 gene MP:0004217 salt-sensitive hypertension IAGP N RGD:12798539|PMID:21257920 20170324 RGD 1564010 Edaradd EDAR associated via death domain gene MP:0000379 decreased hair follicle number IAGP N RGD:2304219|PMID:15829729 20201217 RGD compared to heterozygous animals 1564010 Edaradd EDAR associated via death domain gene MP:0000380 small hair follicles IAGP N RGD:2304219|PMID:15829729 20201214 RGD compared to heterozygous animals 1564010 Edaradd EDAR associated via death domain gene MP:0000400 abnormal awl hair morphology IAGP N RGD:14398762|PMID:22013926 20190430 RGD DNA:missense mutation:exon:p.Pro153Ser(rat) 1564010 Edaradd EDAR associated via death domain gene MP:0000410 waved hair IAGP N RGD:2304219|PMID:15829729 20201214 RGD compared to heterozygous animals 1564010 Edaradd EDAR associated via death domain gene MP:0000416 sparse hair IAGP N RGD:2304219|PMID:15829729 20201214 RGD compared to heterozygous animals 1564010 Edaradd EDAR associated via death domain gene MP:0000762 abnormal tongue morphology IAGP N RGD:14398762|PMID:22013926 20190430 RGD DNA:missense mutation:exon:p.Pro153Ser(rat) 1564010 Edaradd EDAR associated via death domain gene MP:0001262 decreased body weight IAGP N RGD:2304219|PMID:15829729 20201214 RGD compared to heterozygous animals 1564010 Edaradd EDAR associated via death domain gene MP:0002074 abnormal hair texture IAGP N RGD:2304219|PMID:15829729 20201214 RGD compared to heterozygous animals 1564010 Edaradd EDAR associated via death domain gene MP:0002716 small male preputial gland IAGP N RGD:14398762|PMID:22013926 20190430 RGD DNA:missense mutation:exon:p.Pro153Ser(rat) 1564010 Edaradd EDAR associated via death domain gene MP:0003344 mammary gland hypoplasia IAGP N RGD:2304219|PMID:15829729 20201214 RGD in females, compared to heterozygous animals 1564010 Edaradd EDAR associated via death domain gene MP:0006236 absent Meibomian glands IAGP N RGD:14398762|PMID:22013926 20190430 RGD DNA:missense mutation:exon:p.Pro153Ser(rat) 1564010 Edaradd EDAR associated via death domain gene MP:0006367 absent sweat gland IAGP N RGD:14398762|PMID:22013926 20190430 RGD DNA:missense mutation:exon:p.Pro153Ser(rat) 1564010 Edaradd EDAR associated via death domain gene MP:0009506 abnormal mammary gland alveolus morphology IAGP N RGD:14398762|PMID:22013926 20190430 RGD DNA:missense mutation:exon:p.Pro153Ser(rat) 1564010 Edaradd EDAR associated via death domain gene MP:0014033 abnormal submucosal gland morphology IAGP N RGD:14398763|PMID:31028034 20190430 RGD 1564010 Edaradd EDAR associated via death domain gene MP:0030457 abnormal molar cusp morphology IAGP N RGD:14398762|PMID:22013926 20190430 RGD DNA:missense mutation:exon:p.Pro153Ser(rat) 1564395 Plekha6 pleckstrin homology domain containing A6 gene MP:0002871 albuminuria IAGP N RGD:12802369|PMID:23460292 20170407 RGD 1564395 Plekha6 pleckstrin homology domain containing A6 gene MP:0004217 salt-sensitive hypertension IAGP N RGD:12802369|PMID:23460292 20170407 RGD 1564507 Nckap5 NCK-associated protein 5 gene MP:0004217 salt-sensitive hypertension IAGP N RGD:12798539|PMID:21257920 20170324 RGD 1564531 Trpv3 transient receptor potential cation channel, subfamily V, member 3 gene MP:0000324 increased mast cell number IAGP N RGD:150520053|PMID:16858425 20211025 RGD DNA:missense mutation:cds:G1717T (rat) 1565378 Spata22 spermatogenesis associated 22 gene MP:0001930 abnormal meiosis treatment IDA N RGD:38549346|PMID:23903057 20200831 RGD 1565378 Spata22 spermatogenesis associated 22 gene MP:0004852 decreased testis weight treatment IDA N RGD:38549346|PMID:23903057 20200831 RGD 1565378 Spata22 spermatogenesis associated 22 gene MP:0008279 arrest of spermiogenesis treatment IDA N RGD:38549346|PMID:23903057 20200831 RGD 1565378 Spata22 spermatogenesis associated 22 gene MP:0013236 ovary degeneration treatment IDA N RGD:38549346|PMID:23903057 20200831 RGD 1565499 Col4a5 collagen type IV alpha 5 chain gene MP:0001262 decreased body weight IMP N RGD:329845598|PMID:34675305 20240118 RGD 1565499 Col4a5 collagen type IV alpha 5 chain gene MP:0001762 polyuria IMP N RGD:329845598|PMID:34675305 20240118 RGD 1565499 Col4a5 collagen type IV alpha 5 chain gene MP:0002083 premature death onset IMP N RGD:329845598|PMID:34675305 20240118 RGD 1565499 Col4a5 collagen type IV alpha 5 chain gene MP:0005325 abnormal renal glomerulus morphology IMP N RGD:329845598|PMID:34675305 20240115 RGD 1565499 Col4a5 collagen type IV alpha 5 chain gene MP:0005553 increased circulating creatinine level IMP N RGD:329845598|PMID:34675305 20240115 RGD 1565499 Col4a5 collagen type IV alpha 5 chain gene MP:0005558 decreased creatinine clearance IMP N RGD:329845598|PMID:34675305 20240115 RGD 1565499 Col4a5 collagen type IV alpha 5 chain gene MP:0005565 increased blood urea nitrogen level IMP N RGD:329845598|PMID:34675305 20240118 RGD 1565499 Col4a5 collagen type IV alpha 5 chain gene MP:0011377 renal glomerulus fibrosis IMP N RGD:329845598|PMID:34675305 20240115 RGD 1565499 Col4a5 collagen type IV alpha 5 chain gene MP:0011409 increased renal glomerulus basement membrane thickness IMP N RGD:329845598|PMID:34675305 20240115 RGD 1565754 Fxn frataxin gene MP:0011630 increased mitochondrial size IMP N RGD:401793739|PMID:29223733 20230817 RGD 1566012 Frem2 FRAS1 related extracellular matrix 2 gene MP:0000564 syndactyly IAGP N RGD:13464328|PMID:21756877 20180103 RGD 1566012 Frem2 FRAS1 related extracellular matrix 2 gene MP:0009263 abnormal eyelid fusion IAGP N RGD:13464328|PMID:21756877 20180103 RGD 1566012 Frem2 FRAS1 related extracellular matrix 2 gene MP:0010977 fused right lung lobes IAGP N RGD:13464328|PMID:21756877 20180103 RGD 1566437 SS-Chr XBN/Mcwi strain MP:0005540 decreased urine albumin level sexual_dimorphism IAGP XCO:0000022 N RGD:2300225|PMID:18653478 20200122 RGD compared to male S-Chr XBN/Mcwi 1566455 HTX/HcjRrrc strain MP:0001891 hydrocephaly IAGP N RGD:1559414|PMID:7257730 19990101 RGD 1566456 BDIX/Zte strain MP:0002021 increased incidence of induced tumors IAGP N RGD:1559300|PMID:16003739 19990101 RGD 1576302 Schws4 Schwannoma susceptibility QTL 4 qtl MP:0002021 increased incidence of induced tumors IAGP N RGD:1559300|PMID:16003739 19990101 RGD 1576303 Ept7 Estrogen-induced pituitary tumorigenesis QTL 7 qtl MP:0000635 pituitary gland hyperplasia IDA N RGD:1642526|PMID:17876666 20070928 RGD 1576304 Schws7 Schwannoma susceptibility QTL 7 qtl MP:0002021 increased incidence of induced tumors IAGP N RGD:1559300|PMID:16003739 19990101 RGD 1576305 Emca6 Estrogen-induced mammary cancer QTL 6 qtl MP:0001883 increased mammary adenocarcinoma incidence susceptibility IDA N RGD:1642522|PMID:16885383 20070928 RGD estrogen induced 1576306 Schws3 Schwannoma susceptibility QTL 3 qtl MP:0002021 increased incidence of induced tumors IAGP N RGD:1559300|PMID:16003739 19990101 RGD 1576308 Schws1 Schwannoma susceptibility QTL 1 qtl MP:0002021 increased incidence of induced tumors IAGP N RGD:1559300|PMID:16003739 19990101 RGD 1576309 Emca7 Estrogen-induced mammary cancer QTL 7 qtl MP:0001883 increased mammary adenocarcinoma incidence IDA N RGD:1642522|PMID:16885383 20070928 RGD estrogen induced 1576310 Schws2 Schwannoma susceptibility QTL 2 qtl MP:0002021 increased incidence of induced tumors IAGP N RGD:1559300|PMID:16003739 19990101 RGD 1576311 Pia26 Pristane induced arthritis QTL 26 qtl MP:0002936 joint swelling IDA N RGD:1358860|PMID:15641042 20081215 RGD 1576312 Emca8 Estrogen-induced mammary cancer QTL 8 qtl MP:0001883 increased mammary adenocarcinoma incidence susceptibility IDA N RGD:1642522|PMID:16885383 20070928 RGD estrogen induced 1576314 Eutr1 Estrogen induced uterine response QTL 1 qtl MP:0002254 reproductive system inflammation IAGP N RGD:1559292|PMID:16284801 19990101 RGD 1576315 Schws6 Schwannoma susceptibility QTL 6 qtl MP:0002021 increased incidence of induced tumors IAGP N RGD:1559300|PMID:16003739 19990101 RGD 1576316 Ept5 Estrogen-induced pituitary tumorigenesis QTL 5 qtl MP:0000635 pituitary gland hyperplasia IDA N RGD:1642526|PMID:17876666 20070928 RGD 1576317 Eutr2 Estrogen induced uterine response QTL 2 qtl MP:0002254 reproductive system inflammation IAGP N RGD:1559291|PMID:16284802 19990101 RGD 1576318 Schws5 Schwannoma susceptibility QTL 5 qtl MP:0002021 increased incidence of induced tumors IAGP N RGD:1559300|PMID:16003739 19990101 RGD 1578646 Bmd18 Bone mineral density QTL 18 qtl MP:0000062 increased bone mineral density IAGP N RGD:1578307|PMID:16461031 19990101 RGD 1578647 Bmd17 Bone mineral density QTL 17 qtl MP:0000062 increased bone mineral density IAGP N RGD:1578307|PMID:16461031 19990101 RGD 1578648 Bss11 Bone structure and strength QTL 11 qtl MP:0003795 abnormal bone structure IAGP N RGD:1578307|PMID:16461031 19990101 RGD 1578649 Bmd8 Bone mineral density QTL 8 qtl MP:0000062 increased bone mineral density IAGP N RGD:1578307|PMID:16461031 19990101 RGD 1578650 Bmd6 Bone mineral density QTL 6 qtl MP:0000062 increased bone mineral density IAGP N RGD:1578307|PMID:16461031 19990101 RGD 1578651 Bmd7 Bone mineral density QTL 7 qtl MP:0000062 increased bone mineral density IAGP N RGD:1578307|PMID:16461031 19990101 RGD 1578652 Bmd15 Bone mineral density QTL 15 qtl MP:0000062 increased bone mineral density IAGP N RGD:1578307|PMID:16461031 19990101 RGD 1578653 Vnigr3 Vascular neointimal growth QTL 3 qtl MP:0005489 vascular smooth muscle hyperplasia IDA N RGD:2316923|PMID:20026763 20100317 RGD 1578653 Vnigr3 Vascular neointimal growth QTL 3 qtl MP:0006134 artery occlusion IDA N RGD:2316923|PMID:20026763 20100317 RGD 1578654 Bss10 Bone structure and strength QTL 10 qtl MP:0003795 abnormal bone structure IAGP N RGD:1578307|PMID:16461031 19990101 RGD 1578655 Bmd11 Bone mineral density QTL 11 qtl MP:0000062 increased bone mineral density IAGP N RGD:1578307|PMID:16461031 19990101 RGD 1578657 Bss12 Bone structure and strength QTL 12 qtl MP:0003795 abnormal bone structure IAGP N RGD:1578307|PMID:16461031 19990101 RGD 1578658 Bss13 Bone structure and strength QTL 13 qtl MP:0003795 abnormal bone structure IAGP N RGD:1578307|PMID:16461031 19990101 RGD 1578659 Tspe1 Trichinella spiralis expulsion QTL 1 qtl MP:0005026 decreased susceptibility to parasitic infection IAGP N RGD:1578305|PMID:16465509 19990101 RGD 1578660 Bss19 Bone structure and strength QTL 19 qtl MP:0003795 abnormal bone structure IAGP N RGD:1578307|PMID:16461031 19990101 RGD 1578661 Bss20 Bone structure and strength QTL 20 qtl MP:0003795 abnormal bone structure IAGP N RGD:1578307|PMID:16461031 19990101 RGD 1578662 Bss15 Bone structure and strength QTL 15 qtl MP:0003795 abnormal bone structure IAGP N RGD:1578307|PMID:16461031 19990101 RGD 1578663 Bss18 Bone structure and strength QTL 18 qtl MP:0003795 abnormal bone structure IAGP N RGD:1578307|PMID:16461031 19990101 RGD 1578664 Bmd9 Bone mineral QTL density 9 qtl MP:0000062 increased bone mineral density IAGP N RGD:1578307|PMID:16461031 19990101 RGD 1578665 Bss16 Bone structure and strength QTL 16 qtl MP:0003795 abnormal bone structure IAGP N RGD:1578307|PMID:16461031 19990101 RGD 1578667 Bss21 Bone structure and strength QTL 21 qtl MP:0003795 abnormal bone structure IAGP N RGD:1578307|PMID:16461031 19990101 RGD 1578668 Bmd14 Bone mineral density QTL 14 qtl MP:0000062 increased bone mineral density IAGP N RGD:1578307|PMID:16461031 19990101 RGD 1578669 Bss9 Bone structure and strength QTL 9 qtl MP:0003795 abnormal bone structure IAGP N RGD:1578307|PMID:16461031 19990101 RGD 1578670 Bss14 Bone structure and strength QTL 14 qtl MP:0003795 abnormal bone structure IAGP N RGD:1578307|PMID:16461031 19990101 RGD 1578671 Bmd10 Bone mineral density QTL 10 qtl MP:0000062 increased bone mineral density IAGP N RGD:1578307|PMID:16461031 19990101 RGD 1578672 Bmd16 Bone mineral density QTL 16 qtl MP:0000062 increased bone mineral density IAGP N RGD:1578307|PMID:16461031 19990101 RGD 1578673 Bmd13 Bone mineral density QTL 13 qtl MP:0000062 increased bone mineral density IAGP N RGD:1578307|PMID:16461031 19990101 RGD 1578674 Bmd12 Bone mineral density QTL 12 qtl MP:0000062 increased bone mineral density IAGP N RGD:1578307|PMID:16461031 19990101 RGD 1578675 Bss17 Bone structure and strength QTL 17 qtl MP:0003795 abnormal bone structure IAGP N RGD:1578307|PMID:16461031 19990101 RGD 1578692 BN.LEW-(D10Rat32-D10Rat116)/Ciml strain MP:0005026 decreased susceptibility to parasitic infection IAGP N RGD:1578521|PMID:16407112 19990101 RGD 1578693 LEW.BN-(D10Mco17-D10Rat221)/Ciml strain MP:0005027 increased susceptibility to parasitic infection IAGP N RGD:1578521|PMID:16407112 19990101 RGD 1578697 BN.LEW-(D10Rat32-D10Rat31)/Ciml strain MP:0005026 decreased susceptibility to parasitic infection IAGP N RGD:1578521|PMID:16407112 19990101 RGD 1578699 BG anemic Belgrade strain MP:0000691 enlarged spleen IAGP N RGD:1578513|PMID:9210290 20201112 RGD 1578699 BG anemic Belgrade strain MP:0001770 abnormal iron level IAGP N RGD:1578513|PMID:9210290 19990101 RGD 1578699 BG anemic Belgrade strain MP:0002810 microcytic anemia IAGP N RGD:729808|PMID:9448300 19990101 RGD 1578702 LEW.BN-(D10Rat32-D10Rat133)/Ciml strain MP:0005027 increased susceptibility to parasitic infection IAGP N RGD:1578521|PMID:16407112 19990101 RGD 1578704 WLP Warsaw Low Prefering strain MP:0003546 decreased alcohol consumption IAGP N RGD:1358540|PMID:15215567 19990101 RGD compared to WHP rats 1578704 WLP Warsaw Low Prefering strain MP:0012042 low alcohol preference IAGP N RGD:1358540|PMID:15215567 20200911 RGD compared to WHP 1578705 LEW.BN-(D10Arb4-D10Rat133)/Ciml strain MP:0005027 increased susceptibility to parasitic infection IAGP N RGD:1578521|PMID:16407112 19990101 RGD 1578706 LEW.BN-(D10Mco17-D10Mco14)/Ciml strain MP:0005026 decreased susceptibility to parasitic infection IAGP N RGD:1578521|PMID:16407112 19990101 RGD 1578708 LEW.BN-(D10Mgh7-D10Rat221)/Ciml strain MP:0005027 increased susceptibility to parasitic infection IAGP N RGD:1578521|PMID:16407112 19990101 RGD 1578709 IA incisor absent strain MP:0003053 delayed tooth eruption IAGP N RGD:1578477|PMID:818350 19990101 RGD 1578710 LEW.1AR1-iddm/Ztm strain MP:0001559 hyperglycemia IAGP N RGD:1547853|PMID:16075370 19990101 RGD compared to LEW.1AR1/Ztm strain 1578710 LEW.1AR1-iddm/Ztm strain MP:0003944 abnormal T cell subpopulation ratio IAGP N RGD:1547853|PMID:16075370 20200512 RGD compared to LEW.1AR1/Ztm strain 1578710 LEW.1AR1-iddm/Ztm strain MP:0005215 abnormal pancreatic islet morphology IAGP N RGD:1547853|PMID:16075370 19990101 RGD compared to LEW.1AR1/Ztm strain 1578710 LEW.1AR1-iddm/Ztm strain MP:0005350 increased susceptibility to autoimmune disorder IAGP N RGD:1547853|PMID:16075370 19990101 RGD compared to LEW.1AR1/Ztm strain 1578710 LEW.1AR1-iddm/Ztm strain MP:0014121 increased pancreatic islet cell apoptosis susceptibility IAGP N RGD:41412198|PMID:11596676 20210223 RGD 1578711 LEW.BN-(D10Mco17-D10Rat133)/Ciml strain MP:0005027 increased susceptibility to parasitic infection IAGP N RGD:1578521|PMID:16407112 19990101 RGD 1578712 BN.LEW-(D10Mco17-D10Mco14)/Ciml strain MP:0005027 increased susceptibility to parasitic infection IAGP N RGD:1578521|PMID:16407112 19990101 RGD 1578714 BN.LEW-(D10Mco17-D10Rat80)/Ciml strain MP:0005026 decreased susceptibility to parasitic infection IAGP N RGD:1578521|PMID:16407112 19990101 RGD 1578715 ANT Alcohol-Nontolerant strain MP:0001393 ataxia induced IAGP XCO:0000325 N RGD:1578556|PMID:15082942 19990101 RGD compared to treated AT 1578717 WHP Warsaw High Prefering strain MP:0001987 alcohol preference IAGP N RGD:1358540|PMID:15215567 20200911 RGD compared to WLP rats 1578717 WHP Warsaw High Prefering strain MP:0003545 increased alcohol consumption IAGP N RGD:1358540|PMID:15215567 19990101 RGD compared to WLP rats 1578717 WHP Warsaw High Prefering strain MP:0009751 enhanced behavioral response to alcohol IAGP N RGD:1358540|PMID:15215567 20200911 RGD compared to WLP, Wistar, and saline treated WHP rats 1578717 WHP Warsaw High Prefering strain MP:0011940 decreased food intake IAGP N RGD:1358540|PMID:15215567 20200911 RGD compared to WLP rats 1578755 Pur5 Proteinuria QTL 5 qtl MP:0002962 increased urine protein level IAGP N RGD:1578520|PMID:16534143 19990101 RGD 1578756 Iddm22 Insulin dependent diabetes mellitus QTL 22 qtl MP:0001559 hyperglycemia IAGP N RGD:1547853|PMID:16075370 19990101 RGD 1578756 Iddm22 Insulin dependent diabetes mellitus QTL 22 qtl MP:0005215 abnormal pancreatic islet morphology IAGP N RGD:1547853|PMID:16075370 19990101 RGD 1578756 Iddm22 Insulin dependent diabetes mellitus QTL 22 qtl MP:0005350 increased susceptibility to autoimmune disorder IAGP N RGD:1547853|PMID:16075370 19990101 RGD 1578757 Pur6 Proteinuria QTL 6 qtl MP:0002962 increased urine protein level IAGP N RGD:1578520|PMID:16534143 19990101 RGD 1578758 Tcas9 Tongue tumor susceptibility QTL 9 qtl MP:0010272 increased tongue tumor incidence IDA N RGD:634723|PMID:11429048 20111115 RGD 1578759 Uae30 Urinary albumin excretion QTL 30 qtl MP:0002871 albuminuria IAGP N RGD:1578520|PMID:16534143 19990101 RGD 1578760 Cm53 Cardiac mass QTL 53 qtl MP:0002834 decreased heart weight IAGP N RGD:1578520|PMID:16534143 19990101 RGD 1578762 Toxo1 Toxoplasma gondii resistance QTL 1 qtl MP:0005026 decreased susceptibility to parasitic infection IAGP N RGD:1578521|PMID:16407112 19990101 RGD 1578763 Kidm29 Kidney mass QTL 29 qtl MP:0002135 abnormal kidney morphology IAGP N RGD:1578520|PMID:16534143 19990101 RGD 1578766 Tcas11 Tongue tumor susceptibility QTL 11 qtl MP:0010272 increased tongue tumor incidence IDA N RGD:1578522|PMID:16527513 20111115 RGD 1578769 Uae31 Urinary albumin excretion QTL 31 qtl MP:0002871 albuminuria IAGP N RGD:1578520|PMID:16534143 19990101 RGD 1578770 Stresp23 Stress response QTL 23 qtl MP:0002626 increased heart rate IAGP N RGD:1578503|PMID:16239369 19990101 RGD 1578770 Stresp23 Stress response QTL 23 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:1578503|PMID:16239369 19990101 RGD 1578770 Stresp23 Stress response QTL 23 qtl MP:0004051 increased renal sympathetic nerve activity IAGP N RGD:1578503|PMID:16239369 19990101 RGD 1578773 Iddm23 Insulin dependent diabetes mellitus QTL 23 qtl MP:0001559 hyperglycemia IAGP N RGD:1547853|PMID:16075370 19990101 RGD 1578773 Iddm23 Insulin dependent diabetes mellitus QTL 23 qtl MP:0005215 abnormal pancreatic islet morphology IAGP N RGD:1547853|PMID:16075370 19990101 RGD 1578773 Iddm23 Insulin dependent diabetes mellitus QTL 23 qtl MP:0005350 increased susceptibility to autoimmune disorder IAGP N RGD:1547853|PMID:16075370 19990101 RGD 1578774 Tcas8 Tongue tumor susceptibility QTL 8 qtl MP:0010272 increased tongue tumor incidence IDA N RGD:634723|PMID:11429048 20111115 RGD 1578775 Iddm21 Insulin dependent diabetes mellitus QTL 21 qtl MP:0001559 hyperglycemia IAGP N RGD:1547853|PMID:16075370 19990101 RGD 1578775 Iddm21 Insulin dependent diabetes mellitus QTL 21 qtl MP:0005215 abnormal pancreatic islet morphology IAGP N RGD:1547853|PMID:16075370 19990101 RGD 1578775 Iddm21 Insulin dependent diabetes mellitus QTL 21 qtl MP:0005350 increased susceptibility to autoimmune disorder IAGP N RGD:1547853|PMID:16075370 19990101 RGD 1578778 Pur4 Proteinuria QTL 4 qtl MP:0002962 increased urine protein level IAGP N RGD:1578520|PMID:16534143 19990101 RGD 1578779 Tcas10 Tongue tumor susceptibility QTL 10 qtl MP:0010272 increased tongue tumor incidence IDA N RGD:634723|PMID:11429048 20111115 RGD 1578780 Cm52 Cardiac mass QTL 52 qtl MP:0002834 decreased heart weight IAGP N RGD:1578520|PMID:16534143 19990101 RGD 1578791 Nr4a1m1Mcwi nuclear receptor subfamily 4, group A, member 1; mutation 1, Medical College of Wisconsin gene MP:0001262 decreased body weight IMP N RGD:12910103|PMID:24722447 20201210 RGD compared to FHH 1578791 Nr4a1m1Mcwi nuclear receptor subfamily 4, group A, member 1; mutation 1, Medical College of Wisconsin gene MP:0001552 increased circulating triglyceride level IMP N RGD:12910103|PMID:24722447 20201210 RGD compared to FHH 1578791 Nr4a1m1Mcwi nuclear receptor subfamily 4, group A, member 1; mutation 1, Medical College of Wisconsin gene MP:0003215 renal interstitial fibrosis IMP N RGD:12910103|PMID:24722447 20201210 RGD compared to FHH 1578791 Nr4a1m1Mcwi nuclear receptor subfamily 4, group A, member 1; mutation 1, Medical College of Wisconsin gene MP:0003492 abnormal involuntary movement treatment IMP XCO:0000498,XCO:0000520 N RGD:40924655|PMID:29530712 20210304 RGD 1578791 Nr4a1m1Mcwi nuclear receptor subfamily 4, group A, member 1; mutation 1, Medical College of Wisconsin gene MP:0003917 increased kidney weight IMP N RGD:12910103|PMID:24722447 20201210 RGD compared to FHH 1578791 Nr4a1m1Mcwi nuclear receptor subfamily 4, group A, member 1; mutation 1, Medical College of Wisconsin gene MP:0005528 decreased renal glomerular filtration rate IMP N RGD:12910103|PMID:24722447 20190821 RGD 1578791 Nr4a1m1Mcwi nuclear receptor subfamily 4, group A, member 1; mutation 1, Medical College of Wisconsin gene MP:0005558 decreased creatinine clearance IMP N RGD:12910103|PMID:24722447 20201210 RGD compared to FHH 1578791 Nr4a1m1Mcwi nuclear receptor subfamily 4, group A, member 1; mutation 1, Medical College of Wisconsin gene MP:0005565 increased blood urea nitrogen level IMP N RGD:12910103|PMID:24722447 20201210 RGD compared to FHH 1578791 Nr4a1m1Mcwi nuclear receptor subfamily 4, group A, member 1; mutation 1, Medical College of Wisconsin gene MP:0013219 abnormal substantia nigra pars compacta morphology IMP N RGD:40924655|PMID:29530712 20210211 RGD compared to wild-type and untreated 1578791 Nr4a1m1Mcwi nuclear receptor subfamily 4, group A, member 1; mutation 1, Medical College of Wisconsin gene MP:0030585 enhanced behavioral response to amphetamine IMP N RGD:40924655|PMID:29530712 20210211 RGD compared to saline-treated 1578794 Ghsrm1Mcwi growth hormone secretagogue receptor; mutation 1, Medical College of Wisconsin gene MP:0001392 abnormal locomotor behavior IMP N RGD:150520013|PMID:27129673 20211021 RGD compared to wild type rats 1578794 Ghsrm1Mcwi growth hormone secretagogue receptor; mutation 1, Medical College of Wisconsin gene MP:0005120 decreased circulating growth hormone level IMP N RGD:150520013|PMID:27129673 20211021 RGD compared to wild type rats in response to ghrelin (CHEBI:75431) 1578794 Ghsrm1Mcwi growth hormone secretagogue receptor; mutation 1, Medical College of Wisconsin gene MP:0011082 abnormal gastrointestinal motility IMP N RGD:150520012|PMID:21258824 20211021 RGD compared to wild type rats in response to ghrelin (CHEBI:75431) 1578794 Ghsrm1Mcwi growth hormone secretagogue receptor; mutation 1, Medical College of Wisconsin gene MP:0011940 decreased food intake IMP N RGD:150520012|PMID:21258824 20211021 RGD compared to wild type rats in response to ghrelin (CHEBI:75431) 1578794 Ghsrm1Mcwi growth hormone secretagogue receptor; mutation 1, Medical College of Wisconsin gene MP:0011940 decreased food intake IMP N RGD:150520013|PMID:27129673 20211021 RGD compared to wild type rats 1578794 Ghsrm1Mcwi growth hormone secretagogue receptor; mutation 1, Medical College of Wisconsin gene MP:0020871 abnormal locomotor response to cocaine IMP N RGD:150429661|PMID:21790898 20210916 RGD compared to wild type strain FHH/EurMcwi 1578794 Ghsrm1Mcwi growth hormone secretagogue receptor; mutation 1, Medical College of Wisconsin gene MP:0020896 abnormal locomotor sensitization to cocaine IMP N RGD:150429661|PMID:21790898 20210916 RGD compared to wild type strain FHH/EurMcwi 1579683 FHH-Ghsrm1Mcwi strain MP:0001392 abnormal locomotor behavior IMP N RGD:150520013|PMID:27129673 20211020 RGD compared to wild type rats 1579683 FHH-Ghsrm1Mcwi strain MP:0005120 decreased circulating growth hormone level IMP N RGD:150520013|PMID:27129673 20211020 RGD compared to wild type rats in response to ghrelin (CHEBI:75431) 1579683 FHH-Ghsrm1Mcwi strain MP:0011082 abnormal gastrointestinal motility IMP N RGD:150520012|PMID:21258824 20211020 RGD compared to wild type rats in response to ghrelin (CHEBI:75431) 1579683 FHH-Ghsrm1Mcwi strain MP:0011940 decreased food intake IMP N RGD:150520012|PMID:21258824 20211020 RGD compared to wild type rats in response to ghrelin (CHEBI:75431) 1579683 FHH-Ghsrm1Mcwi strain MP:0011940 decreased food intake IMP N RGD:150520013|PMID:27129673 20211020 RGD compared to wild type rats 1579683 FHH-Ghsrm1Mcwi strain MP:0020871 abnormal locomotor response to cocaine IMP N RGD:150429661|PMID:21790898 20210914 RGD compared to wild type strain FHH/EurMcwi 1579683 FHH-Ghsrm1Mcwi strain MP:0020896 abnormal locomotor sensitization to cocaine IMP N RGD:150429661|PMID:21790898 20210914 RGD compared to wild type strain FHH/EurMcwi 1579693 T2DN/Mcwi strain MP:0001552 increased circulating triglyceride level IAGP N RGD:1303373|PMID:14988259 20210125 RGD compared to BN/NHsdMcwi 1579693 T2DN/Mcwi strain MP:0002962 increased urine protein level IAGP N RGD:1303373|PMID:14988259 20120112 RGD compared to GK/Far, BN/NHsdMcwi 1579693 T2DN/Mcwi strain MP:0003917 increased kidney weight IAGP N RGD:1303373|PMID:14988259 20210125 RGD compared to BN/NHsdMcwi 1579693 T2DN/Mcwi strain MP:0005178 increased circulating cholesterol level IAGP N RGD:1303373|PMID:14988259 20200303 RGD compared to BN/NHsdMcwi 1579693 T2DN/Mcwi strain MP:0005293 impaired glucose tolerance IAGP N RGD:1303373|PMID:14988259 20200302 RGD 1579693 T2DN/Mcwi strain MP:0005553 increased circulating creatinine level IAGP N RGD:1303373|PMID:14988259 20200302 RGD compared to GK/Far 1579693 T2DN/Mcwi strain MP:0011294 renal glomerulus hypertrophy IAGP N RGD:1303373|PMID:14988259 20210125 RGD compared to BN/NHsdMcwi 1579693 T2DN/Mcwi strain MP:0011353 expanded mesangial matrix IAGP N RGD:1303373|PMID:14988259 20210125 RGD compared to GK/Far 1579693 T2DN/Mcwi strain MP:0011409 increased renal glomerulus basement membrane thickness IAGP N RGD:1303373|PMID:14988259 20200303 RGD compared to BN/NHsdMcwi 1579693 T2DN/Mcwi strain MP:0011431 increased urine flow rate IAGP N RGD:1303373|PMID:14988259 20200302 RGD compared to GK/Far, BN/NHsdMcwi 1579697 SS.SHR-(D13Rat63-D13Mit1)/Mco strain MP:0001260 increased body weight IAGP N RGD:2314528|PMID:19176703 20091119 RGD compared to SS/Jr 1579697 SS.SHR-(D13Rat63-D13Mit1)/Mco strain MP:0002963 decreased urine protein level IAGP N RGD:2314528|PMID:19176703 20091119 RGD compared to SS/Jr 1579702 SS.SHR-(D9Wox16-D9Rat64)/Mco strain MP:0002834 decreased heart weight IMP N RGD:2302803|PMID:18854752 20201016 RGD 1579702 SS.SHR-(D9Wox16-D9Rat64)/Mco strain MP:0004876 decreased mean systemic arterial blood pressure IMP N RGD:2302803|PMID:18854752 20090205 RGD on 2%NaCl diet; compared to Dahl salt-sensitive (S/jr) rat 1579703 SS.SHR-(D2Rat61-D2Mco18)/Mco strain MP:0005540 decreased urine albumin level IAGP N RGD:1625111|PMID:17504948 20191126 RGD compared to SS/JrMco 1579706 FHH-Nr4a1m1Mcwi strain MP:0001262 decreased body weight IMP N RGD:12910103|PMID:24722447 20191206 RGD compared to FHH 1579706 FHH-Nr4a1m1Mcwi strain MP:0001552 increased circulating triglyceride level IMP N RGD:12910103|PMID:24722447 20191206 RGD compared to FHH 1579706 FHH-Nr4a1m1Mcwi strain MP:0003215 renal interstitial fibrosis IMP N RGD:12910103|PMID:24722447 20191206 RGD compared to FHH 1579706 FHH-Nr4a1m1Mcwi strain MP:0003492 abnormal involuntary movement treatment IMP XCO:0000498,XCO:0000520 N RGD:40924655|PMID:29530712 20210210 RGD 1579706 FHH-Nr4a1m1Mcwi strain MP:0003917 increased kidney weight IMP N RGD:12910103|PMID:24722447 20191206 RGD compared to FHH 1579706 FHH-Nr4a1m1Mcwi strain MP:0005528 decreased renal glomerular filtration rate IMP N RGD:12910103|PMID:24722447 20190821 RGD compared to FHH 1579706 FHH-Nr4a1m1Mcwi strain MP:0005558 decreased creatinine clearance IMP N RGD:12910103|PMID:24722447 20191206 RGD compared to FHH 1579706 FHH-Nr4a1m1Mcwi strain MP:0005565 increased blood urea nitrogen level IMP N RGD:12910103|PMID:24722447 20191206 RGD compared to FHH 1579706 FHH-Nr4a1m1Mcwi strain MP:0013219 abnormal substantia nigra pars compacta morphology induced IMP XCO:0000498 N RGD:40924655|PMID:29530712 20210210 RGD compared to wild-type and untreated 1579706 FHH-Nr4a1m1Mcwi strain MP:0030585 enhanced behavioral response to amphetamine induced IMP XCO:0000520 N RGD:40924655|PMID:29530712 20210210 RGD compared to saline-treated 1579710 GK/Far Goto-Kakizaki strain MP:0001552 increased circulating triglyceride level IAGP N RGD:1303373|PMID:14988259 20200303 RGD compared to BN/NHsdMcwi 1579710 GK/Far Goto-Kakizaki strain MP:0003917 increased kidney weight IAGP N RGD:1303373|PMID:14988259 20200303 RGD compared to BN/NHsdMcwi 1579710 GK/Far Goto-Kakizaki strain MP:0005178 increased circulating cholesterol level IAGP N RGD:1303373|PMID:14988259 20200303 RGD compared to BN/NHsdMcwi 1579710 GK/Far Goto-Kakizaki strain MP:0005293 impaired glucose tolerance IAGP N RGD:1303373|PMID:14988259 19990101 RGD 1579710 GK/Far Goto-Kakizaki strain MP:0011294 renal glomerulus hypertrophy IAGP N RGD:1303373|PMID:14988259 20200303 RGD compared to BN/NHsdMcwi 1579710 GK/Far Goto-Kakizaki strain MP:0011409 increased renal glomerulus basement membrane thickness IAGP N RGD:1303373|PMID:14988259 20200303 RGD compared to BN/NHsdMcwi 1579894 SS.LEW-(D10Rat204-D10Rat9)/Ayd strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:1559293|PMID:16286573 20080417 RGD compared to SS/Jr 1579898 SS.LEW-(D10Chm128-D10Chm121)/Ayd strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:1559293|PMID:16286573 20080417 RGD compared to SS/Jr 1579901 SS.LEW-(D10Chm224-D10Chm6)/Ayd strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:1559293|PMID:16286573 20080417 RGD compared to SS/Jr 1579901 SS.LEW-(D10Chm224-D10Chm6)/Ayd strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:2292238|PMID:18398331 20080417 RGD compared to SS/Jr 1579903 SS.LEW-(D10Chm10-D10Rat11)/Ayd strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:1601352|PMID:17420333 20071117 RGD compared to LEW/Crlc 1579903 SS.LEW-(D10Chm10-D10Rat11)/Ayd strain MP:0004875 increased mean systemic arterial blood pressure IAGP N RGD:1601352|PMID:17420333 20071117 RGD compared to LEW/Crlc 1579903 SS.LEW-(D10Chm10-D10Rat11)/Ayd strain MP:0004876 decreased mean systemic arterial blood pressure IAGP N RGD:1601352|PMID:17420333 20071117 RGD compared to SS/Jr 1579903 SS.LEW-(D10Chm10-D10Rat11)/Ayd strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:2292238|PMID:18398331 20080417 RGD compared to SS/Jr 1579903 SS.LEW-(D10Chm10-D10Rat11)/Ayd strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:7421500|PMID:23814039 20131211 RGD compared to parental SS/Jr 1579903 SS.LEW-(D10Chm10-D10Rat11)/Ayd strain MP:0005333 decreased heart rate IAGP N RGD:1601352|PMID:17420333 20071117 RGD compared to SS/Jr 1579907 SS.LEW-(D10Chm128-D10Chm169)/Ayd strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:1559293|PMID:16286573 20080417 RGD similar to SS/Jr 1579913 SS.LEW-(D10Chm224-D10Chm222)/Ayd strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:1559293|PMID:16286573 20080417 RGD compared to SS/Jr 1579914 SS.LEW-(D10Mco30-D10Got92)/Ayd strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:1559293|PMID:16286573 20080417 RGD similar to SS/Jr 1579915 Bp280 Blood pressure QTL 280 qtl MP:0000230 abnormal systemic arterial blood pressure IAGP N RGD:1599557|PMID:17143582 20081029 RGD 1579916 Bp270 Blood pressure QTL 270 qtl MP:0004875 increased mean systemic arterial blood pressure IAGP N RGD:1599557|PMID:17143582 20081029 RGD 1579917 Bp282 Blood pressure QTL 282 qtl MP:0006264 decreased systemic arterial systolic blood pressure IDA N RGD:1559293|PMID:16286573 20080418 RGD 1579918 Bp279 Blood pressure QTL 279 qtl MP:0000230 abnormal systemic arterial blood pressure IAGP N RGD:1559293|PMID:16286573 20080418 RGD 1579919 Bp281 Blood pressure QTL 281 qtl MP:0000230 abnormal systemic arterial blood pressure IAGP N RGD:1559293|PMID:16286573 20080418 RGD 158013766 SD-Akt1em1Soar strain MP:0004921 decreased placenta weight IMP N RGD:158013768|PMID:36607602 20240618 RGD 158013766 SD-Akt1em1Soar strain MP:0009431 decreased fetal weight IMP N RGD:158013768|PMID:36607602 20240618 RGD 158013766 SD-Akt1em1Soar strain MP:0011521 decreased placental labyrinth size IMP N RGD:158013768|PMID:36607602 20240618 RGD 158013767 Akt1em1Soar AKT serine/threonine kinase 1; CRISPR/Cas9 induced mutant 1, Soar gene MP:0004921 decreased placenta weight IMP N RGD:158013768|PMID:36607602 20240620 RGD 158013767 Akt1em1Soar AKT serine/threonine kinase 1; CRISPR/Cas9 induced mutant 1, Soar gene MP:0009431 decreased fetal weight IMP N RGD:158013768|PMID:36607602 20240620 RGD 158013767 Akt1em1Soar AKT serine/threonine kinase 1; CRISPR/Cas9 induced mutant 1, Soar gene MP:0011521 decreased placental labyrinth size IMP N RGD:158013768|PMID:36607602 20240620 RGD 1580542 PCK-Pkhd1pck/CrljCrl strain MP:0000522 kidney cortex cyst IAGP N RGD:13524566|PMID:25753522 20190903 RGD 1580542 PCK-Pkhd1pck/CrljCrl strain MP:0001492 abnormal pilomotor reflex IAGP N RGD:1580540|PMID:10803363 20061024 RGD 1580542 PCK-Pkhd1pck/CrljCrl strain MP:0001577 anemia IAGP N RGD:1580540|PMID:10803363 20061024 RGD 1580542 PCK-Pkhd1pck/CrljCrl strain MP:0002962 increased urine protein level IAGP N RGD:628435|PMID:11135065 20180523 RGD compared to Crl:SD; 1580542 PCK-Pkhd1pck/CrljCrl strain MP:0002981 increased liver weight IAGP N RGD:1580540|PMID:10803363 20191120 RGD compared to Crj:CD(SD) 1580542 PCK-Pkhd1pck/CrljCrl strain MP:0002981 increased liver weight IAGP N RGD:628435|PMID:11135065 20061024 RGD compared to Crl:SD; 1580542 PCK-Pkhd1pck/CrljCrl strain MP:0003327 liver cyst IAGP N RGD:13524566|PMID:25753522 20190903 RGD 1580542 PCK-Pkhd1pck/CrljCrl strain MP:0003333 liver fibrosis IAGP N RGD:13524566|PMID:25753522 20190903 RGD 1580542 PCK-Pkhd1pck/CrljCrl strain MP:0003675 kidney cyst IAGP N RGD:12910103|PMID:24722447 20191206 RGD compared to Crl:SD, compared to FHH 1580542 PCK-Pkhd1pck/CrljCrl strain MP:0003917 increased kidney weight IAGP N RGD:12910103|PMID:24722447 20191206 RGD compared to Crl:SD, compared to FHH 1580542 PCK-Pkhd1pck/CrljCrl strain MP:0003917 increased kidney weight IAGP N RGD:1580540|PMID:10803363 20061024 RGD compared to Crj:CD(SD) 1580542 PCK-Pkhd1pck/CrljCrl strain MP:0003917 increased kidney weight IAGP N RGD:628435|PMID:11135065 20061024 RGD compared to Crl:SD; 1580542 PCK-Pkhd1pck/CrljCrl strain MP:0004860 dilated kidney collecting duct IAGP N RGD:13524566|PMID:25753522 20190903 RGD 1580542 PCK-Pkhd1pck/CrljCrl strain MP:0004875 increased mean systemic arterial blood pressure IAGP N RGD:12910103|PMID:24722447 20191206 RGD compared to Crl:SD 1580542 PCK-Pkhd1pck/CrljCrl strain MP:0005553 increased circulating creatinine level IAGP N RGD:12910103|PMID:24722447 20191206 RGD compared to Crl:SD, compared to FHH 1580542 PCK-Pkhd1pck/CrljCrl strain MP:0005565 increased blood urea nitrogen level IAGP N RGD:12910103|PMID:24722447 20191206 RGD compared to Crl:SD, compared to FHH 1580542 PCK-Pkhd1pck/CrljCrl strain MP:0005565 increased blood urea nitrogen level IAGP N RGD:628435|PMID:11135065 20061024 RGD compared to Crl:SD; 1580542 PCK-Pkhd1pck/CrljCrl strain MP:0009497 abnormal intrahepatic bile duct morphology IAGP N RGD:13524566|PMID:25753522 20190903 RGD 1580542 PCK-Pkhd1pck/CrljCrl strain MP:0011307 kidney medulla cyst IAGP N RGD:1580540|PMID:10803363 20160923 RGD 1581550 Pur8 Proteinuria QTL 8 qtl MP:0002962 increased urine protein level IAGP N RGD:1578520|PMID:16534143 20130716 RGD 1581554 Pur11 Proteinuria QTL 11 qtl MP:0002962 increased urine protein level IAGP N RGD:1578520|PMID:16534143 20130716 RGD 1581557 Eae16 Experimental allergic encephalomyelitis QTL 16 qtl MP:0003491 abnormal voluntary movement IDA N RGD:629629|PMID:12517974 20121112 RGD 1581557 Eae16 Experimental allergic encephalomyelitis QTL 16 qtl MP:0006082 CNS inflammation IDA N RGD:629629|PMID:12517974 20121112 RGD 1581563 Uae33 Urinary albumin excretion QTL 33 qtl MP:0002871 albuminuria IAGP N RGD:1578520|PMID:16534143 20130716 RGD 1581565 Pur10 Proteinuria QTL 10 qtl MP:0002962 increased urine protein level IAGP N RGD:1578520|PMID:16534143 20130716 RGD 1581569 Uae32 Urinary albumin excretion QTL 32 qtl MP:0002871 albuminuria IAGP N RGD:1578520|PMID:16534143 20130716 RGD 1581570 Eae17 Experimental allergic encephalomyelitis QTL 17 qtl MP:0003491 abnormal voluntary movement IDA N RGD:629629|PMID:12517974 20121112 RGD 1581570 Eae17 Experimental allergic encephalomyelitis QTL 17 qtl MP:0006082 CNS inflammation IDA N RGD:629629|PMID:12517974 20121112 RGD 1581572 Uae35 Urinary albumin excretion QTL 35 qtl MP:0002871 albuminuria IAGP N RGD:1578520|PMID:16534143 20130716 RGD 1581573 Uae36 Urinary albumin excretion QTL 36 qtl MP:0002871 albuminuria IAGP N RGD:1578520|PMID:16534143 20130716 RGD 1581576 Pur7 Proteinuria QTL 7 qtl MP:0002962 increased urine protein level IAGP N RGD:1578520|PMID:16534143 20130716 RGD 1581580 Uae34 Urinary albumin excretion QTL 34 qtl MP:0002871 albuminuria IAGP N RGD:1578520|PMID:16534143 20130716 RGD 1581618 SHRSP/Bbb strain MP:0001262 decreased body weight IAGP N RGD:11040458|PMID:26888427 20200116 RGD compared to SHR/Bbb 1581618 SHRSP/Bbb strain MP:0001262 decreased body weight induced IAGP XCO:0000795 N RGD:7771608|PMID:23901062 20210108 RGD compared to SHRSP-Chr 1F344/Rkb 1581618 SHRSP/Bbb strain MP:0002626 increased heart rate susceptibility IAGP N RGD:1358133|PMID:9286932 20191206 RGD compared to control strain WKY/Bbb; males only 1581618 SHRSP/Bbb strain MP:0002626 increased heart rate susceptibility IAGP XCO:0000022 N RGD:1358133|PMID:9286932 20191206 RGD compared to control strain WKY/Bbb 1581618 SHRSP/Bbb strain MP:0002962 increased urine protein level induced IAGP XCO:0000022, XCO:0000032, XCO:0000030 N RGD:11040458|PMID:26888427 20160816 RGD compared to SHR/Bbb 1581618 SHRSP/Bbb strain MP:0002962 increased urine protein level induced IAGP XCO:0000022, XCO:0000164, XCO:0000032, XCO:0000030 N RGD:2307158|PMID:16835352 20090520 RGD compared to SHRSR/Bbb 1581618 SHRSP/Bbb strain MP:0003076 increased susceptibility to ischemic brain injury induced IAGP XCO:0000022, XCO:0000164, XCO:0000032, XCO:0000030 N RGD:2307158|PMID:16835352 20090520 RGD compared to SHRSR/Bbb 1581618 SHRSP/Bbb strain MP:0003819 increased left ventricle diastolic pressure IAGP N RGD:2293766|PMID:18443590 20191220 RGD as compared to WKY/Bbb 1581618 SHRSP/Bbb strain MP:0003915 increased heart left ventricle weight induced IAGP XCO:0000795 N RGD:7771608|PMID:23901062 20210108 RGD compared to F344/DuCrl, SHRSP-Chr 1F344/Rkb 1581618 SHRSP/Bbb strain MP:0003915 increased heart left ventricle weight susceptibility IAGP N RGD:7771608|PMID:23901062 20201221 RGD compared to F344 1581618 SHRSP/Bbb strain MP:0004875 increased mean systemic arterial blood pressure IAGP N RGD:7771608|PMID:23901062 20210108 RGD compared to F344/DuCrl, 1581618 SHRSP/Bbb strain MP:0004875 increased mean systemic arterial blood pressure induced IAGP XCO:0000795 N RGD:7771608|PMID:23901062 20201221 RGD compared to F344/DuCrl, SHRSP-Chr 1F344/Rkb 1581618 SHRSP/Bbb strain MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:2293766|PMID:18443590 20191220 RGD as compared to WKY/Bbb 1581618 SHRSP/Bbb strain MP:0008770 decreased survivor rate induced IAGP XCO:0000022,XCO:0000164,XCO:0000032,XCO:0000030 N RGD:2307158|PMID:16835352 20191211 RGD compared to SHRSR/Bbb 1581619 BN.PD-(D8Rat39-D8Rat35),SHR-(D2Mit4-D2Rat28),SHR-(D2Rat103-D2Rat107)/Cub strain MP:0000182 increased circulating LDL cholesterol level IAGP N RGD:1580751|PMID:16822831 20061024 RGD compared to BN.PD-(D8Rat39-D8Rat35)/Cub) 1581619 BN.PD-(D8Rat39-D8Rat35),SHR-(D2Mit4-D2Rat28),SHR-(D2Rat103-D2Rat107)/Cub strain MP:0000186 decreased circulating HDL cholesterol level IAGP N RGD:1580751|PMID:16822831 20061024 RGD compared to BN.PD-(D8Rat39-D8Rat35)/Cub 1581619 BN.PD-(D8Rat39-D8Rat35),SHR-(D2Mit4-D2Rat28),SHR-(D2Rat103-D2Rat107)/Cub strain MP:0001552 increased circulating triglyceride level induced IAGP XCO:0000211 N RGD:1580751|PMID:16822831 20061024 RGD compared to BN.PD-(D8Rat39-D8Rat35)/Cub 1581619 BN.PD-(D8Rat39-D8Rat35),SHR-(D2Mit4-D2Rat28),SHR-(D2Rat103-D2Rat107)/Cub strain MP:0003917 increased kidney weight induced IAGP XCO:0000211 N RGD:1580751|PMID:16822831 20200929 RGD compared to BN.PD-(D8Rat39-D8Rat35)/Cub 1581619 BN.PD-(D8Rat39-D8Rat35),SHR-(D2Mit4-D2Rat28),SHR-(D2Rat103-D2Rat107)/Cub strain MP:0003975 increased circulating VLDL triglyceride level induced IAGP XCO:0000211 N RGD:1580751|PMID:16822831 20200929 RGD compared to BN.PD-(D8Rat39-D8Rat35)/Cub 1581619 BN.PD-(D8Rat39-D8Rat35),SHR-(D2Mit4-D2Rat28),SHR-(D2Rat103-D2Rat107)/Cub strain MP:0005293 impaired glucose tolerance IAGP N RGD:1580751|PMID:16822831 20061024 RGD compared to BN.PD-(D8Rat39-D8Rat35)/Cub 1581619 BN.PD-(D8Rat39-D8Rat35),SHR-(D2Mit4-D2Rat28),SHR-(D2Rat103-D2Rat107)/Cub strain MP:0009288 increased epididymal fat pad weight induced IAGP XCO:0000211 N RGD:1580751|PMID:16822831 20200929 RGD compared to BN.PD-(D8Rat39-D8Rat35)/Cub 1581619 BN.PD-(D8Rat39-D8Rat35),SHR-(D2Mit4-D2Rat28),SHR-(D2Rat103-D2Rat107)/Cub strain MP:0009304 increased retroperitoneal fat pad weight induced IAGP XCO:0000211 N RGD:1580751|PMID:16822831 20200929 RGD compared to BN.PD-(D8Rat39-D8Rat35)/Cub 1581622 SD-Tg(Ubc-eGFP-RNAi:Dazl)17-9GarRrrc strain MP:0001925 male infertility IMP N RGD:1580353|PMID:16844779 20061024 RGD 1581626 FHL/EurMcwi Fawn Hooded Low blood pressure strain MP:0002962 increased urine protein level IAGP N RGD:61028|PMID:9887194 20120112 RGD compared to ACI/SegHsd 1581626 FHL/EurMcwi Fawn Hooded Low blood pressure strain MP:0005528 decreased renal glomerular filtration rate IAGP N RGD:61028|PMID:9887194 20200116 RGD compared to FHH/EurMcw, ACI/SegHsd 1581635 WKY/Bbb strain MP:0006263 decreased systemic arterial diastolic blood pressure susceptibility IAGP XCO:0000164 N RGD:629620|PMID:12566390 20200108 RGD compared to WKY.SHRSP-(D1Rat200-D1Rat216)(Shbg-Atp1b2)/Bbb; MMO:0000015 1581635 WKY/Bbb strain MP:0006264 decreased systemic arterial systolic blood pressure susceptibility IAGP XCO:0000164 N RGD:629620|PMID:12566390 20200108 RGD compared to WKY.SHRSP-(D1Rat200-D1Rat216)(Shbg-Atp1b2)/Bbb; MMO:0000015 1582184 SR/JrHsd Dahl Salt-Resistant strain MP:0008770 decreased survivor rate induced IAGP XCO:0000668 N RGD:2302114|PMID:17998886 20090522 RGD as compared to BN/HsdMcwiCrl 1582185 SS.SR-(D3Mco36-D3Got166)/Jr strain MP:0002834 decreased heart weight induced IAGP XCO:0000022 N RGD:1581650|PMID:17028336 20061109 RGD compared to SS/Jr 1582185 SS.SR-(D3Mco36-D3Got166)/Jr strain MP:0003918 decreased kidney weight induced IAGP XCO:0000022 N RGD:1581650|PMID:17028336 20061109 RGD compared to SS/Jr 1582185 SS.SR-(D3Mco36-D3Got166)/Jr strain MP:0006264 decreased systemic arterial systolic blood pressure induced IAGP XCO:0000022 N RGD:1581650|PMID:17028336 20061109 RGD compared to SS/Jr 1582186 FHH.FHH.1BN-(D1Rat183-D1Rat76)/Mcwi strain MP:0002963 decreased urine protein level IAGP N RGD:1579884|PMID:16303858 20200117 RGD compared to FHH/EurMcwi 1582186 FHH.FHH.1BN-(D1Rat183-D1Rat76)/Mcwi strain MP:0005524 abnormal renal plasma flow rate IAGP N RGD:1579884|PMID:16303858 20200117 RGD compared to FHH.FHH.1BN-(D1Rat287-D1Rat84)/Mcwi, FHH.FHH.1BN-(D1Rat173F6B-D1Rat84)/Mcwi, FHH.FHH.1BN-(D1Mgh13-D1Rat89)/Mcwi 1582187 SS.SR-(D3Mco24-D3Got130)/Jr strain MP:0006264 decreased systemic arterial systolic blood pressure induced IAGP XCO:0000022 N RGD:1581650|PMID:17028336 20061109 RGD compared to SS/Jr 1582188 SS.SR-(D3Mco36-D3Mco46)/Jr strain MP:0002834 decreased heart weight induced IAGP XCO:0000022 N RGD:1581650|PMID:17028336 20061109 RGD compared to SS/Jr 1582188 SS.SR-(D3Mco36-D3Mco46)/Jr strain MP:0003918 decreased kidney weight induced IAGP XCO:0000022 N RGD:1581650|PMID:17028336 20061109 RGD compared to SS/Jr 1582188 SS.SR-(D3Mco36-D3Mco46)/Jr strain MP:0006264 decreased systemic arterial systolic blood pressure induced IAGP XCO:0000022 N RGD:1581650|PMID:17028336 20061109 RGD compared to SS/Jr 1582189 SS.SR-(D3Mco39-D3Got130)/Jr strain MP:0001262 decreased body weight induced IAGP XCO:0000022 N RGD:1581650|PMID:17028336 20061109 RGD compared to SS/Jr 1582189 SS.SR-(D3Mco39-D3Got130)/Jr strain MP:0002834 decreased heart weight induced IAGP XCO:0000022 N RGD:1581650|PMID:17028336 20061109 RGD compared to SS/Jr 1582189 SS.SR-(D3Mco39-D3Got130)/Jr strain MP:0006264 decreased systemic arterial systolic blood pressure induced IAGP XCO:0000022 N RGD:1581650|PMID:17028336 20061109 RGD compared to SS/Jr 1582190 SS/JrHsd Dahl Salt-Sensitive strain MP:0001463 abnormal spatial learning IAGP N RGD:1581736|PMID:14665699 20061115 RGD compared to SR/JrHsd 1582190 SS/JrHsd Dahl Salt-Sensitive strain MP:0002625 heart left ventricle hypertrophy IAGP XCO:0000022 N RGD:8657131|PMID:23442991 20210113 RGD compared to Lewis 1582190 SS/JrHsd Dahl Salt-Sensitive strain MP:0005599 increased cardiac muscle contractility susceptibility IAGP N RGD:8657131|PMID:23442991 20210113 RGD compared to Lewis rat 1582191 FHH.FHH.1BN-(D1Rat287-D1Rat84)/Mcwi strain MP:0002963 decreased urine protein level IAGP N RGD:1579884|PMID:16303858 20200117 RGD compared to FHH/EurMcwi 1582191 FHH.FHH.1BN-(D1Rat287-D1Rat84)/Mcwi strain MP:0004876 decreased mean systemic arterial blood pressure IAGP N RGD:1579884|PMID:16303858 20200117 RGD compared to FHH/EurMcwi 1582192 SS.SR-(D3Mco36-D3Got159)/Jr strain MP:0001260 increased body weight induced IAGP XCO:0000022 N RGD:1581650|PMID:17028336 20061109 RGD compared to SS/Jr 1582192 SS.SR-(D3Mco36-D3Got159)/Jr strain MP:0002834 decreased heart weight induced IAGP XCO:0000022 N RGD:1581650|PMID:17028336 20061109 RGD compared to SS/Jr 1582192 SS.SR-(D3Mco36-D3Got159)/Jr strain MP:0006264 decreased systemic arterial systolic blood pressure induced IAGP XCO:0000022 N RGD:1581650|PMID:17028336 20061109 RGD compared to SS/Jr 1582193 FHH.FHH.1BN-(D1Mgh13-D1Rat89)/Mcwi strain MP:0002963 decreased urine protein level IAGP N RGD:1579884|PMID:16303858 20200117 RGD compared to FHH/EurMcwi 1582193 FHH.FHH.1BN-(D1Mgh13-D1Rat89)/Mcwi strain MP:0004876 decreased mean systemic arterial blood pressure IAGP N RGD:1579884|PMID:16303858 20200117 RGD compared to FHH/EurMcwi 1582195 FHH.FHH.1BN-(D1Rat173F6B-D1Rat84)/Mcwi strain MP:0002963 decreased urine protein level IAGP N RGD:1579884|PMID:16303858 20200117 RGD compared to FHH/EurMcwi 1582196 FHH.FHH.1BN-(D1Rat234-D1Rat265)/Mcwi strain MP:0005524 abnormal renal plasma flow rate IAGP N RGD:1579884|PMID:16303858 20200117 RGD compared to FHH.FHH.1BN-(D1Rat287-D1Rat84)/Mcwi, FHH.FHH.1BN-(D1Rat173F6B-D1Rat84)/Mcwi, FHH.FHH.1BN-(D1Mgh13-D1Rat89)/Mcwi 1582197 Gluco27 Glucose level QTL 27 qtl MP:0005559 increased circulating glucose level IAGP N RGD:1580752|PMID:15728334 20061103 RGD 1582199 Insul5 Insulin level QTL 5 qtl MP:0002079 increased circulating insulin level IAGP N RGD:1580752|PMID:15728334 20061103 RGD 1582203 Gluco19 Glucose level QTL 19 qtl MP:0005559 increased circulating glucose level IAGP N RGD:1580752|PMID:15728334 20061103 RGD 1582204 Livw1 Liver weight QTL 1 qtl MP:0002981 increased liver weight IAGP N RGD:1580752|PMID:15728334 20061103 RGD 1582206 Kidm33 Kidney mass QTL 33 qtl MP:0003917 increased kidney weight IAGP N RGD:1580752|PMID:15728334 20061103 RGD 1582208 Kidm32 Kidney mass QTL 32 qtl MP:0003917 increased kidney weight IAGP N RGD:1580752|PMID:15728334 20061103 RGD 1582209 Gluco20 Glucose level QTL 20 qtl MP:0005559 increased circulating glucose level IAGP N RGD:1580752|PMID:15728334 20061103 RGD 1582210 Bw71 Body weight QTL 71 qtl MP:0001260 increased body weight IAGP N RGD:1580752|PMID:15728334 20061103 RGD 1582212 Livw2 Liver weight QTL 2 qtl MP:0002981 increased liver weight IAGP N RGD:1580752|PMID:15728334 20061103 RGD 1582213 Insul6 Insulin level QTL 6 qtl MP:0002079 increased circulating insulin level IAGP N RGD:1580752|PMID:15728334 20061103 RGD 1582214 Stl21 Serum triglyceride level QTL 21 qtl MP:0001552 increased circulating triglyceride level IAGP N RGD:1580752|PMID:15728334 20061103 RGD 1582216 Bw65 Body weight QTL 65 qtl MP:0001260 increased body weight IAGP N RGD:1580752|PMID:15728334 20061103 RGD 1582218 Bw74 Body weight QTL 74 qtl MP:0001260 increased body weight IAGP N RGD:1580752|PMID:15728334 20061103 RGD 1582219 Bw63 Body weight QTL 63 qtl MP:0001260 increased body weight IAGP N RGD:1580752|PMID:15728334 20061103 RGD 1582221 Kidm30 Kidney mass QTL 30 qtl MP:0003917 increased kidney weight IAGP N RGD:1580752|PMID:15728334 20061103 RGD 1582222 Epfw2 Epididymal fat weight QTL 2 qtl MP:0000010 abnormal abdominal fat pad morphology IAGP N RGD:1580752|PMID:15728334 20061103 RGD 1582224 Epfw4 Epididymal fat weight QTL 4 qtl MP:0000010 abnormal abdominal fat pad morphology IAGP N RGD:1580752|PMID:15728334 20061103 RGD 1582225 Bw67 Body weight QTL 67 qtl MP:0001260 increased body weight IAGP N RGD:1580752|PMID:15728334 20061103 RGD 1582226 Bw64 Body weight QTL 64 qtl MP:0001260 increased body weight IAGP N RGD:1580752|PMID:15728334 20061103 RGD 1582227 Gluco30 Glucose level QTL 30 qtl MP:0005559 increased circulating glucose level IAGP N RGD:1580752|PMID:15728334 20061103 RGD 1582228 Epfw3 Epididymal fat weight QTL 3 qtl MP:0000010 abnormal abdominal fat pad morphology IAGP N RGD:1580752|PMID:15728334 20061103 RGD 1582229 Stl20 Serum triglyceride level QTL 20 qtl MP:0001552 increased circulating triglyceride level IAGP N RGD:1580752|PMID:15728334 20061103 RGD 1582230 Bw78 Body weight QTL 78 qtl MP:0010024 increased total body fat amount IDA N RGD:1580752|PMID:15728334 20111107 RGD 1582232 Gluco25 Glucose level QTL 25 qtl MP:0005559 increased circulating glucose level IAGP N RGD:1580752|PMID:15728334 20061103 RGD 1582233 Insul10 Insulin level QTL 10 qtl MP:0002079 increased circulating insulin level IAGP N RGD:1580752|PMID:15728334 20061103 RGD 1582234 Gluco18 Glucose level QTL 18 qtl MP:0005559 increased circulating glucose level IAGP N RGD:1580752|PMID:15728334 20061103 RGD 1582235 Insul8 Insulin level QTL 8 qtl MP:0002079 increased circulating insulin level IAGP N RGD:1580752|PMID:15728334 20061103 RGD 1582236 Gluco22 Glucose level QTL 22 qtl MP:0005559 increased circulating glucose level IAGP N RGD:1580752|PMID:15728334 20061103 RGD 1582237 Kidm34 Kidney mass QTL 34 qtl MP:0003917 increased kidney weight IAGP N RGD:1580752|PMID:15728334 20061103 RGD 1582238 Bw68 Body weight QTL 68 qtl MP:0001260 increased body weight IAGP N RGD:1580752|PMID:15728334 20061103 RGD 1582239 Epfw1 Epididymal fat weight QTL 1 qtl MP:0000010 abnormal abdominal fat pad morphology IAGP N RGD:1580752|PMID:15728334 20061103 RGD 1582241 Bw70 Body weight QTL 70 qtl MP:0001260 increased body weight IAGP N RGD:1580752|PMID:15728334 20061103 RGD 1582242 Gluco28 Glucose level QTL 28 qtl MP:0005559 increased circulating glucose level IAGP N RGD:1580752|PMID:15728334 20061103 RGD 1582243 Bw66 Body weight QTL 66 qtl MP:0001260 increased body weight IAGP N RGD:1580752|PMID:15728334 20061103 RGD 1582244 Bw79 Body weight QTL 79 qtl MP:0010024 increased total body fat amount IDA N RGD:1580752|PMID:15728334 20111107 RGD 1582245 Bw73 Body weight QTL 73 qtl MP:0001260 increased body weight IAGP N RGD:1580752|PMID:15728334 20061103 RGD 1582246 Cm60 Cardiac mass QTL 60 qtl MP:0002833 increased heart weight IAGP N RGD:1580752|PMID:15728334 20061103 RGD 1582248 Insul7 Insulin level QTL 7 qtl MP:0002079 increased circulating insulin level IAGP N RGD:1580752|PMID:15728334 20061103 RGD 1582249 Bw77 Body weight QTL 77 qtl MP:0010024 increased total body fat amount IDA N RGD:1580752|PMID:15728334 20111107 RGD 1582250 Gluco26 Glucose level QTL 26 qtl MP:0005559 increased circulating glucose level IAGP N RGD:1580752|PMID:15728334 20061103 RGD 1582251 Gluco24 Glucose level QTL 24 qtl MP:0005559 increased circulating glucose level IAGP N RGD:1580752|PMID:15728334 20061103 RGD 1582254 Kidm31 Kidney mass QTL 31 qtl MP:0003917 increased kidney weight IAGP N RGD:1580752|PMID:15728334 20061103 RGD 1582255 Gluco29 Glucose level QTL 29 qtl MP:0005559 increased circulating glucose level IAGP N RGD:1580752|PMID:15728334 20061103 RGD 1582256 Insul9 Insulin level QTL 9 qtl MP:0002079 increased circulating insulin level IAGP N RGD:1580752|PMID:15728334 20061103 RGD 1582257 Gluco21 Glucose level QTL 21 qtl MP:0005559 increased circulating glucose level IAGP N RGD:1580752|PMID:15728334 20061103 RGD 1582258 Bw76 Body weight QTL 76 qtl MP:0001260 increased body weight IAGP N RGD:1580752|PMID:15728334 20061103 RGD 1582259 Gluco23 Glucose level QTL 23 qtl MP:0005559 increased circulating glucose level IAGP N RGD:1580752|PMID:15728334 20061103 RGD 1582260 Bw72 Body weight QTL 72 qtl MP:0001260 increased body weight IAGP N RGD:1580752|PMID:15728334 20061103 RGD 1582261 Bw69 Body weight QTL 69 qtl MP:0001260 increased body weight IAGP N RGD:1580752|PMID:15728334 20061103 RGD 1582262 Bw75 Body weight QTL 75 qtl MP:0001260 increased body weight IAGP N RGD:1580752|PMID:15728334 20061103 RGD 1583565 Krt87 keratin 87 gene MP:0002073 abnormal hair growth IAGP N RGD:2316553|PMID:18420582 20100216 RGD DNA:deletion 1583648 Dnd1 DND microRNA-mediated repression inhibitor 1 gene MP:0001156 abnormal spermatogenesis IAGP N RGD:40924659|PMID:22655094 20210826 RGD compared to WKY 1583648 Dnd1 DND microRNA-mediated repression inhibitor 1 gene MP:0001924 infertility IAGP N RGD:40924659|PMID:22655094 20210826 RGD compared to WKY 1583648 Dnd1 DND microRNA-mediated repression inhibitor 1 gene MP:0002016 ovary cyst IAGP N RGD:40924659|PMID:22655094 20210826 RGD compared to WKY 1583648 Dnd1 DND microRNA-mediated repression inhibitor 1 gene MP:0004806 absent germ cells IAGP N RGD:40924659|PMID:22655094 20210826 RGD compared to WKY 1583648 Dnd1 DND microRNA-mediated repression inhibitor 1 gene MP:0004852 decreased testis weight IAGP N RGD:40924659|PMID:22655094 20210826 RGD compared to WKY and heterozygous 1583648 Dnd1 DND microRNA-mediated repression inhibitor 1 gene MP:0004856 decreased ovary weight IAGP N RGD:40924659|PMID:22655094 20210826 RGD compared to WKY 1583648 Dnd1 DND microRNA-mediated repression inhibitor 1 gene MP:0013600 testis degeneration IAGP N RGD:40924659|PMID:22655094 20210826 RGD compared to WKY 1584538 Krt71 keratin 71 gene MP:0003810 abnormal hair cuticle IAGP N RGD:11570415|PMID:20179389 20211021 RGD DNA:deletion:cds:intron 1, p.Val149_Gln154 del 1584538 Krt71 keratin 71 gene MP:0009004 progressive hair loss IAGP N RGD:11570415|PMID:20179389 20211021 RGD DNA:deletion:cds:intron 1, p.Val149_Gln154 del 1584538 Krt71 keratin 71 gene MP:0009351 thin hair shaft IAGP N RGD:11570415|PMID:20179389 20211021 RGD DNA:deletion:cds:intron 1, p.Val149_Gln154 del 1584538 Krt71 keratin 71 gene MP:0010699 dilated hair follicle IAGP N RGD:11570415|PMID:20179389 20211021 RGD DNA:deletion:cds:intron 1, p.Val149_Gln154 del 1586167 Tmem67 transmembrane protein 67 gene MP:0000781 decreased corpus callosum size IAGP N RGD:15014788|PMID:15052665 20201210 RGD 1586167 Tmem67 transmembrane protein 67 gene MP:0000825 dilated lateral ventricle IAGP N RGD:14995942|PMID:30705305 20200130 RGD 1586167 Tmem67 transmembrane protein 67 gene MP:0001255 decreased body height IAGP N RGD:14995942|PMID:30705305 20201210 RGD 1586167 Tmem67 transmembrane protein 67 gene MP:0001262 decreased body weight IAGP N RGD:14995942|PMID:30705305 20200130 RGD 1586167 Tmem67 transmembrane protein 67 gene MP:0001262 decreased body weight IAGP N RGD:15014788|PMID:15052665 20201210 RGD 1586167 Tmem67 transmembrane protein 67 gene MP:0002176 increased brain weight IAGP N RGD:14995942|PMID:30705305 20200130 RGD 1586167 Tmem67 transmembrane protein 67 gene MP:0002962 increased urine protein level IAGP N RGD:1300514|PMID:11095650 20230706 RGD 1586167 Tmem67 transmembrane protein 67 gene MP:0002988 decreased urine osmolality IAGP N RGD:1300514|PMID:11095650 20230706 RGD 1586167 Tmem67 transmembrane protein 67 gene MP:0003070 increased vascular permeability IAGP N RGD:14995942|PMID:30705305 20200131 RGD 1586167 Tmem67 transmembrane protein 67 gene MP:0003917 increased kidney weight IAGP N RGD:1300514|PMID:11095650 20230706 RGD 1586167 Tmem67 transmembrane protein 67 gene MP:0003917 increased kidney weight IAGP N RGD:14995942|PMID:30705305 20200130 RGD 1586167 Tmem67 transmembrane protein 67 gene MP:0003917 increased kidney weight IAGP N RGD:15014788|PMID:15052665 20201210 RGD 1586167 Tmem67 transmembrane protein 67 gene MP:0004875 increased mean systemic arterial blood pressure IAGP N RGD:1300514|PMID:11095650 20201210 RGD 1586167 Tmem67 transmembrane protein 67 gene MP:0004952 increased spleen weight IAGP N RGD:15014788|PMID:15052665 20201210 RGD 1586167 Tmem67 transmembrane protein 67 gene MP:0004955 increased thymus weight IAGP N RGD:15014788|PMID:15052665 20201210 RGD 1586167 Tmem67 transmembrane protein 67 gene MP:0005099 abnormal ciliary body morphology IAGP N RGD:14995942|PMID:30705305 20201210 RGD 1586167 Tmem67 transmembrane protein 67 gene MP:0005553 increased circulating creatinine level IAGP N RGD:1300514|PMID:11095650 20201210 RGD 1586167 Tmem67 transmembrane protein 67 gene MP:0005565 increased blood urea nitrogen level IAGP N RGD:1300514|PMID:11095650 20201210 RGD 1586167 Tmem67 transmembrane protein 67 gene MP:0005565 increased blood urea nitrogen level IAGP N RGD:15014788|PMID:15052665 20201210 RGD 1586167 Tmem67 transmembrane protein 67 gene MP:0006088 abnormal blood-cerebrospinal fluid barrier function IAGP N RGD:14995942|PMID:30705305 20200130 RGD 1586167 Tmem67 transmembrane protein 67 gene MP:0008055 increased urine osmolality IAGP N RGD:1300514|PMID:11095650 20201210 RGD 1586167 Tmem67 transmembrane protein 67 gene MP:0008055 increased urine osmolality IAGP N RGD:15014788|PMID:15052665 20201210 RGD 1586167 Tmem67 transmembrane protein 67 gene MP:0008535 enlarged lateral ventricles IAGP N RGD:14995942|PMID:30705305 20201210 RGD 1586167 Tmem67 transmembrane protein 67 gene MP:0008584 photoreceptor outer segment degeneration IAGP N RGD:11535084|PMID:23516626 20160920 RGD 1586167 Tmem67 transmembrane protein 67 gene MP:0009239 short sperm flagellum IAGP N RGD:8554306|PMID:19515853 20160920 RGD 1586167 Tmem67 transmembrane protein 67 gene MP:0011495 abnormal head shape IAGP N RGD:14995942|PMID:30705305 20200130 RGD 1586167 Tmem67 transmembrane protein 67 gene MP:0011496 abnormal head size IAGP N RGD:14995942|PMID:30705305 20200130 RGD 1586167 Tmem67 transmembrane protein 67 gene MP:0013907 abnormal cerebrospinal fluid flow IAGP N RGD:14995942|PMID:30705305 20200131 RGD 1586167 Tmem67 transmembrane protein 67 gene MP:0020382 increased kidney epithelial cell primary cilium length IAGP N RGD:8554306|PMID:19515853 20160929 RGD 1586167 Tmem67 transmembrane protein 67 gene MP:0030965 increased brain ependyma motile cilium length IAGP N RGD:14995942|PMID:30705305 20200130 RGD 1589721 Gla galactosidase, alpha gene MP:0000414 alopecia IMP N RGD:401976416|PMID:29979634 20240321 RGD 1589721 Gla galactosidase, alpha gene MP:0000647 abnormal sebaceous gland morphology IMP N RGD:401976416|PMID:29979634 20240321 RGD 1589721 Gla galactosidase, alpha gene MP:0000937 abnormal motor neuron morphology IMP N RGD:401976419|PMID:34541380 20240229 RGD compared to wild type 1589721 Gla galactosidase, alpha gene MP:0000965 abnormal sensory neuron morphology IMP N RGD:150429980|PMID:29563343 20211020 RGD 1589721 Gla galactosidase, alpha gene MP:0000965 abnormal sensory neuron morphology IMP N RGD:401976419|PMID:34541380 20240229 RGD compared to wild type 1589721 Gla galactosidase, alpha gene MP:0001260 increased body weight IMP N RGD:401976416|PMID:29979634 20240321 RGD compared to Wild type females 1589721 Gla galactosidase, alpha gene MP:0001262 decreased body weight IMP N RGD:401976416|PMID:29979634 20240321 RGD compared to Wild type males 1589721 Gla galactosidase, alpha gene MP:0001314 cornea opacity severity IMP N RGD:401976417|PMID:31253878 20240815 RGD compared to wild type 1589721 Gla galactosidase, alpha gene MP:0001402 decreased locomotor activity sexual_dimorphism IMP N RGD:401976421|PMID:36660199 20240229 RGD compared to wild type female 1589721 Gla galactosidase, alpha gene MP:0001442 decreased grooming behavior sexual_dimorphism IMP N RGD:401976421|PMID:36660199 20240229 RGD compared to wild type female 1589721 Gla galactosidase, alpha gene MP:0001759 increased urine glucose level onset IMP N RGD:401976416|PMID:29979634 20240321 RGD compared to Wild type males 1589721 Gla galactosidase, alpha gene MP:0002413 abnormal megakaryocyte progenitor cell morphology IMP N RGD:401976418|PMID:34320241 20240229 RGD compared to wild type 1589721 Gla galactosidase, alpha gene MP:0002424 abnormal reticulocyte morphology IMP N RGD:401976418|PMID:34320241 20240229 RGD compared to wild type 1589721 Gla galactosidase, alpha gene MP:0002591 decreased mean corpuscular volume IMP N RGD:401976418|PMID:34320241 20240229 RGD compared to wild type 1589721 Gla galactosidase, alpha gene MP:0002738 hyperresponsive to tactile stimuli IMP N RGD:150429980|PMID:29563343 20211020 RGD 1589721 Gla galactosidase, alpha gene MP:0002840 abnormal lens fiber morphology severity IMP N RGD:401976417|PMID:31253878 20240815 RGD compared to wild type 1589721 Gla galactosidase, alpha gene MP:0002968 increased circulating alkaline phosphatase level onset IMP N RGD:401976416|PMID:29979634 20240321 RGD compared to Wild type 1589721 Gla galactosidase, alpha gene MP:0003131 increased erythrocyte cell number IMP N RGD:401976418|PMID:34320241 20240229 RGD compared to wild type 1589721 Gla galactosidase, alpha gene MP:0003177 allodynia IMP N RGD:150429980|PMID:29563343 20211020 RGD 1589721 Gla galactosidase, alpha gene MP:0004720 abnormal platelet morphology IMP N RGD:401976418|PMID:34320241 20240229 RGD compared to wild type 1589721 Gla galactosidase, alpha gene MP:0004756 abnormal proximal convoluted tubule morphology IMP N RGD:401976416|PMID:29979634 20240321 RGD 1589721 Gla galactosidase, alpha gene MP:0005058 abnormal lysosome morphology IMP N RGD:401976418|PMID:34320241 20240229 RGD compared to wild type 1589721 Gla galactosidase, alpha gene MP:0005058 abnormal lysosome morphology IMP N RGD:401976419|PMID:34541380 20240229 RGD compared to wild type 1589721 Gla galactosidase, alpha gene MP:0005059 lysosomal protein accumulation IMP N RGD:401976418|PMID:34320241 20240229 RGD compared to wild type 1589721 Gla galactosidase, alpha gene MP:0005059 lysosomal protein accumulation IMP N RGD:401976419|PMID:34541380 20240229 RGD compared to wild type 1589721 Gla galactosidase, alpha gene MP:0005140 decreased cardiac muscle contractility onset IMP N RGD:401976416|PMID:29979634 20240321 RGD compared to Wild type 1589721 Gla galactosidase, alpha gene MP:0005179 decreased circulating cholesterol level IMP N RGD:401976416|PMID:29979634 20240321 RGD compared to Wild type female 1589721 Gla galactosidase, alpha gene MP:0005343 increased circulating aspartate transaminase level onset IMP N RGD:401976416|PMID:29979634 20240321 RGD compared to Wild type 1589721 Gla galactosidase, alpha gene MP:0005419 decreased circulating serum albumin level IMP N RGD:401976416|PMID:29979634 20240321 RGD compared to Wild type 1589721 Gla galactosidase, alpha gene MP:0005425 increased macrophage cell number IMP N RGD:401976418|PMID:34320241 20240229 RGD compared to wild type 1589721 Gla galactosidase, alpha gene MP:0005441 increased urine calcium level onset IMP N RGD:401976416|PMID:29979634 20240321 RGD compared to Wild type 1589721 Gla galactosidase, alpha gene MP:0005505 thrombocytosis IMP N RGD:401976418|PMID:34320241 20240229 RGD compared to wild type 1589721 Gla galactosidase, alpha gene MP:0005527 increased renal glomerular filtration rate onset IMP N RGD:401976416|PMID:29979634 20240321 RGD compared to Wild type 1589721 Gla galactosidase, alpha gene MP:0005560 decreased circulating glucose level IMP N RGD:401976416|PMID:29979634 20240321 RGD compared to Wild type males 1589721 Gla galactosidase, alpha gene MP:0005562 decreased mean corpuscular hemoglobin IMP N RGD:401976418|PMID:34320241 20240229 RGD compared to wild type 1589721 Gla galactosidase, alpha gene MP:0005565 increased blood urea nitrogen level onset IMP N RGD:401976416|PMID:29979634 20240321 RGD compared to Wild type 1589721 Gla galactosidase, alpha gene MP:0005567 decreased circulating total protein level IMP N RGD:401976416|PMID:29979634 20240321 RGD compared to Wild type 1589721 Gla galactosidase, alpha gene MP:0005603 neuron hypertrophy IMP N RGD:401976419|PMID:34541380 20240229 RGD compared to wild type 1589721 Gla galactosidase, alpha gene MP:0005627 increased circulating potassium level IMP N RGD:401976416|PMID:29979634 20240321 RGD compared to Wild type 1589721 Gla galactosidase, alpha gene MP:0006298 abnormal platelet activation IMP N RGD:401976418|PMID:34320241 20240227 RGD 1589721 Gla galactosidase, alpha gene MP:0008250 abnormal myeloid leukocyte morphology IMP N RGD:401976418|PMID:34320241 20240229 RGD compared to wild type 1589721 Gla galactosidase, alpha gene MP:0008553 increased circulating tumor necrosis factor level IMP N RGD:401976418|PMID:34320241 20240229 RGD compared to wild type 1589721 Gla galactosidase, alpha gene MP:0008570 lipidosis IMP N RGD:401976419|PMID:34541380 20240229 RGD compared to wild type 1589721 Gla galactosidase, alpha gene MP:0008614 increased circulating interleukin-17 level IMP N RGD:401976418|PMID:34320241 20240229 RGD compared to wild type 1589721 Gla galactosidase, alpha gene MP:0009548 abnormal platelet aggregation IMP N RGD:401976418|PMID:34320241 20240227 RGD 1589721 Gla galactosidase, alpha gene MP:0009906 increased tongue size IMP N RGD:401976416|PMID:29979634 20240321 RGD compared to Wild type 1589721 Gla galactosidase, alpha gene MP:0010097 abnormal retina blood vessel morphology IMP N RGD:401976417|PMID:31253878 20240815 RGD 1589721 Gla galactosidase, alpha gene MP:0010179 rough coat IMP N RGD:401976416|PMID:29979634 20240321 RGD compared to Wild type 1589721 Gla galactosidase, alpha gene MP:0010210 abnormal circulating cytokine level IMP N RGD:401976418|PMID:34320241 20240229 RGD compared to wild type 1589721 Gla galactosidase, alpha gene MP:0010620 thick mitral valve onset IMP N RGD:401976416|PMID:29979634 20240321 RGD compared to Wild type 1589721 Gla galactosidase, alpha gene MP:0010769 abnormal survival IMP N RGD:401976416|PMID:29979634 20240321 RGD compared to Wild type males 1589721 Gla galactosidase, alpha gene MP:0011363 renal glomerulus atrophy onset IMP N RGD:401976416|PMID:29979634 20240321 RGD 1589721 Gla galactosidase, alpha gene MP:0011431 increased urine flow rate IMP N RGD:401976416|PMID:29979634 20240321 RGD compared to Wild type males 1589721 Gla galactosidase, alpha gene MP:0011913 abnormal reticulocyte cell number IMP N RGD:401976418|PMID:34320241 20240229 RGD compared to wild type 1589721 Gla galactosidase, alpha gene MP:0012230 abnormal sphingolipid level IMP N RGD:401976417|PMID:31253878 20240815 RGD in eyes;compared to wild type 1589721 Gla galactosidase, alpha gene MP:0013661 abnormal myeloid cell number IMP N RGD:401976418|PMID:34320241 20240229 RGD compared to wild type 1589721 Gla galactosidase, alpha gene MP:0014062 nervous system inclusion bodies IMP N RGD:150429980|PMID:29563343 20211020 RGD 1589721 Gla galactosidase, alpha gene MP:0020194 abnormal glycosphingolipid level IMP N RGD:150429980|PMID:29563343 20211020 RGD 1589721 Gla galactosidase, alpha gene MP:0020194 abnormal glycosphingolipid level IMP N RGD:401976418|PMID:34320241 20240229 RGD compared to wild type 1589721 Gla galactosidase, alpha gene MP:0020194 abnormal glycosphingolipid level IMP N RGD:401976419|PMID:34541380 20240229 RGD compared to wild type 1589721 Gla galactosidase, alpha gene MP:0020300 long tongue IMP N RGD:401976416|PMID:29979634 20240321 RGD compared to Wild type 1589721 Gla galactosidase, alpha gene MP:0020954 decreased mechanical nociceptive threshold IMP N RGD:150429980|PMID:29563343 20211020 RGD 1589721 Gla galactosidase, alpha gene MP:0021158 decreased heart left ventricle wall thickness onset IMP N RGD:401976416|PMID:29979634 20240321 RGD compared to Wild type 1589721 Gla galactosidase, alpha gene MP:0021198 abnormal sleep duration sexual_dimorphism IMP N RGD:401976421|PMID:36660199 20240229 RGD compared to wild type female 1589755 Tyr tyrosinase gene MP:0005171 absent coat pigmentation IAGP N RGD:1599687|PMID:15760344 20180709 RGD DNA:missense mutation:exon:p.R299H 1589755 Tyr tyrosinase gene MP:0005171 absent coat pigmentation IMP N RGD:12792973|PMID:23409244 20170317 RGD DNA:deletion:cds: 1589818 Ccdc85c coiled-coil domain containing 85C gene MP:0001915 intracranial hemorrhage IMP N RGD:150520163|PMID:31341137 20211028 RGD 1589818 Ccdc85c coiled-coil domain containing 85C gene MP:0002083 premature death IMP N RGD:150520163|PMID:31341137 20211028 RGD 1591785 Pappa2 pappalysin 2 gene MP:0004217 salt-sensitive hypertension IMP N RGD:12792227|PMID:24714719 20170316 RGD 1591785 Pappa2 pappalysin 2 gene MP:0011022 abnormal circadian regulation of systemic arterial blood pressure IMP N RGD:12792227|PMID:24714719 20170316 RGD 1592076 Psme2-ps1 proteasome activator subunit 2, pseudogene 1 gene MP:0004217 salt-sensitive hypertension IAGP N RGD:12798539|PMID:21257920 20170324 RGD 1593265 Atm ATM serine/threonine kinase gene MP:0000136 abnormal microglial cell morphology IMP N RGD:12879399|PMID:28007901 20170418 RGD DNA:deletion:exon: 1593265 Atm ATM serine/threonine kinase gene MP:0000755 hindlimb paralysis IMP N RGD:12879393|PMID:27895165 20170418 RGD 1593265 Atm ATM serine/threonine kinase gene MP:0000755 hindlimb paralysis IMP N RGD:12879399|PMID:28007901 20170418 RGD DNA:deletion:exon: 1593265 Atm ATM serine/threonine kinase gene MP:0000939 decreased motor neuron number IMP N RGD:12879399|PMID:28007901 20170418 RGD DNA:deletion:exon: 1593265 Atm ATM serine/threonine kinase gene MP:0001130 abnormal ovarian folliculogenesis IMP N RGD:12879393|PMID:27895165 20170418 RGD 1593265 Atm ATM serine/threonine kinase gene MP:0001130 abnormal ovarian folliculogenesis IMP N RGD:12879399|PMID:28007901 20170418 RGD DNA:deletion:exon: 1593265 Atm ATM serine/threonine kinase gene MP:0002216 abnormal seminiferous tubule morphology IMP N RGD:12879393|PMID:27895165 20170418 RGD 1593265 Atm ATM serine/threonine kinase gene MP:0002216 abnormal seminiferous tubule morphology IMP N RGD:12879399|PMID:28007901 20170418 RGD DNA:deletion:exon: 1593265 Atm ATM serine/threonine kinase gene MP:0003674 oxidative stress IMP N RGD:12879399|PMID:28007901 20170418 RGD DNA:deletion:exon: 1593265 Atm ATM serine/threonine kinase gene MP:0005018 decreased T cell number IMP N RGD:12879393|PMID:27895165 20170418 RGD 1593265 Atm ATM serine/threonine kinase gene MP:0005091 increased double-positive T cell number IMP N RGD:12879393|PMID:27895165 20170418 RGD 1593265 Atm ATM serine/threonine kinase gene MP:0008918 microgliosis IMP N RGD:12879399|PMID:28007901 20230119 RGD 1593265 Atm ATM serine/threonine kinase gene MP:0010762 abnormal microglial cell activation IMP N RGD:12879399|PMID:28007901 20230119 RGD 1593265 Atm ATM serine/threonine kinase gene MP:0010769 abnormal survival IMP N RGD:12879393|PMID:27895165 20170418 RGD 1593265 Atm ATM serine/threonine kinase gene MP:0011982 decreased microglial cell number IMP N RGD:12879399|PMID:28007901 20230119 RGD 1593265 Atm ATM serine/threonine kinase gene MP:0020448 increased microglial cell activation IMP N RGD:12879399|PMID:28007901 20170418 RGD DNA:deletion:exon: 1593417 Wars2 tryptophanyl tRNA synthetase 2 (mitochondrial) gene MP:0003023 decreased coronary flow rate IMP N RGD:127338472|PMID:27389904 20210708 RGD 1593417 Wars2 tryptophanyl tRNA synthetase 2 (mitochondrial) gene MP:0005602 decreased angiogenesis IMP N RGD:127338472|PMID:27389904 20210708 RGD 1598216 Plekha7 pleckstrin homology domain containing A7 gene MP:0002963 decreased urine protein level IMP N RGD:11079199|PMID:25136115 20171102 RGD 1598216 Plekha7 pleckstrin homology domain containing A7 gene MP:0002963 decreased urine protein level ameliorates IMP XCO:0000795 N RGD:11079199|PMID:25136115 20220203 RGD compared to wild type 1598216 Plekha7 pleckstrin homology domain containing A7 gene MP:0003394 increased cardiac output IMP N RGD:11079199|PMID:25136115 20171102 RGD 1598216 Plekha7 pleckstrin homology domain containing A7 gene MP:0003394 increased cardiac output IMP XCO:0000795 N RGD:11079199|PMID:25136115 20220203 RGD compared to wild type 1598216 Plekha7 pleckstrin homology domain containing A7 gene MP:0004217 salt-sensitive hypertension ameliorates IMP XCO:0000795 N RGD:11079199|PMID:25136115 20220203 RGD compared to wild type 1598216 Plekha7 pleckstrin homology domain containing A7 gene MP:0004879 decreased systemic vascular resistance IMP N RGD:11079199|PMID:25136115 20171102 RGD 1598216 Plekha7 pleckstrin homology domain containing A7 gene MP:0004879 decreased systemic vascular resistance induces IMP XCO:0000795 N RGD:11079199|PMID:25136115 20220203 RGD compared to wild type 1598216 Plekha7 pleckstrin homology domain containing A7 gene MP:0005540 decreased urine albumin level IMP N RGD:11079199|PMID:25136115 20171102 RGD 1598216 Plekha7 pleckstrin homology domain containing A7 gene MP:0005540 decreased urine albumin level ameliorates IMP XCO:0000795 N RGD:11079199|PMID:25136115 20220203 RGD compared to wild type 1598216 Plekha7 pleckstrin homology domain containing A7 gene MP:0005590 increased vasodilation IMP N RGD:11079199|PMID:25136115 20220203 RGD compared to wild type 1598216 Plekha7 pleckstrin homology domain containing A7 gene MP:0011951 increased cardiac stroke volume IMP N RGD:11079199|PMID:25136115 20171102 RGD 1598216 Plekha7 pleckstrin homology domain containing A7 gene MP:0011951 increased cardiac stroke volume induces IMP XCO:0000795 N RGD:11079199|PMID:25136115 20220203 RGD compared to wild type 1598216 Plekha7 pleckstrin homology domain containing A7 gene MP:0012046 decreased susceptibility to hypertension IMP N RGD:11079199|PMID:25136115 20171102 RGD 1598216 Plekha7 pleckstrin homology domain containing A7 gene MP:0012046 decreased susceptibility to hypertension IMP XCO:0000795 N RGD:11079199|PMID:25136115 20220203 RGD compared to wild type 1598797 WF.WKY-(D10Got124-D10Rat187)/Uwm strain MP:0001883 increased mammary adenocarcinoma incidence induced IAGP XCO:0000090 N RGD:1581951|PMID:16568087 20200925 RGD compared to WF/NHsd 1598797 WF.WKY-(D10Got124-D10Rat187)/Uwm strain MP:0003721 increased tumor growth/size induced IAGP XCO:0000090 N RGD:1581951|PMID:16568087 20070103 RGD compared to WF/NHsd 1598798 BBDP/WorN strain MP:0004031 insulitis IAGP N RGD:1578691 20070214 RGD 1598798 BBDP/WorN strain MP:0004803 increased susceptibility to autoimmune diabetes IAGP N RGD:1578691 20070214 RGD 1598799 ACI.FHH-(D1Rat384-D1Rat452)(D17Rat61-D1Arb5)(D17Rat51)/Eur strain MP:0001262 decreased body weight induced IAGP N RGD:1582571|PMID:16837819 20070111 RGD compared to ACI/Eur 1598799 ACI.FHH-(D1Rat384-D1Rat452)(D17Rat61-D1Arb5)(D17Rat51)/Eur strain MP:0006144 increased systemic arterial systolic blood pressure induced IAGP N RGD:1582571|PMID:16837819 20070111 RGD compared to ACI/Eur, ACI.FHH-(D1Rat384-D1Rat156)/Eur 1598800 ACI.FHH-(D1Rat384-D1Rat156)/Eur strain MP:0001262 decreased body weight induced IAGP N RGD:1582571|PMID:16837819 20070111 RGD compared to ACI/Eur 1598800 ACI.FHH-(D1Rat384-D1Rat156)/Eur strain MP:0005264 glomerulosclerosis induced IAGP N RGD:1582571|PMID:16837819 20191210 RGD compared to ACI/Eur 1598800 ACI.FHH-(D1Rat384-D1Rat156)/Eur strain MP:0006144 increased systemic arterial systolic blood pressure induced IAGP N RGD:1582571|PMID:16837819 20070111 RGD compared to ACI/Eur 1598801 ACI.FHH-(D1Mit18-D1Mit8)(D14Mit11-D14Hmgc14b)(D14Rat65-D14Rat90)/Eur strain MP:0002962 increased urine protein level IAGP N RGD:1582571|PMID:16837819 20070111 RGD 1598801 ACI.FHH-(D1Mit18-D1Mit8)(D14Mit11-D14Hmgc14b)(D14Rat65-D14Rat90)/Eur strain MP:0005264 glomerulosclerosis IAGP N RGD:1582571|PMID:16837819 20191210 RGD compared to ACI/Eur, ACI.FHH-(D1Rat384-D1Rat452)(D17Rat61-D1Arb5)(D17Rat51)/Eur 1598801 ACI.FHH-(D1Mit18-D1Mit8)(D14Mit11-D14Hmgc14b)(D14Rat65-D14Rat90)/Eur strain MP:0005264 glomerulosclerosis induced IAGP N RGD:1582571|PMID:16837819 20191210 RGD compared to ACI.FHH-(D1Rat384-D1Rat156) 1598801 ACI.FHH-(D1Mit18-D1Mit8)(D14Mit11-D14Hmgc14b)(D14Rat65-D14Rat90)/Eur strain MP:0006144 increased systemic arterial systolic blood pressure induced IAGP N RGD:1582571|PMID:16837819 20070111 RGD 1598802 BBDR/WorN strain MP:0004804 decreased susceptibility to autoimmune diabetes IAGP N RGD:1578691 20070214 RGD compared to BBDP/WorN 1598803 BBNB/WorN strain MP:0004031 insulitis IAGP N RGD:1578691 20200225 RGD 1598803 BBNB/WorN strain MP:0004803 increased susceptibility to autoimmune diabetes IAGP N RGD:1578691 20200225 RGD 1598804 WKY.GHS-(D1Rat32-D1Mit32) strain MP:0005441 increased urine calcium level IAGP N RGD:1582396|PMID:16611718 20070103 RGD compared to GHS 1598805 Memor8 Memory QTL 8 qtl MP:0001458 abnormal object recognition memory IDA N RGD:1581615|PMID:16837653 20070103 RGD 1598805 Memor8 Memory QTL 8 qtl MP:0001463 abnormal spatial learning IDA N RGD:1581615|PMID:16837653 20070103 RGD 1598807 Glom12 Glomerulus QTL 12 qtl MP:0005327 abnormal mesangial cell morphology IDA N RGD:1581737|PMID:16720678 20070111 RGD 1598809 Memor15 Memory QTL 15 qtl MP:0001360 abnormal social investigation IDA N RGD:1581615|PMID:16837653 20070103 RGD 1598809 Memor15 Memory QTL 15 qtl MP:0002063 abnormal learning/memory/conditioning IDA N RGD:1581615|PMID:16837653 20070103 RGD 1598811 Bp291 Blood pressure QTL 291 qtl MP:0006264 decreased systemic arterial systolic blood pressure IDA N RGD:1581737|PMID:16720678 20070111 RGD 1598813 Memor9 Memory QTL 9 qtl MP:0001458 abnormal object recognition memory IDA N RGD:1581615|PMID:16837653 20070103 RGD 1598813 Memor9 Memory QTL 9 qtl MP:0001463 abnormal spatial learning IDA N RGD:1581615|PMID:16837653 20070103 RGD 1598816 Memor12 Memory QTL 12 qtl MP:0001458 abnormal object recognition memory IDA N RGD:1581615|PMID:16837653 20070103 RGD 1598816 Memor12 Memory QTL 12 qtl MP:0001463 abnormal spatial learning IDA N RGD:1581615|PMID:16837653 20070103 RGD 1598817 Glom13 Glomerulus QTL 13 qtl MP:0005327 abnormal mesangial cell morphology IDA N RGD:1581737|PMID:16720678 20070111 RGD 1598819 Bp292 Blood pressure QTL 292 qtl MP:0006144 increased systemic arterial systolic blood pressure IDA N RGD:1581737|PMID:16720678 20070111 RGD 1598823 Memor16 Memory QTL 16 qtl MP:0001360 abnormal social investigation IDA N RGD:1581615|PMID:16837653 20070103 RGD 1598823 Memor16 Memory QTL 16 qtl MP:0002063 abnormal learning/memory/conditioning IDA N RGD:1581615|PMID:16837653 20070103 RGD 1598824 Memor4 Memory QTL 4 qtl MP:0001458 abnormal object recognition memory IDA N RGD:1581615|PMID:16837653 20070103 RGD 1598824 Memor4 Memory QTL 4 qtl MP:0001463 abnormal spatial learning IDA N RGD:1581615|PMID:16837653 20070103 RGD 1598828 Glom14 Glomerulus QTL 14 qtl MP:0005327 abnormal mesangial cell morphology IDA N RGD:1581737|PMID:16720678 20070111 RGD 1598830 Bp288 Blood pressure QTL 288 qtl MP:0006144 increased systemic arterial systolic blood pressure IDA N RGD:1581737|PMID:16720678 20070111 RGD 1598832 Glom11 Glomerulus QTL 11 qtl MP:0005327 abnormal mesangial cell morphology IDA N RGD:1581737|PMID:16720678 20070111 RGD 1598833 Bp295 Blood pressure QTL 295 qtl MP:0006144 increased systemic arterial systolic blood pressure IDA N RGD:1581737|PMID:16720678 20070111 RGD 1598834 Memor11 Memory QTL 11 qtl MP:0001458 abnormal object recognition memory IDA N RGD:1581615|PMID:16837653 20070103 RGD 1598834 Memor11 Memory QTL 11 qtl MP:0001463 abnormal spatial learning IDA N RGD:1581615|PMID:16837653 20070103 RGD 1598837 Memor13 Memory QTL 13 qtl MP:0001360 abnormal social investigation IDA N RGD:1581615|PMID:16837653 20070103 RGD 1598837 Memor13 Memory QTL 13 qtl MP:0002063 abnormal learning/memory/conditioning IDA N RGD:1581615|PMID:16837653 20070103 RGD 1598838 Bp290 Blood pressure QTL 290 qtl MP:0006144 increased systemic arterial systolic blood pressure IDA N RGD:1581737|PMID:16720678 20070111 RGD 1598841 Memor7 Memory QTL 7 qtl MP:0001458 abnormal object recognition memory IDA N RGD:1581615|PMID:16837653 20070103 RGD 1598841 Memor7 Memory QTL 7 qtl MP:0001463 abnormal spatial learning IDA N RGD:1581615|PMID:16837653 20070103 RGD 1598842 Glom10 Glomerulus QTL 10 qtl MP:0005327 abnormal mesangial cell morphology IDA N RGD:1581737|PMID:16720678 20070111 RGD 1598843 Cm63 Cardiac mass QTL 63 qtl MP:0002834 decreased heart weight IDA N RGD:1581737|PMID:16720678 20070111 RGD 1598846 Bp293 Blood pressure QTL 293 qtl MP:0006144 increased systemic arterial systolic blood pressure IDA N RGD:1581737|PMID:16720678 20070111 RGD 1598847 Cm62 Cardiac mass QTL 62 qtl MP:0002833 increased heart weight IDA N RGD:1581737|PMID:16720678 20070111 RGD 1598849 Memor17 Memory QTL 17 qtl MP:0001360 abnormal social investigation IDA N RGD:1581615|PMID:16837653 20070103 RGD 1598849 Memor17 Memory QTL 17 qtl MP:0002063 abnormal learning/memory/conditioning IDA N RGD:1581615|PMID:16837653 20070103 RGD 1598850 Bp297 Blood pressure QTL 297 qtl MP:0006144 increased systemic arterial systolic blood pressure IDA N RGD:1581737|PMID:16720678 20070111 RGD 1598853 Memor3 Memory QTL 3 qtl MP:0001458 abnormal object recognition memory IDA N RGD:1581615|PMID:16837653 20070103 RGD 1598853 Memor3 Memory QTL 3 qtl MP:0001463 abnormal spatial learning IDA N RGD:1581615|PMID:16837653 20070103 RGD 1598854 Memor10 Memory QTL 10 qtl MP:0001458 abnormal object recognition memory IDA N RGD:1581615|PMID:16837653 20070103 RGD 1598854 Memor10 Memory QTL 10 qtl MP:0001463 abnormal spatial learning IDA N RGD:1581615|PMID:16837653 20070103 RGD 1598855 Bp294 Blood pressure QTL 294 qtl MP:0006144 increased systemic arterial systolic blood pressure IDA N RGD:1581737|PMID:16720678 20070111 RGD 1598856 Memor1 Memory QTL 1 qtl MP:0001458 abnormal object recognition memory IDA N RGD:1581615|PMID:16837653 20070103 RGD 1598856 Memor1 Memory QTL 1 qtl MP:0001463 abnormal spatial learning IDA N RGD:1581615|PMID:16837653 20070103 RGD 1598858 Cm61 Cardiac mass QTL 61 qtl MP:0002833 increased heart weight IDA N RGD:1581737|PMID:16720678 20070111 RGD 1598859 Cm66 Cardiac mass QTL 66 qtl MP:0002833 increased heart weight IDA N RGD:1581737|PMID:16720678 20070111 RGD 1598861 Cm64 Cardiac mass QTL 64 qtl MP:0002833 increased heart weight IDA N RGD:1581737|PMID:16720678 20070111 RGD 1598862 Glom9 Glomerulus QTL 9 qtl MP:0005327 abnormal mesangial cell morphology IDA N RGD:1581737|PMID:16720678 20070111 RGD 1598863 Cm65 Cardiac mass QTL 65 qtl MP:0002833 increased heart weight IDA N RGD:1581737|PMID:16720678 20070111 RGD 1598865 Bp296 Blood pressure QTL 296 qtl MP:0006144 increased systemic arterial systolic blood pressure IDA N RGD:1581737|PMID:16720678 20070111 RGD 1598866 Bp287 Blood pressure QTL 287 qtl MP:0006144 increased systemic arterial systolic blood pressure IDA N RGD:1581737|PMID:16720678 20070111 RGD 1598869 Memor6 Memory QTL 6 qtl MP:0001458 abnormal object recognition memory IDA N RGD:1581615|PMID:16837653 20070103 RGD 1598869 Memor6 Memory QTL 6 qtl MP:0001463 abnormal spatial learning IDA N RGD:1581615|PMID:16837653 20070103 RGD 1598870 Bp289 Blood pressure QTL 289 qtl MP:0006144 increased systemic arterial systolic blood pressure IDA N RGD:1581737|PMID:16720678 20070111 RGD 1598871 Memor5 Memory QTL 5 qtl MP:0001458 abnormal object recognition memory IDA N RGD:1581615|PMID:16837653 20070103 RGD 1598871 Memor5 Memory QTL 5 qtl MP:0001463 abnormal spatial learning IDA N RGD:1581615|PMID:16837653 20070103 RGD 1598872 Memor14 Memory QTL 14 qtl MP:0001360 abnormal social investigation IDA N RGD:1581615|PMID:16837653 20070103 RGD 1598872 Memor14 Memory QTL 14 qtl MP:0002063 abnormal learning/memory/conditioning IDA N RGD:1581615|PMID:16837653 20070103 RGD 1598873 Memor2 Memory QTL 2 qtl MP:0001458 abnormal object recognition memory IDA N RGD:1581615|PMID:16837653 20070103 RGD 1598873 Memor2 Memory QTL 2 qtl MP:0001463 abnormal spatial learning IDA N RGD:1581615|PMID:16837653 20070103 RGD 1598875 Bp286 Blood pressure QTL 286 qtl MP:0003917 increased kidney weight IDA N RGD:1581650|PMID:17028336 20070111 RGD 1598875 Bp286 Blood pressure QTL 286 qtl MP:0006264 decreased systemic arterial systolic blood pressure IDA N RGD:1581650|PMID:17028336 20070111 RGD 1598877 Bp285 Blood pressure QTL 285 qtl MP:0006264 decreased systemic arterial systolic blood pressure IDA N RGD:1581650|PMID:17028336 20070111 RGD 1599567 Sod3m1Mcwi superoxide dismutase 3; mutation 1, Medical College of Wisconsin gene MP:0001613 abnormal vasodilation IMP N RGD:38548929|PMID:24322611 20200827 RGD 1599567 Sod3m1Mcwi superoxide dismutase 3; mutation 1, Medical College of Wisconsin gene MP:0002625 heart left ventricle hypertrophy IMP N RGD:150573712|PMID:31972339 20220113 RGD compared to SS/JrHsdMcwi 1599567 Sod3m1Mcwi superoxide dismutase 3; mutation 1, Medical College of Wisconsin gene MP:0003025 increased vasoconstriction IMP N RGD:38548929|PMID:24322611 20200827 RGD XCO:0000145 1599567 Sod3m1Mcwi superoxide dismutase 3; mutation 1, Medical College of Wisconsin gene MP:0003215 renal interstitial fibrosis onset IMP N RGD:150573712|PMID:31972339 20220113 RGD compared to SS/JrHsdMcwi 1599567 Sod3m1Mcwi superoxide dismutase 3; mutation 1, Medical College of Wisconsin gene MP:0003674 oxidative stress onset IMP N RGD:150573712|PMID:31972339 20220113 RGD compared to SS/JrHsdMcwi 1599567 Sod3m1Mcwi superoxide dismutase 3; mutation 1, Medical College of Wisconsin gene MP:0003985 renal fibrosis onset IMP N RGD:150573712|PMID:31972339 20220113 RGD compared to SS/JrHsdMcwi 1599567 Sod3m1Mcwi superoxide dismutase 3; mutation 1, Medical College of Wisconsin gene MP:0004875 increased mean systemic arterial blood pressure onset IMP N RGD:150573712|PMID:31972339 20220113 RGD compared to SS/JrHsdMcwi 1599567 Sod3m1Mcwi superoxide dismutase 3; mutation 1, Medical College of Wisconsin gene MP:0005264 glomerulosclerosis onset IMP N RGD:150573712|PMID:31972339 20220113 RGD compared to SS/JrHsdMcwi 1599567 Sod3m1Mcwi superoxide dismutase 3; mutation 1, Medical College of Wisconsin gene MP:0005553 increased circulating creatinine level onset IMP N RGD:150573712|PMID:31972339 20220113 RGD compared to SS/JrHsdMcwi 1599567 Sod3m1Mcwi superoxide dismutase 3; mutation 1, Medical College of Wisconsin gene MP:0005590 increased vasodilation IMP N RGD:38548929|PMID:24322611 20210415 RGD compared to SS/JrHsdMcwi;DNA:missense mutation:CDS:p.E124D 1599567 Sod3m1Mcwi superoxide dismutase 3; mutation 1, Medical College of Wisconsin gene MP:0005591 decreased vasodilation IMP N RGD:38548929|PMID:24322611 20210415 RGD compared to SS/JrHsdMcwi;DNA:missense mutation:cds:p.E124D 1599567 Sod3m1Mcwi superoxide dismutase 3; mutation 1, Medical College of Wisconsin gene MP:0006143 increased systemic arterial diastolic blood pressure onset IMP N RGD:150573712|PMID:31972339 20220113 RGD compared to SS/JrHsdMcwi 1599567 Sod3m1Mcwi superoxide dismutase 3; mutation 1, Medical College of Wisconsin gene MP:0006144 increased systemic arterial systolic blood pressure onset IMP N RGD:150573712|PMID:31972339 20220113 RGD compared to SS/JrHsdMcwi 1599567 Sod3m1Mcwi superoxide dismutase 3; mutation 1, Medical College of Wisconsin gene MP:0011377 renal glomerulus fibrosis onset IMP N RGD:150573712|PMID:31972339 20220113 RGD compared to SS/JrHsdMcwi 1599567 Sod3m1Mcwi superoxide dismutase 3; mutation 1, Medical College of Wisconsin gene MP:0011402 renal cast onset IMP N RGD:150573712|PMID:31972339 20220113 RGD compared to SS/JrHsdMcwi 1599567 Sod3m1Mcwi superoxide dismutase 3; mutation 1, Medical College of Wisconsin gene MP:0011939 increased food intake IMP N RGD:150573712|PMID:31972339 20220113 RGD compared to SS/JrHsdMcwi 1599567 Sod3m1Mcwi superoxide dismutase 3; mutation 1, Medical College of Wisconsin gene MP:0011941 increased fluid intake IMP N RGD:150573712|PMID:31972339 20220113 RGD compared to SS/JrHsdMcwi 1599567 Sod3m1Mcwi superoxide dismutase 3; mutation 1, Medical College of Wisconsin gene MP:0012659 decreased superoxide dismutase level IMP N RGD:14369425|PMID:21730301 20220127 RGD in lung 1599567 Sod3m1Mcwi superoxide dismutase 3; mutation 1, Medical College of Wisconsin gene MP:0012659 decreased superoxide dismutase level onset IMP N RGD:150573712|PMID:31972339 20220113 RGD compared to SS/JrHsdMcwi 1599674 BBDP.WF-(D8Rat59-D8Sunn1467)/Sunn strain MP:0004804 decreased susceptibility to autoimmune diabetes IAGP N RGD:1624306|PMID:17389329 20200302 RGD 1599689 Iddm24 Insulin dependent diabetes mellitus QTL 24 qtl MP:0001759 increased urine glucose level IDA N RGD:1624306|PMID:17389329 20111108 RGD 1599689 Iddm24 Insulin dependent diabetes mellitus QTL 24 qtl MP:0004031 insulitis NOT IDA N RGD:1624306|PMID:17389329 20070829 RGD 1599758 SS-Sod3m1Mcwi strain MP:0002625 heart left ventricle hypertrophy IMP N RGD:150573712|PMID:31972339 20220111 RGD compared to SS/JrHsdMcwi 1599758 SS-Sod3m1Mcwi strain MP:0003025 increased vasoconstriction induced IMP XCO:0000145 N RGD:38548929|PMID:24322611 20200827 RGD compared to SS/JrHsdMcwi;DNA:missense mutation:cds:p.E124D 1599758 SS-Sod3m1Mcwi strain MP:0003215 renal interstitial fibrosis onset IMP N RGD:150573712|PMID:31972339 20220111 RGD compared to SS/JrHsdMcwi 1599758 SS-Sod3m1Mcwi strain MP:0003674 oxidative stress onset IMP N RGD:150573712|PMID:31972339 20220111 RGD compared to SS/JrHsdMcwi 1599758 SS-Sod3m1Mcwi strain MP:0003985 renal fibrosis onset IMP N RGD:150573712|PMID:31972339 20220111 RGD compared to SS/JrHsdMcwi 1599758 SS-Sod3m1Mcwi strain MP:0004875 increased mean systemic arterial blood pressure onset IMP N RGD:150573712|PMID:31972339 20220111 RGD compared to SS/JrHsdMcwi 1599758 SS-Sod3m1Mcwi strain MP:0005264 glomerulosclerosis onset IMP N RGD:150573712|PMID:31972339 20220111 RGD compared to SS/JrHsdMcwi 1599758 SS-Sod3m1Mcwi strain MP:0005553 increased circulating creatinine level onset IMP N RGD:150573712|PMID:31972339 20220111 RGD compared to SS/JrHsdMcwi 1599758 SS-Sod3m1Mcwi strain MP:0005590 increased vasodilation induced IMP XCO:0000143,XCO:0000022 N RGD:38548929|PMID:24322611 20210409 RGD compared to SS/JrHsdMcwi;DNA:missense mutation:CDS:p.E124D 1599758 SS-Sod3m1Mcwi strain MP:0005591 decreased vasodilation induced IMP XCO:0000143 N RGD:38548929|PMID:24322611 20200827 RGD compared to SS/JrHsdMcwi;DNA:missense mutation:cds:p.E124D 1599758 SS-Sod3m1Mcwi strain MP:0006143 increased systemic arterial diastolic blood pressure onset IMP N RGD:150573712|PMID:31972339 20220111 RGD compared to SS/JrHsdMcwi 1599758 SS-Sod3m1Mcwi strain MP:0006144 increased systemic arterial systolic blood pressure onset IMP N RGD:150573712|PMID:31972339 20220111 RGD compared to SS/JrHsdMcwi 1599758 SS-Sod3m1Mcwi strain MP:0011377 renal glomerulus fibrosis onset IMP N RGD:150573712|PMID:31972339 20220111 RGD compared to SS/JrHsdMcwi 1599758 SS-Sod3m1Mcwi strain MP:0011402 renal cast onset IMP N RGD:150573712|PMID:31972339 20220111 RGD compared to SS/JrHsdMcwi 1599758 SS-Sod3m1Mcwi strain MP:0011939 increased food intake IMP N RGD:150573712|PMID:31972339 20220111 RGD compared to SS/JrHsdMcwi 1599758 SS-Sod3m1Mcwi strain MP:0011941 increased fluid intake IMP N RGD:150573712|PMID:31972339 20220111 RGD compared to SS/JrHsdMcwi 1599758 SS-Sod3m1Mcwi strain MP:0012659 decreased superoxide dismutase level IMP N RGD:14369425|PMID:21730301 20220125 RGD in lung 1599758 SS-Sod3m1Mcwi strain MP:0012659 decreased superoxide dismutase level onset IMP N RGD:150573712|PMID:31972339 20220111 RGD compared to SS/JrHsdMcwi 1599759 GRY/Idr groggy rat strain MP:0001406 abnormal gait IAGP N RGD:1598976|PMID:17196942 20160613 RGD 1599759 GRY/Idr groggy rat strain MP:0003218 decreased spike-wave discharge type I IAGP N RGD:1598976|PMID:17196942 20170504 RGD 1599760 SPRD.WKY-(D18Wox8-D18Rat44)/Ibmm strain MP:0013782 abnormal mammary duct terminal end bud morphology induced IAGP XCO:0000090 N RGD:1643011|PMID:17597107 20200708 RGD compared to WKY 1599763 SPRD.WKY-(D5Rat190-D5Rat114)/Ibmm strain MP:0009828 increased tumor latency induced IAGP XCO:0000090 N RGD:1599390|PMID:17230524 20200316 RGD compared to 7,12-dimethyletraphene treated SPRD/Ztm 1599763 SPRD.WKY-(D5Rat190-D5Rat114)/Ibmm strain MP:0013782 abnormal mammary duct terminal end bud morphology induced IAGP XCO:0000090 N RGD:1643011|PMID:17597107 20071118 RGD compared to WKY 1599764 COP.DA-(D16Rat12-D16Rat90)/Mco strain MP:0002644 decreased circulating triglyceride level IAGP N RGD:1598978|PMID:17179209 20070309 RGD compared to COP/OlaHsd 1599764 COP.DA-(D16Rat12-D16Rat90)/Mco strain MP:0003060 increased aerobic running capacity IAGP N RGD:1598978|PMID:17179209 20070309 RGD compared to COP/OlaHsd 1599764 COP.DA-(D16Rat12-D16Rat90)/Mco strain MP:0009286 increased abdominal fat pad weight IAGP N RGD:1598978|PMID:17179209 20201113 RGD compared to COP/OlaHsd 1599764 COP.DA-(D16Rat12-D16Rat90)/Mco strain MP:0010934 increased subcutaneous adipose tissue amount IAGP N RGD:1598978|PMID:17179209 20070309 RGD compared to COP/OlaHsd 1599769 COP.DA-(D3Rat233-D3Mgh14)/Mco strain MP:0001262 decreased body weight IAGP N RGD:1598978|PMID:17179209 20070309 RGD compared to COP/OlaHsd 1599769 COP.DA-(D3Rat233-D3Mgh14)/Mco strain MP:0003918 decreased kidney weight IAGP N RGD:1598978|PMID:17179209 20070309 RGD compared to COP/OlaHsd 1599769 COP.DA-(D3Rat233-D3Mgh14)/Mco strain MP:0009109 decreased pancreas weight IAGP N RGD:1598978|PMID:17179209 20070309 RGD compared to COP/OlaHsd 1599769 COP.DA-(D3Rat233-D3Mgh14)/Mco strain MP:0010934 increased subcutaneous adipose tissue amount IAGP N RGD:1598978|PMID:17179209 20070309 RGD compared to COP/OlaHsd 1600311 Rab38ru Rab38, member of RAS oncogene family, ruby allele gene MP:0002075 abnormal coat/hair pigmentation IAGP N RGD:1300411|PMID:15112108 20070307 RGD DNA:point mutation:exon:p.M1I (rat) 1600311 Rab38ru Rab38, member of RAS oncogene family, ruby allele gene MP:0004722 abnormal platelet dense granule number IAGP N RGD:2324691|PMID:18983523 20100511 RGD 1600311 Rab38ru Rab38, member of RAS oncogene family, ruby allele gene MP:0004780 abnormal surfactant secretion IAGP N RGD:2324690|PMID:19897744 20100511 RGD 1600311 Rab38ru Rab38, member of RAS oncogene family, ruby allele gene MP:0005606 increased bleeding time IAGP N RGD:2324690|PMID:19897744 20180501 RGD 1600311 Rab38ru Rab38, member of RAS oncogene family, ruby allele gene MP:0010815 enlarged alveolar lamellar bodies IMP N RGD:13524861|PMID:28438206 20180501 RGD 1600311 Rab38ru Rab38, member of RAS oncogene family, ruby allele gene MP:0010856 dilated respiratory conducting tube IAGP N RGD:2324690|PMID:19897744 20180501 RGD 1600337 F344.GK-(D1Mgh14-D1Rat90)/Swe strain MP:0009113 increased pancreatic beta cell mass IAGP N RGD:1600083|PMID:17130497 20200423 RGD compared to F344/DuCrl2Swe 1600338 SHR.F344-(D12Mgh5-D12Mgh6)/Snk strain MP:0002834 decreased heart weight IAGP N RGD:1599588|PMID:17261463 20070314 RGD compared to SHR/Snk strain 1600338 SHR.F344-(D12Mgh5-D12Mgh6)/Snk strain MP:0004867 decreased platelet calcium level IAGP XCO:0000177|XCO:0000178 N RGD:1599588|PMID:17261463 20070314 RGD compared to SHR/Snk strain 1600338 SHR.F344-(D12Mgh5-D12Mgh6)/Snk strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:1599588|PMID:17261463 20070314 RGD compared to SHR/Snk strain 1600338 SHR.F344-(D12Mgh5-D12Mgh6)/Snk strain MP:0009549 decreased platelet aggregation IAGP N RGD:1599588|PMID:17261463 20070314 RGD compared to SHR/Snk strain 1600339 BN.GK-(D1Wox18-D1Got254)/Ox strain MP:0001260 increased body weight IMP N RGD:2300263|PMID:18698428 20080910 RGD as compared to BN progenitor 1600339 BN.GK-(D1Wox18-D1Got254)/Ox strain MP:0009171 enlarged pancreatic islets IMP N RGD:2300263|PMID:18698428 20201006 RGD compared to BN 1600341 LEW-Tg(Ren2)27/Jmul strain MP:0001260 increased body weight sexual_dimorphism IMP N RGD:2293121|PMID:18456730 20200211 RGD compared to female LEW-Tg(Ren2)27/Jmul 1600341 LEW-Tg(Ren2)27/Jmul strain MP:0002962 increased urine protein level sexual_dimorphism IMP N RGD:2293121|PMID:18456730 20200211 RGD compared to male LEW/Crl, compared to female LEW-Tg(Ren2)27/Jmul 1600341 LEW-Tg(Ren2)27/Jmul strain MP:0003184 increased angiotensin I-converting enzyme activity IMP N RGD:2293121|PMID:18456730 20200211 RGD compared to male LEW/Crl, plasma and cortical 1600341 LEW-Tg(Ren2)27/Jmul strain MP:0003184 increased angiotensin I-converting enzyme activity sexual_dimorphism IMP N RGD:2293121|PMID:18456730 20200211 RGD compared to female LEW-Tg(Ren2)27/Jmul, plasma and cortical 1600341 LEW-Tg(Ren2)27/Jmul strain MP:0003352 increased circulating renin level IMP N RGD:2293121|PMID:18456730 20200211 RGD compared to LEW/Crl�� 1600341 LEW-Tg(Ren2)27/Jmul strain MP:0003352 increased circulating renin level sexual_dimorphism IMP N RGD:2293121|PMID:18456730 20200211 RGD compared to female LEW-Tg(Ren2)27/Jmul 1600341 LEW-Tg(Ren2)27/Jmul strain MP:0003915 increased heart left ventricle weight sexual_dimorphism IMP N RGD:2293121|PMID:18456730 20200211 RGD compared to female LEW-Tg(Ren2)27/Jmul 1600341 LEW-Tg(Ren2)27/Jmul strain MP:0003917 increased kidney weight sexual_dimorphism IMP N RGD:2293121|PMID:18456730 20200211 RGD compared to male LEW/Crl, compared to female LEW-Tg(Ren2)27/Jmul 1600341 LEW-Tg(Ren2)27/Jmul strain MP:0003918 decreased kidney weight sexual_dimorphism IMP N RGD:2293121|PMID:18456730 20200211 RGD compared to female LEW/Crl 1600341 LEW-Tg(Ren2)27/Jmul strain MP:0005583 decreased renin activity sexual_dimorphism IMP N RGD:2293121|PMID:18456730 20200211 RGD compared to female LEW/Crl 1600341 LEW-Tg(Ren2)27/Jmul strain MP:0006144 increased systemic arterial systolic blood pressure IMP N RGD:2293121|PMID:18456730 20080513 RGD compared to LEW/Crl� 1600341 LEW-Tg(Ren2)27/Jmul strain MP:0006144 increased systemic arterial systolic blood pressure sexual_dimorphism IMP N RGD:2293121|PMID:18456730 20200211 RGD compared to female LEW-Tg(Ren2)27/Jmul 1600341 LEW-Tg(Ren2)27/Jmul strain MP:0006376 decreased circulating angiotensinogen level sexual_dimorphism IMP N RGD:2293121|PMID:18456730 20200211 RGD compared to female LEW/Crl 1600341 LEW-Tg(Ren2)27/Jmul strain MP:0010212 abnormal circulating C-reactive protein level IMP N RGD:2293121|PMID:18456730 20200211 RGD compared to LEW/Crl 1600341 LEW-Tg(Ren2)27/Jmul strain MP:0010212 abnormal circulating C-reactive protein level sexual_dimorphism IMP N RGD:2293121|PMID:18456730 20200211 RGD compared to female LEW-Tg(Ren2)27/Jmul 1600341 LEW-Tg(Ren2)27/Jmul strain MP:0011470 increased urine creatinine level IMP N RGD:2293121|PMID:18456730 20080513 RGD 1600341 LEW-Tg(Ren2)27/Jmul strain MP:0011470 increased urine creatinine level sexual_dimorphism IMP N RGD:2293121|PMID:18456730 20200211 RGD compared to female LEW-Tg(Ren2)27/Jmul 1600342 F344.GK-(D1Got250-D1Rat90)/Swe strain MP:0001260 increased body weight IAGP N RGD:1599587|PMID:16951059 20200319 RGD compared to F344/DuCrlSwe 1600342 F344.GK-(D1Got250-D1Rat90)/Swe strain MP:0003058 increased insulin secretion IAGP N RGD:1600083|PMID:17130497 20200423 RGD compared to F344/DuCrl2Swe 1600342 F344.GK-(D1Got250-D1Rat90)/Swe strain MP:0005559 increased circulating glucose level IAGP N RGD:1599587|PMID:16951059 20200319 RGD compared to F344/DuCrlSwe 1600343 SHRSP.WKY-(D1Wox29-D1Arb21)/Izm strain MP:0002843 decreased systemic arterial blood pressure susceptibility IAGP XCO:0000164 N RGD:2302104|PMID:18971556 20081119 RGD compared to SHRSP/Izm; MMO:0000031 1600343 SHRSP.WKY-(D1Wox29-D1Arb21)/Izm strain MP:0004183 abnormal sympathetic nervous system physiology IAGP N RGD:2302408|PMID:19047583 20081217 RGD 1600343 SHRSP.WKY-(D1Wox29-D1Arb21)/Izm strain MP:0004217 salt-sensitive hypertension susceptibility IAGP XCO:0000164 N RGD:2302104|PMID:18971556 20081119 RGD MMO:0000031 1600343 SHRSP.WKY-(D1Wox29-D1Arb21)/Izm strain MP:0004484 abnormal response of heart to induced stress susceptibility IAGP XCO:0000158 N RGD:4889147|PMID:21063213 20191216 RGD compared to SHRSP/Izm in response to restraint stress 1600343 SHRSP.WKY-(D1Wox29-D1Arb21)/Izm strain MP:0004876 decreased mean systemic arterial blood pressure IAGP N RGD:1600255|PMID:17327494 20191210 RGD compared to SHRSP/Izm 1600343 SHRSP.WKY-(D1Wox29-D1Arb21)/Izm strain MP:0005264 glomerulosclerosis susceptibility IAGP XCO:0000164 N RGD:2302104|PMID:18971556 20081119 RGD compared to SHRSP/Izm; MMO:0000496 1600343 SHRSP.WKY-(D1Wox29-D1Arb21)/Izm strain MP:0006058 decreased cerebral infarct size IAGP XCO:0000348 N RGD:1600255|PMID:17327494 20191210 RGD compared to SHRSP/Izm 1600343 SHRSP.WKY-(D1Wox29-D1Arb21)/Izm strain MP:0006059 decreased susceptibility to ischemic brain injury IAGP XCO:0000164 N RGD:2302104|PMID:18971556 20081119 RGD compared to SHRSP/Izm; MMO:0000496 1600343 SHRSP.WKY-(D1Wox29-D1Arb21)/Izm strain MP:0006059 decreased susceptibility to ischemic brain injury IAGP XCO:0000348 N RGD:1600255|PMID:17327494 20191210 RGD compared to SHRSP/Izm 1600343 SHRSP.WKY-(D1Wox29-D1Arb21)/Izm strain MP:0006264 decreased systemic arterial systolic blood pressure susceptibility IAGP N RGD:4889147|PMID:21063213 20191216 RGD baseline compared to SHRSP/Izm 1600343 SHRSP.WKY-(D1Wox29-D1Arb21)/Izm strain MP:0030773 decreased urine noradrenaline level IAGP XCO:0000307 N RGD:4889147|PMID:21063213 20191216 RGD compared to SHRSP/Izm in response to cold stress 1600344 F344.GK-(D1Rat175-D1Rat90)/Swe strain MP:0001260 increased body weight IAGP N RGD:1599587|PMID:16951059 20200319 RGD compared to F344/DuCrlSwe 1600344 F344.GK-(D1Rat175-D1Rat90)/Swe strain MP:0002727 decreased circulating insulin level IAGP N RGD:1599587|PMID:16951059 20200319 RGD compared to F344/DuCrlSwe 1600344 F344.GK-(D1Rat175-D1Rat90)/Swe strain MP:0005559 increased circulating glucose level IAGP N RGD:1599587|PMID:16951059 20200319 RGD compared to F344/DuCrlSwe 1600346 F344.GK-(D1Swe4-D1Rat85)/Swe strain MP:0001262 decreased body weight IAGP N RGD:1599587|PMID:16951059 20200319 RGD compared to F344/DuCrlSwe 1600346 F344.GK-(D1Swe4-D1Rat85)/Swe strain MP:0002079 increased circulating insulin level IAGP N RGD:1599587|PMID:16951059 20200319 RGD compared to F344/DuCrlSwe 1600346 F344.GK-(D1Swe4-D1Rat85)/Swe strain MP:0005560 decreased circulating glucose level IAGP N RGD:1599587|PMID:16951059 20200319 RGD compared to F344/DuCrlSwe 1600358 Mamtr5 Mammary tumor resistance QTL 5 qtl MP:0001883 increased mammary adenocarcinoma incidence IDA N RGD:1599390|PMID:17230524 20070314 RGD 1600358 Mamtr5 Mammary tumor resistance QTL 5 qtl MP:0003721 increased tumor growth/size IDA N RGD:1599390|PMID:17230524 20070314 RGD 1600360 Mcs16 Mammary carcinoma susceptibility QTL 16 qtl MP:0001883 increased mammary adenocarcinoma incidence IDA N RGD:1599317|PMID:16596452 20070309 RGD 1600362 Mcs19 Mammary carcinoma susceptibility QTL 19 qtl MP:0001883 increased mammary adenocarcinoma incidence IDA N RGD:1599317|PMID:16596452 20070309 RGD 1600363 Hc6 Hypercalciuria QTL 6 qtl MP:0002708 nephrolithiasis IDA N RGD:1582396|PMID:16611718 20070309 RGD 1600363 Hc6 Hypercalciuria QTL 6 qtl MP:0005441 increased urine calcium level IDA N RGD:1582396|PMID:16611718 20070309 RGD 1600365 Mcs20 Mammary carcinoma susceptibility QTL 20 qtl MP:0001883 increased mammary adenocarcinoma incidence IDA N RGD:1599317|PMID:16596452 20070309 RGD 1600367 Mcs15 Mammary carcinoma susceptibility QTL 15 qtl MP:0001883 increased mammary adenocarcinoma incidence IAGP N RGD:1581951|PMID:16568087 20070309 RGD 1600369 Hcas8 Hepatocarcinoma susceptibility QTL 8 qtl MP:0003893 increased hepatocyte proliferation IDA N RGD:1599590|PMID:17079458 20070314 RGD 1600369 Hcas8 Hepatocarcinoma susceptibility QTL 8 qtl MP:0010264 increased hepatoma incidence IDA N RGD:1599590|PMID:17079458 20111108 RGD 1600371 Mcs21 Mammary carcinoma susceptibility QTL 21 qtl MP:0001883 increased mammary adenocarcinoma incidence IDA N RGD:1599317|PMID:16596452 20070309 RGD 1600371 Mcs21 Mammary carcinoma susceptibility QTL 21 qtl MP:0002020 increased tumor incidence TAS N RGD:2302423|PMID:19052818 20090204 RGD 1600373 Mamtr6 Mammary tumor resistance QTL 6 qtl MP:0001883 increased mammary adenocarcinoma incidence IDA N RGD:1599390|PMID:17230524 20070314 RGD 1600373 Mamtr6 Mammary tumor resistance QTL 6 qtl MP:0004502 decreased incidence of tumors by chemical induction TAS N RGD:2302423|PMID:19052818 20090204 RGD 1600374 Mcs17 Mammary carcinoma susceptibility QTL 17 qtl MP:0001883 increased mammary adenocarcinoma incidence IDA N RGD:1599317|PMID:16596452 20070309 RGD 1600375 Mcs22 Mammary carcinoma susceptibility QTL 22 qtl MP:0001883 increased mammary adenocarcinoma incidence IDA N RGD:1599317|PMID:16596452 20070309 RGD 1600375 Mcs22 Mammary carcinoma susceptibility QTL 22 qtl MP:0002020 increased tumor incidence TAS N RGD:2302423|PMID:19052818 20090204 RGD 1600376 Arunc5 Aerobic running capacity QTL 5 qtl MP:0003060 increased aerobic running capacity IAGP N RGD:1598978|PMID:17179209 20070309 RGD 1600378 Arunc4 Aerobic running capacity QTL 4 qtl MP:0003060 increased aerobic running capacity IAGP N RGD:1598978|PMID:17179209 20070309 RGD 1600379 Mcs18 Mammary carcinoma susceptibility QTL 18 qtl MP:0001883 increased mammary adenocarcinoma incidence IDA N RGD:1599317|PMID:16596452 20070309 RGD 1600382 Edcs3 Endometrial carcinoma susceptibility QTL3 qtl MP:0004868 increased endometrial carcinoma incidence susceptibility IDA N RGD:1599856|PMID:11745480 20070824 RGD 1600384 Niddm66 Non-insulin dependent diabetes mellitus QTL 66 qtl MP:0005559 increased circulating glucose level IDA N RGD:1599587|PMID:16951059 20070824 RGD 1600386 Calcic2 Intracellular calcium level QTL 2 qtl MP:0001625 cardiac hypertrophy IAGP N RGD:1599588|PMID:17261463 20070314 RGD 1600390 Niddm64 Non-insulin dependent diabetes mellitus QTL 64 qtl MP:0005559 increased circulating glucose level IDA N RGD:1599587|PMID:16951059 20070824 RGD 1600391 Edcs2 Endometrial carcinoma susceptibility QTL2 qtl MP:0004868 increased endometrial carcinoma incidence susceptibility IDA N RGD:1599856|PMID:11745480 20070824 RGD 1600392 Bw123 Body weight QTL 123 qtl MP:0001262 decreased body weight TAS N RGD:1599587|PMID:16951059 20070824 RGD 1600394 Edcs1 Endometrial carcinoma susceptibility QTL1 qtl MP:0004868 increased endometrial carcinoma incidence susceptibility IDA N RGD:1599856|PMID:11745480 20070824 RGD 1600397 Edcs4 Endometrial carcinoma susceptibility QTL 4 qtl MP:0004868 increased endometrial carcinoma incidence susceptibility IDA N RGD:1599856|PMID:11745480 20070824 RGD 1600398 Edcs5 Endometrial carcinoma susceptibility QTL 5 qtl MP:0004868 increased endometrial carcinoma incidence susceptibility IDA N RGD:1599856|PMID:11745480 20070824 RGD 1600490 SS-Chr 1BN/Mcwi strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:2300225|PMID:18653478 20080910 RGD compared to SS/JrHsdMcwi 1600490 SS-Chr 1BN/Mcwi strain MP:0005540 decreased urine albumin level induced IAGP XCO:0000022 N RGD:2300225|PMID:18653478 20080910 RGD compared to SS/JrHsdMcwi 1641831 MWF-Chr 6SHR/Rkb strain MP:0001552 increased circulating triglyceride level IAGP N RGD:1600609|PMID:17167120 20200130 RGD compared to SHR/FubRkb strain 1641831 MWF-Chr 6SHR/Rkb strain MP:0002834 decreased heart weight IAGP N RGD:1600609|PMID:17167120 20200130 RGD compared to SHR/FubRkb strain 1641831 MWF-Chr 6SHR/Rkb strain MP:0005540 decreased urine albumin level sexual_dimorphism IAGP N RGD:1642911|PMID:17953514 20080311 RGD compared to males 1641831 MWF-Chr 6SHR/Rkb strain MP:0005566 decreased blood urea nitrogen level IAGP N RGD:1642911|PMID:17953514 20200128 RGD females compared to female MWF/FubRkb 1641831 MWF-Chr 6SHR/Rkb strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:1600609|PMID:17167120 20080924 RGD compared to SHR/FubRkb strain 1641833 Alc21 Alcohol consumption QTL 21 qtl MP:0003545 increased alcohol consumption IDA N RGD:1578304|PMID:16470346 20080924 RGD 1641850 SHR.WKY-(D1Got158-D1Got161)/Njs strain MP:0004876 decreased mean systemic arterial blood pressure IAGP N RGD:1625015|PMID:17332427 20071116 RGD compared to SHR/NCruk strain 1641851 SHR.PD-(D8Rat42-D8Arb23)/Cub strain MP:0001262 decreased body weight IAGP N RGD:1580747|PMID:16045236 20080924 RGD 1641851 SHR.PD-(D8Rat42-D8Arb23)/Cub strain MP:0002644 decreased circulating triglyceride level IAGP N RGD:1580747|PMID:16045236 20080924 RGD 1641851 SHR.PD-(D8Rat42-D8Arb23)/Cub strain MP:0005331 insulin resistance IAGP N RGD:1580747|PMID:16045236 20080924 RGD 1641851 SHR.PD-(D8Rat42-D8Arb23)/Cub strain MP:0009743 preaxial polydactyly IAGP N RGD:2312786|PMID:19191224 20170626 RGD 1641852 WF.BBDR-(D4Got48-D4Got43)/Wor strain MP:0004804 decreased susceptibility to autoimmune diabetes induced IAGP XCO:0000231,XCO:0000235 N RGD:1600776|PMID:17376830 20080924 RGD 1641853 SS.LEW-(D10Mco38-D10Mgh1)/Jr strain MP:0002834 decreased heart weight induced IAGP XCO:0000022 N RGD:628510|PMID:11641286 20080924 RGD compared to SS/Jr 1641853 SS.LEW-(D10Mco38-D10Mgh1)/Jr strain MP:0002843 decreased systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:628510|PMID:11641286 20080924 RGD compared to SS/Jr 1641854 HAS.LAS-(D5Rat70-D5Rat37)/Rar strain MP:0002863 improved righting response sexual_dimorphism IAGP XCO:0000325 N RGD:1600610|PMID:16953387 20080924 RGD compared to female HAS1 1641856 P.NP-(D4Rat119-D4Rat55)/Iusm strain MP:0000063 decreased bone mineral density IAGP N RGD:2317896|PMID:20200994 20100430 RGD as compared to P/Iusm 1641856 P.NP-(D4Rat119-D4Rat55)/Iusm strain MP:0001260 increased body weight IAGP N RGD:2317896|PMID:20200994 20100430 RGD as compared to P/Iusm 1641856 P.NP-(D4Rat119-D4Rat55)/Iusm strain MP:0001260 increased body weight IAGP N RGD:7394775|PMID:23312492 20131105 RGD compared to P/Iusm 1641856 P.NP-(D4Rat119-D4Rat55)/Iusm strain MP:0003546 decreased alcohol consumption IAGP N RGD:1578304|PMID:16470346 20080924 RGD compared to P/Iusm 1641857 BBDP.WF-(D8Rat16-D8Sunn1467)/Sunn strain MP:0004804 decreased susceptibility to autoimmune diabetes IAGP N RGD:1624306|PMID:17389329 20200302 RGD 1641858 SHR.WKY-(D1Rat420-D1Rat278)/Njs strain MP:0004875 increased mean systemic arterial blood pressure IAGP N RGD:1625015|PMID:17332427 20200204 RGD compared to SHR.WKY-(D1Rat420-D1Got161)/Njs strain 1641859 SS.MNS-(D10Bra1-D10Mit11)/Jr strain MP:0002834 decreased heart weight induced IAGP XCO:0000022 N RGD:628510|PMID:11641286 20080218 RGD compared to SS/Jr 1641859 SS.MNS-(D10Bra1-D10Mit11)/Jr strain MP:0002843 decreased systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:628510|PMID:11641286 20080218 RGD compared to SS/Jr 1641860 SS.MNS-(D10Mco62-D10Mit1)/Jr strain MP:0002834 decreased heart weight induced IAGP XCO:0000022 N RGD:628510|PMID:11641286 20080218 RGD compared to SS/Jr 1641860 SS.MNS-(D10Mco62-D10Mit1)/Jr strain MP:0002843 decreased systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:628510|PMID:11641286 20080218 RGD compared to SS/Jr 1641861 HAS.LAS-(D2Rat53-D2Rat138)/Rar strain MP:0002863 improved righting response sexual_dimorphism IAGP XCO:0000325 N RGD:1600610|PMID:16953387 20080924 RGD compared to female HAS1 1641862 F344-ApcPirc/Uwm strain MP:0001263 weight loss sexual_dimorphism IMP N RGD:1601201|PMID:17360473 20080924 RGD compared to females 1641862 F344-ApcPirc/Uwm strain MP:0001577 anemia sexual_dimorphism IMP N RGD:1601201|PMID:17360473 20080924 RGD compared to females 1641862 F344-ApcPirc/Uwm strain MP:0001661 extended life span sexual_dimorphism IMP N RGD:1601201|PMID:17360473 20200319 RGD compared to males 1641862 F344-ApcPirc/Uwm strain MP:0002044 increased colon adenoma incidence induced IMP XCO:0000345 N RGD:1601201|PMID:17360473 20080924 RGD compared to treated females, mock treated males 1641862 F344-ApcPirc/Uwm strain MP:0002957 increased intestinal adenocarcinoma incidence sexual_dimorphism IMP XCO:0000345 N RGD:1601201|PMID:17360473 20080924 RGD compared to treated females 1641862 F344-ApcPirc/Uwm strain MP:0003269 colon polyps IMP N RGD:1601201|PMID:17360473 20080924 RGD 1641862 F344-ApcPirc/Uwm strain MP:0003293 rectal hemorrhage sexual_dimorphism IMP N RGD:1601201|PMID:17360473 20080924 RGD compared to females 1641863 SHR.PD-(D8Mgh9-D8Rat149)/Cub strain MP:0001552 increased circulating triglyceride level induced IAGP XCO:0000211|XCO:0000246 N RGD:1600413|PMID:17066744 20080924 RGD compared to SHR/OlaIpcv 1641863 SHR.PD-(D8Mgh9-D8Rat149)/Cub strain MP:0001554 increased circulating free fatty acids level induced IAGP XCO:0000211,XCO:0000102 N RGD:1600413|PMID:17066744 20080924 RGD compared to SHR/OlaIpcv 1641863 SHR.PD-(D8Mgh9-D8Rat149)/Cub strain MP:0002702 decreased circulating free fatty acids level induced IAGP XCO:0000246,XCO:0000102 N RGD:1600413|PMID:17066744 20080924 RGD compared to SHR/OlaIpcv 1641863 SHR.PD-(D8Mgh9-D8Rat149)/Cub strain MP:0005178 increased circulating cholesterol level induced IAGP XCO:0000246, XCO:0000102 N RGD:1600413|PMID:17066744 20080924 RGD compared to SHR/OlaIpcv 1641863 SHR.PD-(D8Mgh9-D8Rat149)/Cub strain MP:0005292 improved glucose tolerance induced IAGP XCO:0000246 N RGD:1600413|PMID:17066744 20080924 RGD compared to SHR/OlaIpcv 1641864 WF/CrCrli strain MP:0009314 increased colon adenocarcinoma incidence induced IAGP XCO:0000393 N RGD:1625309|PMID:17510081 20200319 RGD compared to treated ACI/SegHsd 1641865 SD-Brca2m1Uwm strain MP:0000628 abnormal mammary gland development IMP N RGD:1599505|PMID:16964288 20210426 RGD 1641865 SD-Brca2m1Uwm strain MP:0001156 abnormal spermatogenesis IMP N RGD:1599505|PMID:16964288 20210426 RGD 1641865 SD-Brca2m1Uwm strain MP:0001262 decreased body weight IMP N RGD:727990|PMID:12754522 20180430 RGD 1641865 SD-Brca2m1Uwm strain MP:0002020 increased tumor incidence IMP N RGD:1599505|PMID:16964288 20210426 RGD 1641865 SD-Brca2m1Uwm strain MP:0002083 premature death IMP N RGD:1599505|PMID:16964288 20210426 RGD 1641865 SD-Brca2m1Uwm strain MP:0004833 ovary atrophy IMP N RGD:727990|PMID:12754522 20180430 RGD 1641865 SD-Brca2m1Uwm strain MP:0011482 posterior iris synechia IMP N RGD:1599505|PMID:16964288 20210426 RGD 1641865 SD-Brca2m1Uwm strain MP:0031212 decreased eye anterior chamber depth IMP N RGD:1599505|PMID:16964288 20210426 RGD 1641866 SS.LEW-(D10Mit10-D10Rat24)/Jr strain MP:0002834 decreased heart weight induced IAGP XCO:0000022 N RGD:628510|PMID:11641286 20080924 RGD compared to SS/Jr 1641866 SS.LEW-(D10Mit10-D10Rat24)/Jr strain MP:0002843 decreased systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:628510|PMID:11641286 20080924 RGD compared to SS/Jr 1641867 Iusm:P alcohol-preferring strain MP:0000062 increased bone mineral density IAGP N RGD:2317896|PMID:20200994 20100430 RGD compared to NP/Iusm 1641867 Iusm:P alcohol-preferring strain MP:0001262 decreased body weight IAGP N RGD:2317896|PMID:20200994 20100430 RGD as compared to NP/Iusm 1641867 Iusm:P alcohol-preferring strain MP:0001262 decreased body weight onset IAGP N RGD:155883170|PMID:16269906 20230313 RGD 6 months, compared to NP/Iusm 1641867 Iusm:P alcohol-preferring strain MP:0001399 hyperactivity IAGP N RGD:2317896|PMID:20200994 20100430 RGD as compared to NP/Iusm 1641867 Iusm:P alcohol-preferring strain MP:0001745 increased circulating corticosterone level IAGP N RGD:8662401|PMID:24611993 20210714 RGD compared to NP/Iusm 1641867 Iusm:P alcohol-preferring strain MP:0001987 alcohol preference IAGP N RGD:156431211|PMID:9802545 20230306 RGD compared to NP/Iusm 1641867 Iusm:P alcohol-preferring strain MP:0002764 short tibia onset IAGP N RGD:155883170|PMID:16269906 20230313 RGD 6 months, compared to NP/Iusm 1641867 Iusm:P alcohol-preferring strain MP:0002917 decreased synaptic depression IAGP N RGD:149735328|PMID:24082084 20210714 RGD compared to NP/Iusm 1641867 Iusm:P alcohol-preferring strain MP:0003109 short femur onset IAGP N RGD:155883170|PMID:16269906 20230313 RGD 6 months, compared to NP/Iusm 1641867 Iusm:P alcohol-preferring strain MP:0004149 increased bone strength IAGP N RGD:2317896|PMID:20200994 20100430 RGD as compared to NP/Iusm 1641867 Iusm:P alcohol-preferring strain MP:0004351 short humerus onset IAGP N RGD:155883170|PMID:16269906 20230313 RGD 6 months, compared to NP/Iusm 1641868 WF.BBDR-(D4Rat93-D4Rat228)/Wor strain MP:0004803 increased susceptibility to autoimmune diabetes induced IAGP XCO:0000231,XCO:0000235 N RGD:1600776|PMID:17376830 20080924 RGD 1641869 SS.MNS-(D10Mco31-D10Mit11)/Jr strain MP:0002834 decreased heart weight induced IAGP XCO:0000022 N RGD:628510|PMID:11641286 20080218 RGD as compared to SS/Jr 1641869 SS.MNS-(D10Mco31-D10Mit11)/Jr strain MP:0002843 decreased systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:628510|PMID:11641286 20080218 RGD compared to SS/Jr 1641871 SS.MNS-(D10Mco62-D10Mco31)/Jr strain MP:0002834 decreased heart weight induced IAGP XCO:0000022 N RGD:628510|PMID:11641286 20080211 RGD compared to SS/Jr 1641871 SS.MNS-(D10Mco62-D10Mco31)/Jr strain MP:0002843 decreased systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:628510|PMID:11641286 20080211 RGD compared to SS/Jr 1641872 SS.LEW-(D10Mco38-D10Mco41)/Jr strain MP:0002834 decreased heart weight induced IAGP XCO:0000022 N RGD:628510|PMID:11641286 20080924 RGD compared to SS/Jr 1641872 SS.LEW-(D10Mco38-D10Mco41)/Jr strain MP:0002843 decreased systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:628510|PMID:11641286 20080924 RGD compared to SS/Jr 1641875 SHR-Chr YBN/Cub strain MP:0000182 increased circulating LDL cholesterol level induced IAGP XCO:0000025 N RGD:619661|PMID:11304517 20201201 RGD compared to SHR 1641875 SHR-Chr YBN/Cub strain MP:0000186 decreased circulating HDL cholesterol level induced IAGP XCO:0000244 | XCO:0000025 N RGD:619661|PMID:11304517 20080924 RGD compared to SHR 1641875 SHR-Chr YBN/Cub strain MP:0001260 increased body weight induced IAGP XCO:0000022, XCO:0000367 N RGD:619661|PMID:11304517 20080924 RGD compared to SHR 1641875 SHR-Chr YBN/Cub strain MP:0005317 increased triglyceride level induced IAGP XCO:0000244 | XCO:0000025 N RGD:619661|PMID:11304517 20080924 RGD compared to SHR 1641875 SHR-Chr YBN/Cub strain MP:0006263 decreased systemic arterial diastolic blood pressure induced IAGP XCO:0000022 N RGD:619661|PMID:11304517 20080924 RGD compared to SHR 1641875 SHR-Chr YBN/Cub strain MP:0006264 decreased systemic arterial systolic blood pressure induced IAGP XCO:0000022 N RGD:619661|PMID:11304517 20080924 RGD compared to SHR 1641875 SHR-Chr YBN/Cub strain MP:0010167 decreased response to stress-induced hyperthermia IAGP N RGD:61094|PMID:10679499 20171121 RGD compared to SHR 1641876 BBDP.WF-(D8Rat73-D8Sunn1467)/Sunn strain MP:0004804 decreased susceptibility to autoimmune diabetes IAGP N RGD:1624306|PMID:17389329 20200302 RGD 1641877 NP.P-(D4Rat119-D4Rat55)/Iusm strain MP:0000062 increased bone mineral density IAGP N RGD:2317896|PMID:20200994 20100430 RGD as compared to P/Iusm 1641877 NP.P-(D4Rat119-D4Rat55)/Iusm strain MP:0001262 decreased body weight IAGP N RGD:2317896|PMID:20200994 20100430 RGD as compared to NP/Iusm 1641877 NP.P-(D4Rat119-D4Rat55)/Iusm strain MP:0001399 hyperactivity IAGP N RGD:2317896|PMID:20200994 20100430 RGD as compared to NP/Iusm 1641877 NP.P-(D4Rat119-D4Rat55)/Iusm strain MP:0003545 increased alcohol consumption IAGP N RGD:1578304|PMID:16470346 20080924 RGD 1641878 WF.BBDR-(Clcn1-D4Rat228)/Wor strain MP:0004804 decreased susceptibility to autoimmune diabetes induced IAGP XCO:0000231,XCO:0000235 N RGD:1600776|PMID:17376830 20080924 RGD 1641879 SS-Chr 19SHR/Rkb strain MP:0002963 decreased urine protein level IAGP N RGD:1600252|PMID:17143179 20201022 RGD compared to SS/Rkb 1641879 SS-Chr 19SHR/Rkb strain MP:0003916 decreased heart left ventricle weight IAGP N RGD:1600252|PMID:17143179 20071116 RGD compared to SS/Rkb 1641879 SS-Chr 19SHR/Rkb strain MP:0003916 decreased heart left ventricle weight IMP N RGD:2307185|PMID:18824493 20201023 RGD compared to SS/JrRkb 1641879 SS-Chr 19SHR/Rkb strain MP:0003918 decreased kidney weight IAGP N RGD:1600252|PMID:17143179 20071116 RGD compared to SS/Rkb 1641879 SS-Chr 19SHR/Rkb strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:1600252|PMID:17143179 20201022 RGD 1641879 SS-Chr 19SHR/Rkb strain MP:0005179 decreased circulating cholesterol level IMP N RGD:2307185|PMID:18824493 20090520 RGD compared to SS/Rkb 1641879 SS-Chr 19SHR/Rkb strain MP:0005540 decreased urine albumin level IAGP N RGD:1600252|PMID:17143179 20201022 RGD compared to SS/Rkb 1641879 SS-Chr 19SHR/Rkb strain MP:0005608 cardiac interstitial fibrosis severity IAGP XCO:0000022 N RGD:1600252|PMID:17143179 20071116 RGD compared to SS/Rkb 1641879 SS-Chr 19SHR/Rkb strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:1600252|PMID:17143179 20201022 RGD compared to SS/Rkb 1641879 SS-Chr 19SHR/Rkb strain MP:0006264 decreased systemic arterial systolic blood pressure IMP N RGD:2307185|PMID:18824493 20201023 RGD compared to SS/JrRkb 1641879 SS-Chr 19SHR/Rkb strain MP:0031199 decreased aortic weight IAGP XCO:0000022 N RGD:1600252|PMID:17143179 20071116 RGD compared to SS/Rkb 1641885 Alcrsp9 Alcohol response QTL 9 qtl MP:0001987 alcohol preference IDA N RGD:1334439|PMID:15608595 20111108 RGD 1641887 Alcrsp14 Alcohol response QTL 14 qtl MP:0001987 alcohol preference IDA N RGD:1334439|PMID:15608595 20111108 RGD 1641889 Colcr6 Colorectal carcinoma resistance QTL 6 qtl MP:0002044 increased colon adenoma incidence IDA N RGD:1625309|PMID:17510081 20080924 RGD 1641891 Alcrsp17 Alcohol response QTL 17 qtl MP:0001987 alcohol preference IDA N RGD:1334439|PMID:15608595 20111108 RGD 1641893 Alcrsp7 Alcohol response QTL 7 qtl MP:0001523 impaired righting response IDA N RGD:1334439|PMID:15608595 20070824 RGD 1641893 Alcrsp7 Alcohol response QTL 7 qtl MP:0001987 alcohol preference IDA N RGD:1334439|PMID:15608595 20111108 RGD 1641894 Alcrsp12 Alcohol response QTL 12 qtl MP:0001987 alcohol preference IDA N RGD:1334439|PMID:15608595 20111108 RGD 1641895 Bp298 Blood pressure QTL 298 qtl MP:0004184 abnormal baroreceptor physiology TAS N RGD:2302408|PMID:19047583 20081217 RGD 1641895 Bp298 Blood pressure QTL 298 qtl MP:0004876 decreased mean systemic arterial blood pressure IDA N RGD:1600255|PMID:17327494 20070824 RGD 1641897 Alcrsp1 Alcohol response QTL 1 qtl MP:0001523 impaired righting response IDA N RGD:1334439|PMID:15608595 20070824 RGD 1641897 Alcrsp1 Alcohol response QTL 1 qtl MP:0001987 alcohol preference IDA N RGD:1334439|PMID:15608595 20111108 RGD 1641898 Colcr4 Colorectal carcinoma resistance QTL4 qtl MP:0002044 increased colon adenoma incidence IDA N RGD:1625309|PMID:17510081 20080924 RGD 1641900 Alcrsp11 Alcohol response QTL 11 qtl MP:0001987 alcohol preference IDA N RGD:1334439|PMID:15608595 20111108 RGD 1641901 Alcrsp6 Alcohol response QTL 6 qtl MP:0001523 impaired righting response IDA N RGD:1334439|PMID:15608595 20070824 RGD 1641901 Alcrsp6 Alcohol response QTL 6 qtl MP:0001987 alcohol preference IDA N RGD:1334439|PMID:15608595 20111108 RGD 1641902 Colcr7 Colorectal carcinoma resistance QTL 7 qtl MP:0002044 increased colon adenoma incidence IDA N RGD:1625309|PMID:17510081 20080924 RGD 1641903 Alcrsp3 Alcohol response QTL 3 qtl MP:0001523 impaired righting response IDA N RGD:1334439|PMID:15608595 20070824 RGD 1641903 Alcrsp3 Alcohol response QTL 3 qtl MP:0001987 alcohol preference IDA N RGD:1334439|PMID:15608595 20111108 RGD 1641904 Alcrsp4 Alcohol response QTL 4 qtl MP:0001523 impaired righting response IDA N RGD:1334439|PMID:15608595 20070824 RGD 1641904 Alcrsp4 Alcohol response QTL 4 qtl MP:0001987 alcohol preference IDA N RGD:1334439|PMID:15608595 20111108 RGD 1641905 Colcr1 Colorectal carcinoma resistance QTL 1 qtl MP:0002044 increased colon adenoma incidence IDA N RGD:1625309|PMID:17510081 20080924 RGD 1641906 Alcrsp16 Alcohol response QTL 16 qtl MP:0001987 alcohol preference IDA N RGD:1334439|PMID:15608595 20111108 RGD 1641908 Teswt1 Testicular weight QTL 1 qtl MP:0004852 decreased testis weight IDA N RGD:1625009|PMID:16651691 20080924 RGD 1641910 Colcr3 Colorectal carcinoma resistance QTL 3 qtl MP:0002044 increased colon adenoma incidence IDA N RGD:1625309|PMID:17510081 20080924 RGD 1641911 Alcrsp13 Alcohol response QTL 13 qtl MP:0001987 alcohol preference IDA N RGD:1334439|PMID:15608595 20111108 RGD 1641912 Alcrsp18 Alcohol response QTL 18 qtl MP:0001987 alcohol preference IDA N RGD:1334439|PMID:15608595 20111108 RGD 1641913 Colcr2 Colorectal carcinoma resistance QTL 2 qtl MP:0002044 increased colon adenoma incidence IDA N RGD:1625309|PMID:17510081 20080924 RGD 1641915 Colcr9 Colorectal carcinoma resistance QTL 9 qtl MP:0002044 increased colon adenoma incidence IDA N RGD:1625309|PMID:17510081 20080924 RGD 1641917 Colcr5 Colorectal carcinoma resistance QTL 5 qtl MP:0002044 increased colon adenoma incidence IDA N RGD:1625309|PMID:17510081 20080924 RGD 1641918 Alcrsp15 Alcohol response QTL 16 qtl MP:0001987 alcohol preference IDA N RGD:1334439|PMID:15608595 20111108 RGD 1641919 Alc22 Alcohol consumption QTL 22 qtl MP:0003545 increased alcohol consumption IDA N RGD:1578304|PMID:16470346 20080924 RGD 1641920 Colcs1 Colorectal carcinoma susceptibility QTL 1 qtl MP:0002044 increased colon adenoma incidence IDA N RGD:1625309|PMID:17510081 20080924 RGD 1641922 Alcrsp8 Alcohol response QTL 8 qtl MP:0001987 alcohol preference IDA N RGD:1334439|PMID:15608595 20111108 RGD 1641923 Colcr8 Colorectal carcinoma resistance QTL 8 qtl MP:0002044 increased colon adenoma incidence IDA N RGD:1625309|PMID:17510081 20080924 RGD 1641925 Alcrsp2 Alcohol response QTL 2 qtl MP:0001523 impaired righting response IDA N RGD:1334439|PMID:15608595 20070824 RGD 1641925 Alcrsp2 Alcohol response QTL 2 qtl MP:0001987 alcohol preference IDA N RGD:1334439|PMID:15608595 20111108 RGD 1641926 Teswt2 Testicular weight QTL 2 qtl MP:0004852 decreased testis weight IDA N RGD:1625009|PMID:16651691 20080924 RGD 1641927 Alcrsp10 Alcohol response QTL 10 qtl MP:0001987 alcohol preference IDA N RGD:1334439|PMID:15608595 20111108 RGD 1641928 Alcrsp5 Alcohol response QTL 5 qtl MP:0001523 impaired righting response IDA N RGD:1334439|PMID:15608595 20070824 RGD 1641928 Alcrsp5 Alcohol response QTL 5 qtl MP:0001987 alcohol preference IDA N RGD:1334439|PMID:15608595 20111108 RGD 1642017 BBDR/WorBrm strain MP:0004031 insulitis induced IAGP XCO:0000238 N RGD:2313207|PMID:1658938 20200225 RGD 1642017 BBDR/WorBrm strain MP:0004804 decreased susceptibility to autoimmune diabetes IAGP N RGD:1624306|PMID:17389329 20070829 RGD 1642017 BBDR/WorBrm strain MP:0020163 increased susceptibility to virus induced diabetes induced IAGP XCO:0000238 N RGD:2313207|PMID:1658938 20200225 RGD 1642018 BBDP/WorBrm strain MP:0004803 increased susceptibility to autoimmune diabetes IAGP N RGD:1624306|PMID:17389329 20070829 RGD 1642018 BBDP/WorBrm strain MP:0020162 decreased susceptibility to virus induced diabetes induced IAGP XCO:0000238 N RGD:2313207|PMID:1658938 20200225 RGD compared to BBDR/WorBrm 1642036 SHR/OlaIpcv-mtBN/Crl strain MP:0001262 decreased body weight IAGP N RGD:1627567|PMID:17693571 20070829 RGD compared to SHR/OlaIpcv 1642036 SHR/OlaIpcv-mtBN/Crl strain MP:0002079 increased circulating insulin level induced IAGP XCO:0000103 N RGD:1627567|PMID:17693571 20070829 RGD compared to SHR/OlaIpcv 1642036 SHR/OlaIpcv-mtBN/Crl strain MP:0005293 impaired glucose tolerance induced IAGP XCO:0000103 N RGD:1627567|PMID:17693571 20070829 RGD compared to SHR/OlaIpcv 1642036 SHR/OlaIpcv-mtBN/Crl strain MP:0010399 decreased skeletal muscle glycogen level IAGP N RGD:1627567|PMID:17693571 20070829 RGD 1642272 SS.LEW-(D10Mco84-D10Got93)/Mco strain MP:0002834 decreased heart weight induced IAGP XCO:0000022 N RGD:1599269|PMID:17218081 20071116 RGD compared to SS/Jr 1642272 SS.LEW-(D10Mco84-D10Got93)/Mco strain MP:0006264 decreased systemic arterial systolic blood pressure induced IAGP XCO:0000022 N RGD:1599269|PMID:17218081 20071116 RGD compared to SS/Jr 1642275 SS.LEW-(D10Rat29-D10Mco88)/Mco strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:1599269|PMID:17218081 20071116 RGD 1642279 SS.LEW-(D10Arb9-D10Rat161)/Mco strain MP:0001262 decreased body weight induced IAGP XCO:0000022 N RGD:1599269|PMID:17218081 20071116 RGD compared to SS/Jr 1642279 SS.LEW-(D10Arb9-D10Rat161)/Mco strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:1599269|PMID:17218081 20071116 RGD 1642283 SS.LEW-(D10Rat29-D10Got93)/Mco strain MP:0002834 decreased heart weight induced IAGP XCO:0000022 N RGD:1599269|PMID:17218081 20071116 RGD compared to SS/Jr 1642283 SS.LEW-(D10Rat29-D10Got93)/Mco strain MP:0006264 decreased systemic arterial systolic blood pressure induced IAGP XCO:0000022 N RGD:1599269|PMID:17218081 20071116 RGD compared to SS/Jr 1642285 SS.LEW-(D10Arb9-D10Rat57)/Mco strain MP:0002834 decreased heart weight induced IAGP XCO:0000022 N RGD:1599269|PMID:17218081 20071116 RGD compared to SS/Jr 1642285 SS.LEW-(D10Arb9-D10Rat57)/Mco strain MP:0006264 decreased systemic arterial systolic blood pressure induced IAGP XCO:0000022 N RGD:1599269|PMID:17218081 20071116 RGD compared to SS/Jr 1642287 SS.LEW-(D10Arb9-D10Mco84)/Mco strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:1599269|PMID:17218081 20071116 RGD 1642288 SS.LEW-(D10Mco89-D10Got101)/Mco strain MP:0001262 decreased body weight induced IAGP XCO:0000022 N RGD:1599269|PMID:17218081 20071116 RGD compared to SS/Jr 1642288 SS.LEW-(D10Mco89-D10Got101)/Mco strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:1599269|PMID:17218081 20071116 RGD 1642689 BN.OLETF-(D1Rat169-D1Rat90)/Got strain MP:0001362 abnormal anxiety-related response IAGP N RGD:1642680|PMID:17916333 20071009 RGD compared to BN/Crlj 1642689 BN.OLETF-(D1Rat169-D1Rat90)/Got strain MP:0012013 abnormal innate avoidance response IAGP N RGD:1642680|PMID:17916333 20071009 RGD compared to BN/Crlj 1642689 BN.OLETF-(D1Rat169-D1Rat90)/Got strain MP:0013189 abnormal exploration in a new environment IAGP N RGD:1642680|PMID:17916333 20071009 RGD compared to BN/Crlj 1642690 LA-cp/NJcr strain MP:0000182 increased circulating LDL cholesterol level IAGP N RGD:1642389|PMID:17375078 20200323 RGD compared to lean LA/NJcr+/+ rats 1642690 LA-cp/NJcr strain MP:0001260 increased body weight IAGP N RGD:1642389|PMID:17375078 20200323 RGD compared to lean LA/NJcr+/+ rats 1642690 LA-cp/NJcr strain MP:0001260 increased body weight treatment IAGP XCO:0000681 N RGD:1642391|PMID:7600124 20200323 RGD compared to lean LA/NJcr+/+ rats 1642690 LA-cp/NJcr strain MP:0001260 increased body weight treatment IAGP XCO:0000682 N RGD:21408581|PMID:20705262 20200323 RGD compared to lean LA/NJcr+/+ rats 1642690 LA-cp/NJcr strain MP:0001261 obese IAGP N RGD:1642391|PMID:7600124 20071009 RGD compared to lean LA/NJcr+/+ rats 1642690 LA-cp/NJcr strain MP:0001548 hyperlipidemia IAGP N RGD:1642389|PMID:17375078 20071009 RGD compared to lean LA/NJcr+/+ rats 1642690 LA-cp/NJcr strain MP:0001552 increased circulating triglyceride level IAGP N RGD:1642389|PMID:17375078 20200323 RGD compared to lean LA/NJcr+/+ rats 1642690 LA-cp/NJcr strain MP:0001552 increased circulating triglyceride level treatment IAGP XCO:0000681 N RGD:1642391|PMID:7600124 20200320 RGD compared to lean LA/NJcr+/+ rats 1642690 LA-cp/NJcr strain MP:0001552 increased circulating triglyceride level treatment IAGP XCO:0000681 N RGD:21408584|PMID:11978655 20200323 RGD compared to lean LA/NJcr+/+ rats 1642690 LA-cp/NJcr strain MP:0001552 increased circulating triglyceride level treatment IAGP XCO:0000682 N RGD:21408581|PMID:20705262 20200323 RGD compared to lean LA/NJcr+/+ rats 1642690 LA-cp/NJcr strain MP:0001554 increased circulating free fatty acids level treatment IAGP XCO:0000681 N RGD:21408584|PMID:11978655 20200323 RGD compared to lean LA/NJcr+/+ rats 1642690 LA-cp/NJcr strain MP:0001556 increased circulating HDL cholesterol level IAGP N RGD:1642389|PMID:17375078 20200323 RGD compared to lean LA/NJcr+/+ rats 1642690 LA-cp/NJcr strain MP:0002079 increased circulating insulin level IAGP N RGD:1642389|PMID:17375078 20200323 RGD compared to lean LA/NJcr+/+ rats 1642690 LA-cp/NJcr strain MP:0002079 increased circulating insulin level treatment IAGP XCO:0000681 N RGD:1642391|PMID:7600124 20200323 RGD compared to lean LA/NJcr+/+ rats 1642690 LA-cp/NJcr strain MP:0002079 increased circulating insulin level treatment IAGP XCO:0000681 N RGD:21408584|PMID:11978655 20200323 RGD compared to lean LA/NJcr+/+ rats 1642690 LA-cp/NJcr strain MP:0002079 increased circulating insulin level treatment IAGP XCO:0000682 N RGD:21408581|PMID:20705262 20200323 RGD compared to lean LA/NJcr+/+ rats 1642690 LA-cp/NJcr strain MP:0002871 albuminuria IAGP N RGD:1642389|PMID:17375078 20200323 RGD compared to lean LA/NJcr+/+ rats 1642690 LA-cp/NJcr strain MP:0003711 pathological neovascularization treatment IAGP XCO:0000682 N RGD:21408581|PMID:20705262 20200323 RGD compared to lean LA/NJcr+/+ rats 1642690 LA-cp/NJcr strain MP:0003980 increased circulating phospholipid level treatment IAGP XCO:0000681 N RGD:1642391|PMID:7600124 20200323 RGD compared to lean LA/NJcr+/+ rats 1642690 LA-cp/NJcr strain MP:0005178 increased circulating cholesterol level IAGP N RGD:1642389|PMID:17375078 20200323 RGD compared to lean LA/NJcr+/+ rats 1642690 LA-cp/NJcr strain MP:0005178 increased circulating cholesterol level treatment IAGP XCO:0000681 N RGD:1642391|PMID:7600124 20200323 RGD compared to lean LA/NJcr+/+ rats 1642690 LA-cp/NJcr strain MP:0005178 increased circulating cholesterol level treatment IAGP XCO:0000682 N RGD:21408581|PMID:20705262 20200323 RGD compared to lean LA/NJcr+/+ rats 1642690 LA-cp/NJcr strain MP:0005215 abnormal pancreatic islet morphology IAGP N RGD:1642391|PMID:7600124 20200323 RGD compared to lean LA/NJcr+/+ rats 1642690 LA-cp/NJcr strain MP:0005264 glomerulosclerosis IAGP N RGD:1642389|PMID:17375078 20200323 RGD compared to lean LA/NJcr+/+ rats 1642690 LA-cp/NJcr strain MP:0005338 atherosclerotic lesions treatment IAGP XCO:0000681 N RGD:1642391|PMID:7600124 20200323 RGD compared to lean LA/NJcr+/+ rats 1642690 LA-cp/NJcr strain MP:0005338 atherosclerotic lesions treatment IAGP XCO:0000682 N RGD:21408581|PMID:20705262 20200323 RGD compared to lean LA/NJcr+/+ rats 1642690 LA-cp/NJcr strain MP:0005339 increased susceptibility to atherosclerosis IAGP N RGD:1642391|PMID:7600124 20071009 RGD compared to lean LA/NJcr+/+ rats 1642690 LA-cp/NJcr strain MP:0005339 increased susceptibility to atherosclerosis treatment IAGP XCO:0000682 N RGD:21408581|PMID:20705262 20200323 RGD compared to lean LA/NJcr+/+ rats 1642690 LA-cp/NJcr strain MP:0005425 increased macrophage cell number treatment IAGP XCO:0000681 N RGD:1642391|PMID:7600124 20200323 RGD compared to lean LA/NJcr+/+ rats 1642690 LA-cp/NJcr strain MP:0005559 increased circulating glucose level IAGP N RGD:1642391|PMID:7600124 20200323 RGD compared to lean LA/NJcr+/+ rats 1642690 LA-cp/NJcr strain MP:0005669 increased circulating leptin level treatment IAGP XCO:0000681 N RGD:21408584|PMID:11978655 20200323 RGD compared to lean LA/NJcr+/+ rats 1642690 LA-cp/NJcr strain MP:0005669 increased circulating leptin level treatment IAGP XCO:0000682 N RGD:21408581|PMID:20705262 20200323 RGD compared to lean LA/NJcr+/+ rats 1642690 LA-cp/NJcr strain MP:0008641 increased circulating interleukin-1 beta level IAGP N RGD:1642389|PMID:17375078 20200323 RGD compared to lean LA/NJcr+/+ rats 1642690 LA-cp/NJcr strain MP:0009170 abnormal pancreatic islet size treatment IAGP XCO:0000681 N RGD:1642391|PMID:7600124 20200323 RGD compared to lean LA/NJcr+/+ rats 1642690 LA-cp/NJcr strain MP:0011939 increased food intake IAGP N RGD:1642389|PMID:17375078 20200323 RGD compared to lean LA/NJcr+/+ rats 1642690 LA-cp/NJcr strain MP:0011939 increased food intake IAGP N RGD:1642391|PMID:7600124 20200323 RGD compared to lean LA/NJcr+/+ rats 1642690 LA-cp/NJcr strain MP:0011939 increased food intake treatment IAGP XCO:0000682 N RGD:21408581|PMID:20705262 20200323 RGD compared to lean LA/NJcr+/+ rats 1642690 LA-cp/NJcr strain MP:0020411 increased abdominal adipose tissue amount treatment IAGP XCO:0000682 N RGD:21408581|PMID:20705262 20200323 RGD compared to lean LA/NJcr+/+ rats 1642968 SS.LEW-(D10Mco84-D10Rat58)/Mco strain MP:0001625 cardiac hypertrophy IAGP N RGD:13442502|PMID:21357277 20171106 RGD compared to SS/Jr 1642968 SS.LEW-(D10Mco84-D10Rat58)/Mco strain MP:0002833 increased heart weight IAGP N RGD:13442502|PMID:21357277 20191204 RGD compared to SS/Jr 1642968 SS.LEW-(D10Mco84-D10Rat58)/Mco strain MP:0002833 increased heart weight induced IAGP XCO:0000022 N RGD:1642602|PMID:17893371 20071116 RGD compared to SS/Jr 1642968 SS.LEW-(D10Mco84-D10Rat58)/Mco strain MP:0002953 thick ventricular wall IAGP N RGD:13442502|PMID:21357277 20191204 RGD compared to SS/Jr 1642968 SS.LEW-(D10Mco84-D10Rat58)/Mco strain MP:0003394 increased cardiac output IAGP N RGD:13442502|PMID:21357277 20171106 RGD compared to SS/Jr 1642968 SS.LEW-(D10Mco84-D10Rat58)/Mco strain MP:0003721 increased tumor growth/size induced IAGP XCO:0000646 N RGD:11353863|PMID:27073989 20191204 RGD compared to SS/Jr 1642968 SS.LEW-(D10Mco84-D10Rat58)/Mco strain MP:0003900 shortened QT interval IAGP N RGD:13442502|PMID:21357277 20171106 RGD compared to SS/Jr 1642968 SS.LEW-(D10Mco84-D10Rat58)/Mco strain MP:0004499 increased incidence of tumors by chemical induction induced IAGP XCO:0000646 N RGD:11353863|PMID:27073989 20191204 RGD compared to SS/Jr 1642968 SS.LEW-(D10Mco84-D10Rat58)/Mco strain MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:13442502|PMID:21357277 20191204 RGD compared to SS/Jr 1642968 SS.LEW-(D10Mco84-D10Rat58)/Mco strain MP:0006144 increased systemic arterial systolic blood pressure induced IAGP XCO:0000022 N RGD:1642602|PMID:17893371 20071116 RGD compared to SS/Jr 1642968 SS.LEW-(D10Mco84-D10Rat58)/Mco strain MP:0011951 increased cardiac stroke volume IAGP N RGD:13442502|PMID:21357277 20191204 RGD compared to SS/Jr 1642968 SS.LEW-(D10Mco84-D10Rat58)/Mco strain MP:0012436 increased colon tumor incidence induced IAGP XCO:0000646 N RGD:11353863|PMID:27073989 20160726 RGD compared to SS/Jr 1642969 SS.LEW-(D10Mco84-D10Mco134)/Mco strain MP:0002834 decreased heart weight induced IAGP XCO:0000022 N RGD:1642602|PMID:17893371 20071116 RGD compared to SS/Jr 1642969 SS.LEW-(D10Mco84-D10Mco134)/Mco strain MP:0006264 decreased systemic arterial systolic blood pressure induced IAGP XCO:0000022 N RGD:1642602|PMID:17893371 20071116 RGD compared to SS/Jr 1642970 SS.LEW-(D10Mco113-D10Got93)/Mco strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:1642602|PMID:17893371 20071116 RGD 1642971 SS.LEW-(D10Mco84-D10Mco129)/Mco strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:1642602|PMID:17893371 20111115 RGD 1642972 SS.LEW-(D10Mco84-D10Mco143)/Mco strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:1642602|PMID:17893371 20071116 RGD compared to SS/Jr 1642976 Bp301 Blood pressure QTL 301 qtl MP:0002842 increased systemic arterial blood pressure IDA N RGD:1642602|PMID:17893371 20071116 RGD 1642980 Bp300 Blood pressure QTL 300 qtl MP:0002843 decreased systemic arterial blood pressure IDA N RGD:1642602|PMID:17893371 20071116 RGD 1642982 Bp302 Blood pressure QTL 302 qtl MP:0002843 decreased systemic arterial blood pressure IDA N RGD:1642602|PMID:17893371 20071116 RGD 1643001 FH/Unc Fawn-hooded strain MP:0001987 alcohol preference IAGP N RGD:1643000|PMID:17413446 20200514 RGD compared to ACI/N 1643001 FH/Unc Fawn-hooded strain MP:0003545 increased alcohol consumption IAGP N RGD:1643000|PMID:17413446 20200514 RGD compared to ACI/N 1643002 SHR.WKY-(D1Rat420-D1Got161)/Njs strain MP:0004876 decreased mean systemic arterial blood pressure IAGP N RGD:1625015|PMID:17332427 20071117 RGD compared to SHR/NCruk strain 1643004 Pain2 Pain QTL 2 qtl MP:0001970 abnormal pain threshold IDA N RGD:1643003|PMID:17560719 20071117 RGD 1643006 Pain1 Pain QTL 1 qtl MP:0001970 abnormal pain threshold IDA N RGD:1643003|PMID:17560719 20071117 RGD 1643007 DA.ACI-(D12Wox12-D12Rat53)/Arb strain MP:0003436 decreased susceptibility to induced arthritis induced IAGP XCO:0000281|XCO:0000263 N RGD:1600250|PMID:17329308 20071117 RGD compared to DA/Hsd 1643010 F344.OLETF-(D7Rat18-D7Mit2)(D14Rat23-D14Rat12)/Tj strain MP:0001260 increased body weight IAGP N RGD:1643009|PMID:17710484 20071117 RGD compared to F344/Slc 1643010 F344.OLETF-(D7Rat18-D7Mit2)(D14Rat23-D14Rat12)/Tj strain MP:0002079 increased circulating insulin level induced IAGP XCO:0000103 N RGD:1643009|PMID:17710484 20201103 RGD 1643010 F344.OLETF-(D7Rat18-D7Mit2)(D14Rat23-D14Rat12)/Tj strain MP:0005293 impaired glucose tolerance induced IAGP XCO:0000103 N RGD:1643009|PMID:17710484 20071117 RGD compared to F344/Slc 1643010 F344.OLETF-(D7Rat18-D7Mit2)(D14Rat23-D14Rat12)/Tj strain MP:0009289 decreased epididymal fat pad weight IAGP N RGD:1643009|PMID:17710484 20201103 RGD compared to F344/Slc 1643010 F344.OLETF-(D7Rat18-D7Mit2)(D14Rat23-D14Rat12)/Tj strain MP:0011939 increased food intake IAGP N RGD:1643009|PMID:17710484 20201119 RGD compared to F344/Slc 19165133 F344;SD-C3em1Linf strain MP:0020955 increased mechanical nociceptive threshold induced IMP XCO:0000735 N RGD:19165124|PMID:29695418 20200908 RGD 19165134 C3em1Linf complement C3; CRISPR/Cas9 system induced mutant 1, Linf gene MP:0020955 increased mechanical nociceptive threshold IMP N RGD:19165124|PMID:29695418 20201210 RGD 19165134 C3em1Linf complement C3; CRISPR/Cas9 system induced mutant 1, Linf gene MP:0020955 increased mechanical nociceptive threshold induced IMP XCO:0000735 N RGD:19165124|PMID:29695418 20200908 RGD 19259464 SHR-Camk2n1em1Tja-/- SHR-Camk2n1em1Tja-/Camk2n1em1Tja- strain MP:0003916 decreased heart left ventricle weight IMP N RGD:18899561|PMID:31327268 20200206 RGD compared to SHR/NCrl 19259464 SHR-Camk2n1em1Tja-/- SHR-Camk2n1em1Tja-/Camk2n1em1Tja- strain MP:0006263 decreased systemic arterial diastolic blood pressure IMP N RGD:18899561|PMID:31327268 20200206 RGD compared to SHR/NCrl 19259464 SHR-Camk2n1em1Tja-/- SHR-Camk2n1em1Tja-/Camk2n1em1Tja- strain MP:0006264 decreased systemic arterial systolic blood pressure IMP N RGD:18899561|PMID:31327268 20200206 RGD compared to SHR/NCrl 19259464 SHR-Camk2n1em1Tja-/- SHR-Camk2n1em1Tja-/Camk2n1em1Tja- strain MP:0009289 decreased epididymal fat pad weight IMP N RGD:18899561|PMID:31327268 20200206 RGD compared to SHR/NCrl 19259464 SHR-Camk2n1em1Tja-/- SHR-Camk2n1em1Tja-/Camk2n1em1Tja- strain MP:0009299 decreased mesenteric fat pad weight IMP N RGD:18899561|PMID:31327268 20200206 RGD compared to SHR/NCrl 19259464 SHR-Camk2n1em1Tja-/- SHR-Camk2n1em1Tja-/Camk2n1em1Tja- strain MP:0009305 decreased retroperitoneal fat pad weight IMP N RGD:18899561|PMID:31327268 20200206 RGD compared to SHR/NCrl 19259464 SHR-Camk2n1em1Tja-/- SHR-Camk2n1em1Tja-/Camk2n1em1Tja- strain MP:0014169 decreased brown adipose tissue mass IMP N RGD:18899561|PMID:31327268 20200206 RGD compared to SHR/NCrl 19259465 Camk2n1em1Tja calcium/calmodulin-dependent protein kinase II inhibitor 1; ZFN induced mutant 1, Tja gene MP:0003916 decreased heart left ventricle weight IMP N RGD:18899561|PMID:31327268 20200206 RGD 19259465 Camk2n1em1Tja calcium/calmodulin-dependent protein kinase II inhibitor 1; ZFN induced mutant 1, Tja gene MP:0006263 decreased systemic arterial diastolic blood pressure IMP N RGD:18899561|PMID:31327268 20200206 RGD 19259465 Camk2n1em1Tja calcium/calmodulin-dependent protein kinase II inhibitor 1; ZFN induced mutant 1, Tja gene MP:0006264 decreased systemic arterial systolic blood pressure IMP N RGD:18899561|PMID:31327268 20200206 RGD 19259465 Camk2n1em1Tja calcium/calmodulin-dependent protein kinase II inhibitor 1; ZFN induced mutant 1, Tja gene MP:0009289 decreased epididymal fat pad weight IMP N RGD:18899561|PMID:31327268 20200206 RGD 19259465 Camk2n1em1Tja calcium/calmodulin-dependent protein kinase II inhibitor 1; ZFN induced mutant 1, Tja gene MP:0009299 decreased mesenteric fat pad weight IMP N RGD:18899561|PMID:31327268 20200206 RGD 19259465 Camk2n1em1Tja calcium/calmodulin-dependent protein kinase II inhibitor 1; ZFN induced mutant 1, Tja gene MP:0009305 decreased retroperitoneal fat pad weight IMP N RGD:18899561|PMID:31327268 20200206 RGD 19259465 Camk2n1em1Tja calcium/calmodulin-dependent protein kinase II inhibitor 1; ZFN induced mutant 1, Tja gene MP:0014169 decreased brown adipose tissue mass IMP N RGD:18899561|PMID:31327268 20200206 RGD 2024 Acr acrosin gene MP:0001935 decreased litter size IMP N RGD:13464336|PMID:28859281 20180112 RGD 2024 Acr acrosin gene MP:0004542 impaired acrosome reaction IMP N RGD:13464336|PMID:28859281 20180112 RGD 2041 Add1 adducin 1 gene MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:1302895|PMID:15474463 20070514 RGD 2043 Add3 adducin 3 gene MP:0003026 decreased vasoconstriction induces IMP XCO:0000168 N RGD:150340736|PMID:32029431 20210916 RGD compared to WT 2043 Add3 adducin 3 gene MP:0003071 decreased vascular permeability IMP N RGD:150340736|PMID:32029431 20210913 RGD 2043 Add3 adducin 3 gene MP:0003985 renal fibrosis IMP N RGD:150340736|PMID:32029431 20210913 RGD 2043 Add3 adducin 3 gene MP:0005325 abnormal renal glomerulus morphology IMP N RGD:150340736|PMID:32029431 20210913 RGD 2043 Add3 adducin 3 gene MP:0005540 decreased urine albumin level IMP N RGD:150340736|PMID:32029431 20210913 RGD 2043 Add3 adducin 3 gene MP:0011296 decreased tubuloglomerular feedback response IMP N RGD:150340736|PMID:32029431 20210910 RGD 2043 Add3 adducin 3 gene MP:0011296 decreased tubuloglomerular feedback response induces IMP XCO:0000168 N RGD:150340736|PMID:32029431 20210916 RGD compared to WT 2043 Add3 adducin 3 gene MP:0011402 renal cast IMP N RGD:150340736|PMID:32029431 20210913 RGD 2043 Add3 adducin 3 gene MP:0020849 abnormal actin cytoskeleton morphology IMP N RGD:150340736|PMID:32029431 20210910 RGD 2050 Adora2b adenosine A2B receptor gene MP:0001260 increased body weight IMP N RGD:11533328|PMID:26385692 20191125 RGD 2050 Adora2b adenosine A2B receptor gene MP:0001876 decreased inflammatory response IMP N RGD:11533328|PMID:26385692 20191125 RGD 2050 Adora2b adenosine A2B receptor gene MP:0002953 thick ventricular wall IMP N RGD:11533328|PMID:26385692 20191125 RGD 2050 Adora2b adenosine A2B receptor gene MP:0004878 increased systemic vascular resistance IMP N RGD:11533328|PMID:26385692 20191125 RGD 2050 Adora2b adenosine A2B receptor gene MP:0006144 increased systemic arterial systolic blood pressure IMP N RGD:11533328|PMID:26385692 20191125 RGD 2050 Adora2b adenosine A2B receptor gene MP:0008596 increased circulating interleukin-6 level IMP N RGD:11533328|PMID:26385692 20191125 RGD 2070 Agtr1a angiotensin II receptor, type 1a gene MP:0005602 decreased angiogenesis induces IMP N RGD:127345089|PMID:32324784 20210715 RGD 2071 Agtr1b angiotensin II receptor, type 1b gene MP:0001625 cardiac hypertrophy TAS N RGD:629553|PMID:12446719 19990101 RGD 2074 Ahr aryl hydrocarbon receptor gene MP:0000519 hydronephrosis IMP N RGD:13204753|PMID:23859880 20210715 RGD compared to Hsd:SD 2074 Ahr aryl hydrocarbon receptor gene MP:0000536 hydroureter IMP N RGD:13204753|PMID:23859880 20210715 RGD compared to Hsd:SD 2074 Ahr aryl hydrocarbon receptor gene MP:0002590 increased mean corpuscular volume IMP N RGD:13204753|PMID:23859880 20210715 RGD compared to Hsd:SD 2074 Ahr aryl hydrocarbon receptor gene MP:0002606 increased basophil cell number IMP N RGD:13204753|PMID:23859880 20210715 RGD compared to Hsd:SD 2074 Ahr aryl hydrocarbon receptor gene MP:0003179 thrombocytopenia IMP N RGD:13204753|PMID:23859880 20210715 RGD compared to Hsd:SD 2074 Ahr aryl hydrocarbon receptor gene MP:0003548 pulmonary hypertension ameliorates IMP N RGD:401940192|PMID:33836606 20240118 RGD compared to wild type littermates 2074 Ahr aryl hydrocarbon receptor gene MP:0003630 abnormal urothelium morphology IMP N RGD:13204753|PMID:23859880 20210715 RGD compared to Hsd:SD 2074 Ahr aryl hydrocarbon receptor gene MP:0003917 increased kidney weight sexual_dimorphism IMP N RGD:13204753|PMID:23859880 20210715 RGD females compared to Hsd:SD females 2074 Ahr aryl hydrocarbon receptor gene MP:0004789 increased bile salt level sexual_dimorphism IMP N RGD:13204753|PMID:23859880 20210715 RGD females compared to Hsd:SD females 2074 Ahr aryl hydrocarbon receptor gene MP:0004852 decreased testis weight IMP N RGD:13204753|PMID:23859880 20210715 RGD compared to Hsd:SD 2074 Ahr aryl hydrocarbon receptor gene MP:0004856 decreased ovary weight IMP N RGD:13204753|PMID:23859880 20210715 RGD compared to Hsd:SD 2074 Ahr aryl hydrocarbon receptor gene MP:0004860 dilated kidney collecting duct IMP N RGD:13204753|PMID:23859880 20210715 RGD compared to Hsd:SD 2074 Ahr aryl hydrocarbon receptor gene MP:0004953 decreased spleen weight sexual_dimorphism IMP N RGD:13204753|PMID:23859880 20210715 RGD females compared to Hsd:SD females 2074 Ahr aryl hydrocarbon receptor gene MP:0005016 decreased lymphocyte cell number IMP N RGD:13204753|PMID:23859880 20210715 RGD compared to Hsd:SD 2074 Ahr aryl hydrocarbon receptor gene MP:0005343 increased circulating aspartate transaminase level sexual_dimorphism IMP N RGD:13204753|PMID:23859880 20210715 RGD females compared to Hsd:SD females 2074 Ahr aryl hydrocarbon receptor gene MP:0005561 increased mean corpuscular hemoglobin IMP N RGD:13204753|PMID:23859880 20210715 RGD compared to Hsd:SD 2074 Ahr aryl hydrocarbon receptor gene MP:0008028 pregnancy-related premature death induces IMP XCO:0000600 N RGD:407420268|PMID:34747641 20240801 RGD 2074 Ahr aryl hydrocarbon receptor gene MP:0008874 decreased physiological sensitivity to xenobiotic IMP N RGD:405878088|PMID:34256052 20240718 RGD 2074 Ahr aryl hydrocarbon receptor gene MP:0009767 decreased susceptibility to xenobiotic induced morbidity/mortality induces IMP XCO:0000600 N RGD:407420268|PMID:34747641 20240801 RGD 2074 Ahr aryl hydrocarbon receptor gene MP:0010758 increased right ventricle systolic pressure ameliorates IMP N RGD:401940192|PMID:33836606 20240118 RGD compared to wild type littermates 2074 Ahr aryl hydrocarbon receptor gene MP:0011347 abnormal kidney medullary ray morphology IMP N RGD:13204753|PMID:23859880 20210715 RGD compared to Hsd:SD 2074 Ahr aryl hydrocarbon receptor gene MP:0011431 increased urine flow rate sexual_dimorphism IMP N RGD:13204753|PMID:23859880 20210715 RGD males compared to Hsd:SD 2074 Ahr aryl hydrocarbon receptor gene MP:0013880 absent ductus venosus IMP N RGD:13204753|PMID:23859880 20210715 RGD 2074 Ahr aryl hydrocarbon receptor gene MP:0014515 decreased circulating anti-Mullerian hormone level IMP N RGD:405878088|PMID:34256052 20240822 RGD 2074 Ahr aryl hydrocarbon receptor gene MP:0020969 impaired conditioned taste aversion behavior sexual dimorphism IMP N RGD:407419883|PMID:30769105 20240912 RGD 2081 Akt1 AKT serine/threonine kinase 1 gene MP:0004921 decreased placenta weight IMP N RGD:158013768|PMID:36607602 20240620 RGD 2081 Akt1 AKT serine/threonine kinase 1 gene MP:0009431 decreased fetal weight IMP N RGD:158013768|PMID:36607602 20240620 RGD 2081 Akt1 AKT serine/threonine kinase 1 gene MP:0011521 decreased placental labyrinth size IMP N RGD:158013768|PMID:36607602 20240620 RGD 2085 Alb albumin gene MP:0005419 decreased circulating serum albumin level IAGP N RGD:734959|PMID:1690892 20070112 RGD 2087 Aldh1a1 aldehyde dehydrogenase 1 family, member A1 gene MP:0001987 alcohol preference IAGP N RGD:2306323|PMID:11825850 20090408 RGD DNA:polymorphism 21079475 SD-Leprem4Lizh strain MP:0000063 decreased bone mineral density IMP N RGD:12911216|PMID:26537785 20200219 RGD 21079475 SD-Leprem4Lizh strain MP:0000182 increased circulating LDL cholesterol level IMP N RGD:12911216|PMID:26537785 20200218 RGD compared to wild type littermate 21079475 SD-Leprem4Lizh strain MP:0001552 increased circulating triglyceride level IMP N RGD:12911216|PMID:26537785 20200218 RGD compared to wild type littermate 21079475 SD-Leprem4Lizh strain MP:0001556 increased circulating HDL cholesterol level IMP N RGD:12911216|PMID:26537785 20200218 RGD compared to wild type littermate 21079475 SD-Leprem4Lizh strain MP:0002628 hepatic steatosis IMP N RGD:12911216|PMID:26537785 20200219 RGD 21079475 SD-Leprem4Lizh strain MP:0003334 pancreas fibrosis IMP N RGD:12911216|PMID:26537785 20200219 RGD 21079475 SD-Leprem4Lizh strain MP:0005178 increased circulating cholesterol level IMP N RGD:12911216|PMID:26537785 20200218 RGD compared to wild type littermate 21079475 SD-Leprem4Lizh strain MP:0006094 increased fat cell size IMP N RGD:12911216|PMID:26537785 20200219 RGD 21079475 SD-Leprem4Lizh strain MP:0009110 pancreas hyperplasia IMP N RGD:12911216|PMID:26537785 20200219 RGD 21079475 SD-Leprem4Lizh strain MP:0010879 decreased trabecular bone volume IMP N RGD:12911216|PMID:26537785 20200219 RGD 21079475 SD-Leprem4Lizh strain MP:0011353 expanded mesangial matrix IMP N RGD:12911216|PMID:26537785 20200219 RGD 21079475 SD-Leprem4Lizh strain MP:0013630 increased bone trabecular spacing IMP N RGD:12911216|PMID:26537785 20200219 RGD 21079476 Leprem4Lizh leptin receptor; CRISPR/Cas9 induced mutant 4, Lizh gene MP:0000063 decreased bone mineral density IMP N RGD:12911216|PMID:26537785 20200219 RGD 21079476 Leprem4Lizh leptin receptor; CRISPR/Cas9 induced mutant 4, Lizh gene MP:0000182 increased circulating LDL cholesterol level IMP N RGD:12911216|PMID:26537785 20200218 RGD compared to wild type littermate 21079476 Leprem4Lizh leptin receptor; CRISPR/Cas9 induced mutant 4, Lizh gene MP:0001552 increased circulating triglyceride level IMP N RGD:12911216|PMID:26537785 20200218 RGD compared to wild type littermate 21079476 Leprem4Lizh leptin receptor; CRISPR/Cas9 induced mutant 4, Lizh gene MP:0001556 increased circulating HDL cholesterol level IMP N RGD:12911216|PMID:26537785 20200218 RGD compared to wild type littermate 21079476 Leprem4Lizh leptin receptor; CRISPR/Cas9 induced mutant 4, Lizh gene MP:0002628 hepatic steatosis IMP N RGD:12911216|PMID:26537785 20200219 RGD 21079476 Leprem4Lizh leptin receptor; CRISPR/Cas9 induced mutant 4, Lizh gene MP:0003334 pancreas fibrosis IMP N RGD:12911216|PMID:26537785 20200219 RGD 21079476 Leprem4Lizh leptin receptor; CRISPR/Cas9 induced mutant 4, Lizh gene MP:0005178 increased circulating cholesterol level IMP N RGD:12911216|PMID:26537785 20200218 RGD compared to wild type littermate 21079476 Leprem4Lizh leptin receptor; CRISPR/Cas9 induced mutant 4, Lizh gene MP:0006094 increased fat cell size IMP N RGD:12911216|PMID:26537785 20200219 RGD 21079476 Leprem4Lizh leptin receptor; CRISPR/Cas9 induced mutant 4, Lizh gene MP:0009110 pancreas hyperplasia IMP N RGD:12911216|PMID:26537785 20200219 RGD 21079476 Leprem4Lizh leptin receptor; CRISPR/Cas9 induced mutant 4, Lizh gene MP:0010879 decreased trabecular bone volume IMP N RGD:12911216|PMID:26537785 20200219 RGD 21079476 Leprem4Lizh leptin receptor; CRISPR/Cas9 induced mutant 4, Lizh gene MP:0011353 expanded mesangial matrix IMP N RGD:12911216|PMID:26537785 20200219 RGD 21079476 Leprem4Lizh leptin receptor; CRISPR/Cas9 induced mutant 4, Lizh gene MP:0013630 increased bone trabecular spacing IMP N RGD:12911216|PMID:26537785 20200219 RGD 2123 Apc APC regulator of WNT signaling pathway gene MP:0001263 weight loss sexual_dimorphism IMP N RGD:1601201|PMID:17360473 20201210 RGD compared to females 2123 Apc APC regulator of WNT signaling pathway gene MP:0001577 anemia sexual_dimorphism IMP N RGD:1601201|PMID:17360473 20201210 RGD compared to females 2123 Apc APC regulator of WNT signaling pathway gene MP:0001661 extended life span sexual_dimorphism IMP N RGD:1601201|PMID:17360473 20201210 RGD compared to males 2123 Apc APC regulator of WNT signaling pathway gene MP:0002044 increased colon adenoma incidence IMP N RGD:1601201|PMID:17360473 20201210 RGD compared to treated females, mock treated males 2123 Apc APC regulator of WNT signaling pathway gene MP:0002957 increased intestinal adenocarcinoma incidence sexual_dimorphism IMP XCO:0000345 N RGD:1601201|PMID:17360473 20201210 RGD compared to treated females 2123 Apc APC regulator of WNT signaling pathway gene MP:0003269 colon polyps IMP N RGD:1601201|PMID:17360473 20201210 RGD 2123 Apc APC regulator of WNT signaling pathway gene MP:0003293 rectal hemorrhage sexual_dimorphism IMP N RGD:1601201|PMID:17360473 20201210 RGD compared to females 2132 Apoa4 apolipoprotein A4 gene MP:0002628 hepatic steatosis induces IMP XCO:0000102 N RGD:150429948|PMID:31303888 20211014 RGD compared to wild type 2132 Apoa4 apolipoprotein A4 gene MP:0005560 decreased circulating glucose level induces IMP XCO:0000275,XCO:0000102 N RGD:150429948|PMID:31303888 20211014 RGD compared to wild type 2138 Apoe apolipoprotein E gene MP:0000182 increased circulating LDL cholesterol level IMP N RGD:150521536|PMID:30796231 20211109 RGD 2138 Apoe apolipoprotein E gene MP:0000186 decreased circulating HDL cholesterol level IMP N RGD:150521536|PMID:30796231 20211109 RGD 2138 Apoe apolipoprotein E gene MP:0000272 abnormal aorta morphology IMP N RGD:150520219|PMID:29166645 20211108 RGD 2138 Apoe apolipoprotein E gene MP:0002842 increased systemic arterial blood pressure IMP N RGD:150520219|PMID:29166645 20211108 RGD 2138 Apoe apolipoprotein E gene MP:0005178 increased circulating cholesterol level IMP N RGD:150521536|PMID:30796231 20211109 RGD 2138 Apoe apolipoprotein E gene MP:0010535 myocardium steatosis IMP N RGD:13703132|PMID:28808185 20180803 RGD 2143 Aqp4 aquaporin 4 gene MP:0020371 abnormal glymphatic system physiology IMP N RGD:127284879|PMID:33574749 20220120 RGD 2147 Ar androgen receptor gene MP:0002152 abnormal brain morphology IAGP N RGD:10043338|PMID:17490813 20150521 RGD 2147 Ar androgen receptor gene MP:0002797 increased thigmotaxis IAGP N RGD:10043340|PMID:24269497 20150521 RGD 2157 Arrb2 arrestin, beta 2 gene MP:0001987 alcohol preference IAGP N RGD:401938607|PMID:18367649 20231213 RGD 2158 Arsb arylsulfatase B gene MP:0000130 abnormal trabecular bone morphology IAGP N RGD:39131283|PMID:21887218 20200930 RGD 2158 Arsb arylsulfatase B gene MP:0001405 impaired coordination IAGP N RGD:39131283|PMID:21887218 20200930 RGD 2158 Arsb arylsulfatase B gene MP:0001524 impaired limb coordination IAGP N RGD:39131283|PMID:21887218 20200930 RGD 2158 Arsb arylsulfatase B gene MP:0002282 abnormal trachea morphology IAGP N RGD:39131283|PMID:21887218 20200930 RGD 2158 Arsb arylsulfatase B gene MP:0008553 increased circulating tumor necrosis factor level IAGP N RGD:39131283|PMID:21887218 20200930 RGD 2158 Arsb arylsulfatase B gene MP:0010867 abnormal bone trabecula morphology IAGP N RGD:39131283|PMID:21887218 20200930 RGD 2158 Arsb arylsulfatase B gene MP:0013498 trachea inflammation IAGP N RGD:39131283|PMID:21887218 20200930 RGD 2158 Arsb arylsulfatase B gene MP:0030866 abnormal synovial joint membrane morphology IAGP N RGD:39131283|PMID:21887218 20200930 RGD 2158 Arsb arylsulfatase B gene MP:0030895 abnormal tibiofemoral joint morphology IAGP N RGD:39131283|PMID:21887218 20200930 RGD 2180 Atp7b ATPase copper transporting beta gene MP:0000186 decreased circulating HDL cholesterol level IAGP N RGD:2292672|PMID:17303181 20210211 RGD 2180 Atp7b ATPase copper transporting beta gene MP:0000611 jaundice IAGP N RGD:1302456|PMID:11509115 20201214 RGD 2180 Atp7b ATPase copper transporting beta gene MP:0001262 decreased body weight IAGP N RGD:2292672|PMID:17303181 20210211 RGD 2180 Atp7b ATPase copper transporting beta gene MP:0002703 abnormal renal tubule morphology IAGP N RGD:1302456|PMID:11509115 20210218 RGD 2180 Atp7b ATPase copper transporting beta gene MP:0002941 increased circulating alanine transaminase level IAGP N RGD:2292672|PMID:17303181 20210211 RGD 2180 Atp7b ATPase copper transporting beta gene MP:0003066 increased liver copper level IAGP N RGD:2292672|PMID:17303181 20210211 RGD 2180 Atp7b ATPase copper transporting beta gene MP:0003402 decreased liver weight IAGP N RGD:2292672|PMID:17303181 20210211 RGD 2180 Atp7b ATPase copper transporting beta gene MP:0005344 increased circulating bilirubin level IAGP N RGD:2292672|PMID:17303181 20210211 RGD 2180 Atp7b ATPase copper transporting beta gene MP:0006349 decreased circulating copper level IAGP N RGD:2292672|PMID:17303181 20210211 RGD 2180 Atp7b ATPase copper transporting beta gene MP:0008743 decreased liver iron level IAGP N RGD:1302456|PMID:11509115 20210218 RGD compared to LEC/Tj; 2180 Atp7b ATPase copper transporting beta gene MP:0009355 increased liver triglyceride level IAGP N RGD:2292672|PMID:17303181 20210211 RGD 2180 Atp7b ATPase copper transporting beta gene MP:0010027 increased liver cholesterol level IAGP N RGD:2292672|PMID:17303181 20210211 RGD 2180 Atp7b ATPase copper transporting beta gene MP:0031022 hepatic megalocytosis IAGP N RGD:1302456|PMID:11509115 20201214 RGD 2184 Avp arginine vasopressin gene MP:0001762 polyuria IAGP N RGD:2314654|PMID:10919858 20201210 RGD 2191 Bace1 beta-secretase 1 gene MP:0001402 decreased locomotor activity IMP N RGD:13782149|PMID:28281673 20180823 RGD 2191 Bace1 beta-secretase 1 gene MP:0001489 decreased startle reflex IMP N RGD:13782149|PMID:28281673 20180823 RGD 2191 Bace1 beta-secretase 1 gene MP:0001516 abnormal motor coordination/balance IMP N RGD:13782149|PMID:28281673 20180823 RGD 2191 Bace1 beta-secretase 1 gene MP:0001973 increased thermal nociceptive threshold IMP N RGD:13782149|PMID:28281673 20180823 RGD 2191 Bace1 beta-secretase 1 gene MP:0002083 premature death IMP N RGD:13782149|PMID:28281673 20180823 RGD 2191 Bace1 beta-secretase 1 gene MP:0009141 increased prepulse inhibition IMP N RGD:13782149|PMID:28281673 20180823 RGD 2191 Bace1 beta-secretase 1 gene MP:0011731 decreased myelin sheath thickness IMP N RGD:13782149|PMID:28281673 20180823 RGD 2198 Bckdk branched chain ketoacid dehydrogenase kinase gene MP:0000556 abnormal hindlimb morphology IAGP N RGD:39131293|PMID:27472223 20201012 RGD DNA:missense mutation:cds:G369E (rat) 2198 Bckdk branched chain ketoacid dehydrogenase kinase gene MP:0000574 abnormal foot pad morphology IAGP N RGD:39131293|PMID:27472223 20201012 RGD DNA:missense mutation:cds:G369E (rat) 2198 Bckdk branched chain ketoacid dehydrogenase kinase gene MP:0000583 long toenails IAGP N RGD:39131293|PMID:27472223 20201012 RGD DNA:missense mutation:cds:G369E (rat) 2198 Bckdk branched chain ketoacid dehydrogenase kinase gene MP:0001106 abnormal Schwann cell morphology IAGP N RGD:39131293|PMID:27472223 20201012 RGD DNA:missense mutation:cds:G369E (rat) 2198 Bckdk branched chain ketoacid dehydrogenase kinase gene MP:0001265 decreased body size IAGP N RGD:39131293|PMID:27472223 20201012 RGD DNA:missense mutation:cds:G369E (rat) 2198 Bckdk branched chain ketoacid dehydrogenase kinase gene MP:0001922 reduced male fertility IAGP N RGD:39131293|PMID:27472223 20201012 RGD DNA:missense mutation:cds:G369E (rat) 2198 Bckdk branched chain ketoacid dehydrogenase kinase gene MP:0001940 testis hypoplasia IAGP N RGD:39131293|PMID:27472223 20201012 RGD DNA:missense mutation:cds:G369E (rat) 2198 Bckdk branched chain ketoacid dehydrogenase kinase gene MP:0002175 decreased brain weight IAGP N RGD:39131293|PMID:27472223 20201012 RGD DNA:missense mutation:cds:G369E (rat) 2198 Bckdk branched chain ketoacid dehydrogenase kinase gene MP:0002651 abnormal sciatic nerve morphology IAGP N RGD:39131293|PMID:27472223 20201012 RGD DNA:missense mutation:cds:G369E (rat) 2198 Bckdk branched chain ketoacid dehydrogenase kinase gene MP:0003081 abnormal soleus morphology IAGP N RGD:39131293|PMID:27472223 20201012 RGD DNA:missense mutation:cds:G369E (rat) 2198 Bckdk branched chain ketoacid dehydrogenase kinase gene MP:0008535 enlarged lateral ventricles IAGP N RGD:39131293|PMID:27472223 20201012 RGD DNA:missense mutation:cds:G369E (rat) 2198 Bckdk branched chain ketoacid dehydrogenase kinase gene MP:0030716 decreased circulating isoleucine level IAGP N RGD:39131293|PMID:27472223 20201012 RGD DNA:missense mutation:cds:G369E (rat) 2198 Bckdk branched chain ketoacid dehydrogenase kinase gene MP:0030728 decreased circulating valine level IAGP N RGD:39131293|PMID:27472223 20201012 RGD DNA:missense mutation:cds:G369E (rat) 2198 Bckdk branched chain ketoacid dehydrogenase kinase gene MP:0030751 decreased circulating leucine level IAGP N RGD:39131293|PMID:27472223 20201012 RGD DNA:missense mutation:cds:G369E (rat) 2202 Bdnf brain-derived neurotrophic factor gene MP:0001260 increased body weight IMP N RGD:38501054|PMID:23583595 20201210 RGD compared to WT 2202 Bdnf brain-derived neurotrophic factor gene MP:0001260 increased body weight severity IMP N RGD:38501054|PMID:23583595 20210416 RGD 2202 Bdnf brain-derived neurotrophic factor gene MP:0001262 decreased body weight IMP N RGD:38501054|PMID:23583595 20200814 RGD WT compared to homozygous rats 2202 Bdnf brain-derived neurotrophic factor gene MP:0001363 increased anxiety-related response IAGP N RGD:1600586|PMID:16899727 20070316 RGD 2202 Bdnf brain-derived neurotrophic factor gene MP:0001988 cocaine preference severity IMP N RGD:38501054|PMID:23583595 20210416 RGD 2202 Bdnf brain-derived neurotrophic factor gene MP:0002555 addiction IMP N RGD:38501054|PMID:23583595 20200814 RGD WT compared to heterozygous rats 2202 Bdnf brain-derived neurotrophic factor gene MP:0002555 addiction severity IMP N RGD:38501054|PMID:23583595 20210416 RGD 2202 Bdnf brain-derived neurotrophic factor gene MP:0003545 increased alcohol consumption IAGP N RGD:1600586|PMID:16899727 20070316 RGD 2202 Bdnf brain-derived neurotrophic factor gene MP:0009712 impaired conditioned place preference behavior IMP N RGD:38501054|PMID:23583595 20210218 RGD compared to WT 2202 Bdnf brain-derived neurotrophic factor gene MP:0012342 high preference for an addictive substance ameliorates IMP N RGD:38501054|PMID:23583595 20200814 RGD WT compared to heterozygous rats 2204 Cfb complement factor B gene MP:0001780 decreased brown adipose tissue amount IMP N RGD:127285403|PMID:28739975 20220120 RGD compared to wild type SHR 2204 Cfb complement factor B gene MP:0002667 decreased circulating aldosterone level IMP N RGD:127285403|PMID:28739975 20220120 RGD compared to wild type SHR 2204 Cfb complement factor B gene MP:0002891 increased insulin sensitivity IMP N RGD:127285403|PMID:28739975 20220120 RGD compared to wild type SHR 2204 Cfb complement factor B gene MP:0005179 decreased circulating cholesterol level IMP N RGD:127285403|PMID:28739975 20220120 RGD compared to wild type SHR 2204 Cfb complement factor B gene MP:0005318 decreased triglyceride level IMP N RGD:127285403|PMID:28739975 20220120 RGD compared to wild type SHR 2204 Cfb complement factor B gene MP:0006264 decreased systemic arterial systolic blood pressure IMP N RGD:127285403|PMID:28739975 20220120 RGD compared to wild type SHR 2204 Cfb complement factor B gene MP:0008578 decreased circulating interferon-gamma level IMP N RGD:127285403|PMID:28739975 20220120 RGD compared to wild type SHR 2204 Cfb complement factor B gene MP:0008594 decreased circulating interleukin-10 level IMP N RGD:127285403|PMID:28739975 20220120 RGD compared to wild type SHR 2204 Cfb complement factor B gene MP:0009289 decreased epididymal fat pad weight IMP N RGD:127285403|PMID:28739975 20220120 RGD compared to wild type SHR 2204 Cfb complement factor B gene MP:0009299 decreased mesenteric fat pad weight IMP N RGD:127285403|PMID:28739975 20220120 RGD compared to wild type SHR 2204 Cfb complement factor B gene MP:0009305 decreased retroperitoneal fat pad weight IMP N RGD:127285403|PMID:28739975 20220120 RGD compared to wild type SHR 2204 Cfb complement factor B gene MP:0010934 increased subcutaneous adipose tissue amount IMP N RGD:127285403|PMID:28739975 20220120 RGD compared to wild type SHR 2204 Cfb complement factor B gene MP:0013278 decreased fasting circulating glucose level IMP N RGD:127285403|PMID:28739975 20220120 RGD compared to wild type SHR 2219 Brca2 BRCA2, DNA repair associated gene MP:0000628 abnormal mammary gland development IMP N RGD:1599505|PMID:16964288 20210426 RGD 2219 Brca2 BRCA2, DNA repair associated gene MP:0001156 abnormal spermatogenesis IAGP N RGD:1599505|PMID:16964288 20070206 RGD 2219 Brca2 BRCA2, DNA repair associated gene MP:0001156 abnormal spermatogenesis IMP N RGD:1599505|PMID:16964288 20210429 RGD 2219 Brca2 BRCA2, DNA repair associated gene MP:0001262 decreased body weight IMP N RGD:727990|PMID:12754522 20180430 RGD 2219 Brca2 BRCA2, DNA repair associated gene MP:0002020 increased tumor incidence IMP N RGD:1599505|PMID:16964288 20210426 RGD 2219 Brca2 BRCA2, DNA repair associated gene MP:0002083 premature death IMP N RGD:1599505|PMID:16964288 20210426 RGD 2219 Brca2 BRCA2, DNA repair associated gene MP:0003205 testicular atrophy IMP N RGD:727990|PMID:12754522 20180430 RGD 2219 Brca2 BRCA2, DNA repair associated gene MP:0004833 ovary atrophy IMP N RGD:727990|PMID:12754522 20210218 RGD 2219 Brca2 BRCA2, DNA repair associated gene MP:0011482 posterior iris synechia IMP N RGD:1599505|PMID:16964288 20210426 RGD 2219 Brca2 BRCA2, DNA repair associated gene MP:0031212 decreased eye anterior chamber depth IMP N RGD:1599505|PMID:16964288 20210426 RGD 2225 Btg2 BTG anti-proliferation factor 2 gene MP:0002871 albuminuria IAGP N RGD:12802368|PMID:23817491 20170406 RGD 2225 Btg2 BTG anti-proliferation factor 2 gene MP:0004217 salt-sensitive hypertension IAGP N RGD:12802368|PMID:23817491 20170406 RGD 2228 Tspo translocator protein gene MP:0001739 abnormal adrenal gland secretion induces IMP XCO:0000143,XCO:0000228 N RGD:150429771|PMID:29074640 20211007 RGD 2228 Tspo translocator protein gene MP:0002665 decreased circulating corticosterone level induces IMP XCO:0000143,XCO:0000228 N RGD:150429771|PMID:29074640 20211007 RGD 2228 Tspo translocator protein gene MP:0002780 decreased circulating testosterone level IMP N RGD:150429771|PMID:29074640 20211007 RGD 2232 C3 complement C3 gene MP:0020955 increased mechanical nociceptive threshold IMP N RGD:19165124|PMID:29695418 20201210 RGD 2232 C3 complement C3 gene MP:0020955 increased mechanical nociceptive threshold induced IMP XCO:0000735 N RGD:19165124|PMID:29695418 20200908 RGD 2238 C6 complement C6 gene MP:0004824 decreased susceptibility to experimental autoimmune myasthenia gravis IAGP N RGD:1600670|PMID:17034580 20070322 RGD 2244 Cacna1a calcium voltage-gated channel subunit alpha1 A gene MP:0001406 abnormal gait IAGP N RGD:1598976|PMID:17196942 20160613 RGD 2244 Cacna1a calcium voltage-gated channel subunit alpha1 A gene MP:0003218 decreased spike-wave discharge type I IAGP N RGD:1598976|PMID:17196942 20240926 RGD 2245 Cacna1c calcium voltage-gated channel subunit alpha1 C gene MP:0001441 increased grooming behavior IMP N RGD:42724472|PMID:30902660 20210311 RGD compared to wild-type female 2245 Cacna1c calcium voltage-gated channel subunit alpha1 C gene MP:0001529 abnormal vocalization IMP N RGD:42724471|PMID:29739816 20210311 RGD compared to wide-type male 2245 Cacna1c calcium voltage-gated channel subunit alpha1 C gene MP:0001529 abnormal vocalization IMP N RGD:42724472|PMID:30902660 20210311 RGD compared to wild-type female 2245 Cacna1c calcium voltage-gated channel subunit alpha1 C gene MP:0002757 decreased vertical activity IMP N RGD:42724472|PMID:30902660 20210311 RGD compared to wild-type female 2245 Cacna1c calcium voltage-gated channel subunit alpha1 C gene MP:0012307 impaired spatial learning sexual_dimorphism IMP N RGD:42724470|PMID:29800644 20210311 RGD compared to female wild-type 2245 Cacna1c calcium voltage-gated channel subunit alpha1 C gene MP:0014115 cognitive inflexibility sexual_dimorphism IMP N RGD:42724470|PMID:29800644 20210311 RGD compared to male wild-type 2245 Cacna1c calcium voltage-gated channel subunit alpha1 C gene MP:0020437 abnormal social play behavior IMP N RGD:42724471|PMID:29739816 20210311 RGD compared to wide-type male 2246 Cacna1e calcium voltage-gated channel subunit alpha1 E gene MP:0020424 increased kindling response IAGP N RGD:6907065|PMID:20638246 20180712 RGD 2252 Ddr1 discoidin domain receptor tyrosine kinase 1 gene MP:0005023 abnormal wound healing IGI 3140 N RGD:151347403|PMID:28199848 20220119 RGD Myh9 NMIIA RGDID 3140 2252 Ddr1 discoidin domain receptor tyrosine kinase 1 gene MP:0008438 abnormal cutaneous collagen fibril morphology IGI 3140 N RGD:151347403|PMID:28199848 20220119 RGD Myh9 NMIIA RGDID 3140 2263 Camk2d calcium/calmodulin-dependent protein kinase II delta gene MP:0002064 seizures IAGP N RGD:6907065|PMID:20638246 20190823 RGD DNA:SNP:intron:g.24024428G>T 2289 Cckar cholecystokinin A receptor gene MP:0001433 polyphagia IAGP N RGD:7257724|PMID:9530226 20070529 RGD 2289 Cckar cholecystokinin A receptor gene MP:0001777 abnormal body temperature homeostasis IAGP N RGD:1625204|PMID:15178543 20070529 RGD 2289 Cckar cholecystokinin A receptor gene MP:0001986 abnormal taste sensitivity IAGP N RGD:1625203|PMID:16081877 20070529 RGD 2289819 SS.MNS-(D10Mco62-D10Got99)/Mco strain MP:0002834 decreased heart weight induced IAGP XCO:0000022 N RGD:1643425|PMID:18175179 20080218 RGD compared to SS/Jr 2289819 SS.MNS-(D10Mco62-D10Got99)/Mco strain MP:0002843 decreased systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:1643425|PMID:18175179 20080218 RGD compared to SS/Jr 2289821 SS.MNS-(D10Mco30-D10Got91)/3Mco strain MP:0002834 decreased heart weight induced IAGP XCO:0000022 N RGD:1643425|PMID:18175179 20080218 RGD compared to SS/Jr 2289822 SS.MNS-(D10Mco30-D10Got112)/Mco strain MP:0001262 decreased body weight induced IAGP XCO:0000022 N RGD:1643425|PMID:18175179 20080218 RGD compared to SS/Jr 2289823 SS.MNS-(D10Mco62-D10Mco30)/Mco strain MP:0006263 decreased systemic arterial diastolic blood pressure induced IAGP XCO:0000022 N RGD:1643425|PMID:18175179 20080218 RGD compared to SS/Jr 2289823 SS.MNS-(D10Mco62-D10Mco30)/Mco strain MP:0006264 decreased systemic arterial systolic blood pressure induced IAGP XCO:0000022 N RGD:1643425|PMID:18175179 20080218 RGD compared to SS/Jr 2289824 SS.MNS-(D10Mco30-D10Got101)/Mco strain MP:0001262 decreased body weight induced IAGP XCO:0000022 N RGD:1643425|PMID:18175179 20080218 RGD compared to SS/Jr 2289826 SS.MNS-(D10Mco30-D10Got91)/2Mco strain MP:0001262 decreased body weight induced IAGP XCO:0000022 N RGD:1643425|PMID:18175179 20080218 RGD compared to SS/Jr 2289826 SS.MNS-(D10Mco30-D10Got91)/2Mco strain MP:0002834 decreased heart weight induced IAGP XCO:0000022 N RGD:1643425|PMID:18175179 20080218 RGD compared to SS/Jr 2289827 SS.MNS-(D10Mco30-D10Mco31)/Jr strain MP:0002834 decreased heart weight induced IAGP XCO:0000022 N RGD:628510|PMID:11641286 20080218 RGD compared to SS/Jr 2289827 SS.MNS-(D10Mco30-D10Mco31)/Jr strain MP:0002843 decreased systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:628510|PMID:11641286 20080218 RGD as compared to SS/Jr 2289916 SS.MNS-(D10Mco15-D10Mit11)/Jr strain MP:0002834 decreased heart weight induced IAGP XCO:0000022 N RGD:628510|PMID:11641286 20200206 RGD compared to SS/Jr 2289916 SS.MNS-(D10Mco15-D10Mit11)/Jr strain MP:0002843 decreased systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:628510|PMID:11641286 20200206 RGD compared to SS/Jr 2289982 Bp303 Blood pressure QTL 303 qtl MP:0006264 decreased systemic arterial systolic blood pressure IDA N RGD:1643425|PMID:18175179 20080221 RGD 2289983 Bp304 Blood pressure QTL 304 qtl MP:0006264 decreased systemic arterial systolic blood pressure IDA N RGD:1643425|PMID:18175179 20080221 RGD 2289985 Bp305 Blood pressure QTL 305 qtl MP:0006264 decreased systemic arterial systolic blood pressure IDA N RGD:1643425|PMID:18175179 20080221 RGD 2290005 Mcs24 Mammary carcinoma susceptibility QTL 24 qtl MP:0001883 increased mammary adenocarcinoma incidence IDA N RGD:1601189|PMID:17404222 20080222 RGD 2290007 Mcs23 Mammary carcinoma susceptibility QTL 23 qtl MP:0001883 increased mammary adenocarcinoma incidence IDA N RGD:1601189|PMID:17404222 20080222 RGD 2290090 Nrg1Tn(sb-T2/Bart3)2.183Mcwi neuregulin 1; transposon insertion 2.183, Medical College of Wisconsin gene MP:0001260 increased body weight IMP N RGD:39128254|PMID:23022220 20200929 RGD 2290090 Nrg1Tn(sb-T2/Bart3)2.183Mcwi neuregulin 1; transposon insertion 2.183, Medical College of Wisconsin gene MP:0001402 decreased locomotor activity sexual_dimorphism IMP N RGD:405650204|PMID:21620900 20240425 RGD compared to mutant male 2290090 Nrg1Tn(sb-T2/Bart3)2.183Mcwi neuregulin 1; transposon insertion 2.183, Medical College of Wisconsin gene MP:0001488 increased startle reflex sexual_dimorphism IAGP N RGD:405650204|PMID:21620900 20240425 RGD compared to female 2290090 Nrg1Tn(sb-T2/Bart3)2.183Mcwi neuregulin 1; transposon insertion 2.183, Medical College of Wisconsin gene MP:0001745 increased circulating corticosterone level IMP N RGD:10449008|PMID:21092742 20210211 RGD compared to wild-type 2290090 Nrg1Tn(sb-T2/Bart3)2.183Mcwi neuregulin 1; transposon insertion 2.183, Medical College of Wisconsin gene MP:0009142 decreased prepulse inhibition sexual_dimorphism IMP N RGD:405650204|PMID:21620900 20240425 RGD compared to wild type female 2290090 Nrg1Tn(sb-T2/Bart3)2.183Mcwi neuregulin 1; transposon insertion 2.183, Medical College of Wisconsin gene MP:0009456 impaired cued conditioning behavior IMP N RGD:39128254|PMID:23022220 20200929 RGD 2290090 Nrg1Tn(sb-T2/Bart3)2.183Mcwi neuregulin 1; transposon insertion 2.183, Medical College of Wisconsin gene MP:0011617 abnormal habituation IMP N RGD:405650204|PMID:21620900 20240425 RGD 2290103 F344-Nrg1Tn(sb-T2/Bart3)2.183Mcwi strain MP:0001260 increased body weight IMP N RGD:39128254|PMID:23022220 20200929 RGD compared to F344 2290103 F344-Nrg1Tn(sb-T2/Bart3)2.183Mcwi strain MP:0001402 decreased locomotor activity sexual_dimorphism IMP N RGD:405650204|PMID:21620900 20240419 RGD compared to mutant male 2290103 F344-Nrg1Tn(sb-T2/Bart3)2.183Mcwi strain MP:0001488 increased startle reflex sexual_dimorphism IAGP N RGD:405650204|PMID:21620900 20240419 RGD compared to female 2290103 F344-Nrg1Tn(sb-T2/Bart3)2.183Mcwi strain MP:0001745 increased circulating corticosterone level IMP N RGD:10449008|PMID:21092742 20210208 RGD compared to wild-type 2290103 F344-Nrg1Tn(sb-T2/Bart3)2.183Mcwi strain MP:0009142 decreased prepulse inhibition sexual_dimorphism IMP N RGD:405650204|PMID:21620900 20240419 RGD compared to wild type female 2290103 F344-Nrg1Tn(sb-T2/Bart3)2.183Mcwi strain MP:0009456 impaired cued conditioning behavior IMP N RGD:39128254|PMID:23022220 20200929 RGD compared to F344 2290103 F344-Nrg1Tn(sb-T2/Bart3)2.183Mcwi strain MP:0011617 abnormal habituation IMP N RGD:405650204|PMID:21620900 20240419 RGD 2290186 SD-Tg(SOD1*G93A)39 strain MP:0000755 hindlimb paralysis IMP N RGD:2290184|PMID:11717358 20080228 RGD 2290186 SD-Tg(SOD1*G93A)39 strain MP:0000938 motor neuron degeneration IMP N RGD:2290184|PMID:11717358 20080228 RGD 2290186 SD-Tg(SOD1*G93A)39 strain MP:0001262 decreased body weight IMP N RGD:2290184|PMID:11717358 20080228 RGD 2290186 SD-Tg(SOD1*G93A)39 strain MP:0002066 abnormal motor capabilities/coordination/movement IMP N RGD:2290184|PMID:11717358 20080228 RGD 2290186 SD-Tg(SOD1*G93A)39 strain MP:0002083 premature death IMP N RGD:2290184|PMID:11717358 20080228 RGD 2290186 SD-Tg(SOD1*G93A)39 strain MP:0002111 abnormal tail morphology IMP N RGD:2290184|PMID:11717358 20080228 RGD 2290186 SD-Tg(SOD1*G93A)39 strain MP:0003354 astrocytosis IMP N RGD:2290184|PMID:11717358 20200924 RGD 2290186 SD-Tg(SOD1*G93A)39 strain MP:0004263 abnormal limb posture IMP N RGD:2290184|PMID:11717358 20080228 RGD 2290186 SD-Tg(SOD1*G93A)39 strain MP:0008918 microgliosis IMP N RGD:2290184|PMID:11717358 20200924 RGD 2290186 SD-Tg(SOD1*G93A)39 strain MP:0030706 increased glutamine level IMP N RGD:2290184|PMID:11717358 20200924 RGD CSF, compared to control littermates 2290187 SD-Tg(SOD1*H46R)4 strain MP:0000755 hindlimb paralysis IMP N RGD:2290184|PMID:11717358 20080228 RGD 2290187 SD-Tg(SOD1*H46R)4 strain MP:0000938 motor neuron degeneration IMP N RGD:2290184|PMID:11717358 20080228 RGD 2290187 SD-Tg(SOD1*H46R)4 strain MP:0001262 decreased body weight IMP N RGD:2290184|PMID:11717358 20080228 RGD 2290187 SD-Tg(SOD1*H46R)4 strain MP:0002066 abnormal motor capabilities/coordination/movement IMP N RGD:2290184|PMID:11717358 20080228 RGD 2290187 SD-Tg(SOD1*H46R)4 strain MP:0002083 premature death IMP N RGD:2290184|PMID:11717358 20080228 RGD 2290187 SD-Tg(SOD1*H46R)4 strain MP:0002111 abnormal tail morphology IMP N RGD:2290184|PMID:11717358 20080228 RGD 2290187 SD-Tg(SOD1*H46R)4 strain MP:0003354 astrocytosis IMP N RGD:2290184|PMID:11717358 20200924 RGD 2290187 SD-Tg(SOD1*H46R)4 strain MP:0004263 abnormal limb posture IMP N RGD:2290184|PMID:11717358 20080228 RGD 2290187 SD-Tg(SOD1*H46R)4 strain MP:0008918 microgliosis IMP N RGD:2290184|PMID:11717358 20200924 RGD 2290298 SHR-Tg(Thy1-MAPT)318 strain MP:0001516 abnormal motor coordination/balance IAGP N RGD:2290297|PMID:17169350 20080305 RGD compared to SHR 2290298 SHR-Tg(Thy1-MAPT)318 strain MP:0002229 neurodegeneration IMP N RGD:2290296|PMID:16753151 20080305 RGD 2290298 SHR-Tg(Thy1-MAPT)318 strain MP:0003214 neurofibrillary tangles IMP N RGD:2290296|PMID:16753151 20080305 RGD 2290298 SHR-Tg(Thy1-MAPT)318 strain MP:0004250 tau protein deposits IMP N RGD:2290296|PMID:16753151 20080305 RGD 2290298 SHR-Tg(Thy1-MAPT)318 strain MP:0012307 impaired spatial learning IAGP N RGD:2290297|PMID:17169350 20080305 RGD compared to SHR 2290299 SHR-Tg(Thy1-MAPT)72 strain MP:0002229 neurodegeneration IMP N RGD:2290296|PMID:16753151 20080305 RGD 2290299 SHR-Tg(Thy1-MAPT)72 strain MP:0003214 neurofibrillary tangles IMP N RGD:2290296|PMID:16753151 20080305 RGD 2290299 SHR-Tg(Thy1-MAPT)72 strain MP:0004250 tau protein deposits IMP N RGD:2290296|PMID:16753151 20080305 RGD 2290311 SD-Tg(SOD1*G93A)26Dwc strain MP:0000938 motor neuron degeneration IMP N RGD:729817|PMID:11818550 20080307 RGD 2290311 SD-Tg(SOD1*G93A)26Dwc strain MP:0002083 premature death IMP N RGD:729817|PMID:11818550 20080307 RGD 2290311 SD-Tg(SOD1*G93A)26Dwc strain MP:0002269 muscular atrophy IMP N RGD:729817|PMID:11818550 20080307 RGD 2290372 Gluco33 Glucose level QTL 33 qtl MP:0005559 increased circulating glucose level IDA N RGD:1626640|PMID:17213368 20080311 RGD 2290374 Gluco32 Glucose level QTL 32 qtl MP:0002727 decreased circulating insulin level IDA N RGD:1626640|PMID:17213368 20080311 RGD 2290374 Gluco32 Glucose level QTL 32 qtl MP:0005559 increased circulating glucose level IDA N RGD:1626640|PMID:17213368 20080311 RGD 2290375 Gluco34 Glucose level QTL 34 qtl MP:0005559 increased circulating glucose level IDA N RGD:1626640|PMID:17213368 20080311 RGD 2290386 SD-Tg(Wlds)23Cole strain MP:0000940 abnormal motor neuron innervation pattern IMP N RGD:2290382|PMID:15654865 20180815 RGD 2290386 SD-Tg(Wlds)23Cole strain MP:0010654 slow Wallerian degeneration IMP N RGD:2290382|PMID:15654865 20180815 RGD 2290387 SD-Tg(UbC-APPswe)6590 strain MP:0003329 amyloid beta deposits IMP N RGD:2290385|PMID:17506994 20080311 RGD human transgene in a rat model 2290391 SD-Tg(Wlds)79Cole strain MP:0000940 abnormal motor neuron innervation pattern IMP N RGD:2290382|PMID:15654865 20180815 RGD 2290391 SD-Tg(Wlds)79Cole strain MP:0010654 slow Wallerian degeneration IMP N RGD:2290382|PMID:15654865 20180815 RGD 2290393 Uae37 Urinary albumin excretion QTL 37 qtl MP:0002871 albuminuria IDA N RGD:1642911|PMID:17953514 20080311 RGD 2290393 Uae37 Urinary albumin excretion QTL 37 qtl MP:0002962 increased urine protein level IDA N RGD:1642911|PMID:17953514 20120112 RGD 2290429 SS-Tg(ApoC3-CETP)53Opaz strain MP:0000186 decreased circulating HDL cholesterol level IAGP N RGD:2290427|PMID:10581080 20080313 RGD compared to SS/JrHsd 2290429 SS-Tg(ApoC3-CETP)53Opaz strain MP:0001552 increased circulating triglyceride level IAGP N RGD:2290427|PMID:10581080 20080313 RGD compared to SS/JrHsd 2290429 SS-Tg(ApoC3-CETP)53Opaz strain MP:0002083 premature death IAGP N RGD:2290427|PMID:10581080 20080313 RGD compared to SS/JrHsd 2290429 SS-Tg(ApoC3-CETP)53Opaz strain MP:0005178 increased circulating cholesterol level IAGP N RGD:2290427|PMID:10581080 20080313 RGD compared to SS/JrHsd 2290429 SS-Tg(ApoC3-CETP)53Opaz strain MP:0005339 increased susceptibility to atherosclerosis IAGP N RGD:2290427|PMID:10581080 20080313 RGD compared to SS/JrHsd 2290448 Scl54 Serum cholesterol level QTL 54 qtl MP:0003982 increased cholesterol level IDA N RGD:2290428|PMID:17620956 20080313 RGD 2290450 Scl57 Serum cholesterol level QTL 57 qtl MP:0003982 increased cholesterol level IDA N RGD:2290428|PMID:17620956 20080313 RGD 2290451 Scl58 Serum cholesterol level QTL 58 qtl MP:0003982 increased cholesterol level IDA N RGD:2290428|PMID:17620956 20080313 RGD 2290452 Scl56 Serum cholesterol level QTL 56 qtl MP:0003982 increased cholesterol level IDA N RGD:2290428|PMID:17620956 20080313 RGD 2290453 Scl55 Serum cholesterol level QTL 55 qtl MP:0003982 increased cholesterol level IDA N RGD:2290428|PMID:17620956 20080313 RGD 2292168 ISIAH Inherited stress-induced arterial hypertension strain MP:0001441 increased grooming behavior IAGP N RGD:2306974|PMID:19089625 20200123 RGD as compared to WAG rats 2292168 ISIAH Inherited stress-induced arterial hypertension strain MP:0001745 increased circulating corticosterone level IAGP N RGD:2306974|PMID:19089625 20090520 RGD as compared to WAG rats 2292168 ISIAH Inherited stress-induced arterial hypertension strain MP:0002833 increased heart weight IAGP N RGD:1626643|PMID:16700878 20191220 RGD as compared to WAG/Nov 2292168 ISIAH Inherited stress-induced arterial hypertension strain MP:0003917 increased kidney weight IAGP N RGD:1626643|PMID:16700878 20191220 RGD as compared to WAG/Nov 2292168 ISIAH Inherited stress-induced arterial hypertension strain MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:1626643|PMID:16700878 20080411 RGD as compared to WAG/Nov 2292168 ISIAH Inherited stress-induced arterial hypertension strain MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:2306974|PMID:19089625 20200123 RGD as compared to WAG rats 2292168 ISIAH Inherited stress-induced arterial hypertension strain MP:0013307 increased adrenal gland weight IAGP N RGD:1626643|PMID:16700878 20191220 RGD as compared to WAG/Nov 2292216 Bw80 Body weight QTL 80 qtl MP:0001262 decreased body weight IAGP N RGD:1626643|PMID:16700878 20080415 RGD 2292218 Kidm35 Kidney mass QTL 35 qtl MP:0003918 decreased kidney weight IDA N RGD:1626643|PMID:16700878 20080415 RGD 2292220 Bp306 Blood pressure QTL 306 qtl MP:0006144 increased systemic arterial systolic blood pressure IDA N RGD:1626643|PMID:16700878 20080415 RGD 2292222 Bp307 Blood pressure QTL 307 qtl MP:0006144 increased systemic arterial systolic blood pressure IDA N RGD:1626643|PMID:16700878 20080415 RGD stress induced 2292232 Pur16 Proteinuria QTL 16 qtl MP:0002962 increased urine protein level IDA N RGD:2292230|PMID:18064521 20080416 RGD 2292384 SS.LEW-(D10Chm167-D10Chm257)/Ayd strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:2292238|PMID:18398331 20080417 RGD compared to SS/Jr 2292385 SS.LEW-(D10Mco30-D10Got107)/Ayd strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:2292238|PMID:18398331 20080417 RGD 2292386 SS.LEW-(D10Chm155-D10Rat127)/Ayd strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:2292238|PMID:18398331 20080417 RGD compared to SS/Jr 2292387 SS.LEW-(D10Chm224-D10Chm259)/Ayd strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:2292238|PMID:18398331 20080417 RGD compared to SS/Jr 2292388 SS.LEW-(D10Chm246-D10Chm257)/Ayd strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:2292238|PMID:18398331 20080417 RGD compared to SS/Jr 2292388 SS.LEW-(D10Chm246-D10Chm257)/Ayd strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:7421500|PMID:23814039 20131211 RGD compared to SS/Jr 2292389 SS.LEW-(D10Chm10-D10Chm14)/Ayd strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:2292238|PMID:18398331 20080417 RGD compared to SS/Jr 2292390 SS.LEW-(D10Rat194-D10Chm243)/Ayd strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:2292238|PMID:18398331 20080417 RGD compared to SS/Jr 2292436 Bp310 Blood pressure QTL 310 qtl MP:0006264 decreased systemic arterial systolic blood pressure IDA N RGD:2292238|PMID:18398331 20080418 RGD 2292438 Bp311 Blood pressure QTL 311 qtl MP:0006264 decreased systemic arterial systolic blood pressure IDA N RGD:2292238|PMID:18398331 20080418 RGD 2292439 Bp309 Blood pressure QTL 309 qtl MP:0006264 decreased systemic arterial systolic blood pressure IDA N RGD:2292238|PMID:18398331 20080418 RGD 2292440 Bp312 Blood pressure QTL 312 qtl MP:0006264 decreased systemic arterial systolic blood pressure IDA N RGD:2292238|PMID:18398331 20080418 RGD 2292441 Bp308 Blood pressure QTL 308 qtl MP:0006264 decreased systemic arterial systolic blood pressure IDA N RGD:2292238|PMID:18398331 20080418 RGD 2292459 WF.LEW-RVFV strain MP:0009790 decreased susceptibility to viral infection induced morbidity/mortality IAGP N RGD:2292456|PMID:2063951 20080423 RGD compared to WF/Mai 2292526 SS-Tg(Atp1a1)48Opaz strain MP:0001661 extended life span IMP N RGD:2292511|PMID:9739044 20080514 RGD compared to SS/JrHsd 2292526 SS-Tg(Atp1a1)48Opaz strain MP:0005166 decreased susceptibility to injury induced IMP XCO:0000022 N RGD:2292511|PMID:9739044 20080514 RGD compared to SS/JrHsd 2292528 F344-Tg(APPswe)Opaz strain MP:0012306 enhanced spatial learning IAGP N RGD:2292518|PMID:15502881 20080514 RGD compared to F344 control 2292564 ACI.COP-(D6Rat80-D6Rat146)/Shul strain MP:0003447 decreased tumor growth/size induced IAGP XCO:0000092 N RGD:2292503|PMID:18420736 20080424 RGD compared to ACI/SegHsd 2292564 ACI.COP-(D6Rat80-D6Rat146)/Shul strain MP:0004956 decreased thymus weight IAGP XCO:0000092 N RGD:2292503|PMID:18420736 20080424 RGD compared to COP/CrCrl, ACI/SegHsd 2292564 ACI.COP-(D6Rat80-D6Rat146)/Shul strain MP:0005121 decreased circulating prolactin level induced IAGP XCO:0000092 N RGD:2292503|PMID:18420736 20080424 RGD compared to ACI/SegHsd 2292564 ACI.COP-(D6Rat80-D6Rat146)/Shul strain MP:0008939 increased pituitary gland weight induced IAGP XCO:0000092 N RGD:2292503|PMID:18420736 20080424 RGD compared to untreated COP/CrCrl 2292564 ACI.COP-(D6Rat80-D6Rat146)/Shul strain MP:0009828 increased tumor latency induced IAGP XCO:0000092 N RGD:2292503|PMID:18420736 20080424 RGD compared to ACI/SegHsd, ACI.COP-(D3Mgh16-D3Rat119)/Shul, ACI.COP-(D3Rat130-D3Rat114)/Shul, COP/CrCrl, ACI.COP-(D10Mgh20-D10Rat4)/Shul� 2292565 ACI.COP-(D3Mgh16-D3Rat119)/Shul strain MP:0004955 increased thymus weight induced IAGP XCO:0000092 N RGD:2292503|PMID:18420736 20200710 RGD compared to COP/CrCrl 2292565 ACI.COP-(D3Mgh16-D3Rat119)/Shul strain MP:0004956 decreased thymus weight IAGP N RGD:2292503|PMID:18420736 20080424 RGD compared to COP/CrCrl 2292565 ACI.COP-(D3Mgh16-D3Rat119)/Shul strain MP:0005124 increased circulating prolactin level induced IAGP XCO:0000092 N RGD:2292503|PMID:18420736 20080424 RGD compared to COP/CrCrl 2292565 ACI.COP-(D3Mgh16-D3Rat119)/Shul strain MP:0008939 increased pituitary gland weight induced IAGP XCO:0000092 N RGD:2292503|PMID:18420736 20080424 RGD compared to ACI/SegHsd and COP/CrCrl 2292566 ACI.COP-(D3Rat130-D3Rat114)/Shul strain MP:0005121 decreased circulating prolactin level induced IAGP XCO:0000092 N RGD:2292503|PMID:18420736 20080424 RGD compared to ACI/SegHsd 2292566 ACI.COP-(D3Rat130-D3Rat114)/Shul strain MP:0008938 decreased pituitary gland weight induced IAGP XCO:0000092 N RGD:2292503|PMID:18420736 20080424 RGD compared to ACI/SegHsd 2292567 ACI.COP-(D10Mgh20-D10Rat4)/Shul strain MP:0004956 decreased thymus weight IAGP N RGD:2292503|PMID:18420736 20200710 RGD compared to COP/CrCrl, ACI/SegHsd 2292567 ACI.COP-(D10Mgh20-D10Rat4)/Shul strain MP:0005124 increased circulating prolactin level induced IAGP XCO:0000092 N RGD:2292503|PMID:18420736 20200710 RGD compared COP/CrCrl 2292567 ACI.COP-(D10Mgh20-D10Rat4)/Shul strain MP:0008939 increased pituitary gland weight induced IAGP XCO:0000092 N RGD:2292503|PMID:18420736 20200710 RGD compared COP/CrCrl 2292589 Emca10 Estrogen-induced mammary cancer QTL 10 qtl MP:0010269 decreased mammary gland tumor incidence IDA N RGD:2292503|PMID:18420736 20111107 RGD 2292591 Esta4 Estrogen-induced thymic atrophy QTL 4 qtl MP:0003644 thymus atrophy IDA N RGD:2292503|PMID:18420736 20080424 RGD E2 induced for 12 weeks 2292613 Ept16 Estrogen-induced pituitary tumorigenesis QTL 16 qtl MP:0000635 pituitary gland hyperplasia IDA N RGD:2292503|PMID:18420736 20080425 RGD E2 induced for 12 weeks 2292615 Ept17 Estrogen-induced pituitary tumorigenesis QTL 17 qtl MP:0000635 pituitary gland hyperplasia IDA N RGD:2292503|PMID:18420736 20080425 RGD E2 induced for 12 weeks 2292616 Ept15 Estrogen-induced pituitary tumorigenesis QTL 15 qtl MP:0000635 pituitary gland hyperplasia IDA N RGD:2292503|PMID:18420736 20080425 RGD E2 induced for 12 weeks 2292617 Ept18 Estrogen-induced pituitary tumorigenesis QTL 18 qtl MP:0000635 pituitary gland hyperplasia IDA N RGD:2292503|PMID:18420736 20080425 RGD E2 induced for 12 weeks 2292647 SS.LEW-(D1Mco36-D1Rat106)/Mco strain MP:0006264 decreased systemic arterial systolic blood pressure induced IAGP XCO:0000022 N RGD:2291850|PMID:18324438 20080514 RGD compared to SS/Jr 2292648 SS.LEW-(D1Mco36-D1Mco77)/Mco strain MP:0001262 decreased body weight induced IAGP XCO:0000022 N RGD:2291850|PMID:18324438 20080514 RGD compared to SS/Jr 2292648 SS.LEW-(D1Mco36-D1Mco77)/Mco strain MP:0002834 decreased heart weight induced IAGP XCO:0000022 N RGD:2291850|PMID:18324438 20191127 RGD 2292648 SS.LEW-(D1Mco36-D1Mco77)/Mco strain MP:0006264 decreased systemic arterial systolic blood pressure induced IAGP XCO:0000022 N RGD:2291850|PMID:18324438 20080514 RGD compared to SS/Jr 2292649 SS.LEW-(D1Mco36-D1Rat131)/1Mco strain MP:0006264 decreased systemic arterial systolic blood pressure induced IAGP XCO:0000022 N RGD:2291850|PMID:18324438 20080514 RGD compared to SS/Jr 2292650 SS.LEW-(D1Mco36-D1Rat131)/2Mco strain MP:0006264 decreased systemic arterial systolic blood pressure induced IAGP XCO:0000022 N RGD:2291850|PMID:18324438 20080514 RGD compared to SS/Jr 2292651 SS.LEW-(D1Mco99-D1Rat49)/Mco strain MP:0001262 decreased body weight induced IAGP XCO:0000022 N RGD:2291850|PMID:18324438 20080514 RGD compared to SS/Jr 2292651 SS.LEW-(D1Mco99-D1Rat49)/Mco strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:2291850|PMID:18324438 20080514 RGD 2292652 SS.LEW-(D1Mco85-D1Rat49)/Mco strain MP:0002834 decreased heart weight induced IAGP XCO:0000022 N RGD:2291850|PMID:18324438 20080514 RGD compared to SS/Jr 2292652 SS.LEW-(D1Mco85-D1Rat49)/Mco strain MP:0006264 decreased systemic arterial systolic blood pressure induced IAGP XCO:0000022 N RGD:2291850|PMID:18324438 20080514 RGD compared to SS/Jr 2292653 SS.LEW-(D1Mco36-D1Mco101)/Mco strain MP:0006263 decreased systemic arterial diastolic blood pressure induced IAGP XCO:0000022 N RGD:2291850|PMID:18324438 20080514 RGD compared to SS/Jr 2292653 SS.LEW-(D1Mco36-D1Mco101)/Mco strain MP:0006264 decreased systemic arterial systolic blood pressure induced IAGP XCO:0000022 N RGD:2291850|PMID:18324438 20080514 RGD compared to SS/Jr 2292653 SS.LEW-(D1Mco36-D1Mco101)/Mco strain MP:0006266 decreased pulse pressure induced IAGP XCO:0000022 N RGD:2291850|PMID:18324438 20191127 RGD compared to SS/Jr 2293012 ACI.BBDP-(RT1u)(Gimap5)/Sunn strain MP:0004804 decreased susceptibility to autoimmune diabetes IAGP N RGD:2293011|PMID:1446803 20080507 RGD 2293012 ACI.BBDP-(RT1u)(Gimap5)/Sunn strain MP:0005016 decreased lymphocyte cell number IAGP N RGD:2293011|PMID:1446803 20200128 RGD 2293012 ACI.BBDP-(RT1u)(Gimap5)/Sunn strain MP:0020192 decreased lymphocyte activation involved in immune response IAGP N RGD:2293011|PMID:1446803 20200128 RGD 2293083 Iddm25 Insulin dependent diabetes mellitus QTL 25 qtl MP:0005559 increased circulating glucose level IDA N RGD:2303106|PMID:19168599 20111108 RGD 2293084 Iddm26 Insulin dependent diabetes mellitus QTL 26 qtl MP:0005559 increased circulating glucose level IDA N RGD:2303106|PMID:19168599 20111108 RGD 2293085 Iddm29 Insulin dependent diabetes mellitus QTL 29 qtl MP:0005559 increased circulating glucose level IDA N RGD:2303106|PMID:19168599 20111108 RGD 2293086 Iddm30 Insulin dependent diabetes mellitus QTL 30 qtl MP:0005559 increased circulating glucose level IDA N RGD:2303106|PMID:19168599 20111108 RGD 2293087 Iddm27 Insulin dependent diabetes mellitus QTL 27 qtl MP:0005559 increased circulating glucose level IDA N RGD:2303106|PMID:19168599 20111108 RGD 2293088 Iddm28 Insulin dependent diabetes mellitus QTL 28 qtl MP:0005559 increased circulating glucose level IDA N RGD:2303106|PMID:19168599 20111108 RGD 2293089 Iddm31 Insulin dependent diabetes mellitus QTL 31 qtl MP:0005559 increased circulating glucose level IDA N RGD:2303106|PMID:19168599 20111108 RGD 2293120 LOU.BN-(D10Mgh1-D10Mgh14)/Ins strain MP:0003184 increased angiotensin I-converting enzyme activity IAGP N RGD:2293119|PMID:18462270 20080513 RGD compared to LOU 2293120 LOU.BN-(D10Mgh1-D10Mgh14)/Ins strain MP:0003184 increased angiotensin I-converting enzyme activity induced IAGP XCO:0000005 N RGD:2293119|PMID:18462270 20201202 RGD compared to LOU 2293140 Bp313 Blood pressure QTL 313 qtl MP:0006264 decreased systemic arterial systolic blood pressure IDA N RGD:2291850|PMID:18324438 20080514 RGD as compared to SS/Jr 2293142 Bp314 Blood pressure QTL 314 qtl MP:0006264 decreased systemic arterial systolic blood pressure IDA N RGD:2291850|PMID:18324438 20080514 RGD as compared to SS/Jr 2293143 SS.BN-(D13Rat20-D13Rat127)/Mcwi strain MP:0002959 increased urine microalbumin level sexual_dimorphism IAGP XCO:0000022 N RGD:1625678|PMID:17566075 20090831 RGD in male 2293143 SS.BN-(D13Rat20-D13Rat127)/Mcwi strain MP:0004876 decreased mean systemic arterial blood pressure sexual_dimorphism IAGP XCO:0000022 N RGD:1625678|PMID:17566075 20090831 RGD in female, compared to SS/JrHsdMcwi 2293143 SS.BN-(D13Rat20-D13Rat127)/Mcwi strain MP:0005601 increased angiogenesis induced IAGP XCO:0000522 N RGD:2289092|PMID:18198281 20080514 RGD 2293144 SS.BN-(D13Rat91-D13Rat179)/Mcwi strain MP:0002959 increased urine microalbumin level sexual_dimorphism IAGP XCO:0000022 N RGD:1625678|PMID:17566075 20191206 RGD in male 2293144 SS.BN-(D13Rat91-D13Rat179)/Mcwi strain MP:0004875 increased mean systemic arterial blood pressure sexual_dimorphism IAGP XCO:0000022 N RGD:1625678|PMID:17566075 20090831 RGD in male 2293145 SS.BN-(D13Hmgc64-RN34_13048990782)/Mcwi strain MP:0001883 increased mammary adenocarcinoma incidence induced IAGP XCO:0000090 N RGD:4143380|PMID:20737482 20101026 RGD compared to SS/JrHsdMcwi 2293145 SS.BN-(D13Hmgc64-RN34_13048990782)/Mcwi strain MP:0002871 albuminuria induced IAGP XCO:0000022 N RGD:12802368|PMID:23817491 20170406 RGD in male 2293145 SS.BN-(D13Hmgc64-RN34_13048990782)/Mcwi strain MP:0002871 albuminuria induced IAGP XCO:0000022 N RGD:12802369|PMID:23460292 20170407 RGD 2293145 SS.BN-(D13Hmgc64-RN34_13048990782)/Mcwi strain MP:0002959 increased urine microalbumin level sexual_dimorphism IAGP XCO:0000022 N RGD:1625678|PMID:17566075 20090831 RGD in male 2293145 SS.BN-(D13Hmgc64-RN34_13048990782)/Mcwi strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:12802368|PMID:23817491 20170406 RGD in male 2293145 SS.BN-(D13Hmgc64-RN34_13048990782)/Mcwi strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:12802369|PMID:23460292 20170407 RGD 2293145 SS.BN-(D13Hmgc64-RN34_13048990782)/Mcwi strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:12802368|PMID:23817491 20191122 RGD in female, compared to SS/JrHsdMcwi; 2293145 SS.BN-(D13Hmgc64-RN34_13048990782)/Mcwi strain MP:0004876 decreased mean systemic arterial blood pressure sexual_dimorphism IAGP XCO:0000022 N RGD:1625678|PMID:17566075 20090831 RGD in female, compared to SS/JrHsdMcwi; 2293145 SS.BN-(D13Hmgc64-RN34_13048990782)/Mcwi strain MP:0005540 decreased urine albumin level induced IAGP XCO:0000795 N RGD:12802368|PMID:23817491 20191122 RGD in female, compared to SS/JrHsdMcwi; 2293145 SS.BN-(D13Hmgc64-RN34_13048990782)/Mcwi strain MP:0005582 increased renin activity IAGP N RGD:2289092|PMID:18198281 20080515 RGD 2293145 SS.BN-(D13Hmgc64-RN34_13048990782)/Mcwi strain MP:0005601 increased angiogenesis induced IAGP XCO:0000522 N RGD:2289092|PMID:18198281 20080514 RGD 2293145 SS.BN-(D13Hmgc64-RN34_13048990782)/Mcwi strain MP:0010308 decreased tumor latency induced IAGP XCO:0000090 N RGD:4143380|PMID:20737482 20101026 RGD compared to SS/JrHsdMcwi 2293146 SS.BN-(D13Rat20-D13Got22)/Mcwi strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:1625678|PMID:17566075 20090831 RGD 2293341 Glom15 Glomerulus QTL 15 qtl MP:0002743 glomerulonephritis susceptibility IDA N RGD:2293335|PMID:16482158 20080528 RGD 2293343 Glom16 Glomerulus QTL 16 qtl MP:0002743 glomerulonephritis susceptibility IDA N RGD:2293335|PMID:16482158 20080528 RGD 2293354 LEW.WKY-(D16Rat88-D16Rat40)/Tja strain MP:0002962 increased urine protein level induced IAGP XCO:0000769 N RGD:2293336|PMID:18443593 20080529 RGD compared to LEW/Crl 2293355 WKY.LEW-(D16Rat88-D16Rat40)/Tja strain MP:0011079 decreased macrophage cytokine production IAGP N RGD:2293336|PMID:18443593 20080529 RGD compared to WKY/NCrl 2293642 Bss37 Bone structure and strength QTL 37 qtl MP:0003795 abnormal bone structure susceptibility IDA N RGD:2293455|PMID:18158281 20080610 RGD 2293644 Bmd29 Bone mineral density QTL 29 qtl MP:0000062 increased bone mineral density susceptibility IDA N RGD:2293456|PMID:18282130 20080610 RGD 2293644 Bmd29 Bone mineral density QTL 29 qtl MP:0004148 increased compact bone thickness IDA N RGD:2293456|PMID:18282130 20080610 RGD 2293646 Bss25 Bone structure and strength QTL 25 qtl MP:0003795 abnormal bone structure susceptibility IDA N RGD:2293455|PMID:18158281 20080610 RGD 2293648 Bmd31 Bone mineral density QTL 31 qtl MP:0000062 increased bone mineral density susceptibility IDA N RGD:2293456|PMID:18282130 20080610 RGD 2293648 Bmd31 Bone mineral density QTL 31 qtl MP:0004148 increased compact bone thickness IDA N RGD:2293456|PMID:18282130 20080610 RGD 2293650 Bss31 Bone structure and strength QTL 31 qtl MP:0003795 abnormal bone structure susceptibility IDA N RGD:2293455|PMID:18158281 20080610 RGD 2293652 Bmd22 Bone mineral density QTL 22 qtl MP:0000062 increased bone mineral density susceptibility IDA N RGD:2293456|PMID:18282130 20080610 RGD 2293654 Bss30 Bone structure and strength QTL 30 qtl MP:0003795 abnormal bone structure susceptibility IDA N RGD:2293455|PMID:18158281 20080610 RGD 2293655 Bss36 Bone structure and strength QTL 36 qtl MP:0003795 abnormal bone structure susceptibility IDA N RGD:2293455|PMID:18158281 20080610 RGD 2293656 Bss28 Bone structure and strength QTL 28 qtl MP:0003795 abnormal bone structure susceptibility IDA N RGD:2293455|PMID:18158281 20080610 RGD 2293658 Bmd23 Bone mineral density QTL 23 qtl MP:0000062 increased bone mineral density susceptibility IDA N RGD:2293456|PMID:18282130 20080610 RGD 2293659 Bmd35 Bone mineral density QTL 35 qtl MP:0000062 increased bone mineral density susceptibility IDA N RGD:2293456|PMID:18282130 20080610 RGD 2293661 Bss50 Bone structure and strength QTL 50 qtl MP:0001542 abnormal bone strength susceptibility IDA N RGD:2293455|PMID:18158281 20080610 RGD 2293663 Bss33 Bone structure and strength QTL 33 qtl MP:0003795 abnormal bone structure susceptibility IDA N RGD:2293455|PMID:18158281 20080610 RGD 2293664 Bmd28 Bone mineral density QTL 28 qtl MP:0000062 increased bone mineral density susceptibility IDA N RGD:2293456|PMID:18282130 20080610 RGD 2293664 Bmd28 Bone mineral density QTL 28 qtl MP:0004148 increased compact bone thickness IDA N RGD:2293456|PMID:18282130 20080610 RGD 2293666 Bmd38 Bone mineral density QTL 38 qtl MP:0000062 increased bone mineral density susceptibility IDA N RGD:2293456|PMID:18282130 20080610 RGD 2293667 Bss42 Bone structure and strength QTL 42 qtl MP:0001542 abnormal bone strength susceptibility IDA N RGD:2293455|PMID:18158281 20080610 RGD 2293669 Bmd33 Bone mineral density QTL 33 qtl MP:0000062 increased bone mineral density susceptibility IDA N RGD:2293456|PMID:18282130 20080610 RGD 2293671 Bss44 Bone structure and strength QTL 44 qtl MP:0001542 abnormal bone strength susceptibility IDA N RGD:2293455|PMID:18158281 20080610 RGD 2293673 Bss27 Bone structure and strength QTL 27 qtl MP:0003795 abnormal bone structure susceptibility IDA N RGD:2293455|PMID:18158281 20080610 RGD 2293674 Bss39 Bone structure and strength QTL 39 qtl MP:0003795 abnormal bone structure susceptibility IDA N RGD:2293455|PMID:18158281 20080610 RGD 2293676 Bmd19 Bone mineral density QTL 19 qtl MP:0000062 increased bone mineral density susceptibility IDA N RGD:2293456|PMID:18282130 20080610 RGD 2293677 Bss41 Bone structure and strength QTL 41 qtl MP:0001542 abnormal bone strength susceptibility IDA N RGD:2293455|PMID:18158281 20080610 RGD 2293678 Bss24 Bone structure and strength QTL 24 qtl MP:0003795 abnormal bone structure susceptibility IDA N RGD:2293455|PMID:18158281 20080610 RGD 2293679 Bmd30 Bone mineral density QTL 30 qtl MP:0000062 increased bone mineral density susceptibility IDA N RGD:2293456|PMID:18282130 20080610 RGD 2293679 Bmd30 Bone mineral density QTL 30 qtl MP:0004148 increased compact bone thickness IDA N RGD:2293456|PMID:18282130 20080610 RGD 2293680 Bss40 Bone structure and strength QTL 40 qtl MP:0003795 abnormal bone structure susceptibility IDA N RGD:2293455|PMID:18158281 20080610 RGD 2293682 Bmd24 Bone mineral density QTL 24 qtl MP:0000062 increased bone mineral density susceptibility IDA N RGD:2293456|PMID:18282130 20080610 RGD 2293682 Bmd24 Bone mineral density QTL 24 qtl MP:0004148 increased compact bone thickness IDA N RGD:2293456|PMID:18282130 20080610 RGD 2293684 Bmd26 Bone mineral density QTL 26 qtl MP:0000062 increased bone mineral density susceptibility IDA N RGD:2293456|PMID:18282130 20080610 RGD 2293684 Bmd26 Bone mineral density QTL 26 qtl MP:0004148 increased compact bone thickness IDA N RGD:2293456|PMID:18282130 20080610 RGD 2293685 Bmd21 Bone mineral density QTL 21 qtl MP:0000062 increased bone mineral density susceptibility IDA N RGD:2293456|PMID:18282130 20080610 RGD 2293686 Bmd36 Bone mineral density QTL 36 qtl MP:0000062 increased bone mineral density susceptibility IDA N RGD:2293456|PMID:18282130 20080610 RGD 2293687 Bss26 Bone structure and strength QTL 26 qtl MP:0003795 abnormal bone structure susceptibility IDA N RGD:2293455|PMID:18158281 20080610 RGD 2293688 Bss29 Bone structure and strength QTL 29 qtl MP:0003795 abnormal bone structure susceptibility IDA N RGD:2293455|PMID:18158281 20080610 RGD 2293689 Bss47 Bone structure and strength QTL 47 qtl MP:0001542 abnormal bone strength susceptibility IDA N RGD:2293455|PMID:18158281 20080610 RGD 2293690 Bss45 Bone structure and strength QTL 45 qtl MP:0001542 abnormal bone strength susceptibility IDA N RGD:2293455|PMID:18158281 20080610 RGD 2293691 Bmd37 Bone mineral density QTL 37 qtl MP:0000062 increased bone mineral density susceptibility IDA N RGD:2293456|PMID:18282130 20080610 RGD 2293693 Bss22 Bone structure and strength QTL 22 qtl MP:0003795 abnormal bone structure susceptibility IDA N RGD:2293455|PMID:18158281 20080610 RGD 2293694 Bss38 Bone structure and strength QTL 38 qtl MP:0003795 abnormal bone structure susceptibility IDA N RGD:2293455|PMID:18158281 20080610 RGD 2293696 Bmd32 Bone mineral density QTL 32 qtl MP:0000062 increased bone mineral density susceptibility IDA N RGD:2293456|PMID:18282130 20080610 RGD 2293697 Bmd39 Bone mineral density QTL 39 qtl MP:0000062 increased bone mineral density susceptibility IDA N RGD:2293456|PMID:18282130 20080610 RGD 2293698 Bss43 Bone structure and strength QTL 43 qtl MP:0001542 abnormal bone strength susceptibility IDA N RGD:2293455|PMID:18158281 20080610 RGD 2293699 Bss49 Bone structure and strength QTL 49 qtl MP:0001542 abnormal bone strength susceptibility IDA N RGD:2293455|PMID:18158281 20080610 RGD 2293700 Bmd27 Bone mineral density QTL 27 qtl MP:0000062 increased bone mineral density susceptibility IDA N RGD:2293456|PMID:18282130 20080610 RGD 2293700 Bmd27 Bone mineral density QTL 27 qtl MP:0004148 increased compact bone thickness IDA N RGD:2293456|PMID:18282130 20080610 RGD 2293701 Bmd34 Bone mineral density QTL 34 qtl MP:0000062 increased bone mineral density susceptibility IDA N RGD:2293456|PMID:18282130 20080610 RGD 2293702 Bss34 Bone structure and strength QTL 34 qtl MP:0003795 abnormal bone structure susceptibility IDA N RGD:2293455|PMID:18158281 20080610 RGD 2293703 Bss48 Bone structure and strength QTL 48 qtl MP:0001542 abnormal bone strength susceptibility IDA N RGD:2293455|PMID:18158281 20080610 RGD 2293704 Bss35 Bone structure and strength QTL 35 qtl MP:0003795 abnormal bone structure susceptibility IDA N RGD:2293455|PMID:18158281 20080610 RGD 2293705 Bmd25 Bone mineral density QTL 25 qtl MP:0000062 increased bone mineral density susceptibility IDA N RGD:2293456|PMID:18282130 20080610 RGD 2293705 Bmd25 Bone mineral density QTL 25 qtl MP:0004148 increased compact bone thickness IDA N RGD:2293456|PMID:18282130 20080610 RGD 2293706 Bmd20 Bone mineral density QTL 20 qtl MP:0000062 increased bone mineral density susceptibility IDA N RGD:2293456|PMID:18282130 20080610 RGD 2293707 Bss32 Bone structure and strength QTL 32 qtl MP:0003795 abnormal bone structure susceptibility IDA N RGD:2293455|PMID:18158281 20080610 RGD 2293708 Bss46 Bone structure and strength QTL 46 qtl MP:0001542 abnormal bone strength susceptibility IDA N RGD:2293455|PMID:18158281 20080610 RGD 2293709 Bss23 Bone structure and strength QTL 23 qtl MP:0003795 abnormal bone structure susceptibility IDA N RGD:2293455|PMID:18158281 20080610 RGD 2293729 SHR-Gja8m1-/-Cub strain MP:0001297 microphthalmia IAGP N RGD:2293186|PMID:18470322 20080611 RGD 2293729 SHR-Gja8m1-/-Cub strain MP:0001304 cataract IAGP N RGD:2293186|PMID:18470322 20080611 RGD 2293729 SHR-Gja8m1-/-Cub strain MP:0002727 decreased circulating insulin level IAGP N RGD:150429989|PMID:27871290 20211109 RGD 2293729 SHR-Gja8m1-/-Cub strain MP:0005545 abnormal lens development IAGP N RGD:2293186|PMID:18470322 20170412 RGD 2293729 SHR-Gja8m1-/-Cub strain MP:0009289 decreased epididymal fat pad weight IAGP N RGD:150429989|PMID:27871290 20211109 RGD 2293729 SHR-Gja8m1-/-Cub strain MP:0012604 decreased glutathione level IAGP N RGD:150429989|PMID:27871290 20211109 RGD 2293729 SHR-Gja8m1-/-Cub strain MP:0012659 decreased superoxide dismutase level IAGP N RGD:150429989|PMID:27871290 20211109 RGD 2293729 SHR-Gja8m1-/-Cub strain MP:0013278 decreased fasting circulating glucose level induces IAGP XCO:0000275,XCO:0000444 N RGD:150429989|PMID:27871290 20211109 RGD 2293761 LH-Chr 17BN/Mav strain MP:0001262 decreased body weight IAGP N RGD:2290181|PMID:18285521 20080612 RGD as comapred to LH/Mav 2293761 LH-Chr 17BN/Mav strain MP:0003915 increased heart left ventricle weight IAGP N RGD:2290181|PMID:18285521 20080612 RGD as compared to BN/NHsdMcwi 2293761 LH-Chr 17BN/Mav strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:2290181|PMID:18285521 20200611 RGD 2293761 LH-Chr 17BN/Mav strain MP:0004876 decreased mean systemic arterial blood pressure IAGP N RGD:2290181|PMID:18285521 20080612 RGD as comapred to LH/Mav 2293761 LH-Chr 17BN/Mav strain MP:0005318 decreased triglyceride level IAGP N RGD:2290181|PMID:18285521 20080612 RGD as compared to LH/Mav 2293770 SHHF/Bbb strain MP:0003819 increased left ventricle diastolic pressure IAGP N RGD:2293766|PMID:18443590 20191220 RGD as compared to WKY/Bbb 2293770 SHHF/Bbb strain MP:0005598 decreased heart ventricle muscle contractility IAGP N RGD:2293766|PMID:18443590 20191220 RGD as compared to as compared to WKY/Bbb, WKY/Bbb 2293770 SHHF/Bbb strain MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:2293766|PMID:18443590 20191220 RGD as compared to WKY/Bbb 2293835 Kiddil5 Kidney dilation QTL 5 qtl MP:0000519 hydronephrosis IDA N RGD:2293631|PMID:18523158 20080616 RGD 2293835 Kiddil5 Kidney dilation QTL 5 qtl MP:0004194 abnormal kidney pelvis morphology IDA N RGD:2293631|PMID:18523158 20080616 RGD 2293835 Kiddil5 Kidney dilation QTL 5 qtl MP:0005161 hematuria IDA N RGD:2293631|PMID:18523158 20080616 RGD 2293837 Kiddil1 Kidney dilation QTL 1 qtl MP:0000519 hydronephrosis IDA N RGD:2293631|PMID:18523158 20080616 RGD 2293837 Kiddil1 Kidney dilation QTL 1 qtl MP:0004194 abnormal kidney pelvis morphology IDA N RGD:2293631|PMID:18523158 20080616 RGD 2293839 Kiddil2 Kidney dilation QTL 2 qtl MP:0000519 hydronephrosis IDA N RGD:2293631|PMID:18523158 20080616 RGD 2293839 Kiddil2 Kidney dilation QTL 2 qtl MP:0004194 abnormal kidney pelvis morphology IDA N RGD:2293631|PMID:18523158 20080616 RGD 2293840 Kiddil9 Kidney dilation QTL 9 qtl MP:0000519 hydronephrosis IDA N RGD:2293631|PMID:18523158 20080616 RGD 2293840 Kiddil9 Kidney dilation QTL 9 qtl MP:0004194 abnormal kidney pelvis morphology IDA N RGD:2293631|PMID:18523158 20080616 RGD 2293841 Kiddil4 Kidney dilation QTL 4 qtl MP:0000519 hydronephrosis IDA N RGD:2293631|PMID:18523158 20080616 RGD 2293841 Kiddil4 Kidney dilation QTL 4 qtl MP:0004194 abnormal kidney pelvis morphology IDA N RGD:2293631|PMID:18523158 20080616 RGD 2293842 Kiddil3 Kidney dilation QTL 3 qtl MP:0000519 hydronephrosis IDA N RGD:2293631|PMID:18523158 20080616 RGD 2293842 Kiddil3 Kidney dilation QTL 3 qtl MP:0004194 abnormal kidney pelvis morphology IDA N RGD:2293631|PMID:18523158 20080616 RGD 2293843 Kiddil6 Kidney dilation QTL 6 qtl MP:0000519 hydronephrosis IDA N RGD:2293631|PMID:18523158 20080616 RGD 2293843 Kiddil6 Kidney dilation QTL 6 qtl MP:0004194 abnormal kidney pelvis morphology IDA N RGD:2293631|PMID:18523158 20080616 RGD 2293844 Kiddil7 Kidney dilation QTL 7 qtl MP:0000519 hydronephrosis IDA N RGD:2293631|PMID:18523158 20080616 RGD 2293844 Kiddil7 Kidney dilation QTL 7 qtl MP:0004194 abnormal kidney pelvis morphology IDA N RGD:2293631|PMID:18523158 20080616 RGD 2293844 Kiddil7 Kidney dilation QTL 7 qtl MP:0005161 hematuria IDA N RGD:2293631|PMID:18523158 20080616 RGD 2298475 Eau6 Experimental allergic uveoretinitis QTL 6 qtl MP:0001851 eye inflammation IDA N RGD:2296064|PMID:18453595 20080702 RGD 2298475 Eau6 Experimental allergic uveoretinitis QTL 6 qtl MP:0004822 decreased susceptibility to experimental autoimmune uveoretinitis IDA N RGD:2296064|PMID:18453595 20080702 RGD decreased susceptibility due to LEW allele 2298475 Eau6 Experimental allergic uveoretinitis QTL 6 qtl MP:0005197 abnormal uvea morphology IDA N RGD:2296064|PMID:18453595 20080702 RGD induced by peptide R16 2298477 Eau4 Experimental allergic uveoretinitis QTL 4 qtl MP:0001851 eye inflammation IDA N RGD:2296064|PMID:18453595 20080702 RGD 2298477 Eau4 Experimental allergic uveoretinitis QTL 4 qtl MP:0004821 increased susceptibility to experimental autoimmune uveoretinitis IDA N RGD:2296064|PMID:18453595 20080702 RGD induced by peptide R16 2298477 Eau4 Experimental allergic uveoretinitis QTL 4 qtl MP:0005197 abnormal uvea morphology IDA N RGD:2296064|PMID:18453595 20080702 RGD induced by peptide R16 2298478 Eau8 Experimental allergic uveoretinitis QTL 8 qtl MP:0001851 eye inflammation IDA N RGD:2296064|PMID:18453595 20080702 RGD 2298478 Eau8 Experimental allergic uveoretinitis QTL 8 qtl MP:0004822 decreased susceptibility to experimental autoimmune uveoretinitis IDA N RGD:2296064|PMID:18453595 20080702 RGD 2298478 Eau8 Experimental allergic uveoretinitis QTL 8 qtl MP:0005197 abnormal uvea morphology IDA N RGD:2296064|PMID:18453595 20080702 RGD induced by peptide R16 2298479 Eau5 Experimental allergic uveoretinitis QTL 5 qtl MP:0001851 eye inflammation IDA N RGD:2296064|PMID:18453595 20080702 RGD 2298479 Eau5 Experimental allergic uveoretinitis QTL 5 qtl MP:0004821 increased susceptibility to experimental autoimmune uveoretinitis susceptibility IDA N RGD:2296064|PMID:18453595 20080702 RGD due to L allele 2298479 Eau5 Experimental allergic uveoretinitis QTL 5 qtl MP:0004822 decreased susceptibility to experimental autoimmune uveoretinitis IDA N RGD:2296064|PMID:18453595 20080702 RGD decreased susceptibility due to F allele 2298479 Eau5 Experimental allergic uveoretinitis QTL 5 qtl MP:0005197 abnormal uvea morphology IDA N RGD:2296064|PMID:18453595 20080702 RGD induced by peptide R16 2298480 Eau7 Experimental allergic uveoretinitis QTL 7 qtl MP:0001851 eye inflammation IDA N RGD:2296064|PMID:18453595 20080702 RGD 2298480 Eau7 Experimental allergic uveoretinitis QTL 7 qtl MP:0004821 increased susceptibility to experimental autoimmune uveoretinitis susceptibility IDA N RGD:2296064|PMID:18453595 20080702 RGD due to L allele 2298480 Eau7 Experimental allergic uveoretinitis QTL 7 qtl MP:0004822 decreased susceptibility to experimental autoimmune uveoretinitis IDA N RGD:2296064|PMID:18453595 20080702 RGD decreased susceptibility due to F allele 2298480 Eau7 Experimental allergic uveoretinitis QTL 7 qtl MP:0005197 abnormal uvea morphology IDA N RGD:2296064|PMID:18453595 20080702 RGD induced by peptide R16 2298481 Eau9 Experimental allergic uveoretinitis QTL 9 qtl MP:0001851 eye inflammation IDA N RGD:2296064|PMID:18453595 20080702 RGD 2298481 Eau9 Experimental allergic uveoretinitis QTL 9 qtl MP:0004821 increased susceptibility to experimental autoimmune uveoretinitis susceptibility IDA N RGD:2296064|PMID:18453595 20080702 RGD due to L allele 2298481 Eau9 Experimental allergic uveoretinitis QTL 9 qtl MP:0004822 decreased susceptibility to experimental autoimmune uveoretinitis IDA N RGD:2296064|PMID:18453595 20080702 RGD decreased susceptibility due to F allele 2298481 Eau9 Experimental allergic uveoretinitis QTL 9 qtl MP:0005197 abnormal uvea morphology IDA N RGD:2296064|PMID:18453595 20080702 RGD induced by peptide R16 2298494 Kini:DA,PVG-G10 strain MP:0001263 weight loss MODEL: induced IAGP N RGD:2293859|PMID:16624898 20080703 RGD induced by MOG 2298494 Kini:DA,PVG-G10 strain MP:0006082 CNS inflammation induced IAGP N RGD:2293859|PMID:16624898 20080703 RGD induced by MOG 2298495 Eae23 Experimental allergic encephalomyelitis QTL 23 qtl MP:0001263 weight loss IDA N RGD:2293859|PMID:16624898 20080703 RGD induced by MOG 2298495 Eae23 Experimental allergic encephalomyelitis QTL 23 qtl MP:0006082 CNS inflammation IDA N RGD:2293859|PMID:16624898 20080703 RGD induced by MOG 2298498 W/Gaox strain MP:0002725 abnormal vein morphology IAGP N RGD:2298497|PMID:18211296 20080703 RGD compared to wild type Wistar 2298542 Neuinf11 Neuroinflammation QTL 11 qtl MP:0005042 abnormal level of surface class II molecules IDA N RGD:2311085|PMID:19525015 20090807 RGD 2298544 Neuinf9 Neuroinflammation QTL 9 qtl MP:0005042 abnormal level of surface class II molecules IDA N RGD:2311085|PMID:19525015 20090807 RGD 2298545 Neuinf8 Neuroinflammation QTL 8 qtl MP:0005042 abnormal level of surface class II molecules IDA N RGD:2311085|PMID:19525015 20090807 RGD 2298546 Neuinf4 Neuroinflammation QTL 4 qtl MP:0005042 abnormal level of surface class II molecules IDA N RGD:2311085|PMID:19525015 20090807 RGD 2298547 Neuinf5 Neuroinflammation QTL 5 qtl MP:0005042 abnormal level of surface class II molecules IDA N RGD:2311085|PMID:19525015 20090807 RGD 2298548 Neuinf7 Neuroinflammation QTL 7 qtl MP:0005042 abnormal level of surface class II molecules IDA N RGD:2311085|PMID:19525015 20090807 RGD 2298549 Neuinf12 Neuroinflammation QTL 12 qtl MP:0005042 abnormal level of surface class II molecules IDA N RGD:2311085|PMID:19525015 20090807 RGD 2298550 Neuinf6 Neuroinflammation QTL 6 qtl MP:0005042 abnormal level of surface class II molecules IDA N RGD:2311085|PMID:19525015 20090807 RGD 2298551 Neuinf10 Neuroinflammation QTL 10 qtl MP:0005042 abnormal level of surface class II molecules IDA N RGD:2311085|PMID:19525015 20090807 RGD 2298772 WFfzHsd Fuzzy rat strain MP:0009930 fuzzy hair IAGP N RGD:150520038|PMID:20201958 20211022 RGD 2298772 WFfzHsd Fuzzy rat strain MP:0009930 fuzzy hair IAGP N RGD:625461|PMID:12195039 20080723 RGD 2299160 Iddm35 Insulin dependent diabetes mellitus QTL 35 qtl MP:0005559 increased circulating glucose level IDA N RGD:2303106|PMID:19168599 20111109 RGD 2299161 Iddm33 Insulin dependent diabetes mellitus QTL 33 qtl MP:0005559 increased circulating glucose level IDA N RGD:2303106|PMID:19168599 20111109 RGD 2299162 Iddm32 Insulin dependent diabetes mellitus QTL 32 qtl MP:0005559 increased circulating glucose level IDA N RGD:2303106|PMID:19168599 20111109 RGD 2299163 Iddm34 Insulin dependent diabetes mellitus QTL 34 qtl MP:0005559 increased circulating glucose level IDA N RGD:2303106|PMID:19168599 20111109 RGD 2300002 Iddm36 Insulin dependent diabetes mellitus QTL 36 qtl MP:0005559 increased circulating glucose level IDA N RGD:2303106|PMID:19168599 20111108 RGD 2300018 SHRSP.ZUC-(D5Rat4-D5Rat36)/IzmDmcr strain MP:0001260 increased body weight IAGP N RGD:2300017|PMID:14756693 20080829 RGD as compared to SHRSP/Izm 2300018 SHRSP.ZUC-(D5Rat4-D5Rat36)/IzmDmcr strain MP:0001552 increased circulating triglyceride level IAGP N RGD:2300017|PMID:14756693 20080829 RGD compared to SHRSP/Izm and Slc:ZUC-Leprfa 2300018 SHRSP.ZUC-(D5Rat4-D5Rat36)/IzmDmcr strain MP:0002079 increased circulating insulin level IAGP N RGD:2300017|PMID:14756693 20080829 RGD as compared to SHRSP/Izm 2300018 SHRSP.ZUC-(D5Rat4-D5Rat36)/IzmDmcr strain MP:0002981 increased liver weight IAGP N RGD:2300017|PMID:14756693 20200113 RGD compared to SHRSP/Izm 2300018 SHRSP.ZUC-(D5Rat4-D5Rat36)/IzmDmcr strain MP:0005178 increased circulating cholesterol level IAGP N RGD:2300017|PMID:14756693 20080829 RGD as compared to SHRSP/Izm 2300018 SHRSP.ZUC-(D5Rat4-D5Rat36)/IzmDmcr strain MP:0005559 increased circulating glucose level IAGP N RGD:2300017|PMID:14756693 20080829 RGD as compared to SHRSP/Izm 2300018 SHRSP.ZUC-(D5Rat4-D5Rat36)/IzmDmcr strain MP:0005669 increased circulating leptin level IAGP N RGD:2300017|PMID:14756693 20080829 RGD compared to SHRSP/Izm and Slc:ZUC-Leprfa 2300018 SHRSP.ZUC-(D5Rat4-D5Rat36)/IzmDmcr strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:2300017|PMID:14756693 20080829 RGD as compared to SHRSP/Izm 2300018 SHRSP.ZUC-(D5Rat4-D5Rat36)/IzmDmcr strain MP:0009288 increased epididymal fat pad weight IAGP N RGD:2300017|PMID:14756693 20200113 RGD compared to SHRSP/Izm 2300018 SHRSP.ZUC-(D5Rat4-D5Rat36)/IzmDmcr strain MP:0009298 increased mesenteric fat pad weight IAGP N RGD:2300017|PMID:14756693 20200113 RGD compared to SHRSP/Izm 2300018 SHRSP.ZUC-(D5Rat4-D5Rat36)/IzmDmcr strain MP:0011758 renal ischemia IAGP N RGD:2300016|PMID:18712058 20080829 RGD 2300157 Bmd66 Bone mineral density QTL 66 qtl MP:0010119 abnormal bone mineral density IDA N RGD:2300109|PMID:18707222 20111101 RGD 2300159 Bmd61 Bone mineral density QTL 61 qtl MP:0010119 abnormal bone mineral density IDA N RGD:2300109|PMID:18707222 20111101 RGD 2300161 Bmd43 Bone mineral density QTL 43 qtl MP:0010119 abnormal bone mineral density IDA N RGD:2300109|PMID:18707222 20111101 RGD 2300163 Bmd64 Bone mineral density QTL 64 qtl MP:0010119 abnormal bone mineral density IDA N RGD:2300109|PMID:18707222 20111101 RGD 2300164 Bmd44 Bone mineral density QTL 44 qtl MP:0010119 abnormal bone mineral density IDA N RGD:2300109|PMID:18707222 20111101 RGD 2300165 Bmd49 Bone mineral density QTL 49 qtl MP:0010119 abnormal bone mineral density IDA N RGD:2300109|PMID:18707222 20111101 RGD 2300167 Bmd63 Bone mineral density QTL 63 qtl MP:0010119 abnormal bone mineral density IDA N RGD:2300109|PMID:18707222 20111101 RGD 2300168 Bmd47 Bone mineral density QTL 47 qtl MP:0010119 abnormal bone mineral density IDA N RGD:2300109|PMID:18707222 20111101 RGD 2300170 Bmd45 Bone mineral density QTL 45 qtl MP:0010119 abnormal bone mineral density IDA N RGD:2300109|PMID:18707222 20111101 RGD 2300171 Bmd58 Bone mineral density QTL 58 qtl MP:0010119 abnormal bone mineral density IDA N RGD:2300109|PMID:18707222 20111101 RGD 2300172 Bmd57 Bone mineral density QTL 57 qtl MP:0010119 abnormal bone mineral density IDA N RGD:2300109|PMID:18707222 20111101 RGD 2300173 Bmd62 Bone mineral density QTL 62 qtl MP:0010119 abnormal bone mineral density IDA N RGD:2300109|PMID:18707222 20111101 RGD 2300174 Bmd42 Bone mineral density QTL 42 qtl MP:0010119 abnormal bone mineral density IDA N RGD:2300109|PMID:18707222 20111101 RGD 2300175 Bmd40 Bone mineral density QTL 40 qtl MP:0010119 abnormal bone mineral density IDA N RGD:2300109|PMID:18707222 20111101 RGD 2300176 Bmd51 Bone mineral density QTL 51 qtl MP:0010119 abnormal bone mineral density IDA N RGD:2300109|PMID:18707222 20111101 RGD 2300177 Bmd65 Bone mineral density QTL 65 qtl MP:0010119 abnormal bone mineral density IDA N RGD:2300109|PMID:18707222 20111101 RGD 2300178 Bmd54 Bone mineral density QTL 54 qtl MP:0010119 abnormal bone mineral density IDA N RGD:2300109|PMID:18707222 20111101 RGD 2300179 Bmd50 Bone mineral density QTL 50 qtl MP:0010119 abnormal bone mineral density IDA N RGD:2300109|PMID:18707222 20111101 RGD 2300180 Bmd67 Bone mineral density QTL 67 qtl MP:0010119 abnormal bone mineral density IDA N RGD:2300109|PMID:18707222 20111101 RGD 2300181 Bmd55 Bone mineral density QTL 55 qtl MP:0010119 abnormal bone mineral density IDA N RGD:2300109|PMID:18707222 20111101 RGD 2300182 Bmd56 Bone mineral density QTL 56 qtl MP:0010119 abnormal bone mineral density IDA N RGD:2300109|PMID:18707222 20111101 RGD 2300183 Bmd60 Bone mineral density QTL 60 qtl MP:0010119 abnormal bone mineral density IDA N RGD:2300109|PMID:18707222 20111101 RGD 2300184 Bmd53 Bone mineral density QTL 53 qtl MP:0010119 abnormal bone mineral density IDA N RGD:2300109|PMID:18707222 20111101 RGD 2300185 Bmd46 Bone mineral density QTL 46 qtl MP:0010119 abnormal bone mineral density IDA N RGD:2300109|PMID:18707222 20111101 RGD 2300186 Bmd59 Bone mineral density QTL 59 qtl MP:0010119 abnormal bone mineral density IDA N RGD:2300109|PMID:18707222 20111101 RGD 2300187 Bmd41 Bone mineral density QTL 41 qtl MP:0010119 abnormal bone mineral density IDA N RGD:2300109|PMID:18707222 20111101 RGD 2300188 Bmd68 Bone mineral density QTL 68 qtl MP:0010119 abnormal bone mineral density IDA N RGD:2300109|PMID:18707222 20111101 RGD 2300189 Bmd48 Bone mineral density QTL 48 qtl MP:0010119 abnormal bone mineral density IDA N RGD:2300109|PMID:18707222 20111101 RGD 2300190 Bmd52 Bone mineral density QTL 52 qtl MP:0010119 abnormal bone mineral density IDA N RGD:2300109|PMID:18707222 20111101 RGD 2300195 EHC.BN-(D14Rat43-D14Rat132)/Kyu strain MP:0005179 decreased circulating cholesterol level induced IAGP XCO:0000246, XCO:0000025 N RGD:2300117|PMID:18753676 20080908 RGD compared to ExHC/Seac 2300197 Scl59 Serum cholesterol level QTL 59 qtl MP:0005179 decreased circulating cholesterol level IDA N RGD:2300117|PMID:18753676 20080908 RGD cholesterol containing diet 2300215 SHR.BN-(D10Mgh3-D10Rat85)/Ipcv strain MP:0009356 decreased liver triglyceride level induced IMP XCO:0000246 N RGD:1643359|PMID:18071061 20080909 RGD compared to SHR.BN-(D10Mgh3-Srebf1)/Ipcv 2300215 SHR.BN-(D10Mgh3-D10Rat85)/Ipcv strain MP:0010026 decreased liver cholesterol level induced IMP XCO:0000246 N RGD:1643359|PMID:18071061 20080909 RGD compared to SHR.BN-(D10Mgh3-Srebf1)/Ipcv 2300216 SHR-Tg(PEPCK-SREBF1)1Ipcv strain MP:0010027 increased liver cholesterol level induced IMP XCO:0000246 N RGD:1643359|PMID:18071061 20090929 RGD compared to SHR/OlaIpcv; 2300217 SHR.BN-(D10Mgh3-Srebf1)/Ipcv strain MP:0010027 increased liver cholesterol level induced IMP XCO:0000246 N RGD:1643359|PMID:18071061 20080909 RGD compared to SHR/OlaIpcv, SHR.BN-(D10Mgh3-D10Rat85)/Ipcv; 2300218 Hpcl2 Hepatic cholesterol level QTL 2 qtl MP:0003982 increased cholesterol level susceptibility IDA N RGD:1643359|PMID:18071061 20080909 RGD 2300324 Fetw1 Fetal weight QTL 1 qtl MP:0004197 abnormal fetal growth/weight/body size IDA N RGD:2300320|PMID:16914718 20080912 RGD 2300326 Plaw1 Placental weight QTL 1 qtl MP:0004921 decreased placenta weight IDA N RGD:2300320|PMID:16914718 20080912 RGD 2301 Cd36 CD36 molecule gene MP:0002702 decreased circulating free fatty acids level IMP N RGD:68930|PMID:11175782 20070321 RGD 2301 Cd36 CD36 molecule gene MP:0002702 decreased circulating free fatty acids level IMP XCO:0000244 N RGD:1600636|PMID:14640889 20070322 RGD 2301 Cd36 CD36 molecule gene MP:0004876 decreased mean systemic arterial blood pressure IMP N RGD:6893560|PMID:22128087 20120907 RGD 2301 Cd36 CD36 molecule gene MP:0006237 abnormal choroid vasculature morphology IAGP N RGD:2307226|PMID:18288886 20090522 RGD 2301 Cd36 CD36 molecule gene MP:0008032 abnormal lipolysis IAGP N RGD:619666|PMID:9916795 19990101 RGD 2301 Cd36 CD36 molecule gene MP:0008515 thin retina outer nuclear layer IAGP N RGD:2307226|PMID:18288886 20090522 RGD 2301 Cd36 CD36 molecule gene MP:0031001 increased glycogen synthesis IMP N RGD:1600636|PMID:14640889 20070322 RGD compared to SHR/OlaIpcv 2301246 SS.LEW-(D3Rat61-D3Wox1)/Ayd strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:7421500|PMID:23814039 20131211 RGD compared to parental SS/Jr 2301315 LE/Orl Long-Evans/Cryptorchid strain MP:0001146 abnormal testis morphology IAGP N RGD:2301309|PMID:9334653 20081006 RGD 2301315 LE/Orl Long-Evans/Cryptorchid strain MP:0002990 short ureter IAGP N RGD:2301308|PMID:16952701 20081006 RGD 2301315 LE/Orl Long-Evans/Cryptorchid strain MP:0005149 abnormal gubernaculum morphology IAGP N RGD:2301308|PMID:16952701 20170710 RGD 2301315 LE/Orl Long-Evans/Cryptorchid strain MP:0005149 abnormal gubernaculum morphology MODEL: spontaneous IAGP N RGD:2301310|PMID:9016404 20081006 RGD 2301330 KH strain MP:0001156 abnormal spermatogenesis IAGP N RGD:2301322|PMID:6140035 20081006 RGD 2301330 KH strain MP:0001925 male infertility IAGP N RGD:2301322|PMID:6140035 20081006 RGD 2301330 KH strain MP:0001940 testis hypoplasia IAGP N RGD:2301322|PMID:6140035 20081006 RGD 2301330 KH strain MP:0002286 cryptorchism IAGP N RGD:2301322|PMID:6140035 20081006 RGD 2301330 KH strain MP:0002784 abnormal Sertoli cell morphology IAGP N RGD:2301322|PMID:6140035 20081006 RGD 2301330 KH strain MP:0011410 ectopic testis IAGP N RGD:2301322|PMID:6140035 20180504 RGD 2301367 SHRSP.WKY-(D2Mit5-D2Rat133)/Gcrc strain MP:0000231 hypertension susceptibility IAGP N RGD:2301356|PMID:18819818 20200109 RGD similar to SHRSP/Gcrc; MMO:0000015 2301368 SHRSP.WKY-(D2Wox15-D2Rat133)/Gcrc strain MP:0000231 hypertension susceptibility IAGP N RGD:2301356|PMID:18819818 20200109 RGD similar to SHRSP/Gcrc; MMO:0000015 2301369 SHRSP.WKY-(D2Rat132-D2Rat53)/Gcrc strain MP:0000231 hypertension susceptibility IAGP N RGD:2301356|PMID:18819818 20200109 RGD similar to SHRSP/Gcrc; MMO:0000015 2301370 SHRSP.WKY-(D2Wox9-D2Rat231)/Gcrc strain MP:0000231 hypertension susceptibility IAGP XCO:0000164 N RGD:2301356|PMID:18819818 20200109 RGD similar to SHRSP/Gcrc; MMO:0000015 2301370 SHRSP.WKY-(D2Wox9-D2Rat231)/Gcrc strain MP:0006264 decreased systemic arterial systolic blood pressure susceptibility IAGP N RGD:1643008|PMID:17938382 20191210 RGD compared to hypertensive strain SHRSP/Gcrc 2301370 SHRSP.WKY-(D2Wox9-D2Rat231)/Gcrc strain MP:0012046 decreased susceptibility to hypertension susceptibility IAGP N RGD:1643008|PMID:17938382 20191210 RGD compared to hypertensive strain SHRSP/Gcrc 2301371 SHRSP.WKY-(D2Mit21-D2Rat157)/Gcrc strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:1643008|PMID:17938382 20081009 RGD compared to SHRSP/Gcrc 2301371 SHRSP.WKY-(D2Mit21-D2Rat157)/Gcrc strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:2301356|PMID:18819818 20200414 RGD compared to SHRSP/Gcrc; MMO:0000015 2301371 SHRSP.WKY-(D2Mit21-D2Rat157)/Gcrc strain MP:0006264 decreased systemic arterial systolic blood pressure induced IAGP XCO:0000164 N RGD:2301356|PMID:18819818 20200109 RGD compared to SHRSP/Gcrc; MMO:0000015 2301371 SHRSP.WKY-(D2Mit21-D2Rat157)/Gcrc strain MP:0006264 decreased systemic arterial systolic blood pressure susceptibility IAGP XCO:0000164 N RGD:1643008|PMID:17938382 20081009 RGD as compared to SHRSP/Gcrc 2301371 SHRSP.WKY-(D2Mit21-D2Rat157)/Gcrc strain MP:0012046 decreased susceptibility to hypertension susceptibility IAGP N RGD:1643008|PMID:17938382 20191210 RGD compared to hypertensive strain SHRSP/Gcrc 2301381 SS.LEW-(D18Chm41-D18Rat92)/Ayd strain MP:0001260 increased body weight induced IAGP XCO:0000022 N RGD:2301185|PMID:18806617 20100611 RGD compared to SS/Jr 2301381 SS.LEW-(D18Chm41-D18Rat92)/Ayd strain MP:0002625 heart left ventricle hypertrophy induced IAGP XCO:0000022 N RGD:2301185|PMID:18806617 20100611 RGD 2301381 SS.LEW-(D18Chm41-D18Rat92)/Ayd strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:2301185|PMID:18806617 20100611 RGD compared to SS/Jr 2301381 SS.LEW-(D18Chm41-D18Rat92)/Ayd strain MP:0005599 increased cardiac muscle contractility induced IAGP XCO:0000022 N RGD:2301185|PMID:18806617 20100611 RGD compared to LEW 2301381 SS.LEW-(D18Chm41-D18Rat92)/Ayd strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:8657131|PMID:23442991 20210113 RGD compared to SS/JrHsd 2301385 SS.LEW-(D18Rat29-D18Rat55)/Ayd strain MP:0001260 increased body weight induced IAGP XCO:0000022 N RGD:2301185|PMID:18806617 20100611 RGD compared to SS/Jr 2301385 SS.LEW-(D18Rat29-D18Rat55)/Ayd strain MP:0002625 heart left ventricle hypertrophy induced IAGP XCO:0000022 N RGD:2301185|PMID:18806617 20100611 RGD 2301385 SS.LEW-(D18Rat29-D18Rat55)/Ayd strain MP:0002626 increased heart rate induced IAGP XCO:0000022 N RGD:2301185|PMID:18806617 20191205 RGD compared to SS/Jr 2301385 SS.LEW-(D18Rat29-D18Rat55)/Ayd strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:2301185|PMID:18806617 20100611 RGD compared to SS/Jr 2301385 SS.LEW-(D18Rat29-D18Rat55)/Ayd strain MP:0005599 increased cardiac muscle contractility induced IAGP XCO:0000022 N RGD:2301185|PMID:18806617 20100611 RGD compared to LEW 2301386 SS.LEW-(D18Rat61-D18Rat45)/Ayd strain MP:0002843 decreased systemic arterial blood pressure IAGP N RGD:8657072|PMID:21602714 20140530 RGD as compared to parental SS/Jr 2301386 SS.LEW-(D18Rat61-D18Rat45)/Ayd strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:8657131|PMID:23442991 20210113 RGD compared to SS/JrHsd 2301398 Kidm38 Kidney mass QTL 38 qtl MP:0002707 abnormal kidney weight IAGP N RGD:1599557|PMID:17143582 20081029 RGD 2301400 Cm68 Cardiac mass QTL 68 qtl MP:0004857 abnormal heart weight IAGP N RGD:1599557|PMID:17143582 20081029 RGD 2301402 Bp316 Blood pressure QTL 316 qtl MP:0000230 abnormal systemic arterial blood pressure IAGP N RGD:1599557|PMID:17143582 20081029 RGD 2301404 Bp321 Blood pressure QTL 321 qtl MP:0000230 abnormal systemic arterial blood pressure IAGP N RGD:1599557|PMID:17143582 20081029 RGD 2301405 Cm69 Cardiac mass QTL 69 qtl MP:0004857 abnormal heart weight IAGP N RGD:1599557|PMID:17143582 20081029 RGD 2301406 Kidm39 Kidney mass QTL 39 qtl MP:0002707 abnormal kidney weight IAGP N RGD:1599557|PMID:17143582 20081029 RGD 2301408 Kidm36 Kidney mass QTL 36 qtl MP:0002707 abnormal kidney weight IAGP N RGD:1599557|PMID:17143582 20081029 RGD 2301409 Cm70 Cardiac mass QTL 70 qtl MP:0004857 abnormal heart weight IAGP N RGD:1599557|PMID:17143582 20081029 RGD 2301410 Bp317 Blood pressure QTL 317 qtl MP:0000230 abnormal systemic arterial blood pressure IAGP N RGD:1599557|PMID:17143582 20081029 RGD 2301411 Bp320 Blood pressure QTL 320 qtl MP:0000230 abnormal systemic arterial blood pressure IAGP N RGD:1599557|PMID:17143582 20081029 RGD 2301412 Kidm40 Kidney mass QTL 40 qtl MP:0002707 abnormal kidney weight IAGP N RGD:1599557|PMID:17143582 20081029 RGD 2301413 Bp318 Blood pressure QTL 318 qtl MP:0000230 abnormal systemic arterial blood pressure IAGP N RGD:1599557|PMID:17143582 20081029 RGD 2301414 Kidm37 Kidney mass QTL 37 qtl MP:0002707 abnormal kidney weight IAGP N RGD:1599557|PMID:17143582 20081029 RGD 2301415 Cm67 Cardiac mass QTL 67 qtl MP:0002845 abnormal aortic weight IDA N RGD:1599557|PMID:17143582 20081029 RGD 2301415 Cm67 Cardiac mass QTL 67 qtl MP:0003918 decreased kidney weight IDA N RGD:1599557|PMID:17143582 20081029 RGD 2301415 Cm67 Cardiac mass QTL 67 qtl MP:0004857 abnormal heart weight IAGP N RGD:1599557|PMID:17143582 20081029 RGD 2301416 Bp315 Blood pressure QTL 315 qtl MP:0000230 abnormal systemic arterial blood pressure IAGP N RGD:1599557|PMID:17143582 20081029 RGD 2301417 Bp319 Blood pressure QTL 319 qtl MP:0000230 abnormal systemic arterial blood pressure IAGP N RGD:1599557|PMID:17143582 20081029 RGD 2301937 BN.GH-(D18Rat41-D18Mgh4)/Mcwi strain MP:0004184 abnormal baroreceptor physiology IAGP N RGD:2301936|PMID:18925692 20081113 RGD 2301939 BN.GH-(D2Rat22-D2Mgh11)/Mcwi strain MP:0004184 abnormal baroreceptor physiology IAGP N RGD:2301936|PMID:18925692 20191125 RGD 2301962 Cm72 Cardiac mass QTL 72 qtl MP:0002625 heart left ventricle hypertrophy IDA N RGD:2301936|PMID:18925692 20081114 RGD 2301964 Bp323 Blood pressure QTL 323 qtl MP:0006144 increased systemic arterial systolic blood pressure IDA N RGD:2301936|PMID:18925692 20081114 RGD 2301966 Bp322 Blood pressure QTL 322 qtl MP:0006144 increased systemic arterial systolic blood pressure IDA N RGD:2301936|PMID:18925692 20081114 RGD 2301967 Cm73 Cardiac mass QTL 73 qtl MP:0002625 heart left ventricle hypertrophy IDA N RGD:2301936|PMID:18925692 20081114 RGD 2301969 Bp324 Blood pressure QTL 324 qtl MP:0006144 increased systemic arterial systolic blood pressure IDA N RGD:2301936|PMID:18925692 20081114 RGD 2301970 Bw81 Body weight QTL 81 qtl MP:0001260 increased body weight IDA N RGD:2301936|PMID:18925692 20081114 RGD 2301971 Cm71 Cardiac mass QTL 71 qtl MP:0002625 heart left ventricle hypertrophy IDA N RGD:2301936|PMID:18925692 20081114 RGD 2301972 Bp325 Blood pressure QTL 325 qtl MP:0006144 increased systemic arterial systolic blood pressure IDA N RGD:2301936|PMID:18925692 20081114 RGD 2302038 Pia31 Pristane induced arthritis QTL 31 qtl MP:0002936 joint swelling IDA N RGD:2302026|PMID:14674011 20081117 RGD pristane induced 2302038 Pia31 Pristane induced arthritis QTL 31 qtl MP:0003724 increased susceptibility to induced arthritis IDA N RGD:2302026|PMID:14674011 20081117 RGD pristane induced 2302040 Pia35 Pristane induced arthritis QTL 35 qtl MP:0002936 joint swelling IDA N RGD:2302026|PMID:14674011 20081117 RGD pristane induced 2302040 Pia35 Pristane induced arthritis QTL 35 qtl MP:0003724 increased susceptibility to induced arthritis IDA N RGD:2302026|PMID:14674011 20081117 RGD pristane induced 2302042 Pia38 Pristane induced arthritis QTL 38 qtl MP:0002936 joint swelling IDA N RGD:2302026|PMID:14674011 20081117 RGD pristane induced 2302042 Pia38 Pristane induced arthritis QTL 38 qtl MP:0003724 increased susceptibility to induced arthritis severity IDA N RGD:2302026|PMID:14674011 20081117 RGD pristane induced 2302043 Pia27 Pristane induced arthritis QTL 27 qtl MP:0002936 joint swelling no_association IDA N RGD:2302026|PMID:14674011 20081118 RGD pristane induced 2302043 Pia27 Pristane induced arthritis QTL 27 qtl MP:0003724 increased susceptibility to induced arthritis no_association IDA N RGD:2302026|PMID:14674011 20081118 RGD pristane induced 2302045 Pia39 Pristane induced arthritis QTL 39 qtl MP:0002936 joint swelling IDA N RGD:2302026|PMID:14674011 20081117 RGD pristane induced 2302045 Pia39 Pristane induced arthritis QTL 39 qtl MP:0003724 increased susceptibility to induced arthritis IDA N RGD:2302026|PMID:14674011 20081117 RGD pristane induced 2302047 Pia34 Pristane induced arthritis QTL 34 qtl MP:0002936 joint swelling IDA N RGD:2302026|PMID:14674011 20081117 RGD pristane induced 2302047 Pia34 Pristane induced arthritis QTL 34 qtl MP:0003724 increased susceptibility to induced arthritis IDA N RGD:2302026|PMID:14674011 20081117 RGD pristane induced 2302049 Pia32 Pristane induced arthritis QTL 32 qtl MP:0002936 joint swelling IDA N RGD:2302026|PMID:14674011 20081117 RGD pristane induced 2302049 Pia32 Pristane induced arthritis QTL 32 qtl MP:0003724 increased susceptibility to induced arthritis IDA N RGD:2302026|PMID:14674011 20081117 RGD pristane induced 2302051 Pia28 Pristane induced arthritis QTL 28 qtl MP:0002936 joint swelling IDA N RGD:2302026|PMID:14674011 20081117 RGD pristane induced 2302051 Pia28 Pristane induced arthritis QTL 28 qtl MP:0003724 increased susceptibility to induced arthritis IDA N RGD:2302026|PMID:14674011 20081117 RGD pristane induced 2302053 Pia33 Pristane induced arthritis QTL 33 qtl MP:0002936 joint swelling IDA N RGD:2302026|PMID:14674011 20081117 RGD pristane induced 2302053 Pia33 Pristane induced arthritis QTL 33 qtl MP:0003724 increased susceptibility to induced arthritis IDA N RGD:2302026|PMID:14674011 20081117 RGD pristane induced 2302055 Pia30 Pristane induced arthritis QTL 30 qtl MP:0002936 joint swelling IDA N RGD:2302026|PMID:14674011 20081117 RGD pristane induced 2302055 Pia30 Pristane induced arthritis QTL 30 qtl MP:0003724 increased susceptibility to induced arthritis IDA N RGD:2302026|PMID:14674011 20081117 RGD pristane induced 2302057 Pia29 Pristane induced arthritis QTL 29 qtl MP:0002936 joint swelling no_association IDA N RGD:2302026|PMID:14674011 20081118 RGD pristane induced 2302057 Pia29 Pristane induced arthritis QTL 29 qtl MP:0003724 increased susceptibility to induced arthritis no_association IDA N RGD:2302026|PMID:14674011 20081118 RGD pristane induced 2302059 Pia36 Pristane induced arthritis QTL 36 qtl MP:0002936 joint swelling IDA N RGD:2302026|PMID:14674011 20081117 RGD pristane induced 2302059 Pia36 Pristane induced arthritis QTL 36 qtl MP:0003724 increased susceptibility to induced arthritis IDA N RGD:2302026|PMID:14674011 20081117 RGD pristane induced 2302060 Pia37 Pristane induced arthritis QTL 37 qtl MP:0002936 joint swelling IDA N RGD:2302026|PMID:14674011 20081117 RGD pristane induced 2302060 Pia37 Pristane induced arthritis QTL 37 qtl MP:0003724 increased susceptibility to induced arthritis IDA N RGD:2302026|PMID:14674011 20081117 RGD pristane induced 2302081 DA.E3-(D11Got79-D11Wox5)/Rhd strain MP:0002493 increased IgG level IAGP N RGD:2302066|PMID:18779593 20210930 RGD compared to DA 2302081 DA.E3-(D11Got79-D11Wox5)/Rhd strain MP:0002494 increased IgM level IAGP N RGD:2302066|PMID:18779593 20210930 RGD compared to DA 2302081 DA.E3-(D11Got79-D11Wox5)/Rhd strain MP:0002497 increased IgE level IAGP N RGD:2302066|PMID:18779593 20210930 RGD compared to DA 2302081 DA.E3-(D11Got79-D11Wox5)/Rhd strain MP:0005011 increased eosinophil cell number induces IAGP XCO:0000906, XCO:0000908 N RGD:2302066|PMID:18779593 20210930 RGD compared to DA 2302081 DA.E3-(D11Got79-D11Wox5)/Rhd strain MP:0031055 bronchitis induces IAGP XCO:0000906, XCO:0000908 N RGD:2302066|PMID:18779593 20210929 RGD compared to DA 2302106 SHRSP.WKY-(D1Rat44-D1Arb21)/Izm strain MP:0002843 decreased systemic arterial blood pressure susceptibility IAGP XCO:0000164 N RGD:2302104|PMID:18971556 20081119 RGD compared to SHRSP/Izm; MMO:0000031 2302106 SHRSP.WKY-(D1Rat44-D1Arb21)/Izm strain MP:0006059 decreased susceptibility to ischemic brain injury IAGP XCO:0000164 N RGD:2302104|PMID:18971556 20081119 RGD compared to SHRSP/Izm; MMO:0000496 2302108 SHRSP.WKY-(D1Mgh5-D1Wox29)/Izm strain MP:0002843 decreased systemic arterial blood pressure susceptibility IAGP XCO:0000164 N RGD:2302104|PMID:18971556 20081119 RGD compared to SHRSP/Izm; MMO:0000031 2302108 SHRSP.WKY-(D1Mgh5-D1Wox29)/Izm strain MP:0004217 salt-sensitive hypertension susceptibility IAGP XCO:0000164 N RGD:2302104|PMID:18971556 20081119 RGD MMO:0000031 2302108 SHRSP.WKY-(D1Mgh5-D1Wox29)/Izm strain MP:0006059 decreased susceptibility to ischemic brain injury IAGP XCO:0000164 N RGD:2302104|PMID:18971556 20200110 RGD compared to SHRSP/Izm; MMO:0000496 2302109 SHRSP.WKY-(D1Mgh5-D1Rat44)/Izm strain MP:0002843 decreased systemic arterial blood pressure susceptibility IAGP XCO:0000164 N RGD:2302104|PMID:18971556 20081119 RGD compared to SHRSP/Izm; MMO:0000031 2302109 SHRSP.WKY-(D1Mgh5-D1Rat44)/Izm strain MP:0004217 salt-sensitive hypertension susceptibility IAGP XCO:0000164 N RGD:2302104|PMID:18971556 20081119 RGD MMO:0000031 2302109 SHRSP.WKY-(D1Mgh5-D1Rat44)/Izm strain MP:0006059 decreased susceptibility to ischemic brain injury IAGP XCO:0000164 N RGD:2302104|PMID:18971556 20200110 RGD compared to SHRSP/Izm; MMO:0000496 2302110 SHRSP.WKY-(Apbb1-D1Arb21)/Izm strain MP:0004217 salt-sensitive hypertension susceptibility IAGP XCO:0000164 N RGD:2302104|PMID:18971556 20200110 RGD MMO:0000031 2302110 SHRSP.WKY-(Apbb1-D1Arb21)/Izm strain MP:0005264 glomerulosclerosis susceptibility IAGP XCO:0000164 N RGD:2302104|PMID:18971556 20200110 RGD compared to SHRSP/Izm; MMO:0000496 2302110 SHRSP.WKY-(Apbb1-D1Arb21)/Izm strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:4889147|PMID:21063213 20191216 RGD baseline compared to SHRSP/Izm 2302132 SHRSP-Tg(Tagln-ACE2)6918Bdr strain MP:0004876 decreased mean systemic arterial blood pressure IMP N RGD:2302131|PMID:18809792 20081120 RGD as compared to SHRSP 2302141 F344-Tg(Cyp1a1-Ren2)10Jmul strain MP:0001263 weight loss MODEL: induced IMP N RGD:2302140|PMID:11448960 20081121 RGD indole-3 carbinol induced 2302141 F344-Tg(Cyp1a1-Ren2)10Jmul strain MP:0001762 polyuria MODEL: induced IMP N RGD:2302140|PMID:11448960 20180508 RGD indole-3 carbinol induced 2302141 F344-Tg(Cyp1a1-Ren2)10Jmul strain MP:0002962 increased urine protein level MODEL: induced IMP N RGD:2302140|PMID:11448960 20120112 RGD 2302141 F344-Tg(Cyp1a1-Ren2)10Jmul strain MP:0003352 increased circulating renin level MODEL: induced IMP N RGD:2302140|PMID:11448960 20081121 RGD indole-3 carbinol induced 2302141 F344-Tg(Cyp1a1-Ren2)10Jmul strain MP:0006144 increased systemic arterial systolic blood pressure MODEL: induced IMP N RGD:2302140|PMID:11448960 20081121 RGD indole-3 carbinol induced 2302148 SHR-Tg(EEF1A1-Cd36)10Ipcv strain MP:0002702 decreased circulating free fatty acids level induced IAGP XCO:0000244 N RGD:68930|PMID:11175782 20081121 RGD compared to SHR/OlaIpcv 2302148 SHR-Tg(EEF1A1-Cd36)10Ipcv strain MP:0005292 improved glucose tolerance induced IAGP XCO:0000244, XCO:0000275 N RGD:68930|PMID:11175782 20081121 RGD compared to SHR/OlaIpcv 2302149 SHR-Tg(EEF1A1-Cd36)19Ipcv strain MP:0002702 decreased circulating free fatty acids level induced IAGP XCO:0000244 N RGD:68930|PMID:11175782 20081121 RGD compared to SHR/OlaIpcv 2302149 SHR-Tg(EEF1A1-Cd36)19Ipcv strain MP:0005292 improved glucose tolerance induced IAGP XCO:0000244, XCO:0000275 N RGD:68930|PMID:11175782 20081121 RGD compared to SHR/OlaIpcv 2302150 SHR-Tg(EEF1A1-Cd36)93Ipcv strain MP:0002702 decreased circulating free fatty acids level induced IMP XCO:0000244 N RGD:1600636|PMID:14640889 20081121 RGD compared to SHR/OlaIpcv 2302150 SHR-Tg(EEF1A1-Cd36)93Ipcv strain MP:0005292 improved glucose tolerance induced IMP XCO:0000244, XCO:0000103 N RGD:1600636|PMID:14640889 20081121 RGD compared to SHR/OlaIpcv 2302150 SHR-Tg(EEF1A1-Cd36)93Ipcv strain MP:0020867 increased lipogenesis induced IMP XCO:0000245 N RGD:1600636|PMID:14640889 20081121 RGD compared to SHR/OlaIpcv 2302150 SHR-Tg(EEF1A1-Cd36)93Ipcv strain MP:0031001 increased glycogen synthesis IMP N RGD:1600636|PMID:14640889 20081121 RGD compared to SHR/OlaIpcv 2302151 SHR-Tg(EEF1A1-Cd36)106Ipcv strain MP:0002702 decreased circulating free fatty acids level induced IMP XCO:0000244 N RGD:1600636|PMID:14640889 20081121 RGD compared to SHR/OlaIpcv 2302151 SHR-Tg(EEF1A1-Cd36)106Ipcv strain MP:0031001 increased glycogen synthesis IMP XCO:0000099|XCO:0000245 N RGD:1600636|PMID:14640889 20081121 RGD compared to SHR/OlaIpcv 2302273 Gluco35 Glucose level QTL 35 qtl MP:0005559 increased circulating glucose level IAGP N RGD:2298688|PMID:18612083 20081208 RGD 2302275 Gluco37 Glucose level QTL 37 qtl MP:0005559 increased circulating glucose level IAGP N RGD:2298688|PMID:18612083 20081208 RGD 2302276 Bw82 Body weight QTL 82 qtl MP:0001260 increased body weight IAGP N RGD:2298688|PMID:18612083 20081208 RGD 2302277 Gluco38 Glucose level QTL 38 qtl MP:0005559 increased circulating glucose level IAGP N RGD:2298688|PMID:18612083 20081208 RGD 2302278 Gluco36 Glucose level QTL 36 qtl MP:0005559 increased circulating glucose level IAGP N RGD:2298688|PMID:18612083 20081208 RGD 2302279 F344.SDT-(D3Wox9-D3Arb20)/Kbe strain MP:0001869 pancreas inflammation IAGP N RGD:2298688|PMID:18612083 20081208 RGD 2302279 F344.SDT-(D3Wox9-D3Arb20)/Kbe strain MP:0003334 pancreas fibrosis IAGP N RGD:2298688|PMID:18612083 20081208 RGD 2302365 Gluco40 Glucose level QTL 40 qtl MP:0005559 increased circulating glucose level IDA N RGD:619689|PMID:10720472 20081215 RGD 2302367 Slep5 Serum leptin concentration QTL 5 qtl MP:0005669 increased circulating leptin level IDA N RGD:619689|PMID:10720472 20081215 RGD 2302369 Scl60 Serum cholesterol level QTL 60 qtl MP:0005178 increased circulating cholesterol level IDA N RGD:619689|PMID:10720472 20081215 RGD 2302371 Stl22 Serum triglyceride level QTL 22 qtl MP:0001552 increased circulating triglyceride level IDA N RGD:619689|PMID:10720472 20081215 RGD 2302373 Gluco39 Glucose level QTL 39 qtl MP:0005559 increased circulating glucose level IDA N RGD:619689|PMID:10720472 20081215 RGD 2302375 Bw83 Body weight QTL 83 qtl MP:0001260 increased body weight IDA N RGD:619689|PMID:10720472 20081215 RGD 2302375 Bw83 Body weight QTL 83 qtl MP:0006087 increased body mass index IDA N RGD:619689|PMID:10720472 20081215 RGD 2302377 Scl61 Serum cholesterol level QTL 61 qtl MP:0005178 increased circulating cholesterol level IDA N RGD:619689|PMID:10720472 20081215 RGD 2302378 Insul11 Insulin level QTL 11 qtl MP:0002079 increased circulating insulin level IDA N RGD:619689|PMID:10720472 20081215 RGD 2302380 Slep6 Serum leptin concentration QTL 6 qtl MP:0005669 increased circulating leptin level IDA N RGD:619689|PMID:10720472 20081215 RGD 2302381 Bw84 Body weight QTL 84 qtl MP:0001260 increased body weight IDA N RGD:619689|PMID:10720472 20081215 RGD 2302381 Bw84 Body weight QTL 84 qtl MP:0006087 increased body mass index IDA N RGD:619689|PMID:10720472 20081215 RGD 2302387 DA.ACI-(D2Mit12-D2Mgh29)/Nsi strain MP:0002936 joint swelling IAGP N RGD:1358860|PMID:15641042 20081215 RGD 2302387 DA.ACI-(D2Mit12-D2Mgh29)/Nsi strain MP:0003436 decreased susceptibility to induced arthritis IAGP N RGD:1358860|PMID:15641042 20081215 RGD compared to DA rats 2302666 Scr:sP Sardinian alcohol-preferring rats strain MP:0003545 increased alcohol consumption MODEL IAGP N RGD:2302665|PMID:18946467 20090106 RGD compared to Wistar 2302984 SS.BN-(D13Rat151-D13Rat197)/Mcwi strain MP:0002959 increased urine microalbumin level sexual_dimorphism IAGP XCO:0000022 N RGD:1625678|PMID:17566075 20090127 RGD in male 2302984 SS.BN-(D13Rat151-D13Rat197)/Mcwi strain MP:0004876 decreased mean systemic arterial blood pressure sexual_dimorphism IAGP XCO:0000022 N RGD:1625678|PMID:17566075 20090127 RGD in female, compared to SS/JrHsdMcwi 2302985 SS.BN-(D13Rat111-D13Got22)/Mcwi strain MP:0002959 increased urine microalbumin level induced IAGP XCO:0000022 N RGD:1625678|PMID:17566075 20090127 RGD as compared to SS/JrHsdMcwi 2302985 SS.BN-(D13Rat111-D13Got22)/Mcwi strain MP:0002963 decreased urine protein level induced IAGP XCO:0000022 N RGD:12798539|PMID:21257920 20170324 RGD compared to SS/JrHsdMcwi 2302985 SS.BN-(D13Rat111-D13Got22)/Mcwi strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:12798539|PMID:21257920 20170324 RGD compared to SS/JrHsdMcwi 2302985 SS.BN-(D13Rat111-D13Got22)/Mcwi strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:1625678|PMID:17566075 20090127 RGD as compared to SS/JrHsdMcwi 2302986 SS.BN-(D13Rat88-D13Rat91)/Mcwi strain MP:0002959 increased urine microalbumin level sexual_dimorphism IAGP XCO:0000022 N RGD:1625678|PMID:17566075 20201119 RGD compared to female 2302986 SS.BN-(D13Rat88-D13Rat91)/Mcwi strain MP:0004875 increased mean systemic arterial blood pressure sexual_dimorphism IAGP XCO:0000022 N RGD:1625678|PMID:17566075 20201119 RGD compared to female 2302986 SS.BN-(D13Rat88-D13Rat91)/Mcwi strain MP:0004876 decreased mean systemic arterial blood pressure sexual_dimorphism IAGP XCO:0000022 N RGD:1625678|PMID:17566075 20090127 RGD compared to female SS/JrHsdMcwi 2302987 SS.BN-(D13Rat7-D13Rat60)/Mcwi strain MP:0002959 increased urine microalbumin level sexual_dimorphism IAGP XCO:0000022 N RGD:1625678|PMID:17566075 20191206 RGD 2302987 SS.BN-(D13Rat7-D13Rat60)/Mcwi strain MP:0004875 increased mean systemic arterial blood pressure sexual_dimorphism IAGP XCO:0000022 N RGD:1625678|PMID:17566075 20090127 RGD in male 2302987 SS.BN-(D13Rat7-D13Rat60)/Mcwi strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:1625678|PMID:17566075 20090127 RGD compared to SS/JrHsdMcwi 2302989 SS.BN-(D13Rat57-D13Rat192)/Mcwi strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:1625678|PMID:17566075 20090127 RGD 2302994 SS.BN-(D13Rat127-D13Rat61)/Mcwi strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:1625678|PMID:17566075 20090127 RGD 2302995 SS.BN-(D13Rat115-D13Rat101)/Mcwi strain MP:0004875 increased mean systemic arterial blood pressure sexual_dimorphism IAGP XCO:0000022 N RGD:1625678|PMID:17566075 20090127 RGD as compared to female on 8% NaCl diet 2302995 SS.BN-(D13Rat115-D13Rat101)/Mcwi strain MP:0004876 decreased mean systemic arterial blood pressure sexual_dimorphism IAGP XCO:0000022 N RGD:1625678|PMID:17566075 20090127 RGD compared to female SS/JrHsdMcwi on 8% NaCl diet 2302996 SS.BN-(D13Rat7-D13Rat88)/Mcwi strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:1625678|PMID:17566075 20090127 RGD in male, compared to SS/JrHsdMcwi 2302997 SS.BN-(D13Rat91-D13Got45)/Mcwi strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:1625678|PMID:17566075 20090127 RGD 2302999 SS.BN-(D13Rat178-D13Got45)/Mcwi strain MP:0004875 increased mean systemic arterial blood pressure sexual_dimorphism IAGP XCO:0000022 N RGD:1625678|PMID:17566075 20090127 RGD in male 2303000 SS.BN-(D13Rat123-D13Rat150)/Mcwi strain MP:0002959 increased urine microalbumin level sexual_dimorphism IAGP XCO:0000022 N RGD:1625678|PMID:17566075 20201119 RGD compared to female 2303000 SS.BN-(D13Rat123-D13Rat150)/Mcwi strain MP:0004875 increased mean systemic arterial blood pressure sexual_dimorphism IAGP XCO:0000022 N RGD:1625678|PMID:17566075 20090127 RGD compared to female 2303001 SS.BN-(D13Rat111-D13Rat127)/Mcwi strain MP:0002959 increased urine microalbumin level sexual_dimorphism IAGP XCO:0000022 N RGD:1625678|PMID:17566075 20090127 RGD in male 2303001 SS.BN-(D13Rat111-D13Rat127)/Mcwi strain MP:0004876 decreased mean systemic arterial blood pressure sexual_dimorphism IAGP XCO:0000022 N RGD:1625678|PMID:17566075 20090127 RGD in female, compared to SS/JrHsdMcwi 2303002 SS.BN-(D13Rat123-D13Rat197)/Mcwi strain MP:0002959 increased urine microalbumin level sexual_dimorphism IAGP XCO:0000022 N RGD:1625678|PMID:17566075 20090127 RGD in male 2303002 SS.BN-(D13Rat123-D13Rat197)/Mcwi strain MP:0004876 decreased mean systemic arterial blood pressure sexual_dimorphism IAGP XCO:0000022 N RGD:1625678|PMID:17566075 20090127 RGD in female, compared to SS/JrHsdMcwi 2303003 SS.BN-(D13Rat7-D13Rat127)/Mcwi strain MP:0004876 decreased mean systemic arterial blood pressure sexual_dimorphism IAGP XCO:0000022 N RGD:1625678|PMID:17566075 20090127 RGD in female, compared to SS/JrHsdMcwi 2303004 SS.BN-(D13Rat115-D13Rat61)/Mcwi strain MP:0002959 increased urine microalbumin level sexual_dimorphism IAGP XCO:0000022 N RGD:1625678|PMID:17566075 20090127 RGD in male 2303004 SS.BN-(D13Rat115-D13Rat61)/Mcwi strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:1625678|PMID:17566075 20090127 RGD compared to SS/JrHsdMcwi 2303005 SS.BN-(D13Rat127-D13Rat77)/Mcwi strain MP:0002959 increased urine microalbumin level sexual_dimorphism IAGP XCO:0000022 N RGD:1625678|PMID:17566075 20191206 RGD in male 2303005 SS.BN-(D13Rat127-D13Rat77)/Mcwi strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:1625678|PMID:17566075 20090127 RGD 2303006 SS.BN-(D13Rat101-D13Rat46)/Mcwi strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:1625678|PMID:17566075 20090127 RGD compared to SS/JrHsdMcwi 2303007 SS.BN-(D13Rat127-D13Rat46)/Mcwi strain MP:0002959 increased urine microalbumin level sexual_dimorphism IAGP XCO:0000022 N RGD:1625678|PMID:17566075 20090127 RGD in male 2303007 SS.BN-(D13Rat127-D13Rat46)/Mcwi strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:1625678|PMID:17566075 20090127 RGD as compared to SS/JrHsdMcwi 2303008 SS.BN-(D13Rat61-D13GRat197)/Mcwi strain MP:0002959 increased urine microalbumin level sexual_dimorphism IAGP XCO:0000022 N RGD:1625678|PMID:17566075 20191206 RGD in male 2303008 SS.BN-(D13Rat61-D13GRat197)/Mcwi strain MP:0004875 increased mean systemic arterial blood pressure sexual_dimorphism IAGP XCO:0000022 N RGD:1625678|PMID:17566075 20090127 RGD in male 2303009 SS.BN-(D13Rat183-D13Rat192)/Mcwi strain MP:0002959 increased urine microalbumin level sexual_dimorphism IAGP XCO:0000022 N RGD:1625678|PMID:17566075 20191206 RGD in male 2303009 SS.BN-(D13Rat183-D13Rat192)/Mcwi strain MP:0004875 increased mean systemic arterial blood pressure sexual_dimorphism IAGP XCO:0000022 N RGD:1625678|PMID:17566075 20090127 RGD in male 2303010 SS.BN-(D13Got51-D13Rat192)/Mcwi strain MP:0002959 increased urine microalbumin level sexual_dimorphism IAGP XCO:0000022 N RGD:1625678|PMID:17566075 20191205 RGD in male 2303010 SS.BN-(D13Got51-D13Rat192)/Mcwi strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:1625678|PMID:17566075 20090127 RGD 2303011 SS.BN-(D13Got51-D13Rat57)/Mcwi strain MP:0002959 increased urine microalbumin level sexual_dimorphism IAGP XCO:0000022 N RGD:1625678|PMID:17566075 20191205 RGD in male 2303011 SS.BN-(D13Got51-D13Rat57)/Mcwi strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:1625678|PMID:17566075 20090127 RGD 2303028 Bp329 Blood pressure QTL 329 qtl MP:0004876 decreased mean systemic arterial blood pressure IDA N RGD:1625678|PMID:17566075 20090127 RGD 8% NaCl diet 2303030 Bp327 Blood pressure QTL 327 qtl MP:0004876 decreased mean systemic arterial blood pressure IDA N RGD:1625678|PMID:17566075 20090127 RGD 8% NaCl diet 2303031 Bp326 Blood pressure QTL 326 qtl MP:0004876 decreased mean systemic arterial blood pressure IDA N RGD:1625678|PMID:17566075 20090127 RGD 8% NaCl diet 2303032 Bp328 Blood pressure QTL 328 qtl MP:0004876 decreased mean systemic arterial blood pressure IDA N RGD:1625678|PMID:17566075 20090127 RGD 8% NaCl diet 2303116 SPRD.WKY-(D10Rat91-D10Rat135)/Ibmm strain MP:0003447 decreased tumor growth/size induced IAGP XCO:0000090 N RGD:2302423|PMID:19052818 20200318 RGD compared to treated SPRD/Ztm 2303117 SPRD.WKY-(D5Rat190-D5Rat114)(D18Rat102-D18Rat44)/Ibmm strain MP:0003447 decreased tumor growth/size induced IAGP XCO:0000090 N RGD:2302423|PMID:19052818 20200318 RGD compared to treated SPRD/Ztm, SPRD.WKY-(D18Wox-D18Rat44)/Ibmm 2303118 Mamtr7 Mammary tumor resistance QTL 7 qtl MP:0001883 increased mammary adenocarcinoma incidence IDA N RGD:2302423|PMID:19052818 20090204 RGD 2303118 Mamtr7 Mammary tumor resistance QTL 7 qtl MP:0004502 decreased incidence of tumors by chemical induction IDA N RGD:2302423|PMID:19052818 20090204 RGD 2303120 Mamtr8 Mammary tumor resistance QTL 8 qtl MP:0001883 increased mammary adenocarcinoma incidence IDA N RGD:2302423|PMID:19052818 20090204 RGD 2303120 Mamtr8 Mammary tumor resistance QTL 8 qtl MP:0004502 decreased incidence of tumors by chemical induction IDA N RGD:2302423|PMID:19052818 20090204 RGD 2303148 SS.SHR-(D9Wox16-D9Rat76)/Mco strain MP:0001260 increased body weight IMP N RGD:2302803|PMID:18854752 20201016 RGD on 2%NaCl diet; compared to Dahl salt-sensitive (S/jr) rat 2303150 SS.SHR-(D9Mco74-D9Rat64)/Mco strain MP:0002834 decreased heart weight IMP N RGD:2302803|PMID:18854752 20201016 RGD 2303150 SS.SHR-(D9Mco74-D9Rat64)/Mco strain MP:0004876 decreased mean systemic arterial blood pressure IMP N RGD:2302803|PMID:18854752 20090205 RGD on 2%NaCl diet; compared to Dahl salt-sensitive (S/jr) rat 2303152 SS.SHR-(D9Mco72-D9Mco93)/Mco strain MP:0002834 decreased heart weight IMP N RGD:2302803|PMID:18854752 20201016 RGD 2303152 SS.SHR-(D9Mco72-D9Mco93)/Mco strain MP:0002963 decreased urine protein level IMP N RGD:2302803|PMID:18854752 20201016 RGD 2303152 SS.SHR-(D9Mco72-D9Mco93)/Mco strain MP:0004876 decreased mean systemic arterial blood pressure IMP N RGD:2302803|PMID:18854752 20090205 RGD on 2%NaCl diet; compared to Dahl salt-sensitive (S/jr) rat 2303153 SS.SHR-(D9Rat7-D9Mco93)/Mco strain MP:0002834 decreased heart weight IMP N RGD:2302803|PMID:18854752 20201016 RGD 2303153 SS.SHR-(D9Rat7-D9Mco93)/Mco strain MP:0004876 decreased mean systemic arterial blood pressure IMP N RGD:2302803|PMID:18854752 20201016 RGD on 2%NaCl diet; compared to Dahl salt-sensitive (S/jr) rat 2303154 SS.SHR-(D9Wox16-D9Mco85)/Mco strain MP:0001262 decreased body weight IMP N RGD:2302803|PMID:18854752 20201016 RGD on 2%NaCl diet; compared to Dahl salt-sensitive (S/jr) rat 2303154 SS.SHR-(D9Wox16-D9Mco85)/Mco strain MP:0002834 decreased heart weight IMP N RGD:2302803|PMID:18854752 20201016 RGD 2303154 SS.SHR-(D9Wox16-D9Mco85)/Mco strain MP:0004876 decreased mean systemic arterial blood pressure IMP N RGD:2302803|PMID:18854752 20201016 RGD on 2%NaCl diet; compared to Dahl salt-sensitive (S/jr) rat 2303168 Bp330 Blood pressure QTL 330 qtl MP:0006264 decreased systemic arterial systolic blood pressure IDA N RGD:2303163|PMID:8829824 20090205 RGD 2303170 Bp332 Blood pressure QTL 332 qtl MP:0006144 increased systemic arterial systolic blood pressure IDA N RGD:2303163|PMID:8829824 20090205 RGD 2303171 Bp331 Blood pressure QTL 331 qtl MP:0006264 decreased systemic arterial systolic blood pressure IDA N RGD:2303163|PMID:8829824 20090205 RGD 2303178 Bp334 Blood pressure QTL 334 qtl MP:0004876 decreased mean systemic arterial blood pressure IAGP N RGD:2302803|PMID:18854752 20090205 RGD on 2% NaCl diet 2303180 Bp333 Blood pressure QTL 333 qtl MP:0002963 decreased urine protein level IAGP N RGD:2302803|PMID:18854752 20090205 RGD on 2% NaCl diet 2303180 Bp333 Blood pressure QTL 333 qtl MP:0004876 decreased mean systemic arterial blood pressure IAGP N RGD:2302803|PMID:18854752 20090205 RGD on 2% NaCl diet 2303559 Gluco54 Glucose level QTL 54 qtl MP:0005559 increased circulating glucose level IDA N RGD:2312611|PMID:19697080 20090825 RGD 2303561 Bw91 Body weight QTL 91 qtl MP:0001260 increased body weight IDA N RGD:2312611|PMID:19697080 20090826 RGD 2303563 Bw89 Body weight QTL 89 qtl MP:0001260 increased body weight IDA N RGD:2312611|PMID:19697080 20090826 RGD 2303564 Gluco43 Glucose level QTL 43 qtl MP:0005559 increased circulating glucose level IDA N RGD:2312611|PMID:19697080 20090825 RGD 2303566 Bw90 Body weight QTL 90 qtl MP:0001260 increased body weight IDA N RGD:2312611|PMID:19697080 20090826 RGD 2303568 Bw88 Body weight QTL 88 qtl MP:0001260 increased body weight IDA N RGD:2312611|PMID:19697080 20090826 RGD 2303569 Gluco44 Glucose level QTL 44 qtl MP:0005560 decreased circulating glucose level IDA N RGD:2312611|PMID:19697080 20090825 RGD 2303570 Gluco48 Glucose level QTL 48 qtl MP:0005559 increased circulating glucose level IDA N RGD:2312611|PMID:19697080 20090825 RGD 2303571 Bw92 Body weight QTL 92 qtl MP:0001260 increased body weight IDA N RGD:2312611|PMID:19697080 20090826 RGD 2303572 Insul13 Insulin level QTL 13 qtl MP:0002079 increased circulating insulin level IDA N RGD:2312611|PMID:19697080 20090826 RGD 2303574 Gluco42 Glucose level QTL 42 qtl MP:0005559 increased circulating glucose level IDA N RGD:2312611|PMID:19697080 20090825 RGD 2303575 Insul14 Insulin level QTL 14 qtl MP:0002079 increased circulating insulin level IDA N RGD:2312611|PMID:19697080 20090826 RGD 2303576 Gluco45 Glucose level QTL 45 qtl MP:0005559 increased circulating glucose level IDA N RGD:2312611|PMID:19697080 20090825 RGD 2303577 Gluco47 Glucose level QTL 47 qtl MP:0005559 increased circulating glucose level IDA N RGD:2312611|PMID:19697080 20090825 RGD 2303578 Gluco50 Glucose level QTL 50 qtl MP:0005559 increased circulating glucose level IDA N RGD:2312611|PMID:19697080 20090825 RGD 2303579 Insul12 Insulin level QTL 12 qtl MP:0002079 increased circulating insulin level IDA N RGD:2312611|PMID:19697080 20090826 RGD 2303580 Gluco49 Glucose level QTL 49 qtl MP:0005559 increased circulating glucose level IDA N RGD:2312611|PMID:19697080 20090825 RGD 2303581 Bw85 Body weight QTL 85 qtl MP:0001260 increased body weight IDA N RGD:2312611|PMID:19697080 20090826 RGD 2303582 Gluco53 Glucose level QTL 53 qtl MP:0005559 increased circulating glucose level IDA N RGD:2312611|PMID:19697080 20090825 RGD 2303584 Gluco55 Glucose level QTL 55 qtl MP:0005559 increased circulating glucose level IDA N RGD:2312611|PMID:19697080 20090825 RGD 2303585 Bw86 Body weight QTL 86 qtl MP:0001260 increased body weight IDA N RGD:2312611|PMID:19697080 20090826 RGD 2303586 Gluco52 Glucose level QTL 52 qtl MP:0005560 decreased circulating glucose level IDA N RGD:2312611|PMID:19697080 20090825 RGD 2303587 Bw93 Body weight QTL 93 qtl MP:0001260 increased body weight IDA N RGD:2312611|PMID:19697080 20090826 RGD 2303589 Bw87 Body weight QTL 87 qtl MP:0001260 increased body weight IDA N RGD:2312611|PMID:19697080 20090826 RGD 2303591 Gluco41 Glucose level QTL 41 qtl MP:0005560 decreased circulating glucose level IDA N RGD:2312611|PMID:19697080 20090825 RGD 2303592 Gluco51 Glucose level QTL 51 qtl MP:0005559 increased circulating glucose level IDA N RGD:2312611|PMID:19697080 20090825 RGD 2303593 Gluco46 Glucose level QTL 46 qtl MP:0005560 decreased circulating glucose level IDA N RGD:2312611|PMID:19697080 20090825 RGD 2303640 WAG/RijCmcr strain MP:0003426 pulmonary interstitial fibrosis MODEL: induced IAGP N RGD:2303635|PMID:18470747 20090220 RGD whole thorax irradiation 2303759 WT/Jtt whitish teeth rat strain MP:0002576 abnormal enamel morphology IAGP N RGD:2303758|PMID:17710440 20090225 RGD 2303759 WT/Jtt whitish teeth rat strain MP:0002650 abnormal ameloblast morphology IAGP N RGD:2303758|PMID:17710440 20090225 RGD 2303759 WT/Jtt whitish teeth rat strain MP:0002689 abnormal molar morphology IAGP N RGD:2303758|PMID:17710440 20090225 RGD 2303759 WT/Jtt whitish teeth rat strain MP:0010096 abnormal incisor color IAGP N RGD:13593564|PMID:16324133 20090225 RGD 2303759 WT/Jtt whitish teeth rat strain MP:0030450 abnormal enamel mineralization IAGP N RGD:2303758|PMID:17710440 20180523 RGD 2303792 WTC.ZI-Atrnzi/Kyo strain MP:0000745 tremors IAGP N RGD:67998|PMID:11209055 20090209 RGD compared to WTC 2303792 WTC.ZI-Atrnzi/Kyo strain MP:0005409 darkened coat color IAGP N RGD:67998|PMID:11209055 20201116 RGD compared to WTC 2303792 WTC.ZI-Atrnzi/Kyo strain MP:0008025 brain vacuoles IAGP N RGD:67998|PMID:11209055 20090209 RGD compared to WTC 2303792 WTC.ZI-Atrnzi/Kyo strain MP:0008025 brain vacuoles severity IMP N RGD:2303790|PMID:9606416 20090226 RGD 2303986 WKAH.LEC-Atp7bhts/Tj strain MP:0000611 jaundice IAGP N RGD:1302456|PMID:11509115 20191119 RGD 2303986 WKAH.LEC-Atp7bhts/Tj strain MP:0002703 abnormal renal tubule morphology IAGP N RGD:1302456|PMID:11509115 20191119 RGD 2303986 WKAH.LEC-Atp7bhts/Tj strain MP:0008743 decreased liver iron level IAGP N RGD:1302456|PMID:11509115 20191119 RGD compared to LEC/Tj; 2303986 WKAH.LEC-Atp7bhts/Tj strain MP:0031022 hepatic megalocytosis IAGP N RGD:1302456|PMID:11509115 20191119 RGD 2304017 F344.CVD-Unc5ccvd/Kyo strain MP:0000865 absent cerebellum vermis IAGP N RGD:1302461|PMID:14993736 20170406 RGD 2304039 WIC-Tgrdw/Kts strain MP:0001262 decreased body weight IAGP N RGD:13605608|PMID:10760744 20180607 RGD 2304039 WIC-Tgrdw/Kts strain MP:0001262 decreased body weight IAGP N RGD:730133|PMID:11089535 20210929 RGD compared to wild type and heterozygotes 2304039 WIC-Tgrdw/Kts strain MP:0003351 decreased circulating levels of thyroid hormone IAGP N RGD:13605608|PMID:10760744 20180607 RGD 2304039 WIC-Tgrdw/Kts strain MP:0005135 increased thyroid-stimulating hormone level IAGP N RGD:13605608|PMID:10760744 20180607 RGD 2304039 WIC-Tgrdw/Kts strain MP:0008321 small adenohypophysis IAGP N RGD:12880373|PMID:3366187 20170503 RGD 2304039 WIC-Tgrdw/Kts strain MP:0008321 small adenohypophysis IAGP N RGD:730133|PMID:11089535 20170503 RGD 2304039 WIC-Tgrdw/Kts strain MP:0009378 abnormal endoplasmic reticulum morphology IAGP N RGD:730133|PMID:11089535 20210929 RGD compared to wild type and heterozygotes 2304039 WIC-Tgrdw/Kts strain MP:0020168 decreased thyroid gland weight IAGP N RGD:13605608|PMID:10760744 20180607 RGD 2304039 WIC-Tgrdw/Kts strain MP:0020354 increased endoplasmic reticulum stress IAGP N RGD:730133|PMID:11089535 20210929 RGD compared to wild type and heterozygotes 2304047 F344.ZUC-Leprfa/Tj strain MP:0001260 increased body weight IAGP N RGD:11532750|PMID:27523322 20160906 RGD as compared to F344/NSlc; 2304047 F344.ZUC-Leprfa/Tj strain MP:0003059 decreased insulin secretion IAGP N RGD:11532750|PMID:27523322 20160906 RGD as compared to F344/NSlc; 2304047 F344.ZUC-Leprfa/Tj strain MP:0005293 impaired glucose tolerance IAGP N RGD:11532750|PMID:27523322 20160906 RGD 2304047 F344.ZUC-Leprfa/Tj strain MP:0005331 insulin resistance IAGP N RGD:11532750|PMID:27523322 20160906 RGD 2304047 F344.ZUC-Leprfa/Tj strain MP:0005559 increased circulating glucose level IAGP N RGD:7394771|PMID:23304119 20131104 RGD at 15 wks of age 2304047 F344.ZUC-Leprfa/Tj strain MP:0011939 increased food intake IAGP N RGD:10755343|PMID:26296322 20160906 RGD as compared to F344/NSlc; 2304098 SHRSP.WKY-(D1Smu13-D1Arb21)/Izm strain MP:0006264 decreased systemic arterial systolic blood pressure susceptibility IAGP N RGD:4889147|PMID:21063213 20191216 RGD baseline compared to SHRSP/Izm 2304098 SHRSP.WKY-(D1Smu13-D1Arb21)/Izm strain MP:0030773 decreased urine noradrenaline level IAGP XCO:0000307 N RGD:4889147|PMID:21063213 20191216 RGD compared to SHRSP/Izm in response to cold stress 2304221 WTC-swh/Kyo strain MP:0000379 decreased hair follicle number IAGP N RGD:2304219|PMID:15829729 20090310 RGD compared to heterozygous animals 2304221 WTC-swh/Kyo strain MP:0000380 small hair follicles IAGP N RGD:2304219|PMID:15829729 20090310 RGD compared to heterozygous animals 2304221 WTC-swh/Kyo strain MP:0000400 abnormal awl hair morphology IAGP N RGD:14398762|PMID:22013926 20190430 RGD DNA:missense mutation:exon:p.Pro153Ser(rat) 2304221 WTC-swh/Kyo strain MP:0000410 waved hair IAGP N RGD:2304219|PMID:15829729 20090310 RGD compared to heterozygous animals 2304221 WTC-swh/Kyo strain MP:0000416 sparse hair IAGP N RGD:2304219|PMID:15829729 20090310 RGD compared to heterozygous animals 2304221 WTC-swh/Kyo strain MP:0000762 abnormal tongue morphology IAGP N RGD:14398762|PMID:22013926 20190430 RGD DNA:missense mutation:exon:p.Pro153Ser(rat) 2304221 WTC-swh/Kyo strain MP:0001262 decreased body weight IAGP N RGD:2304219|PMID:15829729 20090310 RGD compared to heterozygous animals 2304221 WTC-swh/Kyo strain MP:0002074 abnormal hair texture IAGP N RGD:2304219|PMID:15829729 20090310 RGD compared to heterozygous animals 2304221 WTC-swh/Kyo strain MP:0002716 small male preputial gland IAGP N RGD:14398762|PMID:22013926 20190430 RGD DNA:missense mutation:exon:p.Pro153Ser(rat) 2304221 WTC-swh/Kyo strain MP:0003344 mammary gland hypoplasia IAGP N RGD:2304219|PMID:15829729 20090310 RGD in females, compared to heterozygous animals 2304221 WTC-swh/Kyo strain MP:0006236 absent Meibomian glands IAGP N RGD:14398762|PMID:22013926 20190430 RGD DNA:missense mutation:exon:p.Pro153Ser(rat) 2304221 WTC-swh/Kyo strain MP:0006367 absent sweat gland IAGP N RGD:14398762|PMID:22013926 20190430 RGD DNA:missense mutation:exon:p.Pro153Ser(rat) 2304221 WTC-swh/Kyo strain MP:0009506 abnormal mammary gland alveolus morphology IAGP N RGD:14398762|PMID:22013926 20190430 RGD DNA:missense mutation:exon:p.Pro153Ser(rat) 2304221 WTC-swh/Kyo strain MP:0014033 abnormal submucosal gland morphology IAGP N RGD:14398763|PMID:31028034 20190430 RGD 2304221 WTC-swh/Kyo strain MP:0030457 abnormal molar cusp morphology IAGP N RGD:14398762|PMID:22013926 20190430 RGD DNA:missense mutation:exon:p.Pro153Ser(rat) 2304242 WTC-Kcnq1dfkKyo strain MP:0000035 abnormal membranous labyrinth morphology IAGP N RGD:1581602|PMID:16368876 20191217 RGD compared to WTC/Kyo 2304242 WTC-Kcnq1dfkKyo strain MP:0001262 decreased body weight IAGP N RGD:1581602|PMID:16368876 20170411 RGD compared to WTC/Kyo 2304242 WTC-Kcnq1dfkKyo strain MP:0003233 prolonged QT interval IAGP N RGD:1581602|PMID:16368876 20191217 RGD compared to WTC/Kyo 2304242 WTC-Kcnq1dfkKyo strain MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:1581602|PMID:16368876 20191217 RGD compared to WTC/Kyo 2304242 WTC-Kcnq1dfkKyo strain MP:0008006 increased stomach pH IAGP N RGD:1581602|PMID:16368876 20191217 RGD compared to WTC/Kyo 2304242 WTC-Kcnq1dfkKyo strain MP:0010799 stomach mucosa hyperplasia IAGP N RGD:1581602|PMID:16368876 20170411 RGD compared to WTC/Kyo 2304242 WTC-Kcnq1dfkKyo strain MP:0011967 increased or absent threshold for auditory brainstem response IAGP N RGD:1581602|PMID:16368876 20200124 RGD compared to WTC/Kyo 2305 Cd247 Cd247 molecule gene MP:0004217 salt-sensitive hypertension severity IMP XCO:0000022 N RGD:13442481|PMID:24343121 20171102 RGD 2305 Cd247 Cd247 molecule gene MP:0004876 decreased mean systemic arterial blood pressure IMP N RGD:13442481|PMID:24343121 20201210 RGD compared to wild-type 2305 Cd247 Cd247 molecule gene MP:0004876 decreased mean systemic arterial blood pressure induced IMP XCO:0000022 N RGD:13442481|PMID:24343121 20171102 RGD compared to wild-type 2305 Cd247 Cd247 molecule gene MP:0005017 decreased B cell number IMP N RGD:13442481|PMID:24343121 20171102 RGD 2305 Cd247 Cd247 molecule gene MP:0005018 decreased T cell number IMP N RGD:13442481|PMID:24343121 20171102 RGD 2305 Cd247 Cd247 molecule gene MP:0005095 decreased T cell proliferation IMP N RGD:13442481|PMID:24343121 20171102 RGD compared to wild-type 2305 Cd247 Cd247 molecule gene MP:0005540 decreased urine albumin level IMP N RGD:13442481|PMID:24343121 20201210 RGD 2305 Cd247 Cd247 molecule gene MP:0005540 decreased urine albumin level induced IMP XCO:0000022 N RGD:13442481|PMID:24343121 20171102 RGD 2305 Cd247 Cd247 molecule gene MP:0013276 absent alpha-beta T cells IMP N RGD:13442481|PMID:24343121 20171102 RGD 2305926 Iddm37 Insulin dependent diabetes mellitus QTL 37 qtl MP:0004031 insulitis IDA N RGD:2313174|PMID:19720792 20120918 RGD 2305971 SHRSP.SHR-(D18Rat73-D18Rat11)/Izm strain MP:0002843 decreased systemic arterial blood pressure IAGP N RGD:7411685|PMID:23690346 20131119 RGD compared to SHRSP/Izm 2305973 SHRSP.SHR-(D1Rat93-D1Rat269)/Izm strain MP:0002843 decreased systemic arterial blood pressure IAGP N RGD:7411685|PMID:23690346 20131119 RGD compared to SHRSP/Izm 2306022 KCI/Kyo strain MP:0001394 circling IAGP N RGD:2306012|PMID:19151506 20090318 RGD 2306022 KCI/Kyo strain MP:0001522 impaired swimming IAGP N RGD:2306012|PMID:19151506 20090318 RGD 2306022 KCI/Kyo strain MP:0004408 decreased cochlear hair cell number IAGP N RGD:2306012|PMID:19151506 20090318 RGD 2306022 KCI/Kyo strain MP:0004521 abnormal cochlear hair cell stereociliary bundle morphology IAGP N RGD:2306012|PMID:19151506 20201218 RGD 2306022 KCI/Kyo strain MP:0006336 abnormal otoacoustic response IAGP N RGD:2306012|PMID:19151506 20090318 RGD 2306022 KCI/Kyo strain MP:0011967 increased or absent threshold for auditory brainstem response IAGP N RGD:2306012|PMID:19151506 20201218 RGD 2306041 F344-Scn1am2Kyo strain MP:0012349 increased susceptibility to induction of seizure by inducing agent IMP N RGD:12792282|PMID:20410126 20170315 RGD 2306042 F344-Scn1am1Kyo strain MP:0012349 increased susceptibility to induction of seizure by inducing agent IMP N RGD:12792282|PMID:20410126 20170315 RGD 2306059 DA.Cg-Foxn1rnu Lystbg/Slc strain MP:0000705 athymia IAGP N RGD:2306054|PMID:15516787 20200508 RGD 2306059 DA.Cg-Foxn1rnu Lystbg/Slc strain MP:0003815 hairless IAGP N RGD:2306054|PMID:15516787 20200508 RGD 2306059 DA.Cg-Foxn1rnu Lystbg/Slc strain MP:0005070 impaired natural killer cell mediated cytotoxicity IAGP N RGD:2306054|PMID:15516787 20160829 RGD 2306059 DA.Cg-Foxn1rnu Lystbg/Slc strain MP:0005606 increased bleeding time IAGP N RGD:2306054|PMID:15516787 20160829 RGD 2306064 MPR/Iar strain MP:0000130 abnormal trabecular bone morphology IAGP N RGD:39131283|PMID:21887218 20200930 RGD compared to normal and treated 2306064 MPR/Iar strain MP:0001405 impaired coordination IAGP N RGD:39131283|PMID:21887218 20200930 RGD compared to treated 2306064 MPR/Iar strain MP:0001524 impaired limb coordination IAGP N RGD:39131283|PMID:21887218 20200930 RGD compared to treated 2306064 MPR/Iar strain MP:0002282 abnormal trachea morphology IAGP N RGD:39131283|PMID:21887218 20200930 RGD compared to normal and treated 2306064 MPR/Iar strain MP:0008553 increased circulating tumor necrosis factor level IAGP N RGD:39131283|PMID:21887218 20200930 RGD compared to normal and treated 2306064 MPR/Iar strain MP:0013498 trachea inflammation IAGP N RGD:39131283|PMID:21887218 20200930 RGD compared to treated 2306064 MPR/Iar strain MP:0030866 abnormal synovial joint membrane morphology IAGP N RGD:39131283|PMID:21887218 20200930 RGD compared to normal and treated 2306064 MPR/Iar strain MP:0030895 abnormal tibiofemoral joint morphology IAGP N RGD:39131283|PMID:21887218 20200930 RGD compared to normal and treated 2306070 WIC-Tg(Wap-GH1)1Mni strain MP:0001260 increased body weight IAGP N RGD:13593540|PMID:7889111 20180522 RGD 2306070 WIC-Tg(Wap-GH1)1Mni strain MP:0008994 early vaginal opening IAGP N RGD:13593540|PMID:7889111 20180522 RGD 2306073 WIC-Tg(Wap-GH1)2Mni strain MP:0001260 increased body weight IAGP N RGD:13593541|PMID:9645676 20180522 RGD 2306073 WIC-Tg(Wap-GH1)2Mni strain MP:0001559 hyperglycemia IAGP N RGD:13593541|PMID:9645676 20180522 RGD 2306073 WIC-Tg(Wap-GH1)2Mni strain MP:0002079 increased circulating insulin level IAGP N RGD:13593541|PMID:9645676 20180522 RGD 2306073 WIC-Tg(Wap-GH1)2Mni strain MP:0006094 increased fat cell size IAGP N RGD:13593541|PMID:9645676 20180522 RGD 2306073 WIC-Tg(Wap-GH1)2Mni strain MP:0008994 early vaginal opening IAGP N RGD:13593540|PMID:7889111 20180522 RGD 2306073 WIC-Tg(Wap-GH1)2Mni strain MP:0009288 increased epididymal fat pad weight IAGP N RGD:13593541|PMID:9645676 20180522 RGD 2306529 BBDR.BBDP-(D4Rhw11-D4Rhw10)/Rhw strain MP:0004031 insulitis susceptibility IAGP N RGD:2306526|PMID:19351909 20200303 RGD 2306529 BBDR.BBDP-(D4Rhw11-D4Rhw10)/Rhw strain MP:0004803 increased susceptibility to autoimmune diabetes IAGP N RGD:2306526|PMID:19351909 20090427 RGD compared to BBDR/Rhw 2306529 BBDR.BBDP-(D4Rhw11-D4Rhw10)/Rhw strain MP:0005018 decreased T cell number IAGP N RGD:2306526|PMID:19351909 20090427 RGD compared to BBDR/Rhw 2306529 BBDR.BBDP-(D4Rhw11-D4Rhw10)/Rhw strain MP:0005580 periinsulitis susceptibility IAGP N RGD:2306526|PMID:19351909 20200303 RGD 2306529 BBDR.BBDP-(D4Rhw11-D4Rhw10)/Rhw strain MP:0012765 decreased alpha-beta T cell number IAGP N RGD:1598569|PMID:17130479 20200306 RGD compared to BBDR 2306532 BBDR.F344-(D4Rat27-D4Rhw8),BBDP-(D4Rhw6-D4Rat62)/Rhw strain MP:0004804 decreased susceptibility to autoimmune diabetes IAGP N RGD:2306526|PMID:19351909 20090427 RGD as compared to BBDR.BBDP-(D4Rhw11-D4Rhw10)/Rhw 2306532 BBDR.F344-(D4Rat27-D4Rhw8),BBDP-(D4Rhw6-D4Rat62)/Rhw strain MP:0005018 decreased T cell number IAGP N RGD:2306526|PMID:19351909 20090427 RGD 2306532 BBDR.F344-(D4Rat27-D4Rhw8),BBDP-(D4Rhw6-D4Rat62)/Rhw strain MP:0005580 periinsulitis susceptibility IAGP N RGD:2306526|PMID:19351909 20200303 RGD 2306533 BBDR.F344-(D4Rat102-D4Rhw8),BBDP-(D4Rhw6-D4Rat62)/2Rhw strain MP:0004804 decreased susceptibility to autoimmune diabetes IAGP N RGD:2306526|PMID:19351909 20090427 RGD 2306533 BBDR.F344-(D4Rat102-D4Rhw8),BBDP-(D4Rhw6-D4Rat62)/2Rhw strain MP:0005018 decreased T cell number IAGP N RGD:2306526|PMID:19351909 20090427 RGD 2306533 BBDR.F344-(D4Rat102-D4Rhw8),BBDP-(D4Rhw6-D4Rat62)/2Rhw strain MP:0005580 periinsulitis susceptibility IAGP N RGD:2306526|PMID:19351909 20200303 RGD 2306534 BBDR.F344-(D4Rat102-D4Rat27),BBDP-(D4Rhw11-D4Rhw10)/Rhw strain MP:0004804 decreased susceptibility to autoimmune diabetes IAGP N RGD:2306526|PMID:19351909 20090427 RGD as compared to BBDR.BBDP-(D4Rhw11-D4Rhw10)/Rhw 2306534 BBDR.F344-(D4Rat102-D4Rat27),BBDP-(D4Rhw11-D4Rhw10)/Rhw strain MP:0005018 decreased T cell number IAGP N RGD:2306526|PMID:19351909 20090427 RGD 2306534 BBDR.F344-(D4Rat102-D4Rat27),BBDP-(D4Rhw11-D4Rhw10)/Rhw strain MP:0005580 periinsulitis susceptibility IAGP N RGD:2306526|PMID:19351909 20200303 RGD 2306535 BBDR.F344-(D4Rat253-D4Rat27),BBDP-(D4Rhw11-D4Rhw10)/Rhw strain MP:0004804 decreased susceptibility to autoimmune diabetes IAGP N RGD:2306526|PMID:19351909 20090427 RGD as compared to BBDR.BBDP-(D4Rhw11-D4Rhw10)/Rhw 2306535 BBDR.F344-(D4Rat253-D4Rat27),BBDP-(D4Rhw11-D4Rhw10)/Rhw strain MP:0005018 decreased T cell number IAGP N RGD:2306526|PMID:19351909 20090427 RGD 2306535 BBDR.F344-(D4Rat253-D4Rat27),BBDP-(D4Rhw11-D4Rhw10)/Rhw strain MP:0005580 periinsulitis susceptibility IAGP N RGD:2306526|PMID:19351909 20200303 RGD 2306536 BBDR.F344-(D4Arb11-D4Rat27),BBDP-(D4Rhw11-D4Rhw10)/Rhw strain MP:0004804 decreased susceptibility to autoimmune diabetes IAGP N RGD:2306526|PMID:19351909 20090427 RGD compared to BBDR.BBDP-(D4Rhw11-D4Rhw10)/Rhw 2306536 BBDR.F344-(D4Arb11-D4Rat27),BBDP-(D4Rhw11-D4Rhw10)/Rhw strain MP:0005018 decreased T cell number IAGP N RGD:2306526|PMID:19351909 20090427 RGD 2306536 BBDR.F344-(D4Arb11-D4Rat27),BBDP-(D4Rhw11-D4Rhw10)/Rhw strain MP:0005580 periinsulitis susceptibility IAGP N RGD:2306526|PMID:19351909 20200303 RGD 2306537 BBDR.F344-(D4Rat102-D4Rhw8),BBDP-(D4Rhw6-D4Rat62)/1Rhw strain MP:0004804 decreased susceptibility to autoimmune diabetes IAGP N RGD:2306526|PMID:19351909 20090427 RGD 2306537 BBDR.F344-(D4Rat102-D4Rhw8),BBDP-(D4Rhw6-D4Rat62)/1Rhw strain MP:0005018 decreased T cell number IAGP N RGD:2306526|PMID:19351909 20090427 RGD 2306537 BBDR.F344-(D4Rat102-D4Rhw8),BBDP-(D4Rhw6-D4Rat62)/1Rhw strain MP:0005580 periinsulitis susceptibility IAGP N RGD:2306526|PMID:19351909 20200303 RGD 2306538 BBDR.F344-(D4Rat153-D4Rat27),BBDP-(D4Rhw11-D4Rhw10)/Rhw strain MP:0004804 decreased susceptibility to autoimmune diabetes IAGP N RGD:2306526|PMID:19351909 20090427 RGD as compared to BBDR.BBDP-(D4Rhw11-D4Rhw10)/Rhw 2306538 BBDR.F344-(D4Rat153-D4Rat27),BBDP-(D4Rhw11-D4Rhw10)/Rhw strain MP:0005018 decreased T cell number IAGP N RGD:2306526|PMID:19351909 20090427 RGD 2306538 BBDR.F344-(D4Rat153-D4Rat27),BBDP-(D4Rhw11-D4Rhw10)/Rhw strain MP:0005580 periinsulitis susceptibility IAGP N RGD:2306526|PMID:19351909 20200303 RGD 2306539 BBDR.F344-(D4Rat102-D4Rhw8),BBDP-(D4Rhw6-D4Rat62)/3Rhw strain MP:0004804 decreased susceptibility to autoimmune diabetes IAGP N RGD:2306526|PMID:19351909 20090427 RGD as compared to BBDR.BBDP-(D4Rhw11-D4Rhw10)/Rhw 2306539 BBDR.F344-(D4Rat102-D4Rhw8),BBDP-(D4Rhw6-D4Rat62)/3Rhw strain MP:0005018 decreased T cell number IAGP N RGD:2306526|PMID:19351909 20090427 RGD 2306539 BBDR.F344-(D4Rat102-D4Rhw8),BBDP-(D4Rhw6-D4Rat62)/3Rhw strain MP:0005580 periinsulitis susceptibility IAGP N RGD:2306526|PMID:19351909 20200303 RGD 2306540 BBDR.F344-(D4Got33-D4Rhw8),BBDP-(D4Rhw6-D4Rat62)/Rhw strain MP:0004804 decreased susceptibility to autoimmune diabetes IAGP N RGD:2306526|PMID:19351909 20090427 RGD 2306540 BBDR.F344-(D4Got33-D4Rhw8),BBDP-(D4Rhw6-D4Rat62)/Rhw strain MP:0005018 decreased T cell number IAGP N RGD:2306526|PMID:19351909 20090427 RGD 2306540 BBDR.F344-(D4Got33-D4Rhw8),BBDP-(D4Rhw6-D4Rat62)/Rhw strain MP:0005580 periinsulitis susceptibility IAGP N RGD:2306526|PMID:19351909 20200303 RGD 2306541 BBDR.F344-(D4Rat153-D4Rhw8),BBDP-(D4Rhw6-D4Rat62)/Rhw strain MP:0004804 decreased susceptibility to autoimmune diabetes IAGP N RGD:1598569|PMID:17130479 20200306 RGD BBDR.BBDP-(D4Rhw11-D4Rhw10)/Rhw 2306541 BBDR.F344-(D4Rat153-D4Rhw8),BBDP-(D4Rhw6-D4Rat62)/Rhw strain MP:0004804 decreased susceptibility to autoimmune diabetes IAGP N RGD:2306526|PMID:19351909 20090427 RGD compared to BBDR.BBDP-(D4Rhw11-D4Rhw10)/Rhw 2306541 BBDR.F344-(D4Rat153-D4Rhw8),BBDP-(D4Rhw6-D4Rat62)/Rhw strain MP:0005018 decreased T cell number IAGP N RGD:2306526|PMID:19351909 20090427 RGD compared to BBDR.BBDP-(D4Rhw11-D4Rhw10)/Rhw 2306541 BBDR.F344-(D4Rat153-D4Rhw8),BBDP-(D4Rhw6-D4Rat62)/Rhw strain MP:0005580 periinsulitis susceptibility IAGP N RGD:2306526|PMID:19351909 20200303 RGD 2306541 BBDR.F344-(D4Rat153-D4Rhw8),BBDP-(D4Rhw6-D4Rat62)/Rhw strain MP:0012765 decreased alpha-beta T cell number IAGP N RGD:1598569|PMID:17130479 20200306 RGD BBDR.BBDP-(D4Rhw11-D4Rhw10)/Rhw 2306542 BBDR.F344-(D4Rat253-D4Rhw8),BBDP-(D4Rhw6-D4Rat62)/Rhw strain MP:0004804 decreased susceptibility to autoimmune diabetes IAGP N RGD:2306526|PMID:19351909 20090427 RGD 2306542 BBDR.F344-(D4Rat253-D4Rhw8),BBDP-(D4Rhw6-D4Rat62)/Rhw strain MP:0005016 decreased lymphocyte cell number IAGP N RGD:2306526|PMID:19351909 20090427 RGD 2306542 BBDR.F344-(D4Rat253-D4Rhw8),BBDP-(D4Rhw6-D4Rat62)/Rhw strain MP:0005580 periinsulitis susceptibility IAGP N RGD:2306526|PMID:19351909 20200303 RGD 2306543 BBDR.F344-(D4Got59-D4Rhw8),BBDP-(D4Rhw6-D4Rat62)/Rhw strain MP:0004804 decreased susceptibility to autoimmune diabetes IAGP N RGD:2306526|PMID:19351909 20090427 RGD as compared to BBDR.BBDP-(D4Rhw11-D4Rhw10)/Rhw 2306543 BBDR.F344-(D4Got59-D4Rhw8),BBDP-(D4Rhw6-D4Rat62)/Rhw strain MP:0005018 decreased T cell number IAGP N RGD:2306526|PMID:19351909 20090427 RGD 2306543 BBDR.F344-(D4Got59-D4Rhw8),BBDP-(D4Rhw6-D4Rat62)/Rhw strain MP:0005580 periinsulitis susceptibility IAGP N RGD:2306526|PMID:19351909 20200303 RGD 2306544 BBDR.F344-(D4Rat26-D4Rhw8),BBDP-(D4Rhw6-D4Rat62)/Rhw strain MP:0004804 decreased susceptibility to autoimmune diabetes IAGP N RGD:2306526|PMID:19351909 20090427 RGD 2306544 BBDR.F344-(D4Rat26-D4Rhw8),BBDP-(D4Rhw6-D4Rat62)/Rhw strain MP:0005018 decreased T cell number IAGP N RGD:2306526|PMID:19351909 20090427 RGD 2306544 BBDR.F344-(D4Rat26-D4Rhw8),BBDP-(D4Rhw6-D4Rat62)/Rhw strain MP:0005580 periinsulitis susceptibility IAGP N RGD:2306526|PMID:19351909 20200303 RGD 2306545 Iddm39 Insulin dependent diabetes mellitus QTL 39 qtl MP:0004031 insulitis resistance IDA N RGD:2306526|PMID:19351909 20090427 RGD 2306545 Iddm39 Insulin dependent diabetes mellitus QTL 39 qtl MP:0004804 decreased susceptibility to autoimmune diabetes IDA N RGD:2306526|PMID:19351909 20090427 RGD 2306547 Iddm38 Insulin dependent diabetes mellitus QTL 38 qtl MP:0004031 insulitis resistance IDA N RGD:2306526|PMID:19351909 20090427 RGD 2306547 Iddm38 Insulin dependent diabetes mellitus QTL 38 qtl MP:0004804 decreased susceptibility to autoimmune diabetes IDA N RGD:2306526|PMID:19351909 20090427 RGD 2306717 BBDP/WorSunn strain MP:0000708 thymus hyperplasia IAGP N RGD:10043114|PMID:24920533 20200302 RGD compared to ACI.BBDP-(RT1u)(Gimap5)/Sunn 2306717 BBDP/WorSunn strain MP:0002497 increased IgE level IAGP N RGD:10043114|PMID:24920533 20200302 RGD compared to congenic strains 2306717 BBDP/WorSunn strain MP:0005425 increased macrophage cell number IAGP N RGD:10043114|PMID:24920533 20200302 RGD compared to ACI.BBDP-(RT1u)(Gimap5)/Sunn, spleen 2306784 Kini:DA,PVG-G12 strain MP:0000747 muscle weakness induced IAGP XCO:0000292,XCO:0000265 N RGD:2306769|PMID:19299744 20090506 RGD 2306784 Kini:DA,PVG-G12 strain MP:0001263 weight loss induced IAGP XCO:0000292,XCO:0000265 N RGD:2306769|PMID:19299744 20090506 RGD 2306787 Ean3 Experimental allergic neuritis QTL 3 qtl MP:0000747 muscle weakness IDA N RGD:2306769|PMID:19299744 20090506 RGD 2306787 Ean3 Experimental allergic neuritis QTL 3 qtl MP:0000921 demyelination IDA N RGD:2306769|PMID:19299744 20090506 RGD 2306787 Ean3 Experimental allergic neuritis QTL 3 qtl MP:0001263 weight loss IDA N RGD:2306769|PMID:19299744 20090506 RGD 2306789 Ean6 Experimental allergic neuritis QTL 6 qtl MP:0000747 muscle weakness IDA N RGD:2306769|PMID:19299744 20090506 RGD 2306789 Ean6 Experimental allergic neuritis QTL 6 qtl MP:0000921 demyelination IDA N RGD:2306769|PMID:19299744 20090506 RGD 2306790 Ean1 Experimental allergic neuritis QTL 1 qtl MP:0000747 muscle weakness IDA N RGD:2306736|PMID:15342198 20090506 RGD 2306790 Ean1 Experimental allergic neuritis QTL 1 qtl MP:0000921 demyelination IDA N RGD:2306736|PMID:15342198 20090506 RGD 2306792 Ean4 Experimental allergic neuritis QTL 4 qtl MP:0000747 muscle weakness IDA N RGD:2306769|PMID:19299744 20090506 RGD 2306792 Ean4 Experimental allergic neuritis QTL 4 qtl MP:0000921 demyelination IDA N RGD:2306769|PMID:19299744 20090506 RGD 2306792 Ean4 Experimental allergic neuritis QTL 4 qtl MP:0001829 increased activated T cell number IDA N RGD:2306769|PMID:19299744 20090506 RGD 2306792 Ean4 Experimental allergic neuritis QTL 4 qtl MP:0005348 increased T cell proliferation IDA N RGD:2306769|PMID:19299744 20090506 RGD 2306792 Ean4 Experimental allergic neuritis QTL 4 qtl MP:0008559 abnormal interferon-gamma secretion IDA N RGD:2306769|PMID:19299744 20090506 RGD 2306793 Ean5 Experimental allergic neuritis QTL 5 qtl MP:0000747 muscle weakness IDA N RGD:2306769|PMID:19299744 20090506 RGD 2306793 Ean5 Experimental allergic neuritis QTL 5 qtl MP:0000921 demyelination IDA N RGD:2306769|PMID:19299744 20090506 RGD 2306793 Ean5 Experimental allergic neuritis QTL 5 qtl MP:0001829 increased activated T cell number IDA N RGD:2306769|PMID:19299744 20090506 RGD 2306793 Ean5 Experimental allergic neuritis QTL 5 qtl MP:0005348 increased T cell proliferation IDA N RGD:2306769|PMID:19299744 20090506 RGD 2306793 Ean5 Experimental allergic neuritis QTL 5 qtl MP:0008559 abnormal interferon-gamma secretion IDA N RGD:2306769|PMID:19299744 20090506 RGD 2306794 Ean2 Experimental allergic neuritis QTL 2 qtl MP:0000747 muscle weakness IDA N RGD:2306769|PMID:19299744 20090506 RGD 2306794 Ean2 Experimental allergic neuritis QTL 2 qtl MP:0000921 demyelination IDA N RGD:2306769|PMID:19299744 20090506 RGD 2306794 Ean2 Experimental allergic neuritis QTL 2 qtl MP:0001829 increased activated T cell number IDA N RGD:2306769|PMID:19299744 20090506 RGD 2306794 Ean2 Experimental allergic neuritis QTL 2 qtl MP:0005348 increased T cell proliferation IDA N RGD:2306769|PMID:19299744 20090506 RGD 2306794 Ean2 Experimental allergic neuritis QTL 2 qtl MP:0008559 abnormal interferon-gamma secretion IDA N RGD:2306769|PMID:19299744 20090506 RGD 2306815 SS.SR-(D7Rat67-D7Mco7)/Jr strain MP:0002834 decreased heart weight IAGP N RGD:629613|PMID:12682779 20201021 RGD compared to SS/Jr 2306815 SS.SR-(D7Rat67-D7Mco7)/Jr strain MP:0006264 decreased systemic arterial systolic blood pressure MODEL: induced IAGP N RGD:629613|PMID:12682779 20090507 RGD as compared to SS/Jr on 2% Nacl diet 2306816 SS.SR-(D7Mco19-D7Mco7)/Jr strain MP:0002834 decreased heart weight IMP N RGD:629613|PMID:12682779 20201021 RGD compared to SS/Jr 2306816 SS.SR-(D7Mco19-D7Mco7)/Jr strain MP:0006264 decreased systemic arterial systolic blood pressure MODEL: induced IMP N RGD:629613|PMID:12682779 20090507 RGD compared to SS/Jr on 2% Nacl diet 2306817 SS.SR-(D7Uia1-D7Mco19)/Jr strain MP:0004217 salt-sensitive hypertension IAGP N RGD:629613|PMID:12682779 20201021 RGD compared to SS/Jr and congenics 2306818 SS.SR-(D7Rat131-D7Mco7)/Jr strain MP:0002834 decreased heart weight IAGP N RGD:629613|PMID:12682779 20201021 RGD compared to SS/Jr 2306818 SS.SR-(D7Rat131-D7Mco7)/Jr strain MP:0006264 decreased systemic arterial systolic blood pressure MODEL: induced IAGP N RGD:629613|PMID:12682779 20090507 RGD as compared to SS/Jr on 4% Nacl diet 2306819 SS.SR-(D7Uia1-D7Rat131)/Jr strain MP:0004217 salt-sensitive hypertension IAGP N RGD:629613|PMID:12682779 20201021 RGD compared to SS/Jr and congenics 2306820 SS.SR-(D3Arb14-D3Mco36)/Mco strain MP:0006264 decreased systemic arterial systolic blood pressure IMP N RGD:2306800|PMID:19255363 20201023 RGD as compared to SS/Jr and RNO7 congenic on 2% NaCl diet 2306821 Bp335 Blood pressure QTL 335 qtl MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:629613|PMID:12682779 20090507 RGD as compared to SS/Jr on 2% NaCl diet 2306840 E3.DA-(D4Wox22-D4Got132)(D12Wox5-D12Rat26)/Rhd strain MP:0002493 increased IgG level IMP N RGD:2306838|PMID:19180494 20090508 RGD compared to the parental E3/ZtmRhd rats 2306841 E3.DA-(D12Wox5-D12Rat26)/Rhd strain MP:0002493 increased IgG level IMP N RGD:2306838|PMID:19180494 20090508 RGD compared to the parental E3/ZtmRhd rats 2306850 Pia40 Pristane induced arthritis QTL 40 qtl MP:0002933 joint inflammation IDA N RGD:2306838|PMID:19180494 20090508 RGD Induced by Pristane 2306850 Pia40 Pristane induced arthritis QTL 40 qtl MP:0003079 decreased susceptibility to induced joint inflammation IDA N RGD:2306838|PMID:19180494 20090508 RGD Induced by Pristane 2306892 SHR.BN-(D2Rat114-D2Rat123)/Jk strain MP:0004876 decreased mean systemic arterial blood pressure IAGP N RGD:2306880|PMID:19126752 20200411 RGD compared to SHR strain 2306892 SHR.BN-(D2Rat114-D2Rat123)/Jk strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000164 N RGD:2306880|PMID:19126752 20200411 RGD compared to SHR strain 2306892 SHR.BN-(D2Rat114-D2Rat123)/Jk strain MP:0005333 decreased heart rate MODEL: induced IAGP XCO:0000164 N RGD:2306880|PMID:19126752 20090512 RGD as compared to SHR 2306892 SHR.BN-(D2Rat114-D2Rat123)/Jk strain MP:0006263 decreased systemic arterial diastolic blood pressure IAGP N RGD:2306880|PMID:19126752 20200411 RGD compared to SHR strain 2306892 SHR.BN-(D2Rat114-D2Rat123)/Jk strain MP:0006263 decreased systemic arterial diastolic blood pressure induced IAGP XCO:0000164 N RGD:2306880|PMID:19126752 20200411 RGD compared to SHR strain 2306892 SHR.BN-(D2Rat114-D2Rat123)/Jk strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:2306880|PMID:19126752 20200411 RGD compared to SHR strain 2306892 SHR.BN-(D2Rat114-D2Rat123)/Jk strain MP:0006264 decreased systemic arterial systolic blood pressure induced IAGP XCO:0000164 N RGD:2306880|PMID:19126752 20090512 RGD compared to SHR strain 2306893 SHR.BN-(D16Rat87-D16Mgh1)/Jk strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000164 N RGD:2306880|PMID:19126752 20200411 RGD compared to SHR strain 2306893 SHR.BN-(D16Rat87-D16Mgh1)/Jk strain MP:0005333 decreased heart rate induced IAGP XCO:0000164 N RGD:2306880|PMID:19126752 20200411 RGD compared to SHR strain 2306893 SHR.BN-(D16Rat87-D16Mgh1)/Jk strain MP:0006263 decreased systemic arterial diastolic blood pressure induced IAGP XCO:0000164 N RGD:2306880|PMID:19126752 20200411 RGD compared to SHR strain 2306893 SHR.BN-(D16Rat87-D16Mgh1)/Jk strain MP:0006264 decreased systemic arterial systolic blood pressure induced IAGP XCO:0000164 N RGD:2306880|PMID:19126752 20090512 RGD compared to SHR strain 2306894 SHR.BN-(D4Rat33-D4Rat54)/Jk strain MP:0004876 decreased mean systemic arterial blood pressure IAGP XCO:0000164 N RGD:2306880|PMID:19126752 20200411 RGD compared to SHR strain 2306894 SHR.BN-(D4Rat33-D4Rat54)/Jk strain MP:0005333 decreased heart rate IAGP XCO:0000164 N RGD:2306880|PMID:19126752 20200411 RGD compared to SHR strain 2306894 SHR.BN-(D4Rat33-D4Rat54)/Jk strain MP:0006263 decreased systemic arterial diastolic blood pressure IAGP XCO:0000164 N RGD:2306880|PMID:19126752 20200411 RGD compared to SHR strain 2306894 SHR.BN-(D4Rat33-D4Rat54)/Jk strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP XCO:0000164 N RGD:2306880|PMID:19126752 20090512 RGD compared to SHR strain 2306895 SHR.BN-(D2Rat226-D2Rat294)/Jk strain MP:0001260 increased body weight IAGP N RGD:2306880|PMID:19126752 20200411 RGD compared to SHR strain 2306895 SHR.BN-(D2Rat226-D2Rat294)/Jk strain MP:0004876 decreased mean systemic arterial blood pressure IAGP N RGD:2306880|PMID:19126752 20200411 RGD compared to SHR strain 2306895 SHR.BN-(D2Rat226-D2Rat294)/Jk strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000164 N RGD:2306880|PMID:19126752 20200411 RGD compared to SHR strain 2306895 SHR.BN-(D2Rat226-D2Rat294)/Jk strain MP:0005333 decreased heart rate IAGP N RGD:2306880|PMID:19126752 20200411 RGD compared to SHR strain 2306895 SHR.BN-(D2Rat226-D2Rat294)/Jk strain MP:0005333 decreased heart rate induced IAGP XCO:0000164 N RGD:2306880|PMID:19126752 20090512 RGD compared to SHR strain 2306895 SHR.BN-(D2Rat226-D2Rat294)/Jk strain MP:0006263 decreased systemic arterial diastolic blood pressure IAGP N RGD:2306880|PMID:19126752 20200411 RGD compared to SHR strain 2306895 SHR.BN-(D2Rat226-D2Rat294)/Jk strain MP:0006263 decreased systemic arterial diastolic blood pressure induced IAGP XCO:0000164 N RGD:2306880|PMID:19126752 20200411 RGD compared to SHR strain 2306895 SHR.BN-(D2Rat226-D2Rat294)/Jk strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:2306880|PMID:19126752 20200411 RGD compared to SHR strain 2306895 SHR.BN-(D2Rat226-D2Rat294)/Jk strain MP:0006264 decreased systemic arterial systolic blood pressure induced IAGP XCO:0000164 N RGD:2306880|PMID:19126752 20090512 RGD compared to SHR strain 2306899 Bp338 Blood pressure QTL 338 qtl MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:2306880|PMID:19126752 20090512 RGD 2306901 Bp337 Blood pressure QTL 337 qtl MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:2306880|PMID:19126752 20090512 RGD 2306902 Bp339 Blood pressure QTL 339 qtl MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:2306880|PMID:19126752 20090512 RGD 2306903 Bp336 Blood pressure QTL 336 qtl MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:2306880|PMID:19126752 20090512 RGD 2306968 Anxrr23 Anxiety related response QTL 23 qtl MP:0001363 increased anxiety-related response IDA N RGD:625384|PMID:11932246 20090513 RGD 2306970 Anxrr22 Anxiety related response QTL 22 qtl MP:0001363 increased anxiety-related response IDA N RGD:625384|PMID:11932246 20090513 RGD 2306971 Anxrr21 Anxiety related response QTL 21 qtl MP:0001363 increased anxiety-related response IDA N RGD:625384|PMID:11932246 20090513 RGD 2306971 Anxrr21 Anxiety related response QTL 21 qtl MP:0001442 decreased grooming behavior IDA N RGD:625384|PMID:11932246 20090513 RGD 2306971 Anxrr21 Anxiety related response QTL 21 qtl MP:0004000 impaired passive avoidance behavior IDA N RGD:2313899|PMID:18971309 20091030 RGD 2307156 DA/ZtmKini strain MP:0000921 demyelination induced IAGP XCO:0000195 N RGD:4889889|PMID:20856809 20210104 RGD compared to DA.PVG-Eae23 2307156 DA/ZtmKini strain MP:0001263 weight loss severity IAGP XCO:0000265 N RGD:730281|PMID:12915467 20191205 RGD compared to control strains PVG.1AV1/Kini, LEW.1AV1/Kini 2307156 DA/ZtmKini strain MP:0001263 weight loss susceptibility IAGP XCO:0000263|XCO:0000280|XCO:0000281,XCO:0000265|XCO:0000266 N RGD:629560|PMID:12571866 20191202 RGD compared to control strain PVG.1AV1/Kini 2307156 DA/ZtmKini strain MP:0001846 increased inflammatory response severity IAGP XCO:0000265 N RGD:730281|PMID:12915467 20191205 RGD compared to control strains PVG.1AV1/Kini, LEW.1AV1/Kini 2307156 DA/ZtmKini strain MP:0002933 joint inflammation susceptibility IAGP XCO:0000263|XCO:0000280|XCO:0000281,XCO:0000265|XCO:0000266 N RGD:629560|PMID:12571866 20200815 RGD compared to control strain PVG.1AV1/Kini 2307156 DA/ZtmKini strain MP:0002936 joint swelling severity IAGP XCO:0000265 N RGD:730281|PMID:12915467 20191205 RGD compared to control strains PVG.1AV1/Kini, LEW.1AV1/Kini 2307156 DA/ZtmKini strain MP:0002936 joint swelling severity IAGP XCO:0000265,XCO:0000281 N RGD:737659|PMID:8972741 20200814 RGD compared to LEW.1AV1/Kini 2307156 DA/ZtmKini strain MP:0002936 joint swelling susceptibility IAGP XCO:0000265 N RGD:61087|PMID:9600974 19990101 RGD 2307156 DA/ZtmKini strain MP:0002936 joint swelling susceptibility IAGP XCO:0000265 N RGD:737659|PMID:8972741 20200814 RGD 2307156 DA/ZtmKini strain MP:0002993 autoimmune arthritis severity IAGP XCO:0000265 N RGD:730281|PMID:12915467 20191205 RGD compared to control strains PVG.1AV1/Kini, LEW.1AV1/Kini 2307156 DA/ZtmKini strain MP:0003561 rheumatoid arthritis severity IAGP XCO:0000265 N RGD:730281|PMID:12915467 20191205 RGD compared to control strains PVG.1AV1/Kini, LEW.1AV1/Kini 2307156 DA/ZtmKini strain MP:0003724 increased susceptibility to induced arthritis IAGP XCO:0000263|XCO:0000280|XCO:0000281,XCO:0000265|XCO:0000266 N RGD:629560|PMID:12571866 20191202 RGD compared to control strain PVG.1AV1/Kini 2307156 DA/ZtmKini strain MP:0004847 abnormal liver weight severity IAGP XCO:0000265 N RGD:730281|PMID:12915467 20191205 RGD compared to control strains PVG.1AV1/Kini, LEW.1AV1/Kini 2307156 DA/ZtmKini strain MP:0004951 abnormal spleen weight severity IAGP XCO:0000265 N RGD:730281|PMID:12915467 20191205 RGD compared to control strains PVG.1AV1/Kini, LEW.1AV1/Kini 2307156 DA/ZtmKini strain MP:0004954 abnormal thymus weight severity IAGP XCO:0000265 N RGD:730281|PMID:12915467 20191205 RGD compared to control strains PVG.1AV1/Kini, LEW.1AV1/Kini 2307156 DA/ZtmKini strain MP:0006082 CNS inflammation induced IAGP XCO:0000195 N RGD:4888518|PMID:21041731 20200505 RGD 2307156 DA/ZtmKini strain MP:0006082 CNS inflammation induced IAGP XCO:0000195 N RGD:4889889|PMID:20856809 20210104 RGD compared to DA.PVG-Eae23 2307156 DA/ZtmKini strain MP:0009623 enlarged inguinal lymph nodes severity IAGP XCO:0000265 N RGD:730281|PMID:12915467 20191205 RGD compared to control strains PVG.1AV1/Kini, LEW.1AV1/Kini 2307156 DA/ZtmKini strain MP:0010211 abnormal acute phase protein level severity IAGP XCO:0000265 N RGD:730281|PMID:12915467 20191205 RGD compared to control strains PVG.1AV1/Kini, LEW.1AV1/Kini 2307157 PVG.1AV1/Kini strain MP:0002933 joint inflammation penetrance IAGP XCO:0000281,XCO:0000265|XCO:0000263 N RGD:629560|PMID:12571866 20200815 RGD 2307157 PVG.1AV1/Kini strain MP:0003436 decreased susceptibility to induced arthritis penetrance IAGP XCO:0000263|XCO:0000280|XCO:0000281,XCO:0000265|XCO:0000266 N RGD:629560|PMID:12571866 20191202 RGD compared to DA/ZtmKini 2307157 PVG.1AV1/Kini strain MP:0008499 increased IgG1 level IAGP XCO:0000281,XCO:0000265 N RGD:629560|PMID:12571866 20191202 RGD compared to DA/ZtmKini 2307157 PVG.1AV1/Kini strain MP:0008501 increased IgG2b level IAGP XCO:0000281,XCO:0000265 N RGD:629560|PMID:12571866 20191202 RGD compared to DA/ZtmKini 2307157 PVG.1AV1/Kini strain MP:0008896 increased IgG2c level IAGP XCO:0000281,XCO:0000265 N RGD:629560|PMID:12571866 20191202 RGD compared to DA/ZtmKini 2307159 SHRSR.SHRSP-(Klk1-Mt1-ps1)/Bbb strain MP:0002962 increased urine protein level induced IAGP XCO:0000022,XCO:0000164,XCO:0000032,XCO:0000030 N RGD:2307158|PMID:16835352 20090520 RGD compared to SHRSR/Bbb 2307159 SHRSR.SHRSP-(Klk1-Mt1-ps1)/Bbb strain MP:0003076 increased susceptibility to ischemic brain injury induced IAGP XCO:0000022,XCO:0000164,XCO:0000032,XCO:0000030 N RGD:2307158|PMID:16835352 20090520 RGD compared to SHRSR/Bbb 2307160 SHRSR.SHRSP-(Klk1-D1Mit3)/Bbb strain MP:0002963 decreased urine protein level induced IAGP XCO:0000022,XCO:0000164,XCO:0000032,XCO:0000030 N RGD:2307158|PMID:16835352 20090520 RGD compared to SHRSP/Bbb 2307160 SHRSR.SHRSP-(Klk1-D1Mit3)/Bbb strain MP:0003076 increased susceptibility to ischemic brain injury induced IAGP XCO:0000022,XCO:0000164,XCO:0000032,XCO:0000030 N RGD:2307158|PMID:16835352 20191211 RGD compared to SHRSR/Bbb 2307161 SHRSR.SHRSP-(D1Rat134-Mt1-ps1)/Bbb strain MP:0002962 increased urine protein level induced IAGP XCO:0000022,XCO:0000164,XCO:0000032,XCO:0000030 N RGD:2307158|PMID:16835352 20090520 RGD compared to SHRSR/Bbb 2307161 SHRSR.SHRSP-(D1Rat134-Mt1-ps1)/Bbb strain MP:0003076 increased susceptibility to ischemic brain injury induced IAGP XCO:0000022,XCO:0000164,XCO:0000032,XCO:0000030 N RGD:2307158|PMID:16835352 20090520 RGD compared to SHRSR/Bbb 2307166 SHRSP.SHRSR-(Klk1-Mt1-ps1)/Bbb strain MP:0002962 increased urine protein level induced IAGP XCO:0000022,XCO:0000164,XCO:0000032,XCO:0000030 N RGD:2307158|PMID:16835352 20191211 RGD compared to SHRSR/Bbb 2307166 SHRSP.SHRSR-(Klk1-Mt1-ps1)/Bbb strain MP:0006059 decreased susceptibility to ischemic brain injury induced IAGP XCO:0000022,XCO:0000164,XCO:0000032,XCO:0000030 N RGD:2307158|PMID:16835352 20090520 RGD compared to SHRSP/Bbb 2307167 SHRSP.SHRSR-(Klk1-D1Mit3)/Bbb strain MP:0002962 increased urine protein level induced IAGP XCO:0000022,XCO:0000164,XCO:0000032,XCO:0000030 N RGD:2307158|PMID:16835352 20191211 RGD compared to SHRSR/Bbb 2307167 SHRSP.SHRSR-(Klk1-D1Mit3)/Bbb strain MP:0006059 decreased susceptibility to ischemic brain injury induced IAGP XCO:0000022,XCO:0000164,XCO:0000032,XCO:0000030 N RGD:2307158|PMID:16835352 20191211 RGD compared to SHRSP/Bbb 2307167 SHRSP.SHRSR-(Klk1-D1Mit3)/Bbb strain MP:0008770 decreased survivor rate induced IAGP XCO:0000022,XCO:0000164,XCO:0000032,XCO:0000030 N RGD:2307158|PMID:16835352 20191211 RGD compared to SHRSR/Bbb 2307168 SHRSR/Bbb Spontaneously Hypertensive Rat, Stroke Resistant strain MP:0006059 decreased susceptibility to ischemic brain injury induced IAGP XCO:0000022,XCO:0000164,XCO:0000032,XCO:0000030 N RGD:2307158|PMID:16835352 20090520 RGD compared to SHRSP/Bbb 2307169 SHRSP.SHRSR-(D1Rat134-Mt1-ps1)/Bbb strain MP:0002962 increased urine protein level induced IAGP XCO:0000022,XCO:0000164,XCO:0000032,XCO:0000030 N RGD:2307158|PMID:16835352 20191211 RGD compared to SHRSR/Bbb 2307169 SHRSP.SHRSR-(D1Rat134-Mt1-ps1)/Bbb strain MP:0006059 decreased susceptibility to ischemic brain injury induced IAGP XCO:0000022,XCO:0000164,XCO:0000032,XCO:0000030 N RGD:2307158|PMID:16835352 20090520 RGD compared to SHRSP/Bbb 2307172 Activ4 Activity QTL 4 qtl MP:0001399 hyperactivity IDA N RGD:2306974|PMID:19089625 20090520 RGD 2307172 Activ4 Activity QTL 4 qtl MP:0001415 increased exploration in new environment IDA N RGD:2306974|PMID:19089625 20090520 RGD 2307174 Activ3 Activity QTL 3 qtl MP:0001399 hyperactivity IDA N RGD:2306974|PMID:19089625 20090520 RGD 2307174 Activ3 Activity QTL 3 qtl MP:0001415 increased exploration in new environment IDA N RGD:2306974|PMID:19089625 20090520 RGD 2307300 LEW.1AV1/Kini strain MP:0002936 joint swelling penetrance IAGP XCO:0000265, XCO:0000281 N RGD:737659|PMID:8972741 19990101 RGD 2307317 MHS Milan Hypertensive Strain strain MP:0004217 salt-sensitive hypertension IAGP N RGD:126848752|PMID:18480177 20210429 RGD compared to MNS 2307318 BDIX/Ifz strain MP:0002030 increased neurofibrosarcoma incidence IAGP N RGD:11556249|PMID:21427360 20211222 RGD compared to BDIV inbred strain and BDIX.BDIV-D6Mit1-D6Mgh2/Zte congenic strain 2307318 BDIX/Ifz strain MP:0008770 decreased survivor rate IAGP N RGD:11556249|PMID:21427360 20211222 RGD compared to BDIV inbred strain and BDIX.BDIV-D6Mit1-D6Mgh2/Zte congenic strain 2307318 BDIX/Ifz strain MP:0009766 increased susceptibility to xenobiotic induced morbidity/mortality IAGP N RGD:11556249|PMID:21427360 20211222 RGD compared to BDIV inbred strain and BDIX.BDIV-D6Mit1-D6Mgh2/Zte congenic strain 2308852 Crl:LE Long-Evans Rats strain MP:0020162 decreased susceptibility to virus induced diabetes induced IAGP XCO:0000238 N RGD:2313207|PMID:1658938 20200225 RGD compared to BBDR/WorBrm 2308886 SS/HsdMcwiCrl strain MP:0009764 decreased susceptibility to induced morbidity/mortality induced IAGP XCO:0000668 N RGD:2302114|PMID:17998886 20200330 RGD compared to treated FHH/EurMcwiCrl 2311 Cd59b CD59b molecule gene MP:0002640 reticulocytosis IMP N RGD:13792592|PMID:28212662 20180924 RGD 2311 Cd59b CD59b molecule gene MP:0002875 decreased erythrocyte cell number IMP N RGD:13792592|PMID:28212662 20180924 RGD 2311 Cd59b CD59b molecule gene MP:0005615 increased susceptibility to type III hypersensitivity reaction IMP N RGD:13792592|PMID:28212662 20180924 RGD 2311 Cd59b CD59b molecule gene MP:0010067 increased red blood cell distribution width IMP N RGD:13792592|PMID:28212662 20180924 RGD 2311051 SHRSP/A3NCrl Stroke Prone Rats strain MP:0002959 increased urine microalbumin level susceptibility IAGP XCO:0000164,XCO:0000025 N RGD:25824851|PMID:22783192 20200728 RGD compared to standard rat chow fed SHRSP/A3NCrl 2311051 SHRSP/A3NCrl Stroke Prone Rats strain MP:0003915 increased heart left ventricle weight susceptibility IAGP XCO:0000164,XCO:0000025 N RGD:25824851|PMID:22783192 20200728 RGD compared to standard rat chow fed SHRSP/A3NCrl 2311051 SHRSP/A3NCrl Stroke Prone Rats strain MP:0005167 abnormal blood-brain barrier function susceptibility IAGP XCO:0000704 N RGD:27095946|PMID:29486300 20200728 RGD compared to sham operated SHRSP/A3NCrl 2311051 SHRSP/A3NCrl Stroke Prone Rats strain MP:0005591 decreased vasodilation susceptibility IAGP XCO:0000164,XCO:0000025 N RGD:25824851|PMID:22783192 20200728 RGD compared to standard rat chow fed SHRSP/A3NCrl 2311051 SHRSP/A3NCrl Stroke Prone Rats strain MP:0006060 increased cerebral infarct size susceptibility IAGP XCO:0000704 N RGD:27095946|PMID:29486300 20200728 RGD compared to sham operated SHRSP/A3NCrl 2311051 SHRSP/A3NCrl Stroke Prone Rats strain MP:0006080 brain ischemia susceptibility IAGP XCO:0000704 N RGD:27095946|PMID:29486300 20200728 RGD compared to sham operated SHRSP/A3NCrl 2311051 SHRSP/A3NCrl Stroke Prone Rats strain MP:0006316 increased urine sodium level susceptibility IAGP XCO:0000164,XCO:0000025 N RGD:25824851|PMID:22783192 20200728 RGD compared to standard rat chow fed SHRSP/A3NCrl 2311051 SHRSP/A3NCrl Stroke Prone Rats strain MP:0008770 decreased survivor rate susceptibility IAGP XCO:0000164,XCO:0000025 N RGD:25824851|PMID:22783192 20200728 RGD compared to standard rat chow fed SHRSP/A3NCrl 2311051 SHRSP/A3NCrl Stroke Prone Rats strain MP:0011402 renal cast disease_progression IAGP N RGD:30296658|PMID:22031827 20200831 RGD compared to Crl:WI Wistar rat renal cortex 2311051 SHRSP/A3NCrl Stroke Prone Rats strain MP:0011431 increased urine flow rate susceptibility IAGP XCO:0000164,XCO:0000025 N RGD:25824851|PMID:22783192 20200728 RGD compared to standard rat chow fed SHRSP/A3NCrl 2311051 SHRSP/A3NCrl Stroke Prone Rats strain MP:0020455 increased erythrocyte aggregation disease_progression IAGP N RGD:30296658|PMID:22031827 20200831 RGD compared to Crl:WI Wistar rat renal cortex 2311072 FHH/EurMcwiCrl strain MP:0001260 increased body weight IAGP N RGD:25314268|PMID:19420905 20210329 RGD compared to LEW 2311072 FHH/EurMcwiCrl strain MP:0005178 increased circulating cholesterol level IAGP N RGD:25314268|PMID:19420905 20210329 RGD compared to LEW 2311072 FHH/EurMcwiCrl strain MP:0005557 increased creatinine clearance IAGP N RGD:25314268|PMID:19420905 20210329 RGD compared to LEW and MWF/Hsd 2311072 FHH/EurMcwiCrl strain MP:0010754 abnormal heart left ventricle pressure IAGP N RGD:25314268|PMID:19420905 20210329 RGD compared to LEW 2311072 FHH/EurMcwiCrl strain MP:0030662 decreased circulating arginine level IAGP N RGD:25314268|PMID:19420905 20210329 RGD compared to LEW 2312418 Kidm41 Kidney mass QTL 41 qtl MP:0003918 decreased kidney weight IDA N RGD:2312387|PMID:19448344 20090812 RGD 2312420 Pur17 Proteinuria QTL 17 qtl MP:0002962 increased urine protein level IDA N RGD:2312387|PMID:19448344 20090812 RGD 2312447 SD-Tg(Pmp22)Kan strain MP:0000747 muscle weakness IMP N RGD:2312445|PMID:8630243 20090817 RGD 2312447 SD-Tg(Pmp22)Kan strain MP:0000920 abnormal myelination IMP N RGD:2312445|PMID:8630243 20090817 RGD 2312447 SD-Tg(Pmp22)Kan strain MP:0001406 abnormal gait IMP N RGD:2312445|PMID:8630243 20090817 RGD 2312447 SD-Tg(Pmp22)Kan strain MP:0008814 decreased nerve conduction velocity IMP N RGD:2312445|PMID:8630243 20090817 RGD 2312558 Glom17 Glomerulus QTL 17 qtl MP:0000523 cortical renal glomerulopathies IDA N RGD:2312422|PMID:18682577 20090821 RGD 2312560 Pur20 Proteinuria QTL 20 qtl MP:0000523 cortical renal glomerulopathies IDA N RGD:2312422|PMID:18682577 20090821 RGD 2312560 Pur20 Proteinuria QTL 20 qtl MP:0002962 increased urine protein level IDA N RGD:2312422|PMID:18682577 20090821 RGD 2312562 Pur18 Proteinuria QTL 18 qtl MP:0000523 cortical renal glomerulopathies IDA N RGD:2312422|PMID:18682577 20090821 RGD 2312562 Pur18 Proteinuria QTL 18 qtl MP:0002962 increased urine protein level IDA N RGD:2312422|PMID:18682577 20090821 RGD 2312564 Glom18 Glomerulus QTL 18 qtl MP:0000523 cortical renal glomerulopathies IDA N RGD:2312422|PMID:18682577 20090821 RGD 2312566 Glom20 Glomerulus QTL 20 qtl MP:0000523 cortical renal glomerulopathies IDA N RGD:2312422|PMID:18682577 20090821 RGD 2312567 Glom19 Glomerulus QTL 19 qtl MP:0000523 cortical renal glomerulopathies IDA N RGD:2312422|PMID:18682577 20090821 RGD 2312568 Glom21 Glomerulus QTL 21 qtl MP:0000523 cortical renal glomerulopathies IDA N RGD:2312422|PMID:18682577 20090821 RGD 2312569 Pur19 Proteinuria QTL 19 qtl MP:0000523 cortical renal glomerulopathies IDA N RGD:2312422|PMID:18682577 20090821 RGD 2312569 Pur19 Proteinuria QTL 19 qtl MP:0002962 increased urine protein level IDA N RGD:2312422|PMID:18682577 20090821 RGD 2312577 SHR.BN-(D18Rat99-D18Rat82)/Ipcv strain MP:0006143 increased systemic arterial diastolic blood pressure induced IAGP XCO:0000164 N RGD:2312571|PMID:19620519 20200423 RGD 2312577 SHR.BN-(D18Rat99-D18Rat82)/Ipcv strain MP:0006144 increased systemic arterial systolic blood pressure induced IAGP XCO:0000164 N RGD:2312571|PMID:19620519 20090821 RGD 2312577 SHR.BN-(D18Rat99-D18Rat82)/Ipcv strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:2312571|PMID:19620519 20200505 RGD compared to SHR/OlaIpcv strain 2312578 SHR.BN-(D18Rat82)/Ipcv strain MP:0006144 increased systemic arterial systolic blood pressure induced IAGP XCO:0000164 N RGD:2312571|PMID:19620519 20090821 RGD compared to SHR/OlaIpcv strain 2312579 SHR.BN-(D18Rat40-D18Rat82)/Ipcv strain MP:0006143 increased systemic arterial diastolic blood pressure induced IAGP XCO:0000164 N RGD:2312571|PMID:19620519 20200505 RGD 2312579 SHR.BN-(D18Rat40-D18Rat82)/Ipcv strain MP:0006144 increased systemic arterial systolic blood pressure induced IAGP XCO:0000164 N RGD:2312571|PMID:19620519 20090821 RGD 2312579 SHR.BN-(D18Rat40-D18Rat82)/Ipcv strain MP:0006263 decreased systemic arterial diastolic blood pressure IAGP N RGD:2312571|PMID:19620519 20200505 RGD compared to SHR/OlaIpcv strain 2312579 SHR.BN-(D18Rat40-D18Rat82)/Ipcv strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:2312571|PMID:19620519 20200505 RGD compared to SHR/OlaIpcv strain 2312580 SHR.BN-(D18Rat113-D18Rat82)/Ipcv strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:2312571|PMID:19620519 20090821 RGD compared to SHR/OlaIpcv strain 2312598 Bp340 Blood pressure QTL 340 qtl MP:0006143 increased systemic arterial diastolic blood pressure induced IAGP XCO:0000164 N RGD:2312571|PMID:19620519 20200423 RGD 2312598 Bp340 Blood pressure QTL 340 qtl MP:0006144 increased systemic arterial systolic blood pressure induced IAGP XCO:0000164 N RGD:2312571|PMID:19620519 20090824 RGD 2312600 Bp341 Blood pressure QTL 341 qtl MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:2312571|PMID:19620519 20090824 RGD 2312609 MWF-Chr 8SHR/Rkb strain MP:0002962 increased urine protein level IAGP N RGD:2312602|PMID:18647879 20191220 RGD as compared to SHR/FubRkb 2312609 MWF-Chr 8SHR/Rkb strain MP:0003215 renal interstitial fibrosis IAGP N RGD:2312602|PMID:18647879 20191220 RGD as compared to SHR/FubRkb 2312609 MWF-Chr 8SHR/Rkb strain MP:0003916 decreased heart left ventricle weight IAGP N RGD:2312602|PMID:18647879 20191220 RGD as compared to SHR/FubRkb 2312609 MWF-Chr 8SHR/Rkb strain MP:0003918 decreased kidney weight IAGP N RGD:2312602|PMID:18647879 20191220 RGD as compared to SHR/FubRkb 2312609 MWF-Chr 8SHR/Rkb strain MP:0005557 increased creatinine clearance IAGP N RGD:2312602|PMID:18647879 20191220 RGD as compared to MWF/FubRkb 2312609 MWF-Chr 8SHR/Rkb strain MP:0005565 increased blood urea nitrogen level IAGP N RGD:2312602|PMID:18647879 20191220 RGD as compared to SHR/FubRkb 2312609 MWF-Chr 8SHR/Rkb strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:2312602|PMID:18647879 20191220 RGD as compared to SHR/FubRkb 2312609 MWF-Chr 8SHR/Rkb strain MP:0010064 increased circulating creatine level IAGP N RGD:2312602|PMID:18647879 20191220 RGD as compared to SHR/FubRkb 2312644 DA.WOKW-(D3Mit10-D3Rat189)/K strain MP:0003982 increased cholesterol level IAGP N RGD:2312642|PMID:19584880 20090828 RGD only in females; compared to DA/K 2312645 DA.WOKW-(D16Rat88-D16Wox7)/K strain MP:0002079 increased circulating insulin level IAGP N RGD:2312642|PMID:19584880 20090828 RGD only in females; compared to DA/K 2312645 DA.WOKW-(D16Rat88-D16Wox7)/K strain MP:0003982 increased cholesterol level IAGP N RGD:2312642|PMID:19584880 20090828 RGD only in females; compared to DA/K 2312645 DA.WOKW-(D16Rat88-D16Wox7)/K strain MP:0005669 increased circulating leptin level IAGP N RGD:2312642|PMID:19584880 20090828 RGD compared to DA/K 2312645 DA.WOKW-(D16Rat88-D16Wox7)/K strain MP:0010024 increased total body fat amount IAGP N RGD:2312642|PMID:19584880 20111107 RGD only in females; compared to DA/K 2312646 DA.WOKW-(D5Mgh6-D5Mit5)/K strain MP:0003982 increased cholesterol level IAGP N RGD:2312642|PMID:19584880 20090828 RGD only in females; compared to DA/K 2312647 DA.WOKW-(D3Mgh5-D3Rat1)/K strain MP:0003982 increased cholesterol level IAGP N RGD:2312642|PMID:19584880 20090828 RGD only in females; compared to DA/K 2312647 DA.WOKW-(D3Mgh5-D3Rat1)/K strain MP:0005669 increased circulating leptin level IAGP N RGD:2312642|PMID:19584880 20090828 RGD compared to DA/K 2312647 DA.WOKW-(D3Mgh5-D3Rat1)/K strain MP:0010024 increased total body fat amount IAGP N RGD:2312642|PMID:19584880 20111107 RGD compared to DA/K 2312648 DA.WOKW-(D10Mgh2-D10Rat4)/K strain MP:0002079 increased circulating insulin level IAGP N RGD:2312642|PMID:19584880 20090828 RGD compared to DA/K 2312648 DA.WOKW-(D10Mgh2-D10Rat4)/K strain MP:0003982 increased cholesterol level IAGP N RGD:2312642|PMID:19584880 20090828 RGD only in females; compared to DA/K 2312648 DA.WOKW-(D10Mgh2-D10Rat4)/K strain MP:0005669 increased circulating leptin level IAGP N RGD:2312642|PMID:19584880 20090828 RGD compared to DA/K 2312659 Slep7 Serum leptin concentration QTL 7 qtl MP:0005669 increased circulating leptin level IDA N RGD:2312642|PMID:19584880 20090828 RGD 2312660 Bw95 Body weight QTL 95 qtl MP:0010024 increased total body fat amount IDA N RGD:2312642|PMID:19584880 20111107 RGD 2312662 Slep8 Serum leptin concentration QTL 8 qtl MP:0005669 increased circulating leptin level IDA N RGD:2312642|PMID:19584880 20090828 RGD 2312663 Slep9 Serum leptin concentration QTL 9 qtl MP:0005669 increased circulating leptin level IDA N RGD:2312642|PMID:19584880 20090828 RGD 2312664 Scl62 Serum cholesterol level QTL 62 qtl MP:0003982 increased cholesterol level IDA N RGD:2312642|PMID:19584880 20090828 RGD 2312666 Insul16 Insulin level QTL 16 qtl MP:0002079 increased circulating insulin level IDA N RGD:2312642|PMID:19584880 20090828 RGD 2312668 Scl65 Serum cholesterol level QTL 65 qtl MP:0003982 increased cholesterol level IDA N RGD:2312642|PMID:19584880 20090828 RGD 2312669 Stl23 Serum triglyceride level QTL 23 qtl MP:0001552 increased circulating triglyceride level IDA N RGD:2312642|PMID:19584880 20090828 RGD 2312670 Bw94 Body weight QTL 94 qtl MP:0010024 increased total body fat amount IDA N RGD:2312642|PMID:19584880 20111107 RGD 2312671 Scl64 Serum cholesterol level QTL 64 qtl MP:0003982 increased cholesterol level IDA N RGD:2312642|PMID:19584880 20090828 RGD 2312672 Insul15 Insulin level QTL 15 qtl MP:0002079 increased circulating insulin level IDA N RGD:2312642|PMID:19584880 20090828 RGD 2312673 Scl63 Serum cholesterol level QTL 63 qtl MP:0003982 increased cholesterol level IDA N RGD:2312642|PMID:19584880 20090828 RGD 2313046 Bss78 Bone structure and strength QTL 78 qtl MP:0004016 decreased bone mass IDA N RGD:2312767|PMID:19113924 20090909 RGD 2313046 Bss78 Bone structure and strength QTL 78 qtl MP:0004991 decreased bone strength IDA N RGD:2312767|PMID:19113924 20090909 RGD 2313048 Bss84 Bone structure and strength QTL 84 qtl MP:0004016 decreased bone mass IDA N RGD:2312767|PMID:19113924 20090909 RGD 2313048 Bss84 Bone structure and strength QTL 84 qtl MP:0004991 decreased bone strength IDA N RGD:2312767|PMID:19113924 20090909 RGD 2313049 Bss72 Bone structure and strength QTL 72 qtl MP:0004016 decreased bone mass IDA N RGD:2312767|PMID:19113924 20090909 RGD 2313049 Bss72 Bone structure and strength QTL 72 qtl MP:0004991 decreased bone strength IDA N RGD:2312767|PMID:19113924 20090909 RGD 2313051 Bss57 Bone structure and strength QTL 57 qtl MP:0004016 decreased bone mass IDA N RGD:2312767|PMID:19113924 20090909 RGD 2313051 Bss57 Bone structure and strength QTL 57 qtl MP:0004991 decreased bone strength IDA N RGD:2312767|PMID:19113924 20090909 RGD 2313053 Bss51 Bone structure and strength QTL 51 qtl MP:0004016 decreased bone mass IDA N RGD:2312767|PMID:19113924 20090909 RGD 2313053 Bss51 Bone structure and strength QTL 51 qtl MP:0004991 decreased bone strength IDA N RGD:2312767|PMID:19113924 20090909 RGD 2313055 Bw96 Body weight QTL 96 qtl MP:0000062 increased bone mineral density IDA N RGD:2312767|PMID:19113924 20090909 RGD as compared to males 2313057 Bss76 Bone structure and strength QTL 76 qtl MP:0004016 decreased bone mass IDA N RGD:2312767|PMID:19113924 20090909 RGD 2313057 Bss76 Bone structure and strength QTL 76 qtl MP:0004991 decreased bone strength IDA N RGD:2312767|PMID:19113924 20090909 RGD 2313059 Bss55 Bone structure and strength QTL 55 qtl MP:0004016 decreased bone mass IDA N RGD:2312767|PMID:19113924 20090909 RGD 2313059 Bss55 Bone structure and strength QTL 55 qtl MP:0004991 decreased bone strength IDA N RGD:2312767|PMID:19113924 20090909 RGD 2313060 Bss71 Bone structure and strength QTL 71 qtl MP:0000063 decreased bone mineral density IDA N RGD:2312767|PMID:19113924 20090909 RGD as compared to females 2313060 Bss71 Bone structure and strength QTL 71 qtl MP:0004016 decreased bone mass IDA N RGD:2312767|PMID:19113924 20090909 RGD 2313060 Bss71 Bone structure and strength QTL 71 qtl MP:0004991 decreased bone strength IDA N RGD:2312767|PMID:19113924 20090909 RGD 2313062 Bmd73 Bone mineral density QTL 73 qtl MP:0000062 increased bone mineral density IDA N RGD:2312767|PMID:19113924 20090909 RGD as compared to males 2313064 Bmd71 Bone mineral density QTL 71 qtl MP:0000063 decreased bone mineral density IDA N RGD:2312767|PMID:19113924 20090909 RGD as compared to females 2313065 Bss67 Bone structure and strength QTL 67 qtl MP:0004016 decreased bone mass IDA N RGD:2312767|PMID:19113924 20090909 RGD 2313065 Bss67 Bone structure and strength QTL 67 qtl MP:0004991 decreased bone strength IDA N RGD:2312767|PMID:19113924 20090909 RGD 2313066 Bss63 Bone structure and strength QTL 63 qtl MP:0004016 decreased bone mass IDA N RGD:2312767|PMID:19113924 20090909 RGD 2313066 Bss63 Bone structure and strength QTL 63 qtl MP:0004991 decreased bone strength IDA N RGD:2312767|PMID:19113924 20090909 RGD 2313067 Bss77 Bone structure and strength QTL 77 qtl MP:0004016 decreased bone mass IDA N RGD:2312767|PMID:19113924 20090909 RGD 2313067 Bss77 Bone structure and strength QTL 77 qtl MP:0004991 decreased bone strength IDA N RGD:2312767|PMID:19113924 20090909 RGD 2313069 Bss68 Bone structure and strength QTL 68 qtl MP:0004016 decreased bone mass IDA N RGD:2312767|PMID:19113924 20090909 RGD 2313069 Bss68 Bone structure and strength QTL 68 qtl MP:0004991 decreased bone strength IDA N RGD:2312767|PMID:19113924 20090909 RGD 2313070 Bss52 Bone structure and strength QTL 52 qtl MP:0004016 decreased bone mass IDA N RGD:2312767|PMID:19113924 20090909 RGD 2313070 Bss52 Bone structure and strength QTL 52 qtl MP:0004991 decreased bone strength IDA N RGD:2312767|PMID:19113924 20090909 RGD 2313072 Bss53 Bone structure and strength QTL 53 qtl MP:0004016 decreased bone mass IDA N RGD:2312767|PMID:19113924 20090909 RGD 2313072 Bss53 Bone structure and strength QTL 53 qtl MP:0004991 decreased bone strength IDA N RGD:2312767|PMID:19113924 20090909 RGD 2313073 Bmd75 Bone mineral density QTL 75 qtl MP:0000062 increased bone mineral density IDA N RGD:2312767|PMID:19113924 20090909 RGD as compared to males 2313075 Bss66 Bone structure and strength QTL 66 qtl MP:0004016 decreased bone mass IDA N RGD:2312767|PMID:19113924 20090909 RGD 2313075 Bss66 Bone structure and strength QTL 66 qtl MP:0004991 decreased bone strength IDA N RGD:2312767|PMID:19113924 20090909 RGD 2313076 Bss74 Bone structure and strength QTL 74 qtl MP:0004016 decreased bone mass IDA N RGD:2312767|PMID:19113924 20090909 RGD 2313076 Bss74 Bone structure and strength QTL 74 qtl MP:0004991 decreased bone strength IDA N RGD:2312767|PMID:19113924 20090909 RGD 2313077 Bss69 Bone structure and strength QTL 69 qtl MP:0004016 decreased bone mass IDA N RGD:2312767|PMID:19113924 20090909 RGD 2313077 Bss69 Bone structure and strength QTL 69 qtl MP:0004991 decreased bone strength IDA N RGD:2312767|PMID:19113924 20090909 RGD 2313078 Bss54 Bone structure and strength QTL 54 qtl MP:0004016 decreased bone mass IDA N RGD:2312767|PMID:19113924 20090909 RGD 2313078 Bss54 Bone structure and strength QTL 54 qtl MP:0004991 decreased bone strength IDA N RGD:2312767|PMID:19113924 20090909 RGD 2313079 Bss73 Bone structure and strength QTL 73 qtl MP:0004016 decreased bone mass IDA N RGD:2312767|PMID:19113924 20090909 RGD 2313079 Bss73 Bone structure and strength QTL 73 qtl MP:0004991 decreased bone strength IDA N RGD:2312767|PMID:19113924 20090909 RGD 2313080 Bss65 Bone structure and strength QTL 65 qtl MP:0004016 decreased bone mass IDA N RGD:2312767|PMID:19113924 20090909 RGD 2313080 Bss65 Bone structure and strength QTL 65 qtl MP:0004991 decreased bone strength IDA N RGD:2312767|PMID:19113924 20090909 RGD 2313081 Bss64 Bone structure and strength QTL 64 qtl MP:0004016 decreased bone mass IDA N RGD:2312767|PMID:19113924 20090909 RGD 2313081 Bss64 Bone structure and strength QTL 64 qtl MP:0004991 decreased bone strength IDA N RGD:2312767|PMID:19113924 20090909 RGD 2313082 Bss85 Bone structure and strength QTL 85 qtl MP:0004016 decreased bone mass IDA N RGD:2312767|PMID:19113924 20090909 RGD 2313082 Bss85 Bone structure and strength QTL 85 qtl MP:0004991 decreased bone strength IDA N RGD:2312767|PMID:19113924 20090909 RGD 2313083 Bmd74 Bone mineral density QTL 74 qtl MP:0000062 increased bone mineral density IDA N RGD:2312767|PMID:19113924 20090909 RGD as compared to males 2313084 Bss83 Bone structure and strength QTL 83 qtl MP:0004016 decreased bone mass IDA N RGD:2312767|PMID:19113924 20090909 RGD 2313084 Bss83 Bone structure and strength QTL 83 qtl MP:0004991 decreased bone strength IDA N RGD:2312767|PMID:19113924 20090909 RGD 2313085 Bss59 Bone structure and strength QTL 59 qtl MP:0004016 decreased bone mass IDA N RGD:2312767|PMID:19113924 20090909 RGD 2313085 Bss59 Bone structure and strength QTL 59 qtl MP:0004991 decreased bone strength IDA N RGD:2312767|PMID:19113924 20090909 RGD 2313086 Bss60 Bone structure and strength QTL 60 qtl MP:0004016 decreased bone mass IDA N RGD:2312767|PMID:19113924 20090909 RGD 2313086 Bss60 Bone structure and strength QTL 60 qtl MP:0004991 decreased bone strength IDA N RGD:2312767|PMID:19113924 20090909 RGD 2313087 Bmd80 Bone mineral density QTL 80 qtl MP:0000062 increased bone mineral density IDA N RGD:2312767|PMID:19113924 20090909 RGD as compared to males 2313088 Bss75 Bone structure and strength QTL 75 qtl MP:0004016 decreased bone mass IDA N RGD:2312767|PMID:19113924 20090909 RGD 2313088 Bss75 Bone structure and strength QTL 75 qtl MP:0004991 decreased bone strength IDA N RGD:2312767|PMID:19113924 20090909 RGD 2313089 Bss81 Bone structure and strength QTL 81 qtl MP:0004016 decreased bone mass IDA N RGD:2312767|PMID:19113924 20090909 RGD 2313089 Bss81 Bone structure and strength QTL 81 qtl MP:0004991 decreased bone strength IDA N RGD:2312767|PMID:19113924 20090909 RGD 2313090 Bmd69 Bone mineral density QTL 69 qtl MP:0000063 decreased bone mineral density IDA N RGD:2312767|PMID:19113924 20090909 RGD as compared to females 2313092 Bmd72 Bone mineral density QTL 72 qtl MP:0000062 increased bone mineral density IDA N RGD:2312767|PMID:19113924 20090909 RGD as compared to males 2313093 Bmd77 Bone mineral density QTL 77 qtl MP:0000062 increased bone mineral density IDA N RGD:2312767|PMID:19113924 20090909 RGD as compared to males 2313094 Bss58 Bone structure and strength QTL 58 qtl MP:0004016 decreased bone mass IDA N RGD:2312767|PMID:19113924 20090909 RGD 2313094 Bss58 Bone structure and strength QTL 58 qtl MP:0004991 decreased bone strength IDA N RGD:2312767|PMID:19113924 20090909 RGD 2313095 Bss62 Bone structure and strength QTL 62 qtl MP:0004016 decreased bone mass IDA N RGD:2312767|PMID:19113924 20090909 RGD 2313095 Bss62 Bone structure and strength QTL 62 qtl MP:0004991 decreased bone strength IDA N RGD:2312767|PMID:19113924 20090909 RGD 2313096 Bmd78 Bone mineral density QTL 78 qtl MP:0000062 increased bone mineral density IDA N RGD:2312767|PMID:19113924 20090909 RGD as compared to males 2313097 Bss70 Bone structure and strength QTL 70 qtl MP:0000063 decreased bone mineral density IDA N RGD:2312767|PMID:19113924 20090909 RGD as compared to females 2313097 Bss70 Bone structure and strength QTL 70 qtl MP:0004016 decreased bone mass IDA N RGD:2312767|PMID:19113924 20090909 RGD 2313097 Bss70 Bone structure and strength QTL 70 qtl MP:0004991 decreased bone strength IDA N RGD:2312767|PMID:19113924 20090909 RGD 2313098 Bmd70 Bone mineral density QTL 70 qtl MP:0000063 decreased bone mineral density IDA N RGD:2312767|PMID:19113924 20090909 RGD as compared to females 2313099 Bss56 Bone structure and strength QTL 56 qtl MP:0004016 decreased bone mass IDA N RGD:2312767|PMID:19113924 20090909 RGD 2313099 Bss56 Bone structure and strength QTL 56 qtl MP:0004991 decreased bone strength IDA N RGD:2312767|PMID:19113924 20090909 RGD 2313100 Bss82 Bone structure and strength QTL 82 qtl MP:0004016 decreased bone mass IDA N RGD:2312767|PMID:19113924 20090909 RGD 2313100 Bss82 Bone structure and strength QTL 82 qtl MP:0004991 decreased bone strength IDA N RGD:2312767|PMID:19113924 20090909 RGD 2313101 Bmd76 Bone mineral density QTL 76 qtl MP:0000062 increased bone mineral density IDA N RGD:2312767|PMID:19113924 20090909 RGD as compared to males 2313102 Bmd79 Bone mineral density QTL 79 qtl MP:0000062 increased bone mineral density IDA N RGD:2312767|PMID:19113924 20090909 RGD as compared to males 2313103 Bss80 Bone structure and strength QTL 80 qtl MP:0004016 decreased bone mass IDA N RGD:2312767|PMID:19113924 20090909 RGD 2313103 Bss80 Bone structure and strength QTL 80 qtl MP:0004991 decreased bone strength IDA N RGD:2312767|PMID:19113924 20090909 RGD 2313104 Bss61 Bone structure and strength QTL 61 qtl MP:0004016 decreased bone mass IDA N RGD:2312767|PMID:19113924 20090909 RGD 2313104 Bss61 Bone structure and strength QTL 61 qtl MP:0004991 decreased bone strength IDA N RGD:2312767|PMID:19113924 20090909 RGD 2313105 Bss79 Bone structure and strength QTL 79 qtl MP:0004016 decreased bone mass IDA N RGD:2312767|PMID:19113924 20090909 RGD 2313105 Bss79 Bone structure and strength QTL 79 qtl MP:0004991 decreased bone strength IDA N RGD:2312767|PMID:19113924 20090909 RGD 2313343 LH-Chr 13BN/Mav strain MP:0001260 increased body weight IAGP N RGD:2313340|PMID:19462495 20200207 RGD compared to LH/Mav 2313343 LH-Chr 13BN/Mav strain MP:0002644 decreased circulating triglyceride level IAGP N RGD:2313340|PMID:19462495 20200207 RGD compared to LH/Mav 2313343 LH-Chr 13BN/Mav strain MP:0002963 decreased urine protein level IAGP N RGD:2313340|PMID:19462495 20200207 RGD compared to LH/Mav 2313343 LH-Chr 13BN/Mav strain MP:0002963 decreased urine protein level induced IAGP XCO:0000164 N RGD:2313340|PMID:19462495 20200207 RGD compared to LH/Mav 2313343 LH-Chr 13BN/Mav strain MP:0003916 decreased heart left ventricle weight IAGP N RGD:2313340|PMID:19462495 20200207 RGD compared to LH/Mav 2313343 LH-Chr 13BN/Mav strain MP:0004876 decreased mean systemic arterial blood pressure IAGP N RGD:2313340|PMID:19462495 20200207 RGD compared to LH/Mav 2313343 LH-Chr 13BN/Mav strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000164 N RGD:2313340|PMID:19462495 20090918 RGD compared with LH/Mav 2313343 LH-Chr 13BN/Mav strain MP:0005179 decreased circulating cholesterol level IAGP N RGD:2313340|PMID:19462495 20090918 RGD compared with LH/Mav 2313343 LH-Chr 13BN/Mav strain MP:0005527 increased renal glomerular filtration rate IAGP N RGD:2313340|PMID:19462495 20200207 RGD compared to LH/Mav 2313343 LH-Chr 13BN/Mav strain MP:0006317 decreased urine sodium level IAGP XCO:0000164 N RGD:2313340|PMID:19462495 20200207 RGD compared to LH/Mav 2313395 Anxrr26 Anxiety related response QTL 26 qtl MP:0001357 increased aggression towards humans IDA N RGD:2313383|PMID:19363126 20090922 RGD 2313395 Anxrr26 Anxiety related response QTL 26 qtl MP:0001363 increased anxiety-related response IDA N RGD:2313383|PMID:19363126 20090922 RGD 2313397 Coatc1 Coat color QTL1 qtl MP:0002938 white spotting IDA N RGD:2313383|PMID:19363126 20090922 RGD 2313399 Anxrr28 Anxiety related response QTL 28 qtl MP:0001357 increased aggression towards humans IDA N RGD:2313383|PMID:19363126 20090922 RGD 2313399 Anxrr28 Anxiety related response QTL 28 qtl MP:0001363 increased anxiety-related response IDA N RGD:2313383|PMID:19363126 20090922 RGD 2313400 Anxrr25 Anxiety related response QTL 25 qtl MP:0001357 increased aggression towards humans IDA N RGD:2313383|PMID:19363126 20090922 RGD 2313400 Anxrr25 Anxiety related response QTL 25 qtl MP:0001363 increased anxiety-related response IDA N RGD:2313383|PMID:19363126 20090922 RGD 2313401 Anxrr27 Anxiety related response QTL 27 qtl MP:0001357 increased aggression towards humans IDA N RGD:2313383|PMID:19363126 20090922 RGD 2313401 Anxrr27 Anxiety related response QTL 27 qtl MP:0001363 increased anxiety-related response IDA N RGD:2313383|PMID:19363126 20090922 RGD 2313402 Anxrr24 Anxiety related response QTL 24 qtl MP:0001357 increased aggression towards humans IDA N RGD:2313383|PMID:19363126 20090922 RGD 2313402 Anxrr24 Anxiety related response QTL 24 qtl MP:0001363 increased anxiety-related response IDA N RGD:2313383|PMID:19363126 20090922 RGD 2313588 SD-Tg(Ins2-IAPP)Soel strain MP:0002727 decreased circulating insulin level IMP N RGD:2313576|PMID:15161755 20111109 RGD 2313588 SD-Tg(Ins2-IAPP)Soel strain MP:0003339 decreased pancreatic beta cell number IMP N RGD:2313576|PMID:15161755 20091002 RGD 2313588 SD-Tg(Ins2-IAPP)Soel strain MP:0009114 decreased pancreatic beta cell mass IMP N RGD:2313576|PMID:15161755 20091002 RGD 2313588 SD-Tg(Ins2-IAPP)Soel strain MP:0011818 abnormal pancreatic beta cell proliferation IMP N RGD:2313576|PMID:15161755 20091002 RGD 2313588 SD-Tg(Ins2-IAPP)Soel strain MP:0013279 increased fasting circulating glucose level IMP N RGD:2313576|PMID:15161755 20091002 RGD 2313588 SD-Tg(Ins2-IAPP)Soel strain MP:0014117 increased pancreatic beta cell apoptosis IMP N RGD:2313576|PMID:15161755 20091002 RGD 2313693 SHR-Tg(PEPCK-SREBF1)2Ipcv strain MP:0001262 decreased body weight IMP N RGD:2313691|PMID:15809359 20091009 RGD compared to SHR/OlaIpcv; 2313693 SHR-Tg(PEPCK-SREBF1)2Ipcv strain MP:0001552 increased circulating triglyceride level induced IMP XCO:0000244 N RGD:2313691|PMID:15809359 20091009 RGD compared to SHR/OlaIpcv; 2313693 SHR-Tg(PEPCK-SREBF1)2Ipcv strain MP:0001554 increased circulating free fatty acids level induced IMP XCO:0000244 N RGD:2313691|PMID:15809359 20191118 RGD compared to SHR/OlaIpcv; 2313693 SHR-Tg(PEPCK-SREBF1)2Ipcv strain MP:0002079 increased circulating insulin level induced IMP XCO:0000244 N RGD:2313691|PMID:15809359 20091009 RGD compared to SHR/OlaIpcv; 2313693 SHR-Tg(PEPCK-SREBF1)2Ipcv strain MP:0002842 increased systemic arterial blood pressure IMP N RGD:2313691|PMID:15809359 20091009 RGD 2313693 SHR-Tg(PEPCK-SREBF1)2Ipcv strain MP:0002981 increased liver weight IMP N RGD:2313691|PMID:15809359 20091009 RGD compared to SHR/OlaIpcv; 2313693 SHR-Tg(PEPCK-SREBF1)2Ipcv strain MP:0005178 increased circulating cholesterol level induced IMP XCO:0000244 N RGD:2313691|PMID:15809359 20191118 RGD compared to SHR/OlaIpcv; 2313693 SHR-Tg(PEPCK-SREBF1)2Ipcv strain MP:0005559 increased circulating glucose level induced IMP XCO:0000244 N RGD:2313691|PMID:15809359 20091009 RGD compared to SHR/OlaIpcv; 2313693 SHR-Tg(PEPCK-SREBF1)2Ipcv strain MP:0009289 decreased epididymal fat pad weight IMP N RGD:2313691|PMID:15809359 20191118 RGD compared to SHR/OlaIpcv; 2313693 SHR-Tg(PEPCK-SREBF1)2Ipcv strain MP:0009355 increased liver triglyceride level induced IMP XCO:0000244 N RGD:2313691|PMID:15809359 20091009 RGD compared to SHR/OlaIpcv; 2313693 SHR-Tg(PEPCK-SREBF1)2Ipcv strain MP:0010027 increased liver cholesterol level induced IMP XCO:0000244 N RGD:2313691|PMID:15809359 20091009 RGD compared to SHR/OlaIpcv: 2313734 SD-Tg(H1/tetO-RNAi:Insr)29Bdr strain MP:0001262 decreased body weight induced IMP CHEBI:50845 N RGD:2307333|PMID:19340286 20200227 RGD 2313734 SD-Tg(H1/tetO-RNAi:Insr)29Bdr strain MP:0001762 polyuria induced IMP CHEBI:50845 N RGD:2307333|PMID:19340286 20200227 RGD 2313734 SD-Tg(H1/tetO-RNAi:Insr)29Bdr strain MP:0002079 increased circulating insulin level induced IMP CHEBI:50845 N RGD:2307333|PMID:19340286 20091013 RGD 2313734 SD-Tg(H1/tetO-RNAi:Insr)29Bdr strain MP:0002871 albuminuria induced IMP CHEBI:50845 N RGD:2307333|PMID:19340286 20200227 RGD 2313734 SD-Tg(H1/tetO-RNAi:Insr)29Bdr strain MP:0005331 insulin resistance induced IMP CHEBI:50845 N RGD:2307333|PMID:19340286 20200227 RGD 2313734 SD-Tg(H1/tetO-RNAi:Insr)29Bdr strain MP:0005559 increased circulating glucose level induced IMP CHEBI:50845 N RGD:2307333|PMID:19340286 20091013 RGD 2313734 SD-Tg(H1/tetO-RNAi:Insr)29Bdr strain MP:0011941 increased fluid intake induced IMP CHEBI:50845 N RGD:2307333|PMID:19340286 20200227 RGD 2313735 SD-Tg(H1/tetO-RNAi:Insr)14Bdr strain MP:0002079 increased circulating insulin level induced IMP CHEBI:50845 N RGD:2307333|PMID:19340286 20091013 RGD 2313735 SD-Tg(H1/tetO-RNAi:Insr)14Bdr strain MP:0005559 increased circulating glucose level induced IMP CHEBI:50845 N RGD:2307333|PMID:19340286 20091013 RGD 2313854 Bp343 Blood pressure QTL 343 qtl MP:0001263 weight loss IDA N RGD:619627|PMID:10432379 20091022 RGD 2313854 Bp343 Blood pressure QTL 343 qtl MP:0001492 abnormal pilomotor reflex IDA N RGD:619627|PMID:10432379 20091022 RGD 2313854 Bp343 Blood pressure QTL 343 qtl MP:0001657 abnormal induced morbidity/mortality IDA N RGD:619627|PMID:10432379 20091022 RGD 2313854 Bp343 Blood pressure QTL 343 qtl MP:0002064 seizures IDA N RGD:619627|PMID:10432379 20091022 RGD 2313854 Bp343 Blood pressure QTL 343 qtl MP:0002842 increased systemic arterial blood pressure no_association IDA N RGD:619627|PMID:10432379 20091022 RGD 2313854 Bp343 Blood pressure QTL 343 qtl MP:0005202 lethargy IDA N RGD:619627|PMID:10432379 20091022 RGD 2313854 Bp343 Blood pressure QTL 343 qtl MP:0010768 mortality/aging IDA N RGD:619627|PMID:10432379 20091022 RGD 2313856 Bp342 Blood pressure QTL 342 qtl MP:0001263 weight loss IDA N RGD:619627|PMID:10432379 20091022 RGD 2313856 Bp342 Blood pressure QTL 342 qtl MP:0001492 abnormal pilomotor reflex IDA N RGD:619627|PMID:10432379 20091022 RGD 2313856 Bp342 Blood pressure QTL 342 qtl MP:0001657 abnormal induced morbidity/mortality IDA N RGD:619627|PMID:10432379 20091022 RGD 2313856 Bp342 Blood pressure QTL 342 qtl MP:0002064 seizures IDA N RGD:619627|PMID:10432379 20091022 RGD 2313856 Bp342 Blood pressure QTL 342 qtl MP:0002842 increased systemic arterial blood pressure no_association IDA N RGD:619627|PMID:10432379 20091022 RGD 2313856 Bp342 Blood pressure QTL 342 qtl MP:0005202 lethargy IDA N RGD:619627|PMID:10432379 20091022 RGD 2313856 Bp342 Blood pressure QTL 342 qtl MP:0010768 mortality/aging IDA N RGD:619627|PMID:10432379 20091022 RGD 2313922 F344-Tg(Cyp1a1-Ren2)10.LEW-(D10Rat142-D10Rat15)/Jmul strain MP:0003185 decreased angiotensin I-converting enzyme activity IAGP N RGD:2313695|PMID:19307186 20200113 RGD compared to F344-Tg(Cyp1a1-Ren2)10Jmul 2313922 F344-Tg(Cyp1a1-Ren2)10.LEW-(D10Rat142-D10Rat15)/Jmul strain MP:0004875 increased mean systemic arterial blood pressure IAGP N RGD:2313695|PMID:19307186 20200113 RGD compared to F344-Tg(Cyp1a1-Ren2)10Jmul 2313923 LEW-Chr YF344-Tg(Cyp1a1-Ren2)10.F344-(D10Rat99-D10Rat11)/Jmul strain MP:0003184 increased angiotensin I-converting enzyme activity IAGP N RGD:2313695|PMID:19307186 20200113 RGD compared to LEW-Chr YF344-Tg(Cyp1a1-Ren2)10/Jmul 2313923 LEW-Chr YF344-Tg(Cyp1a1-Ren2)10.F344-(D10Rat99-D10Rat11)/Jmul strain MP:0004875 increased mean systemic arterial blood pressure IAGP N RGD:2313695|PMID:19307186 20200113 RGD compared to LEW-Chr YF344-Tg(Cyp1a1-Ren2)10/Jmul 2314001 N:HS Heterogeneous stock strain MP:0001363 increased anxiety-related response IAGP N RGD:2313899|PMID:18971309 20091030 RGD 2314001 N:HS Heterogeneous stock strain MP:0004000 impaired passive avoidance behavior IAGP N RGD:2313899|PMID:18971309 20091030 RGD 2314009 NMcwi:HS Heterogeneous stock strain MP:0002079 increased circulating insulin level induced IAGP XCO:0000103 N RGD:6893578|PMID:22947656 20131022 RGD 2314011 Gluco56 Glucose level QTL 56 qtl MP:0005559 increased circulating glucose level IDA N RGD:2316693|PMID:20068026 20100303 RGD 2314027 SDT.Cg-Leprfa/Jtt SDT fatty strain MP:0001260 increased body weight IAGP N RGD:2314022|PMID:19696902 20091030 RGD compared to SDT/Jcl and pair-fed SDT.ZDF-Leprfa/Jtt rats 2314027 SDT.Cg-Leprfa/Jtt SDT fatty strain MP:0001260 increased body weight IAGP N RGD:2314024|PMID:18421173 20200324 RGD compared to SDT/Jcl rats 2314027 SDT.Cg-Leprfa/Jtt SDT fatty strain MP:0001260 increased body weight IAGP N RGD:2314025|PMID:15725677 20200324 RGD compared to +/+ and +/fa littermates, sexual dimorphism in penetrance 2314027 SDT.Cg-Leprfa/Jtt SDT fatty strain MP:0001304 cataract IAGP N RGD:2314024|PMID:18421173 20200324 RGD compared to SDT/Jcl rats 2314027 SDT.Cg-Leprfa/Jtt SDT fatty strain MP:0001325 abnormal retina morphology IAGP N RGD:2314024|PMID:18421173 20200324 RGD compared to SDT/Jcl rats 2314027 SDT.Cg-Leprfa/Jtt SDT fatty strain MP:0001326 retina degeneration IAGP N RGD:2314024|PMID:18421173 20200324 RGD compared to SDT/Jcl rats 2314027 SDT.Cg-Leprfa/Jtt SDT fatty strain MP:0001433 polyphagia IAGP N RGD:2314024|PMID:18421173 20091030 RGD compared to SDT/Jcl rats 2314027 SDT.Cg-Leprfa/Jtt SDT fatty strain MP:0001552 increased circulating triglyceride level IAGP N RGD:2314022|PMID:19696902 20091030 RGD compared to SDT rats 2314027 SDT.Cg-Leprfa/Jtt SDT fatty strain MP:0001552 increased circulating triglyceride level IAGP N RGD:2314024|PMID:18421173 20200324 RGD compared to SDT/Jcl rats 2314027 SDT.Cg-Leprfa/Jtt SDT fatty strain MP:0002079 increased circulating insulin level IAGP N RGD:2314022|PMID:19696902 20200324 RGD compared to SDT/Jcl rats, only at young age 2314027 SDT.Cg-Leprfa/Jtt SDT fatty strain MP:0002079 increased circulating insulin level IAGP N RGD:2314024|PMID:18421173 20200324 RGD compared to SDT/Jcl rats, only at young age 2314027 SDT.Cg-Leprfa/Jtt SDT fatty strain MP:0002079 increased circulating insulin level IAGP N RGD:2314025|PMID:15725677 20200324 RGD compared to +/+ and +/fa littermates, sexual dimorphism in penetrance 2314027 SDT.Cg-Leprfa/Jtt SDT fatty strain MP:0002705 dilated renal tubule IAGP N RGD:2314024|PMID:18421173 20200324 RGD compared to SDT/Jcl rats 2314027 SDT.Cg-Leprfa/Jtt SDT fatty strain MP:0002840 abnormal lens fiber morphology IAGP N RGD:2314024|PMID:18421173 20200324 RGD compared to SDT/Jcl rats 2314027 SDT.Cg-Leprfa/Jtt SDT fatty strain MP:0004892 increased adiponectin level IAGP N RGD:2314022|PMID:19696902 20091030 RGD compared to SDT rats 2314027 SDT.Cg-Leprfa/Jtt SDT fatty strain MP:0005178 increased circulating cholesterol level IAGP N RGD:2314024|PMID:18421173 20200324 RGD compared to SDT/Jcl rats 2314027 SDT.Cg-Leprfa/Jtt SDT fatty strain MP:0005264 glomerulosclerosis IAGP N RGD:2314024|PMID:18421173 20200324 RGD compared to SDT/Jcl rats 2314027 SDT.Cg-Leprfa/Jtt SDT fatty strain MP:0005452 abnormal adipose tissue amount IAGP N RGD:2314022|PMID:19696902 20200324 RGD compared to SDT/Jcl rats 2314027 SDT.Cg-Leprfa/Jtt SDT fatty strain MP:0005559 increased circulating glucose level IAGP N RGD:2314022|PMID:19696902 20091030 RGD compared to SDT rats 2314027 SDT.Cg-Leprfa/Jtt SDT fatty strain MP:0005559 increased circulating glucose level IAGP N RGD:2314024|PMID:18421173 20200324 RGD compared to SDT/Jcl rats 2314027 SDT.Cg-Leprfa/Jtt SDT fatty strain MP:0005559 increased circulating glucose level IAGP N RGD:2314025|PMID:15725677 20200324 RGD compared to +/+ and +/fa littermates, sexual dimorphism in penetrance 2314027 SDT.Cg-Leprfa/Jtt SDT fatty strain MP:0005565 increased blood urea nitrogen level IAGP N RGD:2314024|PMID:18421173 20200324 RGD compared to SDT/Jcl rats 2314027 SDT.Cg-Leprfa/Jtt SDT fatty strain MP:0005669 increased circulating leptin level IAGP N RGD:2314022|PMID:19696902 20091030 RGD compared to SDT rats 2314027 SDT.Cg-Leprfa/Jtt SDT fatty strain MP:0005669 increased circulating leptin level IAGP N RGD:2314025|PMID:15725677 20200324 RGD compared to +/+ and +/fa littermates, sexual dimorphism in penetrance 2314027 SDT.Cg-Leprfa/Jtt SDT fatty strain MP:0006087 increased body mass index IAGP N RGD:2314025|PMID:15725677 20200324 RGD compared to +/+ and +/fa littermates, sexual dimorphism in penetrance 2314027 SDT.Cg-Leprfa/Jtt SDT fatty strain MP:0006094 increased fat cell size IAGP N RGD:2314022|PMID:19696902 20200324 RGD compared to SDT/Jcl rats 2314027 SDT.Cg-Leprfa/Jtt SDT fatty strain MP:0009294 increased interscapular fat pad weight IAGP N RGD:2314025|PMID:15725677 20200324 RGD compared to +/+ and +/fa littermates, sexual dimorphism in penetrance 2314027 SDT.Cg-Leprfa/Jtt SDT fatty strain MP:0009304 increased retroperitoneal fat pad weight IAGP N RGD:2314025|PMID:15725677 20200324 RGD compared to +/+ and +/fa littermates, sexual dimorphism in penetrance 2314027 SDT.Cg-Leprfa/Jtt SDT fatty strain MP:0009643 abnormal urine homeostasis IAGP N RGD:2314024|PMID:18421173 20091030 RGD compared to SDT/Jcl rats 2314027 SDT.Cg-Leprfa/Jtt SDT fatty strain MP:0011402 renal cast IAGP N RGD:2314024|PMID:18421173 20200324 RGD compared to SDT/Jcl rats 2314027 SDT.Cg-Leprfa/Jtt SDT fatty strain MP:0011939 increased food intake IAGP N RGD:2314022|PMID:19696902 20200324 RGD compared to SDT/Jcl rats 2314027 SDT.Cg-Leprfa/Jtt SDT fatty strain MP:0011939 increased food intake IAGP N RGD:2314025|PMID:15725677 20200324 RGD compared to +/+ and +/fa littermates, sexual dimorphism in penetrance 2314027 SDT.Cg-Leprfa/Jtt SDT fatty strain MP:0012029 abnormal electroretinogram waveform feature IAGP N RGD:2314024|PMID:18421173 20200324 RGD compared to SDT/Jcl rats 2314027 SDT.Cg-Leprfa/Jtt SDT fatty strain MP:0030017 decreased adipocyte glucose uptake IAGP N RGD:2314022|PMID:19696902 20200324 RGD compared to SDT/Jcl and pair-fed SDT.ZDF-Leprfa/Jtt rats 2314162 F344-Oune/Kyo Oune strain MP:0000585 kinked tail IMP N RGD:10045933|PMID:26090680 20210402 RGD compared to F344 2314162 F344-Oune/Kyo Oune strain MP:0000592 short tail IMP N RGD:10045933|PMID:26090680 20210402 RGD compared to F344 2314162 F344-Oune/Kyo Oune strain MP:0001377 abnormal mating frequency IMP N RGD:10045933|PMID:26090680 20210402 RGD compared to F344 2314162 F344-Oune/Kyo Oune strain MP:0001688 abnormal somite development IMP N RGD:10045933|PMID:26090680 20210402 RGD compared to F344 2314162 F344-Oune/Kyo Oune strain MP:0002823 abnormal rib development IMP N RGD:10045933|PMID:26090680 20210402 RGD compared to F344 2314162 F344-Oune/Kyo Oune strain MP:0003049 abnormal lumbar vertebrae morphology IMP N RGD:10045933|PMID:26090680 20210402 RGD compared to F344 2314162 F344-Oune/Kyo Oune strain MP:0004709 cervical vertebrae degeneration IMP N RGD:10045933|PMID:26090680 20210402 RGD compared to F344 2314162 F344-Oune/Kyo Oune strain MP:0005225 abnormal vertebrae development IMP N RGD:10045933|PMID:26090680 20210402 RGD compared to F344 2314163 F344-Kcna1Adms/Kyo ADMS (autosomal dominant myokymia and seizures) rat strain MP:0000947 convulsive seizures IAGP N RGD:10047237|PMID:22206926 20170504 RGD 2314163 F344-Kcna1Adms/Kyo ADMS (autosomal dominant myokymia and seizures) rat strain MP:0009358 environmentally induced seizures IAGP N RGD:10047237|PMID:22206926 20170504 RGD 2314230 F344-Hrkrh/Kyo Hairless Kyoto, Hanako strain MP:0000580 deformed nails IMP N RGD:150520024|PMID:21325752 20211021 RGD 2314230 F344-Hrkrh/Kyo Hairless Kyoto, Hanako strain MP:0001211 wrinkled skin IMP N RGD:150520024|PMID:21325752 20211021 RGD 2314230 F344-Hrkrh/Kyo Hairless Kyoto, Hanako strain MP:0003815 hairless IMP N RGD:150520024|PMID:21325752 20211021 RGD 2314230 F344-Hrkrh/Kyo Hairless Kyoto, Hanako strain MP:0010699 dilated hair follicle IMP N RGD:150520024|PMID:21325752 20211021 RGD 2314230 F344-Hrkrh/Kyo Hairless Kyoto, Hanako strain MP:0030570 abnormal piliary canal morphology IMP N RGD:150520024|PMID:21325752 20211021 RGD 2314368 F344-Kcnn2Trdk/Kyo Tremor dominant Kyoto strain MP:0000745 tremors IMP N RGD:38508907|PMID:28917524 20210715 RGD DNA:missense mutation:cds:c. 866T>A (p. I289N)(rat) 2314376 KFRS4/Kyo strain MP:0001194 dermatitis sexual_dimorphism IAGP N RGD:150429840|PMID:26454563 20211005 RGD compared to control PVG/Seac rats; more frequent in females 2314376 KFRS4/Kyo strain MP:0001246 mixed cellular infiltration to dermis sexual_dimorphism IAGP N RGD:150429840|PMID:26454563 20211005 RGD compared to control PVG/Seac rats; more frequent in females 2314376 KFRS4/Kyo strain MP:0001304 cataract IAGP N RGD:126925973|PMID:23226368 20210524 RGD 2314376 KFRS4/Kyo strain MP:0001412 excessive scratching sexual_dimorphism IAGP N RGD:150429840|PMID:26454563 20211005 RGD compared to control PVG/Seac rats; more frequent in females 2314376 KFRS4/Kyo strain MP:0002092 abnormal eye morphology IAGP N RGD:150429836|PMID:22736458 20211005 RGD compared to heterozygous controls 2314376 KFRS4/Kyo strain MP:0002102 abnormal ear morphology IAGP N RGD:150429836|PMID:22736458 20211005 RGD compared to heterozygous controls 2314376 KFRS4/Kyo strain MP:0002579 disorganized secondary lens fibers IAGP N RGD:126925973|PMID:23226368 20210524 RGD 2314376 KFRS4/Kyo strain MP:0002796 impaired skin barrier function sexual_dimorphism IAGP N RGD:150429840|PMID:26454563 20211005 RGD compared to control PVG/Seac rats; more frequent in females 2314376 KFRS4/Kyo strain MP:0002939 head spot IAGP N RGD:150429837|PMID:28356074 20211005 RGD compared to control PVG/Seac strain 2314376 KFRS4/Kyo strain MP:0011697 lens vacuoles IAGP N RGD:126925973|PMID:23226368 20210524 RGD 2314381 KFRS5A/Kyo strain MP:0003810 abnormal hair cuticle IAGP N RGD:11570415|PMID:20179389 20211021 RGD DNA:deletion:cds:intron 1, p.Val149_Gln154 del 2314381 KFRS5A/Kyo strain MP:0009004 progressive hair loss IAGP N RGD:11570415|PMID:20179389 20211021 RGD DNA:deletion:cds:intron 1, p.Val149_Gln154 del 2314381 KFRS5A/Kyo strain MP:0009351 thin hair shaft IAGP N RGD:11570415|PMID:20179389 20211021 RGD DNA:deletion:cds:intron 1, p.Val149_Gln154 del 2314381 KFRS5A/Kyo strain MP:0010699 dilated hair follicle IAGP N RGD:11570415|PMID:20179389 20211021 RGD DNA:deletion:cds:intron 1, p.Val149_Gln154 del 2314396 LCR/Mco Low-capacity runners strain MP:0001260 increased body weight IAGP N RGD:2314394|PMID:11161005 20091112 RGD compared to HCR/Mco 2314396 LCR/Mco Low-capacity runners strain MP:0001260 increased body weight IAGP N RGD:8552896|PMID:24147032 20200325 RGD compared to HCR/Mco 2314396 LCR/Mco Low-capacity runners strain MP:0001260 increased body weight sexual_dimorphism IAGP N RGD:2314392|PMID:11705762 20200325 RGD compared to HCR/Mco; sexual dimorphism, males only 2314396 LCR/Mco Low-capacity runners strain MP:0002833 increased heart weight sexual_dimorphism IAGP N RGD:2314392|PMID:11705762 20091112 RGD compared to HCR/Mco; sexual dimorphism, males only 2314396 LCR/Mco Low-capacity runners strain MP:0003023 decreased coronary flow rate IAGP N RGD:2314392|PMID:11705762 20200325 RGD compared to HCR/Mco 2314396 LCR/Mco Low-capacity runners strain MP:0003061 decreased aerobic running capacity IAGP N RGD:2314392|PMID:11705762 20200325 RGD compared to HCR/Mco 2314396 LCR/Mco Low-capacity runners strain MP:0003061 decreased aerobic running capacity IAGP N RGD:2314394|PMID:11161005 20091112 RGD compared to HCR/Mco 2314396 LCR/Mco Low-capacity runners strain MP:0003061 decreased aerobic running capacity IAGP N RGD:8552896|PMID:24147032 20200325 RGD compared to HCR/Mco 2314396 LCR/Mco Low-capacity runners strain MP:0003393 decreased cardiac output IAGP N RGD:2314392|PMID:11705762 20200325 RGD compared to HCR/Mco 2314396 LCR/Mco Low-capacity runners strain MP:0011952 decreased cardiac stroke volume IAGP N RGD:2314392|PMID:11705762 20200325 RGD compared to HCR/Mco 2314397 HCR/Mco High-capacity runners strain MP:0001262 decreased body weight IAGP N RGD:2314394|PMID:11161005 20091112 RGD compared to LCR/Mco 2314397 HCR/Mco High-capacity runners strain MP:0001262 decreased body weight IAGP N RGD:8552896|PMID:24147032 20200325 RGD compared to LCR/Mco 2314397 HCR/Mco High-capacity runners strain MP:0001262 decreased body weight sexual_dimorphism IAGP N RGD:2314392|PMID:11705762 20200325 RGD compared to LCR/Mco; sexual dimorphism, males only 2314397 HCR/Mco High-capacity runners strain MP:0002834 decreased heart weight sexual_dimorphism IAGP N RGD:2314392|PMID:11705762 20091112 RGD compared to LCR/Mco; sexual dimorphism, males only 2314397 HCR/Mco High-capacity runners strain MP:0003022 increased coronary flow rate IAGP N RGD:2314392|PMID:11705762 20200325 RGD compared to LCR/Mco 2314397 HCR/Mco High-capacity runners strain MP:0003060 increased aerobic running capacity IAGP N RGD:2314392|PMID:11705762 20200325 RGD compared to LCR/Mco 2314397 HCR/Mco High-capacity runners strain MP:0003060 increased aerobic running capacity IAGP N RGD:2314394|PMID:11161005 20091112 RGD compared to LCR/Mco 2314397 HCR/Mco High-capacity runners strain MP:0003060 increased aerobic running capacity IAGP N RGD:8552896|PMID:24147032 20200325 RGD compared to LCR/Mco 2314397 HCR/Mco High-capacity runners strain MP:0003394 increased cardiac output IAGP N RGD:2314392|PMID:11705762 20200325 RGD compared to LCR/Mco 2314397 HCR/Mco High-capacity runners strain MP:0011951 increased cardiac stroke volume IAGP N RGD:2314392|PMID:11705762 20200325 RGD compared to LCR/Mco 2314415 LEW-Tg(H1/tetO-RNAi:Insr)4Hrjb strain MP:0001262 decreased body weight induced IMP CHEBI:50845 N RGD:2314405|PMID:19017805 20200227 RGD 2314415 LEW-Tg(H1/tetO-RNAi:Insr)4Hrjb strain MP:0002079 increased circulating insulin level induced IMP CHEBI:50845 N RGD:2314405|PMID:19017805 20200227 RGD 2314415 LEW-Tg(H1/tetO-RNAi:Insr)4Hrjb strain MP:0005559 increased circulating glucose level induced IMP CHEBI:50845 N RGD:2314405|PMID:19017805 20200227 RGD 2314415 LEW-Tg(H1/tetO-RNAi:Insr)4Hrjb strain MP:0011941 increased fluid intake induced IMP CHEBI:50845 N RGD:2314405|PMID:19017805 20200227 RGD 2314493 SBH.SBN-(D1Mgh2-D1Rat74)/Ygl strain MP:0006264 decreased systemic arterial systolic blood pressure IMP N RGD:631172|PMID:12441404 20091118 RGD compared to SBH/Ygl 2314494 SBH.SBN-(D1Rat137-D1Rat123)/Ygl strain MP:0006264 decreased systemic arterial systolic blood pressure IMP N RGD:631172|PMID:12441404 20091118 RGD compared to SBH/Ygl 2314496 SBH.SBN-(D1Mgh2-D1Mgh11)/Ygl strain MP:0006264 decreased systemic arterial systolic blood pressure IMP N RGD:631172|PMID:12441404 20091118 RGD compared to SBH/Ygl 2314498 SBH.SBN-(D1Rat137-D1Rat83)/Ygl strain MP:0006264 decreased systemic arterial systolic blood pressure IMP N RGD:631172|PMID:12441404 20091118 RGD compared to SBH/Ygl 2314500 SBH.SBN-(D1Mgh2-D1Rat101)/Ygl strain MP:0006264 decreased systemic arterial systolic blood pressure IMP N RGD:631172|PMID:12441404 20091118 RGD compared to SBH/Ygl 2314501 SBH.SBN-(D1Wox11-D1Rat137)/Ygl strain MP:0006264 decreased systemic arterial systolic blood pressure IMP N RGD:631172|PMID:12441404 20091118 RGD compared to SBH/Ygl 2314530 SS.SHR-(D8Uia1-D8Rat90)/Mco strain MP:0002963 decreased urine protein level IAGP N RGD:2314528|PMID:19176703 20091119 RGD compared to SS/Jr 2314531 SHR.SS-(D13Rat1-D13Mgh6)/Mco strain MP:0002962 increased urine protein level IAGP N RGD:2314528|PMID:19176703 20091119 RGD compared to SHR/NHsd 2314532 SHR.SS-(D8Uia1-D8Rat90)/Mco strain MP:0002962 increased urine protein level IAGP N RGD:2314528|PMID:19176703 20091119 RGD compared to SHR/NHsd 2314655 BRAT-Avpdi/BluHsd Brattleboro strain MP:0001762 polyuria IAGP N RGD:2314654|PMID:10919858 20091123 RGD 2314861 WAG/RijYcb strain MP:0012359 increased partial thromboplastin time IAGP N RGD:7245962|PMID:20158945 20160825 RGD 2314885 Mir146b microRNA 146b gene MP:0003985 renal fibrosis sexual_dimorphism IMP XCO:0000017 N RGD:127285407|PMID:31668631 20220526 RGD 2314903 F8m1Ycb coagulation factor VIII, procoagulant component; mutation 1, Ycb gene MP:0000208 decreased hematocrit IAGP N RGD:7245964|PMID:20626616 20180525 RGD DNA,protein:missense mutation,decreased activity:exon:p.L176P(rat) 2314903 F8m1Ycb coagulation factor VIII, procoagulant component; mutation 1, Ycb gene MP:0002874 decreased hemoglobin content IAGP N RGD:7245964|PMID:20626616 20180525 RGD DNA,protein:missense mutation,decreased activity:exon:p.L176P(rat) 2314903 F8m1Ycb coagulation factor VIII, procoagulant component; mutation 1, Ycb gene MP:0002875 decreased erythrocyte cell number IAGP N RGD:7245964|PMID:20626616 20180525 RGD DNA,protein:missense mutation,decreased activity:exon:p.L176P(rat) 2314904 WAG-F8m1Ycb strain MP:0000208 decreased hematocrit IAGP N RGD:7245964|PMID:20626616 20130617 RGD 2314904 WAG-F8m1Ycb strain MP:0002874 decreased hemoglobin content IAGP N RGD:7245964|PMID:20626616 20130617 RGD 2316631 F344.GK-(D1Swe8-D1Gpam-1)/Swe strain MP:0002727 decreased circulating insulin level induced IAGP XCO:0000102 N RGD:2316628|PMID:19965390 20100218 RGD compared to F344.GK-(D1Got251-D1Gpam-1)/Swe 2316631 F344.GK-(D1Swe8-D1Gpam-1)/Swe strain MP:0003059 decreased insulin secretion induced IAGP XCO:0000275 N RGD:2316628|PMID:19965390 20100218 RGD compared to F344.GK-(D1Got251-D1Gpam-1)/Swe 2316631 F344.GK-(D1Swe8-D1Gpam-1)/Swe strain MP:0005293 impaired glucose tolerance induced IAGP XCO:0000103 N RGD:2316628|PMID:19965390 20200225 RGD compared to F344.GK-(D1Got251-D1Gpam-1)/Swe 2316631 F344.GK-(D1Swe8-D1Gpam-1)/Swe strain MP:0020848 abnormal exocytosis induced IAGP XCO:0000184 N RGD:2316628|PMID:19965390 20100218 RGD compared to F344.GK-(D1Got251-D1Gpam-1)/Swe 2316649 Bp344 Blood pressure QTL 344 qtl MP:0006264 decreased systemic arterial systolic blood pressure IDA N RGD:2312639|PMID:19423552 20100222 RGD 2316896 Gluco57 Glucose level QTL 57 qtl MP:0005559 increased circulating glucose level IDA N RGD:2316856|PMID:19584172 20100305 RGD 2316925 SHR.BN-(D3Rat159-D3Rat1)/Mco strain MP:0001863 blood vessel inflammation IAGP N RGD:2316923|PMID:20026763 20201208 RGD compared to SHR/NHsd 2316925 SHR.BN-(D3Rat159-D3Rat1)/Mco strain MP:0003025 increased vasoconstriction IAGP N RGD:2316923|PMID:20026763 20201208 RGD compared to SHR/NHsd 2316925 SHR.BN-(D3Rat159-D3Rat1)/Mco strain MP:0006134 artery occlusion IAGP N RGD:2316923|PMID:20026763 20100317 RGD 2316927 SHR.BN-(D6Rat40-D6Rat170)/Mco strain MP:0005489 vascular smooth muscle hyperplasia IAGP N RGD:2316923|PMID:20026763 20100317 RGD 2316927 SHR.BN-(D6Rat40-D6Rat170)/Mco strain MP:0006134 artery occlusion IAGP N RGD:2316923|PMID:20026763 20100317 RGD 2316928 SHR.BN-(D3Rat159-D3Rat1)(D6Rat40-D6Rat170)/Mco strain MP:0005489 vascular smooth muscle hyperplasia IAGP N RGD:2316923|PMID:20026763 20100317 RGD 2316928 SHR.BN-(D3Rat159-D3Rat1)(D6Rat40-D6Rat170)/Mco strain MP:0006134 artery occlusion IAGP N RGD:2316923|PMID:20026763 20100317 RGD 2316947 Rf58 Renal function QTL 58 qtl MP:0003606 kidney failure IDA N RGD:2316856|PMID:19584172 20100305 RGD 2316949 Gluco60 Glucose level QTL 60 qtl MP:0005559 increased circulating glucose level IDA N RGD:2316856|PMID:19584172 20100305 RGD 2316950 Scl66 Serum cholesterol level QTL 66 qtl MP:0005178 increased circulating cholesterol level IDA N RGD:2316856|PMID:19584172 20100305 RGD 2316952 Pur22 Proteinuria QTL 22 qtl MP:0002962 increased urine protein level IDA N RGD:2316856|PMID:19584172 20100305 RGD 2316954 Rf57 Renal function QTL 57 qtl MP:0003606 kidney failure IDA N RGD:2316856|PMID:19584172 20100305 RGD 2316955 Stl24 Serum triglyceride level QTL 24 qtl MP:0001552 increased circulating triglyceride level IDA N RGD:2316856|PMID:19584172 20100305 RGD 2316957 Pur21 Proteinuria QTL 21 qtl MP:0002962 increased urine protein level IDA N RGD:2316856|PMID:19584172 20100305 RGD 2316958 Gluco58 Glucose level QTL 58 qtl MP:0005559 increased circulating glucose level IDA N RGD:2316856|PMID:19584172 20100305 RGD 2316959 Gluco59 Glucose level QTL 59 qtl MP:0005559 increased circulating glucose level IDA N RGD:2316856|PMID:19584172 20100305 RGD 2317027 Aia22 Adjuvant induced arthritis QTL 22 qtl MP:0002933 joint inflammation IDA N RGD:2316974|PMID:19526527 20100311 RGD induced by peptidoglycan-polysaccharide 2317029 Aia19 Adjuvant induced arthritis QTL 19 qtl MP:0002933 joint inflammation IDA N RGD:2316974|PMID:19526527 20100311 RGD induced by peptidoglycan-polysaccharide 2317030 Wbc5 White blood cell count QTL 5 qtl MP:0000221 decreased leukocyte cell number IDA N RGD:2316974|PMID:19526527 20100311 RGD induced by peptidoglycan-polysaccharide 2317032 Ginf2 Gastrointestinal inflammation QTL 2 qtl MP:0001858 intestinal inflammation IDA N RGD:2316974|PMID:19526527 20100311 RGD induced by peptidoglycan-polysaccharide 2317032 Ginf2 Gastrointestinal inflammation QTL 2 qtl MP:0002500 granulomatous inflammation IDA N RGD:2316974|PMID:19526527 20100311 RGD induced by peptidoglycan-polysaccharide 2317034 Aia9 Adjuvant induced arthritis QTL 9 qtl MP:0002933 joint inflammation IDA N RGD:2316974|PMID:19526527 20100311 RGD induced by peptidoglycan-polysaccharide 2317035 Aia16 Adjuvant induced arthritis QTL 16 qtl MP:0002933 joint inflammation IDA N RGD:2316974|PMID:19526527 20100311 RGD induced by peptidoglycan-polysaccharide 2317036 Livw3 Liver weight QTL 3 qtl MP:0003402 decreased liver weight IDA N RGD:2316974|PMID:19526527 20100311 RGD induced by peptidoglycan-polysaccharide 2317038 Ginf3 Gastrointestinal inflammation QTL 3 qtl MP:0001858 intestinal inflammation IDA N RGD:2316974|PMID:19526527 20100311 RGD induced by peptidoglycan-polysaccharide 2317038 Ginf3 Gastrointestinal inflammation QTL 3 qtl MP:0002500 granulomatous inflammation IDA N RGD:2316974|PMID:19526527 20100311 RGD induced by peptidoglycan-polysaccharide 2317039 Aia6 Adjuvant induced arthritis QTL 6 qtl MP:0002933 joint inflammation IDA N RGD:2316974|PMID:19526527 20100311 RGD induced by peptidoglycan-polysaccharide 2317040 Aia21 Adjuvant induced arthritis QTL 21 qtl MP:0002933 joint inflammation IDA N RGD:2316974|PMID:19526527 20100311 RGD induced by peptidoglycan-polysaccharide 2317041 Aia14 Adjuvant induced arthritis QTL 14 qtl MP:0002933 joint inflammation IDA N RGD:2316974|PMID:19526527 20100311 RGD induced by peptidoglycan-polysaccharide 2317042 Aia20 Adjuvant induced arthritis QTL 20 qtl MP:0002933 joint inflammation IDA N RGD:2316974|PMID:19526527 20100311 RGD induced by peptidoglycan-polysaccharide 2317043 Aia7 Adjuvant induced arthritis QTL 7 qtl MP:0002933 joint inflammation IDA N RGD:2316974|PMID:19526527 20100311 RGD induced by peptidoglycan-polysaccharide 2317044 Aia23 Adjuvant induced arthritis QTL 23 qtl MP:0002933 joint inflammation IDA N RGD:2316974|PMID:19526527 20100311 RGD induced by peptidoglycan-polysaccharide 2317045 Aia11 Adjuvant induced arthritis QTL 11 qtl MP:0002933 joint inflammation IDA N RGD:2316974|PMID:19526527 20100311 RGD induced by peptidoglycan-polysaccharide 2317046 Aia8 Adjuvant induced arthritis QTL 8 qtl MP:0002933 joint inflammation IDA N RGD:2316974|PMID:19526527 20100311 RGD induced by peptidoglycan-polysaccharide 2317047 Wbc4 White blood cell count QTL 4 qtl MP:0000221 decreased leukocyte cell number IDA N RGD:2316974|PMID:19526527 20100311 RGD induced by peptidoglycan-polysaccharide 2317048 Ginf1 Gastrointestinal inflammation QTL 1 qtl MP:0001858 intestinal inflammation IDA N RGD:2316974|PMID:19526527 20100311 RGD induced by peptidoglycan-polysaccharide 2317048 Ginf1 Gastrointestinal inflammation QTL 1 qtl MP:0002500 granulomatous inflammation IDA N RGD:2316974|PMID:19526527 20100311 RGD induced by peptidoglycan-polysaccharide 2317050 Aia24 Adjuvant induced arthritis QTL 24 qtl MP:0002933 joint inflammation IDA N RGD:2316974|PMID:19526527 20100311 RGD induced by peptidoglycan-polysaccharide 2317051 Aia18 Adjuvant induced arthritis QTL 18 qtl MP:0002933 joint inflammation IDA N RGD:2316974|PMID:19526527 20100311 RGD induced by peptidoglycan-polysaccharide 2317052 Aia17 Adjuvant induced arthritis QTL 17 qtl MP:0002933 joint inflammation IDA N RGD:2316974|PMID:19526527 20100311 RGD induced by peptidoglycan-polysaccharide 2317053 Aia25 Adjuvant induced arthritis QTL 25 qtl MP:0002933 joint inflammation IDA N RGD:2316974|PMID:19526527 20100311 RGD induced by peptidoglycan-polysaccharide 2317054 Aia12 Adjuvant induced arthritis QTL 12 qtl MP:0002933 joint inflammation IDA N RGD:2316974|PMID:19526527 20100311 RGD induced by peptidoglycan-polysaccharide 2317055 Aia10 Adjuvant induced arthritis QTL 10 qtl MP:0002933 joint inflammation IDA N RGD:2316974|PMID:19526527 20100311 RGD induced by peptidoglycan-polysaccharide 2317056 Wbc3 White blood cell count QTL 3 qtl MP:0000221 decreased leukocyte cell number IDA N RGD:2316974|PMID:19526527 20100311 RGD induced by peptidoglycan-polysaccharide 2317057 Aia27 Adjuvant induced arthritis QTL 27 qtl MP:0002933 joint inflammation IDA N RGD:2316974|PMID:19526527 20100311 RGD induced by peptidoglycan-polysaccharide 2317058 Aia13 Adjuvant induced arthritis QTL 13 qtl MP:0002933 joint inflammation IDA N RGD:2316974|PMID:19526527 20100311 RGD induced by peptidoglycan-polysaccharide 2317059 Aia15 Adjuvant induced arthritis QTL 15 qtl MP:0002933 joint inflammation IDA N RGD:2316974|PMID:19526527 20100311 RGD induced by peptidoglycan-polysaccharide 2317060 Aia26 Adjuvant induced arthritis QTL 26 qtl MP:0002933 joint inflammation IDA N RGD:2316974|PMID:19526527 20100311 RGD induced by peptidoglycan-polysaccharide 2317196 DA.PVG.1AV1-(D8Rat146-D8Got145) strain MP:0000938 motor neuron degeneration IAGP N RGD:2317162|PMID:19526058 20100319 RGD 2317197 DA.PVG.1AV1-(D8Rat41-D8Rat24) strain MP:0000938 motor neuron degeneration IAGP N RGD:2317162|PMID:19526058 20100319 RGD 2317201 DA.PVG.1AV1-(D8Rat24-D8Got145) strain MP:0000938 motor neuron degeneration IAGP N RGD:2317162|PMID:19526058 20100319 RGD 2317278 Taiep/Dun strain MP:0000745 tremors IAGP N RGD:150429639|PMID:28393430 20210910 RGD progressive with age 2317278 Taiep/Dun strain MP:0000745 tremors IAGP N RGD:2317274|PMID:14694906 20201026 RGD 2317278 Taiep/Dun strain MP:0000921 demyelination IAGP N RGD:150429639|PMID:28393430 20210910 RGD progressive with age 2317278 Taiep/Dun strain MP:0005404 abnormal axon morphology IAGP N RGD:9999446|PMID:21107138 20201005 RGD 2317278 Taiep/Dun strain MP:0006219 optic nerve degeneration IAGP N RGD:9999446|PMID:21107138 20201005 RGD 2317278 Taiep/Dun strain MP:0008721 abnormal chemokine level IAGP N RGD:9999447|PMID:25883747 20150421 RGD compared to SD 2317577 Eae24 Experimental allergic encephalomyelitis QTL 24 qtl MP:0006082 CNS inflammation IDA N RGD:2317591|PMID:19675581 20100423 RGD 2317586 Eae25 Experimental allergic encephalomyelitis QTL 25 qtl MP:0001263 weight loss IDA N RGD:2317591|PMID:19675581 20100423 RGD 2317586 Eae25 Experimental allergic encephalomyelitis QTL 25 qtl MP:0006082 CNS inflammation IDA N RGD:2317591|PMID:19675581 20100423 RGD 2317587 Eae26 Experimental allergic encephalomyelitis QTL 26 qtl MP:0001263 weight loss IDA N RGD:2317591|PMID:19675581 20100423 RGD 2317587 Eae26 Experimental allergic encephalomyelitis QTL 26 qtl MP:0006082 CNS inflammation IDA N RGD:2317591|PMID:19675581 20100423 RGD 2317588 Eae27 Experimental allergic encephalomyelitis QTL 27 qtl MP:0006082 CNS inflammation IDA N RGD:2317591|PMID:19675581 20100423 RGD 2317590 DA.PVG.1AV1-(D4Rat23-D4Rat108)/Kini strain MP:0004800 decreased susceptibility to experimental autoimmune encephalomyelitis induced IAGP XCO:0000195 N RGD:2317591|PMID:19675581 20100423 RGD Compared to DA/ZtmKini 2317595 DA.PVG.1AV1-(D4Rat23-D4Mit12)/Kini strain MP:0004800 decreased susceptibility to experimental autoimmune encephalomyelitis induced IAGP XCO:0000195 N RGD:2317591|PMID:19675581 20100423 RGD Compared to DA/ZtmKini 2317750 Glom26 Glomerulus QTL 26 qtl MP:0002743 glomerulonephritis IDA N RGD:2293335|PMID:16482158 20100421 RGD 2317752 Glom23 Glomerulus QTL 23 qtl MP:0002743 glomerulonephritis IDA N RGD:2293335|PMID:16482158 20100421 RGD 2317753 Glom24 Glomerulus QTL 24 qtl MP:0002743 glomerulonephritis IDA N RGD:2293335|PMID:16482158 20100421 RGD 2317754 Glom25 Glomerulus QTL 25 qtl MP:0002743 glomerulonephritis IDA N RGD:2293335|PMID:16482158 20100421 RGD 2317755 Glom22 Glomerulus QTL 22 qtl MP:0002743 glomerulonephritis IDA N RGD:2293335|PMID:16482158 20100421 RGD 2317791 DA.PVG.1AV1-(D4Got60-D4Kini1)/Kini strain MP:0004800 decreased susceptibility to experimental autoimmune encephalomyelitis induced IAGP XCO:0000195 N RGD:2317591|PMID:19675581 20100423 RGD Compared to DA/ZtmKini 2317812 AT.ANT-(D1Uia12-D1Rat288)/Rar strain MP:0001516 abnormal motor coordination/balance MODEL: induced IAGP N RGD:2317807|PMID:19500156 20100429 RGD alcohol 2317812 AT.ANT-(D1Uia12-D1Rat288)/Rar strain MP:0001987 alcohol preference MODEL: induced IAGP N RGD:2317807|PMID:19500156 20111108 RGD 2317813 AT.ANT-(D1Rat234-D1Rat47)/Rar strain MP:0001516 abnormal motor coordination/balance MODEL: induced IAGP N RGD:2317807|PMID:19500156 20100429 RGD alcohol 2317813 AT.ANT-(D1Rat234-D1Rat47)/Rar strain MP:0001987 alcohol preference MODEL: induced IAGP N RGD:2317807|PMID:19500156 20111108 RGD 2317814 AT.ANT-(D1Rat273-D1Rat158)/Rar strain MP:0001516 abnormal motor coordination/balance MODEL: induced IAGP N RGD:2317807|PMID:19500156 20100429 RGD alcohol 2317814 AT.ANT-(D1Rat273-D1Rat158)/Rar strain MP:0001987 alcohol preference MODEL: induced IAGP N RGD:2317807|PMID:19500156 20111108 RGD 2317815 AT.ANT-(D1Rat35-D1Rat47)/Rar strain MP:0001516 abnormal motor coordination/balance MODEL: induced IAGP N RGD:2317807|PMID:19500156 20100429 RGD alcohol 2317815 AT.ANT-(D1Rat35-D1Rat47)/Rar strain MP:0001987 alcohol preference MODEL: induced IAGP N RGD:2317807|PMID:19500156 20111108 RGD 2317816 AT.ANT-(D1Rat234-D1Rat158)/Rar strain MP:0001516 abnormal motor coordination/balance MODEL: induced IAGP N RGD:2317807|PMID:19500156 20100429 RGD alcohol 2317816 AT.ANT-(D1Rat234-D1Rat158)/Rar strain MP:0001987 alcohol preference MODEL: induced IAGP N RGD:2317807|PMID:19500156 20111108 RGD 2317817 AT.ANT-(D1Rat183-D1Rat288)/Rar strain MP:0001516 abnormal motor coordination/balance MODEL: induced IAGP N RGD:2317807|PMID:19500156 20100429 RGD alcohol 2317817 AT.ANT-(D1Rat183-D1Rat288)/Rar strain MP:0001987 alcohol preference MODEL: induced IAGP N RGD:2317807|PMID:19500156 20111108 RGD 2317818 AT.ANT-(D1Rat273-D1Rat288)/Rar strain MP:0001516 abnormal motor coordination/balance MODEL: induced IAGP N RGD:2317807|PMID:19500156 20100429 RGD alcohol 2317819 AT.ANT-(D1Rat35-D1Rat288)/Rar strain MP:0001516 abnormal motor coordination/balance MODEL: induced IAGP N RGD:2317807|PMID:19500156 20100429 RGD alcohol 2317819 AT.ANT-(D1Rat35-D1Rat288)/Rar strain MP:0001987 alcohol preference MODEL: induced IAGP N RGD:2317807|PMID:19500156 20111108 RGD 2317820 AT.ANT-(D1Rat158-D1Rat288)/Rar strain MP:0001516 abnormal motor coordination/balance MODEL: induced IAGP N RGD:2317807|PMID:19500156 20100429 RGD alcohol 2317820 AT.ANT-(D1Rat158-D1Rat288)/Rar strain MP:0001987 alcohol preference MODEL: induced IAGP N RGD:2317807|PMID:19500156 20111108 RGD 2317822 AT.ANT-(D1Rat35-D1Rat38)/Rar strain MP:0001516 abnormal motor coordination/balance MODEL: induced IAGP N RGD:2317807|PMID:19500156 20100429 RGD alcohol 2317822 AT.ANT-(D1Rat35-D1Rat38)/Rar strain MP:0001987 alcohol preference MODEL: induced IAGP N RGD:2317807|PMID:19500156 20111108 RGD 2317825 AT.ANT-(D1Rat234-D1Rat35)/Rar strain MP:0001516 abnormal motor coordination/balance MODEL: induced IAGP N RGD:2317807|PMID:19500156 20100429 RGD alcohol 2317825 AT.ANT-(D1Rat234-D1Rat35)/Rar strain MP:0001987 alcohol preference MODEL: induced IAGP N RGD:2317807|PMID:19500156 20111108 RGD 2317827 AT.ANT-(D1Rat234-D1Rat38)/Rar strain MP:0001516 abnormal motor coordination/balance MODEL: induced IAGP N RGD:2317807|PMID:19500156 20100429 RGD alcohol 2317827 AT.ANT-(D1Rat234-D1Rat38)/Rar strain MP:0001987 alcohol preference MODEL: induced IAGP N RGD:2317807|PMID:19500156 20111108 RGD 2317833 Alcrsp19 Alcohol response QTL 19 qtl MP:0001516 abnormal motor coordination/balance IDA N RGD:2317807|PMID:19500156 20100429 RGD alcohol 2317833 Alcrsp19 Alcohol response QTL 19 qtl MP:0001523 impaired righting response IDA N RGD:2317807|PMID:19500156 20100429 RGD alcohol 2317833 Alcrsp19 Alcohol response QTL 19 qtl MP:0001987 alcohol preference IDA N RGD:2317807|PMID:19500156 20111108 RGD 2317840 Alcrsp20 Alcohol response QTL 20 qtl MP:0001516 abnormal motor coordination/balance IDA N RGD:2317807|PMID:19500156 20100429 RGD alcohol 2317840 Alcrsp20 Alcohol response QTL 20 qtl MP:0001987 alcohol preference IDA N RGD:2317807|PMID:19500156 20111108 RGD 2317848 Alcrsp21 Alcohol response QTL 21 qtl MP:0001516 abnormal motor coordination/balance IDA N RGD:2317807|PMID:19500156 20100429 RGD alcohol 2317848 Alcrsp21 Alcohol response QTL 21 qtl MP:0001987 alcohol preference IDA N RGD:2317807|PMID:19500156 20111108 RGD 2317851 Alcrsp22 Alcohol response QTL 22 qtl MP:0001516 abnormal motor coordination/balance IDA N RGD:2317807|PMID:19500156 20100429 RGD alcohol 2317851 Alcrsp22 Alcohol response QTL 22 qtl MP:0001523 impaired righting response IDA N RGD:2317807|PMID:19500156 20100429 RGD alcohol 2317851 Alcrsp22 Alcohol response QTL 22 qtl MP:0001987 alcohol preference IDA N RGD:2317807|PMID:19500156 20111108 RGD 2317879 Alcrsp27 Alcohol response QTL 27 qtl MP:0001516 abnormal motor coordination/balance IDA N RGD:2317807|PMID:19500156 20100429 RGD alcohol 2317879 Alcrsp27 Alcohol response QTL 27 qtl MP:0001523 impaired righting response IDA N RGD:2317807|PMID:19500156 20100429 RGD alcohol 2317879 Alcrsp27 Alcohol response QTL 27 qtl MP:0001987 alcohol preference IDA N RGD:2317807|PMID:19500156 20111108 RGD 2317880 Alcrsp25 Alcohol response QTL 25 qtl MP:0001516 abnormal motor coordination/balance IDA N RGD:2317807|PMID:19500156 20100429 RGD alcohol 2317880 Alcrsp25 Alcohol response QTL 25 qtl MP:0001987 alcohol preference IDA N RGD:2317807|PMID:19500156 20111108 RGD 2317882 Alcrsp24 Alcohol response QTL 24 qtl MP:0001516 abnormal motor coordination/balance IDA N RGD:2317807|PMID:19500156 20100429 RGD alcohol 2317882 Alcrsp24 Alcohol response QTL 24 qtl MP:0001987 alcohol preference IDA N RGD:2317807|PMID:19500156 20111108 RGD 2317883 Alcrsp26 Alcohol response QTL 26 qtl MP:0001516 abnormal motor coordination/balance IDA N RGD:2317807|PMID:19500156 20100429 RGD alcohol 2317883 Alcrsp26 Alcohol response QTL 26 qtl MP:0001987 alcohol preference IDA N RGD:2317807|PMID:19500156 20111108 RGD 2317885 Alcrsp28 Alcohol response QTL 28 qtl MP:0001516 abnormal motor coordination/balance IDA N RGD:2317807|PMID:19500156 20100429 RGD alcohol 2317885 Alcrsp28 Alcohol response QTL 28 qtl MP:0001987 alcohol preference IDA N RGD:2317807|PMID:19500156 20111108 RGD 2317886 Alcrsp23 Alcohol response QTL 23 qtl MP:0001516 abnormal motor coordination/balance IDA N RGD:2317807|PMID:19500156 20100429 RGD alcohol 2317886 Alcrsp23 Alcohol response QTL 23 qtl MP:0001987 alcohol preference IDA N RGD:2317807|PMID:19500156 20111108 RGD 2317891 SHR-Chr 6MWF/Rkb strain MP:0003915 increased heart left ventricle weight IAGP N RGD:2317887|PMID:20388842 20200203 RGD compared to MWF/FubRkb 2317891 SHR-Chr 6MWF/Rkb strain MP:0004875 increased mean systemic arterial blood pressure IAGP N RGD:2317887|PMID:20388842 20200203 RGD compared to MWF/FubRkb 2317891 SHR-Chr 6MWF/Rkb strain MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:2317887|PMID:20388842 20100429 RGD compared to MWF/FubRkb 2317891 SHR-Chr 6MWF/Rkb strain MP:0006144 increased systemic arterial systolic blood pressure induced IAGP XCO:0000121 N RGD:2317887|PMID:20388842 20200203 RGD compared to SHR/FubRkb 2318412 Oca2 OCA2 melanosomal transmembrane protein gene MP:0006159 ocular albinism IAGP N RGD:1579834|PMID:16245028 20140916 RGD 2320121 Angptl8 angiopoietin-like 8 gene MP:0001262 decreased body weight IMP N RGD:38549347|PMID:30042156 20210715 RGD compared to wild type rats 2320121 Angptl8 angiopoietin-like 8 gene MP:0002644 decreased circulating triglyceride level IMP N RGD:38549347|PMID:30042156 20210715 RGD compared to wild type rats 2320121 Angptl8 angiopoietin-like 8 gene MP:0002644 decreased circulating triglyceride level induces IMP XCO:0000013 N RGD:38549347|PMID:30042156 20210715 RGD compared to wild type rats 2320121 Angptl8 angiopoietin-like 8 gene MP:0003976 decreased circulating VLDL triglyceride level IMP N RGD:38549347|PMID:30042156 20210715 RGD compared to wild type rats 2320121 Angptl8 angiopoietin-like 8 gene MP:0005659 decreased susceptibility to diet-induced obesity IMP N RGD:38549347|PMID:30042156 20210715 RGD compared to wild type rats 2320121 Angptl8 angiopoietin-like 8 gene MP:0009269 decreased fat cell size IMP N RGD:38549347|PMID:30042156 20210715 RGD compared to wild type rats 2320121 Angptl8 angiopoietin-like 8 gene MP:0009289 decreased epididymal fat pad weight IMP N RGD:38549347|PMID:30042156 20210715 RGD compared to wild type rats 2322311 Msh6 mutS homolog 6 gene MP:0002020 increased tumor incidence IMP N RGD:2292505|PMID:18417481 20210428 RGD 2322311 Msh6 mutS homolog 6 gene MP:0002083 premature death IMP N RGD:2292505|PMID:18417481 20210428 RGD 2323 Cdkn2a cyclin-dependent kinase inhibitor 2A gene MP:0010309 increased mesothelioma incidence IAGP N RGD:7248760|PMID:20065947 20190813 RGD DNA:deletion 2324 Cdkn2b cyclin-dependent kinase inhibitor 2B gene MP:0010309 increased mesothelioma incidence IAGP N RGD:7248760|PMID:20065947 20190813 RGD DNA:deletion 2324617 Coatc2 Coat color QTL 2 qtl MP:0002075 abnormal coat/hair pigmentation IDA N RGD:2317982|PMID:20364790 20100506 RGD 2324619 Coatc4 Coat color QTL 4 qtl MP:0002075 abnormal coat/hair pigmentation IDA N RGD:2317982|PMID:20364790 20100506 RGD 2324620 Coatc3 Coat color QTL 3 qtl MP:0002075 abnormal coat/hair pigmentation IDA N RGD:2317982|PMID:20364790 20100506 RGD 2324621 Coatc5 Coat color QTL 5 qtl MP:0002075 abnormal coat/hair pigmentation IDA N RGD:2317982|PMID:20364790 20100506 RGD 2324631 DA.E3-(D4Wox49-D4Got136)/Rhd strain MP:0002933 joint inflammation susceptibility IAGP N RGD:2324629|PMID:20200546 20100506 RGD 2324631 DA.E3-(D4Wox49-D4Got136)/Rhd strain MP:0002936 joint swelling susceptibility IAGP N RGD:2324629|PMID:20200546 20100506 RGD 2325143 SHR/NHsdMco Spontaneously Hypertensive Rat strain MP:0001262 decreased body weight IAGP N RGD:1625111|PMID:17504948 20191126 RGD compared to SS/JrMco, SS.SHR-(D2Rat61-D2Mco18)/Mco 2325143 SHR/NHsdMco Spontaneously Hypertensive Rat strain MP:0002644 decreased circulating triglyceride level IAGP N RGD:1625111|PMID:17504948 20191126 RGD compared to SS/JrMco, SS.SHR-(D2Rat61-D2Mco18)/Mco 2325143 SHR/NHsdMco Spontaneously Hypertensive Rat strain MP:0005179 decreased circulating cholesterol level IAGP N RGD:1625111|PMID:17504948 20191126 RGD compared to SS/JrMco, SS.SHR-(D2Rat61-D2Mco18)/Mco 2325143 SHR/NHsdMco Spontaneously Hypertensive Rat strain MP:0005554 decreased circulating creatinine level IAGP N RGD:1625111|PMID:17504948 20191126 RGD compared to SS/JrMco, SS.SHR-(D2Rat61-D2Mco18)/Mco 2325143 SHR/NHsdMco Spontaneously Hypertensive Rat strain MP:0006316 increased urine sodium level IAGP N RGD:1625111|PMID:17504948 20191126 RGD compared to SS/JrMco, SS.SHR-(D2Rat61-D2Mco18)/Mco 2325143 SHR/NHsdMco Spontaneously Hypertensive Rat strain MP:0009349 increased urine pH IAGP N RGD:1625111|PMID:17504948 20191126 RGD compared to SS/JrMco, SS.SHR-(D2Rat61-D2Mco18)/Mco 2325346 Mir195 microRNA 195 gene MP:0008469 abnormal protein level IMP N RGD:45073134|PMID:32272873 20210716 RGD Syp, Gap43 2325346 Mir195 microRNA 195 gene MP:0008946 abnormal neuron number IMP N RGD:45073134|PMID:32272873 20210715 RGD in hippocampus 2325346 Mir195 microRNA 195 gene MP:0020551 abnormal postsynaptic density morphology IMP N RGD:45073134|PMID:32272873 20210716 RGD 2325422 Mir542 microRNA 542 gene MP:0011346 renal tubule atrophy ameliorates IMP N RGD:401900731|PMID:32470449 20231117 RGD 2325495 Mir500 microRNA 500 gene MP:0001973 increased thermal nociceptive threshold induces IMP XCO:0000735 N RGD:405850240|PMID:27277808 20240606 RGD 2325495 Mir500 microRNA 500 gene MP:0014382 increased miniature inhibitory postsynaptic current frequency IMP N RGD:405850240|PMID:27277808 20240606 RGD 2325495 Mir500 microRNA 500 gene MP:0020955 increased mechanical nociceptive threshold induces IMP XCO:0000735 N RGD:405850240|PMID:27277808 20240606 RGD 2325544 Mir222 microRNA 222 gene MP:0002891 increased insulin sensitivity treatment IMP N RGD:151893462|PMID:33230470 20220420 RGD associated with polycystic ovary syndrome; 2325553 Mir200c microRNA 200c gene MP:0005257 abnormal intraocular pressure treatment IMP N RGD:155882562|PMID:23272142 20230130 RGD 2325591 Mir29b1 microRNA 29b-1 gene MP:0005591 decreased vasodilation IMP N RGD:13702880|PMID:29374012 20200508 RGD 2325724 PVG.LEW-(D1Rat270-D1Rat68)/Kini strain MP:0002936 joint swelling IAGP N RGD:6892695|PMID:20072140 20100607 RGD 2325724 PVG.LEW-(D1Rat270-D1Rat68)/Kini strain MP:0003724 increased susceptibility to induced arthritis IAGP N RGD:6892695|PMID:20072140 20100607 RGD 2325724 PVG.LEW-(D1Rat270-D1Rat68)/Kini strain MP:0006082 CNS inflammation induced IAGP XCO:0000195 N RGD:6892695|PMID:20072140 20100607 RGD 2325725 Eae31 Experimental allergic encephalomyelitis QTL 31 qtl MP:0006082 CNS inflammation IDA N RGD:6892695|PMID:20072140 20100607 RGD 2325726 Eae30 Experimental allergic encephalomyelitis QTL 30 qtl MP:0006082 CNS inflammation IDA N RGD:6892695|PMID:20072140 20100607 RGD 2325727 Pia41 Pristane induced arthritis QTL 41 qtl MP:0002936 joint swelling IDA N RGD:6892695|PMID:20072140 20100607 RGD 2325727 Pia41 Pristane induced arthritis QTL 41 qtl MP:0003724 increased susceptibility to induced arthritis IDA N RGD:6892695|PMID:20072140 20100607 RGD 2325727 Pia41 Pristane induced arthritis QTL 41 qtl MP:0006082 CNS inflammation IDA N RGD:6892695|PMID:20072140 20100607 RGD 2325754 SD-Pax6Sey/Mce strain MP:0001297 microphthalmia IAGP N RGD:1601213|PMID:7981749 20100609 RGD 2325754 SD-Pax6Sey/Mce strain MP:0001325 abnormal retina morphology IAGP N RGD:1601213|PMID:7981749 20170223 RGD 2325773 WKY.LEW-(D13Arb15-D13Rat58)/Tja strain MP:0002743 glomerulonephritis resistance IDA N RGD:2325762|PMID:20488952 20100610 RGD 2325773 WKY.LEW-(D13Arb15-D13Rat58)/Tja strain MP:0002962 increased urine protein level IDA N RGD:2325762|PMID:20488952 20120112 RGD 2325774 WKY.LEW-(D13Arb10-D13Arb15)(D16Rat88-D16Rat40)/Tja strain MP:0002743 glomerulonephritis resistance IDA N RGD:2325762|PMID:20488952 20100610 RGD 2325774 WKY.LEW-(D13Arb10-D13Arb15)(D16Rat88-D16Rat40)/Tja strain MP:0002962 increased urine protein level IDA N RGD:2325762|PMID:20488952 20120112 RGD 2325796 SS.LEW-(D3Rat52-D3Chm57)/Ayd strain MP:0001262 decreased body weight induced IAGP XCO:0000022 N RGD:2301185|PMID:18806617 20100611 RGD compared to SS/Jr 2325796 SS.LEW-(D3Rat52-D3Chm57)/Ayd strain MP:0002625 heart left ventricle hypertrophy induced IAGP XCO:0000022 N RGD:2301185|PMID:18806617 20100611 RGD 2325796 SS.LEW-(D3Rat52-D3Chm57)/Ayd strain MP:0002626 increased heart rate induced IAGP XCO:0000022 N RGD:2301185|PMID:18806617 20191205 RGD compared to SS/Jr 2325796 SS.LEW-(D3Rat52-D3Chm57)/Ayd strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:2301185|PMID:18806617 20100611 RGD compared to SS/Jr 2325796 SS.LEW-(D3Rat52-D3Chm57)/Ayd strain MP:0005599 increased cardiac muscle contractility induced IAGP XCO:0000022 N RGD:2301185|PMID:18806617 20191205 RGD compared to SS/Jr 2325798 SS.LEW-(D10Got112-Igfbp4)/Ayd strain MP:0002625 heart left ventricle hypertrophy induced IAGP XCO:0000022 N RGD:2301185|PMID:18806617 20100611 RGD 2325798 SS.LEW-(D10Got112-Igfbp4)/Ayd strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:2301185|PMID:18806617 20100611 RGD compared to SS/Jr 2325798 SS.LEW-(D10Got112-Igfbp4)/Ayd strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:7421500|PMID:23814039 20131211 RGD compared to SS/Jr 2325801 SS.LEW-(D16Chm36-D16Mit2)/Ayd strain MP:0001260 increased body weight induced IAGP XCO:0000022 N RGD:2301185|PMID:18806617 20100611 RGD compared to SS/Jr 2325801 SS.LEW-(D16Chm36-D16Mit2)/Ayd strain MP:0002625 heart left ventricle hypertrophy induced IAGP XCO:0000022 N RGD:2301185|PMID:18806617 20100611 RGD compared to LEW 2325801 SS.LEW-(D16Chm36-D16Mit2)/Ayd strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:2301185|PMID:18806617 20100611 RGD compared to SS/Jr 2325803 SS.LEW-(D16Rat112-D16Chm60)/Ayd strain MP:0002625 heart left ventricle hypertrophy induced IAGP XCO:0000022 N RGD:2301185|PMID:18806617 20100611 RGD 2325803 SS.LEW-(D16Rat112-D16Chm60)/Ayd strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:2301185|PMID:18806617 20100611 RGD compared to SS/Jr 2325803 SS.LEW-(D16Rat112-D16Chm60)/Ayd strain MP:0005599 increased cardiac muscle contractility induced IAGP XCO:0000022 N RGD:2301185|PMID:18806617 20100611 RGD compared to LEW 2325836 Bp346 Blood pressure QTL 346 qtl MP:0004876 decreased mean systemic arterial blood pressure IDA N RGD:2301185|PMID:18806617 20100611 RGD 2325838 Bp347 Blood pressure QTL 347 qtl MP:0004876 decreased mean systemic arterial blood pressure IDA N RGD:2301185|PMID:18806617 20100611 RGD 2325839 Bp348 Blood pressure QTL 348 qtl MP:0004876 decreased mean systemic arterial blood pressure IDA N RGD:2301185|PMID:18806617 20100611 RGD 2325840 Bp345 Blood pressure QTL 345 qtl MP:0004876 decreased mean systemic arterial blood pressure IDA N RGD:2301185|PMID:18806617 20100611 RGD 2326 Cebpa CCAAT/enhancer binding protein alpha gene MP:0001547 abnormal lipid level IDA N RGD:704418|PMID:12865412 19990101 RGD 2332 Cftr CF transmembrane conductance regulator gene MP:0000219 increased neutrophil cell number IMP N RGD:11566051|PMID:24608905 20161130 RGD 2332 Cftr CF transmembrane conductance regulator gene MP:0001262 decreased body weight IMP N RGD:126928119|PMID:31942562 20210526 RGD 2332 Cftr CF transmembrane conductance regulator gene MP:0001262 decreased body weight IMP N RGD:151347176|PMID:29190650 20220120 RGD 2332 Cftr CF transmembrane conductance regulator gene MP:0001732 postnatal growth retardation IMP N RGD:126928119|PMID:31942562 20210526 RGD 2332 Cftr CF transmembrane conductance regulator gene MP:0001732 postnatal growth retardation treatment IMP N RGD:126928119|PMID:31942562 20210526 RGD DietGel 31M and 6% osmotic laxative (PEG3350) and DietGel Boost added to drinking water 2332 Cftr CF transmembrane conductance regulator gene MP:0002238 abnormal nasal mucosa morphology IMP N RGD:11566051|PMID:24608905 20161130 RGD 2332 Cftr CF transmembrane conductance regulator gene MP:0003109 short femur IMP N RGD:151347176|PMID:29190650 20220120 RGD 2332 Cftr CF transmembrane conductance regulator gene MP:0003120 abnormal tracheal cartilage morphology IMP N RGD:11566051|PMID:24608905 20161130 RGD 2332 Cftr CF transmembrane conductance regulator gene MP:0003557 absent vas deferens IMP N RGD:126928119|PMID:31942562 20210527 RGD 2332 Cftr CF transmembrane conductance regulator gene MP:0004148 increased compact bone thickness IMP N RGD:151347176|PMID:29190650 20220120 RGD 2332 Cftr CF transmembrane conductance regulator gene MP:0004701 decreased circulating insulin-like growth factor I level IMP N RGD:151347176|PMID:29190650 20220120 RGD 2332 Cftr CF transmembrane conductance regulator gene MP:0005018 decreased T cell number IMP N RGD:11566051|PMID:24608905 20161130 RGD 2332 Cftr CF transmembrane conductance regulator gene MP:0005416 abnormal circulating protein level IMP N RGD:11566051|PMID:24608905 20161130 RGD 2332 Cftr CF transmembrane conductance regulator gene MP:0005419 decreased circulating serum albumin level IMP N RGD:11566051|PMID:24608905 20161130 RGD 2332 Cftr CF transmembrane conductance regulator gene MP:0005565 increased blood urea nitrogen level IMP N RGD:11566051|PMID:24608905 20161130 RGD 2332 Cftr CF transmembrane conductance regulator gene MP:0006395 abnormal epiphyseal plate morphology IMP N RGD:151347176|PMID:29190650 20220120 RGD 2332 Cftr CF transmembrane conductance regulator gene MP:0008108 abnormal small intestinal villus morphology IMP N RGD:11566051|PMID:24608905 20161130 RGD 2332 Cftr CF transmembrane conductance regulator gene MP:0008770 decreased survivor rate IMP N RGD:126928119|PMID:31942562 20210526 RGD 2332 Cftr CF transmembrane conductance regulator gene MP:0008770 decreased survivor rate treatment IMP N RGD:126928119|PMID:31942562 20210526 RGD DietGel 31M and 6% osmotic laxative (PEG3350) and DietGel Boost added to drinking water 2332 Cftr CF transmembrane conductance regulator gene MP:0010879 decreased trabecular bone volume IMP N RGD:151347176|PMID:29190650 20220120 RGD 2332 Cftr CF transmembrane conductance regulator gene MP:0010965 decreased compact bone volume IMP N RGD:151347176|PMID:29190650 20220120 RGD 2332 Cftr CF transmembrane conductance regulator gene MP:0012007 abnormal chloride level IMP N RGD:11566051|PMID:24608905 20161130 RGD 2332 Cftr CF transmembrane conductance regulator gene MP:0012020 abnormal olfactory epithelium physiology IMP N RGD:126928119|PMID:31942562 20210526 RGD 2332 Cftr CF transmembrane conductance regulator gene MP:0013129 abnormal tooth color IMP N RGD:11566051|PMID:24608905 20161130 RGD 2332 Cftr CF transmembrane conductance regulator gene MP:0013494 abnormal trachea gland morphology IMP N RGD:11566051|PMID:24608905 20161130 RGD 2332 Cftr CF transmembrane conductance regulator gene MP:0014028 decreased respiratory epithelial chloride transmembrane transport IMP N RGD:126928119|PMID:31942562 20210526 RGD 2332 Cftr CF transmembrane conductance regulator gene MP:0014183 increased respiratory epithelial sodium ion transmembrane transport IMP N RGD:126928119|PMID:31942562 20210526 RGD 2332 Cftr CF transmembrane conductance regulator gene MP:0030544 abnormal enamel development IMP N RGD:126928119|PMID:31942562 20210526 RGD 2347 Chrna5 cholinergic receptor nicotinic alpha 5 subunit gene MP:0003545 increased alcohol consumption IMP N RGD:150530288|PMID:31288250 20211209 RGD compared to wild type 2347 Chrna5 cholinergic receptor nicotinic alpha 5 subunit gene MP:0009756 impaired behavioral response to nicotine IMP N RGD:14694852|PMID:30293722 20211209 RGD 2347 Chrna5 cholinergic receptor nicotinic alpha 5 subunit gene MP:0012342 high preference for an addictive substance IMP N RGD:150530288|PMID:31288250 20211209 RGD compared to wild type 2347 Chrna5 cholinergic receptor nicotinic alpha 5 subunit gene MP:0020906 abnormal acquisiton of operant behavior for a cocaine reinforcer IMP N RGD:150530292|PMID:32841724 20211209 RGD 2347 Chrna5 cholinergic receptor nicotinic alpha 5 subunit gene MP:0020908 abnormal reinstatement of an extinguished operant behavior for a cocaine reinforcer IMP N RGD:150530292|PMID:32841724 20211209 RGD 2348 Chrna7 cholinergic receptor nicotinic alpha 7 subunit gene MP:0012307 impaired spatial learning IMP N RGD:151708697|PMID:17055644 20220414 RGD 2366 Abcc2 ATP binding cassette subfamily C member 2 gene MP:0005167 abnormal blood-brain barrier function IAGP N RGD:704399|PMID:12663688 19990101 RGD 2366 Abcc2 ATP binding cassette subfamily C member 2 gene MP:0005344 increased circulating bilirubin level IAGP N RGD:14985241|PMID:19525466 20191015 RGD 2366 Abcc2 ATP binding cassette subfamily C member 2 gene MP:0008875 abnormal xenobiotic pharmacokinetics IMP N RGD:14392811|PMID:22711747 20210916 RGD 2370 Cntf ciliary neurotrophic factor gene MP:0005386 behavior/neurological phenotype IDA N RGD:628474|PMID:12040055 19990101 RGD 2375 Col2a1 collagen type II alpha 1 chain gene MP:0002657 chondrodystrophy IDA N RGD:704421|PMID:10853827 19990101 RGD 2379 Comt catechol-O-methyltransferase gene MP:0001905 abnormal dopamine level IDA N RGD:704422|PMID:12535946 19990101 RGD 2379 Comt catechol-O-methyltransferase gene MP:0002063 abnormal learning/memory/conditioning TAS N RGD:704422|PMID:12535946 19990101 RGD 2387 Cp ceruloplasmin gene MP:0004151 decreased circulating iron level IMP N RGD:38549582|PMID:31560858 20200902 RGD 2387 Cp ceruloplasmin gene MP:0006349 decreased circulating copper level IMP N RGD:38549582|PMID:31560858 20200902 RGD 2387 Cp ceruloplasmin gene MP:0008807 increased liver iron level IMP N RGD:38549582|PMID:31560858 20200902 RGD 2387 Cp ceruloplasmin gene MP:0008808 decreased spleen iron level IMP N RGD:38549582|PMID:31560858 20200902 RGD 2387 Cp ceruloplasmin gene MP:0011896 increased circulating unsaturated transferrin level IMP N RGD:38549582|PMID:31560858 20200902 RGD 2387 Cp ceruloplasmin gene MP:0012661 decreased circulating ceruloplasmin level IMP N RGD:38549582|PMID:31560858 20200902 RGD 2387 Cp ceruloplasmin gene MP:0030601 increased circulating manganese level IMP N RGD:38549582|PMID:31560858 20200902 RGD 2401 Crebbp CREB binding protein gene MP:0001625 cardiac hypertrophy IDA N RGD:1298794|PMID:12477714 20061031 RGD 2401 Crebbp CREB binding protein gene MP:0020422 decreased freezing behavior IMP N RGD:126848802|PMID:32206715 20210504 RGD 2415 Cryba1 crystallin, beta A1 gene MP:0000259 abnormal vascular development IAGP N RGD:2303652|PMID:17931883 20090220 RGD DNA:insertion:exon 2415 Cryba1 crystallin, beta A1 gene MP:0001303 abnormal lens morphology IAGP N RGD:38676460|PMID:26303524 20200918 RGD 2415 Cryba1 crystallin, beta A1 gene MP:0001306 small lens IMP N RGD:126925760|PMID:15721615 20210519 RGD 2415 Cryba1 crystallin, beta A1 gene MP:0002182 abnormal astrocyte morphology IMP N RGD:2303652|PMID:17931883 20210519 RGD 2415 Cryba1 crystallin, beta A1 gene MP:0002792 abnormal retina vasculature morphology IMP N RGD:2303652|PMID:17931883 20210519 RGD 2415 Cryba1 crystallin, beta A1 gene MP:0003734 abnormal retina inner plexiform layer morphology IMP N RGD:126925760|PMID:15721615 20210519 RGD 2415 Cryba1 crystallin, beta A1 gene MP:0005099 abnormal ciliary body morphology IAGP N RGD:38676460|PMID:26303524 20200918 RGD 2415 Cryba1 crystallin, beta A1 gene MP:0005241 abnormal retina ganglion layer morphology IAGP N RGD:38676460|PMID:26303524 20200918 RGD 2415 Cryba1 crystallin, beta A1 gene MP:0005241 abnormal retina ganglion layer morphology IMP N RGD:126925760|PMID:15721615 20210519 RGD 2415 Cryba1 crystallin, beta A1 gene MP:0008260 abnormal autophagy IMP N RGD:126925759|PMID:21266465 20210519 RGD 2415 Cryba1 crystallin, beta A1 gene MP:0008842 lipofuscinosis IMP N RGD:126925759|PMID:21266465 20210519 RGD 2415 Cryba1 crystallin, beta A1 gene MP:0011996 abnormal retina inner nuclear layer thickness IMP N RGD:126925760|PMID:15721615 20210519 RGD 2415 Cryba1 crystallin, beta A1 gene MP:0011997 abnormal retina outer nuclear layer thickness IMP N RGD:126925760|PMID:15721615 20210519 RGD 2415 Cryba1 crystallin, beta A1 gene MP:0030006 decreased retina apoptosis IMP N RGD:126925760|PMID:15721615 20210519 RGD 2425 Csf1r colony stimulating factor 1 receptor gene MP:0000195 decreased circulating calcium level IMP N RGD:41404725|PMID:30249809 20210413 RGD 2425 Csf1r colony stimulating factor 1 receptor gene MP:0000198 decreased circulating phosphate level IMP N RGD:41404725|PMID:30249809 20210413 RGD 2425 Csf1r colony stimulating factor 1 receptor gene MP:0000223 decreased monocyte cell number IMP N RGD:41404725|PMID:30249809 20210413 RGD 2425 Csf1r colony stimulating factor 1 receptor gene MP:0000322 increased granulocyte number IMP N RGD:41404725|PMID:30249809 20210413 RGD 2425 Csf1r colony stimulating factor 1 receptor gene MP:0000913 abnormal brain development IMP N RGD:126781687|PMID:33450391 20210414 RGD 2425 Csf1r colony stimulating factor 1 receptor gene MP:0001262 decreased body weight IMP N RGD:41404725|PMID:30249809 20210413 RGD 2425 Csf1r colony stimulating factor 1 receptor gene MP:0001732 postnatal growth retardation IMP N RGD:126781687|PMID:33450391 20210414 RGD 2425 Csf1r colony stimulating factor 1 receptor gene MP:0001783 decreased white adipose tissue amount IMP N RGD:41404725|PMID:30249809 20210413 RGD 2425 Csf1r colony stimulating factor 1 receptor gene MP:0002083 premature death IMP N RGD:126781687|PMID:33450391 20210414 RGD 2425 Csf1r colony stimulating factor 1 receptor gene MP:0002680 decreased corpora lutea number IMP N RGD:41404725|PMID:30249809 20210413 RGD 2425 Csf1r colony stimulating factor 1 receptor gene MP:0002942 decreased circulating alanine transaminase level IMP N RGD:41404725|PMID:30249809 20210413 RGD 2425 Csf1r colony stimulating factor 1 receptor gene MP:0003884 decreased macrophage cell number IMP N RGD:41404725|PMID:30249809 20210413 RGD 2425 Csf1r colony stimulating factor 1 receptor gene MP:0004985 decreased osteoclast cell number IMP N RGD:41404725|PMID:30249809 20210413 RGD 2425 Csf1r colony stimulating factor 1 receptor gene MP:0008119 decreased Langerhans cell number IMP N RGD:41404725|PMID:30249809 20210413 RGD 2425 Csf1r colony stimulating factor 1 receptor gene MP:0008222 decreased hippocampal commissure size IMP N RGD:126781687|PMID:33450391 20210414 RGD 2425 Csf1r colony stimulating factor 1 receptor gene MP:0008226 decreased anterior commissure size IMP N RGD:126781687|PMID:33450391 20210414 RGD 2425 Csf1r colony stimulating factor 1 receptor gene MP:0011380 enlarged brain ventricles IMP N RGD:126781687|PMID:33450391 20210414 RGD 2425 Csf1r colony stimulating factor 1 receptor gene MP:0011982 decreased microglial cell number IMP N RGD:126781687|PMID:33450391 20210414 RGD 2425 Csf1r colony stimulating factor 1 receptor gene MP:0011982 decreased microglial cell number IMP N RGD:41404725|PMID:30249809 20210413 RGD 2425 Csf1r colony stimulating factor 1 receptor gene MP:0012460 decreased dentate gyrus size IMP N RGD:126781687|PMID:33450391 20210414 RGD 2425 Csf1r colony stimulating factor 1 receptor gene MP:0020545 decreased hippocampal fornix size IMP N RGD:126781687|PMID:33450391 20210414 RGD 2425 Csf1r colony stimulating factor 1 receptor gene MP:0020573 abnormal corpus callosum size IMP N RGD:126781687|PMID:33450391 20210414 RGD 2425 Csf1r colony stimulating factor 1 receptor gene MP:0030088 microdontia IMP N RGD:41404725|PMID:30249809 20210413 RGD 2425 Csf1r colony stimulating factor 1 receptor gene MP:0030610 absent teeth IMP N RGD:126781687|PMID:33450391 20210414 RGD 2453 Cyp11b1 cytochrome P450, family 11, subfamily b, polypeptide 1 gene MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:69709|PMID:7981756 20150304 RGD 2454 Cyp11b2 cytochrome P450, family 11, subfamily b, polypeptide 2 gene MP:0000639 abnormal adrenal gland morphology IAGP N RGD:727991|PMID:11832364 19990101 RGD 2454 Cyp11b2 cytochrome P450, family 11, subfamily b, polypeptide 2 gene MP:0000706 small thymus IAGP N RGD:727991|PMID:11832364 19990101 RGD 2454 Cyp11b2 cytochrome P450, family 11, subfamily b, polypeptide 2 gene MP:0001745 increased circulating corticosterone level IAGP N RGD:727991|PMID:11832364 19990101 RGD 2454 Cyp11b2 cytochrome P450, family 11, subfamily b, polypeptide 2 gene MP:0002666 increased circulating aldosterone level IAGP N RGD:727991|PMID:11832364 19990101 RGD 2454 Cyp11b2 cytochrome P450, family 11, subfamily b, polypeptide 2 gene MP:0003916 decreased heart left ventricle weight IAGP N RGD:727991|PMID:11832364 19990101 RGD 2469 Cyp2c11 cytochrome P450, subfamily 2, polypeptide 11 gene MP:0001935 decreased litter size IMP N RGD:150429710|PMID:29444903 20210920 RGD compared to wild type 2469 Cyp2c11 cytochrome P450, subfamily 2, polypeptide 11 gene MP:0002683 delayed fertility IMP N RGD:150429710|PMID:29444903 20210920 RGD compared to wild type 2469 Cyp2c11 cytochrome P450, subfamily 2, polypeptide 11 gene MP:0008875 abnormal xenobiotic pharmacokinetics IMP XCO:0000252 N RGD:150429710|PMID:29444903 20210920 RGD compared to wild type 2469 Cyp2c11 cytochrome P450, subfamily 2, polypeptide 11 gene MP:0008875 abnormal xenobiotic pharmacokinetics sexual_dimorphism IAGP XCO:0000252 N RGD:150429710|PMID:29444903 20210920 RGD compared between male and female 2493 Ace angiotensin I converting enzyme gene MP:0003184 increased angiotensin I-converting enzyme activity IAGP N RGD:8157605|PMID:16229862 20140203 RGD DNA:insertion:intron:IVS16ins287 2493 Ace angiotensin I converting enzyme gene MP:0003185 decreased angiotensin I-converting enzyme activity IAGP N RGD:8157602|PMID:9484988 20140203 RGD DNA:repeat:intron:IVS13+40(CA)?-26 2507 Dmd dystrophin gene MP:0000747 muscle weakness IMP N RGD:11040981|PMID:25005781 20170428 RGD 2507 Dmd dystrophin gene MP:0000747 muscle weakness IMP N RGD:12880034|PMID:25310701 20170502 RGD 2507 Dmd dystrophin gene MP:0000749 muscle degeneration IMP N RGD:11040981|PMID:25005781 20170428 RGD 2507 Dmd dystrophin gene MP:0001258 decreased body length IMP N RGD:12880034|PMID:25310701 20170502 RGD 2507 Dmd dystrophin gene MP:0001262 decreased body weight IMP N RGD:11040981|PMID:25005781 20170502 RGD 2507 Dmd dystrophin gene MP:0001262 decreased body weight IMP N RGD:12880034|PMID:25310701 20170502 RGD 2507 Dmd dystrophin gene MP:0001402 decreased locomotor activity IMP N RGD:12880034|PMID:25310701 20170502 RGD 2507 Dmd dystrophin gene MP:0002833 increased heart weight IMP N RGD:11040981|PMID:25005781 20170502 RGD 2507 Dmd dystrophin gene MP:0002834 decreased heart weight IMP N RGD:12880034|PMID:25310701 20170502 RGD 2507 Dmd dystrophin gene MP:0006086 decreased body mass index IMP N RGD:12880034|PMID:25310701 20170502 RGD 2507 Dmd dystrophin gene MP:0009402 decreased skeletal muscle fiber diameter IMP N RGD:11040981|PMID:25005781 20170502 RGD 2507 Dmd dystrophin gene MP:0009402 decreased skeletal muscle fiber diameter IMP N RGD:12880034|PMID:25310701 20170502 RGD 2507 Dmd dystrophin gene MP:0009404 centrally nucleated skeletal muscle fibers IMP N RGD:11040981|PMID:25005781 20170428 RGD 2507 Dmd dystrophin gene MP:0009427 increased tibialis anterior weight IMP N RGD:11040981|PMID:25005781 20170502 RGD 2507 Dmd dystrophin gene MP:0009428 decreased tibialis anterior weight IMP N RGD:12880034|PMID:25310701 20170502 RGD 2507 Dmd dystrophin gene MP:0010090 increased circulating creatine kinase level IMP N RGD:12880034|PMID:25310701 20170502 RGD 2507 Dmd dystrophin gene MP:0011925 abnormal heart echocardiography feature IMP N RGD:12880034|PMID:25310701 20170502 RGD 2507 Dmd dystrophin gene MP:0020280 increased creatine kinase level IMP N RGD:11040981|PMID:25005781 20170502 RGD 2515 Dpp4 dipeptidylpeptidase 4 gene MP:0001262 decreased body weight IAGP N RGD:1626460|PMID:14568317 20070809 RGD 2515 Dpp4 dipeptidylpeptidase 4 gene MP:0001263 weight loss IAGP N RGD:41408336|PMID:19327106 20210211 RGD compared to DA/Ztm 2515 Dpp4 dipeptidylpeptidase 4 gene MP:0001364 decreased anxiety-related response IAGP N RGD:41408336|PMID:19327106 20210211 RGD compared to DA/Ztm 2515 Dpp4 dipeptidylpeptidase 4 gene MP:0001392 abnormal locomotor behavior IAGP N RGD:1626460|PMID:14568317 20070809 RGD 2515 Dpp4 dipeptidylpeptidase 4 gene MP:0001415 increased exploration in new environment IAGP N RGD:41408336|PMID:19327106 20210211 RGD compared to DA/Ztm 2515 Dpp4 dipeptidylpeptidase 4 gene MP:0001422 abnormal drinking behavior IAGP N RGD:1626460|PMID:14568317 20070809 RGD 2515 Dpp4 dipeptidylpeptidase 4 gene MP:0001566 increased circulating phosphate level IAGP N RGD:41408336|PMID:19327106 20210211 RGD compared to DA/Ztm 2515 Dpp4 dipeptidylpeptidase 4 gene MP:0001970 abnormal pain threshold IAGP N RGD:1626460|PMID:14568317 20070809 RGD 2515 Dpp4 dipeptidylpeptidase 4 gene MP:0002557 abnormal social/conspecific interaction behavior IAGP N RGD:1626460|PMID:14568317 20070809 RGD 2515 Dpp4 dipeptidylpeptidase 4 gene MP:0002644 decreased circulating triglyceride level IAGP N RGD:41408336|PMID:19327106 20210211 RGD compared to DA/Ztm 2515 Dpp4 dipeptidylpeptidase 4 gene MP:0002664 decreased circulating adrenocorticotropin level IAGP N RGD:41408336|PMID:19327106 20210211 RGD compared to DA/Ztm 2515 Dpp4 dipeptidylpeptidase 4 gene MP:0002665 decreased circulating corticosterone level IAGP N RGD:41408336|PMID:19327106 20210211 RGD compared to DA/Ztm 2515 Dpp4 dipeptidylpeptidase 4 gene MP:0002712 increased circulating glucagon level IAGP N RGD:41408336|PMID:19327106 20210211 RGD compared to DA/Ztm 2515 Dpp4 dipeptidylpeptidase 4 gene MP:0002799 abnormal passive avoidance behavior IAGP N RGD:1626460|PMID:14568317 20070809 RGD 2515 Dpp4 dipeptidylpeptidase 4 gene MP:0002942 decreased circulating alanine transaminase level IAGP N RGD:41408336|PMID:19327106 20210211 RGD compared to DA/Ztm 2515 Dpp4 dipeptidylpeptidase 4 gene MP:0002966 decreased circulating alkaline phosphatase level IAGP N RGD:41408336|PMID:19327106 20210211 RGD compared to DA/Ztm 2515 Dpp4 dipeptidylpeptidase 4 gene MP:0004977 increased B-1 B cell number IAGP N RGD:41408336|PMID:19327106 20210211 RGD compared to DA/Ztm 2515 Dpp4 dipeptidylpeptidase 4 gene MP:0005012 decreased eosinophil cell number IAGP N RGD:41408336|PMID:19327106 20210211 RGD compared to DA/Ztm 2515 Dpp4 dipeptidylpeptidase 4 gene MP:0005016 decreased lymphocyte cell number IAGP N RGD:41408336|PMID:19327106 20210211 RGD compared to DA/Ztm 2515 Dpp4 dipeptidylpeptidase 4 gene MP:0005070 impaired natural killer cell mediated cytotoxicity IAGP N RGD:41408336|PMID:19327106 20210211 RGD compared to DA/Ztm 2515 Dpp4 dipeptidylpeptidase 4 gene MP:0005292 improved glucose tolerance IAGP N RGD:41408336|PMID:19327106 20210211 RGD compared to DA/Ztm 2515 Dpp4 dipeptidylpeptidase 4 gene MP:0005565 increased blood urea nitrogen level IAGP N RGD:41408336|PMID:19327106 20210211 RGD compared to DA/Ztm 2515 Dpp4 dipeptidylpeptidase 4 gene MP:0005632 decreased circulating aspartate transaminase level IAGP N RGD:41408336|PMID:19327106 20210211 RGD compared to DA/Ztm 2515 Dpp4 dipeptidylpeptidase 4 gene MP:0005659 decreased susceptibility to diet-induced obesity IAGP N RGD:41408336|PMID:19327106 20210211 RGD compared to DA/Ztm 2515 Dpp4 dipeptidylpeptidase 4 gene MP:0008044 increased NK cell number IAGP N RGD:41408336|PMID:19327106 20210211 RGD compared to DA/Ztm 2515 Dpp4 dipeptidylpeptidase 4 gene MP:0008597 decreased circulating interleukin-6 level IAGP N RGD:41408336|PMID:19327106 20210211 RGD compared to DA/Ztm 2515 Dpp4 dipeptidylpeptidase 4 gene MP:0008706 decreased interleukin-6 secretion IAGP N RGD:41408336|PMID:19327106 20210211 RGD compared to DA/Ztm 2515 Dpp4 dipeptidylpeptidase 4 gene MP:0010167 decreased response to stress-induced hyperthermia IAGP N RGD:41408336|PMID:19327106 20210211 RGD compared to DA/Ztm 2515 Dpp4 dipeptidylpeptidase 4 gene MP:0010182 decreased susceptibility to weight gain IAGP N RGD:41408336|PMID:19327106 20210211 RGD compared to DA/Ztm 2518 Drd1 dopamine receptor D1 gene MP:0001262 decreased body weight IMP N RGD:13825241|PMID:27483345 20210520 RGD compared to wild type 2518 Drd1 dopamine receptor D1 gene MP:0001360 abnormal social investigation IMP N RGD:13825241|PMID:27483345 20210520 RGD compared to wild type 2518 Drd1 dopamine receptor D1 gene MP:0001529 abnormal vocalization IMP N RGD:13825241|PMID:27483345 20210520 RGD compared to wild type 2518 Drd1 dopamine receptor D1 gene MP:0002757 decreased vertical activity IMP N RGD:13825241|PMID:27483345 20210520 RGD compared to wild type 2518 Drd1 dopamine receptor D1 gene MP:0020395 abnormal response to social novelty IMP N RGD:13825241|PMID:27483345 20210520 RGD compared to wild type 2520 Drd2 dopamine receptor D2 gene MP:0002806 abnormal conditioned emotional response IDA N RGD:1581463|PMID:11311883 19990101 RGD decreased after administration of D2 antagonist 2520 Drd2 dopamine receptor D2 gene MP:0003460 decreased fear-related response IDA N RGD:1581463|PMID:11311883 19990101 RGD decreased after administration of D2 antagonist 2520 Drd2 dopamine receptor D2 gene MP:0003545 increased alcohol consumption IDA N RGD:1580677|PMID:12086672 19990101 RGD 2520 Drd2 dopamine receptor D2 gene MP:0004924 abnormal behavior IAGP N RGD:1581462|PMID:11814400 19990101 RGD 2528 Dyrk1a dual specificity tyrosine phosphorylation regulated kinase 1A gene MP:0001262 decreased body weight IMP N RGD:14929209|PMID:28266534 20190918 RGD 25314294 MWF/Ztm Munich Wistar Fromter strain MP:0000231 hypertension ameliorates IAGP XCO:0000555 N RGD:25314263|PMID:10516341 20210415 RGD compared to untreated MWF 25314294 MWF/Ztm Munich Wistar Fromter strain MP:0000521 abnormal kidney cortex morphology sexual_dimorphism IAGP N RGD:25314254|PMID:3199667 20210312 RGD compared to female MWF/Ztm 25314294 MWF/Ztm Munich Wistar Fromter strain MP:0001260 increased body weight onset IAGP N RGD:25314286|PMID:6602356 20210716 RGD compared to Lew 25314294 MWF/Ztm Munich Wistar Fromter strain MP:0002608 increased hematocrit sexual_dimorphism IAGP N RGD:25314254|PMID:3199667 20210312 RGD compared to female MWF/Ztm 25314294 MWF/Ztm Munich Wistar Fromter strain MP:0002828 abnormal renal glomerular capsule morphology onset IAGP N RGD:25314286|PMID:6602356 20210716 RGD compared to Lew 25314294 MWF/Ztm Munich Wistar Fromter strain MP:0002842 increased systemic arterial blood pressure sexual_dimorphism IAGP N RGD:25314254|PMID:3199667 20210312 RGD compared to female MWF/Ztm 25314294 MWF/Ztm Munich Wistar Fromter strain MP:0002963 decreased urine protein level treatment IDA N RGD:25314243|PMID:7894005 20211108 RGD 25314294 MWF/Ztm Munich Wistar Fromter strain MP:0003917 increased kidney weight sexual_dimorphism IAGP N RGD:25314254|PMID:3199667 20210312 RGD compared to female MWF/Ztm 25314294 MWF/Ztm Munich Wistar Fromter strain MP:0003917 increased kidney weight treatment IAGP XCO:0000555 N RGD:25314250|PMID:10703671 20210707 RGD compared to control MWF and Wi 25314294 MWF/Ztm Munich Wistar Fromter strain MP:0005264 glomerulosclerosis ameliorates IAGP XCO:0000555 N RGD:25314263|PMID:10516341 20210415 RGD compared to untreated MWF 25314294 MWF/Ztm Munich Wistar Fromter strain MP:0005325 abnormal renal glomerulus morphology onset IAGP N RGD:25314286|PMID:6602356 20210716 RGD compared to Lew 25314294 MWF/Ztm Munich Wistar Fromter strain MP:0005325 abnormal renal glomerulus morphology sexual_dimorphism IAGP N RGD:25314254|PMID:3199667 20210312 RGD compared to female MWF/Ztm 25314294 MWF/Ztm Munich Wistar Fromter strain MP:0005527 increased renal glomerular filtration rate sexual_dimorphism IAGP N RGD:25314254|PMID:3199667 20210312 RGD compared to female MWF/Ztm 25314294 MWF/Ztm Munich Wistar Fromter strain MP:0005556 abnormal renal filtration rate sexual_dimorphism IAGP N RGD:25314254|PMID:3199667 20210312 RGD compared to female MWF/Ztm 25314294 MWF/Ztm Munich Wistar Fromter strain MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:25314250|PMID:10703671 20210707 RGD compared to control MWF and Wi 25314294 MWF/Ztm Munich Wistar Fromter strain MP:0006264 decreased systemic arterial systolic blood pressure treatment IDA N RGD:25314243|PMID:7894005 20211108 RGD 25314294 MWF/Ztm Munich Wistar Fromter strain MP:0008837 increased transforming growth factor beta level treatment IAGP XCO:0000555 N RGD:25314270|PMID:16395266 20210402 RGD compared to treated and Wi 25314294 MWF/Ztm Munich Wistar Fromter strain MP:0010064 increased circulating creatine level treatment IAGP XCO:0000555 N RGD:25314270|PMID:16395266 20210402 RGD compared to treated and Wi 25314294 MWF/Ztm Munich Wistar Fromter strain MP:0011294 renal glomerulus hypertrophy IAGP N RGD:14401564|PMID:16400008 20210708 RGD compared to Wi and 10-20 week MWF 25314294 MWF/Ztm Munich Wistar Fromter strain MP:0011753 decreased podocyte number IAGP N RGD:14401564|PMID:16400008 20210708 RGD compared to Wi and 10-20 week MWF 25330093 SD-Mir146bem1Mcwi strain MP:0003985 renal fibrosis sexual_dimorphism IMP XCO:0000017 N RGD:127285407|PMID:31668631 20220114 RGD 2535 Ednra endothelin receptor type A gene MP:0002625 heart left ventricle hypertrophy IDA N RGD:1581830|PMID:16157796 20061026 RGD 2535 Ednra endothelin receptor type A gene MP:0003215 renal interstitial fibrosis IMP N RGD:1581844|PMID:12538737 20061026 RGD 2535 Ednra endothelin receptor type A gene MP:0003675 kidney cyst IMP N RGD:1581844|PMID:12538737 20061026 RGD 2535 Ednra endothelin receptor type A gene MP:0005264 glomerulosclerosis IDA N RGD:1581830|PMID:16157796 20061026 RGD 2535 Ednra endothelin receptor type A gene MP:0006144 increased systemic arterial systolic blood pressure IDA N RGD:1581830|PMID:16157796 20061026 RGD 2536 Ednrb endothelin receptor type B gene MP:0000351 increased cell proliferation IMP N RGD:4892578|PMID:18683040 20061027 RGD 2536 Ednrb endothelin receptor type B gene MP:0000692 small spleen IAGP N RGD:7207471|PMID:22975636 20171206 RGD 2536 Ednrb endothelin receptor type B gene MP:0001045 abnormal enteric ganglia morphology IAGP N RGD:628515|PMID:8570650 20061030 RGD 2536 Ednrb endothelin receptor type B gene MP:0001045 abnormal enteric ganglia morphology IAGP N RGD:628516|PMID:9739043 20061026 RGD 2536 Ednrb endothelin receptor type B gene MP:0002075 abnormal coat/hair pigmentation IAGP N RGD:628515|PMID:8570650 20061030 RGD 2536 Ednrb endothelin receptor type B gene MP:0002080 prenatal lethality IGI RGD:1554306 N RGD:126777688|PMID:31170185 20210407 RGD critical region in GK/Slc (RGD:1554306) Chr 2 2536 Ednrb endothelin receptor type B gene MP:0002842 increased systemic arterial blood pressure IDA N RGD:1581856|PMID:16179487 20061027 RGD 2536 Ednrb endothelin receptor type B gene MP:0002926 aganglionic megacolon IAGP N RGD:6480215|PMID:22132166 20210218 RGD 2536 Ednrb endothelin receptor type B gene MP:0002926 aganglionic megacolon IAGP N RGD:6480217|PMID:21915282 20170329 RGD 2536 Ednrb endothelin receptor type B gene MP:0003204 decreased neuron apoptosis IMP N RGD:4892578|PMID:18683040 20061027 RGD 2536 Ednrb endothelin receptor type B gene MP:0003215 renal interstitial fibrosis IMP N RGD:1581844|PMID:12538737 20061026 RGD 2536 Ednrb endothelin receptor type B gene MP:0003675 kidney cyst IMP N RGD:1581844|PMID:12538737 20061026 RGD 2536 Ednrb endothelin receptor type B gene MP:0004364 thin stria vascularis IAGP N RGD:6480217|PMID:21915282 20210218 RGD 2536 Ednrb endothelin receptor type B gene MP:0004750 syndromic hearing loss IAGP N RGD:6480217|PMID:21915282 20210218 RGD 2536 Ednrb endothelin receptor type B gene MP:0004956 decreased thymus weight IAGP N RGD:7207471|PMID:22975636 20171206 RGD 2536 Ednrb endothelin receptor type B gene MP:0005408 hypopigmentation IAGP N RGD:6480217|PMID:21915282 20170406 RGD 2536 Ednrb endothelin receptor type B gene MP:0005533 increased body temperature IDA N RGD:1581859|PMID:16123229 20061027 RGD 2536 Ednrb endothelin receptor type B gene MP:0008470 abnormal spleen B cell follicle morphology IAGP N RGD:7207471|PMID:22975636 20171206 RGD 2536 Ednrb endothelin receptor type B gene MP:0008477 decreased spleen red pulp amount IAGP N RGD:7207471|PMID:22975636 20171207 RGD 2536 Ednrb endothelin receptor type B gene MP:0008770 decreased survivor rate IAGP N RGD:6480217|PMID:21915282 20210218 RGD 2536 Ednrb endothelin receptor type B gene MP:0009323 abnormal spleen development IAGP N RGD:7207471|PMID:22975636 20171206 RGD 2543 Egfr epidermal growth factor receptor gene MP:0001927 abnormal estrous cycle IDA N RGD:70386|PMID:11796513 20061030 RGD 2543 Egfr epidermal growth factor receptor gene MP:0002625 heart left ventricle hypertrophy IDA N RGD:1580955|PMID:12624003 20061030 RGD 2543 Egfr epidermal growth factor receptor gene MP:0003985 renal fibrosis IDA N RGD:1581909|PMID:15033924 20061030 RGD 2561 Erbb2 erb-b2 receptor tyrosine kinase 2 gene MP:0001272 increased metastatic potential IDA N RGD:1582128|PMID:1359541 20061101 RGD 2581 Esr1 estrogen receptor 1 gene MP:0000628 abnormal mammary gland development IMP N RGD:8552987|PMID:24506075 20140501 RGD 2581 Esr1 estrogen receptor 1 gene MP:0001119 abnormal female reproductive system morphology IMP N RGD:8552987|PMID:24506075 20140501 RGD 2581 Esr1 estrogen receptor 1 gene MP:0001145 abnormal male reproductive system morphology IMP N RGD:8552987|PMID:24506075 20170623 RGD 2581 Esr1 estrogen receptor 1 gene MP:0001147 small testis IMP N RGD:8552987|PMID:24506075 20140501 RGD 2581 Esr1 estrogen receptor 1 gene MP:0001750 increased circulating follicle stimulating hormone level IMP N RGD:8552987|PMID:24506075 20170623 RGD 2581 Esr1 estrogen receptor 1 gene MP:0001751 increased circulating luteinizing hormone level IMP N RGD:8552987|PMID:24506075 20170623 RGD 2581 Esr1 estrogen receptor 1 gene MP:0002160 abnormal reproductive system morphology IMP N RGD:8552987|PMID:24506075 20140501 RGD 2581 Esr1 estrogen receptor 1 gene MP:0003956 abnormal body size IMP N RGD:8552987|PMID:24506075 20170623 RGD 2581 Esr1 estrogen receptor 1 gene MP:0004852 decreased testis weight IMP N RGD:8552987|PMID:24506075 20170623 RGD 2582 Esr2 estrogen receptor 2 gene MP:0001134 absent corpus luteum IMP N RGD:38548924|PMID:28520870 20200825 RGD 2582 Esr2 estrogen receptor 2 gene MP:0001134 absent corpus luteum IMP N RGD:38548925|PMID:29580824 20200825 RGD 2582 Esr2 estrogen receptor 2 gene MP:0001926 female infertility IMP N RGD:38548925|PMID:29580824 20200825 RGD 2582 Esr2 estrogen receptor 2 gene MP:0002773 decreased circulating luteinizing hormone level IMP N RGD:38548924|PMID:28520870 20200825 RGD 2582 Esr2 estrogen receptor 2 gene MP:0002790 decreased circulating follicle stimulating hormone level IMP N RGD:38548924|PMID:28520870 20200825 RGD 2582 Esr2 estrogen receptor 2 gene MP:0004805 absent oocytes IMP N RGD:38548924|PMID:28520870 20201214 RGD compared to wild type 2582 Esr2 estrogen receptor 2 gene MP:0004856 decreased ovary weight IMP N RGD:38548924|PMID:28520870 20201214 RGD 2582 Esr2 estrogen receptor 2 gene MP:0004856 decreased ovary weight IMP N RGD:38548925|PMID:29580824 20200825 RGD 2582 Esr2 estrogen receptor 2 gene MP:0004905 decreased uterus weight IMP N RGD:38548924|PMID:28520870 20200825 RGD 2582 Esr2 estrogen receptor 2 gene MP:0005158 ovary hypoplasia IMP N RGD:38548924|PMID:28520870 20201214 RGD compared to wild type 2582 Esr2 estrogen receptor 2 gene MP:0005181 decreased circulating estradiol level IMP N RGD:38548924|PMID:28520870 20200825 RGD 2582 Esr2 estrogen receptor 2 gene MP:0005185 decreased circulating progesterone level IMP N RGD:38548925|PMID:29580824 20200825 RGD 2582 Esr2 estrogen receptor 2 gene MP:0008869 anovulation IMP N RGD:38548924|PMID:28520870 20201214 RGD compared to wild type 2582 Esr2 estrogen receptor 2 gene MP:0008869 anovulation IMP N RGD:38548925|PMID:29580824 20200825 RGD 2582 Esr2 estrogen receptor 2 gene MP:0009013 abnormal proestrus IMP N RGD:38548924|PMID:28520870 20200825 RGD 2582 Esr2 estrogen receptor 2 gene MP:0009819 abnormal circulating androgen level IMP N RGD:38548925|PMID:29580824 20200825 RGD 2583 Ets1 ETS proto-oncogene 1, transcription factor gene MP:0005554 decreased circulating creatinine level induces IAGP XCO:0000795 N RGD:150429812|PMID:31932071 20211007 RGD compared to littermate 2583 Ets1 ETS proto-oncogene 1, transcription factor gene MP:0031404 increased tubuloglomerular feedback response induces IMP XCO:0000795 N RGD:150429812|PMID:31932071 20220630 RGD compared to wild type littermate 2586 F2r coagulation factor II (thrombin) receptor gene MP:0002736 abnormal nociception after inflammation IDA N RGD:1582348|PMID:12126749 20061106 RGD 2590 Fabp1 fatty acid binding protein 1 gene MP:0005516 enhanced liver regeneration IAGP N RGD:1578454|PMID:15532708 19990101 RGD 2609 Fgf2 fibroblast growth factor 2 gene MP:0001363 increased anxiety-related response IMP N RGD:405866182|PMID:25071177 20240620 RGD compared to control treated bHR strain 2614 Fh fumarate hydratase gene MP:0000208 decreased hematocrit IMP N RGD:13792708|PMID:27556703 20181008 RGD 2614 Fh fumarate hydratase gene MP:0000221 decreased leukocyte cell number IMP N RGD:13792708|PMID:27556703 20181008 RGD 2614 Fh fumarate hydratase gene MP:0000223 decreased monocyte cell number IMP N RGD:13792708|PMID:27556703 20181008 RGD 2614 Fh fumarate hydratase gene MP:0001260 increased body weight IMP N RGD:13792708|PMID:27556703 20181008 RGD male only; 2614 Fh fumarate hydratase gene MP:0001935 decreased litter size IMP N RGD:13792708|PMID:27556703 20181008 RGD 2614 Fh fumarate hydratase gene MP:0002135 abnormal kidney morphology IMP N RGD:13792708|PMID:27556703 20181008 RGD 2614 Fh fumarate hydratase gene MP:0002619 abnormal lymphocyte morphology IMP N RGD:13792708|PMID:27556703 20181008 RGD 2614 Fh fumarate hydratase gene MP:0005012 decreased eosinophil cell number IMP N RGD:13792708|PMID:27556703 20181008 RGD 2614 Fh fumarate hydratase gene MP:0005016 decreased lymphocyte cell number IMP N RGD:13792708|PMID:27556703 20181008 RGD 2614 Fh fumarate hydratase gene MP:0005553 increased circulating creatinine level IMP N RGD:13792708|PMID:27556703 20181008 RGD 2614 Fh fumarate hydratase gene MP:0005565 increased blood urea nitrogen level IMP N RGD:13792708|PMID:27556703 20181008 RGD 2614 Fh fumarate hydratase gene MP:0008762 embryonic lethality IMP N RGD:13792708|PMID:27556703 20181008 RGD 2614 Fh fumarate hydratase gene MP:0008822 decreased blood uric acid level IMP N RGD:13792708|PMID:27556703 20181008 RGD 2623 Fmr1 fragile X messenger ribonucleoprotein 1 gene MP:0001148 enlarged testis IMP N RGD:38501107|PMID:28894415 20200818 RGD 2623 Fmr1 fragile X messenger ribonucleoprotein 1 gene MP:0001148 enlarged testis IMP N RGD:38548928|PMID:30877790 20200922 RGD DNA:deletion:intron 7, exon 8: 2623 Fmr1 fragile X messenger ribonucleoprotein 1 gene MP:0001148 enlarged testis IMP N RGD:9831152|PMID:24773431 20170921 RGD 2623 Fmr1 fragile X messenger ribonucleoprotein 1 gene MP:0001262 decreased body weight IMP N RGD:405100966|PMID:35328827 20240404 RGD compared to wild type 2623 Fmr1 fragile X messenger ribonucleoprotein 1 gene MP:0001399 hyperactivity IMP N RGD:401976422|PMID:38378836 20240307 RGD 2623 Fmr1 fragile X messenger ribonucleoprotein 1 gene MP:0001399 hyperactivity IMP N RGD:401976427|PMID:36581671 20240321 RGD compared to wild type controls 2623 Fmr1 fragile X messenger ribonucleoprotein 1 gene MP:0001468 abnormal temporal memory IMP N RGD:38501107|PMID:28894415 20200818 RGD 2623 Fmr1 fragile X messenger ribonucleoprotein 1 gene MP:0001486 abnormal startle reflex no_association IAGP N RGD:35668860|PMID:32144356 20240321 RGD compared to wild type controls 2623 Fmr1 fragile X messenger ribonucleoprotein 1 gene MP:0001486 abnormal startle reflex sexual_dimorphism IAGP N RGD:35668860|PMID:32144356 20240321 RGD in wild type controls 2623 Fmr1 fragile X messenger ribonucleoprotein 1 gene MP:0002803 abnormal operant conditioning behavior IMP N RGD:38548928|PMID:30877790 20200922 RGD DNA:deletion:intron 7, exon 8: 2623 Fmr1 fragile X messenger ribonucleoprotein 1 gene MP:0002882 abnormal neuron morphology IMP N RGD:11080370|PMID:26166728 20240321 RGD compared to wild type controls 2623 Fmr1 fragile X messenger ribonucleoprotein 1 gene MP:0003088 abnormal prepulse inhibition no_association IAGP N RGD:35668860|PMID:32144356 20240321 RGD compared to wild type controls 2623 Fmr1 fragile X messenger ribonucleoprotein 1 gene MP:0003088 abnormal prepulse inhibition sexual_dimorphism IAGP N RGD:35668860|PMID:32144356 20240321 RGD in wild type controls 2623 Fmr1 fragile X messenger ribonucleoprotein 1 gene MP:0003412 abnormal afterhyperpolarization IMP N RGD:401976434|PMID:36536454 20240328 RGD 2623 Fmr1 fragile X messenger ribonucleoprotein 1 gene MP:0005179 decreased circulating cholesterol level IMP N RGD:405100966|PMID:35328827 20240404 RGD compared to wild type 2623 Fmr1 fragile X messenger ribonucleoprotein 1 gene MP:0008840 abnormal spike wave discharge IMP N RGD:401976423|PMID:38107412 20240321 RGD compared to wild type controls 2623 Fmr1 fragile X messenger ribonucleoprotein 1 gene MP:0009141 increased prepulse inhibition IMP N RGD:9831152|PMID:24773431 20170921 RGD 2623 Fmr1 fragile X messenger ribonucleoprotein 1 gene MP:0010026 decreased liver cholesterol level IMP N RGD:405100966|PMID:35328827 20240404 RGD compared to wild type 2623 Fmr1 fragile X messenger ribonucleoprotein 1 gene MP:0010748 abnormal visual evoked potential IMP N RGD:38548926|PMID:27465362 20200922 RGD DNA:deletion:intron 7, exon 8: 2623 Fmr1 fragile X messenger ribonucleoprotein 1 gene MP:0011620 abnormal habituation to a new environment IMP N RGD:401976434|PMID:36536454 20240328 RGD 2623 Fmr1 fragile X messenger ribonucleoprotein 1 gene MP:0011940 decreased food intake IMP N RGD:405100966|PMID:35328827 20240404 RGD compared to wild type 2623 Fmr1 fragile X messenger ribonucleoprotein 1 gene MP:0012006 abnormal hippocampus physiology IMP N RGD:401976434|PMID:36536454 20240328 RGD 2623 Fmr1 fragile X messenger ribonucleoprotein 1 gene MP:0012307 impaired spatial learning IMP N RGD:38501107|PMID:28894415 20200818 RGD 2623 Fmr1 fragile X messenger ribonucleoprotein 1 gene MP:0012307 impaired spatial learning IMP N RGD:401976422|PMID:38378836 20240307 RGD 2623 Fmr1 fragile X messenger ribonucleoprotein 1 gene MP:0012307 impaired spatial learning IMP N RGD:401976434|PMID:36536454 20240328 RGD 2623 Fmr1 fragile X messenger ribonucleoprotein 1 gene MP:0012343 increased gnawing activity IMP N RGD:9831152|PMID:24773431 20170119 RGD 2623 Fmr1 fragile X messenger ribonucleoprotein 1 gene MP:0014255 increased paired-pulse inhibition IMP N RGD:401976422|PMID:38378836 20240307 RGD 2623 Fmr1 fragile X messenger ribonucleoprotein 1 gene MP:0014255 increased paired-pulse inhibition IMP N RGD:401976423|PMID:38107412 20240321 RGD compared to wild type controls 2623 Fmr1 fragile X messenger ribonucleoprotein 1 gene MP:0014365 impaired short-term object recognition memory IMP N RGD:401976422|PMID:38378836 20240321 RGD compared to wild type controls 2623 Fmr1 fragile X messenger ribonucleoprotein 1 gene MP:0020395 abnormal response to social novelty IMP N RGD:38501107|PMID:28894415 20200818 RGD 2623 Fmr1 fragile X messenger ribonucleoprotein 1 gene MP:0020395 abnormal response to social novelty IMP N RGD:9831152|PMID:24773431 20170119 RGD 2623 Fmr1 fragile X messenger ribonucleoprotein 1 gene MP:0020437 abnormal social play behavior IMP N RGD:9831152|PMID:24773431 20170921 RGD 2623 Fmr1 fragile X messenger ribonucleoprotein 1 gene MP:0020870 decreased thigmotaxis onset IMP N RGD:401976427|PMID:36581671 20240321 RGD in juveniles, compared to wild type controls 2623 Fmr1 fragile X messenger ribonucleoprotein 1 gene MP:0021119 abnormal auditory behavior IMP N RGD:405100968|PMID:34751141 20240404 RGD compared to wild type 2623 Fmr1 fragile X messenger ribonucleoprotein 1 gene MP:0031391 increased locomotor activity IMP N RGD:401976434|PMID:36536454 20240328 RGD 2652 Gad1 glutamate decarboxylase 1 gene MP:0001402 decreased locomotor activity IMP N RGD:158012686|PMID:33293518 20240606 RGD 2652 Gad1 glutamate decarboxylase 1 gene MP:0001402 decreased locomotor activity IMP N RGD:401900162|PMID:24200867 20231108 RGD 2652 Gad1 glutamate decarboxylase 1 gene MP:0002083 premature death IMP N RGD:158012686|PMID:33293518 20240606 RGD 2652 Gad1 glutamate decarboxylase 1 gene MP:0002573 behavioral despair IMP N RGD:158012686|PMID:33293518 20240606 RGD 2652 Gad1 glutamate decarboxylase 1 gene MP:0002757 decreased vertical activity IMP N RGD:158012686|PMID:33293518 20240606 RGD 2652 Gad1 glutamate decarboxylase 1 gene MP:0003461 abnormal response to novel object IMP N RGD:158012686|PMID:33293518 20240606 RGD 2652 Gad1 glutamate decarboxylase 1 gene MP:0003867 increased defecation amount IMP N RGD:158012686|PMID:33293518 20240606 RGD 2652 Gad1 glutamate decarboxylase 1 gene MP:0008840 abnormal spike wave discharge onset IMP N RGD:405855846|PMID:37830095 20240613 RGD 2652 Gad1 glutamate decarboxylase 1 gene MP:0009674 decreased birth weight IMP N RGD:158012686|PMID:33293518 20240606 RGD 2652 Gad1 glutamate decarboxylase 1 gene MP:0012307 impaired spatial learning IMP N RGD:158012686|PMID:33293518 20240606 RGD 2652 Gad1 glutamate decarboxylase 1 gene MP:0021111 decreased social investigation IMP N RGD:158012686|PMID:33293518 20240606 RGD 2652 Gad1 glutamate decarboxylase 1 gene MP:0030733 decreased gamma-aminobutyric acid level IMP N RGD:158012686|PMID:33293518 20240606 RGD 2670 Gck glucokinase gene MP:0001552 increased circulating triglyceride level IDA N RGD:2301945|PMID:10512368 20081111 RGD overexpression sufficient to lower blood glucose significantly increased circulating FFA and TG levels (p<0.05) 2670 Gck glucokinase gene MP:0001554 increased circulating free fatty acids level IDA N RGD:2301945|PMID:10512368 20081111 RGD overexpression sufficient to lower blood glucose significantly increased circulating FFA and TG levels (p<0.05) 2670 Gck glucokinase gene MP:0005560 decreased circulating glucose level IDA N RGD:2301945|PMID:10512368 20081111 RGD 2686 Gh1 growth hormone 1 gene MP:0005136 decreased growth hormone level IAGP N RGD:1578506|PMID:2152867 20210416 RGD 2686 Gh1 growth hormone 1 gene MP:0005138 decreased prolactin level IAGP N RGD:1578506|PMID:2152867 20210416 RGD 2688 Ghrhr growth hormone releasing hormone receptor gene MP:0001501 abnormal sleep pattern IDA N RGD:728477|PMID:12161265 19990101 RGD 2703 Glp1r glucagon-like peptide 1 receptor gene MP:0002626 increased heart rate IDA N RGD:625448|PMID:12093887 20061129 RGD 2703 Glp1r glucagon-like peptide 1 receptor gene MP:0002842 increased systemic arterial blood pressure IDA N RGD:625448|PMID:12093887 20061129 RGD 2703 Glp1r glucagon-like peptide 1 receptor gene MP:0003058 increased insulin secretion IDA N RGD:625448|PMID:12093887 20061129 RGD 2703 Glp1r glucagon-like peptide 1 receptor gene MP:0005560 decreased circulating glucose level NOT IDA N RGD:625448|PMID:12093887 20061129 RGD 2715 Gnal G protein subunit alpha L gene MP:0001392 abnormal locomotor behavior IMP N RGD:150429833|PMID:31678405 20211004 RGD 2715 Gnal G protein subunit alpha L gene MP:0001475 reduced long-term depression IMP N RGD:150429833|PMID:31678405 20211004 RGD 2715 Gnal G protein subunit alpha L gene MP:0001732 postnatal growth retardation IMP N RGD:150429833|PMID:31678405 20211004 RGD 2715 Gnal G protein subunit alpha L gene MP:0002082 postnatal lethality IMP N RGD:150429833|PMID:31678405 20211004 RGD 2715 Gnal G protein subunit alpha L gene MP:0002804 abnormal motor learning IMP N RGD:150429833|PMID:31678405 20211004 RGD 2715 Gnal G protein subunit alpha L gene MP:0002917 decreased synaptic depression IMP N RGD:150429833|PMID:31678405 20211004 RGD 2737 Grin2a glutamate ionotropic receptor NMDA type subunit 2A gene MP:0003076 increased susceptibility to ischemic brain injury IDA N RGD:734740|PMID:14502288 19990101 RGD 2737 Grin2a glutamate ionotropic receptor NMDA type subunit 2A gene MP:0020911 abnormal drug-induced reinstatement of an extinguished operant behavior for a drug reinforcer ameliorates IMP N RGD:401938637|PMID:23671067 20231215 RGD 2741 Nr3c1 nuclear receptor subfamily 3, group C, member 1 gene MP:0001745 increased circulating corticosterone level sexual_dimorphism IMP XCO:0000159 N RGD:407571699|PMID:31329100 20241107 RGD compared to female wild type littermate 2741 Nr3c1 nuclear receptor subfamily 3, group C, member 1 gene MP:0003063 increased coping response sexual_dimorphism IMP XCO:0001269 N RGD:407571699|PMID:31329100 20241107 RGD compared to male wild type littermate 2741 Nr3c1 nuclear receptor subfamily 3, group C, member 1 gene MP:0009455 enhanced cued conditioning behavior sexual_dimorphism IMP N RGD:407571699|PMID:31329100 20241107 RGD associated with abnormal freezing behavior (MP:0020420); compared to female wild type littermate 2741 Nr3c1 nuclear receptor subfamily 3, group C, member 1 gene MP:0012318 slow extinction of fear memory sexual_dimorphism IMP N RGD:407571699|PMID:31329100 20241107 RGD associated with abnormal freezing behavior (MP:0020420); compared to female wild type littermate 2741 Nr3c1 nuclear receptor subfamily 3, group C, member 1 gene MP:0020421 increased freezing behavior sexual_dimorphism IMP N RGD:407571699|PMID:31329100 20241107 RGD compared to female wild type littermate 2743 Grm2 glutamate metabotropic receptor 2 gene MP:0001973 increased thermal nociceptive threshold IMP N RGD:38501063|PMID:30283001 20200821 RGD knock-out compared to wild-type rats 2743 Grm2 glutamate metabotropic receptor 2 gene MP:0001981 increased chemically-elicited antinociception IMP N RGD:38501063|PMID:30283001 20200821 RGD knock-out compared to wild-type rats 2743 Grm2 glutamate metabotropic receptor 2 gene MP:0002555 addiction IMP N RGD:38501064|PMID:28700935 20200821 RGD knockout compared to wild type 2743 Grm2 glutamate metabotropic receptor 2 gene MP:0005445 abnormal neurotransmitter secretion IMP N RGD:38501063|PMID:30283001 20200821 RGD knock-out compared to wild-type rats 2743 Grm2 glutamate metabotropic receptor 2 gene MP:0005445 abnormal neurotransmitter secretion IMP N RGD:38501064|PMID:28700935 20200821 RGD knockout compared to wild type 2743 Grm2 glutamate metabotropic receptor 2 gene MP:0009748 abnormal behavioral response to addictive substance IMP N RGD:38501063|PMID:30283001 20200821 RGD knock-out compared to wild-type rats 2743 Grm2 glutamate metabotropic receptor 2 gene MP:0009752 enhanced behavioral response to nicotine IMP N RGD:38501064|PMID:28700935 20200821 RGD knockout compared to wild type 2743 Grm2 glutamate metabotropic receptor 2 gene MP:0009753 enhanced behavioral response to morphine IMP N RGD:38501063|PMID:30283001 20200821 RGD knock-out compared to wild-type rats 2743 Grm2 glutamate metabotropic receptor 2 gene MP:0009753 enhanced behavioral response to morphine IMP N RGD:38501064|PMID:28700935 20200821 RGD knockout compared to wild type 2743 Grm2 glutamate metabotropic receptor 2 gene MP:0009754 enhanced behavioral response to cocaine IMP N RGD:38501064|PMID:28700935 20200821 RGD knockout compared to wild type 2743 Grm2 glutamate metabotropic receptor 2 gene MP:0009774 abnormal behavioral withdrawal response IMP N RGD:38501063|PMID:30283001 20200821 RGD knock-out compared to wild-type rats 2743 Grm2 glutamate metabotropic receptor 2 gene MP:0012342 high preference for an addictive substance IMP N RGD:38501063|PMID:30283001 20200821 RGD knock-out compared to wild-type rats 2743 Grm2 glutamate metabotropic receptor 2 gene MP:0013919 abnormal response to electrical stimuli IMP N RGD:38501064|PMID:28700935 20200821 RGD knockout compared to wild type 2743 Grm2 glutamate metabotropic receptor 2 gene MP:0020159 abnormal behavioral response to morphine IMP N RGD:38501063|PMID:30283001 20200821 RGD knock-out compared to wild-type rats 2743 Grm2 glutamate metabotropic receptor 2 gene MP:0020374 abnormal nocifensive behavior IMP N RGD:38501063|PMID:30283001 20200821 RGD knock-out compared to wild-type rats 2743 Grm2 glutamate metabotropic receptor 2 gene MP:0020876 increased nervous system dopamine level IMP N RGD:38501063|PMID:30283001 20200821 RGD knock-out compared to wild-type rats 2743 Grm2 glutamate metabotropic receptor 2 gene MP:0020905 abnormal cocaine self-administration IMP N RGD:38501064|PMID:28700935 20210225 RGD KO compared to wild-type rats 2743 Grm2 glutamate metabotropic receptor 2 gene MP:0020907 abnormal extinction of cocaine self-administration IMP N RGD:38501064|PMID:28700935 20200821 RGD knockout compared to wild type 2743 Grm2 glutamate metabotropic receptor 2 gene MP:0020909 abnormal cue-induced reinstatement of an extinguished operant behavior for a cocaine reinforcer IMP N RGD:38501063|PMID:30283001 20200821 RGD knock-out compared to wild-type rats 2743 Grm2 glutamate metabotropic receptor 2 gene MP:0020909 abnormal cue-induced reinstatement of an extinguished operant behavior for a cocaine reinforcer IMP N RGD:38501064|PMID:28700935 20200821 RGD knockout compared to wild type 2806 Hmox1 heme oxygenase 1 gene MP:0002843 decreased systemic arterial blood pressure IDA N RGD:1580453|PMID:12215473 19990101 RGD 2806 Hmox1 heme oxygenase 1 gene MP:0005590 increased vasodilation IDA N RGD:1580452|PMID:15057912 19990101 RGD 2827 Hras HRas proto-oncogene, GTPase gene MP:0006072 abnormal retina apoptosis IDA N RGD:1358731|PMID:14988264 19990101 RGD 2835 Hsd11b2 hydroxysteroid 11-beta dehydrogenase 2 gene MP:0000642 enlarged adrenal glands IMP N RGD:13800514|PMID:26077568 20220203 RGD compared to wild type 2835 Hsd11b2 hydroxysteroid 11-beta dehydrogenase 2 gene MP:0001262 decreased body weight IMP N RGD:13800514|PMID:26077568 20220203 RGD compared to wild type 2835 Hsd11b2 hydroxysteroid 11-beta dehydrogenase 2 gene MP:0002833 increased heart weight IMP N RGD:13800514|PMID:26077568 20220203 RGD compared to wild type 2835 Hsd11b2 hydroxysteroid 11-beta dehydrogenase 2 gene MP:0002891 increased insulin sensitivity IMP N RGD:13800514|PMID:26077568 20220203 RGD compared to wild type 2835 Hsd11b2 hydroxysteroid 11-beta dehydrogenase 2 gene MP:0003353 decreased circulating renin level IMP N RGD:13800514|PMID:26077568 20220203 RGD compared to wild type 2835 Hsd11b2 hydroxysteroid 11-beta dehydrogenase 2 gene MP:0003402 decreased liver weight IMP N RGD:13800514|PMID:26077568 20220203 RGD compared to wild type 2835 Hsd11b2 hydroxysteroid 11-beta dehydrogenase 2 gene MP:0003917 increased kidney weight IMP N RGD:13800514|PMID:26077568 20220203 RGD compared to wild type 2835 Hsd11b2 hydroxysteroid 11-beta dehydrogenase 2 gene MP:0004217 salt-sensitive hypertension IMP N RGD:13800514|PMID:26077568 20220203 RGD 2835 Hsd11b2 hydroxysteroid 11-beta dehydrogenase 2 gene MP:0004757 abnormal distal convoluted tubule morphology IMP N RGD:13800514|PMID:26077568 20220203 RGD 2835 Hsd11b2 hydroxysteroid 11-beta dehydrogenase 2 gene MP:0008289 abnormal adrenal medulla morphology IMP N RGD:13800514|PMID:26077568 20220203 RGD 2835 Hsd11b2 hydroxysteroid 11-beta dehydrogenase 2 gene MP:0008293 abnormal adrenal gland zona glomerulosa morphology IMP N RGD:13800514|PMID:26077568 20220203 RGD 2835 Hsd11b2 hydroxysteroid 11-beta dehydrogenase 2 gene MP:0008295 abnormal adrenal gland zona reticularis morphology IMP N RGD:13800514|PMID:26077568 20220203 RGD 2835 Hsd11b2 hydroxysteroid 11-beta dehydrogenase 2 gene MP:0009269 decreased fat cell size IMP N RGD:13800514|PMID:26077568 20220203 RGD compared to wild type 2835 Hsd11b2 hydroxysteroid 11-beta dehydrogenase 2 gene MP:0009299 decreased mesenteric fat pad weight IMP N RGD:13800514|PMID:26077568 20220203 RGD compared to wild type 2846 Htr1b 5-hydroxytryptamine receptor 1B gene MP:0002065 abnormal fear/anxiety-related behavior IDA N RGD:625756|PMID:12040062 19990101 RGD 2868 Igf1 insulin-like growth factor 1 gene MP:0001625 cardiac hypertrophy IDA N RGD:1580474|PMID:15996002 19990101 RGD 2887 Il15 interleukin 15 gene MP:0004953 decreased spleen weight IMP N RGD:12910490|PMID:28395334 20170616 RGD 2887 Il15 interleukin 15 gene MP:0008045 decreased NK cell number IMP N RGD:12910490|PMID:28395334 20170616 RGD 2887 Il15 interleukin 15 gene MP:0008957 abnormal placenta junctional zone morphology IMP N RGD:12910490|PMID:28395334 20170616 RGD 2887 Il15 interleukin 15 gene MP:0012726 abnormal uterine spiral artery morphology IMP N RGD:12910490|PMID:28395334 20170616 RGD 2912 Inha inhibin subunit alpha gene MP:0001927 abnormal estrous cycle IDA N RGD:2290396|PMID:15359127 20080311 RGD rat transgene introduced into female mice 2912 Inha inhibin subunit alpha gene MP:0001934 increased litter size IDA N RGD:2290396|PMID:15359127 20080311 RGD rat transgene introduced into female mice 2917 Insr insulin receptor gene MP:0001262 decreased body weight induced IMP CHEBI:50845 N RGD:2314405|PMID:19017805 20200227 RGD 2917 Insr insulin receptor gene MP:0002079 increased circulating insulin level induced IMP CHEBI:50845 N RGD:2314405|PMID:19017805 20200227 RGD 2917 Insr insulin receptor gene MP:0005559 increased circulating glucose level induced IMP CHEBI:50845 N RGD:2314405|PMID:19017805 20200227 RGD 2917 Insr insulin receptor gene MP:0011941 increased fluid intake induced IMP CHEBI:50845 N RGD:2314405|PMID:19017805 20200227 RGD 2949 Kcna1 potassium voltage-gated channel subfamily A member 1 gene MP:0000947 convulsive seizures IAGP N RGD:10047237|PMID:22206926 20170504 RGD 2949 Kcna1 potassium voltage-gated channel subfamily A member 1 gene MP:0009358 environmentally induced seizures IAGP N RGD:10047237|PMID:22206926 20170504 RGD 2957 Kcnj1 potassium inwardly-rectifying channel, subfamily J, member 1 gene MP:0001262 decreased body weight IMP N RGD:13782272|PMID:23753405 20180906 RGD 2957 Kcnj1 potassium inwardly-rectifying channel, subfamily J, member 1 gene MP:0002608 increased hematocrit IMP N RGD:13782272|PMID:23753405 20180906 RGD 2957 Kcnj1 potassium inwardly-rectifying channel, subfamily J, member 1 gene MP:0003017 decreased circulating bicarbonate level IMP N RGD:13782272|PMID:23753405 20180906 RGD 2957 Kcnj1 potassium inwardly-rectifying channel, subfamily J, member 1 gene MP:0003019 increased circulating chloride level IMP N RGD:13782272|PMID:23753405 20180906 RGD 2957 Kcnj1 potassium inwardly-rectifying channel, subfamily J, member 1 gene MP:0004217 salt-sensitive hypertension IMP N RGD:13782272|PMID:23753405 20180906 RGD 2957 Kcnj1 potassium inwardly-rectifying channel, subfamily J, member 1 gene MP:0005565 increased blood urea nitrogen level IMP N RGD:13782272|PMID:23753405 20180906 RGD 2957 Kcnj1 potassium inwardly-rectifying channel, subfamily J, member 1 gene MP:0005627 increased circulating potassium level IMP N RGD:13782272|PMID:23753405 20180906 RGD 2957 Kcnj1 potassium inwardly-rectifying channel, subfamily J, member 1 gene MP:0005633 increased circulating sodium level IMP N RGD:13782272|PMID:23753405 20180906 RGD 2957 Kcnj1 potassium inwardly-rectifying channel, subfamily J, member 1 gene MP:0012046 decreased susceptibility to hypertension IMP N RGD:13782272|PMID:23753405 20180906 RGD 2961 Kcnmb1 potassium calcium-activated channel subfamily M regulatory beta subunit 1 gene MP:0002842 increased systemic arterial blood pressure IDA N RGD:1298970|PMID:14551242 19990101 RGD 2963 Kcnn2 potassium calcium-activated channel subfamily N member 2 gene MP:0000745 tremors IMP N RGD:38508907|PMID:28917524 20210805 RGD DNA:missense mutation:cds:c. 866T>A (p. I289N)(rat) 2965 Kdr kinase insert domain receptor gene MP:0001463 abnormal spatial learning IDA N RGD:1581594|PMID:15258583 20080408 RGD 2965 Kdr kinase insert domain receptor gene MP:0002792 abnormal retina vasculature morphology IDA N RGD:1581593|PMID:15951738 20080408 RGD inhibition significantly reduces retinal neovascularization 2965 Kdr kinase insert domain receptor gene MP:0002799 abnormal passive avoidance behavior IDA N RGD:1581594|PMID:15258583 20080408 RGD 2965 Kdr kinase insert domain receptor gene MP:0003360 abnormal depression-related behavior IDA N RGD:2292006|PMID:17360578 20080408 RGD 2965 Kdr kinase insert domain receptor gene MP:0003711 pathological neovascularization IDA N RGD:2292014|PMID:14988842 20080408 RGD inhibition reduces portal-systemic collateral vessel formation 2990 Lamp2 lysosomal-associated membrane protein 2 gene MP:0001392 abnormal locomotor behavior IMP N RGD:13703117|PMID:29720683 20180803 RGD in hemizygote mutant male (LAMP2y/-) 2990 Lamp2 lysosomal-associated membrane protein 2 gene MP:0002063 abnormal learning/memory/conditioning IMP N RGD:13703117|PMID:29720683 20180803 RGD in hemizygote mutant male (LAMP2y/-) 2990 Lamp2 lysosomal-associated membrane protein 2 gene MP:0002083 premature death IMP N RGD:13703118|PMID:28124283 20180803 RGD in hemizygote mutant male (LAMP2y/-) 2990 Lamp2 lysosomal-associated membrane protein 2 gene MP:0002833 increased heart weight IMP N RGD:13703117|PMID:29720683 20180803 RGD in hemizygote mutant male (LAMP2y/-) 2990 Lamp2 lysosomal-associated membrane protein 2 gene MP:0002953 thick ventricular wall IMP N RGD:13703117|PMID:29720683 20180803 RGD in hemizygote mutant male (LAMP2y/-) 2990 Lamp2 lysosomal-associated membrane protein 2 gene MP:0002968 increased circulating alkaline phosphatase level IMP N RGD:13703118|PMID:28124283 20180803 RGD in hemizygote mutant male (LAMP2y/-) 2990 Lamp2 lysosomal-associated membrane protein 2 gene MP:0005178 increased circulating cholesterol level IMP N RGD:13703118|PMID:28124283 20180803 RGD in hemizygote mutant male (LAMP2y/-) 2990 Lamp2 lysosomal-associated membrane protein 2 gene MP:0005343 increased circulating aspartate transaminase level IMP N RGD:13703118|PMID:28124283 20180803 RGD in hemizygote mutant male (LAMP2y/-) 2990 Lamp2 lysosomal-associated membrane protein 2 gene MP:0005415 intrahepatic cholestasis IMP N RGD:13703118|PMID:28124283 20180803 RGD in hemizygote mutant male (LAMP2y/-) 2990 Lamp2 lysosomal-associated membrane protein 2 gene MP:0005559 increased circulating glucose level IMP N RGD:13703118|PMID:28124283 20180803 RGD in hemizygote mutant male (LAMP2y/-) 2990 Lamp2 lysosomal-associated membrane protein 2 gene MP:0008489 slow postnatal weight gain IMP N RGD:13703118|PMID:28124283 20180803 RGD in hemizygote mutant male (LAMP2y/-) 2990 Lamp2 lysosomal-associated membrane protein 2 gene MP:0010724 thick interventricular septum IMP N RGD:13703117|PMID:29720683 20180803 RGD in hemizygote mutant male (LAMP2y/-) 2990 Lamp2 lysosomal-associated membrane protein 2 gene MP:0012144 decreased b-wave amplitude IMP N RGD:13703117|PMID:29720683 20180803 RGD in hemizygote mutant male (LAMP2y/-) 2990 Lamp2 lysosomal-associated membrane protein 2 gene MP:0014046 abnormal mitophagy IMP N RGD:13703118|PMID:28124283 20180803 RGD in hemizygote mutant male (LAMP2y/-) 2990 Lamp2 lysosomal-associated membrane protein 2 gene MP:0020280 increased creatine kinase level IMP N RGD:13703117|PMID:29720683 20180803 RGD in hemizygote mutant male (LAMP2y/-) 2998 Ldlr low density lipoprotein receptor gene MP:0001260 increased body weight IMP N RGD:12910100|PMID:28469073 20201210 RGD 2998 Ldlr low density lipoprotein receptor gene MP:0001554 increased circulating free fatty acids level IMP N RGD:12910100|PMID:28469073 20201210 RGD 2998 Ldlr low density lipoprotein receptor gene MP:0005293 impaired glucose tolerance IMP N RGD:12910100|PMID:28469073 20201210 RGD 2998 Ldlr low density lipoprotein receptor gene MP:0005669 increased circulating leptin level IMP N RGD:12910100|PMID:28469073 20201210 RGD 2998 Ldlr low density lipoprotein receptor gene MP:0009355 increased liver triglyceride level IMP N RGD:12910100|PMID:28469073 20201210 RGD 2998 Ldlr low density lipoprotein receptor gene MP:0010027 increased liver cholesterol level IMP N RGD:12910100|PMID:28469073 20201210 RGD 2998 Ldlr low density lipoprotein receptor gene MP:0010359 increased liver free fatty acids level IMP N RGD:12910104|PMID:27378433 20170608 RGD 3000 Lep leptin gene MP:0000182 increased circulating LDL cholesterol level IMP N RGD:12904911|PMID:22948215 20201210 RGD 3000 Lep leptin gene MP:0001260 increased body weight IMP N RGD:12904911|PMID:22948215 20201210 RGD 3000 Lep leptin gene MP:0001552 increased circulating triglyceride level IMP N RGD:8549777|PMID:23800849 20170317 RGD DNA:nonsense mutation:cds: 3000 Lep leptin gene MP:0001556 increased circulating HDL cholesterol level IMP N RGD:12904911|PMID:22948215 20201210 RGD 3000 Lep leptin gene MP:0005018 decreased T cell number IMP N RGD:12904911|PMID:22948215 20201210 RGD 3000 Lep leptin gene MP:0005178 increased circulating cholesterol level IMP N RGD:8549777|PMID:23800849 20170317 RGD DNA:nonsense mutation:cds: 3000 Lep leptin gene MP:0005559 increased circulating glucose level IMP N RGD:12904911|PMID:22948215 20201210 RGD 3000 Lep leptin gene MP:0008750 abnormal interferon level IMP N RGD:12904911|PMID:22948215 20201210 RGD 3000 Lep leptin gene MP:0009355 increased liver triglyceride level IMP N RGD:8549777|PMID:23800849 20170317 RGD DNA:nonsense mutation:cds: 3001 Lepr leptin receptor gene MP:0000063 decreased bone mineral density IMP N RGD:12911216|PMID:26537785 20200219 RGD 3001 Lepr leptin receptor gene MP:0000182 increased circulating LDL cholesterol level IMP N RGD:12911216|PMID:26537785 20200218 RGD 3001 Lepr leptin receptor gene MP:0000231 hypertension IAGP N RGD:401960095|PMID:30278832 20240206 RGD DNA:mutations:cds: : (rat) 3001 Lepr leptin receptor gene MP:0000231 hypertension IMP N RGD:12911217|PMID:27465994 20170707 RGD 3001 Lepr leptin receptor gene MP:0000731 increased collagen deposition in the muscles treatment IAGP N RGD:401965412|PMID:33568522 20240206 RGD compared to treated 3001 Lepr leptin receptor gene MP:0000747 muscle weakness IAGP N RGD:401960103|PMID:32710530 20240206 RGD DNA:mutations:cds: : (rat) 3001 Lepr leptin receptor gene MP:0001260 increased body weight IAGP N RGD:13432147|PMID:23154293 20170921 RGD 3001 Lepr leptin receptor gene MP:0001260 increased body weight IAGP N RGD:401965414|PMID:10901178 20240206 RGD DNA:mutations::cds: : (rat) 3001 Lepr leptin receptor gene MP:0001260 increased body weight IMP N RGD:12911217|PMID:27465994 20200702 RGD 3001 Lepr leptin receptor gene MP:0001260 increased body weight sexual_dimorphism IAGP N RGD:7365117|PMID:20159938 20201210 RGD compared to BN 3001 Lepr leptin receptor gene MP:0001260 increased body weight treatment IAGP XCO:0000015 N RGD:628581|PMID:11500530 20201210 RGD compared to ad lib fed rats 3001 Lepr leptin receptor gene MP:0001261 obese IAGP N RGD:401960103|PMID:32710530 20240206 RGD DNA:mutations:cds: : (rat) 3001 Lepr leptin receptor gene MP:0001261 obese IAGP N RGD:401965413|PMID:28746409 20240206 RGD DNA:mutations:cds: : (rat) 3001 Lepr leptin receptor gene MP:0001261 obese IAGP N RGD:628581|PMID:11500530 20201210 RGD compared to heterozygous controls +/fa 3001 Lepr leptin receptor gene MP:0001261 obese IAGP N RGD:628910|PMID:9843879 20201210 RGD compared to age-matched lean heterozygous +/fa rats 3001 Lepr leptin receptor gene MP:0001261 obese treatment IAGP N RGD:401965412|PMID:33568522 20240206 RGD 3001 Lepr leptin receptor gene MP:0001261 obese treatment IAGP XCO:0000015 N RGD:628581|PMID:11500530 20201210 RGD compared to ad lib fed rats 3001 Lepr leptin receptor gene MP:0001433 polyphagia IAGP N RGD:13432147|PMID:23154293 20170921 RGD 3001 Lepr leptin receptor gene MP:0001548 hyperlipidemia IAGP N RGD:628581|PMID:11500530 20201210 RGD compared to heterozygous controls +/fa 3001 Lepr leptin receptor gene MP:0001552 increased circulating triglyceride level IMP N RGD:12910507|PMID:27225180 20170619 RGD 3001 Lepr leptin receptor gene MP:0001552 increased circulating triglyceride level IMP N RGD:12911216|PMID:26537785 20200218 RGD 3001 Lepr leptin receptor gene MP:0001552 increased circulating triglyceride level disease_progression IMP N RGD:12911217|PMID:27465994 20201210 RGD 3001 Lepr leptin receptor gene MP:0001552 increased circulating triglyceride level treatment IAGP XCO:0000015 N RGD:628581|PMID:11500530 20201210 RGD compared to ad lib fed rats 3001 Lepr leptin receptor gene MP:0001556 increased circulating HDL cholesterol level IMP N RGD:12911216|PMID:26537785 20200218 RGD 3001 Lepr leptin receptor gene MP:0002079 increased circulating insulin level IAGP N RGD:401965413|PMID:28746409 20240206 RGD DNA:mutations:cds: : (rat) 3001 Lepr leptin receptor gene MP:0002079 increased circulating insulin level IMP N RGD:12911217|PMID:27465994 20200702 RGD 3001 Lepr leptin receptor gene MP:0002625 heart left ventricle hypertrophy treatment IAGP N RGD:401965412|PMID:33568522 20240206 RGD 3001 Lepr leptin receptor gene MP:0002628 hepatic steatosis IAGP N RGD:13432147|PMID:23154293 20170921 RGD 3001 Lepr leptin receptor gene MP:0002628 hepatic steatosis IMP N RGD:12911216|PMID:26537785 20200219 RGD 3001 Lepr leptin receptor gene MP:0002705 dilated renal tubule IAGP N RGD:401965414|PMID:10901178 20240206 RGD DNA:mutations:cds: : (rat) 3001 Lepr leptin receptor gene MP:0002747 abnormal aortic valve morphology IAGP N RGD:401960103|PMID:32710530 20240206 RGD DNA:mutations:cds: : (rat) 3001 Lepr leptin receptor gene MP:0002871 albuminuria sexual_dimorphism IAGP N RGD:7365117|PMID:20159938 20201210 RGD compared to BN 3001 Lepr leptin receptor gene MP:0002871 albuminuria treatment IAGP XCO:0000015 N RGD:628581|PMID:11500530 20201210 RGD compared to ad lib fed rats 3001 Lepr leptin receptor gene MP:0002941 increased circulating alanine transaminase level IAGP N RGD:13432147|PMID:23154293 20170921 RGD 3001 Lepr leptin receptor gene MP:0002941 increased circulating alanine transaminase level IMP N RGD:12910507|PMID:27225180 20170619 RGD 3001 Lepr leptin receptor gene MP:0002959 increased urine microalbumin level IAGP N RGD:401960095|PMID:30278832 20240206 RGD DNA:mutations:cds: : (rat) 3001 Lepr leptin receptor gene MP:0002959 increased urine microalbumin level IAGP N RGD:401965413|PMID:28746409 20240206 RGD DNA:mutations:cds: : (rat) 3001 Lepr leptin receptor gene MP:0002962 increased urine protein level IAGP N RGD:401965414|PMID:10901178 20240206 RGD DNA:mutations:cds: : (rat) 3001 Lepr leptin receptor gene MP:0002962 increased urine protein level IMP N RGD:12911217|PMID:27465994 20170707 RGD 3001 Lepr leptin receptor gene MP:0003215 renal interstitial fibrosis IAGP N RGD:401960095|PMID:30278832 20240206 RGD DNA:mutations:cds: : (rat) 3001 Lepr leptin receptor gene MP:0003215 renal interstitial fibrosis IAGP N RGD:401965414|PMID:10901178 20240206 RGD DNA:mutations:cds: : (rat) 3001 Lepr leptin receptor gene MP:0003215 renal interstitial fibrosis disease_progression IMP N RGD:12911217|PMID:27465994 20201210 RGD compared to SS/JrHsdMcwi 3001 Lepr leptin receptor gene MP:0003334 pancreas fibrosis IMP N RGD:12911216|PMID:26537785 20200219 RGD 3001 Lepr leptin receptor gene MP:0003819 increased left ventricle diastolic pressure IAGP N RGD:401960103|PMID:32710530 20240206 RGD DNA:mutations:cds: : (rat) 3001 Lepr leptin receptor gene MP:0003915 increased heart left ventricle weight IAGP N RGD:401960103|PMID:32710530 20240206 RGD DNA:mutations:cds: : (rat) 3001 Lepr leptin receptor gene MP:0003991 arteriosclerosis IAGP N RGD:401965414|PMID:10901178 20240206 RGD DNA:mutations:cds: : (rat) 3001 Lepr leptin receptor gene MP:0004875 increased mean systemic arterial blood pressure IAGP N RGD:401960103|PMID:32710530 20240206 RGD DNA:mutations:cds: : (rat) 3001 Lepr leptin receptor gene MP:0004890 decreased energy expenditure treatment IAGP N RGD:401965412|PMID:33568522 20240206 RGD 3001 Lepr leptin receptor gene MP:0005178 increased circulating cholesterol level IAGP N RGD:13432147|PMID:23154293 20170921 RGD 3001 Lepr leptin receptor gene MP:0005178 increased circulating cholesterol level IAGP N RGD:401960095|PMID:30278832 20240206 RGD DNA:mutations:cds: : (rat) 3001 Lepr leptin receptor gene MP:0005178 increased circulating cholesterol level IAGP N RGD:401965413|PMID:28746409 20240206 RGD DNA:mutations:cds: : (rat) 3001 Lepr leptin receptor gene MP:0005178 increased circulating cholesterol level IAGP N RGD:401965414|PMID:10901178 20240206 RGD DNA:mutations:cds: : (rat) 3001 Lepr leptin receptor gene MP:0005178 increased circulating cholesterol level IMP N RGD:12910507|PMID:27225180 20170619 RGD 3001 Lepr leptin receptor gene MP:0005178 increased circulating cholesterol level IMP N RGD:12911216|PMID:26537785 20200218 RGD 3001 Lepr leptin receptor gene MP:0005178 increased circulating cholesterol level disease_progression IMP N RGD:12911217|PMID:27465994 20200702 RGD 3001 Lepr leptin receptor gene MP:0005264 glomerulosclerosis IAGP N RGD:401965413|PMID:28746409 20240206 RGD DNA:mutations:cds: : (rat) 3001 Lepr leptin receptor gene MP:0005264 glomerulosclerosis disease_progression IMP N RGD:12911217|PMID:27465994 20201210 RGD 3001 Lepr leptin receptor gene MP:0005288 abnormal oxygen consumption treatment IAGP N RGD:401965412|PMID:33568522 20240206 RGD 3001 Lepr leptin receptor gene MP:0005293 impaired glucose tolerance IMP N RGD:12910507|PMID:27225180 20170619 RGD 3001 Lepr leptin receptor gene MP:0005293 impaired glucose tolerance IMP N RGD:12911217|PMID:27465994 20201210 RGD compared to SS/JrHsdMcwi 3001 Lepr leptin receptor gene MP:0005317 increased triglyceride level IAGP N RGD:401960095|PMID:30278832 20240206 RGD DNA:mutations:cds: : (rat) 3001 Lepr leptin receptor gene MP:0005317 increased triglyceride level IAGP N RGD:401965413|PMID:28746409 20240206 RGD DNA:mutations:cds: : (rat) 3001 Lepr leptin receptor gene MP:0005317 increased triglyceride level IAGP N RGD:401965414|PMID:10901178 20240206 RGD DNA:mutations:cds: : (rat) 3001 Lepr leptin receptor gene MP:0005331 insulin resistance IMP N RGD:12911217|PMID:27465994 20170707 RGD 3001 Lepr leptin receptor gene MP:0005343 increased circulating aspartate transaminase level IMP N RGD:12910507|PMID:27225180 20170619 RGD 3001 Lepr leptin receptor gene MP:0005450 abnormal energy expenditure treatment IAGP N RGD:401965412|PMID:33568522 20240206 RGD compared to treated 3001 Lepr leptin receptor gene MP:0005526 decreased renal plasma flow rate IAGP N RGD:401965414|PMID:10901178 20240206 RGD DNA:mutations::cds: : (rat) 3001 Lepr leptin receptor gene MP:0005528 decreased renal glomerular filtration rate IAGP N RGD:401965414|PMID:10901178 20240206 RGD DNA:mutations::cds: : (rat) 3001 Lepr leptin receptor gene MP:0005531 increased renal vascular resistance IAGP N RGD:401965414|PMID:10901178 20240206 RGD DNA:mutations::cds: : (rat) 3001 Lepr leptin receptor gene MP:0005553 increased circulating creatinine level IMP N RGD:12911217|PMID:27465994 20200702 RGD 3001 Lepr leptin receptor gene MP:0005558 decreased creatinine clearance IAGP N RGD:401965414|PMID:10901178 20240206 RGD DNA:mutations:cds: : (rat) 3001 Lepr leptin receptor gene MP:0005559 increased circulating glucose level IAGP N RGD:401960103|PMID:32710530 20240206 RGD DNA:mutations:cds: : (rat) 3001 Lepr leptin receptor gene MP:0005559 increased circulating glucose level IAGP N RGD:401965413|PMID:28746409 20240206 RGD DNA:mutations:cds: : (rat) 3001 Lepr leptin receptor gene MP:0005559 increased circulating glucose level IAGP N RGD:401965414|PMID:10901178 20240206 RGD DNA:mutations:cds: : (rat) 3001 Lepr leptin receptor gene MP:0005565 increased blood urea nitrogen level IAGP N RGD:401960095|PMID:30278832 20240206 RGD DNA:mutations:cds: : (rat) 3001 Lepr leptin receptor gene MP:0005565 increased blood urea nitrogen level IAGP N RGD:401965413|PMID:28746409 20240206 RGD DNA:mutations:cds: : (rat) 3001 Lepr leptin receptor gene MP:0005669 increased circulating leptin level IAGP N RGD:11570540|PMID:9032111 20210211 RGD compared to lean littermates 3001 Lepr leptin receptor gene MP:0005669 increased circulating leptin level IMP N RGD:12911217|PMID:27465994 20200702 RGD 3001 Lepr leptin receptor gene MP:0006087 increased body mass index IAGP N RGD:11570540|PMID:9032111 20210211 RGD compared to lean littermates 3001 Lepr leptin receptor gene MP:0006094 increased fat cell size IMP N RGD:12910507|PMID:27225180 20170619 RGD 3001 Lepr leptin receptor gene MP:0006094 increased fat cell size IMP N RGD:12911216|PMID:26537785 20200219 RGD 3001 Lepr leptin receptor gene MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:13432147|PMID:23154293 20170921 RGD 3001 Lepr leptin receptor gene MP:0006144 increased systemic arterial systolic blood pressure onset IMP N RGD:12911217|PMID:27465994 20201210 RGD compared to SS/JrHsdMcwi 3001 Lepr leptin receptor gene MP:0006144 increased systemic arterial systolic blood pressure treatment IAGP N RGD:401965412|PMID:33568522 20240206 RGD compared to treated 3001 Lepr leptin receptor gene MP:0008140 podocyte foot process effacement IMP N RGD:12911217|PMID:27465994 20200702 RGD 3001 Lepr leptin receptor gene MP:0008770 decreased survivor rate IAGP N RGD:13432147|PMID:23154293 20170921 RGD 3001 Lepr leptin receptor gene MP:0009110 pancreas hyperplasia IMP N RGD:12911216|PMID:26537785 20200219 RGD 3001 Lepr leptin receptor gene MP:0009130 increased white fat cell number IAGP N RGD:628910|PMID:9843879 20201210 RGD compared to age-matched lean heterozygous +/fa rats 3001 Lepr leptin receptor gene MP:0009285 increased gonadal fat pad weight sexual_dimorphism IAGP N RGD:7365117|PMID:20159938 20201210 RGD compared to BN 3001 Lepr leptin receptor gene MP:0009288 increased epididymal fat pad weight IAGP N RGD:628910|PMID:9843879 20201210 RGD compared to age-matched lean heterozygous +/fa rats 3001 Lepr leptin receptor gene MP:0009292 increased inguinal fat pad weight IAGP N RGD:628910|PMID:9843879 20201210 RGD compared to age-matched lean heterozygous +/fa rats 3001 Lepr leptin receptor gene MP:0009304 increased retroperitoneal fat pad weight IAGP N RGD:628910|PMID:9843879 20201210 RGD compared to age-matched lean heterozygous +/fa rats 3001 Lepr leptin receptor gene MP:0009304 increased retroperitoneal fat pad weight sexual_dimorphism IAGP N RGD:7365117|PMID:20159938 20201210 RGD compared to BN 3001 Lepr leptin receptor gene MP:0010018 pulmonary vascular congestion treatment IAGP N RGD:401965412|PMID:33568522 20240206 RGD 3001 Lepr leptin receptor gene MP:0010754 abnormal heart left ventricle pressure treatment IAGP N RGD:401965412|PMID:33568522 20240206 RGD 3001 Lepr leptin receptor gene MP:0010879 decreased trabecular bone volume IMP N RGD:12911216|PMID:26537785 20200219 RGD 3001 Lepr leptin receptor gene MP:0011294 renal glomerulus hypertrophy IAGP N RGD:401960095|PMID:30278832 20240206 RGD DNA:mutations:cds: : (rat) 3001 Lepr leptin receptor gene MP:0011346 renal tubule atrophy IAGP N RGD:401965414|PMID:10901178 20240206 RGD DNA:mutations:cds: : (rat) 3001 Lepr leptin receptor gene MP:0011353 expanded mesangial matrix IAGP N RGD:401960095|PMID:30278832 20240206 RGD DNA:mutations:cds: : (rat) 3001 Lepr leptin receptor gene MP:0011353 expanded mesangial matrix IMP N RGD:12911216|PMID:26537785 20200219 RGD 3001 Lepr leptin receptor gene MP:0011377 renal glomerulus fibrosis treatment IAGP XCO:0000015 N RGD:628581|PMID:11500530 20201210 RGD compared to ad lib fed rats; increased desmin, fibronectin and collagenase 3001 Lepr leptin receptor gene MP:0011402 renal cast IAGP N RGD:401960095|PMID:30278832 20240206 RGD DNA:mutations:cds: : (rat) 3001 Lepr leptin receptor gene MP:0011402 renal cast IAGP N RGD:401965413|PMID:28746409 20240206 RGD DNA:mutations:cds: : (rat) 3001 Lepr leptin receptor gene MP:0011402 renal cast IAGP N RGD:401965414|PMID:10901178 20240206 RGD DNA:mutations:cds: : (rat) 3001 Lepr leptin receptor gene MP:0011409 increased renal glomerulus basement membrane thickness IAGP N RGD:401960095|PMID:30278832 20240206 RGD DNA:mutations:cds: : (rat) 3001 Lepr leptin receptor gene MP:0011431 increased urine flow rate IAGP N RGD:401965414|PMID:10901178 20240206 RGD DNA:mutations:cds: : (rat) 3001 Lepr leptin receptor gene MP:0011855 abnormal glomerular filtration barrier morphology IMP N RGD:12911217|PMID:27465994 20200702 RGD 3001 Lepr leptin receptor gene MP:0011929 abnormal aortic valve flow IAGP N RGD:401960103|PMID:32710530 20240206 RGD DNA:mutations:cds: : (rat) 3001 Lepr leptin receptor gene MP:0011939 increased food intake IAGP N RGD:628910|PMID:9843879 20201210 RGD compared to age-matched lean heterozygous +/fa rats 3001 Lepr leptin receptor gene MP:0011941 increased fluid intake IAGP N RGD:401965414|PMID:10901178 20240206 RGD DNA:mutations::cds: : (rat) 3001 Lepr leptin receptor gene MP:0012106 impaired exercise endurance treatment IAGP N RGD:401965412|PMID:33568522 20240206 RGD 3001 Lepr leptin receptor gene MP:0013630 increased bone trabecular spacing IMP N RGD:12911216|PMID:26537785 20200219 RGD 3001 Lepr leptin receptor gene MP:0014144 abnormal white adipose tissue mass treatment IAGP N RGD:401965412|PMID:33568522 20240206 RGD compared to treated 3001 Lepr leptin receptor gene MP:0014145 increased white adipose tissue mass treatment IAGP N RGD:401965412|PMID:33568522 20240206 RGD DNA:mutations:cds: : (rat) 3001 Lepr leptin receptor gene MP:0020252 abnormal collagen level treatment IAGP N RGD:401965412|PMID:33568522 20240206 RGD compared to treated 3001 Lepr leptin receptor gene MP:0020989 increased urine lipocalin 2 level IAGP N RGD:401960095|PMID:30278832 20240206 RGD DNA:mutations:cds: : (rat) 3001 Lepr leptin receptor gene MP:0021162 increased heart left ventricle anterior wall thickness IAGP N RGD:401960103|PMID:32710530 20240206 RGD DNA:mutations:cds: : (rat) 3020 Lta lymphotoxin alpha gene MP:0005671 abnormal response to transplant IDA N RGD:1580413|PMID:9798700 19990101 RGD 3032 Smad3 SMAD family member 3 gene MP:0003333 liver fibrosis IDA N RGD:2300428|PMID:14512875 20080919 RGD 3057 Mc4r melanocortin 4 receptor gene MP:0000008 increased white adipose tissue amount IMP N RGD:6478803|PMID:21527895 20181129 RGD 3057 Mc4r melanocortin 4 receptor gene MP:0001257 increased body length IMP N RGD:6478803|PMID:21527895 20181129 RGD 3057 Mc4r melanocortin 4 receptor gene MP:0001260 increased body weight IMP N RGD:13825242|PMID:24400148 20210609 RGD 3057 Mc4r melanocortin 4 receptor gene MP:0001260 increased body weight IMP N RGD:6478803|PMID:21527895 20181129 RGD 3057 Mc4r melanocortin 4 receptor gene MP:0001261 obese IMP N RGD:13825198|PMID:20531371 20201012 RGD 3057 Mc4r melanocortin 4 receptor gene MP:0001402 decreased locomotor activity IMP N RGD:6478803|PMID:21527895 20120612 RGD 3057 Mc4r melanocortin 4 receptor gene MP:0001432 abnormal food preference IMP N RGD:6478803|PMID:21527895 20120612 RGD 3057 Mc4r melanocortin 4 receptor gene MP:0001433 polyphagia IMP N RGD:13825242|PMID:24400148 20210609 RGD 3057 Mc4r melanocortin 4 receptor gene MP:0001433 polyphagia IMP N RGD:6478803|PMID:21527895 20120612 RGD 3057 Mc4r melanocortin 4 receptor gene MP:0001552 increased circulating triglyceride level IMP N RGD:13825242|PMID:24400148 20181130 RGD 3057 Mc4r melanocortin 4 receptor gene MP:0001554 increased circulating free fatty acids level IMP N RGD:13825242|PMID:24400148 20181130 RGD 3057 Mc4r melanocortin 4 receptor gene MP:0001762 polyuria IMP N RGD:13825242|PMID:24400148 20210609 RGD 3057 Mc4r melanocortin 4 receptor gene MP:0002079 increased circulating insulin level IMP N RGD:13825242|PMID:24400148 20181130 RGD 3057 Mc4r melanocortin 4 receptor gene MP:0002833 increased heart weight IMP N RGD:13825242|PMID:24400148 20181130 RGD 3057 Mc4r melanocortin 4 receptor gene MP:0003025 increased vasoconstriction IMP XCO:0000312 N RGD:13825242|PMID:24400148 20210624 RGD 3057 Mc4r melanocortin 4 receptor gene MP:0003026 decreased vasoconstriction IMP XCO:0000145 N RGD:13825242|PMID:24400148 20210624 RGD 3057 Mc4r melanocortin 4 receptor gene MP:0003867 increased defecation amount IMP N RGD:6478803|PMID:21527895 20181129 RGD 3057 Mc4r melanocortin 4 receptor gene MP:0003917 increased kidney weight IMP N RGD:13825242|PMID:24400148 20181130 RGD 3057 Mc4r melanocortin 4 receptor gene MP:0004876 decreased mean systemic arterial blood pressure IMP XCO:0000843 N RGD:13825242|PMID:24400148 20210624 RGD 3057 Mc4r melanocortin 4 receptor gene MP:0004878 increased systemic vascular resistance IMP N RGD:13825242|PMID:24400148 20210609 RGD 3057 Mc4r melanocortin 4 receptor gene MP:0005178 increased circulating cholesterol level IMP N RGD:13825242|PMID:24400148 20181130 RGD 3057 Mc4r melanocortin 4 receptor gene MP:0005333 decreased heart rate IMP N RGD:13825242|PMID:24400148 20210609 RGD 3057 Mc4r melanocortin 4 receptor gene MP:0005333 decreased heart rate IMP XCO:0000630 N RGD:13825242|PMID:24400148 20210610 RGD compared with WI-MC4r^m1Hubr 3057 Mc4r melanocortin 4 receptor gene MP:0005669 increased circulating leptin level IMP N RGD:13825242|PMID:24400148 20210609 RGD 3057 Mc4r melanocortin 4 receptor gene MP:0005669 increased circulating leptin level IMP N RGD:6478803|PMID:21527895 20181129 RGD 3057 Mc4r melanocortin 4 receptor gene MP:0006094 increased fat cell size IMP N RGD:6478803|PMID:21527895 20181129 RGD 3057 Mc4r melanocortin 4 receptor gene MP:0006353 increased glycosylated hemoglobin level IMP N RGD:13825242|PMID:24400148 20181130 RGD 3057 Mc4r melanocortin 4 receptor gene MP:0010934 increased subcutaneous adipose tissue amount IMP N RGD:6478803|PMID:21527895 20181129 RGD 3057 Mc4r melanocortin 4 receptor gene MP:0011941 increased fluid intake IMP N RGD:13825242|PMID:24400148 20210609 RGD 3057 Mc4r melanocortin 4 receptor gene MP:0011941 increased fluid intake IMP N RGD:6478803|PMID:21527895 20181129 RGD 3075 Mecp2 methyl CpG binding protein 2 gene MP:0000120 malocclusion IMP N RGD:11568037|PMID:27313794 20210325 RGD 3075 Mecp2 methyl CpG binding protein 2 gene MP:0000120 malocclusion sexual_dimorphism IMP N RGD:40924662|PMID:27329765 20210325 RGD compared to female heterozygote mutant 3075 Mecp2 methyl CpG binding protein 2 gene MP:0001255 decreased body height IMP N RGD:11568037|PMID:27313794 20210325 RGD 3075 Mecp2 methyl CpG binding protein 2 gene MP:0001260 increased body weight sexual_dimorphism IMP N RGD:40924662|PMID:27329765 20210325 RGD compared to SD wild-type female 3075 Mecp2 methyl CpG binding protein 2 gene MP:0001262 decreased body weight IMP N RGD:11568037|PMID:27313794 20210325 RGD 3075 Mecp2 methyl CpG binding protein 2 gene MP:0001402 decreased locomotor activity IMP N RGD:11568037|PMID:27313794 20210325 RGD 3075 Mecp2 methyl CpG binding protein 2 gene MP:0001402 decreased locomotor activity IMP N RGD:40924662|PMID:27329765 20210325 RGD compared to SD wild-type 3075 Mecp2 methyl CpG binding protein 2 gene MP:0001407 short stride length IMP N RGD:40924662|PMID:27329765 20210325 RGD compared to SD wild-type 3075 Mecp2 methyl CpG binding protein 2 gene MP:0001513 limb grasping IMP N RGD:40924662|PMID:27329765 20210325 RGD compared to SD wild-type 3075 Mecp2 methyl CpG binding protein 2 gene MP:0001516 abnormal motor coordination/balance IMP N RGD:40924662|PMID:27329765 20210325 RGD compared to SD wild-type 3075 Mecp2 methyl CpG binding protein 2 gene MP:0002083 premature death sexual_dimorphism IMP N RGD:40924662|PMID:27329765 20210325 RGD compared to male SD wild-type 3075 Mecp2 methyl CpG binding protein 2 gene MP:0002175 decreased brain weight IMP N RGD:40924662|PMID:27329765 20210325 RGD compared to SD wild-type 3075 Mecp2 methyl CpG binding protein 2 gene MP:0002669 abnormal scrotum morphology IMP N RGD:40924662|PMID:27329765 20210325 RGD compared to SD wild-type male 3075 Mecp2 methyl CpG binding protein 2 gene MP:0005402 abnormal action potential IMP N RGD:11568037|PMID:27313794 20210325 RGD 3075 Mecp2 methyl CpG binding protein 2 gene MP:0005572 abnormal pulmonary respiratory rate IMP N RGD:11568037|PMID:27313794 20210325 RGD 3075 Mecp2 methyl CpG binding protein 2 gene MP:0005573 increased pulmonary respiratory rate sexual_dimorphism IMP N RGD:40924662|PMID:27329765 20210325 RGD compared to SD wild-type female 3075 Mecp2 methyl CpG binding protein 2 gene MP:0005574 decreased pulmonary respiratory rate sexual_dimorphism IMP N RGD:40924662|PMID:27329765 20210325 RGD compared to SD wild-type male 3075 Mecp2 methyl CpG binding protein 2 gene MP:0009004 progressive hair loss IMP N RGD:40924662|PMID:27329765 20210325 RGD compared to SD wild-type 3075 Mecp2 methyl CpG binding protein 2 gene MP:0009105 penis prolapse IMP N RGD:11568037|PMID:27313794 20210325 RGD 3075 Mecp2 methyl CpG binding protein 2 gene MP:0010053 decreased grip strength IMP N RGD:11568037|PMID:27313794 20210325 RGD 3075 Mecp2 methyl CpG binding protein 2 gene MP:0010179 rough coat sexual_dimorphism IMP N RGD:40924662|PMID:27329765 20210325 RGD compared to SD wild-type male 3075 Mecp2 methyl CpG binding protein 2 gene MP:0010946 hyperpnea IMP N RGD:11568037|PMID:27313794 20210325 RGD 3075 Mecp2 methyl CpG binding protein 2 gene MP:0020395 abnormal response to social novelty IMP N RGD:11568037|PMID:27313794 20210325 RGD 3078 Men1 menin 1 gene MP:0000488 abnormal intestinal epithelium morphology severity IMP N RGD:1304318|PMID:15054094 20170825 RGD 3088 Mgp matrix Gla protein gene MP:0006133 calcified artery IDA N RGD:2293588|PMID:17138823 20080605 RGD 3115 Mstn myostatin gene MP:0001260 increased body weight IMP N RGD:151347429|PMID:25640143 20220127 RGD compared to wild type 3115 Mstn myostatin gene MP:0001260 increased body weight sexual_dimorphism IMP N RGD:13831345|PMID:27289021 20220127 RGD compared to wild type male 3115 Mstn myostatin gene MP:0003397 increased muscle weight IMP N RGD:13831345|PMID:27289021 20190102 RGD 3115 Mstn myostatin gene MP:0004818 increased skeletal muscle mass IMP N RGD:151347429|PMID:25640143 20220127 RGD compared to wild type 3115 Mstn myostatin gene MP:0009399 increased skeletal muscle fiber size IMP N RGD:151347429|PMID:25640143 20220127 RGD compared to wild type 3115 Mstn myostatin gene MP:0010025 decreased total body fat amount IMP N RGD:13831345|PMID:27289021 20190102 RGD 3130 Myc MYC proto-oncogene, bHLH transcription factor gene MP:0003927 increased cellular glucose import IMP N RGD:7207891|PMID:22842522 20130212 RGD 3130 Myc MYC proto-oncogene, bHLH transcription factor gene MP:0005332 abnormal amino acid level IMP N RGD:7207891|PMID:22842522 20130212 RGD 3130 Myc MYC proto-oncogene, bHLH transcription factor gene MP:0010954 abnormal cellular respiration IMP N RGD:7207891|PMID:22842522 20130212 RGD 3130 Myc MYC proto-oncogene, bHLH transcription factor gene MP:0011631 decreased mitochondrial size IMP N RGD:7240532|PMID:22629444 20130214 RGD 3130 Myc MYC proto-oncogene, bHLH transcription factor gene MP:0011635 abnormal mitochondrial crista morphology IMP N RGD:7240532|PMID:22629444 20130214 RGD 3130 Myc MYC proto-oncogene, bHLH transcription factor gene MP:0011704 decreased fibroblast proliferation IMP N RGD:7207891|PMID:22842522 20130212 RGD 3143 Myo5a myosin VA gene MP:0001186 pigmentation phenotype IAGP N RGD:61493|PMID:10920234 20090206 RGD dilute coat color 3143 Myo5a myosin VA gene MP:0001393 ataxia IAGP N RGD:1600835|PMID:17185506 20210914 RGD DNA:rearrangement, deletion:exon:141-bp deletion position 1442-1582 3143 Myo5a myosin VA gene MP:0002880 opisthotonus IAGP N RGD:1600835|PMID:17185506 20070328 RGD DNA:rearrangement:exon:a 141-bp exon skipped 3143 Myo5a myosin VA gene MP:0003996 clonic seizures IAGP N RGD:1600835|PMID:17185506 20210914 RGD DNA:rearrangement, deletion:exon:141-bp deletion position 1442-1582 3143 Myo5a myosin VA gene MP:0009378 abnormal endoplasmic reticulum morphology IAGP N RGD:1600835|PMID:17185506 20210914 RGD DNA:rearrangement, deletion:exon:141-bp deletion position 1442-1582 3193 Nppa natriuretic peptide A gene MP:0001262 decreased body weight IMP N RGD:8662415|PMID:24006081 20190717 RGD as compared to the wild-type 3193 Nppa natriuretic peptide A gene MP:0002833 increased heart weight IMP N RGD:8662415|PMID:24006081 20190717 RGD as compared to the wild-type 3193 Nppa natriuretic peptide A gene MP:0004875 increased mean systemic arterial blood pressure IMP N RGD:8662415|PMID:24006081 20190717 RGD as compared to the wild-type 3193 Nppa natriuretic peptide A gene MP:0006143 increased systemic arterial diastolic blood pressure IMP N RGD:8662415|PMID:24006081 20190717 RGD as compared to the wild-type 3193 Nppa natriuretic peptide A gene MP:0006144 increased systemic arterial systolic blood pressure IMP N RGD:8662415|PMID:24006081 20190717 RGD as compared to the wild-type 3194 Nppb natriuretic peptide B gene MP:0000231 hypertension IMP N RGD:12910116|PMID:26063669 20170609 RGD 3194 Nppb natriuretic peptide B gene MP:0001625 cardiac hypertrophy IMP N RGD:12910116|PMID:26063669 20170609 RGD 3194 Nppb natriuretic peptide B gene MP:0002962 increased urine protein level IMP N RGD:12910116|PMID:26063669 20201210 RGD 3194 Nppb natriuretic peptide B gene MP:0003233 prolonged QT interval IMP N RGD:12910116|PMID:26063669 20170609 RGD 3195 Npr1 natriuretic peptide receptor 1 gene MP:0002842 increased systemic arterial blood pressure IAGP N RGD:1357231|PMID:7629399 19990101 RGD 3195 Npr1 natriuretic peptide receptor 1 gene MP:0006143 increased systemic arterial diastolic blood pressure IAGP N RGD:628585|PMID:12511524 19990101 RGD 3197 Npy neuropeptide Y gene MP:0001262 decreased body weight IAGP N RGD:11530013|PMID:27461754 20201210 RGD as compared to NP/Iusm; 3197 Npy neuropeptide Y gene MP:0001987 alcohol preference IAGP N RGD:11530013|PMID:27461754 20201210 RGD as compared to NP/Iusm; 3197 Npy neuropeptide Y gene MP:0003545 increased alcohol consumption IAGP N RGD:11530013|PMID:27461754 20201210 RGD as compared to NP/Iusm; 3227 Odc1 ornithine decarboxylase 1 gene MP:0003068 enlarged kidney TAS N RGD:1578327|PMID:12716758 19990101 RGD 3241 P2rx7 purinergic receptor P2X 7 gene MP:0004876 decreased mean systemic arterial blood pressure IMP N RGD:14995937|PMID:31630543 20191105 RGD 3241 P2rx7 purinergic receptor P2X 7 gene MP:0005556 abnormal renal filtration rate IMP N RGD:14995937|PMID:31630543 20191105 RGD 3249 Serpine1 serpin family E member 1 gene MP:0001273 decreased metastatic potential IMP N RGD:2306009|PMID:18460465 20170927 RGD 3258 Pax6 paired box 6 gene MP:0001070 abnormal abducens nerve morphology IAGP N RGD:731242|PMID:9247338 20170223 RGD 3258 Pax6 paired box 6 gene MP:0001076 abnormal hypoglossal nerve morphology IAGP N RGD:731242|PMID:9247338 20170223 RGD 3258 Pax6 paired box 6 gene MP:0001297 microphthalmia IAGP N RGD:8552339|PMID:21203536 20180403 RGD DNA:frameshift mutation:cds: 3258 Pax6 paired box 6 gene MP:0001325 abnormal retina morphology IAGP N RGD:1601213|PMID:7981749 20170223 RGD 3258 Pax6 paired box 6 gene MP:0002092 abnormal eye morphology QTM N RGD:731242|PMID:9247338 19990101 RGD 3258 Pax6 paired box 6 gene MP:0002233 abnormal nose morphology IAGP N RGD:1601213|PMID:7981749 20070410 RGD 3258 Pax6 paired box 6 gene MP:0002557 abnormal social/conspecific interaction behavior IAGP N RGD:8552339|PMID:21203536 20180403 RGD DNA:frameshift mutation:cds: 3258 Pax6 paired box 6 gene MP:0002757 decreased vertical activity IAGP N RGD:8552339|PMID:21203536 20170223 RGD DNA:frameshift mutation:cds: 3258 Pax6 paired box 6 gene MP:0003460 decreased fear-related response IAGP N RGD:8552339|PMID:21203536 20180403 RGD DNA:frameshift mutation:cds: 3258 Pax6 paired box 6 gene MP:0005215 abnormal pancreatic islet morphology IAGP N RGD:12790972|PMID:17178107 20170223 RGD 3258 Pax6 paired box 6 gene MP:0005253 abnormal eye physiology IAGP N RGD:1601213|PMID:7981749 20070410 RGD 3258 Pax6 paired box 6 gene MP:0006369 supernumerary incisors IAGP N RGD:12790971|PMID:16795023 20170223 RGD 3258 Pax6 paired box 6 gene MP:0009142 decreased prepulse inhibition IAGP N RGD:8552339|PMID:21203536 20180403 RGD DNA:frameshift mutation:cds: 3258 Pax6 paired box 6 gene MP:0010070 decreased serotonin level IAGP N RGD:8552339|PMID:21203536 20170223 RGD DNA:frameshift mutation:cds: 3258 Pax6 paired box 6 gene MP:0010147 abnormal endocrine pancreas physiology IAGP N RGD:12790972|PMID:17178107 20170223 RGD 3258 Pax6 paired box 6 gene MP:0011275 abnormal behavioral response to light IAGP N RGD:8552339|PMID:21203536 20180403 RGD DNA:frameshift mutation:cds: 3258 Pax6 paired box 6 gene MP:0020351 decreased vocalization IAGP N RGD:8552339|PMID:21203536 20180403 RGD in female pups;DNA:frameshift mutation:cds: 329333019 SD-Spon2em1Holi strain MP:0004883 abnormal vascular wound healing IMP N RGD:329328927|PMID:25751394 20230427 RGD 329333021 Spon2em1Holi spondin 2; TALEN induced mutant1, Holi gene MP:0004883 abnormal vascular wound healing IMP N RGD:329328927|PMID:25751394 20230504 RGD 329845597 WKY-Col4a5em1Matsu strain MP:0001262 decreased body weight IMP N RGD:329845598|PMID:34675305 20240115 RGD 329845597 WKY-Col4a5em1Matsu strain MP:0001762 polyuria IMP N RGD:329845598|PMID:34675305 20240115 RGD 329845597 WKY-Col4a5em1Matsu strain MP:0002083 premature death onset IMP N RGD:329845598|PMID:34675305 20240115 RGD 329845597 WKY-Col4a5em1Matsu strain MP:0005553 increased circulating creatinine level IMP N RGD:329845598|PMID:34675305 20240115 RGD 329845597 WKY-Col4a5em1Matsu strain MP:0005558 decreased creatinine clearance IMP N RGD:329845598|PMID:34675305 20240115 RGD 329845597 WKY-Col4a5em1Matsu strain MP:0005565 increased blood urea nitrogen level IMP N RGD:329845598|PMID:34675305 20240115 RGD 329845599 WKY-Col4a5em2Matsu strain MP:0002083 premature death onset IMP N RGD:329845598|PMID:34675305 20240115 RGD 329845600 WKY-Col4a5em3Matsu strain MP:0002083 premature death onset IMP N RGD:329845598|PMID:34675305 20240115 RGD 329969888 Col4a5em1Matsu collagen type IV alpha 5 chain; CRISPR/Cas9 induced mutant 1, Matsu gene MP:0001262 decreased body weight IMP N RGD:329845598|PMID:34675305 20240118 RGD 329969888 Col4a5em1Matsu collagen type IV alpha 5 chain; CRISPR/Cas9 induced mutant 1, Matsu gene MP:0001762 polyuria IMP N RGD:329845598|PMID:34675305 20240118 RGD 329969888 Col4a5em1Matsu collagen type IV alpha 5 chain; CRISPR/Cas9 induced mutant 1, Matsu gene MP:0002083 premature death onset IMP N RGD:329845598|PMID:34675305 20240118 RGD 329969888 Col4a5em1Matsu collagen type IV alpha 5 chain; CRISPR/Cas9 induced mutant 1, Matsu gene MP:0005553 increased circulating creatinine level IMP N RGD:329845598|PMID:34675305 20240118 RGD 329969888 Col4a5em1Matsu collagen type IV alpha 5 chain; CRISPR/Cas9 induced mutant 1, Matsu gene MP:0005558 decreased creatinine clearance IMP N RGD:329845598|PMID:34675305 20240118 RGD 329969888 Col4a5em1Matsu collagen type IV alpha 5 chain; CRISPR/Cas9 induced mutant 1, Matsu gene MP:0005565 increased blood urea nitrogen level IMP N RGD:329845598|PMID:34675305 20240118 RGD 329969892 Col4a5em2Matsu collagen type IV alpha 5 chain; CRISPR/Cas9 induced mutant 2, Matsu gene MP:0002083 premature death onset IMP N RGD:329845598|PMID:34675305 20240118 RGD 329969893 Col4a5em3Matsu collagen type IV alpha 5 chain; CRISPR/Cas9 induced mutant 3, Matsu gene MP:0002083 premature death onset IMP N RGD:329845598|PMID:34675305 20240118 RGD 3334 Anks6 ankyrin repeat and sterile alpha motif domain containing 6 gene MP:0000208 decreased hematocrit IAGP N RGD:1300446|PMID:7933831 20210211 RGD compared to PKD 3334 Anks6 ankyrin repeat and sterile alpha motif domain containing 6 gene MP:0002083 premature death IAGP N RGD:1300446|PMID:7933831 20210211 RGD 3334 Anks6 ankyrin repeat and sterile alpha motif domain containing 6 gene MP:0003068 enlarged kidney IAGP N RGD:1300446|PMID:7933831 20210211 RGD 3334 Anks6 ankyrin repeat and sterile alpha motif domain containing 6 gene MP:0003917 increased kidney weight IAGP N RGD:1300446|PMID:7933831 20210211 RGD compared to PKD 3334 Anks6 ankyrin repeat and sterile alpha motif domain containing 6 gene MP:0005553 increased circulating creatinine level IAGP N RGD:1300446|PMID:7933831 20210211 RGD compared to PKD 3334 Anks6 ankyrin repeat and sterile alpha motif domain containing 6 gene MP:0005565 increased blood urea nitrogen level IAGP N RGD:1300446|PMID:7933831 20210211 RGD compared to PKD 3343 Plau plasminogen activator, urokinase gene MP:0000598 abnormal liver morphology treatment IMP N RGD:7241553|PMID:23018346 20180109 RGD 3344 Plcb1 phospholipase C beta 1 gene MP:0003360 abnormal depression-related behavior IDA N RGD:1582557|PMID:15536495 20061113 RGD 3350 Pld2 phospholipase D2 gene MP:0002975 vascular smooth muscle hypertrophy IDA N RGD:1642674|PMID:16113073 20071008 RGD angiotensin II induced 3354 Plp1 proteolipid protein 1 gene MP:0000745 tremors IAGP N RGD:1358781|PMID:2479544 19990101 RGD 3354 Plp1 proteolipid protein 1 gene MP:0000745 tremors IAGP N RGD:1358782|PMID:434110 19990101 RGD 3354 Plp1 proteolipid protein 1 gene MP:0002083 premature death IAGP N RGD:1358781|PMID:2479544 19990101 RGD 3354 Plp1 proteolipid protein 1 gene MP:0002083 premature death IAGP N RGD:1358782|PMID:434110 19990101 RGD 3358 Pmch pro-melanin-concentrating hormone gene MP:0001783 decreased white adipose tissue amount IMP N RGD:150429945|PMID:19934402 20211021 RGD 3358 Pmch pro-melanin-concentrating hormone gene MP:0003402 decreased liver weight IMP N RGD:150429945|PMID:19934402 20211021 RGD 3358 Pmch pro-melanin-concentrating hormone gene MP:0003961 decreased lean body mass IMP N RGD:150429945|PMID:19934402 20211021 RGD 3358 Pmch pro-melanin-concentrating hormone gene MP:0004890 decreased energy expenditure IMP N RGD:150429945|PMID:19934402 20211021 RGD 3358 Pmch pro-melanin-concentrating hormone gene MP:0004956 decreased thymus weight induces IMP XCO:0000030 N RGD:150429945|PMID:19934402 20211021 RGD 3358 Pmch pro-melanin-concentrating hormone gene MP:0005668 decreased circulating leptin level IMP N RGD:150429944|PMID:23555928 20211014 RGD compared to wild-type 3358 Pmch pro-melanin-concentrating hormone gene MP:0005668 decreased circulating leptin level IMP N RGD:150429945|PMID:19934402 20211021 RGD 3358 Pmch pro-melanin-concentrating hormone gene MP:0009133 decreased white fat cell size IMP N RGD:150429944|PMID:23555928 20220512 RGD 3358 Pmch pro-melanin-concentrating hormone gene MP:0011940 decreased food intake IMP N RGD:150429945|PMID:19934402 20211021 RGD 3358 Pmch pro-melanin-concentrating hormone gene MP:0012311 decreased defecation amount IMP N RGD:150429945|PMID:19934402 20211021 RGD 3358 Pmch pro-melanin-concentrating hormone gene MP:0014143 decreased body fat mass IMP N RGD:150429944|PMID:23555928 20211014 RGD compared to wild-type 3358 Pmch pro-melanin-concentrating hormone gene MP:0014143 decreased body fat mass IMP N RGD:150429945|PMID:19934402 20211021 RGD 3358 Pmch pro-melanin-concentrating hormone gene MP:0014146 decreased white adipose tissue mass IMP N RGD:150429944|PMID:23555928 20211014 RGD compared to wild-type 3358 Pmch pro-melanin-concentrating hormone gene MP:0014169 decreased brown adipose tissue mass IMP N RGD:150429944|PMID:23555928 20211014 RGD compared to wild-type 3358 Pmch pro-melanin-concentrating hormone gene MP:0021022 decreased adipose tissue noradrenaline turnover IMP N RGD:150429944|PMID:23555928 20220512 RGD 3371 Pparg peroxisome proliferator-activated receptor gamma gene MP:0002981 increased liver weight induces IAGP XCO:0000025 N RGD:127285618|PMID:27381370 20220113 RGD 3371 Pparg peroxisome proliferator-activated receptor gamma gene MP:0005293 impaired glucose tolerance IAGP N RGD:127285618|PMID:27381370 20220113 RGD compared to wild type rats 3371 Pparg peroxisome proliferator-activated receptor gamma gene MP:0005331 insulin resistance induces IAGP XCO:0000025 N RGD:127285618|PMID:27381370 20220113 RGD compared to wild type rats 3371 Pparg peroxisome proliferator-activated receptor gamma gene MP:0006094 increased fat cell size IAGP N RGD:127285618|PMID:27381370 20220113 RGD 3371 Pparg peroxisome proliferator-activated receptor gamma gene MP:0008907 decreased total fat pad weight induces IAGP XCO:0000069 N RGD:127285618|PMID:27381370 20220113 RGD compared to wild type rats 3371 Pparg peroxisome proliferator-activated receptor gamma gene MP:0009289 decreased epididymal fat pad weight IAGP N RGD:127285618|PMID:27381370 20220113 RGD 3371 Pparg peroxisome proliferator-activated receptor gamma gene MP:0009355 increased liver triglyceride level IAGP N RGD:127285618|PMID:27381370 20220113 RGD 3371 Pparg peroxisome proliferator-activated receptor gamma gene MP:0010238 increased skeletal muscle weight induces IAGP XCO:0000025 N RGD:127285618|PMID:27381370 20220113 RGD 3371 Pparg peroxisome proliferator-activated receptor gamma gene MP:0011168 abnormal fat cell differentiation IAGP N RGD:127285618|PMID:27381370 20220113 RGD 3382 Ppp3ca protein phosphatase 3 catalytic subunit alpha gene MP:0001625 cardiac hypertrophy IDA N RGD:1580700|PMID:16799071 19990101 RGD 3383 Ppp3cb protein phosphatase 3 catalytic subunit beta gene MP:0001625 cardiac hypertrophy IDA N RGD:1580703|PMID:16496058 19990101 RGD 3392 Prkar1b protein kinase cAMP-dependent type I regulatory subunit beta gene MP:0001473 reduced long-term potentiation IMP N RGD:150519900|PMID:33479380 20211021 RGD 3392 Prkar1b protein kinase cAMP-dependent type I regulatory subunit beta gene MP:0001973 increased thermal nociceptive threshold IMP N RGD:150519900|PMID:33479380 20211021 RGD 3392 Prkar1b protein kinase cAMP-dependent type I regulatory subunit beta gene MP:0002574 increased vertical activity IMP N RGD:150519900|PMID:33479380 20211021 RGD 3392 Prkar1b protein kinase cAMP-dependent type I regulatory subunit beta gene MP:0002912 abnormal excitatory postsynaptic potential IMP N RGD:150519900|PMID:33479380 20211021 RGD 3392 Prkar1b protein kinase cAMP-dependent type I regulatory subunit beta gene MP:0020422 decreased freezing behavior IMP N RGD:150519900|PMID:33479380 20211021 RGD 3399 Prkcz protein kinase C, zeta gene MP:0002805 abnormal conditioned taste aversion behavior IDA N RGD:1642657|PMID:17702943 20071005 RGD inhibition eliminates long term memory of taste aversion stimulus 3399 Prkcz protein kinase C, zeta gene MP:0002975 vascular smooth muscle hypertrophy IDA N RGD:1642674|PMID:16113073 20071008 RGD angiotensin II induced 3399 Prkcz protein kinase C, zeta gene MP:0003008 enhanced long-term potentiation IDA N RGD:1642696|PMID:15728837 20071009 RGD normal enhancement of long-term potentiation 3401 Prkg2 protein kinase cGMP-dependent 2 gene MP:0000165 abnormal long bone hypertrophic chondrocyte zone IAGP N RGD:150429792|PMID:15466490 20210929 RGD DNA:deletion:cds (rat) 3401 Prkg2 protein kinase cGMP-dependent 2 gene MP:0000592 short tail IAGP N RGD:150429793|PMID:19149413 20210929 RGD DNA:deletion:cds (rat) 3401 Prkg2 protein kinase cGMP-dependent 2 gene MP:0001258 decreased body length IAGP N RGD:150429793|PMID:19149413 20210929 RGD DNA:deletion:cds (rat) 3401 Prkg2 protein kinase cGMP-dependent 2 gene MP:0001262 decreased body weight IAGP N RGD:150429793|PMID:19149413 20210929 RGD DNA:deletion:cds (rat) 3401 Prkg2 protein kinase cGMP-dependent 2 gene MP:0001732 postnatal growth retardation IAGP N RGD:150429792|PMID:15466490 20210929 RGD DNA:deletion:cds (rat) 3401 Prkg2 protein kinase cGMP-dependent 2 gene MP:0001732 postnatal growth retardation IAGP N RGD:150429793|PMID:19149413 20210929 RGD DNA:deletion:cds (rat) 3401 Prkg2 protein kinase cGMP-dependent 2 gene MP:0002999 abnormal bone healing IAGP N RGD:150429792|PMID:15466490 20210929 RGD DNA:deletion:cds (rat) 3401 Prkg2 protein kinase cGMP-dependent 2 gene MP:0006398 increased long bone epiphyseal plate size IAGP N RGD:150429792|PMID:15466490 20210929 RGD DNA:deletion:cds (rat) 3401 Prkg2 protein kinase cGMP-dependent 2 gene MP:0008272 abnormal endochondral bone ossification IAGP N RGD:150429793|PMID:19149413 20210929 RGD DNA:deletion:cds (rat) 3401 Prkg2 protein kinase cGMP-dependent 2 gene MP:0009305 decreased retroperitoneal fat pad weight IAGP N RGD:150429793|PMID:19149413 20210929 RGD DNA:deletion:cds (rat) 3401 Prkg2 protein kinase cGMP-dependent 2 gene MP:0030315 small neurocranium IAGP N RGD:150429793|PMID:19149413 20210929 RGD DNA:deletion:cds (rat) 3419 Klk6 kallikrein related-peptidase 6 gene MP:0000921 demyelination IAGP N RGD:1358596|PMID:12023317 19990101 RGD 3425 Psen1 presenilin 1 gene MP:0006042 increased apoptosis IDA N RGD:1304239|PMID:11895366 19990101 RGD 3553 Reln reelin gene MP:0001392 abnormal locomotor behavior IAGP N RGD:729917|PMID:12820163 20100429 RGD 3554 Ren renin gene MP:0001262 decreased body weight IMP N RGD:7771614|PMID:21242461 20220203 RGD compared to wild type 3554 Ren renin gene MP:0002135 abnormal kidney morphology exacerbates IMP N RGD:7771614|PMID:21242461 20220203 RGD compared to wild type 3554 Ren renin gene MP:0002626 increased heart rate IMP N RGD:7771614|PMID:21242461 20220203 RGD compared to wild type 3554 Ren renin gene MP:0002842 increased systemic arterial blood pressure IAGP N RGD:61046|PMID:8567976 19990101 RGD 3554 Ren renin gene MP:0002871 albuminuria IAGP N RGD:12802368|PMID:23817491 20170406 RGD 3554 Ren renin gene MP:0002941 increased circulating alanine transaminase level IMP N RGD:7771614|PMID:21242461 20220203 RGD compared to wild type 3554 Ren renin gene MP:0002963 decreased urine protein level IMP N RGD:7771614|PMID:21242461 20220203 RGD compared to wild type 3554 Ren renin gene MP:0003017 decreased circulating bicarbonate level IMP N RGD:7771614|PMID:21242461 20220203 RGD compared to wild type 3554 Ren renin gene MP:0004217 salt-sensitive hypertension IAGP N RGD:12802368|PMID:23817491 20170406 RGD 3554 Ren renin gene MP:0004876 decreased mean systemic arterial blood pressure IMP N RGD:7771614|PMID:21242461 20220203 RGD compared to wild type 3554 Ren renin gene MP:0004876 decreased mean systemic arterial blood pressure sexual_dimorphism IMP N RGD:7771614|PMID:21242461 20220203 RGD compared to wild type male 3554 Ren renin gene MP:0005553 increased circulating creatinine level IMP N RGD:7771614|PMID:21242461 20220203 RGD compared to wild type 3554 Ren renin gene MP:0005558 decreased creatinine clearance IMP N RGD:7771614|PMID:21242461 20220203 RGD compared to wild type 3554 Ren renin gene MP:0005565 increased blood urea nitrogen level IMP N RGD:7771614|PMID:21242461 20220203 RGD 3554 Ren renin gene MP:0006263 decreased systemic arterial diastolic blood pressure IMP N RGD:7771614|PMID:21242461 20220203 RGD compared to wild type 3554 Ren renin gene MP:0006263 decreased systemic arterial diastolic blood pressure sexual_dimorphism IMP N RGD:7771614|PMID:21242461 20220203 RGD compared to wild type male 3554 Ren renin gene MP:0006264 decreased systemic arterial systolic blood pressure IMP N RGD:7771614|PMID:21242461 20220203 RGD compared to wild type 3554 Ren renin gene MP:0006264 decreased systemic arterial systolic blood pressure sexual_dimorphism IMP N RGD:7771614|PMID:21242461 20220203 RGD compared to wild type male 3554 Ren renin gene MP:0011431 increased urine flow rate IMP N RGD:7771614|PMID:21242461 20220203 RGD compared to wild type 3554 Ren renin gene MP:0011471 decreased urine creatinine level IMP N RGD:7771614|PMID:21242461 20220203 RGD compared to wild type 3555 Resp18 regulated endocrine-specific protein 18 gene MP:0002962 increased urine protein level IMP N RGD:14348960|PMID:29570433 20190201 RGD 3555 Resp18 regulated endocrine-specific protein 18 gene MP:0004217 salt-sensitive hypertension IMP N RGD:14348960|PMID:29570433 20190201 RGD 35668861 LEW-Tg(HLA-B*2705,B2M)Tg/021-3Reh strain MP:0001150 enlarged scrotum sexual_dimorphism IAGP N RGD:25671476|PMID:22488218 20200709 RGD in males 35668863 LEW-Tg(HLA-B*2705,B2M)21-3RehTg/Tg strain MP:0001150 enlarged scrotum sexual_dimorphism IAGP N RGD:25671476|PMID:22488218 20200709 RGD in males 35668863 LEW-Tg(HLA-B*2705,B2M)21-3RehTg/Tg strain MP:0005036 diarrhea IAGP N RGD:25671476|PMID:22488218 19990101 RGD 35668863 LEW-Tg(HLA-B*2705,B2M)21-3RehTg/Tg strain MP:0020242 increased autopod size IAGP N RGD:25671476|PMID:22488218 20200709 RGD 3684 Slc11a2 solute carrier family 11 member 2 gene MP:0005637 abnormal iron homeostasis IAGP N RGD:1580428|PMID:14675167 19990101 RGD 3684 Slc11a2 solute carrier family 11 member 2 gene MP:0005637 abnormal iron homeostasis IAGP N RGD:729808|PMID:9448300 19990101 RGD 3714 Slc6a4 solute carrier family 6 member 4 gene MP:0001363 increased anxiety-related response IMP N RGD:4889509|PMID:18295409 20210527 RGD compared to wild type littermate 3714 Slc6a4 solute carrier family 6 member 4 gene MP:0003026 decreased vasoconstriction IMP N RGD:4889513|PMID:18263707 20101203 RGD 3714 Slc6a4 solute carrier family 6 member 4 gene MP:0008911 induced hyperactivity induces IMP XCO:0001017 N RGD:4889490|PMID:18581099 20231221 RGD compared to wild type littermate 3714 Slc6a4 solute carrier family 6 member 4 gene MP:0009676 abnormal hemostasis IMP N RGD:4889487|PMID:19246633 20101202 RGD 3714 Slc6a4 solute carrier family 6 member 4 gene MP:0009710 anhedonia IMP N RGD:4889509|PMID:18295409 20210527 RGD compared to wild type littermate 3714 Slc6a4 solute carrier family 6 member 4 gene MP:0009713 enhanced conditioned place preference behavior IMP N RGD:4889490|PMID:18581099 20231221 RGD compared to wild type littermate 3714 Slc6a4 solute carrier family 6 member 4 gene MP:0009754 enhanced behavioral response to cocaine IMP N RGD:4889490|PMID:18581099 20101202 RGD 3714 Slc6a4 solute carrier family 6 member 4 gene MP:0010070 decreased serotonin level IMP N RGD:4889487|PMID:19246633 20101202 RGD 3714 Slc6a4 solute carrier family 6 member 4 gene MP:0010166 increased response to stress-induced hyperthermia IMP N RGD:4889490|PMID:18581099 20101202 RGD 3714 Slc6a4 solute carrier family 6 member 4 gene MP:0020523 decreased susceptibility to induced hypothermia IMP N RGD:4889490|PMID:18581099 20231221 RGD compared to wild type littermate 3714 Slc6a4 solute carrier family 6 member 4 gene MP:0020905 abnormal cocaine self-administration IMP N RGD:401938631|PMID:30144237 20240104 RGD 3714 Slc6a4 solute carrier family 6 member 4 gene MP:0020906 abnormal acquisiton of operant behavior for a cocaine reinforcer IMP N RGD:4889490|PMID:18581099 20231221 RGD compared to wild type littermate 3729 Snca synuclein alpha gene MP:0008236 decreased susceptibility to neuronal excitotoxicity IMP N RGD:13506279|PMID:16837598 20230412 RGD 3733 Sod3 superoxide dismutase 3 gene MP:0001613 abnormal vasodilation IMP N RGD:38548929|PMID:24322611 20200827 RGD DNA:missense mutation:CDS:p.E124D 3733 Sod3 superoxide dismutase 3 gene MP:0002625 heart left ventricle hypertrophy IMP N RGD:150573712|PMID:31972339 20220113 RGD compared to SS/JrHsdMcwi 3733 Sod3 superoxide dismutase 3 gene MP:0003025 increased vasoconstriction IMP N RGD:38548929|PMID:24322611 20200827 RGD XCO:0000145;DNA:missense mutation:cds:p.E124D 3733 Sod3 superoxide dismutase 3 gene MP:0003215 renal interstitial fibrosis onset IMP N RGD:150573712|PMID:31972339 20220113 RGD compared to SS/JrHsdMcwi 3733 Sod3 superoxide dismutase 3 gene MP:0003674 oxidative stress onset IMP N RGD:150573712|PMID:31972339 20220113 RGD compared to SS/JrHsdMcwi 3733 Sod3 superoxide dismutase 3 gene MP:0003985 renal fibrosis onset IMP N RGD:150573712|PMID:31972339 20220113 RGD compared to SS/JrHsdMcwi 3733 Sod3 superoxide dismutase 3 gene MP:0004875 increased mean systemic arterial blood pressure onset IMP N RGD:150573712|PMID:31972339 20220113 RGD compared to SS/JrHsdMcwi 3733 Sod3 superoxide dismutase 3 gene MP:0005264 glomerulosclerosis onset IMP N RGD:150573712|PMID:31972339 20220113 RGD compared to SS/JrHsdMcwi 3733 Sod3 superoxide dismutase 3 gene MP:0005553 increased circulating creatinine level onset IMP N RGD:150573712|PMID:31972339 20220113 RGD compared to SS/JrHsdMcwi 3733 Sod3 superoxide dismutase 3 gene MP:0005590 increased vasodilation IMP N RGD:38548929|PMID:24322611 20210415 RGD compared to SS/JrHsdMcwi;DNA:missense mutation:CDS:p.E124D 3733 Sod3 superoxide dismutase 3 gene MP:0005591 decreased vasodilation IMP N RGD:38548929|PMID:24322611 20210415 RGD compared to SS/JrHsdMcwi;DNA:missense mutation:cds:p.E124D 3733 Sod3 superoxide dismutase 3 gene MP:0006143 increased systemic arterial diastolic blood pressure onset IMP N RGD:150573712|PMID:31972339 20220113 RGD compared to SS/JrHsdMcwi 3733 Sod3 superoxide dismutase 3 gene MP:0006144 increased systemic arterial systolic blood pressure onset IMP N RGD:150573712|PMID:31972339 20220113 RGD compared to SS/JrHsdMcwi 3733 Sod3 superoxide dismutase 3 gene MP:0011377 renal glomerulus fibrosis onset IMP N RGD:150573712|PMID:31972339 20220113 RGD compared to SS/JrHsdMcwi 3733 Sod3 superoxide dismutase 3 gene MP:0011402 renal cast onset IMP N RGD:150573712|PMID:31972339 20220113 RGD compared to SS/JrHsdMcwi 3733 Sod3 superoxide dismutase 3 gene MP:0011939 increased food intake IMP N RGD:150573712|PMID:31972339 20220113 RGD compared to SS/JrHsdMcwi 3733 Sod3 superoxide dismutase 3 gene MP:0011941 increased fluid intake IMP N RGD:150573712|PMID:31972339 20220113 RGD compared to SS/JrHsdMcwi 3733 Sod3 superoxide dismutase 3 gene MP:0012659 decreased superoxide dismutase level IMP N RGD:14369425|PMID:21730301 20220127 RGD in lung 3733 Sod3 superoxide dismutase 3 gene MP:0012659 decreased superoxide dismutase level onset IMP N RGD:150573712|PMID:31972339 20220113 RGD compared to SS/JrHsdMcwi 3786 Abcc8 ATP binding cassette subfamily C member 8 gene MP:0001262 decreased body weight IMP N RGD:150573710|PMID:30616503 20220113 RGD compared to wild type 3786 Abcc8 ATP binding cassette subfamily C member 8 gene MP:0002891 increased insulin sensitivity induces IMP XCO:0000245 N RGD:150573710|PMID:30616503 20220113 RGD 3786 Abcc8 ATP binding cassette subfamily C member 8 gene MP:0003059 decreased insulin secretion IMP N RGD:150573710|PMID:30616503 20220113 RGD compared to wild type 3786 Abcc8 ATP binding cassette subfamily C member 8 gene MP:0005293 impaired glucose tolerance IAGP N RGD:150573710|PMID:30616503 20220113 RGD compared to wild type 3786 Abcc8 ATP binding cassette subfamily C member 8 gene MP:0008489 slow postnatal weight gain IMP N RGD:150573710|PMID:30616503 20220113 RGD compared to wild type male 3786 Abcc8 ATP binding cassette subfamily C member 8 gene MP:0010400 increased liver glycogen level IMP N RGD:150573710|PMID:30616503 20220113 RGD compared to wild type 3786 Abcc8 ATP binding cassette subfamily C member 8 gene MP:0010401 increased skeletal muscle glycogen level IMP N RGD:150573710|PMID:30616503 20220113 RGD compared to wild type 3786 Abcc8 ATP binding cassette subfamily C member 8 gene MP:0013278 decreased fasting circulating glucose level IAGP N RGD:150573710|PMID:30616503 20220113 RGD compared to wild type 3804 Syt2 synaptotagmin 2 gene MP:0002871 albuminuria IAGP N RGD:12802369|PMID:23460292 20170407 RGD 3804 Syt2 synaptotagmin 2 gene MP:0004217 salt-sensitive hypertension IAGP N RGD:12802369|PMID:23460292 20170407 RGD 38456008 LOU/C strain MP:0002023 increased B cell derived lymphoma incidence susceptibility IAGP N RGD:634815|PMID:902252 20111114 RGD 3848 Tg thyroglobulin gene MP:0001262 decreased body weight IAGP N RGD:13605608|PMID:10760744 20201210 RGD 3848 Tg thyroglobulin gene MP:0001262 decreased body weight IAGP N RGD:730133|PMID:11089535 20210929 RGD DNA:missense mutation:cds:p.G2320R (rat) 3848 Tg thyroglobulin gene MP:0003351 decreased circulating levels of thyroid hormone IAGP N RGD:13605608|PMID:10760744 20201210 RGD 3848 Tg thyroglobulin gene MP:0005135 increased thyroid-stimulating hormone level IAGP N RGD:13605608|PMID:10760744 20201210 RGD 3848 Tg thyroglobulin gene MP:0008321 small adenohypophysis IAGP N RGD:12880373|PMID:3366187 20170503 RGD 3848 Tg thyroglobulin gene MP:0008321 small adenohypophysis IAGP N RGD:730133|PMID:11089535 20170503 RGD 3848 Tg thyroglobulin gene MP:0009378 abnormal endoplasmic reticulum morphology IAGP N RGD:730133|PMID:11089535 20210929 RGD DNA:missense mutation:cds:p.G2320R (rat) 3848 Tg thyroglobulin gene MP:0020168 decreased thyroid gland weight IAGP N RGD:13605608|PMID:10760744 20201210 RGD 3848 Tg thyroglobulin gene MP:0020354 increased endoplasmic reticulum stress IAGP N RGD:730133|PMID:11089535 20210929 RGD DNA:missense mutation:cds:p.G2320R (rat) 38501060 SD-Cpem1Ang+/- strain MP:0006349 decreased circulating copper level IMP N RGD:38549582|PMID:31560858 20200902 RGD 38501060 SD-Cpem1Ang+/- strain MP:0012661 decreased circulating ceruloplasmin level IMP N RGD:38549582|PMID:31560858 20200902 RGD 38501061 SD-Cpem1Ang-/- strain MP:0004151 decreased circulating iron level IMP N RGD:38549582|PMID:31560858 20200902 RGD 38501061 SD-Cpem1Ang-/- strain MP:0006349 decreased circulating copper level IMP N RGD:38549582|PMID:31560858 20200902 RGD compared to SD-Cpem1Ang+/- and wild-type 38501061 SD-Cpem1Ang-/- strain MP:0008807 increased liver iron level IMP N RGD:38549582|PMID:31560858 20200902 RGD 38501061 SD-Cpem1Ang-/- strain MP:0008808 decreased spleen iron level IMP N RGD:38549582|PMID:31560858 20200902 RGD 38501061 SD-Cpem1Ang-/- strain MP:0011896 increased circulating unsaturated transferrin level IMP N RGD:38549582|PMID:31560858 20200902 RGD 38501061 SD-Cpem1Ang-/- strain MP:0012661 decreased circulating ceruloplasmin level IMP N RGD:38549582|PMID:31560858 20200902 RGD compared to SD-Cpem1Ang+/- and wild-type 38501061 SD-Cpem1Ang-/- strain MP:0030601 increased circulating manganese level IMP N RGD:38549582|PMID:31560858 20200902 RGD 38501062 Cpem1Ang ceruloplasmin; CRISPR/Cas9 induced mutant1, Ang gene MP:0004151 decreased circulating iron level IMP N RGD:38549582|PMID:31560858 20200902 RGD 38501062 Cpem1Ang ceruloplasmin; CRISPR/Cas9 induced mutant1, Ang gene MP:0006349 decreased circulating copper level IMP N RGD:38549582|PMID:31560858 20200902 RGD 38501062 Cpem1Ang ceruloplasmin; CRISPR/Cas9 induced mutant1, Ang gene MP:0008807 increased liver iron level IMP N RGD:38549582|PMID:31560858 20200902 RGD 38501062 Cpem1Ang ceruloplasmin; CRISPR/Cas9 induced mutant1, Ang gene MP:0008808 decreased spleen iron level IMP N RGD:38549582|PMID:31560858 20200902 RGD 38501062 Cpem1Ang ceruloplasmin; CRISPR/Cas9 induced mutant1, Ang gene MP:0011896 increased circulating unsaturated transferrin level IMP N RGD:38549582|PMID:31560858 20200902 RGD 38501062 Cpem1Ang ceruloplasmin; CRISPR/Cas9 induced mutant1, Ang gene MP:0012661 decreased circulating ceruloplasmin level IMP N RGD:38549582|PMID:31560858 20200902 RGD 38501062 Cpem1Ang ceruloplasmin; CRISPR/Cas9 induced mutant1, Ang gene MP:0030601 increased circulating manganese level IMP N RGD:38549582|PMID:31560858 20200902 RGD 38501086 SD-Bmpr2em1Ang+/- strain MP:0002975 vascular smooth muscle hypertrophy IMP N RGD:38500244|PMID:25593290 20200924 RGD 38501087 Bmpr2em1Ang bone morphogenetic protein receptor type 2; ZFN induced mutant 1, Ang gene MP:0002975 vascular smooth muscle hypertrophy IMP N RGD:38500244|PMID:25593290 20200924 RGD 38543943 SD-Rag2em1Hera strain MP:0000692 small spleen IMP N RGD:38508903|PMID:30206106 20200821 RGD 38543943 SD-Rag2em1Hera strain MP:0002021 increased incidence of induced tumors induced IMP XCO:0000709 N RGD:38508903|PMID:30206106 20200821 RGD compared to wild-type and heterozygous 38543943 SD-Rag2em1Hera strain MP:0004956 decreased thymus weight IMP N RGD:38508903|PMID:30206106 20200821 RGD 38543943 SD-Rag2em1Hera strain MP:0005092 decreased double-positive T cell number IMP N RGD:38508903|PMID:30206106 20200821 RGD 38543943 SD-Rag2em1Hera strain MP:0008044 increased NK cell number IMP N RGD:38508903|PMID:30206106 20200821 RGD 38543943 SD-Rag2em1Hera strain MP:0008212 absent mature B cells IMP N RGD:38508903|PMID:30206106 20200821 RGD 38548914 SD-Rag1/Rag2em1Mlit strain MP:0001805 decreased IgG level IMP N RGD:38508906|PMID:29944447 20200821 RGD 38548914 SD-Rag1/Rag2em1Mlit strain MP:0001806 decreased IgM level IMP N RGD:38508906|PMID:29944447 20200821 RGD 38548914 SD-Rag1/Rag2em1Mlit strain MP:0001823 thymus hypoplasia IMP N RGD:38508906|PMID:29944447 20200821 RGD 38548914 SD-Rag1/Rag2em1Mlit strain MP:0002021 increased incidence of induced tumors induced IMP XCO:0000709 N RGD:38508906|PMID:29944447 20200821 RGD compared to wild-type 38548914 SD-Rag1/Rag2em1Mlit strain MP:0004956 decreased thymus weight IMP N RGD:38508906|PMID:29944447 20200821 RGD 38548914 SD-Rag1/Rag2em1Mlit strain MP:0005092 decreased double-positive T cell number IMP N RGD:38508906|PMID:29944447 20200821 RGD 38548914 SD-Rag1/Rag2em1Mlit strain MP:0005232 abnormal mesenteric lymph node morphology IMP N RGD:38508906|PMID:29944447 20200821 RGD 38548914 SD-Rag1/Rag2em1Mlit strain MP:0008044 increased NK cell number IMP N RGD:38508906|PMID:29944447 20200821 RGD 38548914 SD-Rag1/Rag2em1Mlit strain MP:0008083 decreased single-positive T cell number IMP N RGD:38508906|PMID:29944447 20200821 RGD 38548915 SD-Il2rgem1-/y/Mlit strain MP:0001805 decreased IgG level IMP N RGD:38508906|PMID:29944447 20200821 RGD 38548915 SD-Il2rgem1-/y/Mlit strain MP:0001806 decreased IgM level IMP N RGD:38508906|PMID:29944447 20200821 RGD 38548915 SD-Il2rgem1-/y/Mlit strain MP:0001807 decreased IgA level IMP N RGD:38508906|PMID:29944447 20200821 RGD 38548915 SD-Il2rgem1-/y/Mlit strain MP:0001823 thymus hypoplasia IMP N RGD:38508906|PMID:29944447 20200821 RGD 38548915 SD-Il2rgem1-/y/Mlit strain MP:0002021 increased incidence of induced tumors induced IMP XCO:0000709 N RGD:38508906|PMID:29944447 20200821 RGD compared to wild-type 38548915 SD-Il2rgem1-/y/Mlit strain MP:0004956 decreased thymus weight IMP N RGD:38508906|PMID:29944447 20200821 RGD 38548915 SD-Il2rgem1-/y/Mlit strain MP:0005092 decreased double-positive T cell number IMP N RGD:38508906|PMID:29944447 20200821 RGD 38548915 SD-Il2rgem1-/y/Mlit strain MP:0005232 abnormal mesenteric lymph node morphology IMP N RGD:38508906|PMID:29944447 20200821 RGD 38548915 SD-Il2rgem1-/y/Mlit strain MP:0008045 decreased NK cell number IMP N RGD:38508906|PMID:29944447 20200821 RGD 38548915 SD-Il2rgem1-/y/Mlit strain MP:0008083 decreased single-positive T cell number IMP N RGD:38508906|PMID:29944447 20200821 RGD 38548916 SD-Rag1/Rag2em1MlitIl2rgem1Mlit-/y strain MP:0001805 decreased IgG level IMP N RGD:38508906|PMID:29944447 20200821 RGD 38548916 SD-Rag1/Rag2em1MlitIl2rgem1Mlit-/y strain MP:0001806 decreased IgM level IMP N RGD:38508906|PMID:29944447 20200821 RGD 38548916 SD-Rag1/Rag2em1MlitIl2rgem1Mlit-/y strain MP:0001807 decreased IgA level IMP N RGD:38508906|PMID:29944447 20200821 RGD 38548916 SD-Rag1/Rag2em1MlitIl2rgem1Mlit-/y strain MP:0001823 thymus hypoplasia IMP N RGD:38508906|PMID:29944447 20200821 RGD 38548916 SD-Rag1/Rag2em1MlitIl2rgem1Mlit-/y strain MP:0002021 increased incidence of induced tumors induced IMP XCO:0000709 N RGD:38508906|PMID:29944447 20200821 RGD compared to wild-type 38548916 SD-Rag1/Rag2em1MlitIl2rgem1Mlit-/y strain MP:0004956 decreased thymus weight IMP N RGD:38508906|PMID:29944447 20200821 RGD 38548916 SD-Rag1/Rag2em1MlitIl2rgem1Mlit-/y strain MP:0005092 decreased double-positive T cell number IMP N RGD:38508906|PMID:29944447 20200821 RGD 38548916 SD-Rag1/Rag2em1MlitIl2rgem1Mlit-/y strain MP:0005232 abnormal mesenteric lymph node morphology IMP N RGD:38508906|PMID:29944447 20200821 RGD 38548916 SD-Rag1/Rag2em1MlitIl2rgem1Mlit-/y strain MP:0008045 decreased NK cell number IMP N RGD:38508906|PMID:29944447 20200821 RGD 38548916 SD-Rag1/Rag2em1MlitIl2rgem1Mlit-/y strain MP:0008083 decreased single-positive T cell number IMP N RGD:38508906|PMID:29944447 20200821 RGD 38548927 HsdCpb:WU Wistar Wu Rat strain MP:0000221 decreased leukocyte cell number induces IAGP XCO:0000641 N RGD:24922219|PMID:22258067 20210713 RGD compared to control 38548927 HsdCpb:WU Wistar Wu Rat strain MP:0003215 renal interstitial fibrosis induced IAGP XCO:0000114 N RGD:25314248|PMID:20864942 20210324 RGD compared to WU-sham 38548927 HsdCpb:WU Wistar Wu Rat strain MP:0003215 renal interstitial fibrosis treatment IAGP XCO:0000114,XCO:0000548 N RGD:25314248|PMID:20864942 20210324 RGD compared to WU-sham and MWF-Nx-ACEI 38548927 HsdCpb:WU Wistar Wu Rat strain MP:0003916 decreased heart left ventricle weight treatment IAGP XCO:0000114,XCO:0000548 N RGD:25314248|PMID:20864942 20210325 RGD compared to WU-Nx and MWF-Nx-ACEI 38548927 HsdCpb:WU Wistar Wu Rat strain MP:0005264 glomerulosclerosis induced IAGP XCO:0000114 N RGD:25314248|PMID:20864942 20210324 RGD compared to WU-sham 38548927 HsdCpb:WU Wistar Wu Rat strain MP:0005264 glomerulosclerosis treatment IAGP XCO:0000114,XCO:0000548 N RGD:25314248|PMID:20864942 20210324 RGD compared to WU-Nx and MWF-Nx-ACEI 38548927 HsdCpb:WU Wistar Wu Rat strain MP:0005522 increased circulating atrial natriuretic factor treatment IAGP XCO:0000114,XCO:0000548 N RGD:25314248|PMID:20864942 20210325 RGD compared to WU-Nx and MWF-Nx-ACEI 38548927 HsdCpb:WU Wistar Wu Rat strain MP:0005557 increased creatinine clearance treatment IAGP XCO:0000114,XCO:0000548 N RGD:25314248|PMID:20864942 20210324 RGD compared to WU-sham and WU-Nx 38548927 HsdCpb:WU Wistar Wu Rat strain MP:0005600 increased heart ventricle muscle contractility treatment IAGP XCO:0000114,XCO:0000548 N RGD:25314248|PMID:20864942 20210324 RGD compared to WU-Nx and WU-sham 38548927 HsdCpb:WU Wistar Wu Rat strain MP:0005608 cardiac interstitial fibrosis treatment IAGP XCO:0000114,XCO:0000548 N RGD:25314248|PMID:20864942 20210324 RGD compared to WU-Nx 38548927 HsdCpb:WU Wistar Wu Rat strain MP:0006264 decreased systemic arterial systolic blood pressure treatment IAGP XCO:0000114,XCO:0000548 N RGD:25314248|PMID:20864942 20210325 RGD compared to WU-Nx and MWF-Nx-ACEI 38548927 HsdCpb:WU Wistar Wu Rat strain MP:0020418 increased cardiac muscle relaxation treatment IAGP XCO:0000114,XCO:0000548 N RGD:25314248|PMID:20864942 20210324 RGD compared to WU-Nx, MWF-Nx-ACEI and WU-sham 38549356 SD-Defb23em2MlitDefb26em2Mlit strain MP:0001935 decreased litter size IMP N RGD:13782190|PMID:29141997 20200831 RGD 38549356 SD-Defb23em2MlitDefb26em2Mlit strain MP:0003666 impaired sperm capacitation IMP N RGD:13782190|PMID:29141997 20200831 RGD 38549356 SD-Defb23em2MlitDefb26em2Mlit strain MP:0013288 premature acrosome reaction IMP N RGD:13782190|PMID:29141997 20200831 RGD 38549356 SD-Defb23em2MlitDefb26em2Mlit strain MP:0020451 decreased sperm progressive motility IMP N RGD:13782190|PMID:29141997 20200831 RGD 38549357 SD-Defb23em2MlitDefb26em2MlitDefb42em1Mlit strain MP:0001935 decreased litter size IMP N RGD:13782190|PMID:29141997 20200831 RGD 38549357 SD-Defb23em2MlitDefb26em2MlitDefb42em1Mlit strain MP:0003666 impaired sperm capacitation IMP N RGD:13782190|PMID:29141997 20200831 RGD 38549357 SD-Defb23em2MlitDefb26em2MlitDefb42em1Mlit strain MP:0013288 premature acrosome reaction IMP N RGD:13782190|PMID:29141997 20200831 RGD 38549357 SD-Defb23em2MlitDefb26em2MlitDefb42em1Mlit strain MP:0020451 decreased sperm progressive motility IMP N RGD:13782190|PMID:29141997 20200831 RGD 38596327 WI-Tbc1d4em1Gdcz strain MP:0005293 impaired glucose tolerance induced IMP XCO:0000103 N RGD:38596323|PMID:32053588 20200903 RGD 38596327 WI-Tbc1d4em1Gdcz strain MP:0005293 impaired glucose tolerance induced IMP XCO:0000103 N RGD:38596332|PMID:31034517 20200903 RGD 38596327 WI-Tbc1d4em1Gdcz strain MP:0005331 insulin resistance induced IMP XCO:0000103 N RGD:38596323|PMID:32053588 20200903 RGD compared to female wild-type 38596330 Tbc1d4em1 TBC1 domain family, member 4; CRISPR/Cas9 system induced mutant 1, gene MP:0005293 impaired glucose tolerance IMP N RGD:38596323|PMID:32053588 20200903 RGD 38596330 Tbc1d4em1 TBC1 domain family, member 4; CRISPR/Cas9 system induced mutant 1, gene MP:0005293 impaired glucose tolerance IMP N RGD:38596332|PMID:31034517 20200903 RGD 38596330 Tbc1d4em1 TBC1 domain family, member 4; CRISPR/Cas9 system induced mutant 1, gene MP:0005331 insulin resistance IMP N RGD:38596323|PMID:32053588 20200903 RGD 38596330 Tbc1d4em1 TBC1 domain family, member 4; CRISPR/Cas9 system induced mutant 1, gene MP:0005331 insulin resistance IMP N RGD:38596332|PMID:31034517 20200903 RGD 38596339 SD-Rarres2em1Msu strain MP:0002965 increased circulating serum albumin level sexual_dimorphism IAGP N RGD:38596340|PMID:29906243 20200904 RGD compared to male knockout 38596339 SD-Rarres2em1Msu strain MP:0003025 increased vasoconstriction induced IMP XCO:0000734 N RGD:38596340|PMID:29906243 20200904 RGD compared to wild-type 38596339 SD-Rarres2em1Msu strain MP:0003025 increased vasoconstriction sexual_dimorphism IAGP XCO:0000734 N RGD:38596340|PMID:29906243 20200904 RGD compared to female knockout 38596339 SD-Rarres2em1Msu strain MP:0004875 increased mean systemic arterial blood pressure sexual_dimorphism IMP XCO:0000192,XCO:0000022 N RGD:38596340|PMID:29906243 20200904 RGD compared to male wild-type 38596339 SD-Rarres2em1Msu strain MP:0004876 decreased mean systemic arterial blood pressure sexual_dimorphism IMP XCO:0000192,XCO:0000022 N RGD:38596340|PMID:29906243 20200904 RGD compared to female wild-type 38596339 SD-Rarres2em1Msu strain MP:0005333 decreased heart rate sexual_dimorphism IMP XCO:0000192,XCO:0000022 N RGD:38596340|PMID:29906243 20200904 RGD compared to male wild-type 38596339 SD-Rarres2em1Msu strain MP:0005632 decreased circulating aspartate transaminase level sexual_dimorphism IMP N RGD:38596340|PMID:29906243 20200904 RGD compared to male wild-type 38596339 SD-Rarres2em1Msu strain MP:0006144 increased systemic arterial systolic blood pressure sexual_dimorphism IMP XCO:0000192,XCO:0000022 N RGD:38596340|PMID:29906243 20200904 RGD compared to male wild-type 38596339 SD-Rarres2em1Msu strain MP:0006263 decreased systemic arterial diastolic blood pressure sexual_dimorphism IMP XCO:0000192,XCO:0000022 N RGD:38596340|PMID:29906243 20200904 RGD compared to female wild-type 38596339 SD-Rarres2em1Msu strain MP:0006264 decreased systemic arterial systolic blood pressure sexual_dimorphism IMP XCO:0000192,XCO:0000022 N RGD:38596340|PMID:29906243 20200904 RGD compared to female wild-type 38596339 SD-Rarres2em1Msu strain MP:0006265 increased pulse pressure sexual_dimorphism IMP XCO:0000192,XCO:0000022 N RGD:38596340|PMID:29906243 20200904 RGD compared to male wild-type 38596341 Rarres2em1Msu retinoic acid receptor responder 2; CRISPR/Cas9 induced mutant 1, Msu gene MP:0002965 increased circulating serum albumin level sexual_dimorphism IAGP N RGD:38596340|PMID:29906243 20201210 RGD compared to male knockout 38596341 Rarres2em1Msu retinoic acid receptor responder 2; CRISPR/Cas9 induced mutant 1, Msu gene MP:0002965 increased circulating serum albumin level sexual_dimorphism IMP N RGD:38596340|PMID:29906243 20200904 RGD 38596341 Rarres2em1Msu retinoic acid receptor responder 2; CRISPR/Cas9 induced mutant 1, Msu gene MP:0003025 increased vasoconstriction IMP N RGD:38596340|PMID:29906243 20201210 RGD compared to wild-type 38596341 Rarres2em1Msu retinoic acid receptor responder 2; CRISPR/Cas9 induced mutant 1, Msu gene MP:0003025 increased vasoconstriction sexual_dimorphism IAGP XCO:0000734 N RGD:38596340|PMID:29906243 20201210 RGD compared to female knockout 38596341 Rarres2em1Msu retinoic acid receptor responder 2; CRISPR/Cas9 induced mutant 1, Msu gene MP:0003025 increased vasoconstriction sexual_dimorphism IMP XCO:0000734 N RGD:38596340|PMID:29906243 20200904 RGD 38596341 Rarres2em1Msu retinoic acid receptor responder 2; CRISPR/Cas9 induced mutant 1, Msu gene MP:0004875 increased mean systemic arterial blood pressure sexual_dimorphism IMP N RGD:38596340|PMID:29906243 20200904 RGD 38596341 Rarres2em1Msu retinoic acid receptor responder 2; CRISPR/Cas9 induced mutant 1, Msu gene MP:0004875 increased mean systemic arterial blood pressure sexual_dimorphism IMP XCO:0000192,XCO:0000022 N RGD:38596340|PMID:29906243 20201210 RGD compared to male wild-type 38596341 Rarres2em1Msu retinoic acid receptor responder 2; CRISPR/Cas9 induced mutant 1, Msu gene MP:0004876 decreased mean systemic arterial blood pressure sexual_dimorphism IMP N RGD:38596340|PMID:29906243 20200904 RGD 38596341 Rarres2em1Msu retinoic acid receptor responder 2; CRISPR/Cas9 induced mutant 1, Msu gene MP:0004876 decreased mean systemic arterial blood pressure sexual_dimorphism IMP XCO:0000192,XCO:0000022 N RGD:38596340|PMID:29906243 20201210 RGD compared to female wild-type 38596341 Rarres2em1Msu retinoic acid receptor responder 2; CRISPR/Cas9 induced mutant 1, Msu gene MP:0005333 decreased heart rate sexual_dimorphism IMP N RGD:38596340|PMID:29906243 20200904 RGD 38596341 Rarres2em1Msu retinoic acid receptor responder 2; CRISPR/Cas9 induced mutant 1, Msu gene MP:0005333 decreased heart rate sexual_dimorphism IMP XCO:0000192,XCO:0000022 N RGD:38596340|PMID:29906243 20201210 RGD compared to male wild-type 38596341 Rarres2em1Msu retinoic acid receptor responder 2; CRISPR/Cas9 induced mutant 1, Msu gene MP:0005632 decreased circulating aspartate transaminase level sexual_dimorphism IMP N RGD:38596340|PMID:29906243 20200904 RGD 38596341 Rarres2em1Msu retinoic acid receptor responder 2; CRISPR/Cas9 induced mutant 1, Msu gene MP:0005632 decreased circulating aspartate transaminase level sexual_dimorphism IMP N RGD:38596340|PMID:29906243 20201210 RGD compared to male wild-type 38596341 Rarres2em1Msu retinoic acid receptor responder 2; CRISPR/Cas9 induced mutant 1, Msu gene MP:0006143 increased systemic arterial diastolic blood pressure sexual_dimorphism IMP N RGD:38596340|PMID:29906243 20200904 RGD 38596341 Rarres2em1Msu retinoic acid receptor responder 2; CRISPR/Cas9 induced mutant 1, Msu gene MP:0006144 increased systemic arterial systolic blood pressure sexual_dimorphism IMP N RGD:38596340|PMID:29906243 20200904 RGD 38596341 Rarres2em1Msu retinoic acid receptor responder 2; CRISPR/Cas9 induced mutant 1, Msu gene MP:0006144 increased systemic arterial systolic blood pressure sexual_dimorphism IMP XCO:0000192,XCO:0000022 N RGD:38596340|PMID:29906243 20201210 RGD compared to male wild-type 38596341 Rarres2em1Msu retinoic acid receptor responder 2; CRISPR/Cas9 induced mutant 1, Msu gene MP:0006263 decreased systemic arterial diastolic blood pressure sexual_dimorphism IMP N RGD:38596340|PMID:29906243 20200904 RGD 38596341 Rarres2em1Msu retinoic acid receptor responder 2; CRISPR/Cas9 induced mutant 1, Msu gene MP:0006263 decreased systemic arterial diastolic blood pressure sexual_dimorphism IMP XCO:0000192,XCO:0000022 N RGD:38596340|PMID:29906243 20201210 RGD compared to female wild-type 38596341 Rarres2em1Msu retinoic acid receptor responder 2; CRISPR/Cas9 induced mutant 1, Msu gene MP:0006264 decreased systemic arterial systolic blood pressure sexual_dimorphism IMP N RGD:38596340|PMID:29906243 20200904 RGD 38596341 Rarres2em1Msu retinoic acid receptor responder 2; CRISPR/Cas9 induced mutant 1, Msu gene MP:0006264 decreased systemic arterial systolic blood pressure sexual_dimorphism IMP XCO:0000192,XCO:0000022 N RGD:38596340|PMID:29906243 20201210 RGD compared to female wild-type 38596341 Rarres2em1Msu retinoic acid receptor responder 2; CRISPR/Cas9 induced mutant 1, Msu gene MP:0006265 increased pulse pressure sexual_dimorphism IMP N RGD:38596340|PMID:29906243 20200904 RGD 38596341 Rarres2em1Msu retinoic acid receptor responder 2; CRISPR/Cas9 induced mutant 1, Msu gene MP:0006265 increased pulse pressure sexual_dimorphism IMP XCO:0000192,XCO:0000022 N RGD:38596340|PMID:29906243 20201210 RGD compared to male wild-type 38599014 Defb23em2MlitDefb26em2Mlit defensin beta 23, defensin beta 26; CRISPR/Cas9 induced mutant2, Mlit gene MP:0001935 decreased litter size IMP N RGD:13782190|PMID:29141997 20201210 RGD 38599014 Defb23em2MlitDefb26em2Mlit defensin beta 23, defensin beta 26; CRISPR/Cas9 induced mutant2, Mlit gene MP:0003666 impaired sperm capacitation IMP N RGD:13782190|PMID:29141997 20201210 RGD 38599014 Defb23em2MlitDefb26em2Mlit defensin beta 23, defensin beta 26; CRISPR/Cas9 induced mutant2, Mlit gene MP:0013288 premature acrosome reaction IMP N RGD:13782190|PMID:29141997 20201210 RGD 38599014 Defb23em2MlitDefb26em2Mlit defensin beta 23, defensin beta 26; CRISPR/Cas9 induced mutant2, Mlit gene MP:0020451 decreased sperm progressive motility IMP N RGD:13782190|PMID:29141997 20201210 RGD 38599146 BN-Aireem1Ang-/- strain MP:0000414 alopecia IMP N RGD:38599145|PMID:29959280 20200910 RGD 38599146 BN-Aireem1Ang-/- strain MP:0000703 abnormal thymus morphology IMP N RGD:38599145|PMID:29959280 20200910 RGD 38599146 BN-Aireem1Ang-/- strain MP:0003725 increased autoantibody level IMP N RGD:38599145|PMID:29959280 20200910 RGD 38599146 BN-Aireem1Ang-/- strain MP:0005554 decreased circulating creatinine level IMP N RGD:38599145|PMID:29959280 20200910 RGD 38599146 BN-Aireem1Ang-/- strain MP:0008043 abnormal NK cell number IMP N RGD:38599145|PMID:29959280 20200910 RGD 38599146 BN-Aireem1Ang-/- strain MP:0010016 variable depigmentation IMP N RGD:38599145|PMID:29959280 20200910 RGD 38599146 BN-Aireem1Ang-/- strain MP:0011627 decreased skin pigmentation IMP N RGD:38599145|PMID:29959280 20200910 RGD 38599146 BN-Aireem1Ang-/- strain MP:0012400 nail dystrophy IMP N RGD:38599145|PMID:29959280 20200910 RGD 38599146 BN-Aireem1Ang-/- strain MP:0020242 increased autopod size IMP N RGD:38599145|PMID:29959280 20200910 RGD 38599147 SD.BN-Aireem1Ang-/- strain MP:0000414 alopecia IMP N RGD:38599145|PMID:29959280 20200910 RGD 38599147 SD.BN-Aireem1Ang-/- strain MP:0010016 variable depigmentation IMP N RGD:38599145|PMID:29959280 20200910 RGD 38599147 SD.BN-Aireem1Ang-/- strain MP:0011627 decreased skin pigmentation IMP N RGD:38599145|PMID:29959280 20200910 RGD 38599147 SD.BN-Aireem1Ang-/- strain MP:0012400 nail dystrophy IMP N RGD:38599145|PMID:29959280 20200910 RGD 38599147 SD.BN-Aireem1Ang-/- strain MP:0020242 increased autopod size IMP N RGD:38599145|PMID:29959280 20200910 RGD 38599148 Aireem1Ang autoimmune regulator; ZFN induced mutant1, Ang gene MP:0000414 alopecia IMP N RGD:38599145|PMID:29959280 20200910 RGD 38599148 Aireem1Ang autoimmune regulator; ZFN induced mutant1, Ang gene MP:0000703 abnormal thymus morphology IMP N RGD:38599145|PMID:29959280 20200910 RGD 38599148 Aireem1Ang autoimmune regulator; ZFN induced mutant1, Ang gene MP:0003725 increased autoantibody level IMP N RGD:38599145|PMID:29959280 20200910 RGD 38599148 Aireem1Ang autoimmune regulator; ZFN induced mutant1, Ang gene MP:0005554 decreased circulating creatinine level IMP N RGD:38599145|PMID:29959280 20200910 RGD 38599148 Aireem1Ang autoimmune regulator; ZFN induced mutant1, Ang gene MP:0008043 abnormal NK cell number IMP N RGD:38599145|PMID:29959280 20200910 RGD 38599148 Aireem1Ang autoimmune regulator; ZFN induced mutant1, Ang gene MP:0010016 variable depigmentation IMP N RGD:38599145|PMID:29959280 20200910 RGD 38599148 Aireem1Ang autoimmune regulator; ZFN induced mutant1, Ang gene MP:0011627 decreased skin pigmentation IMP N RGD:38599145|PMID:29959280 20200910 RGD 38599148 Aireem1Ang autoimmune regulator; ZFN induced mutant1, Ang gene MP:0012400 nail dystrophy IMP N RGD:38599145|PMID:29959280 20200910 RGD 38599148 Aireem1Ang autoimmune regulator; ZFN induced mutant1, Ang gene MP:0020242 increased autopod size IMP N RGD:38599145|PMID:29959280 20200910 RGD 38599152 WI-Lpin1m1Hubr strain MP:0000351 increased cell proliferation IMP N RGD:38599010|PMID:21715287 20200913 RGD compared to Wild type 38599152 WI-Lpin1m1Hubr strain MP:0001263 weight loss IMP N RGD:38599010|PMID:21715287 20200913 RGD compared to Wild type and heterozygous 38599152 WI-Lpin1m1Hubr strain MP:0002651 abnormal sciatic nerve morphology IMP N RGD:38599010|PMID:21715287 20200913 RGD compared to Wild type 38599152 WI-Lpin1m1Hubr strain MP:0011174 lipodystrophy IMP N RGD:38599010|PMID:21715287 20200913 RGD compared to Wild type 38599152 WI-Lpin1m1Hubr strain MP:0013438 dysmyelination IMP N RGD:38599010|PMID:21715287 20200913 RGD compared to Wild type 38599153 Lpin1m1Hubr lipin 1; ENU induced mutant 1, Hubr gene MP:0000351 increased cell proliferation IMP N RGD:38599010|PMID:21715287 20201210 RGD compared to Wild type 38599153 Lpin1m1Hubr lipin 1; ENU induced mutant 1, Hubr gene MP:0001263 weight loss IMP N RGD:38599010|PMID:21715287 20201210 RGD compared to Wild type and heterozygous 38599153 Lpin1m1Hubr lipin 1; ENU induced mutant 1, Hubr gene MP:0002651 abnormal sciatic nerve morphology IMP N RGD:38599010|PMID:21715287 20201210 RGD compared to Wild type 38599153 Lpin1m1Hubr lipin 1; ENU induced mutant 1, Hubr gene MP:0011174 lipodystrophy IMP N RGD:38599010|PMID:21715287 20201210 RGD compared to Wild type 38599153 Lpin1m1Hubr lipin 1; ENU induced mutant 1, Hubr gene MP:0013438 dysmyelination IMP N RGD:38599010|PMID:21715287 20201210 RGD compared to Wild type 38599155 BN-Themism1Adej strain MP:0002581 abnormal ileum morphology IAGP N RGD:38599149|PMID:22275874 20200914 RGD compared to BN 38599155 BN-Themism1Adej strain MP:0003271 abnormal duodenum morphology IAGP N RGD:38599149|PMID:22275874 20200914 RGD compared to BN 38599155 BN-Themism1Adej strain MP:0004002 abnormal jejunum morphology IAGP N RGD:38599149|PMID:22275874 20200914 RGD compared to BN 38599155 BN-Themism1Adej strain MP:0005348 increased T cell proliferation induced IAGP XCO:0000644 N RGD:38599149|PMID:22275874 20200914 RGD compared to BN 38599155 BN-Themism1Adej strain MP:0008567 decreased interferon-gamma secretion induced IAGP XCO:0000644 N RGD:38599149|PMID:22275874 20200914 RGD compared to BN 38599155 BN-Themism1Adej strain MP:0008660 increased interleukin-10 secretion induced IAGP XCO:0000644 N RGD:38599149|PMID:22275874 20200914 RGD compared to BN 38599155 BN-Themism1Adej strain MP:0008681 increased interleukin-17 secretion induced IAGP XCO:0000644 N RGD:38599149|PMID:22275874 20200914 RGD compared to BN 38599155 BN-Themism1Adej strain MP:0008699 increased interleukin-4 secretion induced IAGP XCO:0000644 N RGD:38599149|PMID:22275874 20200914 RGD compared to BN 38599155 BN-Themism1Adej strain MP:0013956 decreased colon length IAGP N RGD:38599149|PMID:22275874 20200914 RGD compared to BN 38599155 BN-Themism1Adej strain MP:0013958 decreased small intestine length IAGP N RGD:38599149|PMID:22275874 20200914 RGD compared to BN 38599156 Themism1Adej thymocyte selection associated; mutant1, Adej gene MP:0002581 abnormal ileum morphology IAGP N RGD:38599149|PMID:22275874 20201210 RGD compared to BN 38599156 Themism1Adej thymocyte selection associated; mutant1, Adej gene MP:0003271 abnormal duodenum morphology IAGP N RGD:38599149|PMID:22275874 20201210 RGD compared to BN 38599156 Themism1Adej thymocyte selection associated; mutant1, Adej gene MP:0004002 abnormal jejunum morphology IAGP N RGD:38599149|PMID:22275874 20201210 RGD compared to BN 38599156 Themism1Adej thymocyte selection associated; mutant1, Adej gene MP:0005348 increased T cell proliferation IAGP N RGD:38599149|PMID:22275874 20201210 RGD compared to BN 38599156 Themism1Adej thymocyte selection associated; mutant1, Adej gene MP:0008567 decreased interferon-gamma secretion IAGP N RGD:38599149|PMID:22275874 20201210 RGD compared to BN 38599156 Themism1Adej thymocyte selection associated; mutant1, Adej gene MP:0008660 increased interleukin-10 secretion IAGP N RGD:38599149|PMID:22275874 20201210 RGD compared to BN 38599156 Themism1Adej thymocyte selection associated; mutant1, Adej gene MP:0008681 increased interleukin-17 secretion IAGP N RGD:38599149|PMID:22275874 20201210 RGD compared to BN 38599156 Themism1Adej thymocyte selection associated; mutant1, Adej gene MP:0008699 increased interleukin-4 secretion IAGP N RGD:38599149|PMID:22275874 20201210 RGD compared to BN 38599156 Themism1Adej thymocyte selection associated; mutant1, Adej gene MP:0013956 decreased colon length IAGP N RGD:38599149|PMID:22275874 20201210 RGD compared to BN 38599156 Themism1Adej thymocyte selection associated; mutant1, Adej gene MP:0013958 decreased small intestine length IAGP N RGD:38599149|PMID:22275874 20201210 RGD compared to BN 38599157 F344-Depdc5em1Kyo+/- strain MP:0000823 abnormal lateral ventricle morphology IMP N RGD:11573213|PMID:26873552 20200921 RGD 38599157 F344-Depdc5em1Kyo+/- strain MP:0002882 abnormal neuron morphology IMP N RGD:11573213|PMID:26873552 20200921 RGD 38599157 F344-Depdc5em1Kyo+/- strain MP:0003412 abnormal afterhyperpolarization IMP N RGD:11573213|PMID:26873552 20200921 RGD 38599157 F344-Depdc5em1Kyo+/- strain MP:0003477 abnormal nerve fiber response IMP N RGD:11573213|PMID:26873552 20200921 RGD 38599157 F344-Depdc5em1Kyo+/- strain MP:0008547 abnormal neocortex morphology IMP N RGD:11573213|PMID:26873552 20200921 RGD 38599158 F344-Depdc5em2Kyo+/- strain MP:0000823 abnormal lateral ventricle morphology IMP N RGD:11573213|PMID:26873552 20200921 RGD 38599158 F344-Depdc5em2Kyo+/- strain MP:0002882 abnormal neuron morphology IMP N RGD:11573213|PMID:26873552 20200921 RGD 38599158 F344-Depdc5em2Kyo+/- strain MP:0003412 abnormal afterhyperpolarization IMP N RGD:11573213|PMID:26873552 20200921 RGD 38599158 F344-Depdc5em2Kyo+/- strain MP:0003477 abnormal nerve fiber response IMP N RGD:11573213|PMID:26873552 20200921 RGD 38599158 F344-Depdc5em2Kyo+/- strain MP:0008547 abnormal neocortex morphology IMP N RGD:11573213|PMID:26873552 20200921 RGD 38599194 Depdc5em1Kyo DEP domain containing 5, GATOR1 subcomplex subunit; TALEN induced mutant1, Kyo gene MP:0000823 abnormal lateral ventricle morphology IMP N RGD:11573213|PMID:26873552 20201210 RGD 38599194 Depdc5em1Kyo DEP domain containing 5, GATOR1 subcomplex subunit; TALEN induced mutant1, Kyo gene MP:0002882 abnormal neuron morphology IMP N RGD:11573213|PMID:26873552 20201210 RGD 38599194 Depdc5em1Kyo DEP domain containing 5, GATOR1 subcomplex subunit; TALEN induced mutant1, Kyo gene MP:0003412 abnormal afterhyperpolarization IMP N RGD:11573213|PMID:26873552 20201210 RGD 38599194 Depdc5em1Kyo DEP domain containing 5, GATOR1 subcomplex subunit; TALEN induced mutant1, Kyo gene MP:0003477 abnormal nerve fiber response IMP N RGD:11573213|PMID:26873552 20201210 RGD 38599194 Depdc5em1Kyo DEP domain containing 5, GATOR1 subcomplex subunit; TALEN induced mutant1, Kyo gene MP:0008547 abnormal neocortex morphology IMP N RGD:11573213|PMID:26873552 20201210 RGD 38599195 Depdc5em2Kyo DEP domain containing 5, GATOR1 subcomplex subunit; TALEN induced mutant2, Kyo gene MP:0000823 abnormal lateral ventricle morphology IMP N RGD:11573213|PMID:26873552 20201210 RGD 38599195 Depdc5em2Kyo DEP domain containing 5, GATOR1 subcomplex subunit; TALEN induced mutant2, Kyo gene MP:0002882 abnormal neuron morphology IMP N RGD:11573213|PMID:26873552 20201210 RGD 38599195 Depdc5em2Kyo DEP domain containing 5, GATOR1 subcomplex subunit; TALEN induced mutant2, Kyo gene MP:0003412 abnormal afterhyperpolarization IMP N RGD:11573213|PMID:26873552 20201210 RGD 38599195 Depdc5em2Kyo DEP domain containing 5, GATOR1 subcomplex subunit; TALEN induced mutant2, Kyo gene MP:0003477 abnormal nerve fiber response IMP N RGD:11573213|PMID:26873552 20201210 RGD 38599195 Depdc5em2Kyo DEP domain containing 5, GATOR1 subcomplex subunit; TALEN induced mutant2, Kyo gene MP:0008547 abnormal neocortex morphology IMP N RGD:11573213|PMID:26873552 20201210 RGD 38599208 SHR-Prdx2em1Izm strain MP:0002083 premature death IMP N RGD:151347623|PMID:30655626 20220131 RGD 38599208 SHR-Prdx2em1Izm strain MP:0003674 oxidative stress exacerbates IMP N RGD:151347623|PMID:30655626 20220131 RGD compared to wild type 38599208 SHR-Prdx2em1Izm strain MP:0005264 glomerulosclerosis exacerbates IMP N RGD:151347623|PMID:30655626 20220131 RGD ompared to wild type 38599208 SHR-Prdx2em1Izm strain MP:0006144 increased systemic arterial systolic blood pressure IMP N RGD:151347623|PMID:30655626 20220131 RGD compared to wild type 38676253 F344-Hcn1em1Kyo strain MP:0001961 abnormal reflex IMP N RGD:26923909|PMID:30408474 20211028 RGD 38676253 F344-Hcn1em1Kyo strain MP:0003217 increased spike-wave discharge type I onset IMP N RGD:26923909|PMID:30408474 20211028 RGD 38676253 F344-Hcn1em1Kyo strain MP:0003218 decreased spike-wave discharge type I treatment IMP XCO:0000913 N RGD:26923909|PMID:30408474 20211101 RGD compared to untreated 38676253 F344-Hcn1em1Kyo strain MP:0003481 decreased nerve fiber response intensity induces IMP XCO:0000055 N RGD:26923909|PMID:30408474 20211028 RGD 38676253 F344-Hcn1em1Kyo strain MP:0003996 clonic seizures induces IMP XCO:0000887 N RGD:26923909|PMID:30408474 20211028 RGD 38676253 F344-Hcn1em1Kyo strain MP:0008035 behavioral arrest IMP N RGD:26923909|PMID:30408474 20211028 RGD 38676254 F344-Ppargm1Kyo strain MP:0002981 increased liver weight induces IAGP XCO:0000025 N RGD:127285618|PMID:27381370 20220111 RGD 38676254 F344-Ppargm1Kyo strain MP:0005293 impaired glucose tolerance IAGP N RGD:127285618|PMID:27381370 20220111 RGD compared to wild type rats 38676254 F344-Ppargm1Kyo strain MP:0005331 insulin resistance induces IAGP XCO:0000025 N RGD:127285618|PMID:27381370 20220111 RGD compared to wild type rats 38676254 F344-Ppargm1Kyo strain MP:0006094 increased fat cell size IAGP N RGD:127285618|PMID:27381370 20220111 RGD 38676254 F344-Ppargm1Kyo strain MP:0008907 decreased total fat pad weight induces IAGP XCO:0000069 N RGD:127285618|PMID:27381370 20220111 RGD compared to wild type rats 38676254 F344-Ppargm1Kyo strain MP:0009289 decreased epididymal fat pad weight IAGP N RGD:127285618|PMID:27381370 20220111 RGD 38676254 F344-Ppargm1Kyo strain MP:0009355 increased liver triglyceride level IAGP N RGD:127285618|PMID:27381370 20220111 RGD 38676254 F344-Ppargm1Kyo strain MP:0010238 increased skeletal muscle weight induces IAGP XCO:0000025 N RGD:127285618|PMID:27381370 20220111 RGD 38676254 F344-Ppargm1Kyo strain MP:0011168 abnormal fat cell differentiation IAGP N RGD:127285618|PMID:27381370 20220111 RGD 38676450 F344-Phf24em2Kyo strain MP:0001364 decreased anxiety-related response IMP N RGD:127285809|PMID:31039378 20210701 RGD compared to F344/Stm 38676450 F344-Phf24em2Kyo strain MP:0001399 hyperactivity IMP N RGD:127285809|PMID:31039378 20210701 RGD compared to F344/NSlc 38676450 F344-Phf24em2Kyo strain MP:0002906 increased susceptibility to pharmacologically induced seizures IMP XCO:0000887|XCO:0000888 N RGD:127285809|PMID:31039378 20210701 RGD compared to F344/NSlc 38676450 F344-Phf24em2Kyo strain MP:0012307 impaired spatial learning IMP N RGD:127285809|PMID:31039378 20210701 RGD compared to F344/Stm 38676450 F344-Phf24em2Kyo strain MP:0013140 excessive vocalization IMP N RGD:127285809|PMID:31039378 20210701 RGD compared to F344/Stm 38676450 F344-Phf24em2Kyo strain MP:0020424 increased kindling response susceptibility IMP XCO:0000887 N RGD:127285809|PMID:31039378 20210701 RGD compared to F344/NSlc 38676459 HHR/Hat Hirosaki hairless rat strain MP:0003815 hairless IAGP N RGD:2316553|PMID:18420582 20200918 RGD 38676459 HHR/Hat Hirosaki hairless rat strain MP:0006271 abnormal involution of the mammary gland IAGP N RGD:2291942|PMID:16227201 20200918 RGD 38676461 HiSER/Hat Hirosaki small-eye rat strain MP:0001297 microphthalmia IAGP N RGD:38676460|PMID:26303524 20200918 RGD 38676461 HiSER/Hat Hirosaki small-eye rat strain MP:0001303 abnormal lens morphology IAGP N RGD:38676460|PMID:26303524 20200918 RGD 38676461 HiSER/Hat Hirosaki small-eye rat strain MP:0005099 abnormal ciliary body morphology IAGP N RGD:38676460|PMID:26303524 20200918 RGD 38676461 HiSER/Hat Hirosaki small-eye rat strain MP:0005241 abnormal retina ganglion layer morphology IAGP N RGD:38676460|PMID:26303524 20200918 RGD 38676461 HiSER/Hat Hirosaki small-eye rat strain MP:0009859 eye opacity disease_progression IAGP N RGD:38676460|PMID:26303524 20200918 RGD 38676462 Cryba1Hiser crystallin, beta A1; HiSER mutant gene MP:0001303 abnormal lens morphology IAGP N RGD:38676460|PMID:26303524 20200918 RGD 38676462 Cryba1Hiser crystallin, beta A1; HiSER mutant gene MP:0005099 abnormal ciliary body morphology IAGP N RGD:38676460|PMID:26303524 20200918 RGD 38676462 Cryba1Hiser crystallin, beta A1; HiSER mutant gene MP:0005241 abnormal retina ganglion layer morphology IAGP N RGD:38676460|PMID:26303524 20200918 RGD 3870 Tlr4 toll-like receptor 4 gene MP:0008561 decreased tumor necrosis factor secretion IMP N RGD:12910488|PMID:24199847 20170615 RGD 3876 Tnf tumor necrosis factor gene MP:0001260 increased body weight IAGP N RGD:1357163|PMID:9590569 19990101 RGD 3876 Tnf tumor necrosis factor gene MP:0002842 increased systemic arterial blood pressure IAGP N RGD:1357163|PMID:9590569 19990101 RGD 3876 Tnf tumor necrosis factor gene MP:0005333 decreased heart rate IAGP N RGD:1357163|PMID:9590569 19990101 RGD 3880 Faslg Fas ligand gene MP:0002229 neurodegeneration IDA N RGD:1358616|PMID:15644446 19990101 RGD 3882 Tnnt2 troponin T2, cardiac type gene MP:0004084 abnormal cardiac muscle relaxation IDA N RGD:1580434|PMID:10946062 19990101 RGD 3886 Tnr tenascin R gene MP:0004217 salt-sensitive hypertension IMP N RGD:12792227|PMID:24714719 20170316 RGD 3886 Tnr tenascin R gene MP:0011022 abnormal circadian regulation of systemic arterial blood pressure IMP N RGD:12792227|PMID:24714719 20170316 RGD 3889 Tp53 tumor protein p53 gene MP:0001153 small seminiferous tubules IMP N RGD:14995504|PMID:28834365 20210930 RGD compared to SD 3889 Tp53 tumor protein p53 gene MP:0001154 seminiferous tubule degeneration IMP N RGD:14995504|PMID:28834365 20210930 RGD compared to SD 3889 Tp53 tumor protein p53 gene MP:0001262 decreased body weight IMP N RGD:14995504|PMID:28834365 20210930 RGD compared to SD 3889 Tp53 tumor protein p53 gene MP:0002020 increased tumor incidence IMP N RGD:11075077|PMID:22917926 20170920 RGD 3889 Tp53 tumor protein p53 gene MP:0002083 premature death IMP N RGD:12738450|PMID:27528400 20210428 RGD 3889 Tp53 tumor protein p53 gene MP:0004227 increased cellular sensitivity to ionizing radiation IMP N RGD:14995504|PMID:28834365 20210930 RGD compared to SD 3889 Tp53 tumor protein p53 gene MP:0004852 decreased testis weight IMP N RGD:14995504|PMID:28834365 20191029 RGD 3889 Tp53 tumor protein p53 gene MP:0004930 small epididymis IMP N RGD:14995504|PMID:28834365 20210930 RGD compared to SD 3889 Tp53 tumor protein p53 gene MP:0014052 increased male germ cell apoptosis IMP N RGD:14995504|PMID:28834365 20191029 RGD 3889 Tp53 tumor protein p53 gene MP:0020851 abnormal vacuole morphology IMP N RGD:14995504|PMID:28834365 20210930 RGD seminiferous tubule; compared to SD 3908 Tsc2 TSC complex subunit 2 gene MP:0008762 embryonic lethality IMP N RGD:11568651|PMID:25088526 20161208 RGD 3911 Tshr thyroid stimulating hormone receptor gene MP:0001924 infertility IMP N RGD:150521601|PMID:29507327 20211111 RGD 3911 Tshr thyroid stimulating hormone receptor gene MP:0003499 thyroid gland hypoplasia IMP N RGD:150521601|PMID:29507327 20211111 RGD 3911 Tshr thyroid stimulating hormone receptor gene MP:0005122 increased circulating thyroid-stimulating hormone level IMP N RGD:150521601|PMID:29507327 20211111 RGD 3911 Tshr thyroid stimulating hormone receptor gene MP:0005478 decreased circulating thyroxine level IMP N RGD:150521601|PMID:29507327 20211111 RGD 3911 Tshr thyroid stimulating hormone receptor gene MP:0005479 decreased circulating triiodothyronine level IMP N RGD:150521601|PMID:29507327 20211111 RGD 39128239 GK/CskCrlj strain MP:0001262 decreased body weight IAGP N RGD:127338471|PMID:10323602 20220512 RGD compared to Crlj:WI. 39128239 GK/CskCrlj strain MP:0002079 increased circulating insulin level induces IAGP XCO:0000102 N RGD:127338471|PMID:10323602 20220512 RGD compared to Crlj:WI. 39128239 GK/CskCrlj strain MP:0003058 increased insulin secretion induces IAGP XCO:0000102,XCO:0000941,XCO:0000252,XCO:0000104 N RGD:127338471|PMID:10323602 20220512 RGD compared to Crlj:WI 39128239 GK/CskCrlj strain MP:0003059 decreased insulin secretion induces IAGP XCO:0000102,XCO:0000941,XCO:0000939,XCO:0000103 N RGD:127338471|PMID:10323602 20220512 RGD compared to Crlj:WI. 39128239 GK/CskCrlj strain MP:0005293 impaired glucose tolerance induces IAGP XCO:0000102,XCO:0000103 N RGD:127338471|PMID:10323602 20220512 RGD compared to Crlj:WI 39128239 GK/CskCrlj strain MP:0013279 increased fasting circulating glucose level IAGP N RGD:127338471|PMID:10323602 20220512 RGD compared to Crlj:WI. 3935 Ugt1a1 UDP glucuronosyltransferase family 1 member A1 gene MP:0002591 decreased mean corpuscular volume IAGP N RGD:1354701|PMID:20323028 20201210 RGD compared to Gunn rats 3935 Ugt1a1 UDP glucuronosyltransferase family 1 member A1 gene MP:0002640 reticulocytosis IAGP N RGD:1354701|PMID:20323028 20201210 RGD compared to Gunn rats 3935 Ugt1a1 UDP glucuronosyltransferase family 1 member A1 gene MP:0002988 decreased urine osmolality treatment IAGP XCO:0000683, XCO:0000283 N RGD:1354700|PMID:1127102 20201210 RGD 3935 Ugt1a1 UDP glucuronosyltransferase family 1 member A1 gene MP:0005344 increased circulating bilirubin level IAGP N RGD:13432067|PMID:16337205 20170918 RGD 3935 Ugt1a1 UDP glucuronosyltransferase family 1 member A1 gene MP:0005344 increased circulating bilirubin level IAGP N RGD:1354701|PMID:20323028 20201210 RGD compared to Gunn rats 3935 Ugt1a1 UDP glucuronosyltransferase family 1 member A1 gene MP:0005344 increased circulating bilirubin level IAGP N RGD:1354702|PMID:15753292 20201210 RGD 3935 Ugt1a1 UDP glucuronosyltransferase family 1 member A1 gene MP:0005344 increased circulating bilirubin level treatment IAGP XCO:0000683, XCO:0000283 N RGD:1354700|PMID:1127102 20201210 RGD 3935 Ugt1a1 UDP glucuronosyltransferase family 1 member A1 gene MP:0008489 slow postnatal weight gain IAGP N RGD:1354701|PMID:20323028 20201210 RGD compared to Gunn rats 3935 Ugt1a1 UDP glucuronosyltransferase family 1 member A1 gene MP:0010108 abnormal renal water reabsorption treatment IAGP XCO:0000683, XCO:0000283 N RGD:1354700|PMID:1127102 20201210 RGD 3935 Ugt1a1 UDP glucuronosyltransferase family 1 member A1 gene MP:0013305 isosthenuria treatment IAGP XCO:0000683, XCO:0000283 N RGD:1354700|PMID:1127102 20201210 RGD 39457945 WI- Lpar1m1Hubr strain MP:0001265 decreased body size IMP N RGD:13825198|PMID:20531371 20201012 RGD 39457945 WI- Lpar1m1Hubr strain MP:0003935 abnormal craniofacial development IMP N RGD:13825198|PMID:20531371 20201012 RGD 39457947 SD-Bckdkm1Dbsa strain MP:0000556 abnormal hindlimb morphology IAGP N RGD:39131293|PMID:27472223 20201012 RGD compared to NTac:SD 39457947 SD-Bckdkm1Dbsa strain MP:0000574 abnormal foot pad morphology IAGP N RGD:39131293|PMID:27472223 20201012 RGD compared to NTac:SD 39457947 SD-Bckdkm1Dbsa strain MP:0000583 long toenails IAGP N RGD:39131293|PMID:27472223 20201012 RGD compared to NTac:SD 39457947 SD-Bckdkm1Dbsa strain MP:0001265 decreased body size IAGP N RGD:39131293|PMID:27472223 20201012 RGD compared to NTac:SD 39457947 SD-Bckdkm1Dbsa strain MP:0001922 reduced male fertility IAGP N RGD:39131293|PMID:27472223 20201012 RGD compared to NTac:SD 39457947 SD-Bckdkm1Dbsa strain MP:0001940 testis hypoplasia IAGP N RGD:39131293|PMID:27472223 20201012 RGD compared to NTac:SD 39457947 SD-Bckdkm1Dbsa strain MP:0002175 decreased brain weight IAGP N RGD:39131293|PMID:27472223 20201012 RGD compared to NTac:SD 39457947 SD-Bckdkm1Dbsa strain MP:0003081 abnormal soleus morphology IAGP N RGD:39131293|PMID:27472223 20201012 RGD compared to NTac:SD 39457947 SD-Bckdkm1Dbsa strain MP:0008535 enlarged lateral ventricles IAGP N RGD:39131293|PMID:27472223 20201012 RGD compared to NTac:SD 39457947 SD-Bckdkm1Dbsa strain MP:0030716 decreased circulating isoleucine level IAGP N RGD:39131293|PMID:27472223 20201012 RGD compared to NTac:SD 39457947 SD-Bckdkm1Dbsa strain MP:0030728 decreased circulating valine level IAGP N RGD:39131293|PMID:27472223 20201012 RGD compared to NTac:SD 39457947 SD-Bckdkm1Dbsa strain MP:0030751 decreased circulating leucine level IAGP N RGD:39131293|PMID:27472223 20201012 RGD compared to NTac:SD 39457950 SD-Ngly1em1Ta-/- strain MP:0000161 scoliosis sexual_dimorphism IMP N RGD:39457703|PMID:32259258 20201013 RGD compared to wild type 39457950 SD-Ngly1em1Ta-/- strain MP:0000832 abnormal thalamus morphology IMP N RGD:39457703|PMID:32259258 20201013 RGD 39457950 SD-Ngly1em1Ta-/- strain MP:0001265 decreased body size IMP N RGD:39457703|PMID:32259258 20201013 RGD 39457950 SD-Ngly1em1Ta-/- strain MP:0001402 decreased locomotor activity IMP N RGD:39457703|PMID:32259258 20201013 RGD 39457950 SD-Ngly1em1Ta-/- strain MP:0001407 short stride length IMP N RGD:39457703|PMID:32259258 20201013 RGD 39457950 SD-Ngly1em1Ta-/- strain MP:0001489 decreased startle reflex penetrance IMP N RGD:39457703|PMID:32259258 20201013 RGD compared to wild type 39457950 SD-Ngly1em1Ta-/- strain MP:0001513 limb grasping IMP N RGD:39457703|PMID:32259258 20201013 RGD 39457950 SD-Ngly1em1Ta-/- strain MP:0001522 impaired swimming IMP N RGD:39457703|PMID:32259258 20201013 RGD 39457950 SD-Ngly1em1Ta-/- strain MP:0001525 impaired balance IMP N RGD:39457703|PMID:32259258 20201013 RGD 39457950 SD-Ngly1em1Ta-/- strain MP:0001924 infertility IMP N RGD:39457703|PMID:32259258 20201013 RGD 39457950 SD-Ngly1em1Ta-/- strain MP:0002175 decreased brain weight IMP N RGD:39457703|PMID:32259258 20201013 RGD 39457950 SD-Ngly1em1Ta-/- strain MP:0002651 abnormal sciatic nerve morphology IMP N RGD:39457703|PMID:32259258 20201013 RGD 39457950 SD-Ngly1em1Ta-/- strain MP:0003225 axonal dystrophy IMP N RGD:39457703|PMID:32259258 20201013 RGD 39457950 SD-Ngly1em1Ta-/- strain MP:0005498 hyporesponsive to tactile stimuli IMP N RGD:39457703|PMID:32259258 20201013 RGD 39457950 SD-Ngly1em1Ta-/- strain MP:0009422 decreased gastrocnemius weight IMP N RGD:39457703|PMID:32259258 20201013 RGD 39457950 SD-Ngly1em1Ta-/- strain MP:0009428 decreased tibialis anterior weight IMP N RGD:39457703|PMID:32259258 20201013 RGD 39457950 SD-Ngly1em1Ta-/- strain MP:0010053 decreased grip strength IMP N RGD:39457703|PMID:32259258 20201013 RGD 39457950 SD-Ngly1em1Ta-/- strain MP:0011110 preweaning lethality, incomplete penetrance IMP N RGD:39457703|PMID:32259258 20201013 RGD 39457950 SD-Ngly1em1Ta-/- strain MP:0012307 impaired spatial learning IMP N RGD:39457703|PMID:32259258 20201013 RGD 39457950 SD-Ngly1em1Ta-/- strain MP:0013178 tail necrosis IMP N RGD:39457703|PMID:32259258 20201013 RGD 3959 Vdr vitamin D receptor gene MP:0000130 abnormal trabecular bone morphology IMP N RGD:32716373|PMID:32231239 20210325 RGD 3959 Vdr vitamin D receptor gene MP:0000163 abnormal cartilage morphology IMP N RGD:32716373|PMID:32231239 20210325 RGD 3959 Vdr vitamin D receptor gene MP:0000195 decreased circulating calcium level treatment IMP XCO:0000545 N RGD:32716373|PMID:32231239 20210325 RGD compared to Jcl:Wi and untreated 3959 Vdr vitamin D receptor gene MP:0000414 alopecia IMP N RGD:32716373|PMID:32231239 20210401 RGD 3959 Vdr vitamin D receptor gene MP:0000559 abnormal femur morphology IMP N RGD:32716373|PMID:32231239 20210325 RGD 3959 Vdr vitamin D receptor gene MP:0002708 nephrolithiasis IMP N RGD:32716373|PMID:32231239 20210401 RGD 3959 Vdr vitamin D receptor gene MP:0002904 increased circulating parathyroid hormone level IMP XCO:0000545 N RGD:32716373|PMID:32231239 20210401 RGD 3959 Vdr vitamin D receptor gene MP:0002904 increased circulating parathyroid hormone level treatment IMP XCO:0000545 N RGD:32716373|PMID:32231239 20210325 RGD compared to Jcl:Wi and treated 3959 Vdr vitamin D receptor gene MP:0009445 osteomalacia IMP N RGD:32716373|PMID:32231239 20210325 RGD 3959 Vdr vitamin D receptor gene MP:0009931 abnormal skin appearance IMP N RGD:32716373|PMID:32231239 20210401 RGD 3970 Foxn1 forkhead box N1 gene MP:0000705 athymia IAGP N RGD:1300512|PMID:8790387 19990101 RGD 3970 Foxn1 forkhead box N1 gene MP:0002073 abnormal hair growth IAGP N RGD:1300512|PMID:8790387 19990101 RGD 401901198 SHHFcp/cp/MccGmiCrl strain MP:0000231 hypertension IAGP N RGD:401901261|PMID:24831821 20231207 RGD compared to lean strain SHHFcp/+/MccGmiCrl 401901198 SHHFcp/cp/MccGmiCrl strain MP:0001261 obese IAGP N RGD:401901261|PMID:24831821 20231207 RGD compared to lean strain SHHFcp/+/MccGmiCrl 401901198 SHHFcp/cp/MccGmiCrl strain MP:0001625 cardiac hypertrophy IAGP N RGD:401901261|PMID:24831821 20231207 RGD compared to lean strain SHHFcp/+/MccGmiCrl 401901198 SHHFcp/cp/MccGmiCrl strain MP:0001625 cardiac hypertrophy treatment IAGP N RGD:401901266|PMID:19836216 20231207 RGD compared to Wistar age-matched controls 401901198 SHHFcp/cp/MccGmiCrl strain MP:0001762 polyuria IAGP N RGD:401901261|PMID:24831821 20231207 RGD compared to lean strain SHHFcp/+/MccGmiCrl 401901198 SHHFcp/cp/MccGmiCrl strain MP:0002625 heart left ventricle hypertrophy IAGP N RGD:401901261|PMID:24831821 20231207 RGD 401901198 SHHFcp/cp/MccGmiCrl strain MP:0002962 increased urine protein level IAGP N RGD:401901261|PMID:24831821 20231207 RGD compared to lean strain SHHFcp/+/MccGmiCrl 401901198 SHHFcp/cp/MccGmiCrl strain MP:0003141 cardiac fibrosis IAGP N RGD:401901261|PMID:24831821 20231207 RGD compared to lean strain SHHFcp/+/MccGmiCrl 401901198 SHHFcp/cp/MccGmiCrl strain MP:0003949 abnormal circulating lipid level IAGP N RGD:401901261|PMID:24831821 20231207 RGD compared to lean strain SHHFcp/+/MccGmiCrl 401901198 SHHFcp/cp/MccGmiCrl strain MP:0005331 insulin resistance IAGP N RGD:401901261|PMID:24831821 20231207 RGD compared to lean strain SHHFcp/+/MccGmiCrl 401901198 SHHFcp/cp/MccGmiCrl strain MP:0005528 decreased renal glomerular filtration rate IAGP N RGD:401901261|PMID:24831821 20231207 RGD compared to lean strain SHHFcp/+/MccGmiCrl 401901198 SHHFcp/cp/MccGmiCrl strain MP:0011294 renal glomerulus hypertrophy IAGP N RGD:401901261|PMID:24831821 20231207 RGD compared to lean strain SHHFcp/+/MccGmiCrl 401901198 SHHFcp/cp/MccGmiCrl strain MP:0011402 renal cast IAGP N RGD:401901261|PMID:24831821 20231207 RGD compared to lean strain SHHFcp/+/MccGmiCrl 401901199 SHHFcp/+/MccGmiCrl strain MP:0001625 cardiac hypertrophy treatment IAGP N RGD:401901248|PMID:20601374 20231206 RGD 401901199 SHHFcp/+/MccGmiCrl strain MP:0001625 cardiac hypertrophy treatment IAGP N RGD:401901266|PMID:19836216 20231207 RGD compared to Wistar age-matched controls 401901199 SHHFcp/+/MccGmiCrl strain MP:0001853 heart inflammation treatment IAGP N RGD:401901248|PMID:20601374 20231206 RGD 401901199 SHHFcp/+/MccGmiCrl strain MP:0002625 heart left ventricle hypertrophy IAGP N RGD:401901261|PMID:24831821 20231207 RGD 401901199 SHHFcp/+/MccGmiCrl strain MP:0002625 heart left ventricle hypertrophy treatment IAGP N RGD:401901248|PMID:20601374 20231206 RGD 401901199 SHHFcp/+/MccGmiCrl strain MP:0003141 cardiac fibrosis treatment IAGP N RGD:401901248|PMID:20601374 20231206 RGD 401901201 SHHFcp/+/Mcc strain MP:0000231 hypertension IAGP N RGD:1625790|PMID:9931137 20231206 RGD compared to Sprague Dawley controls 401901201 SHHFcp/+/Mcc strain MP:0002625 heart left ventricle hypertrophy IAGP N RGD:1625790|PMID:9931137 20231206 RGD compared to Sprague Dawley controls 401901201 SHHFcp/+/Mcc strain MP:0003823 increased left ventricle developed pressure IAGP N RGD:1625790|PMID:9931137 20231206 RGD compared to Sprague Dawley controls 401901201 SHHFcp/+/Mcc strain MP:0005140 decreased cardiac muscle contractility IAGP N RGD:1625790|PMID:9931137 20231206 RGD compared to Sprague Dawley controls 401940195 SD-Ahrem1Iexas-/- strain MP:0003548 pulmonary hypertension ameliorates IMP N RGD:401940192|PMID:33836606 20240115 RGD compared to wild type littermates 401940195 SD-Ahrem1Iexas-/- strain MP:0010758 increased right ventricle systolic pressure ameliorates IMP N RGD:401940192|PMID:33836606 20240115 RGD compared to wild type littermates 401940199 Ahrem1Iexas aryl hydrocarbon receptor; CRISPR/Cas9 induced mutant1, Iexas gene MP:0003548 pulmonary hypertension ameliorates IMP N RGD:401940192|PMID:33836606 20240118 RGD compared to wild type littermates 401940199 Ahrem1Iexas aryl hydrocarbon receptor; CRISPR/Cas9 induced mutant1, Iexas gene MP:0010758 increased right ventricle systolic pressure ameliorates IMP N RGD:401940192|PMID:33836606 20240118 RGD compared to wild type littermates 401960101 ZSF1-Leprfa/cp/Crl strain MP:0000231 hypertension IAGP N RGD:401960095|PMID:30278832 20240206 RGD compared to lean leptin receptor sufficient littermates ZSF1-Leprlean/Crl (RS:0005317) 401960101 ZSF1-Leprfa/cp/Crl strain MP:0000731 increased collagen deposition in the muscles treatment IAGP N RGD:401965412|PMID:33568522 20240206 RGD compared to treated 401960101 ZSF1-Leprfa/cp/Crl strain MP:0000747 muscle weakness IAGP N RGD:401960103|PMID:32710530 20240206 RGD compared to lean leptin receptor sufficient littermates ZSF1-Leprlean/Crl (RS:0005317) 401960101 ZSF1-Leprfa/cp/Crl strain MP:0001260 increased body weight IAGP N RGD:401965414|PMID:10901178 20240206 RGD compared to lean littermates ZSF1-Leprlean/Crl (RS:0005317) 401960101 ZSF1-Leprfa/cp/Crl strain MP:0001261 obese IAGP N RGD:401960103|PMID:32710530 20240206 RGD compared to lean leptin receptor sufficient littermates ZSF1-Leprlean/Crl (RS:0005317) 401960101 ZSF1-Leprfa/cp/Crl strain MP:0001261 obese IAGP N RGD:401965413|PMID:28746409 20240206 RGD compared to lean ZSF1-Leprlean/Crl (RS:0005317) 401960101 ZSF1-Leprfa/cp/Crl strain MP:0001261 obese treatment IAGP N RGD:401965412|PMID:33568522 20240206 RGD 401960101 ZSF1-Leprfa/cp/Crl strain MP:0002079 increased circulating insulin level IAGP N RGD:401965413|PMID:28746409 20240206 RGD compared to lean ZSF1-Leprlean/Crl (RS:0005317) 401960101 ZSF1-Leprfa/cp/Crl strain MP:0002625 heart left ventricle hypertrophy treatment IAGP N RGD:401965412|PMID:33568522 20240206 RGD compared to lean leptin receptor sufficient littermates ZSF1-Leprlean/Crl (RS:0005317), compared to treated obese 401960101 ZSF1-Leprfa/cp/Crl strain MP:0002705 dilated renal tubule IAGP N RGD:401965414|PMID:10901178 20240206 RGD compared to WKY, SHR, ZSF1-Leprlean/Crl 401960101 ZSF1-Leprfa/cp/Crl strain MP:0002747 abnormal aortic valve morphology IAGP N RGD:401960103|PMID:32710530 20240206 RGD compared to lean leptin receptor sufficient littermates ZSF1-Leprlean/Crl (RS:0005317) 401960101 ZSF1-Leprfa/cp/Crl strain MP:0002833 increased heart weight IAGP N RGD:401965414|PMID:10901178 20240206 RGD compared to SHR and WKY controls 401960101 ZSF1-Leprfa/cp/Crl strain MP:0002959 increased urine microalbumin level IAGP N RGD:401960095|PMID:30278832 20240206 RGD compared to lean leptin receptor sufficient littermates ZSF1-Leprlean/Crl (RS:0005317) 401960101 ZSF1-Leprfa/cp/Crl strain MP:0002959 increased urine microalbumin level IAGP N RGD:401965413|PMID:28746409 20240206 RGD compared to lean ZSF1-Leprlean/Crl (RS:0005317) 401960101 ZSF1-Leprfa/cp/Crl strain MP:0002962 increased urine protein level IAGP N RGD:401965414|PMID:10901178 20240206 RGD compared to WKY, SHR, ZSF1-Leprlean/Crl 401960101 ZSF1-Leprfa/cp/Crl strain MP:0002972 abnormal cardiac muscle contractility IAGP N RGD:401965414|PMID:10901178 20240206 RGD compared to WKY controls 401960101 ZSF1-Leprfa/cp/Crl strain MP:0003215 renal interstitial fibrosis IAGP N RGD:401960095|PMID:30278832 20240206 RGD compared to lean leptin receptor sufficient littermates ZSF1-Leprlean/Crl (RS:0005317) 401960101 ZSF1-Leprfa/cp/Crl strain MP:0003215 renal interstitial fibrosis IAGP N RGD:401965414|PMID:10901178 20240206 RGD compared to WKY, SHR, ZSF1-Leprlean/Crl 401960101 ZSF1-Leprfa/cp/Crl strain MP:0003819 increased left ventricle diastolic pressure IAGP N RGD:401960103|PMID:32710530 20240206 RGD compared to lean leptin receptor sufficient littermates ZSF1-Leprlean/Crl (RS:0005317) 401960101 ZSF1-Leprfa/cp/Crl strain MP:0003820 increased left ventricle systolic pressure IAGP N RGD:401965414|PMID:10901178 20240206 RGD compared to WKY controls 401960101 ZSF1-Leprfa/cp/Crl strain MP:0003821 decreased left ventricle diastolic pressure IAGP N RGD:401965414|PMID:10901178 20240206 RGD compared to SHR controls 401960101 ZSF1-Leprfa/cp/Crl strain MP:0003915 increased heart left ventricle weight IAGP N RGD:401960103|PMID:32710530 20240206 RGD compared to lean leptin receptor sufficient littermates ZSF1-Leprlean/Crl (RS:0005317) 401960101 ZSF1-Leprfa/cp/Crl strain MP:0003917 increased kidney weight IAGP N RGD:401965414|PMID:10901178 20240206 RGD compared to WKY, SHR, SHHF, ZSF1-Leprlean/Crl 401960101 ZSF1-Leprfa/cp/Crl strain MP:0003991 arteriosclerosis IAGP N RGD:401965414|PMID:10901178 20240206 RGD compared to WKY, SHR, ZSF1-Leprlean/Crl 401960101 ZSF1-Leprfa/cp/Crl strain MP:0004875 increased mean systemic arterial blood pressure IAGP N RGD:401960103|PMID:32710530 20240206 RGD compared to lean leptin receptor sufficient littermates ZSF1-Leprlean/Crl (RS:0005317) 401960101 ZSF1-Leprfa/cp/Crl strain MP:0004875 increased mean systemic arterial blood pressure IAGP N RGD:401965414|PMID:10901178 20240206 RGD compared to WKY controls 401960101 ZSF1-Leprfa/cp/Crl strain MP:0004890 decreased energy expenditure treatment IAGP N RGD:401965412|PMID:33568522 20240206 RGD 401960101 ZSF1-Leprfa/cp/Crl strain MP:0005178 increased circulating cholesterol level IAGP N RGD:401960095|PMID:30278832 20240206 RGD compared to lean leptin receptor sufficient littermates ZSF1-Leprlean/Crl (RS:0005317) 401960101 ZSF1-Leprfa/cp/Crl strain MP:0005178 increased circulating cholesterol level IAGP N RGD:401965413|PMID:28746409 20240206 RGD compared to lean ZSF1-Leprlean/Crl (RS:0005317) 401960101 ZSF1-Leprfa/cp/Crl strain MP:0005178 increased circulating cholesterol level IAGP N RGD:401965414|PMID:10901178 20240206 RGD compared to WKY, SHR, ZSF1-Leprlean/Crl 401960101 ZSF1-Leprfa/cp/Crl strain MP:0005264 glomerulosclerosis IAGP N RGD:401965413|PMID:28746409 20240206 RGD compared to lean ZSF1-Leprlean/Crl (RS:0005317) 401960101 ZSF1-Leprfa/cp/Crl strain MP:0005264 glomerulosclerosis IAGP N RGD:401965414|PMID:10901178 20240206 RGD compared to WKY, SHR, SHHF, ZSF1-Leprlean/Crl 401960101 ZSF1-Leprfa/cp/Crl strain MP:0005288 abnormal oxygen consumption treatment IAGP N RGD:401965412|PMID:33568522 20240206 RGD compared to lean leptin receptor sufficient littermates ZSF1-Leprlean/Crl (RS:0005317), compared to treated obese 401960101 ZSF1-Leprfa/cp/Crl strain MP:0005317 increased triglyceride level IAGP N RGD:401960095|PMID:30278832 20240206 RGD compared to lean leptin receptor sufficient littermates ZSF1-Leprlean/Crl (RS:0005317) 401960101 ZSF1-Leprfa/cp/Crl strain MP:0005317 increased triglyceride level IAGP N RGD:401965413|PMID:28746409 20240206 RGD compared to lean ZSF1-Leprlean/Crl (RS:0005317) 401960101 ZSF1-Leprfa/cp/Crl strain MP:0005317 increased triglyceride level IAGP N RGD:401965414|PMID:10901178 20240206 RGD compared to WKY, SHR, ZSF1-Leprlean/Crl 401960101 ZSF1-Leprfa/cp/Crl strain MP:0005450 abnormal energy expenditure treatment IAGP N RGD:401965412|PMID:33568522 20240206 RGD compared to treated 401960101 ZSF1-Leprfa/cp/Crl strain MP:0005526 decreased renal plasma flow rate IAGP N RGD:401965414|PMID:10901178 20240206 RGD compared to lean littermates ZSF1-Leprlean/Crl (RS:0005317) 401960101 ZSF1-Leprfa/cp/Crl strain MP:0005528 decreased renal glomerular filtration rate IAGP N RGD:401965414|PMID:10901178 20240206 RGD compared to lean littermates ZSF1-Leprlean/Crl (RS:0005317) 401960101 ZSF1-Leprfa/cp/Crl strain MP:0005531 increased renal vascular resistance IAGP N RGD:401965414|PMID:10901178 20240206 RGD compared to lean littermates ZSF1-Leprlean/Crl (RS:0005317) 401960101 ZSF1-Leprfa/cp/Crl strain MP:0005553 increased circulating creatinine level IAGP N RGD:401965414|PMID:10901178 20240206 RGD compared to WKY, SHR 401960101 ZSF1-Leprfa/cp/Crl strain MP:0005558 decreased creatinine clearance IAGP N RGD:401965414|PMID:10901178 20240206 RGD compared to WKY, SHR, ZSF1-Leprlean/Crl 401960101 ZSF1-Leprfa/cp/Crl strain MP:0005559 increased circulating glucose level IAGP N RGD:401960103|PMID:32710530 20240206 RGD compared to lean leptin receptor sufficient littermates ZSF1-Leprlean/Crl (RS:0005317) 401960101 ZSF1-Leprfa/cp/Crl strain MP:0005559 increased circulating glucose level IAGP N RGD:401965413|PMID:28746409 20240206 RGD compared to lean ZSF1-Leprlean/Crl (RS:0005317) 401960101 ZSF1-Leprfa/cp/Crl strain MP:0005559 increased circulating glucose level IAGP N RGD:401965414|PMID:10901178 20240206 RGD compared to WKY, SHR, ZSF1-Leprlean/Crl 401960101 ZSF1-Leprfa/cp/Crl strain MP:0005565 increased blood urea nitrogen level IAGP N RGD:401960095|PMID:30278832 20240206 RGD compared to lean leptin receptor sufficient littermates ZSF1-Leprlean/Crl (RS:0005317) 401960101 ZSF1-Leprfa/cp/Crl strain MP:0005565 increased blood urea nitrogen level IAGP N RGD:401965413|PMID:28746409 20240206 RGD compared to lean ZSF1-Leprlean/Crl (RS:0005317) 401960101 ZSF1-Leprfa/cp/Crl strain MP:0006144 increased systemic arterial systolic blood pressure treatment IAGP N RGD:401965412|PMID:33568522 20240206 RGD compared to treated 401960101 ZSF1-Leprfa/cp/Crl strain MP:0010018 pulmonary vascular congestion treatment IAGP N RGD:401965412|PMID:33568522 20240206 RGD compared to lean leptin receptor sufficient littermates ZSF1-Leprlean/Crl (RS:0005317), compared to treated obese 401960101 ZSF1-Leprfa/cp/Crl strain MP:0010754 abnormal heart left ventricle pressure treatment IAGP N RGD:401965412|PMID:33568522 20240206 RGD compared to lean leptin receptor sufficient littermates ZSF1-Leprlean/Crl (RS:0005317), compared to treated obese 401960101 ZSF1-Leprfa/cp/Crl strain MP:0011294 renal glomerulus hypertrophy IAGP N RGD:401960095|PMID:30278832 20240206 RGD compared to lean leptin receptor sufficient littermates ZSF1-Leprlean/Crl (RS:0005317) 401960101 ZSF1-Leprfa/cp/Crl strain MP:0011346 renal tubule atrophy IAGP N RGD:401965414|PMID:10901178 20240206 RGD compared to WKY, SHR, ZSF1-Leprlean/Crl 401960101 ZSF1-Leprfa/cp/Crl strain MP:0011353 expanded mesangial matrix IAGP N RGD:401960095|PMID:30278832 20240206 RGD compared to lean leptin receptor sufficient littermates ZSF1-Leprlean/Crl (RS:0005317) 401960101 ZSF1-Leprfa/cp/Crl strain MP:0011402 renal cast IAGP N RGD:401960095|PMID:30278832 20240206 RGD compared to lean leptin receptor sufficient littermates ZSF1-Leprlean/Crl (RS:0005317) 401960101 ZSF1-Leprfa/cp/Crl strain MP:0011402 renal cast IAGP N RGD:401965413|PMID:28746409 20240206 RGD compared to lean ZSF1-Leprlean/Crl (RS:0005317) 401960101 ZSF1-Leprfa/cp/Crl strain MP:0011402 renal cast IAGP N RGD:401965414|PMID:10901178 20240206 RGD compared to WKY, SHR, ZSF1-Leprlean/Crl 401960101 ZSF1-Leprfa/cp/Crl strain MP:0011409 increased renal glomerulus basement membrane thickness IAGP N RGD:401960095|PMID:30278832 20240206 RGD compared to lean leptin receptor sufficient littermates ZSF1-Leprlean/Crl (RS:0005317) 401960101 ZSF1-Leprfa/cp/Crl strain MP:0011431 increased urine flow rate IAGP N RGD:401965414|PMID:10901178 20240206 RGD compared to WKY, SHR, ZSF1-Leprlean/Crl 401960101 ZSF1-Leprfa/cp/Crl strain MP:0011929 abnormal aortic valve flow IAGP N RGD:401960103|PMID:32710530 20240206 RGD compared to lean leptin receptor sufficient littermates ZSF1-Leprlean/Crl (RS:0005317) 401960101 ZSF1-Leprfa/cp/Crl strain MP:0011941 increased fluid intake IAGP N RGD:401965414|PMID:10901178 20240206 RGD compared to lean littermates ZSF1-Leprlean/Crl (RS:0005317) 401960101 ZSF1-Leprfa/cp/Crl strain MP:0012106 impaired exercise endurance treatment IAGP N RGD:401965412|PMID:33568522 20240206 RGD compared to lean leptin receptor sufficient littermates ZSF1-Leprlean/Crl (RS:0005317), compared to treated obese 401960101 ZSF1-Leprfa/cp/Crl strain MP:0014144 abnormal white adipose tissue mass treatment IAGP N RGD:401965412|PMID:33568522 20240206 RGD compared to treated 401960101 ZSF1-Leprfa/cp/Crl strain MP:0014145 increased white adipose tissue mass treatment IAGP N RGD:401965412|PMID:33568522 20240206 RGD 401960101 ZSF1-Leprfa/cp/Crl strain MP:0020252 abnormal collagen level treatment IAGP N RGD:401965412|PMID:33568522 20240206 RGD compared to treated 401960101 ZSF1-Leprfa/cp/Crl strain MP:0020989 increased urine lipocalin 2 level IAGP N RGD:401960095|PMID:30278832 20240206 RGD compared to lean leptin receptor sufficient littermates ZSF1-Leprlean/Crl (RS:0005317) 401960101 ZSF1-Leprfa/cp/Crl strain MP:0021162 increased heart left ventricle anterior wall thickness IAGP N RGD:401960103|PMID:32710530 20240206 RGD compared to lean leptin receptor sufficient littermates ZSF1-Leprlean/Crl (RS:0005317) 405100226 LE-Fmr1em1Pwc strain MP:0001363 increased anxiety-related response IMP N RGD:405100224|PMID:33031903 20240322 RGD 405100226 LE-Fmr1em1Pwc strain MP:0001402 decreased locomotor activity sexual_dimorphism IMP N RGD:405100224|PMID:33031903 20240322 RGD compared to wild type male 405100226 LE-Fmr1em1Pwc strain MP:0003459 increased fear-related response sexual_dimorphism IMP N RGD:405100224|PMID:33031903 20240322 RGD compared to wild type female 405100226 LE-Fmr1em1Pwc strain MP:0004994 abnormal brain wave pattern sexual_dimorphism IMP N RGD:405100224|PMID:33031903 20240322 RGD compared to male mutant 405847397 Wakil: bHR High Responder strain MP:0020909 abnormal cue-induced reinstatement of an extinguished operant behavior for a cocaine reinforcer IAGP N RGD:405855871|PMID:27114539 20240614 RGD compared to bLR low responder strain 405847400 Wakil: bLR Low Responder strain MP:0001363 increased anxiety-related response IAGP N RGD:405866182|PMID:25071177 20240620 RGD compared to bHR strain 405850241 SD-Mir500 em1Cgen strain MP:0001973 increased thermal nociceptive threshold induces IMP XCO:0000735 N RGD:405850240|PMID:27277808 20240604 RGD 405850241 SD-Mir500 em1Cgen strain MP:0014382 increased miniature inhibitory postsynaptic current frequency IMP N RGD:405850240|PMID:27277808 20240604 RGD 405850241 SD-Mir500 em1Cgen strain MP:0020955 increased mechanical nociceptive threshold induces IMP XCO:0000735 N RGD:405850240|PMID:27277808 20240604 RGD 405850242 Mir500 em1Cgen microRNA 500 gene MP:0001973 increased thermal nociceptive threshold induces IMP XCO:0000735 N RGD:405850240|PMID:27277808 20240606 RGD 405850242 Mir500 em1Cgen microRNA 500 gene MP:0014382 increased miniature inhibitory postsynaptic current frequency IMP N RGD:405850240|PMID:27277808 20240606 RGD 405850242 Mir500 em1Cgen microRNA 500 gene MP:0020955 increased mechanical nociceptive threshold induces IMP XCO:0000735 N RGD:405850240|PMID:27277808 20240606 RGD 405855876 SD-Foxo4em1Soar strain MP:0004920 increased placenta weight IMP N RGD:158013768|PMID:36607602 20240618 RGD 405855876 SD-Foxo4em1Soar strain MP:0008957 abnormal placenta junctional zone morphology IMP N RGD:158013768|PMID:36607602 20240618 RGD 405855876 SD-Foxo4em1Soar strain MP:0011520 increased placental labyrinth size IMP N RGD:158013768|PMID:36607602 20240618 RGD 405855878 Foxo4em1Soar forkhead box O4; CRISPR/Cas9 induced mutant 1, Soar gene MP:0004920 increased placenta weight IMP N RGD:158013768|PMID:36607602 20240620 RGD 405855878 Foxo4em1Soar forkhead box O4; CRISPR/Cas9 induced mutant 1, Soar gene MP:0008957 abnormal placenta junctional zone morphology IMP N RGD:158013768|PMID:36607602 20240620 RGD 405855878 Foxo4em1Soar forkhead box O4; CRISPR/Cas9 induced mutant 1, Soar gene MP:0011520 increased placental labyrinth size IMP N RGD:158013768|PMID:36607602 20240620 RGD 407420262 SD-Nme7em1Pdra-/- strain MP:0000825 dilated lateral ventricle onset IMP N RGD:407420260|PMID:33916973 20240725 RGD compared to wild type SD littermate 407420262 SD-Nme7em1Pdra-/- strain MP:0001265 decreased body size IMP N RGD:407420260|PMID:33916973 20240725 RGD compared to heterzygeous, wild type littermate 407420262 SD-Nme7em1Pdra-/- strain MP:0002066 abnormal motor capabilities/coordination/movement onset IMP N RGD:407420260|PMID:33916973 20240725 RGD compared to wild type SD littermate 407420262 SD-Nme7em1Pdra-/- strain MP:0002152 abnormal brain morphology onset IMP N RGD:407420260|PMID:33916973 20240725 RGD compared to wild type SD littermate 407420262 SD-Nme7em1Pdra-/- strain MP:0008458 abnormal cortical ventricular zone morphology onset IMP N RGD:407420260|PMID:33916973 20240725 RGD compared to wild type SD littermate 407420262 SD-Nme7em1Pdra-/- strain MP:0011084 lethality at weaning, incomplete penetrance IMP N RGD:407420260|PMID:33916973 20240725 RGD compared to heterzygeous, wild type littermate 407420262 SD-Nme7em1Pdra-/- strain MP:0011252 situs inversus totalis IMP N RGD:407420260|PMID:33916973 20240725 RGD 407420262 SD-Nme7em1Pdra-/- strain MP:0012506 brain atrophy IMP N RGD:407420260|PMID:33916973 20240725 RGD compared to wild type SD littermate 40902840 Esr2em1Soar estrogen receptor 2; ZFN induced mutant 1, Soar gene MP:0001134 absent corpus luteum IMP N RGD:38548924|PMID:28520870 20201214 RGD 40902840 Esr2em1Soar estrogen receptor 2; ZFN induced mutant 1, Soar gene MP:0001134 absent corpus luteum IMP N RGD:38548925|PMID:29580824 20201214 RGD 40902840 Esr2em1Soar estrogen receptor 2; ZFN induced mutant 1, Soar gene MP:0001926 female infertility IMP N RGD:38548925|PMID:29580824 20201214 RGD 40902840 Esr2em1Soar estrogen receptor 2; ZFN induced mutant 1, Soar gene MP:0002773 decreased circulating luteinizing hormone level IMP N RGD:38548924|PMID:28520870 20201214 RGD 40902840 Esr2em1Soar estrogen receptor 2; ZFN induced mutant 1, Soar gene MP:0002790 decreased circulating follicle stimulating hormone level IMP N RGD:38548924|PMID:28520870 20201214 RGD 40902840 Esr2em1Soar estrogen receptor 2; ZFN induced mutant 1, Soar gene MP:0004805 absent oocytes IMP N RGD:38548924|PMID:28520870 20201214 RGD compared to wild type 40902840 Esr2em1Soar estrogen receptor 2; ZFN induced mutant 1, Soar gene MP:0004856 decreased ovary weight IMP N RGD:38548924|PMID:28520870 20201214 RGD 40902840 Esr2em1Soar estrogen receptor 2; ZFN induced mutant 1, Soar gene MP:0004856 decreased ovary weight IMP N RGD:38548925|PMID:29580824 20201214 RGD compared to wild type 40902840 Esr2em1Soar estrogen receptor 2; ZFN induced mutant 1, Soar gene MP:0004905 decreased uterus weight IMP N RGD:38548924|PMID:28520870 20201214 RGD 40902840 Esr2em1Soar estrogen receptor 2; ZFN induced mutant 1, Soar gene MP:0005158 ovary hypoplasia IMP N RGD:38548924|PMID:28520870 20201214 RGD compared to wild type 40902840 Esr2em1Soar estrogen receptor 2; ZFN induced mutant 1, Soar gene MP:0005181 decreased circulating estradiol level IMP N RGD:38548924|PMID:28520870 20201214 RGD 40902840 Esr2em1Soar estrogen receptor 2; ZFN induced mutant 1, Soar gene MP:0005185 decreased circulating progesterone level IMP N RGD:38548925|PMID:29580824 20201214 RGD compared to wild type 40902840 Esr2em1Soar estrogen receptor 2; ZFN induced mutant 1, Soar gene MP:0008869 anovulation IMP N RGD:38548924|PMID:28520870 20201214 RGD compared to wild type 40902840 Esr2em1Soar estrogen receptor 2; ZFN induced mutant 1, Soar gene MP:0008869 anovulation IMP N RGD:38548925|PMID:29580824 20201214 RGD compared to wild type 40902840 Esr2em1Soar estrogen receptor 2; ZFN induced mutant 1, Soar gene MP:0009013 abnormal proestrus IMP N RGD:38548924|PMID:28520870 20201214 RGD 40902840 Esr2em1Soar estrogen receptor 2; ZFN induced mutant 1, Soar gene MP:0009819 abnormal circulating androgen level IMP N RGD:38548925|PMID:29580824 20201214 RGD compared to wild type 40902862 Kiss1tm1Nips KiSS-1 metastasis-suppressor; targeted mutant 1, Nips gene MP:0002773 decreased circulating luteinizing hormone level IMP N RGD:10059342|PMID:25582792 20201217 RGD 40902862 Kiss1tm1Nips KiSS-1 metastasis-suppressor; targeted mutant 1, Nips gene MP:0003379 absent sexual maturation IMP N RGD:10059342|PMID:25582792 20201217 RGD 40924649 Beta IIM strain MP:0001552 increased circulating triglyceride level IAGP N RGD:724733|PMID:3440679 20210118 RGD compared to Alpha IIM 40924649 Beta IIM strain MP:0005559 increased circulating glucose level IAGP N RGD:724733|PMID:3440679 20210118 RGD compared to Alpha IIM 40924656 BN.ZUC-Leprfa strain MP:0005669 increased circulating leptin level IAGP N RGD:11570540|PMID:9032111 20210119 RGD compared to lean littermates 40924656 BN.ZUC-Leprfa strain MP:0006087 increased body mass index IAGP N RGD:11570540|PMID:9032111 20210119 RGD compared to lean littermates 40924661 LA-cp/NRll strain MP:0005669 increased circulating leptin level IAGP N RGD:11570540|PMID:9032111 20210119 RGD compared to lean littermates 40924661 LA-cp/NRll strain MP:0006087 increased body mass index IAGP N RGD:11570540|PMID:9032111 20210119 RGD compared to lean littermates 4107048 SS.SR-(D7Rat16-D7Rat189)/Jr strain MP:0006264 decreased systemic arterial systolic blood pressure IMP N RGD:69711|PMID:11247666 20100712 RGD as compared to SS/Jr on 2% Nacl diet 4107052 SS.SR-(D7Rat16-D7Mgh5)/Jr strain MP:0006264 decreased systemic arterial systolic blood pressure IMP N RGD:69711|PMID:11247666 20100712 RGD as compared to SS/Jr on 2% Nacl diet 4139856 Ets1em1Mcwi v-ets erythroblastosis virus E26 oncogene homolog 1 (avian); zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0005554 decreased circulating creatinine level induces IAGP XCO:0000795 N RGD:150429812|PMID:31932071 20211007 RGD compared to littermate 4139856 Ets1em1Mcwi v-ets erythroblastosis virus E26 oncogene homolog 1 (avian); zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0031404 increased tubuloglomerular feedback response induces IMP XCO:0000795 N RGD:150429812|PMID:31932071 20220630 RGD compared to wild type littermate 4139858 Sh2b3em1Mcwi SH2B adaptor protein 3; zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0004973 increased regulatory T cell number IMP N RGD:13442483|PMID:25776069 20171103 RGD 4139858 Sh2b3em1Mcwi SH2B adaptor protein 3; zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0005540 decreased urine albumin level IMP N RGD:13442483|PMID:25776069 20171103 RGD 4139858 Sh2b3em1Mcwi SH2B adaptor protein 3; zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0012046 decreased susceptibility to hypertension IMP N RGD:13442483|PMID:25776069 20171103 RGD 4139863 Renem1Mcwi renin; zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0001262 decreased body weight IMP N RGD:7771614|PMID:21242461 20220203 RGD compared to wild type 4139863 Renem1Mcwi renin; zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0002135 abnormal kidney morphology exacerbates IMP N RGD:7771614|PMID:21242461 20220203 RGD compared to wild type 4139863 Renem1Mcwi renin; zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0002626 increased heart rate IMP N RGD:7771614|PMID:21242461 20220203 RGD compared to wild type 4139863 Renem1Mcwi renin; zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0002941 increased circulating alanine transaminase level IMP N RGD:7771614|PMID:21242461 20220203 RGD compared to wild type 4139863 Renem1Mcwi renin; zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0002963 decreased urine protein level IMP N RGD:7771614|PMID:21242461 20220203 RGD compared to wild type 4139863 Renem1Mcwi renin; zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0003017 decreased circulating bicarbonate level IMP N RGD:7771614|PMID:21242461 20220203 RGD compared to wild type 4139863 Renem1Mcwi renin; zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0004876 decreased mean systemic arterial blood pressure IMP N RGD:7771614|PMID:21242461 20220203 RGD compared to wild type 4139863 Renem1Mcwi renin; zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0004876 decreased mean systemic arterial blood pressure sexual_dimorphism IMP N RGD:7771614|PMID:21242461 20220203 RGD compared to wild type male 4139863 Renem1Mcwi renin; zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0005553 increased circulating creatinine level IMP N RGD:7771614|PMID:21242461 20220203 RGD compared to wild type 4139863 Renem1Mcwi renin; zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0005558 decreased creatinine clearance IMP N RGD:7771614|PMID:21242461 20220203 RGD compared to wild type 4139863 Renem1Mcwi renin; zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0005565 increased blood urea nitrogen level IMP N RGD:7771614|PMID:21242461 20220203 RGD 4139863 Renem1Mcwi renin; zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0006263 decreased systemic arterial diastolic blood pressure IMP N RGD:7771614|PMID:21242461 20220203 RGD compared to wild type 4139863 Renem1Mcwi renin; zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0006263 decreased systemic arterial diastolic blood pressure sexual_dimorphism IMP N RGD:7771614|PMID:21242461 20220203 RGD compared to wild type male 4139863 Renem1Mcwi renin; zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0006264 decreased systemic arterial systolic blood pressure IMP N RGD:7771614|PMID:21242461 20220203 RGD compared to wild type 4139863 Renem1Mcwi renin; zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0006264 decreased systemic arterial systolic blood pressure sexual_dimorphism IMP N RGD:7771614|PMID:21242461 20220203 RGD compared to wild type male 4139863 Renem1Mcwi renin; zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0011431 increased urine flow rate IMP N RGD:7771614|PMID:21242461 20220203 RGD compared to wild type 4139863 Renem1Mcwi renin; zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0011471 decreased urine creatinine level IMP N RGD:7771614|PMID:21242461 20220203 RGD compared to wild type 4139865 Rag1em1Mcwi recombination activating gene 1; zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0004875 increased mean systemic arterial blood pressure IMP N RGD:7207429|PMID:23364523 20201210 RGD on 4% NaCl diet 4139865 Rag1em1Mcwi recombination activating gene 1; zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0004956 decreased thymus weight IMP N RGD:7207429|PMID:23364523 20170417 RGD 4139865 Rag1em1Mcwi recombination activating gene 1; zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0005017 decreased B cell number IMP N RGD:7207429|PMID:23364523 20170417 RGD 4139865 Rag1em1Mcwi recombination activating gene 1; zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0005018 decreased T cell number IMP N RGD:7207429|PMID:23364523 20170417 RGD 4139865 Rag1em1Mcwi recombination activating gene 1; zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0005540 decreased urine albumin level IMP N RGD:7207429|PMID:23364523 20170417 RGD 4139866 Rag1em2Mcwi recombination activating gene 1; zinc finger nuclease induced mutant 2, Medical College of Wisconsin gene MP:0004875 increased mean systemic arterial blood pressure IMP N RGD:7207429|PMID:23364523 20201210 RGD on 4% NaCl diet 4139866 Rag1em2Mcwi recombination activating gene 1; zinc finger nuclease induced mutant 2, Medical College of Wisconsin gene MP:0004956 decreased thymus weight IMP N RGD:7207429|PMID:23364523 20170417 RGD 4139866 Rag1em2Mcwi recombination activating gene 1; zinc finger nuclease induced mutant 2, Medical College of Wisconsin gene MP:0005540 decreased urine albumin level IMP N RGD:7207429|PMID:23364523 20201210 RGD as compared to SS-Rag1em1Mcwi on 4% NaCl diet 4139867 Rab38em1Mcwi RAB38, member RAS oncogene family; zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0002962 increased urine protein level IAGP N RGD:13782139|PMID:23291471 20201210 RGD compared to FHH-Tg(CAG-Rab38)1Mcwi, FHH.BN-(D1Hmgc14-D1Hmgc15)/Mcwi 4139868 Nox4em2Mcwi NADPH oxidase 4; zinc finger nuclease induced mutant 2, Medical College of Wisconsin gene MP:0003674 oxidative stress severity IMP N RGD:11085830|PMID:26644237 20190103 RGD 4139868 Nox4em2Mcwi NADPH oxidase 4; zinc finger nuclease induced mutant 2, Medical College of Wisconsin gene MP:0004876 decreased mean systemic arterial blood pressure IMP N RGD:11085830|PMID:26644237 20201210 RGD compared to SS/JrHsdMcwi 4139868 Nox4em2Mcwi NADPH oxidase 4; zinc finger nuclease induced mutant 2, Medical College of Wisconsin gene MP:0004876 decreased mean systemic arterial blood pressure induced IMP XCO:0000022 N RGD:11085830|PMID:26644237 20190103 RGD 4139868 Nox4em2Mcwi NADPH oxidase 4; zinc finger nuclease induced mutant 2, Medical College of Wisconsin gene MP:0005540 decreased urine albumin level IMP N RGD:11085830|PMID:26644237 20201210 RGD compared to SS/JrHsdMcwi 4139868 Nox4em2Mcwi NADPH oxidase 4; zinc finger nuclease induced mutant 2, Medical College of Wisconsin gene MP:0005540 decreased urine albumin level induced IMP XCO:0000022 N RGD:11085830|PMID:26644237 20190103 RGD 4139868 Nox4em2Mcwi NADPH oxidase 4; zinc finger nuclease induced mutant 2, Medical College of Wisconsin gene MP:0012046 decreased susceptibility to hypertension IMP N RGD:11085830|PMID:26644237 20201210 RGD compared to SS/JrHsdMcwi 4139868 Nox4em2Mcwi NADPH oxidase 4; zinc finger nuclease induced mutant 2, Medical College of Wisconsin gene MP:0012046 decreased susceptibility to hypertension induced IMP XCO:0000022 N RGD:11085830|PMID:26644237 20190103 RGD 4139869 Mmp2em2Mcwi matrix metallopeptidase 2; zinc finger nuclease induced mutant 2, Medical College of Wisconsin gene MP:0002963 decreased urine protein level IMP N RGD:401827835|PMID:37643020 20231116 RGD compared to wild type SS 4139869 Mmp2em2Mcwi matrix metallopeptidase 2; zinc finger nuclease induced mutant 2, Medical College of Wisconsin gene MP:0003071 decreased vascular permeability ameliorates IMP N RGD:401827835|PMID:37643020 20231116 RGD associated with Experimental Diabetes Mellitus, compared to wild type SS 4139869 Mmp2em2Mcwi matrix metallopeptidase 2; zinc finger nuclease induced mutant 2, Medical College of Wisconsin gene MP:0003215 renal interstitial fibrosis ameliorates IMP N RGD:401827835|PMID:37643020 20231116 RGD compared to wild type SS 4139869 Mmp2em2Mcwi matrix metallopeptidase 2; zinc finger nuclease induced mutant 2, Medical College of Wisconsin gene MP:0003918 decreased kidney weight IMP N RGD:401827835|PMID:37643020 20231116 RGD associated Experimental Diabetes Mellitus, hypertension; compared to wild type SS 4139869 Mmp2em2Mcwi matrix metallopeptidase 2; zinc finger nuclease induced mutant 2, Medical College of Wisconsin gene MP:0005264 glomerulosclerosis ameliorates IMP N RGD:401827835|PMID:37643020 20231116 RGD compared to wild type SS 4139869 Mmp2em2Mcwi matrix metallopeptidase 2; zinc finger nuclease induced mutant 2, Medical College of Wisconsin gene MP:0005527 increased renal glomerular filtration rate IMP N RGD:401827835|PMID:37643020 20231116 RGD compared to wild type SS 4139869 Mmp2em2Mcwi matrix metallopeptidase 2; zinc finger nuclease induced mutant 2, Medical College of Wisconsin gene MP:0005554 decreased circulating creatinine level IMP N RGD:401827835|PMID:37643020 20231116 RGD compared to wild type SS 4139869 Mmp2em2Mcwi matrix metallopeptidase 2; zinc finger nuclease induced mutant 2, Medical College of Wisconsin gene MP:0008838 decreased transforming growth factor beta level IMP N RGD:401827835|PMID:37643020 20231116 RGD compared to wild type SS 4139869 Mmp2em2Mcwi matrix metallopeptidase 2; zinc finger nuclease induced mutant 2, Medical College of Wisconsin gene MP:0011863 abnormal podocyte physiology ameliorates IMP N RGD:401827835|PMID:37643020 20231116 RGD associated with Experimental Diabetes Mellitus, compared to wild type SS 4139873 SS-Rag1em2Mcwi strain MP:0004875 increased mean systemic arterial blood pressure IMP N RGD:7207429|PMID:23364523 20130204 RGD on 4% NaCl diet 4139873 SS-Rag1em2Mcwi strain MP:0004956 decreased thymus weight IMP N RGD:7207429|PMID:23364523 20130204 RGD as compared to SS 4139873 SS-Rag1em2Mcwi strain MP:0005540 decreased urine albumin level IMP N RGD:7207429|PMID:23364523 20130204 RGD as compared to SS-Rag1em1Mcwi on 4% NaCl diet 4139884 SS-Rag1em1Mcwi strain MP:0004875 increased mean systemic arterial blood pressure IMP N RGD:7207429|PMID:23364523 20130204 RGD on 4% NaCl diet 4139884 SS-Rag1em1Mcwi strain MP:0005017 decreased B cell number IMP N RGD:7207429|PMID:23364523 20170417 RGD as compared to SS 4139884 SS-Rag1em1Mcwi strain MP:0005018 decreased T cell number IMP N RGD:7207429|PMID:23364523 20170417 RGD as compared to SS 4140405 LEXF6A/Stm strain MP:0002024 increased T cell derived lymphoma incidence penetrance IAGP XCO:0000437 N RGD:619600|PMID:10360666 20200710 RGD 4140405 LEXF6A/Stm strain MP:0002026 increased leukemia incidence penetrance IAGP XCO:0000437 N RGD:619600|PMID:10360666 20200710 RGD 4140408 LEXF8C/Stm strain MP:0002026 increased leukemia incidence induced IAGP XCO:0000437 N RGD:619600|PMID:10360666 20200710 RGD 4140413 LEXF1B/Stm strain MP:0002024 increased T cell derived lymphoma incidence induced IAGP XCO:0000437 N RGD:619600|PMID:10360666 20200710 RGD 41404646 SD-Lrp5em1Vari strain MP:0000559 abnormal femur morphology IMP N RGD:40902996|PMID:32833527 20210206 RGD 41404646 SD-Lrp5em1Vari strain MP:0009346 decreased trabecular bone thickness IMP N RGD:40902996|PMID:32833527 20210206 RGD 41404646 SD-Lrp5em1Vari strain MP:0010097 abnormal retina blood vessel morphology IMP N RGD:40902996|PMID:32833527 20210206 RGD 41404646 SD-Lrp5em1Vari strain MP:0010098 abnormal retina blood vessel pattern IMP N RGD:40902996|PMID:32833527 20210206 RGD 41404646 SD-Lrp5em1Vari strain MP:0010869 decreased bone trabecula number IMP N RGD:40902996|PMID:32833527 20210206 RGD 41404646 SD-Lrp5em1Vari strain MP:0010873 decreased trabecular bone mass IMP N RGD:40902996|PMID:32833527 20210206 RGD 41404646 SD-Lrp5em1Vari strain MP:0013630 increased bone trabecular spacing IMP N RGD:40902996|PMID:32833527 20210206 RGD 41404647 Lrp5em1Vari LDL receptor related protein 5;CRISPR/Cas9 induced mutant 1, Vari gene MP:0000559 abnormal femur morphology IMP N RGD:40902996|PMID:32833527 20210211 RGD 41404647 Lrp5em1Vari LDL receptor related protein 5;CRISPR/Cas9 induced mutant 1, Vari gene MP:0009346 decreased trabecular bone thickness IMP N RGD:40902996|PMID:32833527 20210211 RGD 41404647 Lrp5em1Vari LDL receptor related protein 5;CRISPR/Cas9 induced mutant 1, Vari gene MP:0010097 abnormal retina blood vessel morphology IMP N RGD:40902996|PMID:32833527 20210211 RGD 41404647 Lrp5em1Vari LDL receptor related protein 5;CRISPR/Cas9 induced mutant 1, Vari gene MP:0010098 abnormal retina blood vessel pattern IMP N RGD:40902996|PMID:32833527 20210211 RGD 41404647 Lrp5em1Vari LDL receptor related protein 5;CRISPR/Cas9 induced mutant 1, Vari gene MP:0010869 decreased bone trabecula number IMP N RGD:40902996|PMID:32833527 20210211 RGD 41404647 Lrp5em1Vari LDL receptor related protein 5;CRISPR/Cas9 induced mutant 1, Vari gene MP:0010873 decreased trabecular bone mass IMP N RGD:40902996|PMID:32833527 20210211 RGD 41404647 Lrp5em1Vari LDL receptor related protein 5;CRISPR/Cas9 induced mutant 1, Vari gene MP:0013630 increased bone trabecular spacing IMP N RGD:40902996|PMID:32833527 20210211 RGD 41404648 SD-Lrp5em2Vari strain MP:0000559 abnormal femur morphology IMP N RGD:40902996|PMID:32833527 20210206 RGD 41404648 SD-Lrp5em2Vari strain MP:0009346 decreased trabecular bone thickness IMP N RGD:40902996|PMID:32833527 20210206 RGD 41404648 SD-Lrp5em2Vari strain MP:0010097 abnormal retina blood vessel morphology IMP N RGD:40902996|PMID:32833527 20210206 RGD 41404648 SD-Lrp5em2Vari strain MP:0010098 abnormal retina blood vessel pattern IMP N RGD:40902996|PMID:32833527 20210206 RGD 41404648 SD-Lrp5em2Vari strain MP:0010873 decreased trabecular bone mass IMP N RGD:40902996|PMID:32833527 20210206 RGD 41404648 SD-Lrp5em2Vari strain MP:0013630 increased bone trabecular spacing sexual_dimorphism IMP N RGD:40902996|PMID:32833527 20210206 RGD 41404650 Lrp5em2Vari LDL receptor related protein 5; CRISPR/Cas9 induced mutant 2, Vari gene MP:0000559 abnormal femur morphology IMP N RGD:40902996|PMID:32833527 20210211 RGD 41404650 Lrp5em2Vari LDL receptor related protein 5; CRISPR/Cas9 induced mutant 2, Vari gene MP:0009346 decreased trabecular bone thickness IMP N RGD:40902996|PMID:32833527 20210211 RGD 41404650 Lrp5em2Vari LDL receptor related protein 5; CRISPR/Cas9 induced mutant 2, Vari gene MP:0010097 abnormal retina blood vessel morphology IMP N RGD:40902996|PMID:32833527 20210211 RGD 41404650 Lrp5em2Vari LDL receptor related protein 5; CRISPR/Cas9 induced mutant 2, Vari gene MP:0010098 abnormal retina blood vessel pattern IMP N RGD:40902996|PMID:32833527 20210211 RGD 41404650 Lrp5em2Vari LDL receptor related protein 5; CRISPR/Cas9 induced mutant 2, Vari gene MP:0010873 decreased trabecular bone mass IMP N RGD:40902996|PMID:32833527 20210211 RGD 41404650 Lrp5em2Vari LDL receptor related protein 5; CRISPR/Cas9 induced mutant 2, Vari gene MP:0013630 increased bone trabecular spacing sexual_dimorphism IMP N RGD:40902996|PMID:32833527 20210211 RGD 41404651 SD-Lrp5em3Vari strain MP:0000559 abnormal femur morphology IMP N RGD:40902996|PMID:32833527 20210206 RGD 41404651 SD-Lrp5em3Vari strain MP:0009346 decreased trabecular bone thickness IMP N RGD:40902996|PMID:32833527 20210206 RGD 41404651 SD-Lrp5em3Vari strain MP:0010097 abnormal retina blood vessel morphology IMP N RGD:40902996|PMID:32833527 20210206 RGD 41404651 SD-Lrp5em3Vari strain MP:0010098 abnormal retina blood vessel pattern IMP N RGD:40902996|PMID:32833527 20210206 RGD 41404651 SD-Lrp5em3Vari strain MP:0010869 decreased bone trabecula number IMP N RGD:40902996|PMID:32833527 20210206 RGD 41404651 SD-Lrp5em3Vari strain MP:0010873 decreased trabecular bone mass IMP N RGD:40902996|PMID:32833527 20210206 RGD 41404651 SD-Lrp5em3Vari strain MP:0013630 increased bone trabecular spacing sexual_dimorphism IMP N RGD:40902996|PMID:32833527 20210206 RGD 41404652 Lrp5em3Vari LDL receptor related protein 5; CRISPR/Cas9 induced mutant 3, Vari gene MP:0000559 abnormal femur morphology IMP N RGD:40902996|PMID:32833527 20210211 RGD 41404652 Lrp5em3Vari LDL receptor related protein 5; CRISPR/Cas9 induced mutant 3, Vari gene MP:0009346 decreased trabecular bone thickness IMP N RGD:40902996|PMID:32833527 20210211 RGD 41404652 Lrp5em3Vari LDL receptor related protein 5; CRISPR/Cas9 induced mutant 3, Vari gene MP:0010097 abnormal retina blood vessel morphology IMP N RGD:40902996|PMID:32833527 20210211 RGD 41404652 Lrp5em3Vari LDL receptor related protein 5; CRISPR/Cas9 induced mutant 3, Vari gene MP:0010098 abnormal retina blood vessel pattern IMP N RGD:40902996|PMID:32833527 20210211 RGD 41404652 Lrp5em3Vari LDL receptor related protein 5; CRISPR/Cas9 induced mutant 3, Vari gene MP:0010869 decreased bone trabecula number IMP N RGD:40902996|PMID:32833527 20210211 RGD 41404652 Lrp5em3Vari LDL receptor related protein 5; CRISPR/Cas9 induced mutant 3, Vari gene MP:0010873 decreased trabecular bone mass IMP N RGD:40902996|PMID:32833527 20210211 RGD 41404652 Lrp5em3Vari LDL receptor related protein 5; CRISPR/Cas9 induced mutant 3, Vari gene MP:0013630 increased bone trabecular spacing sexual_dimorphism IMP N RGD:40902996|PMID:32833527 20210211 RGD 41404723 DA.W-Ncf1W/Rhd strain MP:0003186 abnormal redox activity severity IAGP XCO:0000263 N RGD:41404729|PMID:21275845 20210208 RGD DNA:polymorphism:M153T (rat) 41404723 DA.W-Ncf1W/Rhd strain MP:0003436 decreased susceptibility to induced arthritis severity IAGP XCO:0000263 N RGD:41404729|PMID:21275845 20210208 RGD DNA:polymorphism:M153T (rat) 41408337 DA.F344-Dpp4DPPIV/SvH strain MP:0001263 weight loss induced IAGP XCO:0000801 N RGD:41408336|PMID:19327106 20210209 RGD compared to DA/Ztm 41408337 DA.F344-Dpp4DPPIV/SvH strain MP:0001364 decreased anxiety-related response IAGP N RGD:41408336|PMID:19327106 20210209 RGD compared to DA/Ztm 41408337 DA.F344-Dpp4DPPIV/SvH strain MP:0001415 increased exploration in new environment IAGP N RGD:41408336|PMID:19327106 20210209 RGD compared to DA/Ztm 41408337 DA.F344-Dpp4DPPIV/SvH strain MP:0001566 increased circulating phosphate level IAGP N RGD:41408336|PMID:19327106 20210209 RGD compared to DA/Ztm 41408337 DA.F344-Dpp4DPPIV/SvH strain MP:0002644 decreased circulating triglyceride level IAGP N RGD:41408336|PMID:19327106 20210209 RGD compared to DA/Ztm 41408337 DA.F344-Dpp4DPPIV/SvH strain MP:0002664 decreased circulating adrenocorticotropin level IAGP N RGD:41408336|PMID:19327106 20210209 RGD compared to DA/Ztm 41408337 DA.F344-Dpp4DPPIV/SvH strain MP:0002665 decreased circulating corticosterone level IAGP N RGD:41408336|PMID:19327106 20210209 RGD compared to DA/Ztm 41408337 DA.F344-Dpp4DPPIV/SvH strain MP:0002712 increased circulating glucagon level IAGP N RGD:41408336|PMID:19327106 20210209 RGD compared to DA/Ztm 41408337 DA.F344-Dpp4DPPIV/SvH strain MP:0002942 decreased circulating alanine transaminase level IAGP N RGD:41408336|PMID:19327106 20210209 RGD compared to DA/Ztm 41408337 DA.F344-Dpp4DPPIV/SvH strain MP:0002966 decreased circulating alkaline phosphatase level IAGP N RGD:41408336|PMID:19327106 20210209 RGD compared to DA/Ztm 41408337 DA.F344-Dpp4DPPIV/SvH strain MP:0004977 increased B-1 B cell number IAGP N RGD:41408336|PMID:19327106 20210209 RGD compared to DA/Ztm 41408337 DA.F344-Dpp4DPPIV/SvH strain MP:0005012 decreased eosinophil cell number IAGP N RGD:41408336|PMID:19327106 20210209 RGD compared to DA/Ztm 41408337 DA.F344-Dpp4DPPIV/SvH strain MP:0005016 decreased lymphocyte cell number IAGP N RGD:41408336|PMID:19327106 20210209 RGD compared to DA/Ztm 41408337 DA.F344-Dpp4DPPIV/SvH strain MP:0005070 impaired natural killer cell mediated cytotoxicity IAGP N RGD:41408336|PMID:19327106 20210209 RGD compared to DA/Ztm 41408337 DA.F344-Dpp4DPPIV/SvH strain MP:0005292 improved glucose tolerance induced IAGP XCO:0000103 N RGD:41408336|PMID:19327106 20210209 RGD compared to DA/Ztm 41408337 DA.F344-Dpp4DPPIV/SvH strain MP:0005565 increased blood urea nitrogen level IAGP N RGD:41408336|PMID:19327106 20210209 RGD compared to DA/Ztm 41408337 DA.F344-Dpp4DPPIV/SvH strain MP:0005632 decreased circulating aspartate transaminase level IAGP N RGD:41408336|PMID:19327106 20210209 RGD compared to DA/Ztm 41408337 DA.F344-Dpp4DPPIV/SvH strain MP:0005659 decreased susceptibility to diet-induced obesity induced IAGP XCO:0000015 N RGD:41408336|PMID:19327106 20210209 RGD compared to DA/Ztm 41408337 DA.F344-Dpp4DPPIV/SvH strain MP:0008044 increased NK cell number IAGP N RGD:41408336|PMID:19327106 20210209 RGD compared to DA/Ztm 41408337 DA.F344-Dpp4DPPIV/SvH strain MP:0008597 decreased circulating interleukin-6 level IAGP N RGD:41408336|PMID:19327106 20210209 RGD compared to DA/Ztm 41408337 DA.F344-Dpp4DPPIV/SvH strain MP:0008706 decreased interleukin-6 secretion IAGP N RGD:41408336|PMID:19327106 20210209 RGD compared to DA/Ztm 41408337 DA.F344-Dpp4DPPIV/SvH strain MP:0010167 decreased response to stress-induced hyperthermia IAGP N RGD:41408336|PMID:19327106 20210209 RGD compared to DA/Ztm 41408337 DA.F344-Dpp4DPPIV/SvH strain MP:0010182 decreased susceptibility to weight gain IAGP N RGD:41408336|PMID:19327106 20210209 RGD compared to DA/Ztm 41408339 WI.SD-PcloTn(sb-B-Geo)Fkh strain MP:0000852 small cerebellum IMP N RGD:41408338|PMID:31074746 20210210 RGD compared to wild-type rat 41408339 WI.SD-PcloTn(sb-B-Geo)Fkh strain MP:0000890 thin cerebellar molecular layer IMP N RGD:41408338|PMID:31074746 20210210 RGD compared to wild-type rat 41408339 WI.SD-PcloTn(sb-B-Geo)Fkh strain MP:0001258 decreased body length IMP N RGD:41408338|PMID:31074746 20210210 RGD compared to wild-type rat 41408339 WI.SD-PcloTn(sb-B-Geo)Fkh strain MP:0001262 decreased body weight IMP N RGD:41408338|PMID:31074746 20210210 RGD compared to wild-type rat 41408339 WI.SD-PcloTn(sb-B-Geo)Fkh strain MP:0002175 decreased brain weight IMP N RGD:41408338|PMID:31074746 20210210 RGD compared to wild-type rat 41408339 WI.SD-PcloTn(sb-B-Geo)Fkh strain MP:0004099 abnormal cerebellar glomerulus morphology IMP N RGD:41408338|PMID:31074746 20210210 RGD compared to wild-type rat 41408339 WI.SD-PcloTn(sb-B-Geo)Fkh strain MP:0006099 thin cerebellar granule layer IMP N RGD:41408338|PMID:31074746 20210210 RGD compared to wild-type rat 41408339 WI.SD-PcloTn(sb-B-Geo)Fkh strain MP:0011269 increased excitatory postsynaptic current amplitude IMP N RGD:41408338|PMID:31074746 20210210 RGD compared to wild-type rat 41408339 WI.SD-PcloTn(sb-B-Geo)Fkh strain MP:0020533 decreased pons size IMP N RGD:41408338|PMID:31074746 20210210 RGD compared to wild-type rat 41408340 PcloTn(sb-B-Geo)Fkh presynaptic cytomatrix protein; sleeping beauty transposon induced mutant, Fkh gene MP:0000852 small cerebellum IMP N RGD:41408338|PMID:31074746 20210211 RGD compared to wild-type rat 41408340 PcloTn(sb-B-Geo)Fkh presynaptic cytomatrix protein; sleeping beauty transposon induced mutant, Fkh gene MP:0000890 thin cerebellar molecular layer IMP N RGD:41408338|PMID:31074746 20210211 RGD compared to wild-type rat 41408340 PcloTn(sb-B-Geo)Fkh presynaptic cytomatrix protein; sleeping beauty transposon induced mutant, Fkh gene MP:0001258 decreased body length IMP N RGD:41408338|PMID:31074746 20210211 RGD compared to wild-type rat 41408340 PcloTn(sb-B-Geo)Fkh presynaptic cytomatrix protein; sleeping beauty transposon induced mutant, Fkh gene MP:0001262 decreased body weight IMP N RGD:41408338|PMID:31074746 20210211 RGD compared to wild-type rat 41408340 PcloTn(sb-B-Geo)Fkh presynaptic cytomatrix protein; sleeping beauty transposon induced mutant, Fkh gene MP:0002175 decreased brain weight IMP N RGD:41408338|PMID:31074746 20210211 RGD compared to wild-type rat 41408340 PcloTn(sb-B-Geo)Fkh presynaptic cytomatrix protein; sleeping beauty transposon induced mutant, Fkh gene MP:0004099 abnormal cerebellar glomerulus morphology IMP N RGD:41408338|PMID:31074746 20210211 RGD compared to wild-type rat 41408340 PcloTn(sb-B-Geo)Fkh presynaptic cytomatrix protein; sleeping beauty transposon induced mutant, Fkh gene MP:0004770 abnormal synaptic vesicle recycling IMP N RGD:41408338|PMID:31074746 20210210 RGD 41408340 PcloTn(sb-B-Geo)Fkh presynaptic cytomatrix protein; sleeping beauty transposon induced mutant, Fkh gene MP:0004792 abnormal synaptic vesicle number IMP N RGD:41408338|PMID:31074746 20210210 RGD 41408340 PcloTn(sb-B-Geo)Fkh presynaptic cytomatrix protein; sleeping beauty transposon induced mutant, Fkh gene MP:0006099 thin cerebellar granule layer IMP N RGD:41408338|PMID:31074746 20210211 RGD compared to wild-type rat 41408340 PcloTn(sb-B-Geo)Fkh presynaptic cytomatrix protein; sleeping beauty transposon induced mutant, Fkh gene MP:0011269 increased excitatory postsynaptic current amplitude IMP N RGD:41408338|PMID:31074746 20210211 RGD compared to wild-type rat 41408340 PcloTn(sb-B-Geo)Fkh presynaptic cytomatrix protein; sleeping beauty transposon induced mutant, Fkh gene MP:0020533 decreased pons size IMP N RGD:41408338|PMID:31074746 20210211 RGD compared to wild-type rat 41410881 WI-Grm2em1 strain MP:0001973 increased thermal nociceptive threshold IMP N RGD:38501063|PMID:30283001 20210217 RGD KO compared to wild-type rats 41410881 WI-Grm2em1 strain MP:0001981 increased chemically-elicited antinociception IMP N RGD:38501063|PMID:30283001 20210217 RGD KO compared to wild-type rats 41410881 WI-Grm2em1 strain MP:0002555 addiction IMP N RGD:38501064|PMID:28700935 20210217 RGD KO compared to wild-type rats 41410881 WI-Grm2em1 strain MP:0005445 abnormal neurotransmitter secretion IMP N RGD:38501063|PMID:30283001 20210217 RGD KO compared to wild-type rats 41410881 WI-Grm2em1 strain MP:0005445 abnormal neurotransmitter secretion IMP N RGD:38501064|PMID:28700935 20210217 RGD KO compared to wild-type rats 41410881 WI-Grm2em1 strain MP:0009748 abnormal behavioral response to addictive substance IMP N RGD:38501063|PMID:30283001 20210217 RGD KO compared to wild-type rats 41410881 WI-Grm2em1 strain MP:0009752 enhanced behavioral response to nicotine IMP N RGD:38501064|PMID:28700935 20210217 RGD KO compared to wild-type rats 41410881 WI-Grm2em1 strain MP:0009753 enhanced behavioral response to morphine IMP N RGD:38501063|PMID:30283001 20210217 RGD KO compared to wild-type rats 41410881 WI-Grm2em1 strain MP:0009754 enhanced behavioral response to cocaine IMP N RGD:38501064|PMID:28700935 20210217 RGD KO compared to wild-type rats 41410881 WI-Grm2em1 strain MP:0009774 abnormal behavioral withdrawal response IMP N RGD:38501063|PMID:30283001 20210217 RGD KO compared to wild-type rats 41410881 WI-Grm2em1 strain MP:0012342 high preference for an addictive substance IMP N RGD:38501063|PMID:30283001 20210217 RGD KO compared to wild-type rats 41410881 WI-Grm2em1 strain MP:0013919 abnormal response to electrical stimuli IMP N RGD:38501064|PMID:28700935 20210217 RGD KO compared to wild-type rats 41410881 WI-Grm2em1 strain MP:0020159 abnormal behavioral response to morphine IMP N RGD:38501063|PMID:30283001 20210217 RGD KO compared to wild-type rats 41410881 WI-Grm2em1 strain MP:0020374 abnormal nocifensive behavior IMP N RGD:38501063|PMID:30283001 20210217 RGD KO compared to wild-type rats 41410881 WI-Grm2em1 strain MP:0020876 increased nervous system dopamine level IMP N RGD:38501063|PMID:30283001 20210217 RGD KO compared to wild-type rats 41410881 WI-Grm2em1 strain MP:0020905 abnormal cocaine self-administration IMP N RGD:38501064|PMID:28700935 20210217 RGD KO compared to wild-type rats 41410881 WI-Grm2em1 strain MP:0020907 abnormal extinction of cocaine self-administration IMP N RGD:38501064|PMID:28700935 20210217 RGD KO compared to wild-type rats 41410881 WI-Grm2em1 strain MP:0020909 abnormal cue-induced reinstatement of an extinguished operant behavior for a cocaine reinforcer IMP N RGD:38501063|PMID:30283001 20210217 RGD KO compared to wild-type rats 41410881 WI-Grm2em1 strain MP:0020909 abnormal cue-induced reinstatement of an extinguished operant behavior for a cocaine reinforcer IMP N RGD:38501064|PMID:28700935 20210217 RGD KO compared to wild-type rats 41410882 Grm2em1 glutamate metabotropic receptor 2; endonuclease induced mutant 1 gene MP:0001973 increased thermal nociceptive threshold IMP N RGD:38501063|PMID:30283001 20210225 RGD KO compared to wild-type rats 41410882 Grm2em1 glutamate metabotropic receptor 2; endonuclease induced mutant 1 gene MP:0001981 increased chemically-elicited antinociception IMP N RGD:38501063|PMID:30283001 20210225 RGD KO compared to wild-type rats 41410882 Grm2em1 glutamate metabotropic receptor 2; endonuclease induced mutant 1 gene MP:0002555 addiction IMP N RGD:38501064|PMID:28700935 20210225 RGD KO compared to wild-type rats 41410882 Grm2em1 glutamate metabotropic receptor 2; endonuclease induced mutant 1 gene MP:0005445 abnormal neurotransmitter secretion IMP N RGD:38501063|PMID:30283001 20210225 RGD KO compared to wild-type rats 41410882 Grm2em1 glutamate metabotropic receptor 2; endonuclease induced mutant 1 gene MP:0005445 abnormal neurotransmitter secretion IMP N RGD:38501064|PMID:28700935 20210225 RGD KO compared to wild-type rats 41410882 Grm2em1 glutamate metabotropic receptor 2; endonuclease induced mutant 1 gene MP:0009748 abnormal behavioral response to addictive substance IMP N RGD:38501063|PMID:30283001 20210225 RGD KO compared to wild-type rats 41410882 Grm2em1 glutamate metabotropic receptor 2; endonuclease induced mutant 1 gene MP:0009752 enhanced behavioral response to nicotine IMP N RGD:38501064|PMID:28700935 20210225 RGD KO compared to wild-type rats 41410882 Grm2em1 glutamate metabotropic receptor 2; endonuclease induced mutant 1 gene MP:0009753 enhanced behavioral response to morphine IMP N RGD:38501063|PMID:30283001 20210225 RGD KO compared to wild-type rats 41410882 Grm2em1 glutamate metabotropic receptor 2; endonuclease induced mutant 1 gene MP:0009754 enhanced behavioral response to cocaine IMP N RGD:38501064|PMID:28700935 20210225 RGD KO compared to wild-type rats 41410882 Grm2em1 glutamate metabotropic receptor 2; endonuclease induced mutant 1 gene MP:0009774 abnormal behavioral withdrawal response IMP N RGD:38501063|PMID:30283001 20210225 RGD KO compared to wild-type rats 41410882 Grm2em1 glutamate metabotropic receptor 2; endonuclease induced mutant 1 gene MP:0012342 high preference for an addictive substance IMP N RGD:38501063|PMID:30283001 20210225 RGD KO compared to wild-type rats 41410882 Grm2em1 glutamate metabotropic receptor 2; endonuclease induced mutant 1 gene MP:0013919 abnormal response to electrical stimuli IMP N RGD:38501064|PMID:28700935 20210225 RGD KO compared to wild-type rats 41410882 Grm2em1 glutamate metabotropic receptor 2; endonuclease induced mutant 1 gene MP:0020159 abnormal behavioral response to morphine IMP N RGD:38501063|PMID:30283001 20210225 RGD KO compared to wild-type rats 41410882 Grm2em1 glutamate metabotropic receptor 2; endonuclease induced mutant 1 gene MP:0020374 abnormal nocifensive behavior IMP N RGD:38501063|PMID:30283001 20210225 RGD KO compared to wild-type rats 41410882 Grm2em1 glutamate metabotropic receptor 2; endonuclease induced mutant 1 gene MP:0020876 increased nervous system dopamine level IMP N RGD:38501063|PMID:30283001 20210225 RGD KO compared to wild-type rats 41410882 Grm2em1 glutamate metabotropic receptor 2; endonuclease induced mutant 1 gene MP:0020905 abnormal cocaine self-administration IMP N RGD:38501064|PMID:28700935 20210225 RGD KO compared to wild-type rats 41410882 Grm2em1 glutamate metabotropic receptor 2; endonuclease induced mutant 1 gene MP:0020907 abnormal extinction of cocaine self-administration IMP N RGD:38501064|PMID:28700935 20210225 RGD KO compared to wild-type rats 41410882 Grm2em1 glutamate metabotropic receptor 2; endonuclease induced mutant 1 gene MP:0020909 abnormal cue-induced reinstatement of an extinguished operant behavior for a cocaine reinforcer IMP N RGD:38501063|PMID:30283001 20210225 RGD KO compared to wild-type rats 41410882 Grm2em1 glutamate metabotropic receptor 2; endonuclease induced mutant 1 gene MP:0020909 abnormal cue-induced reinstatement of an extinguished operant behavior for a cocaine reinforcer IMP N RGD:38501064|PMID:28700935 20210225 RGD KO compared to wild-type rats 4142544 WKY/Kiha strain MP:0001552 increased circulating triglyceride level IAGP N RGD:4142533|PMID:20093130 20170815 RGD as compared to WKY/Izm 4142544 WKY/Kiha strain MP:0004892 increased adiponectin level IAGP N RGD:4142533|PMID:20093130 20170815 RGD as compared to WKY/Izm 4142544 WKY/Kiha strain MP:0005178 increased circulating cholesterol level IAGP N RGD:4142533|PMID:20093130 20170815 RGD as compared to WKY/Izm 4145088 SS.BN-(D6Rat119-D6Arb3)/Mcwi strain MP:0001883 increased mammary adenocarcinoma incidence induced IAGP XCO:0000090 N RGD:4143380|PMID:20737482 20101026 RGD compared to SS/JrHsdMcwi 4145088 SS.BN-(D6Rat119-D6Arb3)/Mcwi strain MP:0004499 increased incidence of tumors by chemical induction induced IAGP XCO:0000090 N RGD:4143380|PMID:20737482 20101026 RGD compared to SS/JrHsdMcwi 4145088 SS.BN-(D6Rat119-D6Arb3)/Mcwi strain MP:0010308 decreased tumor latency induced IAGP XCO:0000090 N RGD:4143380|PMID:20737482 20101025 RGD compared to SS/JrHsdMcwi 4145089 SS.BN-(D6Rat149-D6Rat18)/Mcwi strain MP:0008770 decreased survivor rate induced IAGP XCO:0000090 N RGD:4143380|PMID:20737482 20191211 RGD compared to SS/JrHsdMcwi 4145089 SS.BN-(D6Rat149-D6Rat18)/Mcwi strain MP:0009766 increased susceptibility to xenobiotic induced morbidity/mortality induced IAGP XCO:0000090 N RGD:4143380|PMID:20737482 20191211 RGD compared to SS/JrHsdMcwi 4145090 SS.BN-(D6Rat149-D6Got171)/Mcwi strain MP:0008770 decreased survivor rate induced IAGP XCO:0000090 N RGD:4143380|PMID:20737482 20101026 RGD compared to SS/JrHsdMcwi 4145090 SS.BN-(D6Rat149-D6Got171)/Mcwi strain MP:0009766 increased susceptibility to xenobiotic induced morbidity/mortality induced IAGP XCO:0000090 N RGD:4143380|PMID:20737482 20101026 RGD compared to SS/JrHsdMcwi 4145091 SS.BN-(D6Rat149-D6Arb3)/Mcwi strain MP:0008770 decreased survivor rate induced IAGP XCO:0000090 N RGD:4143380|PMID:20737482 20101026 RGD compared to SS/JrHsdMcwi 4145091 SS.BN-(D6Rat149-D6Arb3)/Mcwi strain MP:0009766 increased susceptibility to xenobiotic induced morbidity/mortality induced IAGP XCO:0000090 N RGD:4143380|PMID:20737482 20191211 RGD compared to SS/JrHsdMcwi 4145117 Mcs27 Mammary carcinoma susceptibility QTL 27 qtl MP:0001883 increased mammary adenocarcinoma incidence IDA N RGD:4143380|PMID:20737482 20101026 RGD DMBA induced 4145118 Mcs26 Mammary carcinoma susceptibility QTL 26 qtl MP:0001883 increased mammary adenocarcinoma incidence IDA N RGD:4143380|PMID:20737482 20101026 RGD DMBA induced 42721974 LEW-Nek8lpk/Arc strain MP:0020382 increased kidney epithelial cell primary cilium length IAGP N RGD:40924667|PMID:22899815 20210302 RGD compared to control Lewis 42721975 Nek8lpkArc NIMA-related kinase 8; lpk mutant, Arc gene MP:0020382 increased kidney epithelial cell primary cilium length IAGP N RGD:40924667|PMID:22899815 20210304 RGD compared to control Lewis 42721977 SD-Pde6bem1Baek strain MP:0001326 retina degeneration IMP N RGD:40924664|PMID:31009522 20210303 RGD compared to wild-type 42721977 SD-Pde6bem1Baek strain MP:0008450 retina photoreceptor degeneration IMP N RGD:40924664|PMID:31009522 20210303 RGD compared to wild-type 42721977 SD-Pde6bem1Baek strain MP:0008515 thin retina outer nuclear layer IMP N RGD:40924664|PMID:31009522 20210303 RGD compared to wild-type 42721977 SD-Pde6bem1Baek strain MP:0008518 retina outer nuclear layer degeneration IMP N RGD:40924664|PMID:31009522 20210303 RGD compared to wild-type 42721977 SD-Pde6bem1Baek strain MP:0010098 abnormal retina blood vessel pattern IMP N RGD:40924664|PMID:31009522 20210303 RGD compared to wild-type 42721977 SD-Pde6bem1Baek strain MP:0030005 increased retina apoptosis IMP N RGD:40924664|PMID:31009522 20210303 RGD compared to wild-type 42721979 Pde6bem1Baek phosphodiesterase 6B; Cpf1-CRISPR induced mutant1, Baek gene MP:0001326 retina degeneration IMP N RGD:40924664|PMID:31009522 20210304 RGD compared to wild-type 42721979 Pde6bem1Baek phosphodiesterase 6B; Cpf1-CRISPR induced mutant1, Baek gene MP:0008450 retina photoreceptor degeneration IMP N RGD:40924664|PMID:31009522 20210304 RGD compared to wild-type 42721979 Pde6bem1Baek phosphodiesterase 6B; Cpf1-CRISPR induced mutant1, Baek gene MP:0008515 thin retina outer nuclear layer IMP N RGD:40924664|PMID:31009522 20210304 RGD compared to wild-type 42721979 Pde6bem1Baek phosphodiesterase 6B; Cpf1-CRISPR induced mutant1, Baek gene MP:0008518 retina outer nuclear layer degeneration IMP N RGD:40924664|PMID:31009522 20210304 RGD compared to wild-type 42721979 Pde6bem1Baek phosphodiesterase 6B; Cpf1-CRISPR induced mutant1, Baek gene MP:0010098 abnormal retina blood vessel pattern IMP N RGD:40924664|PMID:31009522 20210304 RGD compared to wild-type 42721979 Pde6bem1Baek phosphodiesterase 6B; Cpf1-CRISPR induced mutant1, Baek gene MP:0030005 increased retina apoptosis IMP N RGD:40924664|PMID:31009522 20210304 RGD compared to wild-type 42722004 F344-Tg(HIV)1Hsd strain MP:0000063 decreased bone mineral density IMP N RGD:42722617|PMID:20643942 20210305 RGD compared to WT littermates 42722004 F344-Tg(HIV)1Hsd strain MP:0003674 oxidative stress IMP N RGD:42722618|PMID:19193217 20210305 RGD compared to WT littermates 42722004 F344-Tg(HIV)1Hsd strain MP:0004984 increased osteoclast cell number IMP N RGD:42722617|PMID:20643942 20210305 RGD compared to WT littermates 42722004 F344-Tg(HIV)1Hsd strain MP:0004992 increased bone resorption IMP N RGD:42722617|PMID:20643942 20210305 RGD compared to WT littermates 42722004 F344-Tg(HIV)1Hsd strain MP:0005443 abnormal ethanol metabolism IMP N RGD:405100715|PMID:23413777 20240326 RGD compared to wild type F344 controls 42722004 F344-Tg(HIV)1Hsd strain MP:0009322 increased splenocyte apoptosis IMP N RGD:42722619|PMID:11481487 20210305 RGD compared to WT littermates 42722004 F344-Tg(HIV)1Hsd strain MP:0009336 increased splenocyte proliferation IMP N RGD:42722619|PMID:11481487 20210305 RGD compared to WT littermates 42722004 F344-Tg(HIV)1Hsd strain MP:0010873 decreased trabecular bone mass IMP N RGD:42722617|PMID:20643942 20210305 RGD compared to WT littermates 42722004 F344-Tg(HIV)1Hsd strain MP:0010879 decreased trabecular bone volume IMP N RGD:42722617|PMID:20643942 20210305 RGD compared to WT littermates 42722004 F344-Tg(HIV)1Hsd strain MP:0010894 pulmonary alveolar edema IMP N RGD:42722618|PMID:19193217 20210305 RGD compared to WT littermates 42722004 F344-Tg(HIV)1Hsd strain MP:0012604 decreased glutathione level IMP N RGD:42722618|PMID:19193217 20210305 RGD compared to WT littermates 42722004 F344-Tg(HIV)1Hsd strain MP:0014026 abnormal respiratory epithelial transmembrane transport IMP N RGD:42722618|PMID:19193217 20210305 RGD compared to WT littermates 42722004 F344-Tg(HIV)1Hsd strain MP:0021033 decreased tumor necrosis factor receptor superfamily member 11b level IMP N RGD:42722617|PMID:20643942 20220420 RGD compared to WT littermates 45073130 SD-Fmr1em1Mzhe strain MP:0001148 enlarged testis IMP N RGD:38501107|PMID:28894415 20210329 RGD compared to SD control;DNA:deletion, SNP:exon 4: 45073130 SD-Fmr1em1Mzhe strain MP:0001468 abnormal temporal memory IMP N RGD:38501107|PMID:28894415 20210329 RGD compared to SD control;DNA:deletion, SNP:exon 4: 45073130 SD-Fmr1em1Mzhe strain MP:0012307 impaired spatial learning IMP N RGD:38501107|PMID:28894415 20210329 RGD compared to SD control;DNA:deletion, SNP:exon 4: 45073130 SD-Fmr1em1Mzhe strain MP:0020395 abnormal response to social novelty IMP N RGD:38501107|PMID:28894415 20210329 RGD compared to SD control;DNA:deletion, SNP:exon 4: 45073133 SD-Pon1em1Lizh strain MP:0000322 increased granulocyte number IMP N RGD:45073131|PMID:30262871 20210715 RGD in peripheral blood, compared to SD 45073133 SD-Pon1em1Lizh strain MP:0000706 small thymus IMP N RGD:45073131|PMID:30262871 20210715 RGD compared to SD 45073133 SD-Pon1em1Lizh strain MP:0000715 decreased thymocyte number IMP N RGD:45073131|PMID:30262871 20210715 RGD compared to SD 45073133 SD-Pon1em1Lizh strain MP:0001825 arrested T cell differentiation IMP N RGD:45073131|PMID:30262871 20210715 RGD compared to SD 45073133 SD-Pon1em1Lizh strain MP:0003674 oxidative stress IMP N RGD:45073131|PMID:30262871 20210715 RGD compared to SD 45073133 SD-Pon1em1Lizh strain MP:0005017 decreased B cell number IMP N RGD:45073131|PMID:30262871 20210715 RGD in spleen, compared to SD 45073133 SD-Pon1em1Lizh strain MP:0005018 decreased T cell number IMP N RGD:45073131|PMID:30262871 20210715 RGD compared to SD 45073133 SD-Pon1em1Lizh strain MP:0005425 increased macrophage cell number IMP N RGD:45073131|PMID:30262871 20210715 RGD in bone marrow and peripheral blood, compared to SD 45073133 SD-Pon1em1Lizh strain MP:0006413 increased T cell apoptosis IMP N RGD:45073131|PMID:30262871 20210715 RGD compared to SD 4889411 SHRSP.WKY-(D1Smu13-D1Wox33)/Izm strain MP:0004484 abnormal response of heart to induced stress susceptibility IAGP XCO:0000158 N RGD:4889147|PMID:21063213 20191216 RGD compared to SHRSP/Izm in response to restraint stress 4889411 SHRSP.WKY-(D1Smu13-D1Wox33)/Izm strain MP:0006264 decreased systemic arterial systolic blood pressure severity IAGP XCO:0000307|XCO:0000158 N RGD:4889147|PMID:21063213 20101202 RGD compared to SHRSP/Izm under cold and restraint stress 4889411 SHRSP.WKY-(D1Smu13-D1Wox33)/Izm strain MP:0030773 decreased urine noradrenaline level severity IAGP XCO:0000307 N RGD:4889147|PMID:21063213 20101202 RGD compared to SHRSP/Izm in response to cold stress 4889414 WKY.SHRSP-(D1Rat171-D1Wox33)/Izm strain MP:0004484 abnormal response of heart to induced stress susceptibility IAGP XCO:0000158 N RGD:4889147|PMID:21063213 20191216 RGD compared to WKY/Izm in response to restraint stress 4889414 WKY.SHRSP-(D1Rat171-D1Wox33)/Izm strain MP:0006144 increased systemic arterial systolic blood pressure susceptibility IAGP N RGD:4889147|PMID:21063213 20101202 RGD baseline compared to WKY/Izm 4889414 WKY.SHRSP-(D1Rat171-D1Wox33)/Izm strain MP:0006144 increased systemic arterial systolic blood pressure susceptibility IAGP XCO:0000307|XCO:0000158 N RGD:4889147|PMID:21063213 20191216 RGD compared to WKY/Izm under cold and restraint stress 4889414 WKY.SHRSP-(D1Rat171-D1Wox33)/Izm strain MP:0030772 increased urine noradrenaline level susceptibility IAGP XCO:0000307|XCO:0000158 N RGD:4889147|PMID:21063213 20191216 RGD compared to WKY/Izm under cold and restraint stress 4889419 Cstrr2 Cold stress response QTL 2 qtl MP:0004484 abnormal response of heart to induced stress IDA N RGD:4889147|PMID:21063213 20101202 RGD 4889419 Cstrr2 Cold stress response QTL 2 qtl MP:0030772 increased urine noradrenaline level IDA N RGD:4889147|PMID:21063213 20101202 RGD 4889428 Stresp24 Stress response QTL 24 qtl MP:0002067 abnormal sensory capabilities/reflexes/nociception IDA N RGD:4889147|PMID:21063213 20101202 RGD 4889428 Stresp24 Stress response QTL 24 qtl MP:0005665 increased circulating noradrenaline level IDA N RGD:4889147|PMID:21063213 20101202 RGD 4889450 DA.PVG.1AV1-(D1Rat248-D1Rat10)/Kini strain MP:0006082 CNS inflammation induced IAGP XCO:0000195 N RGD:4888518|PMID:21041731 20200505 RGD 4889451 Eae29 Experimental allergic encephalomyelitis QTL 29 qtl MP:0006082 CNS inflammation IDA N RGD:4888518|PMID:21041731 20101202 RGD 4889464 GK/Ox strain MP:0001260 increased body weight sexual_dimorphism IAGP N RGD:4889455|PMID:20878524 20200421 RGD compared to female GK/Ox 4889464 GK/Ox strain MP:0001260 increased body weight susceptibility IAGP N RGD:4889455|PMID:20878524 20200316 RGD compared to BN/Crl 4889464 GK/Ox strain MP:0001556 increased circulating HDL cholesterol level IAGP N RGD:2300263|PMID:18698428 20201006 RGD compared to BN.GK-(D1Wox18-D1Got254)/Ox 4889464 GK/Ox strain MP:0001745 increased circulating corticosterone level sexual_dimorphism IAGP N RGD:4889455|PMID:20878524 20200316 RGD compared to male BN/Crl 4889464 GK/Ox strain MP:0002079 increased circulating insulin level IAGP N RGD:2300263|PMID:18698428 20201006 RGD compared to BN.GK-(D1Wox18-D1Got254)/Ox 4889464 GK/Ox strain MP:0002079 increased circulating insulin level sexual_dimorphism IAGP N RGD:4889455|PMID:20878524 20200421 RGD compared to female GK/Ox 4889464 GK/Ox strain MP:0002079 increased circulating insulin level susceptibility IAGP N RGD:4889455|PMID:20878524 20111109 RGD compared to BN/Crl 4889464 GK/Ox strain MP:0003059 decreased insulin secretion susceptibility IAGP N RGD:4889455|PMID:20878524 20101203 RGD compared to BN/Crl 4889464 GK/Ox strain MP:0003980 increased circulating phospholipid level IAGP N RGD:2300263|PMID:18698428 20201006 RGD compared to BN.GK-(D1Wox18-D1Got254)/Ox 4889464 GK/Ox strain MP:0004702 increased circulating insulin-like growth factor I level sexual_dimorphism IAGP N RGD:4889455|PMID:20878524 20200421 RGD male compared to female 4889464 GK/Ox strain MP:0005138 decreased prolactin level sexual_dimorphism IAGP N RGD:4889455|PMID:20878524 20200421 RGD compared to male BN/Crl 4889464 GK/Ox strain MP:0005139 increased prolactin level sexual_dimorphism IAGP N RGD:4889455|PMID:20878524 20200316 RGD compared to male GK/Ox 4889464 GK/Ox strain MP:0005145 increased circulating VLDL cholesterol level IAGP N RGD:2300263|PMID:18698428 20201006 RGD compared to BN.GK-(D1Wox18-D1Got254)/Ox 4889464 GK/Ox strain MP:0005293 impaired glucose tolerance susceptibility IAGP N RGD:4889455|PMID:20878524 20101203 RGD compared to BN/Crl 4889464 GK/Ox strain MP:0005331 insulin resistance susceptibility IAGP N RGD:4889455|PMID:20878524 20101203 RGD compared to BN/Crl 4889464 GK/Ox strain MP:0005559 increased circulating glucose level susceptibility IAGP N RGD:4889455|PMID:20878524 20101202 RGD compared to BN/Crl 4889464 GK/Ox strain MP:0009114 decreased pancreatic beta cell mass susceptibility IAGP N RGD:4889455|PMID:20878524 20101203 RGD compared to BN/Crl 4889464 GK/Ox strain MP:0013279 increased fasting circulating glucose level IAGP N RGD:2300263|PMID:18698428 20201006 RGD compared to BN.GK-(D1Wox18-D1Got254)/Ox 4889492 Pancm2 Pancreatic morphology QTL 2 qtl MP:0009114 decreased pancreatic beta cell mass IDA N RGD:4889455|PMID:20878524 20101203 RGD 4889494 Scort2 Serum corticosterone level QTL 2 qtl MP:0002665 decreased circulating corticosterone level IDA N RGD:4889455|PMID:20878524 20101203 RGD 4889499 CDS-Chr 4CDR/Ygl strain MP:0005559 increased circulating glucose level IAGP N RGD:2326163|PMID:20530722 20101207 RGD compared to CDR/Ygl 4889499 CDS-Chr 4CDR/Ygl strain MP:0005560 decreased circulating glucose level IAGP N RGD:2326163|PMID:20530722 20101207 RGD compared to CDS/Ygl on diabetogenic diet 4889499 CDS-Chr 4CDR/Ygl strain MP:0009108 increased pancreas weight IAGP N RGD:2326163|PMID:20530722 20101207 RGD compared to CDS/Ygl on diabetogenic diet 4889511 Gluco61 Glucose level QTL 61 qtl MP:0002727 decreased circulating insulin level IDA N RGD:2326163|PMID:20530722 20101203 RGD 4889511 Gluco61 Glucose level QTL 61 qtl MP:0005559 increased circulating glucose level IDA N RGD:2326163|PMID:20530722 20101203 RGD 4889511 Gluco61 Glucose level QTL 61 qtl MP:0009109 decreased pancreas weight IDA N RGD:2326163|PMID:20530722 20101203 RGD 4889521 Gluco62 Glucose level QTL 62 qtl MP:0002727 decreased circulating insulin level IDA N RGD:2326163|PMID:20530722 20101207 RGD 4889521 Gluco62 Glucose level QTL 62 qtl MP:0005559 increased circulating glucose level IDA N RGD:2326163|PMID:20530722 20101207 RGD 4889521 Gluco62 Glucose level QTL 62 qtl MP:0009109 decreased pancreas weight IDA N RGD:2326163|PMID:20530722 20101207 RGD 4889606 Gluco63 Glucose level QTL 63 qtl MP:0002727 decreased circulating insulin level IDA N RGD:2326163|PMID:20530722 20101207 RGD 4889606 Gluco63 Glucose level QTL 63 qtl MP:0005559 increased circulating glucose level IDA N RGD:2326163|PMID:20530722 20101207 RGD 4889606 Gluco63 Glucose level QTL 63 qtl MP:0009109 decreased pancreas weight IDA N RGD:2326163|PMID:20530722 20101207 RGD 4889610 Pancm3 Pancreatic morphology QTL 3 qtl MP:0009108 increased pancreas weight IDA N RGD:2326163|PMID:20530722 20101207 RGD 4889817 SBN-Chr 1SBH/Ygl strain MP:0002962 increased urine protein level disease_progression IAGP XCO:0000112 N RGD:629619|PMID:12045297 20200410 RGD compared to SBN/Ygl 4889817 SBN-Chr 1SBH/Ygl strain MP:0005554 decreased circulating creatinine level induced IAGP XCO:0000112 N RGD:629619|PMID:12045297 20101208 RGD compared to SBH/Ygl and SBN/Ygl 4889820 SBH-Chr 1SBN/Ygl strain MP:0002963 decreased urine protein level induced IAGP XCO:0000112 N RGD:4889613|PMID:20876844 20101209 RGD compared to SBH/Ygl 4889820 SBH-Chr 1SBN/Ygl strain MP:0002963 decreased urine protein level induced IAGP XCO:0000112 N RGD:629619|PMID:12045297 20200410 RGD compared to SBH/Ygl 4889820 SBH-Chr 1SBN/Ygl strain MP:0005264 glomerulosclerosis penetrance IAGP N RGD:629619|PMID:12045297 20200410 RGD compared to SBH/Ygl and SBN/Ygl 4889820 SBH-Chr 1SBN/Ygl strain MP:0005553 increased circulating creatinine level induced IAGP XCO:0000112 N RGD:629619|PMID:12045297 20101208 RGD compared to SBN/Ygl 4889820 SBH-Chr 1SBN/Ygl strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:629619|PMID:12045297 20101208 RGD compared to SBH/Ygl 4889822 SBN-Chr 17SBH/Ygl strain MP:0002962 increased urine protein level disease_progression IAGP N RGD:629619|PMID:12045297 20200410 RGD compared to SBN/Ygl 4889822 SBN-Chr 17SBH/Ygl strain MP:0005554 decreased circulating creatinine level induced IAGP XCO:0000112 N RGD:629619|PMID:12045297 20101208 RGD compared to SBH/Ygl 4889834 Pur24 Proteinuria QTL 24 qtl MP:0002962 increased urine protein level IDA N RGD:4889613|PMID:20876844 20101209 RGD 4889848 Pur25 Proteinuria QTL 25 qtl MP:0002962 increased urine protein level IDA N RGD:4889613|PMID:20876844 20101209 RGD 4889852 Pur26 Proteinuria QTL 26 qtl MP:0002962 increased urine protein level IDA N RGD:4889613|PMID:20876844 20101209 RGD 4889857 Pur27 Proteinuria QTL 27 qtl MP:0002962 increased urine protein level IDA N RGD:4889613|PMID:20876844 20101209 RGD 4889859 Pur28 Proteinuria QTL 28 qtl MP:0002962 increased urine protein level IDA N RGD:4889613|PMID:20876844 20101209 RGD 4889861 Pur29 Proteinuria QTL 29 qtl MP:0002962 increased urine protein level IDA N RGD:4889613|PMID:20876844 20101209 RGD 4889870 Pur30 Proteinuria QTL 30 qtl MP:0002962 increased urine protein level IDA N RGD:4889613|PMID:20876844 20101209 RGD 4889875 SBH-Chr 2SBN/Ygl strain MP:0002963 decreased urine protein level induced IAGP XCO:0000112 N RGD:4889613|PMID:20876844 20101209 RGD compared to SBH/Ygl 4889877 SBH-Chr 20SBN/Ygl strain MP:0002963 decreased urine protein level induced IAGP XCO:0000112 N RGD:4889613|PMID:20876844 20101209 RGD compared to SBH/Ygl 4889879 SBH-Chr XSBN/Ygl strain MP:0002962 increased urine protein level induced IAGP XCO:0000112 N RGD:4889613|PMID:20876844 20101209 RGD same as SBH/Ygl 4889882 SBH-Chr 17SBN/Ygl strain MP:0002963 decreased urine protein level sexual_dimorphism IAGP XCO:0000112 N RGD:4889613|PMID:20876844 20101209 RGD compared to SBH/Ygl male 4889891 Eae32 Experimental allergic encephalomyelitis QTL 32 qtl MP:0006082 CNS inflammation resistance IDA N RGD:4889889|PMID:20856809 20101209 RGD 4889894 Eae33 Experimental allergic encephalomyelitis QTL 33 qtl MP:0006082 CNS inflammation resistance IDA N RGD:4889889|PMID:20856809 20101209 RGD 4889919 Bss86 Bone structure and strength QTL 86 qtl MP:0004991 decreased bone strength IDA N RGD:4889918|PMID:20699128 20101210 RGD 4889929 Bss87 Bone structure and strength QTL 87 qtl MP:0004991 decreased bone strength IDA N RGD:4889918|PMID:20699128 20101210 RGD 4889933 Bss88 Bone structure and strength QTL 88 qtl MP:0004991 decreased bone strength IDA N RGD:4889918|PMID:20699128 20101210 RGD 4889938 Bss89 Bone structure and strength QTL 89 qtl MP:0004991 decreased bone strength IDA N RGD:4889918|PMID:20699128 20101210 RGD 4889943 Bss90 Bone structure and strength QTL 90 qtl MP:0004991 decreased bone strength IDA N RGD:4889918|PMID:20699128 20101210 RGD 4889948 Bss91 Bone structure and strength QTL 91 qtl MP:0004991 decreased bone strength IDA N RGD:4889918|PMID:20699128 20101210 RGD 4889951 Bss92 Bone structure and strength QTL 92 qtl MP:0004991 decreased bone strength IDA N RGD:4889918|PMID:20699128 20101210 RGD 4889955 Bss93 Bone structure and strength QTL 93 qtl MP:0004991 decreased bone strength IDA N RGD:4889918|PMID:20699128 20101210 RGD 4889962 Bss94 Bone structure and strength QTL 94 qtl MP:0004991 decreased bone strength IDA N RGD:4889918|PMID:20699128 20101210 RGD 4889966 Bss95 Bone structure and strength QTL 95 qtl MP:0004991 decreased bone strength IDA N RGD:4889918|PMID:20699128 20101210 RGD 4889969 Bss96 Bone structure and strength QTL 96 qtl MP:0004991 decreased bone strength IDA N RGD:4889918|PMID:20699128 20101210 RGD 4889972 Bss97 Bone structure and strength QTL 97 qtl MP:0004991 decreased bone strength IDA N RGD:4889918|PMID:20699128 20101210 RGD 4889975 Bmd81 Bone mineral density QTL 81 qtl MP:0000062 increased bone mineral density IDA N RGD:4889918|PMID:20699128 20101210 RGD 4891048 SS.LEW-(D7Rat73-D7Rat128)/Ayd strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:4891049|PMID:21192272 20110105 RGD compared to SS/Jr 4891048 SS.LEW-(D7Rat73-D7Rat128)/Ayd strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:7421500|PMID:23814039 20110105 RGD compared to SS/Jr 4891165 Wig/Ymas wiggling strain MP:0001399 hyperactivity IAGP N RGD:4891167|PMID:17610585 20110111 RGD 4891380 SS.SR-(D9Mco95-D9Mco98)/Mco strain MP:0001661 extended life span induced IAGP XCO:0000022 N RGD:4889902|PMID:20716646 20110112 RGD compared to SS/Jr 4891380 SS.SR-(D9Mco95-D9Mco98)/Mco strain MP:0002834 decreased heart weight induced IAGP XCO:0000022 N RGD:4889902|PMID:20716646 20110112 RGD compared to SS/Jr 4891380 SS.SR-(D9Mco95-D9Mco98)/Mco strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:4889902|PMID:20716646 20110112 RGD compared to SS/Jr 4891380 SS.SR-(D9Mco95-D9Mco98)/Mco strain MP:0006263 decreased systemic arterial diastolic blood pressure induced IAGP XCO:0000022 N RGD:4889902|PMID:20716646 20110112 RGD compared to SS/Jr 4891380 SS.SR-(D9Mco95-D9Mco98)/Mco strain MP:0006264 decreased systemic arterial systolic blood pressure induced IAGP XCO:0000022 N RGD:4889902|PMID:20716646 20110112 RGD compared to SS/Jr 4891380 SS.SR-(D9Mco95-D9Mco98)/Mco strain MP:0006266 decreased pulse pressure induced IAGP XCO:0000022 N RGD:4889902|PMID:20716646 20191209 RGD compared to SS/Jr 4891383 SS.SR-(D9Mco98-Resp18)/1Mco strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:4889902|PMID:20716646 20110112 RGD 4891383 SS.SR-(D9Mco98-Resp18)/1Mco strain MP:0006144 increased systemic arterial systolic blood pressure induced IAGP XCO:0000022 N RGD:4889902|PMID:20716646 20110112 RGD compared to SS/Jr 4891386 SS.SR-(D9Mco98-Resp18)/2Mco strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:4889902|PMID:20716646 20110112 RGD compared to SS/Jr 4891386 SS.SR-(D9Mco98-Resp18)/2Mco strain MP:0006144 increased systemic arterial systolic blood pressure induced IAGP XCO:0000022 N RGD:4889902|PMID:20716646 20110112 RGD compared to SS/Jr 4891388 SS.SR-(D9Mco95-D9Mco100)/1Mco strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:4889902|PMID:20716646 20110112 RGD 4891392 SS.SR-(D9Mco95-D9Mco102)/Mco strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:4889902|PMID:20716646 20110112 RGD 4891394 SS.SR-(D9Mco101-Resp18)/Mco strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:4889902|PMID:20716646 20110112 RGD 4891400 SS.SR-(D9Mco14-Resp18)/1Mco strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:4889902|PMID:20716646 20110112 RGD 4891402 SS.SR-(D9Mco14-Resp18)/2Mco strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:4889902|PMID:20716646 20110112 RGD 5131906 Alms1em1Mcwi Alstrom syndrome 1 homolog (human); zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0001260 increased body weight IMP N RGD:151361229|PMID:30385718 20220303 RGD compared to wild type 5131906 Alms1em1Mcwi Alstrom syndrome 1 homolog (human); zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0004217 salt-sensitive hypertension exacerbates IMP N RGD:151361229|PMID:30385718 20220303 RGD compared to wild type 5131906 Alms1em1Mcwi Alstrom syndrome 1 homolog (human); zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0004875 increased mean systemic arterial blood pressure exacerbates IMP N RGD:151361229|PMID:30385718 20220303 RGD compared to wild type 5131906 Alms1em1Mcwi Alstrom syndrome 1 homolog (human); zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0006144 increased systemic arterial systolic blood pressure exacerbates IMP N RGD:151361229|PMID:30385718 20220303 RGD compared to wild type 5131906 Alms1em1Mcwi Alstrom syndrome 1 homolog (human); zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0006316 increased urine sodium level induces IMP XCO:0000925 N RGD:151361229|PMID:30385718 20220303 RGD 5131906 Alms1em1Mcwi Alstrom syndrome 1 homolog (human); zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0011431 increased urine flow rate induces IMP XCO:0000925 N RGD:151361229|PMID:30385718 20220303 RGD 5131919 Cdh13em1Mcwi cadherin 13; zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0002850 saccharin preference IMP N RGD:13503340|PMID:28387990 20201210 RGD knock-out compared to wild-type rats 5131919 Cdh13em1Mcwi cadherin 13; zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0020909 abnormal cue-induced reinstatement of an extinguished operant behavior for a cocaine reinforcer IMP N RGD:13503340|PMID:28387990 20201210 RGD knock-out compared to wild-type rats 5131922 SS-Cdh13em1Mcwi strain MP:0002850 saccharin preference IMP N RGD:13503340|PMID:28387990 20200814 RGD knock-out compared to wild-type rats 5131922 SS-Cdh13em1Mcwi strain MP:0020909 abnormal cue-induced reinstatement of an extinguished operant behavior for a cocaine reinforcer IMP N RGD:13503340|PMID:28387990 20200819 RGD knock-out compared to wild-type rats 5134683 WF.WKY-(D7Rat171-D7Rat128)/1Uwm strain MP:0010269 decreased mammary gland tumor incidence induced IAGP XCO:0000090 N RGD:5133689|PMID:21625632 20200925 RGD compared to WF/NHsd 5134685 WF.WKY-(D7Rat171-D7Rat128)/2Uwm strain MP:0010269 decreased mammary gland tumor incidence induced IAGP XCO:0000090 N RGD:5133689|PMID:21625632 20200925 RGD compared to WF/NHsd 5134687 WF.WKY-(D7Rat51-D7Rat128)/Uwm strain MP:0001883 increased mammary adenocarcinoma incidence induced IAGP XCO:0000090 N RGD:5133689|PMID:21625632 20110705 RGD compared to other Chr7 congenic strains 5134689 WF.WKY-(D7Uwm25-D7Rat128)/Uwm strain MP:0001883 increased mammary adenocarcinoma incidence induced IAGP XCO:0000090 N RGD:5133689|PMID:21625632 20110705 RGD compared to other Chr7 congenic strains 5134692 WF.WKY-(D7Rat171-D7Rat45)/Uwm strain MP:0010269 decreased mammary gland tumor incidence induced IAGP XCO:0000090 N RGD:5133689|PMID:21625632 20200925 RGD compared to WF/NHsd 5134951 WF.COP-(D7Rat39-D7Uwm12)/1Uwm strain MP:0010269 decreased mammary gland tumor incidence induced IAGP XCO:0000090 N RGD:5133689|PMID:21625632 20200925 RGD compared to WF/NHsd 5134953 WF.COP-(D7Rat39-D7Uwm12)/2Uwm strain MP:0010269 decreased mammary gland tumor incidence induced IAGP XCO:0000090 N RGD:5133689|PMID:21625632 20200925 RGD compared to WF/NHsd 5135031 BN.MES-Cyba/Sna strain MP:0001656 focal hepatic necrosis IAGP N RGD:5134976|PMID:20660993 20110711 RGD 5135031 BN.MES-Cyba/Sna strain MP:0002941 increased circulating alanine transaminase level IAGP N RGD:5134976|PMID:20660993 20200708 RGD compared to BN/SsNSlc 5135031 BN.MES-Cyba/Sna strain MP:0005011 increased eosinophil cell number IAGP N RGD:5134976|PMID:20660993 20110711 RGD in bone marrow; compared to BN/SsNSlc 5135031 BN.MES-Cyba/Sna strain MP:0005012 decreased eosinophil cell number IAGP N RGD:5134976|PMID:20660993 20200708 RGD in blood; compared to MES/SLC 5135031 BN.MES-Cyba/Sna strain MP:0005343 increased circulating aspartate transaminase level IAGP N RGD:5134976|PMID:20660993 20200708 RGD compared to BN/SsNSlc 5135224 Leukc1 Leukocyte quantity QTL 1 qtl MP:0005011 increased eosinophil cell number IDA N RGD:5135221|PMID:16151696 20110713 RGD 5135226 Leukc2 Leukocyte quantity QTL 2 qtl MP:0005011 increased eosinophil cell number IDA N RGD:5135221|PMID:16151696 20110713 RGD 5135477 ACI.BN-(D5Uwm70-D5Mgh15)/Shul strain MP:0009828 increased tumor latency induced IAGP XCO:0000092 N RGD:7364727|PMID:23151807 20200319 RGD compared to treated ACI/SegHsd 5135479 ACI.BN-(D5Rat113-D5Rat36)/Shul strain MP:0009828 increased tumor latency induced IAGP XCO:0000092 N RGD:7364727|PMID:23151807 20200319 RGD compared to treated ACI/SegHsd 5135481 ACI.BN-(D5Mgh17-D5Rat98)/Shul strain MP:0009828 increased tumor latency induced IAGP XCO:0000092 N RGD:7364727|PMID:23151807 20200319 RGD compared to treated ACI/SegHsd 5143964 Mstnem1Mcwi myostatin; zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0001260 increased body weight IMP N RGD:151347429|PMID:25640143 20220127 RGD compared to wild type 5143964 Mstnem1Mcwi myostatin; zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0004818 increased skeletal muscle mass IMP N RGD:151347429|PMID:25640143 20220127 RGD compared to wild type 5143964 Mstnem1Mcwi myostatin; zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0009399 increased skeletal muscle fiber size IMP N RGD:151347429|PMID:25640143 20220127 RGD compared to wild type 5143979 Plekha7em4Mcwi pleckstrin homology domain containing, family A member 7; zinc finger nuclease induced mutant 4, Medical College of Wisconsin gene MP:0002963 decreased urine protein level IMP N RGD:11079199|PMID:25136115 20171102 RGD 5143979 Plekha7em4Mcwi pleckstrin homology domain containing, family A member 7; zinc finger nuclease induced mutant 4, Medical College of Wisconsin gene MP:0002963 decreased urine protein level ameliorates IMP XCO:0000795 N RGD:11079199|PMID:25136115 20220203 RGD compared to wild type 5143979 Plekha7em4Mcwi pleckstrin homology domain containing, family A member 7; zinc finger nuclease induced mutant 4, Medical College of Wisconsin gene MP:0003394 increased cardiac output IMP N RGD:11079199|PMID:25136115 20171102 RGD 5143979 Plekha7em4Mcwi pleckstrin homology domain containing, family A member 7; zinc finger nuclease induced mutant 4, Medical College of Wisconsin gene MP:0003394 increased cardiac output IMP XCO:0000795 N RGD:11079199|PMID:25136115 20220203 RGD compared to wild type 5143979 Plekha7em4Mcwi pleckstrin homology domain containing, family A member 7; zinc finger nuclease induced mutant 4, Medical College of Wisconsin gene MP:0004217 salt-sensitive hypertension ameliorates IMP XCO:0000795 N RGD:11079199|PMID:25136115 20220203 RGD compared to wild type 5143979 Plekha7em4Mcwi pleckstrin homology domain containing, family A member 7; zinc finger nuclease induced mutant 4, Medical College of Wisconsin gene MP:0004879 decreased systemic vascular resistance IMP N RGD:11079199|PMID:25136115 20171102 RGD 5143979 Plekha7em4Mcwi pleckstrin homology domain containing, family A member 7; zinc finger nuclease induced mutant 4, Medical College of Wisconsin gene MP:0004879 decreased systemic vascular resistance induces IMP XCO:0000795 N RGD:11079199|PMID:25136115 20220203 RGD compared to wild type 5143979 Plekha7em4Mcwi pleckstrin homology domain containing, family A member 7; zinc finger nuclease induced mutant 4, Medical College of Wisconsin gene MP:0005540 decreased urine albumin level IMP N RGD:11079199|PMID:25136115 20171102 RGD 5143979 Plekha7em4Mcwi pleckstrin homology domain containing, family A member 7; zinc finger nuclease induced mutant 4, Medical College of Wisconsin gene MP:0005540 decreased urine albumin level ameliorates IMP XCO:0000795 N RGD:11079199|PMID:25136115 20220203 RGD compared to wild type 5143979 Plekha7em4Mcwi pleckstrin homology domain containing, family A member 7; zinc finger nuclease induced mutant 4, Medical College of Wisconsin gene MP:0005590 increased vasodilation IMP N RGD:11079199|PMID:25136115 20220203 RGD compared to wild type 5143979 Plekha7em4Mcwi pleckstrin homology domain containing, family A member 7; zinc finger nuclease induced mutant 4, Medical College of Wisconsin gene MP:0011951 increased cardiac stroke volume IMP N RGD:11079199|PMID:25136115 20171102 RGD 5143979 Plekha7em4Mcwi pleckstrin homology domain containing, family A member 7; zinc finger nuclease induced mutant 4, Medical College of Wisconsin gene MP:0011951 increased cardiac stroke volume induces IMP XCO:0000795 N RGD:11079199|PMID:25136115 20220203 RGD compared to wild type 5143979 Plekha7em4Mcwi pleckstrin homology domain containing, family A member 7; zinc finger nuclease induced mutant 4, Medical College of Wisconsin gene MP:0012046 decreased susceptibility to hypertension IMP N RGD:11079199|PMID:25136115 20171102 RGD 5143979 Plekha7em4Mcwi pleckstrin homology domain containing, family A member 7; zinc finger nuclease induced mutant 4, Medical College of Wisconsin gene MP:0012046 decreased susceptibility to hypertension IMP XCO:0000795 N RGD:11079199|PMID:25136115 20220203 RGD compared to wild type 5144089 Ncf2em1Mcwi neutrophil cytosolic factor 2; zinc finger nuclease induced mutant 1,Mcwi gene MP:0004217 salt-sensitive hypertension ameliorates IMP N RGD:9587793|PMID:22326221 20230928 RGD compared to wild-type littermates 5144089 Ncf2em1Mcwi neutrophil cytosolic factor 2; zinc finger nuclease induced mutant 1,Mcwi gene MP:0012046 decreased susceptibility to hypertension IMP N RGD:9587793|PMID:22326221 20171101 RGD 5144089 Ncf2em1Mcwi neutrophil cytosolic factor 2; zinc finger nuclease induced mutant 1,Mcwi gene MP:0012046 decreased susceptibility to hypertension induces IMP XCO:0000795 N RGD:9587793|PMID:22326221 20230928 RGD compared to wild-type littermates 5144089 Ncf2em1Mcwi neutrophil cytosolic factor 2; zinc finger nuclease induced mutant 1,Mcwi gene MP:0020447 decreased NAD(P)H oxidase activity IMP N RGD:9587793|PMID:22326221 20171101 RGD 5144089 Ncf2em1Mcwi neutrophil cytosolic factor 2; zinc finger nuclease induced mutant 1,Mcwi gene MP:0020447 decreased NAD(P)H oxidase activity induces IMP XCO:0000795 N RGD:9587793|PMID:22326221 20230928 RGD compared to wild-type littermates 5144104 SS-Ncf2em1Mcwi strain MP:0012046 decreased susceptibility to hypertension induces IMP XCO:0000795 N RGD:9587793|PMID:22326221 20171101 RGD compared to wild-type littermates 5144104 SS-Ncf2em1Mcwi strain MP:0020447 decreased NAD(P)H oxidase activity induces IMP XCO:0000795 N RGD:9587793|PMID:22326221 20171101 RGD compared to wild-type littermates 5144110 ACI.BN-(D5Mgh17-D5Mgh15)/Shul strain MP:0009828 increased tumor latency induced IAGP XCO:0000092 N RGD:7364727|PMID:23151807 20200319 RGD compared to treated ACI/SegHsd 5147594 FHH.PCK-(D9Rat35-D9Rat70)/Mcwi strain MP:0000601 small liver IAGP N RGD:9685714|PMID:22669842 20150122 RGD as compared to PCK/CrljCrl-Pkhd1pck/Crl 5147594 FHH.PCK-(D9Rat35-D9Rat70)/Mcwi strain MP:0003675 kidney cyst MODEL: partially resistant IAGP N RGD:9685714|PMID:22669842 20150122 RGD as compared to PCK/CrljCrl-Pkhd1pck/Crl 5147594 FHH.PCK-(D9Rat35-D9Rat70)/Mcwi strain MP:0005553 increased circulating creatinine level IAGP N RGD:12910103|PMID:24722447 20191206 RGD compared to FHH 5147594 FHH.PCK-(D9Rat35-D9Rat70)/Mcwi strain MP:0005554 decreased circulating creatinine level IAGP N RGD:9685714|PMID:22669842 20150122 RGD as compared to PCK/CrljCrl-Pkhd1pck/Crl 5147594 FHH.PCK-(D9Rat35-D9Rat70)/Mcwi strain MP:0005565 increased blood urea nitrogen level IAGP N RGD:12910103|PMID:24722447 20191206 RGD compared to FHH 5147594 FHH.PCK-(D9Rat35-D9Rat70)/Mcwi strain MP:0005566 decreased blood urea nitrogen level IAGP N RGD:9685714|PMID:22669842 20150122 RGD as compared to PCK/CrljCrl-Pkhd1pck/Crl 5147594 FHH.PCK-(D9Rat35-D9Rat70)/Mcwi strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:9685714|PMID:22669842 20150122 RGD as compared to PCK/CrljCrl-Pkhd1pck/Crl 5508304 WUN-Abcc2TR-/HsdRrrc strain MP:0004772 abnormal bile secretion IAGP N RGD:5508303|PMID:4018730 20190802 RGD 5508304 WUN-Abcc2TR-/HsdRrrc strain MP:0004789 increased bile salt level IAGP N RGD:5508303|PMID:4018730 20190802 RGD 5508304 WUN-Abcc2TR-/HsdRrrc strain MP:0005344 increased circulating bilirubin level IAGP N RGD:14985241|PMID:19525466 20191015 RGD 5508304 WUN-Abcc2TR-/HsdRrrc strain MP:0008875 abnormal xenobiotic pharmacokinetics IMP N RGD:14392811|PMID:22711747 20210916 RGD compared to wildtype controls, CHEBI:9334|CHEBI:51619 5508318 Agtr1aem5Mcwi angiotensin II receptor, type 1a; zinc finger nuclease induced mutant 5, Medical College of Wisconsin gene MP:0005602 decreased angiogenesis induces IMP N RGD:127345089|PMID:32324784 20210715 RGD 5508324 Nppbem2Mcwi natriuretic peptide B; zinc finger nuclease induced mutant 2, Medical College of Wisconsin gene MP:0000231 hypertension IMP N RGD:12910116|PMID:26063669 20201210 RGD 5508324 Nppbem2Mcwi natriuretic peptide B; zinc finger nuclease induced mutant 2, Medical College of Wisconsin gene MP:0001625 cardiac hypertrophy IMP N RGD:12910116|PMID:26063669 20201210 RGD 5508324 Nppbem2Mcwi natriuretic peptide B; zinc finger nuclease induced mutant 2, Medical College of Wisconsin gene MP:0002962 increased urine protein level IMP N RGD:12910116|PMID:26063669 20201210 RGD 5508324 Nppbem2Mcwi natriuretic peptide B; zinc finger nuclease induced mutant 2, Medical College of Wisconsin gene MP:0003233 prolonged QT interval IMP N RGD:12910116|PMID:26063669 20201210 RGD 5508365 SS-Agtr1aem5Mcwi strain MP:0005602 decreased angiogenesis induces IMP N RGD:127345089|PMID:32324784 20210708 RGD 5508397 HotHsd:SD Sprague Dawley strain MP:0008236 decreased susceptibility to neuronal excitotoxicity IAGP N RGD:13524860|PMID:17804792 20180502 RGD compared to Wistar rat 5508828 Leukc3 Leukocyte quantity QTL 3 qtl MP:0005011 increased eosinophil cell number IDA N RGD:5135222|PMID:17090969 20111025 RGD 5509086 ACI.BN-(D5Rat72-D5Rat36)/Shul strain MP:0009828 increased tumor latency induced IAGP XCO:0000092 N RGD:7364727|PMID:23151807 20200319 RGD compared to treated ACI/SegHsd 5509087 ACI.BN-(D5Rat113-D5Rat159)/Shul strain MP:0009828 increased tumor latency induced IAGP XCO:0000092 N RGD:7364727|PMID:23151807 20200319 RGD compared to treated ACI/SegHsd 5509982 Sh2b3em2Mcwi SH2B adaptor protein 3; zinc finger nuclease induced mutant 2, Medical College of Wisconsin gene MP:0000219 increased neutrophil cell number IMP N RGD:12904914|PMID:25628389 20170526 RGD 5509982 Sh2b3em2Mcwi SH2B adaptor protein 3; zinc finger nuclease induced mutant 2, Medical College of Wisconsin gene MP:0000220 increased monocyte cell number IMP N RGD:12904914|PMID:25628389 20170526 RGD 5509982 Sh2b3em2Mcwi SH2B adaptor protein 3; zinc finger nuclease induced mutant 2, Medical College of Wisconsin gene MP:0005013 increased lymphocyte cell number IMP N RGD:12904914|PMID:25628389 20170526 RGD 5509982 Sh2b3em2Mcwi SH2B adaptor protein 3; zinc finger nuclease induced mutant 2, Medical College of Wisconsin gene MP:0005598 decreased heart ventricle muscle contractility IMP N RGD:12904914|PMID:25628389 20170526 RGD 5683890 SS-Chr 12BN.SS-(D12Hmgc3-D12Hmgc6)/Mcwi strain MP:0002625 heart left ventricle hypertrophy IAGP N RGD:7204442|PMID:22868394 20200317 RGD compared to SS-Chr 12BN/Mcwi 5683890 SS-Chr 12BN.SS-(D12Hmgc3-D12Hmgc6)/Mcwi strain MP:0002871 albuminuria IAGP XCO:0000022 N RGD:8693701|PMID:25001272 20210118 RGD compared to SS-Chr12BN 5683890 SS-Chr 12BN.SS-(D12Hmgc3-D12Hmgc6)/Mcwi strain MP:0002953 thick ventricular wall IAGP XCO:0000022 N RGD:7204442|PMID:22868394 20121218 RGD compared to SS-Chr 12BN/Mcwi 5683890 SS-Chr 12BN.SS-(D12Hmgc3-D12Hmgc6)/Mcwi strain MP:0002962 increased urine protein level IAGP XCO:0000022 N RGD:7204442|PMID:22868394 20121218 RGD compared to SS-Chr 12BN/Mcwi, SS-Chr 12BN.SS-(D12Arb13-D12Mit2)/Mcwi, SS-Chr 12BN.SS-(D12Hmgc3-D12Rat79)/Mcwi 5683890 SS-Chr 12BN.SS-(D12Hmgc3-D12Hmgc6)/Mcwi strain MP:0002962 increased urine protein level IAGP XCO:0000022 N RGD:8693701|PMID:25001272 20210118 RGD compared to SS-Chr12BN 5683890 SS-Chr 12BN.SS-(D12Hmgc3-D12Hmgc6)/Mcwi strain MP:0004217 salt-sensitive hypertension IAGP XCO:0000022 N RGD:7204442|PMID:22868394 20121218 RGD compared to SS-Chr 12BN/Mcwi, SS-Chr 12BN.SS-(D12Arb13-D12Mit2)/Mcwi, SS-Chr 12BN.SS-(D12Hmgc3-D12Rat79)/Mcwi 5683890 SS-Chr 12BN.SS-(D12Hmgc3-D12Hmgc6)/Mcwi strain MP:0004875 increased mean systemic arterial blood pressure IAGP N RGD:8693701|PMID:25001272 20140724 RGD 8% NaCl diet 5683890 SS-Chr 12BN.SS-(D12Hmgc3-D12Hmgc6)/Mcwi strain MP:0004875 increased mean systemic arterial blood pressure IAGP XCO:0000022 N RGD:7204442|PMID:22868394 20121218 RGD compared to SS-Chr 12BN/Mcwi, SS-Chr 12BN.SS-(D12Arb13-D12Mit2)/Mcwi, SS-Chr 12BN.SS-(D12Hmgc3-D12Rat79)/Mcwi 5683890 SS-Chr 12BN.SS-(D12Hmgc3-D12Hmgc6)/Mcwi strain MP:0005608 cardiac interstitial fibrosis IAGP XCO:0000022 N RGD:7204442|PMID:22868394 20121218 RGD compared to SS-Chr 12BN/Mcwi 5683890 SS-Chr 12BN.SS-(D12Hmgc3-D12Hmgc6)/Mcwi strain MP:0010724 thick interventricular septum IAGP N RGD:7204442|PMID:22868394 20121218 RGD as compared to SS-Chr 12BN/Mcwi 5684888 Pia42 Pristane induced arthritis QTL 42 qtl MP:0002933 joint inflammation IDA N RGD:1600250|PMID:17329308 20120104 RGD 5686318 SS-Sh2b3em1Mcwi-/- SS-Sh2b3em1Mcwi-/Sh2b3em1Mcwi- strain MP:0004973 increased regulatory T cell number IMP N RGD:13442483|PMID:25776069 20171103 RGD compared to Dahl SS 5686318 SS-Sh2b3em1Mcwi-/- SS-Sh2b3em1Mcwi-/Sh2b3em1Mcwi- strain MP:0005540 decreased urine albumin level IMP N RGD:13442483|PMID:25776069 20171103 RGD compared to Dahl SS 5686318 SS-Sh2b3em1Mcwi-/- SS-Sh2b3em1Mcwi-/Sh2b3em1Mcwi- strain MP:0012046 decreased susceptibility to hypertension IMP N RGD:13442483|PMID:25776069 20171103 RGD compared to Dahl SS 5686668 SS-Cdh13em1Mcwi-/- SS-Cdh13em1Mcwi-/Cdh13em1Mcwi- strain MP:0020909 abnormal cue-induced reinstatement of an extinguished operant behavior for a cocaine reinforcer IMP N RGD:13503340|PMID:28387990 20200819 RGD knock-out compared to wild-type rats 5686713 SS-Mstnem1Mcwi-/- SS-Mstnem1Mcwi-/Mstnem1Mcwi- strain MP:0001260 increased body weight IMP N RGD:151347429|PMID:25640143 20220120 RGD compared to wild type 5686713 SS-Mstnem1Mcwi-/- SS-Mstnem1Mcwi-/Mstnem1Mcwi- strain MP:0004818 increased skeletal muscle mass IMP N RGD:151347429|PMID:25640143 20220120 RGD compared to wild type 5686713 SS-Mstnem1Mcwi-/- SS-Mstnem1Mcwi-/Mstnem1Mcwi- strain MP:0009399 increased skeletal muscle fiber size IMP N RGD:151347429|PMID:25640143 20220120 RGD compared to wild type 5686730 SS-Nppbem2Mcwi-/- SS-Nppbem2Mcwi-/Nppbem2Mcwi- strain MP:0000231 hypertension IMP N RGD:12910116|PMID:26063669 20170609 RGD 5686730 SS-Nppbem2Mcwi-/- SS-Nppbem2Mcwi-/Nppbem2Mcwi- strain MP:0001625 cardiac hypertrophy IMP N RGD:12910116|PMID:26063669 20170609 RGD 5686730 SS-Nppbem2Mcwi-/- SS-Nppbem2Mcwi-/Nppbem2Mcwi- strain MP:0002962 increased urine protein level IMP N RGD:12910116|PMID:26063669 20170609 RGD 5686730 SS-Nppbem2Mcwi-/- SS-Nppbem2Mcwi-/Nppbem2Mcwi- strain MP:0003233 prolonged QT interval IMP N RGD:12910116|PMID:26063669 20170609 RGD 5686758 SS-Plekha7em4Mcwi-/- SS-Plekha7em4Mcwi-/Plekha7em4Mcwi- strain MP:0002963 decreased urine protein level ameliorates IMP XCO:0000795 N RGD:11079199|PMID:25136115 20171102 RGD compared to wild type 5686758 SS-Plekha7em4Mcwi-/- SS-Plekha7em4Mcwi-/Plekha7em4Mcwi- strain MP:0003394 increased cardiac output IMP XCO:0000795 N RGD:11079199|PMID:25136115 20171102 RGD compared to wild type 5686758 SS-Plekha7em4Mcwi-/- SS-Plekha7em4Mcwi-/Plekha7em4Mcwi- strain MP:0004217 salt-sensitive hypertension ameliorates IMP XCO:0000795 N RGD:11079199|PMID:25136115 20220131 RGD compared to wild type 5686758 SS-Plekha7em4Mcwi-/- SS-Plekha7em4Mcwi-/Plekha7em4Mcwi- strain MP:0004879 decreased systemic vascular resistance induces IMP XCO:0000795 N RGD:11079199|PMID:25136115 20171102 RGD compared to wild type 5686758 SS-Plekha7em4Mcwi-/- SS-Plekha7em4Mcwi-/Plekha7em4Mcwi- strain MP:0005540 decreased urine albumin level ameliorates IMP XCO:0000795 N RGD:11079199|PMID:25136115 20171102 RGD compared to wild type 5686758 SS-Plekha7em4Mcwi-/- SS-Plekha7em4Mcwi-/Plekha7em4Mcwi- strain MP:0005590 increased vasodilation IMP N RGD:11079199|PMID:25136115 20220131 RGD compared to wild type 5686758 SS-Plekha7em4Mcwi-/- SS-Plekha7em4Mcwi-/Plekha7em4Mcwi- strain MP:0011951 increased cardiac stroke volume induces IMP XCO:0000795 N RGD:11079199|PMID:25136115 20171102 RGD compared to wild type 5686758 SS-Plekha7em4Mcwi-/- SS-Plekha7em4Mcwi-/Plekha7em4Mcwi- strain MP:0012046 decreased susceptibility to hypertension IMP XCO:0000795 N RGD:11079199|PMID:25136115 20171102 RGD compared to wild type 5686766 SS-Sh2b3em2Mcwi-/- SS-Sh2b3em2Mcwi-/Sh2b3em2Mcwi- strain MP:0000219 increased neutrophil cell number IMP N RGD:12904914|PMID:25628389 20170526 RGD 5686766 SS-Sh2b3em2Mcwi-/- SS-Sh2b3em2Mcwi-/Sh2b3em2Mcwi- strain MP:0000220 increased monocyte cell number IMP N RGD:12904914|PMID:25628389 20170526 RGD 5686766 SS-Sh2b3em2Mcwi-/- SS-Sh2b3em2Mcwi-/Sh2b3em2Mcwi- strain MP:0005013 increased lymphocyte cell number IMP N RGD:12904914|PMID:25628389 20170526 RGD 5686766 SS-Sh2b3em2Mcwi-/- SS-Sh2b3em2Mcwi-/Sh2b3em2Mcwi- strain MP:0005598 decreased heart ventricle muscle contractility IMP N RGD:12904914|PMID:25628389 20170526 RGD 5686832 ACI.FHH-(D1Mit18-D1Rat90)(D3Got102-D3Got149)(D14Mit11-D14Rat33)(D14Rat65-D14Rat90)/Mcwi strain MP:0004875 increased mean systemic arterial blood pressure induced IAGP XCO:0000113 N RGD:5684423|PMID:21127141 20120127 RGD compared to ACI.FHH-(D1Mit18-D1Rat90)(D14Mit11-D14Rat33)(D14Rat65-D14Rat90)/EurMcwi, ACI.FHH-(D1Mit18-D1Rat90)(D3Rat6-D3Got149)(D14Mit11-D14Rat33)(D14Rat65-D14Rat90)/Mcwi 5686832 ACI.FHH-(D1Mit18-D1Rat90)(D3Got102-D3Got149)(D14Mit11-D14Rat33)(D14Rat65-D14Rat90)/Mcwi strain MP:0011402 renal cast induced IAGP XCO:0000113 N RGD:5684423|PMID:21127141 20120127 RGD 5686842 Rf59 Renal function QTL 59 qtl MP:0002962 increased urine protein level IDA N RGD:5684423|PMID:21127141 20120127 RGD 5687698 Adora2bem2Mcwi adenosine A2B receptor; zinc finger nuclease induced mutant 2, Medical College of Wisconsin gene MP:0001260 increased body weight IMP N RGD:11533328|PMID:26385692 20191125 RGD 5687698 Adora2bem2Mcwi adenosine A2B receptor; zinc finger nuclease induced mutant 2, Medical College of Wisconsin gene MP:0001876 decreased inflammatory response IMP N RGD:11533328|PMID:26385692 20191125 RGD 5687698 Adora2bem2Mcwi adenosine A2B receptor; zinc finger nuclease induced mutant 2, Medical College of Wisconsin gene MP:0002953 thick ventricular wall IMP N RGD:11533328|PMID:26385692 20191125 RGD 5687698 Adora2bem2Mcwi adenosine A2B receptor; zinc finger nuclease induced mutant 2, Medical College of Wisconsin gene MP:0004878 increased systemic vascular resistance IMP N RGD:11533328|PMID:26385692 20191125 RGD 5687698 Adora2bem2Mcwi adenosine A2B receptor; zinc finger nuclease induced mutant 2, Medical College of Wisconsin gene MP:0006144 increased systemic arterial systolic blood pressure IMP N RGD:11533328|PMID:26385692 20191125 RGD 5687698 Adora2bem2Mcwi adenosine A2B receptor; zinc finger nuclease induced mutant 2, Medical College of Wisconsin gene MP:0008596 increased circulating interleukin-6 level IMP N RGD:11533328|PMID:26385692 20191125 RGD 5687703 Cd247em1Mcwi Cd247 molecule; zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0004217 salt-sensitive hypertension severity IMP XCO:0000022 N RGD:13442481|PMID:24343121 20171102 RGD 5687703 Cd247em1Mcwi Cd247 molecule; zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0004876 decreased mean systemic arterial blood pressure IMP N RGD:13442481|PMID:24343121 20201210 RGD compared to wild-type 5687703 Cd247em1Mcwi Cd247 molecule; zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0004876 decreased mean systemic arterial blood pressure induced IMP XCO:0000022 N RGD:13442481|PMID:24343121 20171102 RGD compared to wild-type 5687703 Cd247em1Mcwi Cd247 molecule; zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0005017 decreased B cell number IMP N RGD:13442481|PMID:24343121 20171102 RGD 5687703 Cd247em1Mcwi Cd247 molecule; zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0005018 decreased T cell number IMP N RGD:13442481|PMID:24343121 20171102 RGD 5687703 Cd247em1Mcwi Cd247 molecule; zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0005095 decreased T cell proliferation IMP N RGD:13442481|PMID:24343121 20171102 RGD 5687703 Cd247em1Mcwi Cd247 molecule; zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0005540 decreased urine albumin level IMP N RGD:13442481|PMID:24343121 20201210 RGD 5687703 Cd247em1Mcwi Cd247 molecule; zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0005540 decreased urine albumin level induced IMP XCO:0000022 N RGD:13442481|PMID:24343121 20171102 RGD 5687703 Cd247em1Mcwi Cd247 molecule; zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0013276 absent alpha-beta T cells IMP N RGD:13442481|PMID:24343121 20171102 RGD 5687705 Resp18em2Mcwi regulated endocrine-specific protein 18; zinc finger nuclease induced mutant 2, Medical College of Wisconsin gene MP:0002962 increased urine protein level IMP N RGD:14348960|PMID:29570433 20190201 RGD 5687705 Resp18em2Mcwi regulated endocrine-specific protein 18; zinc finger nuclease induced mutant 2, Medical College of Wisconsin gene MP:0004217 salt-sensitive hypertension IMP N RGD:14348960|PMID:29570433 20190201 RGD 5687721 Nr2f2em1Mcwi nuclear receptor subfamily 2, group F, member 2; zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0002963 decreased urine protein level IMP N RGD:10401852|PMID:25687237 20171102 RGD compared to SS/JrHsdMcw 5687721 Nr2f2em1Mcwi nuclear receptor subfamily 2, group F, member 2; zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0005600 increased heart ventricle muscle contractility IMP N RGD:10401852|PMID:25687237 20171102 RGD compared to SS/JrHsdMcw 5687981 SS-Alms1em1Mcwi-/- SS-Alms1em1Mcwi-/Alms1em1Mcwi- strain MP:0001260 increased body weight IMP N RGD:151361229|PMID:30385718 20220301 RGD compared to wild type 5687981 SS-Alms1em1Mcwi-/- SS-Alms1em1Mcwi-/Alms1em1Mcwi- strain MP:0004217 salt-sensitive hypertension exacerbates IMP N RGD:151361229|PMID:30385718 20220301 RGD compared to wild type 5687981 SS-Alms1em1Mcwi-/- SS-Alms1em1Mcwi-/Alms1em1Mcwi- strain MP:0004875 increased mean systemic arterial blood pressure exacerbates IMP N RGD:151361229|PMID:30385718 20220301 RGD compared to wild type 5687981 SS-Alms1em1Mcwi-/- SS-Alms1em1Mcwi-/Alms1em1Mcwi- strain MP:0006144 increased systemic arterial systolic blood pressure exacerbates IMP N RGD:151361229|PMID:30385718 20220301 RGD compared to wild type 5687981 SS-Alms1em1Mcwi-/- SS-Alms1em1Mcwi-/Alms1em1Mcwi- strain MP:0006316 increased urine sodium level induces IMP XCO:0000925 N RGD:151361229|PMID:30385718 20220301 RGD 5687981 SS-Alms1em1Mcwi-/- SS-Alms1em1Mcwi-/Alms1em1Mcwi- strain MP:0011431 increased urine flow rate induces IMP XCO:0000925 N RGD:151361229|PMID:30385718 20220301 RGD 5688010 SS-Ets1em1Mcwi-/+ SS-Ets1em1Mcwi-/Ets1em1Mcwi+ strain MP:0005554 decreased circulating creatinine level induces IAGP XCO:0000795 N RGD:150429812|PMID:31932071 20210930 RGD compared to wild type littermate 5688010 SS-Ets1em1Mcwi-/+ SS-Ets1em1Mcwi-/Ets1em1Mcwi+ strain MP:0031404 increased tubuloglomerular feedback response induces IMP XCO:0000795 N RGD:150429812|PMID:31932071 20220624 RGD compared to wild type littermate 5688030 SS-Mmp2em1Mcwi-/- SS-Mmp2em1Mcwi-/Mmp2em1Mcwi- strain MP:0002963 decreased urine protein level IMP N RGD:401827835|PMID:37643020 20231109 RGD compared to wild type SS 5688030 SS-Mmp2em1Mcwi-/- SS-Mmp2em1Mcwi-/Mmp2em1Mcwi- strain MP:0003071 decreased vascular permeability ameliorates IMP N RGD:401827835|PMID:37643020 20231109 RGD associated with Experimental Diabetes Mellitus, compared to wild type SS 5688030 SS-Mmp2em1Mcwi-/- SS-Mmp2em1Mcwi-/Mmp2em1Mcwi- strain MP:0003215 renal interstitial fibrosis ameliorates IMP N RGD:401827835|PMID:37643020 20231109 RGD compared to wild type SS 5688030 SS-Mmp2em1Mcwi-/- SS-Mmp2em1Mcwi-/Mmp2em1Mcwi- strain MP:0003918 decreased kidney weight IMP N RGD:401827835|PMID:37643020 20231109 RGD associated Experimental Diabetes Mellitus, hypertension; compared to wild type SS 5688030 SS-Mmp2em1Mcwi-/- SS-Mmp2em1Mcwi-/Mmp2em1Mcwi- strain MP:0005264 glomerulosclerosis ameliorates IMP N RGD:401827835|PMID:37643020 20231109 RGD compared to wild type SS 5688030 SS-Mmp2em1Mcwi-/- SS-Mmp2em1Mcwi-/Mmp2em1Mcwi- strain MP:0005527 increased renal glomerular filtration rate IMP N RGD:401827835|PMID:37643020 20231109 RGD compared to wild type SS 5688030 SS-Mmp2em1Mcwi-/- SS-Mmp2em1Mcwi-/Mmp2em1Mcwi- strain MP:0005554 decreased circulating creatinine level IMP N RGD:401827835|PMID:37643020 20231109 RGD compared to wild type SS 5688030 SS-Mmp2em1Mcwi-/- SS-Mmp2em1Mcwi-/Mmp2em1Mcwi- strain MP:0008838 decreased transforming growth factor beta level IMP N RGD:401827835|PMID:37643020 20231109 RGD compared to wild type SS 5688030 SS-Mmp2em1Mcwi-/- SS-Mmp2em1Mcwi-/Mmp2em1Mcwi- strain MP:0011863 abnormal podocyte physiology ameliorates IMP N RGD:401827835|PMID:37643020 20231109 RGD associated with Experimental Diabetes Mellitus, compared to wild type SS 5688066 SS-Ncf2em1Mcwi-/- SS-Ncf2em1Mcwi-/Ncf2em1Mcwi- strain MP:0004217 salt-sensitive hypertension ameliorates IMP N RGD:9587793|PMID:22326221 20230927 RGD compared to wild-type littermates 5688066 SS-Ncf2em1Mcwi-/- SS-Ncf2em1Mcwi-/Ncf2em1Mcwi- strain MP:0012046 decreased susceptibility to hypertension induces IMP XCO:0000795 N RGD:9587793|PMID:22326221 20230927 RGD compared to wild-type littermates 5688066 SS-Ncf2em1Mcwi-/- SS-Ncf2em1Mcwi-/Ncf2em1Mcwi- strain MP:0020447 decreased NAD(P)H oxidase activity induces IMP XCO:0000795 N RGD:9587793|PMID:22326221 20230927 RGD compared to wild-type littermates 5688074 SS-Nox4em2Mcwi-/- SS-Nox4em2Mcwi-/Nox4em2Mcwi- strain MP:0003674 oxidative stress severity IMP N RGD:11085830|PMID:26644237 20190103 RGD compared to SS/JrHsdMcwi 5688074 SS-Nox4em2Mcwi-/- SS-Nox4em2Mcwi-/Nox4em2Mcwi- strain MP:0004876 decreased mean systemic arterial blood pressure induced IMP XCO:0000022 N RGD:11085830|PMID:26644237 20191122 RGD compared to SS/JrHsdMcwi 5688074 SS-Nox4em2Mcwi-/- SS-Nox4em2Mcwi-/Nox4em2Mcwi- strain MP:0005540 decreased urine albumin level induced IMP XCO:0000022 N RGD:11085830|PMID:26644237 20190103 RGD compared to SS/JrHsdMcwi 5688074 SS-Nox4em2Mcwi-/- SS-Nox4em2Mcwi-/Nox4em2Mcwi- strain MP:0012046 decreased susceptibility to hypertension induced IMP XCO:0000022 N RGD:11085830|PMID:26644237 20190103 RGD compared to SS/JrHsdMcwi 5688087 FHH.BN-(D1Hmgc14-D1Hmgc15)/Mcwi-Rab38em1Mcwi-/- FHH.BN-(D1Hmgc14-D1Hmgc15)/Mcwi-Rab38em1Mcwi-/Rab38em1Mcwi- strain MP:0002962 increased urine protein level IAGP N RGD:13782139|PMID:23291471 20191212 RGD compared to FHH-Tg(CAG-Rab38)1Mcwi, FHH.BN-(D1Hmgc14-D1Hmgc15)/Mcwi 5688092 SS-Rag1em1Mcwi-/- SS-Rag1em1Mcwi-/Rag1em1Mcwi- strain MP:0004875 increased mean systemic arterial blood pressure IMP N RGD:7207429|PMID:23364523 20181011 RGD on 4% NaCl diet 5688092 SS-Rag1em1Mcwi-/- SS-Rag1em1Mcwi-/Rag1em1Mcwi- strain MP:0005017 decreased B cell number IMP N RGD:7207429|PMID:23364523 20181011 RGD as compared to SS 5688092 SS-Rag1em1Mcwi-/- SS-Rag1em1Mcwi-/Rag1em1Mcwi- strain MP:0005018 decreased T cell number IMP N RGD:7207429|PMID:23364523 20181011 RGD as compared to SS 5688096 SS-Rag1em2Mcwi-/- SS-Rag1em2Mcwi-/Rag1em2Mcwi- strain MP:0004875 increased mean systemic arterial blood pressure IMP N RGD:7207429|PMID:23364523 20181011 RGD on 4% NaCl diet 5688096 SS-Rag1em2Mcwi-/- SS-Rag1em2Mcwi-/Rag1em2Mcwi- strain MP:0004956 decreased thymus weight IMP N RGD:7207429|PMID:23364523 20181011 RGD as compared to SS 5688096 SS-Rag1em2Mcwi-/- SS-Rag1em2Mcwi-/Rag1em2Mcwi- strain MP:0005540 decreased urine albumin level IMP N RGD:7207429|PMID:23364523 20181011 RGD as compared to SS-Rag1em1Mcwi on 4% NaCl diet 5688102 SS-Renem1Mcwi-/- SS-Renem1Mcwi-/Renem1Mcwi- strain MP:0001262 decreased body weight IMP N RGD:7771614|PMID:21242461 20220128 RGD compared to wild type 5688102 SS-Renem1Mcwi-/- SS-Renem1Mcwi-/Renem1Mcwi- strain MP:0002135 abnormal kidney morphology exacerbates IMP N RGD:7771614|PMID:21242461 20220128 RGD compared to wild type 5688102 SS-Renem1Mcwi-/- SS-Renem1Mcwi-/Renem1Mcwi- strain MP:0002626 increased heart rate IMP N RGD:7771614|PMID:21242461 20220128 RGD compared to wild type 5688102 SS-Renem1Mcwi-/- SS-Renem1Mcwi-/Renem1Mcwi- strain MP:0002941 increased circulating alanine transaminase level IMP N RGD:7771614|PMID:21242461 20220128 RGD compared to wild type 5688102 SS-Renem1Mcwi-/- SS-Renem1Mcwi-/Renem1Mcwi- strain MP:0002963 decreased urine protein level IMP N RGD:7771614|PMID:21242461 20220128 RGD compared to wild type 5688102 SS-Renem1Mcwi-/- SS-Renem1Mcwi-/Renem1Mcwi- strain MP:0003017 decreased circulating bicarbonate level IMP N RGD:7771614|PMID:21242461 20220128 RGD compared to wild type 5688102 SS-Renem1Mcwi-/- SS-Renem1Mcwi-/Renem1Mcwi- strain MP:0004876 decreased mean systemic arterial blood pressure IMP N RGD:7771614|PMID:21242461 20220128 RGD compared to wild type 5688102 SS-Renem1Mcwi-/- SS-Renem1Mcwi-/Renem1Mcwi- strain MP:0005553 increased circulating creatinine level IMP N RGD:7771614|PMID:21242461 20220128 RGD compared to wild type 5688102 SS-Renem1Mcwi-/- SS-Renem1Mcwi-/Renem1Mcwi- strain MP:0005558 decreased creatinine clearance IMP N RGD:7771614|PMID:21242461 20220128 RGD compared to wild type 5688102 SS-Renem1Mcwi-/- SS-Renem1Mcwi-/Renem1Mcwi- strain MP:0005565 increased blood urea nitrogen level IMP N RGD:7771614|PMID:21242461 20220128 RGD 5688102 SS-Renem1Mcwi-/- SS-Renem1Mcwi-/Renem1Mcwi- strain MP:0006263 decreased systemic arterial diastolic blood pressure IMP N RGD:7771614|PMID:21242461 20220128 RGD compared to wild type 5688102 SS-Renem1Mcwi-/- SS-Renem1Mcwi-/Renem1Mcwi- strain MP:0006264 decreased systemic arterial systolic blood pressure IMP N RGD:7771614|PMID:21242461 20220128 RGD compared to wild type 5688102 SS-Renem1Mcwi-/- SS-Renem1Mcwi-/Renem1Mcwi- strain MP:0011431 increased urine flow rate IMP N RGD:7771614|PMID:21242461 20220128 RGD compared to wild type 5688102 SS-Renem1Mcwi-/- SS-Renem1Mcwi-/Renem1Mcwi- strain MP:0011471 decreased urine creatinine level IMP N RGD:7771614|PMID:21242461 20220128 RGD compared to wild type 5688119 SS-Tgfb1em3Mcwi+/- SS-Tgfb1em3Mcwi+/Tgfb1em3Mcwi- strain MP:0002963 decreased urine protein level induces IMP N RGD:13446413|PMID:23249995 20210824 RGD Compared with wild type littermates SS-Tgfb1em3Mcwi+/+ 5688119 SS-Tgfb1em3Mcwi+/- SS-Tgfb1em3Mcwi+/Tgfb1em3Mcwi- strain MP:0004154 renal tubular necrosis ameliorates IMP XCO:0000795 N RGD:13446413|PMID:23249995 20210824 RGD Compared with wild type littermates SS-Tgfb1em3Mcwi+/+ 5688119 SS-Tgfb1em3Mcwi+/- SS-Tgfb1em3Mcwi+/Tgfb1em3Mcwi- strain MP:0005540 decreased urine albumin level induces IMP N RGD:13446413|PMID:23249995 20210824 RGD Compared with wild type littermates SS-Tgfb1em3Mcwi+/+ 5688119 SS-Tgfb1em3Mcwi+/- SS-Tgfb1em3Mcwi+/Tgfb1em3Mcwi- strain MP:0008838 decreased transforming growth factor beta level induces IMP XCO:0000795 N RGD:13446413|PMID:23249995 20210824 RGD Compared with wild type littermates SS-Tgfb1em3Mcwi+/+ 5688119 SS-Tgfb1em3Mcwi+/- SS-Tgfb1em3Mcwi+/Tgfb1em3Mcwi- strain MP:0020993 abnormal urine cytokine level induces IMP XCO:0000795 N RGD:13446413|PMID:23249995 20210824 RGD Compared with wild type littermates SS-Tgfb1em3Mcwi+/+ 60990 LH/MavRrrc Lyon Hypertensive strain MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:61057|PMID:7981757 19990101 RGD compared with LN/Mav 60993 FHH Fawn Hooded Hypertensive strain MP:0003025 increased vasoconstriction induced IMP XCO:0000466 N RGD:13446412|PMID:25397684 20201221 RGD compared to FHH.1BN and SD 60993 FHH Fawn Hooded Hypertensive strain MP:0031184 increased cerebral blood flow rate induced IMP XCO:0000466 N RGD:13446412|PMID:25397684 20201221 RGD compared to FHH.1BN and SD 60997 DA DA strain MP:0001845 abnormal inflammatory response IAGP XCO:0000263 N RGD:61088|PMID:8909256 20191105 RGD 60997 DA DA strain MP:0001846 increased inflammatory response IAGP N RGD:628543|PMID:12461526 20220531 RGD 60997 DA DA strain MP:0002499 chronic inflammation IAGP XCO:0000263 N RGD:61088|PMID:8909256 20191105 RGD 60997 DA DA strain MP:0002936 joint swelling IAGP XCO:0000263 N RGD:61088|PMID:8909256 20191105 RGD 60997 DA DA strain MP:0003186 abnormal redox activity IAGP N RGD:628543|PMID:12461526 20220531 RGD 60997 DA DA strain MP:0003724 increased susceptibility to induced arthritis IAGP N RGD:628543|PMID:12461526 20220531 RGD 60997 DA DA strain MP:0003724 increased susceptibility to induced arthritis IAGP XCO:0000263 N RGD:61088|PMID:8909256 20191105 RGD 60997 DA DA strain MP:0004799 increased susceptibility to experimental autoimmune encephalomyelitis induced IAGP XCO:0000195 N RGD:61068|PMID:9692888 20200622 RGD compared to PAG.1AV1 60997 DA DA strain MP:0005515 uveitis penetrance IAGP N RGD:40903004|PMID:8045717 20201222 RGD associated with herpes simplex virus; compared to PVG rat strain 60997 DA DA strain MP:0008078 increased CD8-positive, alpha-beta T cell number IAGP XCO:0000263 N RGD:61088|PMID:8909256 20191105 RGD 60997 DA DA strain MP:0008596 increased circulating interleukin-6 level IAGP XCO:0000263 N RGD:61088|PMID:8909256 20191105 RGD 60997 DA DA strain MP:0009764 decreased susceptibility to induced morbidity/mortality induced IAGP XCO:0000195 N RGD:61068|PMID:9692888 20200615 RGD compared to treated PVG.1AV1 60997 DA DA strain MP:0009791 increased susceptibility to viral infection induced morbidity/mortality penetrance IAGP N RGD:40903004|PMID:8045717 20201222 RGD compared to PVG rat strain; HSV-1 McKrae virus strain 60997 DA DA strain MP:0020445 abnormal NAD(P)H oxidase activity IAGP N RGD:628543|PMID:12461526 20220531 RGD 60999 LEW Lewis strain MP:0001260 increased body weight sexual_dimorphism IAGP N RGD:1299960|PMID:14709677 20200408 RGD compared to LEW females 60999 LEW Lewis strain MP:0002644 decreased circulating triglyceride level sexual_dimorphism IAGP N RGD:1299960|PMID:14709677 20200408 RGD compared to LEW females 60999 LEW Lewis strain MP:0005178 increased circulating cholesterol level sexual_dimorphism IAGP N RGD:1299960|PMID:14709677 20200408 RGD compared to LEW females 60999 LEW Lewis strain MP:0005515 uveitis susceptibility IAGP N RGD:40903004|PMID:8045717 20201222 RGD associated with herpes simplex virus; compared to PVG rat strain 60999 LEW Lewis strain MP:0006263 decreased systemic arterial diastolic blood pressure sexual_dimorphism IAGP N RGD:1299960|PMID:14709677 20200408 RGD compared to LEW females 60999 LEW Lewis strain MP:0006264 decreased systemic arterial systolic blood pressure sexual_dimorphism IAGP N RGD:1299960|PMID:14709677 20200408 RGD compared to LEW females 60999 LEW Lewis strain MP:0009791 increased susceptibility to viral infection induced morbidity/mortality susceptibility IAGP N RGD:40903004|PMID:8045717 20201222 RGD compared to PVG rat strain; HSV-1 McKrae virus strain 61000 SHR Spontaneously Hypertensive Rat strain MP:0002972 abnormal cardiac muscle contractility IAGP N RGD:401965414|PMID:10901178 20240206 RGD compared to WKY controls 61000 SHR Spontaneously Hypertensive Rat strain MP:0003820 increased left ventricle systolic pressure IAGP N RGD:401965414|PMID:10901178 20240206 RGD compared to WKY controls 61000 SHR Spontaneously Hypertensive Rat strain MP:0003915 increased heart left ventricle weight IAGP N RGD:13513906|PMID:16882881 20200214 RGD compared to WKY 61000 SHR Spontaneously Hypertensive Rat strain MP:0004875 increased mean systemic arterial blood pressure IAGP N RGD:401965414|PMID:10901178 20240206 RGD compared to WKY controls 61000 SHR Spontaneously Hypertensive Rat strain MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:13513906|PMID:16882881 20200214 RGD compared to WKY 61000 SHR Spontaneously Hypertensive Rat strain MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:2316962|PMID:16928787 20191202 RGD compared with WKY 61000 SHR Spontaneously Hypertensive Rat strain MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:619655|PMID:9171954 20201201 RGD compared to WKY 61006 PVG PVG strain MP:0009790 decreased susceptibility to viral infection induced morbidity/mortality severity IAGP N RGD:40903004|PMID:8045717 20201222 RGD compared to Lewis, AO, DA rat strains; HSV-1 McKrae virus strain 61006 PVG PVG strain MP:0020162 decreased susceptibility to virus induced diabetes induced IAGP XCO:0000238 N RGD:2313207|PMID:1658938 20200225 RGD compared to BBDR/WorBrm 61007 WF Wistar Furth strain MP:0003447 decreased tumor growth/size induced IAGP XCO:0000351 N RGD:61091|PMID:9563479 20200319 RGD tongue carcinoma, compared to treated DA/Slc 61007 WF Wistar Furth strain MP:0010271 decreased tongue tumor incidence induced IAGP XCO:0000351 N RGD:61091|PMID:9563479 20200319 RGD compared to treated DA/Slc 61008 WAG Wistar Albino Glaxo strain MP:0001745 increased circulating corticosterone level induced IAGP XCO:0000159 N RGD:2306974|PMID:19089625 20090520 RGD 61010 SHRSP Spontaneously Hypertensive Rat, Stroke Prone strain MP:0002833 increased heart weight IAGP N RGD:12904885|PMID:2941600 20191216 RGD compared to SHRSR and WKY 61010 SHRSP Spontaneously Hypertensive Rat, Stroke Prone strain MP:0002834 decreased heart weight induced IAGP XCO:0000382 N RGD:12904885|PMID:2941600 20191216 RGD compared to untreated SHRSP 61010 SHRSP Spontaneously Hypertensive Rat, Stroke Prone strain MP:0005264 glomerulosclerosis treatment IAGP XCO:0000382 N RGD:12904885|PMID:2941600 20191216 RGD compared to SHRSR and WKY 61010 SHRSP Spontaneously Hypertensive Rat, Stroke Prone strain MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:12904885|PMID:2941600 20191216 RGD compared to SHRSR and WKY 61010 SHRSP Spontaneously Hypertensive Rat, Stroke Prone strain MP:0006264 decreased systemic arterial systolic blood pressure treatment IAGP XCO:0000382 N RGD:12904885|PMID:2941600 20191216 RGD compared to untreated SHRSP 61014 OLETF Otsuka Long-Evans Tokushima fatty strain MP:0001260 increased body weight IAGP N RGD:21406435|PMID:30225267 20200313 RGD compared to LETO rats 61014 OLETF Otsuka Long-Evans Tokushima fatty strain MP:0001260 increased body weight IAGP N RGD:61072|PMID:9585427 20191105 RGD 61014 OLETF Otsuka Long-Evans Tokushima fatty strain MP:0001262 decreased body weight IAGP N RGD:625760|PMID:12420133 20201201 RGD compared to F344/Slc 61014 OLETF Otsuka Long-Evans Tokushima fatty strain MP:0001552 increased circulating triglyceride level IAGP N RGD:21406435|PMID:30225267 20200313 RGD compared to LETO rats and OLETF rats treated with rosiglitazone 61014 OLETF Otsuka Long-Evans Tokushima fatty strain MP:0001554 increased circulating free fatty acids level IAGP N RGD:21406435|PMID:30225267 20200313 RGD compared to LETO rats and OLETF rats treated with rosiglitazone 61014 OLETF Otsuka Long-Evans Tokushima fatty strain MP:0001559 hyperglycemia IAGP N RGD:1625203|PMID:16081877 20191107 RGD LETO 61014 OLETF Otsuka Long-Evans Tokushima fatty strain MP:0001573 abnormal circulating alanine transaminase level IAGP N RGD:21406435|PMID:30225267 20200313 RGD compared to LETO rats and OLETF rats treated with rosiglitazone 61014 OLETF Otsuka Long-Evans Tokushima fatty strain MP:0001777 abnormal body temperature homeostasis IAGP N RGD:1625204|PMID:15178543 20070529 RGD LETO 61014 OLETF Otsuka Long-Evans Tokushima fatty strain MP:0001986 abnormal taste sensitivity IAGP N RGD:1625203|PMID:16081877 20070529 RGD LETO 61014 OLETF Otsuka Long-Evans Tokushima fatty strain MP:0002079 increased circulating insulin level IAGP N RGD:1625203|PMID:16081877 20191107 RGD LETO 61014 OLETF Otsuka Long-Evans Tokushima fatty strain MP:0002079 increased circulating insulin level IAGP N RGD:21406435|PMID:30225267 20200313 RGD compared to LETO rats and OLETF rats treated with rosiglitazone 61014 OLETF Otsuka Long-Evans Tokushima fatty strain MP:0004893 decreased adiponectin level IAGP N RGD:21406435|PMID:30225267 20200313 RGD compared to LETO rats and OLETF rats treated with rosiglitazone 61014 OLETF Otsuka Long-Evans Tokushima fatty strain MP:0005293 impaired glucose tolerance IAGP N RGD:21406435|PMID:30225267 20200313 RGD compared to LETO rats and OLETF rats treated with rosiglitazone 61014 OLETF Otsuka Long-Evans Tokushima fatty strain MP:0005331 insulin resistance IAGP N RGD:21406435|PMID:30225267 20200313 RGD compared to LETO rats and OLETF rats treated with rosiglitazone 61014 OLETF Otsuka Long-Evans Tokushima fatty strain MP:0005452 abnormal adipose tissue amount IAGP N RGD:21406435|PMID:30225267 20200313 RGD compared to LETO rats 61014 OLETF Otsuka Long-Evans Tokushima fatty strain MP:0005452 abnormal adipose tissue amount IAGP N RGD:619672|PMID:11853145 20191105 RGD 61014 OLETF Otsuka Long-Evans Tokushima fatty strain MP:0005559 increased circulating glucose level IAGP N RGD:21406435|PMID:30225267 20200313 RGD compared to LETO rats 61014 OLETF Otsuka Long-Evans Tokushima fatty strain MP:0005669 increased circulating leptin level IAGP N RGD:1625203|PMID:16081877 20191107 RGD LETO 61014 OLETF Otsuka Long-Evans Tokushima fatty strain MP:0011020 abnormal circadian temperature homeostasis IAGP N RGD:1625204|PMID:15178543 20191107 RGD LETO 61014 OLETF Otsuka Long-Evans Tokushima fatty strain MP:0011939 increased food intake IAGP N RGD:1625200|PMID:16815799 20070529 RGD LETO 61014 OLETF Otsuka Long-Evans Tokushima fatty strain MP:0011939 increased food intake IAGP N RGD:21406435|PMID:30225267 20200313 RGD compared to LETO rats 61014 OLETF Otsuka Long-Evans Tokushima fatty strain MP:0013279 increased fasting circulating glucose level IAGP N RGD:61072|PMID:9585427 20191105 RGD 61014 OLETF Otsuka Long-Evans Tokushima fatty strain MP:0030968 decreased circulating adiponectin level IAGP N RGD:21406435|PMID:30225267 20200313 RGD compared to LETO rats and OLETF rats treated with rosiglitazone 61096 SHR/NCruk Spontaneously Hypertensive Rat strain MP:0005282 decreased fatty acids level induced IAGP XCO:0000256 N RGD:61078|PMID:9171835 20191205 RGD compared to WKY/NCruk strain 61096 SHR/NCruk Spontaneously Hypertensive Rat strain MP:0006094 increased fat cell size IAGP N RGD:61078|PMID:9171835 20191205 RGD compared to WKY/NCruk strain 61096 SHR/NCruk Spontaneously Hypertensive Rat strain MP:0009305 decreased retroperitoneal fat pad weight IAGP N RGD:61078|PMID:9171835 20191205 RGD compared to WKY/NCruk strain 61096 SHR/NCruk Spontaneously Hypertensive Rat strain MP:0030017 decreased adipocyte glucose uptake induced IAGP XCO:0000245 N RGD:61078|PMID:9171835 20191205 RGD compared to WKY/NCruk strain 61097 WKY/NCruk strain MP:0002608 increased hematocrit IAGP XCO:0000010 N RGD:69699|PMID:11157698 19990101 RGD compared to WKY/NCruk in normal air 61097 WKY/NCruk strain MP:0002833 increased heart weight IAGP N RGD:69706|PMID:10205229 19990101 RGD compared to F344/NHsd 61097 WKY/NCruk strain MP:0002843 decreased systemic arterial blood pressure IAGP N RGD:69706|PMID:10205229 19990101 RGD compared to F344/NHsd 61097 WKY/NCruk strain MP:0003913 increased heart right ventricle weight IAGP N RGD:69706|PMID:10205229 19990101 RGD compared to F344/NHsd 61097 WKY/NCruk strain MP:0003915 increased heart left ventricle weight IAGP N RGD:69706|PMID:10205229 19990101 RGD compared to F344/NHsd 61097 WKY/NCruk strain MP:0004012 increased pulmonary artery pressure induced IAGP XCO:0000010 N RGD:69699|PMID:11157698 19990101 RGD compared to WKY/NCruk in normal air and hypoxic F344/NHsd 61098 BXH/Ipcv strain MP:0020968 enhanced conditioned taste aversion behavior IAGP N RGD:631221|PMID:11958542 20210121 RGD compared to SHR/OlaIpcv 61099 HXB/Ipcv strain MP:0020968 enhanced conditioned taste aversion behavior IAGP N RGD:631221|PMID:11958542 20210121 RGD compared to SHR/OlaIpcv 61100 SHR/Ola strain MP:0002702 decreased circulating free fatty acids level IAGP N RGD:61078|PMID:9171835 20191205 RGD compared to BN-Lx 61100 SHR/Ola strain MP:0004185 abnormal adipocyte glucose uptake susceptibility IAGP N RGD:619666|PMID:9916795 20201214 RGD compared to BN/Crl 61100 SHR/Ola strain MP:0004875 increased mean systemic arterial blood pressure IAGP N RGD:628911|PMID:2708818 20200121 RGD compared to BN-Lx/Cub and SHR.BN-RT1n strains 61100 SHR/Ola strain MP:0005179 decreased circulating cholesterol level IAGP N RGD:61079|PMID:8698878 19990101 RGD compared to BN-Lx 61100 SHR/Ola strain MP:0006094 increased fat cell size IAGP N RGD:61078|PMID:9171835 20191205 RGD compared to BN-Lx 61100 SHR/Ola strain MP:0006143 increased systemic arterial diastolic blood pressure IAGP N RGD:628911|PMID:2708818 20200121 RGD compared to BN-Lx/Cub strain 61100 SHR/Ola strain MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:628911|PMID:2708818 20200121 RGD compared to BN-Lx/Cub strain 61100 SHR/Ola strain MP:0020870 decreased thigmotaxis IAGP N RGD:737695|PMID:14739700 20200219 RGD compared to BN-Lx/Cub strain 61100 SHR/Ola strain MP:0030017 decreased adipocyte glucose uptake IAGP N RGD:61078|PMID:9171835 19990101 RGD compared to BN-Lx 61103 WKY strain MP:0002834 decreased heart weight IAGP N RGD:12904885|PMID:2941600 20191216 RGD compared to SHRSP and SHRSR 61103 WKY strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:12904885|PMID:2941600 20191216 RGD compared to SHRSP and SHRSR 61104 LEW/NCrl strain MP:0001263 weight loss induced IAGP XCO:0000022 N RGD:61040|PMID:9685318 20081126 RGD on 8% NaCl diet 61105 WKY/NHsd strain MP:0001364 decreased anxiety-related response IAGP N RGD:2293622|PMID:18518967 20080610 RGD compared to F344/NHsd 61105 WKY/NHsd strain MP:0001382 abnormal nursing IAGP N RGD:1300040|PMID:15158425 20201106 RGD compared to F344/NHsd; 61105 WKY/NHsd strain MP:0001402 decreased locomotor activity induced IAGP XCO:0000157 N RGD:2293622|PMID:18518967 20080610 RGD compared to F344/NHsd 61105 WKY/NHsd strain MP:0001442 decreased grooming behavior induced IAGP XCO:0000157 N RGD:2293622|PMID:18518967 20080610 RGD compared to F344/NHsd 61105 WKY/NHsd strain MP:0001522 impaired swimming IAGP N RGD:4891104|PMID:14593430 20201216 RGD compared to F344, SD and Wi 61105 WKY/NHsd strain MP:0002665 decreased circulating corticosterone level sexual_dimorphism IAGP N RGD:1598980|PMID:16895972 20080311 RGD compared to F344/NHsd males 61105 WKY/NHsd strain MP:0002757 decreased vertical activity IAGP N RGD:1578499|PMID:16490266 20061215 RGD 61105 WKY/NHsd strain MP:0002757 decreased vertical activity IAGP N RGD:2293622|PMID:18518967 20080610 RGD compared to F344/NHsd 61105 WKY/NHsd strain MP:0005135 increased thyroid-stimulating hormone level IAGP N RGD:1302891|PMID:15514085 19990101 RGD compared to F344/NHsd 61105 WKY/NHsd strain MP:0005293 impaired glucose tolerance IAGP XCO:0000103 N RGD:6893578|PMID:22947656 20131021 RGD 61105 WKY/NHsd strain MP:0005293 impaired glucose tolerance induced IAGP XCO:0000103 N RGD:2316693|PMID:20068026 20200825 RGD compared to BN/SsN, BUF/N, F344/N 61105 WKY/NHsd strain MP:0005331 insulin resistance IAGP N RGD:6893578|PMID:22947656 20131021 RGD 61105 WKY/NHsd strain MP:0009327 abnormal maternal grooming IAGP N RGD:1300040|PMID:15158425 20201106 RGD compared to F344/NHsd; 61105 WKY/NHsd strain MP:0013308 decreased adrenal gland weight sexual_dimorphism IAGP N RGD:1598980|PMID:16895972 20080311 RGD compared to F344/NHsd males 61106 SHR.BN-(D8Mit5-D8Mgh6)/Ipcv strain MP:0002834 decreased heart weight IAGP N RGD:61054|PMID:9045857 20200122 RGD compared to SHR/Ola 61106 SHR.BN-(D8Mit5-D8Mgh6)/Ipcv strain MP:0006263 decreased systemic arterial diastolic blood pressure IAGP N RGD:61054|PMID:9045857 19990101 RGD compared to SHR/Ola 61106 SHR.BN-(D8Mit5-D8Mgh6)/Ipcv strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:61054|PMID:9045857 20200122 RGD compared to SHR/Ola 61107 BB/OK BioBreeding rat strain MP:0001552 increased circulating triglyceride level susceptibility IAGP N RGD:619684|PMID:9329742 20200302 RGD compared to SHR/Mol; sexual dimorphism 61107 BB/OK BioBreeding rat strain MP:0002963 decreased urine protein level susceptibility IAGP N RGD:619684|PMID:9329742 20200302 RGD compared to SHR/Mol 61107 BB/OK BioBreeding rat strain MP:0005293 impaired glucose tolerance susceptibility IAGP N RGD:619684|PMID:9329742 20200302 RGD compared to SHR/Mol 61107 BB/OK BioBreeding rat strain MP:0011467 decreased urine urea nitrogen level susceptibility IAGP N RGD:619684|PMID:9329742 20200302 RGD compared to SHR/Mol 61107 BB/OK BioBreeding rat strain MP:0011469 abnormal urine creatinine level susceptibility IAGP N RGD:619684|PMID:9329742 20200302 RGD compared to SHR/Mol; sexual dimorphism 61109 F344/NHsd F344/NHsd strain MP:0000635 pituitary gland hyperplasia IAGP N RGD:61074|PMID:9337394 19990101 RGD as compared to BN/SsNHsd 61109 F344/NHsd F344/NHsd strain MP:0001363 increased anxiety-related response IAGP N RGD:2293622|PMID:18518967 20080610 RGD as compared to WKY/NHsd 61109 F344/NHsd F344/NHsd strain MP:0001399 hyperactivity IAGP N RGD:2293622|PMID:18518967 20080610 RGD as compared to WKY/NHsd 61109 F344/NHsd F344/NHsd strain MP:0001441 increased grooming behavior IAGP N RGD:2293622|PMID:18518967 20080610 RGD as compared to WKY/NHsd 61109 F344/NHsd F344/NHsd strain MP:0002608 increased hematocrit IAGP N RGD:69699|PMID:11157698 19990101 RGD as compared to WKY/Cruk 61109 F344/NHsd F344/NHsd strain MP:0002834 decreased heart weight IAGP N RGD:69706|PMID:10205229 19990101 RGD as compared to WKY/Cruk 61109 F344/NHsd F344/NHsd strain MP:0002842 increased systemic arterial blood pressure IAGP N RGD:69706|PMID:10205229 19990101 RGD as compared to WKY/Cruk 61109 F344/NHsd F344/NHsd strain MP:0002975 vascular smooth muscle hypertrophy IAGP N RGD:10401832|PMID:26258299 20151014 RGD 61109 F344/NHsd F344/NHsd strain MP:0003109 short femur IAGP N RGD:6480192|PMID:21334473 20200414 RGD compared to WKY/NHsd 61109 F344/NHsd F344/NHsd strain MP:0003721 increased tumor growth/size induced IAGP XCO:0000210,XCO:0000442,XCO:0000206 N RGD:619598|PMID:10493520 20200225 RGD compared to BN/SsNHsd 61109 F344/NHsd F344/NHsd strain MP:0003914 decreased heart right ventricle weight IAGP N RGD:69706|PMID:10205229 19990101 RGD as compared to WKY/Cruk 61109 F344/NHsd F344/NHsd strain MP:0003916 decreased heart left ventricle weight IAGP N RGD:69706|PMID:10205229 19990101 RGD as compared to WKY/Cruk 61109 F344/NHsd F344/NHsd strain MP:0004013 decreased pulmonary artery pressure IAGP N RGD:69699|PMID:11157698 19990101 RGD as compared to WKY/Cruk 61109 F344/NHsd F344/NHsd strain MP:0004013 decreased pulmonary artery pressure induced IAGP XCO:0000010 N RGD:10401832|PMID:26258299 20200130 RGD as compared to WKY/Cruk 61109 F344/NHsd F344/NHsd strain MP:0004202 pulmonary hyperplasia IAGP N RGD:10401832|PMID:26258299 20151014 RGD 61109 F344/NHsd F344/NHsd strain MP:0004748 increased susceptibility to age-related hearing loss onset IAGP N RGD:2293526|PMID:18508213 20080603 RGD 61109 F344/NHsd F344/NHsd strain MP:0004822 decreased susceptibility to experimental autoimmune uveoretinitis resistance IAGP N RGD:2293749|PMID:18281616 20080612 RGD as compared to LEW/SsNHsd 61109 F344/NHsd F344/NHsd strain MP:0006325 impaired hearing onset IAGP N RGD:2293526|PMID:18508213 20080603 RGD 61109 F344/NHsd F344/NHsd strain MP:0008331 increased lactotroph cell number IAGP N RGD:1581610|PMID:16416090 20200313 RGD compared to F344.BN-(D3Mgh13-D3Mgh7)/Dlw 61109 F344/NHsd F344/NHsd strain MP:0008331 increased lactotroph cell number induced IAGP XCO:0000295 N RGD:1300042|PMID:15166088 20200313 RGD compared to F344/NHsd, diethylstilbestrol treated F344.BN-(D5Rat1-D5Mit5)/Dlw 61109 F344/NHsd F344/NHsd strain MP:0008331 increased lactotroph cell number induced IAGP XCO:0000295 N RGD:1581610|PMID:16416090 20200313 RGD compared to F344/NHsd, diethylstilbestrol treated F344.BN-(D3Mgh13-D3Mgh7)/Dlw 61109 F344/NHsd F344/NHsd strain MP:0008770 decreased survivor rate induced IAGP XCO:0000668 N RGD:2302114|PMID:17998886 20090522 RGD as compared to BN/HsdMcwiCrl 61109 F344/NHsd F344/NHsd strain MP:0008939 increased pituitary gland weight induced IAGP XCO:0000295 N RGD:1300042|PMID:15166088 20200313 RGD compared to F344/NHsd, diethylstilbestrol treated F344.BN-(D5Rat1-D5Mit5)/Dlw 61109 F344/NHsd F344/NHsd strain MP:0010124 decreased bone mineral content IAGP N RGD:6480192|PMID:21334473 20200414 RGD compared to females of BN/SsNHsd, BUF/NHsd, WKY/NHsd 61109 F344/NHsd F344/NHsd strain MP:0020330 increased capillary density induced IAGP XCO:0000295 N RGD:1300042|PMID:15166088 20200313 RGD compared to F344/NHsd, diethylstilbestrol treated F344.BN-(D5Rat1-D5Mit5)/Dlw, in pituitary gland 61109 F344/NHsd F344/NHsd strain MP:0020330 increased capillary density induced IAGP XCO:0000295 N RGD:1581610|PMID:16416090 20200313 RGD compared to F344/NHsd 61109 F344/NHsd F344/NHsd strain MP:0021066 increased tumor nonattached pericyte number induces IAGP XCO:0000295 N RGD:1581610|PMID:16416090 20231024 RGD compared to F344/NHsd 61110 SHR/Mol strain MP:0000231 hypertension IAGP N RGD:619656|PMID:11414700 19990101 RGD 61110 SHR/Mol strain MP:0001262 decreased body weight IAGP N RGD:69701|PMID:9530625 20191206 RGD compared to strain BB/OK 61110 SHR/Mol strain MP:0002644 decreased circulating triglyceride level sexual_dimorphism IAGP N RGD:619656|PMID:11414700 20200103 RGD in males, compared to Wild/K strain 61110 SHR/Mol strain MP:0005178 increased circulating cholesterol level sexual_dimorphism IAGP N RGD:619656|PMID:11414700 20200103 RGD in males, compared to Wild/K strain 61110 SHR/Mol strain MP:0005560 decreased circulating glucose level IAGP N RGD:619656|PMID:11414700 20200103 RGD compared to Wild/K strain 61110 SHR/Mol strain MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:619656|PMID:11414700 19990101 RGD compared to Wild/K strain 61111 DA/Slc dark agouti strain MP:0005026 decreased susceptibility to parasitic infection IAGP N RGD:1578305|PMID:16465509 19990101 RGD 61113 BN-Lx strain MP:0001548 hyperlipidemia IAGP N RGD:61079|PMID:8698878 19990101 RGD as compared to SHR/OlaIpcv 61113 BN-Lx strain MP:0002842 increased systemic arterial blood pressure IAGP N RGD:61079|PMID:8698878 19990101 RGD as compared to SHR/OlaIpcv 61114 DA/Bkl strain MP:0003724 increased susceptibility to induced arthritis induced IAGP XCO:0000281 N RGD:61066|PMID:10857786 19990101 RGD compared to BN/SsN 61116 SHRSP/A3 strain MP:0001426 polydipsia IAGP N RGD:150429659|PMID:26574044 20210914 RGD compared to SHR-B2 61116 SHRSP/A3 strain MP:0001916 intracerebral hemorrhage IAGP XCO:0000795 N RGD:149735373|PMID:32300198 20210910 RGD compared to SHRSP.SHR-(rs106374972-rs106170276)/Utx 61116 SHRSP/A3 strain MP:0002067 abnormal sensory capabilities/reflexes/nociception IAGP XCO:0000795 N RGD:149735373|PMID:32300198 20210910 RGD compared to SHRSP.SHR-(rs106374972-rs106170276)/Utx 61116 SHRSP/A3 strain MP:0002135 abnormal kidney morphology IAGP XCO:0000795 N RGD:149735373|PMID:32300198 20210910 RGD compared to SHRSP.SHR-(rs106374972-rs106170276)/Utx 61116 SHRSP/A3 strain MP:0002176 increased brain weight IAGP XCO:0000795 N RGD:149735373|PMID:32300198 20210910 RGD compared to SHRSP.SHR-(rs106374972-rs106170276)/Utx 61116 SHRSP/A3 strain MP:0002666 increased circulating aldosterone level IAGP N RGD:150429659|PMID:26574044 20210914 RGD compared to SHR-B2 61116 SHRSP/A3 strain MP:0002988 decreased urine osmolality IAGP N RGD:150429659|PMID:26574044 20210914 RGD compared to SHR-B2 61116 SHRSP/A3 strain MP:0004119 hypokalemia IAGP N RGD:150429659|PMID:26574044 20210914 RGD compared to SHR-B2 61116 SHRSP/A3 strain MP:0005178 increased circulating cholesterol level sexual_dimorphism IAGP N RGD:61092|PMID:10634822 19990101 RGD compared to male SHRSP/A3 61116 SHRSP/A3 strain MP:0005238 increased brain size IAGP XCO:0000795 N RGD:149735373|PMID:32300198 20210910 RGD compared to SHRSP.SHR-(rs106374972-rs106170276)/Utx 61116 SHRSP/A3 strain MP:0005610 increased circulating antidiuretic hormone level IAGP N RGD:150429659|PMID:26574044 20210914 RGD compared to SHR-B2 61116 SHRSP/A3 strain MP:0008688 decreased interleukin-2 secretion IAGP XCO:0000891,XCO:0000889 N RGD:149735373|PMID:32300198 20210910 RGD in T cells compared to SHR/Utx, SHRSP.SHR-(rs106374972-rs106170276)/Utx 61116 SHRSP/A3 strain MP:0008997 increased blood osmolality IAGP N RGD:150429659|PMID:26574044 20210914 RGD compared to SHR-B2 61116 SHRSP/A3 strain MP:0009763 increased susceptibility to induced morbidity/mortality IAGP XCO:0000795 N RGD:149735373|PMID:32300198 20210910 RGD compared to SHRSP.SHR-(rs106374972-rs106170276)/Utx 61116 SHRSP/A3 strain MP:0011431 increased urine flow rate IAGP N RGD:150429659|PMID:26574044 20210914 RGD compared to SHR-B2 61116 SHRSP/A3 strain MP:0011471 decreased urine creatinine level IAGP N RGD:150429659|PMID:26574044 20210914 RGD compared to SHR-B2 61116 SHRSP/A3 strain MP:0020879 abnormal calcium level IAGP XCO:0000178,XCO:0000185 N RGD:149735373|PMID:32300198 20210910 RGD in PBMC compared to SHR/Utx, SHRSP.SHR-(rs106374972-rs106170276)/Utx 61117 BN-Lx/Cub Brown Norway with polydactyly-luxate strain MP:0001935 decreased litter size IAGP N RGD:631224|PMID:10615258 20200311 RGD compared to SHR/OlaIpcv 61117 BN-Lx/Cub Brown Norway with polydactyly-luxate strain MP:0005178 increased circulating cholesterol level induced IAGP XCO:0000246 N RGD:628911|PMID:2708818 20200121 RGD compared to SHR/Ola strain 61117 BN-Lx/Cub Brown Norway with polydactyly-luxate strain MP:0020968 enhanced conditioned taste aversion behavior IAGP N RGD:631221|PMID:11958542 20240909 RGD compared to SHR/OlaIpcv strain 61276 Crhr1 corticotropin releasing hormone receptor 1 gene MP:0002797 increased thigmotaxis IDA N RGD:1626231|PMID:17550594 20070725 RGD in an induced arthritis pain model 61276 Crhr1 corticotropin releasing hormone receptor 1 gene MP:0003545 increased alcohol consumption IAGP N RGD:1626233|PMID:17015825 20070725 RGD DNA:polymorphism:promoter 61307 Ncf1 neutrophil cytosolic factor 1 gene MP:0003724 increased susceptibility to induced arthritis IAGP N RGD:628543|PMID:12461526 20070315 RGD 61324 Eae5 Experimental allergic encephalomyelitis QTL 5 qtl MP:0000754 paresis QTM N RGD:61031|PMID:10640775 19990101 RGD 61325 Aia5 Adjuvant induced arthritis QTL 5 qtl MP:0002936 joint swelling QTM N RGD:61519 19990101 RGD 61326 Eae6 Experimental allergic encephalomyelitis QTL 6 qtl MP:0000754 paresis QTM N RGD:61031|PMID:10640775 19990101 RGD 61327 Eae7 Experimental allergic encephalomyelitis QTL 7 qtl MP:0000754 paresis QTM N RGD:61031|PMID:10640775 19990101 RGD 61328 Eae8 Experimental allergic encephalomyelitis QTL 8 qtl MP:0000754 paresis QTM N RGD:61031|PMID:10640775 19990101 RGD 61329 Eae9 Experimental allergic encephalomyelitis QTL 9 qtl MP:0000754 paresis QTM N RGD:61031|PMID:10640775 19990101 RGD 61330 Eau1 Experimental allergic uveoretinitis QTL 1 qtl MP:0001851 eye inflammation IDA N RGD:2296064|PMID:18453595 20080702 RGD 61330 Eau1 Experimental allergic uveoretinitis QTL 1 qtl MP:0005197 abnormal uvea morphology QTM N RGD:61073|PMID:10323205 19990101 RGD 61331 Eau2 Experimental allergic uveoretinitis QTL 2 qtl MP:0001851 eye inflammation IDA N RGD:2296064|PMID:18453595 20080702 RGD 61331 Eau2 Experimental allergic uveoretinitis QTL 2 qtl MP:0005197 abnormal uvea morphology QTM N RGD:61073|PMID:10323205 19990101 RGD 61332 Eau3 Experimental allergic uveoretinitis QTL 3 qtl MP:0001851 eye inflammation IDA N RGD:2296064|PMID:18453595 20080702 RGD 61332 Eau3 Experimental allergic uveoretinitis QTL 3 qtl MP:0005197 abnormal uvea morphology QTM N RGD:61073|PMID:10323205 19990101 RGD 61333 Gluco16 Glucose level QTL 16 qtl MP:0004185 abnormal adipocyte glucose uptake IAGP N RGD:61078|PMID:9171835 19990101 RGD 61334 Gluco17 Glucose level QTL 17 qtl MP:0004185 abnormal adipocyte glucose uptake IAGP N RGD:61078|PMID:9171835 19990101 RGD 61335 Bp20 Blood pressure QTL 20 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:61045|PMID:9132270 19990101 RGD 61336 Bp21 Blood pressure QTL 21 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:61045|PMID:9132270 19990101 RGD 61337 Bp22 Blood pressure QTL 22 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:61045|PMID:9132270 19990101 RGD 61338 Bp23 Blood pressure QTL 23 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:61045|PMID:9132270 19990101 RGD 61339 Bp24 Blood pressure QTL 24 qtl MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:61046|PMID:8567976 19990101 RGD 61340 Bp25 Blood pressure QTL 25 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:61047|PMID:9271663 19990101 RGD 61341 Bp26 Blood pressure QTL 26 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:61048|PMID:9336384 19990101 RGD 61342 Bp27 Blood pressure QTL 27 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:61049|PMID:8609235 19990101 RGD 61343 Bp28 Blood pressure QTL 28 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:61050|PMID:8094726 19990101 RGD 61344 Bp29 Blood pressure QTL 29 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:61051|PMID:9774356 19990101 RGD 61345 Rf1 Renal disease susceptibility QTL 1 qtl MP:0002962 increased urine protein level IDA N RGD:61060|PMID:8528250 20120112 RGD 61345 Rf1 Renal disease susceptibility QTL 1 qtl MP:0005264 glomerulosclerosis QTM N RGD:61060|PMID:8528250 19990101 RGD 61346 Rf2 Renal disease susceptibility QTL 2 qtl MP:0002962 increased urine protein level IDA N RGD:61060|PMID:8528250 20120112 RGD 61346 Rf2 Renal disease susceptibility QTL 2 qtl MP:0005264 glomerulosclerosis QTM N RGD:61060|PMID:8528250 19990101 RGD 61347 Bp197 Blood pressure QTL 197 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:61060|PMID:8528250 19990101 RGD 61348 Bp30 Blood pressure QTL 30 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:61049|PMID:8609235 19990101 RGD 61349 Bp31 Blood pressure QTL 31 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:61043|PMID:8952608 19990101 RGD 61350 Bp32 Blood pressure QTL 32 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:61044|PMID:7560090 19990101 RGD 61351 Bp33 Blood pressure QTL 33 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:61044|PMID:7560090 19990101 RGD 61352 Bp34 Blood pressure QTL 34 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:61053|PMID:9722941 19990101 RGD 61353 Bp35 Blood pressure QTL 35 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:61054|PMID:9045857 19990101 RGD 61354 Pia10 Pristane induced arthritis QTL 10 qtl MP:0002936 joint swelling QTM N RGD:61519 19990101 RGD 61355 Bp36 Blood pressure QTL 36 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:61040|PMID:9685318 19990101 RGD 61356 Bp37 Blood pressure QTL 37 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:61040|PMID:9685318 19990101 RGD 61357 Bp38 Blood pressure QTL 38 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:61040|PMID:9685318 19990101 RGD 61358 Bp39 Blood pressure QTL 39 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:61040|PMID:9685318 19990101 RGD 61359 Eaex Experimental allergic encephalomyelitis QTL x qtl MP:0000754 paresis QTM N RGD:61031|PMID:10640775 19990101 RGD 61360 Eaey Experimental allergic encephalomyelitis QTL y qtl MP:0000754 paresis QTM N RGD:61031|PMID:10640775 19990101 RGD 61362 Oia2 Oil induced arthritis QTL 2 qtl MP:0002936 joint swelling IAGP N RGD:61087|PMID:9600974 19990101 RGD 61363 Oia3 Oil induced arthritis QTL 3 qtl MP:0002936 joint swelling QTM N RGD:61087|PMID:9600974 19990101 RGD 61364 Iddm2 Insulin dependent diabetes mellitus QTL 2 qtl MP:0005559 increased circulating glucose level QTM N RGD:61075|PMID:1303251 19990101 RGD 61365 Iddm1 Insulin dependent diabetes mellitus QTL 1 qtl MP:0005015 increased T cell number IDA N RGD:61075|PMID:1303251 20120928 RGD 61365 Iddm1 Insulin dependent diabetes mellitus QTL 1 qtl MP:0005559 increased circulating glucose level QTM N RGD:61076|PMID:7026724 19990101 RGD 61366 Iddm3 Insulin dependent diabetes mellitus QTL 3 qtl MP:0001261 obese QTM N RGD:61075|PMID:1303251 19990101 RGD 61366 Iddm3 Insulin dependent diabetes mellitus QTL 3 qtl MP:0005559 increased circulating glucose level QTM N RGD:61075|PMID:1303251 19990101 RGD 61367 Iddm4 Insulin dependent diabetes mellitus QTL 4 qtl MP:0005559 increased circulating glucose level IAGP N RGD:61075|PMID:1303251 19990101 RGD 61368 Mcs1 Mammary carcinoma susceptibility QTL 1 qtl MP:0001883 increased mammary adenocarcinoma incidence QTM N RGD:61080|PMID:8168109 19990101 RGD 61369 Mcs2 Mammary carcinoma susceptibility QTL 2 qtl MP:0001883 increased mammary adenocarcinoma incidence QTM N RGD:61081|PMID:9584103 19990101 RGD 61370 Mcs3 Mammary carcinoma susceptibility QTL 3 qtl MP:0001883 increased mammary adenocarcinoma incidence QTM N RGD:61081|PMID:9584103 19990101 RGD 61371 Edpm1 Estrogen-dependent pituitary mass QTL 1 qtl MP:0000635 pituitary gland hyperplasia IAGP N RGD:61074|PMID:9337394 19990101 RGD 61372 Bp40 Blood pressure QTL 40 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:61040|PMID:9685318 19990101 RGD 61373 Mcs4 Mammary carcinoma susceptibility QTL 4 qtl MP:0001883 increased mammary adenocarcinoma incidence QTM N RGD:61081|PMID:9584103 19990101 RGD 61374 Edpm2 Estrogen-dependent pituitary mass QTL 2 qtl MP:0000635 pituitary gland hyperplasia QTM N RGD:61074|PMID:9337394 19990101 RGD 61375 Bp41 Blood pressure QTL 41 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:61040|PMID:9685318 19990101 RGD 61376 Bp42 Blood pressure QTL 42 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:61055|PMID:9199194 19990101 RGD 61377 Edpm3 Estrogen-dependent pituitary mass QTL 3 qtl MP:0000635 pituitary gland hyperplasia QTM N RGD:61074|PMID:9337394 19990101 RGD 61378 Bp43 Blood pressure QTL 43 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:61055|PMID:9199194 19990101 RGD 61379 Bp44 Blood pressure QTL 44 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:61055|PMID:9199194 19990101 RGD 61380 Edpm5 Estrogen-dependent pituitary mass QTL 5 qtl MP:0000635 pituitary gland hyperplasia QTM N RGD:61074|PMID:9337394 19990101 RGD 61381 Bp45 Blood pressure QTL 45 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:61055|PMID:9199194 19990101 RGD 61382 Bp46 Blood pressure QTL 46 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:61055|PMID:9199194 19990101 RGD 61383 Bp47 Blood pressure QTL 47 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:61055|PMID:9199194 19990101 RGD 61384 Bp48 Blood pressure QTL 48 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:61055|PMID:9199194 19990101 RGD 61385 Edpm9 Estrogen-dependent pituitary mass QTL 9 qtl MP:0000635 pituitary gland hyperplasia QTM N RGD:61074|PMID:9337394 19990101 RGD 61386 Bp49 Blood pressure QTL 49 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:61056|PMID:9241273 19990101 RGD 61386 Bp49 Blood pressure QTL 49 qtl MP:0006060 increased cerebral infarct size IDA N RGD:61056|PMID:9241273 20070618 RGD 61387 Bp1 Blood pressure QTL 1 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:61036|PMID:1655275 19990101 RGD 61388 Bp2 Blood pressure QTL 2 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:61036|PMID:1655275 19990101 RGD 61389 Bp3 Blood pressure QTL 3 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:61052|PMID:1656270 19990101 RGD 61390 Bp4 Blood pressure QTL 4 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:61052|PMID:1656270 19990101 RGD 61391 Bp5 Blood pressure QTL 5 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:61057|PMID:7981757 19990101 RGD 61391 Bp5 Blood pressure QTL 5 qtl MP:0006143 increased systemic arterial diastolic blood pressure IDA N RGD:61057|PMID:7981757 20121002 RGD 61392 Bp6 Blood pressure QTL 6 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:61057|PMID:7981757 19990101 RGD 61392 Bp6 Blood pressure QTL 6 qtl MP:0006265 increased pulse pressure IDA N RGD:61057|PMID:7981757 20121002 RGD 61393 Bp7 Blood pressure QTL 7 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:61059|PMID:8201007 19990101 RGD 61394 Bp8 Blood pressure QTL 8 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:61059|PMID:8201007 19990101 RGD 61395 Nka1 Natural killer alloreactivity QTL 1 qtl MP:0005070 impaired natural killer cell mediated cytotoxicity IAGP N RGD:61084|PMID:9521051 19990101 RGD 61396 Bp9 Blood pressure QTL 9 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:70857|PMID:9299556 19990101 RGD 61397 Bw17 Body weight QTL 17 qtl MP:0001260 increased body weight QTM N RGD:61061|PMID:8528248 19990101 RGD 61398 Bp50 Blood pressure QTL 50 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:61058|PMID:9329963 19990101 RGD 61399 Tcat1 Tongue tumor resistance QTL 1 qtl MP:0010271 decreased tongue tumor incidence QTM N RGD:61091|PMID:9563479 19990101 RGD 61400 Niddm1 Non-insulin dependent diabetes mellitus QTL 1 qtl MP:0001260 increased body weight IDA N RGD:61082|PMID:8528247 19990101 RGD 61400 Niddm1 Non-insulin dependent diabetes mellitus QTL 1 qtl MP:0005293 impaired glucose tolerance IDA N RGD:61082|PMID:8528247 19990101 RGD 61401 Niddm2 Non-insulin dependent diabetes mellitus QTL 2 qtl MP:0005293 impaired glucose tolerance QTM N RGD:61082|PMID:8528247 19990101 RGD 61401 Niddm2 Non-insulin dependent diabetes mellitus QTL 2 qtl MP:0005559 increased circulating glucose level QTM N RGD:61082|PMID:8528247 19990101 RGD 61402 Niddm3 Non-insulin dependent diabetes mellitus QTL 3 qtl MP:0005293 impaired glucose tolerance IDA N RGD:61082|PMID:8528247 19990101 RGD 61402 Niddm3 Non-insulin dependent diabetes mellitus QTL 3 qtl MP:0005559 increased circulating glucose level IDA N RGD:61082|PMID:8528247 19990101 RGD 61403 Niddm4 Non-insulin dependent diabetes mellitus QTL 4 qtl MP:0001260 increased body weight QTM N RGD:61083|PMID:9169130 19990101 RGD 61403 Niddm4 Non-insulin dependent diabetes mellitus QTL 4 qtl MP:0005215 abnormal pancreatic islet morphology QTM N RGD:61083|PMID:9169130 19990101 RGD 61404 Bw120 Body weight QTL 120 qtl MP:0001260 increased body weight QTM N RGD:61083|PMID:9169130 19990101 RGD 61404 Bw120 Body weight QTL 120 qtl MP:0005559 increased circulating glucose level QTM N RGD:61083|PMID:9169130 19990101 RGD 61405 Niddm6 Non-insulin dependent diabetes mellitus QTL 6 qtl MP:0005559 increased circulating glucose level QTM N RGD:61083|PMID:9169130 19990101 RGD 61406 Scwia1 Streptococcal cell wall induced arthritis QTL 1 qtl MP:0002936 joint swelling QTM N RGD:61064|PMID:10331011 19990101 RGD 61407 Scl12 Serum cholesterol level QTL 12 qtl MP:0001556 increased circulating HDL cholesterol level QTM N RGD:61079|PMID:8698878 19990101 RGD 61408 Scl23 Serum cholesterol level QTL 23 qtl MP:0001556 increased circulating HDL cholesterol level QTM N RGD:61079|PMID:8698878 19990101 RGD 61409 Scl13 Serum cholesterol level QTL 13 qtl MP:0001556 increased circulating HDL cholesterol level QTM N RGD:61079|PMID:8698878 19990101 RGD 61410 Bw19 Body weight QTL 19 qtl MP:0001260 increased body weight IDA N RGD:61082|PMID:8528247 19990101 RGD 61411 Pia1 Pristane induced arthritis QTL 1 qtl MP:0002936 joint swelling QTM N RGD:61089|PMID:9843218 19990101 RGD 61412 Pia2 Pristane induced arthritis QTL 2 qtl MP:0002936 joint swelling QTM N RGD:61089|PMID:9843218 19990101 RGD 61413 Eae10 Experimental allergic encephalomyelitis QTL 10 qtl MP:0000754 paresis QTM N RGD:61031|PMID:10640775 19990101 RGD 61414 Pia3 Pristane induced arthritis QTL 3 qtl MP:0002936 joint swelling QTM N RGD:61089|PMID:9843218 19990101 RGD 61415 Eae11 Experimental allergic encephalomyelitis QTL 11 qtl MP:0000754 paresis QTM N RGD:61031|PMID:10640775 19990101 RGD 61416 Pia4 Pristane induced arthritis QTL 4 qtl MP:0002936 joint swelling QTM N RGD:61089|PMID:9843218 19990101 RGD 61417 Cia10 Collagen induced arthritis QTL 10 qtl MP:0002933 joint inflammation QTM N RGD:61063|PMID:9870869 19990101 RGD 61417 Cia10 Collagen induced arthritis QTL 10 qtl MP:0002936 joint swelling QTM N RGD:61063|PMID:9870869 19990101 RGD 61418 Pia5 Pristane induced arthritis QTL 5 qtl MP:0002933 joint inflammation QTM N RGD:61089|PMID:9843218 19990101 RGD 61418 Pia5 Pristane induced arthritis QTL 5 qtl MP:0002936 joint swelling QTM N RGD:61089|PMID:9843218 19990101 RGD 61419 Cia11 Collagen induced arthritis QTL 11 qtl MP:0002936 joint swelling QTM N RGD:61066|PMID:10857786 19990101 RGD 61420 Pia6 Pristane induced arthritis QTL 6 qtl MP:0002936 joint swelling QTM N RGD:61089|PMID:9843218 19990101 RGD 61421 Cia12 Collagen induced arthritis QTL 12 qtl MP:0002936 joint swelling QTM N RGD:61066|PMID:10857786 19990101 RGD 61422 Cia13 Collagen induced arthritis QTL 13 qtl MP:0002933 joint inflammation QTM N RGD:61067|PMID:11001927 19990101 RGD 61422 Cia13 Collagen induced arthritis QTL 13 qtl MP:0002936 joint swelling QTM N RGD:61067|PMID:11001927 19990101 RGD 61423 Cia14 Collagen induced arthritis QTL 14 qtl MP:0002936 joint swelling QTM N RGD:61066|PMID:10857786 19990101 RGD 61424 Scl1 Serum cholesterol level QTL 1 qtl MP:0005179 decreased circulating cholesterol level QTM N RGD:61092|PMID:10634822 19990101 RGD 61425 Cia15 Collagen induced arthritis QTL 15 qtl MP:0002936 joint swelling QTM N RGD:61067|PMID:11001927 19990101 RGD 61426 Scl2 Serum cholesterol level QTL 2 qtl MP:0005179 decreased circulating cholesterol level QTM N RGD:61092|PMID:10634822 19990101 RGD 61427 Cia16 Collagen induced arthritis QTL 16 qtl MP:0002936 joint swelling QTM N RGD:61067|PMID:11001927 19990101 RGD 61428 Scl3 Serum cholesterol level QTL 3 qtl MP:0005179 decreased circulating cholesterol level QTM N RGD:61092|PMID:10634822 19990101 RGD 61429 Cia17 Collagen induced arthritis QTL 17 qtl MP:0002936 joint swelling QTM N RGD:61067|PMID:11001927 19990101 RGD 61430 Cia18 Collagen induced arthritis QTL 18 qtl MP:0002936 joint swelling QTM N RGD:61067|PMID:11001927 19990101 RGD 61431 Cia19 Collagen induced arthritis QTL 19 qtl MP:0002936 joint swelling QTM N RGD:61067|PMID:11001927 19990101 RGD 61432 Cia1 Collagen induced arthritis QTL 1 qtl MP:0002936 joint swelling QTM N RGD:61062|PMID:8782824 19990101 RGD 61433 Cia2 Collagen induced arthritis QTL 2 qtl MP:0002933 joint inflammation QTM N RGD:61062|PMID:8782824 19990101 RGD 61433 Cia2 Collagen induced arthritis QTL 2 qtl MP:0002936 joint swelling QTM N RGD:61062|PMID:8782824 19990101 RGD 61434 Cia3 Collagen induced arthritis QTL 3 qtl MP:0002933 joint inflammation QTM N RGD:61062|PMID:8782824 19990101 RGD 61434 Cia3 Collagen induced arthritis QTL 3 qtl MP:0002936 joint swelling QTM N RGD:61062|PMID:8782824 19990101 RGD 61435 Cia4 Collagen induced arthritis QTL 4 qtl MP:0002933 joint inflammation QTM N RGD:61062|PMID:8782824 19990101 RGD 61435 Cia4 Collagen induced arthritis QTL 4 qtl MP:0002936 joint swelling QTM N RGD:61069|PMID:10398805 19990101 RGD 61436 Cia5 Collagen induced arthritis QTL 5 qtl MP:0002933 joint inflammation QTM N RGD:61062|PMID:8782824 19990101 RGD 61436 Cia5 Collagen induced arthritis QTL 5 qtl MP:0002936 joint swelling QTM N RGD:61062|PMID:8782824 19990101 RGD 61437 Cia6 Collagen induced arthritis QTL 6 qtl MP:0002936 joint swelling QTM N RGD:61067|PMID:11001927 19990101 RGD 61438 Cia7 Collagen induced arthritis QTL 7 qtl MP:0002933 joint inflammation QTM N RGD:61063|PMID:9870869 19990101 RGD 61438 Cia7 Collagen induced arthritis QTL 7 qtl MP:0002936 joint swelling QTM N RGD:61067|PMID:11001927 19990101 RGD 61439 Cia8 Collagen induced arthritis QTL 8 qtl MP:0002936 joint swelling QTM N RGD:61069|PMID:10398805 19990101 RGD 61440 Cia9 Collagen induced arthritis QTL 9 qtl MP:0002933 joint inflammation QTM N RGD:61063|PMID:9870869 19990101 RGD 61440 Cia9 Collagen induced arthritis QTL 9 qtl MP:0002936 joint swelling QTM N RGD:61063|PMID:9870869 19990101 RGD 61441 Btemp1 Thermal response to stress QTL 1 qtl MP:0005533 increased body temperature QTM N RGD:61094|PMID:10679499 19990101 RGD 61441 Btemp1 Thermal response to stress QTL 1 qtl MP:0010166 increased response to stress-induced hyperthermia IAGP N RGD:61094|PMID:10679499 20171121 RGD 61442 Strs1 Sensitivity to stroke QTL 1 qtl MP:0006080 brain ischemia QTM N RGD:61093|PMID:8696337 19990101 RGD 61443 Btemp2 Thermal response to stress QTL 2 qtl MP:0005533 increased body temperature induced IAGP XCO:0000159, XCO:0000022 N RGD:61094|PMID:10679499 19990101 RGD 61443 Btemp2 Thermal response to stress QTL 2 qtl MP:0010166 increased response to stress-induced hyperthermia IAGP N RGD:61094|PMID:10679499 20171121 RGD 61444 Strs2 Sensitivity to stroke QTL 2 qtl MP:0006080 brain ischemia IAGP N RGD:61093|PMID:8696337 19990101 RGD 61445 Strs3 Sensitivity to stroke QTL 3 qtl MP:0006080 brain ischemia QTM N RGD:61093|PMID:8696337 19990101 RGD 61446 Coreg2 Compensatory renal growth QTL 2 qtl MP:0002955 increased compensatory renal growth QTM N RGD:61071|PMID:10864582 19990101 RGD 61447 Tcas1 Tongue tumor susceptibility QTL 1 qtl MP:0010272 increased tongue tumor incidence IDA N RGD:61091|PMID:9563479 20111115 RGD 61448 Ciaa1 CIA Autoantibody QTL 1 qtl MP:0002493 increased IgG level QTM N RGD:61062|PMID:8782824 19990101 RGD 61448 Ciaa1 CIA Autoantibody QTL 1 qtl MP:0002933 joint inflammation QTM N RGD:61066|PMID:10857786 19990101 RGD 61449 Ciaa2 CIA Autoantibody QTL 2 qtl MP:0002493 increased IgG level QTM N RGD:61518 19990101 RGD 61449 Ciaa2 CIA Autoantibody QTL 2 qtl MP:0002933 joint inflammation QTM N RGD:61066|PMID:10857786 19990101 RGD 61450 Ciaa3 CIA Autoantibody QTL 3 qtl MP:0002493 increased IgG level QTM N RGD:61066|PMID:10857786 19990101 RGD 61450 Ciaa3 CIA Autoantibody QTL 3 qtl MP:0002933 joint inflammation QTM N RGD:61066|PMID:10857786 19990101 RGD 61451 Ciaa4 CIA Autoantibody QTL 4 qtl MP:0002493 increased IgG level QTM N RGD:61067|PMID:11001927 19990101 RGD 61452 Ciaa5 CIA Autoantibody QTL 5 qtl MP:0002493 increased IgG level QTM N RGD:61067|PMID:11001927 19990101 RGD 61453 Pur1 Proteinuria QTL 1 qtl MP:0002962 increased urine protein level IDA N RGD:619599|PMID:9799838 20120112 RGD 61455 Niddm7 Non-insulin dependent diabetes mellitus QTL 7 qtl MP:0005293 impaired glucose tolerance QTM N RGD:61061|PMID:8528248 19990101 RGD 61457 Niddm8 Non-insulin dependent diabetes mellitus QTL 8 qtl MP:0002079 increased circulating insulin level QTM N RGD:61061|PMID:8528248 19990101 RGD 61458 Bp10 Blood pressure QTL 10 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:619639|PMID:7768551 19990101 RGD 61460 Niddm9 Non-insulin dependent diabetes mellitus QTL 9 qtl MP:0002079 increased circulating insulin level QTM N RGD:61061|PMID:8528248 19990101 RGD 61461 Bp11 Blood pressure QTL 11 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:61037|PMID:1363813 19990101 RGD 61462 Niddm10 Non-insulin dependent diabetes mellitus QTL 10 qtl MP:0005293 impaired glucose tolerance QTM N RGD:61061|PMID:8528248 19990101 RGD 61463 Bp12 Blood pressure QTL 12 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:61037|PMID:1363813 19990101 RGD 61464 Niddm11 Non-insulin dependent diabetes mellitus QTL 11 qtl MP:0002079 increased circulating insulin level QTM N RGD:61061|PMID:8528248 19990101 RGD 61465 Bp13 Blood pressure QTL 13 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:61041|PMID:8901842 19990101 RGD 61466 Niddm12 Non-insulin dependent diabetes mellitus QTL 12 qtl MP:0001260 increased body weight IDA N RGD:61061|PMID:8528248 19990101 RGD 61466 Niddm12 Non-insulin dependent diabetes mellitus QTL 12 qtl MP:0005559 increased circulating glucose level IDA N RGD:61061|PMID:8528248 19990101 RGD 61467 Bp14 Blood pressure QTL 14 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:61041|PMID:8901842 19990101 RGD 61468 Bp15 Blood pressure QTL 15 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:61041|PMID:8901842 19990101 RGD 61469 Bp16 Blood pressure QTL 16 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:61043|PMID:8952608 19990101 RGD 61471 Bp18 Blood pressure QTL 18 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:61045|PMID:9132270 19990101 RGD 61472 Aia1 Adjuvant induced arthritis QTL 1 qtl MP:0002936 joint swelling QTM N RGD:61035|PMID:9780220 19990101 RGD 61473 Bp19 Blood pressure QTL 19 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:61045|PMID:9132270 19990101 RGD 61474 Eae1 Experimental allergic encephalomyelitis QTL 1 qtl MP:0000754 paresis QTM N RGD:61031|PMID:10640775 19990101 RGD 61475 Aia2 Adjuvant induced arthritis QTL 2 qtl MP:0002933 joint inflammation QTM N RGD:61035|PMID:9780220 19990101 RGD 61475 Aia2 Adjuvant induced arthritis QTL 2 qtl MP:0002936 joint swelling QTM N RGD:61035|PMID:9780220 19990101 RGD 61476 Aia3 Adjuvant induced arthritis QTL 3 qtl MP:0002936 joint swelling QTM N RGD:61035|PMID:9780220 19990101 RGD 61477 Aia4 Adjuvant induced arthritis QTL 4 qtl MP:0002936 joint swelling QTM N RGD:61035|PMID:9780220 19990101 RGD 61498 BN/NHsdMcwi strain MP:0001262 decreased body weight IAGP N RGD:2290181|PMID:18285521 20200611 RGD comapred to LH/Mav 61498 BN/NHsdMcwi strain MP:0002963 decreased urine protein level IAGP N RGD:1357409|PMID:15758045 20201030 RGD compared to FHH and congenic 61498 BN/NHsdMcwi strain MP:0003022 increased coronary flow rate induced IAGP XCO:0000464,XCO:0000010 N RGD:1342469|PMID:10749737 20200228 RGD compared to SS/JrHsdMcwi 61498 BN/NHsdMcwi strain MP:0003038 decreased myocardial infarct size IAGP XCO:0000464,XCO:0000010 N RGD:1342469|PMID:10749737 19990101 RGD compared to SS/JrHsdMcwi 61498 BN/NHsdMcwi strain MP:0003039 increased time of peak ischemic contracture induced IAGP XCO:0000464,XCO:0000010 N RGD:1342469|PMID:10749737 20200228 RGD compared to SS/JrHsdMcwi 61498 BN/NHsdMcwi strain MP:0003823 increased left ventricle developed pressure induced IAGP XCO:0000464,XCO:0000010 N RGD:1342469|PMID:10749737 20200228 RGD compared to SS/JrHsdMcwi 61498 BN/NHsdMcwi strain MP:0003824 decreased left ventricle developed pressure induced IAGP XCO:0000464,XCO:0000010 N RGD:1342469|PMID:10749737 20200228 RGD 61498 BN/NHsdMcwi strain MP:0004502 decreased incidence of tumors by chemical induction induced IAGP XCO:0000090 N RGD:2301186|PMID:18786441 20081119 RGD compared to SS/JrHsdMcwi 61498 BN/NHsdMcwi strain MP:0004876 decreased mean systemic arterial blood pressure IAGP N RGD:2290181|PMID:18285521 20200611 RGD comapred to LH/Mav 61498 BN/NHsdMcwi strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:2300225|PMID:18653478 20200122 RGD compared to male and female SS/JrHsdMcwi 61498 BN/NHsdMcwi strain MP:0005179 decreased circulating cholesterol level IAGP N RGD:2290181|PMID:18285521 20200611 RGD 61498 BN/NHsdMcwi strain MP:0005318 decreased triglyceride level IAGP N RGD:2290181|PMID:18285521 20200611 RGD 61498 BN/NHsdMcwi strain MP:0005540 decreased urine albumin level induced IAGP XCO:0000022 N RGD:2300225|PMID:18653478 20200122 RGD compared to male and female SS/JrHsdMcwi 61498 BN/NHsdMcwi strain MP:0005571 decreased lactate dehydrogenase level induced IAGP XCO:0000464,XCO:0000010 N RGD:1342469|PMID:10749737 20200228 RGD compared to SS/JrHsdMcwi 61498 BN/NHsdMcwi strain MP:0005583 decreased renin activity induced IAGP XCO:0000022 N RGD:727992|PMID:14532335 19990101 RGD compared to SS/JrHsdMcwi 61498 BN/NHsdMcwi strain MP:0009764 decreased susceptibility to induced morbidity/mortality induced IAGP XCO:0000668 N RGD:2302114|PMID:17998886 20200330 RGD compared to treated NBL/CrCrl, SHR/NHsd, LEW/NHsd, FHH/EurMcwiCrl, DA/OlaHsd 61499 SS/JrHsdMcwi strain MP:0001260 increased body weight induces IAGP XCO:0000245,XCO:0000241 N RGD:149735534|PMID:29923767 20210726 RGD compared to wild type and SS-Trpc6em1Mcwi vehicle-treated control 61499 SS/JrHsdMcwi strain MP:0001262 decreased body weight induces IAGP XCO:0000245,XCO:0000241 N RGD:149735534|PMID:29923767 20210726 RGD compared to wild type and SS-Trpc6em1Mcwi vehicle-treated control 61499 SS/JrHsdMcwi strain MP:0001552 increased circulating triglyceride level induced IAGP XCO:0000022 N RGD:727992|PMID:14532335 19990101 RGD compared to BN/NHsdMcwi 61499 SS/JrHsdMcwi strain MP:0001625 cardiac hypertrophy induced IAGP XCO:0000022 N RGD:727992|PMID:14532335 19990101 RGD 61499 SS/JrHsdMcwi strain MP:0001883 increased mammary adenocarcinoma incidence induced IAGP XCO:0000090 N RGD:2301186|PMID:18786441 20081119 RGD compared to BN/NHsdMcwi 61499 SS/JrHsdMcwi strain MP:0002625 heart left ventricle hypertrophy induced IAGP XCO:0000022 N RGD:727992|PMID:14532335 19990101 RGD 61499 SS/JrHsdMcwi strain MP:0002626 increased heart rate induced IAGP XCO:0000022 N RGD:727992|PMID:14532335 19990101 RGD compared to BN/NHsdMcwi 61499 SS/JrHsdMcwi strain MP:0002871 albuminuria induced IAGP XCO:0000022 N RGD:12802369|PMID:23460292 20170407 RGD 61499 SS/JrHsdMcwi strain MP:0002871 albuminuria induced IAGP XCO:0000795 N RGD:12802368|PMID:23817491 20170407 RGD 61499 SS/JrHsdMcwi strain MP:0002959 increased urine microalbumin level induces IAGP XCO:0000245,XCO:0000241 N RGD:149735534|PMID:29923767 20210726 RGD compared to vehicle-treated control 61499 SS/JrHsdMcwi strain MP:0002962 increased urine protein level induced IAGP XCO:0000022 N RGD:727992|PMID:14532335 19990101 RGD compared to BN/NHsdMcwi 61499 SS/JrHsdMcwi strain MP:0003023 decreased coronary flow rate induced IAGP XCO:0000464,XCO:0000010 N RGD:1342469|PMID:10749737 20200228 RGD 61499 SS/JrHsdMcwi strain MP:0003025 increased vasoconstriction induced IAGP XCO:0000022,XCO:0000612 N RGD:12792230|PMID:27270176 20210405 RGD compared to SS-Shc1em5Mcwi 61499 SS/JrHsdMcwi strain MP:0003824 decreased left ventricle developed pressure induced IAGP XCO:0000464,XCO:0000010 N RGD:1342469|PMID:10749737 20200228 RGD 61499 SS/JrHsdMcwi strain MP:0003917 increased kidney weight induced IAGP XCO:0000022 N RGD:727992|PMID:14532335 19990101 RGD compared to BN/NHsdMcwi 61499 SS/JrHsdMcwi strain MP:0004217 salt-sensitive hypertension IAGP N RGD:12798539|PMID:21257920 20170407 RGD 61499 SS/JrHsdMcwi strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:12802369|PMID:23460292 20170407 RGD 61499 SS/JrHsdMcwi strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:727992|PMID:14532335 19990101 RGD 61499 SS/JrHsdMcwi strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000795 N RGD:12802368|PMID:23817491 20170407 RGD 61499 SS/JrHsdMcwi strain MP:0004217 salt-sensitive hypertension treatment IAGP XCO:0000022,XCO:0000032 N RGD:38500204|PMID:28931751 20200813 RGD compared to SS-Kcnj16em1Mcwi 61499 SS/JrHsdMcwi strain MP:0004875 increased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:2300225|PMID:18653478 20080910 RGD compared to BN/NHsdMcwi 61499 SS/JrHsdMcwi strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000645 N RGD:1626639|PMID:17589973 20070816 RGD compared to BN/NHsdMcwi, lower infusion of anesthetic propofol. 61499 SS/JrHsdMcwi strain MP:0005178 increased circulating cholesterol level induced IAGP XCO:0000022 N RGD:727992|PMID:14532335 19990101 RGD compared to BN/NHsdMcwi 61499 SS/JrHsdMcwi strain MP:0005264 glomerulosclerosis induces IAGP XCO:0000245,XCO:0000241 N RGD:149735534|PMID:29923767 20210726 RGD compared to wild type vehicle-treated control 61499 SS/JrHsdMcwi strain MP:0005333 decreased heart rate induced IAGP XCO:0000464,XCO:0000010 N RGD:1342469|PMID:10749737 20200228 RGD 61499 SS/JrHsdMcwi strain MP:0005553 increased circulating creatinine level induced IAGP XCO:0000022 N RGD:727992|PMID:14532335 19990101 RGD compared to BN/NHsdMcwi 61499 SS/JrHsdMcwi strain MP:0005557 increased creatinine clearance induces IAGP XCO:0000245,XCO:0000241 N RGD:149735534|PMID:29923767 20210726 RGD compared to wild type and SS-Trpc6em1Mcwi 61499 SS/JrHsdMcwi strain MP:0008140 podocyte foot process effacement induces IAGP XCO:0000245,XCO:0000241 N RGD:149735534|PMID:29923767 20210726 RGD compared to control and STZ treated SS-Trpc6em1Mcwi 61499 SS/JrHsdMcwi strain MP:0011296 decreased tubuloglomerular feedback response IAGP N RGD:12792230|PMID:27270176 20200131 RGD compared to SS-Chr 2BN/Mcwi,SS-Shc1em1Mcwi, SS-Shc1em4Mcwi 61499 SS/JrHsdMcwi strain MP:0011402 renal cast IAGP N RGD:38500204|PMID:28931751 20200813 RGD compared to SS-Kcnj16em1Mcwi 61499 SS/JrHsdMcwi strain MP:0011431 increased urine flow rate induces IAGP XCO:0000245,XCO:0000241 N RGD:149735534|PMID:29923767 20210726 RGD compared to wild type and SS-Trpc6em1Mcwi vehicle-treated control 61824 Kcnj16 potassium inwardly-rectifying channel, subfamily J, member 16 gene MP:0001262 decreased body weight IMP N RGD:38500204|PMID:28931751 20201210 RGD compared to SS/JrHsdMcwi 61824 Kcnj16 potassium inwardly-rectifying channel, subfamily J, member 16 gene MP:0002318 hypercapnia IMP N RGD:38500203|PMID:30605394 20201210 RGD compared to SS/JrHsdMcwi 61824 Kcnj16 potassium inwardly-rectifying channel, subfamily J, member 16 gene MP:0002320 hyperventilation IMP N RGD:38500203|PMID:30605394 20201210 RGD compared to SS/JrHsdMcwi 61824 Kcnj16 potassium inwardly-rectifying channel, subfamily J, member 16 gene MP:0002667 decreased circulating aldosterone level IMP N RGD:38500204|PMID:28931751 20201210 RGD compared to SS/JrHsdMcwi 61824 Kcnj16 potassium inwardly-rectifying channel, subfamily J, member 16 gene MP:0002843 decreased systemic arterial blood pressure IMP N RGD:38500204|PMID:28931751 20201210 RGD compared to SS/JrHsdMcwi 61824 Kcnj16 potassium inwardly-rectifying channel, subfamily J, member 16 gene MP:0002960 decreased urine microalbumin level IMP N RGD:38500204|PMID:28931751 20201210 RGD compared to SS/JrHsdMcwi 61824 Kcnj16 potassium inwardly-rectifying channel, subfamily J, member 16 gene MP:0003017 decreased circulating bicarbonate level IMP N RGD:38500203|PMID:30605394 20201210 RGD compared to SS/JrHsdMcwi 61824 Kcnj16 potassium inwardly-rectifying channel, subfamily J, member 16 gene MP:0003019 increased circulating chloride level IMP N RGD:38500203|PMID:30605394 20201210 RGD compared to SS/JrHsdMcwi 61824 Kcnj16 potassium inwardly-rectifying channel, subfamily J, member 16 gene MP:0004119 hypokalemia IMP N RGD:38500204|PMID:28931751 20201210 RGD compared to SS/JrHsdMcwi 61824 Kcnj16 potassium inwardly-rectifying channel, subfamily J, member 16 gene MP:0005333 decreased heart rate IMP N RGD:38500204|PMID:28931751 20201210 RGD compared to SS/JrHsdMcwi 61824 Kcnj16 potassium inwardly-rectifying channel, subfamily J, member 16 gene MP:0005528 decreased renal glomerular filtration rate IMP N RGD:38500204|PMID:28931751 20201210 RGD compared to SS/JrHsdMcwi 61824 Kcnj16 potassium inwardly-rectifying channel, subfamily J, member 16 gene MP:0005565 increased blood urea nitrogen level IMP N RGD:38500204|PMID:28931751 20201210 RGD compared to SS/JrHsdMcwi 61824 Kcnj16 potassium inwardly-rectifying channel, subfamily J, member 16 gene MP:0005628 decreased circulating potassium level IMP N RGD:38500203|PMID:30605394 20201210 RGD compared to SS/JrHsdMcwi 61824 Kcnj16 potassium inwardly-rectifying channel, subfamily J, member 16 gene MP:0009763 increased susceptibility to induced morbidity/mortality treatment IMP XCO:0000022,CHEBI:34558 N RGD:38500204|PMID:28931751 20201210 RGD compared to SS/JrHsdMcwi 61824 Kcnj16 potassium inwardly-rectifying channel, subfamily J, member 16 gene MP:0010092 increased circulating magnesium level IMP N RGD:38500204|PMID:28931751 20201210 RGD compared to SS/JrHsdMcwi 61824 Kcnj16 potassium inwardly-rectifying channel, subfamily J, member 16 gene MP:0012551 metabolic acidosis IMP N RGD:38500203|PMID:30605394 20201210 RGD compared to SS/JrHsdMcwi 61861 Gabra6 gamma-aminobutyric acid type A receptor subunit alpha6 gene MP:0001987 alcohol preference IAGP N RGD:1626511|PMID:14615016 20070810 RGD DNA:polymorphism:CDS:amino acid R100Q, Q allele higher in the alcohol preferring ANA line than the AA non-preferring line (P<0.0001) 61903 Gpr182 G protein-coupled receptor 182 gene MP:0001613 abnormal vasodilation IDA N RGD:61533|PMID:7592696 19990101 RGD 61932 Fah fumarylacetoacetate hydrolase gene MP:0001262 decreased body weight IMP N RGD:14398823|PMID:27510266 20191120 RGD after NTBC withdrawal in the drinking water 61932 Fah fumarylacetoacetate hydrolase gene MP:0011085 postnatal lethality, complete penetrance IMP N RGD:14398823|PMID:27510266 20190502 RGD 61932 Fah fumarylacetoacetate hydrolase gene MP:0013139 moribund IMP N RGD:14398823|PMID:27510266 20191120 RGD 61932 Fah fumarylacetoacetate hydrolase gene MP:0013723 increased circulating tyrosine level IMP N RGD:14398823|PMID:27510266 20191120 RGD after NTBC withdrawal in the drinking water 61958 S1pr1 sphingosine-1-phosphate receptor 1 gene MP:0001625 cardiac hypertrophy IMP N RGD:1357201|PMID:11549339 20061025 RGD 619613 Bp77 Blood pressure QTL 77 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:70855|PMID:11509479 19990101 RGD 619614 Bp78 Blood pressure QTL 78 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:70855|PMID:11509479 19990101 RGD 619615 Bp80 Blood pressure QTL 80 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:70857|PMID:9299556 19990101 RGD 619616 Bp79 Blood pressure QTL 79 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:70857|PMID:9299556 19990101 RGD 619617 Bp283 Blood pressure QTL 283 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:70856|PMID:11053483 19990101 RGD 619618 Rf3 Renal disease susceptibility QTL 3 qtl MP:0002962 increased urine protein level IDA N RGD:70856|PMID:11053483 20120112 RGD 619618 Rf3 Renal disease susceptibility QTL 3 qtl MP:0005264 glomerulosclerosis QTM N RGD:70856|PMID:11053483 19990101 RGD 619619 Rf4 Renal disease susceptibility QTL 4 qtl MP:0005264 glomerulosclerosis QTM N RGD:70856|PMID:11053483 19990101 RGD 619620 Rf5 Renal disease susceptibility QTL 5 qtl MP:0002962 increased urine protein level IDA N RGD:70856|PMID:11053483 20120112 RGD 619620 Rf5 Renal disease susceptibility QTL 5 qtl MP:0005264 glomerulosclerosis QTM N RGD:70856|PMID:11053483 19990101 RGD 619706 Ptprk protein tyrosine phosphatase, receptor type, K gene MP:0008076 abnormal CD4-positive T cell differentiation IAGP N RGD:15036800|PMID:17434290 20090211 RGD 619715 Sv2a synaptic vesicle glycoprotein 2a gene MP:0002906 increased susceptibility to pharmacologically induced seizures IMP N RGD:12792961|PMID:27265781 20170317 RGD DNA:mutation:cds:p.L174Q(rat) 619715 Sv2a synaptic vesicle glycoprotein 2a gene MP:0020424 increased kindling response IMP N RGD:12792961|PMID:27265781 20170317 RGD DNA:mutation:cds:p.L174Q(rat) 619730 Tubb4a tubulin, beta 4A class IVa gene MP:0000745 tremors IAGP N RGD:150429639|PMID:28393430 20210910 RGD DNA:missense mutation:cds:p.Ala302Thr (rat) 619730 Tubb4a tubulin, beta 4A class IVa gene MP:0000921 demyelination IAGP N RGD:150429639|PMID:28393430 20210910 RGD DNA:missense mutation:cds:p.Ala302Thr (rat) 619745 Cdh13 cadherin 13 gene MP:0002850 saccharin preference IMP N RGD:13503340|PMID:28387990 20200814 RGD knock-out compared to wild-type rats 619745 Cdh13 cadherin 13 gene MP:0020909 abnormal cue-induced reinstatement of an extinguished operant behavior for a cocaine reinforcer IMP N RGD:13503340|PMID:28387990 20200819 RGD knock-out compared to wild-type rats 619769 Fmod fibromodulin gene MP:0002871 albuminuria IAGP N RGD:12802368|PMID:23817491 20170406 RGD 619769 Fmod fibromodulin gene MP:0004217 salt-sensitive hypertension IAGP N RGD:12802368|PMID:23817491 20170406 RGD 619777 L1cam L1 cell adhesion molecule gene MP:0000780 abnormal corpus callosum morphology IMP N RGD:14695001|PMID:30738385 20190725 RGD 619777 L1cam L1 cell adhesion molecule gene MP:0001732 postnatal growth retardation IMP N RGD:14695001|PMID:30738385 20190725 RGD 619777 L1cam L1 cell adhesion molecule gene MP:0008534 enlarged fourth ventricle IMP N RGD:14695001|PMID:30738385 20190725 RGD 619777 L1cam L1 cell adhesion molecule gene MP:0008535 enlarged lateral ventricles IMP N RGD:14695001|PMID:30738385 20190725 RGD 619788 Trpc6 transient receptor potential cation channel, subfamily C, member 6 gene MP:0001262 decreased body weight induces IMP XCO:0000245,XCO:0000241 N RGD:149735534|PMID:29923767 20210729 RGD compared to wild type and SS-Trpc6em1Mcwi vehicle-treated control 619788 Trpc6 transient receptor potential cation channel, subfamily C, member 6 gene MP:0002959 increased urine microalbumin level induces IMP XCO:0000245,XCO:0000241 N RGD:149735534|PMID:29923767 20210729 RGD compared to vehicle-treated control 619788 Trpc6 transient receptor potential cation channel, subfamily C, member 6 gene MP:0005264 glomerulosclerosis induces IMP XCO:0000245,XCO:0000241 N RGD:149735534|PMID:29923767 20210729 RGD compared to wild type vehicle-treated control 619788 Trpc6 transient receptor potential cation channel, subfamily C, member 6 gene MP:0005558 decreased creatinine clearance induces IMP XCO:0000245,XCO:0000241 N RGD:149735534|PMID:29923767 20210729 RGD compared to STZ-treated wild type 619788 Trpc6 transient receptor potential cation channel, subfamily C, member 6 gene MP:0005559 increased circulating glucose level induces IMP XCO:0000245,XCO:0000241 N RGD:149735534|PMID:29923767 20210729 RGD compared to vehicle-treated wild type and control 619788 Trpc6 transient receptor potential cation channel, subfamily C, member 6 gene MP:0011431 increased urine flow rate induces IMP XCO:0000245,XCO:0000241 N RGD:149735534|PMID:29923767 20210729 RGD compared to vehicle-treated wild type and control 619790 Rag1 recombination activating 1 gene MP:0000333 decreased bone marrow cell number IMP N RGD:13628403|PMID:29688994 20201210 RGD 619790 Rag1 recombination activating 1 gene MP:0000692 small spleen IMP N RGD:7204134|PMID:23150522 20170331 RGD 619790 Rag1 recombination activating 1 gene MP:0000694 spleen hypoplasia IMP N RGD:13628403|PMID:29688994 20201210 RGD 619790 Rag1 recombination activating 1 gene MP:0000706 small thymus IMP N RGD:7204131|PMID:23136839 20201210 RGD 619790 Rag1 recombination activating 1 gene MP:0000706 small thymus IMP N RGD:7204134|PMID:23150522 20170331 RGD 619790 Rag1 recombination activating 1 gene MP:0000715 decreased thymocyte number IMP N RGD:13628403|PMID:29688994 20201210 RGD 619790 Rag1 recombination activating 1 gene MP:0002217 small lymph nodes IMP N RGD:7204134|PMID:23150522 20170331 RGD 619790 Rag1 recombination activating 1 gene MP:0004875 increased mean systemic arterial blood pressure IMP N RGD:7207429|PMID:23364523 20201210 RGD on 4% NaCl diet 619790 Rag1 recombination activating 1 gene MP:0004956 decreased thymus weight IMP N RGD:7207429|PMID:23364523 20170331 RGD 619790 Rag1 recombination activating 1 gene MP:0005017 decreased B cell number IMP N RGD:7204131|PMID:23136839 20201210 RGD 619790 Rag1 recombination activating 1 gene MP:0005017 decreased B cell number IMP N RGD:7204134|PMID:23150522 20170331 RGD 619790 Rag1 recombination activating 1 gene MP:0005017 decreased B cell number IMP N RGD:7207429|PMID:23364523 20201210 RGD as compared to SS 619790 Rag1 recombination activating 1 gene MP:0005018 decreased T cell number IMP N RGD:7204131|PMID:23136839 20201210 RGD 619790 Rag1 recombination activating 1 gene MP:0005018 decreased T cell number IMP N RGD:7204134|PMID:23150522 20170331 RGD 619790 Rag1 recombination activating 1 gene MP:0005018 decreased T cell number IMP N RGD:7207429|PMID:23364523 20170417 RGD 619790 Rag1 recombination activating 1 gene MP:0005540 decreased urine albumin level IMP N RGD:7207429|PMID:23364523 20170417 RGD 619790 Rag1 recombination activating 1 gene MP:0008045 decreased NK cell number IMP N RGD:13628403|PMID:29688994 20201210 RGD 619790 Rag1 recombination activating 1 gene MP:0008075 decreased CD4-positive, alpha-beta T cell number IMP N RGD:13628403|PMID:29688994 20201210 RGD 619790 Rag1 recombination activating 1 gene MP:0008079 decreased CD8-positive, alpha-beta T cell number IMP N RGD:13628403|PMID:29688994 20201210 RGD 619790 Rag1 recombination activating 1 gene MP:0008101 lymph node hypoplasia IMP N RGD:13628403|PMID:29688994 20201210 RGD 619790 Rag1 recombination activating 1 gene MP:0008211 decreased mature B cell number IMP N RGD:13628403|PMID:29688994 20201210 RGD 619816 Tnfsf4 TNF superfamily member 4 gene MP:0005671 abnormal response to transplant IDA N RGD:1580395|PMID:12626546 19990101 RGD 619830 Cd40 CD40 molecule gene MP:0002963 decreased urine protein level IMP N RGD:14398462|PMID:27692815 20190418 RGD 619830 Cd40 CD40 molecule gene MP:0005554 decreased circulating creatinine level IMP N RGD:14398462|PMID:27692815 20190418 RGD 619830 Cd40 CD40 molecule gene MP:0005557 increased creatinine clearance IMP N RGD:14398462|PMID:27692815 20190418 RGD 619830 Cd40 CD40 molecule gene MP:0020254 decreased collagen level IMP N RGD:14398462|PMID:27692815 20190418 RGD 619845 Gper1 G protein-coupled estrogen receptor 1 gene MP:0001257 increased body length IMP N RGD:39939000|PMID:30354811 20220210 RGD compared to wild type SS rat 619845 Gper1 G protein-coupled estrogen receptor 1 gene MP:0001260 increased body weight IMP N RGD:39939000|PMID:30354811 20220210 RGD compared to wild type SS rat 619845 Gper1 G protein-coupled estrogen receptor 1 gene MP:0004876 decreased mean systemic arterial blood pressure IMP N RGD:39939000|PMID:30354811 20220210 RGD compared to wild type SS rat 619845 Gper1 G protein-coupled estrogen receptor 1 gene MP:0005590 increased vasodilation IMP N RGD:39939000|PMID:30354811 20220210 RGD compared to wild type SS rat 619845 Gper1 G protein-coupled estrogen receptor 1 gene MP:0006263 decreased systemic arterial diastolic blood pressure IMP N RGD:39939000|PMID:30354811 20220210 RGD compared to wild type SS rat 619845 Gper1 G protein-coupled estrogen receptor 1 gene MP:0006264 decreased systemic arterial systolic blood pressure IMP N RGD:39939000|PMID:30354811 20220210 RGD compared to wild type SS rat 619845 Gper1 G protein-coupled estrogen receptor 1 gene MP:0006266 decreased pulse pressure IMP N RGD:39939000|PMID:30354811 20220210 RGD compared to wild type SS rat 619845 Gper1 G protein-coupled estrogen receptor 1 gene MP:0010358 abnormal free fatty acids level IMP N RGD:39939000|PMID:30354811 20220210 RGD compared to wild type SS rat 61986 Grk6 G protein-coupled receptor kinase 6 gene MP:0001392 abnormal locomotor behavior IMP N RGD:5684919|PMID:20410529 20171130 RGD associated with Parkinson Disease 61986 Grk6 G protein-coupled receptor kinase 6 gene MP:0003492 abnormal involuntary movement IMP N RGD:5684919|PMID:20410529 20171130 RGD associated with Parkinson Disease 619877 Nme2 NME/NM23 nucleoside diphosphate kinase 2 gene MP:0001273 decreased metastatic potential IMP N RGD:5132885|PMID:9854145 20110606 RGD 619951 Abcb1a ATP binding cassette subfamily B member 1A gene MP:0000599 enlarged liver IAGP N RGD:8657335|PMID:23569176 20140604 RGD 619951 Abcb1a ATP binding cassette subfamily B member 1A gene MP:0001260 increased body weight IAGP N RGD:8657335|PMID:23569176 20140604 RGD 619951 Abcb1a ATP binding cassette subfamily B member 1A gene MP:0001666 abnormal intestinal absorption IMP N RGD:8657330|PMID:22049154 20170607 RGD 619951 Abcb1a ATP binding cassette subfamily B member 1A gene MP:0003068 enlarged kidney IAGP N RGD:8657335|PMID:23569176 20140604 RGD 619951 Abcb1a ATP binding cassette subfamily B member 1A gene MP:0005167 abnormal blood-brain barrier function IMP N RGD:8657330|PMID:22049154 20170607 RGD 619951 Abcb1a ATP binding cassette subfamily B member 1A gene MP:0008875 abnormal xenobiotic pharmacokinetics IMP N RGD:14392811|PMID:22711747 20210916 RGD 619951 Abcb1a ATP binding cassette subfamily B member 1A gene MP:0008875 abnormal xenobiotic pharmacokinetics IMP N RGD:150429695|PMID:24398459 20210923 RGD compared to wildtype control, CHEBI:6532|CHEBI:4551|CHEBI:40050|CHEBI:28593|CHEBI:8364|CHEBI:45783|CHEBI:9948|CHEBI:3723 61997 Kcnk3 potassium two pore domain channel subfamily K member 3 gene MP:0002626 increased heart rate IMP N RGD:151347452|PMID:31347976 20220203 RGD 61997 Kcnk3 potassium two pore domain channel subfamily K member 3 gene MP:0003034 increased pulmonary vascular resistance IMP N RGD:151347452|PMID:31347976 20220203 RGD 61997 Kcnk3 potassium two pore domain channel subfamily K member 3 gene MP:0005591 decreased vasodilation IMP N RGD:151347452|PMID:31347976 20220203 RGD 61997 Kcnk3 potassium two pore domain channel subfamily K member 3 gene MP:0010758 increased right ventricle systolic pressure onset IMP N RGD:151347452|PMID:31347976 20220203 RGD 61997 Kcnk3 potassium two pore domain channel subfamily K member 3 gene MP:0011641 abnormal pulmonary collagen fibril morphology IMP N RGD:151347452|PMID:31347976 20220203 RGD 620006 Rin1 Ras and Rab interactor 1 gene MP:0002063 abnormal learning/memory/conditioning IMP N RGD:126790555|PMID:32174475 20210429 RGD 620006 Rin1 Ras and Rab interactor 1 gene MP:0020422 decreased freezing behavior IMP N RGD:126790555|PMID:32174475 20210429 RGD 620007 Cyp2j4 cytochrome P450, family 2, subfamily j, polypeptide 4 gene MP:0000008 increased white adipose tissue amount induces IMP XCO:0000914 N RGD:150520032|PMID:29656108 20211104 RGD compared to wild type and standard diet 620007 Cyp2j4 cytochrome P450, family 2, subfamily j, polypeptide 4 gene MP:0001260 increased body weight induces IMP XCO:0000914 N RGD:150520032|PMID:29656108 20211104 RGD compared to standard diet 620007 Cyp2j4 cytochrome P450, family 2, subfamily j, polypeptide 4 gene MP:0001260 increased body weight onset IMP N RGD:150520032|PMID:29656108 20211104 RGD compared to wild type 620007 Cyp2j4 cytochrome P450, family 2, subfamily j, polypeptide 4 gene MP:0002079 increased circulating insulin level IMP N RGD:150520032|PMID:29656108 20211104 RGD compared to wild type 620007 Cyp2j4 cytochrome P450, family 2, subfamily j, polypeptide 4 gene MP:0005559 increased circulating glucose level induces IMP XCO:0000914 N RGD:150520032|PMID:29656108 20211104 RGD compared to wild type 620007 Cyp2j4 cytochrome P450, family 2, subfamily j, polypeptide 4 gene MP:0006094 increased fat cell size induces IMP XCO:0000914 N RGD:150520032|PMID:29656108 20211104 RGD compared to standard diet and wild type 620007 Cyp2j4 cytochrome P450, family 2, subfamily j, polypeptide 4 gene MP:0008752 abnormal tumor necrosis factor level induces IMP XCO:0000914 N RGD:150520032|PMID:29656108 20211104 RGD compared to standard diet 620007 Cyp2j4 cytochrome P450, family 2, subfamily j, polypeptide 4 gene MP:0009355 increased liver triglyceride level induces IMP XCO:0000914 N RGD:150520032|PMID:29656108 20211104 RGD compared to wild type 620007 Cyp2j4 cytochrome P450, family 2, subfamily j, polypeptide 4 gene MP:0013258 abnormal extracellular matrix morphology induces IMP XCO:0000914 N RGD:150520032|PMID:29656108 20211104 RGD compared to standard diet 620007 Cyp2j4 cytochrome P450, family 2, subfamily j, polypeptide 4 gene MP:0020253 increased collagen level induces IMP XCO:0000914 N RGD:150520032|PMID:29656108 20211104 RGD compared to wild type 620029 Nr4a1 nuclear receptor subfamily 4, group A, member 1 gene MP:0001262 decreased body weight IMP N RGD:12910103|PMID:24722447 20201210 RGD compared to FHH 620029 Nr4a1 nuclear receptor subfamily 4, group A, member 1 gene MP:0001552 increased circulating triglyceride level IMP N RGD:12910103|PMID:24722447 20201210 RGD compared to FHH 620029 Nr4a1 nuclear receptor subfamily 4, group A, member 1 gene MP:0002871 albuminuria IMP N RGD:12910103|PMID:24722447 20170608 RGD 620029 Nr4a1 nuclear receptor subfamily 4, group A, member 1 gene MP:0003215 renal interstitial fibrosis IMP N RGD:12910103|PMID:24722447 20201210 RGD compared to FHH 620029 Nr4a1 nuclear receptor subfamily 4, group A, member 1 gene MP:0003492 abnormal involuntary movement treatment IMP XCO:0000498,XCO:0000520 N RGD:40924655|PMID:29530712 20210304 RGD 620029 Nr4a1 nuclear receptor subfamily 4, group A, member 1 gene MP:0003917 increased kidney weight IMP N RGD:12910103|PMID:24722447 20201210 RGD compared to FHH 620029 Nr4a1 nuclear receptor subfamily 4, group A, member 1 gene MP:0005528 decreased renal glomerular filtration rate IMP N RGD:12910103|PMID:24722447 20190821 RGD 620029 Nr4a1 nuclear receptor subfamily 4, group A, member 1 gene MP:0005558 decreased creatinine clearance IMP N RGD:12910103|PMID:24722447 20201210 RGD compared to FHH 620029 Nr4a1 nuclear receptor subfamily 4, group A, member 1 gene MP:0005565 increased blood urea nitrogen level IMP N RGD:12910103|PMID:24722447 20201210 RGD compared to FHH 620029 Nr4a1 nuclear receptor subfamily 4, group A, member 1 gene MP:0013219 abnormal substantia nigra pars compacta morphology IMP N RGD:40924655|PMID:29530712 20210211 RGD compared to wild-type and untreated 620029 Nr4a1 nuclear receptor subfamily 4, group A, member 1 gene MP:0013284 abnormal renal glomerular filtration IMP N RGD:12910103|PMID:24722447 20170608 RGD 620029 Nr4a1 nuclear receptor subfamily 4, group A, member 1 gene MP:0030585 enhanced behavioral response to amphetamine IMP N RGD:40924655|PMID:29530712 20210218 RGD compared to saline-treated 62003 Bmal1 basic helix-loop-helix ARNT like 1 gene MP:0001262 decreased body weight IMP N RGD:155598602|PMID:32306766 20221027 RGD compared to wild type 62003 Bmal1 basic helix-loop-helix ARNT like 1 gene MP:0002626 increased heart rate sexual_dimorphism IMP N RGD:155598602|PMID:32306766 20221027 RGD in female 62003 Bmal1 basic helix-loop-helix ARNT like 1 gene MP:0004876 decreased mean systemic arterial blood pressure IMP N RGD:155598602|PMID:32306766 20221027 RGD compared to wild type 62003 Bmal1 basic helix-loop-helix ARNT like 1 gene MP:0006263 decreased systemic arterial diastolic blood pressure IMP N RGD:155598602|PMID:32306766 20221027 RGD compared to wild type 62003 Bmal1 basic helix-loop-helix ARNT like 1 gene MP:0006264 decreased systemic arterial systolic blood pressure IMP N RGD:155598602|PMID:32306766 20221027 RGD compared to wild type 62003 Bmal1 basic helix-loop-helix ARNT like 1 gene MP:0006274 abnormal urine sodium level sex_dimorphism IMP N RGD:155598602|PMID:32306766 20221027 RGD in male 62003 Bmal1 basic helix-loop-helix ARNT like 1 gene MP:0011940 decreased food intake IMP N RGD:155598602|PMID:32306766 20221027 RGD compared to wild type 620036 Ep300 E1A binding protein p300 gene MP:0001625 cardiac hypertrophy IDA N RGD:1298794|PMID:12477714 20061031 RGD 620062 Pon1 paraoxonase 1 gene MP:0000322 increased granulocyte number IMP N RGD:45073131|PMID:30262871 20210722 RGD in peripheral blood, compared to SD 620062 Pon1 paraoxonase 1 gene MP:0000706 small thymus IMP N RGD:45073131|PMID:30262871 20210722 RGD compared to SD 620062 Pon1 paraoxonase 1 gene MP:0000715 decreased thymocyte number IMP N RGD:45073131|PMID:30262871 20210722 RGD compared to SD 620062 Pon1 paraoxonase 1 gene MP:0001825 arrested T cell differentiation IMP N RGD:45073131|PMID:30262871 20210722 RGD compared to SD 620062 Pon1 paraoxonase 1 gene MP:0003674 oxidative stress IMP N RGD:45073131|PMID:30262871 20210722 RGD compared to SD 620062 Pon1 paraoxonase 1 gene MP:0005017 decreased B cell number IMP N RGD:45073131|PMID:30262871 20210722 RGD in spleen, compared to SD 620062 Pon1 paraoxonase 1 gene MP:0005018 decreased T cell number IMP N RGD:45073131|PMID:30262871 20210722 RGD compared to SD 620062 Pon1 paraoxonase 1 gene MP:0005425 increased macrophage cell number IMP N RGD:45073131|PMID:30262871 20210722 RGD in bone marrow and peripheral blood, compared to SD 620062 Pon1 paraoxonase 1 gene MP:0006413 increased T cell apoptosis IMP N RGD:45073131|PMID:30262871 20210722 RGD compared to SD 620063 Ilk integrin-linked kinase gene MP:0003333 liver fibrosis IDA N RGD:2302063|PMID:16941698 20081117 RGD carbon tetrachloride-induced 620063 Ilk integrin-linked kinase gene MP:0008143 abnormal dendrite morphology IMP N RGD:2301736|PMID:18602949 20081030 RGD inhibition in the nucleus accumbens decreases dendrite density of medium spiny neurons 620100 Mgat5 alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase gene MP:0004217 salt-sensitive hypertension IAGP N RGD:12798539|PMID:21257920 20170324 RGD 620112 Cited2 Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 gene MP:0003789 increased osteosarcoma incidence IAGP N RGD:5147850|PMID:19825367 20190807 RGD DNA:deletion 620195 Mmp12 matrix metallopeptidase 12 gene MP:0001935 decreased litter size IMP N RGD:12910498|PMID:27807143 20201210 RGD 620195 Mmp12 matrix metallopeptidase 12 gene MP:0009431 decreased fetal weight IMP N RGD:12910498|PMID:27807143 20201210 RGD 620195 Mmp12 matrix metallopeptidase 12 gene MP:0012727 abnormal uterine spiral artery remodeling IMP N RGD:12910498|PMID:27807143 20170616 RGD 620226 Prelp proline and arginine rich end leucine rich repeat protein gene MP:0002871 albuminuria IAGP N RGD:12802368|PMID:23817491 20170406 RGD 620226 Prelp proline and arginine rich end leucine rich repeat protein gene MP:0004217 salt-sensitive hypertension IAGP N RGD:12802368|PMID:23817491 20170406 RGD 620268 Abcc6 ATP binding cassette subfamily C member 6 gene MP:0001566 increased circulating phosphate level IAGP N RGD:13792593|PMID:28111129 20180920 RGD 620287 Mybph myosin binding protein H gene MP:0002871 albuminuria IAGP N RGD:12802369|PMID:23460292 20170407 RGD 620287 Mybph myosin binding protein H gene MP:0004217 salt-sensitive hypertension IAGP N RGD:12802369|PMID:23460292 20170407 RGD 620298 Abcg5 ATP binding cassette subfamily G member 5 gene MP:0010077 increased phytosterol level IAGP N RGD:1598659|PMID:16026620 20061209 RGD DNA:missense mutation: p.G583C , 1757G>T (rat) 620360 Nfe2l2 NFE2 like bZIP transcription factor 2 gene MP:0000601 small liver IMP N RGD:12910550|PMID:27071940 20201210 RGD 620360 Nfe2l2 NFE2 like bZIP transcription factor 2 gene MP:0001613 abnormal vasodilation IMP N RGD:11344212|PMID:26637559 20170913 RGD 620360 Nfe2l2 NFE2 like bZIP transcription factor 2 gene MP:0005591 decreased vasodilation IMP XCO:0000143, XCO:0000191, XCO:0000795 N RGD:11344212|PMID:26637559 20210610 RGD compared to SD 620360 Nfe2l2 NFE2 like bZIP transcription factor 2 gene MP:0009766 increased susceptibility to xenobiotic induced morbidity/mortality IMP CHEBI:2504 N RGD:12910550|PMID:27071940 20201210 RGD 620360 Nfe2l2 NFE2 like bZIP transcription factor 2 gene MP:0010096 abnormal incisor color IMP N RGD:12910550|PMID:27071940 20201210 RGD 62037 Arc activity-regulated cytoskeleton-associated protein gene MP:0009753 enhanced behavioral response to morphine IMP N RGD:11087075|PMID:25746394 20231212 RGD 620446 Shc1 SHC adaptor protein 1 gene MP:0003025 increased vasoconstriction IMP N RGD:12792230|PMID:27270176 20200131 RGD 620446 Shc1 SHC adaptor protein 1 gene MP:0005264 glomerulosclerosis ameliorates IMP N RGD:12792230|PMID:27270176 20210409 RGD 620446 Shc1 SHC adaptor protein 1 gene MP:0005540 decreased urine albumin level IMP N RGD:12792230|PMID:27270176 20200131 RGD 620446 Shc1 SHC adaptor protein 1 gene MP:0011296 decreased tubuloglomerular feedback response IMP N RGD:12792230|PMID:27270176 20200131 RGD 620475 Npy2r neuropeptide Y receptor Y2 gene MP:0003545 increased alcohol consumption IDA N RGD:1642509|PMID:15670655 20070921 RGD 620505 Crh corticotropin releasing hormone gene MP:0001648 abnormal apoptosis IDA N RGD:704423|PMID:11908464 19990101 RGD 620505 Crh corticotropin releasing hormone gene MP:0005167 abnormal blood-brain barrier function IDA N RGD:704425|PMID:12663088 19990101 RGD 620505 Crh corticotropin releasing hormone gene MP:0005181 decreased circulating estradiol level IDA N RGD:704424|PMID:12450317 19990101 RGD 620505 Crh corticotropin releasing hormone gene MP:0005185 decreased circulating progesterone level IDA N RGD:704424|PMID:12450317 19990101 RGD 620563 Lpar1 lysophosphatidic acid receptor 1 gene MP:0001265 decreased body size IMP N RGD:13825198|PMID:20531371 20201012 RGD 620563 Lpar1 lysophosphatidic acid receptor 1 gene MP:0003935 abnormal craniofacial development IMP N RGD:13825198|PMID:20531371 20181129 RGD 620568 Kit KIT proto-oncogene receptor tyrosine kinase gene MP:0000371 diluted coat color IMP N RGD:5133424|PMID:1912576 20170623 RGD 620568 Kit KIT proto-oncogene receptor tyrosine kinase gene MP:0000373 belly spot IMP N RGD:5133424|PMID:1912576 20170623 RGD 620568 Kit KIT proto-oncogene receptor tyrosine kinase gene MP:0001473 reduced long-term potentiation IMP N RGD:2292520|PMID:11112797 20170623 RGD 620568 Kit KIT proto-oncogene receptor tyrosine kinase gene MP:0002811 macrocytic anemia IMP N RGD:5133424|PMID:1912576 20170623 RGD 620568 Kit KIT proto-oncogene receptor tyrosine kinase gene MP:0002875 decreased erythrocyte cell number IMP N RGD:5133424|PMID:1912576 20170623 RGD 620568 Kit KIT proto-oncogene receptor tyrosine kinase gene MP:0003290 intestinal hypoperistalsis IMP N RGD:12910748|PMID:7542218 20170623 RGD 620568 Kit KIT proto-oncogene receptor tyrosine kinase gene MP:0004789 increased bile salt level IMP N RGD:12910748|PMID:7542218 20170623 RGD 620568 Kit KIT proto-oncogene receptor tyrosine kinase gene MP:0009536 abnormal interstitial cell of Cajal morphology IMP N RGD:12910822|PMID:17322067 20170626 RGD 620568 Kit KIT proto-oncogene receptor tyrosine kinase gene MP:0011696 absent mast cells IMP N RGD:5133424|PMID:1912576 20170623 RGD 620568 Kit KIT proto-oncogene receptor tyrosine kinase gene MP:0012307 impaired spatial learning IMP N RGD:2292520|PMID:11112797 20170623 RGD 620573 Cyba cytochrome b-245 alpha chain gene MP:0002978 absent otoliths IAGP N RGD:11040542|PMID:19406829 20170828 RGD DNA:deletion:splice junction: 620573 Cyba cytochrome b-245 alpha chain gene MP:0020447 decreased NAD(P)H oxidase activity IAGP N RGD:11040542|PMID:19406829 20170828 RGD DNA:deletion:splice junction: 620593 Ccr3 C-C motif chemokine receptor 3 gene MP:0014114 abnormal cognition ameliorates IMP N RGD:407571672|PMID:39156650 20240925 RGD 620600 Nox4 NADPH oxidase 4 gene MP:0003674 oxidative stress severity IMP N RGD:11085830|PMID:26644237 20190103 RGD 620600 Nox4 NADPH oxidase 4 gene MP:0004217 salt-sensitive hypertension severity IMP N RGD:11085830|PMID:26644237 20190103 RGD 620600 Nox4 NADPH oxidase 4 gene MP:0004876 decreased mean systemic arterial blood pressure IMP N RGD:11085830|PMID:26644237 20201210 RGD compared to SS/JrHsdMcwi 620600 Nox4 NADPH oxidase 4 gene MP:0004876 decreased mean systemic arterial blood pressure induced IMP XCO:0000022 N RGD:11085830|PMID:26644237 20190103 RGD 620600 Nox4 NADPH oxidase 4 gene MP:0005540 decreased urine albumin level IMP N RGD:11085830|PMID:26644237 20201210 RGD compared to SS/JrHsdMcwi 620600 Nox4 NADPH oxidase 4 gene MP:0005540 decreased urine albumin level induced IMP XCO:0000022 N RGD:11085830|PMID:26644237 20190103 RGD 620600 Nox4 NADPH oxidase 4 gene MP:0012046 decreased susceptibility to hypertension IMP N RGD:11085830|PMID:26644237 20201210 RGD compared to SS/JrHsdMcwi 620600 Nox4 NADPH oxidase 4 gene MP:0012046 decreased susceptibility to hypertension induced IMP XCO:0000022 N RGD:11085830|PMID:26644237 20190103 RGD 620634 Hr HR, lysine demethylase and nuclear receptor corepressor gene MP:0000580 deformed nails IMP N RGD:150520024|PMID:21325752 20211021 RGD 620634 Hr HR, lysine demethylase and nuclear receptor corepressor gene MP:0001211 wrinkled skin IMP N RGD:150520024|PMID:21325752 20211021 RGD 620634 Hr HR, lysine demethylase and nuclear receptor corepressor gene MP:0003815 hairless IMP N RGD:150520024|PMID:21325752 20211021 RGD 620634 Hr HR, lysine demethylase and nuclear receptor corepressor gene MP:0010699 dilated hair follicle IMP N RGD:150520024|PMID:21325752 20211021 RGD 620634 Hr HR, lysine demethylase and nuclear receptor corepressor gene MP:0030570 abnormal piliary canal morphology IMP N RGD:150520024|PMID:21325752 20211021 RGD 620640 Cyp2d4 cytochrome P450, family 2, subfamily d, polypeptide 4 gene MP:0002066 abnormal motor capabilities/coordination/movement IAGP N RGD:1358549|PMID:12629505 20070423 RGD 620670 Dcx doublecortin gene MP:0000913 abnormal brain development IMP N RGD:1304461|PMID:14625554 19990101 RGD 620688 Hcn1 hyperpolarization-activated cyclic nucleotide-gated potassium channel 1 gene MP:0001961 abnormal reflex IMP N RGD:26923909|PMID:30408474 20211104 RGD 620688 Hcn1 hyperpolarization-activated cyclic nucleotide-gated potassium channel 1 gene MP:0003217 increased spike-wave discharge type I onset IMP N RGD:26923909|PMID:30408474 20211104 RGD 620688 Hcn1 hyperpolarization-activated cyclic nucleotide-gated potassium channel 1 gene MP:0003218 decreased spike-wave discharge type I treatment IMP XCO:0000913 N RGD:26923909|PMID:30408474 20211104 RGD compared to untreated 620688 Hcn1 hyperpolarization-activated cyclic nucleotide-gated potassium channel 1 gene MP:0003481 decreased nerve fiber response intensity induces IMP XCO:0000055 N RGD:26923909|PMID:30408474 20211104 RGD 620688 Hcn1 hyperpolarization-activated cyclic nucleotide-gated potassium channel 1 gene MP:0003996 clonic seizures induces IMP XCO:0000887 N RGD:26923909|PMID:30408474 20211104 RGD 620688 Hcn1 hyperpolarization-activated cyclic nucleotide-gated potassium channel 1 gene MP:0008035 behavioral arrest IMP N RGD:26923909|PMID:30408474 20211104 RGD 620711 Dhh desert hedgehog signaling molecule gene MP:0002780 decreased circulating testosterone level IMP N RGD:38548923|PMID:21062903 20200826 RGD 620711 Dhh desert hedgehog signaling molecule gene MP:0002789 male pseudohermaphroditism IMP N RGD:38548923|PMID:21062903 20200826 RGD 620711 Dhh desert hedgehog signaling molecule gene MP:0013603 abnormal fetal Leydig cell differentiation IMP N RGD:38548923|PMID:21062903 20200826 RGD 620711 Dhh desert hedgehog signaling molecule gene MP:0013604 abnormal adult Leydig cell differentiation IMP N RGD:38548923|PMID:21062903 20200826 RGD 620734 Ctnnd2 catenin delta 2 gene MP:0003651 abnormal axon extension IMP N RGD:407532699|PMID:32554807 20240911 RGD 620836 Adgrl3 adhesion G protein-coupled receptor L3 gene MP:0001399 hyperactivity IMP N RGD:127285660|PMID:31176715 20210701 RGD compared to wild type 620836 Adgrl3 adhesion G protein-coupled receptor L3 gene MP:0001488 increased startle reflex IMP N RGD:127285660|PMID:31176715 20210701 RGD compared to wild type 620836 Adgrl3 adhesion G protein-coupled receptor L3 gene MP:0008489 slow postnatal weight gain sexual_dimorphism IMP N RGD:127285660|PMID:31176715 20210701 RGD compared to wild type male 620836 Adgrl3 adhesion G protein-coupled receptor L3 gene MP:0030585 enhanced behavioral response to amphetamine sexual_dimorphism IMP N RGD:127285660|PMID:31176715 20210701 RGD compared to wild type female 620850 Nppc natriuretic peptide C gene MP:0001258 decreased body length IMP N RGD:127284867|PMID:29566041 20220120 RGD compared to wild type 620850 Nppc natriuretic peptide C gene MP:0001262 decreased body weight IMP N RGD:127284867|PMID:29566041 20220120 RGD compared to wild type 620850 Nppc natriuretic peptide C gene MP:0002764 short tibia IMP N RGD:127284867|PMID:29566041 20220120 RGD compared to wild type 620850 Nppc natriuretic peptide C gene MP:0002834 decreased heart weight IMP N RGD:127284867|PMID:29566041 20220120 RGD compared to wild type 620850 Nppc natriuretic peptide C gene MP:0003109 short femur IMP N RGD:127284867|PMID:29566041 20220120 RGD compared to wild type 620850 Nppc natriuretic peptide C gene MP:0003409 decreased width of hypertrophic chondrocyte zone IMP N RGD:127284867|PMID:29566041 20220120 RGD compared to wild type 620850 Nppc natriuretic peptide C gene MP:0003918 decreased kidney weight IMP N RGD:127284867|PMID:29566041 20220120 RGD compared to wild type 620850 Nppc natriuretic peptide C gene MP:0004355 short radius IMP N RGD:127284867|PMID:29566041 20220120 RGD compared to wild type 620850 Nppc natriuretic peptide C gene MP:0004657 small sacral vertebrae IMP N RGD:127284867|PMID:29566041 20220120 RGD compared to wild type 620850 Nppc natriuretic peptide C gene MP:0011862 decreased cranium length IMP N RGD:127284867|PMID:29566041 20220120 RGD compared to wild type 620851 Npr2 natriuretic peptide receptor 2 gene MP:0001625 cardiac hypertrophy IAGP N RGD:1601488|PMID:16537417 20070423 RGD 620854 Dusp5 dual specificity phosphatase 5 gene MP:0003026 decreased vasoconstriction IMP N RGD:13446412|PMID:25397684 20201224 RGD compared to FHH.1BN 620874 Chi3l1 chitinase 3 like 1 gene MP:0002871 albuminuria IAGP N RGD:12802369|PMID:23460292 20170407 RGD 620874 Chi3l1 chitinase 3 like 1 gene MP:0004217 salt-sensitive hypertension IAGP N RGD:12802369|PMID:23460292 20170407 RGD 62088 P2ry2 purinergic receptor P2Y2 gene MP:0000218 increased leukocyte cell number IMP N RGD:2316657|PMID:19155635 20181120 RGD 62088 P2ry2 purinergic receptor P2Y2 gene MP:0000219 increased neutrophil cell number IMP N RGD:2316657|PMID:19155635 20181120 RGD 62088 P2ry2 purinergic receptor P2Y2 gene MP:0002941 increased circulating alanine transaminase level IMP N RGD:2316657|PMID:19155635 20181120 RGD 62088 P2ry2 purinergic receptor P2Y2 gene MP:0002968 increased circulating alkaline phosphatase level IMP N RGD:2316657|PMID:19155635 20181120 RGD 62088 P2ry2 purinergic receptor P2Y2 gene MP:0005013 increased lymphocyte cell number IMP N RGD:2316657|PMID:19155635 20181120 RGD 62088 P2ry2 purinergic receptor P2Y2 gene MP:0005325 abnormal renal glomerulus morphology IMP N RGD:2316657|PMID:19155635 20181120 RGD 62088 P2ry2 purinergic receptor P2Y2 gene MP:0008993 abnormal portal triad morphology IMP N RGD:2316657|PMID:19155635 20181120 RGD 62088 P2ry2 purinergic receptor P2Y2 gene MP:0011353 expanded mesangial matrix IMP N RGD:2316657|PMID:19155635 20181120 RGD 62088 P2ry2 purinergic receptor P2Y2 gene MP:0013440 abnormal exorbital lacrimal gland morphology IMP N RGD:2316657|PMID:19155635 20181120 RGD 620979 Dnmt1 DNA methyltransferase 1 gene MP:0008877 abnormal DNA methylation IMP N RGD:126925233|PMID:32051532 20210518 RGD 620998 Nell1 neural EGFL like 1 gene MP:0002116 abnormal craniofacial bone morphology IMP N RGD:633405|PMID:12235118 19990101 RGD 621063 Csf1 colony stimulating factor 1 gene MP:0000062 increased bone mineral density IAGP N RGD:628338|PMID:12379742 20210218 RGD 621063 Csf1 colony stimulating factor 1 gene MP:0000065 abnormal bone marrow cavity morphology IAGP N RGD:628338|PMID:12379742 20210218 RGD 621063 Csf1 colony stimulating factor 1 gene MP:0001265 decreased body size IAGP N RGD:70875|PMID:12074592 20180430 RGD 621063 Csf1 colony stimulating factor 1 gene MP:0003723 abnormal long bone morphology IAGP N RGD:628338|PMID:12379742 20170629 RGD 621063 Csf1 colony stimulating factor 1 gene MP:0030610 absent teeth IAGP N RGD:628338|PMID:12379742 20170629 RGD 621114 Ttn titin gene MP:0000280 thin ventricular wall IAGP N RGD:11565821|PMID:27869827 20170711 RGD 621114 Ttn titin gene MP:0002972 abnormal cardiac muscle contractility IAGP N RGD:11565821|PMID:27869827 20170711 RGD 621114 Ttn titin gene MP:0003824 decreased left ventricle developed pressure IAGP N RGD:11565821|PMID:27869827 20170711 RGD 621114 Ttn titin gene MP:0011952 decreased cardiac stroke volume IAGP N RGD:11565821|PMID:27869827 20170711 RGD 621114 Ttn titin gene MP:0020419 decreased cardiac muscle relaxation IAGP N RGD:11565821|PMID:27869827 20170711 RGD 621119 Nlgn3 neuroligin 3 gene MP:0001262 decreased body weight IMP N RGD:126790492|PMID:28958035 20210423 RGD 621119 Nlgn3 neuroligin 3 gene MP:0001262 decreased body weight IMP N RGD:9831152|PMID:24773431 20170921 RGD 621119 Nlgn3 neuroligin 3 gene MP:0001360 abnormal social investigation IMP N RGD:126790492|PMID:28958035 20210423 RGD 621119 Nlgn3 neuroligin 3 gene MP:0001363 increased anxiety-related response IMP N RGD:126790492|PMID:28958035 20210423 RGD 621119 Nlgn3 neuroligin 3 gene MP:0001364 decreased anxiety-related response IMP N RGD:9831152|PMID:24773431 20170921 RGD 621119 Nlgn3 neuroligin 3 gene MP:0001399 hyperactivity IMP N RGD:126790492|PMID:28958035 20210423 RGD 621119 Nlgn3 neuroligin 3 gene MP:0001441 increased grooming behavior IMP N RGD:9831152|PMID:24773431 20170921 RGD 621119 Nlgn3 neuroligin 3 gene MP:0002574 increased vertical activity IMP N RGD:9831152|PMID:24773431 20170921 RGD 621119 Nlgn3 neuroligin 3 gene MP:0004994 abnormal brain wave pattern IMP N RGD:126790492|PMID:28958035 20210423 RGD 621119 Nlgn3 neuroligin 3 gene MP:0009142 decreased prepulse inhibition IMP N RGD:126790492|PMID:28958035 20210423 RGD 621119 Nlgn3 neuroligin 3 gene MP:0009142 decreased prepulse inhibition IMP N RGD:9831152|PMID:24773431 20170921 RGD 621119 Nlgn3 neuroligin 3 gene MP:0012288 abnormal paradoxical sleep pattern IMP N RGD:126790492|PMID:28958035 20210423 RGD during light cycle 621119 Nlgn3 neuroligin 3 gene MP:0012289 abnormal non-rapid eye movement sleep pattern IMP N RGD:126790492|PMID:28958035 20210423 RGD during light cycle 621119 Nlgn3 neuroligin 3 gene MP:0012343 increased gnawing activity IMP N RGD:126790492|PMID:28958035 20210423 RGD 621119 Nlgn3 neuroligin 3 gene MP:0012343 increased gnawing activity IMP N RGD:9831152|PMID:24773431 20170921 RGD 621119 Nlgn3 neuroligin 3 gene MP:0020437 abnormal social play behavior IMP N RGD:126790492|PMID:28958035 20210423 RGD 621119 Nlgn3 neuroligin 3 gene MP:0020437 abnormal social play behavior IMP N RGD:9831152|PMID:24773431 20170921 RGD 621120 Cdk4 cyclin-dependent kinase 4 gene MP:0002006 neoplasm IDA N RGD:625485|PMID:12070150 19990101 RGD 621123 Ptprv protein tyrosine phosphatase, receptor type, V gene MP:0002871 albuminuria IAGP N RGD:12802369|PMID:23460292 20170407 RGD 621123 Ptprv protein tyrosine phosphatase, receptor type, V gene MP:0004217 salt-sensitive hypertension IAGP N RGD:12802369|PMID:23460292 20170407 RGD 621137 Rnpep arginyl aminopeptidase gene MP:0002871 albuminuria IAGP N RGD:12802369|PMID:23460292 20170407 RGD 621137 Rnpep arginyl aminopeptidase gene MP:0004217 salt-sensitive hypertension IAGP N RGD:12802369|PMID:23460292 20170407 RGD 621276 Trpc4 transient receptor potential cation channel, subfamily C, member 4 gene MP:0020906 abnormal acquisiton of operant behavior for a cocaine reinforcer IMP N RGD:126848803|PMID:26988269 20210506 RGD 621276 Trpc4 transient receptor potential cation channel, subfamily C, member 4 gene MP:0020906 abnormal acquisiton of operant behavior for a cocaine reinforcer IMP N RGD:126848805|PMID:24555056 20210506 RGD 621304 Atp2b3 ATPase plasma membrane Ca2+ transporting 3 gene MP:0000745 tremors IAGP N RGD:13825260|PMID:27013529 20181204 RGD 621316 Mmp2 matrix metallopeptidase 2 gene MP:0002963 decreased urine protein level IMP N RGD:401827835|PMID:37643020 20231116 RGD compared to wild type SS 621316 Mmp2 matrix metallopeptidase 2 gene MP:0003071 decreased vascular permeability ameliorates IMP N RGD:401827835|PMID:37643020 20231116 RGD associated with Experimental Diabetes Mellitus, compared to wild type SS 621316 Mmp2 matrix metallopeptidase 2 gene MP:0003215 renal interstitial fibrosis ameliorates IMP N RGD:401827835|PMID:37643020 20231116 RGD compared to wild type SS 621316 Mmp2 matrix metallopeptidase 2 gene MP:0003918 decreased kidney weight IMP N RGD:401827835|PMID:37643020 20231116 RGD associated Experimental Diabetes Mellitus, hypertension; compared to wild type SS 621316 Mmp2 matrix metallopeptidase 2 gene MP:0005264 glomerulosclerosis ameliorates IMP N RGD:401827835|PMID:37643020 20231116 RGD compared to wild type SS 621316 Mmp2 matrix metallopeptidase 2 gene MP:0005527 increased renal glomerular filtration rate IMP N RGD:401827835|PMID:37643020 20231116 RGD compared to wild type SS 621316 Mmp2 matrix metallopeptidase 2 gene MP:0005554 decreased circulating creatinine level IMP N RGD:401827835|PMID:37643020 20231116 RGD compared to wild type SS 621316 Mmp2 matrix metallopeptidase 2 gene MP:0008838 decreased transforming growth factor beta level IMP N RGD:401827835|PMID:37643020 20231116 RGD compared to wild type SS 621316 Mmp2 matrix metallopeptidase 2 gene MP:0011863 abnormal podocyte physiology ameliorates IMP N RGD:401827835|PMID:37643020 20231116 RGD associated with Experimental Diabetes Mellitus, compared to wild type SS 621341 Nrg1 neuregulin 1 gene MP:0001260 increased body weight IMP N RGD:39128254|PMID:23022220 20200929 RGD 621341 Nrg1 neuregulin 1 gene MP:0001402 decreased locomotor activity sexual_dimorphism IMP N RGD:405650204|PMID:21620900 20240425 RGD compared to mutant male 621341 Nrg1 neuregulin 1 gene MP:0001488 increased startle reflex sexual_dimorphism IAGP N RGD:405650204|PMID:21620900 20240425 RGD compared to female 621341 Nrg1 neuregulin 1 gene MP:0001745 increased circulating corticosterone level IMP N RGD:10449008|PMID:21092742 20151211 RGD DNA:transposon insertion 621341 Nrg1 neuregulin 1 gene MP:0008414 abnormal spatial reference memory IMP N RGD:10449010|PMID:23098760 20151211 RGD DNA:transposon insertion 621341 Nrg1 neuregulin 1 gene MP:0008428 abnormal spatial working memory IMP N RGD:10449010|PMID:23098760 20151211 RGD DNA:transposon insertion 621341 Nrg1 neuregulin 1 gene MP:0009142 decreased prepulse inhibition sexual_dimorphism IMP N RGD:405650204|PMID:21620900 20240425 RGD compared to wild type female 621341 Nrg1 neuregulin 1 gene MP:0009456 impaired cued conditioning behavior IMP N RGD:39128254|PMID:23022220 20200929 RGD 621341 Nrg1 neuregulin 1 gene MP:0011617 abnormal habituation IMP N RGD:405650204|PMID:21620900 20240425 RGD 621369 Uox urate oxidase gene MP:0005565 increased blood urea nitrogen level IMP N RGD:150521544|PMID:32368418 20211109 RGD 621369 Uox urate oxidase gene MP:0008821 increased blood uric acid level IMP N RGD:150521544|PMID:32368418 20211109 RGD 621369 Uox urate oxidase gene MP:0011405 tubulointerstitial nephritis IMP N RGD:150521544|PMID:32368418 20211109 RGD 621382 Plod1 procollagen-lysine, 2-oxoglutarate 5-dioxygenase 1 gene MP:0001262 decreased body weight IMP N RGD:8662415|PMID:24006081 20190717 RGD as compared to the wild-type 621382 Plod1 procollagen-lysine, 2-oxoglutarate 5-dioxygenase 1 gene MP:0002962 increased urine protein level IMP N RGD:8662415|PMID:24006081 20190717 RGD as compared to the wild-type 621382 Plod1 procollagen-lysine, 2-oxoglutarate 5-dioxygenase 1 gene MP:0006144 increased systemic arterial systolic blood pressure IMP N RGD:8662415|PMID:24006081 20190717 RGD as compared to the wild-type 621397 Ghsr growth hormone secretagogue receptor gene MP:0000005 increased brown adipose tissue amount IMP N RGD:13825258|PMID:29453460 20181204 RGD 621397 Ghsr growth hormone secretagogue receptor gene MP:0001258 decreased body length IMP N RGD:625699|PMID:12045256 20170613 RGD 621397 Ghsr growth hormone secretagogue receptor gene MP:0001262 decreased body weight IMP N RGD:13825258|PMID:29453460 20181204 RGD 621397 Ghsr growth hormone secretagogue receptor gene MP:0001262 decreased body weight IMP N RGD:625699|PMID:12045256 20170613 RGD 621397 Ghsr growth hormone secretagogue receptor gene MP:0001392 abnormal locomotor behavior IMP N RGD:150520013|PMID:27129673 20211020 RGD DNA:missense mutation:cds:nucleotide 1027 621397 Ghsr growth hormone secretagogue receptor gene MP:0005120 decreased circulating growth hormone level IMP N RGD:150520013|PMID:27129673 20211020 RGD DNA:missense mutation:cds:nucleotide 1027 621397 Ghsr growth hormone secretagogue receptor gene MP:0005668 decreased circulating leptin level IMP N RGD:12910109|PMID:19931319 20170609 RGD 621397 Ghsr growth hormone secretagogue receptor gene MP:0009289 decreased epididymal fat pad weight IMP N RGD:625699|PMID:12045256 20170613 RGD 621397 Ghsr growth hormone secretagogue receptor gene MP:0009299 decreased mesenteric fat pad weight IMP N RGD:625699|PMID:12045256 20170613 RGD 621397 Ghsr growth hormone secretagogue receptor gene MP:0009305 decreased retroperitoneal fat pad weight IMP N RGD:625699|PMID:12045256 20170613 RGD 621397 Ghsr growth hormone secretagogue receptor gene MP:0011082 abnormal gastrointestinal motility IMP N RGD:150520012|PMID:21258824 20211021 RGD compared to wild type rats in response to ghrelin (CHEBI:75431) 621397 Ghsr growth hormone secretagogue receptor gene MP:0011940 decreased food intake IMP N RGD:13825258|PMID:29453460 20181204 RGD 621397 Ghsr growth hormone secretagogue receptor gene MP:0011940 decreased food intake IMP N RGD:150520012|PMID:21258824 20211021 RGD compared to wild type rats in response to ghrelin (CHEBI:75431) 621397 Ghsr growth hormone secretagogue receptor gene MP:0011940 decreased food intake IMP N RGD:150520013|PMID:27129673 20211020 RGD DNA:missense mutation:cds:nucleotide 1027 621397 Ghsr growth hormone secretagogue receptor gene MP:0011940 decreased food intake IMP N RGD:625699|PMID:12045256 20170613 RGD 621397 Ghsr growth hormone secretagogue receptor gene MP:0012042 low alcohol preference IMP N RGD:13825259|PMID:30456835 20181204 RGD 621397 Ghsr growth hormone secretagogue receptor gene MP:0020871 abnormal locomotor response to cocaine IMP N RGD:150429661|PMID:21790898 20210914 RGD 621397 Ghsr growth hormone secretagogue receptor gene MP:0020896 abnormal locomotor sensitization to cocaine IMP N RGD:150429661|PMID:21790898 20210914 RGD 621400 Nr1i3 nuclear receptor subfamily 1, group I, member 3 gene MP:0001262 decreased body weight IMP N RGD:13432137|PMID:28716828 20201210 RGD male rats 621424 Lig1 DNA ligase 1 gene MP:0001496 audiogenic seizures IMP N RGD:14995940|PMID:30813600 20200130 RGD 621446 Klf5 KLF transcription factor 5 gene MP:0008469 abnormal protein level IMP N RGD:45073134|PMID:32272873 20210716 RGD Syp, Gap43 621446 Klf5 KLF transcription factor 5 gene MP:0008948 decreased neuron number IMP N RGD:45073134|PMID:32272873 20210715 RGD in hippocampus 621446 Klf5 KLF transcription factor 5 gene MP:0020551 abnormal postsynaptic density morphology IMP N RGD:45073134|PMID:32272873 20210716 RGD 621466 Il2rg interleukin 2 receptor subunit gamma gene MP:0000221 decreased leukocyte cell number IMP N RGD:2316325|PMID:20111598 20170327 RGD 621466 Il2rg interleukin 2 receptor subunit gamma gene MP:0000333 decreased bone marrow cell number IMP N RGD:13628403|PMID:29688994 20180620 RGD 621466 Il2rg interleukin 2 receptor subunit gamma gene MP:0000694 spleen hypoplasia IMP N RGD:13628403|PMID:29688994 20201210 RGD 621466 Il2rg interleukin 2 receptor subunit gamma gene MP:0000694 spleen hypoplasia IMP N RGD:2316325|PMID:20111598 20170327 RGD 621466 Il2rg interleukin 2 receptor subunit gamma gene MP:0000715 decreased thymocyte number IMP N RGD:13628403|PMID:29688994 20180620 RGD 621466 Il2rg interleukin 2 receptor subunit gamma gene MP:0001823 thymus hypoplasia IMP N RGD:2316325|PMID:20111598 20170327 RGD 621466 Il2rg interleukin 2 receptor subunit gamma gene MP:0005018 decreased T cell number IMP N RGD:13628403|PMID:29688994 20180620 RGD 621466 Il2rg interleukin 2 receptor subunit gamma gene MP:0008045 decreased NK cell number IMP N RGD:13628403|PMID:29688994 20180620 RGD 621466 Il2rg interleukin 2 receptor subunit gamma gene MP:0008075 decreased CD4-positive, alpha-beta T cell number IMP N RGD:13628403|PMID:29688994 20180620 RGD 621466 Il2rg interleukin 2 receptor subunit gamma gene MP:0008079 decreased CD8-positive, alpha-beta T cell number IMP N RGD:13628403|PMID:29688994 20180620 RGD 621466 Il2rg interleukin 2 receptor subunit gamma gene MP:0008101 lymph node hypoplasia IMP N RGD:13628403|PMID:29688994 20180620 RGD 621466 Il2rg interleukin 2 receptor subunit gamma gene MP:0008211 decreased mature B cell number IMP N RGD:13628403|PMID:29688994 20180620 RGD 621503 Kcnq1 potassium voltage-gated channel subfamily Q member 1 gene MP:0001262 decreased body weight IAGP N RGD:1581602|PMID:16368876 20061017 RGD DNA:deletion:exon (rat) 621503 Kcnq1 potassium voltage-gated channel subfamily Q member 1 gene MP:0001525 impaired balance IAGP N RGD:1581602|PMID:16368876 20061017 RGD DNA:deletion:exon (rat) 621503 Kcnq1 potassium voltage-gated channel subfamily Q member 1 gene MP:0001544 abnormal cardiovascular system physiology IAGP N RGD:1581602|PMID:16368876 20061017 RGD DNA:deletion:exon (rat) 621503 Kcnq1 potassium voltage-gated channel subfamily Q member 1 gene MP:0003233 prolonged QT interval IAGP N RGD:1581602|PMID:16368876 20200124 RGD DNA:deletion:exon (rat) 621503 Kcnq1 potassium voltage-gated channel subfamily Q member 1 gene MP:0005211 increased stomach mucosa thickness IAGP N RGD:1581602|PMID:16368876 20061017 RGD DNA:deletion:exon (rat) 621503 Kcnq1 potassium voltage-gated channel subfamily Q member 1 gene MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:1581602|PMID:16368876 20200124 RGD DNA:deletion:exon (rat) 621503 Kcnq1 potassium voltage-gated channel subfamily Q member 1 gene MP:0008006 increased stomach pH IAGP N RGD:1581602|PMID:16368876 20200124 RGD DNA:deletion:exon (rat) 621503 Kcnq1 potassium voltage-gated channel subfamily Q member 1 gene MP:0011967 increased or absent threshold for auditory brainstem response IAGP N RGD:1581602|PMID:16368876 20200124 RGD DNA:deletion:exon (rat) 621535 Cacna1f calcium voltage-gated channel subunit alpha1 F gene MP:0002734 abnormal mechanical nociception IAGP N RGD:13792551|PMID:22800190 20180912 RGD DNA:mutation:cds: c.2941C>T 621535 Cacna1f calcium voltage-gated channel subunit alpha1 F gene MP:0002841 impaired skeletal muscle contractility IAGP N RGD:13782369|PMID:25748727 20180910 RGD DNA:mutation:cds: c.2941C>T (rat) 621535 Cacna1f calcium voltage-gated channel subunit alpha1 F gene MP:0004022 abnormal cone electrophysiology IAGP N RGD:13782370|PMID:18246026 20180910 RGD DNA:mutation:cds: c.2941C>T (rat) 621535 Cacna1f calcium voltage-gated channel subunit alpha1 F gene MP:0006068 abnormal retina horizontal cell morphology IAGP N RGD:13782386|PMID:22634626 20180910 RGD DNA:mutation:cds: c.2941C>T (rat) 621535 Cacna1f calcium voltage-gated channel subunit alpha1 F gene MP:0008519 thin retina outer plexiform layer IAGP N RGD:13782386|PMID:22634626 20180910 RGD DNA:mutation:cds: c.2941C>T (rat) 621535 Cacna1f calcium voltage-gated channel subunit alpha1 F gene MP:0010053 decreased grip strength IAGP N RGD:13782369|PMID:25748727 20180910 RGD DNA:mutation:cds: c.2941C>T (rat) 621535 Cacna1f calcium voltage-gated channel subunit alpha1 F gene MP:0012031 abnormal b-wave amplitude IAGP N RGD:13782370|PMID:18246026 20180910 RGD DNA:mutation:cds: c.2941C>T (rat) 621535 Cacna1f calcium voltage-gated channel subunit alpha1 F gene MP:0012143 decreased a-wave amplitude IAGP N RGD:13782370|PMID:18246026 20180910 RGD DNA:mutation:cds: c.2941C>T (rat) 621535 Cacna1f calcium voltage-gated channel subunit alpha1 F gene MP:0020439 absent b-wave IAGP N RGD:13782191|PMID:23425697 20180910 RGD DNA:mutation:cds: c.2941C>T (rat) 621541 Or2z2 olfactory receptor family 2 subfamily Z member 2 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 621629 Or1n1 olfactory receptor family 1 subfamily N member 1 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 621693 Aspa aspartoacylase gene MP:0008025 brain vacuoles IMP N RGD:13464274|PMID:27026062 20180103 RGD 621693 Aspa aspartoacylase gene MP:0013438 dysmyelination IMP N RGD:13464274|PMID:27026062 20180103 RGD 621743 Ddx52 DExD-box helicase 52 gene MP:0002842 increased systemic arterial blood pressure IAGP N RGD:1599269|PMID:17218081 20090212 RGD DNA:polymorphism 621782 Il1rl2 interleukin 1 receptor-like 2 gene MP:0003223 decreased cardiomyocyte apoptosis IMP N RGD:126925167|PMID:32048631 20210513 RGD compared to Wild Type in cardiopulmonary bypass model 621782 Il1rl2 interleukin 1 receptor-like 2 gene MP:0003674 oxidative stress IMP N RGD:126925167|PMID:32048631 20210513 RGD compared to Wild Type in cardiopulmonary bypass model 621782 Il1rl2 interleukin 1 receptor-like 2 gene MP:0003820 increased left ventricle systolic pressure IMP N RGD:126925167|PMID:32048631 20210513 RGD compared to Wild Type in cardiopulmonary bypass model 621782 Il1rl2 interleukin 1 receptor-like 2 gene MP:0003884 decreased macrophage cell number IMP N RGD:126925167|PMID:32048631 20210513 RGD compared to Wild Type in cardiopulmonary bypass model 621782 Il1rl2 interleukin 1 receptor-like 2 gene MP:0003957 abnormal nitric oxide homeostasis IMP N RGD:126925167|PMID:32048631 20210513 RGD compared to Wild Type in cardiopulmonary bypass model 621782 Il1rl2 interleukin 1 receptor-like 2 gene MP:0005599 increased cardiac muscle contractility IMP N RGD:126925167|PMID:32048631 20210513 RGD compared to Wild Type in cardiopulmonary bypass model 621782 Il1rl2 interleukin 1 receptor-like 2 gene MP:0008554 decreased circulating tumor necrosis factor level IMP N RGD:126925167|PMID:32048631 20210513 RGD compared to Wild Type in cardiopulmonary bypass model 621782 Il1rl2 interleukin 1 receptor-like 2 gene MP:0008658 decreased interleukin-1 beta secretion IMP N RGD:126925167|PMID:32048631 20210513 RGD compared to Wild Type in cardiopulmonary bypass model 621782 Il1rl2 interleukin 1 receptor-like 2 gene MP:0010209 abnormal circulating chemokine level IMP N RGD:126925167|PMID:32048631 20210513 RGD compared to Wild Type in cardiopulmonary bypass model 621782 Il1rl2 interleukin 1 receptor-like 2 gene MP:0011972 decreased circulating lactate dehydrogenase level IMP N RGD:126925167|PMID:32048631 20210513 RGD compared to Wild Type in cardiopulmonary bypass model 621782 Il1rl2 interleukin 1 receptor-like 2 gene MP:0031076 decreased circulating troponin level IMP N RGD:126925167|PMID:32048631 20210513 RGD compared to Wild Type in cardiopulmonary bypass model 621782 Il1rl2 interleukin 1 receptor-like 2 gene MP:0031107 abnormal circulating myoglobin level IMP N RGD:126925167|PMID:32048631 20210513 RGD compared to Wild Type in cardiopulmonary bypass model 621808 Park7 Parkinsonism associated deglycase gene MP:0001406 abnormal gait IMP N RGD:13210569|PMID:24969022 20170912 RGD 621808 Park7 Parkinsonism associated deglycase gene MP:0001516 abnormal motor coordination/balance IMP N RGD:13210569|PMID:24969022 20170912 RGD 621808 Park7 Parkinsonism associated deglycase gene MP:0001906 increased dopamine level IMP N RGD:13210569|PMID:24969022 20170912 RGD 621808 Park7 Parkinsonism associated deglycase gene MP:0002757 decreased vertical activity IMP N RGD:13210569|PMID:24969022 20170912 RGD 621808 Park7 Parkinsonism associated deglycase gene MP:0003244 loss of dopaminergic neurons IMP N RGD:13210569|PMID:24969022 20170912 RGD 621808 Park7 Parkinsonism associated deglycase gene MP:0004142 abnormal muscle tone IMP N RGD:13210569|PMID:24969022 20170912 RGD 621808 Park7 Parkinsonism associated deglycase gene MP:0010069 increased serotonin level IMP N RGD:13210569|PMID:24969022 20170912 RGD 621808 Park7 Parkinsonism associated deglycase gene MP:0020078 decreased brain tyrosine 3-monooxygenase activity IMP N RGD:13210569|PMID:24969022 20170912 RGD 621820 Gja3 gap junction protein, alpha 3 gene MP:0001304 cataract NAS N RGD:1599824|PMID:16271086 20070216 RGD 621837 Lyst lysosomal trafficking regulator gene MP:0001186 pigmentation phenotype IAGP N RGD:1302441|PMID:12638234 20090206 RGD beige coat color; ACI/N or DA/Ham rat 621837 Lyst lysosomal trafficking regulator gene MP:0005606 increased bleeding time IAGP N RGD:1302441|PMID:12638234 20090206 RGD in beige mutant rats 625659 DRH/Seac strain MP:0010265 decreased hepatoma incidence induced IAGP XCO:0000207 N RGD:625382|PMID:11756240 20090216 RGD chemically-induced 628372 ACI.FHH-(D1Mit34-D1Rat156)/Eur strain MP:0002962 increased urine protein level induced IAGP XCO:0000112, XCO:0000121 N RGD:625641|PMID:11875190 20120112 RGD compared to ACI/Eur 628372 ACI.FHH-(D1Mit34-D1Rat156)/Eur strain MP:0006144 increased systemic arterial systolic blood pressure induced IAGP XCO:0000112 N RGD:625641|PMID:11875190 20201202 RGD compared to ACI/Eur 628486 NER/Kyo Noda epileptic rat, GMS strain MP:0003997 tonic-clonic seizures penetrance IAGP N RGD:2313241|PMID:19713079 20200530 RGD 628486 NER/Kyo Noda epileptic rat, GMS strain MP:0003997 tonic-clonic seizures susceptibility IAGP N RGD:628480|PMID:9578020 20200530 RGD 628525 Ni/Hin strain MP:0000522 kidney cortex cyst IAGP N RGD:628433|PMID:11092972 19990101 RGD 628659 Nrxn1 neurexin 1 gene MP:0001262 decreased body weight IMP N RGD:12914797|PMID:25420124 20210527 RGD compared to wild type littermate 628659 Nrxn1 neurexin 1 gene MP:0001399 hyperactivity IMP N RGD:12914797|PMID:25420124 20210527 RGD 628659 Nrxn1 neurexin 1 gene MP:0001488 increased startle reflex IMP N RGD:12914797|PMID:25420124 20210527 RGD compared to wild type littermate 628659 Nrxn1 neurexin 1 gene MP:0011620 abnormal habituation to a new environment IMP N RGD:12914797|PMID:25420124 20210527 RGD 628659 Nrxn1 neurexin 1 gene MP:0012296 impaired discrimination learning sexual_dimorphism IMP N RGD:12914797|PMID:25420124 20210527 RGD compared to wild type male 628742 Lgi1 leucine-rich, glioma inactivated 1 gene MP:0001496 audiogenic seizures IMP N RGD:14995940|PMID:30813600 20191105 RGD 628742 Lgi1 leucine-rich, glioma inactivated 1 gene MP:0002083 premature death IMP N RGD:12792971|PMID:22589250 20170317 RGD DNA:missense mutation:cds:p.L385R (c.1154T>G) 628742 Lgi1 leucine-rich, glioma inactivated 1 gene MP:0012349 increased susceptibility to induction of seizure by inducing agent IMP N RGD:12792971|PMID:22589250 20170317 RGD DNA:missense mutation:cds:p.L385R (c.1154T>G) 628752 Rab38 RAB38, member RAS oncogene family gene MP:0002075 abnormal coat/hair pigmentation IAGP N RGD:1300411|PMID:15112108 20070307 RGD DNA:point mutation:exon:p.M1I 628752 Rab38 RAB38, member RAS oncogene family gene MP:0002962 increased urine protein level IAGP N RGD:13782139|PMID:23291471 20201210 RGD compared to FHH-Tg(CAG-Rab38)1Mcwi, FHH.BN-(D1Hmgc14-D1Hmgc15)/Mcwi 628752 Rab38 RAB38, member RAS oncogene family gene MP:0004722 abnormal platelet dense granule number IAGP N RGD:2324691|PMID:18983523 20100511 RGD 628752 Rab38 RAB38, member RAS oncogene family gene MP:0004780 abnormal surfactant secretion IAGP N RGD:2324690|PMID:19897744 20100511 RGD 628752 Rab38 RAB38, member RAS oncogene family gene MP:0005606 increased bleeding time IAGP N RGD:2324690|PMID:19897744 20180501 RGD 628752 Rab38 RAB38, member RAS oncogene family gene MP:0010815 enlarged alveolar lamellar bodies IMP N RGD:13524861|PMID:28438206 20180501 RGD 628752 Rab38 RAB38, member RAS oncogene family gene MP:0010856 dilated respiratory conducting tube IAGP N RGD:2324690|PMID:19897744 20180501 RGD 628772 Shank2 SH3 and multiple ankyrin repeat domains 2 gene MP:0001360 abnormal social investigation IMP N RGD:126790534|PMID:29970986 20210426 RGD 628772 Shank2 SH3 and multiple ankyrin repeat domains 2 gene MP:0001399 hyperactivity IMP N RGD:126790534|PMID:29970986 20210426 RGD 628772 Shank2 SH3 and multiple ankyrin repeat domains 2 gene MP:0002574 increased vertical activity IMP N RGD:126790534|PMID:29970986 20210426 RGD 628772 Shank2 SH3 and multiple ankyrin repeat domains 2 gene MP:0002803 abnormal operant conditioning behavior IMP N RGD:126790534|PMID:29970986 20210426 RGD 628772 Shank2 SH3 and multiple ankyrin repeat domains 2 gene MP:0003234 enhanced NMDA-mediated synaptic currents IMP N RGD:126790534|PMID:29970986 20210426 RGD 628772 Shank2 SH3 and multiple ankyrin repeat domains 2 gene MP:0004738 abnormal auditory brainstem response IMP N RGD:126790534|PMID:29970986 20210426 RGD 628772 Shank2 SH3 and multiple ankyrin repeat domains 2 gene MP:0012315 impaired learning IMP N RGD:126790534|PMID:29970986 20210426 RGD 628772 Shank2 SH3 and multiple ankyrin repeat domains 2 gene MP:0012316 enhanced conditioning behavior IMP N RGD:126790534|PMID:29970986 20210426 RGD 628772 Shank2 SH3 and multiple ankyrin repeat domains 2 gene MP:0020338 abnormal hippocampal pyramidal neuron dendrite morphology IMP N RGD:126790534|PMID:29970986 20210426 RGD 628772 Shank2 SH3 and multiple ankyrin repeat domains 2 gene MP:0020396 abnormal social recognition IMP N RGD:126790534|PMID:29970986 20210426 RGD 628772 Shank2 SH3 and multiple ankyrin repeat domains 2 gene MP:0020437 abnormal social play behavior IMP N RGD:126790534|PMID:29970986 20210426 RGD 628772 Shank2 SH3 and multiple ankyrin repeat domains 2 gene MP:0020870 decreased thigmotaxis IMP N RGD:126790534|PMID:29970986 20210426 RGD 628830 Myo7a myosin VIIA gene MP:0001394 circling IAGP N RGD:1581470|PMID:15965244 20170713 RGD DNA:nonsense mutation:cds 628830 Myo7a myosin VIIA gene MP:0001399 hyperactivity IAGP N RGD:1581470|PMID:15965244 20170713 RGD DNA:nonsense mutation:cds 628830 Myo7a myosin VIIA gene MP:0004521 abnormal cochlear hair cell stereociliary bundle morphology IAGP N RGD:1581470|PMID:15965244 20170713 RGD DNA:nonsense mutation:cds 628830 Myo7a myosin VIIA gene MP:0004738 abnormal auditory brainstem response IAGP N RGD:1581470|PMID:15965244 20170713 RGD DNA:nonsense mutation:cds 628830 Myo7a myosin VIIA gene MP:0004742 abnormal vestibular system physiology IAGP N RGD:1581470|PMID:15965244 20170713 RGD DNA:nonsense mutation:cds 628831 Nr1h4 nuclear receptor subfamily 1, group H, member 4 gene MP:0003333 liver fibrosis IDA N RGD:1625201|PMID:15980055 20070529 RGD 628831 Nr1h4 nuclear receptor subfamily 1, group H, member 4 gene MP:0003333 liver fibrosis treatment IMP N RGD:15042868|PMID:19418582 20191213 RGD mRNA:altered expression:liver (rat) 628835 Gpr37l1 G protein-coupled receptor 37-like 1 gene MP:0002871 albuminuria IAGP N RGD:12802369|PMID:23460292 20170407 RGD 628835 Gpr37l1 G protein-coupled receptor 37-like 1 gene MP:0004217 salt-sensitive hypertension IAGP N RGD:12802369|PMID:23460292 20170407 RGD 628871 Gimap5 GTPase, IMAP family member 5 gene MP:0005534 decreased body temperature IAGP N RGD:2303768|PMID:17705691 20090305 RGD 628890 Gja8 gap junction protein, alpha 8 gene MP:0000183 decreased circulating LDL cholesterol level IAGP N RGD:150429989|PMID:27871290 20231005 RGD 628890 Gja8 gap junction protein, alpha 8 gene MP:0000186 decreased circulating HDL cholesterol level IAGP N RGD:150429989|PMID:27871290 20231005 RGD 628890 Gja8 gap junction protein, alpha 8 gene MP:0001297 microphthalmia IAGP N RGD:2293186|PMID:18470322 20231005 RGD 628890 Gja8 gap junction protein, alpha 8 gene MP:0001304 cataract IAGP N RGD:2293186|PMID:18470322 20231005 RGD 628890 Gja8 gap junction protein, alpha 8 gene MP:0001304 cataract IAGP N RGD:629571|PMID:12356818 19990101 RGD 628890 Gja8 gap junction protein, alpha 8 gene MP:0001552 increased circulating triglyceride level IAGP N RGD:150429989|PMID:27871290 20231005 RGD 628890 Gja8 gap junction protein, alpha 8 gene MP:0002079 increased circulating insulin level IAGP N RGD:150429989|PMID:27871290 20231005 RGD 628890 Gja8 gap junction protein, alpha 8 gene MP:0002727 decreased circulating insulin level IAGP N RGD:150429989|PMID:27871290 20231005 RGD 628890 Gja8 gap junction protein, alpha 8 gene MP:0005545 abnormal lens development IAGP N RGD:2293186|PMID:18470322 20170412 RGD DNA:missense mutation:cds:p.L7Q(rat) 628890 Gja8 gap junction protein, alpha 8 gene MP:0008553 increased circulating tumor necrosis factor level IAGP N RGD:150429989|PMID:27871290 20231005 RGD 628890 Gja8 gap junction protein, alpha 8 gene MP:0008614 increased circulating interleukin-17 level IAGP N RGD:150429989|PMID:27871290 20231005 RGD 628890 Gja8 gap junction protein, alpha 8 gene MP:0008663 increased interleukin-12 secretion IAGP N RGD:150429989|PMID:27871290 20231005 RGD 628890 Gja8 gap junction protein, alpha 8 gene MP:0008684 increased interleukin-18 secretion IAGP N RGD:150429989|PMID:27871290 20231005 RGD 628890 Gja8 gap junction protein, alpha 8 gene MP:0008705 increased interleukin-6 secretion IAGP N RGD:150429989|PMID:27871290 20231005 RGD 628890 Gja8 gap junction protein, alpha 8 gene MP:0009288 increased epididymal fat pad weight IAGP N RGD:150429989|PMID:27871290 20231005 RGD 628890 Gja8 gap junction protein, alpha 8 gene MP:0009289 decreased epididymal fat pad weight IAGP N RGD:150429989|PMID:27871290 20231005 RGD 628890 Gja8 gap junction protein, alpha 8 gene MP:0009699 hyperchylomicronemia IAGP N RGD:150429989|PMID:27871290 20231005 RGD 628890 Gja8 gap junction protein, alpha 8 gene MP:0011603 decreased glutathione peroxidase activity IAGP N RGD:150429989|PMID:27871290 20231005 RGD 628890 Gja8 gap junction protein, alpha 8 gene MP:0012604 decreased glutathione level IAGP N RGD:150429989|PMID:27871290 20231005 RGD 628890 Gja8 gap junction protein, alpha 8 gene MP:0012629 decreased glutathione reductase level IAGP N RGD:150429989|PMID:27871290 20231005 RGD 628890 Gja8 gap junction protein, alpha 8 gene MP:0012655 increased catalase level IAGP N RGD:150429989|PMID:27871290 20231005 RGD 628890 Gja8 gap junction protein, alpha 8 gene MP:0012659 decreased superoxide dismutase level IAGP N RGD:150429989|PMID:27871290 20231005 RGD 628890 Gja8 gap junction protein, alpha 8 gene MP:0013278 decreased fasting circulating glucose level induces IAGP XCO:0000275,XCO:0000444 N RGD:150429989|PMID:27871290 20231005 RGD 628890 Gja8 gap junction protein, alpha 8 gene MP:0031251 increased circulating CCL3 level IAGP N RGD:150429989|PMID:27871290 20231005 RGD 628907 SHR.BN-RT1n strain MP:0004876 decreased mean systemic arterial blood pressure IAGP N RGD:628911|PMID:2708818 20200128 RGD compared to SHR/Ola 628908 SHR.BN-(D1Mit3-Igf2)/Ipcv strain MP:0000530 abnormal kidney vasculature morphology IAGP N RGD:632218|PMID:10454439 20200109 RGD compared to SHR/Ola strain 628908 SHR.BN-(D1Mit3-Igf2)/Ipcv strain MP:0002962 increased urine protein level IAGP N RGD:632218|PMID:10454439 20200109 RGD compared to SHR/Ola strain 628908 SHR.BN-(D1Mit3-Igf2)/Ipcv strain MP:0004876 decreased mean systemic arterial blood pressure IAGP N RGD:632218|PMID:10454439 20200109 RGD compared to SHR/Ola strain 628908 SHR.BN-(D1Mit3-Igf2)/Ipcv strain MP:0005325 abnormal renal glomerulus morphology IAGP N RGD:632218|PMID:10454439 20200109 RGD compared to SHR/Ola strain 628908 SHR.BN-(D1Mit3-Igf2)/Ipcv strain MP:0006263 decreased systemic arterial diastolic blood pressure IAGP N RGD:61048|PMID:9336384 20200505 RGD compared to SHR/Ola strain 628908 SHR.BN-(D1Mit3-Igf2)/Ipcv strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:61048|PMID:9336384 19990101 RGD compared to SHR/Ola strain 628908 SHR.BN-(D1Mit3-Igf2)/Ipcv strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:632218|PMID:10454439 20200109 RGD compared to SHR/Ola strain 628909 SHR.BN-(D13Arb5-Ren1)/Ipcv strain MP:0000186 decreased circulating HDL cholesterol level induced IAGP XCO:0000025,XCO:0000246 N RGD:61512|PMID:10330997 20200506 RGD compared to SHR/Ola 628909 SHR.BN-(D13Arb5-Ren1)/Ipcv strain MP:0000186 decreased circulating HDL cholesterol level induced IAGP XCO:0000025,XCO:0000246 N RGD:619652|PMID:9453331 20200122 RGD compared to SHR/Ola 628909 SHR.BN-(D13Arb5-Ren1)/Ipcv strain MP:0001552 increased circulating triglyceride level induced IAGP XCO:0000025,XCO:0000246 N RGD:619652|PMID:9453331 20200122 RGD compared to SHR/Ola 628909 SHR.BN-(D13Arb5-Ren1)/Ipcv strain MP:0005145 increased circulating VLDL cholesterol level induced IAGP XCO:0000025,XCO:0000246 N RGD:61512|PMID:10330997 20200506 RGD compared to SHR/Ola 628909 SHR.BN-(D13Arb5-Ren1)/Ipcv strain MP:0005145 increased circulating VLDL cholesterol level induced IAGP XCO:0000025,XCO:0000246 N RGD:619652|PMID:9453331 20200122 RGD compared to SHR/Ola 628909 SHR.BN-(D13Arb5-Ren1)/Ipcv strain MP:0005178 increased circulating cholesterol level induced IAGP XCO:0000025,XCO:0000246 N RGD:61512|PMID:10330997 20200122 RGD compared to SHR/Ola 628909 SHR.BN-(D13Arb5-Ren1)/Ipcv strain MP:0005178 increased circulating cholesterol level induced IAGP XCO:0000025,XCO:0000246 N RGD:619652|PMID:9453331 20200506 RGD compared to SHR/Ola 628909 SHR.BN-(D13Arb5-Ren1)/Ipcv strain MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:619652|PMID:9453331 19990101 RGD compared to SHR/Ola 628909 SHR.BN-(D13Arb5-Ren1)/Ipcv strain MP:0006264 decreased systemic arterial systolic blood pressure sexual_dimorphism IAGP N RGD:61046|PMID:8567976 19990101 RGD males compared to SR/Jr males 628909 SHR.BN-(D13Arb5-Ren1)/Ipcv strain MP:0010330 abnormal circulating lipoprotein level induced IAGP XCO:0000025,XCO:0000246 N RGD:61512|PMID:10330997 20200506 RGD increased IDL compared to SHR/Ola 628909 SHR.BN-(D13Arb5-Ren1)/Ipcv strain MP:0010330 abnormal circulating lipoprotein level induced IAGP XCO:0000025,XCO:0000246 N RGD:619652|PMID:9453331 20200506 RGD increased IDL compared to SHR/Ola 629459 ZUC-LeprfaSteJrpz-/- strain MP:0000523 cortical renal glomerulopathies IAGP N RGD:628436|PMID:11135055 19990101 RGD compared to heterozygous +/fa rats 629459 ZUC-LeprfaSteJrpz-/- strain MP:0001254 increased body height susceptibility IAGP N RGD:24922198|PMID:10719837 20200430 RGD compared to heterozygous controls +/fa 629459 ZUC-LeprfaSteJrpz-/- strain MP:0001254 increased body height treatment IAGP CHEBI:28689|XCO:0000015 N RGD:24922198|PMID:10719837 20200430 RGD compared to DHEA treated and calorie restricted rats 629459 ZUC-LeprfaSteJrpz-/- strain MP:0001260 increased body weight susceptibility IAGP N RGD:24922198|PMID:10719837 20200430 RGD compared to heterozygous controls +/fa 629459 ZUC-LeprfaSteJrpz-/- strain MP:0001260 increased body weight treatment IAGP CHEBI:28689 N RGD:628436|PMID:11135055 20200430 RGD compared to quinapril treated rats 629459 ZUC-LeprfaSteJrpz-/- strain MP:0001260 increased body weight treatment IAGP CHEBI:28689|XCO:0000015 N RGD:24922198|PMID:10719837 20200430 RGD compared to DHEA treated and calorie restricted rats 629459 ZUC-LeprfaSteJrpz-/- strain MP:0001261 obese susceptibility IAGP CHEBI:28689|XCO:0000591|XCO:0000015 N RGD:628436|PMID:11135055 20200430 RGD compared to treated and control strain 629459 ZUC-LeprfaSteJrpz-/- strain MP:0001552 increased circulating triglyceride level susceptibility IAGP N RGD:24922198|PMID:10719837 20200430 RGD compared to heterozygous controls +/fa 629459 ZUC-LeprfaSteJrpz-/- strain MP:0001552 increased circulating triglyceride level treatment IAGP CHEBI:28689|XCO:0000015 N RGD:24922198|PMID:10719837 20200430 RGD compared to DHEA treated and calorie restricted rats 629459 ZUC-LeprfaSteJrpz-/- strain MP:0001554 increased circulating free fatty acids level susceptibility IAGP N RGD:24922198|PMID:10719837 20200430 RGD compared to heterozygous controls +/fa 629459 ZUC-LeprfaSteJrpz-/- strain MP:0001554 increased circulating free fatty acids level treatment IAGP CHEBI:28689|XCO:0000015 N RGD:24922198|PMID:10719837 20200430 RGD compared to DHEA treated and calorie restricted rats 629459 ZUC-LeprfaSteJrpz-/- strain MP:0001745 increased circulating corticosterone level susceptibility IAGP N RGD:24922198|PMID:10719837 20200430 RGD compared to heterozygous controls +/fa 629459 ZUC-LeprfaSteJrpz-/- strain MP:0001745 increased circulating corticosterone level treatment IAGP CHEBI:28689|XCO:0000015 N RGD:24922198|PMID:10719837 20200430 RGD compared to DHEA treated and calorie restricted rats 629459 ZUC-LeprfaSteJrpz-/- strain MP:0002079 increased circulating insulin level susceptibility IAGP N RGD:24922198|PMID:10719837 20200430 RGD compared to heterozygous controls +/fa 629459 ZUC-LeprfaSteJrpz-/- strain MP:0002079 increased circulating insulin level treatment IAGP CHEBI:28689|XCO:0000015 N RGD:24922198|PMID:10719837 20200430 RGD compared to DHEA treated and calorie restricted rats 629459 ZUC-LeprfaSteJrpz-/- strain MP:0002871 albuminuria disease_progression IAGP N RGD:628436|PMID:11135055 20200430 RGD compared to heterozygous +/fa rats 629459 ZUC-LeprfaSteJrpz-/- strain MP:0002871 albuminuria treatment IAGP CHEBI:28689|XCO:0000591|XCO:0000015 N RGD:628436|PMID:11135055 20200430 RGD compared to treated rats and control +/fa strain 629459 ZUC-LeprfaSteJrpz-/- strain MP:0003215 renal interstitial fibrosis treatment IAGP CHEBI:28689|XCO:0000591|XCO:0000015 N RGD:628436|PMID:11135055 20200430 RGD compared to treated rats and control +/fa strain 629459 ZUC-LeprfaSteJrpz-/- strain MP:0003917 increased kidney weight susceptibility IAGP N RGD:628436|PMID:11135055 20200430 RGD compared to heterozygous +/fa rats 629459 ZUC-LeprfaSteJrpz-/- strain MP:0003917 increased kidney weight treatment IAGP CHEBI:28689|XCO:0000591|XCO:0000015 N RGD:628436|PMID:11135055 20200430 RGD compared to treated rats and control +/fa strain 629459 ZUC-LeprfaSteJrpz-/- strain MP:0005178 increased circulating cholesterol level IAGP N RGD:628436|PMID:11135055 19990101 RGD compared to heterozygous +/fa rats 629459 ZUC-LeprfaSteJrpz-/- strain MP:0005178 increased circulating cholesterol level susceptibility IAGP N RGD:24922198|PMID:10719837 20200430 RGD compared to heterozygous controls +/fa 629459 ZUC-LeprfaSteJrpz-/- strain MP:0005178 increased circulating cholesterol level treatment IAGP CHEBI:28689 N RGD:628436|PMID:11135055 20200430 RGD compared to quinapril treated rats 629459 ZUC-LeprfaSteJrpz-/- strain MP:0005178 increased circulating cholesterol level treatment IAGP CHEBI:28689|XCO:0000015 N RGD:24922198|PMID:10719837 20200430 RGD compared to DHEA treated and calorie restricted rats 629459 ZUC-LeprfaSteJrpz-/- strain MP:0005528 decreased renal glomerular filtration rate treatment IAGP CHEBI:28689|XCO:0000591|XCO:0000015 N RGD:628436|PMID:11135055 20200430 RGD compared to treated rats and control +/fa strain 629459 ZUC-LeprfaSteJrpz-/- strain MP:0005557 increased creatinine clearance treatment IAGP CHEBI:28689|XCO:0000591|XCO:0000015 N RGD:628436|PMID:11135055 20200430 RGD compared to treated rats and control +/fa strain 629459 ZUC-LeprfaSteJrpz-/- strain MP:0005559 increased circulating glucose level susceptibility IAGP N RGD:24922198|PMID:10719837 20200430 RGD compared to heterozygous controls +/fa 629459 ZUC-LeprfaSteJrpz-/- strain MP:0005559 increased circulating glucose level treatment IAGP CHEBI:28689|XCO:0000015 N RGD:24922198|PMID:10719837 20200430 RGD compared to DHEA treated and calorie restricted rats 629459 ZUC-LeprfaSteJrpz-/- strain MP:0005669 increased circulating leptin level susceptibility IAGP N RGD:24922198|PMID:10719837 20200430 RGD compared to heterozygous controls +/fa 629459 ZUC-LeprfaSteJrpz-/- strain MP:0005669 increased circulating leptin level treatment IAGP CHEBI:28689|XCO:0000015 N RGD:24922198|PMID:10719837 20200430 RGD compared to DHEA treated and calorie restricted rats 629459 ZUC-LeprfaSteJrpz-/- strain MP:0008908 increased total fat pad weight susceptibility IAGP N RGD:24922198|PMID:10719837 20200430 RGD compared to heterozygous controls +/fa 629459 ZUC-LeprfaSteJrpz-/- strain MP:0008908 increased total fat pad weight treatment IAGP CHEBI:28689|XCO:0000015 N RGD:24922198|PMID:10719837 20200430 RGD compared to DHEA treated and calorie restricted rats 629459 ZUC-LeprfaSteJrpz-/- strain MP:0009288 increased epididymal fat pad weight susceptibility IAGP N RGD:24922198|PMID:10719837 20200430 RGD compared to heterozygous controls +/fa 629459 ZUC-LeprfaSteJrpz-/- strain MP:0009288 increased epididymal fat pad weight treatment IAGP CHEBI:28689|XCO:0000015 N RGD:24922198|PMID:10719837 20200430 RGD compared to DHEA treated and calorie restricted rats 629459 ZUC-LeprfaSteJrpz-/- strain MP:0009304 increased retroperitoneal fat pad weight susceptibility IAGP N RGD:24922198|PMID:10719837 20200430 RGD compared to heterozygous controls +/fa 629459 ZUC-LeprfaSteJrpz-/- strain MP:0009304 increased retroperitoneal fat pad weight treatment IAGP CHEBI:28689|XCO:0000015 N RGD:24922198|PMID:10719837 20200430 RGD compared to DHEA treated and calorie restricted rats 629459 ZUC-LeprfaSteJrpz-/- strain MP:0011377 renal glomerulus fibrosis treatment IAGP CHEBI:28689|XCO:0000591|XCO:0000015 N RGD:628436|PMID:11135055 20200430 RGD compared to treated rats and control +/fa strain 629459 ZUC-LeprfaSteJrpz-/- strain MP:0011939 increased food intake susceptibility IAGP N RGD:24922198|PMID:10719837 20200430 RGD compared to heterozygous controls +/fa 629459 ZUC-LeprfaSteJrpz-/- strain MP:0011939 increased food intake treatment IAGP CHEBI:28689 N RGD:628436|PMID:11135055 20200430 RGD compared to quinapril treated rats 629459 ZUC-LeprfaSteJrpz-/- strain MP:0011939 increased food intake treatment IAGP CHEBI:28689|XCO:0000015 N RGD:24922198|PMID:10719837 20200430 RGD compared to DHEA treated and calorie restricted rats 629462 ZUC-LeprfaSte-/- strain MP:0001260 increased body weight sexual_dimorphism IAGP N RGD:7365117|PMID:20159938 20131023 RGD compared to BN 629462 ZUC-LeprfaSte-/- strain MP:0001260 increased body weight treatment IAGP XCO:0000015 N RGD:628581|PMID:11500530 20200430 RGD compared to ad lib fed rats 629462 ZUC-LeprfaSte-/- strain MP:0001261 obese IAGP N RGD:628581|PMID:11500530 19990101 RGD compared to heterozygous controls +/fa 629462 ZUC-LeprfaSte-/- strain MP:0001261 obese IAGP N RGD:628910|PMID:9843879 20200430 RGD compared to age-matched lean heterozygous +/fa rats 629462 ZUC-LeprfaSte-/- strain MP:0001261 obese treatment IAGP XCO:0000015 N RGD:628581|PMID:11500530 20200430 RGD compared to ad lib fed rats 629462 ZUC-LeprfaSte-/- strain MP:0001548 hyperlipidemia IAGP N RGD:628581|PMID:11500530 19990101 RGD compared to heterozygous controls +/fa 629462 ZUC-LeprfaSte-/- strain MP:0001552 increased circulating triglyceride level treatment IAGP XCO:0000015 N RGD:628581|PMID:11500530 20200430 RGD compared to ad lib fed rats 629462 ZUC-LeprfaSte-/- strain MP:0002871 albuminuria sexual_dimorphism IAGP N RGD:7365117|PMID:20159938 20131023 RGD compared to BN 629462 ZUC-LeprfaSte-/- strain MP:0002871 albuminuria treatment IAGP XCO:0000015 N RGD:628581|PMID:11500530 20200430 RGD compared to ad lib fed rats 629462 ZUC-LeprfaSte-/- strain MP:0009130 increased white fat cell number IAGP N RGD:628910|PMID:9843879 20200430 RGD compared to age-matched lean heterozygous +/fa rats 629462 ZUC-LeprfaSte-/- strain MP:0009285 increased gonadal fat pad weight sexual_dimorphism IAGP N RGD:7365117|PMID:20159938 20201002 RGD compared to BN 629462 ZUC-LeprfaSte-/- strain MP:0009288 increased epididymal fat pad weight IAGP N RGD:628910|PMID:9843879 20200430 RGD compared to age-matched lean heterozygous +/fa rats 629462 ZUC-LeprfaSte-/- strain MP:0009292 increased inguinal fat pad weight IAGP N RGD:628910|PMID:9843879 20200430 RGD compared to age-matched lean heterozygous +/fa rats 629462 ZUC-LeprfaSte-/- strain MP:0009304 increased retroperitoneal fat pad weight IAGP N RGD:628910|PMID:9843879 20200430 RGD compared to age-matched lean heterozygous +/fa rats 629462 ZUC-LeprfaSte-/- strain MP:0009304 increased retroperitoneal fat pad weight sexual_dimorphism IAGP N RGD:7365117|PMID:20159938 20131023 RGD compared to BN 629462 ZUC-LeprfaSte-/- strain MP:0011377 renal glomerulus fibrosis treatment IAGP XCO:0000015 N RGD:628581|PMID:11500530 20200430 RGD compared to ad lib fed rats; increased desmin, fibronectin and collagenase 629462 ZUC-LeprfaSte-/- strain MP:0011939 increased food intake IAGP N RGD:628910|PMID:9843879 20200430 RGD compared to age-matched lean heterozygous +/fa rats 629465 SHR/NCrlCrlj strain MP:0001554 increased circulating free fatty acids level IAGP N RGD:629460|PMID:10391208 20140430 RGD compared to SHR/Izm 629465 SHR/NCrlCrlj strain MP:0002644 decreased circulating triglyceride level IAGP N RGD:629460|PMID:10391208 20140430 RGD compared to SHR/Izm 629465 SHR/NCrlCrlj strain MP:0005560 decreased circulating glucose level IAGP N RGD:629460|PMID:10391208 20140430 RGD compared to SHR/Izm 629465 SHR/NCrlCrlj strain MP:0009289 decreased epididymal fat pad weight IAGP N RGD:629460|PMID:10391208 20201005 RGD compared to SHR/Izm 629482 WKY.SHR-(D1Wox19-D1Mit2)/Njs strain MP:0004875 increased mean systemic arterial blood pressure IAGP N RGD:70855|PMID:11509479 20200210 RGD compared to WKY/NCruk strain 629482 WKY.SHR-(D1Wox19-D1Mit2)/Njs strain MP:0006143 increased systemic arterial diastolic blood pressure IAGP N RGD:61051|PMID:9774356 19990101 RGD compared to WKY 629482 WKY.SHR-(D1Wox19-D1Mit2)/Njs strain MP:0006143 increased systemic arterial diastolic blood pressure IAGP N RGD:70855|PMID:11509479 20200210 RGD compared to WKY/NCruk strain 629482 WKY.SHR-(D1Wox19-D1Mit2)/Njs strain MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:61051|PMID:9774356 19990101 RGD compared to WKY 629482 WKY.SHR-(D1Wox19-D1Mit2)/Njs strain MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:70855|PMID:11509479 20200210 RGD compared to WKY/NCruk strain 629484 LEW-tl strain MP:0001265 decreased body size IAGP N RGD:70875|PMID:12074592 20180430 RGD 629485 LE/Stm strain MP:0002026 increased leukemia incidence induced IAGP XCO:0000437 N RGD:619600|PMID:10360666 19990101 RGD 629486 PVG/OlaHsd strain MP:0008770 decreased survivor rate induced IAGP XCO:0000668 N RGD:2302114|PMID:17998886 20090522 RGD as compared to BN/HsdMcwiCrl 629487 SHR.WKY-(D1Wox19-D1Wox34)/Njs strain MP:0004876 decreased mean systemic arterial blood pressure IAGP N RGD:70855|PMID:11509479 20200210 RGD compared to SHR/NCruk strain 629487 SHR.WKY-(D1Wox19-D1Wox34)/Njs strain MP:0006263 decreased systemic arterial diastolic blood pressure IAGP N RGD:61051|PMID:9774356 19990101 RGD compared to SHR 629487 SHR.WKY-(D1Wox19-D1Wox34)/Njs strain MP:0006263 decreased systemic arterial diastolic blood pressure IAGP N RGD:70855|PMID:11509479 20200210 RGD compared to SHR/NCruk strain 629487 SHR.WKY-(D1Wox19-D1Wox34)/Njs strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:61051|PMID:9774356 20191203 RGD compared to SHR 629487 SHR.WKY-(D1Wox19-D1Wox34)/Njs strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:70855|PMID:11509479 20200210 RGD compared to SHR/NCruk strain 629488 SI-Tg(Ednrb)Ywa transgenic spotting lethal strain MP:0002075 abnormal coat/hair pigmentation IMP N RGD:628516|PMID:9739043 20171204 RGD 629488 SI-Tg(Ednrb)Ywa transgenic spotting lethal strain MP:0003270 intestinal obstruction IAGP N RGD:628516|PMID:9739043 20171201 RGD 629488 SI-Tg(Ednrb)Ywa transgenic spotting lethal strain MP:0006144 increased systemic arterial systolic blood pressure IMP N RGD:13782267|PMID:11078344 20180830 RGD 629490 DA.F344-Aia1/1 strain MP:0002936 joint swelling induced IAGP XCO:0000266 N RGD:625379|PMID:11953987 19990101 RGD compared to F344/NHsd 629491 DA.F344-Aia1/2 strain MP:0002936 joint swelling induced IAGP XCO:0000266 N RGD:625379|PMID:11953987 19990101 RGD compared to F344/NHsd 629492 Sl strain MP:0000477 abnormal intestine morphology IMP N RGD:628516|PMID:9739043 19990101 RGD 629492 Sl strain MP:0001045 abnormal enteric ganglia morphology IAGP N RGD:628515|PMID:8570650 20061030 RGD 629492 Sl strain MP:0002075 abnormal coat/hair pigmentation IAGP N RGD:628515|PMID:8570650 20061030 RGD 629492 Sl strain MP:0002926 aganglionic megacolon IAGP N RGD:628515|PMID:8570650 20061030 RGD 629492 Sl strain MP:0003270 intestinal obstruction IMP N RGD:628516|PMID:9739043 19990101 RGD 629493 DA.F344-Aia1/3 strain MP:0002936 joint swelling induced IAGP XCO:0000266 N RGD:625379|PMID:11953987 19990101 RGD compared to F344/NHsd 629494 DA.F344-Aia1/4 strain MP:0002936 joint swelling induced IAGP XCO:0000266 N RGD:625379|PMID:11953987 19990101 RGD compared to F344/NHsd 629501 SD-Tg(Ren2)27 strain MP:0003353 decreased circulating renin level IMP N RGD:628589|PMID:2181319 20200211 RGD 629501 SD-Tg(Ren2)27 strain MP:0003915 increased heart left ventricle weight IMP N RGD:13513906|PMID:16882881 20200214 RGD compared to non-transgenic littermate SD-Tg(Ren2)27-/- 629501 SD-Tg(Ren2)27 strain MP:0005583 decreased renin activity IMP N RGD:628589|PMID:2181319 20200211 RGD in plasma, kidney 629501 SD-Tg(Ren2)27 strain MP:0006144 increased systemic arterial systolic blood pressure IMP N RGD:13513906|PMID:16882881 20191202 RGD compared with SD-Tg(Ren2)27-/- 629501 SD-Tg(Ren2)27 strain MP:0006144 increased systemic arterial systolic blood pressure IMP N RGD:628589|PMID:2181319 19990101 RGD compared to wild-type littermate 629501 SD-Tg(Ren2)27 strain MP:0011540 increased urine aldosterone level IMP N RGD:628589|PMID:2181319 20200211 RGD in male 629502 SHR.BN-(Il6-Npy) strain MP:0002843 decreased systemic arterial blood pressure IMP N RGD:2300254|PMID:18587397 20080910 RGD as compared to SHR progenitor 629502 SHR.BN-(Il6-Npy) strain MP:0030016 increased adipocyte glucose uptake IAGP N RGD:619666|PMID:9916795 20201214 RGD compared to SHR 629503 SHR.BN-(D19Rat57-D19Mit7)/Ipcv strain MP:0000186 decreased circulating HDL cholesterol level induced IAGP XCO:0000025,XCO:0000246 N RGD:61512|PMID:10330997 19990101 RGD compared to SHR/Ola 629503 SHR.BN-(D19Rat57-D19Mit7)/Ipcv strain MP:0001552 increased circulating triglyceride level induced IAGP XCO:0000025,XCO:0000246 N RGD:61512|PMID:10330997 20200122 RGD compared to SHR/Ola 629503 SHR.BN-(D19Rat57-D19Mit7)/Ipcv strain MP:0002843 decreased systemic arterial blood pressure induced IAGP XCO:0000025,XCO:0000246 N RGD:61512|PMID:10330997 20200122 RGD compared to SHR/Ola 629503 SHR.BN-(D19Rat57-D19Mit7)/Ipcv strain MP:0005145 increased circulating VLDL cholesterol level induced IAGP XCO:0000025,XCO:0000246 N RGD:61512|PMID:10330997 20200122 RGD compared to SHR/Ola 629503 SHR.BN-(D19Rat57-D19Mit7)/Ipcv strain MP:0005178 increased circulating cholesterol level induced IAGP XCO:0000025,XCO:0000246 N RGD:61512|PMID:10330997 20200122 RGD compared to SHR/Ola 629503 SHR.BN-(D19Rat57-D19Mit7)/Ipcv strain MP:0006263 decreased systemic arterial diastolic blood pressure induced IAGP XCO:0000164 N RGD:619647|PMID:9931113 19990101 RGD compared to SHR/Ola 629503 SHR.BN-(D19Rat57-D19Mit7)/Ipcv strain MP:0006264 decreased systemic arterial systolic blood pressure induced IAGP XCO:0000164 N RGD:619647|PMID:9931113 20200122 RGD compared to SHR/Ola 629504 WKY.SHR-(D1Mit3-D1Rat57)/Iwai strain MP:0002842 increased systemic arterial blood pressure IAGP N RGD:628906|PMID:9774355 19990101 RGD compared to WKY 629509 FHH/EurMcwi strain MP:0000249 abnormal blood vessel physiology IAGP N RGD:61023|PMID:10070148 20191206 RGD compared to FHL/EurMcwi 629509 FHH/EurMcwi strain MP:0002962 increased urine protein level IAGP N RGD:1303373|PMID:14988259 20200302 RGD compared to BN/NHsdMcwi 629509 FHH/EurMcwi strain MP:0002962 increased urine protein level IAGP N RGD:1357409|PMID:15758045 20201030 RGD compared to BN 629509 FHH/EurMcwi strain MP:0002962 increased urine protein level IAGP N RGD:13782139|PMID:23291471 20191212 RGD compared to FHL/EurMcwi 629509 FHH/EurMcwi strain MP:0002962 increased urine protein level IAGP N RGD:61028|PMID:9887194 20200116 RGD compared to FHL/EurMcw, ACI/SegHsd 629509 FHH/EurMcwi strain MP:0003071 decreased vascular permeability induces IMP XCO:0000329 N RGD:150340736|PMID:32029431 20210913 RGD Associated with hypertension, compared to FHH-Tg(CAG-Add3)McwiRoman 629509 FHH/EurMcwi strain MP:0003985 renal fibrosis induces IMP XCO:0000329 N RGD:150340736|PMID:32029431 20210913 RGD compared to FHH-Tg(CAG-Add3)McwiRoman 629509 FHH/EurMcwi strain MP:0004875 increased mean systemic arterial blood pressure IAGP N RGD:61028|PMID:9887194 20200116 RGD compared to FHL/EurMcwi 629509 FHH/EurMcwi strain MP:0005325 abnormal renal glomerulus morphology induces IMP XCO:0000329 N RGD:150340736|PMID:32029431 20210913 RGD compared to FHH-Tg(CAG-Add3)McwiRoman 629509 FHH/EurMcwi strain MP:0005524 abnormal renal plasma flow rate IAGP N RGD:1579884|PMID:16303858 20200117 RGD compared to FHH.FHH.1BN-(D1Rat287-D1Rat84)/Mcwi, FHH.FHH.1BN-(D1Rat173F6B-D1Rat84)/Mcwi, FHH.FHH.1BN-(D1Mgh13-D1Rat89)/Mcwi 629509 FHH/EurMcwi strain MP:0008874 decreased physiological sensitivity to xenobiotic IAGP N RGD:61023|PMID:10070148 20191206 RGD compared to FHL/EurMcwi 629509 FHH/EurMcwi strain MP:0011296 decreased tubuloglomerular feedback response induces IMP XCO:0000168 N RGD:150340736|PMID:32029431 20210913 RGD compared to FHH-Tg(CAG-Add3)McwiRoman 629509 FHH/EurMcwi strain MP:0011402 renal cast induces IMP XCO:0000329 N RGD:150340736|PMID:32029431 20210913 RGD compared to FHH-Tg(CAG-Add3)McwiRoman 629509 FHH/EurMcwi strain MP:0011856 abnormal glomerular filtration barrier function IAGP N RGD:1357409|PMID:15758045 20201030 RGD compared to BN 629509 FHH/EurMcwi strain MP:0020849 abnormal actin cytoskeleton morphology IMP N RGD:150340736|PMID:32029431 20210913 RGD compared to FHH-Tg(CAG-Add3)McwiRoman 629510 SS.BN-(D12Arb13-D12Rat79)/Mcwi strain MP:0005540 decreased urine albumin level sexual_dimorphism IAGP XCO:0000022 N RGD:2300225|PMID:18653478 20200122 RGD compared to female SS/JrHsdMcwi, male SS.BN-(D12Arb13-D12Rat79)/Mcwi 629511 SS-Chr 2BN/Mcwi strain MP:0003009 abnormal cytokine secretion IAGP N RGD:4890416|PMID:20044442 20191121 RGD increased GM-CSF secretion compared to SS/Hsd; 629511 SS-Chr 2BN/Mcwi strain MP:0003025 increased vasoconstriction induced IAGP XCO:0000022,XCO:0000612 N RGD:12792230|PMID:27270176 20210405 RGD compared to SS-Shc1em5Mcwi 629511 SS-Chr 2BN/Mcwi strain MP:0003025 increased vasoconstriction induced IAGP XCO:0000613, XCO:0000022 N RGD:12792230|PMID:27270176 20200131 RGD compared to SS/JrHsdMcwi, SS-Shc1em5Mcwi 629511 SS-Chr 2BN/Mcwi strain MP:0004876 decreased mean systemic arterial blood pressure sexual_dimorphism IAGP XCO:0000022 N RGD:2300225|PMID:18653478 20200122 RGD compared to male SS-Chr 2BN/Mcwi�� 629511 SS-Chr 2BN/Mcwi strain MP:0005264 glomerulosclerosis ameliorates IAGP N RGD:12792230|PMID:27270176 20210409 RGD compared to SS/JrHsdMcwi 629511 SS-Chr 2BN/Mcwi strain MP:0005540 decreased urine albumin level IAGP N RGD:12792230|PMID:27270176 20200131 RGD compared to SS/JrHsdMcwi 629511 SS-Chr 2BN/Mcwi strain MP:0005540 decreased urine albumin level sexual_dimorphism IAGP XCO:0000022 N RGD:2300225|PMID:18653478 20200122 RGD compared to female SS/JrHsdMcwi, male SS-Chr 2BN/Mcwi�� 629511 SS-Chr 2BN/Mcwi strain MP:0008560 increased tumor necrosis factor secretion IAGP N RGD:4890416|PMID:20044442 20191121 RGD compared to SS/Hsd; 629511 SS-Chr 2BN/Mcwi strain MP:0008660 increased interleukin-10 secretion IAGP N RGD:4890416|PMID:20044442 20191121 RGD compared to SS/Hsd; 629511 SS-Chr 2BN/Mcwi strain MP:0011517 hyperoxaluria induced IAGP XCO:0000649 N RGD:2313354|PMID:19493966 20090918 RGD compared with SS/JrHsdMcwi 629513 SS-Chr 4BN/Mcwi strain MP:0004876 decreased mean systemic arterial blood pressure sexual_dimorphism IAGP XCO:0000022 N RGD:2300225|PMID:18653478 20200122 RGD compared to female SS/JrHsdMcwi, male SS-Chr 4BN/Mcwi�� 629514 SS-Chr 6BN/Mcwi strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:2300225|PMID:18653478 20191212 RGD 629514 SS-Chr 6BN/Mcwi strain MP:0005540 decreased urine albumin level induced IAGP XCO:0000022 N RGD:2300225|PMID:18653478 20080910 RGD compared to male and female SS/JrHsdMcwi� 629514 SS-Chr 6BN/Mcwi strain MP:0008770 decreased survivor rate induced IAGP XCO:0000090 N RGD:4143380|PMID:20737482 20191211 RGD compared to SS/JrHsdMcwi 629514 SS-Chr 6BN/Mcwi strain MP:0009766 increased susceptibility to xenobiotic induced morbidity/mortality induced IAGP XCO:0000090 N RGD:4143380|PMID:20737482 20191211 RGD compared to SS/JrHsdMcwi 629515 SS-Chr 7BN/Mcwi strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:2300225|PMID:18653478 20080910 RGD compared to male SS/JrHsdMcwi 629515 SS-Chr 7BN/Mcwi strain MP:0005540 decreased urine albumin level induced IAGP XCO:0000022 N RGD:2300225|PMID:18653478 20080910 RGD compared to SS/JrHsdMcwi on 8% NaCl diet 629515 SS-Chr 7BN/Mcwi strain MP:0011517 hyperoxaluria induced IAGP XCO:0000649 N RGD:2313354|PMID:19493966 20090918 RGD compared with SS/JrHsdMcwi 629516 SS-Chr 8BN/Mcwi strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:2300225|PMID:18653478 20080910 RGD compared to male SS/JrHsdMcwi 629516 SS-Chr 8BN/Mcwi strain MP:0005540 decreased urine albumin level induced IAGP XCO:0000022 N RGD:2300225|PMID:18653478 20080910 RGD compared to SS/JrHsdMcwi 629517 SS-Chr YBN/Mcwi strain MP:0005540 decreased urine albumin level induced IAGP XCO:0000022 N RGD:2300225|PMID:18653478 20080910 RGD compared to male SS/JrHsdMcwi 629518 SS-Chr 9BN/Mcwi strain MP:0005540 decreased urine albumin level sexual_dimorphism IAGP XCO:0000022 N RGD:2300225|PMID:18653478 20200122 RGD compared to male SS-Chr 9BN/Mcwi, female SS/JrHsdMCWi 629518 SS-Chr 9BN/Mcwi strain MP:0010308 decreased tumor latency induced IAGP XCO:0000090 N RGD:4143380|PMID:20737482 20191211 RGD compared to SS/JrHsdMcwi 629520 FHH-Chr 1BN/Mcwi strain MP:0002963 decreased urine protein level IAGP N RGD:1579884|PMID:16303858 20200117 RGD compared to FHH/EurMcwi 629520 FHH-Chr 1BN/Mcwi strain MP:0004876 decreased mean systemic arterial blood pressure IAGP N RGD:1579884|PMID:16303858 20200117 RGD compared to FHH/EurMcwi 629520 FHH-Chr 1BN/Mcwi strain MP:0031183 decreased cerebral blood flow rate induced IMP XCO:0000466 N RGD:13446412|PMID:25397684 20201221 RGD compared to FHH.1BN 629521 SS-Chr 11BN/Mcwi strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:2300225|PMID:18653478 20191212 RGD 629521 SS-Chr 11BN/Mcwi strain MP:0005540 decreased urine albumin level induced IAGP XCO:0000022 N RGD:2300225|PMID:18653478 20080910 RGD compared to SS/JrHsdMcwi 629522 SS-Chr 20BN/Mcwi strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:2300225|PMID:18653478 20080910 RGD compared to male SS/JrHsdMcwi 629522 SS-Chr 20BN/Mcwi strain MP:0005540 decreased urine albumin level induced IAGP XCO:0000022 N RGD:2300225|PMID:18653478 20191212 RGD compared to female SS/JrHsdMcwi 629523 SS-Chr 13BN/Mcwi strain MP:0001883 increased mammary adenocarcinoma incidence induced IAGP XCO:0000090 N RGD:4143380|PMID:20737482 20191211 RGD compared to SS/JrHsdMcwi 629523 SS-Chr 13BN/Mcwi strain MP:0002963 decreased urine protein level induced IAGP XCO:0000022 N RGD:12798539|PMID:21257920 20170324 RGD compared to SS/JrHsdMcwi 629523 SS-Chr 13BN/Mcwi strain MP:0003352 increased circulating renin level IAGP N RGD:2289092|PMID:18198281 20080515 RGD compared to SS/JrHsdMcwi 629523 SS-Chr 13BN/Mcwi strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:12798539|PMID:21257920 20170324 RGD compared to SS/JrHsdMcwi 629523 SS-Chr 13BN/Mcwi strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:2289092|PMID:18198281 20191213 RGD compared to male SS/JrHsdMcwi 629523 SS-Chr 13BN/Mcwi strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000645 N RGD:1626639|PMID:17589973 20070816 RGD compared to SS/JrHsdMcwi, higher infusion of anesthetic propofol 629523 SS-Chr 13BN/Mcwi strain MP:0004876 decreased mean systemic arterial blood pressure sexual_dimorphism IAGP XCO:0000022 N RGD:2300225|PMID:18653478 20080910 RGD compared to male SS/JrHsdMcwi 629523 SS-Chr 13BN/Mcwi strain MP:0005540 decreased urine albumin level induced IAGP XCO:0000022 N RGD:2300225|PMID:18653478 20080910 RGD compared to SS/JrHsdMcwi 629523 SS-Chr 13BN/Mcwi strain MP:0005601 increased angiogenesis induced IAGP XCO:0000522 N RGD:2289092|PMID:18198281 20080514 RGD compared to SS/JrHsdMcwi 629524 SS-Chr 16BN/Mcwi strain MP:0001883 increased mammary adenocarcinoma incidence induced IAGP XCO:0000090 N RGD:4143380|PMID:20737482 20101025 RGD compared to SS/JrHsdMcwi 629524 SS-Chr 16BN/Mcwi strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:2300225|PMID:18653478 20080910 RGD compared to male SS/JrHsdMcwi 629524 SS-Chr 16BN/Mcwi strain MP:0004876 decreased mean systemic arterial blood pressure sexual_dimorphism IAGP XCO:0000022 N RGD:2300225|PMID:18653478 20191212 RGD in female 629524 SS-Chr 16BN/Mcwi strain MP:0005330 cardiomyopathy IAGP N RGD:1598977|PMID:17204904 20070117 RGD 629524 SS-Chr 16BN/Mcwi strain MP:0005540 decreased urine albumin level induced IAGP XCO:0000022 N RGD:2300225|PMID:18653478 20191212 RGD compared to SS/JrHsdMcwi 629524 SS-Chr 16BN/Mcwi strain MP:0005540 decreased urine albumin level sexual_dimorphism IAGP XCO:0000022 N RGD:2300225|PMID:18653478 20191212 RGD in female 629525 SS-Chr 18BN/Mcwi strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:2300225|PMID:18653478 20080910 RGD compared to male SS/JrHsdMcwi 629525 SS-Chr 18BN/Mcwi strain MP:0005540 decreased urine albumin level induced IAGP XCO:0000022 N RGD:2300225|PMID:18653478 20080910 RGD compared to SS/JrHsdMcwi 629525 SS-Chr 18BN/Mcwi strain MP:0011517 hyperoxaluria induced IAGP XCO:0000649 N RGD:2313354|PMID:19493966 20090918 RGD compared with SS/JrHsdMcwi 629578 SS.LEW-(D5Rat130-D5Mco10)/Jr strain MP:0002843 decreased systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:619649|PMID:11875185 19990101 RGD compared to SS/Jr 631158 DXE1/Ztm strain MP:0002993 autoimmune arthritis severity IAGP XCO:0000263 N RGD:629570|PMID:11090241 20191121 RGD compared to control strain E3/ZtmRhd 631158 DXE1/Ztm strain MP:0003724 increased susceptibility to induced arthritis severity IAGP XCO:0000263 N RGD:629570|PMID:11090241 20191121 RGD compared to control strain E3/ZtmRhd 631160 DXE2/Ztm strain MP:0003561 rheumatoid arthritis severity IAGP XCO:0000263 N RGD:629570|PMID:11090241 20191121 RGD compared to control strain E3/ZtmRhd 631160 DXE2/Ztm strain MP:0003724 increased susceptibility to induced arthritis severity IAGP XCO:0000263 N RGD:629570|PMID:11090241 20191121 RGD compared to control strain E3/ZtmRhd 631161 DXE3/Ztm strain MP:0003436 decreased susceptibility to induced arthritis resistance IAGP XCO:0000263 N RGD:629570|PMID:11090241 20191121 RGD compared to induced strain DA/Ztm 631182 DA/BklArbN strain MP:0002993 autoimmune arthritis induced IAGP XCO:0000281 N RGD:631168|PMID:11003387 20200720 RGD 631182 DA/BklArbN strain MP:0003561 rheumatoid arthritis induced IAGP XCO:0000281|XCO:0000263|XCO:0000265 N RGD:629569|PMID:12209529 20200720 RGD 631198 Cm22 Cardiac mass QTL 22 qtl MP:0002625 heart left ventricle hypertrophy IAGP N RGD:61484|PMID:9495256 19990101 RGD 631199 Cm23 Cardiac mass QTL 23 qtl MP:0002625 heart left ventricle hypertrophy IAGP N RGD:61484|PMID:9495256 19990101 RGD 631200 Cm25 Cardiac mass QTL 25 qtl MP:0002625 heart left ventricle hypertrophy QTM N RGD:69706|PMID:10205229 19990101 RGD 631201 Panci1 Pancreas inflammation QTL 1 qtl MP:0001260 increased body weight QTM N RGD:619682|PMID:11414764 19990101 RGD 631201 Panci1 Pancreas inflammation QTL 1 qtl MP:0001869 pancreas inflammation QTM N RGD:619682|PMID:11414764 19990101 RGD 631202 Gluco13 Glucose level QTL 13 qtl MP:0001260 increased body weight QTM N RGD:631173|PMID:12705906 19990101 RGD 631202 Gluco13 Glucose level QTL 13 qtl MP:0005293 impaired glucose tolerance QTM N RGD:631173|PMID:12705906 19990101 RGD 631203 Gluco14 Glucose level QTL 14 qtl MP:0005293 impaired glucose tolerance QTM N RGD:631173|PMID:12705906 19990101 RGD 631204 Gluco15 Glucose level QTL 15 qtl MP:0005293 impaired glucose tolerance QTM N RGD:631173|PMID:12705906 19990101 RGD 631205 Bp196 Blood pressure QTL 196 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:61484|PMID:9495256 19990101 RGD 631206 Niddm40 Non-insulin dependent diabetes mellitus QTL 40 qtl MP:0005293 impaired glucose tolerance IDA N RGD:619671|PMID:10902185 19990101 RGD 631207 Niddm41 Non-insulin dependent diabetes mellitus QTL 41 qtl MP:0005293 impaired glucose tolerance IDA N RGD:619671|PMID:10902185 19990101 RGD 631208 Bw1 Body weight QTL1 qtl MP:0000010 abnormal abdominal fat pad morphology QTM N RGD:619690|PMID:11087657 19990101 RGD 631209 Bw2 Body weight QTL2 qtl MP:0005337 abnormal retroperitoneal fat pad morphology QTM N RGD:619690|PMID:11087657 19990101 RGD 631210 Bw3 Body weight QTL3 qtl MP:0000010 abnormal abdominal fat pad morphology QTM N RGD:619690|PMID:11087657 19990101 RGD 631211 Bw4 Body weight QTL4 qtl MP:0005337 abnormal retroperitoneal fat pad morphology QTM N RGD:619690|PMID:11087657 19990101 RGD 631212 Bw5 Body weight QTL5 qtl MP:0005337 abnormal retroperitoneal fat pad morphology QTM N RGD:619690|PMID:11087657 19990101 RGD 631213 Bw60 Body weight QTL60 qtl MP:0005337 abnormal retroperitoneal fat pad morphology QTM N RGD:619690|PMID:11087657 19990101 RGD 631214 Bw61 Body weight QTL61 qtl MP:0000013 abnormal adipose tissue distribution QTM N RGD:619672|PMID:11853145 19990101 RGD 631215 Stl8 Serum triglyceride level QTL 8 qtl MP:0001552 increased circulating triglyceride level QTM N RGD:70852|PMID:10644432 19990101 RGD 631216 Stl9 Serum triglyceride level QTL 9 qtl MP:0001552 increased circulating triglyceride level QTM N RGD:70852|PMID:10644432 19990101 RGD 631217 Activ1 Activity QTL 1 qtl MP:0001399 hyperactivity QTM N RGD:631170|PMID:8944030 19990101 RGD 631217 Activ1 Activity QTL 1 qtl MP:0001415 increased exploration in new environment QTM N RGD:631228|PMID:12660808 19990101 RGD 631219 SDT/Jcl strain MP:0000187 abnormal triglyceride level IAGP N RGD:628479|PMID:11469401 20180125 RGD 631219 SDT/Jcl strain MP:0001262 decreased body weight IAGP N RGD:2298688|PMID:18612083 20200130 RGD 631219 SDT/Jcl strain MP:0001262 decreased body weight IAGP N RGD:628479|PMID:11469401 19990101 RGD compared to Crj:CD(SD) controls, sexual dimorphism 631219 SDT/Jcl strain MP:0001304 cataract IAGP N RGD:628479|PMID:11469401 19990101 RGD 631219 SDT/Jcl strain MP:0001426 polydipsia IAGP N RGD:628479|PMID:11469401 20180125 RGD associated with diabetes mellitus 631219 SDT/Jcl strain MP:0001433 polyphagia IAGP N RGD:628479|PMID:11469401 20180125 RGD associated with diabetes mellitus 631219 SDT/Jcl strain MP:0001559 hyperglycemia IAGP N RGD:2298688|PMID:18612083 20180404 RGD 631219 SDT/Jcl strain MP:0001559 hyperglycemia IAGP N RGD:631173|PMID:12705906 19990101 RGD 631219 SDT/Jcl strain MP:0001759 increased urine glucose level IAGP N RGD:628479|PMID:11469401 20180125 RGD 631219 SDT/Jcl strain MP:0001762 polyuria IAGP N RGD:628479|PMID:11469401 20180125 RGD associated with diabetes mellitus 631219 SDT/Jcl strain MP:0001869 pancreas inflammation IAGP N RGD:2298688|PMID:18612083 20200130 RGD 631219 SDT/Jcl strain MP:0001944 abnormal pancreas morphology IAGP N RGD:628479|PMID:11469401 19990101 RGD 631219 SDT/Jcl strain MP:0002727 decreased circulating insulin level IAGP N RGD:628479|PMID:11469401 19990101 RGD 631219 SDT/Jcl strain MP:0002840 abnormal lens fiber morphology IAGP N RGD:628479|PMID:11469401 20200130 RGD 631219 SDT/Jcl strain MP:0002901 increased urine phosphate level induced IAGP XCO:0000018, XCO:0000547 N RGD:12914778|PMID:28674323 20170712 RGD 631219 SDT/Jcl strain MP:0002904 increased circulating parathyroid hormone level induced IAGP XCO:0000018,XCO:0000547 N RGD:12914778|PMID:28674323 20201006 RGD 631219 SDT/Jcl strain MP:0003334 pancreas fibrosis IAGP N RGD:2298688|PMID:18612083 20200130 RGD 631219 SDT/Jcl strain MP:0003334 pancreas fibrosis IAGP N RGD:628479|PMID:11469401 19990101 RGD 631219 SDT/Jcl strain MP:0005293 impaired glucose tolerance IAGP N RGD:2298688|PMID:18612083 20200130 RGD 631219 SDT/Jcl strain MP:0005293 impaired glucose tolerance IAGP N RGD:628479|PMID:11469401 19990101 RGD 631219 SDT/Jcl strain MP:0005293 impaired glucose tolerance IAGP N RGD:631173|PMID:12705906 20200130 RGD 631219 SDT/Jcl strain MP:0005441 increased urine calcium level induced IAGP XCO:0000018, XCO:0000547 N RGD:12914778|PMID:28674323 20170712 RGD 631219 SDT/Jcl strain MP:0005559 increased circulating glucose level IAGP N RGD:2314024|PMID:18421173 20200324 RGD compared to Sprague Dawley rats 631219 SDT/Jcl strain MP:0005559 increased circulating glucose level IAGP N RGD:628479|PMID:11469401 19990101 RGD 631219 SDT/Jcl strain MP:0005559 increased circulating glucose level IAGP N RGD:631173|PMID:12705906 19990101 RGD 631219 SDT/Jcl strain MP:0009168 decreased pancreatic islet number IAGP N RGD:628479|PMID:11469401 20081208 RGD 631260 Tcas2 Tongue tumor susceptibility QTL 2 qtl MP:0010272 increased tongue tumor incidence IDA N RGD:631169|PMID:12448007 20111115 RGD 631261 Tcas3 Tongue tumor susceptibility QTL 3 qtl MP:0010272 increased tongue tumor incidence IDA N RGD:631169|PMID:12448007 20111115 RGD 631262 Tcas4 Tongue tumor susceptibility QTL 4 qtl MP:0010272 increased tongue tumor incidence IDA N RGD:631169|PMID:12448007 20111115 RGD 631263 Cm24 Cardiac mass QTL 24 qtl MP:0002625 heart left ventricle hypertrophy QTM N RGD:619659|PMID:11157676 19990101 RGD 631264 Scl22 Serum cholesterol level QTL 22 qtl MP:0005178 increased circulating cholesterol level QTM N RGD:61055|PMID:9199194 19990101 RGD 631265 Iresp1 Immunoglobin response QTL1 qtl MP:0005613 increased susceptibility to type II hypersensitivity reaction QTM N RGD:619646|PMID:10898507 19990101 RGD 631266 Bp132 Blood pressure QTL 132 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:619621|PMID:10406815 19990101 RGD 631266 Bp132 Blood pressure QTL 132 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:68910|PMID:10642295 19990101 RGD 631267 Cia20 Collagen induced arthritis QTL 20 qtl MP:0002936 joint swelling QTM N RGD:631168|PMID:11003387 19990101 RGD 631268 Cia21 Collagen induced arthritis QTL 21 qtl MP:0002936 joint swelling QTM N RGD:631168|PMID:11003387 19990101 RGD 631269 Cia22 Collagen induced arthritis QTL 22 qtl MP:0002936 joint swelling QTM N RGD:631168|PMID:11003387 19990101 RGD 631270 Cia23 Collagen induced arthritis QTL 23 qtl MP:0002936 joint swelling QTM N RGD:631168|PMID:11003387 19990101 RGD 631271 Lecl1 Lens clarity QTL 1 qtl MP:0001314 cornea opacity QTM N RGD:68701|PMID:11252169 19990101 RGD 631272 Lanf1 Left ventricular atrial natriuretic factor QTL 1 qtl MP:0005522 increased circulating atrial natriuretic factor QTM N RGD:619659|PMID:11157676 19990101 RGD 631273 Lecl2 Lens clarity QTL 2 qtl MP:0001314 cornea opacity QTM N RGD:68701|PMID:11252169 19990101 RGD 631274 Sprol1 Serum protein level QTL 1 qtl MP:0005568 increased circulating total protein level QTM N RGD:61055|PMID:9199194 19990101 RGD 631278 SHRSP.WKY-(D2Rat13-D2Rat157)/Gcrc strain MP:0004875 increased mean systemic arterial blood pressure sexual_dimorphism IAGP N RGD:68910|PMID:10642295 20200415 RGD compared to WKY/Gcrc 631278 SHRSP.WKY-(D2Rat13-D2Rat157)/Gcrc strain MP:0006143 increased systemic arterial diastolic blood pressure sexual_dimorphism IAGP N RGD:68910|PMID:10642295 20200415 RGD compared to WKY/Gcrc 631278 SHRSP.WKY-(D2Rat13-D2Rat157)/Gcrc strain MP:0006144 increased systemic arterial systolic blood pressure sexual_dimorphism IAGP N RGD:68910|PMID:10642295 20200415 RGD compared to WKY/Gcrc 631278 SHRSP.WKY-(D2Rat13-D2Rat157)/Gcrc strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:1643008|PMID:17938382 20081009 RGD compared to SHRSP/Gcrc 631278 SHRSP.WKY-(D2Rat13-D2Rat157)/Gcrc strain MP:0006264 decreased systemic arterial systolic blood pressure induced IAGP XCO:0000164 N RGD:2301356|PMID:18819818 20200109 RGD compared to SHRSP/Gcrc; MMO:0000015 631278 SHRSP.WKY-(D2Rat13-D2Rat157)/Gcrc strain MP:0006264 decreased systemic arterial systolic blood pressure susceptibility IAGP N RGD:68910|PMID:10642295 20191205 RGD compared to spontaneously hypertensive strain SHRSP/Gcrc 631278 SHRSP.WKY-(D2Rat13-D2Rat157)/Gcrc strain MP:0006264 decreased systemic arterial systolic blood pressure susceptibility IAGP XCO:0000164 N RGD:1643008|PMID:17938382 20081009 RGD as compared to SHRSP/Gcrc 631278 SHRSP.WKY-(D2Rat13-D2Rat157)/Gcrc strain MP:0006266 decreased pulse pressure IAGP N RGD:7401270|PMID:23648703 20131118 RGD as compared to parental SHRSP/Gcrc 631278 SHRSP.WKY-(D2Rat13-D2Rat157)/Gcrc strain MP:0010757 decreased right ventricle diastolic pressure IAGP N RGD:7401270|PMID:23648703 20131118 RGD at normal salt and 1% salt diet 631278 SHRSP.WKY-(D2Rat13-D2Rat157)/Gcrc strain MP:0010759 decreased right ventricle systolic pressure IAGP N RGD:7401270|PMID:23648703 20131118 RGD at normal salt and 1% salt diet 631278 SHRSP.WKY-(D2Rat13-D2Rat157)/Gcrc strain MP:0012046 decreased susceptibility to hypertension susceptibility IAGP N RGD:1643008|PMID:17938382 20191210 RGD compared to hypertensive strain SHRSP/Gcrc 631278 SHRSP.WKY-(D2Rat13-D2Rat157)/Gcrc strain MP:0012046 decreased susceptibility to hypertension susceptibility IAGP N RGD:68910|PMID:10642295 20191205 RGD compared to spontaneously hypertensive strain SHRSP/Gcrc 631279 SHRSP.WKY-(D2Rat13-D2Mit5)/Gcrc strain MP:0000231 hypertension susceptibility IAGP XCO:0000164 N RGD:2301356|PMID:18819818 20200109 RGD similar to SHRSP/Gcrc 631279 SHRSP.WKY-(D2Rat13-D2Mit5)/Gcrc strain MP:0004217 salt-sensitive hypertension sexual_dimorphism IAGP N RGD:68910|PMID:10642295 20200415 RGD 631279 SHRSP.WKY-(D2Rat13-D2Mit5)/Gcrc strain MP:0004217 salt-sensitive hypertension susceptibility IAGP XCO:0000164 N RGD:68910|PMID:10642295 20191205 RGD compared to control strain WKY/Gcrc 631279 SHRSP.WKY-(D2Rat13-D2Mit5)/Gcrc strain MP:0012045 increased susceptibility to hypertension sexual_dimorphism IAGP N RGD:68910|PMID:10642295 20200415 RGD 631279 SHRSP.WKY-(D2Rat13-D2Mit5)/Gcrc strain MP:0012045 increased susceptibility to hypertension susceptibility IAGP N RGD:68910|PMID:10642295 20191205 RGD compared to control strain WKY/Gcrc 631280 WKY.SHRSP-(D2Mit5-D2Mgh12)/Gcrc strain MP:0002842 increased systemic arterial blood pressure IAGP N RGD:68910|PMID:10642295 19990101 RGD 631280 WKY.SHRSP-(D2Mit5-D2Mgh12)/Gcrc strain MP:0002842 increased systemic arterial blood pressure IAGP N RGD:728179|PMID:11980293 20201027 RGD 631280 WKY.SHRSP-(D2Mit5-D2Mgh12)/Gcrc strain MP:0004216 salt-resistant hypertension IAGP XCO:0000164 N RGD:68910|PMID:10642295 20191205 RGD compared to spontaneously hypertensive strain SHRSP/Gcrc 631280 WKY.SHRSP-(D2Mit5-D2Mgh12)/Gcrc strain MP:0006144 increased systemic arterial systolic blood pressure susceptibility IAGP N RGD:68910|PMID:10642295 20191205 RGD compared to control strain WKY/Gcrc 631280 WKY.SHRSP-(D2Mit5-D2Mgh12)/Gcrc strain MP:0012045 increased susceptibility to hypertension susceptibility IAGP N RGD:68910|PMID:10642295 20191205 RGD compared to control strain WKY/Gcrc 631281 WKY.SHRSP-(Fst-Pklr)/Gcrc strain MP:0002843 decreased systemic arterial blood pressure IAGP N RGD:68910|PMID:10642295 19990101 RGD 631281 WKY.SHRSP-(Fst-Pklr)/Gcrc strain MP:0012046 decreased susceptibility to hypertension susceptibility IAGP N RGD:68910|PMID:10642295 20191205 RGD compared to spontaneously hypertensive strain SHRSP/Gcrc 631282 DA.F344-(D10Arb20-D10Arb22)/Arb strain MP:0002933 joint inflammation IAGP N RGD:1359065|PMID:15944295 20070214 RGD 631282 DA.F344-(D10Arb20-D10Arb22)/Arb strain MP:0002936 joint swelling IAGP N RGD:1359065|PMID:15944295 20070214 RGD 631282 DA.F344-(D10Arb20-D10Arb22)/Arb strain MP:0002993 autoimmune arthritis induced IAGP XCO:0000281 N RGD:631168|PMID:11003387 20200720 RGD 631282 DA.F344-(D10Arb20-D10Arb22)/Arb strain MP:0003561 rheumatoid arthritis induced IAGP XCO:0000281|XCO:0000263 N RGD:629569|PMID:12209529 20200720 RGD 631282 DA.F344-(D10Arb20-D10Arb22)/Arb strain MP:0003561 rheumatoid arthritis penetrance IAGP XCO:0000265 N RGD:629569|PMID:12209529 20200720 RGD 631283 DA.F344-(D10Arb21-D10Arb22)/Arb strain MP:0002993 autoimmune arthritis induced IAGP XCO:0000281 N RGD:631168|PMID:11003387 20200720 RGD 631286 WKY/Izm Wistar-Kyoto strain MP:0004052 decreased renal sympathetic nerve activity induced IAGP XCO:0000337 N RGD:1578503|PMID:16239369 20191209 RGD compared to hypertensive strain SHRSP/Izm 631286 WKY/Izm Wistar-Kyoto strain MP:0004876 decreased mean systemic arterial blood pressure susceptibility IAGP N RGD:1578503|PMID:16239369 20191209 RGD compared to hypertensive strain SHRSP/Izm 631286 WKY/Izm Wistar-Kyoto strain MP:0005178 increased circulating cholesterol level sexual_dimorphism IAGP N RGD:61092|PMID:10634822 19990101 RGD compared to male WKY/Izm 631286 WKY/Izm Wistar-Kyoto strain MP:0005293 impaired glucose tolerance IAGP N RGD:730283|PMID:14623828 20191206 RGD compared to SHRSP/Izm, MMO:0000326 631286 WKY/Izm Wistar-Kyoto strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:730283|PMID:14623828 20191206 RGD compared to SHRSP/Izm 631286 WKY/Izm Wistar-Kyoto strain MP:0012046 decreased susceptibility to hypertension IAGP N RGD:730283|PMID:14623828 20191206 RGD compared to SHRSP/Izm 631286 WKY/Izm Wistar-Kyoto strain MP:0012046 decreased susceptibility to hypertension susceptibility IAGP N RGD:1578503|PMID:16239369 20191209 RGD compared to hypertensive strain SHRSP/Izm 631286 WKY/Izm Wistar-Kyoto strain MP:0012574 decreased noradrenaline level induced IAGP XCO:0000373 N RGD:2296063|PMID:16445571 20200203 RGD compared to sham surgery 631286 WKY/Izm Wistar-Kyoto strain MP:0030769 decreased urine dopamine level susceptibility IAGP N RGD:1302892|PMID:15480093 20200110 RGD compared to SHRSP/Izm 631286 WKY/Izm Wistar-Kyoto strain MP:0030771 decreased urine adrenaline level susceptibility IAGP N RGD:1302892|PMID:15480093 20200110 RGD compared to SHRSP/Izm 631286 WKY/Izm Wistar-Kyoto strain MP:0030773 decreased urine noradrenaline level susceptibility IAGP N RGD:1302892|PMID:15480093 20200110 RGD compared to SHRSP/Izm 631294 F344.GK-(D1Arb42a-D1Rat90)/Swe strain MP:0001260 increased body weight IAGP N RGD:619677|PMID:10580437 20200429 RGD compared t F344/DuCrlSwe 631294 F344.GK-(D1Arb42a-D1Rat90)/Swe strain MP:0001552 increased circulating triglyceride level IAGP N RGD:619677|PMID:10580437 20200429 RGD compared t F344/DuCrlSwe 631294 F344.GK-(D1Arb42a-D1Rat90)/Swe strain MP:0001556 increased circulating HDL cholesterol level IAGP N RGD:619677|PMID:10580437 20180129 RGD compared to F344/DuCrlSwe 631294 F344.GK-(D1Arb42a-D1Rat90)/Swe strain MP:0002078 abnormal glucose homeostasis IAGP N RGD:1599587|PMID:16951059 20200319 RGD compared to F344/DuCrlSwe 631294 F344.GK-(D1Arb42a-D1Rat90)/Swe strain MP:0002079 increased circulating insulin level IAGP N RGD:619677|PMID:10580437 20200429 RGD compared t F344/DuCrlSwe 631294 F344.GK-(D1Arb42a-D1Rat90)/Swe strain MP:0002727 decreased circulating insulin level IAGP N RGD:1599587|PMID:16951059 20200319 RGD compared to F344/DuCrlSwe 631294 F344.GK-(D1Arb42a-D1Rat90)/Swe strain MP:0005293 impaired glucose tolerance IAGP N RGD:1599587|PMID:16951059 20070226 RGD compared to F344/DuCrlSwe 631294 F344.GK-(D1Arb42a-D1Rat90)/Swe strain MP:0005559 increased circulating glucose level IAGP N RGD:1599587|PMID:16951059 20070226 RGD compared to F344/DuCrlSwe 631294 F344.GK-(D1Arb42a-D1Rat90)/Swe strain MP:0005559 increased circulating glucose level IAGP N RGD:619677|PMID:10580437 20200429 RGD compared t F344/DuCrlSwe 631294 F344.GK-(D1Arb42a-D1Rat90)/Swe strain MP:0009288 increased epididymal fat pad weight IAGP N RGD:619677|PMID:10580437 20200429 RGD compared t F344/DuCrlSwe 631338 Rcan1 regulator of calcineurin 1 gene MP:0001625 cardiac hypertrophy IDA N RGD:1581475|PMID:15899894 20061017 RGD 631345 Abcg2 ATP binding cassette subfamily G member 2 gene MP:0008875 abnormal xenobiotic pharmacokinetics IMP N RGD:14392811|PMID:22711747 20210916 RGD 631375 Egln1 egl-9 family hypoxia-inducible factor 1 gene MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:11251783|PMID:20231529 20160622 RGD DNA:duplication 631494 Bp95 Blood pressure QTL 95 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:68885|PMID:11160999 19990101 RGD 631495 Bp96 Blood pressure QTL 96 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:619642|PMID:9449402 19990101 RGD 631496 Bp97 Blood pressure QTL 97 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:619642|PMID:9449402 19990101 RGD 631497 Bp98 Blood pressure QTL 98 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:619642|PMID:9449402 19990101 RGD 631498 Bp100 Blood pressure QTL 100 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:619655|PMID:9171954 19990101 RGD 631499 Stl1 Serum triglyceride level QTL 1 qtl MP:0001552 increased circulating triglyceride level IAGP N RGD:619656|PMID:11414700 19990101 RGD compared to Wild/K strain 631500 Bp99 Blood pressure QTL 99 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:619650|PMID:7852741 19990101 RGD 631501 Bp101 Blood pressure QTL 101 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:619656|PMID:11414700 19990101 RGD compared to Wild/K strain 631502 Cm26 Cardiac mass QTL 26 qtl MP:0002625 heart left ventricle hypertrophy IAGP N RGD:619658|PMID:11045938 19990101 RGD 631503 Bp102 Blood pressure QTL 102 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:619656|PMID:11414700 19990101 RGD compared to Wild/K strain 631504 Cm27 Cardiac mass QTL 27 qtl MP:0002625 heart left ventricle hypertrophy IAGP N RGD:619658|PMID:11045938 19990101 RGD 631504 Cm27 Cardiac mass QTL 27 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:619658|PMID:11045938 19990101 RGD 631505 Bp103 Blood pressure QTL 103 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:619656|PMID:11414700 19990101 RGD compared to Wild/K strain 631506 Bp104 Blood pressure QTL 104 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:619656|PMID:11414700 19990101 RGD compared to Wild/K strain 631507 Bp105 Blood pressure QTL 105 qtl MP:0001625 cardiac hypertrophy IAGP N RGD:619651|PMID:11403354 19990101 RGD 631507 Bp105 Blood pressure QTL 105 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:619651|PMID:11403354 19990101 RGD 631508 Sald1 Serum aldosterone level QTL 1 qtl MP:0002666 increased circulating aldosterone level QTM N RGD:629577|PMID:12482837 19990101 RGD 631509 Sald2 Serum aldosterone level QTL 2 qtl MP:0002666 increased circulating aldosterone level QTM N RGD:629577|PMID:12482837 19990101 RGD 631510 Spl2 Serum phospholipid level QTL 2 qtl MP:0001548 hyperlipidemia QTM N RGD:629577|PMID:12482837 19990101 RGD 631511 Pia7 Pristane induced arthritis QTL 7 qtl MP:0002933 joint inflammation IAGP N RGD:629560|PMID:12571866 19990101 RGD 631512 Scl6 Serum cholesterol level QTL 6 qtl MP:0005178 increased circulating cholesterol level QTM N RGD:629577|PMID:12482837 19990101 RGD 631513 Scl7 Serum cholesterol level QTL 7 qtl MP:0005178 increased circulating cholesterol level QTM N RGD:629577|PMID:12482837 19990101 RGD 631514 Scl8 Serum cholesterol level QTL8 qtl MP:0005178 increased circulating cholesterol level QTM N RGD:629577|PMID:12482837 19990101 RGD 631515 Bw10 Body weight QTL 10 qtl MP:0001260 increased body weight IAGP N RGD:619656|PMID:11414700 19990101 RGD compared to Wild/K strain 631516 Gluco31 Glucose level QTL 31 qtl MP:0005559 increased circulating glucose level IAGP N RGD:619656|PMID:11414700 19990101 RGD compared to Wild/K strain 631517 Scl9 Serum cholesterol level QTL 9 qtl MP:0005178 increased circulating cholesterol level QTM N RGD:629577|PMID:12482837 19990101 RGD 631518 Bw11 Body weight QTL 11 qtl MP:0001260 increased body weight IAGP N RGD:619656|PMID:11414700 19990101 RGD compared to Wild/K strain 631519 Pia11 Pristane induced arthritis QTL 11 qtl MP:0002936 joint swelling IAGP N RGD:631225|PMID:12111642 19990101 RGD 631520 Bp73 Blood pressure QTL 73 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:631320|PMID:12661916 19990101 RGD 631520 Bp73 Blood pressure QTL 73 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:70380|PMID:11773968 19990101 RGD 631521 Pia12 Pristane induced arthritis QTL 12 qtl MP:0002936 joint swelling IAGP N RGD:631225|PMID:12111642 19990101 RGD 631522 Bp74 Blood pressure QTL 74 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:70380|PMID:11773968 19990101 RGD 631523 Pia13 Pristane induced arthritis QTL 13 qtl MP:0002936 joint swelling IAGP N RGD:631225|PMID:12111642 19990101 RGD 631524 Bp75 Blood pressure QTL 75 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:70460|PMID:11919686 19990101 RGD 631525 Pia14 Pristane induced arthritis QTL 14 qtl MP:0002936 joint swelling IAGP N RGD:631225|PMID:12111642 19990101 RGD 631526 Bp76 Blood pressure QTL 76 qtl MP:0002843 decreased systemic arterial blood pressure QTM N RGD:619625|PMID:9607182 19990101 RGD 631526 Bp76 Blood pressure QTL 76 qtl MP:0002843 decreased systemic arterial blood pressure QTM N RGD:619626|PMID:9096100 19990101 RGD 631527 Tls1 T-lymphoma susceptibility QTL 1 qtl MP:0002024 increased T cell derived lymphoma incidence IAGP N RGD:619600|PMID:10360666 19990101 RGD 631528 Scl11 Serum cholesterol level QTL 11 qtl MP:0005178 increased circulating cholesterol level IAGP N RGD:619656|PMID:11414700 19990101 RGD compared to Wild/K strain 631529 Tls2 T-lymphoma susceptibility QTL 2 qtl MP:0002024 increased T cell derived lymphoma incidence IAGP N RGD:619600|PMID:10360666 19990101 RGD 631530 Tls3 T-lymphoma susceptibility QTL 3 qtl MP:0002024 increased T cell derived lymphoma incidence IAGP N RGD:619600|PMID:10360666 19990101 RGD 631531 Iresp2 Immunoglobin response QTL2 qtl MP:0002497 increased IgE level QTM N RGD:619646|PMID:10898507 19990101 RGD 631532 Cm50 Cardiac mass QTL 50 qtl MP:0002833 increased heart weight QTM N RGD:619631|PMID:10051321 19990101 RGD 631533 Iresp3 Immunoglobin response QTL3 qtl MP:0002497 increased IgE level QTM N RGD:619646|PMID:10898507 19990101 RGD 631534 Lnnr1 Liver neoplastic nodule remodeling QTL 1 qtl MP:0010266 decreased liver tumor incidence IDA N RGD:629574|PMID:12672032 20111107 RGD 631535 Cm51 Cardiac mass QTL 51 qtl MP:0002833 increased heart weight QTM N RGD:619631|PMID:10051321 19990101 RGD 631536 Lnnr2 Liver neoplastic nodule remodeling QTL 2 qtl MP:0010266 decreased liver tumor incidence IDA N RGD:629574|PMID:12672032 20111107 RGD 631537 Oia4 Oil induced arthritis QTL 4 qtl MP:0002936 joint swelling QTM N RGD:62404|PMID:11230175 19990101 RGD 631538 Oia5 Oil induced arthritis QTL 5 qtl MP:0002936 joint swelling QTM N RGD:62404|PMID:11230175 19990101 RGD 631539 Oia6 Oil induced arthritis QTL 6 qtl MP:0002936 joint swelling QTM N RGD:62404|PMID:11230175 19990101 RGD 631540 Bw9 Body weight QTL 9 qtl MP:0001260 increased body weight QTM N RGD:619631|PMID:10051321 19990101 RGD 631541 Bp81 Blood pressure QTL 81 qtl MP:0002833 increased heart weight QTM N RGD:619631|PMID:10051321 19990101 RGD 631541 Bp81 Blood pressure QTL 81 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:619631|PMID:10051321 19990101 RGD 631542 Bp82 Blood pressure QTL 82 qtl MP:0002833 increased heart weight QTM N RGD:619631|PMID:10051321 19990101 RGD 631542 Bp82 Blood pressure QTL 82 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:619631|PMID:10051321 19990101 RGD 631543 Bp83 Blood pressure QTL 83 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:619631|PMID:10051321 19990101 RGD 631544 Bp84 Blood pressure QTL 84 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:619634|PMID:10604486 19990101 RGD 631544 Bp84 Blood pressure QTL 84 qtl MP:0004184 abnormal baroreceptor physiology TAS N RGD:2302408|PMID:19047583 20081217 RGD 631545 Bp85 Blood pressure QTL 85 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:619634|PMID:10604486 19990101 RGD 631546 Bp86 Blood pressure QTL 86 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:619634|PMID:10604486 19990101 RGD 631547 Bp87 Blood pressure QTL 87 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:619634|PMID:10604486 19990101 RGD 631548 Bp88 Blood pressure QTL 88 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:619643|PMID:10523340 19990101 RGD 631549 Bp89 Blood pressure QTL 89 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:619635|PMID:10779121 19990101 RGD 631550 Bw7 Body weight QTL 7 qtl MP:0001260 increased body weight QTM N RGD:629577|PMID:12482837 19990101 RGD 631551 Vetf1 Vascular elastic tissue fragility QTL 1 qtl MP:0005340 abnormal susceptibility to atherosclerosis QTM N RGD:619605|PMID:11526202 19990101 RGD 631552 Vetf2 Vascular elastic tissue fragility QTL 2 qtl MP:0005340 abnormal susceptibility to atherosclerosis QTM N RGD:619605|PMID:11526202 19990101 RGD 631554 Bp133 Blood pressure QTL 133 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:619633|PMID:7568016 19990101 RGD 631555 Bp134 Blood pressure QTL 134 qtl MP:0002842 increased systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:619633|PMID:7568016 19990101 RGD 631556 Bp135 Blood pressure QTL 135 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:631181|PMID:8476428 19990101 RGD 631557 Bp136 Blood pressure QTL 136 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:628510|PMID:11641286 19990101 RGD 631558 Bp137 Blood pressure QTL 137 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:628510|PMID:11641286 19990101 RGD 631559 Hcuc1 Hepatic copper content QTL 1 qtl MP:0003066 increased liver copper level QTM N RGD:619607|PMID:11741328 19990101 RGD 631560 Apr1 Acute phase response QTL 1 qtl MP:0010211 abnormal acute phase protein level IAGP N RGD:629561|PMID:11817600 19990101 RGD 631561 Hcuc2 Hepatic copper content QTL 2 qtl MP:0003066 increased liver copper level QTM N RGD:619607|PMID:11741328 19990101 RGD 631562 Apr2 Acute phase response QTL 2 qtl MP:0010211 abnormal acute phase protein level QTM N RGD:629561|PMID:11817600 19990101 RGD 631563 Hcuc3 Hepatic copper content QTL 3 qtl MP:0003066 increased liver copper level QTM N RGD:629572|PMID:12094018 19990101 RGD 631564 Apr3 Acute phase response QTL 3 qtl MP:0008595 abnormal circulating interleukin-6 level IDA N RGD:629561|PMID:11817600 20111101 RGD 631565 Hcuc4 Hepatic copper content QTL 4 qtl MP:0003066 increased liver copper level QTM N RGD:629572|PMID:12094018 19990101 RGD 631566 Bp90 Blood pressure QTL 90 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:619640|PMID:9541488 19990101 RGD 631567 Bp91 Blood pressure QTL 91 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:619640|PMID:9541488 19990101 RGD 631568 Bp92 Blood pressure QTL 92 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:61516|PMID:11015598 19990101 RGD 631569 Bp93 Blood pressure QTL 93 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:68885|PMID:11160999 19990101 RGD 631570 Bp94 Blood pressure QTL 94 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:68885|PMID:11160999 19990101 RGD 631571 SS.LEW-(D1Uia8-D1Mco38)/Jr strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP XCO:0000022 N RGD:68885|PMID:11160999 19990101 RGD compared to SS/Jr 631572 SBH/Ygl Sabra hypertension prone strain MP:0002743 glomerulonephritis IAGP N RGD:629619|PMID:12045297 20200813 RGD compared to SBN/Ygl 631572 SBH/Ygl Sabra hypertension prone strain MP:0002743 glomerulonephritis severity IAGP XCO:0000112 N RGD:629619|PMID:12045297 20200813 RGD compared to uninephrectomized SBN/Ygl 631572 SBH/Ygl Sabra hypertension prone strain MP:0002962 increased urine protein level IAGP XCO:0000112 N RGD:629619|PMID:12045297 20200813 RGD compared to SBH/Ygl control 631572 SBH/Ygl Sabra hypertension prone strain MP:0002962 increased urine protein level induced IAGP XCO:0000022 N RGD:4889613|PMID:20876844 20101209 RGD in males, compared to SBH/Ygl control, salt-loaded SBN/Ygl 631572 SBH/Ygl Sabra hypertension prone strain MP:0002962 increased urine protein level severity IAGP N RGD:629619|PMID:12045297 20200410 RGD compared to SBN/Ygl 631572 SBH/Ygl Sabra hypertension prone strain MP:0002962 increased urine protein level severity IAGP XCO:0000112 N RGD:629619|PMID:12045297 20200410 RGD in females, compared to SBH/Ygl control 631572 SBH/Ygl Sabra hypertension prone strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:629619|PMID:12045297 20101208 RGD in males, compared to SBN/Ygl 631572 SBH/Ygl Sabra hypertension prone strain MP:0005553 increased circulating creatinine level sexual_dimorphism IAGP N RGD:629619|PMID:12045297 20101208 RGD in males, compared to SBN/Ygl 631572 SBH/Ygl Sabra hypertension prone strain MP:0005553 increased circulating creatinine level sexual_dimorphism IAGP XCO:0000112 N RGD:629619|PMID:12045297 20200813 RGD in males, compared to SBH/Ygl control, uninephrectomized SBN/Ygl 631572 SBH/Ygl Sabra hypertension prone strain MP:0006144 increased systemic arterial systolic blood pressure induced IAGP XCO:0000022 N RGD:629619|PMID:12045297 20200410 RGD in males, compared to SBH/Ygl control, salt-loaded SBN/Ygl 631573 SBN/Ygl Sabra hypertension resistant strain MP:0002743 glomerulonephritis sexual_dimorphism IAGP XCO:0000112 N RGD:629619|PMID:12045297 20200813 RGD in males, compared to SBN/Ygl control 631573 SBN/Ygl Sabra hypertension resistant strain MP:0002962 increased urine protein level IAGP N RGD:629619|PMID:12045297 20101208 RGD 631573 SBN/Ygl Sabra hypertension resistant strain MP:0002962 increased urine protein level severity IAGP XCO:0000112 N RGD:629619|PMID:12045297 20200813 RGD compared to SBN/Ygl control 631576 LEW/CrlCrlj strain MP:0001260 increased body weight IAGP N RGD:619658|PMID:11045938 20200311 RGD compared to SHR/Izm 631576 LEW/CrlCrlj strain MP:0003916 decreased heart left ventricle weight IAGP N RGD:619658|PMID:11045938 20200311 RGD compared to SHR/Izm 631576 LEW/CrlCrlj strain MP:0004876 decreased mean systemic arterial blood pressure IAGP N RGD:619658|PMID:11045938 20200311 RGD compared to SHR/Izm 631577 SHR/Izm strain MP:0002625 heart left ventricle hypertrophy IAGP N RGD:619658|PMID:11045938 20200108 RGD compared to LEW/CrlCrlj strain 631577 SHR/Izm strain MP:0002842 increased systemic arterial blood pressure IAGP N RGD:619658|PMID:11045938 19990101 RGD compared to LEW/CrlCrlj strain 631577 SHR/Izm strain MP:0004051 increased renal sympathetic nerve activity IAGP N RGD:40902813|PMID:541053 20080627 RGD compared to WKY 631577 SHR/Izm strain MP:0004875 increased mean systemic arterial blood pressure IAGP N RGD:40902813|PMID:541053 20201210 RGD compared to WKY 631578 SHR.BN-(D2Rat171-D2Arb24)/Ipcv strain MP:0001260 increased body weight IAGP N RGD:619651|PMID:11403354 19990101 RGD compared to SHR/OlaIpcv strain 631578 SHR.BN-(D2Rat171-D2Arb24)/Ipcv strain MP:0002834 decreased heart weight IAGP N RGD:619651|PMID:11403354 19990101 RGD compared to SHR/OlaIpcv strain 631578 SHR.BN-(D2Rat171-D2Arb24)/Ipcv strain MP:0005289 increased oxygen consumption IAGP N RGD:150429949|PMID:29261326 20211013 RGD compared to SHR/OlaIpcv strain 631578 SHR.BN-(D2Rat171-D2Arb24)/Ipcv strain MP:0006263 decreased systemic arterial diastolic blood pressure IAGP N RGD:619651|PMID:11403354 19990101 RGD compared to SHR/OlaIpcv strain 631578 SHR.BN-(D2Rat171-D2Arb24)/Ipcv strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:619651|PMID:11403354 19990101 RGD compared to SHR/OlaIpcv strain 631578 SHR.BN-(D2Rat171-D2Arb24)/Ipcv strain MP:0020968 enhanced conditioned taste aversion behavior IAGP N RGD:631221|PMID:11958542 20240906 RGD compared to SHR/OlaIpcv strain 631579 LEW/OlaHsd strain MP:0001260 increased body weight IAGP N RGD:629577|PMID:12482837 20200408 RGD compared to BC/CpbU 631579 LEW/OlaHsd strain MP:0001260 increased body weight sexual_dimorphism IAGP N RGD:629577|PMID:12482837 20200408 RGD compared to LEW/OlaHsd females 631579 LEW/OlaHsd strain MP:0003980 increased circulating phospholipid level induced IAGP XCO:0000246,XCO:0000025 N RGD:629577|PMID:12482837 20200408 RGD compared to treated BC/CpbU 631579 LEW/OlaHsd strain MP:0005178 increased circulating cholesterol level induced IAGP XCO:0000246,XCO:0000025 N RGD:629577|PMID:12482837 19990101 RGD compared to LEW/OlaHds, treated BC/CpbU 631581 LEW.1F strain MP:0001846 increased inflammatory response IAGP N RGD:631225|PMID:12111642 19990101 RGD 631581 LEW.1F strain MP:0002933 joint inflammation induced IAGP XCO:0000263 N RGD:629561|PMID:11817600 20191122 RGD compared to control strain E3 631581 LEW.1F strain MP:0002936 joint swelling induced IAGP XCO:0000263 N RGD:629561|PMID:11817600 20191122 RGD compared to control strain E3 631581 LEW.1F strain MP:0003201 extremity edema induced IAGP XCO:0000263 N RGD:629561|PMID:11817600 20191122 RGD compared to control strain E3 631581 LEW.1F strain MP:0003724 increased susceptibility to induced arthritis induced IAGP XCO:0000263 N RGD:629561|PMID:11817600 20191122 RGD compared to control strain E3 631581 LEW.1F strain MP:0008596 increased circulating interleukin-6 level induced IAGP XCO:0000263 N RGD:629561|PMID:11817600 20191122 RGD compared to control strain E3 631581 LEW.1F strain MP:0010211 abnormal acute phase protein level induced IAGP XCO:0000263 N RGD:629561|PMID:11817600 20191122 RGD compared to control strain E3 631581 LEW.1F strain MP:0012331 increased circulating fibrinogen level induced IAGP XCO:0000263 N RGD:629561|PMID:11817600 20191122 RGD compared to control strain E3 631581 LEW.1F strain MP:0030805 abnormal limb joint morphology induced IAGP XCO:0000263 N RGD:629561|PMID:11817600 20191122 RGD compared to control strain E3 631585 SS.LEW-(D16Mit2-D16Rat12)/Ayd strain MP:0003916 decreased heart left ventricle weight induced IAGP XCO:0000022 N RGD:70460|PMID:11919686 20201123 RGD compared to SS/Jr 631585 SS.LEW-(D16Mit2-D16Rat12)/Ayd strain MP:0003918 decreased kidney weight induced IAGP XCO:0000022 N RGD:70460|PMID:11919686 20201123 RGD compared to SS/Jr 631585 SS.LEW-(D16Mit2-D16Rat12)/Ayd strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:70460|PMID:11919686 20201123 RGD compared to SS/Jr 631585 SS.LEW-(D16Mit2-D16Rat12)/Ayd strain MP:0006263 decreased systemic arterial diastolic blood pressure induced IAGP XCO:0000022 N RGD:70460|PMID:11919686 20201123 RGD compared to SS/Jr 631585 SS.LEW-(D16Mit2-D16Rat12)/Ayd strain MP:0006264 decreased systemic arterial systolic blood pressure induced IAGP XCO:0000022 N RGD:70460|PMID:11919686 20201123 RGD compared to SS/Jr 631585 SS.LEW-(D16Mit2-D16Rat12)/Ayd strain MP:0031199 decreased aortic weight induced IAGP XCO:0000022 N RGD:70460|PMID:11919686 20201123 RGD compared to SS/Jr 631586 SS.MNS-(D10Mco14-D10Mit11)/Jr strain MP:0002834 decreased heart weight induced IAGP XCO:0000022 N RGD:619626|PMID:9096100 20070607 RGD compared to SS/Jr 631586 SS.MNS-(D10Mco14-D10Mit11)/Jr strain MP:0002843 decreased systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:619626|PMID:9096100 19990101 RGD compared to SS/Jr 631587 SS.MNS-(D10M11Mit119-D10Mit11)/Jr strain MP:0002834 decreased heart weight IAGP XCO:0000022 N RGD:619640|PMID:9541488 20201123 RGD compared to SS/Jr 631587 SS.MNS-(D10M11Mit119-D10Mit11)/Jr strain MP:0002834 decreased heart weight induced IAGP XCO:0000022 N RGD:619626|PMID:9096100 19990101 RGD compared to SS/Jr 631587 SS.MNS-(D10M11Mit119-D10Mit11)/Jr strain MP:0002834 decreased heart weight induced IAGP XCO:0000022 N RGD:628510|PMID:11641286 19990101 RGD compared to SS/Jr 631587 SS.MNS-(D10M11Mit119-D10Mit11)/Jr strain MP:0002843 decreased systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:619626|PMID:9096100 19990101 RGD compared to SS/Jr 631587 SS.MNS-(D10M11Mit119-D10Mit11)/Jr strain MP:0002843 decreased systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:628510|PMID:11641286 20080218 RGD as compared to SS/Jr 631587 SS.MNS-(D10M11Mit119-D10Mit11)/Jr strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP XCO:0000022 N RGD:619640|PMID:9541488 20201123 RGD compared to SS/Jr 631588 SS.MNS-(D10Mit11-Vamp2)/Mco strain MP:0002843 decreased systemic arterial blood pressure IMP N RGD:619625|PMID:9607182 19990101 RGD compared to SS/JrMco 631589 SHR.WKY-(D1Wox34-D1Rat164)/Njs strain MP:0006263 decreased systemic arterial diastolic blood pressure IAGP N RGD:70855|PMID:11509479 19990101 RGD compared to SHR/NCruk strain 631589 SHR.WKY-(D1Wox34-D1Rat164)/Njs strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:70855|PMID:11509479 20200128 RGD compared to SHR/NCruk strain 631590 SHR.WKY-(D1Wox34-Sah)/Njs strain MP:0006263 decreased systemic arterial diastolic blood pressure IAGP N RGD:70855|PMID:11509479 20200128 RGD compared to SHR/NCruk strain 631590 SHR.WKY-(D1Wox34-Sah)/Njs strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:70855|PMID:11509479 20200128 RGD compared to SHR/NCruk strain 631591 WKY.SHR-(D1Rat56-D1M7Mit206)/Njs strain MP:0006143 increased systemic arterial diastolic blood pressure IAGP N RGD:70855|PMID:11509479 20200129 RGD compared to WKY/NCruk strain 631591 WKY.SHR-(D1Rat56-D1M7Mit206)/Njs strain MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:70855|PMID:11509479 19990101 RGD compared to WKY/NCruk strain 631592 WKY.SHR-(D1Rat236-D1M7Mit206)/Njs strain MP:0006143 increased systemic arterial diastolic blood pressure IAGP N RGD:70855|PMID:11509479 20200129 RGD compared to WKY/NCruk strain 631592 WKY.SHR-(D1Rat236-D1M7Mit206)/Njs strain MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:70855|PMID:11509479 19990101 RGD compared to WKY/NCruk strain 631594 BN/Rj strain MP:0002493 increased IgG level induced IAGP XCO:0000369 N RGD:619646|PMID:10898507 19990101 RGD compared to LEW/Rj 631594 BN/Rj strain MP:0002497 increased IgE level induced IAGP XCO:0000369 N RGD:619646|PMID:10898507 19990101 RGD compared to LEW/Rj 631594 BN/Rj strain MP:0003139 patent ductus arteriosus IAGP N RGD:8662443|PMID:17356016 20210112 RGD compared to LOU/MBbb 631594 BN/Rj strain MP:0003279 aneurysm IAGP N RGD:8662443|PMID:17356016 20210112 RGD compared to LOU/MBbb 631594 BN/Rj strain MP:0003907 decreased aorta elastin content IAGP N RGD:8662443|PMID:17356016 20140624 RGD compared to LOU.MBbb 631594 BN/Rj strain MP:0004194 abnormal kidney pelvis morphology IAGP N RGD:2293631|PMID:18523158 20080616 RGD 631594 BN/Rj strain MP:0009870 abnormal abdominal aorta morphology IAGP N RGD:8662443|PMID:17356016 20210112 RGD compared to LOU/MBbb 631594 BN/Rj strain MP:0010468 abnormal thoracic aorta morphology IAGP N RGD:8662443|PMID:17356016 20210112 RGD compared to LOU/MBbb 631595 LEW.1AV1.DA-(D10Rat92-D10Rat135)/Ubc strain MP:0001846 increased inflammatory response induced IAGP XCO:0000265 N RGD:61087|PMID:9600974 19990101 RGD compared to LEW.1AV1/Kini 631596 LEW.1AV1.DA-(D10Rat92-D10Wox17)/Ubc strain MP:0001263 weight loss induced IAGP XCO:0000280 N RGD:62404|PMID:11230175 20201116 RGD compared to LEW.1AV1 631596 LEW.1AV1.DA-(D10Rat92-D10Wox17)/Ubc strain MP:0001846 increased inflammatory response induced IAGP XCO:0000280 N RGD:62404|PMID:11230175 19990101 RGD compared to LEW.1AV1 631596 LEW.1AV1.DA-(D10Rat92-D10Wox17)/Ubc strain MP:0012331 increased circulating fibrinogen level induced IAGP XCO:0000280 N RGD:62404|PMID:11230175 20201116 RGD compared to LEW.1AV1 631597 LEW.1AV1.DA-(D10Wox17-D10Rat135)/Ubc strain MP:0001263 weight loss induced IAGP XCO:0000280 N RGD:62404|PMID:11230175 20201116 RGD compared to LEW.1AV1 631597 LEW.1AV1.DA-(D10Wox17-D10Rat135)/Ubc strain MP:0001846 increased inflammatory response induced IAGP XCO:0000280 N RGD:62404|PMID:11230175 19990101 RGD compared to LEW.1AV1 631597 LEW.1AV1.DA-(D10Wox17-D10Rat135)/Ubc strain MP:0012331 increased circulating fibrinogen level induced IAGP XCO:0000280 N RGD:62404|PMID:11230175 20201116 RGD compared to LEW.1AV1 631598 LEW.1AV1.DA-(D10Got154-D10Rat135)/Ubc strain MP:0001263 weight loss induced IAGP XCO:0000280 N RGD:62404|PMID:11230175 20201116 RGD compared to LEW.1AV1 631598 LEW.1AV1.DA-(D10Got154-D10Rat135)/Ubc strain MP:0001846 increased inflammatory response induced IAGP XCO:0000280 N RGD:62404|PMID:11230175 19990101 RGD compared to LEW.1AV1 631598 LEW.1AV1.DA-(D10Got154-D10Rat135)/Ubc strain MP:0012331 increased circulating fibrinogen level induced IAGP XCO:0000280 N RGD:62404|PMID:11230175 20201116 RGD compared to LEW.1AV1 631599 SHRSP/Izm strain MP:0000231 hypertension susceptibility IAGP N RGD:1578503|PMID:16239369 20191209 RGD compared to control strain WKY/Izm 631599 SHRSP/Izm strain MP:0001262 decreased body weight induced IAGP XCO:0000010 N RGD:2296063|PMID:16445571 20080627 RGD compared to WKY/Izm, WKY.SHRSP-(D1Wox29-D1Arb21)/Izm after sham surgery 631599 SHRSP/Izm strain MP:0001762 polyuria induced IAGP XCO:0000373 N RGD:2296063|PMID:16445571 20200203 RGD compared to sham surgery 631599 SHRSP/Izm strain MP:0002608 increased hematocrit induced IAGP XCO:0000100 N RGD:2296063|PMID:16445571 20200203 RGD compared to WKY/Izm, WKY.SHRSP-(D1Wox29-D1Arb21)/Izm after sham surgery 631599 SHRSP/Izm strain MP:0002842 increased systemic arterial blood pressure IAGP N RGD:619634|PMID:10604486 19990101 RGD 631599 SHRSP/Izm strain MP:0002871 albuminuria susceptibility IAGP XCO:0000164 N RGD:2302104|PMID:18971556 20200110 RGD compared to SHRSP.WKY/Izm congenics 631599 SHRSP/Izm strain MP:0003076 increased susceptibility to ischemic brain injury IAGP XCO:0000164 N RGD:730283|PMID:14623828 20191206 RGD compared to control strain WKY/Izm 631599 SHRSP/Izm strain MP:0003076 increased susceptibility to ischemic brain injury severity IAGP XCO:0000348 N RGD:1600255|PMID:17327494 20191210 RGD compared to congenic SHRSP.WKY-(D1Wox29-D1Arb21)/Izm, with age 631599 SHRSP/Izm strain MP:0003918 decreased kidney weight induced IAGP XCO:0000010 N RGD:2296063|PMID:16445571 20080627 RGD compared to WKY/Izm, WKY.SHRSP-(D1Wox29-D1Arb21)/Izm after sham surgery 631599 SHRSP/Izm strain MP:0004051 increased renal sympathetic nerve activity induced IAGP XCO:0000337 N RGD:1578503|PMID:16239369 20191209 RGD compared to control strain WKY/Izm 631599 SHRSP/Izm strain MP:0004217 salt-sensitive hypertension susceptibility IAGP XCO:0000164 N RGD:730283|PMID:14623828 20191206 RGD compared to control strain WKY/Izm 631599 SHRSP/Izm strain MP:0004484 abnormal response of heart to induced stress induced IAGP XCO:0000337 N RGD:1578503|PMID:16239369 20191209 RGD compared to control strain WKY/Izm 631599 SHRSP/Izm strain MP:0004875 increased mean systemic arterial blood pressure induced IAGP XCO:0000100 N RGD:2296063|PMID:16445571 20080627 RGD compared to WKY/Izm, WKY.SHRSP-(D1Wox29-D1Arb21)/Izm after sham surgery 631599 SHRSP/Izm strain MP:0004875 increased mean systemic arterial blood pressure severity IAGP N RGD:1600255|PMID:17327494 20191210 RGD compared to congenic SHRSP.WKY-(D1Wox29-D1Arb21)/Izm, with age 631599 SHRSP/Izm strain MP:0004875 increased mean systemic arterial blood pressure susceptibility IAGP N RGD:1578503|PMID:16239369 20191209 RGD compared to control strain WKY/Izm 631599 SHRSP/Izm strain MP:0005525 increased renal plasma flow rate induced IAGP XCO:0000373 N RGD:2296063|PMID:16445571 20200203 RGD 631599 SHRSP/Izm strain MP:0005526 decreased renal plasma flow rate induced IAGP XCO:0000100 N RGD:2296063|PMID:16445571 20080627 RGD compared to WKY/Izm, WKY.SHRSP-(D1Wox29-D1Arb21)/Izm after sham surgery 631599 SHRSP/Izm strain MP:0005530 decreased renal vascular resistance IAGP N RGD:2296062|PMID:18565192 20080627 RGD after renal denervation 631599 SHRSP/Izm strain MP:0005531 increased renal vascular resistance induced IAGP XCO:0000100 N RGD:2296063|PMID:16445571 20080627 RGD compared to WKY/Izm, WKY.SHRSP-(D1Wox29-D1Arb21)/Izm after sham surgery 631599 SHRSP/Izm strain MP:0006060 increased cerebral infarct size severity IAGP XCO:0000348 N RGD:1600255|PMID:17327494 20191210 RGD compared to congenic SHRSP.WKY-(D1Wox29-D1Arb21)/Izm, with age 631599 SHRSP/Izm strain MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:730283|PMID:14623828 20191206 RGD compared to control strain WKY/Izm, greater in male, increased with aging 631599 SHRSP/Izm strain MP:0006316 increased urine sodium level induced IAGP XCO:0000100 N RGD:2296063|PMID:16445571 20080627 RGD compared to WKY/Izm, WKY.SHRSP-(D1Wox29-D1Arb21)/Izm after sham surgery 631599 SHRSP/Izm strain MP:0006316 increased urine sodium level induced IAGP XCO:0000373 N RGD:2296063|PMID:16445571 20200203 RGD compared to sham surgery. 631599 SHRSP/Izm strain MP:0010109 abnormal renal sodium reabsorption susceptibility IAGP XCO:0000373 N RGD:2296063|PMID:16445571 20200107 RGD compared to WKY/Izm and WKY.SHRSP-(D1Wox29-D1Arb21)/Izm 631599 SHRSP/Izm strain MP:0010697 abnormal systemic arterial blood pressure regulation susceptibility IAGP N RGD:1578503|PMID:16239369 20191209 RGD compared to control strain WKY/Izm 631599 SHRSP/Izm strain MP:0011295 abnormal tubuloglomerular feedback response induced IAGP XCO:0000100 N RGD:2296063|PMID:16445571 20200203 RGD compared to WKY/Izm, WKY.SHRSP-(D1Wox29-D1Arb21)/Izm after sham surgery 631599 SHRSP/Izm strain MP:0011296 decreased tubuloglomerular feedback response induced IAGP XCO:0000373 N RGD:2296063|PMID:16445571 20200107 RGD compared to WKY/Izm 631599 SHRSP/Izm strain MP:0012045 increased susceptibility to hypertension IAGP N RGD:730283|PMID:14623828 20191206 RGD compared to control strain WKY/Izm, greater in male, increased with aging 631599 SHRSP/Izm strain MP:0012045 increased susceptibility to hypertension susceptibility IAGP N RGD:1578503|PMID:16239369 20191209 RGD compared to control strain WKY/Izm 631599 SHRSP/Izm strain MP:0012574 decreased noradrenaline level induced IAGP XCO:0000373 N RGD:2296063|PMID:16445571 20200203 RGD compared to sham surgery 631599 SHRSP/Izm strain MP:0030768 increased urine dopamine level susceptibility IAGP XCO:0000307 N RGD:1302892|PMID:15480093 20200109 RGD compared to WKY/Izm 631599 SHRSP/Izm strain MP:0030770 increased urine adrenaline level susceptibility IAGP XCO:0000307 N RGD:1302892|PMID:15480093 20200109 RGD compared to WKY/Izm 631599 SHRSP/Izm strain MP:0030772 increased urine noradrenaline level susceptibility IAGP XCO:0000307 N RGD:1302892|PMID:15480093 20200109 RGD compared to WKY/Izm 631600 WKY.SHRSP-(Mt1pa-D1Rat200)/Bbb strain MP:0002842 increased systemic arterial blood pressure IAGP N RGD:619643|PMID:10523340 19990101 RGD compared to WKY/Bbb 631600 WKY.SHRSP-(Mt1pa-D1Rat200)/Bbb strain MP:0004216 salt-resistant hypertension IAGP N RGD:619643|PMID:10523340 19990101 RGD 631600 WKY.SHRSP-(Mt1pa-D1Rat200)/Bbb strain MP:0006143 increased systemic arterial diastolic blood pressure IAGP N RGD:619643|PMID:10523340 19990101 RGD compared to WKY/Bbb 631600 WKY.SHRSP-(Mt1pa-D1Rat200)/Bbb strain MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:619643|PMID:10523340 19990101 RGD compared to WKY/Bbb 631601 WKY.SHRSP-(Asgr1-Vamp2)/Bbb strain MP:0002842 increased systemic arterial blood pressure susceptibility IAGP XCO:0000164 N RGD:629620|PMID:12566390 19990101 RGD compared to WKY/Bbb; MMO:0000015 631601 WKY.SHRSP-(Asgr1-Vamp2)/Bbb strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:619633|PMID:7568016 19990101 RGD compared to WKY/Bbb 631601 WKY.SHRSP-(Asgr1-Vamp2)/Bbb strain MP:0006143 increased systemic arterial diastolic blood pressure IAGP N RGD:619633|PMID:7568016 20200114 RGD compared to WKY/Bbb 631601 WKY.SHRSP-(Asgr1-Vamp2)/Bbb strain MP:0006143 increased systemic arterial diastolic blood pressure IAGP XCO:0000022 N RGD:619633|PMID:7568016 20200107 RGD compared to WKY/Bbb 631601 WKY.SHRSP-(Asgr1-Vamp2)/Bbb strain MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:619633|PMID:7568016 20200114 RGD compared to WKY/Bbb 631601 WKY.SHRSP-(Asgr1-Vamp2)/Bbb strain MP:0006144 increased systemic arterial systolic blood pressure IAGP XCO:0000022 N RGD:619633|PMID:7568016 19990101 RGD compared to WKY/Bbb 631602 BN/Elh strain MP:0003211 abnormal aorta elastic fiber morphology severity IAGP N RGD:619605|PMID:11526202 20191125 RGD 631602 BN/Elh strain MP:0020099 increased susceptibility to diet-induced aortic fatty streak lesions IAGP N RGD:619605|PMID:11526202 20191125 RGD 631604 SHR/Snk strain MP:0002833 increased heart weight IAGP N RGD:1599588|PMID:17261463 20200120 RGD compared to F344/Snk control strain 631604 SHR/Snk strain MP:0002842 increased systemic arterial blood pressure IAGP N RGD:631181|PMID:8476428 19990101 RGD 631604 SHR/Snk strain MP:0004866 increased platelet calcium level IAGP XCO:0000317,XCO:0000177|XCO:0000178 N RGD:1599588|PMID:17261463 20200129 RGD also with thrombin alone; compared to F344/Snk control strain 631604 SHR/Snk strain MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:1599588|PMID:17261463 20200120 RGD compared to F344/Snk control strain 631604 SHR/Snk strain MP:0009586 increased platelet aggregation IAGP XCO:0000317 N RGD:1599588|PMID:17261463 20200129 RGD compared to F344/Snk control strain 631605 SS.LEW-(D10Arb9-D10Got101)/Jr strain MP:0002834 decreased heart weight induced IAGP XCO:0000022 N RGD:628510|PMID:11641286 20070607 RGD compared to SS/Jr 631605 SS.LEW-(D10Arb9-D10Got101)/Jr strain MP:0002843 decreased systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:628510|PMID:11641286 19990101 RGD compared to SS/Jr 631606 SS.MNS-(D10Rat13-D10Mit11)/Jr strain MP:0002834 decreased heart weight induced IAGP XCO:0000022 N RGD:628510|PMID:11641286 20070607 RGD compared to SS/Jr 631606 SS.MNS-(D10Rat13-D10Mit11)/Jr strain MP:0002843 decreased systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:628510|PMID:11641286 20070607 RGD compared to SS/Jr 631607 SS.WKY-(D2N35-Mme)/Mco strain MP:0002834 decreased heart weight IAGP XCO:0000022 N RGD:619640|PMID:9541488 20201123 RGD compared to SS/Jr 631607 SS.WKY-(D2N35-Mme)/Mco strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP XCO:0000022 N RGD:619640|PMID:9541488 20201123 RGD compared to SS/Jr 631642 Stl2 Serum triglyceride level QTL 2 qtl MP:0001552 increased circulating triglyceride level QTM N RGD:619667|PMID:9633608 19990101 RGD 631643 Bp120 Blood pressure QTL 120 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:629623|PMID:12569259 19990101 RGD 631645 Bp121 Blood pressure QTL 121 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:629623|PMID:12569259 19990101 RGD 631646 Stl4 Serum triglyceride level QTL 4 qtl MP:0001552 increased circulating triglyceride level QTM N RGD:631174|PMID:12687333 19990101 RGD 631646 Stl4 Serum triglyceride level QTL 4 qtl MP:0002079 increased circulating insulin level QTM N RGD:631174|PMID:12687333 19990101 RGD 631647 Bp122 Blood pressure QTL 122 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:629623|PMID:12569259 19990101 RGD 631648 Stl5 Serum triglyceride level QTL 5 qtl MP:0001552 increased circulating triglyceride level QTM N RGD:631174|PMID:12687333 19990101 RGD 631649 Bp123 Blood pressure QTL 123 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:629623|PMID:12569259 19990101 RGD 631650 Stl6 Serum triglyceride level QTL 6 qtl MP:0001552 increased circulating triglyceride level QTM N RGD:631174|PMID:12687333 19990101 RGD 631651 Bp124 Blood pressure QTL 124 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:629623|PMID:12569259 19990101 RGD 631652 Bp106 Blood pressure QTL 106 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:629620|PMID:12566390 19990101 RGD 631653 Bp125 Blood pressure QTL 125 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:629623|PMID:12569259 19990101 RGD 631654 Bp107 Blood pressure QTL 107 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:629620|PMID:12566390 19990101 RGD 631655 Bp126 Blood pressure QTL 126 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:629623|PMID:12569259 19990101 RGD 631656 Bp108 Blood pressure QTL 108 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:629621|PMID:12775577 19990101 RGD 631658 Cm7 Cardiac mass QTL 7 qtl MP:0002845 abnormal aortic weight QTM N RGD:629621|PMID:12775577 19990101 RGD 631660 Hcar1 Hepatocarcinoma resistance QTL 1 qtl MP:0010265 decreased hepatoma incidence IDA N RGD:619598|PMID:10493520 20111107 RGD 631662 Hcar2 Hepatocarcinoma resistance QTL 2 qtl MP:0010265 decreased hepatoma incidence IDA N RGD:619598|PMID:10493520 20111107 RGD 631663 Bw6 Body weight QTL 6 qtl MP:0001260 increased body weight QTM N RGD:629577|PMID:12482837 19990101 RGD 631664 Hcar3 Hepatocarcinoma resistance QTL 3 qtl MP:0010265 decreased hepatoma incidence IDA N RGD:619598|PMID:10493520 20111107 RGD 631665 Bw8 Body weight QTL 8 qtl MP:0001260 increased body weight IAGP N RGD:619631|PMID:10051321 19990101 RGD 631666 Iddm5 Insulin dependent diabetes mellitus QTL 5 qtl MP:0005559 increased circulating glucose level IDA N RGD:625443|PMID:8586150 19990101 RGD 631667 Iddm6 Insulin dependent diabetes mellitus QTL 6 qtl MP:0005559 increased circulating glucose level IDA N RGD:625443|PMID:8586150 19990101 RGD 631668 Iddm7 Insulin dependent diabetes mellitus QTL 7 qtl MP:0005559 increased circulating glucose level IAGP N RGD:631165|PMID:9080298 19990101 RGD 631669 Iddm9 Insulin dependent diabetes mellitus QTL 9 qtl MP:0005559 increased circulating glucose level IAGP N RGD:6903877|PMID:9858659 19990101 RGD 631670 Iddm10 Insulin dependent diabetes mellitus QTL 10 qtl MP:0005559 increased circulating glucose level QTM N RGD:6903877|PMID:9858659 19990101 RGD 631671 Iddm11 Insulin dependent diabetes mellitus QTL 11 qtl MP:0001869 pancreas inflammation QTM N RGD:61480|PMID:9892222 19990101 RGD 631671 Iddm11 Insulin dependent diabetes mellitus QTL 11 qtl MP:0004031 insulitis IDA N RGD:61480|PMID:9892222 20120918 RGD 631671 Iddm11 Insulin dependent diabetes mellitus QTL 11 qtl MP:0005559 increased circulating glucose level QTM N RGD:61480|PMID:9892222 19990101 RGD 631672 Iddm12 Insulin dependent diabetes mellitus QTL 12 qtl MP:0005559 increased circulating glucose level QTM N RGD:61480|PMID:9892222 19990101 RGD 631673 Iddm13 Insulin dependent diabetes mellitus QTL 13 qtl MP:0005559 increased circulating glucose level QTM N RGD:61480|PMID:9892222 19990101 RGD 631674 Iddm14 Insulin dependent diabetes mellitus QTL 14 qtl MP:0005559 increased circulating glucose level QTM N RGD:61479|PMID:10535446 19990101 RGD 631675 Iddm15 Insulin dependent diabetes mellitus QTL 15 qtl MP:0003870 decreased urine glucose level IAGP N RGD:619685|PMID:11327715 19990101 RGD 631675 Iddm15 Insulin dependent diabetes mellitus QTL 15 qtl MP:0005560 decreased circulating glucose level IAGP N RGD:619685|PMID:11327715 19990101 RGD 631676 Cm8 Cardiac mass QTL 8 qtl MP:0002845 abnormal aortic weight QTM N RGD:629621|PMID:12775577 19990101 RGD 631678 Cm9 Cardiac mass QTL 9 qtl MP:0002845 abnormal aortic weight QTM N RGD:629621|PMID:12775577 19990101 RGD 631679 Cm10 Cardiac mass QTL 10 qtl MP:0002625 heart left ventricle hypertrophy QTM N RGD:629621|PMID:12775577 19990101 RGD 631680 Cm11 Cardiac mass QTL 11 qtl MP:0002625 heart left ventricle hypertrophy QTM N RGD:629621|PMID:12775577 19990101 RGD 631681 Cm12 Cardiac mass QTL 12 qtl MP:0002625 heart left ventricle hypertrophy QTM N RGD:629621|PMID:12775577 19990101 RGD 631682 Bp115 Blood pressure QTL 115 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:629622|PMID:12473864 19990101 RGD 631683 Bp116 Blood pressure QTL 116 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:629622|PMID:12473864 19990101 RGD 631684 Bp117 Blood pressure QTL 117 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:629623|PMID:12569259 19990101 RGD 631685 Bp118 Blood pressure QTL 118 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:629623|PMID:12569259 19990101 RGD 631686 Bp119 Blood pressure QTL 119 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:629623|PMID:12569259 19990101 RGD 631687 Hcas1 Hepatocarcinoma susceptibility QTL 1 qtl MP:0003331 increased hepatocellular carcinoma incidence IDA N RGD:619598|PMID:10493520 20111107 RGD 631688 Hcas2 Hepatocarcinoma susceptibility QTL 2 qtl MP:0003331 increased hepatocellular carcinoma incidence IDA N RGD:619598|PMID:10493520 20111107 RGD 631689 Scl4 Serum cholesterol level QTL 4 qtl MP:0005178 increased circulating cholesterol level QTM N RGD:619667|PMID:9633608 19990101 RGD 631690 Scl5 Serum cholesterol level QTL 5 qtl MP:0001552 increased circulating triglyceride level QTM N RGD:619667|PMID:9633608 19990101 RGD 631694 WKY.SHRSP-(D1Rat200-D1Rat216)/Bbb strain MP:0002842 increased systemic arterial blood pressure susceptibility IAGP XCO:0000164 N RGD:629620|PMID:12566390 19990101 RGD compared to WKY/Bbb; MMO:0000015 631695 SS/JrRkb strain MP:0002842 increased systemic arterial blood pressure IAGP N RGD:629621|PMID:12775577 19990101 RGD compared to SHR/FubRkb on 4% NaCl diet 631695 SS/JrRkb strain MP:0003915 increased heart left ventricle weight IAGP N RGD:629621|PMID:12775577 19990101 RGD compared to SHR/FubRkb on 4% NaCl diet 631695 SS/JrRkb strain MP:0005608 cardiac interstitial fibrosis IAGP N RGD:629621|PMID:12775577 20201117 RGD on 4% NaCl diet 631695 SS/JrRkb strain MP:0011749 perivascular fibrosis IMP N RGD:2307185|PMID:18824493 20201023 RGD compared to SS-Chr 19SHR/Rkb 631695 SS/JrRkb strain MP:0031200 increased aortic weight IAGP N RGD:629621|PMID:12775577 20201117 RGD compared to SHR/FubRkb on 4% NaCl diet 631696 SHR/FubRkb strain MP:0000231 hypertension IAGP N RGD:25314252|PMID:23868088 20210311 RGD compared to MWF and WKY 631696 SHR/FubRkb strain MP:0002833 increased heart weight IAGP N RGD:1642911|PMID:17953514 20200219 RGD females compared to female MWF/FubRkb, female MWF-Chr 6SHR/Rkb 631696 SHR/FubRkb strain MP:0005554 decreased circulating creatinine level IAGP N RGD:1642911|PMID:17953514 20200219 RGD females compared to female MWF/FubRkb, female MWF-Chr 6SHR/Rkb 631696 SHR/FubRkb strain MP:0005566 decreased blood urea nitrogen level IAGP N RGD:1642911|PMID:17953514 20200219 RGD compared to female MWF/Rkb 631696 SHR/FubRkb strain MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:1642911|PMID:17953514 20080311 RGD compared to MWF/FubRkb, females compared to female SHR/FubRkb, female MWF-Chr 6SHR/Rkb 631696 SHR/FubRkb strain MP:0006264 decreased systemic arterial systolic blood pressure sexual_dimorphism IAGP N RGD:1642911|PMID:17953514 20200219 RGD compared to male SHR/FubRkb 631700 BB.SHR-(Gnal-D18Mit9)/K strain MP:0000221 decreased leukocyte cell number IAGP N RGD:619685|PMID:11327715 20200206 RGD compared to BB/OK 631700 BB.SHR-(Gnal-D18Mit9)/K strain MP:0001260 increased body weight IAGP N RGD:619685|PMID:11327715 20200206 RGD compared to BB/OK, sexual dimorphism 631700 BB.SHR-(Gnal-D18Mit9)/K strain MP:0001552 increased circulating triglyceride level IAGP N RGD:619685|PMID:11327715 20200206 RGD compared to BB/OK, sexual dimorphism 631700 BB.SHR-(Gnal-D18Mit9)/K strain MP:0004804 decreased susceptibility to autoimmune diabetes IAGP N RGD:619685|PMID:11327715 20200206 RGD compared to BB/OK 631700 BB.SHR-(Gnal-D18Mit9)/K strain MP:0005178 increased circulating cholesterol level IAGP N RGD:619685|PMID:11327715 20200206 RGD compared to BB/OK, sexual dimorphism 631700 BB.SHR-(Gnal-D18Mit9)/K strain MP:0005559 increased circulating glucose level IAGP N RGD:619685|PMID:11327715 19990101 RGD 631703 SS.LEW-(D10Rat207-D10Mgh1)/Ayd strain MP:0002843 decreased systemic arterial blood pressure IMP N RGD:69734|PMID:11471055 19990101 RGD 631827 Alc4 Alcohol consumption QTL 4 qtl MP:0001987 alcohol preference QTM N RGD:631230|PMID:10979603 19990101 RGD 631828 Alc5 Alcohol consumption QTL 5 qtl MP:0001987 alcohol preference QTM N RGD:631230|PMID:10979603 19990101 RGD 631829 Alc6 Alcohol consumption QTL 6 qtl MP:0001987 alcohol preference QTM N RGD:631230|PMID:10979603 19990101 RGD 631830 Alc7 Alcohol consumption QTL 7 qtl MP:0001987 alcohol preference QTM N RGD:724636|PMID:12960747 19990101 RGD 631831 Alc8 Alcohol consumption QTL 8 qtl MP:0001987 alcohol preference QTM N RGD:631229|PMID:11958543 19990101 RGD 631832 Sach1 Saccharin preference QTL 1 qtl MP:0002850 saccharin preference IAGP N RGD:631229|PMID:11958543 19990101 RGD 631832 Sach1 Saccharin preference QTL 1 qtl MP:0002850 saccharin preference IDA N RGD:631229|PMID:11958543 20111114 RGD 631833 Sach2 Saccharin preference QTL 2 qtl MP:0002850 saccharin preference IAGP N RGD:631229|PMID:11958543 19990101 RGD 631833 Sach2 Saccharin preference QTL 2 qtl MP:0002850 saccharin preference IDA N RGD:631229|PMID:11958543 20111114 RGD 631834 Sach3 Saccharin preference QTL 3 qtl MP:0002850 saccharin preference IAGP N RGD:631229|PMID:11958543 19990101 RGD 631834 Sach3 Saccharin preference QTL 3 qtl MP:0002850 saccharin preference IDA N RGD:631229|PMID:11958543 20111114 RGD 631835 Scl67 Serum cholesterol level QTL 67 qtl MP:0005178 increased circulating cholesterol level QTM N RGD:619669|PMID:11071303 19990101 RGD 631835 Scl67 Serum cholesterol level QTL 67 qtl MP:0010024 increased total body fat amount IDA N RGD:619669|PMID:11071303 20111107 RGD 631836 Stl31 Serum triglyceride level QTL 31 qtl MP:0001552 increased circulating triglyceride level QTM N RGD:619669|PMID:11071303 19990101 RGD 631837 Niddm35 Non-insulin dependent diabetes mellitus QTL 35 qtl MP:0003059 decreased insulin secretion QTM N RGD:619688|PMID:11723056 19990101 RGD 631838 Niddm36 Non-insulin dependent diabetes mellitus QTL 36 qtl MP:0003059 decreased insulin secretion QTM N RGD:619688|PMID:11723056 19990101 RGD 631839 Niddm37 Non-insulin dependent diabetes mellitus QTL 37 qtl MP:0005559 increased circulating glucose level IDA N RGD:619676|PMID:10218444 19990101 RGD 631840 Niddm38 Non-insulin dependent diabetes mellitus QTL 38 qtl MP:0005559 increased circulating glucose level IDA N RGD:619676|PMID:10218444 19990101 RGD 631841 Niddm39 Non-insulin dependent diabetes mellitus QTL 39 qtl MP:0005559 increased circulating glucose level IDA N RGD:619676|PMID:10218444 19990101 RGD 631842 Inf1 Infertility severity QTL 1 qtl MP:0001157 small seminal vesicle IAGP N RGD:631224|PMID:10615258 19990101 RGD 631842 Inf1 Infertility severity QTL 1 qtl MP:0001922 reduced male fertility IAGP N RGD:631224|PMID:10615258 19990101 RGD 631842 Inf1 Infertility severity QTL 1 qtl MP:0001935 decreased litter size IAGP N RGD:631224|PMID:10615258 19990101 RGD 631843 Bw116 Body weight QTL 116 qtl MP:0001260 increased body weight QTM N RGD:619678|PMID:10373320 19990101 RGD 631843 Bw116 Body weight QTL 116 qtl MP:0005178 increased circulating cholesterol level QTM N RGD:619669|PMID:11071303 19990101 RGD 631844 Iusm:HAD1 high-alcohol-drinking strain MP:0001262 decreased body weight onset IAGP N RGD:155883170|PMID:16269906 20230313 RGD 6 months; compared to Iusm:LAD1 631844 Iusm:HAD1 high-alcohol-drinking strain MP:0002764 short tibia onset IAGP N RGD:155883170|PMID:16269906 20230313 RGD 6 months, compared to Iusm:LAD1 631844 Iusm:HAD1 high-alcohol-drinking strain MP:0003109 short femur onset IAGP N RGD:155883170|PMID:16269906 20230313 RGD 6 months, compared to Iusm:LAD1 631844 Iusm:HAD1 high-alcohol-drinking strain MP:0004351 short humerus onset IAGP N RGD:155883170|PMID:16269906 20230313 RGD 6 months, compared to Iusm:LAD1 631844 Iusm:HAD1 high-alcohol-drinking strain MP:0004359 short ulna onset IAGP N RGD:155883170|PMID:16269906 20230313 RGD 6 months, compared to Iusm:LAD1 631847 F344.GK-(D1Mit7-D1Mgh25)/Swe strain MP:0002079 increased circulating insulin level IAGP N RGD:737717|PMID:10958757 20180129 RGD compared to F344/NCrl rats 631847 F344.GK-(D1Mit7-D1Mgh25)/Swe strain MP:0005293 impaired glucose tolerance induced IAGP XCO:0000103 N RGD:737717|PMID:10958757 20180129 RGD compared to F344/NCrl 631847 F344.GK-(D1Mit7-D1Mgh25)/Swe strain MP:0030017 decreased adipocyte glucose uptake induced IAGP XCO:0000245 N RGD:737717|PMID:10958757 20180129 RGD compared to F344/NCrl rats 631848 SHR/OlaIpcv strain MP:0001552 increased circulating triglyceride level IAGP N RGD:728088|PMID:10925780 20200409 RGD compared to BN/Cub 631848 SHR/OlaIpcv strain MP:0001554 increased circulating free fatty acids level IAGP N RGD:728088|PMID:10925780 20200409 RGD compared to BN/Cub 631848 SHR/OlaIpcv strain MP:0002079 increased circulating insulin level IAGP N RGD:728088|PMID:10925780 20200409 RGD compared to BN/Cub 631848 SHR/OlaIpcv strain MP:0002842 increased systemic arterial blood pressure IAGP N RGD:728088|PMID:10925780 20200409 RGD compared to PD/Cub, BN/Cub 631848 SHR/OlaIpcv strain MP:0002981 increased liver weight IAGP N RGD:728088|PMID:10925780 20200409 RGD compared to BN/Cub 631848 SHR/OlaIpcv strain MP:0003917 increased kidney weight IAGP N RGD:728088|PMID:10925780 20200409 RGD compared to BN/Cub 631848 SHR/OlaIpcv strain MP:0005559 increased circulating glucose level IAGP N RGD:728088|PMID:10925780 20200409 RGD compared to BN/Cub 631848 SHR/OlaIpcv strain MP:0006143 increased systemic arterial diastolic blood pressure induced IAGP XCO:0000164 N RGD:2312571|PMID:19620519 20200423 RGD 631848 SHR/OlaIpcv strain MP:0006144 increased systemic arterial systolic blood pressure induced IAGP XCO:0000164 N RGD:2312571|PMID:19620519 20090821 RGD 631848 SHR/OlaIpcv strain MP:0010955 abnormal respiratory electron transport chain IAGP N RGD:150429949|PMID:29261326 20211013 RGD compared to SHR-2 634305 Mamtr1 Mammary tumor resistance QTL 1 qtl MP:0010269 decreased mammary gland tumor incidence IAGP N RGD:631852|PMID:12844486 20111107 RGD 634306 Bp140 Blood pressure QTL 140 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:631322|PMID:11924719 19990101 RGD 634307 Bp141 Blood pressure QTL 141 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:631324|PMID:10523818 19990101 RGD 634308 Sach6 Saccharin preference QTL 6 qtl MP:0002805 abnormal conditioned taste aversion behavior QTM N RGD:631221|PMID:11958542 19990101 RGD 634310 Bp142 Blood pressure QTL 142 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:631324|PMID:10523818 19990101 RGD 634311 Sach7 Saccharin preference QTL 7 qtl MP:0002805 abnormal conditioned taste aversion behavior QTM N RGD:631221|PMID:11958542 19990101 RGD 634312 Bp143 Blood pressure QTL 143 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:631325|PMID:11984003 19990101 RGD 634313 Niddm43 Non-insulin dependent diabetes mellitus QTL 43 qtl MP:0002727 decreased circulating insulin level QTM N RGD:619688|PMID:11723056 19990101 RGD 634313 Niddm43 Non-insulin dependent diabetes mellitus QTL 43 qtl MP:0005293 impaired glucose tolerance QTM N RGD:619688|PMID:11723056 19990101 RGD 634314 Niddm44 Non-insulin dependent diabetes mellitus QTL 44 qtl MP:0002727 decreased circulating insulin level QTM N RGD:619688|PMID:11723056 19990101 RGD 634314 Niddm44 Non-insulin dependent diabetes mellitus QTL 44 qtl MP:0005293 impaired glucose tolerance QTM N RGD:619688|PMID:11723056 19990101 RGD 634315 Niddm45 Non-insulin dependent diabetes mellitus QTL 45 qtl MP:0005457 abnormal percent body fat/body weight QTM N RGD:619678|PMID:10373320 19990101 RGD 634315 Niddm45 Non-insulin dependent diabetes mellitus QTL 45 qtl MP:0005559 increased circulating glucose level QTM N RGD:619678|PMID:10373320 19990101 RGD 634317 Bw117 Body weight QTL 117 qtl MP:0010024 increased total body fat amount IDA N RGD:619678|PMID:10373320 20111107 RGD 634318 Bw118 Body weight QTL 118 qtl MP:0001262 decreased body weight QTM N RGD:619678|PMID:10373320 19990101 RGD 634318 Bw118 Body weight QTL 118 qtl MP:0005560 decreased circulating glucose level IAGP N RGD:619678|PMID:10373320 19990101 RGD 634318 Bw118 Body weight QTL 118 qtl MP:0010025 decreased total body fat amount IDA N RGD:619678|PMID:10373320 20111104 RGD 634319 Bw119 Body weight QTL 119 qtl MP:0005293 impaired glucose tolerance QTM N RGD:619678|PMID:10373320 19990101 RGD 634319 Bw119 Body weight QTL 119 qtl MP:0010025 decreased total body fat amount IDA N RGD:619678|PMID:10373320 20111104 RGD 634320 Niddm49 Non-insulin dependent diabetes mellitus QTL 49 qtl MP:0005560 decreased circulating glucose level QTM N RGD:619678|PMID:10373320 19990101 RGD 634321 Hc1 Hypercalciuria QTL 1 qtl MP:0005441 increased urine calcium level QTM N RGD:631855|PMID:12819244 19990101 RGD 634322 Bw12 Body weight QTL 12 qtl MP:0001260 increased body weight QTM N RGD:619682|PMID:11414764 19990101 RGD 634323 Hc2 Hypercalciuria QTL 2 qtl MP:0005441 increased urine calcium level QTM N RGD:631855|PMID:12819244 19990101 RGD 634325 Bw13 Body weight QTL 13 qtl MP:0001260 increased body weight QTM N RGD:619682|PMID:11414764 19990101 RGD 634325 Bw13 Body weight QTL 13 qtl MP:0001869 pancreas inflammation QTM N RGD:619682|PMID:11414764 19990101 RGD 634325 Bw13 Body weight QTL 13 qtl MP:0002079 increased circulating insulin level QTM N RGD:619682|PMID:11414764 19990101 RGD 634326 Hc3 Hypercalciuria QTL 3 qtl MP:0005441 increased urine calcium level QTM N RGD:631855|PMID:12819244 19990101 RGD 634327 Hc4 Hypercalciuria QTL 4 qtl MP:0005441 increased urine calcium level QTM N RGD:631855|PMID:12819244 19990101 RGD 634328 Hc5 Hypercalciuria QTL 5 qtl MP:0005441 increased urine calcium level QTM N RGD:631855|PMID:12819244 19990101 RGD 634329 Pia15 Pristane induced arthritis QTL 15 qtl MP:0002936 joint swelling QTM N RGD:631850|PMID:12817024 19990101 RGD 634330 Pia16 Pristane induced arthritis QTL 16 qtl MP:0002936 joint swelling QTM N RGD:631850|PMID:12817024 19990101 RGD 634331 Pia17 Pristane induced arthritis QTL 17 qtl MP:0002936 joint swelling QTM N RGD:631850|PMID:12817024 19990101 RGD 634332 Pia18 Pristane induced arthritis QTL 18 qtl MP:0002936 joint swelling QTM N RGD:631850|PMID:12817024 19990101 RGD 634333 Pia19 Pristane induced arthritis QTL 19 qtl MP:0002936 joint swelling QTM N RGD:631850|PMID:12817024 19990101 RGD 634334 Xhs3 X-ray hypersensitivity QTL 3 qtl MP:0002879 increased cellular sensitivity to X-ray irradiation QTM N RGD:631318|PMID:11381618 19990101 RGD 634335 Anxrr16 Anxiety related response QTL 16 qtl MP:0001363 increased anxiety-related response IAGP N RGD:631324|PMID:10523818 19990101 RGD 634336 Anxrr17 Anxiety related response QTL 17 qtl MP:0001364 decreased anxiety-related response IAGP N RGD:631324|PMID:10523818 19990101 RGD 634338 Hcar4 Hepatocarcinoma resistance QTL 4 qtl MP:0010265 decreased hepatoma incidence IDA N RGD:619609|PMID:10850431 20111107 RGD 634339 Niddm50 Non-insulin dependent diabetes mellitus QTL 50 qtl MP:0005457 abnormal percent body fat/body weight QTM N RGD:619678|PMID:10373320 19990101 RGD 634339 Niddm50 Non-insulin dependent diabetes mellitus QTL 50 qtl MP:0005559 increased circulating glucose level QTM N RGD:619678|PMID:10373320 19990101 RGD 634340 Hcar5 Hepatocarcinoma resistance QTL 5 qtl MP:0010265 decreased hepatoma incidence IDA N RGD:619609|PMID:10850431 20111107 RGD 634341 Bw121 Body weight QTL 121 qtl MP:0001260 increased body weight QTM N RGD:619678|PMID:10373320 19990101 RGD 634341 Bw121 Body weight QTL 121 qtl MP:0010024 increased total body fat amount IDA N RGD:619678|PMID:10373320 20111107 RGD 634342 Cia24 Collagen induced arthritis QTL 24 qtl MP:0002936 joint swelling QTM N RGD:61066|PMID:10857786 19990101 RGD 634343 Hcar6 Hepatocarcinoma resistance QTL 6 qtl MP:0010265 decreased hepatoma incidence IDA N RGD:619609|PMID:10850431 20111107 RGD 634344 Hcar7 Hepatocarcinoma resistance QTL 7 qtl MP:0010265 decreased hepatoma incidence IDA N RGD:619609|PMID:10850431 20111107 RGD 634346 Insul4 Insulin level QTL 4 qtl MP:0001869 pancreas inflammation QTM N RGD:619682|PMID:11414764 19990101 RGD 634346 Insul4 Insulin level QTL 4 qtl MP:0002079 increased circulating insulin level QTM N RGD:619682|PMID:11414764 19990101 RGD 634346 Insul4 Insulin level QTL 4 qtl MP:0002833 increased heart weight QTM N RGD:619682|PMID:11414764 19990101 RGD 634347 Hcar8 Hepatocarcinoma resistance QTL 8 qtl MP:0010265 decreased hepatoma incidence IDA N RGD:619609|PMID:10850431 20111107 RGD 634348 Bp138 Blood pressure QTL 138 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:631321|PMID:12358148 19990101 RGD 634349 Bp139 Blood pressure QTL 139 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:631851|PMID:12790759 19990101 RGD 634350 Apr4 Acute phase response QTL 4 qtl MP:0010211 abnormal acute phase protein level QTM N RGD:629561|PMID:11817600 19990101 RGD 634351 Apr5 Acute phase response QTL 5 qtl MP:0008595 abnormal circulating interleukin-6 level IDA N RGD:629561|PMID:11817600 20111101 RGD 634352 Apr6 Acute phase response QTL 6 qtl MP:0008595 abnormal circulating interleukin-6 level IDA N RGD:629561|PMID:11817600 20111101 RGD 634353 Rends2 Renal damage susceptibility QTL 2 qtl MP:0000530 abnormal kidney vasculature morphology QTM N RGD:631854|PMID:12874092 19990101 RGD 634354 Rends3 Renal damage susceptibility QTL 3 qtl MP:0000530 abnormal kidney vasculature morphology QTM N RGD:631854|PMID:12874092 19990101 RGD 634355 Rends4 Renal damage susceptibility QTL 4 qtl MP:0000530 abnormal kidney vasculature morphology QTM N RGD:631854|PMID:12874092 19990101 RGD 634359 WF.WKY-(D5Pas1-D5Uwm37)/Uwm strain MP:0004502 decreased incidence of tumors by chemical induction induced IAGP XCO:0000090 N RGD:631852|PMID:12844486 20200304 RGD compared to WF/NHsd 634359 WF.WKY-(D5Pas1-D5Uwm37)/Uwm strain MP:0010269 decreased mammary gland tumor incidence induced IAGP XCO:0000090 N RGD:631852|PMID:12844486 20200304 RGD compared to WF/NHsd 634363 LEW/NIcoCrlf strain MP:0001745 increased circulating corticosterone level induced IAGP XCO:0000703 N RGD:1598975|PMID:17052845 20070119 RGD 634363 LEW/NIcoCrlf strain MP:0001745 increased circulating corticosterone level sexual_dimorphism IAGP N RGD:1598975|PMID:17052845 20200511 RGD females compared to males 634363 LEW/NIcoCrlf strain MP:0001973 increased thermal nociceptive threshold induced IAGP XCO:0000703 N RGD:1598975|PMID:17052845 20200511 RGD 634363 LEW/NIcoCrlf strain MP:0003546 decreased alcohol consumption IAGP N RGD:1598390|PMID:16923148 20061121 RGD 634363 LEW/NIcoCrlf strain MP:0012347 low sweet preference IAGP N RGD:1598390|PMID:16923148 20061121 RGD compared to SHR/NIcoCrlf strain 634364 SHR/NIcoCrlf strain MP:0001364 decreased anxiety-related response IAGP N RGD:1598390|PMID:16923148 20061121 RGD compared to LEW/NlcoCrlf strain 634364 SHR/NIcoCrlf strain MP:0001399 hyperactivity sexual_dimorphism IAGP N RGD:1598390|PMID:16923148 20200508 RGD females compared to LEW/NIcoCrlf females 634364 SHR/NIcoCrlf strain MP:0001399 hyperactivity sexual_dimorphism IAGP N RGD:4109649|PMID:9821556 20200414 RGD compared to LEW/NIcoCrlf strain 634364 SHR/NIcoCrlf strain MP:0001745 increased circulating corticosterone level induced IAGP XCO:0000703 N RGD:1598975|PMID:17052845 20070119 RGD 634364 SHR/NIcoCrlf strain MP:0001745 increased circulating corticosterone level sexual_dimorphism IAGP N RGD:1598975|PMID:17052845 20200511 RGD females compared to males 634364 SHR/NIcoCrlf strain MP:0001973 increased thermal nociceptive threshold IAGP N RGD:1598975|PMID:17052845 20200511 RGD compared to LEW/NIcoCrlf strain 634364 SHR/NIcoCrlf strain MP:0001973 increased thermal nociceptive threshold induced IAGP XCO:0000703 N RGD:1598975|PMID:17052845 20200511 RGD 634364 SHR/NIcoCrlf strain MP:0001987 alcohol preference IAGP N RGD:1598390|PMID:16923148 20200508 RGD compared to LEW/NlcoCrlf strain at lower alcohol concentrations 634364 SHR/NIcoCrlf strain MP:0001987 alcohol preference sexual_dimorphism IAGP N RGD:1598390|PMID:16923148 20061121 RGD females compared to LEW/NlcoCrlf females at higher alcohol concentrations 634364 SHR/NIcoCrlf strain MP:0002065 abnormal fear/anxiety-related behavior IAGP N RGD:631324|PMID:10523818 19990101 RGD compared to LEW/NIcoCrlf strain 634364 SHR/NIcoCrlf strain MP:0002065 abnormal fear/anxiety-related behavior sexual_dimorphism IAGP N RGD:631324|PMID:10523818 19990101 RGD compared to males 634364 SHR/NIcoCrlf strain MP:0006144 increased systemic arterial systolic blood pressure sexual_dimorphism IAGP N RGD:4109649|PMID:9821556 20200414 RGD compared to females 634364 SHR/NIcoCrlf strain MP:0020870 decreased thigmotaxis IAGP N RGD:4109649|PMID:9821556 20200414 RGD compared to LEW/NIcoCrlf strain 634365 SS/Hsd strain MP:0000182 increased circulating LDL cholesterol level IAGP N RGD:737694|PMID:14739155 19990101 RGD compared to SR/Hsd 634365 SS/Hsd strain MP:0001261 obese IAGP N RGD:737694|PMID:14739155 19990101 RGD compared to SR/Hsd 634365 SS/Hsd strain MP:0001552 increased circulating triglyceride level IAGP N RGD:737694|PMID:14739155 19990101 RGD compared to SR/Hsd 634365 SS/Hsd strain MP:0001556 increased circulating HDL cholesterol level IAGP N RGD:737694|PMID:14739155 19990101 RGD compared to SR/Hsd 634365 SS/Hsd strain MP:0002842 increased systemic arterial blood pressure IAGP N RGD:4890416|PMID:20044442 20191121 RGD compared to BN/Crl 634365 SS/Hsd strain MP:0011640 abnormal aorta collagen fibril morphology IAGP N RGD:4890416|PMID:20044442 20191121 RGD compared to SS-Chr 2BN/Mcwi, BN/Crl 634366 SR/Hsd strain MP:0010182 decreased susceptibility to weight gain IAGP N RGD:737694|PMID:14739155 19990101 RGD compared to SS/Hsd 634370 F344.GK-(D1Mgh10-D1Rat119)/Swe strain MP:0001556 increased circulating HDL cholesterol level IAGP N RGD:619677|PMID:10580437 20180129 RGD compared to F344/DuCrlSwe 634372 GHS strain MP:0003639 abnormal response to vitamins IAGP N RGD:13432078|PMID:9593778 20170918 RGD 634373 DA/ZtmRhd strain MP:0002933 joint inflammation induced IAGP XCO:0000263 N RGD:629561|PMID:11817600 20191122 RGD compared to control strain E3 634373 DA/ZtmRhd strain MP:0002936 joint swelling induced IAGP XCO:0000263 N RGD:629561|PMID:11817600 20191122 RGD compared to control strain E3 634373 DA/ZtmRhd strain MP:0003724 increased susceptibility to induced arthritis induced IAGP XCO:0000263 N RGD:2302026|PMID:14674011 20081117 RGD compared to E3/ZtmRhd 634373 DA/ZtmRhd strain MP:0003724 increased susceptibility to induced arthritis induced IAGP XCO:0000263 N RGD:629561|PMID:11817600 20191122 RGD compared to control strain E3 634373 DA/ZtmRhd strain MP:0004622 sacral vertebral fusion induced IAGP XCO:0000263 N RGD:629561|PMID:11817600 20191122 RGD compared to control strain E3 634373 DA/ZtmRhd strain MP:0008596 increased circulating interleukin-6 level induced IAGP XCO:0000263 N RGD:629561|PMID:11817600 20191122 RGD compared to control strain E3 634373 DA/ZtmRhd strain MP:0010211 abnormal acute phase protein level induced IAGP XCO:0000263 N RGD:629561|PMID:11817600 20191122 RGD compared to control strain E3 634373 DA/ZtmRhd strain MP:0012331 increased circulating fibrinogen level induced IAGP XCO:0000263 N RGD:629561|PMID:11817600 20191122 RGD compared to control strain E3 634373 DA/ZtmRhd strain MP:0030805 abnormal limb joint morphology induced IAGP XCO:0000263 N RGD:629561|PMID:11817600 20191122 RGD compared to control strain E3 634374 E3/ZtmRhd strain MP:0003436 decreased susceptibility to induced arthritis induced IAGP XCO:0000263 N RGD:2302026|PMID:14674011 20081117 RGD compared to DA/ZtmRhd 634376 LEA/Ncu strain MP:0003992 increased mortality induced by ionizing radiation IAGP N RGD:631318|PMID:11381618 19990101 RGD compared to BN/Sea 634377 BN/Sea BN/Sea strain MP:0003010 decreased mortality induced by ionizing radiation IAGP N RGD:69702|PMID:11003700 20201029 RGD compared to LEC/Ncu 634380 iP/Iusm inbred alcohol-preferring strain MP:0001987 alcohol preference IAGP N RGD:1643000|PMID:17413446 20200514 RGD compared to ACI/N 634380 iP/Iusm inbred alcohol-preferring strain MP:0003545 increased alcohol consumption IAGP N RGD:1643000|PMID:17413446 20200514 RGD compared to ACI/N 634382 SHR.BN-(D5Wox12-D5Wox20)/Ipcv strain MP:0001260 increased body weight IAGP N RGD:631851|PMID:12790759 20200108 RGD compared to SHR/OlaIpcv strain 634382 SHR.BN-(D5Wox12-D5Wox20)/Ipcv strain MP:0003918 decreased kidney weight IAGP N RGD:631851|PMID:12790759 20200108 RGD compared to SHR/OlaIpcv strain 634382 SHR.BN-(D5Wox12-D5Wox20)/Ipcv strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:631851|PMID:12790759 20200108 RGD compared to SHR/OlaIpcv strain 6478680 Anxrr29 Anxiety related response QTL 29 qtl MP:0001363 increased anxiety-related response IDA N RGD:6218999|PMID:21516450 20120312 RGD 6478684 Anxrr30 Anxiety related response QTL 30 qtl MP:0001363 increased anxiety-related response IDA N RGD:6218999|PMID:21516450 20120312 RGD 6478686 Anxrr31 Anxiety related response QTL 31 qtl MP:0001363 increased anxiety-related response IDA N RGD:6218999|PMID:21516450 20120312 RGD 6478693 Anxrr32 Anxiety related response QTL 32 qtl MP:0001363 increased anxiety-related response IDA N RGD:6218999|PMID:21516450 20120312 RGD 6478700 Anxrr33 Anxiety related response QTL 33 qtl MP:0001363 increased anxiety-related response IDA N RGD:6218999|PMID:21516450 20120312 RGD 6478718 Anxrr34 Anxiety related response QTL 34 qtl MP:0001363 increased anxiety-related response IDA N RGD:6218999|PMID:21516450 20120312 RGD 6478720 Alc23 Alcohol consumption QTL 23 qtl MP:0003545 increased alcohol consumption IDA N RGD:6218999|PMID:21516450 20120312 RGD 6478724 Anxrr35 Anxiety related response QTL 35 qtl MP:0001363 increased anxiety-related response IDA N RGD:6218999|PMID:21516450 20120312 RGD 6478728 Anxrr36 Anxiety related response QTL 36 qtl MP:0001363 increased anxiety-related response IDA N RGD:6218999|PMID:21516450 20120312 RGD 6478733 Anxrr37 Anxiety related response QTL 37 qtl MP:0001363 increased anxiety-related response IDA N RGD:6218999|PMID:21516450 20120312 RGD 6478737 Anxrr38 Anxiety related response QTL 38 qtl MP:0001363 increased anxiety-related response IDA N RGD:6218999|PMID:21516450 20120312 RGD 6478740 Anxrr39 Anxiety related response QTL 39 qtl MP:0001363 increased anxiety-related response IDA N RGD:6218999|PMID:21516450 20120312 RGD 6478743 Anxrr40 Anxiety related response QTL 40 qtl MP:0001363 increased anxiety-related response IDA N RGD:6218999|PMID:21516450 20120312 RGD 6478745 Anxrr41 Anxiety related response QTL 41 qtl MP:0001363 increased anxiety-related response IDA N RGD:6218999|PMID:21516450 20120312 RGD 6478748 Anxrr42 Anxiety related response QTL 42 qtl MP:0001363 increased anxiety-related response IDA N RGD:6218999|PMID:21516450 20120312 RGD 6478754 Anxrr43 Anxiety related response QTL 43 qtl MP:0001363 increased anxiety-related response IDA N RGD:6218999|PMID:21516450 20120312 RGD 6478757 Anxrr44 Anxiety related response QTL 44 qtl MP:0001363 increased anxiety-related response IDA N RGD:6218999|PMID:21516450 20120312 RGD 6478760 Anxrr45 Anxiety related response QTL 45 qtl MP:0001363 increased anxiety-related response IDA N RGD:6218999|PMID:21516450 20120312 RGD 6478763 Anxrr46 Anxiety related response QTL 46 qtl MP:0001363 increased anxiety-related response IDA N RGD:6218999|PMID:21516450 20120312 RGD 6478766 Anxrr47 Anxiety related response QTL 47 qtl MP:0001363 increased anxiety-related response IDA N RGD:6218999|PMID:21516450 20120312 RGD 6478769 Anxrr48 Anxiety related response QTL 48 qtl MP:0001363 increased anxiety-related response IDA N RGD:6218999|PMID:21516450 20120312 RGD 6478772 Anxrr49 Anxiety related response QTL 49 qtl MP:0001363 increased anxiety-related response IDA N RGD:6218999|PMID:21516450 20120312 RGD 6478775 Anxrr50 Anxiety related response QTL 50 qtl MP:0001363 increased anxiety-related response IDA N RGD:6218999|PMID:21516450 20120312 RGD 6478778 Anxrr51 Anxiety related response QTL 51 qtl MP:0001363 increased anxiety-related response IDA N RGD:6218999|PMID:21516450 20120312 RGD 6478782 Anxrr52 Anxiety related response QTL 52 qtl MP:0001363 increased anxiety-related response IDA N RGD:6218999|PMID:21516450 20120312 RGD 6478785 Anxrr53 Anxiety related response QTL 53 qtl MP:0001363 increased anxiety-related response IDA N RGD:6218999|PMID:21516450 20120312 RGD 6478788 STOCK-Tp53tm1(EGFP-Pac)Qly/Rrrc p53 knockout rat strain MP:0002036 increased rhabdomyosarcoma incidence IAGP N RGD:12792958|PMID:22791818 20170316 RGD 6478788 STOCK-Tp53tm1(EGFP-Pac)Qly/Rrrc p53 knockout rat strain MP:0003667 increased hemangiosarcoma incidence IAGP N RGD:12792958|PMID:22791818 20170316 RGD 6478788 STOCK-Tp53tm1(EGFP-Pac)Qly/Rrrc p53 knockout rat strain MP:0004499 increased incidence of tumors by chemical induction IAGP N RGD:12792958|PMID:22791818 20170316 RGD 6478788 STOCK-Tp53tm1(EGFP-Pac)Qly/Rrrc p53 knockout rat strain MP:0010273 increased classified tumor incidence IAGP N RGD:12792958|PMID:22791818 20170316 RGD 6478788 STOCK-Tp53tm1(EGFP-Pac)Qly/Rrrc p53 knockout rat strain MP:0012431 increased lymphoma incidence IAGP N RGD:12792958|PMID:22791818 20170316 RGD 6480190 NAft:HS Heterogeneous stock strain MP:0001260 increased body weight IAGP N RGD:6480192|PMID:21334473 20200414 RGD compared to females of ACI/N, BN/SsNHsd, F344/NHsd 6480190 NAft:HS Heterogeneous stock strain MP:0001363 increased anxiety-related response IAGP N RGD:6480191|PMID:19447285 20120314 RGD compared to RHA/N-di 6480190 NAft:HS Heterogeneous stock strain MP:0001364 decreased anxiety-related response sexual_dimorphism IAGP N RGD:6480211|PMID:22118015 20120315 RGD compared to males 6480190 NAft:HS Heterogeneous stock strain MP:0001399 hyperactivity sexual_dimorphism IAGP N RGD:6480211|PMID:22118015 20201216 RGD compared to males 6480190 NAft:HS Heterogeneous stock strain MP:0003460 decreased fear-related response sexual_dimorphism IAGP N RGD:6480211|PMID:22118015 20120315 RGD compared to males 6480190 NAft:HS Heterogeneous stock strain MP:0004348 long femur IAGP N RGD:6480192|PMID:21334473 20200414 RGD compared to females of BN/SsNHsd, WKY/NHsd 6480190 NAft:HS Heterogeneous stock strain MP:0010124 decreased bone mineral content IAGP N RGD:6480192|PMID:21334473 20200414 RGD compared to female BUF/NHsd 6480190 NAft:HS Heterogeneous stock strain MP:0012293 impaired active avoidance behavior IAGP N RGD:6480191|PMID:19447285 20120314 RGD compared to RHA/N-di 6480190 NAft:HS Heterogeneous stock strain MP:0013618 decreased areal bone mineral density IAGP N RGD:6480192|PMID:21334473 20200414 RGD female 6480190 NAft:HS Heterogeneous stock strain MP:0030788 abnormal femur head morphology IAGP N RGD:6480192|PMID:21334473 20120314 RGD compared to female WKY/NHsd 6480190 NAft:HS Heterogeneous stock strain MP:0030789 abnormal femur neck morphology IAGP N RGD:6480192|PMID:21334473 20200414 RGD narrower femur neck width 6480210 SHR-Chr 8MWF/Rkb strain MP:0002871 albuminuria induced IAGP XCO:0000100 N RGD:6480206|PMID:22108208 20200421 RGD compared to treated SHR/FubRkb 6480210 SHR-Chr 8MWF/Rkb strain MP:0002871 albuminuria induced IAGP XCO:0000113 N RGD:6480206|PMID:22108208 20200421 RGD compared to treated SHR/FubRkb 6480210 SHR-Chr 8MWF/Rkb strain MP:0003916 decreased heart left ventricle weight induced IAGP XCO:0000100 N RGD:6480206|PMID:22108208 20200421 RGD compared to treated SHR/FubRkb 6480210 SHR-Chr 8MWF/Rkb strain MP:0003916 decreased heart left ventricle weight induced IAGP XCO:0000113 N RGD:6480206|PMID:22108208 20200421 RGD compared to treated SHR/FubRkb 6480210 SHR-Chr 8MWF/Rkb strain MP:0005264 glomerulosclerosis induced IAGP XCO:0000113 N RGD:6480206|PMID:22108208 20200421 RGD compared to sham surgical control condition SHR-Chr8MWF/Rkb, treated SHR/FubRkb 6480210 SHR-Chr 8MWF/Rkb strain MP:0006144 increased systemic arterial systolic blood pressure induced IAGP XCO:0000113 N RGD:6480206|PMID:22108208 20200421 RGD compared to sham surgical control condition SHR-Chr8MWF/Rkb 6480210 SHR-Chr 8MWF/Rkb strain MP:0006264 decreased systemic arterial systolic blood pressure induced IAGP XCO:0000100 N RGD:6480206|PMID:22108208 20200421 RGD compared to treated SHR/FubRkb 6480210 SHR-Chr 8MWF/Rkb strain MP:0011405 tubulointerstitial nephritis induced IAGP XCO:0000113 N RGD:6480206|PMID:22108208 20200427 RGD compared to sham surgical control condition SHR-Chr8MWF/Rkb, treated SHR/FubRkb 6480218 AR-Ednrbsl/Hkv Aganglionosis rat strain MP:0000692 small spleen IAGP N RGD:7207471|PMID:22975636 20171206 RGD 6480218 AR-Ednrbsl/Hkv Aganglionosis rat strain MP:0002926 aganglionic megacolon IAGP N RGD:6480217|PMID:21915282 20120315 RGD 6480218 AR-Ednrbsl/Hkv Aganglionosis rat strain MP:0004364 thin stria vascularis IAGP N RGD:6480217|PMID:21915282 20171206 RGD 6480218 AR-Ednrbsl/Hkv Aganglionosis rat strain MP:0004750 syndromic hearing loss IAGP N RGD:6480217|PMID:21915282 20120315 RGD 6480218 AR-Ednrbsl/Hkv Aganglionosis rat strain MP:0004956 decreased thymus weight IAGP N RGD:7207471|PMID:22975636 20171206 RGD 6480218 AR-Ednrbsl/Hkv Aganglionosis rat strain MP:0005408 hypopigmentation IAGP N RGD:6480217|PMID:21915282 20120315 RGD 6480218 AR-Ednrbsl/Hkv Aganglionosis rat strain MP:0008470 abnormal spleen B cell follicle morphology IAGP N RGD:7207471|PMID:22975636 20171206 RGD 6480218 AR-Ednrbsl/Hkv Aganglionosis rat strain MP:0008477 decreased spleen red pulp amount IAGP N RGD:7207471|PMID:22975636 20171207 RGD 6480218 AR-Ednrbsl/Hkv Aganglionosis rat strain MP:0009323 abnormal spleen development IAGP N RGD:7207471|PMID:22975636 20171206 RGD 6480220 LEH/Hkv Aganglionosis rat strain MP:0002926 aganglionic megacolon IAGP N RGD:6480217|PMID:21915282 20120315 RGD 6480220 LEH/Hkv Aganglionosis rat strain MP:0004750 syndromic hearing loss IAGP N RGD:6480217|PMID:21915282 20120315 RGD 6480220 LEH/Hkv Aganglionosis rat strain MP:0005408 hypopigmentation IAGP N RGD:6480217|PMID:21915282 20120315 RGD 6480223 F344.AR-Ednrbsl/Hkv Aganglionosis rat strain MP:0002926 aganglionic megacolon penetrance IAGP N RGD:6480215|PMID:22132166 20120315 RGD 6480223 F344.AR-Ednrbsl/Hkv Aganglionosis rat strain MP:0004750 syndromic hearing loss IAGP N RGD:6480217|PMID:21915282 20120315 RGD 6480223 F344.AR-Ednrbsl/Hkv Aganglionosis rat strain MP:0008770 decreased survivor rate IAGP N RGD:6480217|PMID:21915282 20120315 RGD 6480225 Gdil1 Gastrointestinal dilation QTL 1 qtl MP:0002926 aganglionic megacolon IDA N RGD:6480217|PMID:21915282 20120316 RGD 6480773 Gluco64 Glucose level QTL 64 qtl MP:0005293 impaired glucose tolerance IDA N RGD:6893578|PMID:22947656 20131022 RGD 6480777 Insul17 Insulin level QTL 17 qtl MP:0002079 increased circulating insulin level IDA N RGD:6893578|PMID:22947656 20131022 RGD 6480780 Insul18 Insulin level QTL 18 qtl MP:0002079 increased circulating insulin level IDA N RGD:6893578|PMID:22947656 20131022 RGD 6480783 Insul19 Insulin level QTL 19 qtl MP:0002079 increased circulating insulin level IDA N RGD:6893578|PMID:22947656 20131022 RGD 6480866 BN-Chr 13LH/MavRrrc strain MP:0005527 increased renal glomerular filtration rate induced IAGP XCO:0000164 N RGD:2313340|PMID:19462495 20200207 RGD compared to BN/NHsdMcwi 6480866 BN-Chr 13LH/MavRrrc strain MP:0006316 increased urine sodium level IAGP N RGD:2313340|PMID:19462495 20200207 RGD compared to BN/NHsdMcwi 6480866 BN-Chr 13LH/MavRrrc strain MP:0006316 increased urine sodium level induced IAGP XCO:0000164 N RGD:2313340|PMID:19462495 20200207 RGD compared to BN/NHsdMcwi 6482243 WI-CitfhJjlo/Rrrc flathead rat strain MP:0003708 binucleate IAGP N RGD:13204832|PMID:11932363 20170721 RGD 6482243 WI-CitfhJjlo/Rrrc flathead rat strain MP:0012138 decreased forebrain size IAGP N RGD:13204832|PMID:11932363 20170721 RGD 6482243 WI-CitfhJjlo/Rrrc flathead rat strain MP:0012174 flat head IAGP N RGD:13204836|PMID:10219263 20170721 RGD 6482245 SS-Tg(Atp1a1)24OpazRrrc strain MP:0001661 extended life span IMP N RGD:2292511|PMID:9739044 20201104 RGD 6482245 SS-Tg(Atp1a1)24OpazRrrc strain MP:0004876 decreased mean systemic arterial blood pressure induced IMP XCO:0000022 N RGD:2292511|PMID:9739044 20080514 RGD compared to SS/JrHsd 6482245 SS-Tg(Atp1a1)24OpazRrrc strain MP:0005166 decreased susceptibility to injury induced IMP XCO:0000022 N RGD:2292511|PMID:9739044 20201104 RGD compared to SS/JrHsd 6482245 SS-Tg(Atp1a1)24OpazRrrc strain MP:0006263 decreased systemic arterial diastolic blood pressure induced IMP XCO:0000022 N RGD:2292511|PMID:9739044 20201104 RGD compared to SS/JrHsd 6482245 SS-Tg(Atp1a1)24OpazRrrc strain MP:0006264 decreased systemic arterial systolic blood pressure induced IMP XCO:0000022 N RGD:2292511|PMID:9739044 20201104 RGD compared to SS/JrHsd 6482247 FDIO/Rrrc strain MP:0001260 increased body weight susceptibility IAGP N RGD:6482246|PMID:12855420 20200330 RGD compared to F344 6482247 FDIO/Rrrc strain MP:0002079 increased circulating insulin level IAGP XCO:0000015,XCO:0000025 N RGD:24922212|PMID:15879056 20200330 RGD compared to standard diet fed rats and F344 control strain 6482247 FDIO/Rrrc strain MP:0002079 increased circulating insulin level susceptibility IAGP XCO:0000015,XCO:0000025 N RGD:6482246|PMID:12855420 20200330 RGD compared to standard diet fed rats and F344 rats 6482247 FDIO/Rrrc strain MP:0002981 increased liver weight susceptibility IAGP XCO:0000015,XCO:0000025 N RGD:6482246|PMID:12855420 20200330 RGD compared to standard diet fed rats 6482247 FDIO/Rrrc strain MP:0003926 decreased cellular glucose uptake susceptibility IAGP N RGD:24922212|PMID:15879056 20200330 RGD compared to F344 6482247 FDIO/Rrrc strain MP:0005291 abnormal glucose tolerance susceptibility IAGP N RGD:24922212|PMID:15879056 20200330 RGD compared to F344 6482247 FDIO/Rrrc strain MP:0005291 abnormal glucose tolerance susceptibility IAGP XCO:0000015,XCO:0000025 N RGD:6482246|PMID:12855420 20200330 RGD compared to standard diet fed rats and F344 rats 6482247 FDIO/Rrrc strain MP:0005331 insulin resistance susceptibility IAGP N RGD:24922212|PMID:15879056 20200330 RGD compared to F344 6482247 FDIO/Rrrc strain MP:0005455 increased susceptibility to weight gain IAGP N RGD:6482246|PMID:12855420 20120420 RGD diet, sexual dimorphism 6482247 FDIO/Rrrc strain MP:0005669 increased circulating leptin level IAGP XCO:0000015,XCO:0000025 N RGD:24922212|PMID:15879056 20200330 RGD compared to standard diet fed rats 6482247 FDIO/Rrrc strain MP:0005669 increased circulating leptin level susceptibility IAGP XCO:0000015,XCO:0000025 N RGD:6482246|PMID:12855420 20200330 RGD compared to standard diet fed rats and F344 rats 6482247 FDIO/Rrrc strain MP:0008908 increased total fat pad weight susceptibility IAGP N RGD:24922212|PMID:15879056 20200330 RGD compared to F344 6482247 FDIO/Rrrc strain MP:0009288 increased epididymal fat pad weight susceptibility IAGP N RGD:24922212|PMID:15879056 20200330 RGD compared to F344 6482247 FDIO/Rrrc strain MP:0009292 increased inguinal fat pad weight susceptibility IAGP N RGD:24922212|PMID:15879056 20200330 RGD compared to F344 6482247 FDIO/Rrrc strain MP:0009298 increased mesenteric fat pad weight susceptibility IAGP N RGD:24922212|PMID:15879056 20200330 RGD compared to F344 6482247 FDIO/Rrrc strain MP:0009304 increased retroperitoneal fat pad weight susceptibility IAGP N RGD:24922212|PMID:15879056 20200330 RGD compared to F344 6482247 FDIO/Rrrc strain MP:0011939 increased food intake susceptibility IAGP N RGD:6482246|PMID:12855420 20200330 RGD compared to F344 6482247 FDIO/Rrrc strain MP:0014142 increased body fat mass susceptibility IAGP XCO:0000015,XCO:0000025 N RGD:6482246|PMID:12855420 20200330 RGD compared to standard diet fed rats 6482247 FDIO/Rrrc strain MP:0020102 increased hepatic glucose production susceptibility IAGP N RGD:24922212|PMID:15879056 20200330 RGD compared to F344 6482298 MWF/ZtmRrrc Munich Wistar Fromter strain MP:0005264 glomerulosclerosis treatment IAGP XCO:0000542 N RGD:12910758|PMID:1688888 20210709 RGD 6482298 MWF/ZtmRrrc Munich Wistar Fromter strain MP:0005528 decreased renal glomerular filtration rate treatment IAGP XCO:0000542 N RGD:12910758|PMID:1688888 20210709 RGD 6482298 MWF/ZtmRrrc Munich Wistar Fromter strain MP:0006144 increased systemic arterial systolic blood pressure treatment IAGP XCO:0000542 N RGD:12910758|PMID:1688888 20210709 RGD 6482674 HIS/NdkRrrc High-Saccharin-Consuming (HiS) Rat strain MP:0001988 cocaine preference induced IAGP XCO:0000367, XCO:0000163 N RGD:6482649|PMID:16596398 20120425 RGD compared to LOS/NdkRrrc 6482674 HIS/NdkRrrc High-Saccharin-Consuming (HiS) Rat strain MP:0002850 saccharin preference induced IAGP XCO:0000298, XCO:0000483, XCO:0000367 N RGD:6482648|PMID:8976546 20120425 RGD compared to HIS/NdkRrrc 6482676 LOS/NdkRrrc Low-Saccharin-Consuming (HiS) Rat strain MP:0002849 abnormal saccharin consumption induced IAGP XCO:0000298, XCO:0000483, XCO:0000367 N RGD:6482648|PMID:8976546 20120425 RGD compared to HIS/NdkRrrc 6482680 SD-Tg(MMTV-Erbb2)1UwmRrrc strain MP:0010269 decreased mammary gland tumor incidence induced IMP XCO:0000201 N RGD:6482679|PMID:12150826 20200310 RGD in males 6482680 SD-Tg(MMTV-Erbb2)1UwmRrrc strain MP:0010299 increased mammary gland tumor incidence induced IMP XCO:0000094,CHEBI:16330 N RGD:6482679|PMID:12150826 20200310 RGD in females 6482680 SD-Tg(MMTV-Erbb2)1UwmRrrc strain MP:0010299 increased mammary gland tumor incidence sexual_dimorphism IMP N RGD:6482679|PMID:12150826 20200310 RGD compared to females 6484581 SS-Resp18em2Mcwi strain MP:0002962 increased urine protein level IMP N RGD:14348960|PMID:29570433 20190201 RGD 6484581 SS-Resp18em2Mcwi strain MP:0004217 salt-sensitive hypertension IMP N RGD:14348960|PMID:29570433 20190201 RGD 6484582 SS-Cd247em1Mcwi strain MP:0004217 salt-sensitive hypertension severity IMP XCO:0000022 N RGD:13442481|PMID:24343121 20171102 RGD 6484582 SS-Cd247em1Mcwi strain MP:0004876 decreased mean systemic arterial blood pressure induced IMP XCO:0000022 N RGD:13442481|PMID:24343121 20171102 RGD compared to wild-type 6484582 SS-Cd247em1Mcwi strain MP:0005017 decreased B cell number IMP N RGD:13442481|PMID:24343121 20171102 RGD 6484582 SS-Cd247em1Mcwi strain MP:0005018 decreased T cell number IMP N RGD:13442481|PMID:24343121 20171102 RGD 6484582 SS-Cd247em1Mcwi strain MP:0005095 decreased T cell proliferation IMP N RGD:13442481|PMID:24343121 20171102 RGD 6484582 SS-Cd247em1Mcwi strain MP:0005540 decreased urine albumin level induced IMP XCO:0000022 N RGD:13442481|PMID:24343121 20171102 RGD 6484582 SS-Cd247em1Mcwi strain MP:0013276 absent alpha-beta T cells IMP N RGD:13442481|PMID:24343121 20171102 RGD 6484583 SS-Nr2f2em1Mcwi strain MP:0002963 decreased urine protein level IMP N RGD:10401852|PMID:25687237 20171102 RGD compared to SS/JrHsdMcw 6484583 SS-Nr2f2em1Mcwi strain MP:0005600 increased heart ventricle muscle contractility IMP N RGD:10401852|PMID:25687237 20171102 RGD compared to SS/JrHsdMcw 6484701 Leprem2Mcwi leptin receptor; zinc finger nuclease induced mutant 2, Medical College of Wisconsin gene MP:0001260 increased body weight IMP N RGD:12911217|PMID:27465994 20200702 RGD 6484701 Leprem2Mcwi leptin receptor; zinc finger nuclease induced mutant 2, Medical College of Wisconsin gene MP:0001552 increased circulating triglyceride level disease_progression IMP N RGD:12911217|PMID:27465994 20200702 RGD 6484701 Leprem2Mcwi leptin receptor; zinc finger nuclease induced mutant 2, Medical College of Wisconsin gene MP:0002079 increased circulating insulin level IMP N RGD:12911217|PMID:27465994 20200702 RGD 6484701 Leprem2Mcwi leptin receptor; zinc finger nuclease induced mutant 2, Medical College of Wisconsin gene MP:0002962 increased urine protein level IMP N RGD:12911217|PMID:27465994 20200702 RGD 6484701 Leprem2Mcwi leptin receptor; zinc finger nuclease induced mutant 2, Medical College of Wisconsin gene MP:0003215 renal interstitial fibrosis disease_progression IMP N RGD:12911217|PMID:27465994 20200702 RGD compared to SS/JrHsdMcwi 6484701 Leprem2Mcwi leptin receptor; zinc finger nuclease induced mutant 2, Medical College of Wisconsin gene MP:0005178 increased circulating cholesterol level disease_progression IMP N RGD:12911217|PMID:27465994 20200702 RGD 6484701 Leprem2Mcwi leptin receptor; zinc finger nuclease induced mutant 2, Medical College of Wisconsin gene MP:0005264 glomerulosclerosis disease_progression IMP N RGD:12911217|PMID:27465994 20201210 RGD 6484701 Leprem2Mcwi leptin receptor; zinc finger nuclease induced mutant 2, Medical College of Wisconsin gene MP:0005293 impaired glucose tolerance IMP N RGD:12911217|PMID:27465994 20200702 RGD compared to SS/JrHsdMcwi 6484701 Leprem2Mcwi leptin receptor; zinc finger nuclease induced mutant 2, Medical College of Wisconsin gene MP:0005331 insulin resistance IMP N RGD:12911217|PMID:27465994 20200702 RGD 6484701 Leprem2Mcwi leptin receptor; zinc finger nuclease induced mutant 2, Medical College of Wisconsin gene MP:0005553 increased circulating creatinine level IMP N RGD:12911217|PMID:27465994 20200702 RGD 6484701 Leprem2Mcwi leptin receptor; zinc finger nuclease induced mutant 2, Medical College of Wisconsin gene MP:0005669 increased circulating leptin level IMP N RGD:12911217|PMID:27465994 20200702 RGD 6484701 Leprem2Mcwi leptin receptor; zinc finger nuclease induced mutant 2, Medical College of Wisconsin gene MP:0006144 increased systemic arterial systolic blood pressure onset IMP N RGD:12911217|PMID:27465994 20201210 RGD compared to SS/JrHsdMcwi 6484701 Leprem2Mcwi leptin receptor; zinc finger nuclease induced mutant 2, Medical College of Wisconsin gene MP:0008140 podocyte foot process effacement IMP N RGD:12911217|PMID:27465994 20170707 RGD 6484701 Leprem2Mcwi leptin receptor; zinc finger nuclease induced mutant 2, Medical College of Wisconsin gene MP:0011855 abnormal glomerular filtration barrier morphology IMP N RGD:12911217|PMID:27465994 20200702 RGD 6484715 SS-Adora2bem2Mcwi strain MP:0001260 increased body weight IMP N RGD:11533328|PMID:26385692 20191125 RGD compared to SS/JrHsdMcwi 6484715 SS-Adora2bem2Mcwi strain MP:0001876 decreased inflammatory response IMP N RGD:11533328|PMID:26385692 20191125 RGD compared to SS/JrHsdMcwi 6484715 SS-Adora2bem2Mcwi strain MP:0002953 thick ventricular wall IMP N RGD:11533328|PMID:26385692 20191125 RGD compared to SS/JrHsdMcwi 6484715 SS-Adora2bem2Mcwi strain MP:0004878 increased systemic vascular resistance IMP N RGD:11533328|PMID:26385692 20191125 RGD compared to SS/JrHsdMcwi 6484715 SS-Adora2bem2Mcwi strain MP:0006144 increased systemic arterial systolic blood pressure IMP N RGD:11533328|PMID:26385692 20191125 RGD compared to SS/JrHsdMcwi 6484715 SS-Adora2bem2Mcwi strain MP:0008596 increased circulating interleukin-6 level IMP N RGD:11533328|PMID:26385692 20191125 RGD compared to SS/JrHsdMcwi 6484719 SS-Leprem2Mcwi strain MP:0001260 increased body weight IMP N RGD:12911217|PMID:27465994 20191216 RGD compared to SS/JrHsdMcwi 6484719 SS-Leprem2Mcwi strain MP:0001552 increased circulating triglyceride level disease_progression IMP N RGD:12911217|PMID:27465994 20191216 RGD 6484719 SS-Leprem2Mcwi strain MP:0002079 increased circulating insulin level IMP N RGD:12911217|PMID:27465994 20170707 RGD compared to SS/JrHsdMcwi 6484719 SS-Leprem2Mcwi strain MP:0002962 increased urine protein level IMP N RGD:12911217|PMID:27465994 20191216 RGD compared to SS/JrHsdMcwi 6484719 SS-Leprem2Mcwi strain MP:0003215 renal interstitial fibrosis disease_progression IMP N RGD:12911217|PMID:27465994 20170707 RGD compared to SS/JrHsdMcwi 6484719 SS-Leprem2Mcwi strain MP:0005178 increased circulating cholesterol level disease_progression IMP N RGD:12911217|PMID:27465994 20191216 RGD 6484719 SS-Leprem2Mcwi strain MP:0005264 glomerulosclerosis disease_progression IMP N RGD:12911217|PMID:27465994 20170707 RGD 6484719 SS-Leprem2Mcwi strain MP:0005293 impaired glucose tolerance IMP N RGD:12911217|PMID:27465994 20170707 RGD compared to SS/JrHsdMcwi 6484719 SS-Leprem2Mcwi strain MP:0005553 increased circulating creatinine level IMP N RGD:12911217|PMID:27465994 20191216 RGD compared to SS/JrHsdMcwi 6484719 SS-Leprem2Mcwi strain MP:0005669 increased circulating leptin level IMP N RGD:12911217|PMID:27465994 20191216 RGD compared to SS/JrHsdMcwi 6484719 SS-Leprem2Mcwi strain MP:0006144 increased systemic arterial systolic blood pressure onset IMP N RGD:12911217|PMID:27465994 20170707 RGD compared to SS/JrHsdMcwi 6484719 SS-Leprem2Mcwi strain MP:0008140 podocyte foot process effacement IMP N RGD:12911217|PMID:27465994 20200702 RGD 6484719 SS-Leprem2Mcwi strain MP:0011855 abnormal glomerular filtration barrier morphology IMP N RGD:12911217|PMID:27465994 20191216 RGD compared to SS/JrHsdMcwi 67935 WOKW strain MP:0000186 decreased circulating HDL cholesterol level IAGP N RGD:1357168|PMID:11374884 19990101 RGD compared to DA/K 67935 WOKW strain MP:0000186 decreased circulating HDL cholesterol level IAGP N RGD:619689|PMID:10720472 20191212 RGD compared to DA/K 67935 WOKW strain MP:0000188 abnormal circulating glucose level IAGP N RGD:1357168|PMID:11374884 20191216 RGD compared to DA/K 67935 WOKW strain MP:0001260 increased body weight IAGP N RGD:1357168|PMID:11374884 19990101 RGD compared to DA/K 67935 WOKW strain MP:0001260 increased body weight IAGP N RGD:1624313|PMID:17473932 20200316 RGD compared to DA/K 67935 WOKW strain MP:0001260 increased body weight IAGP N RGD:619689|PMID:10720472 20191212 RGD compared to DA/K 67935 WOKW strain MP:0001552 increased circulating triglyceride level IAGP N RGD:1357168|PMID:11374884 19990101 RGD compared to DA/K 67935 WOKW strain MP:0001552 increased circulating triglyceride level IAGP N RGD:619689|PMID:10720472 20191212 RGD compared to DA/K 67935 WOKW strain MP:0002079 increased circulating insulin level IAGP N RGD:1357168|PMID:11374884 19990101 RGD compared to DA/K 67935 WOKW strain MP:0002079 increased circulating insulin level IAGP N RGD:619689|PMID:10720472 20191212 RGD compared to DA/K 67935 WOKW strain MP:0002962 increased urine protein level IAGP N RGD:1624313|PMID:17473932 20200316 RGD compared to DA/K 67935 WOKW strain MP:0005179 decreased circulating cholesterol level IAGP N RGD:1357168|PMID:11374884 19990101 RGD compared to DA/K 67935 WOKW strain MP:0005179 decreased circulating cholesterol level IAGP N RGD:619689|PMID:10720472 20191212 RGD compared to DA/K 67935 WOKW strain MP:0005293 impaired glucose tolerance IAGP N RGD:1357168|PMID:11374884 19990101 RGD compared to DA/K 67935 WOKW strain MP:0005293 impaired glucose tolerance IAGP N RGD:619689|PMID:10720472 19990101 RGD compared to DA/K 67935 WOKW strain MP:0005559 increased circulating glucose level IAGP N RGD:619689|PMID:10720472 20191212 RGD compared to DA/K 67935 WOKW strain MP:0005669 increased circulating leptin level IAGP N RGD:1357168|PMID:11374884 19990101 RGD compared to DA/K 67935 WOKW strain MP:0005669 increased circulating leptin level IAGP N RGD:619689|PMID:10720472 20191212 RGD compared to DA/K 67935 WOKW strain MP:0006087 increased body mass index IAGP N RGD:1357168|PMID:11374884 19990101 RGD compared to DA/K 68019 CRDH Cohen Rosenthal Diabetic Hypertensive strain MP:0000275 heart hyperplasia IAGP N RGD:724741|PMID:8136099 19990101 RGD compared to CD and SHR 68019 CRDH Cohen Rosenthal Diabetic Hypertensive strain MP:0001560 abnormal circulating insulin level IAGP N RGD:724741|PMID:8136099 19990101 RGD compared to CD and SHR 68019 CRDH Cohen Rosenthal Diabetic Hypertensive strain MP:0001759 increased urine glucose level severity IAGP N RGD:724741|PMID:8136099 20200129 RGD compared to SHR 68019 CRDH Cohen Rosenthal Diabetic Hypertensive strain MP:0002842 increased systemic arterial blood pressure IAGP N RGD:1354689|PMID:14643580 19990101 RGD compared to WKY and CD 68019 CRDH Cohen Rosenthal Diabetic Hypertensive strain MP:0002842 increased systemic arterial blood pressure IAGP N RGD:724741|PMID:8136099 19990101 RGD compared to CD 68019 CRDH Cohen Rosenthal Diabetic Hypertensive strain MP:0002962 increased urine protein level severity IAGP N RGD:724741|PMID:8136099 20200129 RGD compared to SHR 68019 CRDH Cohen Rosenthal Diabetic Hypertensive strain MP:0003674 oxidative stress IAGP N RGD:1354689|PMID:14643580 19990101 RGD compared to WKY, SHR, and CD strains 68019 CRDH Cohen Rosenthal Diabetic Hypertensive strain MP:0005293 impaired glucose tolerance severity IAGP N RGD:724741|PMID:8136099 20200129 RGD compared to CD and SHR 68019 CRDH Cohen Rosenthal Diabetic Hypertensive strain MP:0005328 abnormal circulating creatinine level severity IAGP N RGD:724741|PMID:8136099 20200129 RGD compared to CD and SHR 68019 CRDH Cohen Rosenthal Diabetic Hypertensive strain MP:0005558 decreased creatinine clearance severity IAGP N RGD:724741|PMID:8136099 20200129 RGD compared to CD and SHR 68019 CRDH Cohen Rosenthal Diabetic Hypertensive strain MP:0005559 increased circulating glucose level IAGP N RGD:724741|PMID:8136099 19990101 RGD compared to SHR 68019 CRDH Cohen Rosenthal Diabetic Hypertensive strain MP:0009644 uremia severity IAGP N RGD:724741|PMID:8136099 20200129 RGD compared to CD and SHR 68019 CRDH Cohen Rosenthal Diabetic Hypertensive strain MP:0010951 abnormal lipid oxidation IAGP N RGD:1354689|PMID:14643580 20200129 RGD compared to WKY, SHR, and CD strains 68019 CRDH Cohen Rosenthal Diabetic Hypertensive strain MP:0010953 abnormal fatty acid oxidation IAGP N RGD:1354689|PMID:14643580 20200129 RGD compared to WKY, SHR, and CD strains 68036 FH strain MP:0004725 decreased platelet serotonin level IAGP N RGD:724730|PMID:1169825 20111109 RGD 68036 FH strain MP:0005178 increased circulating cholesterol level IAGP N RGD:724730|PMID:1169825 20210108 RGD compared to W 68036 FH strain MP:0005560 decreased circulating glucose level IAGP N RGD:724730|PMID:1169825 20210108 RGD compared to W 68036 FH strain MP:0012359 increased partial thromboplastin time IAGP N RGD:724730|PMID:1169825 20210108 RGD compared to W 68036 FH strain MP:0012619 increased circulating factor X level IAGP N RGD:724730|PMID:1169825 20210111 RGD compared to W 68036 FH strain MP:0020985 increased circulating factor XI level IAGP N RGD:724730|PMID:1169825 20210121 RGD compared to W 68047 HMT strain MP:0001661 extended life span sexual_dimorphism IAGP N RGD:724737|PMID:7370169 20200810 RGD compared to male 68047 HMT strain MP:0002038 increased carcinoma incidence IAGP N RGD:724737|PMID:7370169 20111114 RGD 68073 LETL strain MP:0001426 polydipsia IAGP N RGD:724731|PMID:1682194 19990101 RGD 68073 LETL strain MP:0001759 increased urine glucose level IAGP N RGD:724731|PMID:1682194 19990101 RGD 68073 LETL strain MP:0001762 polyuria IAGP N RGD:724731|PMID:1682194 20201222 RGD 68073 LETL strain MP:0005559 increased circulating glucose level IAGP N RGD:724731|PMID:1682194 19990101 RGD 68079 LOU strain MP:0001262 decreased body weight IAGP N RGD:1342467|PMID:15471977 19990101 RGD 68099 MWF strain MP:0000231 hypertension treatment IAGP XCO:0000535 N RGD:2325229|PMID:19164508 20210723 RGD compared to WKY and untreated 68099 MWF strain MP:0002847 abnormal renal glomerular filtration rate ameliorates IAGP XCO:0000677 N RGD:25314266|PMID:25680709 20210708 RGD compared to untreated 68099 MWF strain MP:0005264 glomerulosclerosis treatment IAGP XCO:0000535 N RGD:2325229|PMID:19164508 20210723 RGD compared to WKY and untreated 68099 MWF strain MP:0005325 abnormal renal glomerulus morphology onset IAGP N RGD:25314266|PMID:25680709 20210708 RGD 68099 MWF strain MP:0011753 decreased podocyte number treatment IAGP XCO:0000535 N RGD:2325229|PMID:19164508 20210723 RGD compared to WKY, MWF 40 weeks and untreated 68104 NIG-III/Hok strain MP:0005172 decreased eye pigmentation IAGP N RGD:1579834|PMID:16245028 20210224 RGD 68114 OXYS/Nov strain MP:0000921 demyelination IAGP N RGD:13503332|PMID:24047616 20180111 RGD 68114 OXYS/Nov strain MP:0003329 amyloid beta deposits IAGP N RGD:13503332|PMID:24047616 20180111 RGD 68114 OXYS/Nov strain MP:0005548 retina pigment epithelium atrophy IAGP N RGD:13503349|PMID:22683466 20180115 RGD 68114 OXYS/Nov strain MP:0008535 enlarged lateral ventricles IAGP N RGD:13503332|PMID:24047616 20180111 RGD 68114 OXYS/Nov strain MP:0020038 retina macular degeneration sexual_dimorphism IAGP N RGD:7794750|PMID:22300709 20200416 RGD compared to female 68137 SHHF strain MP:0000231 hypertension IAGP N RGD:628511|PMID:12384454 20231206 RGD 68137 SHHF strain MP:0002079 increased circulating insulin level IAGP N RGD:401965414|PMID:10901178 20240206 RGD compared to WKY, SHR, ZSF1-Leprfa/cp/Crl 68137 SHHF strain MP:0002705 dilated renal tubule IAGP N RGD:401965414|PMID:10901178 20240206 RGD compared to WKY, SHR 68137 SHHF strain MP:0002833 increased heart weight IAGP N RGD:401965414|PMID:10901178 20240206 RGD compared to SHR and WKY controls 68137 SHHF strain MP:0002962 increased urine protein level IAGP N RGD:401965414|PMID:10901178 20240206 RGD compared to WKY, SHR 68137 SHHF strain MP:0002972 abnormal cardiac muscle contractility IAGP N RGD:401965414|PMID:10901178 20240206 RGD compared to WKY controls 68137 SHHF strain MP:0003215 renal interstitial fibrosis IAGP N RGD:401965414|PMID:10901178 20240206 RGD compared to WKY, SHR 68137 SHHF strain MP:0003819 increased left ventricle diastolic pressure IAGP N RGD:401965414|PMID:10901178 20240206 RGD compared to WKY, SHR 68137 SHHF strain MP:0003820 increased left ventricle systolic pressure IAGP N RGD:401965414|PMID:10901178 20240206 RGD compared to WKY controls 68137 SHHF strain MP:0003821 decreased left ventricle diastolic pressure IAGP N RGD:401965414|PMID:10901178 20240206 RGD compared to SHR controls 68137 SHHF strain MP:0003991 arteriosclerosis IAGP N RGD:401965414|PMID:10901178 20240206 RGD compared to WKY, SHR 68137 SHHF strain MP:0004875 increased mean systemic arterial blood pressure IAGP N RGD:401965414|PMID:10901178 20240206 RGD compared to WKY controls 68137 SHHF strain MP:0005178 increased circulating cholesterol level IAGP N RGD:401965414|PMID:10901178 20240206 RGD compared to WKY, SHR 68137 SHHF strain MP:0005264 glomerulosclerosis IAGP N RGD:401965414|PMID:10901178 20240206 RGD compared to WKY, SHR 68137 SHHF strain MP:0005317 increased triglyceride level IAGP N RGD:401965414|PMID:10901178 20240206 RGD compared to WKY, SHR 68137 SHHF strain MP:0005558 decreased creatinine clearance IAGP N RGD:401965414|PMID:10901178 20240206 RGD compared to WKY, SHR 68137 SHHF strain MP:0005559 increased circulating glucose level IAGP N RGD:401965414|PMID:10901178 20240206 RGD compared to WKY, SHR 68137 SHHF strain MP:0011346 renal tubule atrophy IAGP N RGD:401965414|PMID:10901178 20240206 RGD compared to WKY, SHR 68137 SHHF strain MP:0011402 renal cast IAGP N RGD:401965414|PMID:10901178 20240206 RGD compared to WKY, SHR 68137 SHHF strain MP:0011431 increased urine flow rate IAGP N RGD:401965414|PMID:10901178 20240206 RGD compared to WKY, SHR 68145 TF strain MP:0002780 decreased circulating testosterone level IMP N RGD:38548923|PMID:21062903 20200826 RGD 68145 TF strain MP:0002789 male pseudohermaphroditism IMP N RGD:38548923|PMID:21062903 20200826 RGD 68145 TF strain MP:0013603 abnormal fetal Leydig cell differentiation IMP N RGD:38548923|PMID:21062903 20200826 RGD 68145 TF strain MP:0013604 abnormal adult Leydig cell differentiation IMP N RGD:38548923|PMID:21062903 20200826 RGD 68149 TM Tester Moriyama rat strain MP:0005606 increased bleeding time IAGP N RGD:1302447|PMID:9250486 19990101 RGD 68164 UChA strain MP:0012042 low alcohol preference IAGP N RGD:625612|PMID:6683362 19990101 RGD compared to UChB 68165 UChB strain MP:0001987 alcohol preference IAGP N RGD:625612|PMID:6683362 19990101 RGD compared to UChA 68186 WKHA/N strain MP:0001399 hyperactivity IAGP N RGD:631170|PMID:8944030 19990101 RGD 68189 HTX/Hcj strain MP:0001891 hydrocephaly IAGP N RGD:1559414|PMID:7257730 19990101 RGD 68337 Htt huntingtin gene MP:0001524 impaired limb coordination IMP N RGD:13452381|PMID:12620967 20171117 RGD 68337 Htt huntingtin gene MP:0002229 neurodegeneration IMP N RGD:13452380|PMID:25162006 20171117 RGD 68337 Htt huntingtin gene MP:0005643 decreased dopamine level IMP N RGD:13452381|PMID:12620967 20171117 RGD 68337 Htt huntingtin gene MP:0014115 cognitive inflexibility IMP N RGD:13452381|PMID:12620967 20171117 RGD 68384 Ccnd1 cyclin D1 gene MP:0000351 increased cell proliferation IDA N RGD:704417|PMID:12668975 19990101 RGD 68384 Ccnd1 cyclin D1 gene MP:0002658 abnormal liver regeneration IDA N RGD:704417|PMID:12668975 19990101 RGD 68411 Sh2b3 SH2B adaptor protein 3 gene MP:0000219 increased neutrophil cell number IMP N RGD:12904914|PMID:25628389 20170526 RGD 68411 Sh2b3 SH2B adaptor protein 3 gene MP:0000220 increased monocyte cell number IMP N RGD:12904914|PMID:25628389 20170526 RGD 68411 Sh2b3 SH2B adaptor protein 3 gene MP:0004973 increased regulatory T cell number IMP N RGD:13442483|PMID:25776069 20171103 RGD 68411 Sh2b3 SH2B adaptor protein 3 gene MP:0005013 increased lymphocyte cell number IMP N RGD:12904914|PMID:25628389 20170526 RGD 68411 Sh2b3 SH2B adaptor protein 3 gene MP:0005540 decreased urine albumin level IMP N RGD:13442483|PMID:25776069 20171103 RGD 68411 Sh2b3 SH2B adaptor protein 3 gene MP:0005598 decreased heart ventricle muscle contractility IMP N RGD:12904914|PMID:25628389 20170526 RGD 68411 Sh2b3 SH2B adaptor protein 3 gene MP:0012046 decreased susceptibility to hypertension IMP N RGD:13442483|PMID:25776069 20171103 RGD 68438 Oprl1 opioid related nociceptin receptor 1 gene MP:0001363 increased anxiety-related response IMP N RGD:126925219|PMID:21184763 20210520 RGD 68438 Oprl1 opioid related nociceptin receptor 1 gene MP:0003063 increased coping response IMP N RGD:126925219|PMID:21184763 20210520 RGD 68438 Oprl1 opioid related nociceptin receptor 1 gene MP:0003858 enhanced coordination IMP N RGD:126925219|PMID:21184763 20210520 RGD 68438 Oprl1 opioid related nociceptin receptor 1 gene MP:0008532 decreased chemical nociceptive threshold induces IMP XCO:0000834 N RGD:126925219|PMID:21184763 20210520 RGD 68438 Oprl1 opioid related nociceptin receptor 1 gene MP:0009046 muscle twitch IMP N RGD:126925219|PMID:21184763 20210520 RGD 68438 Oprl1 opioid related nociceptin receptor 1 gene MP:0009713 enhanced conditioned place preference behavior IMP N RGD:14348962|PMID:21095077 20190204 RGD 68438 Oprl1 opioid related nociceptin receptor 1 gene MP:0020954 decreased mechanical nociceptive threshold IMP N RGD:14349028|PMID:25704616 20190206 RGD 6893332 Cm74 Cardiac mass QTL 74 qtl MP:0002833 increased heart weight IDA N RGD:1554311|PMID:16097372 20120824 RGD 6893336 Cm75 Cardiac mass QTL 75 qtl MP:0002833 increased heart weight IDA N RGD:1554311|PMID:16097372 20120824 RGD 6893338 Cm76 Cardiac mass QTL 76 qtl MP:0002833 increased heart weight IDA N RGD:1554311|PMID:16097372 20120824 RGD 6893340 Cm77 Cardiac mass QTL 77 qtl MP:0002833 increased heart weight IDA N RGD:1554311|PMID:16097372 20120824 RGD 6893342 Cm78 Cardiac mass QTL 78 qtl MP:0002833 increased heart weight IDA N RGD:1554311|PMID:16097372 20120824 RGD 6893344 Cm79 Cardiac mass QTL 79 qtl MP:0002833 increased heart weight IDA N RGD:1554311|PMID:16097372 20120824 RGD 6893347 Bw98 Body weight QTL 98 qtl MP:0001262 decreased body weight IDA N RGD:1554311|PMID:16097372 20120824 RGD 6893350 Bw99 Body weight QTL 99 qtl MP:0001262 decreased body weight IDA N RGD:1554311|PMID:16097372 20120824 RGD 6893352 Bw100 Body weight QTL 100 qtl MP:0001262 decreased body weight IDA N RGD:1554311|PMID:16097372 20120824 RGD 6893355 Bw101 Body weight QTL 101 qtl MP:0001262 decreased body weight IDA N RGD:1554311|PMID:16097372 20120824 RGD 6893357 Bw102 Body weight QTL 102 qtl MP:0001262 decreased body weight IDA N RGD:1554311|PMID:16097372 20120824 RGD 6893359 Bw103 Body weight QTL 103 qtl MP:0001262 decreased body weight IDA N RGD:1554311|PMID:16097372 20120824 RGD 6893361 Bw104 Body weight QTL 104 qtl MP:0001262 decreased body weight IDA N RGD:1554311|PMID:16097372 20120824 RGD 6893363 Bw105 Body weight QTL 105 qtl MP:0001262 decreased body weight IDA N RGD:1554311|PMID:16097372 20120824 RGD 6893366 Bw106 Body weight QTL 106 qtl MP:0001262 decreased body weight IDA N RGD:1554311|PMID:16097372 20120824 RGD 6893368 Bw107 Body weight QTL 107 qtl MP:0001262 decreased body weight IDA N RGD:1554311|PMID:16097372 20120824 RGD 6893419 Hvcn1em2Mcwi hydrogen voltage-gated channel 1; zinc finger nuclease induced mutant 2, Medical College of Wisconsin gene MP:0011854 cerebral edema IMP N RGD:14985213|PMID:31250553 20201210 RGD 6893423 Kcnj16em1Mcwi potassium inwardly-rectifying channel, subfamily J, member 16; zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0001262 decreased body weight IMP N RGD:38500204|PMID:28931751 20201210 RGD compared to SS/JrHsdMcwi 6893423 Kcnj16em1Mcwi potassium inwardly-rectifying channel, subfamily J, member 16; zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0002318 hypercapnia IMP N RGD:38500203|PMID:30605394 20201210 RGD compared to SS/JrHsdMcwi 6893423 Kcnj16em1Mcwi potassium inwardly-rectifying channel, subfamily J, member 16; zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0002320 hyperventilation IMP N RGD:38500203|PMID:30605394 20201210 RGD compared to SS/JrHsdMcwi 6893423 Kcnj16em1Mcwi potassium inwardly-rectifying channel, subfamily J, member 16; zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0002667 decreased circulating aldosterone level IMP N RGD:38500204|PMID:28931751 20201210 RGD compared to SS/JrHsdMcwi 6893423 Kcnj16em1Mcwi potassium inwardly-rectifying channel, subfamily J, member 16; zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0002843 decreased systemic arterial blood pressure IMP N RGD:38500204|PMID:28931751 20201210 RGD compared to SS/JrHsdMcwi 6893423 Kcnj16em1Mcwi potassium inwardly-rectifying channel, subfamily J, member 16; zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0002960 decreased urine microalbumin level IMP N RGD:38500204|PMID:28931751 20201210 RGD compared to SS/JrHsdMcwi 6893423 Kcnj16em1Mcwi potassium inwardly-rectifying channel, subfamily J, member 16; zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0003017 decreased circulating bicarbonate level IMP N RGD:38500203|PMID:30605394 20201210 RGD compared to SS/JrHsdMcwi 6893423 Kcnj16em1Mcwi potassium inwardly-rectifying channel, subfamily J, member 16; zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0003019 increased circulating chloride level IMP N RGD:38500203|PMID:30605394 20201210 RGD compared to SS/JrHsdMcwi 6893423 Kcnj16em1Mcwi potassium inwardly-rectifying channel, subfamily J, member 16; zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0004119 hypokalemia IMP N RGD:38500204|PMID:28931751 20201210 RGD compared to SS/JrHsdMcwi 6893423 Kcnj16em1Mcwi potassium inwardly-rectifying channel, subfamily J, member 16; zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0005333 decreased heart rate IMP N RGD:38500204|PMID:28931751 20201210 RGD compared to SS/JrHsdMcwi 6893423 Kcnj16em1Mcwi potassium inwardly-rectifying channel, subfamily J, member 16; zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0005528 decreased renal glomerular filtration rate IMP N RGD:38500204|PMID:28931751 20201210 RGD compared to SS/JrHsdMcwi 6893423 Kcnj16em1Mcwi potassium inwardly-rectifying channel, subfamily J, member 16; zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0005565 increased blood urea nitrogen level IMP N RGD:38500204|PMID:28931751 20201210 RGD compared to SS/JrHsdMcwi 6893423 Kcnj16em1Mcwi potassium inwardly-rectifying channel, subfamily J, member 16; zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0005628 decreased circulating potassium level IMP N RGD:38500203|PMID:30605394 20201210 RGD compared to SS/JrHsdMcwi 6893423 Kcnj16em1Mcwi potassium inwardly-rectifying channel, subfamily J, member 16; zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0009763 increased susceptibility to induced morbidity/mortality treatment IMP XCO:0000022,CHEBI:34558 N RGD:38500204|PMID:28931751 20201210 RGD compared to SS/JrHsdMcwi 6893423 Kcnj16em1Mcwi potassium inwardly-rectifying channel, subfamily J, member 16; zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0010092 increased circulating magnesium level IMP N RGD:38500204|PMID:28931751 20201210 RGD compared to SS/JrHsdMcwi 6893423 Kcnj16em1Mcwi potassium inwardly-rectifying channel, subfamily J, member 16; zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0012551 metabolic acidosis IMP N RGD:38500203|PMID:30605394 20201210 RGD compared to SS/JrHsdMcwi 6893434 SS-Kcnj16em1Mcwi-/- strain MP:0001262 decreased body weight IMP N RGD:38500204|PMID:28931751 20200813 RGD compared to SS/JrHsdMcwi 6893434 SS-Kcnj16em1Mcwi-/- strain MP:0002318 hypercapnia IMP N RGD:38500203|PMID:30605394 20200813 RGD compared to SS/JrHsdMcwi 6893434 SS-Kcnj16em1Mcwi-/- strain MP:0002320 hyperventilation IMP N RGD:38500203|PMID:30605394 20200813 RGD compared to SS/JrHsdMcwi 6893434 SS-Kcnj16em1Mcwi-/- strain MP:0002667 decreased circulating aldosterone level IMP N RGD:38500204|PMID:28931751 20200813 RGD compared to SS/JrHsdMcwi 6893434 SS-Kcnj16em1Mcwi-/- strain MP:0002843 decreased systemic arterial blood pressure IMP N RGD:38500204|PMID:28931751 20200813 RGD compared to SS/JrHsdMcwi 6893434 SS-Kcnj16em1Mcwi-/- strain MP:0002960 decreased urine microalbumin level IMP N RGD:38500204|PMID:28931751 20200813 RGD compared to SS/JrHsdMcwi 6893434 SS-Kcnj16em1Mcwi-/- strain MP:0003017 decreased circulating bicarbonate level IMP N RGD:38500203|PMID:30605394 20200813 RGD compared to SS/JrHsdMcwi 6893434 SS-Kcnj16em1Mcwi-/- strain MP:0003019 increased circulating chloride level IMP N RGD:38500203|PMID:30605394 20200813 RGD compared to SS/JrHsdMcwi 6893434 SS-Kcnj16em1Mcwi-/- strain MP:0004119 hypokalemia IMP N RGD:38500204|PMID:28931751 20200813 RGD compared to SS/JrHsdMcwi 6893434 SS-Kcnj16em1Mcwi-/- strain MP:0005333 decreased heart rate IMP N RGD:38500204|PMID:28931751 20200813 RGD compared to SS/JrHsdMcwi 6893434 SS-Kcnj16em1Mcwi-/- strain MP:0005528 decreased renal glomerular filtration rate IMP N RGD:38500204|PMID:28931751 20200813 RGD compared to SS/JrHsdMcwi 6893434 SS-Kcnj16em1Mcwi-/- strain MP:0005565 increased blood urea nitrogen level IMP N RGD:38500204|PMID:28931751 20200813 RGD compared to SS/JrHsdMcwi 6893434 SS-Kcnj16em1Mcwi-/- strain MP:0005628 decreased circulating potassium level IMP N RGD:38500203|PMID:30605394 20200813 RGD compared to SS/JrHsdMcwi 6893434 SS-Kcnj16em1Mcwi-/- strain MP:0009763 increased susceptibility to induced morbidity/mortality treatment IMP XCO:0000022,CHEBI:34558 N RGD:38500204|PMID:28931751 20200813 RGD compared to SS/JrHsdMcwi 6893434 SS-Kcnj16em1Mcwi-/- strain MP:0010092 increased circulating magnesium level IMP N RGD:38500204|PMID:28931751 20200813 RGD compared to SS/JrHsdMcwi 6893434 SS-Kcnj16em1Mcwi-/- strain MP:0012551 metabolic acidosis IMP N RGD:38500203|PMID:30605394 20200813 RGD compared to SS/JrHsdMcwi 6893439 SS-Hvcn1em2Mcwi-/- strain MP:0011854 cerebral edema IMP N RGD:14985213|PMID:31250553 20191107 RGD 6893530 BBDR.LA-(D5Rat98-D5Rat233)/Rhw strain MP:0001260 increased body weight IAGP N RGD:6893459|PMID:19996157 20120905 RGD compared to BBDR/Rhw 6893530 BBDR.LA-(D5Rat98-D5Rat233)/Rhw strain MP:0001261 obese IAGP N RGD:6893459|PMID:19996157 20200304 RGD compared to BBDR/Rhw 6893530 BBDR.LA-(D5Rat98-D5Rat233)/Rhw strain MP:0001869 pancreas inflammation IAGP N RGD:6893459|PMID:19996157 20200304 RGD compared to BBDR/Rhw 6893530 BBDR.LA-(D5Rat98-D5Rat233)/Rhw strain MP:0002079 increased circulating insulin level IAGP N RGD:6893459|PMID:19996157 20200304 RGD compared to BBDR/Rhw, in females 6893530 BBDR.LA-(D5Rat98-D5Rat233)/Rhw strain MP:0005016 decreased lymphocyte cell number IAGP N RGD:6893459|PMID:19996157 20200304 RGD compared to BBDR/Rhw 6893530 BBDR.LA-(D5Rat98-D5Rat233)/Rhw strain MP:0005178 increased circulating cholesterol level IAGP N RGD:6893459|PMID:19996157 20200304 RGD compared to BBDR/Rhw 6893530 BBDR.LA-(D5Rat98-D5Rat233)/Rhw strain MP:0005215 abnormal pancreatic islet morphology IAGP N RGD:6893459|PMID:19996157 20200304 RGD compared to BBDR/Rhw 6893530 BBDR.LA-(D5Rat98-D5Rat233)/Rhw strain MP:0005491 pancreatic islet hyperplasia IAGP N RGD:6893459|PMID:19996157 20200304 RGD compared to BBDR/Rhw 6893530 BBDR.LA-(D5Rat98-D5Rat233)/Rhw strain MP:0005559 increased circulating glucose level IAGP N RGD:6893459|PMID:19996157 20200304 RGD compared to BBDR/Rhw, in males 6893530 BBDR.LA-(D5Rat98-D5Rat233)/Rhw strain MP:0005669 increased circulating leptin level IAGP N RGD:6893459|PMID:19996157 20200304 RGD compared to BBDR/Rhw 6893530 BBDR.LA-(D5Rat98-D5Rat233)/Rhw strain MP:0009285 increased gonadal fat pad weight IAGP N RGD:6893459|PMID:19996157 20200304 RGD compared to BBDR/Rhw 6893530 BBDR.LA-(D5Rat98-D5Rat233)/Rhw strain MP:0009298 increased mesenteric fat pad weight IAGP N RGD:6893459|PMID:19996157 20200304 RGD compared to BBDR/Rhw 6893530 BBDR.LA-(D5Rat98-D5Rat233)/Rhw strain MP:0009304 increased retroperitoneal fat pad weight IAGP N RGD:6893459|PMID:19996157 20200304 RGD compared to BBDR/Rhw 6893530 BBDR.LA-(D5Rat98-D5Rat233)/Rhw strain MP:0020087 increased susceptibility to non-insulin-dependent diabetes IAGP N RGD:6893459|PMID:19996157 20200304 RGD compared to BBDR/Rhw 6893535 BBDR.LA-(D5Rat98-D5Rat233), BBDP-(D4Mit6-D4Mit7)/Rhw strain MP:0001261 obese IAGP N RGD:6893459|PMID:19996157 20200304 RGD compared to BBDR/Rhw 6893535 BBDR.LA-(D5Rat98-D5Rat233), BBDP-(D4Mit6-D4Mit7)/Rhw strain MP:0001869 pancreas inflammation IAGP N RGD:6893459|PMID:19996157 20200304 RGD compared to BBDR/Rhw 6893535 BBDR.LA-(D5Rat98-D5Rat233), BBDP-(D4Mit6-D4Mit7)/Rhw strain MP:0002079 increased circulating insulin level IAGP N RGD:6893459|PMID:19996157 20120905 RGD 6893535 BBDR.LA-(D5Rat98-D5Rat233), BBDP-(D4Mit6-D4Mit7)/Rhw strain MP:0005178 increased circulating cholesterol level IAGP N RGD:6893459|PMID:19996157 20120905 RGD in females 6893535 BBDR.LA-(D5Rat98-D5Rat233), BBDP-(D4Mit6-D4Mit7)/Rhw strain MP:0005215 abnormal pancreatic islet morphology IAGP N RGD:6893459|PMID:19996157 20200304 RGD compared to BBDR/Rhw 6893535 BBDR.LA-(D5Rat98-D5Rat233), BBDP-(D4Mit6-D4Mit7)/Rhw strain MP:0005491 pancreatic islet hyperplasia IAGP N RGD:6893459|PMID:19996157 20200304 RGD compared to BBDR/Rhw 6893535 BBDR.LA-(D5Rat98-D5Rat233), BBDP-(D4Mit6-D4Mit7)/Rhw strain MP:0005669 increased circulating leptin level IAGP N RGD:6893459|PMID:19996157 20120905 RGD 6893535 BBDR.LA-(D5Rat98-D5Rat233), BBDP-(D4Mit6-D4Mit7)/Rhw strain MP:0020087 increased susceptibility to non-insulin-dependent diabetes IAGP N RGD:6893459|PMID:19996157 20200304 RGD compared to BBDR/Rhw 6893678 Bw108 Body weight QTL 108 qtl MP:0001260 increased body weight IDA N RGD:61516|PMID:11015598 20120918 RGD 6893681 Bw109 Body weight QTL 109 qtl MP:0001260 increased body weight IDA N RGD:61516|PMID:11015598 20120918 RGD 6893683 Bw110 Body weight QTL 110 qtl MP:0001260 increased body weight IDA N RGD:61516|PMID:11015598 20120918 RGD 6893685 Bw111 Body weight QTL 111 qtl MP:0001260 increased body weight IDA N RGD:61516|PMID:11015598 20120918 RGD 68954 Wfs1 wolframin ER transmembrane glycoprotein gene MP:0001059 optic nerve atrophy onset IMP N RGD:149735331|PMID:28860598 20210805 RGD 68954 Wfs1 wolframin ER transmembrane glycoprotein gene MP:0001263 weight loss onset IMP N RGD:149735331|PMID:28860598 20210805 RGD 68954 Wfs1 wolframin ER transmembrane glycoprotein gene MP:0001559 hyperglycemia onset IMP N RGD:149735331|PMID:28860598 20210805 RGD 68954 Wfs1 wolframin ER transmembrane glycoprotein gene MP:0001759 increased urine glucose level onset IMP N RGD:149735331|PMID:28860598 20210805 RGD 68954 Wfs1 wolframin ER transmembrane glycoprotein gene MP:0003059 decreased insulin secretion induces IMP XCO:0000135 N RGD:150519890|PMID:29976929 20211014 RGD 68954 Wfs1 wolframin ER transmembrane glycoprotein gene MP:0005277 abnormal brainstem morphology onset IMP N RGD:149735331|PMID:28860598 20210805 RGD 68954 Wfs1 wolframin ER transmembrane glycoprotein gene MP:0005293 impaired glucose tolerance onset IMP N RGD:149735331|PMID:28860598 20210805 RGD 68954 Wfs1 wolframin ER transmembrane glycoprotein gene MP:0005559 increased circulating glucose level onset IMP N RGD:149735331|PMID:28860598 20210805 RGD 68954 Wfs1 wolframin ER transmembrane glycoprotein gene MP:0009114 decreased pancreatic beta cell mass onset IMP N RGD:149735331|PMID:28860598 20210805 RGD 68954 Wfs1 wolframin ER transmembrane glycoprotein gene MP:0009168 decreased pancreatic islet number onset IMP N RGD:149735331|PMID:28860598 20210805 RGD 68954 Wfs1 wolframin ER transmembrane glycoprotein gene MP:0009172 small pancreatic islets onset IMP N RGD:149735331|PMID:28860598 20210805 RGD 68954 Wfs1 wolframin ER transmembrane glycoprotein gene MP:0009392 retina gliosis onset IMP N RGD:149735331|PMID:28860598 20210805 RGD 68954 Wfs1 wolframin ER transmembrane glycoprotein gene MP:0010050 hypermyelination onset IMP N RGD:149735331|PMID:28860598 20210805 RGD 68954 Wfs1 wolframin ER transmembrane glycoprotein gene MP:0020354 increased endoplasmic reticulum stress onset IMP N RGD:149735331|PMID:28860598 20210805 RGD 68954 Wfs1 wolframin ER transmembrane glycoprotein gene MP:0020354 increased endoplasmic reticulum stress treatment IMP XCO:0000135 N RGD:150519890|PMID:29976929 20211014 RGD 6902893 BB.SHR-(Acsm3-Igf2)/K strain MP:0001262 decreased body weight sexual_dimorphism IAGP N RGD:69701|PMID:9530625 20120919 RGD only males; as compared to BB/OK males 6903294 Stl30 Serum triglyceride level QTL 30 qtl MP:0001552 increased circulating triglyceride level IDA N RGD:1299960|PMID:14709677 20121002 RGD 6903300 Scl33 Serum cholesterol QTL 33 qtl MP:0005178 increased circulating cholesterol level IDA N RGD:1299960|PMID:14709677 20121002 RGD 6903303 Scl34 Serum cholesterol QTL 34 qtl MP:0005178 increased circulating cholesterol level IDA N RGD:1299960|PMID:14709677 20121002 RGD 6903306 Scl35 Serum cholesterol QTL 35 qtl MP:0005178 increased circulating cholesterol level IDA N RGD:1299960|PMID:14709677 20121002 RGD 6903308 Scl36 Serum cholesterol QTL 36 qtl MP:0005178 increased circulating cholesterol level IDA N RGD:1299960|PMID:14709677 20121002 RGD 6903312 Bw112 Body weight QTL 112 qtl MP:0001260 increased body weight IDA N RGD:1299960|PMID:14709677 20121002 RGD 6903316 Bw113 Body weight QTL 113 qtl MP:0001260 increased body weight IDA N RGD:1299960|PMID:14709677 20121002 RGD 6903319 Bw114 Body weight QTL 114 qtl MP:0001260 increased body weight IDA N RGD:1299960|PMID:14709677 20121002 RGD 6903345 Bp349 Blood pressure QTL 349 qtl MP:0002842 increased systemic arterial blood pressure IDA N RGD:69700|PMID:11015589 20121002 RGD 6903345 Bp349 Blood pressure QTL 349 qtl MP:0004217 salt-sensitive hypertension IDA N RGD:69700|PMID:11015589 20121002 RGD 6903347 Bp350 Blood pressure QTL 350 qtl MP:0002842 increased systemic arterial blood pressure IDA N RGD:69700|PMID:11015589 20121002 RGD 6903347 Bp350 Blood pressure QTL 350 qtl MP:0004217 salt-sensitive hypertension IDA N RGD:69700|PMID:11015589 20121002 RGD 6903349 Bp351 Blood pressure QTL 351 qtl MP:0002842 increased systemic arterial blood pressure IDA N RGD:69700|PMID:11015589 20121002 RGD 6903349 Bp351 Blood pressure QTL 351 qtl MP:0004217 salt-sensitive hypertension IDA N RGD:69700|PMID:11015589 20121002 RGD 6903351 Bp352 Blood pressure QTL 352 qtl MP:0002842 increased systemic arterial blood pressure IDA N RGD:69700|PMID:11015589 20121002 RGD 6903351 Bp352 Blood pressure QTL 352 qtl MP:0004217 salt-sensitive hypertension IDA N RGD:69700|PMID:11015589 20121002 RGD 6903353 Bp353 Blood pressure QTL 353 qtl MP:0004217 salt-sensitive hypertension IDA N RGD:69700|PMID:11015589 20121002 RGD 6903353 Bp353 Blood pressure QTL 353 qtl MP:0006143 increased systemic arterial diastolic blood pressure IDA N RGD:69700|PMID:11015589 20121002 RGD 6903356 Bp354 Blood pressure QTL 354 qtl MP:0002843 decreased systemic arterial blood pressure IDA N RGD:69700|PMID:11015589 20121002 RGD 6903356 Bp354 Blood pressure QTL 354 qtl MP:0004217 salt-sensitive hypertension IDA N RGD:69700|PMID:11015589 20121002 RGD 6903359 Bp355 Blood pressure QTL 355 qtl MP:0004217 salt-sensitive hypertension IDA N RGD:69700|PMID:11015589 20121002 RGD 6903359 Bp355 Blood pressure QTL 355 qtl MP:0006264 decreased systemic arterial systolic blood pressure IDA N RGD:69700|PMID:11015589 20121002 RGD 6903917 SS.SHR-(D9Mco72-D9Mco109)/Mco strain MP:0002963 decreased urine protein level induced IAGP XCO:0000795 N RGD:6903249|PMID:21814219 20121008 RGD compared to SS/Jr 6903920 SS.SHR-(D9Mco72-D9Uia4)/Mco strain MP:0002834 decreased heart weight induced IAGP XCO:0000795 N RGD:6903249|PMID:21814219 20121008 RGD compared to SS/Jr 6903920 SS.SHR-(D9Mco72-D9Uia4)/Mco strain MP:0002963 decreased urine protein level induced IAGP XCO:0000795 N RGD:6903249|PMID:21814219 20121008 RGD compared to SS/Jr 6903920 SS.SHR-(D9Mco72-D9Uia4)/Mco strain MP:0006264 decreased systemic arterial systolic blood pressure induced IAGP XCO:0000795 N RGD:6903249|PMID:21814219 20121008 RGD compared to SS/Jr 6903922 SS.SHR-(D9Mco72-D9Mco106)/Mco strain MP:0002834 decreased heart weight induced IAGP XCO:0000795 N RGD:6903249|PMID:21814219 20121008 RGD compared to SS/Jr 6903922 SS.SHR-(D9Mco72-D9Mco106)/Mco strain MP:0002963 decreased urine protein level induced IAGP XCO:0000795 N RGD:6903249|PMID:21814219 20121008 RGD compared to SS/Jr 6903922 SS.SHR-(D9Mco72-D9Mco106)/Mco strain MP:0006264 decreased systemic arterial systolic blood pressure induced IAGP XCO:0000795 N RGD:6903249|PMID:21814219 20121008 RGD compared to SS/Jr 6903925 SS.SHR-(D9Mco72-D9Mco105)/Mco strain MP:0002834 decreased heart weight induced IAGP XCO:0000795 N RGD:6903249|PMID:21814219 20121008 RGD compared to SS/Jr 6903925 SS.SHR-(D9Mco72-D9Mco105)/Mco strain MP:0006263 decreased systemic arterial diastolic blood pressure induced IAGP XCO:0000795 N RGD:6903249|PMID:21814219 20121008 RGD compared to SS/Jr 6903925 SS.SHR-(D9Mco72-D9Mco105)/Mco strain MP:0006264 decreased systemic arterial systolic blood pressure induced IAGP XCO:0000795 N RGD:6903249|PMID:21814219 20121008 RGD compared to SS/Jr 6903928 SS.SHR-(D9Rat7-D9Got111)/Mco strain MP:0006264 decreased systemic arterial systolic blood pressure induced IAGP XCO:0000795 N RGD:6903249|PMID:21814219 20121008 RGD compared to SS/Jr 6903936 SS.SHR-(D9Rat7-D9Rat84)/Mco strain MP:0002833 increased heart weight induced IAGP XCO:0000795 N RGD:6903249|PMID:21814219 20121008 RGD compared to SS/Jr 6903936 SS.SHR-(D9Rat7-D9Rat84)/Mco strain MP:0002963 decreased urine protein level induced IAGP XCO:0000795 N RGD:6903249|PMID:21814219 20121008 RGD compared to SS/Jr 6903936 SS.SHR-(D9Rat7-D9Rat84)/Mco strain MP:0006263 decreased systemic arterial diastolic blood pressure induced IAGP XCO:0000795 N RGD:6903249|PMID:21814219 20121008 RGD compared to SS/Jr 6903936 SS.SHR-(D9Rat7-D9Rat84)/Mco strain MP:0006264 decreased systemic arterial systolic blood pressure induced IAGP XCO:0000795 N RGD:6903249|PMID:21814219 20121008 RGD compared to SS/Jr 6903937 Bp356 Blood pressure QTL 356 qtl MP:0006263 decreased systemic arterial diastolic blood pressure IDA N RGD:6903249|PMID:21814219 20121008 RGD 6903937 Bp356 Blood pressure QTL 356 qtl MP:0006264 decreased systemic arterial systolic blood pressure IDA N RGD:6903249|PMID:21814219 20121008 RGD 6903941 Pur31 Proteinuria QTL 31 qtl MP:0002963 decreased urine protein level IDA N RGD:6903249|PMID:21814219 20121008 RGD 69057 Nr1i2 nuclear receptor subfamily 1, group I, member 2 gene MP:0001260 increased body weight IMP N RGD:13432137|PMID:28716828 20201210 RGD 69057 Nr1i2 nuclear receptor subfamily 1, group I, member 2 gene MP:0005319 abnormal enzyme/coenzyme level IMP N RGD:127285625|PMID:27856527 20210701 RGD Por 69057 Nr1i2 nuclear receptor subfamily 1, group I, member 2 gene MP:0020169 increased thyroid gland weight IMP N RGD:38549342|PMID:29548889 20210701 RGD 69062 Cdkn1b cyclin-dependent kinase inhibitor 1B gene MP:0001260 increased body weight IMP N RGD:126908018|PMID:30893315 20210510 RGD in KO rat 69062 Cdkn1b cyclin-dependent kinase inhibitor 1B gene MP:0001304 cataract IMP N RGD:126908018|PMID:30893315 20210510 RGD in KO rat 69062 Cdkn1b cyclin-dependent kinase inhibitor 1B gene MP:0001921 reduced fertility IMP N RGD:126908018|PMID:30893315 20210510 RGD in KO rat 69062 Cdkn1b cyclin-dependent kinase inhibitor 1B gene MP:0002050 increased pheochromocytoma incidence IAGP N RGD:619590|PMID:12036912 20201210 RGD 69062 Cdkn1b cyclin-dependent kinase inhibitor 1B gene MP:0002176 increased brain weight IMP N RGD:126908018|PMID:30893315 20210510 RGD in KO rat 69062 Cdkn1b cyclin-dependent kinase inhibitor 1B gene MP:0002981 increased liver weight IMP N RGD:126908018|PMID:30893315 20210510 RGD in KO rat 69062 Cdkn1b cyclin-dependent kinase inhibitor 1B gene MP:0003498 thyroid gland hyperplasia IAGP N RGD:619590|PMID:12036912 20201210 RGD 69062 Cdkn1b cyclin-dependent kinase inhibitor 1B gene MP:0004952 increased spleen weight IMP N RGD:126908018|PMID:30893315 20210510 RGD in KO rat 69062 Cdkn1b cyclin-dependent kinase inhibitor 1B gene MP:0004955 increased thymus weight IMP N RGD:126908018|PMID:30893315 20210510 RGD in KO rat 69062 Cdkn1b cyclin-dependent kinase inhibitor 1B gene MP:0005124 increased circulating prolactin level IMP N RGD:126908018|PMID:30893315 20210610 RGD at 4-6 weeks 69062 Cdkn1b cyclin-dependent kinase inhibitor 1B gene MP:0005182 increased circulating estradiol level IMP N RGD:126908018|PMID:30893315 20210510 RGD in KO rat 69062 Cdkn1b cyclin-dependent kinase inhibitor 1B gene MP:0005630 increased lung weight IMP N RGD:126908018|PMID:30893315 20210510 RGD in KO rat 69062 Cdkn1b cyclin-dependent kinase inhibitor 1B gene MP:0008939 increased pituitary gland weight IMP N RGD:126908018|PMID:30893315 20210510 RGD in KO rat 69062 Cdkn1b cyclin-dependent kinase inhibitor 1B gene MP:0009296 increased mammary fat pad weight IMP N RGD:126908018|PMID:30893315 20210610 RGD 69062 Cdkn1b cyclin-dependent kinase inhibitor 1B gene MP:0010173 increased mammary gland epithelial cell proliferation IMP N RGD:126908018|PMID:30893315 20210610 RGD 69062 Cdkn1b cyclin-dependent kinase inhibitor 1B gene MP:0013781 abnormal mammary gland luminal epithelium morphology IMP N RGD:126908018|PMID:30893315 20210610 RGD 69063 Atrn attractin gene MP:0000745 tremors IAGP N RGD:1299186|PMID:12379762 20070731 RGD DNA:deletion:exon 69063 Atrn attractin gene MP:0000745 tremors IAGP N RGD:67998|PMID:11209055 20201214 RGD DNA:deletion 69063 Atrn attractin gene MP:0005409 darkened coat color IAGP N RGD:67998|PMID:11209055 20070731 RGD DNA:deletion 69063 Atrn attractin gene MP:0008025 brain vacuoles IAGP N RGD:67998|PMID:11209055 20201214 RGD DNA:deletion 6907054 WF.WKY-(D5Uwm67-D5Uwm98)/Uwm strain MP:0010269 decreased mammary gland tumor incidence induced IAGP XCO:0000090 N RGD:5684388|PMID:21205740 20200925 RGD compared to WF homozygous congenic controls or WF/NHsd 6907057 WF.WKY-(D5Uwm76-D5Uwm61)/Uwm strain MP:0010269 decreased mammary gland tumor incidence induced IAGP XCO:0000090 N RGD:5684388|PMID:21205740 20200925 RGD compared to WF homozygous congenic controls or WF/NHsd 6907059 WF.WKY-(D5Uwm76-D5Uwm98)/Uwm strain MP:0010269 decreased mammary gland tumor incidence induced IAGP XCO:0000090 N RGD:5684388|PMID:21205740 20200925 RGD compared to WF homozygous congenic controls or WF/NHsd 6907063 WF.WKY-(D5Uwm76-D5Got18)/Uwm strain MP:0010269 decreased mammary gland tumor incidence induced IAGP XCO:0000090 N RGD:5684388|PMID:21205740 20200925 RGD compared to WF homozygous congenic controls or WF/NHsd 6907076 WF.WKY-(D5Uwm78-D5Uwm98)/Uwm strain MP:0010269 decreased mammary gland tumor incidence induced IAGP XCO:0000090 N RGD:5684388|PMID:21205740 20200925 RGD compared to WF homozygous congenic controls or WF/NHsd 6907080 WF.WKY-(D5Uwm67-D5Uwm81)/Uwm strain MP:0010299 increased mammary gland tumor incidence induced IAGP N RGD:5684388|PMID:21205740 20121030 RGD DMBA induced; as compared to WKY/NHsd 6907084 WF.WKY-(D5Uwm76-D5Uwm92)/Uwm strain MP:0010269 decreased mammary gland tumor incidence induced IAGP XCO:0000090|XCO:0000675 N RGD:5684388|PMID:21205740 20200925 RGD compared to WF homozygous congenic controls or WF/NHsd 6907090 WF.WKY-(D5Uwm78-D5Uwm93)/Uwm strain MP:0010269 decreased mammary gland tumor incidence induced IAGP XCO:0000090 N RGD:5684388|PMID:21205740 20200925 RGD compared to WF homozygous congenic controls or WF/NHsd 6907096 WF.WKY-(D5Uwm85-D5Uwm92)/Uwm strain MP:0010269 decreased mammary gland tumor incidence induced IAGP XCO:0000090 N RGD:5684388|PMID:21205740 20200925 RGD compared to WF homozygous congenic controls or WF/NHsd 6907098 WF.WKY-(D5Uwm82-D5Uwm92)/Uwm strain MP:0010269 decreased mammary gland tumor incidence induced IAGP XCO:0000090 N RGD:5684388|PMID:21205740 20200925 RGD compared to WF homozygous congenic controls or WF/NHsd 6907100 WF.WKY-(D5Uwm82-D5Uwm91)/Uwm strain MP:0010269 decreased mammary gland tumor incidence induced IAGP XCO:0000090 N RGD:5684388|PMID:21205740 20200925 RGD compared to WF homozygous congenic controls or WF/NHsd 6907104 WF.WKY-(D5Uwm77-D5Uwm91)/Uwm strain MP:0010269 decreased mammary gland tumor incidence induced IAGP XCO:0000090 N RGD:5684388|PMID:21205740 20200925 RGD compared to WF homozygous congenic controls or WF/NHsd 6907110 Mcs28 Mammary carcinoma susceptibility QTL 28 qtl MP:0010269 decreased mammary gland tumor incidence IAGP N RGD:5684388|PMID:21205740 20121030 RGD 6907115 Mcs29 Mammary carcinoma susceptibility QTL 29 qtl MP:0010299 increased mammary gland tumor incidence IDA N RGD:5684388|PMID:21205740 20121030 RGD 6907363 Bp357 Blood pressure QTL 357 qtl MP:0002842 increased systemic arterial blood pressure IDA N RGD:61058|PMID:9329963 20121031 RGD 6909122 Insul22 Insulin level QTL 22 qtl MP:0002727 decreased circulating insulin level IAGP N RGD:1626640|PMID:17213368 20121107 RGD 6909128 Pancm4 Pancreatic morphology QTL 4 qtl MP:0009109 decreased pancreas weight IAGP N RGD:1626640|PMID:17213368 20121107 RGD 69192 Cyp27b1 cytochrome P450, family 27, subfamily b, polypeptide 1 gene MP:0000163 abnormal cartilage morphology IMP N RGD:32716373|PMID:32231239 20210325 RGD 69192 Cyp27b1 cytochrome P450, family 27, subfamily b, polypeptide 1 gene MP:0000195 decreased circulating calcium level treatment IMP XCO:0000545 N RGD:32716373|PMID:32231239 20210325 RGD compared to Jcl:Wi and untreated 69192 Cyp27b1 cytochrome P450, family 27, subfamily b, polypeptide 1 gene MP:0000559 abnormal femur morphology treatment IMP XCO:0000545 N RGD:32716373|PMID:32231239 20210325 RGD compared to Jcl:Wi and untreated 69192 Cyp27b1 cytochrome P450, family 27, subfamily b, polypeptide 1 gene MP:0001255 decreased body height IMP N RGD:32716373|PMID:32231239 20210325 RGD 69192 Cyp27b1 cytochrome P450, family 27, subfamily b, polypeptide 1 gene MP:0001260 increased body weight treatment IMP XCO:0000545 N RGD:32716373|PMID:32231239 20210325 RGD compared to untreated 69192 Cyp27b1 cytochrome P450, family 27, subfamily b, polypeptide 1 gene MP:0002904 increased circulating parathyroid hormone level treatment IMP XCO:0000545 N RGD:32716373|PMID:32231239 20210325 RGD compared to Jcl:Wi and treated 69192 Cyp27b1 cytochrome P450, family 27, subfamily b, polypeptide 1 gene MP:0009445 osteomalacia treatment IMP XCO:0000545 N RGD:32716373|PMID:32231239 20210325 RGD compared to Jcl:Wi and treated 69192 Cyp27b1 cytochrome P450, family 27, subfamily b, polypeptide 1 gene MP:0010769 abnormal survival IMP N RGD:32716373|PMID:32231239 20210325 RGD compared to CE-2 diet containing 1.15% calcium fed Cyp27b1-KO rats 69192 Cyp27b1 cytochrome P450, family 27, subfamily b, polypeptide 1 gene MP:0020011 increased bone mineral density of femur treatment IMP XCO:0000545 N RGD:32716373|PMID:32231239 20210325 RGD compared to Jcl:Wi and untreated 69219 Aldh2 aldehyde dehydrogenase 2 family member gene MP:0001987 alcohol preference IAGP N RGD:2306341|PMID:15900217 20090409 RGD DNA:polymorphism 69219 Aldh2 aldehyde dehydrogenase 2 family member gene MP:0002570 alcohol aversion IMP N RGD:15036815|PMID:11535626 20191120 RGD 69283 Mertk MER proto-oncogene, tyrosine kinase gene MP:0008515 thin retina outer nuclear layer IAGP N RGD:69668|PMID:11592982 20190802 RGD 69300 Slco1b2 solute carrier organic anion transporter family member 1B2 gene MP:0008875 abnormal xenobiotic pharmacokinetics IMP N RGD:150521535|PMID:32528832 20211109 RGD 69305 Nr2f2 nuclear receptor subfamily 2, group F, member 2 gene MP:0002963 decreased urine protein level IMP N RGD:10401852|PMID:25687237 20171102 RGD compared to SS/JrHsdMcw 69305 Nr2f2 nuclear receptor subfamily 2, group F, member 2 gene MP:0005600 increased heart ventricle muscle contractility IMP N RGD:10401852|PMID:25687237 20171102 RGD compared to SS/JrHsdMcw 69309 Fabp4 fatty acid binding protein 4 gene MP:0005669 increased circulating leptin level IAGP N RGD:737686|PMID:14724732 19990101 RGD 69364 Scn1a sodium voltage-gated channel alpha subunit 1 gene MP:0012349 increased susceptibility to induction of seizure by inducing agent IMP N RGD:12792282|PMID:20410126 20210218 RGD 69368 Scn9a sodium voltage-gated channel alpha subunit 9 gene MP:0001970 abnormal pain threshold induces IMP XCO:0000834 N RGD:150429745|PMID:31550995 20211007 RGD 69368 Scn9a sodium voltage-gated channel alpha subunit 9 gene MP:0001973 increased thermal nociceptive threshold induces IMP XCO:0000308 N RGD:150429745|PMID:31550995 20211007 RGD 69368 Scn9a sodium voltage-gated channel alpha subunit 9 gene MP:0002578 impaired ability to fire action potentials induces IMP XCO:0000240 N RGD:150429745|PMID:31550995 20211007 RGD 69368 Scn9a sodium voltage-gated channel alpha subunit 9 gene MP:0003412 abnormal afterhyperpolarization induces IMP XCO:0000240 N RGD:150429745|PMID:31550995 20211007 RGD 69368 Scn9a sodium voltage-gated channel alpha subunit 9 gene MP:0008531 increased chemical nociceptive threshold induces IMP XCO:0000834 N RGD:150429745|PMID:31550995 20211007 RGD 69368 Scn9a sodium voltage-gated channel alpha subunit 9 gene MP:0020523 decreased susceptibility to induced hypothermia induces IMP XCO:0000306,XCO:0000165 N RGD:150429745|PMID:31550995 20211007 RGD 69406 Pclo piccolo (presynaptic cytomatrix protein) gene MP:0000852 small cerebellum IMP N RGD:41408338|PMID:31074746 20210211 RGD compared to wild-type rat 69406 Pclo piccolo (presynaptic cytomatrix protein) gene MP:0000890 thin cerebellar molecular layer IMP N RGD:41408338|PMID:31074746 20210211 RGD compared to wild-type rat 69406 Pclo piccolo (presynaptic cytomatrix protein) gene MP:0001258 decreased body length IMP N RGD:41408338|PMID:31074746 20210211 RGD compared to wild-type rat 69406 Pclo piccolo (presynaptic cytomatrix protein) gene MP:0001262 decreased body weight IMP N RGD:41408338|PMID:31074746 20210211 RGD compared to wild-type rat 69406 Pclo piccolo (presynaptic cytomatrix protein) gene MP:0002175 decreased brain weight IMP N RGD:41408338|PMID:31074746 20210211 RGD compared to wild-type rat 69406 Pclo piccolo (presynaptic cytomatrix protein) gene MP:0004099 abnormal cerebellar glomerulus morphology IMP N RGD:41408338|PMID:31074746 20210211 RGD compared to wild-type rat 69406 Pclo piccolo (presynaptic cytomatrix protein) gene MP:0004770 abnormal synaptic vesicle recycling IMP N RGD:41408338|PMID:31074746 20210210 RGD 69406 Pclo piccolo (presynaptic cytomatrix protein) gene MP:0004792 abnormal synaptic vesicle number IMP N RGD:41408338|PMID:31074746 20210210 RGD 69406 Pclo piccolo (presynaptic cytomatrix protein) gene MP:0006099 thin cerebellar granule layer IMP N RGD:41408338|PMID:31074746 20210211 RGD compared to wild-type rat 69406 Pclo piccolo (presynaptic cytomatrix protein) gene MP:0011269 increased excitatory postsynaptic current amplitude IMP N RGD:41408338|PMID:31074746 20210211 RGD compared to wild-type rat 69406 Pclo piccolo (presynaptic cytomatrix protein) gene MP:0020533 decreased pons size IMP N RGD:41408338|PMID:31074746 20210211 RGD compared to wild-type rat 69418 Ubd ubiquitin D gene MP:0003037 increased myocardial infarct size IMP N RGD:126925221|PMID:29438664 20210517 RGD associated with induced myocardial infarction 69418 Ubd ubiquitin D gene MP:0003222 increased cardiomyocyte apoptosis IMP N RGD:126925221|PMID:29438664 20210517 RGD associated with induced myocardial infarction 69418 Ubd ubiquitin D gene MP:0005140 decreased cardiac muscle contractility IMP N RGD:126925221|PMID:29438664 20210517 RGD associated with induced myocardial infarction 69418 Ubd ubiquitin D gene MP:0005608 cardiac interstitial fibrosis IMP N RGD:126925221|PMID:29438664 20210517 RGD associated with induced myocardial infarction 69423 Srebf1 sterol regulatory element binding transcription factor 1 gene MP:0003983 decreased cholesterol level IAGP N RGD:1643359|PMID:18071061 20090609 RGD 69638 BN/Ka Brown Norway Katholiek (kininogen or kinin deficient) strain MP:0000186 decreased circulating HDL cholesterol level IAGP N RGD:1302825|PMID:15238617 20201001 RGD compared to W and BN 69638 BN/Ka Brown Norway Katholiek (kininogen or kinin deficient) strain MP:0001552 increased circulating triglyceride level induced IAGP XCO:0000246|XCO:0000025 N RGD:1302825|PMID:15238617 20201001 RGD compared to BN 69638 BN/Ka Brown Norway Katholiek (kininogen or kinin deficient) strain MP:0001556 increased circulating HDL cholesterol level induced IAGP XCO:0000246|XCO:0000025 N RGD:1302825|PMID:15238617 20201001 RGD compared to W and BN 69638 BN/Ka Brown Norway Katholiek (kininogen or kinin deficient) strain MP:0002628 hepatic steatosis induced IAGP XCO:0000246|XCO:0000025 N RGD:1302825|PMID:15238617 20201001 RGD compared to W and BN 69638 BN/Ka Brown Norway Katholiek (kininogen or kinin deficient) strain MP:0002644 decreased circulating triglyceride level IAGP N RGD:1302825|PMID:15238617 20201001 RGD compared to W and BN 69638 BN/Ka Brown Norway Katholiek (kininogen or kinin deficient) strain MP:0002644 decreased circulating triglyceride level induced IAGP XCO:0000246|XCO:0000025 N RGD:1302825|PMID:15238617 20201001 RGD compared to W 69638 BN/Ka Brown Norway Katholiek (kininogen or kinin deficient) strain MP:0003907 decreased aorta elastin content IAGP N RGD:1302825|PMID:15238617 20201001 RGD compared to BN 69638 BN/Ka Brown Norway Katholiek (kininogen or kinin deficient) strain MP:0003907 decreased aorta elastin content induced IAGP XCO:0000246|XCO:0000025 N RGD:1302825|PMID:15238617 20201001 RGD compared to BN 69638 BN/Ka Brown Norway Katholiek (kininogen or kinin deficient) strain MP:0006042 increased apoptosis induced IAGP XCO:0000246|XCO:0000025 N RGD:1302825|PMID:15238617 20201001 RGD compared to W and BN 69638 BN/Ka Brown Norway Katholiek (kininogen or kinin deficient) strain MP:0008577 increased circulating interferon-gamma level IAGP N RGD:1302825|PMID:15238617 20201001 RGD compared to W 69638 BN/Ka Brown Norway Katholiek (kininogen or kinin deficient) strain MP:0008577 increased circulating interferon-gamma level induced IAGP XCO:0000246|XCO:0000025 N RGD:1302825|PMID:15238617 20201001 RGD compared to W and BN 69638 BN/Ka Brown Norway Katholiek (kininogen or kinin deficient) strain MP:0008594 decreased circulating interleukin-10 level IAGP N RGD:1302825|PMID:15238617 20201001 RGD compared to BN 69638 BN/Ka Brown Norway Katholiek (kininogen or kinin deficient) strain MP:0008594 decreased circulating interleukin-10 level induced IAGP XCO:0000246|XCO:0000025 N RGD:1302825|PMID:15238617 20201001 RGD compared to BN 69638 BN/Ka Brown Norway Katholiek (kininogen or kinin deficient) strain MP:0008603 decreased circulating interleukin-4 level IAGP N RGD:1302825|PMID:15238617 20201001 RGD compared to BN 69638 BN/Ka Brown Norway Katholiek (kininogen or kinin deficient) strain MP:0008603 decreased circulating interleukin-4 level induced IAGP XCO:0000246|XCO:0000025 N RGD:1302825|PMID:15238617 20201001 RGD compared to BN 69638 BN/Ka Brown Norway Katholiek (kininogen or kinin deficient) strain MP:0008642 decreased circulating interleukin-1 beta level IAGP N RGD:1302825|PMID:15238617 20201001 RGD compared to BN 69638 BN/Ka Brown Norway Katholiek (kininogen or kinin deficient) strain MP:0008642 decreased circulating interleukin-1 beta level MODEL: induced IAGP XCO:0000246|XCO:0000025 N RGD:1302825|PMID:15238617 20201001 RGD compared to BN 70153 Bp59 Blood pressure QTL 59 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:69692|PMID:11082136 19990101 RGD 70154 Insul2 Insulin level QTL 2 qtl MP:0002727 decreased circulating insulin level QTM N RGD:69703|PMID:9819774 19990101 RGD 70155 Gcs1 Gastric cancer susceptibility QTL1 qtl MP:0002021 increased incidence of induced tumors QTM N RGD:69698|PMID:10706129 19990101 RGD 70156 Niddm30 Non-insulin dependent diabetes mellitus QTL 30 qtl MP:0005293 impaired glucose tolerance QTM N RGD:69696|PMID:10594234 19990101 RGD 70157 Niddm32 Non-insulin dependent diabetes mellitus QTL 32 qtl MP:0005293 impaired glucose tolerance QTM N RGD:69696|PMID:10594234 19990101 RGD 70158 Bp60 Blood pressure QTL 60 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:69692|PMID:11082136 19990101 RGD 70159 Bp61 Blood pressure QTL 61 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:69711|PMID:11247666 19990101 RGD 70160 Bw18 Body weight QTL 18 qtl MP:0001261 obese IAGP N RGD:69701|PMID:9530625 19990101 RGD 70161 Bp62 Blood pressure QTL 62 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:61516|PMID:11015598 19990101 RGD 70162 Bp63 Blood pressure QTL 63 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:61043|PMID:8952608 19990101 RGD 70163 Bw20 Body weight QTL 20 qtl MP:0001261 obese IAGP N RGD:69701|PMID:9530625 19990101 RGD 70164 Bw21 Body weight QTL 21 qtl MP:0001261 obese QTM N RGD:69691|PMID:9824537 19990101 RGD 70165 Bp64 Blood pressure QTL 64 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:69713|PMID:9931114 19990101 RGD 70166 Bp65 Blood pressure QTL 65 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:69713|PMID:9931114 19990101 RGD 70167 Bw22 Body weight QTL 22 qtl MP:0001261 obese QTM N RGD:69707|PMID:9530522 19990101 RGD 70168 Eae12 Experimental allergic encephalomyelitis QTL 12 qtl MP:0000754 paresis QTM N RGD:69695|PMID:10545597 19990101 RGD 70168 Eae12 Experimental allergic encephalomyelitis QTL 12 qtl MP:0000921 demyelination QTM N RGD:69695|PMID:10545597 19990101 RGD 70168 Eae12 Experimental allergic encephalomyelitis QTL 12 qtl MP:0001845 abnormal inflammatory response QTM N RGD:69695|PMID:10545597 19990101 RGD 70169 Eae13 Experimental allergic encephalomyelitis QTL 13 qtl MP:0000754 paresis QTM N RGD:69695|PMID:10545597 19990101 RGD 70169 Eae13 Experimental allergic encephalomyelitis QTL 13 qtl MP:0000921 demyelination QTM N RGD:69695|PMID:10545597 19990101 RGD 70170 Eae14 Experimental allergic encephalomyelitis QTL 14 qtl MP:0000754 paresis QTM N RGD:69695|PMID:10545597 19990101 RGD 70170 Eae14 Experimental allergic encephalomyelitis QTL 14 qtl MP:0000921 demyelination QTM N RGD:69695|PMID:10545597 19990101 RGD 70170 Eae14 Experimental allergic encephalomyelitis QTL 14 qtl MP:0001845 abnormal inflammatory response QTM N RGD:69695|PMID:10545597 19990101 RGD 70171 Cari1 Carrageenan-induced inflammation QTL 1 qtl MP:0001845 abnormal inflammatory response QTM N RGD:69693|PMID:10087293 19990101 RGD 70172 Eae15 Experimental allergic encephalomyelitis QTL 15 qtl MP:0000754 paresis QTM N RGD:69695|PMID:10545597 19990101 RGD 70172 Eae15 Experimental allergic encephalomyelitis QTL 15 qtl MP:0000921 demyelination QTM N RGD:69695|PMID:10545597 19990101 RGD 70172 Eae15 Experimental allergic encephalomyelitis QTL 15 qtl MP:0001846 increased inflammatory response QTM N RGD:69695|PMID:10545597 19990101 RGD 70173 Niddm19 Non-insulin dependent diabetes mellitus QTL 19 qtl MP:0005293 impaired glucose tolerance QTM N RGD:69691|PMID:9824537 19990101 RGD 70173 Niddm19 Non-insulin dependent diabetes mellitus QTL 19 qtl MP:0005293 impaired glucose tolerance QTM N RGD:69696|PMID:10594234 19990101 RGD 70174 BpQTLCluster2 Blood pressure QTL cluster 2 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:68932|PMID:10779487 19990101 RGD 70175 BpQTLCluster3 Blood pressure QTL cluster 3 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:68932|PMID:10779487 19990101 RGD 70176 Mcsm1 Mammary carcinoma susceptibility modifier QTL 1 qtl MP:0001883 increased mammary adenocarcinoma incidence QTM N RGD:62417|PMID:11139513 19990101 RGD 70177 Xhs1 X-ray hypersensitivity QTL 1 qtl MP:0002879 increased cellular sensitivity to X-ray irradiation QTM N RGD:69702|PMID:11003700 19990101 RGD 70178 Eaez Experimental allergic encephalomyelitis QTL z qtl MP:0000754 paresis QTM N RGD:61031|PMID:10640775 19990101 RGD 70178 Eaez Experimental allergic encephalomyelitis QTL z qtl MP:0001845 abnormal inflammatory response QTM N RGD:61031|PMID:10640775 19990101 RGD 70179 Xhs2 X-ray hypersensitivity QTL 2 qtl MP:0002879 increased cellular sensitivity to X-ray irradiation QTM N RGD:69702|PMID:11003700 19990101 RGD 70180 BpQTLcluster10 Blood pressure QTL cluster 10 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:68932|PMID:10779487 19990101 RGD 70181 BpQTLcluster11 Blood pressure QTL cluster 11 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:68932|PMID:10779487 19990101 RGD 70182 BpQTLcluster12 Blood pressure QTL cluster 12 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:68932|PMID:10779487 19990101 RGD 70183 BpQTLcluster13 Blood pressure QTL cluster 13 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:68932|PMID:10779487 19990101 RGD 70184 BpQTLcluster14 Blood pressure QTL cluster 14 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:68932|PMID:10779487 19990101 RGD 70185 BpQTLcluster15 Blood pressure QTL cluster 15 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:68932|PMID:10779487 19990101 RGD 70186 Niddm26 Non-insulin dependent diabetes mellitus QTL 26 qtl MP:0005293 impaired glucose tolerance QTM N RGD:69696|PMID:10594234 19990101 RGD 70187 Pancm5 Pancreatic morphology QTL 5 qtl MP:0005520 impaired pancreas regeneration QTM N RGD:69697|PMID:9745032 19990101 RGD 70188 BpQTLcluster1 Blood pressure QTL cluster 1 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:68932|PMID:10779487 19990101 RGD 70189 Mcs5 Mammary carcinoma susceptibility QTL 5 qtl MP:0001883 increased mammary adenocarcinoma incidence QTM N RGD:62417|PMID:11139513 19990101 RGD 70190 Mcs6 Mammary carcinoma susceptibility QTL 6 qtl MP:0001883 increased mammary adenocarcinoma incidence QTM N RGD:62417|PMID:11139513 19990101 RGD 70191 BpQTLcluster4 Blood pressure QTL cluster 4 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:68932|PMID:10779487 19990101 RGD 70192 BpQTLcluster5 Blood pressure QTL cluster 5 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:68932|PMID:10779487 19990101 RGD 70193 Mcs7 Mammary carcinoma susceptibility QTL 7 qtl MP:0001883 increased mammary adenocarcinoma incidence QTM N RGD:62417|PMID:11139513 19990101 RGD 70194 BpQTLcluster6 Blood pressure QTL cluster 6 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:68932|PMID:10779487 19990101 RGD 70195 Mcs8 Mammary carcinoma susceptibility QTL 8 qtl MP:0001883 increased mammary adenocarcinoma incidence QTM N RGD:62417|PMID:11139513 19990101 RGD 70196 BpQTLcluster7 Blood pressure QTL cluster 7 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:68932|PMID:10779487 19990101 RGD 70197 BpQTLcluster8 Blood pressure QTL cluster 8 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:68932|PMID:10779487 19990101 RGD 70198 BpQTLcluster9 Blood pressure QTL cluster 9 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:68932|PMID:10779487 19990101 RGD 70199 Coreg1 Compensatory renal growth QTL 1 qtl MP:0002955 increased compensatory renal growth QTM N RGD:69708|PMID:10732705 19990101 RGD 70200 Alc18 Alcohol consumption QTL 18 qtl MP:0001987 alcohol preference QTM N RGD:69704|PMID:9880658 19990101 RGD 70201 Gcr1 Gastric cancer resistance QTL 1 qtl MP:0002053 decreased incidence of induced tumors QTM N RGD:69698|PMID:10706129 19990101 RGD 70202 Alc19 Alcohol consumption QTL 19 qtl MP:0001987 alcohol preference QTM N RGD:69704|PMID:9880658 19990101 RGD 70203 Gcr2 Gastric cancer resistance QTL 2 qtl MP:0002053 decreased incidence of induced tumors QTM N RGD:69698|PMID:10706129 19990101 RGD 70204 Niddm20 Non-insulin dependent diabetes mellitus QTL 20 qtl MP:0005293 impaired glucose tolerance IAGP N RGD:69691|PMID:9824537 19990101 RGD 70204 Niddm20 Non-insulin dependent diabetes mellitus QTL 20 qtl MP:0005293 impaired glucose tolerance IAGP N RGD:69696|PMID:10594234 19990101 RGD 70205 Gcr3 Gastric cancer resistance QTL 3 qtl MP:0002053 decreased incidence of induced tumors QTM N RGD:69698|PMID:10706129 19990101 RGD 70206 Alc20 Alcohol consumption QTL 20 qtl MP:0001987 alcohol preference QTM N RGD:69704|PMID:9880658 19990101 RGD 70207 Niddm31 Non-insulin dependent diabetes mellitus QTL 31 qtl MP:0005293 impaired glucose tolerance QTM N RGD:69696|PMID:10594234 19990101 RGD 70208 Niddm22 Non-insulin dependent diabetes mellitus QTL 22 qtl MP:0005293 impaired glucose tolerance QTM N RGD:69691|PMID:9824537 19990101 RGD 70208 Niddm22 Non-insulin dependent diabetes mellitus QTL 22 qtl MP:0005293 impaired glucose tolerance QTM N RGD:69696|PMID:10594234 19990101 RGD 70209 Niddm23 Non-insulin dependent diabetes mellitus QTL 23 qtl MP:0005293 impaired glucose tolerance QTM N RGD:69696|PMID:10594234 19990101 RGD 70210 Cm15 Cardiac mass QTL 15 qtl MP:0000276 heart right ventricle hypertrophy QTM N RGD:69699|PMID:11157698 19990101 RGD 70210 Cm15 Cardiac mass QTL 15 qtl MP:0002975 vascular smooth muscle hypertrophy IDA N RGD:10401832|PMID:26258299 20151014 RGD 70210 Cm15 Cardiac mass QTL 15 qtl MP:0004202 pulmonary hyperplasia IDA N RGD:10401832|PMID:26258299 20151014 RGD 70211 Niddm24 Non-insulin dependent diabetes mellitus QTL 24 qtl MP:0005293 impaired glucose tolerance IAGP N RGD:69696|PMID:10594234 19990101 RGD 70212 Niddm25 Non-insulin dependent diabetes mellitus QTL 25 qtl MP:0005293 impaired glucose tolerance QTM N RGD:69696|PMID:10594234 19990101 RGD 70213 Niddm27 Non-insulin dependent diabetes mellitus QTL 27 qtl MP:0005293 impaired glucose tolerance QTM N RGD:69696|PMID:10594234 19990101 RGD 70214 Niddm28 Non-insulin dependent diabetes mellitus QTL 28 qtl MP:0005293 impaired glucose tolerance QTM N RGD:69696|PMID:10594234 19990101 RGD 70215 Niddm29 Non-insulin dependent diabetes mellitus QTL 29 qtl MP:0005293 impaired glucose tolerance QTM N RGD:69696|PMID:10594234 19990101 RGD 70216 Cm14 Cardiac mass QTL 14 qtl MP:0000274 enlarged heart IAGP N RGD:69705|PMID:9922389 19990101 RGD 70216 Cm14 Cardiac mass QTL 14 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:70067 19990101 RGD 70218 Cm28 Cardiac mass QTL 28 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:61516|PMID:11015598 19990101 RGD 70220 Bp55 Blood pressure QTL 55 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:61043|PMID:8952608 19990101 RGD 70221 Bp56 Blood pressure QTL 56 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:69713|PMID:9931114 19990101 RGD 70222 Eae2 Experimental allergic encephalomyelitis QTL 2 qtl MP:0000754 paresis QTM N RGD:69694|PMID:9973459 19990101 RGD 70222 Eae2 Experimental allergic encephalomyelitis QTL 2 qtl MP:0001846 increased inflammatory response QTM N RGD:69694|PMID:9973459 19990101 RGD 70223 Bp57 Blood pressure QTL 57 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:69692|PMID:11082136 19990101 RGD 70224 Eae3 Experimental allergic encephalomyelitis QTL 3 qtl MP:0000754 paresis IDA N RGD:69694|PMID:9973459 20100217 RGD 70224 Eae3 Experimental allergic encephalomyelitis QTL 3 qtl MP:0001846 increased inflammatory response IDA N RGD:69694|PMID:9973459 20100217 RGD 70225 Bp58 Blood pressure QTL 58 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:69692|PMID:11082136 19990101 RGD 70226 Eae4 Experimental allergic encephalomyelitis QTL 4 qtl MP:0000754 paresis QTM N RGD:69712|PMID:10072499 19990101 RGD 70226 Eae4 Experimental allergic encephalomyelitis QTL 4 qtl MP:0001846 increased inflammatory response QTM N RGD:69712|PMID:10072499 19990101 RGD 70363 Bp71 Blood pressure QTL 71 qtl MP:0002843 decreased systemic arterial blood pressure QTM N RGD:69734|PMID:11471055 19990101 RGD 70364 Bp72 Blood pressure QTL 72 qtl MP:0002843 decreased systemic arterial blood pressure QTM N RGD:69734|PMID:11471055 19990101 RGD 70410 AA Alko, Alcohol strain MP:0001987 alcohol preference IAGP N RGD:70283|PMID:17795073 20201103 RGD 70411 ANA Alko, Non-Alcohol strain MP:0012042 low alcohol preference IAGP N RGD:70283|PMID:17795073 19990101 RGD 70429 AO strain MP:0005515 uveitis susceptibility IAGP N RGD:40903004|PMID:8045717 20201222 RGD associated with herpes simplex virus; compared to PVG rat strain 70429 AO strain MP:0009791 increased susceptibility to viral infection induced morbidity/mortality susceptibility IAGP N RGD:40903004|PMID:8045717 20201222 RGD compared to PVG rat strain; HSV-1 McKrae virus strain 70454 WKY/N strain MP:0001260 increased body weight sexual_dimorphism IAGP N RGD:7245528|PMID:1877683 20200203 RGD compared to female WKY/N 70454 WKY/N strain MP:0001402 decreased locomotor activity sexual_dimorphism IAGP N RGD:7245528|PMID:1877683 20200203 RGD compared to female WKY/N 70454 WKY/N strain MP:0002626 increased heart rate sexual_dimorphism IAGP N RGD:7245528|PMID:1877683 20200203 RGD compared to female WKY/N 70454 WKY/N strain MP:0006144 increased systemic arterial systolic blood pressure sexual_dimorphism IAGP N RGD:7245528|PMID:1877683 20200203 RGD compared to female WKY/N 70459 ZDF Vancouver diabetic fatty Zucker strain MP:0000187 abnormal triglyceride level treatment IAGP XCO:0000667 N RGD:68896|PMID:11254461 20200212 RGD decreased muscle triglyceride level 70459 ZDF Vancouver diabetic fatty Zucker strain MP:0001559 hyperglycemia IAGP N RGD:68929|PMID:11334402 20200205 RGD 70459 ZDF Vancouver diabetic fatty Zucker strain MP:0002727 decreased circulating insulin level IAGP N RGD:68929|PMID:11334402 20200205 RGD 70459 ZDF Vancouver diabetic fatty Zucker strain MP:0003564 abnormal insulin secretion IAGP N RGD:68929|PMID:11334402 20200205 RGD 70459 ZDF Vancouver diabetic fatty Zucker strain MP:0005292 improved glucose tolerance treatment IAGP XCO:0000667 N RGD:68896|PMID:11254461 20200212 RGD 70459 ZDF Vancouver diabetic fatty Zucker strain MP:0005293 impaired glucose tolerance IAGP N RGD:68929|PMID:11334402 20200205 RGD 70459 ZDF Vancouver diabetic fatty Zucker strain MP:0005559 increased circulating glucose level IAGP N RGD:68929|PMID:11334402 20200205 RGD 70459 ZDF Vancouver diabetic fatty Zucker strain MP:0008853 decreased abdominal adipose tissue amount treatment IAGP XCO:0000667 N RGD:68896|PMID:11254461 20200212 RGD 70459 ZDF Vancouver diabetic fatty Zucker strain MP:0009425 increased soleus weight treatment IAGP XCO:0000667 N RGD:68896|PMID:11254461 20200212 RGD 70459 ZDF Vancouver diabetic fatty Zucker strain MP:0031001 increased glycogen synthesis treatment IAGP XCO:0000667 N RGD:68896|PMID:11254461 20200212 RGD in adipose tissue and skeletal muscle 70495 Map2k1 mitogen activated protein kinase kinase 1 gene MP:0000740 impaired smooth muscle contractility IDA N RGD:2293329|PMID:10198244 20080527 RGD inhibition decreases both calcium-stimulated and unstimulated myogenic tone in middle cerebral arteries (p<0.001) 70508 SD Sprague-Dawley strain MP:0006144 increased systemic arterial systolic blood pressure induced IAGP XCO:0000022 N RGD:68927|PMID:11246877 19990101 RGD compared to control 70509 F344/NRrrc strain MP:0003331 increased hepatocellular carcinoma incidence induced IAGP XCO:0000210,XCO:0000442,XCO:0000206 N RGD:619598|PMID:10493520 19990101 RGD compared to BN/SsNHsd 70547 Crhr2 corticotropin releasing hormone receptor 2 gene MP:0001987 alcohol preference IAGP N RGD:8662401|PMID:24611993 20210714 RGD DNA:polymorphism, missense mutation:promoter, cds 708419 Brinp2 BMP/retinoic acid inducible neural specific 2 gene MP:0004217 salt-sensitive hypertension IMP N RGD:12792227|PMID:24714719 20170316 RGD 708419 Brinp2 BMP/retinoic acid inducible neural specific 2 gene MP:0011022 abnormal circadian regulation of systemic arterial blood pressure IMP N RGD:12792227|PMID:24714719 20170316 RGD 708422 Or1f45 olfactory receptor family 1 subfamily F member 45 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 708429 Golgb1 golgin B1 gene MP:0001785 edema IAGP N RGD:40902994|PMID:21851869 20210121 RGD 708429 Golgb1 golgin B1 gene MP:0002082 postnatal lethality IAGP N RGD:40902994|PMID:21851869 20210121 RGD 708429 Golgb1 golgin B1 gene MP:0014101 decreased chondrocyte proliferation IAGP N RGD:40902994|PMID:21851869 20210121 RGD 708430 Camk2n1 calcium/calmodulin-dependent protein kinase II inhibitor 1 gene MP:0003916 decreased heart left ventricle weight IMP N RGD:18899561|PMID:31327268 20200206 RGD 708430 Camk2n1 calcium/calmodulin-dependent protein kinase II inhibitor 1 gene MP:0006263 decreased systemic arterial diastolic blood pressure IMP N RGD:18899561|PMID:31327268 20200206 RGD 708430 Camk2n1 calcium/calmodulin-dependent protein kinase II inhibitor 1 gene MP:0006264 decreased systemic arterial systolic blood pressure IMP N RGD:18899561|PMID:31327268 20200206 RGD 708430 Camk2n1 calcium/calmodulin-dependent protein kinase II inhibitor 1 gene MP:0009289 decreased epididymal fat pad weight IMP N RGD:18899561|PMID:31327268 20200206 RGD 708430 Camk2n1 calcium/calmodulin-dependent protein kinase II inhibitor 1 gene MP:0009299 decreased mesenteric fat pad weight IMP N RGD:18899561|PMID:31327268 20200206 RGD 708430 Camk2n1 calcium/calmodulin-dependent protein kinase II inhibitor 1 gene MP:0009305 decreased retroperitoneal fat pad weight IMP N RGD:18899561|PMID:31327268 20200206 RGD 708430 Camk2n1 calcium/calmodulin-dependent protein kinase II inhibitor 1 gene MP:0014169 decreased brown adipose tissue mass IMP N RGD:18899561|PMID:31327268 20200206 RGD 708465 Otos otospiralin gene MP:0005191 head tilt IMP N RGD:1302368|PMID:11880501 19990101 RGD 708584 Spon2 spondin 2 gene MP:0004883 abnormal vascular wound healing IMP N RGD:329328927|PMID:25751394 20230803 RGD 70878 Cit citron rho-interacting serine/threonine kinase gene MP:0003708 binucleate IAGP N RGD:13204832|PMID:11932363 20170721 RGD 70878 Cit citron rho-interacting serine/threonine kinase gene MP:0012138 decreased forebrain size IAGP N RGD:13204832|PMID:11932363 20170721 RGD 70878 Cit citron rho-interacting serine/threonine kinase gene MP:0012174 flat head IAGP N RGD:13204836|PMID:10219263 20180501 RGD 70944 Cplx1 complexin 1 gene MP:0001262 decreased body weight IMP N RGD:127285808|PMID:31875236 20210701 RGD 70944 Cplx1 complexin 1 gene MP:0001363 increased anxiety-related response IMP N RGD:127285808|PMID:31875236 20210701 RGD 70944 Cplx1 complexin 1 gene MP:0001406 abnormal gait IMP N RGD:127285808|PMID:31875236 20210701 RGD 70944 Cplx1 complexin 1 gene MP:0001407 short stride length IMP N RGD:127285808|PMID:31875236 20210701 RGD 70944 Cplx1 complexin 1 gene MP:0001415 increased exploration in new environment IMP N RGD:127285808|PMID:31875236 20210701 RGD 70944 Cplx1 complexin 1 gene MP:0001442 decreased grooming behavior IMP N RGD:127285808|PMID:31875236 20210701 RGD 70944 Cplx1 complexin 1 gene MP:0001524 impaired limb coordination IMP N RGD:127285808|PMID:31875236 20210701 RGD 70944 Cplx1 complexin 1 gene MP:0002083 premature death IMP N RGD:127285808|PMID:31875236 20210701 RGD 70944 Cplx1 complexin 1 gene MP:0002733 abnormal thermal nociception IMP N RGD:127285808|PMID:31875236 20210701 RGD 70944 Cplx1 complexin 1 gene MP:0002757 decreased vertical activity IMP N RGD:127285808|PMID:31875236 20210701 RGD 70944 Cplx1 complexin 1 gene MP:0003449 abnormal intestinal goblet cell morphology IMP N RGD:127285808|PMID:31875236 20210701 RGD 70944 Cplx1 complexin 1 gene MP:0005210 disorganized stomach mucosa IMP N RGD:127285808|PMID:31875236 20210701 RGD 70944 Cplx1 complexin 1 gene MP:0014219 decreased intestinal mucosa thickness IMP N RGD:127285808|PMID:31875236 20210701 RGD 70944 Cplx1 complexin 1 gene MP:0020336 abnormal motor neuron dendrite morphology IMP N RGD:127285808|PMID:31875236 20210701 RGD 70968 Ddah1 dimethylarginine dimethylaminohydrolase 1 gene MP:0003674 oxidative stress exacerbates IMP XCO:0000642 N RGD:151347602|PMID:31402164 20220203 RGD 70968 Ddah1 dimethylarginine dimethylaminohydrolase 1 gene MP:0003913 increased heart right ventricle weight exacerbates IMP XCO:0000642 N RGD:151347602|PMID:31402164 20220203 RGD 70968 Ddah1 dimethylarginine dimethylaminohydrolase 1 gene MP:0006050 pulmonary fibrosis induces IMP XCO:0000642 N RGD:151347602|PMID:31402164 20220203 RGD compared to wild type 70968 Ddah1 dimethylarginine dimethylaminohydrolase 1 gene MP:0010758 increased right ventricle systolic pressure induces IMP XCO:0000642 N RGD:151347602|PMID:31402164 20220203 RGD compared to wild type 70968 Ddah1 dimethylarginine dimethylaminohydrolase 1 gene MP:0010996 increased aorta wall thickness exacerbates IMP XCO:0000642 N RGD:151347602|PMID:31402164 20220203 RGD 70968 Ddah1 dimethylarginine dimethylaminohydrolase 1 gene MP:0010996 increased aorta wall thickness induces IMP N RGD:151347602|PMID:31402164 20220203 RGD compared to wild type 70982 Gsk3b glycogen synthase kinase 3 beta gene MP:0002229 neurodegeneration IDA N RGD:1358648|PMID:15073173 19990101 RGD 71009 Adcy3 adenylate cyclase 3 gene MP:0001984 abnormal olfaction IDA N RGD:70798|PMID:2255909 19990101 RGD 71009 Adcy3 adenylate cyclase 3 gene MP:0009305 decreased retroperitoneal fat pad weight IAGP N RGD:38548922|PMID:29193816 20200824 RGD DNA:missense mutation:cds:p.L121P (rat, WKY/N) 71024 Actr3 actin related protein 3 gene MP:0002962 increased urine protein level IAGP N RGD:2292230|PMID:18064521 20161221 RGD DNA:missense mutation:cds:p.L111F 71034 Htr7 5-hydroxytryptamine receptor 7 gene MP:0002644 decreased circulating triglyceride level IMP N RGD:14696717|PMID:31125290 20190718 RGD in male 71034 Htr7 5-hydroxytryptamine receptor 7 gene MP:0002966 decreased circulating alkaline phosphatase level IMP N RGD:14696717|PMID:31125290 20190718 RGD in male 71034 Htr7 5-hydroxytryptamine receptor 7 gene MP:0003025 increased vasoconstriction IMP N RGD:14696718|PMID:31125292 20190719 RGD 71034 Htr7 5-hydroxytryptamine receptor 7 gene MP:0005179 decreased circulating cholesterol level IMP N RGD:14696717|PMID:31125290 20190718 RGD in male 71037 Prlhr prolactin releasing hormone receptor gene MP:0001261 obese IAGP N RGD:1641829|PMID:15854142 20070823 RGD 71037 Prlhr prolactin releasing hormone receptor gene MP:0001433 polyphagia IAGP N RGD:1641829|PMID:15854142 20070823 RGD 71037 Prlhr prolactin releasing hormone receptor gene MP:0009304 increased retroperitoneal fat pad weight IAGP N RGD:38548922|PMID:29193816 20200824 RGD DNA, protein:misense mutation,deletion:cds:p.1-64 (rat, WKY/N, BUF/N,MR/N, ) 71082 Bmpr2 bone morphogenetic protein receptor type 2 gene MP:0002975 vascular smooth muscle hypertrophy IMP N RGD:38500244|PMID:25593290 20200924 RGD 71112 Bw115 Body weight QTL 115 qtl MP:0001260 increased body weight QTM N RGD:61072|PMID:9585427 19990101 RGD 71112 Bw115 Body weight QTL 115 qtl MP:0001260 increased body weight QTM N RGD:619678|PMID:10373320 19990101 RGD 71112 Bw115 Body weight QTL 115 qtl MP:0005559 increased circulating glucose level QTM N RGD:61072|PMID:9585427 19990101 RGD 71113 Cari2 Carrageenan-induced inflammation QTL 2 qtl MP:0001845 abnormal inflammatory response QTM N RGD:70860|PMID:11306811 19990101 RGD 71114 Niddm14 Non-insulin dependent diabetes mellitus QTL 14 qtl MP:0001260 increased body weight QTM N RGD:61072|PMID:9585427 19990101 RGD 71114 Niddm14 Non-insulin dependent diabetes mellitus QTL 14 qtl MP:0005559 increased circulating glucose level QTM N RGD:61072|PMID:9585427 19990101 RGD 71115 Niddm15 Non-insulin dependent diabetes mellitus QTL 15 qtl MP:0001260 increased body weight QTM N RGD:61072|PMID:9585427 19990101 RGD 71115 Niddm15 Non-insulin dependent diabetes mellitus QTL 15 qtl MP:0005293 impaired glucose tolerance QTM N RGD:61072|PMID:9585427 19990101 RGD 71115 Niddm15 Non-insulin dependent diabetes mellitus QTL 15 qtl MP:0005559 increased circulating glucose level QTM N RGD:61072|PMID:9585427 19990101 RGD 71116 Niddm16 Non-insulin dependent diabetes mellitus QTL 16 qtl MP:0005559 increased circulating glucose level QTM N RGD:619678|PMID:10373320 19990101 RGD 71117 Niddm17 Non-insulin dependent diabetes mellitus QTL 17 qtl MP:0005293 impaired glucose tolerance QTM N RGD:70861|PMID:8702404 19990101 RGD 71118 Thym1 Thymus enlargement QTL 1 qtl MP:0000708 thymus hyperplasia QTM N RGD:70859|PMID:10792781 19990101 RGD 71119 Thym2 Thymus enlargement QTL 2 qtl MP:0000708 thymus hyperplasia QTM N RGD:70859|PMID:10792781 19990101 RGD 71120 Niddm21 Non-insulin dependent diabetes mellitus QTL 21 qtl MP:0005293 impaired glucose tolerance QTM N RGD:61021|PMID:10051320 19990101 RGD 71120 Niddm21 Non-insulin dependent diabetes mellitus QTL 21 qtl MP:0005559 increased circulating glucose level contributes_to IDA N RGD:2300331|PMID:18421176 20080912 RGD heterozygous genotype at the Niddm21 locus 7204132 Rag1em1Ztm recombination activating gene 1; zinc finger nuclease induced mutant 1, Zentrales Tierlaboratorium, Medizinische Hochschule Hannover gene MP:0000706 small thymus IMP N RGD:7204131|PMID:23136839 20180508 RGD 7204132 Rag1em1Ztm recombination activating gene 1; zinc finger nuclease induced mutant 1, Zentrales Tierlaboratorium, Medizinische Hochschule Hannover gene MP:0005017 decreased B cell number IMP N RGD:7204131|PMID:23136839 20180508 RGD 7204132 Rag1em1Ztm recombination activating gene 1; zinc finger nuclease induced mutant 1, Zentrales Tierlaboratorium, Medizinische Hochschule Hannover gene MP:0005018 decreased T cell number IMP N RGD:7204131|PMID:23136839 20180508 RGD 7204133 LEW-Rag1em1Ztm strain MP:0000706 small thymus IMP N RGD:7204131|PMID:23136839 20121217 RGD 7204133 LEW-Rag1em1Ztm strain MP:0005017 decreased B cell number IMP N RGD:7204131|PMID:23136839 20121217 RGD 7204133 LEW-Rag1em1Ztm strain MP:0005018 decreased T cell number IMP N RGD:7204131|PMID:23136839 20121217 RGD 7204135 Rag1em1Ang recombination activating gene 1; zinc finger nuclease induced mutant 1, Ignacio Anegon gene MP:0000333 decreased bone marrow cell number IMP N RGD:13628403|PMID:29688994 20180620 RGD 7204135 Rag1em1Ang recombination activating gene 1; zinc finger nuclease induced mutant 1, Ignacio Anegon gene MP:0000692 small spleen IMP N RGD:7204134|PMID:23150522 20180507 RGD 7204135 Rag1em1Ang recombination activating gene 1; zinc finger nuclease induced mutant 1, Ignacio Anegon gene MP:0000694 spleen hypoplasia IMP N RGD:13628403|PMID:29688994 20180620 RGD 7204135 Rag1em1Ang recombination activating gene 1; zinc finger nuclease induced mutant 1, Ignacio Anegon gene MP:0000706 small thymus IMP N RGD:7204134|PMID:23150522 20180507 RGD 7204135 Rag1em1Ang recombination activating gene 1; zinc finger nuclease induced mutant 1, Ignacio Anegon gene MP:0000715 decreased thymocyte number IMP N RGD:13628403|PMID:29688994 20180620 RGD 7204135 Rag1em1Ang recombination activating gene 1; zinc finger nuclease induced mutant 1, Ignacio Anegon gene MP:0002217 small lymph nodes IMP N RGD:7204134|PMID:23150522 20180507 RGD 7204135 Rag1em1Ang recombination activating gene 1; zinc finger nuclease induced mutant 1, Ignacio Anegon gene MP:0005017 decreased B cell number IMP N RGD:7204134|PMID:23150522 20180507 RGD 7204135 Rag1em1Ang recombination activating gene 1; zinc finger nuclease induced mutant 1, Ignacio Anegon gene MP:0005018 decreased T cell number IMP N RGD:7204134|PMID:23150522 20180507 RGD 7204135 Rag1em1Ang recombination activating gene 1; zinc finger nuclease induced mutant 1, Ignacio Anegon gene MP:0008045 decreased NK cell number IMP N RGD:13628403|PMID:29688994 20180620 RGD 7204135 Rag1em1Ang recombination activating gene 1; zinc finger nuclease induced mutant 1, Ignacio Anegon gene MP:0008075 decreased CD4-positive, alpha-beta T cell number IMP N RGD:13628403|PMID:29688994 20180620 RGD 7204135 Rag1em1Ang recombination activating gene 1; zinc finger nuclease induced mutant 1, Ignacio Anegon gene MP:0008079 decreased CD8-positive, alpha-beta T cell number IMP N RGD:13628403|PMID:29688994 20180620 RGD 7204135 Rag1em1Ang recombination activating gene 1; zinc finger nuclease induced mutant 1, Ignacio Anegon gene MP:0008101 lymph node hypoplasia IMP N RGD:13628403|PMID:29688994 20180620 RGD 7204135 Rag1em1Ang recombination activating gene 1; zinc finger nuclease induced mutant 1, Ignacio Anegon gene MP:0008211 decreased mature B cell number IMP N RGD:13628403|PMID:29688994 20180620 RGD 7204136 SD-Rag1em1Ang strain MP:0000333 decreased bone marrow cell number IMP N RGD:13628403|PMID:29688994 20180620 RGD 7204136 SD-Rag1em1Ang strain MP:0000692 small spleen IMP N RGD:7204134|PMID:23150522 20121217 RGD 7204136 SD-Rag1em1Ang strain MP:0000694 spleen hypoplasia IMP N RGD:13628403|PMID:29688994 20180620 RGD 7204136 SD-Rag1em1Ang strain MP:0000706 small thymus IMP N RGD:7204134|PMID:23150522 20121217 RGD 7204136 SD-Rag1em1Ang strain MP:0000715 decreased thymocyte number IMP N RGD:13628403|PMID:29688994 20180620 RGD 7204136 SD-Rag1em1Ang strain MP:0002217 small lymph nodes IMP N RGD:7204134|PMID:23150522 20121217 RGD 7204136 SD-Rag1em1Ang strain MP:0005017 decreased B cell number IMP N RGD:7204134|PMID:23150522 20121217 RGD 7204136 SD-Rag1em1Ang strain MP:0005018 decreased T cell number IMP N RGD:7204134|PMID:23150522 20121217 RGD 7204136 SD-Rag1em1Ang strain MP:0008045 decreased NK cell number IMP N RGD:13628403|PMID:29688994 20180620 RGD 7204136 SD-Rag1em1Ang strain MP:0008075 decreased CD4-positive, alpha-beta T cell number IMP N RGD:13628403|PMID:29688994 20180620 RGD 7204136 SD-Rag1em1Ang strain MP:0008079 decreased CD8-positive, alpha-beta T cell number IMP N RGD:13628403|PMID:29688994 20180620 RGD 7204136 SD-Rag1em1Ang strain MP:0008101 lymph node hypoplasia IMP N RGD:13628403|PMID:29688994 20180620 RGD 7204136 SD-Rag1em1Ang strain MP:0008211 decreased mature B cell number IMP N RGD:13628403|PMID:29688994 20180620 RGD 7204484 Bp358 Blood pressure QTL 358 qtl MP:0002962 increased urine protein level IAGP N RGD:7204442|PMID:22868394 20121219 RGD 7204484 Bp358 Blood pressure QTL 358 qtl MP:0004875 increased mean systemic arterial blood pressure IAGP N RGD:7204442|PMID:22868394 20121219 RGD 7207885 Glom27 Glomerulus QTL 27 qtl MP:0002743 glomerulonephritis IAGP N RGD:7207870|PMID:22445570 20130212 RGD 7240514 DA.PVG.1AV1-(D4Kiru12-D4Kiru55)/Kiru strain MP:0003436 decreased susceptibility to induced arthritis induced IAGP XCO:0000265 N RGD:1642519|PMID:17665455 20130213 RGD compared to DA/ZtmKini 7241042 Park7em1Sage parkinson protein 7; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0001406 abnormal gait IMP N RGD:13210569|PMID:24969022 20201210 RGD 7241042 Park7em1Sage parkinson protein 7; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0001516 abnormal motor coordination/balance IMP N RGD:13210569|PMID:24969022 20201210 RGD 7241042 Park7em1Sage parkinson protein 7; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0001906 increased dopamine level IMP N RGD:13210569|PMID:24969022 20201210 RGD 7241042 Park7em1Sage parkinson protein 7; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0002757 decreased vertical activity IMP N RGD:13210569|PMID:24969022 20201210 RGD 7241042 Park7em1Sage parkinson protein 7; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0003244 loss of dopaminergic neurons IMP N RGD:13210569|PMID:24969022 20201210 RGD 7241042 Park7em1Sage parkinson protein 7; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0004142 abnormal muscle tone IMP N RGD:13210569|PMID:24969022 20201210 RGD 7241042 Park7em1Sage parkinson protein 7; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0010069 increased serotonin level IMP N RGD:13210569|PMID:24969022 20201210 RGD 7241042 Park7em1Sage parkinson protein 7; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0020078 decreased brain tyrosine 3-monooxygenase activity IMP N RGD:13210569|PMID:24969022 20201210 RGD 7241045 Lrrk2em1Sage leucine-rich repeat kinase 2; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0000203 abnormal circulating aspartate transaminase level IMP N RGD:13462048|PMID:23799078 20180824 RGD 7241045 Lrrk2em1Sage leucine-rich repeat kinase 2; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0001260 increased body weight IMP N RGD:12880447|PMID:24244710 20170508 RGD 7241045 Lrrk2em1Sage leucine-rich repeat kinase 2; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0001747 hypersecretion of adrenocorticotropin IMP N RGD:13462048|PMID:23799078 20180824 RGD 7241045 Lrrk2em1Sage leucine-rich repeat kinase 2; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0001751 increased circulating luteinizing hormone level IMP N RGD:13462048|PMID:23799078 20180824 RGD 7241045 Lrrk2em1Sage leucine-rich repeat kinase 2; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0002176 increased brain weight IMP N RGD:12880447|PMID:24244710 20170508 RGD 7241045 Lrrk2em1Sage leucine-rich repeat kinase 2; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0002644 decreased circulating triglyceride level IMP N RGD:13462048|PMID:23799078 20180824 RGD 7241045 Lrrk2em1Sage leucine-rich repeat kinase 2; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0002874 decreased hemoglobin content IMP N RGD:13462048|PMID:23799078 20180824 RGD 7241045 Lrrk2em1Sage leucine-rich repeat kinase 2; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0002875 decreased erythrocyte cell number IMP N RGD:12880447|PMID:24244710 20170508 RGD 7241045 Lrrk2em1Sage leucine-rich repeat kinase 2; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0002942 decreased circulating alanine transaminase level IMP N RGD:13462048|PMID:23799078 20180824 RGD 7241045 Lrrk2em1Sage leucine-rich repeat kinase 2; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0002965 increased circulating serum albumin level IMP N RGD:13462048|PMID:23799078 20180824 RGD 7241045 Lrrk2em1Sage leucine-rich repeat kinase 2; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0003020 decreased circulating chloride level IMP N RGD:13462048|PMID:23799078 20180824 RGD 7241045 Lrrk2em1Sage leucine-rich repeat kinase 2; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0005012 decreased eosinophil cell number IMP N RGD:13462048|PMID:23799078 20180824 RGD 7241045 Lrrk2em1Sage leucine-rich repeat kinase 2; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0005016 decreased lymphocyte cell number IMP N RGD:13462048|PMID:23799078 20180824 RGD 7241045 Lrrk2em1Sage leucine-rich repeat kinase 2; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0005121 decreased circulating prolactin level IMP N RGD:13462048|PMID:23799078 20180824 RGD 7241045 Lrrk2em1Sage leucine-rich repeat kinase 2; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0005178 increased circulating cholesterol level IMP N RGD:12880447|PMID:24244710 20170508 RGD 7241045 Lrrk2em1Sage leucine-rich repeat kinase 2; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0005238 increased brain size IMP N RGD:12880447|PMID:24244710 20170508 RGD 7241045 Lrrk2em1Sage leucine-rich repeat kinase 2; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0005455 increased susceptibility to weight gain IMP N RGD:13462048|PMID:23799078 20180824 RGD 7241045 Lrrk2em1Sage leucine-rich repeat kinase 2; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0005553 increased circulating creatinine level IMP N RGD:12880447|PMID:24244710 20170508 RGD 7241045 Lrrk2em1Sage leucine-rich repeat kinase 2; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0005628 decreased circulating potassium level IMP N RGD:13462048|PMID:23799078 20180824 RGD 7241045 Lrrk2em1Sage leucine-rich repeat kinase 2; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0005635 decreased circulating bilirubin level IMP N RGD:13462048|PMID:23799078 20180824 RGD 7241045 Lrrk2em1Sage leucine-rich repeat kinase 2; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0010815 enlarged alveolar lamellar bodies IMP N RGD:13462051|PMID:24465451 20190103 RGD 7241045 Lrrk2em1Sage leucine-rich repeat kinase 2; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0010891 increased alveolar lamellar body number IMP N RGD:12880447|PMID:24244710 20170508 RGD 7241045 Lrrk2em1Sage leucine-rich repeat kinase 2; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0010993 decreased surfactant secretion IMP N RGD:13462051|PMID:24465451 20190103 RGD 7241046 Pink1em1Sage PTEN induced putative kinase 1; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0001260 increased body weight IMP N RGD:13210569|PMID:24969022 20201210 RGD 7241046 Pink1em1Sage PTEN induced putative kinase 1; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0001402 decreased locomotor activity IMP N RGD:13210569|PMID:24969022 20201210 RGD 7241046 Pink1em1Sage PTEN induced putative kinase 1; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0001406 abnormal gait IMP N RGD:13210569|PMID:24969022 20201210 RGD 7241046 Pink1em1Sage PTEN induced putative kinase 1; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0001516 abnormal motor coordination/balance IMP N RGD:13210569|PMID:24969022 20201210 RGD 7241046 Pink1em1Sage PTEN induced putative kinase 1; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0001906 increased dopamine level IMP N RGD:13210569|PMID:24969022 20201210 RGD 7241046 Pink1em1Sage PTEN induced putative kinase 1; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0002757 decreased vertical activity IMP N RGD:13210569|PMID:24969022 20201210 RGD 7241046 Pink1em1Sage PTEN induced putative kinase 1; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0003244 loss of dopaminergic neurons IMP N RGD:13210569|PMID:24969022 20201210 RGD 7241046 Pink1em1Sage PTEN induced putative kinase 1; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0004142 abnormal muscle tone IMP N RGD:13210569|PMID:24969022 20201210 RGD 7241046 Pink1em1Sage PTEN induced putative kinase 1; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0005289 increased oxygen consumption onset IMP N RGD:11560775|PMID:25421206 20210218 RGD compared to LEH 7241046 Pink1em1Sage PTEN induced putative kinase 1; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0010053 decreased grip strength IMP N RGD:13210569|PMID:24969022 20201210 RGD 7241046 Pink1em1Sage PTEN induced putative kinase 1; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0010069 increased serotonin level IMP N RGD:13210569|PMID:24969022 20201210 RGD 7241046 Pink1em1Sage PTEN induced putative kinase 1; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0020078 decreased brain tyrosine 3-monooxygenase activity IMP N RGD:13210569|PMID:24969022 20201210 RGD 7241046 Pink1em1Sage PTEN induced putative kinase 1; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0020543 decreased substantia nigra size IMP N RGD:11560775|PMID:25421206 20210218 RGD compared to LEH 7241046 Pink1em1Sage PTEN induced putative kinase 1; zinc finger nuclease induced mutant 1, Sigma Advanced Genetic Engineering Labs gene MP:0020726 decreased substantia nigra cell number IMP N RGD:11560775|PMID:25421206 20210218 RGD compared to LEH 7241049 LE-Pink1em1Sage-/- strain MP:0001260 increased body weight IMP N RGD:13210569|PMID:24969022 20170912 RGD 7241049 LE-Pink1em1Sage-/- strain MP:0001402 decreased locomotor activity IMP N RGD:13210569|PMID:24969022 20170912 RGD 7241049 LE-Pink1em1Sage-/- strain MP:0001406 abnormal gait IMP N RGD:13210569|PMID:24969022 20170912 RGD 7241049 LE-Pink1em1Sage-/- strain MP:0001516 abnormal motor coordination/balance IMP N RGD:13210569|PMID:24969022 20170912 RGD 7241049 LE-Pink1em1Sage-/- strain MP:0001906 increased dopamine level IMP N RGD:13210569|PMID:24969022 20170912 RGD 7241049 LE-Pink1em1Sage-/- strain MP:0002757 decreased vertical activity IMP N RGD:13210569|PMID:24969022 20170912 RGD 7241049 LE-Pink1em1Sage-/- strain MP:0003244 loss of dopaminergic neurons IMP N RGD:13210569|PMID:24969022 20170912 RGD 7241049 LE-Pink1em1Sage-/- strain MP:0004142 abnormal muscle tone IMP N RGD:13210569|PMID:24969022 20170912 RGD 7241049 LE-Pink1em1Sage-/- strain MP:0005289 increased oxygen consumption onset IMP N RGD:11560775|PMID:25421206 20210212 RGD compared to LEH 7241049 LE-Pink1em1Sage-/- strain MP:0010053 decreased grip strength IMP N RGD:13210569|PMID:24969022 20170912 RGD 7241049 LE-Pink1em1Sage-/- strain MP:0010069 increased serotonin level IMP N RGD:13210569|PMID:24969022 20170912 RGD 7241049 LE-Pink1em1Sage-/- strain MP:0020078 decreased brain tyrosine 3-monooxygenase activity IMP N RGD:13210569|PMID:24969022 20170912 RGD 7241049 LE-Pink1em1Sage-/- strain MP:0020543 decreased substantia nigra size IMP N RGD:11560775|PMID:25421206 20210212 RGD compared to LEH 7241049 LE-Pink1em1Sage-/- strain MP:0020726 decreased substantia nigra cell number IMP N RGD:11560775|PMID:25421206 20210212 RGD compared to LEH 7241055 LE-Park7em1Sage-/- strain MP:0001406 abnormal gait IMP N RGD:13210569|PMID:24969022 20170912 RGD 7241055 LE-Park7em1Sage-/- strain MP:0001516 abnormal motor coordination/balance IMP N RGD:13210569|PMID:24969022 20170912 RGD 7241055 LE-Park7em1Sage-/- strain MP:0001906 increased dopamine level IMP N RGD:13210569|PMID:24969022 20170912 RGD 7241055 LE-Park7em1Sage-/- strain MP:0002757 decreased vertical activity IMP N RGD:13210569|PMID:24969022 20170912 RGD 7241055 LE-Park7em1Sage-/- strain MP:0003244 loss of dopaminergic neurons IMP N RGD:13210569|PMID:24969022 20170912 RGD 7241055 LE-Park7em1Sage-/- strain MP:0004142 abnormal muscle tone IMP N RGD:13210569|PMID:24969022 20170912 RGD 7241055 LE-Park7em1Sage-/- strain MP:0010069 increased serotonin level IMP N RGD:13210569|PMID:24969022 20170912 RGD 7241055 LE-Park7em1Sage-/- strain MP:0020078 decreased brain tyrosine 3-monooxygenase activity IMP N RGD:13210569|PMID:24969022 20170912 RGD 7241056 LE-Lrrk2em1Sage-/- strain MP:0000203 abnormal circulating aspartate transaminase level IMP N RGD:13462048|PMID:23799078 20180824 RGD 7241056 LE-Lrrk2em1Sage-/- strain MP:0001260 increased body weight IMP N RGD:12880447|PMID:24244710 20170508 RGD 7241056 LE-Lrrk2em1Sage-/- strain MP:0001747 hypersecretion of adrenocorticotropin IMP N RGD:13462048|PMID:23799078 20180824 RGD 7241056 LE-Lrrk2em1Sage-/- strain MP:0001751 increased circulating luteinizing hormone level IMP N RGD:13462048|PMID:23799078 20180824 RGD 7241056 LE-Lrrk2em1Sage-/- strain MP:0002176 increased brain weight IMP N RGD:12880447|PMID:24244710 20170508 RGD 7241056 LE-Lrrk2em1Sage-/- strain MP:0002644 decreased circulating triglyceride level IMP N RGD:13462048|PMID:23799078 20180824 RGD 7241056 LE-Lrrk2em1Sage-/- strain MP:0002874 decreased hemoglobin content IMP N RGD:13462048|PMID:23799078 20180824 RGD 7241056 LE-Lrrk2em1Sage-/- strain MP:0002875 decreased erythrocyte cell number IMP N RGD:12880447|PMID:24244710 20170508 RGD 7241056 LE-Lrrk2em1Sage-/- strain MP:0002942 decreased circulating alanine transaminase level IMP N RGD:13462048|PMID:23799078 20180824 RGD 7241056 LE-Lrrk2em1Sage-/- strain MP:0002965 increased circulating serum albumin level IMP N RGD:13462048|PMID:23799078 20180824 RGD 7241056 LE-Lrrk2em1Sage-/- strain MP:0003020 decreased circulating chloride level IMP N RGD:13462048|PMID:23799078 20180824 RGD 7241056 LE-Lrrk2em1Sage-/- strain MP:0005012 decreased eosinophil cell number IMP N RGD:13462048|PMID:23799078 20180824 RGD 7241056 LE-Lrrk2em1Sage-/- strain MP:0005016 decreased lymphocyte cell number IMP N RGD:13462048|PMID:23799078 20180824 RGD 7241056 LE-Lrrk2em1Sage-/- strain MP:0005121 decreased circulating prolactin level IMP N RGD:13462048|PMID:23799078 20180824 RGD 7241056 LE-Lrrk2em1Sage-/- strain MP:0005178 increased circulating cholesterol level IMP N RGD:12880447|PMID:24244710 20170508 RGD 7241056 LE-Lrrk2em1Sage-/- strain MP:0005238 increased brain size IMP N RGD:12880447|PMID:24244710 20170508 RGD 7241056 LE-Lrrk2em1Sage-/- strain MP:0005455 increased susceptibility to weight gain IMP N RGD:13462048|PMID:23799078 20180824 RGD 7241056 LE-Lrrk2em1Sage-/- strain MP:0005553 increased circulating creatinine level IMP N RGD:12880447|PMID:24244710 20170508 RGD 7241056 LE-Lrrk2em1Sage-/- strain MP:0005628 decreased circulating potassium level IMP N RGD:13462048|PMID:23799078 20180824 RGD 7241056 LE-Lrrk2em1Sage-/- strain MP:0005635 decreased circulating bilirubin level IMP N RGD:13462048|PMID:23799078 20180824 RGD 7241056 LE-Lrrk2em1Sage-/- strain MP:0010815 enlarged alveolar lamellar bodies IMP N RGD:13462051|PMID:24465451 20190103 RGD 7241056 LE-Lrrk2em1Sage-/- strain MP:0010891 increased alveolar lamellar body number IMP N RGD:12880447|PMID:24244710 20170508 RGD 7241056 LE-Lrrk2em1Sage-/- strain MP:0010993 decreased surfactant secretion IMP N RGD:13462051|PMID:24465451 20190103 RGD 7241240 DA.BN-(D9Mit6-D9Rat29)/Kini strain MP:0009764 decreased susceptibility to induced morbidity/mortality induced IAGP XCO:0000356 N RGD:7241236|PMID:20368159 20200505 RGD compared to DA/ZtmKini 7241243 DA.BN-(D9Wox24-D9Rat20)/Kini strain MP:0009764 decreased susceptibility to induced morbidity/mortality induced IAGP XCO:0000356 N RGD:7241236|PMID:20368159 20200505 RGD compared to DA/ZtmKini 7241244 DA.BN-(D9Wox24-D9Wox18)/Kini strain MP:0009764 decreased susceptibility to induced morbidity/mortality induced IAGP XCO:0000356 N RGD:7241236|PMID:20368159 20200505 RGD compared to DA/ZtmKini 7241245 DA.BN-(D9Wox24-D9Rat139)/Kini strain MP:0009764 decreased susceptibility to induced morbidity/mortality induced IAGP XCO:0000356 N RGD:7241236|PMID:20368159 20200505 RGD compared to DA/ZtmKini 7241246 DA.BN-(D9Wox24-D9Rat44)/Kini strain MP:0009764 decreased susceptibility to induced morbidity/mortality induced IAGP XCO:0000356 N RGD:7241236|PMID:20368159 20200505 RGD compared to DA/ZtmKini 7241248 LEW.BN-(D9Wox24-D9Got22)/Kini strain MP:0004800 decreased susceptibility to experimental autoimmune encephalomyelitis induced IAGP XCO:0000688 N RGD:7241236|PMID:20368159 20200505 RGD compared to LEW/Rj 7241265 SHR-Chr YWKY/Akr strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:7241263|PMID:8505094 20130307 RGD for males as compared to the SHR/NHsd males 7241265 SHR-Chr YWKY/Akr strain MP:0006264 decreased systemic arterial systolic blood pressure induced IAGP XCO:0000203 N RGD:7241263|PMID:8505094 20130307 RGD compared to sham control 7241265 SHR-Chr YWKY/Akr strain MP:0010167 decreased response to stress-induced hyperthermia IAGP N RGD:61094|PMID:10679499 20171121 RGD compared to SHR 7241267 WKY-Chr YSHR/Akr strain MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:7241263|PMID:8505094 20130307 RGD for males as compared to WKY/NHsd males 7241267 WKY-Chr YSHR/Akr strain MP:0006264 decreased systemic arterial systolic blood pressure induced IAGP XCO:0000203 N RGD:7241263|PMID:8505094 20130307 RGD compared to shame control 7241271 SHR.BN-(D10Mit4-D10Wox11)/Cub strain MP:0010167 decreased response to stress-induced hyperthermia IAGP N RGD:61094|PMID:10679499 20171121 RGD compared to SHR 7241593 Rbm20m1Mlgw RNA binding motif protein 20; mutation 1, Marion Greaser gene MP:0003061 decreased aerobic running capacity IMP N RGD:126925234|PMID:24367651 20210520 RGD 7241594 (SDxF344)F1-Rbm20m1Mlgw strain MP:0003061 decreased aerobic running capacity IMP N RGD:126925234|PMID:24367651 20210518 RGD 7241811 BBDP.WF-(D8Rat73-D8Sunn1467)(D13Rat124-D13Mgh5)/Sunn strain MP:0004804 decreased susceptibility to autoimmune diabetes IAGP N RGD:1624306|PMID:17389329 20200302 RGD 7243862 Mcs30 Mammary carcinoma susceptibility QTL 30 qtl MP:0010299 increased mammary gland tumor incidence IDA N RGD:7327193|PMID:24023717 20130918 RGD 7243965 DA.F344-(D4Arb21-D4Arb4)/Arb strain MP:0003079 decreased susceptibility to induced joint inflammation induced IAGP XCO:0000263 N RGD:7243954|PMID:22076633 20130604 RGD compared to BklArbNsi 7243966 DA.F344-(D4Arb5-D4Arb4)/Arb strain MP:0003079 decreased susceptibility to induced joint inflammation induced IAGP XCO:0000281|XCO:0000263 N RGD:7243954|PMID:22076633 20130604 RGD compared to BklArbNsi 724513 Uae14 Urinary albumin excretion QTL 14 qtl MP:0002871 albuminuria QTM N RGD:634633|PMID:12799471 19990101 RGD 724514 Uae15 Urinary albumin excretion QTL 15 qtl MP:0002871 albuminuria QTM N RGD:634633|PMID:12799471 19990101 RGD 724515 Uae16 Urinary albumin excretion QTL 16 qtl MP:0002871 albuminuria QTM N RGD:634633|PMID:12799471 19990101 RGD 724516 Uae17 Urinary albumin excretion QTL 17 qtl MP:0002871 albuminuria QTM N RGD:634633|PMID:12799471 19990101 RGD 724517 Uae18 Urinary albumin excretion QTL 18 qtl MP:0002871 albuminuria QTM N RGD:634633|PMID:12799471 19990101 RGD 724518 Uae19 Urinary albumin excretion QTL 19 qtl MP:0002871 albuminuria QTM N RGD:634633|PMID:12799471 19990101 RGD 724519 Bp144 Blood pressure QTL 144 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:619638|PMID:8938440 19990101 RGD 724520 Bp145 Blood pressure QTL 145 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:634618|PMID:12397040 19990101 RGD 724521 Uae1 Urinary albumin excretion QTL 1 qtl MP:0002962 increased urine protein level IDA N RGD:634618|PMID:12397040 20120112 RGD 724522 Bp146 Blood pressure QTL 146 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:634618|PMID:12397040 19990101 RGD 724523 Tsu1 Thymus enlargement suppressive QTL 1 qtl MP:0000706 small thymus QTM N RGD:634729|PMID:9234381 19990101 RGD 724524 Uae2 Urinary albumin excretion QTL 2 qtl MP:0002962 increased urine protein level IDA N RGD:634618|PMID:12397040 20120112 RGD 724525 Bp147 Blood pressure QTL 147 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:634618|PMID:12397040 19990101 RGD 724526 Uae3 Urinary albumin excretion QTL 3 qtl MP:0002962 increased urine protein level IDA N RGD:634618|PMID:12397040 20120112 RGD 724527 Bp148 Blood pressure QTL 148 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:704345|PMID:12939233 19990101 RGD 724528 Uae4 Urinary albumin excretion QTL 4 qtl MP:0002962 increased urine protein level IDA N RGD:634618|PMID:12397040 20120112 RGD 724529 Cm16 Cardiac mass QTL 16 qtl MP:0002833 increased heart weight QTM N RGD:634617|PMID:12707388 19990101 RGD 724529 Cm16 Cardiac mass QTL 16 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:634617|PMID:12707388 19990101 RGD 724530 Bp149 Blood pressure QTL 149 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:704345|PMID:12939233 19990101 RGD 724531 Uae5 Urinary albumin excretion QTL 5 qtl MP:0002871 albuminuria QTM N RGD:634617|PMID:12707388 19990101 RGD 724531 Uae5 Urinary albumin excretion QTL 5 qtl MP:0002962 increased urine protein level IDA N RGD:634617|PMID:12707388 20120112 RGD 724532 Cm17 Cardiac mass QTL 17 qtl MP:0002833 increased heart weight QTM N RGD:634617|PMID:12707388 19990101 RGD 724533 Rf51 Renal function QTL 51 qtl MP:0005526 decreased renal plasma flow rate QTM N RGD:619628|PMID:10545438 19990101 RGD 724533 Rf51 Renal function QTL 51 qtl MP:0005528 decreased renal glomerular filtration rate QTM N RGD:619628|PMID:10545438 19990101 RGD 724533 Rf51 Renal function QTL 51 qtl MP:0005531 increased renal vascular resistance QTM N RGD:619628|PMID:10545438 19990101 RGD 724534 Uae6 Urinary albumin excretion QTL 6 qtl MP:0002871 albuminuria QTM N RGD:634617|PMID:12707388 19990101 RGD 724534 Uae6 Urinary albumin excretion QTL 6 qtl MP:0002962 increased urine protein level IDA N RGD:634617|PMID:12707388 20120112 RGD 724534 Uae6 Urinary albumin excretion QTL 6 qtl MP:0005264 glomerulosclerosis QTM N RGD:634617|PMID:12707388 19990101 RGD 724535 Cm18 Cardiac mass QTL 18 qtl MP:0002833 increased heart weight QTM N RGD:634617|PMID:12707388 19990101 RGD 724536 Uae7 Urinary albumin excretion QTL 7 qtl MP:0002871 albuminuria IDA N RGD:634617|PMID:12707388 19990101 RGD 724536 Uae7 Urinary albumin excretion QTL 7 qtl MP:0002962 increased urine protein level IDA N RGD:634617|PMID:12707388 20120112 RGD 724537 Niddm52 Non-insulin dependent diabetes mellitus QTL 52 qtl MP:0005293 impaired glucose tolerance QTM N RGD:619670|PMID:11381614 19990101 RGD 724538 Kidm1 Kidney mass QTL 1 qtl MP:0002702 decreased circulating free fatty acids level QTM N RGD:634617|PMID:12707388 19990101 RGD 724539 Cm19 Cardiac mass QTL 19 qtl MP:0002833 increased heart weight QTM N RGD:634617|PMID:12707388 19990101 RGD 724540 Uae8 Urinary albumin excretion QTL 8 qtl MP:0002871 albuminuria QTM N RGD:634617|PMID:12707388 19990101 RGD 724540 Uae8 Urinary albumin excretion QTL 8 qtl MP:0002962 increased urine protein level IDA N RGD:634617|PMID:12707388 20120112 RGD 724541 Niddm53 Non-insulin dependent diabetes mellitus QTL 53 qtl MP:0005293 impaired glucose tolerance QTM N RGD:619670|PMID:11381614 19990101 RGD 724542 Kidm2 Kidney mass QTL 2 qtl MP:0002702 decreased circulating free fatty acids level QTM N RGD:634617|PMID:12707388 19990101 RGD 724543 Cm20 Cardiac mass QTL 20 qtl MP:0002833 increased heart weight QTM N RGD:634617|PMID:12707388 19990101 RGD 724544 Uae9 Urinary albumin excretion QTL 9 qtl MP:0002871 albuminuria QTM N RGD:634617|PMID:12707388 19990101 RGD 724545 Niddm54 Non-insulin dependent diabetes mellitus QTL 54 qtl MP:0005293 impaired glucose tolerance QTM N RGD:619670|PMID:11381614 19990101 RGD 724546 Kidm3 Kidney mass QTL 3 qtl MP:0002702 decreased circulating free fatty acids level QTM N RGD:634617|PMID:12707388 19990101 RGD 724547 Cm21 Cardiac mass QTL 21 qtl MP:0002833 increased heart weight QTM N RGD:634617|PMID:12707388 19990101 RGD 724548 Niddm55 Non-insulin dependent diabetes mellitus QTL 55 qtl MP:0005293 impaired glucose tolerance QTM N RGD:619670|PMID:11381614 19990101 RGD 724549 Niddm56 Non-insulin dependent diabetes mellitus QTL 56 qtl MP:0005293 impaired glucose tolerance QTM N RGD:619670|PMID:11381614 19990101 RGD 724550 Thym3 Thymus enlargement QTL 3 qtl MP:0000709 enlarged thymus QTM N RGD:70859|PMID:10792781 19990101 RGD 724551 Glom1 Glomerulus QTL 1 qtl MP:0005325 abnormal renal glomerulus morphology IDA N RGD:634618|PMID:12397040 20111108 RGD 724552 Glom2 Glomerulus QTL 2 qtl MP:0005325 abnormal renal glomerulus morphology IDA N RGD:634618|PMID:12397040 20111108 RGD 7245527 WKHA/Edh strain MP:0001260 increased body weight sexual_dimorphism IAGP N RGD:7245528|PMID:1877683 20200203 RGD compared to female 7245527 WKHA/Edh strain MP:0001262 decreased body weight IAGP N RGD:7245528|PMID:1877683 20200203 RGD compared to WKY/N 7245527 WKHA/Edh strain MP:0001399 hyperactivity IAGP N RGD:7245528|PMID:1877683 20200203 RGD compared to WKY/N 7245527 WKHA/Edh strain MP:0001402 decreased locomotor activity sexual_dimorphism IAGP N RGD:7245528|PMID:1877683 20200203 RGD compared to female 7245527 WKHA/Edh strain MP:0005333 decreased heart rate sexual_dimorphism IAGP N RGD:7245528|PMID:1877683 20200203 RGD compared to female SHR/N 7245527 WKHA/Edh strain MP:0006144 increased systemic arterial systolic blood pressure sexual_dimorphism IAGP N RGD:7245528|PMID:1877683 20200203 RGD compared to female 7245527 WKHA/Edh strain MP:0006264 decreased systemic arterial systolic blood pressure sexual_dimorphism IAGP N RGD:7245528|PMID:1877683 20200203 RGD compared to female SHR/N 7245527 WKHA/Edh strain MP:0008772 increased heart ventricle size IAGP N RGD:7245528|PMID:1877683 20200203 RGD compared to WKY/N 724553 Glom3 Glomerulus QTL 3 qtl MP:0005325 abnormal renal glomerulus morphology IDA N RGD:634618|PMID:12397040 20111108 RGD 724554 Iddm17 Insulin dependent diabetes mellitus QTL 17 qtl MP:0001869 pancreas inflammation QTM N RGD:634732|PMID:9329965 19990101 RGD 724555 Bp150 Blood pressure QTL 150 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:704345|PMID:12939233 19990101 RGD 7245556 WKHT/Edh strain MP:0000279 ventricular hypoplasia IAGP N RGD:7245528|PMID:1877683 20200203 RGD compared to male WKHA/Edh 7245556 WKHT/Edh strain MP:0001260 increased body weight IAGP N RGD:7245528|PMID:1877683 20200203 RGD compared to WKHA/Edh 7245556 WKHT/Edh strain MP:0001260 increased body weight sexual_dimorphism IAGP N RGD:7245528|PMID:1877683 20200203 RGD compared to female 7245556 WKHT/Edh strain MP:0001262 decreased body weight sexual_dimorphism IAGP N RGD:7245528|PMID:1877683 20200203 RGD compared to WKY/N female 7245556 WKHT/Edh strain MP:0001402 decreased locomotor activity IAGP N RGD:7245528|PMID:1877683 20200203 RGD compared to WKHA/Edh, SHR/N 7245556 WKHT/Edh strain MP:0002626 increased heart rate IAGP N RGD:7245528|PMID:1877683 20200203 RGD compared to SHR/N 7245556 WKHT/Edh strain MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:7245528|PMID:1877683 20200203 RGD compared to WKHA/Edh 724556 Pur2 Proteinuria QTL 2 qtl MP:0002962 increased urine protein level IDA N RGD:634617|PMID:12707388 20120112 RGD 724557 Plsm1 Polydactyly-luxate syndrome (PLS) morphotypes QTL 1 qtl MP:0000562 polydactyly IDA N RGD:632346|PMID:8997636 19990101 RGD 724558 Plsm2 Polydactyly-luxate syndrome (PLS) morphotypes QTL 2 qtl MP:0000562 polydactyly IDA N RGD:632346|PMID:8997636 19990101 RGD 724559 Pancm1 Pancreatic morphology QTL 1 qtl MP:0005215 abnormal pancreatic islet morphology QTM N RGD:61083|PMID:9169130 19990101 RGD 724560 Plsm3 Polydactyly-luxate syndrome (PLS) morphotypes QTL 3 qtl MP:0002764 short tibia IDA N RGD:632346|PMID:8997636 19990101 RGD 724561 Plsm4 Polydactyly-luxate syndrome (PLS) morphotypes QTL 4 qtl MP:0000562 polydactyly IDA N RGD:632346|PMID:8997636 19990101 RGD 724562 Rends1 Renal damage susceptibility QTL 1 qtl MP:0000530 abnormal kidney vasculature morphology IAGP N RGD:632218|PMID:10454439 19990101 RGD 724562 Rends1 Renal damage susceptibility QTL 1 qtl MP:0002962 increased urine protein level IAGP N RGD:632218|PMID:10454439 20120112 RGD 724562 Rends1 Renal damage susceptibility QTL 1 qtl MP:0005325 abnormal renal glomerulus morphology IAGP N RGD:632218|PMID:10454439 19990101 RGD 724563 Uae10 Urinary albumin excretion QTL 10 qtl MP:0002871 albuminuria IDA N RGD:634617|PMID:12707388 19990101 RGD 724563 Uae10 Urinary albumin excretion QTL 10 qtl MP:0002962 increased urine protein level IDA N RGD:634617|PMID:12707388 20120112 RGD 724564 Uae11 Urinary albumin excretion QTL 11 qtl MP:0002871 albuminuria QTM N RGD:634617|PMID:12707388 19990101 RGD 724565 Tcas5 Tongue tumor susceptibility QTL 5 qtl MP:0010272 increased tongue tumor incidence IDA N RGD:634723|PMID:11429048 20111115 RGD 724566 Uae12 Urinary albumin excretion QTL 12 qtl MP:0002871 albuminuria QTM N RGD:634617|PMID:12707388 19990101 RGD 724567 Tcas6 Tongue tumor susceptibility QTL 6 qtl MP:0010272 increased tongue tumor incidence IDA N RGD:634723|PMID:11429048 20111115 RGD 724568 Uae13 Urinary albumin excretion QTL 13 qtl MP:0002871 albuminuria QTM N RGD:634633|PMID:12799471 19990101 RGD 724569 MWF/FubRkb Munich Wistar Fromter strain MP:0001260 increased body weight IAGP N RGD:634618|PMID:12397040 20191216 RGD compared to LEW/Rkb 724569 MWF/FubRkb Munich Wistar Fromter strain MP:0001552 increased circulating triglyceride level IAGP N RGD:1600609|PMID:17167120 20200130 RGD compared to SHR/FubRkb strain 724569 MWF/FubRkb Munich Wistar Fromter strain MP:0002834 decreased heart weight IAGP N RGD:1600609|PMID:17167120 20200130 RGD compared to SHR/FubRkb, MWF-Chr 6SHR/Rkb strains 724569 MWF/FubRkb Munich Wistar Fromter strain MP:0002871 albuminuria IAGP N RGD:1600609|PMID:17167120 20200130 RGD compared to SHR/FubRkb strain 724569 MWF/FubRkb Munich Wistar Fromter strain MP:0002871 albuminuria IAGP N RGD:1642911|PMID:17953514 20200219 RGD females compared to female SHR/FubRkb, female MWF-Chr 6SHR/Rkb 724569 MWF/FubRkb Munich Wistar Fromter strain MP:0002871 albuminuria IAGP N RGD:2292240|PMID:18199599 20210712 RGD compared to SHR/FubRkb 724569 MWF/FubRkb Munich Wistar Fromter strain MP:0002871 albuminuria IAGP N RGD:2317887|PMID:20388842 20200203 RGD compared to SHR/FubRkb, SHR-Chr 6MWF/Rkb 724569 MWF/FubRkb Munich Wistar Fromter strain MP:0003215 renal interstitial fibrosis IAGP N RGD:2312602|PMID:18647879 20191220 RGD as compared to SHR/FubRkb 724569 MWF/FubRkb Munich Wistar Fromter strain MP:0003215 renal interstitial fibrosis induced IAGP XCO:0000114 N RGD:25314248|PMID:20864942 20210324 RGD compared to WU-Nx, WU-Nx-ACEI, and MWF-Sham 724569 MWF/FubRkb Munich Wistar Fromter strain MP:0003215 renal interstitial fibrosis sexual_dimorphism IAGP N RGD:1642911|PMID:17953514 20200219 RGD males compared to SHR/FubRkb, female MWF/FubRkb 724569 MWF/FubRkb Munich Wistar Fromter strain MP:0003215 renal interstitial fibrosis treatment IAGP XCO:0000114,XCO:0000548 N RGD:25314248|PMID:20864942 20210324 RGD compared to MWF-Nx-ACEI 724569 MWF/FubRkb Munich Wistar Fromter strain MP:0003821 decreased left ventricle diastolic pressure treatment IAGP XCO:0000114,XCO:0000548 N RGD:25314248|PMID:20864942 20210324 RGD compared to MWF-Nx 724569 MWF/FubRkb Munich Wistar Fromter strain MP:0003915 increased heart left ventricle weight IAGP N RGD:25314272|PMID:16915036 20210709 RGD compared to Wi 724569 MWF/FubRkb Munich Wistar Fromter strain MP:0003915 increased heart left ventricle weight induced IAGP XCO:0000114 N RGD:25314248|PMID:20864942 20210324 RGD compared to WU-sham, MWF-sham, WU-Nx, MWF-Nx-ACEI treated and WU-Nx-ACEI treated 724569 MWF/FubRkb Munich Wistar Fromter strain MP:0003915 increased heart left ventricle weight treatment IAGP XCO:0000114,XCO:0000548 N RGD:25314248|PMID:20864942 20210324 RGD compared to WU-Nx-ACEI treated 724569 MWF/FubRkb Munich Wistar Fromter strain MP:0003916 decreased heart left ventricle weight IAGP N RGD:2312602|PMID:18647879 20191220 RGD as compared to SHR/FubRkb 724569 MWF/FubRkb Munich Wistar Fromter strain MP:0003918 decreased kidney weight IAGP N RGD:1600609|PMID:17167120 20200130 RGD compared to SHR/FubRkb strain 724569 MWF/FubRkb Munich Wistar Fromter strain MP:0003918 decreased kidney weight IAGP N RGD:2312602|PMID:18647879 20191220 RGD compared to SHR/FubRkb strain 724569 MWF/FubRkb Munich Wistar Fromter strain MP:0004505 decreased renal glomerulus number IAGP N RGD:15023481|PMID:30900988 20210819 RGD compared to SHR, MWF-6SHR, MWF.SHR-(D6Rat1-D6Mgh4) 724569 MWF/FubRkb Munich Wistar Fromter strain MP:0004505 decreased renal glomerulus number IAGP N RGD:1600609|PMID:17167120 20200130 RGD compared to SHR/FubRkb, MWF-Chr 6SHR/Rkb strains 724569 MWF/FubRkb Munich Wistar Fromter strain MP:0005178 increased circulating cholesterol level IAGP N RGD:1600609|PMID:17167120 20200130 RGD compared to SHR/FubRkb, MWF-Chr 6SHR/Rkb strains 724569 MWF/FubRkb Munich Wistar Fromter strain MP:0005264 glomerulosclerosis IAGP N RGD:634618|PMID:12397040 20191216 RGD compared to LEW/Rkb 724569 MWF/FubRkb Munich Wistar Fromter strain MP:0005264 glomerulosclerosis induced IAGP XCO:0000114 N RGD:25314248|PMID:20864942 20210324 RGD compared to WU-sham, WU-Nx, MWF-Nx-ACEI and MWF-Sham-Nx-ACEI 724569 MWF/FubRkb Munich Wistar Fromter strain MP:0005264 glomerulosclerosis sexual_dimorphism IAGP N RGD:1642911|PMID:17953514 20200219 RGD compared to female MWF/Rkb 724569 MWF/FubRkb Munich Wistar Fromter strain MP:0005264 glomerulosclerosis treatment IAGP XCO:0000114,XCO:0000548 N RGD:25314248|PMID:20864942 20210324 RGD compared to MWF-Nx-ACEI 724569 MWF/FubRkb Munich Wistar Fromter strain MP:0005325 abnormal renal glomerulus morphology IAGP N RGD:634618|PMID:12397040 20191216 RGD compared to LEW/Rkb 724569 MWF/FubRkb Munich Wistar Fromter strain MP:0005522 increased circulating atrial natriuretic factor induced IAGP XCO:0000114 N RGD:25314248|PMID:20864942 20210324 RGD compared to WU-sham, MWF-sham, WU-Nx, MWF-Nx-ACEI treated and WU-Nx-ACEI treated 724569 MWF/FubRkb Munich Wistar Fromter strain MP:0005522 increased circulating atrial natriuretic factor treatment IAGP XCO:0000114,XCO:0000548 N RGD:25314248|PMID:20864942 20210324 RGD compared to WU-Nx-ACEI treated 724569 MWF/FubRkb Munich Wistar Fromter strain MP:0005540 decreased urine albumin level sexual_dimorphism IAGP N RGD:1642911|PMID:17953514 20200219 RGD compared to male MWF/FubRkb 724569 MWF/FubRkb Munich Wistar Fromter strain MP:0005540 decreased urine albumin level sexual_dimorphism IAGP N RGD:2292240|PMID:18199599 20210712 RGD compared to male SHR/FubRkb 724569 MWF/FubRkb Munich Wistar Fromter strain MP:0005557 increased creatinine clearance treatment IAGP XCO:0000114,XCO:0000548 N RGD:25314248|PMID:20864942 20210324 RGD compared to MWF-Nx 724569 MWF/FubRkb Munich Wistar Fromter strain MP:0005558 decreased creatinine clearance induced IAGP XCO:0000114 N RGD:25314248|PMID:20864942 20210324 RGD compared to MWF-Sham 724569 MWF/FubRkb Munich Wistar Fromter strain MP:0005565 increased blood urea nitrogen level IAGP N RGD:1600609|PMID:17167120 20200130 RGD compared to SHR/FubRkb, MWF-Chr 6SHR/Rkb strains 724569 MWF/FubRkb Munich Wistar Fromter strain MP:0005565 increased blood urea nitrogen level IAGP N RGD:1642911|PMID:17953514 20200219 RGD females compared to female SHR/FubRkb, female MWF-Chr 6SHR/Rkb 724569 MWF/FubRkb Munich Wistar Fromter strain MP:0005565 increased blood urea nitrogen level IAGP N RGD:2312602|PMID:18647879 20191220 RGD as compared to SHR/FubRkb 724569 MWF/FubRkb Munich Wistar Fromter strain MP:0005598 decreased heart ventricle muscle contractility induced IAGP XCO:0000114 N RGD:25314248|PMID:20864942 20210324 RGD compared to MWF-sham and WU-Nx 724569 MWF/FubRkb Munich Wistar Fromter strain MP:0005600 increased heart ventricle muscle contractility treatment IAGP XCO:0000114,XCO:0000548 N RGD:25314248|PMID:20864942 20210324 RGD compared to MWF-Nx 724569 MWF/FubRkb Munich Wistar Fromter strain MP:0005608 cardiac interstitial fibrosis induced IAGP XCO:0000114 N RGD:25314248|PMID:20864942 20210324 RGD compared to MWF-Sham 724569 MWF/FubRkb Munich Wistar Fromter strain MP:0005608 cardiac interstitial fibrosis treatment IAGP XCO:0000114,XCO:0000548 N RGD:25314248|PMID:20864942 20210324 RGD compared to WU-Nx 724569 MWF/FubRkb Munich Wistar Fromter strain MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:25314272|PMID:16915036 20210709 RGD compared to Wi 724569 MWF/FubRkb Munich Wistar Fromter strain MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:634618|PMID:12397040 19990101 RGD compared to LEW/Rkb 724569 MWF/FubRkb Munich Wistar Fromter strain MP:0006144 increased systemic arterial systolic blood pressure induced IAGP XCO:0000114 N RGD:25314248|PMID:20864942 20210324 RGD compared to WU-sham, MWF-sham, WU-Nx, MWF-Nx-ACEI treated and WU-Nx-ACEI treated 724569 MWF/FubRkb Munich Wistar Fromter strain MP:0006144 increased systemic arterial systolic blood pressure treatment IAGP XCO:0000114,XCO:0000548 N RGD:25314248|PMID:20864942 20210324 RGD compared to WU-Nx-ACEI treated 724569 MWF/FubRkb Munich Wistar Fromter strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:1600609|PMID:17167120 20200130 RGD compared to SHR/FubRkb, MWF-Chr 6SHR/Rkb strains 724569 MWF/FubRkb Munich Wistar Fromter strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:1642911|PMID:17953514 20200219 RGD compared to SHR/FubRkb 724569 MWF/FubRkb Munich Wistar Fromter strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:2312602|PMID:18647879 20191220 RGD compared to SHR/FubRkb strain 724569 MWF/FubRkb Munich Wistar Fromter strain MP:0010064 increased circulating creatine level IAGP N RGD:2312602|PMID:18647879 20191220 RGD as compared to SHR/FubRkb 724569 MWF/FubRkb Munich Wistar Fromter strain MP:0011760 abnormal ureteric bud tip morphology IAGP N RGD:25314259|PMID:22871889 20210709 RGD compared to SHR and MWF-Chr 6SHR/Rkb 724569 MWF/FubRkb Munich Wistar Fromter strain MP:0020312 increased hydroxymethylbilane synthase activity IAGP N RGD:1642911|PMID:17953514 20200219 RGD compared to SHR/FubRkb, MWF-Chr 6SHR/Rkb 724569 MWF/FubRkb Munich Wistar Fromter strain MP:0020418 increased cardiac muscle relaxation treatment IAGP XCO:0000114,XCO:0000548 N RGD:25314248|PMID:20864942 20210324 RGD compared to MWF-Nx 724569 MWF/FubRkb Munich Wistar Fromter strain MP:0020419 decreased cardiac muscle relaxation induced IAGP XCO:0000114 N RGD:25314248|PMID:20864942 20210324 RGD compared to MWF-sham and WU-Nx 724572 SS.LEW-(D10Wox51-D10Rat27)/Ayd strain MP:0002843 decreased systemic arterial blood pressure IAGP N RGD:704345|PMID:12939233 19990101 RGD 724573 SS/JrTol Dahl salt-sensitive (SS/Jr) rats strain MP:0001552 increased circulating triglyceride level IAGP N RGD:1625111|PMID:17504948 20191126 RGD compared to SHR/NHsdMco, SS.SHR-(D2Rat61-D2Mco18)/Mco 724573 SS/JrTol Dahl salt-sensitive (SS/Jr) rats strain MP:0003016 increased circulating bicarbonate level IAGP N RGD:1625111|PMID:17504948 20191126 RGD compared to SHR/NHsdMco, SS.SHR-(D2Rat61-D2Mco18)/Mco 724573 SS/JrTol Dahl salt-sensitive (SS/Jr) rats strain MP:0003917 increased kidney weight IAGP N RGD:1625111|PMID:17504948 20191126 RGD compared to SHR/NHsdMco, SS.SHR-(D2Rat61-D2Mco18)/Mco 724573 SS/JrTol Dahl salt-sensitive (SS/Jr) rats strain MP:0005178 increased circulating cholesterol level IAGP N RGD:1625111|PMID:17504948 20191126 RGD compared to SHR/NHsdMco, SS.SHR-(D2Rat61-D2Mco18)/Mco 724573 SS/JrTol Dahl salt-sensitive (SS/Jr) rats strain MP:0005565 increased blood urea nitrogen level IAGP N RGD:1625111|PMID:17504948 20191126 RGD compared to SHR/NHsdMco, SS.SHR-(D2Rat61-D2Mco18)/Mco 724573 SS/JrTol Dahl salt-sensitive (SS/Jr) rats strain MP:0005627 increased circulating potassium level IAGP N RGD:1625111|PMID:17504948 20191126 RGD compared to SHR/NHsdMco, SS.SHR-(D2Rat61-D2Mco18)/Mco 724573 SS/JrTol Dahl salt-sensitive (SS/Jr) rats strain MP:0005633 increased circulating sodium level IAGP N RGD:1625111|PMID:17504948 20191126 RGD compared to SHR/NHsdMco, SS.SHR-(D2Rat61-D2Mco18)/Mco 724573 SS/JrTol Dahl salt-sensitive (SS/Jr) rats strain MP:0011377 renal glomerulus fibrosis severity IAGP N RGD:1625111|PMID:17504948 20191126 RGD 724574 SHR/NHsd strain MP:0001262 decreased body weight IAGP N RGD:61516|PMID:11015598 19990101 RGD compared to SS/Jr 724574 SHR/NHsd strain MP:0003025 increased vasoconstriction IAGP N RGD:2316923|PMID:20026763 20201208 RGD compared to BN/SsNHsd 724574 SHR/NHsd strain MP:0010166 increased response to stress-induced hyperthermia IAGP N RGD:61094|PMID:10679499 20171121 RGD compared to BN-Lx 724575 SS.LEW-(D10Rat17-D10Mgh1)/Ayd strain MP:0002843 decreased systemic arterial blood pressure IAGP N RGD:704345|PMID:12939233 20201022 RGD compared to Dahl SS 724577 SS.LEW-(D10Rat27-Igfbp4)/Ayd strain MP:0002843 decreased systemic arterial blood pressure IAGP N RGD:704345|PMID:12939233 19990101 RGD 7247279 SD-Tg(TRE-FUS-R521C)Xgx strain MP:0000753 paralysis IMP N RGD:9685710|PMID:21408206 20190726 RGD 7247279 SD-Tg(TRE-FUS-R521C)Xgx strain MP:0003224 neuron degeneration IMP N RGD:9685710|PMID:21408206 20190726 RGD 7247279 SD-Tg(TRE-FUS-R521C)Xgx strain MP:0008143 abnormal dendrite morphology IMP N RGD:7247277|PMID:22833456 20190726 RGD 7247279 SD-Tg(TRE-FUS-R521C)Xgx strain MP:0008414 abnormal spatial reference memory IMP N RGD:7247277|PMID:22833456 20190726 RGD 7247279 SD-Tg(TRE-FUS-R521C)Xgx strain MP:0011743 abnormal Golgi apparatus morphology IMP N RGD:7247277|PMID:22833456 20190726 RGD 7247286 F344-Tg(APP)21Besey strain MP:0003329 amyloid beta deposits IMP N RGD:7247288|PMID:22017494 20190726 RGD induced by human Alzheimer brain extracts containing aggregated Abeta 7247290 SD-Tg(Ubc-P2ry2)Besey strain MP:0000218 increased leukocyte cell number IMP N RGD:2316657|PMID:19155635 20181120 RGD 7247290 SD-Tg(Ubc-P2ry2)Besey strain MP:0000219 increased neutrophil cell number IMP N RGD:2316657|PMID:19155635 20181120 RGD 7247290 SD-Tg(Ubc-P2ry2)Besey strain MP:0002941 increased circulating alanine transaminase level IMP N RGD:2316657|PMID:19155635 20181120 RGD 7247290 SD-Tg(Ubc-P2ry2)Besey strain MP:0002968 increased circulating alkaline phosphatase level IMP N RGD:2316657|PMID:19155635 20181120 RGD 7247290 SD-Tg(Ubc-P2ry2)Besey strain MP:0005013 increased lymphocyte cell number IMP N RGD:2316657|PMID:19155635 20181120 RGD 7247290 SD-Tg(Ubc-P2ry2)Besey strain MP:0005325 abnormal renal glomerulus morphology IMP N RGD:2316657|PMID:19155635 20181120 RGD 7247290 SD-Tg(Ubc-P2ry2)Besey strain MP:0008993 abnormal portal triad morphology IMP N RGD:2316657|PMID:19155635 20181120 RGD 7247290 SD-Tg(Ubc-P2ry2)Besey strain MP:0011353 expanded mesangial matrix IMP N RGD:2316657|PMID:19155635 20181120 RGD 7247290 SD-Tg(Ubc-P2ry2)Besey strain MP:0013440 abnormal exorbital lacrimal gland morphology IMP N RGD:2316657|PMID:19155635 20181120 RGD 7247442 Uae39 Urinary albumin excretion QTL 39 qtl MP:0002871 albuminuria IAGP N RGD:1578520|PMID:16534143 20130716 RGD 7248453 SS.BN-(D12Hmgc3-AU047911)/Mcwi strain MP:0002871 albuminuria IAGP XCO:0000022 N RGD:8693701|PMID:25001272 20210118 RGD compared to SS-Chr12BN 7248453 SS.BN-(D12Hmgc3-AU047911)/Mcwi strain MP:0002962 increased urine protein level IAGP N RGD:8693701|PMID:25001272 20140724 RGD 7248453 SS.BN-(D12Hmgc3-AU047911)/Mcwi strain MP:0002962 increased urine protein level IAGP XCO:0000022 N RGD:8693701|PMID:25001272 20210118 RGD compared to SS-Chr12BN 7248453 SS.BN-(D12Hmgc3-AU047911)/Mcwi strain MP:0004875 increased mean systemic arterial blood pressure IAGP N RGD:8693701|PMID:25001272 20140724 RGD 8% NaCl diet 7248453 SS.BN-(D12Hmgc3-AU047911)/Mcwi strain MP:0005264 glomerulosclerosis IAGP XCO:0000022 N RGD:8693701|PMID:25001272 20210118 RGD compared to SS-Chr12BN 7248453 SS.BN-(D12Hmgc3-AU047911)/Mcwi strain MP:0011402 renal cast IAGP XCO:0000022 N RGD:8693701|PMID:25001272 20210118 RGD compared to SS-Chr12BN 7248453 SS.BN-(D12Hmgc3-AU047911)/Mcwi strain MP:0011405 tubulointerstitial nephritis IAGP XCO:0000022 N RGD:8693701|PMID:25001272 20210118 RGD compared to SS-Chr12BN 7257661 Tlr4em1Geh toll-like receptor 4; mutation 1, Gregg E. Homanics gene MP:0008561 decreased tumor necrosis factor secretion IMP N RGD:12910488|PMID:24199847 20170615 RGD 7257663 WI-Tlr4em1Geh strain MP:0008561 decreased tumor necrosis factor secretion IMP N RGD:12910488|PMID:24199847 20170615 RGD 727792 Isca1 iron-sulfur cluster assembly 1 gene MP:0010955 abnormal respiratory electron transport chain IMP N RGD:39131292|PMID:31016283 20201001 RGD 727792 Isca1 iron-sulfur cluster assembly 1 gene MP:0011092 embryonic lethality, complete penetrance IMP N RGD:39131292|PMID:31016283 20201001 RGD 727799 Astn1 astrotactin 1 gene MP:0004217 salt-sensitive hypertension IMP N RGD:12792227|PMID:24714719 20170316 RGD 727799 Astn1 astrotactin 1 gene MP:0011022 abnormal circadian regulation of systemic arterial blood pressure IMP N RGD:12792227|PMID:24714719 20170316 RGD 727845 F8 coagulation factor VIII gene MP:0000208 decreased hematocrit IAGP N RGD:7245964|PMID:20626616 20180525 RGD DNA,protein:missense mutation,decreased activity:exon:p.L176P(rat) 727845 F8 coagulation factor VIII gene MP:0000218 increased leukocyte cell number IMP N RGD:11530071|PMID:24931420 20201210 RGD as compared to wild type Sprague Dawley 727845 F8 coagulation factor VIII gene MP:0001914 hemorrhage IMP N RGD:11530071|PMID:24931420 20201210 RGD 727845 F8 coagulation factor VIII gene MP:0002874 decreased hemoglobin content IAGP N RGD:7245964|PMID:20626616 20180525 RGD DNA,protein:missense mutation,decreased activity:exon:p.L176P(rat) 727845 F8 coagulation factor VIII gene MP:0002875 decreased erythrocyte cell number IAGP N RGD:7245964|PMID:20626616 20180525 RGD DNA,protein:missense mutation,decreased activity:exon:p.L176P(rat) 727845 F8 coagulation factor VIII gene MP:0002933 joint inflammation treatment IMP N RGD:150520059|PMID:27060449 20211026 RGD 727845 F8 coagulation factor VIII gene MP:0002998 abnormal bone remodeling treatment IMP N RGD:150520059|PMID:27060449 20211026 RGD 727845 F8 coagulation factor VIII gene MP:0005245 hemarthrosis treatment IMP N RGD:150520059|PMID:27060449 20211026 RGD 727845 F8 coagulation factor VIII gene MP:0005245 hemarthrosis treatment IMP N RGD:150520060|PMID:31899798 20211026 RGD 727845 F8 coagulation factor VIII gene MP:0005419 decreased circulating serum albumin level IMP N RGD:11530071|PMID:24931420 20201210 RGD as compared to wild type Sprague Dawley 727845 F8 coagulation factor VIII gene MP:0005505 thrombocytosis IMP N RGD:11530071|PMID:24931420 20201210 RGD as compared to wild type Sprague Dawley 727845 F8 coagulation factor VIII gene MP:0005567 decreased circulating total protein level IMP N RGD:11530071|PMID:24931420 20201210 RGD as compared to wild type Sprague Dawley 727845 F8 coagulation factor VIII gene MP:0005606 increased bleeding time treatment IMP N RGD:150520060|PMID:31899798 20211026 RGD 727845 F8 coagulation factor VIII gene MP:0009676 abnormal hemostasis treatment IMP N RGD:150520060|PMID:31899798 20211026 RGD 727845 F8 coagulation factor VIII gene MP:0012359 increased partial thromboplastin time IMP N RGD:11530071|PMID:24931420 20201210 RGD as compared to wild type Sprague Dawley 727850 Kiss1 KiSS-1 metastasis-suppressor gene MP:0002773 decreased circulating luteinizing hormone level IMP N RGD:10059342|PMID:25582792 20170815 RGD 727850 Kiss1 KiSS-1 metastasis-suppressor gene MP:0003378 early sexual maturation IDA N RGD:2292180|PMID:15486019 20080411 RGD via chronic central administration of kisspeptin-10 to immature females 727850 Kiss1 KiSS-1 metastasis-suppressor gene MP:0003379 absent sexual maturation IMP N RGD:10059342|PMID:25582792 20170815 RGD 727865 Or7a38c olfactory receptor family 7 subfamily A member 38C gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 727916 Rffl ring finger and FYVE-like domain containing E3 ubiquitin protein ligase gene MP:0003900 shortened QT interval IAGP N RGD:13442502|PMID:21357277 20171106 RGD as compared to SS/Jr 727921 Zbtb16 zinc finger and BTB domain containing 16 gene MP:0001262 decreased body weight IMP N RGD:150340623|PMID:28396530 20220203 RGD compared to wild type SHR/OlaIpcv; 727921 Zbtb16 zinc finger and BTB domain containing 16 gene MP:0002644 decreased circulating triglyceride level IMP N RGD:150340623|PMID:28396530 20220203 RGD compared to wild type SHR/OlaIpcv; 727921 Zbtb16 zinc finger and BTB domain containing 16 gene MP:0002891 increased insulin sensitivity IMP N RGD:150340623|PMID:28396530 20220203 RGD compared to wild type SHR/OlaIpcv; 727921 Zbtb16 zinc finger and BTB domain containing 16 gene MP:0004565 decreased myocardial fiber size IMP N RGD:150340623|PMID:28396530 20220203 RGD compared to wild type SHR/OlaIpcv; 727921 Zbtb16 zinc finger and BTB domain containing 16 gene MP:0004686 decreased length of long bones IAGP N RGD:40924666|PMID:27727328 20210224 RGD 727921 Zbtb16 zinc finger and BTB domain containing 16 gene MP:0005179 decreased circulating cholesterol level IMP N RGD:150340623|PMID:28396530 20220203 RGD compared to wild type SHR/OlaIpcv; 727921 Zbtb16 zinc finger and BTB domain containing 16 gene MP:0005292 improved glucose tolerance IMP N RGD:150340623|PMID:28396530 20220203 RGD compared to wild type SHR/OlaIpcv; 727921 Zbtb16 zinc finger and BTB domain containing 16 gene MP:0005608 cardiac interstitial fibrosis ameliorates IMP N RGD:150340623|PMID:28396530 20220203 RGD 727921 Zbtb16 zinc finger and BTB domain containing 16 gene MP:0006281 abnormal tail development IAGP N RGD:40924666|PMID:27727328 20210224 RGD 727921 Zbtb16 zinc finger and BTB domain containing 16 gene MP:0009289 decreased epididymal fat pad weight IMP N RGD:150340623|PMID:28396530 20220203 RGD compared to wild type SHR/OlaIpcv; 727921 Zbtb16 zinc finger and BTB domain containing 16 gene MP:0009356 decreased liver triglyceride level IMP N RGD:150340623|PMID:28396530 20220203 RGD compared to wild type SHR/OlaIpcv; 727921 Zbtb16 zinc finger and BTB domain containing 16 gene MP:0009431 decreased fetal weight IAGP N RGD:40924666|PMID:27727328 20210224 RGD 727921 Zbtb16 zinc finger and BTB domain containing 16 gene MP:0009743 preaxial polydactyly IAGP N RGD:2312786|PMID:19191224 20210416 RGD 727921 Zbtb16 zinc finger and BTB domain containing 16 gene MP:0010026 decreased liver cholesterol level IMP N RGD:150340623|PMID:28396530 20220203 RGD compared to wild type SHR/OlaIpcv; 727921 Zbtb16 zinc finger and BTB domain containing 16 gene MP:0011102 embryonic lethality, incomplete penetrance IAGP N RGD:40924666|PMID:27727328 20210224 RGD 727921 Zbtb16 zinc finger and BTB domain containing 16 gene MP:0011722 abnormal ossification involved in bone maturation IAGP N RGD:40924666|PMID:27727328 20210224 RGD 728134 SS.LEW-(D1Rat35-D1Rat49)/Jr strain MP:0002834 decreased heart weight IAGP XCO:0000022 N RGD:68885|PMID:11160999 19990101 RGD compared to SS/Jr 728134 SS.LEW-(D1Rat35-D1Rat49)/Jr strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP XCO:0000022 N RGD:68885|PMID:11160999 19990101 RGD compared to SS/Jr 728134 SS.LEW-(D1Rat35-D1Rat49)/Jr strain MP:0006264 decreased systemic arterial systolic blood pressure induced IAGP XCO:0000022 N RGD:2291850|PMID:18324438 20080514 RGD compared to SS/Jr 728135 SS.LEW-(D5Uwm14-D5Uwm31)/Jr strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:619649|PMID:11875185 19990101 RGD 728137 SS.LEW-(D10Rat141-D10Mgh1)/Ayd strain MP:0002834 decreased heart weight IMP N RGD:625380|PMID:11791025 19990101 RGD compared to SS/Jr 728137 SS.LEW-(D10Rat141-D10Mgh1)/Ayd strain MP:0002843 decreased systemic arterial blood pressure IMP N RGD:625380|PMID:11791025 20201112 RGD compared to SS/Jr 728138 SS.MNS-(Mme-Gca)/Ayd strain MP:0002843 decreased systemic arterial blood pressure IMP N RGD:625376|PMID:11773603 20201112 RGD compared to SS/Jr 728139 WKY.SHRSP-(D1Rat200-D1Rat216)(Shbg-Atp1b2)/Bbb strain MP:0002842 increased systemic arterial blood pressure susceptibility IAGP XCO:0000164 N RGD:629620|PMID:12566390 19990101 RGD compared to WKY/Bbb; MMO:0000015 728139 WKY.SHRSP-(D1Rat200-D1Rat216)(Shbg-Atp1b2)/Bbb strain MP:0006143 increased systemic arterial diastolic blood pressure susceptibility IAGP XCO:0000164 N RGD:629620|PMID:12566390 19990101 RGD compared to WKY/Bbb; MMO:0000015 728139 WKY.SHRSP-(D1Rat200-D1Rat216)(Shbg-Atp1b2)/Bbb strain MP:0006144 increased systemic arterial systolic blood pressure susceptibility IAGP XCO:0000164 N RGD:629620|PMID:12566390 19990101 RGD compared to WKY/Bbb; MMO:0000015 728142 BN.SHR-(Il6-Cd36)/Cub strain MP:0002981 increased liver weight IAGP N RGD:632347|PMID:12118727 20200313 RGD 728142 BN.SHR-(Il6-Cd36)/Cub strain MP:0005293 impaired glucose tolerance IAGP N RGD:632347|PMID:12118727 20200313 RGD compared to BN/Cub 728142 BN.SHR-(Il6-Cd36)/Cub strain MP:0009288 increased epididymal fat pad weight IAGP N RGD:632347|PMID:12118727 20200313 RGD 728143 SS.LEW-(D1Mco38-D1Rat49)/Jr strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP XCO:0000022 N RGD:68885|PMID:11160999 19990101 RGD compared to SS/Jr 728144 BN.PD-(D8Rat39-D8Rat35)/Cub strain MP:0005293 impaired glucose tolerance IAGP N RGD:632347|PMID:12118727 20200313 RGD compared to BN/Cub 728145 SS.LEW-(D5Rat130-D5Rat108)/Jr strain MP:0002843 decreased systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:619649|PMID:11875185 19990101 RGD compared to SS/Jr 728146 F344.BN-(D3Mgh13-D3Mgh7)/Dlw strain MP:0008331 increased lactotroph cell number induced IAGP XCO:0000295 N RGD:1581610|PMID:16416090 20200313 RGD compared to F344.BN-(D3Mgh13-D3Mgh7)/Dlw 728146 F344.BN-(D3Mgh13-D3Mgh7)/Dlw strain MP:0020330 increased capillary density IAGP N RGD:1581610|PMID:16416090 20200313 RGD compared to F344/NHsd 728146 F344.BN-(D3Mgh13-D3Mgh7)/Dlw strain MP:0020330 increased capillary density induced IAGP XCO:0000295 N RGD:1581610|PMID:16416090 20200313 RGD compared to F344.BN-(D3Mgh13-D3Mgh7)/Dlw, diethylstilbestrol treated F344/NHsd 728146 F344.BN-(D3Mgh13-D3Mgh7)/Dlw strain MP:0021058 increased tumor perivascular space size IAGP N RGD:1581610|PMID:16416090 20231024 RGD compared to F344/NHsd 728146 F344.BN-(D3Mgh13-D3Mgh7)/Dlw strain MP:0021058 increased tumor perivascular space size induces IAGP XCO:0000295 N RGD:1581610|PMID:16416090 20231024 RGD compared to diethylstilbestrol treated F344/NHsd 728146 F344.BN-(D3Mgh13-D3Mgh7)/Dlw strain MP:0021066 increased tumor nonattached pericyte number IAGP N RGD:1581610|PMID:16416090 20231024 RGD compared to F344/NHsd 728146 F344.BN-(D3Mgh13-D3Mgh7)/Dlw strain MP:0021066 increased tumor nonattached pericyte number induces IAGP XCO:0000295 N RGD:1581610|PMID:16416090 20231024 RGD compared to diethylstilbestrol treated F344/NHsd 728147 BN.PD-(D8Rat39-D8Rat35),SHR-(D4Mgh2-Cd36),SHR-(D20Wox3-D20Mgh5)/Cub strain MP:0001552 increased circulating triglyceride level IAGP N RGD:632347|PMID:12118727 20200313 RGD compared to BN.PD-(D8Rat39-D8Rat35)/Cub, BN.SHR-(Il6-Cd36)/Cub, BN/Cub 728147 BN.PD-(D8Rat39-D8Rat35),SHR-(D4Mgh2-Cd36),SHR-(D20Wox3-D20Mgh5)/Cub strain MP:0001552 increased circulating triglyceride level induced IAGP XCO:0000432 N RGD:632347|PMID:12118727 20200313 RGD compared to BN.PD-(D8Rat39-D8Rat35)/Cub, BN.SHR-(Il6-Cd36)/Cub, BN/Cub 728147 BN.PD-(D8Rat39-D8Rat35),SHR-(D4Mgh2-Cd36),SHR-(D20Wox3-D20Mgh5)/Cub strain MP:0001554 increased circulating free fatty acids level induced IAGP XCO:0000432 N RGD:632347|PMID:12118727 20200313 RGD compared to BN.PD-(D8Rat39-D8Rat35)/Cub, BN.SHR-(Il6-Cd36)/Cub, BN/Cub 728147 BN.PD-(D8Rat39-D8Rat35),SHR-(D4Mgh2-Cd36),SHR-(D20Wox3-D20Mgh5)/Cub strain MP:0005293 impaired glucose tolerance IAGP N RGD:632347|PMID:12118727 20200313 RGD compared to BN/Cub 728147 BN.PD-(D8Rat39-D8Rat35),SHR-(D4Mgh2-Cd36),SHR-(D20Wox3-D20Mgh5)/Cub strain MP:0009289 decreased epididymal fat pad weight IAGP N RGD:632347|PMID:12118727 20200313 RGD 728147 BN.PD-(D8Rat39-D8Rat35),SHR-(D4Mgh2-Cd36),SHR-(D20Wox3-D20Mgh5)/Cub strain MP:0013279 increased fasting circulating glucose level IAGP N RGD:632347|PMID:12118727 20200313 RGD compared to BN.PD-(D8Rat39-D8Rat35)/Cub, BN.SHR-(Il6-Cd36)/Cub, BN/Cub 728148 SS.LEW-(D16Uia2-D16Rat12)/Ayd strain MP:0003916 decreased heart left ventricle weight induced IAGP XCO:0000022 N RGD:70460|PMID:11919686 20201123 RGD compared to SS/Jr 728148 SS.LEW-(D16Uia2-D16Rat12)/Ayd strain MP:0003918 decreased kidney weight induced IAGP XCO:0000022 N RGD:70460|PMID:11919686 20201123 RGD compared to SS/Jr 728148 SS.LEW-(D16Uia2-D16Rat12)/Ayd strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:70460|PMID:11919686 20201123 RGD compared to SS/Jr 728148 SS.LEW-(D16Uia2-D16Rat12)/Ayd strain MP:0006263 decreased systemic arterial diastolic blood pressure induced IAGP XCO:0000022 N RGD:70460|PMID:11919686 20201123 RGD compared to SS/Jr 728148 SS.LEW-(D16Uia2-D16Rat12)/Ayd strain MP:0006264 decreased systemic arterial systolic blood pressure induced IAGP XCO:0000022 N RGD:70460|PMID:11919686 20201123 RGD compared to SS/Jr 728148 SS.LEW-(D16Uia2-D16Rat12)/Ayd strain MP:0031199 decreased aortic weight induced IAGP XCO:0000022 N RGD:70460|PMID:11919686 20201123 RGD compared to SS/Jr 728153 SS.LEW-(D1Rat196-D1Rat49)/Jr strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP XCO:0000022 N RGD:68885|PMID:11160999 19990101 RGD compared to SS/Jr 728155 BBDR.BBDP-(D4Mit6-D4Mit7)/1Rhw strain MP:0001869 pancreas inflammation susceptibility IAGP N RGD:6893459|PMID:19996157 20200304 RGD compared to BBDR/Rhw 728155 BBDR.BBDP-(D4Mit6-D4Mit7)/1Rhw strain MP:0004129 abnormal respiratory quotient IAGP N RGD:2293508|PMID:18465680 20080611 RGD compared to DR.lyp/+ 728155 BBDR.BBDP-(D4Mit6-D4Mit7)/1Rhw strain MP:0004803 increased susceptibility to autoimmune diabetes IAGP N RGD:2293508|PMID:18465680 20080611 RGD compared to DR.lyp/+ 728155 BBDR.BBDP-(D4Mit6-D4Mit7)/1Rhw strain MP:0004803 increased susceptibility to autoimmune diabetes susceptibility IAGP N RGD:6893459|PMID:19996157 20200304 RGD compared to BBDR/Rhw 728155 BBDR.BBDP-(D4Mit6-D4Mit7)/1Rhw strain MP:0005215 abnormal pancreatic islet morphology susceptibility IAGP N RGD:6893459|PMID:19996157 20200304 RGD compared to BBDR/Rhw 728156 SS.LEW-(D5Mco34-D5Mco10)/Jr strain MP:0002843 decreased systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:619649|PMID:11875185 19990101 RGD compared to SS/Jr 728157 SS.LEW-(D5Rat130-D5Mit19)/Jr strain MP:0002843 decreased systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:619649|PMID:11875185 19990101 RGD compared to SS/Jr 728158 SS.LEW-(D5Uia4-D5Mco10)/Jr strain MP:0002842 increased systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:619649|PMID:11875185 19990101 RGD compared to SS/Jr 728158 SS.LEW-(D5Uia4-D5Mco10)/Jr strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:619649|PMID:11875185 20200109 RGD compared to SS/Jr 728159 SS.LEW-(D1Mco36-D1Rat49)/Jr strain MP:0002834 decreased heart weight IAGP XCO:0000022 N RGD:68885|PMID:11160999 20080514 RGD compared to SS/Jr 728159 SS.LEW-(D1Mco36-D1Rat49)/Jr strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP XCO:0000022 N RGD:68885|PMID:11160999 19990101 RGD compared to SS/Jr 728159 SS.LEW-(D1Mco36-D1Rat49)/Jr strain MP:0006264 decreased systemic arterial systolic blood pressure induced IAGP XCO:0000022 N RGD:2291850|PMID:18324438 20080514 RGD compared to SS/Jr 728161 PD/Cub polydactylous strain MP:0001260 increased body weight IAGP N RGD:1580750|PMID:15007394 20200414 RGD compared to BN/Cub 728161 PD/Cub polydactylous strain MP:0001552 increased circulating triglyceride level IAGP N RGD:1580750|PMID:15007394 20200414 RGD compared to BN/Cub 728161 PD/Cub polydactylous strain MP:0001552 increased circulating triglyceride level IAGP N RGD:728088|PMID:10925780 20200409 RGD compared to SHR/OlaIpcv, BN/Cub 728161 PD/Cub polydactylous strain MP:0001552 increased circulating triglyceride level treatment IAGP XCO:0000469 N RGD:1580750|PMID:15007394 20200414 RGD 728161 PD/Cub polydactylous strain MP:0001554 increased circulating free fatty acids level IAGP N RGD:1580750|PMID:15007394 20200414 RGD compared to BN/Cub 728161 PD/Cub polydactylous strain MP:0001554 increased circulating free fatty acids level IAGP N RGD:728088|PMID:10925780 20200409 RGD compared to BN/Cub 728161 PD/Cub polydactylous strain MP:0001554 increased circulating free fatty acids level treatment IAGP XCO:0000469 N RGD:1580750|PMID:15007394 20200414 RGD 728161 PD/Cub polydactylous strain MP:0002079 increased circulating insulin level IAGP N RGD:1580750|PMID:15007394 20200414 RGD compared to BN/Cub 728161 PD/Cub polydactylous strain MP:0002079 increased circulating insulin level IAGP N RGD:728088|PMID:10925780 20200409 RGD compared to BN/Cub 728161 PD/Cub polydactylous strain MP:0002079 increased circulating insulin level treatment IAGP XCO:0000469|XCO:0000679 N RGD:1580750|PMID:15007394 20200414 RGD 728161 PD/Cub polydactylous strain MP:0002644 decreased circulating triglyceride level treatment IAGP XCO:0000679 N RGD:1580750|PMID:15007394 20200421 RGD 728161 PD/Cub polydactylous strain MP:0002702 decreased circulating free fatty acids level treatment IAGP XCO:0000679 N RGD:1580750|PMID:15007394 20200421 RGD 728161 PD/Cub polydactylous strain MP:0002842 increased systemic arterial blood pressure IAGP N RGD:1580750|PMID:15007394 20200414 RGD compared to BN/Cub 728161 PD/Cub polydactylous strain MP:0002842 increased systemic arterial blood pressure IAGP N RGD:728088|PMID:10925780 20170627 RGD compared to BN/Cub 728161 PD/Cub polydactylous strain MP:0002981 increased liver weight IAGP N RGD:728088|PMID:10925780 20170627 RGD compared to BN/Cub 728161 PD/Cub polydactylous strain MP:0002981 increased liver weight treatment IAGP XCO:0000469|XCO:0000679 N RGD:1580750|PMID:15007394 20200414 RGD 728161 PD/Cub polydactylous strain MP:0003443 increased circulating glycerol level treatment IAGP XCO:0000469 N RGD:1580750|PMID:15007394 20200414 RGD 728161 PD/Cub polydactylous strain MP:0003917 increased kidney weight treatment IAGP XCO:0000469|XCO:0000679 N RGD:1580750|PMID:15007394 20200414 RGD 728161 PD/Cub polydactylous strain MP:0003918 decreased kidney weight IAGP N RGD:728088|PMID:10925780 20200409 RGD compared to SHR/Ola, BN/Cub 728161 PD/Cub polydactylous strain MP:0005178 increased circulating cholesterol level treatment IAGP XCO:0000469 N RGD:1580750|PMID:15007394 20200414 RGD 728161 PD/Cub polydactylous strain MP:0005179 decreased circulating cholesterol level treatment IAGP XCO:0000679 N RGD:1580750|PMID:15007394 20200421 RGD 728161 PD/Cub polydactylous strain MP:0005293 impaired glucose tolerance IAGP N RGD:1580750|PMID:15007394 20200416 RGD compared to BN/Cub 728161 PD/Cub polydactylous strain MP:0005559 increased circulating glucose level IAGP N RGD:1580750|PMID:15007394 20200414 RGD compared to BN/Cub 728161 PD/Cub polydactylous strain MP:0005559 increased circulating glucose level IAGP N RGD:728088|PMID:10925780 20200409 RGD compared to BN/Cub 728161 PD/Cub polydactylous strain MP:0009288 increased epididymal fat pad weight IAGP N RGD:1580750|PMID:15007394 20200416 RGD compared to BN/Cub 728161 PD/Cub polydactylous strain MP:0009288 increased epididymal fat pad weight IAGP N RGD:728088|PMID:10925780 20170627 RGD compared to SHR/OlaIpcv, BN/Cub 728161 PD/Cub polydactylous strain MP:0009288 increased epididymal fat pad weight treatment IAGP XCO:0000469|XCO:0000679 N RGD:1580750|PMID:15007394 20200416 RGD 728162 SS.LEW-(D1Mco87-D1Rat71)/Jr strain MP:0001260 increased body weight induced IAGP XCO:0000022 N RGD:2291850|PMID:18324438 20080514 RGD compared to SS/Jr 728162 SS.LEW-(D1Mco87-D1Rat71)/Jr strain MP:0002833 increased heart weight IAGP XCO:0000022 N RGD:68885|PMID:11160999 19990101 RGD compared to SS/Jr 728162 SS.LEW-(D1Mco87-D1Rat71)/Jr strain MP:0002833 increased heart weight induced IAGP XCO:0000022 N RGD:2291850|PMID:18324438 20191205 RGD compared to SS/Jr 728162 SS.LEW-(D1Mco87-D1Rat71)/Jr strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:2291850|PMID:18324438 20080514 RGD 728163 SS.LEW-(D1Uia2-D1Rat49)/Jr strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP XCO:0000022 N RGD:68885|PMID:11160999 19990101 RGD compared to SS/Jr 728165 SS.LEW-(D1Rat196-D1Mco36)/Jr strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP XCO:0000022 N RGD:68885|PMID:11160999 19990101 RGD compared to SS/Jr 728170 SS.MNS-(Mme-D2Mit14)/Ayd strain MP:0002843 decreased systemic arterial blood pressure IMP N RGD:625376|PMID:11773603 20201112 RGD compared to SS/Jr 728183 WF/N strain MP:0020162 decreased susceptibility to virus induced diabetes induced IAGP XCO:0000238 N RGD:2313207|PMID:1658938 20200225 RGD compared to BBDR/WorBrm 728184 SHRSP/A3N strain MP:0001262 decreased body weight susceptibility IAGP N RGD:27095952|PMID:17551266 20200728 RGD compared to WKY/NCrl 728184 SHRSP/A3N strain MP:0001262 decreased body weight susceptibility IAGP XCO:0000164,XCO:0000025 N RGD:27095952|PMID:17551266 20200728 RGD compared to standard rat chow fed SHRSP/A3N 728184 SHRSP/A3N strain MP:0001625 cardiac hypertrophy susceptibility IAGP XCO:0000164,XCO:0000025 N RGD:27095952|PMID:17551266 20200728 RGD compared to standard rat chow fed SHRSP/A3N 728184 SHRSP/A3N strain MP:0002962 increased urine protein level IAGP N RGD:30296650|PMID:11682445 20200831 RGD compared to WKY/N 728184 SHRSP/A3N strain MP:0003215 renal interstitial fibrosis IAGP N RGD:28912746|PMID:11907153 20200902 RGD compared to WKY/N 728184 SHRSP/A3N strain MP:0003215 renal interstitial fibrosis IAGP N RGD:30296650|PMID:11682445 20200831 RGD compared to WKY/N 728184 SHRSP/A3N strain MP:0003393 decreased cardiac output susceptibility IAGP N RGD:27095952|PMID:17551266 20200728 RGD compared to WKY/NCrl 728184 SHRSP/A3N strain MP:0003393 decreased cardiac output susceptibility IAGP XCO:0000164,XCO:0000025 N RGD:27095952|PMID:17551266 20200728 RGD compared to standard rat chow fed SHRSP/A3N 728184 SHRSP/A3N strain MP:0003985 renal fibrosis IAGP N RGD:28912746|PMID:11907153 20200902 RGD compared to WKY/N 728184 SHRSP/A3N strain MP:0005264 glomerulosclerosis IAGP N RGD:28912746|PMID:11907153 20200902 RGD compared to WKY/N 728184 SHRSP/A3N strain MP:0005264 glomerulosclerosis IAGP N RGD:30296650|PMID:11682445 20200831 RGD compared to WKY/N 728184 SHRSP/A3N strain MP:0005565 increased blood urea nitrogen level IAGP N RGD:30296650|PMID:11682445 20200831 RGD compared to WKY/N 728184 SHRSP/A3N strain MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:28912746|PMID:11907153 20200902 RGD compared to WKY/N 728184 SHRSP/A3N strain MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:30296650|PMID:11682445 20200831 RGD compared to WKY/N 728184 SHRSP/A3N strain MP:0006144 increased systemic arterial systolic blood pressure susceptibility IAGP N RGD:27095952|PMID:17551266 20200728 RGD compared to WKY/NCrl 728184 SHRSP/A3N strain MP:0006144 increased systemic arterial systolic blood pressure susceptibility IAGP N RGD:36049805|PMID:3611778 20200902 RGD compared to WKY/N 728184 SHRSP/A3N strain MP:0006144 increased systemic arterial systolic blood pressure susceptibility IAGP XCO:0000164,XCO:0000025 N RGD:27095952|PMID:17551266 20200728 RGD compared to standard rat chow fed SHRSP/A3N 728184 SHRSP/A3N strain MP:0008770 decreased survivor rate susceptibility IAGP XCO:0000164,XCO:0000025 N RGD:27095952|PMID:17551266 20200728 RGD compared to standard rat chow fed SHRSP/A3N 728184 SHRSP/A3N strain MP:0011402 renal cast IAGP N RGD:28912746|PMID:11907153 20200902 RGD compared to WKY/N 728184 SHRSP/A3N strain MP:0011402 renal cast IAGP N RGD:30296650|PMID:11682445 20200831 RGD compared to WKY/N 728184 SHRSP/A3N strain MP:0011442 abnormal renal sodium ion transport susceptibility IAGP N RGD:36049805|PMID:3611778 20200902 RGD compared to WKY/N 728184 SHRSP/A3N strain MP:0011758 renal ischemia IAGP N RGD:28912746|PMID:11907153 20200902 RGD compared to WKY/N 728184 SHRSP/A3N strain MP:0011952 decreased cardiac stroke volume susceptibility IAGP XCO:0000164,XCO:0000025 N RGD:27095952|PMID:17551266 20200728 RGD compared to standard rat chow fed SHRSP/A3N 728184 SHRSP/A3N strain MP:0011978 abnormal potassium ion homeostasis susceptibility IAGP N RGD:36049805|PMID:3611778 20200902 RGD compared to WKY/N 728194 SHR/N strain MP:0001260 increased body weight IAGP N RGD:731210|PMID:14678232 20200117 RGD compared to WKY/N control strain 728194 SHR/N strain MP:0001260 increased body weight sexual_dimorphism IAGP N RGD:7245528|PMID:1877683 20200203 RGD compared to female SHR/N 728194 SHR/N strain MP:0001262 decreased body weight sexual_dimorphism IAGP N RGD:7245528|PMID:1877683 20200203 RGD compared to female WKY/N 728194 SHR/N strain MP:0001399 hyperactivity IAGP N RGD:7245528|PMID:1877683 20200203 RGD compared to WKY/N 728194 SHR/N strain MP:0001402 decreased locomotor activity sexual_dimorphism IAGP N RGD:7245528|PMID:1877683 20200203 RGD compared to female SHR/N 728194 SHR/N strain MP:0002625 heart left ventricle hypertrophy IAGP N RGD:61484|PMID:9495256 19990101 RGD compared to DRY control strain 728194 SHR/N strain MP:0002626 increased heart rate sexual_dimorphism IAGP N RGD:7245528|PMID:1877683 20200203 RGD compared to female WKY/N 728194 SHR/N strain MP:0003915 increased heart left ventricle weight IAGP N RGD:731210|PMID:14678232 20200117 RGD compared to WKY/N control strain 728194 SHR/N strain MP:0004875 increased mean systemic arterial blood pressure IAGP N RGD:61484|PMID:9495256 19990101 RGD compared to DRY control strain 728194 SHR/N strain MP:0004875 increased mean systemic arterial blood pressure IAGP N RGD:731210|PMID:14678232 19990101 RGD compared to WKY/N control strain 728194 SHR/N strain MP:0005333 decreased heart rate sexual_dimorphism IAGP N RGD:7245528|PMID:1877683 20200203 RGD compared to female SHR/N 728194 SHR/N strain MP:0006143 increased systemic arterial diastolic blood pressure IAGP N RGD:731210|PMID:14678232 20200117 RGD compared to WKY/N control strain 728194 SHR/N strain MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:7245528|PMID:1877683 20200203 RGD compared to WKY/N 728194 SHR/N strain MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:731210|PMID:14678232 20200117 RGD compared to WKY/N control strain 728194 SHR/N strain MP:0006144 increased systemic arterial systolic blood pressure sexual_dimorphism IAGP N RGD:7245528|PMID:1877683 20200203 RGD compared to female SHR/N 728194 SHR/N strain MP:0008772 increased heart ventricle size IAGP N RGD:7245528|PMID:1877683 20200203 RGD compared to female WKY/N 728326 Brca2m1Uwm BRCA2, DNA repair associated; mutation 1, University of Wisconsin-Madison gene MP:0000628 abnormal mammary gland development IMP N RGD:1599505|PMID:16964288 20210429 RGD 728326 Brca2m1Uwm BRCA2, DNA repair associated; mutation 1, University of Wisconsin-Madison gene MP:0001156 abnormal spermatogenesis IMP N RGD:1599505|PMID:16964288 20210429 RGD 728326 Brca2m1Uwm BRCA2, DNA repair associated; mutation 1, University of Wisconsin-Madison gene MP:0001262 decreased body weight IMP N RGD:727990|PMID:12754522 20180430 RGD 728326 Brca2m1Uwm BRCA2, DNA repair associated; mutation 1, University of Wisconsin-Madison gene MP:0002020 increased tumor incidence IMP N RGD:1599505|PMID:16964288 20210429 RGD 728326 Brca2m1Uwm BRCA2, DNA repair associated; mutation 1, University of Wisconsin-Madison gene MP:0002083 premature death IMP N RGD:1599505|PMID:16964288 20210429 RGD 728326 Brca2m1Uwm BRCA2, DNA repair associated; mutation 1, University of Wisconsin-Madison gene MP:0003205 testicular atrophy IMP N RGD:727990|PMID:12754522 20180430 RGD 728326 Brca2m1Uwm BRCA2, DNA repair associated; mutation 1, University of Wisconsin-Madison gene MP:0004833 ovary atrophy IMP N RGD:727990|PMID:12754522 20180430 RGD 728326 Brca2m1Uwm BRCA2, DNA repair associated; mutation 1, University of Wisconsin-Madison gene MP:0011482 posterior iris synechia IMP N RGD:1599505|PMID:16964288 20210429 RGD 728326 Brca2m1Uwm BRCA2, DNA repair associated; mutation 1, University of Wisconsin-Madison gene MP:0031212 decreased eye anterior chamber depth IMP N RGD:1599505|PMID:16964288 20210429 RGD 728328 Srebf1_v2 sterol regulatory element binding factor 1, variant 2 gene MP:0003983 decreased cholesterol level IAGP N RGD:1643359|PMID:18071061 20090609 RGD 728383 UPL/Cas Upjohn Pharmaceuticals Limited strain MP:0001304 cataract IAGP N RGD:727242|PMID:8282038 19990101 RGD 728384 SS.LEW-(D10Rat24-Igfbp4)/Ayd strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:7421500|PMID:23814039 20191203 RGD 728384 SS.LEW-(D10Rat24-Igfbp4)/Ayd strain MP:0004217 salt-sensitive hypertension susceptibility IAGP N RGD:704345|PMID:12939233 20201022 RGD 728386 SS.LEW-(D10Rat119-D10Rat133)/Ayd strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:7421500|PMID:23814039 20191203 RGD 728386 SS.LEW-(D10Rat119-D10Rat133)/Ayd strain MP:0004217 salt-sensitive hypertension susceptibility IAGP N RGD:704345|PMID:12939233 20201022 RGD 728388 SS.LEW-(D10Rat119-D10Mgh1)/Ayd strain MP:0002843 decreased systemic arterial blood pressure IAGP N RGD:704345|PMID:12939233 20201022 RGD compared to Dahl SS 728392 RHA/N-di Roman high avoidance-di mutation strain MP:0001263 weight loss induced IAGP XCO:0000297 N RGD:2314670|PMID:3736782 20200709 RGD compared to induced RHA/N 728392 RHA/N-di Roman high avoidance-di mutation strain MP:0001426 polydipsia IAGP N RGD:2314670|PMID:3736782 20091123 RGD compared to RHA/N 728392 RHA/N-di Roman high avoidance-di mutation strain MP:0002988 decreased urine osmolality IAGP N RGD:2314670|PMID:3736782 20091123 RGD compared to RHA/N 728392 RHA/N-di Roman high avoidance-di mutation strain MP:0005611 decreased circulating antidiuretic hormone level IAGP N RGD:2314670|PMID:3736782 20091123 RGD compared to RHA/N 728392 RHA/N-di Roman high avoidance-di mutation strain MP:0008997 increased blood osmolality IAGP N RGD:2314670|PMID:3736782 20091123 RGD compared to RHA/N 728393 SS.LEW-(D10Got125-D10Rat120)/Ayd strain MP:0004217 salt-sensitive hypertension susceptibility IAGP N RGD:704345|PMID:12939233 20201022 RGD 728394 SS.LEW-(D10Rat55-D10Rat13)/Ayd strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:7421500|PMID:23814039 20191203 RGD 728394 SS.LEW-(D10Rat55-D10Rat13)/Ayd strain MP:0004217 salt-sensitive hypertension susceptibility IAGP N RGD:704345|PMID:12939233 20201022 RGD 728395 SS.LEW-(D10Rat55-D10Rat120)/Ayd strain MP:0004217 salt-sensitive hypertension susceptibility IAGP N RGD:704345|PMID:12939233 20201022 RGD 728396 SS.LEW-(D10Mco15-D10Mgh1)/Ayd strain MP:0004217 salt-sensitive hypertension susceptibility IAGP N RGD:704345|PMID:12939233 20201022 RGD 731164 Uae25 Urinary albumin excretion QTL 25 qtl MP:0002871 albuminuria IAGP N RGD:730279|PMID:14638907 19990101 RGD 731165 Uae21 Urinary albumin excretion QTL 21 qtl MP:0002871 albuminuria IAGP N RGD:730279|PMID:14638907 19990101 RGD 731166 Mamtr2 Mammary tumor resistance QTL 2 qtl MP:0010269 decreased mammary gland tumor incidence IDA N RGD:724790|PMID:14522903 20111107 RGD 731167 Glom4 Glomerulus QTL 4 qtl MP:0005325 abnormal renal glomerulus morphology IAGP N RGD:730279|PMID:14638907 20111108 RGD 731168 Bp154 Blood pressure QTL 154 qtl MP:0002843 decreased systemic arterial blood pressure IAGP N RGD:730283|PMID:14623828 19990101 RGD 731169 Bp153 Blood pressure QTL 153 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:728381|PMID:14597851 19990101 RGD 731170 Pur3 Proteinuria QTL 3 qtl MP:0002962 increased urine protein level IAGP N RGD:730279|PMID:14638907 20120112 RGD 731171 Glom6 Glomerulus QTL 6 qtl MP:0005325 abnormal renal glomerulus morphology IAGP N RGD:730279|PMID:14638907 20111108 RGD 731172 Bp151 Blood pressure QTL 151 qtl MP:0000230 abnormal systemic arterial blood pressure IAGP N RGD:724791|PMID:14517349 19990101 RGD 731173 Uae22 Urinary albumin excretion QTL 22 qtl MP:0002871 albuminuria IAGP N RGD:730279|PMID:14638907 19990101 RGD 731174 Uae23 Urinary albumin excretion QTL 23 qtl MP:0002871 albuminuria IAGP N RGD:730279|PMID:14638907 19990101 RGD 731175 Uae20 Urinary albumin excretion QTL 20 qtl MP:0002871 albuminuria IAGP N RGD:730279|PMID:14638907 19990101 RGD 731176 Glom5 Glomerulus QTL 5 qtl MP:0005325 abnormal renal glomerulus morphology IAGP N RGD:730279|PMID:14638907 20111108 RGD 731177 Uae26 Urinary albumin excretion QTL 26 qtl MP:0002871 albuminuria IAGP N RGD:730279|PMID:14638907 19990101 RGD 731178 Oia7 Oil induced arthritis QTL 7 qtl MP:0002936 joint swelling IAGP N RGD:730281|PMID:12915467 19990101 RGD 731179 Mamtr3 Mammary tumor resistance QTL 3 qtl MP:0010269 decreased mammary gland tumor incidence IDA N RGD:724790|PMID:14522903 20111107 RGD 731180 Bp152 Blood pressure QTL 152 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:724791|PMID:14517349 19990101 RGD 731181 Uae27 Urinary albumin excretion QTL 27 qtl MP:0002871 albuminuria IAGP N RGD:730279|PMID:14638907 19990101 RGD 731182 Uae24 Urinary albumin excretion QTL 24 qtl MP:0002871 albuminuria IAGP N RGD:730279|PMID:14638907 19990101 RGD 731183 Pia20 Pristane induced arthritis QTL 20 qtl MP:0002936 joint swelling QTM N RGD:730280|PMID:14624754 19990101 RGD 731184 Mamtr4 Mammary tumor resistance QTL 4 qtl MP:0010269 decreased mammary gland tumor incidence IDA N RGD:724790|PMID:14522903 20111107 RGD 731185 MWF/Fub Munich Wistar Fromter strain MP:0001260 increased body weight induces IAGP XCO:0000022 N RGD:25314241|PMID:10872564 20210709 RGD compared to female and Lew 731185 MWF/Fub Munich Wistar Fromter strain MP:0001262 decreased body weight IAGP N RGD:25314290|PMID:17921827 20210709 RGD compared to Wi 731185 MWF/Fub Munich Wistar Fromter strain MP:0001262 decreased body weight IAGP N RGD:730279|PMID:14638907 20200117 RGD compared to SHR/Fub strain 731185 MWF/Fub Munich Wistar Fromter strain MP:0003215 renal interstitial fibrosis IAGP N RGD:730279|PMID:14638907 20200117 RGD compared to SHR/Fub strain 731185 MWF/Fub Munich Wistar Fromter strain MP:0003917 increased kidney weight induces IAGP XCO:0000022 N RGD:25314241|PMID:10872564 20210709 RGD compared to female and Lew 731185 MWF/Fub Munich Wistar Fromter strain MP:0003918 decreased kidney weight IAGP N RGD:25314290|PMID:17921827 20210709 RGD compared to Wi 731185 MWF/Fub Munich Wistar Fromter strain MP:0003918 decreased kidney weight IAGP N RGD:730279|PMID:14638907 20200117 RGD compared to SHR/Fub strain 731185 MWF/Fub Munich Wistar Fromter strain MP:0004217 salt-sensitive hypertension induces IAGP XCO:0000022 N RGD:25314241|PMID:10872564 20210709 RGD compared to standard diet and LEW 731185 MWF/Fub Munich Wistar Fromter strain MP:0005325 abnormal renal glomerulus morphology IAGP N RGD:25314287|PMID:23241663 20210708 RGD compared to Wi 731185 MWF/Fub Munich Wistar Fromter strain MP:0005325 abnormal renal glomerulus morphology IAGP N RGD:730279|PMID:14638907 20111108 RGD compared to SHR/Fub strain 731185 MWF/Fub Munich Wistar Fromter strain MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:25314290|PMID:17921827 20210709 RGD compared to Wi 731185 MWF/Fub Munich Wistar Fromter strain MP:0006316 increased urine sodium level induces IAGP XCO:0000022 N RGD:25314241|PMID:10872564 20210709 RGD compared to Lew 731187 Iusm:HAD2 high-alcohol-drinking strain MP:0000482 long fibula onset IAGP N RGD:155883170|PMID:16269906 20230313 RGD 6 months, compared to Iusm:LAD2 731187 Iusm:HAD2 high-alcohol-drinking strain MP:0001260 increased body weight IAGP N RGD:155883170|PMID:16269906 20230313 RGD compared to Iusm:LAD2 731187 Iusm:HAD2 high-alcohol-drinking strain MP:0004348 long femur onset IAGP N RGD:155883170|PMID:16269906 20230313 RGD 6 months, compared to Iusm:LAD2 731187 Iusm:HAD2 high-alcohol-drinking strain MP:0004350 long humerus onset IAGP N RGD:155883170|PMID:16269906 20230313 RGD 6 months, compared to Iusm:LAD2 731187 Iusm:HAD2 high-alcohol-drinking strain MP:0004370 long ulna onset IAGP N RGD:155883170|PMID:16269906 20230313 RGD 6 months, compared to Iusm:LAD2 731189 SHRSP.WKY-(Klk1-D1Rat116)/Izm strain MP:0000230 abnormal systemic arterial blood pressure IAGP N RGD:730283|PMID:14623828 19990101 RGD 731189 SHRSP.WKY-(Klk1-D1Rat116)/Izm strain MP:0001262 decreased body weight IAGP N RGD:730283|PMID:14623828 20191206 RGD compared to SHRSP/Izm, in male 731189 SHRSP.WKY-(Klk1-D1Rat116)/Izm strain MP:0002834 decreased heart weight IAGP N RGD:730283|PMID:14623828 20191206 RGD compared to SHRSP/Izm, in female 731189 SHRSP.WKY-(Klk1-D1Rat116)/Izm strain MP:0005293 impaired glucose tolerance IAGP N RGD:730283|PMID:14623828 20191206 RGD compared to SHRSP/Izm, MMO:0000326 731189 SHRSP.WKY-(Klk1-D1Rat116)/Izm strain MP:0005559 increased circulating glucose level IAGP N RGD:730283|PMID:14623828 20191206 RGD compared to SHRSP/Izm, in female 731189 SHRSP.WKY-(Klk1-D1Rat116)/Izm strain MP:0006059 decreased susceptibility to ischemic brain injury IAGP XCO:0000164 N RGD:730283|PMID:14623828 20191206 RGD compared to SHRSP/Izm 731189 SHRSP.WKY-(Klk1-D1Rat116)/Izm strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:730283|PMID:14623828 20191206 RGD compared to SHRSP/Izm 731189 SHRSP.WKY-(Klk1-D1Rat116)/Izm strain MP:0012046 decreased susceptibility to hypertension IAGP N RGD:730283|PMID:14623828 20191206 RGD compared to SHRSP/Izm 731191 SHRSP.WKY-(D2Rat14-D2Mgh12)/Gcrc strain MP:0002843 decreased systemic arterial blood pressure IAGP N RGD:728179|PMID:11980293 19990101 RGD 731191 SHRSP.WKY-(D2Rat14-D2Mgh12)/Gcrc strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:728179|PMID:11980293 19990101 RGD 731192 SS.LEW-(D3Rat52-D3Rat130)/Ayd strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:724791|PMID:14517349 19990101 RGD compared to SS/Jr 731192 SS.LEW-(D3Rat52-D3Rat130)/Ayd strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:7421500|PMID:23814039 20131211 RGD compared to parental SS/Jr 731192 SS.LEW-(D3Rat52-D3Rat130)/Ayd strain MP:0006263 decreased systemic arterial diastolic blood pressure induced IAGP XCO:0000022 N RGD:724791|PMID:14517349 20191202 RGD compared to SS/Jr 731192 SS.LEW-(D3Rat52-D3Rat130)/Ayd strain MP:0006264 decreased systemic arterial systolic blood pressure induced IAGP XCO:0000022 N RGD:724791|PMID:14517349 20191202 RGD compared to SS/Jr 731194 SS.LEW-(D3Chm64-D3Rat17)/Ayd strain MP:0004875 increased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:724791|PMID:14517349 19990101 RGD compared to SS/Jr 731194 SS.LEW-(D3Chm64-D3Rat17)/Ayd strain MP:0006143 increased systemic arterial diastolic blood pressure induced IAGP XCO:0000022 N RGD:724791|PMID:14517349 20191202 RGD 731194 SS.LEW-(D3Chm64-D3Rat17)/Ayd strain MP:0006144 increased systemic arterial systolic blood pressure induced IAGP XCO:0000022 N RGD:724791|PMID:14517349 20191202 RGD 731195 DA.E3-(D14Wox8-D14Rat64)/Rhd strain MP:0002993 autoimmune arthritis IAGP N RGD:730280|PMID:14624754 19990101 RGD 734471 SS.LEW-(D1Mgh7-D1Mco41)/Jr strain MP:0002843 decreased systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:61514|PMID:11015570 19990101 RGD compared to SS/Jr 734472 SS.LEW-(D1Mco2-D1Wox6)/Jr strain MP:0001260 increased body weight induced IAGP XCO:0000022 N RGD:61514|PMID:11015570 19990101 RGD compared to SS/Jr 734472 SS.LEW-(D1Mco2-D1Wox6)/Jr strain MP:0002843 decreased systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:61514|PMID:11015570 19990101 RGD compared to SS/Jr 734474 SS.LEW-(D5Mit9-D5Mco10)/Jr strain MP:0001262 decreased body weight induced IAGP XCO:0000022 N RGD:61040|PMID:9685318 19990101 RGD compared to SS/Jr 734474 SS.LEW-(D5Mit9-D5Mco10)/Jr strain MP:0002834 decreased heart weight induced IAGP XCO:0000022 N RGD:61040|PMID:9685318 19990101 RGD compared to SS/Jr 734474 SS.LEW-(D5Mit9-D5Mco10)/Jr strain MP:0006264 decreased systemic arterial systolic blood pressure induced IAGP XCO:0000022 N RGD:61040|PMID:9685318 19990101 RGD compared to SS/Jr 734475 DA/OlaHsd strain MP:0001262 decreased body weight IAGP N RGD:1598978|PMID:17179209 20201113 RGD compared to COP/OlaHsd 734475 DA/OlaHsd strain MP:0002626 increased heart rate induced IAGP XCO:0000296 N RGD:731241|PMID:11015562 20200629 RGD compared to COP/OlaHsd 734475 DA/OlaHsd strain MP:0002833 increased heart weight IAGP N RGD:1598978|PMID:17179209 20201113 RGD compared to COP/OlaHsd 734475 DA/OlaHsd strain MP:0003022 increased coronary flow rate induced IAGP XCO:0000464,XCO:0000010 N RGD:1342469|PMID:10749737 20200228 RGD compared to SS/JrHsdMcwi 734475 DA/OlaHsd strain MP:0003023 decreased coronary flow rate induced IAGP XCO:0000464,XCO:0000010 N RGD:1342469|PMID:10749737 20200228 RGD 734475 DA/OlaHsd strain MP:0003060 increased aerobic running capacity IAGP N RGD:1598978|PMID:17179209 20201113 RGD compared to COP/OlaHsd 734475 DA/OlaHsd strain MP:0003402 decreased liver weight IAGP N RGD:1598978|PMID:17179209 20201113 RGD compared to COP/OlaHsd 734475 DA/OlaHsd strain MP:0003823 increased left ventricle developed pressure induced IAGP XCO:0000464,XCO:0000010 N RGD:1342469|PMID:10749737 20200228 RGD compared to SS/JrHsdMcwi 734475 DA/OlaHsd strain MP:0003824 decreased left ventricle developed pressure induced IAGP XCO:0000464,XCO:0000010 N RGD:1342469|PMID:10749737 20200228 RGD 734475 DA/OlaHsd strain MP:0003915 increased heart left ventricle weight IAGP N RGD:1598978|PMID:17179209 20201113 RGD compared to COP/OlaHsd 734475 DA/OlaHsd strain MP:0009286 increased abdominal fat pad weight IAGP N RGD:1598978|PMID:17179209 20201113 RGD compared to COP/OlaHsd 734475 DA/OlaHsd strain MP:0009304 increased retroperitoneal fat pad weight IAGP N RGD:1598978|PMID:17179209 20201113 RGD compared to COP/OlaHsd 734475 DA/OlaHsd strain MP:0010934 increased subcutaneous adipose tissue amount IAGP N RGD:1598978|PMID:17179209 20201113 RGD compared to COP/OlaHsd 734476 Crl:CD(SD) strain MP:0002079 increased circulating insulin level induces IAGP XCO:0000275,XCO:0000102,XCO:0000025 N RGD:150521607|PMID:28177704 20211123 RGD 734478 F344/DuCrl strain MP:0003916 decreased heart left ventricle weight IAGP N RGD:7771608|PMID:23901062 20201221 RGD compared to SHRSP 734478 F344/DuCrl strain MP:0004876 decreased mean systemic arterial blood pressure IAGP N RGD:7771608|PMID:23901062 20201221 RGD compared to SHRSP 734478 F344/DuCrl strain MP:0020088 decreased susceptibility to non-insulin-dependent diabetes IAGP N RGD:61082|PMID:8528247 20200303 RGD compared to GK/KyoSwe 734479 SS.LEW-(D1Mco2-D1Rat49)/Jr strain MP:0002834 decreased heart weight induced IAGP XCO:0000022 N RGD:61514|PMID:11015570 20201102 RGD compared to SS/Jr 734479 SS.LEW-(D1Mco2-D1Rat49)/Jr strain MP:0002843 decreased systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:61514|PMID:11015570 20201102 RGD compared to SS/Jr 734480 SS.LEW-(D10Mit10-D10Mgh1)/Jr strain MP:0002834 decreased heart weight induced IAGP XCO:0000022 N RGD:61040|PMID:9685318 19990101 RGD compared to SS/Jr 734480 SS.LEW-(D10Mit10-D10Mgh1)/Jr strain MP:0002834 decreased heart weight induced IAGP XCO:0000022 N RGD:628510|PMID:11641286 20200205 RGD compared to SS/Jr 734480 SS.LEW-(D10Mit10-D10Mgh1)/Jr strain MP:0002843 decreased systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:628510|PMID:11641286 20070607 RGD compared to SS/Jr 734480 SS.LEW-(D10Mit10-D10Mgh1)/Jr strain MP:0006264 decreased systemic arterial systolic blood pressure induced IAGP XCO:0000022 N RGD:61040|PMID:9685318 19990101 RGD compared to SS/Jr 734481 SS.LEW-(D1Mco2-D1Mco35)/Jr strain MP:0002834 decreased heart weight induced IAGP XCO:0000022 N RGD:61040|PMID:9685318 19990101 RGD compared to SS/Jr 734481 SS.LEW-(D1Mco2-D1Mco35)/Jr strain MP:0002834 decreased heart weight induced IAGP XCO:0000022 N RGD:61514|PMID:11015570 19990101 RGD compared to SS/Jr 734481 SS.LEW-(D1Mco2-D1Mco35)/Jr strain MP:0002843 decreased systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:61514|PMID:11015570 19990101 RGD compared to SS/Jr 734481 SS.LEW-(D1Mco2-D1Mco35)/Jr strain MP:0006264 decreased systemic arterial systolic blood pressure induced IAGP XCO:0000022 N RGD:61040|PMID:9685318 19990101 RGD compared to SS/Jr 734483 SS.LEW-(D1Rat42-D1Wox10)/Jr strain MP:0001260 increased body weight induced IAGP XCO:0000022 N RGD:61514|PMID:11015570 19990101 RGD compared to SS/Jr 734483 SS.LEW-(D1Rat42-D1Wox10)/Jr strain MP:0002833 increased heart weight induced IAGP XCO:0000022 N RGD:61514|PMID:11015570 19990101 RGD compared to SS/Jr 734526 OLETF/Got Otsuka Long Evans Tokushima strain MP:0001260 increased body weight IAGP N RGD:1358859|PMID:15883013 20191106 RGD compared to F344/DuCrlCrlj 734526 OLETF/Got Otsuka Long Evans Tokushima strain MP:0001559 hyperglycemia IAGP N RGD:619690|PMID:11087657 20191106 RGD compared to F344/DuCrlCrlj 734526 OLETF/Got Otsuka Long Evans Tokushima strain MP:0009286 increased abdominal fat pad weight IAGP N RGD:1358859|PMID:15883013 20191106 RGD compared to F344/DuCrlCrlj 734526 OLETF/Got Otsuka Long Evans Tokushima strain MP:0009288 increased epididymal fat pad weight IAGP N RGD:1358859|PMID:15883013 20191106 RGD compared to F344/DuCrlCrlj 734526 OLETF/Got Otsuka Long Evans Tokushima strain MP:0009298 increased mesenteric fat pad weight IAGP N RGD:1358859|PMID:15883013 20191106 RGD compared to F344/DuCrlCrlj 734526 OLETF/Got Otsuka Long Evans Tokushima strain MP:0009304 increased retroperitoneal fat pad weight IAGP N RGD:1358859|PMID:15883013 20191106 RGD compared to F344/DuCrlCrlj 734526 OLETF/Got Otsuka Long Evans Tokushima strain MP:0013279 increased fasting circulating glucose level IAGP N RGD:619690|PMID:11087657 20191106 RGD compared to F344/DuCrlCrlj 734531 OLETF.F344-(D1Rat306-D1Rat461)/Got strain MP:0001258 decreased body length IAGP N RGD:734465|PMID:12190994 19990101 RGD compared to OLETF/Got 734531 OLETF.F344-(D1Rat306-D1Rat461)/Got strain MP:0001262 decreased body weight IAGP N RGD:734465|PMID:12190994 19990101 RGD compared to OLETF/Got 734531 OLETF.F344-(D1Rat306-D1Rat461)/Got strain MP:0002176 increased brain weight IAGP N RGD:734465|PMID:12190994 20201106 RGD compared to OLETF/Got 734531 OLETF.F344-(D1Rat306-D1Rat461)/Got strain MP:0002644 decreased circulating triglyceride level IAGP N RGD:734465|PMID:12190994 20201106 RGD compared to OLETF/Got 734531 OLETF.F344-(D1Rat306-D1Rat461)/Got strain MP:0003402 decreased liver weight IAGP N RGD:734465|PMID:12190994 20201106 RGD compared to OLETF/Got 734531 OLETF.F344-(D1Rat306-D1Rat461)/Got strain MP:0005179 decreased circulating cholesterol level IAGP N RGD:734465|PMID:12190994 20201106 RGD compared to OLETF/Got 734531 OLETF.F344-(D1Rat306-D1Rat461)/Got strain MP:0005292 improved glucose tolerance induced IAGP XCO:0000103 N RGD:734465|PMID:12190994 20201106 RGD compared to OLETF/Got 734531 OLETF.F344-(D1Rat306-D1Rat461)/Got strain MP:0006086 decreased body mass index IAGP N RGD:734465|PMID:12190994 19990101 RGD compared to OLETF/Got 734531 OLETF.F344-(D1Rat306-D1Rat461)/Got strain MP:0006352 decreased glycosylated hemoglobin level IAGP N RGD:734465|PMID:12190994 20201106 RGD compared to OLETF/Got 734531 OLETF.F344-(D1Rat306-D1Rat461)/Got strain MP:0009287 decreased abdominal fat pad weight IAGP N RGD:734465|PMID:12190994 20111104 RGD compared to OLETF/Got 734531 OLETF.F344-(D1Rat306-D1Rat461)/Got strain MP:0009299 decreased mesenteric fat pad weight IAGP N RGD:734465|PMID:12190994 20201106 RGD compared to OLETF/Got 734531 OLETF.F344-(D1Rat306-D1Rat461)/Got strain MP:0011940 decreased food intake IAGP N RGD:734465|PMID:12190994 20201106 RGD compared to OLETF/Got 734759 SHRSP/Gcrc Spontaneously hypertensive rat, stroke prone strain MP:0000231 hypertension susceptibility IAGP XCO:0000164 N RGD:2301356|PMID:18819818 20200109 RGD MMO:0000015 734759 SHRSP/Gcrc Spontaneously hypertensive rat, stroke prone strain MP:0002842 increased systemic arterial blood pressure IAGP N RGD:631154|PMID:12624007 20191205 RGD compared to control strain WKY/Gcrc 734759 SHRSP/Gcrc Spontaneously hypertensive rat, stroke prone strain MP:0002962 increased urine protein level IAGP N RGD:13432198|PMID:27755386 20170926 RGD as compared to WKY/Gcrc 734759 SHRSP/Gcrc Spontaneously hypertensive rat, stroke prone strain MP:0004217 salt-sensitive hypertension severity IAGP XCO:0000164 N RGD:61041|PMID:8901842 20191204 RGD compared to control strain WKY/Gcrc; more severe in males 734759 SHRSP/Gcrc Spontaneously hypertensive rat, stroke prone strain MP:0004217 salt-sensitive hypertension susceptibility IAGP XCO:0000164 N RGD:1643008|PMID:17938382 20191210 RGD compared to control strain WKY/Gcrc and congenics 734759 SHRSP/Gcrc Spontaneously hypertensive rat, stroke prone strain MP:0004217 salt-sensitive hypertension susceptibility IAGP XCO:0000164 N RGD:68910|PMID:10642295 20191205 RGD compared to control strain WKY/Gcrc; sexual dimorphism 734759 SHRSP/Gcrc Spontaneously hypertensive rat, stroke prone strain MP:0004875 increased mean systemic arterial blood pressure disease_progression IAGP N RGD:68910|PMID:10642295 20191205 RGD compared to control strain WKY/Gcrc 734759 SHRSP/Gcrc Spontaneously hypertensive rat, stroke prone strain MP:0004875 increased mean systemic arterial blood pressure susceptibility IAGP N RGD:61041|PMID:8901842 20191204 RGD compared to control strain WKY/Gcrc 734759 SHRSP/Gcrc Spontaneously hypertensive rat, stroke prone strain MP:0006143 increased systemic arterial diastolic blood pressure IAGP N RGD:631154|PMID:12624007 20191205 RGD compared to control strain WKY/Gcrc 734759 SHRSP/Gcrc Spontaneously hypertensive rat, stroke prone strain MP:0006143 increased systemic arterial diastolic blood pressure disease_progression IAGP N RGD:68910|PMID:10642295 20191205 RGD compared to control strain WKY/Gcrc 734759 SHRSP/Gcrc Spontaneously hypertensive rat, stroke prone strain MP:0006143 increased systemic arterial diastolic blood pressure susceptibility IAGP N RGD:61041|PMID:8901842 20191204 RGD compared to control strain WKY/Gcrc 734759 SHRSP/Gcrc Spontaneously hypertensive rat, stroke prone strain MP:0006144 increased systemic arterial systolic blood pressure IAGP N RGD:631154|PMID:12624007 20191205 RGD compared to control strain WKY/Gcrc 734759 SHRSP/Gcrc Spontaneously hypertensive rat, stroke prone strain MP:0006144 increased systemic arterial systolic blood pressure disease_progression IAGP N RGD:68910|PMID:10642295 20191205 RGD compared to control strain WKY/Gcrc 734759 SHRSP/Gcrc Spontaneously hypertensive rat, stroke prone strain MP:0006144 increased systemic arterial systolic blood pressure susceptibility IAGP N RGD:1643008|PMID:17938382 20191210 RGD compared to control strain WKY/Gcrc and congenics 734759 SHRSP/Gcrc Spontaneously hypertensive rat, stroke prone strain MP:0006144 increased systemic arterial systolic blood pressure susceptibility IAGP N RGD:61041|PMID:8901842 20191204 RGD compared to control strain WKY/Gcrc 734759 SHRSP/Gcrc Spontaneously hypertensive rat, stroke prone strain MP:0006265 increased pulse pressure susceptibility IAGP N RGD:61041|PMID:8901842 20191204 RGD compared to control strain WKY/Gcrc 734759 SHRSP/Gcrc Spontaneously hypertensive rat, stroke prone strain MP:0008552 abnormal circulating tumor necrosis factor level severity IAGP N RGD:1643008|PMID:17938382 20191210 RGD compared to control strain WKY/Gcrc 734759 SHRSP/Gcrc Spontaneously hypertensive rat, stroke prone strain MP:0010212 abnormal circulating C-reactive protein level severity IAGP N RGD:1643008|PMID:17938382 20191210 RGD compared to control strain WKY/Gcrc 734759 SHRSP/Gcrc Spontaneously hypertensive rat, stroke prone strain MP:0010213 abnormal circulating fibrinogen level severity IAGP N RGD:1643008|PMID:17938382 20191210 RGD compared to control strain WKY/Gcrc 734759 SHRSP/Gcrc Spontaneously hypertensive rat, stroke prone strain MP:0012045 increased susceptibility to hypertension IAGP N RGD:631154|PMID:12624007 20191205 RGD compared to control strain WKY/Gcrc 734759 SHRSP/Gcrc Spontaneously hypertensive rat, stroke prone strain MP:0012045 increased susceptibility to hypertension disease_progression IAGP N RGD:68910|PMID:10642295 20191205 RGD compared to control strain WKY/Gcrc 734759 SHRSP/Gcrc Spontaneously hypertensive rat, stroke prone strain MP:0012045 increased susceptibility to hypertension susceptibility IAGP N RGD:1643008|PMID:17938382 20191210 RGD compared to control strain WKY/Gcrc and congenics 734759 SHRSP/Gcrc Spontaneously hypertensive rat, stroke prone strain MP:0012045 increased susceptibility to hypertension susceptibility IAGP N RGD:61041|PMID:8901842 20191204 RGD compared to control strain WKY/Gcrc 734760 WKY/Gcrc Wistar-Kyoto strain MP:0002834 decreased heart weight IAGP N RGD:13432198|PMID:27755386 20170926 RGD as compared to SHRSP/Gcrc 734760 WKY/Gcrc Wistar-Kyoto strain MP:0002843 decreased systemic arterial blood pressure IAGP N RGD:631154|PMID:12624007 20191205 RGD compared to spontaneously hypertensive strain SHRSP/Gcrc 734760 WKY/Gcrc Wistar-Kyoto strain MP:0003916 decreased heart left ventricle weight IAGP N RGD:13432198|PMID:27755386 20170926 RGD as compared to SHRSP/Gcrc 734760 WKY/Gcrc Wistar-Kyoto strain MP:0003918 decreased kidney weight IAGP N RGD:13432198|PMID:27755386 20170926 RGD as compared to SHRSP/Gcrc 734760 WKY/Gcrc Wistar-Kyoto strain MP:0004876 decreased mean systemic arterial blood pressure IAGP N RGD:61041|PMID:8901842 20191204 RGD compared to spontaneously hypertensive strain SHRSP/Gcrc 734760 WKY/Gcrc Wistar-Kyoto strain MP:0004876 decreased mean systemic arterial blood pressure IAGP N RGD:68910|PMID:10642295 20191205 RGD compared to spontaneously hypertensive strain SHRSP/Gcrc 734760 WKY/Gcrc Wistar-Kyoto strain MP:0006263 decreased systemic arterial diastolic blood pressure IAGP N RGD:13432198|PMID:27755386 20170926 RGD as compared to SHRSP/Gcrc 734760 WKY/Gcrc Wistar-Kyoto strain MP:0006263 decreased systemic arterial diastolic blood pressure IAGP N RGD:61041|PMID:8901842 20191204 RGD compared to spontaneously hypertensive strain SHRSP/Gcrc 734760 WKY/Gcrc Wistar-Kyoto strain MP:0006263 decreased systemic arterial diastolic blood pressure IAGP N RGD:631154|PMID:12624007 20191205 RGD compared to spontaneously hypertensive strain SHRSP/Gcrc 734760 WKY/Gcrc Wistar-Kyoto strain MP:0006263 decreased systemic arterial diastolic blood pressure IAGP N RGD:68910|PMID:10642295 20191205 RGD compared to spontaneously hypertensive strain SHRSP/Gcrc 734760 WKY/Gcrc Wistar-Kyoto strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:13432198|PMID:27755386 20170926 RGD as compared to SHRSP/Gcrc 734760 WKY/Gcrc Wistar-Kyoto strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:1643008|PMID:17938382 20081009 RGD as compared to SHRSP/Gcrc 734760 WKY/Gcrc Wistar-Kyoto strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:61041|PMID:8901842 20191204 RGD compared to spontaneously hypertensive strain SHRSP/Gcrc 734760 WKY/Gcrc Wistar-Kyoto strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:631154|PMID:12624007 20191205 RGD compared to spontaneously hypertensive strain SHRSP/Gcrc 734760 WKY/Gcrc Wistar-Kyoto strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:68910|PMID:10642295 20191205 RGD compared to spontaneously hypertensive strain SHRSP/Gcrc 734760 WKY/Gcrc Wistar-Kyoto strain MP:0006264 decreased systemic arterial systolic blood pressure susceptibility IAGP XCO:0000164 N RGD:1643008|PMID:17938382 20081009 RGD as compared to SHRSP/Gcrc 734760 WKY/Gcrc Wistar-Kyoto strain MP:0006266 decreased pulse pressure IAGP N RGD:13432198|PMID:27755386 20170926 RGD as compared to SHRSP/Gcrc 734760 WKY/Gcrc Wistar-Kyoto strain MP:0012046 decreased susceptibility to hypertension IAGP N RGD:61041|PMID:8901842 20191204 RGD compared to spontaneously hypertensive strain SHRSP/Gcrc 734760 WKY/Gcrc Wistar-Kyoto strain MP:0012046 decreased susceptibility to hypertension IAGP N RGD:631154|PMID:12624007 20191205 RGD compared to spontaneously hypertensive strain SHRSP/Gcrc 734760 WKY/Gcrc Wistar-Kyoto strain MP:0012046 decreased susceptibility to hypertension IAGP N RGD:68910|PMID:10642295 20191205 RGD compared to spontaneously hypertensive strain SHRSP/Gcrc 734760 WKY/Gcrc Wistar-Kyoto strain MP:0012046 decreased susceptibility to hypertension susceptibility IAGP N RGD:1643008|PMID:17938382 20191210 RGD compared to hypertensive strain SHRSP/Gcrc 734767 Niddm57 Non-insulin dependent diabetes mellitus QTL 57 qtl MP:0001260 increased body weight QTM N RGD:619679|PMID:11355573 19990101 RGD 734767 Niddm57 Non-insulin dependent diabetes mellitus QTL 57 qtl MP:0005178 increased circulating cholesterol level QTM N RGD:619679|PMID:11355573 19990101 RGD 734768 Niddm59 Non-insulin dependent diabetes mellitus QTL 59 qtl MP:0001262 decreased body weight IDA N RGD:734465|PMID:12190994 19990101 RGD 734768 Niddm59 Non-insulin dependent diabetes mellitus QTL 59 qtl MP:0005179 decreased circulating cholesterol level IDA N RGD:734465|PMID:12190994 19990101 RGD 734768 Niddm59 Non-insulin dependent diabetes mellitus QTL 59 qtl MP:0005318 decreased triglyceride level IDA N RGD:734465|PMID:12190994 19990101 RGD 734768 Niddm59 Non-insulin dependent diabetes mellitus QTL 59 qtl MP:0010025 decreased total body fat amount IDA N RGD:734465|PMID:12190994 20111104 RGD 734769 Niddm58 Non-insulin dependent diabetes mellitus QTL 58 qtl MP:0001262 decreased body weight IDA N RGD:619683|PMID:11153534 19990101 RGD 734769 Niddm58 Non-insulin dependent diabetes mellitus QTL 58 qtl MP:0002644 decreased circulating triglyceride level IDA N RGD:619683|PMID:11153534 19990101 RGD 734769 Niddm58 Non-insulin dependent diabetes mellitus QTL 58 qtl MP:0002727 decreased circulating insulin level IAGP N RGD:619683|PMID:11153534 19990101 RGD 734769 Niddm58 Non-insulin dependent diabetes mellitus QTL 58 qtl MP:0005292 improved glucose tolerance IAGP N RGD:619683|PMID:11153534 19990101 RGD 734769 Niddm58 Non-insulin dependent diabetes mellitus QTL 58 qtl MP:0010025 decreased total body fat amount IDA N RGD:619683|PMID:11153534 20111104 RGD 7349321 LEXF2D/Stm strain MP:0002026 increased leukemia incidence induced IAGP XCO:0000437 N RGD:619600|PMID:10360666 20200710 RGD 7349322 LEXF8B/Stm strain MP:0002026 increased leukemia incidence penetrance IAGP XCO:0000437 N RGD:619600|PMID:10360666 20200710 RGD 735015 Dsg4 desmoglein 4 gene MP:0000414 alopecia IMP N RGD:150521560|PMID:15606503 20211111 RGD 735015 Dsg4 desmoglein 4 gene MP:0000416 sparse hair IAGP N RGD:150521562|PMID:15617564 20211110 RGD DNA:missense mutation:exon 8 (rat) 735015 Dsg4 desmoglein 4 gene MP:0001211 wrinkled skin IAGP N RGD:150521562|PMID:15617564 20211110 RGD DNA:missense mutation:exon 8 (rat) 735015 Dsg4 desmoglein 4 gene MP:0001242 hyperkeratosis IAGP N RGD:150521562|PMID:15617564 20211110 RGD DNA:missense mutation:exon 8 (rat) 735015 Dsg4 desmoglein 4 gene MP:0001278 kinked vibrissae IAGP N RGD:150521562|PMID:15617564 20211110 RGD DNA:missense mutation:exon 8 (rat) 735015 Dsg4 desmoglein 4 gene MP:0001283 sparse vibrissae IAGP N RGD:150521562|PMID:15617564 20211110 RGD DNA:missense mutation:exon 8 (rat) 735025 Or2y13 olfactory receptor family 2 subfamily Y member 13 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 735088 Flcn folliculin gene MP:0002080 prenatal lethality IAGP N RGD:1302869|PMID:14769940 20070105 RGD 735088 Flcn folliculin gene MP:0008762 embryonic lethality treatment IMP N RGD:13605606|PMID:16369488 20180606 RGD 735109 Unc5c unc-5 netrin receptor C gene MP:0000865 absent cerebellum vermis IAGP N RGD:1302461|PMID:14993736 20170406 RGD 735190 Or10al7 olfactory receptor family 10 subfamily AL member 7 gene MP:0005394 taste/olfaction phenotype IEA N RGD:1303377|PMID:15057822 19990101 RGD 7364940 F344-Tp53tm1(EGFP-Pac)Qly/Rrrc strain MP:0002083 premature death IMP N RGD:12738450|PMID:27528400 20210428 RGD 7365043 SS.SR-(rs65785750-rs106808193)/Opaz strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:7364997|PMID:22860086 20131016 RGD compared to parental SS/JrHsd 7365043 SS.SR-(rs65785750-rs106808193)/Opaz strain MP:0006263 decreased systemic arterial diastolic blood pressure induced IAGP XCO:0000022 N RGD:7364997|PMID:22860086 20131016 RGD compared to parental SS/JrHsd 7365043 SS.SR-(rs65785750-rs106808193)/Opaz strain MP:0006264 decreased systemic arterial systolic blood pressure induced IAGP XCO:0000022 N RGD:7364997|PMID:22860086 20131016 RGD compared to parental SS/JrHsd 7365049 Bp359 Blood pressure QTL 359 qtl MP:0006264 decreased systemic arterial systolic blood pressure induced IAGP XCO:0000022 N RGD:7364997|PMID:22860086 20131016 RGD 737658 PVG.1AV1 Piebald-Virol-Glaxo strain MP:0010539 decreased level of surface class II molecules IAGP N RGD:1358146|PMID:15821736 20170825 RGD compared to DA strain 737688 Pax6Sey paired box gene 6, small eye mutation gene MP:0002233 abnormal nose morphology IAGP N RGD:1601213|PMID:7981749 20070410 RGD 737688 Pax6Sey paired box gene 6, small eye mutation gene MP:0005253 abnormal eye physiology IAGP N RGD:1601213|PMID:7981749 20070410 RGD 737691 BN/Crli strain MP:0008019 increased liver tumor incidence induced IAGP XCO:0000206 N RGD:1599590|PMID:17079458 20070314 RGD compared to F344/Crli ; 737818 Hcar12 Hepatocarcinoma resistance QTL 12 qtl MP:0010265 decreased hepatoma incidence IDA N RGD:629566|PMID:12154055 20111107 RGD 737819 Hcas4 Hepatocarcinoma susceptibility QTL 4 qtl MP:0010264 increased hepatoma incidence IDA N RGD:629566|PMID:12154055 20111108 RGD 737820 Alc9 Alcohol consumption QTL 9 qtl MP:0001987 alcohol preference QTM N RGD:731212|PMID:14634485 19990101 RGD 737821 Hcar9 Hepatocarcinoma resistance QTL 9 qtl MP:0010265 decreased hepatoma incidence IDA N RGD:629566|PMID:12154055 20111107 RGD 737822 Alc10 Alcohol consumption QTL 10 qtl MP:0001987 alcohol preference QTM N RGD:731212|PMID:14634485 19990101 RGD 737823 Alc12 Alcohol consumption QTL 12 qtl MP:0001987 alcohol preference QTM N RGD:731212|PMID:14634485 19990101 RGD 737824 Hcar10 Hepatocarcinoma resistance QTL 10 qtl MP:0010265 decreased hepatoma incidence IDA N RGD:629566|PMID:12154055 20111107 RGD 737825 Alc13 Alcohol consumption QTL 13 qtl MP:0001987 alcohol preference QTM N RGD:731212|PMID:14634485 19990101 RGD 737826 Alc11 Alcohol consumption QTL 11 qtl MP:0001987 alcohol preference QTM N RGD:731212|PMID:14634485 19990101 RGD 737827 Hcar11 Hepatocarcinoma resistance QTL 11 qtl MP:0010265 decreased hepatoma incidence IDA N RGD:629566|PMID:12154055 20111107 RGD 737828 Hcas3 Hepatocarcinoma susceptibility QTL 3 qtl MP:0010264 increased hepatoma incidence IDA N RGD:629566|PMID:12154055 20111108 RGD 737856 Edpm10 Estrogen-dependent pituitary mass QTL 10 qtl MP:0000635 pituitary gland hyperplasia QTM N RGD:61074|PMID:9337394 19990101 RGD 737857 DA.PVG.1AV1-(D4Rat155-D4Rat84) strain MP:0001263 weight loss IAGP XCO:0000266|XCO:0000280 N RGD:629560|PMID:12571866 20200815 RGD compared to PVG.1AV1/Kini 737857 DA.PVG.1AV1-(D4Rat155-D4Rat84) strain MP:0002933 joint inflammation penetrance IAGP XCO:0000280|XCO:0000263|XCO:0000266|XCO:0000281,XCO:0000265 N RGD:629560|PMID:12571866 19990101 RGD compared to DA/ZtmKini 737858 DA.PVG.1AV1-(D4Rat155-Spr) strain MP:0001263 weight loss IAGP XCO:0000281,XCO:0000265|XCO:0000263 N RGD:629560|PMID:12571866 20191202 RGD compared to PVG.1AV1/Kini 737858 DA.PVG.1AV1-(D4Rat155-Spr) strain MP:0003724 increased susceptibility to induced arthritis IAGP XCO:0000263|XCO:0000281,XCO:0000265 N RGD:629560|PMID:12571866 19990101 RGD compared to PVG.1AV1/Kini 737859 DA.PVG.1AV1-(D4Mgh17-D4Rat56) strain MP:0001263 weight loss sexual_dimorphism IAGP XCO:0000281,XCO:0000265 N RGD:629560|PMID:12571866 20191202 RGD in males, compared to DA/ZtmKini 737859 DA.PVG.1AV1-(D4Mgh17-D4Rat56) strain MP:0002933 joint inflammation sexual_dimorphism IAGP XCO:0000281,XCO:0000265 N RGD:629560|PMID:12571866 20191202 RGD in males, compared to DA/ZtmKini 737859 DA.PVG.1AV1-(D4Mgh17-D4Rat56) strain MP:0003724 increased susceptibility to induced arthritis IAGP XCO:0000281,XCO:0000265 N RGD:629560|PMID:12571866 20191202 RGD compared to PVG.1AV1/Kini 737861 DA.PVG.1AV1-(D4Rat63-D4Rat203) strain MP:0001263 weight loss severity IAGP XCO:0000265,XCO:0000281 N RGD:629560|PMID:12571866 20191202 RGD compared to DA/ZtmKini 737861 DA.PVG.1AV1-(D4Rat63-D4Rat203) strain MP:0002933 joint inflammation severity IAGP XCO:0000280|XCO:0000281,XCO:0000265 N RGD:629560|PMID:12571866 20191202 RGD compared to DA/ZtmKini 737861 DA.PVG.1AV1-(D4Rat63-D4Rat203) strain MP:0002933 joint inflammation susceptibility IAGP XCO:0000263 N RGD:629560|PMID:12571866 20191202 RGD compared to PVG.1AV1/Kini 737861 DA.PVG.1AV1-(D4Rat63-D4Rat203) strain MP:0003724 increased susceptibility to induced arthritis IAGP XCO:0000281,XCO:0000265|XCO:0000263|XCO:0000280 N RGD:629560|PMID:12571866 20191202 RGD compared to PVG.1AV1/Kini 737861 DA.PVG.1AV1-(D4Rat63-D4Rat203) strain MP:0008501 increased IgG2b level IAGP XCO:0000281,XCO:0000265 N RGD:629560|PMID:12571866 20191202 RGD compared to DA/ZtmKini 737862 SHRSP.WKY-(D2Rat14-D2Mit5)/Gcrc strain MP:0002843 decreased systemic arterial blood pressure IAGP N RGD:728179|PMID:11980293 19990101 RGD 737862 SHRSP.WKY-(D2Rat14-D2Mit5)/Gcrc strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:728179|PMID:11980293 19990101 RGD 737863 SHRSP.WKY-(D2Wox9-D2Mgh12)/Gcrc strain MP:0002843 decreased systemic arterial blood pressure IAGP N RGD:631154|PMID:12624007 19990101 RGD compared to spontaneously hypertensive strain SHRSP/Gcrc 737863 SHRSP.WKY-(D2Wox9-D2Mgh12)/Gcrc strain MP:0006263 decreased systemic arterial diastolic blood pressure IAGP N RGD:631154|PMID:12624007 19990101 RGD compared to spontaneously hypertensive strain SHRSP/Gcrc 737863 SHRSP.WKY-(D2Wox9-D2Mgh12)/Gcrc strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:1643008|PMID:17938382 20081009 RGD as compared to SHRSP/Gcrc 737863 SHRSP.WKY-(D2Wox9-D2Mgh12)/Gcrc strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:631154|PMID:12624007 19990101 RGD compared to spontaneously hypertensive strain SHRSP/Gcrc 737863 SHRSP.WKY-(D2Wox9-D2Mgh12)/Gcrc strain MP:0006264 decreased systemic arterial systolic blood pressure susceptibility IAGP N RGD:2301356|PMID:18819818 20200109 RGD compared to SHRSP/Gcrc; MMO:0000015 737863 SHRSP.WKY-(D2Wox9-D2Mgh12)/Gcrc strain MP:0012046 decreased susceptibility to hypertension IAGP N RGD:631154|PMID:12624007 20191205 RGD compared to spontaneously hypertensive strain SHRSP/Gcrc 737864 SS.SR-(D13Mit9-D13Mit1)/Jr strain MP:0002843 decreased systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:61047|PMID:9271663 19990101 RGD compared to SS/Jr 737866 WKY.SHRSP-(D2Rat14-D2Mit5) strain MP:0002842 increased systemic arterial blood pressure IAGP N RGD:728179|PMID:11980293 20201027 RGD 737870 DA.E3-(D20Wox3-D20Mgh4)/Rhd strain MP:0005092 decreased double-positive T cell number severity IAGP XCO:0000263 N RGD:631850|PMID:12817024 20191122 RGD compared to inducible strain DA/ZtmRhd 737871 DA.E3-(D12Got46-D12Rat26)/Rhd strain MP:0001876 decreased inflammatory response IAGP N RGD:628543|PMID:12461526 20220531 RGD compared to DA strain 737871 DA.E3-(D12Got46-D12Rat26)/Rhd strain MP:0003436 decreased susceptibility to induced arthritis IAGP N RGD:628543|PMID:12461526 20220531 RGD compared to DA strain 737871 DA.E3-(D12Got46-D12Rat26)/Rhd strain MP:0003436 decreased susceptibility to induced arthritis severity IAGP XCO:0000263 N RGD:631850|PMID:12817024 20191122 RGD compared to inducible strain DA/ZtmRhd 737871 DA.E3-(D12Got46-D12Rat26)/Rhd strain MP:0021039 decreased circulating orosomucoid 1 protein level IAGP N RGD:628543|PMID:12461526 20220531 RGD compared to DA strain 737872 DA.E3-(D4Mit16-D4Mgh11)/Rhd strain MP:0003436 decreased susceptibility to induced arthritis induced IAGP XCO:0000263 N RGD:631850|PMID:12817024 19990101 RGD compared to treated DA/ZtmRhd 737872 DA.E3-(D4Mit16-D4Mgh11)/Rhd strain MP:0003436 decreased susceptibility to induced arthritis severity IAGP XCO:0000263 N RGD:631850|PMID:12817024 20191122 RGD compared to inducible strain DA/ZtmRhd 737873 DA.E3-(D6Wox5-D6Rat90)/Rhd strain MP:0002993 autoimmune arthritis IAGP N RGD:728382|PMID:14611807 19990101 RGD 737891 Crl:SD strain MP:0002963 decreased urine protein level ameliorates IAGP XCO:0000588 N RGD:25314278|PMID:1580281 20210708 RGD compared with untreated 737891 Crl:SD strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000548 N RGD:68697|PMID:11208766 20200211 RGD compared to untreated 737891 Crl:SD strain MP:0004876 decreased mean systemic arterial blood pressure induces IMP XCO:0000897 N RGD:13792700|PMID:27335281 20210929 RGD 737891 Crl:SD strain MP:0005333 decreased heart rate induces IDA N RGD:13792700|PMID:27335281 20211112 RGD Compared to untreated 737891 Crl:SD strain MP:0005333 decreased heart rate induces IMP XCO:0000897 N RGD:13792700|PMID:27335281 20210929 RGD 737891 Crl:SD strain MP:0005633 increased circulating sodium level induces IDA N RGD:13792700|PMID:27335281 20211112 RGD compared to 0 min 737891 Crl:SD strain MP:0006264 decreased systemic arterial systolic blood pressure ameliorates IAGP N RGD:25314278|PMID:1580281 20210723 RGD compared with untreated 737891 Crl:SD strain MP:0008997 increased blood osmolality induces IDA N RGD:13792700|PMID:27335281 20211112 RGD compared to 0 min 737892 ACI/SegHsd strain MP:0001883 increased mammary adenocarcinoma incidence induced IAGP XCO:0000092 N RGD:1642522|PMID:16885383 20070927 RGD compared to treated BN/SsNHsd 737892 ACI/SegHsd strain MP:0002044 increased colon adenoma incidence induced IAGP XCO:0000393 N RGD:1625309|PMID:17510081 20200316 RGD compared to treated WF/CrCrli 737892 ACI/SegHsd strain MP:0004956 decreased thymus weight IAGP N RGD:2292503|PMID:18420736 20200710 RGD compared to COP/CrCrl 737892 ACI/SegHsd strain MP:0005124 increased circulating prolactin level induced IAGP XCO:0000092 N RGD:1358963|PMID:10688907 20200327 RGD compared to ACI/SegHsd 737892 ACI/SegHsd strain MP:0005124 increased circulating prolactin level induced IAGP XCO:0000092 N RGD:2292503|PMID:18420736 20200710 RGD compared to COP/CrCrl 737892 ACI/SegHsd strain MP:0005124 increased circulating prolactin level induced IAGP XCO:0000295 N RGD:1358974|PMID:10342874 20200313 RGD compared to ACI/SegHsd and treated COP/CrCrl 737892 ACI/SegHsd strain MP:0008770 decreased survivor rate induced IAGP XCO:0000668 N RGD:2302114|PMID:17998886 20090522 RGD compared to BN/HsdMcwiCrl 737892 ACI/SegHsd strain MP:0008939 increased pituitary gland weight induced IAGP XCO:0000092 N RGD:1358963|PMID:10688907 20200327 RGD compared to ACI/SegHsd 737892 ACI/SegHsd strain MP:0008939 increased pituitary gland weight induced IAGP XCO:0000092 N RGD:1642526|PMID:17876666 20200327 RGD compared with ACI/SedHsd, treated BN/SsNHsd 737892 ACI/SegHsd strain MP:0008939 increased pituitary gland weight induced IAGP XCO:0000092 N RGD:2292503|PMID:18420736 20200710 RGD compared to COP/CrCrl 737892 ACI/SegHsd strain MP:0008939 increased pituitary gland weight induced IAGP XCO:0000295 N RGD:1358974|PMID:10342874 20200313 RGD 737892 ACI/SegHsd strain MP:0010299 increased mammary gland tumor incidence induced IAGP XCO:0000092 N RGD:1358956|PMID:11713205 20200310 RGD compared to COP/OlaHsd 737892 ACI/SegHsd strain MP:0010299 increased mammary gland tumor incidence induced IAGP XCO:0000092 N RGD:2292503|PMID:18420736 20200710 RGD compared to ACI.COP-(D6Rat80-D6Rat146)/Shul�� 737892 ACI/SegHsd strain MP:0010308 decreased tumor latency MODEL: induced IAGP XCO:0000092 N RGD:1642522|PMID:16885383 20200317 RGD compared to treated BN/SsNHsd 737895 WKY/Ztm strain MP:0004502 decreased incidence of tumors by chemical induction MODEL: control IAGP XCO:0000090 N RGD:1599317|PMID:16596452 20200316 RGD compared to 7,12-dimethyltetraphene treated SPRD/Ztm 737899 BN/Cub strain MP:0002644 decreased circulating triglyceride level IAGP N RGD:632347|PMID:12118727 20200313 RGD compared to BN.SHR-(Il6-Cd36)/Cub, BN.PD-(D8Rat39-D8Rat35)/Cub 737899 BN/Cub strain MP:0002702 decreased circulating free fatty acids level induced IAGP XCO:0000432 N RGD:632347|PMID:12118727 20200313 RGD compared to BN.SHR-(Il6-Cd36)/Cub, BN.PD-(D8Rat39-D8Rat35)/Cub 737899 BN/Cub strain MP:0013278 decreased fasting circulating glucose level IAGP N RGD:632347|PMID:12118727 20200313 RGD compared to BN.SHR-(Il6-Cd36)/Cub, BN.PD-(D8Rat39-D8Rat35)/Cub 737903 Hsd:SD Sprague Dawley strain MP:0001859 kidney inflammation induced IAGP XCO:0000599,XCO:0000367,XCO:0000790 N RGD:6903837|PMID:12675855 20121003 RGD 737903 Hsd:SD Sprague Dawley strain MP:0002498 abnormal acute inflammation induced IAGP XCO:0000599,XCO:0000367,XCO:0000790 N RGD:6903837|PMID:12675855 20121003 RGD 737903 Hsd:SD Sprague Dawley strain MP:0002981 increased liver weight induced IAGP XCO:0000600 N RGD:13204753|PMID:23859880 20210630 RGD 737903 Hsd:SD Sprague Dawley strain MP:0002981 increased liver weight induced IAGP XCO:0000844 N RGD:38549342|PMID:29548889 20210629 RGD 737903 Hsd:SD Sprague Dawley strain MP:0004956 decreased thymus weight induced IAGP XCO:0000600 N RGD:13204753|PMID:23859880 20210630 RGD 737903 Hsd:SD Sprague Dawley strain MP:0005584 abnormal enzyme/coenzyme activity induced IAGP XCO:0000844|XCO:0000845 N RGD:38549342|PMID:29548889 20210629 RGD increased EROD, PROD 737903 Hsd:SD Sprague Dawley strain MP:0020169 increased thyroid gland weight induced IAGP XCO:0000845|XCO:0000844 N RGD:38549342|PMID:29548889 20210629 RGD 737903 Hsd:SD Sprague Dawley strain MP:0021085 increased DNA replication induced IAGP XCO:0000844|XCO:0000845 N RGD:38549342|PMID:29548889 20210629 RGD 737905 LEW/Maas strain MP:0010451 kidney microaneurysm induced IAGP XCO:0000282 N RGD:2312422|PMID:18682577 20090812 RGD compared to LEW/Mol 737906 MWF/Hsd Munich Wistar Fromter strain MP:0000208 decreased hematocrit induces IAGP XCO:0000641 N RGD:24922219|PMID:22258067 20210709 RGD compared to control 737906 MWF/Hsd Munich Wistar Fromter strain MP:0000221 decreased leukocyte cell number induces IAGP XCO:0000641 N RGD:24922219|PMID:22258067 20210709 RGD compared to control 737906 MWF/Hsd Munich Wistar Fromter strain MP:0000276 heart right ventricle hypertrophy induces IAGP XCO:0000641 N RGD:24922219|PMID:22258067 20210709 RGD compared to control 737906 MWF/Hsd Munich Wistar Fromter strain MP:0001262 decreased body weight induces IAGP XCO:0000641 N RGD:24922219|PMID:22258067 20210709 RGD compared to control 737906 MWF/Hsd Munich Wistar Fromter strain MP:0001544 abnormal cardiovascular system physiology induces IAGP XCO:0000641 N RGD:24922219|PMID:22258067 20210709 RGD compared to control 737906 MWF/Hsd Munich Wistar Fromter strain MP:0001552 increased circulating triglyceride level IAGP N RGD:25314268|PMID:19420905 20210329 RGD compared to LEW 737906 MWF/Hsd Munich Wistar Fromter strain MP:0002875 decreased erythrocyte cell number induces IAGP XCO:0000641 N RGD:24922219|PMID:22258067 20210709 RGD compared to control 737906 MWF/Hsd Munich Wistar Fromter strain MP:0003822 decreased left ventricle systolic pressure induces IAGP XCO:0000641 N RGD:24922219|PMID:22258067 20210709 RGD compared to control 737906 MWF/Hsd Munich Wistar Fromter strain MP:0004876 decreased mean systemic arterial blood pressure induces IAGP XCO:0000641 N RGD:24922219|PMID:22258067 20210709 RGD compared to control 737906 MWF/Hsd Munich Wistar Fromter strain MP:0005178 increased circulating cholesterol level IAGP N RGD:25314268|PMID:19420905 20210329 RGD compared to LEW 737906 MWF/Hsd Munich Wistar Fromter strain MP:0005264 glomerulosclerosis IAGP N RGD:25314268|PMID:19420905 20210329 RGD compared to LEW and FHH 737906 MWF/Hsd Munich Wistar Fromter strain MP:0009814 increased prostaglandin level IAGP N RGD:25314268|PMID:19420905 20210329 RGD compared to LEW and FHH 737906 MWF/Hsd Munich Wistar Fromter strain MP:0011431 increased urine flow rate IAGP N RGD:25314268|PMID:19420905 20210329 RGD compared to LEW 737906 MWF/Hsd Munich Wistar Fromter strain MP:0020110 increased thromboxane level IAGP N RGD:25314268|PMID:19420905 20210329 RGD compared to LEW and FHH 737906 MWF/Hsd Munich Wistar Fromter strain MP:0020419 decreased cardiac muscle relaxation induced IAGP XCO:0000143 N RGD:25314268|PMID:19420905 20210329 RGD compared to LEW and FHH 737906 MWF/Hsd Munich Wistar Fromter strain MP:0030661 increased circulating arginine level IAGP N RGD:25314268|PMID:19420905 20210329 RGD compared to FHH 737907 SS.SR-Inha/Jr strain MP:0002834 decreased heart weight induced IAGP XCO:0000022 N RGD:61053|PMID:9722941 19990101 RGD compared to SS/Jr 737907 SS.SR-Inha/Jr strain MP:0002843 decreased systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:61053|PMID:9722941 19990101 RGD compared to SS/Jr 737908 WF/NHsd strain MP:0000208 decreased hematocrit IAGP N RGD:11531111|PMID:3285908 20200623 RGD compared to LE 737908 WF/NHsd strain MP:0000218 increased leukocyte cell number IAGP N RGD:11531112|PMID:3414775 20200623 RGD compared to SD 737908 WF/NHsd strain MP:0001262 decreased body weight IAGP N RGD:11531112|PMID:3414775 20200623 RGD compared to SD 737908 WF/NHsd strain MP:0002599 increased mean platelet volume IAGP N RGD:11531111|PMID:3285908 20160826 RGD compared to LE 737908 WF/NHsd strain MP:0002599 increased mean platelet volume IAGP N RGD:11531112|PMID:3414775 20200623 RGD compared to SD 737908 WF/NHsd strain MP:0003179 thrombocytopenia IAGP N RGD:11531111|PMID:3285908 20160826 RGD compared to LE 737908 WF/NHsd strain MP:0003179 thrombocytopenia IAGP N RGD:11531112|PMID:3414775 20160826 RGD compared to SD 737908 WF/NHsd strain MP:0004499 increased incidence of tumors by chemical induction induced IAGP XCO:0000090 N RGD:631852|PMID:12844486 20200304 RGD compared to WF.WKY-(D5Wox7-D5Uwm37)/Uwm 737908 WF/NHsd strain MP:0005505 thrombocytosis induced IAGP XCO:0000727 N RGD:11531111|PMID:3285908 20200626 RGD compared to untreated WF/Nhsd 737908 WF/NHsd strain MP:0005606 increased bleeding time IAGP N RGD:11531110|PMID:9473225 20160826 RGD compared to Hsd:WI 737908 WF/NHsd strain MP:0008255 decreased megakaryocyte cell number IAGP N RGD:11531112|PMID:3414775 20160826 RGD compared to SD 737908 WF/NHsd strain MP:0010299 increased mammary gland tumor incidence induced IAGP XCO:0000090 N RGD:631852|PMID:12844486 20200304 RGD compared to WF.WKY-(D5Wox7-D5Uwm37)/Uwm 737908 WF/NHsd strain MP:0014060 abnormal platelet alpha-granule morphology IAGP N RGD:11531117|PMID:2040691 20160829 RGD compared to Hsd:WI 737908 WF/NHsd strain MP:0020399 enhanced megakaryocyte emperipolesis IAGP N RGD:11531112|PMID:3414775 20200623 RGD compared to SD 737921 BDIV/lfz strain MP:0004502 decreased incidence of tumors by chemical induction IAGP N RGD:11556249|PMID:21427360 20211222 RGD compared to BDIX inbred strain and BDIX.BDIV-D6Mit1-D6Mgh2/Zte congenic strain 737921 BDIV/lfz strain MP:0009767 decreased susceptibility to xenobiotic induced morbidity/mortality IAGP N RGD:11556249|PMID:21427360 20211222 RGD compared to BDIX inbred strain and BDIX.BDIV-D6Mit1-D6Mgh2/Zte congenic strain 737922 LEW/SsNHsd strain MP:0003023 decreased coronary flow rate induced IAGP XCO:0000464,XCO:0000010 N RGD:1342469|PMID:10749737 20200228 RGD 737922 LEW/SsNHsd strain MP:0003823 increased left ventricle developed pressure induced IAGP XCO:0000464,XCO:0000010 N RGD:1342469|PMID:10749737 20200228 RGD compared to SS/JrHsdMcwi 737922 LEW/SsNHsd strain MP:0003824 decreased left ventricle developed pressure induced IAGP XCO:0000464,XCO:0000010 N RGD:1342469|PMID:10749737 20200228 RGD 737922 LEW/SsNHsd strain MP:0004821 increased susceptibility to experimental autoimmune uveoretinitis induced IAGP XCO:0000288 N RGD:2296064|PMID:18453595 20080630 RGD compared to F344/NHsd 737922 LEW/SsNHsd strain MP:0004821 increased susceptibility to experimental autoimmune uveoretinitis susceptibility IAGP N RGD:2293749|PMID:18281616 20080612 RGD 737922 LEW/SsNHsd strain MP:0005571 decreased lactate dehydrogenase level induced IAGP XCO:0000464,XCO:0000010 N RGD:1342469|PMID:10749737 20200228 RGD compared to SS/JrHsdMcwi 737922 LEW/SsNHsd strain MP:0009764 decreased susceptibility to induced morbidity/mortality induced IAGP XCO:0000668 N RGD:2302114|PMID:17998886 20200330 RGD compared to treated DA/OlaHsd 737926 F344/NCrl strain MP:0001488 increased startle reflex sexual_dimorphism IAGP N RGD:405650204|PMID:21620900 20240419 RGD compared to female 737926 F344/NCrl strain MP:0005319 abnormal enzyme/coenzyme level induces IAGP XCO:0000304 N RGD:127285625|PMID:27856527 20210623 RGD Por 737926 F344/NCrl strain MP:0005319 abnormal enzyme/coenzyme level induces IAGP XCO:0000372,XCO:0000880 N RGD:127285625|PMID:27856527 20210720 RGD Arnt, Por 737926 F344/NCrl strain MP:0005319 abnormal enzyme/coenzyme level induces IAGP XCO:0000879 N RGD:127285625|PMID:27856527 20210720 RGD Arnt 737929 Crl:WI Wistar rats strain MP:0002842 increased systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:68697|PMID:11208766 20200211 RGD compared to no sodium content diet 737930 LEW/Ztm LEW/Ztm strain MP:0003561 rheumatoid arthritis penetrance IAGP XCO:0000263 N RGD:1299867|PMID:15081107 20200720 RGD 737932 LEW/Crl Lewis strain MP:0001260 increased body weight sexual_dimorphism IAGP N RGD:2293121|PMID:18456730 20200211 RGD compared to female LEW/Crl 737932 LEW/Crl Lewis strain MP:0001262 decreased body weight sexual_dimorphism IAGP N RGD:2293121|PMID:18456730 20080513 RGD compared to female LEW-Tg(Ren2)27/Jmul 737932 LEW/Crl Lewis strain MP:0003916 decreased heart left ventricle weight induced IAGP XCO:0000022 N RGD:70460|PMID:11919686 20201123 RGD compared to SS/Jr 737932 LEW/Crl Lewis strain MP:0003916 decreased heart left ventricle weight sexual_dimorphism IAGP N RGD:2293121|PMID:18456730 20200211 RGD compared to female LEW/Crl 737932 LEW/Crl Lewis strain MP:0003918 decreased kidney weight induced IAGP XCO:0000022 N RGD:70460|PMID:11919686 20201123 RGD compared to SS/Jr 737932 LEW/Crl Lewis strain MP:0003918 decreased kidney weight sexual_dimorphism IAGP N RGD:2293121|PMID:18456730 20200211 RGD compared to female LEW/Crl 737932 LEW/Crl Lewis strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:70460|PMID:11919686 20201123 RGD compared to SS/Jr 737932 LEW/Crl Lewis strain MP:0005425 increased macrophage cell number induces IAGP XCO:0000861,XCO:0000266,XCO:0000195 N RGD:38508908|PMID:23664330 20211111 RGD compared to mAb OX8 and 341 treated 737932 LEW/Crl Lewis strain MP:0005583 decreased renin activity sexual_dimorphism IAGP N RGD:2293121|PMID:18456730 20200211 RGD compared to female LEW/Crl in kidney 737932 LEW/Crl Lewis strain MP:0006263 decreased systemic arterial diastolic blood pressure induced IAGP XCO:0000022 N RGD:70460|PMID:11919686 20201123 RGD compared to SS/Jr 737932 LEW/Crl Lewis strain MP:0006264 decreased systemic arterial systolic blood pressure induced IAGP XCO:0000022 N RGD:70460|PMID:11919686 20201123 RGD compared to SS/Jr 737932 LEW/Crl Lewis strain MP:0008074 increased CD4-positive, alpha-beta T cell number induces IAGP XCO:0000861,XCO:0000266,XCO:0000195 N RGD:38508908|PMID:23664330 20211111 RGD compared to mAb OX8,341 treated and CB8KO rat 737932 LEW/Crl Lewis strain MP:0010212 abnormal circulating C-reactive protein level sexual_dimorphism IAGP N RGD:2293121|PMID:18456730 20200211 RGD compared to female LEW/Crl 737932 LEW/Crl Lewis strain MP:0011079 decreased macrophage cytokine production IAGP N RGD:2293336|PMID:18443593 20210107 RGD compared to WKY/NCrl 737932 LEW/Crl Lewis strain MP:0031199 decreased aortic weight induced IAGP XCO:0000022 N RGD:70460|PMID:11919686 20201123 RGD compared to SS/Jr 737950 DA/Ztm strain MP:0000753 paralysis induced IAGP N RGD:1302437|PMID:15240732 20080702 RGD 737950 DA/Ztm strain MP:0003724 increased susceptibility to induced arthritis penetrance IAGP XCO:0000263|XCO:0000280|XCO:0000281,XCO:0000265|XCO:0000266| N RGD:629560|PMID:12571866 20191202 RGD compared to control strain PVG.1AV1 737957 WOKW/K strain MP:0001745 increased circulating corticosterone level induced IAGP XCO:0000798 N RGD:1642517|PMID:17875345 20070925 RGD compared to DA/K 737957 WOKW/K strain MP:0011939 increased food intake IAGP N RGD:1642517|PMID:17875345 20070925 RGD compared to DA/K 737960 Hsd:WI Wistar strain MP:0003023 decreased coronary flow rate induced IAGP XCO:0000464,XCO:0000010 N RGD:1342469|PMID:10749737 20200228 RGD 737960 Hsd:WI Wistar strain MP:0003823 increased left ventricle developed pressure induced IAGP XCO:0000464,XCO:0000010 N RGD:1342469|PMID:10749737 20200228 RGD compared to SS/JrHsdMcwi 737960 Hsd:WI Wistar strain MP:0003824 decreased left ventricle developed pressure induced IAGP XCO:0000464,XCO:0000010 N RGD:1342469|PMID:10749737 20200228 RGD 737960 Hsd:WI Wistar strain MP:0005571 decreased lactate dehydrogenase level induced IAGP XCO:0000464,XCO:0000010 N RGD:1342469|PMID:10749737 20200228 RGD compared to SS/JrHsdMcwi 737962 SPRD/Ztm strain MP:0004499 increased incidence of tumors by chemical induction MODEL: induced IAGP XCO:0000090 N RGD:1599317|PMID:16596452 20200316 RGD compared to 7,12-dimethyltetraphene treated WKY/Ztm 737962 SPRD/Ztm strain MP:0013782 abnormal mammary duct terminal end bud morphology induced IAGP XCO:0000090 N RGD:1643011|PMID:17597107 20200708 RGD compared to WKY 737972 BN/Crl strain MP:0001260 increased body weight sexual_dimorphism IAGP N RGD:4889455|PMID:20878524 20200421 RGD compared to female BN/Crl 737972 BN/Crl strain MP:0004702 increased circulating insulin-like growth factor I level sexual_dimorphism IAGP N RGD:4889455|PMID:20878524 20200421 RGD male compared to female 737972 BN/Crl strain MP:0005137 increased growth hormone level sexual_dimorphism IAGP N RGD:4889455|PMID:20878524 20200421 RGD female compared to male BN/Crl 737972 BN/Crl strain MP:0005139 increased prolactin level sexual_dimorphism IAGP N RGD:4889455|PMID:20878524 20200421 RGD compared to male BN/Crl 737973 Pia21 Pristane induced arthritis QTL 21 qtl MP:0003079 decreased susceptibility to induced joint inflammation IDA N RGD:631850|PMID:12817024 19990101 RGD 737974 Bp161 Blood pressure QTL 161 qtl MP:0002842 increased systemic arterial blood pressure IAGP N RGD:61051|PMID:9774356 19990101 RGD 737975 Bw122 Body weight QTL 122 qtl MP:0001260 increased body weight QTM N RGD:737696|PMID:14756694 19990101 RGD 737976 Pia24 Pristane induced arthritis QTL 24 qtl MP:0002936 joint swelling IAGP N RGD:728382|PMID:14611807 19990101 RGD 737977 Bp160 Blood pressure QTL 160 qtl MP:0002842 increased systemic arterial blood pressure QTM N RGD:61051|PMID:9774356 19990101 RGD 737977 Bp160 Blood pressure QTL 160 qtl MP:0002843 decreased systemic arterial blood pressure QTM N RGD:61051|PMID:9774356 19990101 RGD 737978 Pia23 Pristane induced arthritis QTL 23 qtl MP:0002936 joint swelling IAGP N RGD:631850|PMID:12817024 19990101 RGD 737979 Pia22 Pristane induced arthritis QTL 22 qtl MP:0002933 joint inflammation IAGP N RGD:629560|PMID:12571866 19990101 RGD 738005 Anxrr11 Anxiety related response QTL 11 qtl MP:0001399 hyperactivity IAGP N RGD:737695|PMID:14739700 19990101 RGD 738006 Anxrr14 Anxiety related response QTL 14 qtl MP:0001413 abnormal response to new environment QTM N RGD:731213|PMID:12972953 19990101 RGD 738007 Anxrr7 Anxiety related response QTL 7 qtl MP:0001363 increased anxiety-related response IAGP N RGD:737695|PMID:14739700 19990101 RGD 738007 Anxrr7 Anxiety related response QTL 7 qtl MP:0001402 decreased locomotor activity IAGP N RGD:737695|PMID:14739700 19990101 RGD 738008 Hcar14 Hepatocarcinoma resistance QTL 14 qtl MP:0010265 decreased hepatoma incidence IDA N RGD:737884|PMID:15185337 20111107 RGD 738009 Sach4 Saccharine consumption QTL 4 qtl MP:0002850 saccharin preference IDA N RGD:731213|PMID:12972953 20111114 RGD 738009 Sach4 Saccharine consumption QTL 4 qtl MP:0002850 saccharin preference QTM N RGD:731213|PMID:12972953 19990101 RGD 738010 Lnnr3 Liver neoplastic nodule remodeling QTL 3 qtl MP:0010266 decreased liver tumor incidence IDA N RGD:737884|PMID:15185337 20111107 RGD 738011 Anxrr9 Anxiety related response QTL 9 qtl MP:0001363 increased anxiety-related response IAGP N RGD:737695|PMID:14739700 19990101 RGD 738011 Anxrr9 Anxiety related response QTL 9 qtl MP:0001402 decreased locomotor activity IAGP N RGD:737695|PMID:14739700 19990101 RGD 738012 Anxrr3 Anxiety related response QTL 3 qtl MP:0001363 increased anxiety-related response IAGP N RGD:737695|PMID:14739700 19990101 RGD 738013 Alc15 Alcohol consumption QTL 15 qtl MP:0001425 abnormal alcohol consumption QTM N RGD:731213|PMID:12972953 19990101 RGD 738014 Anxrr15 Anxiety related response QTL 15 qtl MP:0001413 abnormal response to new environment QTM N RGD:731213|PMID:12972953 19990101 RGD 738015 Pia9 Pristane induced arthritis QTL 9 qtl MP:0002933 joint inflammation IAGP N RGD:629560|PMID:12571866 19990101 RGD 738016 Alc16 Alcohol consumption QTL 16 qtl MP:0001987 alcohol preference QTM N RGD:731213|PMID:12972953 19990101 RGD 738017 Hcas7 Hepatocarcinoma susceptibility QTL 7 qtl MP:0010264 increased hepatoma incidence IDA N RGD:737884|PMID:15185337 20111108 RGD 738018 Anxrr4 Anxiety related response QTL 4 qtl MP:0001364 decreased anxiety-related response IAGP N RGD:737695|PMID:14739700 19990101 RGD 738019 Anxrr10 Anxiety related response QTL 10 qtl MP:0001399 hyperactivity IAGP N RGD:737695|PMID:14739700 19990101 RGD 738020 Pia8 Pristane induced arthritis QTL 8 qtl MP:0002936 joint swelling IAGP N RGD:629570|PMID:11090241 19990101 RGD 738021 Hcar13 Hepatocarcinoma resistance QTL 13 qtl MP:0010265 decreased hepatoma incidence IDA N RGD:737884|PMID:15185337 20111107 RGD 738022 Anxrr13 Anxiety related response QTL 13 qtl MP:0001413 abnormal response to new environment QTM N RGD:731213|PMID:12972953 19990101 RGD 738023 Alc17 Alcohol consumption QTL 17 qtl MP:0001987 alcohol preference QTM N RGD:731213|PMID:12972953 19990101 RGD 738024 Sach5 Saccharine consumption QTL 5 qtl MP:0002850 saccharin preference IDA N RGD:731213|PMID:12972953 20111114 RGD 738024 Sach5 Saccharine consumption QTL 5 qtl MP:0002850 saccharin preference QTM N RGD:731213|PMID:12972953 19990101 RGD 738025 Stresp3 Stress response QTL 3 qtl MP:0001363 increased anxiety-related response QTM N RGD:737687|PMID:14722724 19990101 RGD 738025 Stresp3 Stress response QTL 3 qtl MP:0003062 abnormal coping response QTM N RGD:737687|PMID:14722724 19990101 RGD 738026 Lnnr5 Liver neoplastic nodule remodeling QTL 5 qtl MP:0010266 decreased liver tumor incidence IDA N RGD:737884|PMID:15185337 20111107 RGD 738027 Lnnr6 Liver neoplastic nodule remodeling QTL 6 qtl MP:0010266 decreased liver tumor incidence IDA N RGD:737884|PMID:15185337 20111107 RGD 738028 Anxrr12 Anxiety related response QTL 12 qtl MP:0001413 abnormal response to new environment QTM N RGD:731213|PMID:12972953 19990101 RGD 738029 Stresp2 Stress response QTL 2 qtl MP:0001363 increased anxiety-related response QTM N RGD:737687|PMID:14722724 19990101 RGD 738029 Stresp2 Stress response QTL 2 qtl MP:0003062 abnormal coping response QTM N RGD:737687|PMID:14722724 19990101 RGD 738030 Anxrr8 Anxiety related response QTL 8 qtl MP:0001363 increased anxiety-related response IAGP N RGD:737695|PMID:14739700 19990101 RGD 738030 Anxrr8 Anxiety related response QTL 8 qtl MP:0001402 decreased locomotor activity IAGP N RGD:737695|PMID:14739700 19990101 RGD 738031 Alc14 Alcohol consumption QTL 14 qtl MP:0001987 alcohol preference QTM N RGD:731213|PMID:12972953 19990101 RGD 738032 Hcas5 Hepatocarcinoma susceptibility QTL 5 qtl MP:0010264 increased hepatoma incidence IDA N RGD:737884|PMID:15185337 20111108 RGD 738033 Anxrr6 Anxiety related response QTL 6 qtl MP:0001362 abnormal anxiety-related response IAGP N RGD:737695|PMID:14739700 19990101 RGD 738034 Anxrr5 Anxiety related response QTL 5 qtl MP:0001364 decreased anxiety-related response IAGP N RGD:737695|PMID:14739700 19990101 RGD 738035 Stresp1 Stress response QTL 1 qtl MP:0001363 increased anxiety-related response QTM N RGD:737687|PMID:14722724 19990101 RGD 738035 Stresp1 Stress response QTL 1 qtl MP:0003062 abnormal coping response QTM N RGD:737687|PMID:14722724 19990101 RGD 738036 Lnnr4 Liver neoplastic nodule remodeling QTL 4 qtl MP:0010266 decreased liver tumor incidence IDA N RGD:737884|PMID:15185337 20111107 RGD 738037 Hcas6 Hepatocarcinoma susceptibility QTL 6 qtl MP:0010264 increased hepatoma incidence IDA N RGD:737884|PMID:15185337 20111108 RGD 738038 HEP high ethanol preferring strain MP:0001399 hyperactivity IAGP N RGD:731213|PMID:12972953 20200519 RGD compared to WKY 738038 HEP high ethanol preferring strain MP:0001987 alcohol preference IAGP N RGD:731213|PMID:12972953 20200519 RGD compared to WKY 738038 HEP high ethanol preferring strain MP:0002850 saccharin preference IAGP N RGD:731213|PMID:12972953 20200519 RGD compared to WKY 738038 HEP high ethanol preferring strain MP:0003545 increased alcohol consumption IAGP N RGD:731213|PMID:12972953 20200519 RGD compared to WKY 738120 LEW-Tg(HLA-B*2705m1,B2M)133-1TrgTg/Tg strain MP:0001875 testis inflammation IAGP N RGD:731214|PMID:10450519 19990101 RGD 738120 LEW-Tg(HLA-B*2705m1,B2M)133-1TrgTg/Tg strain MP:0002816 colitis IAGP N RGD:731214|PMID:10450519 19990101 RGD 738120 LEW-Tg(HLA-B*2705m1,B2M)133-1TrgTg/Tg strain MP:0002993 autoimmune arthritis IAGP N RGD:731214|PMID:10450519 19990101 RGD 7387227 Uae40 Urinary albumin excretion QTL 40 qtl MP:0002871 albuminuria IAGP N RGD:7365117|PMID:20159938 20131029 RGD 7387235 Uae41 Urinary albumin excretion QTL 41 qtl MP:0002871 albuminuria IAGP N RGD:7365117|PMID:20159938 20131029 RGD 7387267 Uae42 Urinary albumin excretion QTL 42 qtl MP:0002871 albuminuria IAGP N RGD:7365117|PMID:20159938 20131029 RGD 7387280 Uae43 Urinary albumin excretion QTL 43 qtl MP:0002871 albuminuria IAGP N RGD:7365117|PMID:20159938 20131029 RGD 7387283 Uae44 Urinary albumin excretion QTL 44 qtl MP:0002871 albuminuria IAGP N RGD:7365117|PMID:20159938 20131029 RGD 7387289 Uae45 Urinary albumin excretion QTL 45 qtl MP:0002871 albuminuria IAGP N RGD:7365117|PMID:20159938 20131029 RGD 7387292 Kidm42 Kidney mass QTL 42 qtl MP:0003917 increased kidney weight IAGP N RGD:7365117|PMID:20159938 20131029 RGD 7387306 Bw124 Body weight QTL 124 qtl MP:0001260 increased body weight IAGP N RGD:7365117|PMID:20159938 20131029 RGD 7387312 Bw125 Body weight QTL 125 qtl MP:0009304 increased retroperitoneal fat pad weight IAGP N RGD:7365117|PMID:20159938 20131029 RGD 7387318 Stl32 Serum triglyceride level QTL 32 qtl MP:0001552 increased circulating triglyceride level IAGP N RGD:7365117|PMID:20159938 20131029 RGD 7394701 Uae46 Urinary albumin excretion QTL 46 qtl MP:0002871 albuminuria IAGP N RGD:7365117|PMID:20159938 20131030 RGD 7394708 Emca11 Estrogen-induced mammary cancer QTL 11 qtl MP:0001883 increased mammary adenocarcinoma incidence IDA N RGD:7364727|PMID:23151807 20131104 RGD 7394710 Emca12 Estrogen-induced mammary cancer QTL 12 qtl MP:0001883 increased mammary adenocarcinoma incidence IDA N RGD:7364727|PMID:23151807 20131104 RGD 7394712 Emca13 Estrogen-induced mammary cancer QTL 13 qtl MP:0001883 increased mammary adenocarcinoma incidence IDA N RGD:7364727|PMID:23151807 20131104 RGD 7394818 P.NP-(D4Mgh16-D4Rat173)/Iusm strain MP:0001260 increased body weight IAGP N RGD:7394775|PMID:23312492 20131105 RGD 7394826 Bw126 Body weight QTL 126 qtl MP:0001260 increased body weight IAGP N RGD:7394775|PMID:23312492 20131105 RGD 7394837 Memor18 Memory QTL 18 qtl MP:0001463 abnormal spatial learning IDA N RGD:7394833|PMID:23469157 20131107 RGD 7401203 SS.SR-(rs105019230-D17Rat44)/Opaz strain MP:0001463 abnormal spatial learning IAGP N RGD:7394833|PMID:23469157 20131107 RGD compared to Dahl S 7411542 Bw127 Body weight QTL 127 qtl MP:0001260 increased body weight IDA N RGD:7401255|PMID:23596094 20131118 RGD 7411545 Bw128 Body weight QTL 128 qtl MP:0001260 increased body weight IDA N RGD:7401255|PMID:23596094 20131118 RGD 7411547 Bw129 Body weight QTL 129 qtl MP:0001260 increased body weight IDA N RGD:7401255|PMID:23596094 20131118 RGD 7411549 Bw130 Body weight QTL 130 qtl MP:0001260 increased body weight IDA N RGD:7401255|PMID:23596094 20131118 RGD 7411551 Bw131 Body weight QTL 131 qtl MP:0001260 increased body weight IDA N RGD:7401255|PMID:23596094 20131118 RGD 7411555 Bw132 Body weight QTL 132 qtl MP:0001260 increased body weight IDA N RGD:7401255|PMID:23596094 20131118 RGD 7411558 Bw133 Body weight QTL 133 qtl MP:0001260 increased body weight IDA N RGD:7401255|PMID:23596094 20131118 RGD 7411561 Bw134 Body weight QTL 134 qtl MP:0001260 increased body weight IDA N RGD:7401255|PMID:23596094 20131118 RGD 7411564 Bw135 Body weight QTL 135 qtl MP:0001260 increased body weight IDA N RGD:7401255|PMID:23596094 20131118 RGD 7411566 Bw136 Body weight QTL 136 qtl MP:0001260 increased body weight IDA N RGD:7401255|PMID:23596094 20131118 RGD 7411569 Bw137 Body weight QTL 137 qtl MP:0001260 increased body weight IDA N RGD:7401255|PMID:23596094 20131118 RGD 7411571 Bw138 Body weight QTL 138 qtl MP:0001260 increased body weight IDA N RGD:7401255|PMID:23596094 20131118 RGD 7411573 Bw139 Body weight QTL 139 qtl MP:0001260 increased body weight IDA N RGD:7401255|PMID:23596094 20131118 RGD 7411575 Bw140 Body weight QTL 140 qtl MP:0001260 increased body weight IDA N RGD:7401255|PMID:23596094 20131118 RGD 7411577 Bw141 Body weight QTL 141 qtl MP:0001260 increased body weight IDA N RGD:7401255|PMID:23596094 20131118 RGD 7411579 Bw142 Body weight QTL 142 qtl MP:0001260 increased body weight IDA N RGD:7401255|PMID:23596094 20131118 RGD 7411582 Foco3 Food consumption QTL 3 qtl MP:0001260 increased body weight IDA N RGD:7401255|PMID:23596094 20160108 RGD 7411582 Foco3 Food consumption QTL 3 qtl MP:0011939 increased food intake IDA N RGD:7401255|PMID:23596094 20160108 RGD 7411584 Foco4 Food consumption QTL 4 qtl MP:0001260 increased body weight IDA N RGD:7401255|PMID:23596094 20131118 RGD 7411584 Foco4 Food consumption QTL 4 qtl MP:0011939 increased food intake IDA N RGD:7401255|PMID:23596094 20131118 RGD 7411586 Foco5 Food consumption QTL 5 qtl MP:0001260 increased body weight IDA N RGD:7401255|PMID:23596094 20131118 RGD 7411586 Foco5 Food consumption QTL 5 qtl MP:0011939 increased food intake IDA N RGD:7401255|PMID:23596094 20131118 RGD 7411588 Foco6 Food consumption QTL 6 qtl MP:0001260 increased body weight IDA N RGD:7401255|PMID:23596094 20131118 RGD 7411588 Foco6 Food consumption QTL 6 qtl MP:0011939 increased food intake IDA N RGD:7401255|PMID:23596094 20131118 RGD 7411590 Foco7 Food consumption QTL 7 qtl MP:0001260 increased body weight IDA N RGD:7401255|PMID:23596094 20131118 RGD 7411590 Foco7 Food consumption QTL 7 qtl MP:0011939 increased food intake IDA N RGD:7401255|PMID:23596094 20131118 RGD 7411592 Foco8 Food consumption QTL 8 qtl MP:0001260 increased body weight IDA N RGD:7401255|PMID:23596094 20131118 RGD 7411592 Foco8 Food consumption QTL 8 qtl MP:0011939 increased food intake IDA N RGD:7401255|PMID:23596094 20131118 RGD 7411595 Foco9 Food consumption QTL 9 qtl MP:0001260 increased body weight IDA N RGD:7401255|PMID:23596094 20131118 RGD 7411595 Foco9 Food consumption QTL 9 qtl MP:0011939 increased food intake IDA N RGD:7401255|PMID:23596094 20131118 RGD 7411597 Foco10 Food consumption QTL 10 qtl MP:0001260 increased body weight IDA N RGD:7401255|PMID:23596094 20131118 RGD 7411597 Foco10 Food consumption QTL 10 qtl MP:0011939 increased food intake IDA N RGD:7401255|PMID:23596094 20131118 RGD 7411599 Foco11 Food consumption QTL 11 qtl MP:0001260 increased body weight IDA N RGD:7401255|PMID:23596094 20131118 RGD 7411599 Foco11 Food consumption QTL 11 qtl MP:0011939 increased food intake IDA N RGD:7401255|PMID:23596094 20131118 RGD 7411601 Foco12 Food consumption QTL 12 qtl MP:0001260 increased body weight IDA N RGD:7401255|PMID:23596094 20131118 RGD 7411601 Foco12 Food consumption QTL 12 qtl MP:0011939 increased food intake IDA N RGD:7401255|PMID:23596094 20131118 RGD 7411603 Foco13 Food consumption QTL 13 qtl MP:0001260 increased body weight IDA N RGD:7401255|PMID:23596094 20131118 RGD 7411603 Foco13 Food consumption QTL 13 qtl MP:0011939 increased food intake IDA N RGD:7401255|PMID:23596094 20131118 RGD 7411605 Foco14 Food consumption QTL 14 qtl MP:0001260 increased body weight IDA N RGD:7401255|PMID:23596094 20131118 RGD 7411605 Foco14 Food consumption QTL 14 qtl MP:0011939 increased food intake IDA N RGD:7401255|PMID:23596094 20131118 RGD 7411607 Foco15 Food consumption QTL 15 qtl MP:0001260 increased body weight IDA N RGD:7401255|PMID:23596094 20131118 RGD 7411607 Foco15 Food consumption QTL 15 qtl MP:0011939 increased food intake IDA N RGD:7401255|PMID:23596094 20131118 RGD 7411609 Foco16 Food consumption QTL 16 qtl MP:0001260 increased body weight IDA N RGD:7401255|PMID:23596094 20131118 RGD 7411609 Foco16 Food consumption QTL 16 qtl MP:0011939 increased food intake IDA N RGD:7401255|PMID:23596094 20131118 RGD 7411611 Foco17 Food consumption QTL 17 qtl MP:0001260 increased body weight IDA N RGD:7401255|PMID:23596094 20131118 RGD 7411611 Foco17 Food consumption QTL 17 qtl MP:0011939 increased food intake IDA N RGD:7401255|PMID:23596094 20131118 RGD 7411614 Foco18 Food consumption QTL 18 qtl MP:0001260 increased body weight IDA N RGD:7401255|PMID:23596094 20131118 RGD 7411614 Foco18 Food consumption QTL 18 qtl MP:0011939 increased food intake IDA N RGD:7401255|PMID:23596094 20131118 RGD 7411641 Foco19 Food consumption QTL 19 qtl MP:0001260 increased body weight IDA N RGD:7401255|PMID:23596094 20131118 RGD 7411641 Foco19 Food consumption QTL 19 qtl MP:0011939 increased food intake IDA N RGD:7401255|PMID:23596094 20131118 RGD 7411643 Foco20 Food consumption QTL 20 qtl MP:0001260 increased body weight IDA N RGD:7401255|PMID:23596094 20131118 RGD 7411643 Foco20 Food consumption QTL 20 qtl MP:0011939 increased food intake IDA N RGD:7401255|PMID:23596094 20131118 RGD 7411646 Foco21 Food consumption QTL 21 qtl MP:0001260 increased body weight IDA N RGD:7401255|PMID:23596094 20131118 RGD 7411646 Foco21 Food consumption QTL 21 qtl MP:0011939 increased food intake IDA N RGD:7401255|PMID:23596094 20131118 RGD 7411648 Foco22 Food consumption QTL 22 qtl MP:0001260 increased body weight IDA N RGD:7401255|PMID:23596094 20131118 RGD 7411648 Foco22 Food consumption QTL 22 qtl MP:0011939 increased food intake IDA N RGD:7401255|PMID:23596094 20131118 RGD 7411650 Foco23 Food consumption QTL 23 qtl MP:0001260 increased body weight IDA N RGD:7401255|PMID:23596094 20131118 RGD 7411650 Foco23 Food consumption QTL 23 qtl MP:0011939 increased food intake IDA N RGD:7401255|PMID:23596094 20131118 RGD 7411652 Foco24 Food consumption QTL 24 qtl MP:0001260 increased body weight IDA N RGD:7401255|PMID:23596094 20131118 RGD 7411652 Foco24 Food consumption QTL 24 qtl MP:0011939 increased food intake IDA N RGD:7401255|PMID:23596094 20131118 RGD 7411654 Foco25 Food consumption QTL 25 qtl MP:0001260 increased body weight IDA N RGD:7401255|PMID:23596094 20131118 RGD 7411654 Foco25 Food consumption QTL 25 qtl MP:0011939 increased food intake IDA N RGD:7401255|PMID:23596094 20131118 RGD 7411656 Foco26 Food consumption QTL 26 qtl MP:0001260 increased body weight IDA N RGD:7401255|PMID:23596094 20131118 RGD 7411656 Foco26 Food consumption QTL 26 qtl MP:0011939 increased food intake IDA N RGD:7401255|PMID:23596094 20131118 RGD 7411658 Foco27 Food consumption QTL 27 qtl MP:0001260 increased body weight IDA N RGD:7401255|PMID:23596094 20131118 RGD 7411658 Foco27 Food consumption QTL 27 qtl MP:0011939 increased food intake IDA N RGD:7401255|PMID:23596094 20131118 RGD 7411660 Foco28 Food consumption QTL 28 qtl MP:0001260 increased body weight IDA N RGD:7401255|PMID:23596094 20131118 RGD 7411660 Foco28 Food consumption QTL 28 qtl MP:0011939 increased food intake IDA N RGD:7401255|PMID:23596094 20131118 RGD 7411662 Foco29 Food consumption QTL 29 qtl MP:0001260 increased body weight IDA N RGD:7401255|PMID:23596094 20131118 RGD 7411662 Foco29 Food consumption QTL 29 qtl MP:0011939 increased food intake IDA N RGD:7401255|PMID:23596094 20131118 RGD 7411664 Foco30 Food consumption QTL 30 qtl MP:0001260 increased body weight IDA N RGD:7401255|PMID:23596094 20131118 RGD 7411664 Foco30 Food consumption QTL 30 qtl MP:0011939 increased food intake IDA N RGD:7401255|PMID:23596094 20131118 RGD 7411666 Foco31 Food consumption QTL 31 qtl MP:0001260 increased body weight IDA N RGD:7401255|PMID:23596094 20131118 RGD 7411666 Foco31 Food consumption QTL 31 qtl MP:0011939 increased food intake IDA N RGD:7401255|PMID:23596094 20131118 RGD 7411668 Foco32 Food consumption QTL 32 qtl MP:0001260 increased body weight IDA N RGD:7401255|PMID:23596094 20131118 RGD 7411668 Foco32 Food consumption QTL 32 qtl MP:0011939 increased food intake IDA N RGD:7401255|PMID:23596094 20131118 RGD 7411676 SHRSP.WKY-(D3Mgh16-D3Rat114)/Gcrc strain MP:0002135 abnormal kidney morphology IAGP N RGD:7401270|PMID:23648703 20201005 RGD compared to WKY/Gcrc 7411676 SHRSP.WKY-(D3Mgh16-D3Rat114)/Gcrc strain MP:0002834 decreased heart weight IAGP N RGD:13432198|PMID:27755386 20170926 RGD as compared to SHRSP/Gcrc 7411676 SHRSP.WKY-(D3Mgh16-D3Rat114)/Gcrc strain MP:0003916 decreased heart left ventricle weight IAGP N RGD:13432198|PMID:27755386 20170926 RGD as compared to SHRSP/Gcrc 7411676 SHRSP.WKY-(D3Mgh16-D3Rat114)/Gcrc strain MP:0003918 decreased kidney weight IAGP N RGD:13432198|PMID:27755386 20170926 RGD compared to SHRSP/Gcrc 7411676 SHRSP.WKY-(D3Mgh16-D3Rat114)/Gcrc strain MP:0006263 decreased systemic arterial diastolic blood pressure IAGP N RGD:13432198|PMID:27755386 20170926 RGD as compared to SHRSP/Gcrc 7411676 SHRSP.WKY-(D3Mgh16-D3Rat114)/Gcrc strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:13432198|PMID:27755386 20170926 RGD as compared to SHRSP/Gcrc 7411676 SHRSP.WKY-(D3Mgh16-D3Rat114)/Gcrc strain MP:0006266 decreased pulse pressure IAGP N RGD:13432198|PMID:27755386 20170926 RGD as compared to SHRSP/Gcrc 7411676 SHRSP.WKY-(D3Mgh16-D3Rat114)/Gcrc strain MP:0006266 decreased pulse pressure IAGP N RGD:7401270|PMID:23648703 20131118 RGD compared to SHRSP/Gcrc 7411676 SHRSP.WKY-(D3Mgh16-D3Rat114)/Gcrc strain MP:0010757 decreased right ventricle diastolic pressure IAGP N RGD:7401270|PMID:23648703 20131118 RGD compared to SHRSP/Gcrc 7411676 SHRSP.WKY-(D3Mgh16-D3Rat114)/Gcrc strain MP:0010759 decreased right ventricle systolic pressure IAGP N RGD:7401270|PMID:23648703 20131118 RGD compared to SHRSP/Gcrc 7411679 SHRSP.WKY-(D2Rat13-D2Rat157)(D3Mgh16-D3Rat114)/Gcrc strain MP:0002135 abnormal kidney morphology IAGP N RGD:7401270|PMID:23648703 20201005 RGD compared to WKY/Gcrc 7411679 SHRSP.WKY-(D2Rat13-D2Rat157)(D3Mgh16-D3Rat114)/Gcrc strain MP:0006266 decreased pulse pressure IAGP N RGD:7401270|PMID:23648703 20201005 RGD compared to SHRSP/Gcrc 7411679 SHRSP.WKY-(D2Rat13-D2Rat157)(D3Mgh16-D3Rat114)/Gcrc strain MP:0010757 decreased right ventricle diastolic pressure IAGP N RGD:7401270|PMID:23648703 20131118 RGD compared to SHRSP/Gcrc 7411679 SHRSP.WKY-(D2Rat13-D2Rat157)(D3Mgh16-D3Rat114)/Gcrc strain MP:0010759 decreased right ventricle systolic pressure IAGP N RGD:7401270|PMID:23648703 20131118 RGD compared to SHRSP/Gcrc 7411705 SHR.SHRSP-(D1Rat93-D1Rat269)(D18Rat73-D18Rat11)/Izm strain MP:0002842 increased systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:7411685|PMID:23690346 20131119 RGD compared to SHR and baseline 7411707 SHRSP.SHR-(D1Mgh5-D1Got87)/Izm strain MP:0002843 decreased systemic arterial blood pressure IAGP N RGD:7411685|PMID:23690346 20131119 RGD compared to SHRSP/Izm 7411709 SHRSP.SHR-(D1Mit30-D1Rat269)/Izm strain MP:0002843 decreased systemic arterial blood pressure IAGP N RGD:7411685|PMID:23690346 20131119 RGD compared to SHRSP/Izm 7411712 Strs4 Sensitivity to stroke QTL 4 qtl MP:0006080 brain ischemia IDA N RGD:7411685|PMID:23690346 20131119 RGD 7411719 Strs5 Sensitivity to stroke QTL 5 qtl MP:0006080 brain ischemia IDA N RGD:7411685|PMID:23690346 20131119 RGD 7411722 Strs6 Sensitivity to stroke QTL 6 qtl MP:0006080 brain ischemia IDA N RGD:7411685|PMID:23690346 20131119 RGD 7411725 Strs7 Sensitivity to stroke QTL 7 qtl MP:0002842 increased systemic arterial blood pressure IDA N RGD:7411685|PMID:23690346 20131119 RGD 7411725 Strs7 Sensitivity to stroke QTL 7 qtl MP:0006080 brain ischemia IDA N RGD:7411685|PMID:23690346 20131119 RGD 7421599 SS.LEW-(D1Chm64-D1Rat19)/Ayd strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:7421500|PMID:23814039 20131211 RGD compared to parental SS/Jr 7421603 SS.LEW-(D1Rat320-D1Mgh32)/Ayd strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:7421500|PMID:23814039 20131211 RGD compared to parental SS/Jr 7421606 SS.LEW-(D1Uia4-D1Rat320)/Ayd strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:7421500|PMID:23814039 20131211 RGD compared to parental SS/Jr 7421610 SS.LEW-(D5Mit5-D5M4Mit14)/Ayd strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:7421500|PMID:23814039 20131211 RGD 7421612 SS.LEW-(D16Chm48-D16Chm60)/Ayd strain MP:0002625 heart left ventricle hypertrophy IAGP XCO:0000022 N RGD:8657131|PMID:23442991 20210113 RGD compared to Lewis 7421612 SS.LEW-(D16Chm48-D16Chm60)/Ayd strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:7421500|PMID:23814039 20131211 RGD compared to parental SS/Jr 7421612 SS.LEW-(D16Chm48-D16Chm60)/Ayd strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:8657131|PMID:23442991 20210113 RGD compared to SS/JrHsd 7421617 SS.LEW-(D17Chm14-D17Rat65)/Ayd strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:7421500|PMID:23814039 20131211 RGD 7421619 SS.LEW-(D17Chm85-D17Chm71)/Ayd strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:7421500|PMID:23814039 20131211 RGD 7421621 SS.LEW-(D17Chm131-D17Chm93)/Ayd strain MP:0002625 heart left ventricle hypertrophy IAGP XCO:0000022 N RGD:8657131|PMID:23442991 20210113 RGD compared to Lewis 7421621 SS.LEW-(D17Chm131-D17Chm93)/Ayd strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:7421500|PMID:23814039 20131211 RGD compared to parental SS/Jr 7421621 SS.LEW-(D17Chm131-D17Chm93)/Ayd strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:8657131|PMID:23442991 20210113 RGD compared to SS/JrHsd 7421623 SS.LEW-(D17Rat84-D17Chm17)/Ayd strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:7421500|PMID:23814039 20131211 RGD compared to parental SS/Jr 7421626 Bp360 Blood pressure QTL 360 qtl MP:0004876 decreased mean systemic arterial blood pressure IDA N RGD:7421500|PMID:23814039 20131211 RGD Induced 7421628 Bp361 Blood pressure QTL 361 qtl MP:0004876 decreased mean systemic arterial blood pressure IDA N RGD:7421500|PMID:23814039 20131211 RGD Induced 7421630 Bp362 Blood pressure QTL 362 qtl MP:0004876 decreased mean systemic arterial blood pressure IDA N RGD:7421500|PMID:23814039 20131211 RGD Induced 7421634 SS.MNS-(D2Got93-D2Rat222)/Ayd strain MP:0002843 decreased systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:7421631|PMID:19461651 20131206 RGD compared to parental SS/Jr 7421636 SS.MNS-(D2Chm90-D2Rat38)/Ayd strain MP:0002625 heart left ventricle hypertrophy induced IAGP XCO:0000022 N RGD:7421631|PMID:19461651 20201215 RGD compared to C2S.M21 7421638 SS.MNS-(D2Chm381-D2Chm225)/Ayd strain MP:0002843 decreased systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:7421631|PMID:19461651 20131206 RGD compared to parental SS/Jr 7421640 SS.MNS-(D2Rat155-D2Chm161)/Ayd strain MP:0002843 decreased systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:7421631|PMID:19461651 20131206 RGD compared to parental SS/Jr 7421640 SS.MNS-(D2Rat155-D2Chm161)/Ayd strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:8657131|PMID:23442991 20210113 RGD compared to SS/JrHsd 7421643 SS.MNS-(D2Chm254-D2Chm161)/Ayd strain MP:0002843 decreased systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:7421631|PMID:19461651 20131206 RGD compared to parental SS/Jr 7421643 SS.MNS-(D2Chm254-D2Chm161)/Ayd strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:8657131|PMID:23442991 20210113 RGD compared to SS/JrHsd 7421645 SS.MNS-(D2Rat155-D2Chm419)/Ayd strain MP:0002843 decreased systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:7421631|PMID:19461651 20131206 RGD compared to parental SS/Jr 7421647 SS.MNS-(D2Chm161-D2Chm410)/Ayd strain MP:0002843 decreased systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:7421631|PMID:19461651 20131206 RGD compared to parental SS/Jr 7421649 SS.MNS-(D2Chm153-D2Chm410)/Ayd strain MP:0002843 decreased systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:7421631|PMID:19461651 20131206 RGD compared to parental SS/Jr 7421654 SS.MNS-(D2Chm366-D2Rat52)/Ayd strain MP:0002843 decreased systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:7421631|PMID:19461651 20131206 RGD compared to parental SS/Jr 7421654 SS.MNS-(D2Chm366-D2Rat52)/Ayd strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:8657131|PMID:23442991 20210113 RGD compared to SS/JrHsd 7488904 Bp363 Blood pressure QTL 363 qtl MP:0002843 decreased systemic arterial blood pressure IDA N RGD:7421631|PMID:19461651 20131206 RGD as compared to parental SS/Jr 7488925 Bp364 Blood pressure QTL 364 qtl MP:0002843 decreased systemic arterial blood pressure IDA N RGD:7421631|PMID:19461651 20131206 RGD as compared to parental SS/Jr 7488927 Bp365 Blood pressure QTL 365 qtl MP:0002843 decreased systemic arterial blood pressure IDA N RGD:7421631|PMID:19461651 20131206 RGD as compared to parental SS/Jr 7488929 Bp366 Blood pressure QTL 366 qtl MP:0002843 decreased systemic arterial blood pressure IDA N RGD:7421631|PMID:19461651 20131206 RGD as compared to parental SS/Jr 7488931 Bp367 Blood pressure QTL 367 qtl MP:0002843 decreased systemic arterial blood pressure IDA N RGD:7421631|PMID:19461651 20131206 RGD as compared to parental SS/Jr 7488933 Bp368 Blood pressure QTL 368 qtl MP:0002843 decreased systemic arterial blood pressure IDA N RGD:7421631|PMID:19461651 20131206 RGD as compared to parental SS/Jr 7488963 Bp369 Blood pressure QTL 369 qtl MP:0004876 decreased mean systemic arterial blood pressure IDA N RGD:7421500|PMID:23814039 20131211 RGD Induced 7488966 Bp370 Blood pressure QTL 370 qtl MP:0004876 decreased mean systemic arterial blood pressure IDA N RGD:7421500|PMID:23814039 20131211 RGD Induced 7771589 SS.SR-(D2Rat352-rs63922710)/Opaz strain MP:0004876 decreased mean systemic arterial blood pressure IAGP N RGD:7495755|PMID:23861781 20131220 RGD compared to SS/JrHsd 7771589 SS.SR-(D2Rat352-rs63922710)/Opaz strain MP:0006263 decreased systemic arterial diastolic blood pressure IAGP N RGD:7495755|PMID:23861781 20131220 RGD compared to SS/JrHsd 7771589 SS.SR-(D2Rat352-rs63922710)/Opaz strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:7495755|PMID:23861781 20131220 RGD compared to SS/JrHsd 7771589 SS.SR-(D2Rat352-rs63922710)/Opaz strain MP:0006266 decreased pulse pressure IAGP N RGD:7495755|PMID:23861781 20201005 RGD compared to SS/JrHsd 7771589 SS.SR-(D2Rat352-rs63922710)/Opaz strain MP:0012307 impaired spatial learning sexual_dimorphism IAGP N RGD:7495755|PMID:23861781 20131220 RGD in males compared to SS/JrHsd 7771603 Bp371 Blood pressure QTL 371 qtl MP:0004876 decreased mean systemic arterial blood pressure IAGP N RGD:7495755|PMID:23861781 20131220 RGD 7771603 Bp371 Blood pressure QTL 371 qtl MP:0006263 decreased systemic arterial diastolic blood pressure IAGP N RGD:7495755|PMID:23861781 20131220 RGD 7771603 Bp371 Blood pressure QTL 371 qtl MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:7495755|PMID:23861781 20131220 RGD 7771605 Memor19 Memory QTL 19 qtl MP:0012307 impaired spatial learning IAGP N RGD:7495755|PMID:23861781 20131220 RGD 7771610 SHRSP-Chr 1F344/Rkb strain MP:0001260 increased body weight IAGP N RGD:7771608|PMID:23901062 20210108 RGD compared to F344/DuCrl 7771610 SHRSP-Chr 1F344/Rkb strain MP:0001260 increased body weight induced IAGP XCO:0000795 N RGD:7771608|PMID:23901062 20131220 RGD compared to F344/DuCrl 7771610 SHRSP-Chr 1F344/Rkb strain MP:0003915 increased heart left ventricle weight IAGP N RGD:7771608|PMID:23901062 20210108 RGD compared to F344/DuCrl 7771610 SHRSP-Chr 1F344/Rkb strain MP:0003915 increased heart left ventricle weight induced IAGP XCO:0000795 N RGD:7771608|PMID:23901062 20210108 RGD compared to F344/DuCrl 7771610 SHRSP-Chr 1F344/Rkb strain MP:0003916 decreased heart left ventricle weight IAGP N RGD:7771608|PMID:23901062 20131220 RGD compared to SHRSP 7771610 SHRSP-Chr 1F344/Rkb strain MP:0004875 increased mean systemic arterial blood pressure IAGP N RGD:7771608|PMID:23901062 20201221 RGD compared to F344 7771610 SHRSP-Chr 1F344/Rkb strain MP:0004875 increased mean systemic arterial blood pressure induced IAGP XCO:0000795 N RGD:7771608|PMID:23901062 20210108 RGD compared to F344/DuCrl 7771612 Cm80 Cardiac mass QTL 80 qtl MP:0002625 heart left ventricle hypertrophy IAGP N RGD:7771608|PMID:23901062 20131220 RGD 7771612 Cm80 Cardiac mass QTL 80 qtl MP:0003916 decreased heart left ventricle weight IAGP N RGD:7771608|PMID:23901062 20131220 RGD 7794706 SS.LEW-(D5Mco39-D5Mco41)(D5Mco42-D5Mco47)/Mco strain MP:0004876 decreased mean systemic arterial blood pressure IAGP N RGD:7495753|PMID:23757393 20140109 RGD compared to SS/JrMco 7794706 SS.LEW-(D5Mco39-D5Mco41)(D5Mco42-D5Mco47)/Mco strain MP:0006263 decreased systemic arterial diastolic blood pressure IAGP N RGD:7495753|PMID:23757393 20140109 RGD compared to SS/JrMco 7794706 SS.LEW-(D5Mco39-D5Mco41)(D5Mco42-D5Mco47)/Mco strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:7495753|PMID:23757393 20140109 RGD compared to SS/JrMco 7794706 SS.LEW-(D5Mco39-D5Mco41)(D5Mco42-D5Mco47)/Mco strain MP:0006266 decreased pulse pressure IAGP N RGD:7495753|PMID:23757393 20140109 RGD compared to SS/JrMco 7794739 Bp372 Blood pressure QTL 372 qtl MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:7495753|PMID:23757393 20140109 RGD 7794743 Bp373 Blood pressure QTL 373 qtl MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:7495753|PMID:23757393 20140109 RGD 7794784 Mcs31 Mammary carcinoma susceptibility QTL 31 qtl MP:0010299 increased mammary gland tumor incidence IDA N RGD:7794780|PMID:23967281 20140113 RGD 7794788 Mcs32 Mammary carcinoma susceptibility QTL 32 qtl MP:0010299 increased mammary gland tumor incidence IDA N RGD:7794780|PMID:23967281 20140113 RGD 7794791 Mcs33 Mammary carcinoma susceptibility QTL 33 qtl MP:0010299 increased mammary gland tumor incidence IDA N RGD:7794780|PMID:23967281 20140113 RGD 7794793 Mcs34 Mammary carcinoma susceptibility QTL 34 qtl MP:0010299 increased mammary gland tumor incidence IDA N RGD:7794780|PMID:23967281 20140113 RGD 7800671 F344-Sv2am1Kyo strain MP:0002906 increased susceptibility to pharmacologically induced seizures IMP N RGD:12792961|PMID:27265781 20170317 RGD 7800671 F344-Sv2am1Kyo strain MP:0020424 increased kindling response IMP N RGD:12792961|PMID:27265781 20170317 RGD 8142383 SHRSP/BbbUtx strain MP:0002494 increased IgM level IAGP N RGD:150429819|PMID:32075490 20211002 RGD compared to SHR/Utx renal anti-dsDNA antibodies 8142383 SHRSP/BbbUtx strain MP:0002871 albuminuria IAGP N RGD:150429819|PMID:32075490 20211002 RGD compared to SHR/Utx, SHRSP.SHR-(rs197197017-rs198445122)/Utx 8142383 SHRSP/BbbUtx strain MP:0004974 decreased regulatory T cell number IAGP N RGD:150429819|PMID:32075490 20211002 RGD compared to SHR/Utx, SHRSP.SHR-(rs197197017-rs198445122)/Utx kidney 8142383 SHRSP/BbbUtx strain MP:0005014 increased B cell number IAGP N RGD:150429819|PMID:32075490 20211002 RGD compared to SHR/Utx, SHRSP.SHR-(rs197197017-rs198445122)/Utx kidney 8142383 SHRSP/BbbUtx strain MP:0005015 increased T cell number IAGP N RGD:150429819|PMID:32075490 20211002 RGD compared to SHR/Utx, SHRSP.SHR-(rs197197017-rs198445122)/Utx kidney 8142383 SHRSP/BbbUtx strain MP:0005095 decreased T cell proliferation IAGP N RGD:150429819|PMID:32075490 20211002 RGD compared to SHR/Utx, SHRSP.SHR-(rs197197017-rs198445122)/Utx 8142383 SHRSP/BbbUtx strain MP:0005325 abnormal renal glomerulus morphology IAGP N RGD:150429819|PMID:32075490 20211002 RGD compared to SHR/Utx, SHRSP.SHR-(rs197197017-rs198445122)/Utx 8142383 SHRSP/BbbUtx strain MP:0006414 decreased T cell apoptosis IAGP N RGD:150429819|PMID:32075490 20211002 RGD compared to SHR/Utx 8142383 SHRSP/BbbUtx strain MP:0008074 increased CD4-positive, alpha-beta T cell number IAGP N RGD:150429819|PMID:32075490 20211002 RGD compared to SHR/Utx, SHRSP.SHR-(rs197197017-rs198445122)/Utx kidney 8142383 SHRSP/BbbUtx strain MP:0008078 increased CD8-positive, alpha-beta T cell number IAGP N RGD:150429819|PMID:32075490 20211002 RGD compared to SHR/Utx, SHRSP.SHR-(rs197197017-rs198445122)/Utx kidney 8142383 SHRSP/BbbUtx strain MP:0008567 decreased interferon-gamma secretion IAGP N RGD:150429819|PMID:32075490 20211002 RGD compared to SHR/Utx, SHRSP.SHR-(rs197197017-rs198445122)/Utx T cells 8142383 SHRSP/BbbUtx strain MP:0008688 decreased interleukin-2 secretion IAGP N RGD:150429819|PMID:32075490 20211002 RGD compared to SHR/Utx, SHRSP.SHR-(rs197197017-rs198445122)/Utx T cells 8142383 SHRSP/BbbUtx strain MP:0011405 tubulointerstitial nephritis IAGP N RGD:150429819|PMID:32075490 20211002 RGD compared to SHR/Utx, SHRSP.SHR-(rs197197017-rs198445122)/Utx 8142383 SHRSP/BbbUtx strain MP:0011854 cerebral edema IAGP XCO:0000795 N RGD:150429755|PMID:31608789 20210927 RGD compared to SHRSP.SHR-(rs198233821-rs198932221)/Utx 8142383 SHRSP/BbbUtx strain MP:0020879 abnormal calcium level IAGP N RGD:150429819|PMID:32075490 20211002 RGD compared to SHR/Utx, SHRSP.SHR-(rs197197017-rs198445122)/Utx CD4+ T cells 8142383 SHRSP/BbbUtx strain MP:0020989 increased urine lipocalin 2 level IAGP N RGD:150429819|PMID:32075490 20211002 RGD compared to SHR/Utx, SHRSP.SHR-(rs197197017-rs198445122)/Utx 8142383 SHRSP/BbbUtx strain MP:0020992 increased urine HAVCR1 level IAGP N RGD:150429819|PMID:32075490 20211002 RGD compared to SHR/Utx, SHRSP.SHR-(rs197197017-rs198445122)/Utx 8142383 SHRSP/BbbUtx strain MP:0020996 increased urine osteopontin level IAGP N RGD:150429819|PMID:32075490 20211002 RGD compared to SHR/Utx, SHRSP.SHR-(rs197197017-rs198445122)/Utx 8142385 SHR/Utx strain MP:0020988 decreased urine lipocalin 2 level IAGP N RGD:14348961|PMID:29437896 20210216 RGD males compared to SHRSP/BbbUtx males 8142385 SHR/Utx strain MP:0020991 decreased urine HAVCR1 level IAGP N RGD:14348961|PMID:29437896 20210216 RGD males compared to SHRSP/BbbUtx males 8142385 SHR/Utx strain MP:0020995 decreased urine osteopontin level IAGP N RGD:14348961|PMID:29437896 20210216 RGD males compared to SHRSP/BbbUtx males 8549776 F344-Lepm1Kyo F344 OB rat strain MP:0001552 increased circulating triglyceride level IMP N RGD:8549777|PMID:23800849 20170317 RGD 8549776 F344-Lepm1Kyo F344 OB rat strain MP:0005178 increased circulating cholesterol level IMP N RGD:8549777|PMID:23800849 20170317 RGD 8549776 F344-Lepm1Kyo F344 OB rat strain MP:0009355 increased liver triglyceride level IMP N RGD:8549777|PMID:23800849 20170317 RGD 8551785 SS.LEW-(D18Wox7-D18Rat67)/Ayd strain MP:0002843 decreased systemic arterial blood pressure IAGP N RGD:8657072|PMID:21602714 20140530 RGD as compared to parental SS/Jr 8551787 SS.LEW-(D18Rat55-D18Mgh2)/Ayd strain MP:0002843 decreased systemic arterial blood pressure IAGP N RGD:8657072|PMID:21602714 20140530 RGD as compared to parental SS/Jr 8551787 SS.LEW-(D18Rat55-D18Mgh2)/Ayd strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:8657131|PMID:23442991 20210113 RGD compared to SS/JrHsd 8551789 SS.LEW-(D18Chm59-D18Rat1)/Ayd strain MP:0002843 decreased systemic arterial blood pressure IAGP N RGD:8657072|PMID:21602714 20140530 RGD as compared to parental SS/Jr 8552275 F344-Lgi1m1Kyo strain MP:0001496 audiogenic seizures IMP XCO:0000048 N RGD:14995940|PMID:30813600 20191105 RGD compared to F344/NSlc 8552275 F344-Lgi1m1Kyo strain MP:0002083 premature death IMP N RGD:12792971|PMID:22589250 20170317 RGD DNA:missense mutation:cds:p.L385R (c.1154T>G)(Lgi1) 8552275 F344-Lgi1m1Kyo strain MP:0012349 increased susceptibility to induction of seizure by inducing agent IMP N RGD:12792971|PMID:22589250 20170317 RGD DNA:missense mutation:cds:p.L385R (c.1154T>G)(Lgi1) 8552298 DA-Tyrem1Kyo strain MP:0005171 absent coat pigmentation IMP N RGD:12792973|PMID:23409244 20170317 RGD DNA:deletion:cds: 8552341 DA.PVG.1AV1-(D10Got6-D10Rat184)/Kini strain MP:0010539 decreased level of surface class II molecules IAGP N RGD:7242893|PMID:18292553 20170825 RGD 8552782 Vie1 Viral induced encephalitis QTL 1 qtl MP:0001847 brain inflammation IDA N RGD:7240516|PMID:22761571 20140429 RGD 8552791 Vie2 Viral induced encephalitis QTL 2 qtl MP:0001847 brain inflammation IDA N RGD:7240516|PMID:22761571 20140429 RGD 8552796 Vie3 Viral induced encephalitis QTL 3 qtl MP:0001847 brain inflammation IDA N RGD:7240516|PMID:22761571 20140429 RGD 8552801 Bw143 Body weight QTL 143 qtl MP:0001259 abnormal body weight IDA N RGD:7240516|PMID:22761571 20140429 RGD 8552803 Bw144 Body weight QTL 144 qtl MP:0001259 abnormal body weight IDA N RGD:7240516|PMID:22761571 20140429 RGD 8552805 Bw145 Body weight QTL 145 qtl MP:0001259 abnormal body weight IDA N RGD:7240516|PMID:22761571 20140429 RGD 8552807 Vie4 Viral induced encephalitis QTL 4 qtl MP:0001847 brain inflammation IDA N RGD:7240516|PMID:22761571 20140429 RGD 8552809 Vie5 Viral induced encephalitis QTL 5 qtl MP:0001847 brain inflammation IDA N RGD:7240516|PMID:22761571 20140429 RGD 8552891 Epfw5 Epididymal fat weight QTL 5 qtl MP:0009289 decreased epididymal fat pad weight IDA N RGD:8552892|PMID:24099777 20140430 RGD 8552900 Pigfal1 Plasma insulin-like growth factor 1 level QTL 1 qtl MP:0004700 abnormal circulating insulin-like growth factor I level IDA N RGD:7794844|PMID:24028904 20140501 RGD 8552903 Pigfal2 Plasma insulin-like growth factor 1 level QTL 2 qtl MP:0004700 abnormal circulating insulin-like growth factor I level IDA N RGD:7794844|PMID:24028904 20140501 RGD 8552906 Pigfal3 Plasma insulin-like growth factor 1 level QTL 3 qtl MP:0004700 abnormal circulating insulin-like growth factor I level IDA N RGD:7794844|PMID:24028904 20140501 RGD 8552908 Pigfal4 Plasma insulin-like growth factor 1 level QTL 4 qtl MP:0004700 abnormal circulating insulin-like growth factor I level IDA N RGD:7794844|PMID:24028904 20140501 RGD 8552910 Pigfal5 Plasma insulin-like growth factor 1 level QTL 5 qtl MP:0004700 abnormal circulating insulin-like growth factor I level IDA N RGD:7794844|PMID:24028904 20140501 RGD 8552912 Pigfal6 Plasma insulin-like growth factor 1 level QTL 6 qtl MP:0004700 abnormal circulating insulin-like growth factor I level IDA N RGD:7794844|PMID:24028904 20140501 RGD 8552918 Pigfal7 Plasma insulin-like growth factor 1 level QTL 7 qtl MP:0004700 abnormal circulating insulin-like growth factor I level IDA N RGD:7794844|PMID:24028904 20140501 RGD 8552920 Pigfal8 Plasma insulin-like growth factor 1 level QTL 8 qtl MP:0004700 abnormal circulating insulin-like growth factor I level IDA N RGD:7794844|PMID:24028904 20140501 RGD 8552928 Pigfal9 Plasma insulin-like growth factor 1 level QTL 9 qtl MP:0004700 abnormal circulating insulin-like growth factor I level IDA N RGD:7794844|PMID:24028904 20140501 RGD 8552935 Pigfal10 Plasma insulin-like growth factor 1 level QTL 10 qtl MP:0004700 abnormal circulating insulin-like growth factor I level IDA N RGD:7794844|PMID:24028904 20140501 RGD 8552948 Pigfal11 Plasma insulin-like growth factor 1 level QTL 11 qtl MP:0004700 abnormal circulating insulin-like growth factor I level IDA N RGD:7794844|PMID:24028904 20140501 RGD 8552950 Pigfal12 Plasma insulin-like growth factor 1 level QTL 12 qtl MP:0004700 abnormal circulating insulin-like growth factor I level IDA N RGD:7794844|PMID:24028904 20140501 RGD 8552952 Pigfal13 Plasma insulin-like growth factor 1 level QTL 13 qtl MP:0004700 abnormal circulating insulin-like growth factor I level IDA N RGD:7794844|PMID:24028904 20140501 RGD 8552954 Pigfal14 Plasma insulin-like growth factor 1 level QTL 14 qtl MP:0004700 abnormal circulating insulin-like growth factor I level IDA N RGD:7794844|PMID:24028904 20140501 RGD 8552960 Pigfal15 Plasma insulin-like growth factor 1 level QTL 15 qtl MP:0004700 abnormal circulating insulin-like growth factor I level IDA N RGD:7794844|PMID:24028904 20140501 RGD 8552962 Pigfal16 Plasma insulin-like growth factor 1 level QTL 16 qtl MP:0004700 abnormal circulating insulin-like growth factor I level IDA N RGD:7794844|PMID:24028904 20140501 RGD 8552964 Pigfal17 Plasma insulin-like growth factor 1 level QTL 17 qtl MP:0004700 abnormal circulating insulin-like growth factor I level IDA N RGD:7794844|PMID:24028904 20140501 RGD 8552966 Pigfal18 Plasma insulin-like growth factor 1 level QTL 18 qtl MP:0004700 abnormal circulating insulin-like growth factor I level IDA N RGD:7794844|PMID:24028904 20140501 RGD 8552968 Pigfal19 Plasma insulin-like growth factor 1 level QTL 19 qtl MP:0004700 abnormal circulating insulin-like growth factor I level IDA N RGD:7794844|PMID:24028904 20140501 RGD 8553187 FHH.BN(D14Rat98-D14Hmgc4)/Mcwi strain MP:0008139 fused podocyte foot processes ameliorates IAGP N RGD:9685539|PMID:25273069 20210826 RGD compared to FHH 8553187 FHH.BN(D14Rat98-D14Hmgc4)/Mcwi strain MP:0011856 abnormal glomerular filtration barrier function IAGP N RGD:9685539|PMID:25273069 20210826 RGD compared to BN 8553187 FHH.BN(D14Rat98-D14Hmgc4)/Mcwi strain MP:0011856 abnormal glomerular filtration barrier function ameliorates IAGP N RGD:9685539|PMID:25273069 20210826 RGD compared to FHH 8655649 Arrd1 Age-related retinal degeneration QTL 1 qtl MP:0003727 abnormal retina layer morphology IDA N RGD:7794750|PMID:22300709 20140521 RGD 8655655 Arrd2 Age-related retinal degeneration QTL 2 qtl MP:0003727 abnormal retina layer morphology IDA N RGD:7794750|PMID:22300709 20140521 RGD 8655855 Arrd3 Age-related retinal degeneration QTL 3 qtl MP:0001303 abnormal lens morphology IDA N RGD:7794750|PMID:22300709 20140521 RGD 8655906 Rf60 Renal function QTL 60 qtl MP:0005528 decreased renal glomerular filtration rate IDA N RGD:8552897|PMID:24192394 20140523 RGD 8655945 Rf61 Renal function QTL 61 qtl MP:0005528 decreased renal glomerular filtration rate IDA N RGD:8552897|PMID:24192394 20140523 RGD 8655949 Rf62 Renal function QTL 62 qtl MP:0005565 increased blood urea nitrogen level IDA N RGD:8552897|PMID:24192394 20140523 RGD 8655951 Rf63 Renal function QTL 63 qtl MP:0005565 increased blood urea nitrogen level IDA N RGD:8552897|PMID:24192394 20140523 RGD 8655959 Pur32 Proteinuria QTL 32 qtl MP:0002962 increased urine protein level IDA N RGD:8552897|PMID:24192394 20140523 RGD 8655961 Kidm43 Kidney mass QTL 43 qtl MP:0003917 increased kidney weight IDA N RGD:8552897|PMID:24192394 20140523 RGD 8655992 W-LeprfaNin strain MP:0001260 increased body weight IAGP N RGD:8655976|PMID:19369235 20140527 RGD compared to W-Lepr+/+/Nin 8655992 W-LeprfaNin strain MP:0001262 decreased body weight induced IAGP XCO:0000468 N RGD:8657053|PMID:23036575 20200313 RGD 8655992 W-LeprfaNin strain MP:0001326 retina degeneration IAGP N RGD:8655976|PMID:19369235 20140527 RGD compared to W-Lepr+/+/Nin 8655992 W-LeprfaNin strain MP:0001327 decreased retina photoreceptor cell number IAGP N RGD:8655976|PMID:19369235 20190729 RGD 8655992 W-LeprfaNin strain MP:0003674 oxidative stress IAGP N RGD:21408553|PMID:24709042 20200312 RGD 8655992 W-LeprfaNin strain MP:0003729 abnormal photoreceptor outer segment morphology treatment IAGP XCO:0000468 N RGD:8657053|PMID:23036575 20200313 RGD 8655992 W-LeprfaNin strain MP:0005559 increased circulating glucose level IAGP N RGD:8657053|PMID:23036575 20200313 RGD compared to W-Lepr+/+/Nin 8655992 W-LeprfaNin strain MP:0008515 thin retina outer nuclear layer IAGP N RGD:8655976|PMID:19369235 20190729 RGD 8655992 W-LeprfaNin strain MP:0008515 thin retina outer nuclear layer treatment IAGP XCO:0000468 N RGD:8657053|PMID:23036575 20200313 RGD 8655992 W-LeprfaNin strain MP:0008519 thin retina outer plexiform layer IAGP N RGD:8655976|PMID:19369235 20190729 RGD 8655992 W-LeprfaNin strain MP:0011234 abnormal retinol level IAGP N RGD:8657053|PMID:23036575 20200313 RGD compared to W-Lepr+/+/Nin 8657050 Bw146 Body weight QTL 146 qtl MP:0001260 increased body weight IDA N RGD:8657042|PMID:24204914 20140528 RGD 8657079 SS.LEW-(D18Chm124-D18Chm126)/Ayd strain MP:0002843 decreased systemic arterial blood pressure IAGP N RGD:8657072|PMID:21602714 20140530 RGD as compared to parental SS/Jr 8657135 SS.LEW-(D10Chm280-D10Chm216)/Ayd strain MP:0002625 heart left ventricle hypertrophy IAGP XCO:0000022 N RGD:8657131|PMID:23442991 20210113 RGD compared to Lewis 8657135 SS.LEW-(D10Chm280-D10Chm216)/Ayd strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:8657131|PMID:23442991 20210113 RGD compared to SS/JrHsd 8657348 SS.LEW-(D17Chm131-D17Chm93),MNS-(D2Rat155-D2Chm161),LEW-(D18Chm41-D18Rat92)/Ayd strain MP:0002625 heart left ventricle hypertrophy IAGP XCO:0000022 N RGD:8657131|PMID:23442991 20210113 RGD compared to Lewis 8657348 SS.LEW-(D17Chm131-D17Chm93),MNS-(D2Rat155-D2Chm161),LEW-(D18Chm41-D18Rat92)/Ayd strain MP:0003824 decreased left ventricle developed pressure IAGP N RGD:8657131|PMID:23442991 20140605 RGD 8657348 SS.LEW-(D17Chm131-D17Chm93),MNS-(D2Rat155-D2Chm161),LEW-(D18Chm41-D18Rat92)/Ayd strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:8657131|PMID:23442991 20140605 RGD 8657351 SS.MNS-(D2Chm366-D2Rat52),LEW-(D18Rat61-D18Rat45),LEW-(D10Chm128-D10Chm121)/Ayd strain MP:0002625 heart left ventricle hypertrophy IAGP XCO:0000022 N RGD:8657131|PMID:23442991 20210113 RGD compared to Lewis 8657351 SS.MNS-(D2Chm366-D2Rat52),LEW-(D18Rat61-D18Rat45),LEW-(D10Chm128-D10Chm121)/Ayd strain MP:0003824 decreased left ventricle developed pressure IAGP N RGD:8657131|PMID:23442991 20140606 RGD 8657351 SS.MNS-(D2Chm366-D2Rat52),LEW-(D18Rat61-D18Rat45),LEW-(D10Chm128-D10Chm121)/Ayd strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:8657131|PMID:23442991 20140606 RGD compared to SS/JrHsd 8657361 SS.MNS-(D2Chm254-D2Chm161),LEW-(D10Chm246-D10Chm257),LEW-(D16Chm48-D16Chm60),LEW-(D18Rat55-D18Mgh2)/Ayd strain MP:0002625 heart left ventricle hypertrophy IAGP XCO:0000022 N RGD:8657131|PMID:23442991 20210113 RGD compared to Lewis 8657361 SS.MNS-(D2Chm254-D2Chm161),LEW-(D10Chm246-D10Chm257),LEW-(D16Chm48-D16Chm60),LEW-(D18Rat55-D18Mgh2)/Ayd strain MP:0003824 decreased left ventricle developed pressure IAGP N RGD:8657131|PMID:23442991 20140606 RGD 8657361 SS.MNS-(D2Chm254-D2Chm161),LEW-(D10Chm246-D10Chm257),LEW-(D16Chm48-D16Chm60),LEW-(D18Rat55-D18Mgh2)/Ayd strain MP:0006264 decreased systemic arterial systolic blood pressure IAGP N RGD:8657131|PMID:23442991 20140606 RGD compared to SS/JrHsd 8657410 Bp374 Blood pressure QTL 374 qtl MP:0002625 heart left ventricle hypertrophy IDA N RGD:8657382|PMID:23773896 20151130 RGD 8662350 Eae35 Experimental allergic encephalomyelitis QTL 35 qtl MP:0006082 CNS inflammation IDA N RGD:8662331|PMID:20505148 20140620 RGD 8662454 Vetf3 Vascular elastic tissue fragility QTL 3 qtl MP:0009862 abnormal aorta elastic tissue morphology IDA N RGD:8662443|PMID:17356016 20140625 RGD 8662816 Vetf4 Vascular elastic tissue fragility QTL 4 qtl MP:0011317 abnormal renal artery morphology IDA N RGD:8662443|PMID:17356016 20140625 RGD 8662823 Vetf5 Vascular elastic tissue fragility QTL 5 qtl MP:0003139 patent ductus arteriosus IDA N RGD:8662443|PMID:17356016 20140625 RGD 8662828 Vetf6 Vascular elastic tissue fragility QTL 6 qtl MP:0003139 patent ductus arteriosus IDA N RGD:8662443|PMID:17356016 20140625 RGD 8662832 Vetf7 Vascular elastic tissue fragility QTL 7 qtl MP:0003905 abnormal aorta elastin content IDA N RGD:8662443|PMID:17356016 20140625 RGD 8662836 Vetf8 Vascular elastic tissue fragility QTL 8 qtl MP:0009862 abnormal aorta elastic tissue morphology IDA N RGD:8662443|PMID:17356016 20140625 RGD 8662843 Vetf9 Vascular elastic tissue fragility QTL 9 qtl MP:0009862 abnormal aorta elastic tissue morphology IDA N RGD:8662443|PMID:17356016 20140625 RGD 8662860 Vetf10 Vascular elastic tissue fragility QTL 10 qtl MP:0009862 abnormal aorta elastic tissue morphology IDA N RGD:8662443|PMID:17356016 20140625 RGD 8662861 LOU.BN-(D5Rat59-D5Rat133)/Bbb strain MP:0003279 aneurysm IAGP N RGD:8662443|PMID:17356016 20210112 RGD compared to LOU/MBbb and BN/Rj 8693608 Alc24 Alcohol consumption QTL 24 qtl MP:0003545 increased alcohol consumption IDA N RGD:8663441|PMID:24961585 20140718 RGD 8693618 Alc25 Alcohol consumption QTL 25 qtl MP:0003545 increased alcohol consumption IDA N RGD:8663441|PMID:24961585 20140718 RGD 8693622 Alc26 Alcohol consumption QTL 26 qtl MP:0003545 increased alcohol consumption IDA N RGD:8663441|PMID:24961585 20140718 RGD 8693632 Alc27 Alcohol consumption QTL 27 qtl MP:0003545 increased alcohol consumption IDA N RGD:8663441|PMID:24961585 20140718 RGD 8693635 Alc28 Alcohol consumption QTL 28 qtl MP:0003545 increased alcohol consumption IDA N RGD:8663441|PMID:24961585 20140718 RGD 8693637 Alc29 Alcohol consumption QTL 29 qtl MP:0003545 increased alcohol consumption IDA N RGD:8663441|PMID:24961585 20140718 RGD 8693641 Alc30 Alcohol consumption QTL 30 qtl MP:0003545 increased alcohol consumption IDA N RGD:8663441|PMID:24961585 20140718 RGD 8693645 Alc31 Alcohol consumption QTL 31 qtl MP:0003545 increased alcohol consumption IDA N RGD:8663441|PMID:24961585 20140718 RGD 8693654 Alc32 Alcohol consumption QTL 32 qtl MP:0003545 increased alcohol consumption IDA N RGD:8663441|PMID:24961585 20140718 RGD 8693658 Alc33 Alcohol consumption QTL 33 qtl MP:0003545 increased alcohol consumption IDA N RGD:8663441|PMID:24961585 20140718 RGD 8693661 Alc34 Alcohol consumption QTL 34 qtl MP:0003545 increased alcohol consumption IDA N RGD:8663441|PMID:24961585 20140718 RGD 8693690 Alc35 Alcohol consumption QTL 35 qtl MP:0003545 increased alcohol consumption IDA N RGD:8663441|PMID:24961585 20140718 RGD 8693697 Alc36 Alcohol consumption QTL 36 qtl MP:0003545 increased alcohol consumption IDA N RGD:8663441|PMID:24961585 20140718 RGD 8693699 Alc37 Alcohol consumption QTL 37 qtl MP:0003545 increased alcohol consumption IDA N RGD:8663441|PMID:24961585 20140718 RGD 8694166 Bw147 Body weight QTL 147 qtl MP:0001260 increased body weight IDA N RGD:8694157|PMID:25003539 20140728 RGD 8694169 Bw148 Body weight QTL 148 qtl MP:0001260 increased body weight IDA N RGD:8694157|PMID:25003539 20140728 RGD 8694173 Bw149 Body weight QTL 149 qtl MP:0001260 increased body weight IDA N RGD:8694157|PMID:25003539 20140728 RGD 8694179 Bw150 Body weight QTL 150 qtl MP:0001260 increased body weight IDA N RGD:8694157|PMID:25003539 20140728 RGD 8694181 Bw151 Body weight QTL 151 qtl MP:0001260 increased body weight IDA N RGD:8694157|PMID:25003539 20140728 RGD 8694186 Bw152 Body weight QTL 152 qtl MP:0001260 increased body weight IDA N RGD:8694157|PMID:25003539 20140728 RGD 8694189 Bw153 Body weight QTL 153 qtl MP:0001260 increased body weight IDA N RGD:8694157|PMID:25003539 20140728 RGD 8694194 Abfw1 Abdominal fat weight QTL 1 qtl MP:0001260 increased body weight IDA N RGD:8694157|PMID:25003539 20141125 RGD 8694196 Abfw2 Abdominal fat weight QTL 2 qtl MP:0001260 increased body weight IDA N RGD:8694157|PMID:25003539 20141125 RGD 8694198 Abfw3 Abdominal fat weight QTL 3 qtl MP:0001260 increased body weight IDA N RGD:8694157|PMID:25003539 20141125 RGD 8694200 Abfw4 Abdominal fat weight QTL 4 qtl MP:0001260 increased body weight IDA N RGD:8694157|PMID:25003539 20141125 RGD 8694359 Abfw5 Abdominal fat weight QTL 5 qtl MP:0001260 increased body weight IDA N RGD:8694157|PMID:25003539 20141125 RGD 8694361 Abfw6 Abdominal fat weight QTL 6 qtl MP:0001260 increased body weight IDA N RGD:8694157|PMID:25003539 20141125 RGD 8694364 Abfw7 Abdominal fat weight QTL 7 qtl MP:0001260 increased body weight IDA N RGD:8694157|PMID:25003539 20141125 RGD 8694366 Abfw8 Abdominal fat weight QTL 8 qtl MP:0001260 increased body weight IDA N RGD:8694157|PMID:25003539 20141125 RGD 8694370 Bw154 Body weight QTL 154 qtl MP:0001260 increased body weight IDA N RGD:8694157|PMID:25003539 20141124 RGD 8694374 Bw155 Body weight QTL 155 qtl MP:0001260 increased body weight IDA N RGD:8694157|PMID:25003539 20141124 RGD 8694376 Bw156 Body weight QTL 156 qtl MP:0001260 increased body weight IDA N RGD:8694157|PMID:25003539 20141124 RGD 8694378 Bw157 Body weight QTL 157 qtl MP:0001260 increased body weight IDA N RGD:8694157|PMID:25003539 20141124 RGD 8694383 Bw158 Body weight QTL 158 qtl MP:0001260 increased body weight IDA N RGD:8694157|PMID:25003539 20141124 RGD 8694386 Bw159 Body weight QTL 159 qtl MP:0001260 increased body weight IDA N RGD:8694157|PMID:25003539 20141124 RGD 8694389 Bw160 Body weight QTL 160 qtl MP:0001260 increased body weight IDA N RGD:8694157|PMID:25003539 20141124 RGD 8694392 Bw161 Body weight QTL 161 qtl MP:0001260 increased body weight IDA N RGD:8694157|PMID:25003539 20141124 RGD 8694424 Bw162 Body weight QTL 162 qtl MP:0001260 increased body weight IDA N RGD:8694157|PMID:25003539 20141124 RGD 8694427 Bw163 Body weight QTL 163 qtl MP:0001260 increased body weight IDA N RGD:8694157|PMID:25003539 20141124 RGD 8694429 Bw164 Body weight QTL 164 qtl MP:0001260 increased body weight IDA N RGD:8694157|PMID:25003539 20141124 RGD 8694432 Bw165 Body weight QTL 165 qtl MP:0001260 increased body weight IDA N RGD:8694157|PMID:25003539 20141124 RGD 8694435 Bw166 Body weight QTL 166 qtl MP:0001260 increased body weight IDA N RGD:8694157|PMID:25003539 20141124 RGD 8694437 Bw167 Body weight QTL 167 qtl MP:0001260 increased body weight IDA N RGD:8694157|PMID:25003539 20141124 RGD 8694439 Bw168 Body weight QTL 168 qtl MP:0001260 increased body weight IDA N RGD:8694157|PMID:25003539 20141124 RGD 8694441 Bw169 Body weight QTL 169 qtl MP:0001260 increased body weight IDA N RGD:8694157|PMID:25003539 20141124 RGD 8694446 Bw170 Body weight QTL 170 qtl MP:0001260 increased body weight IDA N RGD:8694157|PMID:25003539 20141124 RGD 8694450 Bw171 Body weight QTL 171 qtl MP:0001260 increased body weight IDA N RGD:8694157|PMID:25003539 20141124 RGD 8694453 Bw172 Body weight QTL 172 qtl MP:0001260 increased body weight IDA N RGD:8694157|PMID:25003539 20141124 RGD 9587428 Epfw6 Epididymal fat weight QTL 6 qtl MP:0001260 increased body weight IDA N RGD:8694157|PMID:25003539 20141125 RGD 9588537 Ndufc2em1Mcwi NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 2; zinc finger nuclease induced mutant 1, Medical College of Wisconsin gene MP:0001728 failure of embryo implantation IMP N RGD:11040458|PMID:26888427 20160816 RGD DNA:deletion:exon 1:no homozygous knockout embryos found at implantation stage 9588541 Ndufc2em2Mcwi NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 2; zinc finger nuclease induced mutant 2, Medical College of Wisconsin gene MP:0001728 failure of embryo implantation IMP N RGD:11040458|PMID:26888427 20160816 RGD DNA:deletion:exon 1:no homozygous knockout embryos found at implantation stage 9588541 Ndufc2em2Mcwi NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 2; zinc finger nuclease induced mutant 2, Medical College of Wisconsin gene MP:0002962 increased urine protein level IMP N RGD:11040458|PMID:26888427 20160816 RGD 9588544 SHR-Ndufc2em1Mcwi strain MP:0001728 failure of embryo implantation IMP N RGD:11040458|PMID:26888427 20160816 RGD no homozygous knockout embryos found at implantation stage 9588546 SHR-Ndufc2em2Mcwi strain MP:0001728 failure of embryo implantation IMP N RGD:11040458|PMID:26888427 20160816 RGD no homozygous knockout embryos found at implantation stage 9588549 Nfe2l2em1Mcwi nuclear factor, erythroid 2-like 2; TALEN induced mutant 1, Medical College of Wisconsin gene MP:0001613 abnormal vasodilation IMP N RGD:11344212|PMID:26637559 20170913 RGD 9588549 Nfe2l2em1Mcwi nuclear factor, erythroid 2-like 2; TALEN induced mutant 1, Medical College of Wisconsin gene MP:0005591 decreased vasodilation IMP XCO:0000143, XCO:0000191, XCO:0000795 N RGD:11344212|PMID:26637559 20210610 RGD compared to SD 9589025 Epfw7 Epididymal fat weight QTL 7 qtl MP:0001260 increased body weight IDA N RGD:8694157|PMID:25003539 20141125 RGD 9589028 Epfw8 Epididymal fat weight QTL 8 qtl MP:0001260 increased body weight IDA N RGD:8694157|PMID:25003539 20141125 RGD 9589030 Epfw9 Epididymal fat weight QTL 9 qtl MP:0001260 increased body weight IDA N RGD:8694157|PMID:25003539 20141125 RGD 9589032 Epfw10 Epididymal fat weight QTL 10 qtl MP:0001260 increased body weight IDA N RGD:8694157|PMID:25003539 20141125 RGD 9589034 Epfw11 Epididymal fat weight QTL 11 qtl MP:0001260 increased body weight IDA N RGD:8694157|PMID:25003539 20141125 RGD 9589041 Epfw12 Epididymal fat weight QTL 12 qtl MP:0001260 increased body weight IDA N RGD:8694157|PMID:25003539 20141125 RGD 9589044 Scfw1 Subcutaneous fat weight QTL 1 qtl MP:0001260 increased body weight IDA N RGD:8694157|PMID:25003539 20141125 RGD 9589046 Scfw2 Subcutaneous fat weight QTL 2 qtl MP:0001260 increased body weight IDA N RGD:8694157|PMID:25003539 20141125 RGD 9589048 Scfw3 Subcutaneous fat weight QTL 3 qtl MP:0001260 increased body weight IDA N RGD:8694157|PMID:25003539 20141125 RGD 9589051 Scfw4 Subcutaneous fat weight QTL 4 qtl MP:0001260 increased body weight IDA N RGD:8694157|PMID:25003539 20141125 RGD 9589055 Scfw5 Subcutaneous fat weight QTL 5 qtl MP:0001260 increased body weight IDA N RGD:8694157|PMID:25003539 20141125 RGD 9589057 Scfw6 Subcutaneous fat weight QTL 6 qtl MP:0001260 increased body weight IDA N RGD:8694157|PMID:25003539 20141125 RGD 9589093 Slep10 Serum leptin concentration QTL 10 qtl MP:0005669 increased circulating leptin level IDA N RGD:8694157|PMID:25003539 20141125 RGD 9589097 Slep11 Serum leptin concentration QTL 11 qtl MP:0005669 increased circulating leptin level IDA N RGD:8694157|PMID:25003539 20141125 RGD 9589100 Slep12 Serum leptin concentration QTL 12 qtl MP:0005669 increased circulating leptin level IDA N RGD:8694157|PMID:25003539 20141125 RGD 9589102 Slep13 Serum leptin concentration QTL 13 qtl MP:0005669 increased circulating leptin level IDA N RGD:8694157|PMID:25003539 20141125 RGD 9589106 Insul23 Insulin level QTL 23 qtl MP:0002079 increased circulating insulin level IDA N RGD:8694157|PMID:25003539 20141125 RGD 9589129 Insul24 Insulin level QTL 24 qtl MP:0002079 increased circulating insulin level IDA N RGD:8694157|PMID:25003539 20141125 RGD 9589131 Insul25 Insulin level QTL 25 qtl MP:0002079 increased circulating insulin level IDA N RGD:8694157|PMID:25003539 20141125 RGD 9589133 Insul26 Insulin level QTL 26 qtl MP:0002079 increased circulating insulin level IDA N RGD:8694157|PMID:25003539 20141125 RGD 9589136 Insul27 Insulin level QTL 27 qtl MP:0002079 increased circulating insulin level IDA N RGD:8694157|PMID:25003539 20141125 RGD 9589141 Insul28 Insulin level QTL 28 qtl MP:0002079 increased circulating insulin level IDA N RGD:8694157|PMID:25003539 20141125 RGD 9589149 Insul29 Insulin level QTL 29 qtl MP:0002079 increased circulating insulin level IDA N RGD:8694157|PMID:25003539 20141125 RGD 9589151 Insul30 Insulin level QTL 30 qtl MP:0002079 increased circulating insulin level IDA N RGD:8694157|PMID:25003539 20141211 RGD 9589153 Insul31 Insulin level QTL 31 qtl MP:0002079 increased circulating insulin level IDA N RGD:8694157|PMID:25003539 20141211 RGD 9589155 Insul32 Insulin level QTL 32 qtl MP:0002079 increased circulating insulin level IDA N RGD:8694157|PMID:25003539 20141211 RGD 9589158 Gluco65 Glucose level QTL 65 qtl MP:0005559 increased circulating glucose level IDA N RGD:8694157|PMID:25003539 20141125 RGD 9589164 Gluco66 Glucose level QTL 66 qtl MP:0005559 increased circulating glucose level IDA N RGD:8694157|PMID:25003539 20141125 RGD 9589814 Gluco67 Glucose level QTL 67 qtl MP:0005559 increased circulating glucose level IDA N RGD:8694157|PMID:25003539 20141125 RGD 9589816 Gluco68 Glucose level QTL 68 qtl MP:0005559 increased circulating glucose level IDA N RGD:8694157|PMID:25003539 20141125 RGD 9589820 Insglur3 Insulin/glucose ratio QTL 3 qtl MP:0005331 insulin resistance IDA N RGD:8694157|PMID:25003539 20141125 RGD 9590080 Insglur4 Insulin/glucose ratio QTL 4 qtl MP:0005331 insulin resistance IAGP N RGD:8694157|PMID:25003539 20141125 RGD 9590084 Insglur5 Insulin/glucose ratio QTL 5 qtl MP:0005331 insulin resistance IDA N RGD:8694157|PMID:25003539 20141125 RGD 9590086 Insglur6 Insulin/glucose ratio QTL 6 qtl MP:0005331 insulin resistance IDA N RGD:8694157|PMID:25003539 20141125 RGD 9590088 Insglur7 Insulin/glucose ratio QTL 7 qtl MP:0005331 insulin resistance IDA N RGD:8694157|PMID:25003539 20141125 RGD 9590090 Insglur8 Insulin/glucose ratio QTL 8 qtl MP:0005331 insulin resistance IDA N RGD:8694157|PMID:25003539 20141125 RGD 9590092 Insglur9 Insulin/glucose ratio QTL 9 qtl MP:0005331 insulin resistance IDA N RGD:8694157|PMID:25003539 20141125 RGD 9590095 Sffal3 Serum free fatty acids level QTL 3 qtl MP:0001554 increased circulating free fatty acids level IDA N RGD:8694157|PMID:25003539 20141211 RGD 9590100 Sffal4 Serum free fatty acids level QTL 4 qtl MP:0001554 increased circulating free fatty acids level IDA N RGD:8694157|PMID:25003539 20141211 RGD 9590102 Sffal5 Serum free fatty acids level QTL 5 qtl MP:0001554 increased circulating free fatty acids level IDA N RGD:8694157|PMID:25003539 20141211 RGD 9590104 Sffal6 Serum free fatty acids level QTL 6 qtl MP:0001554 increased circulating free fatty acids level IDA N RGD:8694157|PMID:25003539 20141211 RGD 9590107 Sffal7 Serum free fatty acids level QTL 7 qtl MP:0001554 increased circulating free fatty acids level IDA N RGD:8694157|PMID:25003539 20141211 RGD 9590109 Sffal8 Serum free fatty acids level QTL 8 qtl MP:0001554 increased circulating free fatty acids level IDA N RGD:8694157|PMID:25003539 20141211 RGD 9590136 Scort3 Serum corticosterone level QTL 3 qtl MP:0001745 increased circulating corticosterone level IDA N RGD:8694157|PMID:25003539 20141211 RGD 9590140 Scort4 Serum corticosterone level QTL 4 qtl MP:0001745 increased circulating corticosterone level IDA N RGD:8694157|PMID:25003539 20141211 RGD 9590142 Scort5 Serum corticosterone level QTL 5 qtl MP:0001745 increased circulating corticosterone level IDA N RGD:8694157|PMID:25003539 20141211 RGD 9590144 Scort6 Serum corticosterone level QTL 6 qtl MP:0001745 increased circulating corticosterone level IDA N RGD:8694157|PMID:25003539 20141211 RGD 9590147 Scort7 Serum corticosterone level QTL 7 qtl MP:0001745 increased circulating corticosterone level IDA N RGD:8694157|PMID:25003539 20141211 RGD 9590151 Scort8 Serum corticosterone level QTL 8 qtl MP:0001745 increased circulating corticosterone level IDA N RGD:8694157|PMID:25003539 20141211 RGD 9590154 Scort9 Serum corticosterone level QTL 9 qtl MP:0001745 increased circulating corticosterone level IDA N RGD:8694157|PMID:25003539 20141211 RGD 9590248 Scort10 Serum corticosterone level QTL 10 qtl MP:0001745 increased circulating corticosterone level IDA N RGD:8694157|PMID:25003539 20141211 RGD 9590250 Scort11 Serum corticosterone level QTL 11 qtl MP:0001745 increased circulating corticosterone level IDA N RGD:8694157|PMID:25003539 20141211 RGD 9590252 Scort12 Serum corticosterone level QTL 12 qtl MP:0001745 increased circulating corticosterone level IDA N RGD:8694157|PMID:25003539 20141211 RGD 9590268 Scort13 Serum corticosterone level QTL 13 qtl MP:0001745 increased circulating corticosterone level IDA N RGD:8694157|PMID:25003539 20141211 RGD 9590272 Scort14 Serum corticosterone level QTL 14 qtl MP:0001745 increased circulating corticosterone level IDA N RGD:8694157|PMID:25003539 20141211 RGD 9590275 Scort15 Serum corticosterone level QTL 15 qtl MP:0001745 increased circulating corticosterone level IDA N RGD:8694157|PMID:25003539 20141211 RGD 9590284 SS-Tg(ApoC3-CETP)25Opaz strain MP:0001552 increased circulating triglyceride level IAGP N RGD:2290427|PMID:10581080 20200320 RGD compared to SS/JrHsd 9590284 SS-Tg(ApoC3-CETP)25Opaz strain MP:0005178 increased circulating cholesterol level IAGP N RGD:2290427|PMID:10581080 20200320 RGD compared to SS/JrHsd 9590286 Uminl1 Urine mineral level QTL 1 qtl MP:0009643 abnormal urine homeostasis IDA N RGD:8694157|PMID:25003539 20141216 RGD 9590290 Uminl2 Urine mineral level QTL 2 qtl MP:0009643 abnormal urine homeostasis IDA N RGD:8694157|PMID:25003539 20141216 RGD 9590292 Uminl3 Urine mineral level QTL 3 qtl MP:0009643 abnormal urine homeostasis IDA N RGD:8694157|PMID:25003539 20141216 RGD 9590294 Uminl4 Urine mineral level QTL 4 qtl MP:0009643 abnormal urine homeostasis IDA N RGD:8694157|PMID:25003539 20141216 RGD 9590298 Uminl5 Urine mineral level QTL 5 qtl MP:0009643 abnormal urine homeostasis IDA N RGD:8694157|PMID:25003539 20141216 RGD 9590300 Scort16 Serum corticosterone level QTL 16 qtl MP:0001745 increased circulating corticosterone level IDA N RGD:8694157|PMID:25003539 20141211 RGD 9590304 Scort17 Serum corticosterone level QTL 17 qtl MP:0001745 increased circulating corticosterone level IDA N RGD:8694157|PMID:25003539 20141211 RGD 9590306 Scort18 Serum corticosterone level QTL 18 qtl MP:0001745 increased circulating corticosterone level IDA N RGD:8694157|PMID:25003539 20141211 RGD 9590310 Scort19 Serum corticosterone level QTL 19 qtl MP:0001745 increased circulating corticosterone level IDA N RGD:8694157|PMID:25003539 20141211 RGD 9590313 Scort20 Serum corticosterone level QTL 20 qtl MP:0001745 increased circulating corticosterone level IDA N RGD:8694157|PMID:25003539 20141211 RGD 9590316 Scort21 Serum corticosterone level QTL 21 qtl MP:0001745 increased circulating corticosterone level IDA N RGD:8694157|PMID:25003539 20141211 RGD 9590318 Scort22 Serum corticosterone level QTL 22 qtl MP:0001745 increased circulating corticosterone level IDA N RGD:8694157|PMID:25003539 20141211 RGD 9685065 Swd6 Spike wave discharge measurement QTL 6 qtl MP:0001499 abnormal kindling response IDA N RGD:7794751|PMID:23903052 20141216 RGD 9685068 Swd7 Spike wave discharge measurement QTL 7 qtl MP:0001499 abnormal kindling response IDA N RGD:7794751|PMID:23903052 20141216 RGD 9685623 SD-Pax6Sey2/Mce strain MP:0001070 abnormal abducens nerve morphology IAGP N RGD:731242|PMID:9247338 20170223 RGD 9685623 SD-Pax6Sey2/Mce strain MP:0001076 abnormal hypoglossal nerve morphology IAGP N RGD:731242|PMID:9247338 20170223 RGD 9685623 SD-Pax6Sey2/Mce strain MP:0002557 abnormal social/conspecific interaction behavior IAGP N RGD:8552339|PMID:21203536 20210409 RGD compared to SD 9685623 SD-Pax6Sey2/Mce strain MP:0002757 decreased vertical activity IAGP N RGD:8552339|PMID:21203536 20170223 RGD compared to SD 9685623 SD-Pax6Sey2/Mce strain MP:0003460 decreased fear-related response IAGP N RGD:8552339|PMID:21203536 20210409 RGD compared to SD 9685623 SD-Pax6Sey2/Mce strain MP:0006369 supernumerary incisors IAGP N RGD:12790971|PMID:16795023 20170223 RGD 9685623 SD-Pax6Sey2/Mce strain MP:0010070 decreased serotonin level IAGP N RGD:8552339|PMID:21203536 20170223 RGD compared to SD 9685623 SD-Pax6Sey2/Mce strain MP:0011275 abnormal behavioral response to light IAGP N RGD:8552339|PMID:21203536 20210409 RGD compared to SD 9685623 SD-Pax6Sey2/Mce strain MP:0020351 decreased vocalization IAGP N RGD:8552339|PMID:21203536 20210409 RGD compared to SD 9685791 SS.LEW-(D1Mco36-D1Mco61)/Bj strain MP:0004217 salt-sensitive hypertension induced IAGP XCO:0000022 N RGD:9685377|PMID:25231251 20150306 RGD compared to SS/Jr 9685793 SS.LEW-(D1Rat200-D1Mco136)/Bj strain MP:0004875 increased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:9685377|PMID:25231251 20150306 RGD compared to SS/Jr 9685793 SS.LEW-(D1Rat200-D1Mco136)/Bj strain MP:0006143 increased systemic arterial diastolic blood pressure induced IAGP XCO:0000022 N RGD:9685377|PMID:25231251 20150306 RGD compared to SS/Jr 9685793 SS.LEW-(D1Rat200-D1Mco136)/Bj strain MP:0006144 increased systemic arterial systolic blood pressure induced IAGP XCO:0000022 N RGD:9685377|PMID:25231251 20150306 RGD compared to SS/Jr 9685793 SS.LEW-(D1Rat200-D1Mco136)/Bj strain MP:0006265 increased pulse pressure induced IAGP XCO:0000022 N RGD:9685377|PMID:25231251 20150306 RGD compared to SS/Jr 9685795 SS.LEW-(D1Mco55-D1Wox6)/Bj strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:9685377|PMID:25231251 20150306 RGD compared to SS/Jr 9685795 SS.LEW-(D1Mco55-D1Wox6)/Bj strain MP:0006263 decreased systemic arterial diastolic blood pressure induced IAGP XCO:0000022 N RGD:9685377|PMID:25231251 20150306 RGD compared to SS/Jr 9685795 SS.LEW-(D1Mco55-D1Wox6)/Bj strain MP:0006264 decreased systemic arterial systolic blood pressure induced IAGP XCO:0000022 N RGD:9685377|PMID:25231251 20150306 RGD compared to SS/Jr 9685795 SS.LEW-(D1Mco55-D1Wox6)/Bj strain MP:0006266 decreased pulse pressure induced IAGP XCO:0000022 N RGD:9685377|PMID:25231251 20150306 RGD compared to parental SS/Jr 9685797 SS.LEW-(D1Mco134-D1Wox6)/Bj strain MP:0004876 decreased mean systemic arterial blood pressure induced IAGP XCO:0000022 N RGD:9685377|PMID:25231251 20150306 RGD compared to SS/Jr 9685797 SS.LEW-(D1Mco134-D1Wox6)/Bj strain MP:0006263 decreased systemic arterial diastolic blood pressure induced IAGP XCO:0000022 N RGD:9685377|PMID:25231251 20150306 RGD compared to SS/Jr 9685797 SS.LEW-(D1Mco134-D1Wox6)/Bj strain MP:0006264 decreased systemic arterial systolic blood pressure induced IAGP XCO:0000022 N RGD:9685377|PMID:25231251 20150306 RGD compared to SS/Jr 9685797 SS.LEW-(D1Mco134-D1Wox6)/Bj strain MP:0006266 decreased pulse pressure induced IAGP XCO:0000022 N RGD:9685377|PMID:25231251 20150306 RGD compared to SS/Jr 9685799 Bp375 Blood pressure QTL 375 qtl MP:0006144 increased systemic arterial systolic blood pressure IDA N RGD:9685377|PMID:25231251 20150306 RGD as compared to parental SS 9685802 Bp376 Blood pressure QTL 376 qtl MP:0006264 decreased systemic arterial systolic blood pressure IDA N RGD:9685377|PMID:25231251 20150306 RGD as compared to parental SS 9831158 Y59/Zgd strain MP:0000063 decreased bone mineral density induced IAGP XCO:0000469 N RGD:9831160|PMID:24271527 20150227 RGD 9831158 Y59/Zgd strain MP:0020879 abnormal calcium level induced IAGP XCO:0000469 N RGD:629460|PMID:10391208 20201005 RGD decreased in femur 9831158 Y59/Zgd strain MP:0020885 abnormal phosphate level induced IAGP XCO:0000469 N RGD:629460|PMID:10391208 20201005 RGD decreased in femur